Ligand source activities (1 row/activity)





Ligands Receptor Assay information Chemical information
Sel. page Common
name
GPCRdb ID #Vendors Reference
ligand
Fold selectivity
(Potency)
# tested GPCRs
(Potency)
Species p-value
(-log)
Type Activity
Relation
Activity
Value
Assay Type Assay Description Source Mol
weight
Rot
Bonds
H don H acc LogP Smiles DOI
3658 4076 53 None 1 18 Human 9.5 pAC50 = 9.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1038/s41467-023-40064-9
517 4076 53 None 1 18 Human 9.5 pAC50 = 9.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1038/s41467-023-40064-9
5709 4076 53 None 1 18 Human 9.5 pAC50 = 9.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1038/s41467-023-40064-9
CHEMBL312448 4076 53 None 1 18 Human 9.5 pAC50 = 9.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1038/s41467-023-40064-9
DB06694 4076 53 None 1 18 Human 9.5 pAC50 = 9.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1038/s41467-023-40064-9
11079 2714 63 None 5 7 Human 9.2 pAC50 = 9.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1038/s41467-023-40064-9
3369 2714 63 None 5 7 Human 9.2 pAC50 = 9.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1038/s41467-023-40064-9
4436 2714 63 None 5 7 Human 9.2 pAC50 = 9.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1038/s41467-023-40064-9
5509 2714 63 None 5 7 Human 9.2 pAC50 = 9.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL761 2714 63 None 5 7 Human 9.2 pAC50 = 9.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1038/s41467-023-40064-9
DB06711 2714 63 None 5 7 Human 9.2 pAC50 = 9.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1038/s41467-023-40064-9
2142 3074 58 None -1 18 Human 9.1 pAC50 = 9.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
4920903 3074 58 None -1 18 Human 9.1 pAC50 = 9.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
502 3074 58 None -1 18 Human 9.1 pAC50 = 9.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
5775 3074 58 None -1 18 Human 9.1 pAC50 = 9.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
CHEMBL597 3074 58 None -1 18 Human 9.1 pAC50 = 9.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
DB00692 3074 58 None -1 18 Human 9.1 pAC50 = 9.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
1960 2838 67 None -2 19 Human 8.9 pAC50 = 8.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
439260 2838 67 None -2 19 Human 8.9 pAC50 = 8.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
505 2838 67 None -2 19 Human 8.9 pAC50 = 8.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
CHEMBL1437 2838 67 None -2 19 Human 8.9 pAC50 = 8.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
DB00368 2838 67 None -2 19 Human 8.9 pAC50 = 8.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
11079 2714 63 None 5 7 Human 8.9 pAC50 = 8.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1038/s41467-023-40064-9
3369 2714 63 None 5 7 Human 8.9 pAC50 = 8.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1038/s41467-023-40064-9
4436 2714 63 None 5 7 Human 8.9 pAC50 = 8.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1038/s41467-023-40064-9
5509 2714 63 None 5 7 Human 8.9 pAC50 = 8.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL761 2714 63 None 5 7 Human 8.9 pAC50 = 8.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1038/s41467-023-40064-9
DB06711 2714 63 None 5 7 Human 8.9 pAC50 = 8.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1038/s41467-023-40064-9
46780481 107504 20 None -7 15 Human 8.9 pAC50 = 8.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 10.1038/s41467-023-40064-9
9903970 107504 20 None -7 15 Human 8.9 pAC50 = 8.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 10.1038/s41467-023-40064-9
CHEMBL3187365 107504 20 None -7 15 Human 8.9 pAC50 = 8.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 10.1038/s41467-023-40064-9
CHEMBL3544974 107504 20 None -7 15 Human 8.9 pAC50 = 8.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 10.1038/s41467-023-40064-9
2803 952 58 None -3 14 Human 8.8 pAC50 = 8.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1038/s41467-023-40064-9
516 952 58 None -3 14 Human 8.8 pAC50 = 8.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1038/s41467-023-40064-9
704 952 58 None -3 14 Human 8.8 pAC50 = 8.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1038/s41467-023-40064-9
CHEMBL134 952 58 None -3 14 Human 8.8 pAC50 = 8.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1038/s41467-023-40064-9
DB00575 952 58 None -3 14 Human 8.8 pAC50 = 8.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1038/s41467-023-40064-9
1960 2838 67 None -2 19 Human 8.8 pAC50 = 8.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
439260 2838 67 None -2 19 Human 8.8 pAC50 = 8.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
505 2838 67 None -2 19 Human 8.8 pAC50 = 8.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
CHEMBL1437 2838 67 None -2 19 Human 8.8 pAC50 = 8.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
DB00368 2838 67 None -2 19 Human 8.8 pAC50 = 8.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
129211 3722 78 None -1 14 Human 8.8 pAC50 = 8.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1038/s41467-023-40064-9
2562 3722 78 None -1 14 Human 8.8 pAC50 = 8.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1038/s41467-023-40064-9
488 3722 78 None -1 14 Human 8.8 pAC50 = 8.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1038/s41467-023-40064-9
CHEMBL836 3722 78 None -1 14 Human 8.8 pAC50 = 8.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1038/s41467-023-40064-9
DB00706 3722 78 None -1 14 Human 8.8 pAC50 = 8.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1038/s41467-023-40064-9
124 2960 47 None -8 25 Human 8.7 pAC50 = 8.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1038/s41467-023-40064-9
2032 2960 47 None -8 25 Human 8.7 pAC50 = 8.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1038/s41467-023-40064-9
4636 2960 47 None -8 25 Human 8.7 pAC50 = 8.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1038/s41467-023-40064-9
CHEMBL762 2960 47 None -8 25 Human 8.7 pAC50 = 8.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1038/s41467-023-40064-9
DB00935 2960 47 None -8 25 Human 8.7 pAC50 = 8.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1038/s41467-023-40064-9
16351 102703 47 None -17 17 Human 8.0 pAC50 = 8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 343 0 0 4 4.1 CN1CCN(C2=Nc3ccccc3Sc3ccc(Cl)cc32)CC1 10.1038/s41467-023-40064-9
CHEMBL304902 102703 47 None -17 17 Human 8.0 pAC50 = 8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 343 0 0 4 4.1 CN1CCN(C2=Nc3ccccc3Sc3ccc(Cl)cc32)CC1 10.1038/s41467-023-40064-9
9429 202110 58 None -5 18 Human 6.0 pAC50 = 6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 446 6 0 6 3.2 CN1CCN(CCCN2c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1 10.1038/s41467-023-40064-9
CHEMBL609109 202110 58 None -5 18 Human 6.0 pAC50 = 6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 446 6 0 6 3.2 CN1CCN(CCCN2c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1 10.1038/s41467-023-40064-9
3599 16847 88 None 1 3 Human 5.0 pAC50 = 5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 407 20 0 4 5.7 CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C 10.1038/s41467-023-40064-9
CHEMBL125 16847 88 None 1 3 Human 5.0 pAC50 = 5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 407 20 0 4 5.7 CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C 10.1038/s41467-023-40064-9
3062316 33545 121 None -1 10 Human 5.0 pAC50 = 5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 487 7 3 9 3.3 Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1 10.1038/s41467-023-40064-9
CHEMBL1421 33545 121 None -1 10 Human 5.0 pAC50 = 5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 487 7 3 9 3.3 Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1 10.1038/s41467-023-40064-9
54676537 152830 72 None - 1 Human 5.0 pAC50 = 5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 353 5 1 6 3.5 CC(=O)CC(c1ccc([N+](=O)[O-])cc1)c1c(O)c2ccccc2oc1=O 10.1038/s41467-023-40064-9
CHEMBL397420 152830 72 None - 1 Human 5.0 pAC50 = 5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 353 5 1 6 3.5 CC(=O)CC(c1ccc([N+](=O)[O-])cc1)c1c(O)c2ccccc2oc1=O 10.1038/s41467-023-40064-9
2162 41484 100 None -5 22 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl 10.1038/s41467-023-40064-9
CHEMBL1491 41484 100 None -5 22 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl 10.1038/s41467-023-40064-9
3783 13973 23 None -27 6 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 301 7 3 4 2.9 CC(COc1ccccc1)NC(C)C(O)c1ccc(O)cc1 10.1038/s41467-023-40064-9
CHEMBL1197051 13973 23 None -27 6 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 301 7 3 4 2.9 CC(COc1ccccc1)NC(C)C(O)c1ccc(O)cc1 10.1038/s41467-023-40064-9
6989215 1473 80 None - 1 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 213 3 5 5 -0.5 OC(=O)[C@H]([C@@H](c1ccc(c(c1)O)O)O)N 10.1038/s41467-023-40064-9
7391 1473 80 None - 1 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 213 3 5 5 -0.5 OC(=O)[C@H]([C@@H](c1ccc(c(c1)O)O)O)N 10.1038/s41467-023-40064-9
92974 1473 80 None - 1 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 213 3 5 5 -0.5 OC(=O)[C@H]([C@@H](c1ccc(c(c1)O)O)O)N 10.1038/s41467-023-40064-9
971 1473 80 None - 1 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 213 3 5 5 -0.5 OC(=O)[C@H]([C@@H](c1ccc(c(c1)O)O)O)N 10.1038/s41467-023-40064-9
CHEMBL2103827 1473 80 None - 1 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 213 3 5 5 -0.5 OC(=O)[C@H]([C@@H](c1ccc(c(c1)O)O)O)N 10.1038/s41467-023-40064-9
DB06262 1473 80 None - 1 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 213 3 5 5 -0.5 OC(=O)[C@H]([C@@H](c1ccc(c(c1)O)O)O)N 10.1038/s41467-023-40064-9
242 469 124 None -120 33 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
34 469 124 None -120 33 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
60795 469 124 None -120 33 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
CHEMBL1112 469 124 None -120 33 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
DB01238 469 124 None -120 33 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
2683 102861 25 None -812 24 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 304 15 0 0 6.5 CCCCCCCCCCCCCCCC[n+]1ccccc1 10.1038/s41467-023-40064-9
CHEMBL305906 102861 25 None -812 24 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 304 15 0 0 6.5 CCCCCCCCCCCCCCCC[n+]1ccccc1 10.1038/s41467-023-40064-9
CHEMBL334255 102861 25 None -812 24 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 304 15 0 0 6.5 CCCCCCCCCCCCCCCC[n+]1ccccc1 10.1038/s41467-023-40064-9
31101 726 40 None -199 29 Human 6.0 pAC50 = 6.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
35 726 40 None -199 29 Human 6.0 pAC50 = 6.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
403 726 40 None -199 29 Human 6.0 pAC50 = 6.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
CHEMBL493 726 40 None -199 29 Human 6.0 pAC50 = 6.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
DB01200 726 40 None -199 29 Human 6.0 pAC50 = 6.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
9417 133487 54 None -33 15 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 363 6 1 4 3.3 OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1 10.1038/s41467-023-40064-9
CHEMBL1524185 133487 54 None -33 15 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 363 6 1 4 3.3 OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1 10.1038/s41467-023-40064-9
CHEMBL370753 133487 54 None -33 15 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 363 6 1 4 3.3 OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1 10.1038/s41467-023-40064-9
22530 56100 58 None -3 9 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 276 2 0 2 3.7 CN1CCc2c(c3ccccc3n2Cc2ccccc2)C1 10.1038/s41467-023-40064-9
CHEMBL1600878 56100 58 None -3 9 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 276 2 0 2 3.7 CN1CCc2c(c3ccccc3n2Cc2ccccc2)C1 10.1038/s41467-023-40064-9
CHEMBL1625607 56100 58 None -3 9 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 276 2 0 2 3.7 CN1CCc2c(c3ccccc3n2Cc2ccccc2)C1 10.1038/s41467-023-40064-9
60860 205616 30 None -21 6 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 275 2 3 1 1.3 N=C(N)NCc1cccc(I)c1 10.1038/s41467-023-40064-9
CHEMBL1615777 205616 30 None -21 6 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 275 2 3 1 1.3 N=C(N)NCc1cccc(I)c1 10.1038/s41467-023-40064-9
CHEMBL818 205616 30 None -21 6 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 275 2 3 1 1.3 N=C(N)NCc1cccc(I)c1 10.1038/s41467-023-40064-9
5354 155632 21 None -51 10 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 337 12 2 3 5.6 CCCCCCCCNC(C)C(O)c1ccc(SC(C)C)cc1 10.1038/s41467-023-40064-9
CHEMBL404849 155632 21 None -51 10 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 337 12 2 3 5.6 CCCCCCCCNC(C)C(O)c1ccc(SC(C)C)cc1 10.1038/s41467-023-40064-9
2441 98597 24 None - 1 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 315 1 1 3 2.6 O=C1CN=C(c2ccccn2)c2cc(Br)ccc2N1 10.1038/s41467-023-40064-9
CHEMBL277062 98597 24 None - 1 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 315 1 1 3 2.6 O=C1CN=C(c2ccccn2)c2cc(Br)ccc2N1 10.1038/s41467-023-40064-9
104850 3305 96 None -1071 28 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 462 4 1 4 5.9 Clc1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1 10.1038/s41467-023-40064-9
4150 3305 96 None -1071 28 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 462 4 1 4 5.9 Clc1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1 10.1038/s41467-023-40064-9
743 3305 96 None -1071 28 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 462 4 1 4 5.9 Clc1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1 10.1038/s41467-023-40064-9
CHEMBL111 3305 96 None -1071 28 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 462 4 1 4 5.9 Clc1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1 10.1038/s41467-023-40064-9
DB06155 3305 96 None -1071 28 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 462 4 1 4 5.9 Clc1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1 10.1038/s41467-023-40064-9
1056 3346 116 None -19 10 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 357 7 1 6 2.5 O=C1NC(=O)C(S1)Cc1ccc(cc1)OCCN(c1ccccn1)C 10.1038/s41467-023-40064-9
2405 3346 116 None -19 10 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 357 7 1 6 2.5 O=C1NC(=O)C(S1)Cc1ccc(cc1)OCCN(c1ccccn1)C 10.1038/s41467-023-40064-9
77999 3346 116 None -19 10 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 357 7 1 6 2.5 O=C1NC(=O)C(S1)Cc1ccc(cc1)OCCN(c1ccccn1)C 10.1038/s41467-023-40064-9
CHEMBL121 3346 116 None -19 10 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 357 7 1 6 2.5 O=C1NC(=O)C(S1)Cc1ccc(cc1)OCCN(c1ccccn1)C 10.1038/s41467-023-40064-9
DB00412 3346 116 None -19 10 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 357 7 1 6 2.5 O=C1NC(=O)C(S1)Cc1ccc(cc1)OCCN(c1ccccn1)C 10.1038/s41467-023-40064-9
4499 59745 99 None -6 8 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 388 6 1 7 3.2 COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1c1ccccc1[N+](=O)[O-] 10.1038/s41467-023-40064-9
CHEMBL1726 59745 99 None -6 8 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 388 6 1 7 3.2 COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1c1ccccc1[N+](=O)[O-] 10.1038/s41467-023-40064-9
103 4122 61 None 1 22 Human 8.0 pAC50 = 8.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
2875 4122 61 None 1 22 Human 8.0 pAC50 = 8.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
5736 4122 61 None 1 22 Human 8.0 pAC50 = 8.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
CHEMBL285802 4122 61 None 1 22 Human 8.0 pAC50 = 8.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
DB09225 4122 61 None 1 22 Human 8.0 pAC50 = 8.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
10184665 3960 51 None -645 10 Human 6.0 pAC50 = 6.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O 10.1038/s41467-023-40064-9
4799 3960 51 None -645 10 Human 6.0 pAC50 = 6.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O 10.1038/s41467-023-40064-9
7353 3960 51 None -645 10 Human 6.0 pAC50 = 6.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O 10.1038/s41467-023-40064-9
CHEMBL1198857 3960 51 None -645 10 Human 6.0 pAC50 = 6.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O 10.1038/s41467-023-40064-9
DB09082 3960 51 None -645 10 Human 6.0 pAC50 = 6.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O 10.1038/s41467-023-40064-9
2267 557 71 None -45 14 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
271 557 71 None -45 14 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
7121 557 71 None -45 14 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
CHEMBL639 557 71 None -45 14 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
DB00972 557 71 None -45 14 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
2274 3151 58 None -24 37 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
4917 3151 58 None -24 37 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
7279 3151 58 None -24 37 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
CHEMBL728 3151 58 None -24 37 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
DB00433 3151 58 None -24 37 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
2601 3751 33 None -354 17 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 10.1038/s41467-023-40064-9
443951 3751 33 None -354 17 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 10.1038/s41467-023-40064-9
56 3751 33 None -354 17 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 10.1038/s41467-023-40064-9
CHEMBL73151 3751 33 None -354 17 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 10.1038/s41467-023-40064-9
DB13399 3751 33 None -354 17 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 10.1038/s41467-023-40064-9
11626560 200914 94 None -1 14 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 449 5 2 6 5.0 C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl 10.1038/s41467-023-40064-9
CHEMBL601719 200914 94 None -1 14 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 449 5 2 6 5.0 C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl 10.1038/s41467-023-40064-9
10071196 3102 79 None -831 9 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 427 8 1 3 4.7 CC(COc1ccc(cc1)CNC(=O)N(C1CCN(CC1)C)Cc1ccc(cc1)F)C 10.1038/s41467-023-40064-9
5142 3102 79 None -831 9 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 427 8 1 3 4.7 CC(COc1ccc(cc1)CNC(=O)N(C1CCN(CC1)C)Cc1ccc(cc1)F)C 10.1038/s41467-023-40064-9
8423 3102 79 None -831 9 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 427 8 1 3 4.7 CC(COc1ccc(cc1)CNC(=O)N(C1CCN(CC1)C)Cc1ccc(cc1)F)C 10.1038/s41467-023-40064-9
CHEMBL2111101 3102 79 None -831 9 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 427 8 1 3 4.7 CC(COc1ccc(cc1)CNC(=O)N(C1CCN(CC1)C)Cc1ccc(cc1)F)C 10.1038/s41467-023-40064-9
DB05316 3102 79 None -831 9 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 427 8 1 3 4.7 CC(COc1ccc(cc1)CNC(=O)N(C1CCN(CC1)C)Cc1ccc(cc1)F)C 10.1038/s41467-023-40064-9
3675 7702 68 None -91 4 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 136 3 2 2 0.7 NNCCc1ccccc1 10.1038/s41467-023-40064-9
CHEMBL1089 7702 68 None -91 4 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 136 3 2 2 0.7 NNCCc1ccccc1 10.1038/s41467-023-40064-9
135409453 3744 41 None -363 36 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.1038/s41467-023-40064-9
226 3744 41 None -363 36 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.1038/s41467-023-40064-9
CHEMBL76370 3744 41 None -363 36 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.1038/s41467-023-40064-9
2470 3626 50 None -13803 23 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
3300 3626 50 None -13803 23 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
5265 3626 50 None -13803 23 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
99 3626 50 None -13803 23 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL267930 3626 50 None -13803 23 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
180 400 56 None -63 38 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
200 400 56 None -63 38 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
2160 400 56 None -63 38 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
CHEMBL629 400 56 None -63 38 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
DB00321 400 56 None -63 38 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
4822 45002 47 None -16 10 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 293 0 0 2 4.7 CN1CCC(=C2c3ccccc3Sc3ccccc32)CC1 10.1038/s41467-023-40064-9
CHEMBL152408 45002 47 None -16 10 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 293 0 0 2 4.7 CN1CCC(=C2c3ccccc3Sc3ccccc32)CC1 10.1038/s41467-023-40064-9
16351 102703 47 None -17 17 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 343 0 0 4 4.1 CN1CCN(C2=Nc3ccccc3Sc3ccc(Cl)cc32)CC1 10.1038/s41467-023-40064-9
CHEMBL304902 102703 47 None -17 17 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 343 0 0 4 4.1 CN1CCN(C2=Nc3ccccc3Sc3ccc(Cl)cc32)CC1 10.1038/s41467-023-40064-9
37264 189398 24 None 8 3 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 435 6 2 10 1.3 COc1cc2c(N)nc(N3CCN(C(=O)OCC(C)(C)O)CC3)nc2c(OC)c1OC 10.1038/s41467-023-40064-9
CHEMBL513301 189398 24 None 8 3 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 435 6 2 10 1.3 COc1cc2c(N)nc(N3CCN(C(=O)OCC(C)(C)O)CC3)nc2c(OC)c1OC 10.1038/s41467-023-40064-9
643976 14486 30 None -2 3 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 456 7 6 10 -1.6 Cc1cc2nc3c(=O)[nH]c(=O)nc-3n(C[C@H](O)[C@H](O)[C@H](O)COP(=O)(O)O)c2cc1C 10.1038/s41467-023-40064-9
CHEMBL1201794 14486 30 None -2 3 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 456 7 6 10 -1.6 Cc1cc2nc3c(=O)[nH]c(=O)nc-3n(C[C@H](O)[C@H](O)[C@H](O)COP(=O)(O)O)c2cc1C 10.1038/s41467-023-40064-9
72093 35031 9 None -10 28 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 483 16 1 4 6.3 CCCCCCCCOc1ccccc1C(=O)Nc1ccc(C(=O)OCC[N+](C)(CC)CC)cc1 10.1038/s41467-023-40064-9
CHEMBL1433361 35031 9 None -10 28 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 483 16 1 4 6.3 CCCCCCCCOc1ccccc1C(=O)Nc1ccc(C(=O)OCC[N+](C)(CC)CC)cc1 10.1038/s41467-023-40064-9
CHEMBL2103773 35031 9 None -10 28 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 483 16 1 4 6.3 CCCCCCCCOc1ccccc1C(=O)Nc1ccc(C(=O)OCC[N+](C)(CC)CC)cc1 10.1038/s41467-023-40064-9
65016 10177 86 None -1 3 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 505 11 3 7 2.4 CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1 10.1038/s41467-023-40064-9
CHEMBL116 10177 86 None -1 3 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 505 11 3 7 2.4 CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1 10.1038/s41467-023-40064-9
22323 15267 32 None -3 11 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 287 2 5 2 2.9 CC(C)NC(=N)NC(=N)Nc1ccc(Cl)c(Cl)c1 10.1038/s41467-023-40064-9
9571037 15267 32 None -3 11 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 287 2 5 2 2.9 CC(C)NC(=N)NC(=N)Nc1ccc(Cl)c(Cl)c1 10.1038/s41467-023-40064-9
CHEMBL1213553 15267 32 None -3 11 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 287 2 5 2 2.9 CC(C)NC(=N)NC(=N)Nc1ccc(Cl)c(Cl)c1 10.1038/s41467-023-40064-9
47319 26433 35 None -4 6 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 929 24 0 12 8.1 COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC 10.1038/s41467-023-40064-9
CHEMBL1360 26433 35 None -4 6 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 929 24 0 12 8.1 COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC 10.1038/s41467-023-40064-9
3191 102831 97 None -660 33 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 469 9 0 3 7.2 CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1 10.1038/s41467-023-40064-9
CHEMBL305660 102831 97 None -660 33 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 469 9 0 3 7.2 CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1 10.1038/s41467-023-40064-9
2372 106441 40 None -144 6 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 345 10 2 5 2.6 COc1ccc(CCNCC(O)COc2cccc(C)c2)cc1OC 10.1038/s41467-023-40064-9
CHEMBL314010 106441 40 None -144 6 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 345 10 2 5 2.6 COc1ccc(CCNCC(O)COc2cccc(C)c2)cc1OC 10.1038/s41467-023-40064-9
216416 111554 48 None -141 23 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 413 6 1 3 5.7 Oc1ccc2c(c1)CC[C@H](c1ccccc1)[C@@H]2c1ccc(OCCN2CCCC2)cc1 10.1038/s41467-023-40064-9
CHEMBL328190 111554 48 None -141 23 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 413 6 1 3 5.7 Oc1ccc2c(c1)CC[C@H](c1ccccc1)[C@@H]2c1ccc(OCCN2CCCC2)cc1 10.1038/s41467-023-40064-9
23480 124064 23 None -15 7 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 281 5 1 1 5.0 CC(CC(c1ccccc1)c1ccccc1)NC(C)(C)C 10.1038/s41467-023-40064-9
CHEMBL363295 124064 23 None -15 7 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 281 5 1 1 5.0 CC(CC(c1ccccc1)c1ccccc1)NC(C)(C)C 10.1038/s41467-023-40064-9
135412795 44721 23 None -7 4 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 296 1 1 3 3.4 O=C1CN=C(c2ccccc2)c2c(sc3c2CCCC3)N1 10.1038/s41467-023-40064-9
CHEMBL1521495 44721 23 None -7 4 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 296 1 1 3 3.4 O=C1CN=C(c2ccccc2)c2c(sc3c2CCCC3)N1 10.1038/s41467-023-40064-9
2805 161866 38 None -3 9 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 329 6 0 2 4.9 Clc1ccc(C(OCCN2CCCCC2)c2ccccc2)cc1 10.1038/s41467-023-40064-9
CHEMBL415087 161866 38 None -3 9 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 329 6 0 2 4.9 Clc1ccc(C(OCCN2CCCCC2)c2ccccc2)cc1 10.1038/s41467-023-40064-9
3053 205111 95 None 1 7 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 393 16 5 8 -2.7 O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O 10.1038/s41467-023-40064-9
CHEMBL780 205111 95 None 1 7 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 393 16 5 8 -2.7 O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O 10.1038/s41467-023-40064-9
1024 1558 27 None -1 3 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 165 3 2 2 1.3 CN[C@H]([C@@H](c1ccccc1)O)C 10.1038/s41467-023-40064-9
556 1558 27 None -1 3 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 165 3 2 2 1.3 CN[C@H]([C@@H](c1ccccc1)O)C 10.1038/s41467-023-40064-9
9294 1558 27 None -1 3 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 165 3 2 2 1.3 CN[C@H]([C@@H](c1ccccc1)O)C 10.1038/s41467-023-40064-9
CHEMBL211456 1558 27 None -1 3 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 165 3 2 2 1.3 CN[C@H]([C@@H](c1ccccc1)O)C 10.1038/s41467-023-40064-9
DB01364 1558 27 None -1 3 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 165 3 2 2 1.3 CN[C@H]([C@@H](c1ccccc1)O)C 10.1038/s41467-023-40064-9
119570 3137 96 None -10000 11 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N 10.1038/s41467-023-40064-9
2233 3137 96 None -10000 11 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N 10.1038/s41467-023-40064-9
953 3137 96 None -10000 11 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N 10.1038/s41467-023-40064-9
CHEMBL301265 3137 96 None -10000 11 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N 10.1038/s41467-023-40064-9
DB00413 3137 96 None -10000 11 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N 10.1038/s41467-023-40064-9
2782 31970 67 None -3801 8 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 325 4 0 3 4.3 Clc1ccc(Cn2c(CN3CCCC3)nc3ccccc32)cc1 10.1038/s41467-023-40064-9
CHEMBL1407943 31970 67 None -3801 8 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 325 4 0 3 4.3 Clc1ccc(Cn2c(CN3CCCC3)nc3ccccc32)cc1 10.1038/s41467-023-40064-9
CHEMBL3216363 31970 67 None -3801 8 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 325 4 0 3 4.3 Clc1ccc(Cn2c(CN3CCCC3)nc3ccccc32)cc1 10.1038/s41467-023-40064-9
4528 98098 80 None -5 4 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 238 1 1 2 2.8 CN1Cc2c(N)cccc2C(c2ccccc2)C1 10.1038/s41467-023-40064-9
CHEMBL273575 98098 80 None -5 4 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 238 1 1 2 2.8 CN1Cc2c(N)cccc2C(c2ccccc2)C1 10.1038/s41467-023-40064-9
5311017 120578 11 None -13 5 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 239 5 0 1 3.8 C[C@@H](Cc1ccccc1)N(C)Cc1ccccc1 10.1038/s41467-023-40064-9
CHEMBL3545985 120578 11 None -13 5 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 239 5 0 1 3.8 C[C@@H](Cc1ccccc1)N(C)Cc1ccccc1 10.1038/s41467-023-40064-9
26248 161515 102 None -1 11 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 368 3 1 7 2.0 CC(=O)Oc1cccc2c1C(=O)c1c(OC(C)=O)cc(C(=O)O)cc1C2=O 10.1038/s41467-023-40064-9
CHEMBL41286 161515 102 None -1 11 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 368 3 1 7 2.0 CC(=O)Oc1cccc2c1C(=O)c1c(OC(C)=O)cc(C(=O)O)cc1C2=O 10.1038/s41467-023-40064-9
CHEMBL1630575 56313 0 None -2 6 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 1093 23 16 18 -3.3 CC[C@H](C)C[C@H](C)CCCCCCCCC(=O)N[C@H]1C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]2[C@@H](O)CCN2C(=O)[C@H]([C@H](O)CCN)NC(=O)[C@H]([C@H](O)[C@@H](O)c2ccc(O)cc2)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@H]([C@@H](C)O)NC1=O 10.1038/s41467-023-40064-9
443869 78112 45 None 1 10 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 491 7 1 8 3.8 COC(=O)C1=C(C)NC(C)=C(C(=O)O[C@H]2CCN(Cc3ccccc3)C2)[C@H]1c1cccc([N+](=O)[O-])c1 10.1038/s41467-023-40064-9
CHEMBL2103761 78112 45 None 1 10 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 491 7 1 8 3.8 COC(=O)C1=C(C)NC(C)=C(C(=O)O[C@H]2CCN(Cc3ccccc3)C2)[C@H]1c1cccc([N+](=O)[O-])c1 10.1038/s41467-023-40064-9
68555 103085 21 None -3 7 Human 6.9 pAC50 = 6.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 307 7 1 5 2.6 CNCCc1ccc(OC(=O)C(C)C)c(OC(=O)C(C)C)c1 10.1038/s41467-023-40064-9
CHEMBL307739 103085 21 None -3 7 Human 6.9 pAC50 = 6.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 307 7 1 5 2.6 CNCCc1ccc(OC(=O)C(C)C)c(OC(=O)C(C)C)c1 10.1038/s41467-023-40064-9
15942715 78164 19 None -1 3 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 446 5 1 5 4.0 CCCCOC(=O)C(=O)[C@H]1[C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C 10.1038/s41467-023-40064-9
CHEMBL2105087 78164 19 None -1 3 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 446 5 1 5 4.0 CCCCOC(=O)C(=O)[C@H]1[C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C 10.1038/s41467-023-40064-9
6918178 14413 44 None 1 3 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 484 4 1 5 4.1 CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C 10.1038/s41467-023-40064-9
CHEMBL1200908 14413 44 None 1 3 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 484 4 1 5 4.1 CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C 10.1038/s41467-023-40064-9
667492 43875 43 None 1 4 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 234 1 2 3 0.2 CN1C(=O)/C(=N\NC(N)=S)c2ccccc21 10.1038/s41467-023-40064-9
CHEMBL1512080 43875 43 None 1 4 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 234 1 2 3 0.2 CN1C(=O)/C(=N\NC(N)=S)c2ccccc21 10.1038/s41467-023-40064-9
3652 4066 79 None -2089 15 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 281 7 0 5 3.2 CCCCCCOc1nsnc1C1=CCCN(C1)C 10.1038/s41467-023-40064-9
57 4066 79 None -2089 15 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 281 7 0 5 3.2 CCCCCCOc1nsnc1C1=CCCN(C1)C 10.1038/s41467-023-40064-9
60809 4066 79 None -2089 15 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 281 7 0 5 3.2 CCCCCCOc1nsnc1C1=CCCN(C1)C 10.1038/s41467-023-40064-9
CHEMBL21536 4066 79 None -2089 15 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 281 7 0 5 3.2 CCCCCCOc1nsnc1C1=CCCN(C1)C 10.1038/s41467-023-40064-9
DB15357 4066 79 None -2089 15 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 281 7 0 5 3.2 CCCCCCOc1nsnc1C1=CCCN(C1)C 10.1038/s41467-023-40064-9
213046 2370 59 None -6 17 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 10.1038/s41467-023-40064-9
4168 2370 59 None -6 17 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 10.1038/s41467-023-40064-9
7461 2370 59 None -6 17 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 10.1038/s41467-023-40064-9
CHEMBL1237021 2370 59 None -6 17 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 10.1038/s41467-023-40064-9
DB08815 2370 59 None -6 17 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 10.1038/s41467-023-40064-9
3351 94973 52 None -2 6 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 388 5 0 5 2.8 O=C(COc1ccc(Cl)cc1)N1CCN(Cc2ccc3c(c2)OCO3)CC1 10.1038/s41467-023-40064-9
CHEMBL254857 94973 52 None -2 6 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 388 5 0 5 2.8 O=C(COc1ccc(Cl)cc1)N1CCN(Cc2ccc3c(c2)OCO3)CC1 10.1038/s41467-023-40064-9
6917906 67743 21 None -6 5 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 887 35 10 12 1.7 CCCCCCCCCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)CC[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@@H]1NC(C)=O)C(N)=O)C(=O)O 10.1038/s41467-023-40064-9
CHEMBL1908331 67743 21 None -6 5 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 887 35 10 12 1.7 CCCCCCCCCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)CC[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@@H]1NC(C)=O)C(N)=O)C(=O)O 10.1038/s41467-023-40064-9
98941 46920 17 None -66 11 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 457 7 0 4 6.3 COc1ccc2c(c1)OC(C)(C)C(c1ccccc1)C2c1ccc(OCCN2CCCC2)cc1 10.1038/s41467-023-40064-9
CHEMBL154126 46920 17 None -66 11 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 457 7 0 4 6.3 COc1ccc2c(c1)OC(C)(C)C(c1ccccc1)C2c1ccc(OCCN2CCCC2)cc1 10.1038/s41467-023-40064-9
CHEMBL4743867 214010 14 None -4466 15 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL None None None OCCN1CCN(CCC=C2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1 10.1038/s41467-023-40064-9
3474 38071 57 None -4 8 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 372 6 3 6 3.1 O=C(OCC(O)CO)c1ccccc1Nc1ccnc2cc(Cl)ccc12 10.1038/s41467-023-40064-9
CHEMBL146095 38071 57 None -4 8 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 372 6 3 6 3.1 O=C(OCC(O)CO)c1ccccc1Nc1ccnc2cc(Cl)ccc12 10.1038/s41467-023-40064-9
49843517 78265 41 None -40 8 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 590 13 2 6 8.5 CCCCCCO[C@@H](C)c1cccc(-c2csc(NC(=O)c3cc(Cl)c(/C=C(\C)C(=O)O)c(Cl)c3)n2)c1OC 10.1038/s41467-023-40064-9
CHEMBL2107831 78265 41 None -40 8 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 590 13 2 6 8.5 CCCCCCO[C@@H](C)c1cccc(-c2csc(NC(=O)c3cc(Cl)c(/C=C(\C)C(=O)O)c(Cl)c3)n2)c1OC 10.1038/s41467-023-40064-9
3103 41628 49 None -138 9 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 281 4 0 2 3.9 CN1CCC(OC(c2ccccc2)c2ccccc2)CC1 10.1038/s41467-023-40064-9
CHEMBL1492 41628 49 None -138 9 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 281 4 0 2 3.9 CN1CCC(OC(c2ccccc2)c2ccccc2)CC1 10.1038/s41467-023-40064-9
16222096 80454 67 None -50 7 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 531 4 3 4 3.8 O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1 10.1038/s41467-023-40064-9
CHEMBL2146883 80454 67 None -50 7 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 531 4 3 4 3.8 O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1 10.1038/s41467-023-40064-9
2580 78366 18 None -660 10 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 446 6 1 4 4.1 NC(=O)C1(N2CCCCC2)CCN(CCCN2c3ccccc3CCc3ccccc32)CC1 10.1038/s41467-023-40064-9
CHEMBL2110775 78366 18 None -660 10 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 446 6 1 4 4.1 NC(=O)C1(N2CCCCC2)CCN(CCCN2c3ccccc3CCc3ccccc32)CC1 10.1038/s41467-023-40064-9
448537 160226 89 None -54 31 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 10.1038/s41467-023-40064-9
CHEMBL411 160226 89 None -54 31 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 10.1038/s41467-023-40064-9
16362 3103 71 None -14 35 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
2172 3103 71 None -14 35 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
90 3103 71 None -14 35 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL1423 3103 71 None -14 35 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
DB01100 3103 71 None -14 35 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
3634 84079 51 None 1 9 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 356 7 2 5 3.7 CCN(CC)CCNc1ccc(CO)c2sc3ccccc3c(=O)c12 10.1038/s41467-023-40064-9
CHEMBL22077 84079 51 None 1 9 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 356 7 2 5 3.7 CCN(CC)CCNc1ccc(CO)c2sc3ccccc3c(=O)c12 10.1038/s41467-023-40064-9
3478 5394 103 None -758 4 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 445 7 3 6 2.1 Cc1cnc(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc2)cn1 10.1038/s41467-023-40064-9
CHEMBL1073 5394 103 None -758 4 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 445 7 3 6 2.1 Cc1cnc(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc2)cn1 10.1038/s41467-023-40064-9
72287 61031 38 None 1 9 Human 7.9 pAC50 = 7.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 328 5 0 4 4.5 COc1ccc2c(c1)N(C[C@H](C)CN(C)C)c1ccccc1S2 10.1038/s41467-023-40064-9
CHEMBL1764 61031 38 None 1 9 Human 7.9 pAC50 = 7.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 328 5 0 4 4.5 COc1ccc2c(c1)N(C[C@H](C)CN(C)C)c1ccccc1S2 10.1038/s41467-023-40064-9
19675 51640 43 None -12 15 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 410 7 1 5 5.0 CC(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2 10.1038/s41467-023-40064-9
CHEMBL1584 51640 43 None -12 15 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 410 7 1 5 5.0 CC(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2 10.1038/s41467-023-40064-9
2284 3160 33 None -3 34 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C 10.1038/s41467-023-40064-9
4926 3160 33 None -3 34 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C 10.1038/s41467-023-40064-9
7281 3160 33 None -3 34 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C 10.1038/s41467-023-40064-9
CHEMBL564 3160 33 None -3 34 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C 10.1038/s41467-023-40064-9
DB00420 3160 33 None -3 34 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C 10.1038/s41467-023-40064-9
2398 951 62 None -72 36 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
2801 951 62 None -72 36 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
701 951 62 None -72 36 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
CHEMBL415 951 62 None -72 36 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
DB01242 951 62 None -72 36 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
55483 205074 40 None -8 11 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 356 13 4 4 3.6 Oc1ccc(CCNCCCCCCNCCc2ccccc2)cc1O 10.1038/s41467-023-40064-9
CHEMBL77622 205074 40 None -8 11 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 356 13 4 4 3.6 Oc1ccc(CCNCCCCCCNCCc2ccccc2)cc1O 10.1038/s41467-023-40064-9
2869 4121 89 None -5011 5 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 287 5 2 3 1.9 CN(CCc1c[nH]c2c1cc(C[C@H]1COC(=O)N1)cc2)C 10.1038/s41467-023-40064-9
60 4121 89 None -5011 5 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 287 5 2 3 1.9 CN(CCc1c[nH]c2c1cc(C[C@H]1COC(=O)N1)cc2)C 10.1038/s41467-023-40064-9
60857 4121 89 None -5011 5 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 287 5 2 3 1.9 CN(CCc1c[nH]c2c1cc(C[C@H]1COC(=O)N1)cc2)C 10.1038/s41467-023-40064-9
CHEMBL1185 4121 89 None -5011 5 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 287 5 2 3 1.9 CN(CCc1c[nH]c2c1cc(C[C@H]1COC(=O)N1)cc2)C 10.1038/s41467-023-40064-9
DB00315 4121 89 None -5011 5 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 287 5 2 3 1.9 CN(CCc1c[nH]c2c1cc(C[C@H]1COC(=O)N1)cc2)C 10.1038/s41467-023-40064-9
4762 14437 27 None 1 2 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 177 1 1 2 1.7 CC1NCCOC1c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL1201208 14437 27 None 1 2 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 177 1 1 2 1.7 CC1NCCOC1c1ccccc1 10.1038/s41467-023-40064-9
5556 203237 27 None -33 5 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 342 1 0 4 4.2 Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1Cl)=NC2 10.1038/s41467-023-40064-9
CHEMBL646 203237 27 None -33 5 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 342 1 0 4 4.2 Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1Cl)=NC2 10.1038/s41467-023-40064-9
2218 15251 23 None -5 12 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 322 8 0 2 4.4 CCN(CC)CCCN(c1ccccc1)C1Cc2ccccc2C1 10.1038/s41467-023-40064-9
CHEMBL1213033 15251 23 None -5 12 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 322 8 0 2 4.4 CCN(CC)CCCN(c1ccccc1)C1Cc2ccccc2C1 10.1038/s41467-023-40064-9
2780 110502 36 None -1479 11 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 373 5 2 4 3.3 COc1cc(N)c(Cl)cc1C(=O)NC1CCN(Cc2ccccc2)CC1 10.1038/s41467-023-40064-9
CHEMBL325109 110502 36 None -1479 11 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 373 5 2 4 3.3 COc1cc(N)c(Cl)cc1C(=O)NC1CCN(Cc2ccccc2)CC1 10.1038/s41467-023-40064-9
9417 133487 54 None -33 15 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 363 6 1 4 3.3 OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1 10.1038/s41467-023-40064-9
CHEMBL1524185 133487 54 None -33 15 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 363 6 1 4 3.3 OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1 10.1038/s41467-023-40064-9
CHEMBL370753 133487 54 None -33 15 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 363 6 1 4 3.3 OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1 10.1038/s41467-023-40064-9
5365247 138404 33 None -100 10 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 316 4 0 2 3.8 CN(C)C/C=C(/c1ccc(Br)cc1)c1cccnc1 10.1038/s41467-023-40064-9
CHEMBL37744 138404 33 None -100 10 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 316 4 0 2 3.8 CN(C)C/C=C(/c1ccc(Br)cc1)c1cccnc1 10.1038/s41467-023-40064-9
2318 154832 29 None -20 15 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 351 7 1 3 4.1 CC(Cc1cccc(C(F)(F)F)c1)NCCOC(=O)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL400599 154832 29 None -20 15 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 351 7 1 3 4.1 CC(Cc1cccc(C(F)(F)F)c1)NCCOC(=O)c1ccccc1 10.1038/s41467-023-40064-9
2771 194994 74 None -46 16 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 10.1038/s41467-023-40064-9
CHEMBL1200781 194994 74 None -46 16 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 10.1038/s41467-023-40064-9
CHEMBL549 194994 74 None -46 16 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 10.1038/s41467-023-40064-9
3950 189484 109 None -4 2 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 233 4 1 3 2.3 O=NN(CCCl)C(=O)NC1CCCCC1 10.1038/s41467-023-40064-9
CHEMBL514 189484 109 None -4 2 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 233 4 1 3 2.3 O=NN(CCCl)C(=O)NC1CCCCC1 10.1038/s41467-023-40064-9
37 775 60 None -141 12 Human 6.9 pAC50 = 6.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 10.1038/s41467-023-40064-9
460 775 60 None -141 12 Human 6.9 pAC50 = 6.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 10.1038/s41467-023-40064-9
54746 775 60 None -141 12 Human 6.9 pAC50 = 6.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 10.1038/s41467-023-40064-9
CHEMBL1201087 775 60 None -141 12 Human 6.9 pAC50 = 6.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 10.1038/s41467-023-40064-9
DB00248 775 60 None -141 12 Human 6.9 pAC50 = 6.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 10.1038/s41467-023-40064-9
1599 2326 50 None -7585 21 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
3955 2326 50 None -7585 21 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
7215 2326 50 None -7585 21 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL841 2326 50 None -7585 21 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
DB00836 2326 50 None -7585 21 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
2723 154022 108 None -7 4 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 156 0 1 1 2.7 Cc1cc(O)cc(C)c1Cl 10.1038/s41467-023-40064-9
CHEMBL398440 154022 108 None -7 4 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 156 0 1 1 2.7 Cc1cc(O)cc(C)c1Cl 10.1038/s41467-023-40064-9
135398737 955 93 None -17 43 Human 6.8 pAC50 = 6.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
38 955 93 None -17 43 Human 6.8 pAC50 = 6.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
722 955 93 None -17 43 Human 6.8 pAC50 = 6.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL42 955 93 None -17 43 Human 6.8 pAC50 = 6.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
DB00363 955 93 None -17 43 Human 6.8 pAC50 = 6.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
5351322 94762 38 None 1 9 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 398 4 4 8 1.8 C(=N/NC1=NCCN1)\c1c2ccccc2c(/C=N/NC2=NCCN2)c2ccccc12 10.1038/s41467-023-40064-9
CHEMBL25336 94762 38 None 1 9 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 398 4 4 8 1.8 C(=N/NC1=NCCN1)\c1c2ccccc2c(/C=N/NC2=NCCN2)c2ccccc12 10.1038/s41467-023-40064-9
3117 207818 103 None -20 24 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 296 4 0 4 3.6 CCN(CC)C(=S)SSC(=S)N(CC)CC 10.1038/s41467-023-40064-9
CHEMBL964 207818 103 None -20 24 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 296 4 0 4 3.6 CCN(CC)C(=S)SSC(=S)N(CC)CC 10.1038/s41467-023-40064-9
9818306 14387 15 None -2 5 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 1 1 3 3.8 CC(=O)Oc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12 10.1038/s41467-023-40064-9
CHEMBL1200430 14387 15 None -2 5 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 1 1 3 3.8 CC(=O)Oc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12 10.1038/s41467-023-40064-9
2398 951 62 None -72 36 Human 7.8 pAC50 = 7.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
2801 951 62 None -72 36 Human 7.8 pAC50 = 7.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
701 951 62 None -72 36 Human 7.8 pAC50 = 7.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
CHEMBL415 951 62 None -72 36 Human 7.8 pAC50 = 7.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
DB01242 951 62 None -72 36 Human 7.8 pAC50 = 7.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
2337 3232 77 None -4 29 Human 6.8 pAC50 = 6.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
50 3232 77 None -4 29 Human 6.8 pAC50 = 6.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
5002 3232 77 None -4 29 Human 6.8 pAC50 = 6.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL716 3232 77 None -4 29 Human 6.8 pAC50 = 6.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
DB01224 3232 77 None -4 29 Human 6.8 pAC50 = 6.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
1530 2169 50 None -912 25 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 10.1038/s41467-023-40064-9
3827 2169 50 None -912 25 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 10.1038/s41467-023-40064-9
7206 2169 50 None -912 25 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 10.1038/s41467-023-40064-9
CHEMBL534 2169 50 None -912 25 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 10.1038/s41467-023-40064-9
DB00920 2169 50 None -912 25 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 10.1038/s41467-023-40064-9
243 3180 91 None -1288 5 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 367 6 2 5 2.1 COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(c2c1OCC2)N 10.1038/s41467-023-40064-9
3052762 3180 91 None -1288 5 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 367 6 2 5 2.1 COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(c2c1OCC2)N 10.1038/s41467-023-40064-9
3502 3180 91 None -1288 5 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 367 6 2 5 2.1 COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(c2c1OCC2)N 10.1038/s41467-023-40064-9
CHEMBL117287 3180 91 None -1288 5 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 367 6 2 5 2.1 COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(c2c1OCC2)N 10.1038/s41467-023-40064-9
DB06480 3180 91 None -1288 5 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 367 6 2 5 2.1 COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(c2c1OCC2)N 10.1038/s41467-023-40064-9
2351 4269 49 None -3 22 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 366 10 0 3 4.8 CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1 10.1038/s41467-023-40064-9
CHEMBL1008 4269 49 None -3 22 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 366 10 0 3 4.8 CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1 10.1038/s41467-023-40064-9
CHEMBL1257078 4269 49 None -3 22 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 366 10 0 3 4.8 CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1 10.1038/s41467-023-40064-9
21772 78370 31 None -1000 10 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 293 4 0 1 4.5 CC(CC1c2ccccc2CCc2ccccc21)CN(C)C 10.1038/s41467-023-40064-9
CHEMBL2110816 78370 31 None -1000 10 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 293 4 0 1 4.5 CC(CC1c2ccccc2CCc2ccccc21)CN(C)C 10.1038/s41467-023-40064-9
4413 98045 57 None -4 15 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 347 4 5 4 2.6 N=C(N)Nc1ccc(C(=O)Oc2ccc3cc(C(=N)N)ccc3c2)cc1 10.1038/s41467-023-40064-9
CHEMBL273264 98045 57 None -4 15 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 347 4 5 4 2.6 N=C(N)Nc1ccc(C(=O)Oc2ccc3cc(C(=N)N)ccc3c2)cc1 10.1038/s41467-023-40064-9
60151560 167418 39 None -1 5 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 439 11 1 5 5.3 CCO[C@@H](Cc1ccc(OCCn2c(C)ccc2-c2ccc(SC)cc2)cc1)C(=O)O 10.1038/s41467-023-40064-9
CHEMBL4297530 167418 39 None -1 5 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 439 11 1 5 5.3 CCO[C@@H](Cc1ccc(OCCn2c(C)ccc2-c2ccc(SC)cc2)cc1)C(=O)O 10.1038/s41467-023-40064-9
216239 23763 118 None -8 11 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 464 5 3 4 5.6 CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1 10.1038/s41467-023-40064-9
CHEMBL1200485 23763 118 None -8 11 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 464 5 3 4 5.6 CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1 10.1038/s41467-023-40064-9
CHEMBL1336 23763 118 None -8 11 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 464 5 3 4 5.6 CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1 10.1038/s41467-023-40064-9
1830 2572 44 None -416 11 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 10.1038/s41467-023-40064-9
207 2572 44 None -416 11 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 10.1038/s41467-023-40064-9
23897 2572 44 None -416 11 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 10.1038/s41467-023-40064-9
CHEMBL460 2572 44 None -416 11 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 10.1038/s41467-023-40064-9
DB01618 2572 44 None -416 11 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 10.1038/s41467-023-40064-9
196122 112561 55 None -1 4 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 478 13 1 6 4.5 CCOC1O[C@H]([C@@H](COCc2ccccc2)OCc2ccccc2)[C@H](OCc2ccccc2)[C@H]1O 10.1038/s41467-023-40064-9
CHEMBL3301681 112561 55 None -1 4 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 478 13 1 6 4.5 CCOC1O[C@H]([C@@H](COCc2ccccc2)OCc2ccccc2)[C@H](OCc2ccccc2)[C@H]1O 10.1038/s41467-023-40064-9
392622 56282 95 None -8 20 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 720 17 4 9 5.9 CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1 10.1038/s41467-023-40064-9
CHEMBL163 56282 95 None -8 20 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 720 17 4 9 5.9 CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1 10.1038/s41467-023-40064-9
1570 57269 97 None 2 3 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 127 0 1 3 1.5 On1ccccc1=S 10.1038/s41467-023-40064-9
CHEMBL1650619 57269 97 None 2 3 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 127 0 1 3 1.5 On1ccccc1=S 10.1038/s41467-023-40064-9
1548955 88552 20 None -43 11 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 405 9 0 2 6.6 CCN(CC)CCOc1ccc(C(=C(Cl)c2ccccc2)c2ccccc2)cc1 10.1038/s41467-023-40064-9
2800 88552 20 None -43 11 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 405 9 0 2 6.6 CCN(CC)CCOc1ccc(C(=C(Cl)c2ccccc2)c2ccccc2)cc1 10.1038/s41467-023-40064-9
CHEMBL2355051 88552 20 None -43 11 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 405 9 0 2 6.6 CCN(CC)CCOc1ccc(C(=C(Cl)c2ccccc2)c2ccccc2)cc1 10.1038/s41467-023-40064-9
1155 1616 53 None -257 11 Human 5.8 pAC50 = 5.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
3343 1616 53 None -257 11 Human 5.8 pAC50 = 5.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
557 1616 53 None -257 11 Human 5.8 pAC50 = 5.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
CHEMBL32800 1616 53 None -257 11 Human 5.8 pAC50 = 5.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
DB01288 1616 53 None -257 11 Human 5.8 pAC50 = 5.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
9270 14398 66 None -5 3 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 384 2 0 4 4.4 C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=C[C@@H](OC(C)=O)CC[C@@H]4[C@H]3CC[C@@]21C 10.1038/s41467-023-40064-9
CHEMBL1200624 14398 66 None -5 3 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 384 2 0 4 4.4 C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=C[C@@H](OC(C)=O)CC[C@@H]4[C@H]3CC[C@@]21C 10.1038/s41467-023-40064-9
3158 56237 27 None -125 28 Human 6.8 pAC50 = 6.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 10.1038/s41467-023-40064-9
CHEMBL1628227 56237 27 None -125 28 Human 6.8 pAC50 = 6.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 10.1038/s41467-023-40064-9
60663 175645 42 None -8 12 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 495 11 1 5 5.3 COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C 10.1038/s41467-023-40064-9
CHEMBL1421212 175645 42 None -8 12 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 495 11 1 5 5.3 COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C 10.1038/s41467-023-40064-9
CHEMBL1534525 175645 42 None -8 12 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 495 11 1 5 5.3 COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C 10.1038/s41467-023-40064-9
CHEMBL45816 175645 42 None -8 12 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 495 11 1 5 5.3 COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C 10.1038/s41467-023-40064-9
5994 4609 88 None -5 10 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 1 0 2 4.7 CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C 10.1038/s41467-023-40064-9
CHEMBL103 4609 88 None -5 10 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 1 0 2 4.7 CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C 10.1038/s41467-023-40064-9
4034 55792 55 None -12 18 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 390 5 0 2 5.6 Cc1cccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)c1 10.1038/s41467-023-40064-9
CHEMBL1623 55792 55 None -12 18 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 390 5 0 2 5.6 Cc1cccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)c1 10.1038/s41467-023-40064-9
441383 20301 57 None -165 20 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 531 8 0 8 4.5 CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 10.1038/s41467-023-40064-9
CHEMBL1306 20301 57 None -165 20 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 531 8 0 8 4.5 CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 10.1038/s41467-023-40064-9
2470 3626 50 None -13803 23 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
3300 3626 50 None -13803 23 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
5265 3626 50 None -13803 23 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
99 3626 50 None -13803 23 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL267930 3626 50 None -13803 23 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
5440 28693 37 None -1995 16 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 399 6 0 5 5.0 CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2 10.1038/s41467-023-40064-9
CHEMBL1378 28693 37 None -1995 16 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 399 6 0 5 5.0 CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2 10.1038/s41467-023-40064-9
3926 207218 40 None -2 18 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 491 9 1 3 5.8 Cc1cccc(C)c1NC(=O)CN1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1 10.1038/s41467-023-40064-9
CHEMBL92870 207218 40 None -2 18 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 491 9 1 3 5.8 Cc1cccc(C)c1NC(=O)CN1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1 10.1038/s41467-023-40064-9
31703 194694 63 None -25 9 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 543 5 6 12 0.0 COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 10.1038/s41467-023-40064-9
CHEMBL359744 194694 63 None -25 9 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 543 5 6 12 0.0 COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 10.1038/s41467-023-40064-9
CHEMBL53463 194694 63 None -25 9 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 543 5 6 12 0.0 COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 10.1038/s41467-023-40064-9
24826799 10766 104 None -50 20 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 532 4 1 6 4.5 Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12 10.1038/s41467-023-40064-9
CHEMBL1171837 10766 104 None -50 20 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 532 4 1 6 4.5 Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12 10.1038/s41467-023-40064-9
2162 41484 100 None -5 22 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl 10.1038/s41467-023-40064-9
CHEMBL1491 41484 100 None -5 22 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl 10.1038/s41467-023-40064-9
5584 203188 44 None -9 9 Human 6.8 pAC50 = 6.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 294 4 0 2 4.1 CC(CN(C)C)CN1c2ccccc2CCc2ccccc21 10.1038/s41467-023-40064-9
CHEMBL644 203188 44 None -9 9 Human 6.8 pAC50 = 6.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 294 4 0 2 4.1 CC(CN(C)C)CN1c2ccccc2CCc2ccccc21 10.1038/s41467-023-40064-9
4735 195092 96 None -199 14 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 340 10 4 4 2.9 N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1 10.1038/s41467-023-40064-9
CHEMBL361506 195092 96 None -199 14 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 340 10 4 4 2.9 N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1 10.1038/s41467-023-40064-9
CHEMBL55 195092 96 None -199 14 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 340 10 4 4 2.9 N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1 10.1038/s41467-023-40064-9
CHEMBL508338 188942 0 None -181 15 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL None None None None 10.1038/s41467-023-40064-9
1712 2475 43 None 1 8 Human 7.8 pAC50 = 7.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 386 4 0 4 4.9 CN1CCCCC1CCN1c2ccccc2Sc2c1cc(cc2)S(=O)C 10.1038/s41467-023-40064-9
4078 2475 43 None 1 8 Human 7.8 pAC50 = 7.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 386 4 0 4 4.9 CN1CCCCC1CCN1c2ccccc2Sc2c1cc(cc2)S(=O)C 10.1038/s41467-023-40064-9
7227 2475 43 None 1 8 Human 7.8 pAC50 = 7.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 386 4 0 4 4.9 CN1CCCCC1CCN1c2ccccc2Sc2c1cc(cc2)S(=O)C 10.1038/s41467-023-40064-9
CHEMBL1088 2475 43 None 1 8 Human 7.8 pAC50 = 7.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 386 4 0 4 4.9 CN1CCCCC1CCN1c2ccccc2Sc2c1cc(cc2)S(=O)C 10.1038/s41467-023-40064-9
DB00933 2475 43 None 1 8 Human 7.8 pAC50 = 7.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 386 4 0 4 4.9 CN1CCCCC1CCN1c2ccccc2Sc2c1cc(cc2)S(=O)C 10.1038/s41467-023-40064-9
2865 4112 73 None -23 20 Human 7.8 pAC50 = 7.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
59 4112 73 None -23 20 Human 7.8 pAC50 = 7.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
60854 4112 73 None -23 20 Human 7.8 pAC50 = 7.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL708 4112 73 None -23 20 Human 7.8 pAC50 = 7.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
DB00246 4112 73 None -23 20 Human 7.8 pAC50 = 7.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
10531 1408 21 None -301 26 Human 5.8 pAC50 = 5.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
121 1408 21 None -301 26 Human 5.8 pAC50 = 5.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
888 1408 21 None -301 26 Human 5.8 pAC50 = 5.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
CHEMBL1732 1408 21 None -301 26 Human 5.8 pAC50 = 5.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
DB00320 1408 21 None -301 26 Human 5.8 pAC50 = 5.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
2286 3161 51 None -37 28 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
4927 3161 51 None -37 28 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
7282 3161 51 None -37 28 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
CHEMBL643 3161 51 None -37 28 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
DB01069 3161 51 None -37 28 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
56959 31526 103 None -3 9 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 427 9 2 6 2.3 COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1 10.1038/s41467-023-40064-9
CHEMBL1404 31526 103 None -3 9 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 427 9 2 6 2.3 COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1 10.1038/s41467-023-40064-9
CHEMBL1526084 31526 103 None -3 9 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 427 9 2 6 2.3 COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1 10.1038/s41467-023-40064-9
213 3824 55 None -18 22 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 10.1038/s41467-023-40064-9
2717 3824 55 None -18 22 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 10.1038/s41467-023-40064-9
5533 3824 55 None -18 22 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 10.1038/s41467-023-40064-9
CHEMBL621 3824 55 None -18 22 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 10.1038/s41467-023-40064-9
DB00656 3824 55 None -18 22 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 10.1038/s41467-023-40064-9
6231 29739 33 None -6 4 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 298 0 1 2 3.6 C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C 10.1038/s41467-023-40064-9
CHEMBL1387 29739 33 None -6 4 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 298 0 1 2 3.6 C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C 10.1038/s41467-023-40064-9
2247 504 81 None -26 42 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
249 504 81 None -26 42 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
2603 504 81 None -26 42 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
CHEMBL296419 504 81 None -26 42 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
DB00637 504 81 None -26 42 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
10180 98841 47 None -33 11 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 340 6 1 4 4.5 CCN(CC)CCNc1ccc(C)c2sc3ccccc3c(=O)c12 10.1038/s41467-023-40064-9
CHEMBL279014 98841 47 None -33 11 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 340 6 1 4 4.5 CCN(CC)CCNc1ccc(C)c2sc3ccccc3c(=O)c12 10.1038/s41467-023-40064-9
9324 9206 60 None -3 6 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 404 2 0 4 4.8 CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C 10.1038/s41467-023-40064-9
CHEMBL110691 9206 60 None -3 6 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 404 2 0 4 4.8 CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C 10.1038/s41467-023-40064-9
1662 188681 80 None -1 3 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 162 4 3 3 -0.3 CC(O)(CC(=O)O)CC(=O)O 10.1038/s41467-023-40064-9
CHEMBL50444 188681 80 None -1 3 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 162 4 3 3 -0.3 CC(O)(CC(=O)O)CC(=O)O 10.1038/s41467-023-40064-9
25151352 140581 67 None -4 11 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 417 5 2 4 5.2 FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1 10.1038/s41467-023-40064-9
CHEMBL3813873 140581 67 None -4 11 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 417 5 2 4 5.2 FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1 10.1038/s41467-023-40064-9
4046 2466 33 None -35 17 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 378 2 2 3 4.4 OC(c1cc(nc2c1cccc2C(F)(F)F)C(F)(F)F)C1CCCCN1 10.1038/s41467-023-40064-9
4252 2466 33 None -35 17 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 378 2 2 3 4.4 OC(c1cc(nc2c1cccc2C(F)(F)F)C(F)(F)F)C1CCCCN1 10.1038/s41467-023-40064-9
CHEMBL416956 2466 33 None -35 17 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 378 2 2 3 4.4 OC(c1cc(nc2c1cccc2C(F)(F)F)C(F)(F)F)C1CCCCN1 10.1038/s41467-023-40064-9
DB00358 2466 33 None -35 17 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 378 2 2 3 4.4 OC(c1cc(nc2c1cccc2C(F)(F)F)C(F)(F)F)C1CCCCN1 10.1038/s41467-023-40064-9
54454 5226 88 None -7 14 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 418 6 1 5 4.6 CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21 10.1038/s41467-023-40064-9
CHEMBL1064 5226 88 None -7 14 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 418 6 1 5 4.6 CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21 10.1038/s41467-023-40064-9
9822750 78380 65 None -4 8 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)[C@@H]1c1ccccc1Cl 10.1038/s41467-023-40064-9
CHEMBL2111097 78380 65 None -4 8 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)[C@@H]1c1ccccc1Cl 10.1038/s41467-023-40064-9
119369 2588 74 None -602 7 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C 10.1038/s41467-023-40064-9
2197 2588 74 None -602 7 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C 10.1038/s41467-023-40064-9
4004 2588 74 None -602 7 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C 10.1038/s41467-023-40064-9
CHEMBL420762 2588 74 None -602 7 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C 10.1038/s41467-023-40064-9
2005 78201 91 None - 1 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 173 6 2 2 0.8 CC(=O)NCCCCCC(=O)O 10.1038/s41467-023-40064-9
CHEMBL2105922 78201 91 None - 1 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 173 6 2 2 0.8 CC(=O)NCCCCCC(=O)O 10.1038/s41467-023-40064-9
2162 41484 100 None -5 22 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl 10.1038/s41467-023-40064-9
CHEMBL1491 41484 100 None -5 22 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl 10.1038/s41467-023-40064-9
12555 17929 53 None -38 9 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 309 7 0 4 3.4 CN(C)CCCOc1nn(Cc2ccccc2)c2ccccc12 10.1038/s41467-023-40064-9
CHEMBL12610 17929 53 None -38 9 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 309 7 0 4 3.4 CN(C)CCCOc1nn(Cc2ccccc2)c2ccccc12 10.1038/s41467-023-40064-9
10133 907 78 None -6 4 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 392 4 3 3 4.5 O[C@@H]1CC[C@]2([C@@H](C1)C[C@H]([C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)O)C)C)O)C 10.1038/s41467-023-40064-9
145714624 907 78 None -6 4 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 392 4 3 3 4.5 O[C@@H]1CC[C@]2([C@@H](C1)C[C@H]([C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)O)C)C)O)C 10.1038/s41467-023-40064-9
4361 907 78 None -6 4 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 392 4 3 3 4.5 O[C@@H]1CC[C@]2([C@@H](C1)C[C@H]([C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)O)C)C)O)C 10.1038/s41467-023-40064-9
608 907 78 None -6 4 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 392 4 3 3 4.5 O[C@@H]1CC[C@]2([C@@H](C1)C[C@H]([C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)O)C)C)O)C 10.1038/s41467-023-40064-9
CHEMBL240597 907 78 None -6 4 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 392 4 3 3 4.5 O[C@@H]1CC[C@]2([C@@H](C1)C[C@H]([C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)O)C)C)O)C 10.1038/s41467-023-40064-9
DB06777 907 78 None -6 4 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 392 4 3 3 4.5 O[C@@H]1CC[C@]2([C@@H](C1)C[C@H]([C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)O)C)C)O)C 10.1038/s41467-023-40064-9
657202 12498 6 None -524 4 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 282 6 0 2 3.5 CCCC(CCC)C(=O)O[C@H]1C[C@H]2CC[C@@H](C1)[N+]2(C)C 10.1038/s41467-023-40064-9
CHEMBL1186610 12498 6 None -524 4 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 282 6 0 2 3.5 CCCC(CCC)C(=O)O[C@H]1C[C@H]2CC[C@@H](C1)[N+]2(C)C 10.1038/s41467-023-40064-9
9911830 19116 100 None 1 2 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 454 6 2 7 5.6 COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC 10.1038/s41467-023-40064-9
CHEMBL1289494 19116 100 None 1 2 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 454 6 2 7 5.6 COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC 10.1038/s41467-023-40064-9
5281718 34220 84 None - 1 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 390 5 6 8 0.4 OC[C@H]1O[C@@H](Oc2cc(O)cc(/C=C/c3ccc(O)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O 10.1038/s41467-023-40064-9
CHEMBL142652 34220 84 None - 1 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 390 5 6 8 0.4 OC[C@H]1O[C@@H](Oc2cc(O)cc(/C=C/c3ccc(O)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O 10.1038/s41467-023-40064-9
4041 99483 18 None -19 4 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 270 1 0 2 3.6 CN1CCN=C(c2ccccc2)c2cc(Cl)ccc21 10.1038/s41467-023-40064-9
CHEMBL28333 99483 18 None -19 4 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 270 1 0 2 3.6 CN1CCN=C(c2ccccc2)c2cc(Cl)ccc21 10.1038/s41467-023-40064-9
2695 3812 81 None -2 6 Human 5.7 pAC50 = 5.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 10.1038/s41467-023-40064-9
5504 3812 81 None -2 6 Human 5.7 pAC50 = 5.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 10.1038/s41467-023-40064-9
7310 3812 81 None -2 6 Human 5.7 pAC50 = 5.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 10.1038/s41467-023-40064-9
CHEMBL770 3812 81 None -2 6 Human 5.7 pAC50 = 5.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 10.1038/s41467-023-40064-9
DB00797 3812 81 None -2 6 Human 5.7 pAC50 = 5.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 10.1038/s41467-023-40064-9
45138674 16614 50 None 1 6 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 572 6 1 7 5.7 COc1cccc(N2CCN(C3=Nc4c(F)cccc4[C@H](CC(=O)O)N3c3cc(C(F)(F)F)ccc3OC)CC2)c1 10.1038/s41467-023-40064-9
CHEMBL1241951 16614 50 None 1 6 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 572 6 1 7 5.7 COc1cccc(N2CCN(C3=Nc4c(F)cccc4[C@H](CC(=O)O)N3c3cc(C(F)(F)F)ccc3OC)CC2)c1 10.1038/s41467-023-40064-9
8569 22611 91 None -1 4 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 244 3 2 4 2.3 COc1ccc(C(=O)c2ccccc2O)c(O)c1 10.1038/s41467-023-40064-9
CHEMBL1326877 22611 91 None -1 4 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 244 3 2 4 2.3 COc1ccc(C(=O)c2ccccc2O)c(O)c1 10.1038/s41467-023-40064-9
24821094 67064 93 None -6 8 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 440 5 1 7 4.2 C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1 10.1038/s41467-023-40064-9
CHEMBL1873475 67064 93 None -6 8 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 440 5 1 7 4.2 C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1 10.1038/s41467-023-40064-9
3658 4076 53 None 1 18 Human 8.6 pAC50 = 8.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1038/s41467-023-40064-9
517 4076 53 None 1 18 Human 8.6 pAC50 = 8.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1038/s41467-023-40064-9
5709 4076 53 None 1 18 Human 8.6 pAC50 = 8.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1038/s41467-023-40064-9
CHEMBL312448 4076 53 None 1 18 Human 8.6 pAC50 = 8.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1038/s41467-023-40064-9
DB06694 4076 53 None 1 18 Human 8.6 pAC50 = 8.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1038/s41467-023-40064-9
1028 289 71 None 1 19 Human 8.6 pAC50 = 8.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
139148732 289 71 None 1 19 Human 8.6 pAC50 = 8.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
479 289 71 None 1 19 Human 8.6 pAC50 = 8.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
5816 289 71 None 1 19 Human 8.6 pAC50 = 8.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
CHEMBL679 289 71 None 1 19 Human 8.6 pAC50 = 8.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
DB00668 289 71 None 1 19 Human 8.6 pAC50 = 8.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
2146 3078 67 None -20 15 Human 8.6 pAC50 = 8.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
485 3078 67 None -20 15 Human 8.6 pAC50 = 8.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
6041 3078 67 None -20 15 Human 8.6 pAC50 = 8.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
CHEMBL1215 3078 67 None -20 15 Human 8.6 pAC50 = 8.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
DB00388 3078 67 None -20 15 Human 8.6 pAC50 = 8.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
4151 3580 89 None 1 10 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1038/s41467-023-40064-9
493 3580 89 None 1 10 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1038/s41467-023-40064-9
5312125 3580 89 None 1 10 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1038/s41467-023-40064-9
CHEMBL24778 3580 89 None 1 10 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1038/s41467-023-40064-9
DB06207 3580 89 None 1 10 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1038/s41467-023-40064-9
150 2492 21 None -194 17 Human 7.7 pAC50 = 7.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO 10.1038/s41467-023-40064-9
1764 2492 21 None -194 17 Human 7.7 pAC50 = 7.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO 10.1038/s41467-023-40064-9
8226 2492 21 None -194 17 Human 7.7 pAC50 = 7.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO 10.1038/s41467-023-40064-9
CHEMBL1201356 2492 21 None -194 17 Human 7.7 pAC50 = 7.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO 10.1038/s41467-023-40064-9
DB00353 2492 21 None -194 17 Human 7.7 pAC50 = 7.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO 10.1038/s41467-023-40064-9
135398737 955 93 None -17 43 Human 7.7 pAC50 = 7.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
38 955 93 None -17 43 Human 7.7 pAC50 = 7.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
722 955 93 None -17 43 Human 7.7 pAC50 = 7.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL42 955 93 None -17 43 Human 7.7 pAC50 = 7.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
DB00363 955 93 None -17 43 Human 7.7 pAC50 = 7.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
31729 205761 10 None -131 7 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 287 6 4 4 2.4 CC(NCCc1ccc(O)cc1)C(O)c1ccc(O)cc1 10.1038/s41467-023-40064-9
CHEMBL83063 205761 10 None -131 7 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 287 6 4 4 2.4 CC(NCCc1ccc(O)cc1)C(O)c1ccc(O)cc1 10.1038/s41467-023-40064-9
202 1496 77 None -3 17 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 10.1038/s41467-023-40064-9
60835 1496 77 None -3 17 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 10.1038/s41467-023-40064-9
972 1496 77 None -3 17 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL1175 1496 77 None -3 17 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 10.1038/s41467-023-40064-9
DB00476 1496 77 None -3 17 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 10.1038/s41467-023-40064-9
448537 160226 89 None -54 31 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 10.1038/s41467-023-40064-9
CHEMBL411 160226 89 None -54 31 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 10.1038/s41467-023-40064-9
3035016 12562 50 None -1 3 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 483 3 5 10 0.6 CC(=O)[C@]1(N)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](O)[C@H](O)CO2)C1)C(=O)c1ccccc1C3=O 10.1038/s41467-023-40064-9
CHEMBL1186894 12562 50 None -1 3 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 483 3 5 10 0.6 CC(=O)[C@]1(N)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](O)[C@H](O)CO2)C1)C(=O)c1ccccc1C3=O 10.1038/s41467-023-40064-9
89683805 154409 67 None -6760 6 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 473 6 3 8 4.3 CC(C)(O)CNc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1 10.1038/s41467-023-40064-9
CHEMBL3989908 154409 67 None -6760 6 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 473 6 3 8 4.3 CC(C)(O)CNc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1 10.1038/s41467-023-40064-9
44439 165663 19 None -63 2 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 377 9 3 5 2.8 COc1ccc(CCC(C)NCC(O)c2ccc(O)c([S+](C)[O-])c2)cc1 10.1038/s41467-023-40064-9
CHEMBL424518 165663 19 None -63 2 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 377 9 3 5 2.8 COc1ccc(CCC(C)NCC(O)c2ccc(O)c([S+](C)[O-])c2)cc1 10.1038/s41467-023-40064-9
444795 139974 105 None -57 6 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 300 5 1 1 5.6 CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1 10.1038/s41467-023-40064-9
CHEMBL38 139974 105 None -57 6 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 300 5 1 1 5.6 CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1 10.1038/s41467-023-40064-9
5489013 57375 32 None -21 6 Human 6.7 pAC50 = 6.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 313 8 2 4 3.0 COc1cccc(C(=O)CCN[C@@H](C)[C@H](O)c2ccccc2)c1 10.1038/s41467-023-40064-9
CHEMBL1651913 57375 32 None -21 6 Human 6.7 pAC50 = 6.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 313 8 2 4 3.0 COc1cccc(C(=O)CCN[C@@H](C)[C@H](O)c2ccccc2)c1 10.1038/s41467-023-40064-9
1923 104697 136 None -3 3 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 145 0 1 2 1.9 Oc1cccc2cccnc12 10.1038/s41467-023-40064-9
CHEMBL310555 104697 136 None -3 3 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 145 0 1 2 1.9 Oc1cccc2cccnc12 10.1038/s41467-023-40064-9
1753 2487 28 None 2 4 Human 7.7 pAC50 = 7.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 10.1038/s41467-023-40064-9
483 2487 28 None 2 4 Human 7.7 pAC50 = 7.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 10.1038/s41467-023-40064-9
6082 2487 28 None 2 4 Human 7.7 pAC50 = 7.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 10.1038/s41467-023-40064-9
CHEMBL524 2487 28 None 2 4 Human 7.7 pAC50 = 7.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 10.1038/s41467-023-40064-9
DB00723 2487 28 None 2 4 Human 7.7 pAC50 = 7.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 10.1038/s41467-023-40064-9
2726 916 68 None -29 42 Human 6.7 pAC50 = 6.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
621 916 68 None -29 42 Human 6.7 pAC50 = 6.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
83 916 68 None -29 42 Human 6.7 pAC50 = 6.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
CHEMBL71 916 68 None -29 42 Human 6.7 pAC50 = 6.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
DB00477 916 68 None -29 42 Human 6.7 pAC50 = 6.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
135409453 3744 41 None -363 36 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.1038/s41467-023-40064-9
226 3744 41 None -363 36 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.1038/s41467-023-40064-9
CHEMBL76370 3744 41 None -363 36 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.1038/s41467-023-40064-9
214 3831 58 None -22 28 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
2740 3831 58 None -22 28 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
5566 3831 58 None -22 28 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
66064 3831 58 None -22 28 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
CHEMBL422 3831 58 None -22 28 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
DB00831 3831 58 None -22 28 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
26248 161515 102 None -1 11 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 368 3 1 7 2.0 CC(=O)Oc1cccc2c1C(=O)c1c(OC(C)=O)cc(C(=O)O)cc1C2=O 10.1038/s41467-023-40064-9
CHEMBL41286 161515 102 None -1 11 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 368 3 1 7 2.0 CC(=O)Oc1cccc2c1C(=O)c1c(OC(C)=O)cc(C(=O)O)cc1C2=O 10.1038/s41467-023-40064-9
11289 14406 67 None -2 4 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 380 6 0 3 5.9 COc1ccc(C(Cl)=C(c2ccc(OC)cc2)c2ccc(OC)cc2)cc1 10.1038/s41467-023-40064-9
CHEMBL1200761 14406 67 None -2 4 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 380 6 0 3 5.9 COc1ccc(C(Cl)=C(c2ccc(OC)cc2)c2ccc(OC)cc2)cc1 10.1038/s41467-023-40064-9
2880 97980 49 None -13 9 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 310 5 0 3 4.6 C=C(c1ccccc1OCc1cccc(Cl)c1)n1ccnc1 10.1038/s41467-023-40064-9
CHEMBL27289 97980 49 None -13 9 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 310 5 0 3 4.6 C=C(c1ccccc1OCc1cccc(Cl)c1)n1ccnc1 10.1038/s41467-023-40064-9
3356 203345 81 None -33 3 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 414 7 2 4 3.4 O=C(NCC1CCCCN1)c1cc(OCC(F)(F)F)ccc1OCC(F)(F)F 10.1038/s41467-023-40064-9
CHEMBL1200822 203345 81 None -33 3 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 414 7 2 4 3.4 O=C(NCC1CCCCN1)c1cc(OCC(F)(F)F)ccc1OCC(F)(F)F 10.1038/s41467-023-40064-9
CHEMBL652 203345 81 None -33 3 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 414 7 2 4 3.4 O=C(NCC1CCCCN1)c1cc(OCC(F)(F)F)ccc1OCC(F)(F)F 10.1038/s41467-023-40064-9
54684141 207977 82 None 1 2 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 270 2 2 3 3.0 C/C(O)=C(\C#N)C(=O)Nc1ccc(C(F)(F)F)cc1 10.1038/s41467-023-40064-9
CHEMBL973 207977 82 None 1 2 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 270 2 2 3 3.0 C/C(O)=C(\C#N)C(=O)Nc1ccc(C(F)(F)F)cc1 10.1038/s41467-023-40064-9
1499 2078 47 None -44668 38 Human 5.7 pAC50 = 5.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1038/s41467-023-40064-9
3779 2078 47 None -44668 38 Human 5.7 pAC50 = 5.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1038/s41467-023-40064-9
536 2078 47 None -44668 38 Human 5.7 pAC50 = 5.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1038/s41467-023-40064-9
CHEMBL434 2078 47 None -44668 38 Human 5.7 pAC50 = 5.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1038/s41467-023-40064-9
DB01064 2078 47 None -44668 38 Human 5.7 pAC50 = 5.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1038/s41467-023-40064-9
16564 204972 32 None -144 6 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 207 2 3 3 0.3 N=C(N)NCC1COc2ccccc2O1 10.1038/s41467-023-40064-9
CHEMBL76725 204972 32 None -144 6 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 207 2 3 3 0.3 N=C(N)NCC1COc2ccccc2O1 10.1038/s41467-023-40064-9
2028 2958 80 None -10715 14 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 357 7 1 4 3.3 CCN(CC#CCOC(=O)C(c1ccccc1)(C1CCCCC1)O)CC 10.1038/s41467-023-40064-9
359 2958 80 None -10715 14 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 357 7 1 4 3.3 CCN(CC#CCOC(=O)C(c1ccccc1)(C1CCCCC1)O)CC 10.1038/s41467-023-40064-9
4634 2958 80 None -10715 14 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 357 7 1 4 3.3 CCN(CC#CCOC(=O)C(c1ccccc1)(C1CCCCC1)O)CC 10.1038/s41467-023-40064-9
CHEMBL1231 2958 80 None -10715 14 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 357 7 1 4 3.3 CCN(CC#CCOC(=O)C(c1ccccc1)(C1CCCCC1)O)CC 10.1038/s41467-023-40064-9
DB01062 2958 80 None -10715 14 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 357 7 1 4 3.3 CCN(CC#CCOC(=O)C(c1ccccc1)(C1CCCCC1)O)CC 10.1038/s41467-023-40064-9
34040 28054 72 None -7244 11 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 483 4 0 6 3.9 CO[C@]12C[C@@H](COC(=O)c3cncc(Br)c3)CN(C)[C@@H]1Cc1cn(C)c3cccc2c13 10.1038/s41467-023-40064-9
CHEMBL1372950 28054 72 None -7244 11 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 483 4 0 6 3.9 CO[C@]12C[C@@H](COC(=O)c3cncc(Br)c3)CN(C)[C@@H]1Cc1cn(C)c3cccc2c13 10.1038/s41467-023-40064-9
3081361 93905 123 None -35 14 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 474 5 1 5 4.4 COc1cc2/c(=N/c3ccc(Br)cc3F)nc[nH]c2cc1OCC1CCN(C)CC1 10.1038/s41467-023-40064-9
CHEMBL24828 93905 123 None -35 14 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 474 5 1 5 4.4 COc1cc2/c(=N/c3ccc(Br)cc3F)nc[nH]c2cc1OCC1CCN(C)CC1 10.1038/s41467-023-40064-9
5344 173449 101 None -3981 6 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 267 3 2 5 1.7 Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C 10.1038/s41467-023-40064-9
CHEMBL453 173449 101 None -3981 6 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 267 3 2 5 1.7 Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C 10.1038/s41467-023-40064-9
3157 1458 71 None -38 22 Human 7.7 pAC50 = 7.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
7170 1458 71 None -38 22 Human 7.7 pAC50 = 7.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
954 1458 71 None -38 22 Human 7.7 pAC50 = 7.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
CHEMBL707 1458 71 None -38 22 Human 7.7 pAC50 = 7.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
DB00590 1458 71 None -38 22 Human 7.7 pAC50 = 7.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
2142 3074 58 None -1 18 Human 6.7 pAC50 = 6.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
4920903 3074 58 None -1 18 Human 6.7 pAC50 = 6.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
502 3074 58 None -1 18 Human 6.7 pAC50 = 6.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
5775 3074 58 None -1 18 Human 6.7 pAC50 = 6.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
CHEMBL597 3074 58 None -1 18 Human 6.7 pAC50 = 6.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
DB00692 3074 58 None -1 18 Human 6.7 pAC50 = 6.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
1890 2739 49 None -4 24 Human 5.7 pAC50 = 5.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
4449 2739 49 None -4 24 Human 5.7 pAC50 = 5.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
7247 2739 49 None -4 24 Human 5.7 pAC50 = 5.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
CHEMBL623 2739 49 None -4 24 Human 5.7 pAC50 = 5.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
DB01149 2739 49 None -4 24 Human 5.7 pAC50 = 5.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
10453870 73633 62 None -1 2 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 404 4 4 6 2.1 OC[C@H]1O[C@@H](c2ccc(F)c(Cc3cc4ccccc4s3)c2)[C@H](O)[C@@H](O)[C@@H]1O 10.1038/s41467-023-40064-9
CHEMBL2018096 73633 62 None -1 2 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 404 4 4 6 2.1 OC[C@H]1O[C@@H](c2ccc(F)c(Cc3cc4ccccc4s3)c2)[C@H](O)[C@@H](O)[C@@H]1O 10.1038/s41467-023-40064-9
9419 35892 35 None -72 7 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 295 3 0 3 3.0 CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21 10.1038/s41467-023-40064-9
CHEMBL1442422 35892 35 None -72 7 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 295 3 0 3 3.0 CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21 10.1038/s41467-023-40064-9
4601 206724 35 None -1148 19 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 269 6 0 2 3.7 Cc1ccccc1C(OCCN(C)C)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL1201023 206724 35 None -1148 19 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 269 6 0 2 3.7 Cc1ccccc1C(OCCN(C)C)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL900 206724 35 None -1148 19 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 269 6 0 2 3.7 Cc1ccccc1C(OCCN(C)C)c1ccccc1 10.1038/s41467-023-40064-9
8609 14412 66 None -1 4 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 229 2 2 4 2.2 Nc1ccc(C(=O)Oc2ccccc2)c(O)c1 10.1038/s41467-023-40064-9
CHEMBL1200868 14412 66 None -1 4 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 229 2 2 4 2.2 Nc1ccc(C(=O)Oc2ccccc2)c(O)c1 10.1038/s41467-023-40064-9
5205 78158 58 None -2 8 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 261 0 0 1 3.8 CN1CCC2=C(C1)c1ccccc1Cc1ccccc12 10.1038/s41467-023-40064-9
CHEMBL2104895 78158 58 None -2 8 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 261 0 0 1 3.8 CN1CCC2=C(C1)c1ccccc1Cc1ccccc12 10.1038/s41467-023-40064-9
1209 1645 75 None -91 20 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1038/s41467-023-40064-9
203 1645 75 None -91 20 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1038/s41467-023-40064-9
3386 1645 75 None -91 20 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1038/s41467-023-40064-9
CHEMBL41 1645 75 None -91 20 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1038/s41467-023-40064-9
DB00472 1645 75 None -91 20 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1038/s41467-023-40064-9
2202 3110 96 None -389 10 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 10.1038/s41467-023-40064-9
4850 3110 96 None -389 10 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 10.1038/s41467-023-40064-9
49 3110 96 None -389 10 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 10.1038/s41467-023-40064-9
CHEMBL1371770 3110 96 None -389 10 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 10.1038/s41467-023-40064-9
DB12478 3110 96 None -389 10 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 10.1038/s41467-023-40064-9
39941 118280 54 None - 1 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 301 3 1 3 4.3 CC(C(=O)O)c1ccc2oc(-c3ccc(Cl)cc3)nc2c1 10.1038/s41467-023-40064-9
CHEMBL340978 118280 54 None - 1 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 301 3 1 3 4.3 CC(C(=O)O)c1ccc2oc(-c3ccc(Cl)cc3)nc2c1 10.1038/s41467-023-40064-9
5280453 205948 74 None -5 8 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 416 6 3 3 5.7 C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)CCCC(C)(C)O)CC[C@@H]23)C[C@@H](O)C[C@@H]1O 10.1038/s41467-023-40064-9
CHEMBL846 205948 74 None -5 8 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 416 6 3 3 5.7 C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)CCCC(C)(C)O)CC[C@@H]23)C[C@@H](O)C[C@@H]1O 10.1038/s41467-023-40064-9
2749 32613 101 None 1 3 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 207 1 1 3 2.4 Cc1cc(C2CCCCC2)n(O)c(=O)c1 10.1038/s41467-023-40064-9
CHEMBL1413 32613 101 None 1 3 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 207 1 1 3 2.4 Cc1cc(C2CCCCC2)n(O)c(=O)c1 10.1038/s41467-023-40064-9
9846332 52029 37 None -1 3 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 444 2 3 5 2.4 C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C(Cl)=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO 10.1038/s41467-023-40064-9
CHEMBL1587228 52029 37 None -1 3 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 444 2 3 5 2.4 C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C(Cl)=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO 10.1038/s41467-023-40064-9
3157 1458 71 None -38 22 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
7170 1458 71 None -38 22 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
954 1458 71 None -38 22 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
CHEMBL707 1458 71 None -38 22 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
DB00590 1458 71 None -38 22 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
27901 78178 22 None -33 8 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 286 4 0 3 3.8 CN1CCC(N(Cc2cccs2)c2ccccc2)CC1 10.1038/s41467-023-40064-9
CHEMBL2105458 78178 22 None -33 8 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 286 4 0 3 3.8 CN1CCC(N(Cc2cccs2)c2ccccc2)CC1 10.1038/s41467-023-40064-9
2993 114666 24 None -177 13 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 456 11 2 2 6.2 Cc1cc(N)c2ccccc2[n+]1CCCCCCCCCC[n+]1c(C)cc(N)c2ccccc21 10.1038/s41467-023-40064-9
CHEMBL121663 114666 24 None -177 13 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 456 11 2 2 6.2 Cc1cc(N)c2ccccc2[n+]1CCCCCCCCCC[n+]1c(C)cc(N)c2ccccc21 10.1038/s41467-023-40064-9
CHEMBL333826 114666 24 None -177 13 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 456 11 2 2 6.2 Cc1cc(N)c2ccccc2[n+]1CCCCCCCCCC[n+]1c(C)cc(N)c2ccccc21 10.1038/s41467-023-40064-9
1343 1876 62 None -9 12 Human 7.6 pAC50 = 7.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 10.1038/s41467-023-40064-9
3519 1876 62 None -9 12 Human 7.6 pAC50 = 7.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 10.1038/s41467-023-40064-9
522 1876 62 None -9 12 Human 7.6 pAC50 = 7.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 10.1038/s41467-023-40064-9
CHEMBL862 1876 62 None -9 12 Human 7.6 pAC50 = 7.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 10.1038/s41467-023-40064-9
DB01018 1876 62 None -9 12 Human 7.6 pAC50 = 7.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 10.1038/s41467-023-40064-9
2169 44817 35 None -4 12 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 380 9 3 6 1.4 COc1ccccc1OCCNCC(O)c1ccc(C)c(S(N)(=O)=O)c1 10.1038/s41467-023-40064-9
CHEMBL152231 44817 35 None -4 12 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 380 9 3 6 1.4 COc1ccccc1OCCNCC(O)c1ccc(C)c(S(N)(=O)=O)c1 10.1038/s41467-023-40064-9
9853053 120493 74 None -1 9 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 693 10 2 3 8.4 O=C(NC1CCN(CCCCC2(C(=O)NCC(F)(F)F)c3ccccc3-c3ccccc32)CC1)c1ccccc1-c1ccc(C(F)(F)F)cc1 10.1038/s41467-023-40064-9
CHEMBL354541 120493 74 None -1 9 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 693 10 2 3 8.4 O=C(NC1CCN(CCCCC2(C(=O)NCC(F)(F)F)c3ccccc3-c3ccccc32)CC1)c1ccccc1-c1ccc(C(F)(F)F)cc1 10.1038/s41467-023-40064-9
93154 5404 29 None -316 8 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 304 1 0 2 4.0 c1ccc2c(c1)CCc1ccccc1N2C1CN2CCC1CC2 10.1038/s41467-023-40064-9
CHEMBL107360 5404 29 None -316 8 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 304 1 0 2 4.0 c1ccc2c(c1)CCc1ccccc1N2C1CN2CCC1CC2 10.1038/s41467-023-40064-9
3735 206208 76 None -1 3 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 571 4 2 2 3.7 CCC(Cc1c(I)cc(I)c(N)c1I)C(=O)O 10.1038/s41467-023-40064-9
CHEMBL867 206208 76 None -1 3 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 571 4 2 2 3.7 CCC(Cc1c(I)cc(I)c(N)c1I)C(=O)O 10.1038/s41467-023-40064-9
65863 14433 57 None -14 11 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 436 6 0 4 7.0 Clc1ccc(C(Cn2ccnc2)OCc2csc3c(Cl)cccc23)c(Cl)c1 10.1038/s41467-023-40064-9
CHEMBL1201196 14433 57 None -14 11 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 436 6 0 4 7.0 Clc1ccc(C(Cn2ccnc2)OCc2csc3c(Cl)cccc23)c(Cl)c1 10.1038/s41467-023-40064-9
7547 5472 94 None -3 4 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 2 2 1 5.3 O=C(Nc1ccc(Cl)cc1)Nc1ccc(Cl)c(Cl)c1 10.1038/s41467-023-40064-9
CHEMBL1076347 5472 94 None -3 4 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 2 2 1 5.3 O=C(Nc1ccc(Cl)cc1)Nc1ccc(Cl)c(Cl)c1 10.1038/s41467-023-40064-9
65646 121275 26 None -2 3 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 461 6 2 9 0.8 Cc1oc(=O)oc1COC(=O)[C@@H]1N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1(C)C 10.1038/s41467-023-40064-9
CHEMBL3580454 121275 26 None -2 3 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 461 6 2 9 0.8 Cc1oc(=O)oc1COC(=O)[C@@H]1N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1(C)C 10.1038/s41467-023-40064-9
71743 78238 62 None -1 4 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 353 3 0 4 3.6 O=C(Oc1ccc2c(c1)CCCN2C(=O)C(Cl)Cl)c1ccco1 10.1038/s41467-023-40064-9
CHEMBL2107014 78238 62 None -1 4 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 353 3 0 4 3.6 O=C(Oc1ccc2c(c1)CCCN2C(=O)C(Cl)Cl)c1ccco1 10.1038/s41467-023-40064-9
5440 28693 37 None -1995 16 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 399 6 0 5 5.0 CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2 10.1038/s41467-023-40064-9
CHEMBL1378 28693 37 None -1995 16 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 399 6 0 5 5.0 CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2 10.1038/s41467-023-40064-9
2705 3813 64 None -1288 9 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 325 7 1 2 5.3 Cc1ccc(c(c1)[C@@H](c1ccccc1)CCN(C(C)C)C(C)C)O 10.1038/s41467-023-40064-9
360 3813 64 None -1288 9 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 325 7 1 2 5.3 Cc1ccc(c(c1)[C@@H](c1ccccc1)CCN(C(C)C)C(C)C)O 10.1038/s41467-023-40064-9
443879 3813 64 None -1288 9 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 325 7 1 2 5.3 Cc1ccc(c(c1)[C@@H](c1ccccc1)CCN(C(C)C)C(C)C)O 10.1038/s41467-023-40064-9
CHEMBL1382 3813 64 None -1288 9 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 325 7 1 2 5.3 Cc1ccc(c(c1)[C@@H](c1ccccc1)CCN(C(C)C)C(C)C)O 10.1038/s41467-023-40064-9
DB01036 3813 64 None -1288 9 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 325 7 1 2 5.3 Cc1ccc(c(c1)[C@@H](c1ccccc1)CCN(C(C)C)C(C)C)O 10.1038/s41467-023-40064-9
104870 98852 47 None -8 10 Human 5.6 pAC50 = 5.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 209 2 1 4 1.3 C=CCN1CCc2nc(N)sc2CC1 10.1038/s41467-023-40064-9
5374 98852 47 None -8 10 Human 5.6 pAC50 = 5.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 209 2 1 4 1.3 C=CCN1CCc2nc(N)sc2CC1 10.1038/s41467-023-40064-9
CHEMBL279085 98852 47 None -8 10 Human 5.6 pAC50 = 5.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 209 2 1 4 1.3 C=CCN1CCc2nc(N)sc2CC1 10.1038/s41467-023-40064-9
21722 17960 31 None -16 21 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 284 4 0 2 4.3 CN(C)CCCn1c2c(c3ccccc31)CCCCCC2 10.1038/s41467-023-40064-9
CHEMBL126224 17960 31 None -16 21 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 284 4 0 2 4.3 CN(C)CCCn1c2c(c3ccccc31)CCCCCC2 10.1038/s41467-023-40064-9
5282219 35839 63 None -4 9 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 450 12 1 5 5.7 CC(C)=CCOc1ccc(/C=C/C(=O)c2ccc(OCC=C(C)C)cc2OCC(=O)O)cc1 10.1038/s41467-023-40064-9
CHEMBL1441961 35839 63 None -4 9 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 450 12 1 5 5.7 CC(C)=CCOc1ccc(/C=C/C(=O)c2ccc(OCC=C(C)C)cc2OCC(=O)O)cc1 10.1038/s41467-023-40064-9
16678941 78124 109 None -1 2 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 452 5 2 5 4.7 Cc1ccc(NC(=O)C2(c3ccc4c(c3)OC(F)(F)O4)CC2)nc1-c1cccc(C(=O)O)c1 10.1038/s41467-023-40064-9
CHEMBL2103870 78124 109 None -1 2 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 452 5 2 5 4.7 Cc1ccc(NC(=O)C2(c3ccc4c(c3)OC(F)(F)O4)CC2)nc1-c1cccc(C(=O)O)c1 10.1038/s41467-023-40064-9
71927 78374 18 None -2 2 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 202 2 1 3 0.9 COc1cc(N)cn[n+]1-c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL2106667 78374 18 None -2 2 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 202 2 1 3 0.9 COc1cc(N)cn[n+]1-c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL2110922 78374 18 None -2 2 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 202 2 1 3 0.9 COc1cc(N)cn[n+]1-c1ccccc1 10.1038/s41467-023-40064-9
1549120 196463 85 None -16 19 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 319 4 1 4 2.9 CC(/C=C1\SC(=S)N(CC(=O)O)C1=O)=C\c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL56337 196463 85 None -16 19 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 319 4 1 4 2.9 CC(/C=C1\SC(=S)N(CC(=O)O)C1=O)=C\c1ccccc1 10.1038/s41467-023-40064-9
24821094 67064 93 None -6 8 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 440 5 1 7 4.2 C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1 10.1038/s41467-023-40064-9
CHEMBL1873475 67064 93 None -6 8 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 440 5 1 7 4.2 C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1 10.1038/s41467-023-40064-9
446156 39795 29 None -1 3 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 459 11 3 5 4.9 COCc1c(C(C)C)nc(C(C)C)c(/C=C/[C@@H](O)C[C@@H](O)CC(=O)O)c1-c1ccc(F)cc1 10.1038/s41467-023-40064-9
CHEMBL1477 39795 29 None -1 3 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 459 11 3 5 4.9 COCc1c(C(C)C)nc(C(C)C)c(/C=C/[C@@H](O)C[C@@H](O)CC(=O)O)c1-c1ccc(F)cc1 10.1038/s41467-023-40064-9
1027 1563 73 None -676 7 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 249 0 2 1 2.7 N=C1NCC2N1c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
3241 1563 73 None -676 7 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 249 0 2 1 2.7 N=C1NCC2N1c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
7176 1563 73 None -676 7 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 249 0 2 1 2.7 N=C1NCC2N1c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
CHEMBL1106 1563 73 None -676 7 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 249 0 2 1 2.7 N=C1NCC2N1c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
DB00751 1563 73 None -676 7 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 249 0 2 1 2.7 N=C1NCC2N1c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
37464 19189 26 None -707 8 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 291 6 2 3 3.5 CC(C)(C)NC[C@H](O)COc1ccccc1C1CCCC1 10.1038/s41467-023-40064-9
CHEMBL1290 19189 26 None -707 8 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 291 6 2 3 3.5 CC(C)(C)NC[C@H](O)COc1ccccc1C1CCCC1 10.1038/s41467-023-40064-9
37907 35368 88 None -2 3 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 292 4 0 4 3.7 CC(C)(C)C(=O)C(Oc1ccc(Cl)cc1)n1ccnc1 10.1038/s41467-023-40064-9
CHEMBL1437764 35368 88 None -2 3 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 292 4 0 4 3.7 CC(C)(C)C(=O)C(Oc1ccc(Cl)cc1)n1ccnc1 10.1038/s41467-023-40064-9
3336 94972 30 None -5248 14 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 315 7 1 1 5.6 CC(NCCC(c1ccccc1)c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL1405922 94972 30 None -5248 14 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 315 7 1 1 5.6 CC(NCCC(c1ccccc1)c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL254832 94972 30 None -5248 14 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 315 7 1 1 5.6 CC(NCCC(c1ccccc1)c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
6989 100925 115 None -2 3 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 150 1 1 1 2.8 Cc1ccc(C(C)C)c(O)c1 10.1038/s41467-023-40064-9
CHEMBL29411 100925 115 None -2 3 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 150 1 1 1 2.8 Cc1ccc(C(C)C)c(O)c1 10.1038/s41467-023-40064-9
60663 175645 42 None -8 12 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 495 11 1 5 5.3 COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C 10.1038/s41467-023-40064-9
CHEMBL1421212 175645 42 None -8 12 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 495 11 1 5 5.3 COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C 10.1038/s41467-023-40064-9
CHEMBL1534525 175645 42 None -8 12 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 495 11 1 5 5.3 COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C 10.1038/s41467-023-40064-9
CHEMBL45816 175645 42 None -8 12 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 495 11 1 5 5.3 COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C 10.1038/s41467-023-40064-9
3606 203465 60 None -3 8 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 270 5 2 2 4.8 CCC(c1ccc(O)cc1)C(CC)c1ccc(O)cc1 10.1038/s41467-023-40064-9
CHEMBL6615 203465 60 None -3 8 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 270 5 2 2 4.8 CCC(c1ccc(O)cc1)C(CC)c1ccc(O)cc1 10.1038/s41467-023-40064-9
65948 18524 109 None -12 6 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 582 9 2 9 4.7 CC1=C(C(=O)OC(C)C)C(c2cccc([N+](=O)[O-])c2)C(C(=O)OC2CN(C(c3ccccc3)c3ccccc3)C2)=C(N)N1 10.1038/s41467-023-40064-9
CHEMBL1275868 18524 109 None -12 6 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 582 9 2 9 4.7 CC1=C(C(=O)OC(C)C)C(c2cccc([N+](=O)[O-])c2)C(C(=O)OC2CN(C(c3ccccc3)c3ccccc3)C2)=C(N)N1 10.1038/s41467-023-40064-9
54679224 59873 113 None - 1 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 145 0 2 3 1.1 Oc1cc(O)c(Cl)cn1 10.1038/s41467-023-40064-9
CHEMBL1730601 59873 113 None - 1 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 145 0 2 3 1.1 Oc1cc(O)c(Cl)cn1 10.1038/s41467-023-40064-9
180 400 56 None -63 38 Human 7.6 pAC50 = 7.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
200 400 56 None -63 38 Human 7.6 pAC50 = 7.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
2160 400 56 None -63 38 Human 7.6 pAC50 = 7.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
CHEMBL629 400 56 None -63 38 Human 7.6 pAC50 = 7.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
DB00321 400 56 None -63 38 Human 7.6 pAC50 = 7.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
2389 3306 118 None -13 29 Human 7.6 pAC50 = 7.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
5073 3306 118 None -13 29 Human 7.6 pAC50 = 7.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
96 3306 118 None -13 29 Human 7.6 pAC50 = 7.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
CHEMBL85 3306 118 None -13 29 Human 7.6 pAC50 = 7.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
DB00734 3306 118 None -13 29 Human 7.6 pAC50 = 7.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
2337 3232 77 None -4 29 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
50 3232 77 None -4 29 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
5002 3232 77 None -4 29 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL716 3232 77 None -4 29 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
DB01224 3232 77 None -4 29 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
135 2515 43 None -72 33 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
1796 2515 43 None -72 33 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
4184 2515 43 None -72 33 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
CHEMBL6437 2515 43 None -72 33 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
DB06148 2515 43 None -72 33 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
2333 142310 97 None -2 14 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 422 3 1 3 5.5 CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1 10.1038/s41467-023-40064-9
CHEMBL388590 142310 97 None -2 14 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 422 3 1 3 5.5 CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1 10.1038/s41467-023-40064-9
135 2515 43 None -72 33 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
1796 2515 43 None -72 33 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
4184 2515 43 None -72 33 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
CHEMBL6437 2515 43 None -72 33 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
DB06148 2515 43 None -72 33 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
135400189 44545 73 None -26 4 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 488 8 1 8 2.1 CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12 10.1038/s41467-023-40064-9
CHEMBL1520 44545 73 None -26 4 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 488 8 1 8 2.1 CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12 10.1038/s41467-023-40064-9
1155 1616 53 None -257 11 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
3343 1616 53 None -257 11 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
557 1616 53 None -257 11 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
CHEMBL32800 1616 53 None -257 11 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
DB01288 1616 53 None -257 11 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
65981 18422 102 None -2 3 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 452 10 2 4 5.2 CCOc1cc(CC(=O)N[C@@H](CC(C)C)c2ccccc2N2CCCCC2)ccc1C(=O)O 10.1038/s41467-023-40064-9
CHEMBL1272 18422 102 None -2 3 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 452 10 2 4 5.2 CCOc1cc(CC(=O)N[C@@H](CC(C)C)c2ccccc2N2CCCCC2)ccc1C(=O)O 10.1038/s41467-023-40064-9
6010 30667 44 None -1 2 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 302 0 1 2 4.3 C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O 10.1038/s41467-023-40064-9
CHEMBL1395 30667 44 None -1 2 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 302 0 1 2 4.3 C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O 10.1038/s41467-023-40064-9
5328940 100188 107 None -3 23 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 529 9 1 8 5.2 COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl 10.1038/s41467-023-40064-9
CHEMBL288441 100188 107 None -3 23 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 529 9 1 8 5.2 COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl 10.1038/s41467-023-40064-9
1960 2838 67 None -2 19 Human 6.6 pAC50 = 6.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
439260 2838 67 None -2 19 Human 6.6 pAC50 = 6.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
505 2838 67 None -2 19 Human 6.6 pAC50 = 6.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
CHEMBL1437 2838 67 None -2 19 Human 6.6 pAC50 = 6.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
DB00368 2838 67 None -2 19 Human 6.6 pAC50 = 6.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
2448 99295 70 None -12 15 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 419 6 1 3 4.5 O=C(CCCN1CCC(O)(c2ccc(Br)cc2)CC1)c1ccc(F)cc1 10.1038/s41467-023-40064-9
CHEMBL28218 99295 70 None -12 15 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 419 6 1 3 4.5 O=C(CCCN1CCC(O)(c2ccc(Br)cc2)CC1)c1ccc(F)cc1 10.1038/s41467-023-40064-9
3151 1450 97 None -223 24 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
945 1450 97 None -223 24 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
965 1450 97 None -223 24 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL219916 1450 97 None -223 24 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
DB01184 1450 97 None -223 24 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
6256 9639 86 None - 1 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 296 2 3 6 -0.8 O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1C(F)(F)F 10.1038/s41467-023-40064-9
CHEMBL1129 9639 86 None - 1 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 296 2 3 6 -0.8 O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1C(F)(F)F 10.1038/s41467-023-40064-9
4006 59079 94 None - 1 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 288 4 0 6 3.1 CC(C)OC(=O)C(C(=O)OC(C)C)=C1SC=CS1 10.1038/s41467-023-40064-9
CHEMBL1697754 59079 94 None - 1 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 288 4 0 6 3.1 CC(C)OC(=O)C(C(=O)OC(C)C)=C1SC=CS1 10.1038/s41467-023-40064-9
14052 172554 51 None -5495 5 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 204 9 4 4 -0.3 CC[C@@H](CO)NCCN[C@@H](CC)CO 10.1038/s41467-023-40064-9
CHEMBL44884 172554 51 None -5495 5 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 204 9 4 4 -0.3 CC[C@@H](CO)NCCN[C@@H](CC)CO 10.1038/s41467-023-40064-9
1046 202629 116 None -1412 5 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 123 1 1 3 -0.4 NC(=O)c1cnccn1 10.1038/s41467-023-40064-9
CHEMBL614 202629 116 None -1412 5 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 123 1 1 3 -0.4 NC(=O)c1cnccn1 10.1038/s41467-023-40064-9
43082 60253 37 None -72 10 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 357 6 0 2 5.5 CC(OCCN1CCCCCC1)(c1ccccc1)c1ccc(Cl)cc1 10.1038/s41467-023-40064-9
CHEMBL1742452 60253 37 None -72 10 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 357 6 0 2 5.5 CC(OCCN1CCCCCC1)(c1ccccc1)c1ccc(Cl)cc1 10.1038/s41467-023-40064-9
219024 3275 65 None -6456 5 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 390 4 5 12 -2.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(nc2N)n1ncc(c1)C(=O)NC 10.1038/s41467-023-40064-9
2362 3275 65 None -6456 5 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 390 4 5 12 -2.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(nc2N)n1ncc(c1)C(=O)NC 10.1038/s41467-023-40064-9
5596 3275 65 None -6456 5 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 390 4 5 12 -2.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(nc2N)n1ncc(c1)C(=O)NC 10.1038/s41467-023-40064-9
CHEMBL317052 3275 65 None -6456 5 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 390 4 5 12 -2.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(nc2N)n1ncc(c1)C(=O)NC 10.1038/s41467-023-40064-9
DB06213 3275 65 None -6456 5 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 390 4 5 12 -2.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(nc2N)n1ncc(c1)C(=O)NC 10.1038/s41467-023-40064-9
2520 203985 70 None -50 20 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC 10.1038/s41467-023-40064-9
CHEMBL1280 203985 70 None -50 20 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC 10.1038/s41467-023-40064-9
CHEMBL6966 203985 70 None -50 20 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC 10.1038/s41467-023-40064-9
11154555 797 62 None -1096 10 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 5 1 3 4.3 O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
5037 797 62 None -1096 10 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 5 1 3 4.3 O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
7671 797 62 None -1096 10 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 5 1 3 4.3 O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
CHEMBL2028019 797 62 None -1096 10 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 5 1 3 4.3 O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
CHEMBL3085826 797 62 None -1096 10 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 5 1 3 4.3 O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
DB06016 797 62 None -1096 10 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 5 1 3 4.3 O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
2406 100376 89 None -16 17 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 354 2 2 3 5.9 Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O 10.1038/s41467-023-40064-9
CHEMBL290106 100376 89 None -16 17 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 354 2 2 3 5.9 Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O 10.1038/s41467-023-40064-9
3627 44099 18 None -39 9 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 3 0 2 4.1 CN1CCCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1 10.1038/s41467-023-40064-9
CHEMBL1515447 44099 18 None -39 9 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 3 0 2 4.1 CN1CCCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1 10.1038/s41467-023-40064-9
2247 504 81 None -26 42 Human 7.5 pAC50 = 7.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
249 504 81 None -26 42 Human 7.5 pAC50 = 7.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
2603 504 81 None -26 42 Human 7.5 pAC50 = 7.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
CHEMBL296419 504 81 None -26 42 Human 7.5 pAC50 = 7.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
DB00637 504 81 None -26 42 Human 7.5 pAC50 = 7.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
2749 343 40 None -1 10 Human 7.5 pAC50 = 7.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 298 4 0 3 4.5 CN(CC(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
5574 343 40 None -1 10 Human 7.5 pAC50 = 7.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 298 4 0 3 4.5 CN(CC(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
7237 343 40 None -1 10 Human 7.5 pAC50 = 7.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 298 4 0 3 4.5 CN(CC(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
CHEMBL829 343 40 None -1 10 Human 7.5 pAC50 = 7.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 298 4 0 3 4.5 CN(CC(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
DB01246 343 40 None -1 10 Human 7.5 pAC50 = 7.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 298 4 0 3 4.5 CN(CC(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
2142 3074 58 None -1 18 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
4920903 3074 58 None -1 18 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
502 3074 58 None -1 18 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
5775 3074 58 None -1 18 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
CHEMBL597 3074 58 None -1 18 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
DB00692 3074 58 None -1 18 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
6337614 12964 54 None -26 6 Human 4.5 pAC50 = 4.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 296 1 0 2 2.7 O=C1c2cccc3c2[C@H](CCC3)CN1[C@@H]1CN2CCC1CC2 10.1038/s41467-023-40064-9
CHEMBL1189679 12964 54 None -26 6 Human 4.5 pAC50 = 4.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 296 1 0 2 2.7 O=C1c2cccc3c2[C@H](CCC3)CN1[C@@H]1CN2CCC1CC2 10.1038/s41467-023-40064-9
242 469 124 None -120 33 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
34 469 124 None -120 33 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
60795 469 124 None -120 33 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
CHEMBL1112 469 124 None -120 33 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
DB01238 469 124 None -120 33 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
9051 14410 67 None -5 3 Human 4.5 pAC50 = 4.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 312 1 0 2 4.5 CC(=O)[C@H]1CC[C@H]2[C@@H]3C=CC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C 10.1038/s41467-023-40064-9
CHEMBL1200853 14410 67 None -5 3 Human 4.5 pAC50 = 4.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 312 1 0 2 4.5 CC(=O)[C@H]1CC[C@H]2[C@@H]3C=CC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C 10.1038/s41467-023-40064-9
4121 50805 62 None -1 2 Human 4.5 pAC50 = 4.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 359 2 2 5 0.6 CN1C(CCl)Nc2cc(Cl)c(S(N)(=O)=O)cc2S1(=O)=O 10.1038/s41467-023-40064-9
CHEMBL1577 50805 62 None -1 2 Human 4.5 pAC50 = 4.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 359 2 2 5 0.6 CN1C(CCl)Nc2cc(Cl)c(S(N)(=O)=O)cc2S1(=O)=O 10.1038/s41467-023-40064-9
24765256 173273 23 None -2 4 Human 4.5 pAC50 = 4.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 757 6 3 9 3.9 CC[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H]2CN1C(=O)[C@H](C(C)(C)C)NC(=O)OCC(C)(C)CCCCc1cccc3c1CN(C3)C(=O)O2)C(=O)NS(=O)(=O)C1CC1 10.1038/s41467-023-40064-9
CHEMBL4525964 173273 23 None -2 4 Human 4.5 pAC50 = 4.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 757 6 3 9 3.9 CC[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H]2CN1C(=O)[C@H](C(C)(C)C)NC(=O)OCC(C)(C)CCCCc1cccc3c1CN(C3)C(=O)O2)C(=O)NS(=O)(=O)C1CC1 10.1038/s41467-023-40064-9
15387 45792 55 None 1 8 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 263 5 0 2 3.5 CC1CCN(CCCC(=O)c2ccc(F)cc2)CC1 10.1038/s41467-023-40064-9
CHEMBL1531134 45792 55 None 1 8 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 263 5 0 2 3.5 CC1CCN(CCCC(=O)c2ccc(F)cc2)CC1 10.1038/s41467-023-40064-9
5748845 78202 12 None - 1 Human 4.5 pAC50 = 4.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 522 9 4 13 -3.2 CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[n+]3ccc(N)n3CCO)CS[C@H]12)c1csc(N)n1 10.1038/s41467-023-40064-9
CHEMBL2105940 78202 12 None - 1 Human 4.5 pAC50 = 4.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 522 9 4 13 -3.2 CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[n+]3ccc(N)n3CCO)CS[C@H]12)c1csc(N)n1 10.1038/s41467-023-40064-9
68818 78239 28 None 3 3 Human 8.5 pAC50 = 8.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 217 1 2 3 2.2 c1ccc2c(SC3=NCCN3)c[nH]c2c1 10.1038/s41467-023-40064-9
CHEMBL2107015 78239 28 None 3 3 Human 8.5 pAC50 = 8.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 217 1 2 3 2.2 c1ccc2c(SC3=NCCN3)c[nH]c2c1 10.1038/s41467-023-40064-9
3294 1993 111 None -3 23 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1038/s41467-023-40064-9
71360 1993 111 None -3 23 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1038/s41467-023-40064-9
87 1993 111 None -3 23 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1038/s41467-023-40064-9
CHEMBL14376 1993 111 None -3 23 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1038/s41467-023-40064-9
DB04946 1993 111 None -3 23 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1038/s41467-023-40064-9
115368 3034 47 None -1 9 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 6 0 6 3.4 O=C1N(CCCCN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1CCCC2 10.1038/s41467-023-40064-9
2112 3034 47 None -1 9 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 6 0 6 3.4 O=C1N(CCCCN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1CCCC2 10.1038/s41467-023-40064-9
7556 3034 47 None -1 9 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 6 0 6 3.4 O=C1N(CCCCN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1CCCC2 10.1038/s41467-023-40064-9
CHEMBL1472975 3034 47 None -1 9 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 6 0 6 3.4 O=C1N(CCCCN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1CCCC2 10.1038/s41467-023-40064-9
DB08922 3034 47 None -1 9 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 6 0 6 3.4 O=C1N(CCCCN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1CCCC2 10.1038/s41467-023-40064-9
4151 3580 89 None 1 10 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1038/s41467-023-40064-9
493 3580 89 None 1 10 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1038/s41467-023-40064-9
5312125 3580 89 None 1 10 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1038/s41467-023-40064-9
CHEMBL24778 3580 89 None 1 10 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1038/s41467-023-40064-9
DB06207 3580 89 None 1 10 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1038/s41467-023-40064-9
6077 150674 31 None 3 11 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 326 5 0 4 4.4 CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2 10.1038/s41467-023-40064-9
CHEMBL39560 150674 31 None 3 11 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 326 5 0 4 4.4 CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2 10.1038/s41467-023-40064-9
2107 3033 50 None 2 9 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 365 4 1 5 4.0 N#Cc1ccc2c(c1)N(CCCN1CCC(CC1)O)c1c(S2)cccc1 10.1038/s41467-023-40064-9
4747 3033 50 None 2 9 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 365 4 1 5 4.0 N#Cc1ccc2c(c1)N(CCCN1CCC(CC1)O)c1c(S2)cccc1 10.1038/s41467-023-40064-9
9216 3033 50 None 2 9 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 365 4 1 5 4.0 N#Cc1ccc2c(c1)N(CCCN1CCC(CC1)O)c1c(S2)cccc1 10.1038/s41467-023-40064-9
CHEMBL251940 3033 50 None 2 9 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 365 4 1 5 4.0 N#Cc1ccc2c(c1)N(CCCN1CCC(CC1)O)c1c(S2)cccc1 10.1038/s41467-023-40064-9
DB01608 3033 50 None 2 9 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 365 4 1 5 4.0 N#Cc1ccc2c(c1)N(CCCN1CCC(CC1)O)c1c(S2)cccc1 10.1038/s41467-023-40064-9
62867 3107 35 None -1 9 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 475 8 1 6 4.0 OCCC1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
7557 3107 35 None -1 9 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 475 8 1 6 4.0 OCCC1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
CHEMBL398880 3107 35 None -1 9 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 475 8 1 6 4.0 OCCC1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
DB01621 3107 35 None -1 9 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 475 8 1 6 4.0 OCCC1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
2407 3347 76 None 1 17 Human 8.5 pAC50 = 8.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 315 6 1 3 4.3 CCCN([C@H]1CCc2c(C1)cccc2O)CCc1cccs1 10.1038/s41467-023-40064-9
59227 3347 76 None 1 17 Human 8.5 pAC50 = 8.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 315 6 1 3 4.3 CCCN([C@H]1CCc2c(C1)cccc2O)CCc1cccs1 10.1038/s41467-023-40064-9
941 3347 76 None 1 17 Human 8.5 pAC50 = 8.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 315 6 1 3 4.3 CCCN([C@H]1CCc2c(C1)cccc2O)CCc1cccs1 10.1038/s41467-023-40064-9
CHEMBL1303 3347 76 None 1 17 Human 8.5 pAC50 = 8.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 315 6 1 3 4.3 CCCN([C@H]1CCc2c(C1)cccc2O)CCc1cccs1 10.1038/s41467-023-40064-9
DB05271 3347 76 None 1 17 Human 8.5 pAC50 = 8.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 315 6 1 3 4.3 CCCN([C@H]1CCc2c(C1)cccc2O)CCc1cccs1 10.1038/s41467-023-40064-9
5568 197477 29 None -1 13 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 352 4 0 3 5.3 CN(C)CCCN1c2ccccc2Sc2ccc(C(F)(F)F)cc21 10.1038/s41467-023-40064-9
66069 197477 29 None -1 13 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 352 4 0 3 5.3 CN(C)CCCN1c2ccccc2Sc2ccc(C(F)(F)F)cc21 10.1038/s41467-023-40064-9
CHEMBL1201102 197477 29 None -1 13 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 352 4 0 3 5.3 CN(C)CCCN1c2ccccc2Sc2ccc(C(F)(F)F)cc21 10.1038/s41467-023-40064-9
CHEMBL570 197477 29 None -1 13 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 352 4 0 3 5.3 CN(C)CCCN1c2ccccc2Sc2ccc(C(F)(F)F)cc21 10.1038/s41467-023-40064-9
11976 917 59 None -1 16 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 315 3 0 2 5.2 CN(C)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)Cl 10.1038/s41467-023-40064-9
667467 917 59 None -1 16 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 315 3 0 2 5.2 CN(C)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)Cl 10.1038/s41467-023-40064-9
CHEMBL908 917 59 None -1 16 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 315 3 0 2 5.2 CN(C)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)Cl 10.1038/s41467-023-40064-9
DB01239 917 59 None -1 16 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 315 3 0 2 5.2 CN(C)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)Cl 10.1038/s41467-023-40064-9
2585 800 103 None -50 34 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
522 800 103 None -50 34 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
551 800 103 None -50 34 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
CHEMBL723 800 103 None -50 34 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
DB01136 800 103 None -50 34 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
1524 2168 96 None -23 18 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
197 2168 96 None -23 18 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
3822 2168 96 None -23 18 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
88 2168 96 None -23 18 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
CHEMBL51 2168 96 None -23 18 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
DB12465 2168 96 None -23 18 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
2583 3747 118 None -3019 16 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 514 7 1 5 7.3 CCCc1nc2c(n1Cc1ccc(cc1)c1ccccc1C(=O)O)cc(cc2C)c1nc2c(n1C)cccc2 10.1038/s41467-023-40064-9
592 3747 118 None -3019 16 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 514 7 1 5 7.3 CCCc1nc2c(n1Cc1ccc(cc1)c1ccccc1C(=O)O)cc(cc2C)c1nc2c(n1C)cccc2 10.1038/s41467-023-40064-9
65999 3747 118 None -3019 16 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 514 7 1 5 7.3 CCCc1nc2c(n1Cc1ccc(cc1)c1ccccc1C(=O)O)cc(cc2C)c1nc2c(n1C)cccc2 10.1038/s41467-023-40064-9
CHEMBL1017 3747 118 None -3019 16 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 514 7 1 5 7.3 CCCc1nc2c(n1Cc1ccc(cc1)c1ccccc1C(=O)O)cc(cc2C)c1nc2c(n1C)cccc2 10.1038/s41467-023-40064-9
DB00966 3747 118 None -3019 16 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 514 7 1 5 7.3 CCCc1nc2c(n1Cc1ccc(cc1)c1ccccc1C(=O)O)cc(cc2C)c1nc2c(n1C)cccc2 10.1038/s41467-023-40064-9
3601 14471 9 None -45 9 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 502 9 0 0 8.2 C[N+](C)(CCCCCC[N+](C)(C)C1c2ccccc2-c2ccccc21)C1c2ccccc2-c2ccccc21 10.1038/s41467-023-40064-9
CHEMBL1201349 14471 9 None -45 9 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 502 9 0 0 8.2 C[N+](C)(CCCCCC[N+](C)(C)C1c2ccccc2-c2ccccc21)C1c2ccccc2-c2ccccc21 10.1038/s41467-023-40064-9
212 3777 47 None -28 22 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
2639 3777 47 None -28 22 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
941651 3777 47 None -28 22 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
CHEMBL1201 3777 47 None -28 22 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
DB01623 3777 47 None -28 22 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
1043 1569 14 None -15488 23 Human 5.5 pAC50 = 5.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
149 1569 14 None -15488 23 Human 5.5 pAC50 = 5.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
8223 1569 14 None -15488 23 Human 5.5 pAC50 = 5.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
CHEMBL442 1569 14 None -15488 23 Human 5.5 pAC50 = 5.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
DB00696 1569 14 None -15488 23 Human 5.5 pAC50 = 5.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
118422671 2737 65 None -1023 23 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O 10.1038/s41467-023-40064-9
1887 2737 65 None -1023 23 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O 10.1038/s41467-023-40064-9
71301 2737 65 None -1023 23 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O 10.1038/s41467-023-40064-9
7246 2737 65 None -1023 23 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O 10.1038/s41467-023-40064-9
CHEMBL434394 2737 65 None -1023 23 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O 10.1038/s41467-023-40064-9
DB04861 2737 65 None -1023 23 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O 10.1038/s41467-023-40064-9
4452 2742 19 None -10232 21 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 387 6 2 4 3.8 COc1cc(NC)c(cc1C(=O)NC1CCN(C1C)Cc1ccccc1)Cl 10.1038/s41467-023-40064-9
983 2742 19 None -10232 21 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 387 6 2 4 3.8 COc1cc(NC)c(cc1C(=O)NC1CCN(C1C)Cc1ccccc1)Cl 10.1038/s41467-023-40064-9
CHEMBL20734 2742 19 None -10232 21 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 387 6 2 4 3.8 COc1cc(NC)c(cc1C(=O)NC1CCN(C1C)Cc1ccccc1)Cl 10.1038/s41467-023-40064-9
1720 2936 38 None - 1 Human 5.5 pAC50 = 5.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 211 4 4 4 1.1 OC(c1cc(O)cc(c1)O)CNC(C)C 10.1038/s41467-023-40064-9
4086 2936 38 None - 1 Human 5.5 pAC50 = 5.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 211 4 4 4 1.1 OC(c1cc(O)cc(c1)O)CNC(C)C 10.1038/s41467-023-40064-9
7250 2936 38 None - 1 Human 5.5 pAC50 = 5.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 211 4 4 4 1.1 OC(c1cc(O)cc(c1)O)CNC(C)C 10.1038/s41467-023-40064-9
CHEMBL776 2936 38 None - 1 Human 5.5 pAC50 = 5.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 211 4 4 4 1.1 OC(c1cc(O)cc(c1)O)CNC(C)C 10.1038/s41467-023-40064-9
DB00816 2936 38 None - 1 Human 5.5 pAC50 = 5.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 211 4 4 4 1.1 OC(c1cc(O)cc(c1)O)CNC(C)C 10.1038/s41467-023-40064-9
2389 3306 118 None -13 29 Human 7.5 pAC50 = 7.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
5073 3306 118 None -13 29 Human 7.5 pAC50 = 7.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
96 3306 118 None -13 29 Human 7.5 pAC50 = 7.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
CHEMBL85 3306 118 None -13 29 Human 7.5 pAC50 = 7.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
DB00734 3306 118 None -13 29 Human 7.5 pAC50 = 7.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
228 444 28 None -75 20 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O 10.1038/s41467-023-40064-9
33 444 28 None -75 20 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O 10.1038/s41467-023-40064-9
6005 444 28 None -75 20 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O 10.1038/s41467-023-40064-9
CHEMBL53 444 28 None -75 20 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O 10.1038/s41467-023-40064-9
DB00714 444 28 None -75 20 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O 10.1038/s41467-023-40064-9
2169 44817 35 None -4 12 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 380 9 3 6 1.4 COc1ccccc1OCCNCC(O)c1ccc(C)c(S(N)(=O)=O)c1 10.1038/s41467-023-40064-9
CHEMBL152231 44817 35 None -4 12 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 380 9 3 6 1.4 COc1ccccc1OCCNCC(O)c1ccc(C)c(S(N)(=O)=O)c1 10.1038/s41467-023-40064-9
3584 3748 64 None -69 11 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
5401 3748 64 None -69 11 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
7302 3748 64 None -69 11 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
CHEMBL611 3748 64 None -69 11 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
DB01162 3748 64 None -69 11 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
5482 14388 80 None -3 13 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 386 6 0 4 5.9 Clc1ccc(C(Cn2ccnc2)OCc2ccsc2Cl)c(Cl)c1 10.1038/s41467-023-40064-9
CHEMBL1200438 14388 80 None -3 13 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 386 6 0 4 5.9 Clc1ccc(C(Cn2ccnc2)OCc2ccsc2Cl)c(Cl)c1 10.1038/s41467-023-40064-9
2993 114666 24 None -177 13 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 456 11 2 2 6.2 Cc1cc(N)c2ccccc2[n+]1CCCCCCCCCC[n+]1c(C)cc(N)c2ccccc21 10.1038/s41467-023-40064-9
CHEMBL121663 114666 24 None -177 13 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 456 11 2 2 6.2 Cc1cc(N)c2ccccc2[n+]1CCCCCCCCCC[n+]1c(C)cc(N)c2ccccc21 10.1038/s41467-023-40064-9
CHEMBL333826 114666 24 None -177 13 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 456 11 2 2 6.2 Cc1cc(N)c2ccccc2[n+]1CCCCCCCCCC[n+]1c(C)cc(N)c2ccccc21 10.1038/s41467-023-40064-9
681 1453 72 None -162 15 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 153 2 3 3 0.6 NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
940 1453 72 None -162 15 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 153 2 3 3 0.6 NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
947 1453 72 None -162 15 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 153 2 3 3 0.6 NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
CHEMBL59 1453 72 None -162 15 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 153 2 3 3 0.6 NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
DB00988 1453 72 None -162 15 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 153 2 3 3 0.6 NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
2105 3032 37 None -158 25 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 10.1038/s41467-023-40064-9
47811 3032 37 None -158 25 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 10.1038/s41467-023-40064-9
48 3032 37 None -158 25 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 10.1038/s41467-023-40064-9
CHEMBL531 3032 37 None -158 25 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 10.1038/s41467-023-40064-9
DB01186 3032 37 None -158 25 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 10.1038/s41467-023-40064-9
2220 3112 82 None -269 17 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 295 0 0 2 4.4 CN1CCC(=C2c3ccsc3CCc3c2cccc3)CC1 10.1038/s41467-023-40064-9
27400 3112 82 None -269 17 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 295 0 0 2 4.4 CN1CCC(=C2c3ccsc3CCc3c2cccc3)CC1 10.1038/s41467-023-40064-9
93 3112 82 None -269 17 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 295 0 0 2 4.4 CN1CCC(=C2c3ccsc3CCc3c2cccc3)CC1 10.1038/s41467-023-40064-9
CHEMBL294951 3112 82 None -269 17 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 295 0 0 2 4.4 CN1CCC(=C2c3ccsc3CCc3c2cccc3)CC1 10.1038/s41467-023-40064-9
DB06153 3112 82 None -269 17 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 295 0 0 2 4.4 CN1CCC(=C2c3ccsc3CCc3c2cccc3)CC1 10.1038/s41467-023-40064-9
1086 1577 27 None -91 9 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 312 5 0 3 5.0 CCN(C(CN1c2ccccc2Sc2c1cccc2)C)CC 10.1038/s41467-023-40064-9
3290 1577 27 None -91 9 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 312 5 0 3 5.0 CCN(C(CN1c2ccccc2Sc2c1cccc2)C)CC 10.1038/s41467-023-40064-9
7181 1577 27 None -91 9 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 312 5 0 3 5.0 CCN(C(CN1c2ccccc2Sc2c1cccc2)C)CC 10.1038/s41467-023-40064-9
CHEMBL1206 1577 27 None -91 9 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 312 5 0 3 5.0 CCN(C(CN1c2ccccc2Sc2c1cccc2)C)CC 10.1038/s41467-023-40064-9
DB00392 1577 27 None -91 9 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 312 5 0 3 5.0 CCN(C(CN1c2ccccc2Sc2c1cccc2)C)CC 10.1038/s41467-023-40064-9
2200 20171 61 None 1 12 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 265 5 1 3 2.7 c1ccc(CN(CC2=NCCN2)c2ccccc2)cc1 10.1038/s41467-023-40064-9
CHEMBL1256819 20171 61 None 1 12 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 265 5 1 3 2.7 c1ccc(CN(CC2=NCCN2)c2ccccc2)cc1 10.1038/s41467-023-40064-9
CHEMBL1305 20171 61 None 1 12 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 265 5 1 3 2.7 c1ccc(CN(CC2=NCCN2)c2ccccc2)cc1 10.1038/s41467-023-40064-9
2136 3073 30 None 1 21 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 10.1038/s41467-023-40064-9
4768 3073 30 None 1 21 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 10.1038/s41467-023-40064-9
7268 3073 30 None 1 21 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 10.1038/s41467-023-40064-9
CHEMBL753 3073 30 None 1 21 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 10.1038/s41467-023-40064-9
DB00925 3073 30 None 1 21 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 10.1038/s41467-023-40064-9
68712 100310 60 None -4 7 Human 5.5 pAC50 = 5.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 10.1038/s41467-023-40064-9
CHEMBL289480 100310 60 None -4 7 Human 5.5 pAC50 = 5.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 10.1038/s41467-023-40064-9
65700 78231 28 None -10 8 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 238 1 1 2 3.3 CNC1Cc2ccccc2N(C)c2ccccc21 10.1038/s41467-023-40064-9
CHEMBL2106919 78231 28 None -10 8 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 238 1 1 2 3.3 CNC1Cc2ccccc2N(C)c2ccccc21 10.1038/s41467-023-40064-9
4066 204603 78 None -21 16 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 322 2 0 3 4.6 c1ccc2c(c1)Sc1ccccc1N2CC1CN2CCC1CC2 10.1038/s41467-023-40064-9
CHEMBL73451 204603 78 None -21 16 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 322 2 0 3 4.6 c1ccc2c(c1)Sc1ccccc1N2CC1CN2CCC1CC2 10.1038/s41467-023-40064-9
3108 207264 116 None -1 7 Human 5.5 pAC50 = 5.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 504 12 4 12 -0.0 OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1 10.1038/s41467-023-40064-9
CHEMBL932 207264 116 None -1 7 Human 5.5 pAC50 = 5.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 504 12 4 12 -0.0 OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1 10.1038/s41467-023-40064-9
47936 193398 88 None -74 6 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 410 2 3 7 1.5 C=C[C@@]1(C)CC(=O)[C@@]2(O)[C@](C)(O1)[C@@H](OC(C)=O)[C@@H](O)[C@H]1C(C)(C)CC[C@H](O)[C@@]12C 10.1038/s41467-023-40064-9
CHEMBL52606 193398 88 None -74 6 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 410 2 3 7 1.5 C=C[C@@]1(C)CC(=O)[C@@]2(O)[C@](C)(O1)[C@@H](OC(C)=O)[C@@H](O)[C@H]1C(C)(C)CC[C@H](O)[C@@]12C 10.1038/s41467-023-40064-9
3158 56237 27 None -125 28 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 10.1038/s41467-023-40064-9
CHEMBL1628227 56237 27 None -125 28 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 10.1038/s41467-023-40064-9
1971 2846 38 None -89 32 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1038/s41467-023-40064-9
2404 2846 38 None -89 32 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1038/s41467-023-40064-9
4543 2846 38 None -89 32 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL445 2846 38 None -89 32 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1038/s41467-023-40064-9
DB00540 2846 38 None -89 32 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1038/s41467-023-40064-9
3584 3748 64 None -69 11 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
5401 3748 64 None -69 11 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
7302 3748 64 None -69 11 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
CHEMBL611 3748 64 None -69 11 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
DB01162 3748 64 None -69 11 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
124087 1377 114 None -112 27 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 10.1038/s41467-023-40064-9
7157 1377 114 None -112 27 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 10.1038/s41467-023-40064-9
814 1377 114 None -112 27 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 10.1038/s41467-023-40064-9
CHEMBL1172 1377 114 None -112 27 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 10.1038/s41467-023-40064-9
DB00967 1377 114 None -112 27 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 10.1038/s41467-023-40064-9
441074 19382 82 None -1 11 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 324 4 1 4 3.2 C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12 10.1038/s41467-023-40064-9
CHEMBL1294 19382 82 None -1 11 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 324 4 1 4 3.2 C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12 10.1038/s41467-023-40064-9
115 342 71 None 14 5 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1038/s41467-023-40064-9
2092 342 71 None 14 5 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1038/s41467-023-40064-9
7109 342 71 None 14 5 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1038/s41467-023-40064-9
CHEMBL709 342 71 None 14 5 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1038/s41467-023-40064-9
DB00346 342 71 None 14 5 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1038/s41467-023-40064-9
4260 52528 31 None -3 9 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 279 6 0 4 3.0 CC(=O)Oc1cc(C(C)C)c(OCCN(C)C)cc1C 10.1038/s41467-023-40064-9
CHEMBL159226 52528 31 None -3 9 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 279 6 0 4 3.0 CC(=O)Oc1cc(C(C)C)c(OCCN(C)C)cc1C 10.1038/s41467-023-40064-9
1353 1898 93 None -22 39 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
3559 1898 93 None -22 39 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
86 1898 93 None -22 39 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
CHEMBL54 1898 93 None -22 39 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
DB00502 1898 93 None -22 39 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
5022 1638 76 None -8 9 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 390 4 1 4 3.2 O=c1[nH]c2c(n1CCN1CCN(CC1)c1cccc(c1)C(F)(F)F)cccc2 10.1038/s41467-023-40064-9
6918248 1638 76 None -8 9 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 390 4 1 4 3.2 O=c1[nH]c2c(n1CCN1CCN(CC1)c1cccc(c1)C(F)(F)F)cccc2 10.1038/s41467-023-40064-9
8182 1638 76 None -8 9 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 390 4 1 4 3.2 O=c1[nH]c2c(n1CCN1CCN(CC1)c1cccc(c1)C(F)(F)F)cccc2 10.1038/s41467-023-40064-9
CHEMBL231068 1638 76 None -8 9 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 390 4 1 4 3.2 O=c1[nH]c2c(n1CCN1CCN(CC1)c1cccc(c1)C(F)(F)F)cccc2 10.1038/s41467-023-40064-9
DB04908 1638 76 None -8 9 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 390 4 1 4 3.2 O=c1[nH]c2c(n1CCN1CCN(CC1)c1cccc(c1)C(F)(F)F)cccc2 10.1038/s41467-023-40064-9
6075 150084 42 None -14 20 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 310 2 0 3 4.6 CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1 10.1038/s41467-023-40064-9
CHEMBL395110 150084 42 None -14 20 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 310 2 0 3 4.6 CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1 10.1038/s41467-023-40064-9
5591 157507 90 None -4 17 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 441 5 2 6 4.4 Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2 10.1038/s41467-023-40064-9
CHEMBL408 157507 90 None -4 17 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 441 5 2 6 4.4 Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2 10.1038/s41467-023-40064-9
2181 3106 46 None -1 7 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N 10.1038/s41467-023-40064-9
4830 3106 46 None -1 7 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N 10.1038/s41467-023-40064-9
92 3106 46 None -1 7 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N 10.1038/s41467-023-40064-9
CHEMBL440294 3106 46 None -1 7 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N 10.1038/s41467-023-40064-9
DB09286 3106 46 None -1 7 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N 10.1038/s41467-023-40064-9
2146 3078 67 None -20 15 Human 8.4 pAC50 = 8.4 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
485 3078 67 None -20 15 Human 8.4 pAC50 = 8.4 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
6041 3078 67 None -20 15 Human 8.4 pAC50 = 8.4 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
CHEMBL1215 3078 67 None -20 15 Human 8.4 pAC50 = 8.4 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
DB00388 3078 67 None -20 15 Human 8.4 pAC50 = 8.4 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
17676 7040 29 None -1 13 Human 8.4 pAC50 = 8.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 411 7 1 6 3.5 CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2 10.1038/s41467-023-40064-9
5281082 7040 29 None -1 13 Human 8.4 pAC50 = 8.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 411 7 1 6 3.5 CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2 10.1038/s41467-023-40064-9
CHEMBL1085 7040 29 None -1 13 Human 8.4 pAC50 = 8.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 411 7 1 6 3.5 CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2 10.1038/s41467-023-40064-9
1427 2000 54 None -112 30 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
357 2000 54 None -112 30 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
3696 2000 54 None -112 30 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
CHEMBL11 2000 54 None -112 30 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
DB00458 2000 54 None -112 30 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
1385580 29245 76 None -478 19 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 7 1 4 4.1 O=c1[nH]c2ccccc2n1CCCN1CCN(C(c2ccccc2)c2ccccc2)CC1 10.1038/s41467-023-40064-9
4615 29245 76 None -478 19 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 7 1 4 4.1 O=c1[nH]c2ccccc2n1CCCN1CCN(C(c2ccccc2)c2ccccc2)CC1 10.1038/s41467-023-40064-9
CHEMBL13828 29245 76 None -478 19 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 7 1 4 4.1 O=c1[nH]c2ccccc2n1CCCN1CCN(C(c2ccccc2)c2ccccc2)CC1 10.1038/s41467-023-40064-9
3952 1875 38 None -4 21 Human 7.4 pAC50 = 7.4 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 10.1038/s41467-023-40064-9
5353646 1875 38 None -4 21 Human 7.4 pAC50 = 7.4 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 10.1038/s41467-023-40064-9
5443 1875 38 None -4 21 Human 7.4 pAC50 = 7.4 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 10.1038/s41467-023-40064-9
5702063 1875 38 None -4 21 Human 7.4 pAC50 = 7.4 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 10.1038/s41467-023-40064-9
CHEMBL1331786 1875 38 None -4 21 Human 7.4 pAC50 = 7.4 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 10.1038/s41467-023-40064-9
CHEMBL420 1875 38 None -4 21 Human 7.4 pAC50 = 7.4 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 10.1038/s41467-023-40064-9
4209 3141 75 None -24 17 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
4893 3141 75 None -24 17 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
503 3141 75 None -24 17 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
5385 3141 75 None -24 17 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
CHEMBL2 3141 75 None -24 17 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
DB00457 3141 75 None -24 17 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
5329102 194703 86 None -3 37 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 398 7 3 3 3.3 CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C 10.1038/s41467-023-40064-9
CHEMBL535 194703 86 None -3 37 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 398 7 3 3 3.3 CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C 10.1038/s41467-023-40064-9
5803 162203 84 None 1 8 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 622 4 2 3 4.6 O=C(O)Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1 10.1038/s41467-023-40064-9
CHEMBL41632 162203 84 None 1 8 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 622 4 2 3 4.6 O=C(O)Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1 10.1038/s41467-023-40064-9
71897 78219 19 None -141 7 Human 6.4 pAC50 = 6.4 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 304 4 1 3 2.7 Cc1cc(CCN2CCN(c3cccc(Cl)c3)CC2)n[nH]1 10.1038/s41467-023-40064-9
CHEMBL2106537 78219 19 None -141 7 Human 6.4 pAC50 = 6.4 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 304 4 1 3 2.7 Cc1cc(CCN2CCN(c3cccc(Cl)c3)CC2)n[nH]1 10.1038/s41467-023-40064-9
44591583 184512 96 None 3 2 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 251 2 1 4 1.6 N#Cc1ccc(Oc2ccc3c(c2)COB3O)cc1 10.1038/s41467-023-40064-9
CHEMBL484785 184512 96 None 3 2 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 251 2 1 4 1.6 N#Cc1ccc(Oc2ccc3c(c2)COB3O)cc1 10.1038/s41467-023-40064-9
5453 203596 102 None 1 14 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 189 3 0 1 0.2 S=P(N1CC1)(N1CC1)N1CC1 10.1038/s41467-023-40064-9
CHEMBL671 203596 102 None 1 14 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 189 3 0 1 0.2 S=P(N1CC1)(N1CC1)N1CC1 10.1038/s41467-023-40064-9
1613 2333 53 None -16 34 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
205 2333 53 None -16 34 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
3964 2333 53 None -16 34 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
CHEMBL831 2333 53 None -16 34 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
DB00408 2333 53 None -16 34 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
3947 206372 53 None -6 16 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 418 7 0 3 5.8 CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1 10.1038/s41467-023-40064-9
CHEMBL87708 206372 53 None -6 16 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 418 7 0 3 5.8 CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1 10.1038/s41467-023-40064-9
3152 188387 103 None -9 10 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 379 6 0 4 4.4 COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2 10.1038/s41467-023-40064-9
CHEMBL502 188387 103 None -9 10 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 379 6 0 4 4.4 COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2 10.1038/s41467-023-40064-9
55645 84341 8 None -1258 11 Human 6.4 pAC50 = 6.4 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 395 7 2 4 2.1 CCCN1CC(NS(=O)(=O)N(CC)CC)CC2Cc3c(O)cccc3CC21 10.1038/s41467-023-40064-9
CHEMBL2218861 84341 8 None -1258 11 Human 6.4 pAC50 = 6.4 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 395 7 2 4 2.1 CCCN1CC(NS(=O)(=O)N(CC)CC)CC2Cc3c(O)cccc3CC21 10.1038/s41467-023-40064-9
3689 102744 55 None -64 16 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 325 5 2 3 3.8 CC(C(O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1038/s41467-023-40064-9
CHEMBL1372983 102744 55 None -64 16 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 325 5 2 3 3.8 CC(C(O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1038/s41467-023-40064-9
CHEMBL305187 102744 55 None -64 16 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 325 5 2 3 3.8 CC(C(O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1038/s41467-023-40064-9
60065 84340 6 None -2 11 Human 5.4 pAC50 = 5.4 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 505 7 1 8 4.2 COC(=O)C1=C(C)NC(C)=C(C(=O)O[C@@H]2CCCN(Cc3ccccc3)C2)C1c1cccc([N+](=O)[O-])c1 10.1038/s41467-023-40064-9
CHEMBL2218858 84340 6 None -2 11 Human 5.4 pAC50 = 5.4 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 505 7 1 8 4.2 COC(=O)C1=C(C)NC(C)=C(C(=O)O[C@@H]2CCCN(Cc3ccccc3)C2)C1c1cccc([N+](=O)[O-])c1 10.1038/s41467-023-40064-9
4418 34192 85 None -4 18 Human 6.3 pAC50 = 6.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1038/s41467-023-40064-9
CHEMBL142635 34192 85 None -4 18 Human 6.3 pAC50 = 6.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1038/s41467-023-40064-9
100 3776 58 None -8 38 Human 6.3 pAC50 = 6.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 10.1038/s41467-023-40064-9
2637 3776 58 None -8 38 Human 6.3 pAC50 = 6.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 10.1038/s41467-023-40064-9
5452 3776 58 None -8 38 Human 6.3 pAC50 = 6.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 10.1038/s41467-023-40064-9
CHEMBL479 3776 58 None -8 38 Human 6.3 pAC50 = 6.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 10.1038/s41467-023-40064-9
DB00679 3776 58 None -8 38 Human 6.3 pAC50 = 6.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 10.1038/s41467-023-40064-9
2335 11816 22 None -38 34 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 10.1038/s41467-023-40064-9
8478 11816 22 None -38 34 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 10.1038/s41467-023-40064-9
CHEMBL1182210 11816 22 None -38 34 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 10.1038/s41467-023-40064-9
CHEMBL221753 11816 22 None -38 34 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 10.1038/s41467-023-40064-9
2895 203569 41 None -16 15 Human 6.3 pAC50 = 6.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 275 3 0 1 4.6 CN(C)CCC=C1c2ccccc2C=Cc2ccccc21 10.1038/s41467-023-40064-9
CHEMBL669 203569 41 None -16 15 Human 6.3 pAC50 = 6.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 275 3 0 1 4.6 CN(C)CCC=C1c2ccccc2C=Cc2ccccc21 10.1038/s41467-023-40064-9
54682461 84657 62 None 1 12 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 602 11 2 6 7.3 CCC[C@@]1(CCc2ccccc2)CC(O)=C([C@H](CC)c2cccc(NS(=O)(=O)c3ccc(C(F)(F)F)cn3)c2)C(=O)O1 10.1038/s41467-023-40064-9
CHEMBL222559 84657 62 None 1 12 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 602 11 2 6 7.3 CCC[C@@]1(CCc2ccccc2)CC(O)=C([C@H](CC)c2cccc(NS(=O)(=O)c3ccc(C(F)(F)F)cn3)c2)C(=O)O1 10.1038/s41467-023-40064-9
82153 43871 45 None 11 3 Human 7.3 pAC50 = 7.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 434 2 2 6 2.3 CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1 10.1038/s41467-023-40064-9
CHEMBL1512 43871 45 None 11 3 Human 7.3 pAC50 = 7.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 434 2 2 6 2.3 CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1 10.1038/s41467-023-40064-9
4011 82379 49 None -8 26 Human 6.3 pAC50 = 6.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 277 4 1 1 4.2 CNCCCC12CCC(c3ccccc31)c1ccccc12 10.1038/s41467-023-40064-9
CHEMBL21731 82379 49 None -8 26 Human 6.3 pAC50 = 6.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 277 4 1 1 4.2 CNCCCC12CCC(c3ccccc31)c1ccccc12 10.1038/s41467-023-40064-9
2710 84279 31 None -10 9 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 300 3 0 2 3.7 CN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1 10.1038/s41467-023-40064-9
CHEMBL22150 84279 31 None -10 9 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 300 3 0 2 3.7 CN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1 10.1038/s41467-023-40064-9
54758501 139042 58 None -1621 11 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 486 7 2 8 5.1 C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3)nc3ccsc23)c1 10.1038/s41467-023-40064-9
CHEMBL3786343 139042 58 None -1621 11 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 486 7 2 8 5.1 C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3)nc3ccsc23)c1 10.1038/s41467-023-40064-9
6719 32638 39 None -6 4 Human 5.3 pAC50 = 5.3 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 340 4 0 3 4.1 O=C1c2ccccc2C(=O)C1C(=O)C(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL1413199 32638 39 None -6 4 Human 5.3 pAC50 = 5.3 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 340 4 0 3 4.1 O=C1c2ccccc2C(=O)C1C(=O)C(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
4195 14439 44 None 2 2 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 254 6 3 5 -0.2 COc1ccc(OC)c(C(O)CNC(=O)CN)c1 10.1038/s41467-023-40064-9
CHEMBL1201212 14439 44 None 2 2 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 254 6 3 5 -0.2 COc1ccc(OC)c(C(O)CNC(=O)CN)c1 10.1038/s41467-023-40064-9
36811 1442 37 None -1 17 Human 8.3 pAC50 = 8.3 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
535 1442 37 None -1 17 Human 8.3 pAC50 = 8.3 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
937 1442 37 None -1 17 Human 8.3 pAC50 = 8.3 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
CHEMBL926 1442 37 None -1 17 Human 8.3 pAC50 = 8.3 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
DB00841 1442 37 None -1 17 Human 8.3 pAC50 = 8.3 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
3083544 26778 51 None -407 6 Human 7.3 pAC50 = 7.3 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1038/s41467-023-40064-9
CHEMBL1200811 26778 51 None -407 6 Human 7.3 pAC50 = 7.3 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1038/s41467-023-40064-9
CHEMBL1363 26778 51 None -407 6 Human 7.3 pAC50 = 7.3 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1038/s41467-023-40064-9
CHEMBL1951071 26778 51 None -407 6 Human 7.3 pAC50 = 7.3 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1038/s41467-023-40064-9
CHEMBL605993 26778 51 None -407 6 Human 7.3 pAC50 = 7.3 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1038/s41467-023-40064-9
643976 14486 30 None -2 3 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 456 7 6 10 -1.6 Cc1cc2nc3c(=O)[nH]c(=O)nc-3n(C[C@H](O)[C@H](O)[C@H](O)COP(=O)(O)O)c2cc1C 10.1038/s41467-023-40064-9
CHEMBL1201794 14486 30 None -2 3 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 456 7 6 10 -1.6 Cc1cc2nc3c(=O)[nH]c(=O)nc-3n(C[C@H](O)[C@H](O)[C@H](O)COP(=O)(O)O)c2cc1C 10.1038/s41467-023-40064-9
133 2479 52 None -131 28 Human 7.3 pAC50 = 7.3 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C 10.1038/s41467-023-40064-9
1723 2479 52 None -131 28 Human 7.3 pAC50 = 7.3 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C 10.1038/s41467-023-40064-9
28693 2479 52 None -131 28 Human 7.3 pAC50 = 7.3 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C 10.1038/s41467-023-40064-9
CHEMBL19215 2479 52 None -131 28 Human 7.3 pAC50 = 7.3 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C 10.1038/s41467-023-40064-9
DB13520 2479 52 None -131 28 Human 7.3 pAC50 = 7.3 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C 10.1038/s41467-023-40064-9
3033538 1307 39 None -63 13 Human 6.3 pAC50 = 6.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 10.1038/s41467-023-40064-9
7155 1307 39 None -63 13 Human 6.3 pAC50 = 6.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 10.1038/s41467-023-40064-9
781 1307 39 None -63 13 Human 6.3 pAC50 = 6.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 10.1038/s41467-023-40064-9
CHEMBL1201216 1307 39 None -63 13 Human 6.3 pAC50 = 6.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 10.1038/s41467-023-40064-9
DB00298 1307 39 None -63 13 Human 6.3 pAC50 = 6.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 10.1038/s41467-023-40064-9
2771 194994 74 None -46 16 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 10.1038/s41467-023-40064-9
CHEMBL1200781 194994 74 None -46 16 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 10.1038/s41467-023-40064-9
CHEMBL549 194994 74 None -46 16 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 10.1038/s41467-023-40064-9
191 402 98 None -67 36 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 10.1038/s41467-023-40064-9
201 402 98 None -67 36 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 10.1038/s41467-023-40064-9
2170 402 98 None -67 36 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 10.1038/s41467-023-40064-9
CHEMBL1113 402 98 None -67 36 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 10.1038/s41467-023-40064-9
DB00543 402 98 None -67 36 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 10.1038/s41467-023-40064-9
107641 61113 78 None -2 2 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 295 4 1 2 3.4 CCC(C(=O)O)c1ccc(N2Cc3ccccc3C2=O)cc1 10.1038/s41467-023-40064-9
CHEMBL1765292 61113 78 None -2 2 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 295 4 1 2 3.4 CCC(C(=O)O)c1ccc(N2Cc3ccccc3C2=O)cc1 10.1038/s41467-023-40064-9
2540 4369 111 None -1047 28 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 610 10 1 11 6.3 CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1 10.1038/s41467-023-40064-9
CHEMBL1014 4369 111 None -1047 28 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 610 10 1 11 6.3 CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1 10.1038/s41467-023-40064-9
11504295 2902 47 None -416 8 Human 7.3 pAC50 = 7.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 386 7 4 6 2.4 COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C 10.1038/s41467-023-40064-9
4814 2902 47 None -416 8 Human 7.3 pAC50 = 7.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 386 7 4 6 2.4 COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C 10.1038/s41467-023-40064-9
7543 2902 47 None -416 8 Human 7.3 pAC50 = 7.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 386 7 4 6 2.4 COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C 10.1038/s41467-023-40064-9
CHEMBL605846 2902 47 None -416 8 Human 7.3 pAC50 = 7.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 386 7 4 6 2.4 COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C 10.1038/s41467-023-40064-9
DB09080 2902 47 None -416 8 Human 7.3 pAC50 = 7.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 386 7 4 6 2.4 COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C 10.1038/s41467-023-40064-9
1547484 937 74 None -50 26 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
654 937 74 None -50 26 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
9072 937 74 None -50 26 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL43064 937 74 None -50 26 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
DB00568 937 74 None -50 26 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
5639 98867 75 None 7 13 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 387 7 1 8 0.7 COc1ccccc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1 10.1038/s41467-023-40064-9
CHEMBL279229 98867 75 None 7 13 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 387 7 1 8 0.7 COc1ccccc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1 10.1038/s41467-023-40064-9
2995 204382 53 None -213 18 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 10.1038/s41467-023-40064-9
CHEMBL1696 204382 53 None -213 18 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 10.1038/s41467-023-40064-9
CHEMBL72 204382 53 None -213 18 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 10.1038/s41467-023-40064-9
114948 60267 14 None -457 6 Human 5.2 pAC50 = 5.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 577 5 3 6 2.5 CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12 10.1038/s41467-023-40064-9
CHEMBL1743263 60267 14 None -457 6 Human 5.2 pAC50 = 5.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 577 5 3 6 2.5 CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12 10.1038/s41467-023-40064-9
146570 43424 67 None -1 7 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 324 5 0 3 3.8 CN(C)CCC[C@@]1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 10.1038/s41467-023-40064-9
CHEMBL1508 43424 67 None -1 7 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 324 5 0 3 3.8 CN(C)CCC[C@@]1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 10.1038/s41467-023-40064-9
4167 14468 43 None -109 10 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 309 2 0 2 5.0 CN1CCCC(CC2c3ccccc3Sc3ccccc32)C1 10.1038/s41467-023-40064-9
CHEMBL1201342 14468 43 None -109 10 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 309 2 0 2 5.0 CN1CCCC(CC2c3ccccc3Sc3ccccc32)C1 10.1038/s41467-023-40064-9
2855 4101 104 None -2951 12 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 575 8 2 7 5.7 COc1cc(ccc1Cc1cn(c2c1cc(cc2)NC(=O)OC1CCCC1)C)C(=O)NS(=O)(=O)c1ccccc1C 10.1038/s41467-023-40064-9
3322 4101 104 None -2951 12 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 575 8 2 7 5.7 COc1cc(ccc1Cc1cn(c2c1cc(cc2)NC(=O)OC1CCCC1)C)C(=O)NS(=O)(=O)c1ccccc1C 10.1038/s41467-023-40064-9
5717 4101 104 None -2951 12 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 575 8 2 7 5.7 COc1cc(ccc1Cc1cn(c2c1cc(cc2)NC(=O)OC1CCCC1)C)C(=O)NS(=O)(=O)c1ccccc1C 10.1038/s41467-023-40064-9
CHEMBL603 4101 104 None -2951 12 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 575 8 2 7 5.7 COc1cc(ccc1Cc1cn(c2c1cc(cc2)NC(=O)OC1CCCC1)C)C(=O)NS(=O)(=O)c1ccccc1C 10.1038/s41467-023-40064-9
DB00549 4101 104 None -2951 12 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 575 8 2 7 5.7 COc1cc(ccc1Cc1cn(c2c1cc(cc2)NC(=O)OC1CCCC1)C)C(=O)NS(=O)(=O)c1ccccc1C 10.1038/s41467-023-40064-9
2335 11816 22 None -38 34 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 10.1038/s41467-023-40064-9
8478 11816 22 None -38 34 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 10.1038/s41467-023-40064-9
CHEMBL1182210 11816 22 None -38 34 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 10.1038/s41467-023-40064-9
CHEMBL221753 11816 22 None -38 34 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 10.1038/s41467-023-40064-9
5832 14428 54 None -7 5 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 340 1 0 3 4.1 C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C 10.1038/s41467-023-40064-9
CHEMBL1201146 14428 54 None -7 5 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 340 1 0 3 4.1 C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C 10.1038/s41467-023-40064-9
208898 66169 78 None -9 11 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 556 18 1 6 7.0 CCCCc1oc2ccc(NS(C)(=O)=O)cc2c1C(=O)c1ccc(OCCCN(CCCC)CCCC)cc1 10.1038/s41467-023-40064-9
CHEMBL184412 66169 78 None -9 11 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 556 18 1 6 7.0 CCCCc1oc2ccc(NS(C)(=O)=O)cc2c1C(=O)c1ccc(OCCCN(CCCC)CCCC)cc1 10.1038/s41467-023-40064-9
37 775 60 None -141 12 Human 6.2 pAC50 = 6.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 10.1038/s41467-023-40064-9
460 775 60 None -141 12 Human 6.2 pAC50 = 6.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 10.1038/s41467-023-40064-9
54746 775 60 None -141 12 Human 6.2 pAC50 = 6.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 10.1038/s41467-023-40064-9
CHEMBL1201087 775 60 None -141 12 Human 6.2 pAC50 = 6.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 10.1038/s41467-023-40064-9
DB00248 775 60 None -141 12 Human 6.2 pAC50 = 6.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 10.1038/s41467-023-40064-9
5419 18028 57 None 10 5 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 200 1 1 2 2.1 c1ccc2c(c1)CCCC2C1=NCCN1 10.1038/s41467-023-40064-9
CHEMBL1200413 18028 57 None 10 5 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 200 1 1 2 2.1 c1ccc2c(c1)CCCC2C1=NCCN1 10.1038/s41467-023-40064-9
CHEMBL1266 18028 57 None 10 5 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 200 1 1 2 2.1 c1ccc2c(c1)CCCC2C1=NCCN1 10.1038/s41467-023-40064-9
1028 289 71 None 1 19 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
139148732 289 71 None 1 19 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
479 289 71 None 1 19 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
5816 289 71 None 1 19 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
CHEMBL679 289 71 None 1 19 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
DB00668 289 71 None 1 19 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
1028 289 71 None 1 19 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
139148732 289 71 None 1 19 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
479 289 71 None 1 19 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
5816 289 71 None 1 19 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
CHEMBL679 289 71 None 1 19 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
DB00668 289 71 None 1 19 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
1524 2168 96 None -23 18 Human 7.2 pAC50 = 7.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
197 2168 96 None -23 18 Human 7.2 pAC50 = 7.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
3822 2168 96 None -23 18 Human 7.2 pAC50 = 7.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
88 2168 96 None -23 18 Human 7.2 pAC50 = 7.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
CHEMBL51 2168 96 None -23 18 Human 7.2 pAC50 = 7.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
DB12465 2168 96 None -23 18 Human 7.2 pAC50 = 7.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
2713 205248 82 None -1 27 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
5353524 205248 82 None -1 27 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
5360566 205248 82 None -1 27 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
88536661 205248 82 None -1 27 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
9552079 205248 82 None -1 27 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
CHEMBL1330113 205248 82 None -1 27 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
CHEMBL790 205248 82 None -1 27 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
5324346 205559 59 None 2 3 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 318 9 1 4 3.2 COCCCC/C(=N\OCCN)c1ccc(C(F)(F)F)cc1 10.1038/s41467-023-40064-9
CHEMBL1409 205559 59 None 2 3 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 318 9 1 4 3.2 COCCCC/C(=N\OCCN)c1ccc(C(F)(F)F)cc1 10.1038/s41467-023-40064-9
CHEMBL814 205559 59 None 2 3 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 318 9 1 4 3.2 COCCCC/C(=N\OCCN)c1ccc(C(F)(F)F)cc1 10.1038/s41467-023-40064-9
1353 1898 93 None -22 39 Human 7.2 pAC50 = 7.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
3559 1898 93 None -22 39 Human 7.2 pAC50 = 7.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
86 1898 93 None -22 39 Human 7.2 pAC50 = 7.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
CHEMBL54 1898 93 None -22 39 Human 7.2 pAC50 = 7.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
DB00502 1898 93 None -22 39 Human 7.2 pAC50 = 7.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
102 4096 48 None -380 20 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1038/s41467-023-40064-9
3659 4096 48 None -380 20 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1038/s41467-023-40064-9
8969 4096 48 None -380 20 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1038/s41467-023-40064-9
CHEMBL15245 4096 48 None -380 20 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1038/s41467-023-40064-9
DB01392 4096 48 None -380 20 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1038/s41467-023-40064-9
392622 56282 95 None -8 20 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 720 17 4 9 5.9 CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1 10.1038/s41467-023-40064-9
CHEMBL163 56282 95 None -8 20 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 720 17 4 9 5.9 CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1 10.1038/s41467-023-40064-9
3354 41754 50 None -7 9 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 391 5 0 5 4.4 Cc1c(-c2ccccc2)oc2c(C(=O)OCCN3CCCCC3)cccc2c1=O 10.1038/s41467-023-40064-9
CHEMBL1493 41754 50 None -7 9 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 391 5 0 5 4.4 Cc1c(-c2ccccc2)oc2c(C(=O)OCCN3CCCCC3)cccc2c1=O 10.1038/s41467-023-40064-9
447715 196904 68 None -10 7 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 420 5 3 3 5.1 CC[C@@H]1[C@@H]2C[C@H](O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@H]3[C@H](C)CCC(=O)O)[C@@H]2[C@@H]1O 10.1038/s41467-023-40064-9
CHEMBL566315 196904 68 None -10 7 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 420 5 3 3 5.1 CC[C@@H]1[C@@H]2C[C@H](O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@H]3[C@H](C)CCC(=O)O)[C@@H]2[C@@H]1O 10.1038/s41467-023-40064-9
25382 9125 37 None -16 21 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 291 3 0 1 4.7 CN(C)CCC=C1c2ccccc2C(C)(C)c2ccccc21 10.1038/s41467-023-40064-9
CHEMBL110094 9125 37 None -16 21 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 291 3 0 1 4.7 CN(C)CCC=C1c2ccccc2C(C)(C)c2ccccc21 10.1038/s41467-023-40064-9
2435 3563 83 None -25 21 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1038/s41467-023-40064-9
60149 3563 83 None -25 21 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1038/s41467-023-40064-9
98 3563 83 None -25 21 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1038/s41467-023-40064-9
CHEMBL12713 3563 83 None -25 21 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1038/s41467-023-40064-9
DB06144 3563 83 None -25 21 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1038/s41467-023-40064-9
2683 102861 25 None -812 24 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 304 15 0 0 6.5 CCCCCCCCCCCCCCCC[n+]1ccccc1 10.1038/s41467-023-40064-9
CHEMBL305906 102861 25 None -812 24 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 304 15 0 0 6.5 CCCCCCCCCCCCCCCC[n+]1ccccc1 10.1038/s41467-023-40064-9
CHEMBL334255 102861 25 None -812 24 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 304 15 0 0 6.5 CCCCCCCCCCCCCCCC[n+]1ccccc1 10.1038/s41467-023-40064-9
2435 719 100 None -199 10 Human 6.2 pAC50 = 6.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1038/s41467-023-40064-9
395 719 100 None -199 10 Human 6.2 pAC50 = 6.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1038/s41467-023-40064-9
520 719 100 None -199 10 Human 6.2 pAC50 = 6.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1038/s41467-023-40064-9
5386 719 100 None -199 10 Human 6.2 pAC50 = 6.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1038/s41467-023-40064-9
CHEMBL844 719 100 None -199 10 Human 6.2 pAC50 = 6.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1038/s41467-023-40064-9
DB00484 719 100 None -199 10 Human 6.2 pAC50 = 6.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1038/s41467-023-40064-9
25295 13588 37 None -4 8 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 289 6 0 3 3.3 CN(C)CCN(Cc1ccc(Cl)cc1)c1ccccn1 10.1038/s41467-023-40064-9
CHEMBL1194287 13588 37 None -4 8 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 289 6 0 3 3.3 CN(C)CCN(Cc1ccc(Cl)cc1)c1ccccn1 10.1038/s41467-023-40064-9
10607 202224 100 None - 1 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 414 4 1 8 2.4 COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC 10.1038/s41467-023-40064-9
CHEMBL61 202224 100 None - 1 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 414 4 1 8 2.4 COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC 10.1038/s41467-023-40064-9
73417116 154407 0 None -11 5 Human 5.2 pAC50 = 5.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 266 2 2 2 3.0 N[C@@H]1C[C@H]1c1ccccc1.N[C@H]1C[C@@H]1c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL3989843 154407 0 None -11 5 Human 5.2 pAC50 = 5.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 266 2 2 2 3.0 N[C@@H]1C[C@H]1c1ccccc1.N[C@H]1C[C@@H]1c1ccccc1 10.1038/s41467-023-40064-9
5314 204085 23 None 25 2 Human 6.2 pAC50 = 6.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 290 9 0 4 0.3 C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C 10.1038/s41467-023-40064-9
CHEMBL703 204085 23 None 25 2 Human 6.2 pAC50 = 6.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 290 9 0 4 0.3 C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C 10.1038/s41467-023-40064-9
20628 96519 28 None -17 13 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 324 6 1 5 3.7 CN(C)CCCNc1c2ccccc2nc2cccc([N+](=O)[O-])c12 10.1038/s41467-023-40064-9
CHEMBL26291 96519 28 None -17 13 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 324 6 1 5 3.7 CN(C)CCCNc1c2ccccc2nc2cccc([N+](=O)[O-])c12 10.1038/s41467-023-40064-9
2865 4112 73 None -23 20 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
59 4112 73 None -23 20 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
60854 4112 73 None -23 20 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL708 4112 73 None -23 20 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
DB00246 4112 73 None -23 20 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
5353853 17954 47 None -39 20 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 427 6 0 4 6.1 Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 10.1038/s41467-023-40064-9
9556529 17954 47 None -39 20 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 427 6 0 4 6.1 Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 10.1038/s41467-023-40064-9
CHEMBL1262 17954 47 None -39 20 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 427 6 0 4 6.1 Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 10.1038/s41467-023-40064-9
2402 3345 62 None -354 17 Human 5.2 pAC50 = 5.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 260 7 1 2 3.5 CCCN(CCC)CCc1cccc2c1CC(=N2)O 10.1038/s41467-023-40064-9
5095 3345 62 None -354 17 Human 5.2 pAC50 = 5.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 260 7 1 2 3.5 CCCN(CCC)CCc1cccc2c1CC(=N2)O 10.1038/s41467-023-40064-9
7295 3345 62 None -354 17 Human 5.2 pAC50 = 5.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 260 7 1 2 3.5 CCCN(CCC)CCc1cccc2c1CC(=N2)O 10.1038/s41467-023-40064-9
CHEMBL589 3345 62 None -354 17 Human 5.2 pAC50 = 5.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 260 7 1 2 3.5 CCCN(CCC)CCc1cccc2c1CC(=N2)O 10.1038/s41467-023-40064-9
DB00268 3345 62 None -354 17 Human 5.2 pAC50 = 5.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 260 7 1 2 3.5 CCCN(CCC)CCc1cccc2c1CC(=N2)O 10.1038/s41467-023-40064-9
1593 2325 66 None -3 6 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1038/s41467-023-40064-9
30668 2325 66 None -3 6 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1038/s41467-023-40064-9
9868 2325 66 None -3 6 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1038/s41467-023-40064-9
CHEMBL17860 2325 66 None -3 6 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1038/s41467-023-40064-9
DB04948 2325 66 None -3 6 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1038/s41467-023-40064-9
4567 9916 34 None 2 12 Human 7.2 pAC50 = 7.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 299 7 3 3 3.4 CC(CCc1ccccc1)NC(C)C(O)c1ccc(O)cc1 10.1038/s41467-023-40064-9
CHEMBL114655 9916 34 None 2 12 Human 7.2 pAC50 = 7.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 299 7 3 3 3.4 CC(CCc1ccccc1)NC(C)C(O)c1ccc(O)cc1 10.1038/s41467-023-40064-9
16363 593 53 None -13 21 Human 7.2 pAC50 = 7.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 381 6 1 4 3.8 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
312 593 53 None -13 21 Human 7.2 pAC50 = 7.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 381 6 1 4 3.8 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
9215 593 53 None -13 21 Human 7.2 pAC50 = 7.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 381 6 1 4 3.8 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL297302 593 53 None -13 21 Human 7.2 pAC50 = 7.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 381 6 1 4 3.8 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
DB12867 593 53 None -13 21 Human 7.2 pAC50 = 7.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 381 6 1 4 3.8 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
168871 89101 14 None -53 13 Human 6.2 pAC50 = 6.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 563 4 3 6 2.1 CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12 10.1038/s41467-023-40064-9
CHEMBL2365712 89101 14 None -53 13 Human 6.2 pAC50 = 6.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 563 4 3 6 2.1 CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12 10.1038/s41467-023-40064-9
3598 187797 76 None 1 17 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 404 2 2 2 6.6 Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl 10.1038/s41467-023-40064-9
CHEMBL496 187797 76 None 1 17 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 404 2 2 2 6.6 Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl 10.1038/s41467-023-40064-9
2247 504 81 None -26 42 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
249 504 81 None -26 42 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
2603 504 81 None -26 42 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
CHEMBL296419 504 81 None -26 42 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
DB00637 504 81 None -26 42 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
40466858 16123 67 None -20 4 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 348 6 1 3 4.0 Cc1ccc(/C(=C\CN2CCCC2)c2cccc(/C=C/C(=O)O)n2)cc1 10.1038/s41467-023-40064-9
5284514 16123 67 None -20 4 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 348 6 1 3 4.0 Cc1ccc(/C(=C\CN2CCCC2)c2cccc(/C=C/C(=O)O)n2)cc1 10.1038/s41467-023-40064-9
CHEMBL1224 16123 67 None -20 4 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 348 6 1 3 4.0 Cc1ccc(/C(=C\CN2CCCC2)c2cccc(/C=C/C(=O)O)n2)cc1 10.1038/s41467-023-40064-9
5077 3552 79 None -275 13 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 496 12 1 7 3.9 O=C(NS(=O)(=O)C)COCCCCN(c1cnc(c(n1)c1ccccc1)c1ccccc1)C(C)C 10.1038/s41467-023-40064-9
7552 3552 79 None -275 13 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 496 12 1 7 3.9 O=C(NS(=O)(=O)C)COCCCCN(c1cnc(c(n1)c1ccccc1)c1ccccc1)C(C)C 10.1038/s41467-023-40064-9
9913767 3552 79 None -275 13 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 496 12 1 7 3.9 O=C(NS(=O)(=O)C)COCCCCN(c1cnc(c(n1)c1ccccc1)c1ccccc1)C(C)C 10.1038/s41467-023-40064-9
CHEMBL238804 3552 79 None -275 13 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 496 12 1 7 3.9 O=C(NS(=O)(=O)C)COCCCCN(c1cnc(c(n1)c1ccccc1)c1ccccc1)C(C)C 10.1038/s41467-023-40064-9
DB11362 3552 79 None -275 13 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 496 12 1 7 3.9 O=C(NS(=O)(=O)C)COCCCCN(c1cnc(c(n1)c1ccccc1)c1ccccc1)C(C)C 10.1038/s41467-023-40064-9
1613 2333 53 None -16 34 Human 7.1 pAC50 = 7.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
205 2333 53 None -16 34 Human 7.1 pAC50 = 7.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
3964 2333 53 None -16 34 Human 7.1 pAC50 = 7.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
CHEMBL831 2333 53 None -16 34 Human 7.1 pAC50 = 7.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
DB00408 2333 53 None -16 34 Human 7.1 pAC50 = 7.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
4195 14439 44 None 2 2 Human 5.1 pAC50 = 5.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 254 6 3 5 -0.2 COc1ccc(OC)c(C(O)CNC(=O)CN)c1 10.1038/s41467-023-40064-9
CHEMBL1201212 14439 44 None 2 2 Human 5.1 pAC50 = 5.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 254 6 3 5 -0.2 COc1ccc(OC)c(C(O)CNC(=O)CN)c1 10.1038/s41467-023-40064-9
12488 1644 56 None -19 28 Human 6.1 pAC50 = 6.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F 10.1038/s41467-023-40064-9
941361 1644 56 None -19 28 Human 6.1 pAC50 = 6.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F 10.1038/s41467-023-40064-9
CHEMBL30008 1644 56 None -19 28 Human 6.1 pAC50 = 6.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F 10.1038/s41467-023-40064-9
DB04841 1644 56 None -19 28 Human 6.1 pAC50 = 6.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F 10.1038/s41467-023-40064-9
1909 2803 64 None -1 11 Human 6.1 pAC50 = 6.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 479 9 1 8 3.7 COC(=O)C1=C(C)NC(=C(C1c1cccc(c1)[N+](=O)[O-])C(=O)OCCN(Cc1ccccc1)C)C 10.1038/s41467-023-40064-9
2559 2803 64 None -1 11 Human 6.1 pAC50 = 6.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 479 9 1 8 3.7 COC(=O)C1=C(C)NC(=C(C1c1cccc(c1)[N+](=O)[O-])C(=O)OCCN(Cc1ccccc1)C)C 10.1038/s41467-023-40064-9
4474 2803 64 None -1 11 Human 6.1 pAC50 = 6.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 479 9 1 8 3.7 COC(=O)C1=C(C)NC(=C(C1c1cccc(c1)[N+](=O)[O-])C(=O)OCCN(Cc1ccccc1)C)C 10.1038/s41467-023-40064-9
CHEMBL1484 2803 64 None -1 11 Human 6.1 pAC50 = 6.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 479 9 1 8 3.7 COC(=O)C1=C(C)NC(=C(C1c1cccc(c1)[N+](=O)[O-])C(=O)OCCN(Cc1ccccc1)C)C 10.1038/s41467-023-40064-9
CHEMBL3302409 2803 64 None -1 11 Human 6.1 pAC50 = 6.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 479 9 1 8 3.7 COC(=O)C1=C(C)NC(=C(C1c1cccc(c1)[N+](=O)[O-])C(=O)OCCN(Cc1ccccc1)C)C 10.1038/s41467-023-40064-9
DB00622 2803 64 None -1 11 Human 6.1 pAC50 = 6.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 479 9 1 8 3.7 COC(=O)C1=C(C)NC(=C(C1c1cccc(c1)[N+](=O)[O-])C(=O)OCCN(Cc1ccccc1)C)C 10.1038/s41467-023-40064-9
82146 4498 113 None 1 8 Human 6.1 pAC50 = 6.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 348 3 1 1 6.1 C=C(c1ccc(C(=O)O)cc1)c1cc2c(cc1C)C(C)(C)CCC2(C)C 10.1038/s41467-023-40064-9
CHEMBL1023 4498 113 None 1 8 Human 6.1 pAC50 = 6.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 348 3 1 1 6.1 C=C(c1ccc(C(=O)O)cc1)c1cc2c(cc1C)C(C)(C)CCC2(C)C 10.1038/s41467-023-40064-9
213046 2370 59 None -6 17 Human 7.1 pAC50 = 7.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 10.1038/s41467-023-40064-9
4168 2370 59 None -6 17 Human 7.1 pAC50 = 7.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 10.1038/s41467-023-40064-9
7461 2370 59 None -6 17 Human 7.1 pAC50 = 7.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 10.1038/s41467-023-40064-9
CHEMBL1237021 2370 59 None -6 17 Human 7.1 pAC50 = 7.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 10.1038/s41467-023-40064-9
DB08815 2370 59 None -6 17 Human 7.1 pAC50 = 7.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 10.1038/s41467-023-40064-9
137 369 52 None -3467 8 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
2119 369 52 None -3467 8 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
563 369 52 None -3467 8 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
66368 369 52 None -3467 8 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
CHEMBL266195 369 52 None -3467 8 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
DB00866 369 52 None -3467 8 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
68617 205504 62 None -14 30 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 10.1038/s41467-023-40064-9
CHEMBL1709 205504 62 None -14 30 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 10.1038/s41467-023-40064-9
CHEMBL809 205504 62 None -14 30 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 10.1038/s41467-023-40064-9
11823027 192592 37 None -436 3 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 309 5 4 5 0.6 CC(C)(C)NCC(O)COc1cccc2c1CC(O)C(O)C2 10.1038/s41467-023-40064-9
4411 192592 37 None -436 3 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 309 5 4 5 0.6 CC(C)(C)NCC(O)COc1cccc2c1CC(O)C(O)C2 10.1038/s41467-023-40064-9
CHEMBL521606 192592 37 None -436 3 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 309 5 4 5 0.6 CC(C)(C)NCC(O)COc1cccc2c1CC(O)C(O)C2 10.1038/s41467-023-40064-9
1690 3036 19 None -2 4 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 247 3 0 3 2.2 CCOC(=O)C1(CCN(CC1)C)c1ccccc1 10.1038/s41467-023-40064-9
4058 3036 19 None -2 4 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 247 3 0 3 2.2 CCOC(=O)C1(CCN(CC1)C)c1ccccc1 10.1038/s41467-023-40064-9
5750 3036 19 None -2 4 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 247 3 0 3 2.2 CCOC(=O)C1(CCN(CC1)C)c1ccccc1 10.1038/s41467-023-40064-9
7221 3036 19 None -2 4 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 247 3 0 3 2.2 CCOC(=O)C1(CCN(CC1)C)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL607 3036 19 None -2 4 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 247 3 0 3 2.2 CCOC(=O)C1(CCN(CC1)C)c1ccccc1 10.1038/s41467-023-40064-9
DB00454 3036 19 None -2 4 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 247 3 0 3 2.2 CCOC(=O)C1(CCN(CC1)C)c1ccccc1 10.1038/s41467-023-40064-9
2291 3162 58 None -147 13 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O 10.1038/s41467-023-40064-9
2561 3162 58 None -147 13 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O 10.1038/s41467-023-40064-9
4932 3162 58 None -147 13 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O 10.1038/s41467-023-40064-9
CHEMBL631 3162 58 None -147 13 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O 10.1038/s41467-023-40064-9
DB01182 3162 58 None -147 13 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O 10.1038/s41467-023-40064-9
1588 2311 27 None -467 23 Human 7.1 pAC50 = 7.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 10.1038/s41467-023-40064-9
28864 2311 27 None -467 23 Human 7.1 pAC50 = 7.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 10.1038/s41467-023-40064-9
43 2311 27 None -467 23 Human 7.1 pAC50 = 7.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 10.1038/s41467-023-40064-9
CHEMBL157138 2311 27 None -467 23 Human 7.1 pAC50 = 7.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 10.1038/s41467-023-40064-9
DB00589 2311 27 None -467 23 Human 7.1 pAC50 = 7.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 10.1038/s41467-023-40064-9
82146 4498 113 None 1 8 Human 5.1 pAC50 = 5.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 348 3 1 1 6.1 C=C(c1ccc(C(=O)O)cc1)c1cc2c(cc1C)C(C)(C)CCC2(C)C 10.1038/s41467-023-40064-9
CHEMBL1023 4498 113 None 1 8 Human 5.1 pAC50 = 5.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 348 3 1 1 6.1 C=C(c1ccc(C(=O)O)cc1)c1cc2c(cc1C)C(C)(C)CCC2(C)C 10.1038/s41467-023-40064-9
2803 952 58 None -3 14 Human 8.1 pAC50 = 8.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1038/s41467-023-40064-9
516 952 58 None -3 14 Human 8.1 pAC50 = 8.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1038/s41467-023-40064-9
704 952 58 None -3 14 Human 8.1 pAC50 = 8.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1038/s41467-023-40064-9
CHEMBL134 952 58 None -3 14 Human 8.1 pAC50 = 8.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1038/s41467-023-40064-9
DB00575 952 58 None -3 14 Human 8.1 pAC50 = 8.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1038/s41467-023-40064-9
2470 3626 50 None -13803 23 Human 7.1 pAC50 = 7.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
3300 3626 50 None -13803 23 Human 7.1 pAC50 = 7.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
5265 3626 50 None -13803 23 Human 7.1 pAC50 = 7.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
99 3626 50 None -13803 23 Human 7.1 pAC50 = 7.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL267930 3626 50 None -13803 23 Human 7.1 pAC50 = 7.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
154257 178595 67 None -13 19 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 470 7 2 5 6.3 Cc1c(-c2ccc(O)cc2)n(Cc2ccc(OCCN3CCCCCC3)cc2)c2ccc(O)cc12 10.1038/s41467-023-40064-9
CHEMBL46740 178595 67 None -13 19 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 470 7 2 5 6.3 Cc1c(-c2ccc(O)cc2)n(Cc2ccc(OCCN3CCCCCC3)cc2)c2ccc(O)cc12 10.1038/s41467-023-40064-9
6324616 168800 25 None 1 3 Human 5.1 pAC50 = 5.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 697 2 6 12 4.8 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(cc(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
CHEMBL437765 168800 25 None 1 3 Human 5.1 pAC50 = 5.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 697 2 6 12 4.8 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(cc(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
3949 100586 50 None -8 16 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 468 8 0 5 4.9 COc1ccc(CN2CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC2)c(OC)c1OC 10.1038/s41467-023-40064-9
CHEMBL29188 100586 50 None -8 16 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 468 8 0 5 4.9 COc1ccc(CN2CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC2)c(OC)c1OC 10.1038/s41467-023-40064-9
444029 167733 10 None -1 2 Human 5.1 pAC50 = 5.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 509 6 2 9 2.0 C=C[C@@]1(C)CC(=O)[C@]2(O)[C@@]3(C)[C@@H](O)CCC(C)(C)[C@@H]3[C@H](OC(=O)CCN(C)C)[C@H](OC(C)=O)[C@@]2(C)O1 10.1038/s41467-023-40064-9
CHEMBL4303178 167733 10 None -1 2 Human 5.1 pAC50 = 5.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 509 6 2 9 2.0 C=C[C@@]1(C)CC(=O)[C@]2(O)[C@@]3(C)[C@@H](O)CCC(C)(C)[C@@H]3[C@H](OC(=O)CCN(C)C)[C@H](OC(C)=O)[C@@]2(C)O1 10.1038/s41467-023-40064-9
4631 194949 29 None -1071 5 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 265 9 2 4 2.0 C=CCOc1ccccc1OCC(O)CNC(C)C 10.1038/s41467-023-40064-9
CHEMBL546 194949 29 None -1071 5 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 265 9 2 4 2.0 C=CCOc1ccccc1OCC(O)CNC(C)C 10.1038/s41467-023-40064-9
71398 106412 44 None -1174 14 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 302 5 4 4 3.6 C[C@@H](Cc1ccc(O)c(O)c1)[C@H](C)Cc1ccc(O)c(O)c1 10.1038/s41467-023-40064-9
CHEMBL313972 106412 44 None -1174 14 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 302 5 4 4 3.6 C[C@@H](Cc1ccc(O)c(O)c1)[C@H](C)Cc1ccc(O)c(O)c1 10.1038/s41467-023-40064-9
31101 726 40 None -199 29 Human 6.1 pAC50 = 6.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
35 726 40 None -199 29 Human 6.1 pAC50 = 6.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
403 726 40 None -199 29 Human 6.1 pAC50 = 6.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
CHEMBL493 726 40 None -199 29 Human 6.1 pAC50 = 6.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
DB01200 726 40 None -199 29 Human 6.1 pAC50 = 6.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
11057 176125 23 None -1 25 Human 6.1 pAC50 = 6.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 372 4 0 2 4.5 CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1 10.1038/s41467-023-40064-9
3468 176125 23 None -1 25 Human 6.1 pAC50 = 6.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 372 4 0 2 4.5 CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1 10.1038/s41467-023-40064-9
CHEMBL459265 176125 23 None -1 25 Human 6.1 pAC50 = 6.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 372 4 0 2 4.5 CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1 10.1038/s41467-023-40064-9
CHEMBL64894 176125 23 None -1 25 Human 6.1 pAC50 = 6.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 372 4 0 2 4.5 CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1 10.1038/s41467-023-40064-9
636403 188244 22 None -3 7 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 570 5 2 5 6.8 CC1(C)[C@@H](OC(=O)CCC(=O)O)CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@@](C)(C(=O)O)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12 10.1038/s41467-023-40064-9
CHEMBL499915 188244 22 None -3 7 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 570 5 2 5 6.8 CC1(C)[C@@H](OC(=O)CCC(=O)O)CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@@](C)(C(=O)O)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12 10.1038/s41467-023-40064-9
124087 1377 114 None -112 27 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 10.1038/s41467-023-40064-9
7157 1377 114 None -112 27 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 10.1038/s41467-023-40064-9
814 1377 114 None -112 27 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 10.1038/s41467-023-40064-9
CHEMBL1172 1377 114 None -112 27 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 10.1038/s41467-023-40064-9
DB00967 1377 114 None -112 27 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 10.1038/s41467-023-40064-9
41684 31191 105 None -19 32 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 307 4 1 7 2.2 CC(=O)Oc1ccccc1C(=O)Nc1ncc([N+](=O)[O-])s1 10.1038/s41467-023-40064-9
CHEMBL1401 31191 105 None -19 32 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 307 4 1 7 2.2 CC(=O)Oc1ccccc1C(=O)Nc1ncc([N+](=O)[O-])s1 10.1038/s41467-023-40064-9
5284550 41691 15 None -87 16 Human 6.1 pAC50 = 6.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 295 3 0 2 4.7 CN(C)CC/C=C1\c2ccccc2CSc2ccccc21 10.1038/s41467-023-40064-9
CHEMBL1492500 41691 15 None -87 16 Human 6.1 pAC50 = 6.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 295 3 0 2 4.7 CN(C)CC/C=C1\c2ccccc2CSc2ccccc21 10.1038/s41467-023-40064-9
21855 84217 42 None -112 9 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 292 5 0 2 4.1 CC(C1=C(CCN(C)C)Cc2ccccc21)c1ccccn1 10.1038/s41467-023-40064-9
CHEMBL22108 84217 42 None -112 9 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 292 5 0 2 4.1 CC(C1=C(CCN(C)C)Cc2ccccc21)c1ccccn1 10.1038/s41467-023-40064-9
134 2497 24 None -457 18 Human 6.1 pAC50 = 6.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO 10.1038/s41467-023-40064-9
1775 2497 24 None -457 18 Human 6.1 pAC50 = 6.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO 10.1038/s41467-023-40064-9
9681 2497 24 None -457 18 Human 6.1 pAC50 = 6.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO 10.1038/s41467-023-40064-9
CHEMBL1065 2497 24 None -457 18 Human 6.1 pAC50 = 6.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO 10.1038/s41467-023-40064-9
DB00247 2497 24 None -457 18 Human 6.1 pAC50 = 6.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO 10.1038/s41467-023-40064-9
2391 207430 92 None -9 5 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 361 5 0 5 4.1 CC(=O)Oc1ccc(C(c2ccc(OC(C)=O)cc2)c2ccccn2)cc1 10.1038/s41467-023-40064-9
CHEMBL942 207430 92 None -9 5 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 361 5 0 5 4.1 CC(=O)Oc1ccc(C(c2ccc(OC(C)=O)cc2)c2ccccn2)cc1 10.1038/s41467-023-40064-9
151537 162640 49 None -1 5 Human 5.1 pAC50 = 5.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 543 5 6 12 0.0 COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1 10.1038/s41467-023-40064-9
41867 162640 49 None -1 5 Human 5.1 pAC50 = 5.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 543 5 6 12 0.0 COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1 10.1038/s41467-023-40064-9
CHEMBL417 162640 49 None -1 5 Human 5.1 pAC50 = 5.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 543 5 6 12 0.0 COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1 10.1038/s41467-023-40064-9
3294 1993 111 None -3 23 Human 8.0 pAC50 = 8.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1038/s41467-023-40064-9
71360 1993 111 None -3 23 Human 8.0 pAC50 = 8.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1038/s41467-023-40064-9
87 1993 111 None -3 23 Human 8.0 pAC50 = 8.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1038/s41467-023-40064-9
CHEMBL14376 1993 111 None -3 23 Human 8.0 pAC50 = 8.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1038/s41467-023-40064-9
DB04946 1993 111 None -3 23 Human 8.0 pAC50 = 8.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1038/s41467-023-40064-9
1343 1876 62 None -9 12 Human 8.0 pAC50 = 8.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 10.1038/s41467-023-40064-9
3519 1876 62 None -9 12 Human 8.0 pAC50 = 8.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 10.1038/s41467-023-40064-9
522 1876 62 None -9 12 Human 8.0 pAC50 = 8.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 10.1038/s41467-023-40064-9
CHEMBL862 1876 62 None -9 12 Human 8.0 pAC50 = 8.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 10.1038/s41467-023-40064-9
DB01018 1876 62 None -9 12 Human 8.0 pAC50 = 8.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 10.1038/s41467-023-40064-9
2683 3805 60 None -10 6 Human 8.0 pAC50 = 8.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 10.1038/s41467-023-40064-9
5487 3805 60 None -10 6 Human 8.0 pAC50 = 8.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 10.1038/s41467-023-40064-9
7308 3805 60 None -10 6 Human 8.0 pAC50 = 8.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 10.1038/s41467-023-40064-9
CHEMBL1079 3805 60 None -10 6 Human 8.0 pAC50 = 8.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 10.1038/s41467-023-40064-9
DB00697 3805 60 None -10 6 Human 8.0 pAC50 = 8.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 10.1038/s41467-023-40064-9
4209 3141 75 None -24 17 Human 8.0 pAC50 = 8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
4893 3141 75 None -24 17 Human 8.0 pAC50 = 8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
503 3141 75 None -24 17 Human 8.0 pAC50 = 8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
5385 3141 75 None -24 17 Human 8.0 pAC50 = 8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
CHEMBL2 3141 75 None -24 17 Human 8.0 pAC50 = 8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
DB00457 3141 75 None -24 17 Human 8.0 pAC50 = 8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
12574 2587 88 None -1 8 Human 7.1 pAC50 = 7.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 241 2 2 6 0.8 CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC 10.1038/s41467-023-40064-9
4810 2587 88 None -1 8 Human 7.1 pAC50 = 7.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 241 2 2 6 0.8 CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC 10.1038/s41467-023-40064-9
CHEMBL19236 2587 88 None -1 8 Human 7.1 pAC50 = 7.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 241 2 2 6 0.8 CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC 10.1038/s41467-023-40064-9
DB09242 2587 88 None -1 8 Human 7.1 pAC50 = 7.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 241 2 2 6 0.8 CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC 10.1038/s41467-023-40064-9
2419 3437 84 None -3019 14 Human 6.0 pAC50 = 6.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1038/s41467-023-40064-9
5152 3437 84 None -3019 14 Human 6.0 pAC50 = 6.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1038/s41467-023-40064-9
559 3437 84 None -3019 14 Human 6.0 pAC50 = 6.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1038/s41467-023-40064-9
CHEMBL1263 3437 84 None -3019 14 Human 6.0 pAC50 = 6.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1038/s41467-023-40064-9
DB00938 3437 84 None -3019 14 Human 6.0 pAC50 = 6.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1038/s41467-023-40064-9
25102847 78192 93 None -7 10 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 501 8 2 6 5.5 COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC 10.1038/s41467-023-40064-9
CHEMBL2105717 78192 93 None -7 10 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 501 8 2 6 5.5 COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC 10.1038/s41467-023-40064-9
3397 205465 112 None -1 8 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 276 3 1 3 3.2 CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1 10.1038/s41467-023-40064-9
CHEMBL806 205465 112 None -1 8 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 276 3 1 3 3.2 CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1 10.1038/s41467-023-40064-9
135398745 2893 112 None -14 33 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1038/s41467-023-40064-9
47 2893 112 None -14 33 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1038/s41467-023-40064-9
CHEMBL715 2893 112 None -14 33 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1038/s41467-023-40064-9
DB00334 2893 112 None -14 33 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1038/s41467-023-40064-9
277 1289 62 None -954 29 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 10.1038/s41467-023-40064-9
2913 1289 62 None -954 29 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 10.1038/s41467-023-40064-9
765 1289 62 None -954 29 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 10.1038/s41467-023-40064-9
CHEMBL516 1289 62 None -954 29 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 10.1038/s41467-023-40064-9
DB00434 1289 62 None -954 29 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 10.1038/s41467-023-40064-9
610479 15468 90 None 1 5 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 261 3 2 2 4.1 Cc1c(Cl)cccc1Nc1ccccc1C(=O)O 10.1038/s41467-023-40064-9
CHEMBL121626 15468 90 None 1 5 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 261 3 2 2 4.1 Cc1c(Cl)cccc1Nc1ccccc1C(=O)O 10.1038/s41467-023-40064-9
3280 48419 28 None -5 8 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 10 0 5 5.4 CCOc1ccc(Cc2nccc3cc(OCC)c(OCC)cc23)cc1OCC 10.1038/s41467-023-40064-9
CHEMBL1555736 48419 28 None -5 8 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 10 0 5 5.4 CCOc1ccc(Cc2nccc3cc(OCC)c(OCC)cc23)cc1OCC 10.1038/s41467-023-40064-9
3166 169396 23 None -1230 8 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 317 8 0 3 4.2 CCN(CC)CCOC(=O)C(c1ccccc1)C1CCCCC1 10.1038/s41467-023-40064-9
CHEMBL442444 169396 23 None -1230 8 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 317 8 0 3 4.2 CCN(CC)CCOC(=O)C(c1ccccc1)C1CCCCC1 10.1038/s41467-023-40064-9
2583 3747 118 None -3019 16 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 514 7 1 5 7.3 CCCc1nc2c(n1Cc1ccc(cc1)c1ccccc1C(=O)O)cc(cc2C)c1nc2c(n1C)cccc2 10.1038/s41467-023-40064-9
592 3747 118 None -3019 16 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 514 7 1 5 7.3 CCCc1nc2c(n1Cc1ccc(cc1)c1ccccc1C(=O)O)cc(cc2C)c1nc2c(n1C)cccc2 10.1038/s41467-023-40064-9
65999 3747 118 None -3019 16 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 514 7 1 5 7.3 CCCc1nc2c(n1Cc1ccc(cc1)c1ccccc1C(=O)O)cc(cc2C)c1nc2c(n1C)cccc2 10.1038/s41467-023-40064-9
CHEMBL1017 3747 118 None -3019 16 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 514 7 1 5 7.3 CCCc1nc2c(n1Cc1ccc(cc1)c1ccccc1C(=O)O)cc(cc2C)c1nc2c(n1C)cccc2 10.1038/s41467-023-40064-9
DB00966 3747 118 None -3019 16 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 514 7 1 5 7.3 CCCc1nc2c(n1Cc1ccc(cc1)c1ccccc1C(=O)O)cc(cc2C)c1nc2c(n1C)cccc2 10.1038/s41467-023-40064-9
1201549 594 24 None -138 26 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
333 594 24 None -138 26 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
7601 594 24 None -138 26 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL1201203 594 24 None -138 26 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL438151 594 24 None -138 26 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
DB00245 594 24 None -138 26 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
2600 3750 74 None -151 32 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O 10.1038/s41467-023-40064-9
2608 3750 74 None -151 32 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O 10.1038/s41467-023-40064-9
5405 3750 74 None -151 32 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O 10.1038/s41467-023-40064-9
CHEMBL17157 3750 74 None -151 32 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O 10.1038/s41467-023-40064-9
DB00342 3750 74 None -151 32 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O 10.1038/s41467-023-40064-9
1400 1944 70 None -15 16 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
3658 1944 70 None -15 16 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
7199 1944 70 None -15 16 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
91513 1944 70 None -15 16 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL896 1944 70 None -15 16 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
DB00557 1944 70 None -15 16 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
3678 94763 57 None -33 8 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 281 9 0 1 4.6 CCN(CCCc1ccccc1)CCCc1ccccc1 10.1038/s41467-023-40064-9
CHEMBL253371 94763 57 None -33 8 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 281 9 0 1 4.6 CCN(CCCc1ccccc1)CCCc1ccccc1 10.1038/s41467-023-40064-9
7019 167952 106 None -2 8 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 194 0 1 2 3.0 Nc1c2ccccc2nc2ccccc12 10.1038/s41467-023-40064-9
CHEMBL1308088 167952 106 None -2 8 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 194 0 1 2 3.0 Nc1c2ccccc2nc2ccccc12 10.1038/s41467-023-40064-9
CHEMBL43184 167952 106 None -2 8 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 194 0 1 2 3.0 Nc1c2ccccc2nc2ccccc12 10.1038/s41467-023-40064-9
150311 9780 102 None -2 7 Human 5.0 pAC50 = 5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 409 6 2 3 4.9 O=C1[C@H](CC[C@H](O)c2ccc(F)cc2)[C@@H](c2ccc(O)cc2)N1c1ccc(F)cc1 10.1038/s41467-023-40064-9
CHEMBL1138 9780 102 None -2 7 Human 5.0 pAC50 = 5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 409 6 2 3 4.9 O=C1[C@H](CC[C@H](O)c2ccc(F)cc2)[C@@H](c2ccc(O)cc2)N1c1ccc(F)cc1 10.1038/s41467-023-40064-9
10934575 204463 0 None 3 5 Human 10.0 pEC50 = 10.0 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 235 4 2 4 2.1 CSc1ccc(C)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL72441 204463 0 None 3 5 Human 10.0 pEC50 = 10.0 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 235 4 2 4 2.1 CSc1ccc(C)cc1NCC1=NCCN1 10.1021/jm000542r
44362146 164910 1 None 50 3 Human 9.6 pEC50 = 9.6 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 258 4 1 4 2.8 c1ccc(-c2ccsc2)c(OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
CHEMBL422477 164910 1 None 50 3 Human 9.6 pEC50 = 9.6 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 258 4 1 4 2.8 c1ccc(-c2ccsc2)c(OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
44574074 189445 0 None 977 2 Human 9.4 pEC50 = 9.4 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 262 2 0 4 2.7 c1ccc([C@@H]2Cc3nccn3C2)c(-c2cncnc2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL513691 189445 0 None 977 2 Human 9.4 pEC50 = 9.4 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 262 2 0 4 2.7 c1ccc([C@@H]2Cc3nccn3C2)c(-c2cncnc2)c1 10.1016/j.bmcl.2009.03.166
11109088 204157 0 None 1 5 Human 9.4 pEC50 = 9.4 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 255 4 2 4 2.5 CSc1ccc(Cl)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL70751 204157 0 None 1 5 Human 9.4 pEC50 = 9.4 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 255 4 2 4 2.5 CSc1ccc(Cl)cc1NCC1=NCCN1 10.1021/jm000542r
22493318 44727 0 None 13 3 Human 9.3 pEC50 = 9.3 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 241 4 2 4 2.4 c1coc(-c2ccccc2NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
CHEMBL152155 44727 0 None 13 3 Human 9.3 pEC50 = 9.3 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 241 4 2 4 2.4 c1coc(-c2ccccc2NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
44362194 34352 1 None 10 3 Human 9.3 pEC50 = 9.3 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 242 4 1 4 2.3 c1ccc(-c2ccoc2)c(OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
CHEMBL142784 34352 1 None 10 3 Human 9.3 pEC50 = 9.3 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 242 4 1 4 2.3 c1ccc(-c2ccoc2)c(OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
22493352 48244 0 None 2 3 Human 9.2 pEC50 = 9.2 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 242 4 2 5 1.8 c1ccc(-c2ncco2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
CHEMBL155326 48244 0 None 2 3 Human 9.2 pEC50 = 9.2 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 242 4 2 5 1.8 c1ccc(-c2ncco2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
22493236 60366 0 None 5 3 Human 9.1 pEC50 = 9.1 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 242 4 3 5 0.9 c1ccc(-c2nc[nH]n2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(03)00050-7
CHEMBL17491 60366 0 None 5 3 Human 9.1 pEC50 = 9.1 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 242 4 3 5 0.9 c1ccc(-c2nc[nH]n2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(03)00050-7
44271661 161772 0 None -1 3 Human 9.1 pEC50 = 9.1 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 233 4 2 5 0.9 COC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL414185 161772 0 None -1 3 Human 9.1 pEC50 = 9.1 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 233 4 2 5 0.9 COC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
44271661 161772 0 None -1 3 Human 9.1 pEC50 = 9.1 Functional
Effective concentration showing agonistic activity towards Human alpha-1A adrenergic receptor, expressed in rat 1 fibroblast cells was determinedEffective concentration showing agonistic activity towards Human alpha-1A adrenergic receptor, expressed in rat 1 fibroblast cells was determined
ChEMBL 233 4 2 5 0.9 COC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
CHEMBL414185 161772 0 None -1 3 Human 9.1 pEC50 = 9.1 Functional
Effective concentration showing agonistic activity towards Human alpha-1A adrenergic receptor, expressed in rat 1 fibroblast cells was determinedEffective concentration showing agonistic activity towards Human alpha-1A adrenergic receptor, expressed in rat 1 fibroblast cells was determined
ChEMBL 233 4 2 5 0.9 COC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
22493280 48245 0 None 1 3 Human 9.1 pEC50 = 9.1 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 242 4 2 5 1.8 c1ccc(-c2ccno2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
CHEMBL155327 48245 0 None 1 3 Human 9.1 pEC50 = 9.1 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 242 4 2 5 1.8 c1ccc(-c2ccno2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
44271661 161772 0 None -1 3 Human 9.1 pEC50 = 9.1 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 233 4 2 5 0.9 COC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
CHEMBL414185 161772 0 None -1 3 Human 9.1 pEC50 = 9.1 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 233 4 2 5 0.9 COC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
44369431 45325 0 None 57 3 Human 9.1 pEC50 = 9.1 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 271 4 2 4 3.1 Cc1ccsc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
CHEMBL152693 45325 0 None 57 3 Human 9.1 pEC50 = 9.1 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 271 4 2 4 3.1 Cc1ccsc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
44362208 35403 1 None 3 3 Human 9.0 pEC50 = 9 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 258 4 1 4 2.8 c1csc(-c2ccccc2OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
CHEMBL143801 35403 1 None 3 3 Human 9.0 pEC50 = 9 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 258 4 1 4 2.8 c1csc(-c2ccccc2OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
22493258 98636 0 None 5 3 Human 9.0 pEC50 = 9 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 241 4 3 4 1.5 c1ccc(-c2cc[nH]n2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(03)00050-7
CHEMBL277375 98636 0 None 5 3 Human 9.0 pEC50 = 9 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 241 4 3 4 1.5 c1ccc(-c2cc[nH]n2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(03)00050-7
44574078 178737 0 None 120 3 Human 9.0 pEC50 = 9 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 261 2 0 3 3.3 c1cncc(-c2ccccc2[C@@H]2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL468711 178737 0 None 120 3 Human 9.0 pEC50 = 9 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 261 2 0 3 3.3 c1cncc(-c2ccccc2[C@@H]2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
44219718 188822 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 280 2 0 4 2.8 Fc1ccc(-c2cncnc2)c(C2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL506744 188822 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 280 2 0 4 2.8 Fc1ccc(-c2cncnc2)c(C2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
44362286 98858 1 None 7 2 Human 8.9 pEC50 = 8.9 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 242 4 1 4 2.3 c1coc(-c2ccccc2OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
CHEMBL279136 98858 1 None 7 2 Human 8.9 pEC50 = 8.9 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 242 4 1 4 2.3 c1coc(-c2ccccc2OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
44362195 121063 0 None 2 3 Human 8.9 pEC50 = 8.9 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 241 4 2 3 2.1 c1c[nH]c(-c2ccccc2OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
CHEMBL357129 121063 0 None 2 3 Human 8.9 pEC50 = 8.9 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 241 4 2 3 2.1 c1c[nH]c(-c2ccccc2OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
22493263 98056 0 None 50 3 Human 8.9 pEC50 = 8.9 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 270 5 2 6 1.4 CCn1ncnc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
CHEMBL273316 98056 0 None 50 3 Human 8.9 pEC50 = 8.9 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 270 5 2 6 1.4 CCn1ncnc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
22493365 98436 0 None 15 3 Human 8.9 pEC50 = 8.9 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 241 4 3 4 1.5 c1ccc(-c2cn[nH]c2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(03)00050-7
CHEMBL275844 98436 0 None 15 3 Human 8.9 pEC50 = 8.9 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 241 4 3 4 1.5 c1ccc(-c2cn[nH]c2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(03)00050-7
44329788 208079 0 None - 1 Human 8.9 pEC50 = 8.9 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 275 6 2 5 2.1 CCC(C)OC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL97859 208079 0 None - 1 Human 8.9 pEC50 = 8.9 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 275 6 2 5 2.1 CCC(C)OC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
11098175 204147 0 None 2 4 Human 8.8 pEC50 = 8.8 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 251 5 2 5 1.8 COc1ccc(SC)c(NCC2=NCCN2)c1 10.1021/jm000542r
CHEMBL70691 204147 0 None 2 4 Human 8.8 pEC50 = 8.8 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 251 5 2 5 1.8 COc1ccc(SC)c(NCC2=NCCN2)c1 10.1021/jm000542r
10221005 204299 0 None 72 3 Human 8.7 pEC50 = 8.7 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 267 4 2 5 0.8 Cc1ccc(S(C)(=O)=O)c(NCC2=NCCN2)c1 10.1021/jm000542r
CHEMBL71479 204299 0 None 72 3 Human 8.7 pEC50 = 8.7 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 267 4 2 5 0.8 Cc1ccc(S(C)(=O)=O)c(NCC2=NCCN2)c1 10.1021/jm000542r
44362185 121003 0 None 19 3 Human 8.7 pEC50 = 8.7 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 253 4 1 4 2.1 c1cncc(-c2ccccc2OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
CHEMBL356605 121003 0 None 19 3 Human 8.7 pEC50 = 8.7 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 253 4 1 4 2.1 c1cncc(-c2ccccc2OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
22493343 63941 0 None 19 3 Human 8.7 pEC50 = 8.7 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 256 4 2 6 0.9 Cn1ncnc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
CHEMBL18069 63941 0 None 19 3 Human 8.7 pEC50 = 8.7 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 256 4 2 6 0.9 Cn1ncnc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
44343410 11523 2 None -1 3 Human 8.0 pEC50 = 8 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 219 4 2 3 2.7 CSc1ccccc1NCc1c[nH]cn1 10.1016/s0960-894x(02)00753-9
CHEMBL118055 11523 2 None -1 3 Human 8.0 pEC50 = 8 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 219 4 2 3 2.7 CSc1ccccc1NCc1c[nH]cn1 10.1016/s0960-894x(02)00753-9
9837963 62941 0 None 8 3 Human 8.0 pEC50 = 8 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 255 4 2 5 1.5 Cn1nccc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
CHEMBL17851 62941 0 None 8 3 Human 8.0 pEC50 = 8 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 255 4 2 5 1.5 Cn1nccc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
44329796 208356 0 None 1 3 Human 8.0 pEC50 = 8 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 275 7 2 5 2.1 CCCCOC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL99559 208356 0 None 1 3 Human 8.0 pEC50 = 8 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 275 7 2 5 2.1 CCCCOC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
22493289 49658 0 None 4 3 Human 8.0 pEC50 = 8 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 253 4 2 5 1.6 c1cnc(-c2ccccc2NCC2=NCCN2)nc1 10.1016/s0960-894x(01)00822-8
CHEMBL156661 49658 0 None 4 3 Human 8.0 pEC50 = 8 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 253 4 2 5 1.6 c1cnc(-c2ccccc2NCC2=NCCN2)nc1 10.1016/s0960-894x(01)00822-8
11034737 204505 0 None -1 4 Human 8.0 pEC50 = 8.0 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 289 4 2 4 2.8 CSc1ccc(C(F)(F)F)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL72724 204505 0 None -1 4 Human 8.0 pEC50 = 8.0 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 289 4 2 4 2.8 CSc1ccc(C(F)(F)F)cc1NCC1=NCCN1 10.1021/jm000542r
44362145 34453 3 None - 1 Human 7.0 pEC50 = 7 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 242 4 2 4 1.5 c1ccc(-c2ncc[nH]2)c(OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
CHEMBL142864 34453 3 None - 1 Human 7.0 pEC50 = 7 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 242 4 2 4 1.5 c1ccc(-c2ncc[nH]2)c(OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
22493401 208226 0 None - 1 Human 7.0 pEC50 = 7 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 288 7 2 4 2.0 CCCN(CC)C(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL98769 208226 0 None - 1 Human 7.0 pEC50 = 7 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 288 7 2 4 2.0 CCCN(CC)C(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
22493225 62482 0 None - 1 Human 6.0 pEC50 = 6 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 270 4 2 6 1.2 Cc1nc(-c2ccccc2NCC2=NCCN2)n(C)n1 10.1016/s0960-894x(03)00050-7
CHEMBL17819 62482 0 None - 1 Human 6.0 pEC50 = 6 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 270 4 2 6 1.2 Cc1nc(-c2ccccc2NCC2=NCCN2)n(C)n1 10.1016/s0960-894x(03)00050-7
44574878 178523 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 228 2 1 2 2.7 COc1cccc(C2CCc3nc[nH]c3C2)c1 10.1016/j.bmcl.2009.03.162
CHEMBL466916 178523 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 228 2 1 2 2.7 COc1cccc(C2CCc3nc[nH]c3C2)c1 10.1016/j.bmcl.2009.03.162
22493372 120212 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 256 4 2 5 2.1 Cc1ncc(-c2ccccc2NCC2=NCCN2)o1 10.1016/s0960-894x(01)00822-8
CHEMBL352225 120212 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 256 4 2 5 2.1 Cc1ncc(-c2ccccc2NCC2=NCCN2)o1 10.1016/s0960-894x(01)00822-8
11059195 102145 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 321 4 2 5 1.5 CS(=O)(=O)c1ccc(C(F)(F)F)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL302698 102145 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 321 4 2 5 1.5 CS(=O)(=O)c1ccc(C(F)(F)F)cc1NCC1=NCCN1 10.1021/jm000542r
44574987 178653 0 None - 1 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 250 3 0 3 2.8 FC(F)Oc1ccccc1C1Cc2nccn2C1 10.1016/j.bmcl.2009.03.162
CHEMBL467915 178653 0 None - 1 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 250 3 0 3 2.8 FC(F)Oc1ccccc1C1Cc2nccn2C1 10.1016/j.bmcl.2009.03.162
76632 100022 51 None -5 2 Human 5.0 pEC50 = 5.0 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 181 4 1 3 1.2 COc1ccc(OC)c(CCN)c1 10.1021/jm00144a012
CHEMBL287047 100022 51 None -5 2 Human 5.0 pEC50 = 5.0 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 181 4 1 3 1.2 COc1ccc(OC)c(CCN)c1 10.1021/jm00144a012
44449657 96037 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 265 2 1 3 3.5 Cc1oncc1-c1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL260009 96037 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 265 2 1 3 3.5 Cc1oncc1-c1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
44571891 169992 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 280 3 1 4 2.8 Cc1noc(Cc2cccc3c2CC[C@H]3c2ncc[nH]2)n1 10.1016/j.bmcl.2008.10.066
CHEMBL444252 169992 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 280 3 1 4 2.8 Cc1noc(Cc2cccc3c2CC[C@H]3c2ncc[nH]2)n1 10.1016/j.bmcl.2008.10.066
2435 719 100 None -25 10 Bovine 6.0 pEC50 = 6.0 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
395 719 100 None -25 10 Bovine 6.0 pEC50 = 6.0 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
520 719 100 None -25 10 Bovine 6.0 pEC50 = 6.0 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
5386 719 100 None -25 10 Bovine 6.0 pEC50 = 6.0 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
CHEMBL844 719 100 None -25 10 Bovine 6.0 pEC50 = 6.0 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
DB00484 719 100 None -25 10 Bovine 6.0 pEC50 = 6.0 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
44449690 96132 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 261 2 1 2 3.6 c1ccc(-c2cccc3c2CCC3c2ncc[nH]2)nc1 10.1016/j.bmcl.2008.03.070
CHEMBL260575 96132 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 261 2 1 2 3.6 c1ccc(-c2cccc3c2CCC3c2ncc[nH]2)nc1 10.1016/j.bmcl.2008.03.070
1960 2838 67 None -97 19 Rat 5.9 pEC50 = 5.9 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
439260 2838 67 None -97 19 Rat 5.9 pEC50 = 5.9 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
505 2838 67 None -97 19 Rat 5.9 pEC50 = 5.9 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
CHEMBL1437 2838 67 None -97 19 Rat 5.9 pEC50 = 5.9 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
DB00368 2838 67 None -97 19 Rat 5.9 pEC50 = 5.9 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
44574105 178784 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 305 5 1 4 1.3 CNS(=O)(=O)CCc1ccccc1[C@@H]1Cc2nccn2C1 10.1016/j.bmcl.2009.03.166
CHEMBL469127 178784 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 305 5 1 4 1.3 CNS(=O)(=O)CCc1ccccc1[C@@H]1Cc2nccn2C1 10.1016/j.bmcl.2009.03.166
44574045 189262 0 None 60 2 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 260 2 0 2 3.9 c1ccc(-c2ccccc2[C@@H]2Cc3nccn3C2)cc1 10.1016/j.bmcl.2009.03.166
CHEMBL512062 189262 0 None 60 2 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 260 2 0 2 3.9 c1ccc(-c2ccccc2[C@@H]2Cc3nccn3C2)cc1 10.1016/j.bmcl.2009.03.166
2765 940 19 None 4 7 Human 7.9 pEC50 = 7.9 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1016/s0960-894x(02)00753-9
515 940 19 None 4 7 Human 7.9 pEC50 = 7.9 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1016/s0960-894x(02)00753-9
CHEMBL13852 940 19 None 4 7 Human 7.9 pEC50 = 7.9 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1016/s0960-894x(02)00753-9
DB09202 940 19 None 4 7 Human 7.9 pEC50 = 7.9 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1016/s0960-894x(02)00753-9
22493274 11006 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 258 4 2 4 2.1 c1ccc(N2CCCCC2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(02)00753-9
CHEMBL117581 11006 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 258 4 2 4 2.1 c1ccc(N2CCCCC2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(02)00753-9
10015132 163845 1 None 29 3 Human 7.9 pEC50 = 7.9 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 253 4 1 4 2.1 c1ccc(-c2ccccc2OCC2=NCCN2)nc1 10.1016/s0960-894x(02)00753-9
CHEMBL420683 163845 1 None 29 3 Human 7.9 pEC50 = 7.9 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 253 4 1 4 2.1 c1ccc(-c2ccccc2OCC2=NCCN2)nc1 10.1016/s0960-894x(02)00753-9
9817256 204215 0 None 251 2 Human 7.9 pEC50 = 7.9 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 283 5 2 6 0.5 COc1ccc(S(C)(=O)=O)c(NCC2=NCCN2)c1 10.1016/s0960-894x(02)00753-9
CHEMBL71001 204215 0 None 251 2 Human 7.9 pEC50 = 7.9 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 283 5 2 6 0.5 COc1ccc(S(C)(=O)=O)c(NCC2=NCCN2)c1 10.1016/s0960-894x(02)00753-9
2765 940 19 None 4 7 Human 7.9 pEC50 = 7.9 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1016/s0960-894x(01)00764-8
515 940 19 None 4 7 Human 7.9 pEC50 = 7.9 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1016/s0960-894x(01)00764-8
CHEMBL13852 940 19 None 4 7 Human 7.9 pEC50 = 7.9 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1016/s0960-894x(01)00764-8
DB09202 940 19 None 4 7 Human 7.9 pEC50 = 7.9 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1016/s0960-894x(01)00764-8
10038958 118699 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 273 4 1 5 2.5 Cc1cnsc1-c1ccccc1OCC1=NCCN1 10.1016/s0960-894x(01)00764-8
CHEMBL341747 118699 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 273 4 1 5 2.5 Cc1cnsc1-c1ccccc1OCC1=NCCN1 10.1016/s0960-894x(01)00764-8
10015132 163845 1 None 29 3 Human 7.9 pEC50 = 7.9 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 253 4 1 4 2.1 c1ccc(-c2ccccc2OCC2=NCCN2)nc1 10.1016/s0960-894x(01)00764-8
CHEMBL420683 163845 1 None 29 3 Human 7.9 pEC50 = 7.9 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 253 4 1 4 2.1 c1ccc(-c2ccccc2OCC2=NCCN2)nc1 10.1016/s0960-894x(01)00764-8
22493265 62104 0 None 19 3 Human 7.9 pEC50 = 7.9 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 284 6 2 6 1.8 CCCn1ncnc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
CHEMBL17776 62104 0 None 19 3 Human 7.9 pEC50 = 7.9 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 284 6 2 6 1.8 CCCn1ncnc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
2765 940 19 None 4 7 Human 7.9 pEC50 = 7.9 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1016/s0960-894x(01)00569-8
515 940 19 None 4 7 Human 7.9 pEC50 = 7.9 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1016/s0960-894x(01)00569-8
CHEMBL13852 940 19 None 4 7 Human 7.9 pEC50 = 7.9 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1016/s0960-894x(01)00569-8
DB09202 940 19 None 4 7 Human 7.9 pEC50 = 7.9 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1016/s0960-894x(01)00569-8
44329790 112519 0 None 5 3 Human 7.9 pEC50 = 7.9 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 247 5 2 5 1.3 CCOC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL329928 112519 0 None 5 3 Human 7.9 pEC50 = 7.9 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 247 5 2 5 1.3 CCOC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
22493224 208322 4 None 6 3 Human 7.9 pEC50 = 7.9 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 246 5 3 4 0.9 CCNC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL99362 208322 4 None 6 3 Human 7.9 pEC50 = 7.9 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 246 5 3 4 0.9 CCNC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
2765 940 19 None 4 7 Human 7.9 pEC50 = 7.9 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1016/s0960-894x(01)00822-8
515 940 19 None 4 7 Human 7.9 pEC50 = 7.9 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1016/s0960-894x(01)00822-8
CHEMBL13852 940 19 None 4 7 Human 7.9 pEC50 = 7.9 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1016/s0960-894x(01)00822-8
DB09202 940 19 None 4 7 Human 7.9 pEC50 = 7.9 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1016/s0960-894x(01)00822-8
12924821 102870 7 None - 1 Human 6.9 pEC50 = 6.9 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 207 2 1 3 1.5 COc1ccc(OC)c2c1CCC(N)C2 10.1021/jm00144a012
CHEMBL30596 102870 7 None - 1 Human 6.9 pEC50 = 6.9 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 207 2 1 3 1.5 COc1ccc(OC)c2c1CCC(N)C2 10.1021/jm00144a012
44593577 178440 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 198 1 1 1 2.7 c1ccc(C2CCc3nc[nH]c3C2)cc1 10.1016/j.bmcl.2009.03.162
CHEMBL466296 178440 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 198 1 1 1 2.7 c1ccc(C2CCc3nc[nH]c3C2)cc1 10.1016/j.bmcl.2009.03.162
44343251 10488 2 None - 1 Human 6.9 pEC50 = 6.9 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 251 4 2 4 1.4 CS(=O)(=O)c1ccccc1NCc1c[nH]cn1 10.1016/s0960-894x(02)00753-9
CHEMBL116843 10488 2 None - 1 Human 6.9 pEC50 = 6.9 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 251 4 2 4 1.4 CS(=O)(=O)c1ccccc1NCc1c[nH]cn1 10.1016/s0960-894x(02)00753-9
44362510 118907 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 267 4 1 4 2.4 Cc1cccc(-c2ccccc2OCC2=NCCN2)n1 10.1016/s0960-894x(01)00764-8
CHEMBL342324 118907 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 267 4 1 4 2.4 Cc1cccc(-c2ccccc2OCC2=NCCN2)n1 10.1016/s0960-894x(01)00764-8
22493257 207623 3 None 2 2 Human 6.9 pEC50 = 6.9 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 272 4 2 4 1.3 O=C(c1ccccc1NCC1=NCCN1)N1CCCC1 10.1016/s0960-894x(01)00569-8
CHEMBL95245 207623 3 None 2 2 Human 6.9 pEC50 = 6.9 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 272 4 2 4 1.3 O=C(c1ccccc1NCC1=NCCN1)N1CCCC1 10.1016/s0960-894x(01)00569-8
44362289 121671 1 None - 1 Human 5.9 pEC50 = 5.9 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 254 4 1 5 1.5 c1cnc(-c2ccccc2OCC2=NCCN2)nc1 10.1016/s0960-894x(01)00764-8
CHEMBL358802 121671 1 None - 1 Human 5.9 pEC50 = 5.9 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 254 4 1 5 1.5 c1cnc(-c2ccccc2OCC2=NCCN2)nc1 10.1016/s0960-894x(01)00764-8
44449306 95577 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 305 5 2 3 2.6 CCCS(=O)(=O)Nc1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL257801 95577 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 305 5 2 3 2.6 CCCS(=O)(=O)Nc1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
44449730 156084 0 None 22 2 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 250 2 2 2 2.9 c1cc(-c2cn[nH]c2)c2c(c1)C(c1ncc[nH]1)CC2 10.1016/j.bmcl.2008.03.070
CHEMBL406316 156084 0 None 22 2 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 250 2 2 2 2.9 c1cc(-c2cn[nH]c2)c2c(c1)C(c1ncc[nH]1)CC2 10.1016/j.bmcl.2008.03.070
9817256 204215 0 None 251 2 Human 7.9 pEC50 = 7.9 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 283 5 2 6 0.5 COc1ccc(S(C)(=O)=O)c(NCC2=NCCN2)c1 10.1021/jm000542r
CHEMBL71001 204215 0 None 251 2 Human 7.9 pEC50 = 7.9 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 283 5 2 6 0.5 COc1ccc(S(C)(=O)=O)c(NCC2=NCCN2)c1 10.1021/jm000542r
44449278 95623 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 291 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL257977 95623 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 291 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
44574877 178517 0 None 23 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 228 2 1 2 2.7 COc1ccccc1C1CCc2nc[nH]c2C1 10.1016/j.bmcl.2009.03.162
CHEMBL466869 178517 0 None 23 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 228 2 1 2 2.7 COc1ccccc1C1CCc2nc[nH]c2C1 10.1016/j.bmcl.2009.03.162
44574135 189154 0 None 18 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 268 2 1 3 2.8 Fc1ccc(C2Cc3nccn3C2)c(-c2ccn[nH]2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL511211 189154 0 None 18 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 268 2 1 3 2.8 Fc1ccc(C2Cc3nccn3C2)c(-c2ccn[nH]2)c1 10.1016/j.bmcl.2009.03.166
22493269 46796 0 None 6 3 Human 7.8 pEC50 = 7.8 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 256 4 2 5 2.1 Cc1ncoc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
CHEMBL154023 46796 0 None 6 3 Human 7.8 pEC50 = 7.8 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 256 4 2 5 2.1 Cc1ncoc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
44343257 10468 0 None 13 3 Human 7.8 pEC50 = 7.8 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 250 4 1 2 3.7 c1ccc(-c2ccccc2OCc2c[nH]cn2)cc1 10.1016/s0960-894x(02)00753-9
CHEMBL116700 10468 0 None 13 3 Human 7.8 pEC50 = 7.8 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 250 4 1 2 3.7 c1ccc(-c2ccccc2OCc2c[nH]cn2)cc1 10.1016/s0960-894x(02)00753-9
10199052 207931 0 None 5 3 Human 7.8 pEC50 = 7.8 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 258 5 3 4 1.0 O=C(NC1CC1)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL97044 207931 0 None 5 3 Human 7.8 pEC50 = 7.8 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 258 5 3 4 1.0 O=C(NC1CC1)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
619552 102671 3 None - 1 Rat 5.8 pEC50 = 5.8 Functional
Vasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contractionVasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contraction
ChEMBL 250 2 0 3 2.5 Cn1nc(Cc2ccccc2)c2ccccc2c1=O 10.1016/j.bmcl.2006.02.003
CHEMBL304747 102671 3 None - 1 Rat 5.8 pEC50 = 5.8 Functional
Vasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contractionVasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contraction
ChEMBL 250 2 0 3 2.5 Cn1nc(Cc2ccccc2)c2ccccc2c1=O 10.1016/j.bmcl.2006.02.003
45280075 122337 0 None -91 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 430 10 4 6 2.5 CS(=O)(=O)Nc1cccc([C@@H](O)CNCCOc2ccc3c(C4CC4)n[nH]c3c2)c1 10.1021/acs.jmedchem.5b00638
CHEMBL3600395 122337 0 None -91 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 430 10 4 6 2.5 CS(=O)(=O)Nc1cccc([C@@H](O)CNCCOc2ccc3c(C4CC4)n[nH]c3c2)c1 10.1021/acs.jmedchem.5b00638
44343235 10165 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 241 4 1 4 2.6 c1ccc(-c2ccno2)c(OCc2c[nH]cn2)c1 10.1016/s0960-894x(02)00753-9
CHEMBL115977 10165 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 241 4 1 4 2.6 c1ccc(-c2ccno2)c(OCc2c[nH]cn2)c1 10.1016/s0960-894x(02)00753-9
44362013 35353 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 273 4 1 5 2.5 Cc1cc(-c2ccccc2OCC2=NCCN2)sn1 10.1016/s0960-894x(01)00764-8
CHEMBL143766 35353 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 273 4 1 5 2.5 Cc1cc(-c2ccccc2OCC2=NCCN2)sn1 10.1016/s0960-894x(01)00764-8
481 2872 7 None 8 2 Human 6.8 pEC50 = 6.8 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 248 4 3 4 0.2 NC[C@@H](c1cc(ccc1F)NS(=O)(=O)C)O 10.1021/jm000542r
9838763 2872 7 None 8 2 Human 6.8 pEC50 = 6.8 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 248 4 3 4 0.2 NC[C@@H](c1cc(ccc1F)NS(=O)(=O)C)O 10.1021/jm000542r
CHEMBL72958 2872 7 None 8 2 Human 6.8 pEC50 = 6.8 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 248 4 3 4 0.2 NC[C@@H](c1cc(ccc1F)NS(=O)(=O)C)O 10.1021/jm000542r
10199335 204724 0 None 120 2 Human 7.8 pEC50 = 7.8 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1ccc(F)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL74467 204724 0 None 120 2 Human 7.8 pEC50 = 7.8 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1ccc(F)cc1NCC1=NCCN1 10.1021/jm000542r
44574834 172597 1 None - 1 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 184 1 1 1 2.3 c1ccc2c(c1)CC(c1ncc[nH]1)C2 10.1016/j.bmcl.2009.03.162
CHEMBL449279 172597 1 None - 1 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 184 1 1 1 2.3 c1ccc2c(c1)CC(c1ncc[nH]1)C2 10.1016/j.bmcl.2009.03.162
2146 3078 67 None -186 15 Rat 5.8 pEC50 = 5.8 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
485 3078 67 None -186 15 Rat 5.8 pEC50 = 5.8 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
6041 3078 67 None -186 15 Rat 5.8 pEC50 = 5.8 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
CHEMBL1215 3078 67 None -186 15 Rat 5.8 pEC50 = 5.8 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
DB00388 3078 67 None -186 15 Rat 5.8 pEC50 = 5.8 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
44449247 95385 0 None 1 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 228 2 1 2 2.8 COc1c(C)ccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL256984 95385 0 None 1 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 228 2 1 2 2.8 COc1c(C)ccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
44571843 179297 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 242 4 1 2 2.7 COCCc1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
CHEMBL473425 179297 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 242 4 1 2 2.7 COCCc1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
44571937 189526 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 282 3 1 3 2.9 Fc1ccn(Cc2cccc3c2CCC3c2ncc[nH]2)n1 10.1016/j.bmcl.2008.10.066
CHEMBL514333 189526 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 282 3 1 3 2.9 Fc1ccn(Cc2cccc3c2CCC3c2ncc[nH]2)n1 10.1016/j.bmcl.2008.10.066
9794803 10974 2 None 4 3 Human 7.8 pEC50 = 7.8 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 242 4 2 5 1.8 c1ccc(-c2cnco2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
CHEMBL117381 10974 2 None 4 3 Human 7.8 pEC50 = 7.8 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 242 4 2 5 1.8 c1ccc(-c2cnco2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
44449692 156961 0 None 8 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 251 2 1 3 3.1 c1cc(-c2ncco2)c2c(c1)C(c1ncc[nH]1)CC2 10.1016/j.bmcl.2008.03.070
CHEMBL407308 156961 0 None 8 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 251 2 1 3 3.1 c1cc(-c2ncco2)c2c(c1)C(c1ncc[nH]1)CC2 10.1016/j.bmcl.2008.03.070
44281493 99968 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 247 2 1 3 2.5 COc1ccc(OC)c2c1CC[C@H]1NCCCC21 10.1021/jm00144a012
CHEMBL286702 99968 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 247 2 1 3 2.5 COc1ccc(OC)c2c1CC[C@H]1NCCCC21 10.1021/jm00144a012
44574106 178402 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 317 3 1 3 3.3 CNC(=O)c1cccc(-c2ccccc2[C@@H]2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL466012 178402 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 317 3 1 3 3.3 CNC(=O)c1cccc(-c2ccccc2[C@@H]2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
44574107 188736 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 280 2 0 4 2.8 Fc1ccc(C2Cc3nccn3C2)c(-c2cncnc2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL505414 188736 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 280 2 0 4 2.8 Fc1ccc(C2Cc3nccn3C2)c(-c2cncnc2)c1 10.1016/j.bmcl.2009.03.166
44574935 172598 0 None 19 3 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 218 1 0 2 2.9 Clc1ccccc1C1Cc2nccn2C1 10.1016/j.bmcl.2009.03.162
CHEMBL449284 172598 0 None 19 3 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 218 1 0 2 2.9 Clc1ccccc1C1Cc2nccn2C1 10.1016/j.bmcl.2009.03.162
9794803 10974 2 None 4 3 Human 7.7 pEC50 = 7.7 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 242 4 2 5 1.8 c1ccc(-c2cnco2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(02)00753-9
CHEMBL117381 10974 2 None 4 3 Human 7.7 pEC50 = 7.7 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 242 4 2 5 1.8 c1ccc(-c2cnco2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(02)00753-9
9859855 60367 0 None 12 2 Human 7.7 pEC50 = 7.7 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 254 4 2 4 2.1 Cn1cccc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
CHEMBL17492 60367 0 None 12 2 Human 7.7 pEC50 = 7.7 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 254 4 2 4 2.1 Cn1cccc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
124 2960 47 None -8 25 Human 7.7 pEC50 = 7.7 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1016/s0960-894x(01)00569-8
2032 2960 47 None -8 25 Human 7.7 pEC50 = 7.7 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1016/s0960-894x(01)00569-8
4636 2960 47 None -8 25 Human 7.7 pEC50 = 7.7 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1016/s0960-894x(01)00569-8
CHEMBL762 2960 47 None -8 25 Human 7.7 pEC50 = 7.7 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1016/s0960-894x(01)00569-8
DB00935 2960 47 None -8 25 Human 7.7 pEC50 = 7.7 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1016/s0960-894x(01)00569-8
22493320 4173 0 None 3 3 Human 7.7 pEC50 = 7.7 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 246 4 2 4 0.8 CN(C)C(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL100198 4173 0 None 3 3 Human 7.7 pEC50 = 7.7 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 246 4 2 4 0.8 CN(C)C(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
44329481 4201 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 289 7 2 5 2.4 CCC(CC)OC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL100383 4201 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 289 7 2 5 2.4 CCC(CC)OC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
10378649 108566 0 None 15 3 Human 7.7 pEC50 = 7.7 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 274 7 3 4 1.6 CCCCNC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL320419 108566 0 None 15 3 Human 7.7 pEC50 = 7.7 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 274 7 3 4 1.6 CCCCNC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
124 2960 47 None -8 25 Human 7.7 pEC50 = 7.7 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1016/s0960-894x(01)00822-8
2032 2960 47 None -8 25 Human 7.7 pEC50 = 7.7 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1016/s0960-894x(01)00822-8
4636 2960 47 None -8 25 Human 7.7 pEC50 = 7.7 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1016/s0960-894x(01)00822-8
CHEMBL762 2960 47 None -8 25 Human 7.7 pEC50 = 7.7 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1016/s0960-894x(01)00822-8
DB00935 2960 47 None -8 25 Human 7.7 pEC50 = 7.7 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1016/s0960-894x(01)00822-8
11811395 204678 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 281 5 2 5 1.3 CC(C)S(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL74071 204678 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 281 5 2 5 1.3 CC(C)S(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
44571844 172531 0 None - 1 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 295 4 2 2 3.1 FC(F)(F)CNCc1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
CHEMBL448510 172531 0 None - 1 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 295 4 2 2 3.1 FC(F)(F)CNCc1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
22493367 66155 0 None 1 3 Human 6.7 pEC50 = 6.7 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 298 7 2 6 2.2 CCCCn1ncnc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
CHEMBL18436 66155 0 None 1 3 Human 6.7 pEC50 = 6.7 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 298 7 2 6 2.2 CCCCn1ncnc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
44574075 172552 0 None 72 2 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 251 2 0 4 2.9 c1ccc([C@@H]2Cc3nccn3C2)c(-c2ncco2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL448802 172552 0 None 72 2 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 251 2 0 4 2.9 c1ccc([C@@H]2Cc3nccn3C2)c(-c2ncco2)c1 10.1016/j.bmcl.2009.03.166
44369351 119576 0 None 2 3 Human 8.7 pEC50 = 8.7 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 257 4 2 4 2.8 c1csc(-c2ccccc2NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
CHEMBL346380 119576 0 None 2 3 Human 8.7 pEC50 = 8.7 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 257 4 2 4 2.8 c1csc(-c2ccccc2NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
11140347 204510 1 None -1 5 Human 8.6 pEC50 = 8.6 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 239 4 2 4 2.0 CSc1ccc(F)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL72768 204510 1 None -1 5 Human 8.6 pEC50 = 8.6 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 239 4 2 4 2.0 CSc1ccc(F)cc1NCC1=NCCN1 10.1021/jm000542r
44362196 34458 1 None 7 3 Human 8.6 pEC50 = 8.6 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 259 4 1 5 2.2 c1ccc(-c2nccs2)c(OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
CHEMBL142871 34458 1 None 7 3 Human 8.6 pEC50 = 8.6 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 259 4 1 5 2.2 c1ccc(-c2nccs2)c(OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
44362288 35599 1 None 251 2 Human 8.6 pEC50 = 8.6 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 254 4 1 5 1.5 c1ccc(-c2cnccn2)c(OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
CHEMBL143973 35599 1 None 251 2 Human 8.6 pEC50 = 8.6 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 254 4 1 5 1.5 c1ccc(-c2cnccn2)c(OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
9881853 98446 0 None - 1 Human 8.6 pEC50 = 8.6 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 268 5 2 4 2.6 CCn1cccc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
CHEMBL275902 98446 0 None - 1 Human 8.6 pEC50 = 8.6 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 268 5 2 4 2.6 CCn1cccc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
10198532 207673 0 None 1 3 Human 8.6 pEC50 = 8.6 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 232 4 3 4 0.5 CNC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL95523 207673 0 None 1 3 Human 8.6 pEC50 = 8.6 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 232 4 3 4 0.5 CNC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
44369434 45351 0 None 17 2 Human 8.6 pEC50 = 8.6 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 255 4 2 4 2.7 Cc1ccc(-c2ccccc2NCC2=NCCN2)o1 10.1016/s0960-894x(01)00822-8
CHEMBL152725 45351 0 None 17 2 Human 8.6 pEC50 = 8.6 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 255 4 2 4 2.7 Cc1ccc(-c2ccccc2NCC2=NCCN2)o1 10.1016/s0960-894x(01)00822-8
9947861 204139 0 None 21 3 Human 8.6 pEC50 = 8.6 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 287 4 2 5 1.2 CS(=O)(=O)c1ccc(Cl)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL70634 204139 0 None 21 3 Human 8.6 pEC50 = 8.6 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 287 4 2 5 1.2 CS(=O)(=O)c1ccc(Cl)cc1NCC1=NCCN1 10.1021/jm000542r
124 2960 47 None -8 25 Human 7.7 pEC50 = 7.7 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm000542r
2032 2960 47 None -8 25 Human 7.7 pEC50 = 7.7 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm000542r
4636 2960 47 None -8 25 Human 7.7 pEC50 = 7.7 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm000542r
CHEMBL762 2960 47 None -8 25 Human 7.7 pEC50 = 7.7 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm000542r
DB00935 2960 47 None -8 25 Human 7.7 pEC50 = 7.7 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm000542r
10422033 120949 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 246 5 2 5 1.5 CO/N=C(\C)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
CHEMBL356195 120949 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 246 5 2 5 1.5 CO/N=C(\C)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
44281250 114780 0 None - 1 Human 6.7 pEC50 = 6.7 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 247 2 1 3 2.5 COc1ccc(OC)c2c1CC[C@@H]1NCCCC21 10.1021/jm00144a012
CHEMBL33405 114780 0 None - 1 Human 6.7 pEC50 = 6.7 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 247 2 1 3 2.5 COc1ccc(OC)c2c1CC[C@@H]1NCCCC21 10.1021/jm00144a012
44449691 96133 0 None 2 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 261 2 1 2 3.6 c1cncc(-c2cccc3c2CCC3c2ncc[nH]2)c1 10.1016/j.bmcl.2008.03.070
CHEMBL260576 96133 0 None 2 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 261 2 1 2 3.6 c1cncc(-c2cccc3c2CCC3c2ncc[nH]2)c1 10.1016/j.bmcl.2008.03.070
4038180 204 14 None -1 6 Human 7.7 pEC50 = 7.7 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm960354u
480 204 14 None -1 6 Human 7.7 pEC50 = 7.7 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm960354u
CHEMBL109783 204 14 None -1 6 Human 7.7 pEC50 = 7.7 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm960354u
44449278 95623 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 291 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL257977 95623 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 291 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
1960 2838 67 None -2 19 Human 5.7 pEC50 = 5.7 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
439260 2838 67 None -2 19 Human 5.7 pEC50 = 5.7 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
505 2838 67 None -2 19 Human 5.7 pEC50 = 5.7 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
CHEMBL1437 2838 67 None -2 19 Human 5.7 pEC50 = 5.7 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
DB00368 2838 67 None -2 19 Human 5.7 pEC50 = 5.7 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
10135864 122492 0 None -10 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 404 9 4 6 1.9 Cc1n[nH]c2cc(OCCNC[C@H](O)c3cccc(NS(C)(=O)=O)c3)ccc12 10.1021/acs.jmedchem.5b00638
CHEMBL3601200 122492 0 None -10 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 404 9 4 6 1.9 Cc1n[nH]c2cc(OCCNC[C@H](O)c3cccc(NS(C)(=O)=O)c3)ccc12 10.1021/acs.jmedchem.5b00638
44574937 178637 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 214 2 0 3 2.2 COc1ccccc1C1Cc2nccn2C1 10.1016/j.bmcl.2009.03.162
CHEMBL467688 178637 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 214 2 0 3 2.2 COc1ccccc1C1Cc2nccn2C1 10.1016/j.bmcl.2009.03.162
44449276 95622 0 None 1 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 241 2 2 2 1.8 CNC(=O)c1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL257976 95622 0 None 1 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 241 2 2 2 1.8 CNC(=O)c1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
11090351 163367 0 None 20 2 Human 7.6 pEC50 = 7.6 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1c(F)cccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL419448 163367 0 None 20 2 Human 7.6 pEC50 = 7.6 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1c(F)cccc1NCC1=NCCN1 10.1021/jm000542r
44449278 95623 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 291 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL257977 95623 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 291 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
44593577 178440 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 198 1 1 1 2.7 c1ccc(C2CCc3nc[nH]c3C2)cc1 10.1016/j.bmcl.2009.03.162
CHEMBL466296 178440 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 198 1 1 1 2.7 c1ccc(C2CCc3nc[nH]c3C2)cc1 10.1016/j.bmcl.2009.03.162
10221004 204208 0 None 20 2 Human 6.6 pEC50 = 6.6 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 267 5 2 5 0.9 CCS(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL70973 204208 0 None 20 2 Human 6.6 pEC50 = 6.6 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 267 5 2 5 0.9 CCS(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
22493356 46981 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 266 4 2 4 2.5 Cc1cccnc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
CHEMBL154170 46981 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 266 4 2 4 2.5 Cc1cccnc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
10804826 23583 2 None 1 2 Human 4.6 pEC50 = 4.6 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 309 3 3 5 1.2 CS(=O)(=O)Nc1c(O)ccc2c1CCC[C@@H]2C1=NCCN1 10.1021/jm960354u
CHEMBL133451 23583 2 None 1 2 Human 4.6 pEC50 = 4.6 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 309 3 3 5 1.2 CS(=O)(=O)Nc1c(O)ccc2c1CCC[C@@H]2C1=NCCN1 10.1021/jm960354u
216249 1293 51 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 317 5 2 5 1.4 Clc1ccc(c(c1NS(=O)(=O)C)C)OCC1=NCCN1 10.1016/j.bmcl.2008.03.070
3469 1293 51 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 317 5 2 5 1.4 Clc1ccc(c(c1NS(=O)(=O)C)C)OCC1=NCCN1 10.1016/j.bmcl.2008.03.070
CHEMBL257978 1293 51 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 317 5 2 5 1.4 Clc1ccc(c(c1NS(=O)(=O)C)C)OCC1=NCCN1 10.1016/j.bmcl.2008.03.070
10423384 34566 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 272 4 1 4 3.1 Cc1ccc(-c2ccccc2OCC2=NCCN2)s1 10.1016/s0960-894x(01)00764-8
CHEMBL142958 34566 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 272 4 1 4 3.1 Cc1ccc(-c2ccccc2OCC2=NCCN2)s1 10.1016/s0960-894x(01)00764-8
10084685 119410 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 273 4 1 5 2.5 Cc1csc(-c2ccccc2OCC2=NCCN2)n1 10.1016/s0960-894x(01)00764-8
CHEMBL344957 119410 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 273 4 1 5 2.5 Cc1csc(-c2ccccc2OCC2=NCCN2)n1 10.1016/s0960-894x(01)00764-8
10221066 163138 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 269 5 2 5 2.0 CCn1ccc(-c2ccccc2NCC2=NCCN2)n1 10.1016/s0960-894x(03)00050-7
CHEMBL417999 163138 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 269 5 2 5 2.0 CCn1ccc(-c2ccccc2NCC2=NCCN2)n1 10.1016/s0960-894x(03)00050-7
44271931 98365 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 283 6 2 5 2.4 CCCn1nccc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
CHEMBL275386 98365 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 283 6 2 5 2.4 CCCn1nccc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
10180440 122493 0 None -6 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 420 10 4 7 1.6 COc1n[nH]c2cc(OCCNC[C@H](O)c3cccc(NS(C)(=O)=O)c3)ccc12 10.1021/acs.jmedchem.5b00638
CHEMBL3601201 122493 0 None -6 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 420 10 4 7 1.6 COc1n[nH]c2cc(OCCNC[C@H](O)c3cccc(NS(C)(=O)=O)c3)ccc12 10.1021/acs.jmedchem.5b00638
2683 3805 60 None 1 6 Bovine 6.6 pEC50 = 6.6 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 nan
5487 3805 60 None 1 6 Bovine 6.6 pEC50 = 6.6 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 nan
7308 3805 60 None 1 6 Bovine 6.6 pEC50 = 6.6 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 nan
CHEMBL1079 3805 60 None 1 6 Bovine 6.6 pEC50 = 6.6 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 nan
DB00697 3805 60 None 1 6 Bovine 6.6 pEC50 = 6.6 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 nan
44574138 178481 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 268 2 0 4 2.5 Fc1ccc(C2Cc3nccn3C2)c(-n2cccn2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL466635 178481 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 268 2 0 4 2.5 Fc1ccc(C2Cc3nccn3C2)c(-n2cccn2)c1 10.1016/j.bmcl.2009.03.166
44593557 183894 11 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 262 3 1 2 3.3 COCc1c(Cl)ccc2c1CC[C@H]2c1ncc[nH]1 10.1016/j.bmcl.2009.03.162
CHEMBL481322 183894 11 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 262 3 1 2 3.3 COCc1c(Cl)ccc2c1CC[C@H]2c1ncc[nH]1 10.1016/j.bmcl.2009.03.162
44574874 178369 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 232 1 1 1 3.3 Clc1ccccc1C1CCc2nc[nH]c2C1 10.1016/j.bmcl.2009.03.162
CHEMBL465599 178369 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 232 1 1 1 3.3 Clc1ccccc1C1CCc2nc[nH]c2C1 10.1016/j.bmcl.2009.03.162
122184771 122494 0 None -3 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 434 11 4 7 2.0 CCOc1n[nH]c2cc(OCCNC[C@H](O)c3cccc(NS(C)(=O)=O)c3)ccc12 10.1021/acs.jmedchem.5b00638
CHEMBL3601202 122494 0 None -3 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 434 11 4 7 2.0 CCOc1n[nH]c2cc(OCCNC[C@H](O)c3cccc(NS(C)(=O)=O)c3)ccc12 10.1021/acs.jmedchem.5b00638
44449723 156110 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 264 2 1 3 2.9 Cn1nccc1-c1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL406348 156110 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 264 2 1 3 2.9 Cn1nccc1-c1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
124 2960 47 None -52 25 Rat 6.5 pEC50 = 6.5 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
2032 2960 47 None -52 25 Rat 6.5 pEC50 = 6.5 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
4636 2960 47 None -52 25 Rat 6.5 pEC50 = 6.5 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
CHEMBL762 2960 47 None -52 25 Rat 6.5 pEC50 = 6.5 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
DB00935 2960 47 None -52 25 Rat 6.5 pEC50 = 6.5 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
2146 3078 67 None -20 15 Human 5.5 pEC50 = 5.5 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
485 3078 67 None -20 15 Human 5.5 pEC50 = 5.5 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
6041 3078 67 None -20 15 Human 5.5 pEC50 = 5.5 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
CHEMBL1215 3078 67 None -20 15 Human 5.5 pEC50 = 5.5 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
DB00388 3078 67 None -20 15 Human 5.5 pEC50 = 5.5 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
44574134 178480 0 None 91 3 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 269 2 0 4 3.0 Fc1ccc(-c2ncco2)c(C2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL466634 178480 0 None 91 3 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 269 2 0 4 3.0 Fc1ccc(-c2ncco2)c(C2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
44574077 178736 0 None - 1 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 267 2 0 4 3.3 c1ccc([C@@H]2Cc3nccn3C2)c(-c2nccs2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL468710 178736 0 None - 1 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 267 2 0 4 3.3 c1ccc([C@@H]2Cc3nccn3C2)c(-c2nccs2)c1 10.1016/j.bmcl.2009.03.166
44574136 189017 0 None - 1 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 268 2 1 3 2.8 Fc1ccc(-c2ccn[nH]2)c(C2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL509350 189017 0 None - 1 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 268 2 1 3 2.8 Fc1ccc(-c2ccn[nH]2)c(C2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
44449725 96161 0 None 208 3 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 264 2 2 2 3.2 Cc1n[nH]cc1-c1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL260720 96161 0 None 208 3 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 264 2 2 2 3.2 Cc1n[nH]cc1-c1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
44269124 28787 1 None 23 3 Human 8.5 pEC50 = 8.5 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 252 4 1 3 2.7 c1ccc(-c2ccccc2OCC2=NCCN2)cc1 10.1016/s0960-894x(02)00753-9
CHEMBL13789 28787 1 None 23 3 Human 8.5 pEC50 = 8.5 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 252 4 1 3 2.7 c1ccc(-c2ccccc2OCC2=NCCN2)cc1 10.1016/s0960-894x(02)00753-9
44269124 28787 1 None 23 3 Human 8.5 pEC50 = 8.5 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 252 4 1 3 2.7 c1ccc(-c2ccccc2OCC2=NCCN2)cc1 10.1016/s0960-894x(01)00764-8
CHEMBL13789 28787 1 None 23 3 Human 8.5 pEC50 = 8.5 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 252 4 1 3 2.7 c1ccc(-c2ccccc2OCC2=NCCN2)cc1 10.1016/s0960-894x(01)00764-8
10060965 35204 1 None 39 3 Human 8.5 pEC50 = 8.5 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 256 4 1 4 2.6 Cc1ccoc1-c1ccccc1OCC1=NCCN1 10.1016/s0960-894x(01)00764-8
CHEMBL143562 35204 1 None 39 3 Human 8.5 pEC50 = 8.5 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 256 4 1 4 2.6 Cc1ccoc1-c1ccccc1OCC1=NCCN1 10.1016/s0960-894x(01)00764-8
9816515 62948 0 None 5 3 Human 8.5 pEC50 = 8.5 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 255 4 2 5 1.5 Cn1ccc(-c2ccccc2NCC2=NCCN2)n1 10.1016/s0960-894x(03)00050-7
CHEMBL17856 62948 0 None 5 3 Human 8.5 pEC50 = 8.5 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 255 4 2 5 1.5 Cn1ccc(-c2ccccc2NCC2=NCCN2)n1 10.1016/s0960-894x(03)00050-7
44329797 108079 0 None 67 3 Human 8.5 pEC50 = 8.5 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 261 5 2 5 1.7 CC(C)OC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL319553 108079 0 None 67 3 Human 8.5 pEC50 = 8.5 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 261 5 2 5 1.7 CC(C)OC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
10244367 50013 0 None - 1 Human 8.5 pEC50 = 8.5 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 260 6 2 5 1.9 CC/C(=N\OC)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
CHEMBL156950 50013 0 None - 1 Human 8.5 pEC50 = 8.5 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 260 6 2 5 1.9 CC/C(=N\OC)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
11000184 13020 0 None 4 5 Human 8.5 pEC50 = 8.5 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 235 5 2 4 2.2 CCSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL1190038 13020 0 None 4 5 Human 8.5 pEC50 = 8.5 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 235 5 2 4 2.2 CCSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL540035 13020 0 None 4 5 Human 8.5 pEC50 = 8.5 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 235 5 2 4 2.2 CCSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
44343247 110608 0 None 15 3 Human 8.4 pEC50 = 8.4 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 258 6 3 3 2.2 CCCNC(=O)c1ccccc1NCc1c[nH]cn1 10.1016/s0960-894x(02)00753-9
CHEMBL325745 110608 0 None 15 3 Human 8.4 pEC50 = 8.4 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 258 6 3 3 2.2 CCCNC(=O)c1ccccc1NCc1c[nH]cn1 10.1016/s0960-894x(02)00753-9
15959112 203509 0 None -1 2 Rat 5.5 pEC50 = 5.5 Functional
Vasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contractionVasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contraction
ChEMBL 280 2 1 5 2.7 Oc1nnc(Cc2ccc3c(c2)OCO3)c2ccccc12 10.1016/j.bmcl.2006.02.003
CHEMBL66433 203509 0 None -1 2 Rat 5.5 pEC50 = 5.5 Functional
Vasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contractionVasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contraction
ChEMBL 280 2 1 5 2.7 Oc1nnc(Cc2ccc3c(c2)OCO3)c2ccccc12 10.1016/j.bmcl.2006.02.003
11264016 99618 2 None - 1 Human 4.5 pEC50 = 4.5 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 193 2 1 3 1.1 COc1ccc(OC)c2c1CC(N)C2 10.1021/jm00144a012
CHEMBL284307 99618 2 None - 1 Human 4.5 pEC50 = 4.5 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 193 2 1 3 1.1 COc1ccc(OC)c2c1CC(N)C2 10.1021/jm00144a012
44281507 99899 0 None - 1 Human 4.5 pEC50 = 4.5 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 233 2 1 3 2.4 COc1ccc(OC)c2c1C1CCC2[C@@H](N)C1 10.1021/jm00144a012
CHEMBL286226 99899 0 None - 1 Human 4.5 pEC50 = 4.5 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 233 2 1 3 2.4 COc1ccc(OC)c2c1C1CCC2[C@@H](N)C1 10.1021/jm00144a012
44280965 99955 0 None - 1 Human 4.5 pEC50 = 4.5 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 233 2 1 3 2.4 COc1ccc(OC)c2c1C1CCC2[C@H](N)C1 10.1021/jm00144a012
CHEMBL286609 99955 0 None - 1 Human 4.5 pEC50 = 4.5 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 233 2 1 3 2.4 COc1ccc(OC)c2c1C1CCC2[C@H](N)C1 10.1021/jm00144a012
10804826 23583 2 None -1 2 Rat 4.5 pEC50 = 4.5 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 309 3 3 5 1.2 CS(=O)(=O)Nc1c(O)ccc2c1CCC[C@@H]2C1=NCCN1 10.1021/jm960354u
CHEMBL133451 23583 2 None -1 2 Rat 4.5 pEC50 = 4.5 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 309 3 3 5 1.2 CS(=O)(=O)Nc1c(O)ccc2c1CCC[C@@H]2C1=NCCN1 10.1021/jm960354u
44593557 183894 11 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 262 3 1 2 3.3 COCc1c(Cl)ccc2c1CC[C@H]2c1ncc[nH]1 10.1016/j.bmcl.2009.03.166
CHEMBL481322 183894 11 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 262 3 1 2 3.3 COCc1c(Cl)ccc2c1CC[C@H]2c1ncc[nH]1 10.1016/j.bmcl.2009.03.166
44593557 183894 11 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 262 3 1 2 3.3 COCc1c(Cl)ccc2c1CC[C@H]2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
CHEMBL481322 183894 11 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 262 3 1 2 3.3 COCc1c(Cl)ccc2c1CC[C@H]2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
9816986 164115 0 None 21 3 Human 7.5 pEC50 = 7.5 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 274 6 2 4 1.6 CCN(CC)C(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(02)00753-9
CHEMBL421011 164115 0 None 21 3 Human 7.5 pEC50 = 7.5 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 274 6 2 4 1.6 CCN(CC)C(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(02)00753-9
9816986 164115 0 None 21 3 Human 7.5 pEC50 = 7.5 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 274 6 2 4 1.6 CCN(CC)C(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00764-8
CHEMBL421011 164115 0 None 21 3 Human 7.5 pEC50 = 7.5 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 274 6 2 4 1.6 CCN(CC)C(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00764-8
9816986 164115 0 None 21 3 Human 7.5 pEC50 = 7.5 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 274 6 2 4 1.6 CCN(CC)C(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL421011 164115 0 None 21 3 Human 7.5 pEC50 = 7.5 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 274 6 2 4 1.6 CCN(CC)C(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
44593577 178440 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 198 1 1 1 2.7 c1ccc(C2CCc3nc[nH]c3C2)cc1 10.1016/j.bmcl.2009.03.162
CHEMBL466296 178440 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 198 1 1 1 2.7 c1ccc(C2CCc3nc[nH]c3C2)cc1 10.1016/j.bmcl.2009.03.162
481 2872 7 None 8 2 Human 6.5 pEC50 = 6.5 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 248 4 3 4 0.2 NC[C@@H](c1cc(ccc1F)NS(=O)(=O)C)O 10.1016/s0960-894x(01)00764-8
9838763 2872 7 None 8 2 Human 6.5 pEC50 = 6.5 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 248 4 3 4 0.2 NC[C@@H](c1cc(ccc1F)NS(=O)(=O)C)O 10.1016/s0960-894x(01)00764-8
CHEMBL72958 2872 7 None 8 2 Human 6.5 pEC50 = 6.5 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 248 4 3 4 0.2 NC[C@@H](c1cc(ccc1F)NS(=O)(=O)C)O 10.1016/s0960-894x(01)00764-8
22493344 98634 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 323 5 2 5 2.5 FC(F)(F)Cn1nccc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
CHEMBL277361 98634 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 323 5 2 5 2.5 FC(F)(F)Cn1nccc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
44449277 155159 2 None -1 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 214 2 1 2 2.5 COc1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL402388 155159 2 None -1 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 214 2 1 2 2.5 COc1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
44449305 155586 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 291 4 2 3 2.2 CCS(=O)(=O)Nc1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL404566 155586 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 291 4 2 3 2.2 CCS(=O)(=O)Nc1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
44571889 184005 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 264 3 1 3 2.7 c1cc(Cn2cccn2)c2c(c1)[C@H](c1ncc[nH]1)CC2 10.1016/j.bmcl.2008.10.066
CHEMBL482148 184005 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 264 3 1 3 2.7 c1cc(Cn2cccn2)c2c(c1)[C@H](c1ncc[nH]1)CC2 10.1016/j.bmcl.2008.10.066
44449337 155092 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 284 2 2 2 3.5 Clc1ccc2c(c1-c1ccn[nH]1)CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL402003 155092 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 284 2 2 2 3.5 Clc1ccc2c(c1-c1ccn[nH]1)CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
22493272 44725 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 256 4 2 5 2.1 Cc1nc(-c2ccccc2NCC2=NCCN2)co1 10.1016/s0960-894x(01)00822-8
CHEMBL152154 44725 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 256 4 2 5 2.1 Cc1nc(-c2ccccc2NCC2=NCCN2)co1 10.1016/s0960-894x(01)00822-8
44574133 188352 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 269 2 0 4 3.0 Fc1ccc(C2Cc3nccn3C2)c(-c2ncco2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL501404 188352 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 269 2 0 4 3.0 Fc1ccc(C2Cc3nccn3C2)c(-c2ncco2)c1 10.1016/j.bmcl.2009.03.166
122184835 122515 0 None 3 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 420 10 5 7 1.1 CS(=O)(=O)Nc1cccc([C@@H](O)CNCCOc2ccc3c(CO)n[nH]c3c2)c1 10.1021/acs.jmedchem.5b00638
CHEMBL3601310 122515 0 None 3 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 420 10 5 7 1.1 CS(=O)(=O)Nc1cccc([C@@H](O)CNCCOc2ccc3c(CO)n[nH]c3c2)c1 10.1021/acs.jmedchem.5b00638
44449249 95169 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 291 3 2 3 2.2 Cc1ccc2c(c1NS(C)(=O)=O)CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL255938 95169 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 291 3 2 3 2.2 Cc1ccc2c(c1NS(C)(=O)=O)CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
10420352 168716 10 None -83 2 Human 5.5 pEC50 = 5.5 Functional
Agonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortexAgonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortex
ChEMBL 201 3 4 4 0.5 CNCC(O)c1ccc(O)c(O)c1F 10.1021/jm00118a019
CHEMBL43711 168716 10 None -83 2 Human 5.5 pEC50 = 5.5 Functional
Agonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortexAgonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortex
ChEMBL 201 3 4 4 0.5 CNCC(O)c1ccc(O)c(O)c1F 10.1021/jm00118a019
44280982 99736 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 205 2 1 3 1.3 COc1ccc(OC)c2c1CC1C2[C@@H]1N 10.1021/jm00144a012
CHEMBL285082 99736 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 205 2 1 3 1.3 COc1ccc(OC)c2c1CC1C2[C@@H]1N 10.1021/jm00144a012
124 2960 47 None -8 25 Human 6.5 pEC50 = 6.5 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
2032 2960 47 None -8 25 Human 6.5 pEC50 = 6.5 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
4636 2960 47 None -8 25 Human 6.5 pEC50 = 6.5 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
CHEMBL762 2960 47 None -8 25 Human 6.5 pEC50 = 6.5 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
DB00935 2960 47 None -8 25 Human 6.5 pEC50 = 6.5 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
44574936 178606 0 None - 1 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 218 1 0 2 2.9 Clc1ccc(C2Cc3nccn3C2)cc1 10.1016/j.bmcl.2009.03.162
CHEMBL467495 178606 0 None - 1 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 218 1 0 2 2.9 Clc1ccc(C2Cc3nccn3C2)cc1 10.1016/j.bmcl.2009.03.162
44369646 120137 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 271 4 2 4 3.1 Cc1ccc(-c2ccccc2NCC2=NCCN2)s1 10.1016/s0960-894x(01)00822-8
CHEMBL351543 120137 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 271 4 2 4 3.1 Cc1ccc(-c2ccccc2NCC2=NCCN2)s1 10.1016/s0960-894x(01)00822-8
44571841 179296 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 228 3 1 2 2.6 COCc1cccc2c1CC[C@H]2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
CHEMBL473424 179296 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 228 3 1 2 2.6 COCc1cccc2c1CC[C@H]2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
44574988 189205 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 227 2 1 3 1.3 NC(=O)c1ccccc1C1Cc2nccn2C1 10.1016/j.bmcl.2009.03.162
CHEMBL511576 189205 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 227 2 1 3 1.3 NC(=O)c1ccccc1C1Cc2nccn2C1 10.1016/j.bmcl.2009.03.162
521 1392 69 None -501 5 Bovine 6.4 pEC50 = 6.4 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C nan
5311068 1392 69 None -501 5 Bovine 6.4 pEC50 = 6.4 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C nan
835 1392 69 None -501 5 Bovine 6.4 pEC50 = 6.4 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C nan
CHEMBL778 1392 69 None -501 5 Bovine 6.4 pEC50 = 6.4 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C nan
DB00633 1392 69 None -501 5 Bovine 6.4 pEC50 = 6.4 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C nan
22493349 119661 0 None 2 2 Human 7.4 pEC50 = 7.4 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 256 4 2 5 2.1 Cc1cc(-c2ccccc2NCC2=NCCN2)on1 10.1016/s0960-894x(01)00822-8
CHEMBL347268 119661 0 None 2 2 Human 7.4 pEC50 = 7.4 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 256 4 2 5 2.1 Cc1cc(-c2ccccc2NCC2=NCCN2)on1 10.1016/s0960-894x(01)00822-8
17804479 95631 19 None -1 4 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 198 1 1 1 2.9 c1ccc2c(c1)CCCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL258007 95631 19 None -1 4 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 198 1 1 1 2.9 c1ccc2c(c1)CCCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
10083742 34576 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 256 4 1 5 1.5 Cn1nccc1-c1ccccc1OCC1=NCCN1 10.1016/s0960-894x(01)00764-8
CHEMBL142967 34576 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 256 4 1 5 1.5 Cn1nccc1-c1ccccc1OCC1=NCCN1 10.1016/s0960-894x(01)00764-8
44329739 112297 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 287 5 2 5 2.2 O=C(OC1CCCC1)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL329272 112297 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 287 5 2 5 2.2 O=C(OC1CCCC1)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
104452 203078 73 None -4 2 Rat 5.4 pEC50 = 5.4 Functional
Vasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contractionVasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contraction
ChEMBL 270 2 1 3 3.6 Oc1nnc(Cc2ccc(Cl)cc2)c2ccccc12 10.1016/j.bmcl.2006.02.003
CHEMBL63976 203078 73 None -4 2 Rat 5.4 pEC50 = 5.4 Functional
Vasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contractionVasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contraction
ChEMBL 270 2 1 3 3.6 Oc1nnc(Cc2ccc(Cl)cc2)c2ccccc12 10.1016/j.bmcl.2006.02.003
22493381 98054 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 255 4 2 5 1.5 Cn1cc(-c2ccccc2NCC2=NCCN2)cn1 10.1016/s0960-894x(03)00050-7
CHEMBL273312 98054 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 255 4 2 5 1.5 Cn1cc(-c2ccccc2NCC2=NCCN2)cn1 10.1016/s0960-894x(03)00050-7
22493231 207642 0 None -5 3 Human 6.4 pEC50 = 6.4 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 286 4 2 4 1.7 O=C(c1ccccc1NCC1=NCCN1)N1CCCCC1 10.1016/s0960-894x(01)00569-8
CHEMBL95333 207642 0 None -5 3 Human 6.4 pEC50 = 6.4 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 286 4 2 4 1.7 O=C(c1ccccc1NCC1=NCCN1)N1CCCCC1 10.1016/s0960-894x(01)00569-8
44574104 189465 0 None - 1 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 353 4 1 4 3.3 CS(=O)(=O)Nc1cccc(-c2ccccc2[C@@H]2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL513871 189465 0 None - 1 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 353 4 1 4 3.3 CS(=O)(=O)Nc1cccc(-c2ccccc2[C@@H]2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
9838376 168276 0 None 15 2 Human 8.4 pEC50 = 8.4 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 272 4 2 5 2.5 Cc1nc(-c2ccccc2NCC2=NCCN2)cs1 10.1016/s0960-894x(01)00822-8
CHEMBL434074 168276 0 None 15 2 Human 8.4 pEC50 = 8.4 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 272 4 2 5 2.5 Cc1nc(-c2ccccc2NCC2=NCCN2)cs1 10.1016/s0960-894x(01)00822-8
11108001 10840 2 None -2 5 Human 8.3 pEC50 = 8.3 Functional
Agonist potency at Alpha-1A adrenoceptors assayed in rat-1 fibroblasts expressing human Alpha-1AAgonist potency at Alpha-1A adrenoceptors assayed in rat-1 fibroblasts expressing human Alpha-1A
ChEMBL 221 4 2 4 1.8 CSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL117248 10840 2 None -2 5 Human 8.3 pEC50 = 8.3 Functional
Agonist potency at Alpha-1A adrenoceptors assayed in rat-1 fibroblasts expressing human Alpha-1AAgonist potency at Alpha-1A adrenoceptors assayed in rat-1 fibroblasts expressing human Alpha-1A
ChEMBL 221 4 2 4 1.8 CSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL540542 10840 2 None -2 5 Human 8.3 pEC50 = 8.3 Functional
Agonist potency at Alpha-1A adrenoceptors assayed in rat-1 fibroblasts expressing human Alpha-1AAgonist potency at Alpha-1A adrenoceptors assayed in rat-1 fibroblasts expressing human Alpha-1A
ChEMBL 221 4 2 4 1.8 CSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
9816460 119867 0 None 39 3 Human 8.3 pEC50 = 8.3 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 253 4 2 5 1.6 c1ccc(-c2cnccn2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
CHEMBL349082 119867 0 None 39 3 Human 8.3 pEC50 = 8.3 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 253 4 2 5 1.6 c1ccc(-c2cnccn2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
1028 289 71 None 1 19 Human 6.4 pEC50 = 6.4 Functional
Agonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortexAgonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortex
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
139148732 289 71 None 1 19 Human 6.4 pEC50 = 6.4 Functional
Agonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortexAgonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortex
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
479 289 71 None 1 19 Human 6.4 pEC50 = 6.4 Functional
Agonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortexAgonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortex
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
5816 289 71 None 1 19 Human 6.4 pEC50 = 6.4 Functional
Agonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortexAgonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortex
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
CHEMBL679 289 71 None 1 19 Human 6.4 pEC50 = 6.4 Functional
Agonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortexAgonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortex
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
DB00668 289 71 None 1 19 Human 6.4 pEC50 = 6.4 Functional
Agonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortexAgonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortex
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
11058166 204682 0 None 10 2 Human 7.4 pEC50 = 7.4 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1cccc(F)c1NCC1=NCCN1 10.1021/jm000542r
CHEMBL74114 204682 0 None 10 2 Human 7.4 pEC50 = 7.4 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1cccc(F)c1NCC1=NCCN1 10.1021/jm000542r
44574986 189186 0 None 7 3 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 202 1 0 2 2.4 Fc1ccccc1C1Cc2nccn2C1 10.1016/j.bmcl.2009.03.162
CHEMBL511411 189186 0 None 7 3 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 202 1 0 2 2.4 Fc1ccccc1C1Cc2nccn2C1 10.1016/j.bmcl.2009.03.162
22493415 49943 0 None -1 2 Human 7.4 pEC50 = 7.4 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 268 4 3 6 1.1 Nc1nccc(-c2ccccc2NCC2=NCCN2)n1 10.1016/s0960-894x(01)00822-8
CHEMBL156893 49943 0 None -1 2 Human 7.4 pEC50 = 7.4 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 268 4 3 6 1.1 Nc1nccc(-c2ccccc2NCC2=NCCN2)n1 10.1016/s0960-894x(01)00822-8
44449686 96055 0 None 7 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 267 2 1 3 3.6 c1cc(-c2nccs2)c2c(c1)C(c1ncc[nH]1)CC2 10.1016/j.bmcl.2008.03.070
CHEMBL260116 96055 0 None 7 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 267 2 1 3 3.6 c1cc(-c2nccs2)c2c(c1)C(c1ncc[nH]1)CC2 10.1016/j.bmcl.2008.03.070
25066019 95383 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 325 3 2 3 2.9 CS(=O)(=O)Nc1c(Cl)ccc2c1CCCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL256982 95383 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 325 3 2 3 2.9 CS(=O)(=O)Nc1c(Cl)ccc2c1CCCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
25066019 95383 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 325 3 2 3 2.9 CS(=O)(=O)Nc1c(Cl)ccc2c1CCCC2c1ncc[nH]1 10.1016/j.bmcl.2009.03.162
CHEMBL256982 95383 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 325 3 2 3 2.9 CS(=O)(=O)Nc1c(Cl)ccc2c1CCCC2c1ncc[nH]1 10.1016/j.bmcl.2009.03.162
25066019 95383 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 325 3 2 3 2.9 CS(=O)(=O)Nc1c(Cl)ccc2c1CCCC2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
CHEMBL256982 95383 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 325 3 2 3 2.9 CS(=O)(=O)Nc1c(Cl)ccc2c1CCCC2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
11079593 204092 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1cc(F)ccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL70326 204092 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1cc(F)ccc1NCC1=NCCN1 10.1021/jm000542r
15959119 77027 0 None -1 2 Rat 5.4 pEC50 = 5.4 Functional
Vasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contractionVasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contraction
ChEMBL 310 4 0 3 3.8 C=CCn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1016/j.bmcl.2006.02.003
CHEMBL207277 77027 0 None -1 2 Rat 5.4 pEC50 = 5.4 Functional
Vasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contractionVasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contraction
ChEMBL 310 4 0 3 3.8 C=CCn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1016/j.bmcl.2006.02.003
44369647 47177 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 242 4 2 5 1.8 c1ccc(-c2cnoc2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
CHEMBL154346 47177 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 242 4 2 5 1.8 c1ccc(-c2cnoc2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
44449248 95168 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 248 2 1 2 3.2 COc1c(Cl)ccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL255937 95168 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 248 2 1 2 3.2 COc1c(Cl)ccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
44449338 95662 1 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 184 1 1 1 2.5 c1ccc2c(c1)CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL258178 95662 1 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 184 1 1 1 2.5 c1ccc2c(c1)CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
44449338 95662 1 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 184 1 1 1 2.5 c1ccc2c(c1)CCC2c1ncc[nH]1 10.1016/j.bmcl.2009.03.162
CHEMBL258178 95662 1 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 184 1 1 1 2.5 c1ccc2c(c1)CCC2c1ncc[nH]1 10.1016/j.bmcl.2009.03.162
44593580 178518 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 242 3 1 2 2.8 COCc1ccccc1C1CCc2nc[nH]c2C1 10.1016/j.bmcl.2009.03.162
CHEMBL466876 178518 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 242 3 1 2 2.8 COCc1ccccc1C1CCc2nc[nH]c2C1 10.1016/j.bmcl.2009.03.162
11747739 13203 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1AAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1A
ChEMBL 237 4 2 4 0.8 C[S+]([O-])c1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL1191324 13203 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1AAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1A
ChEMBL 237 4 2 4 0.8 C[S+]([O-])c1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL542402 13203 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1AAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1A
ChEMBL 237 4 2 4 0.8 C[S+]([O-])c1ccccc1NCC1=NCCN1 10.1021/jm000542r
44574103 172564 0 None - 1 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 250 2 0 4 2.4 c1ccc(-n2cccn2)c([C@@H]2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL448908 172564 0 None - 1 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 250 2 0 4 2.4 c1ccc(-n2cccn2)c([C@@H]2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
44574137 189066 0 None - 1 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 268 2 0 4 2.5 Fc1ccc(-n2cccn2)c(C2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL510023 189066 0 None - 1 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 268 2 0 4 2.5 Fc1ccc(-n2cccn2)c(C2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
11108001 10840 2 None -2 5 Human 8.3 pEC50 = 8.3 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 221 4 2 4 1.8 CSc1ccccc1NCC1=NCCN1 10.1016/s0960-894x(02)00753-9
CHEMBL117248 10840 2 None -2 5 Human 8.3 pEC50 = 8.3 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 221 4 2 4 1.8 CSc1ccccc1NCC1=NCCN1 10.1016/s0960-894x(02)00753-9
CHEMBL540542 10840 2 None -2 5 Human 8.3 pEC50 = 8.3 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 221 4 2 4 1.8 CSc1ccccc1NCC1=NCCN1 10.1016/s0960-894x(02)00753-9
44362149 33902 0 None 2 3 Human 8.3 pEC50 = 8.3 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 259 4 1 5 2.2 c1ccc(-c2ccns2)c(OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
CHEMBL142387 33902 0 None 2 3 Human 8.3 pEC50 = 8.3 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 259 4 1 5 2.2 c1ccc(-c2ccns2)c(OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
44362150 119364 0 None 15 2 Human 8.3 pEC50 = 8.3 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 242 4 2 4 1.5 c1ccc(-c2cc[nH]n2)c(OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
CHEMBL344551 119364 0 None 15 2 Human 8.3 pEC50 = 8.3 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 242 4 2 4 1.5 c1ccc(-c2cc[nH]n2)c(OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
10859076 13650 0 None 5 4 Human 8.3 pEC50 = 8.3 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 249 5 2 4 2.6 CC(C)Sc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL1194763 13650 0 None 5 4 Human 8.3 pEC50 = 8.3 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 249 5 2 4 2.6 CC(C)Sc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL553276 13650 0 None 5 4 Human 8.3 pEC50 = 8.3 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 249 5 2 4 2.6 CC(C)Sc1ccccc1NCC1=NCCN1 10.1021/jm000542r
6604803 116492 2 None 1 4 Rat 8.3 pEC50 = 8.3 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 309 3 3 5 1.2 CS(=O)(=O)Nc1c(O)ccc2c1CCC[C@H]2C1=NCCN1 10.1021/jm960354u
CHEMBL336161 116492 2 None 1 4 Rat 8.3 pEC50 = 8.3 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 309 3 3 5 1.2 CS(=O)(=O)Nc1c(O)ccc2c1CCC[C@H]2C1=NCCN1 10.1021/jm960354u
6604803 116492 2 None -1 4 Human 8.3 pEC50 = 8.3 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 309 3 3 5 1.2 CS(=O)(=O)Nc1c(O)ccc2c1CCC[C@H]2C1=NCCN1 10.1021/jm960354u
CHEMBL336161 116492 2 None -1 4 Human 8.3 pEC50 = 8.3 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 309 3 3 5 1.2 CS(=O)(=O)Nc1c(O)ccc2c1CCC[C@H]2C1=NCCN1 10.1021/jm960354u
4038180 204 14 None 1 6 Rat 8.2 pEC50 = 8.2 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm960354u
480 204 14 None 1 6 Rat 8.2 pEC50 = 8.2 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm960354u
CHEMBL109783 204 14 None 1 6 Rat 8.2 pEC50 = 8.2 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm960354u
9816461 10687 7 None 60 2 Human 7.3 pEC50 = 7.3 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 253 4 2 5 0.5 CS(=O)(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(02)00753-9
CHEMBL117094 10687 7 None 60 2 Human 7.3 pEC50 = 7.3 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 253 4 2 5 0.5 CS(=O)(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(02)00753-9
CHEMBL544290 10687 7 None 60 2 Human 7.3 pEC50 = 7.3 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 253 4 2 5 0.5 CS(=O)(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(02)00753-9
44343245 110588 2 None - 1 Human 7.3 pEC50 = 7.3 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 256 4 2 3 3.0 c1ccc(N2CCCCC2)c(NCc2c[nH]cn2)c1 10.1016/s0960-894x(02)00753-9
CHEMBL325648 110588 2 None - 1 Human 7.3 pEC50 = 7.3 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 256 4 2 3 3.0 c1ccc(N2CCCCC2)c(NCc2c[nH]cn2)c1 10.1016/s0960-894x(02)00753-9
44343275 110747 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 240 4 2 4 2.7 c1ccc(-c2cnco2)c(NCc2c[nH]cn2)c1 10.1016/s0960-894x(02)00753-9
CHEMBL326067 110747 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 240 4 2 4 2.7 c1ccc(-c2cnco2)c(NCc2c[nH]cn2)c1 10.1016/s0960-894x(02)00753-9
22493233 169263 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 268 4 2 4 2.4 Cc1ccc(-c2ccccc2NCC2=NCCN2)n1C 10.1016/s0960-894x(03)00050-7
CHEMBL441412 169263 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 268 4 2 4 2.4 Cc1ccc(-c2ccccc2NCC2=NCCN2)n1C 10.1016/s0960-894x(03)00050-7
9903313 172654 0 None 5 3 Human 7.3 pEC50 = 7.3 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 260 5 2 4 1.2 CCN(C)C(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL450018 172654 0 None 5 3 Human 7.3 pEC50 = 7.3 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 260 5 2 4 1.2 CCN(C)C(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
22493379 208103 0 None 2 3 Human 7.3 pEC50 = 7.3 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 260 5 3 4 1.2 CC(C)NC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL98016 208103 0 None 2 3 Human 7.3 pEC50 = 7.3 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 260 5 3 4 1.2 CC(C)NC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
22493411 168006 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 274 6 3 4 1.6 CCC(C)NC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL432192 168006 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 274 6 3 4 1.6 CCC(C)NC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
44329701 207655 0 None -6 3 Human 6.3 pEC50 = 6.3 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 275 6 2 5 1.9 CC(C)COC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL95398 207655 0 None -6 3 Human 6.3 pEC50 = 6.3 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 275 6 2 5 1.9 CC(C)COC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
44574044 178407 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 209 1 0 3 2.1 N#Cc1ccccc1[C@@H]1Cc2nccn2C1 10.1016/j.bmcl.2009.03.166
CHEMBL466046 178407 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 209 1 0 3 2.1 N#Cc1ccccc1[C@@H]1Cc2nccn2C1 10.1016/j.bmcl.2009.03.166
44219719 178654 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 209 1 0 3 2.1 N#Cc1ccccc1C1Cc2nccn2C1 10.1016/j.bmcl.2009.03.162
CHEMBL467916 178654 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 209 1 0 3 2.1 N#Cc1ccccc1C1Cc2nccn2C1 10.1016/j.bmcl.2009.03.162
10399043 120136 0 None -2 3 Human 7.3 pEC50 = 7.3 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 232 5 2 5 1.1 CO/N=C/c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
CHEMBL351542 120136 0 None -2 3 Human 7.3 pEC50 = 7.3 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 232 5 2 5 1.1 CO/N=C/c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
10916464 204130 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 287 4 2 5 1.2 CS(=O)(=O)c1cc(Cl)ccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL70563 204130 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 287 4 2 5 1.2 CS(=O)(=O)c1cc(Cl)ccc1NCC1=NCCN1 10.1021/jm000542r
44574875 188619 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 232 1 1 1 3.3 Clc1cccc(C2CCc3nc[nH]c3C2)c1 10.1016/j.bmcl.2009.03.162
CHEMBL503269 188619 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 232 1 1 1 3.3 Clc1cccc(C2CCc3nc[nH]c3C2)c1 10.1016/j.bmcl.2009.03.162
44449245 95384 0 None 6 3 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 250 2 2 2 2.9 c1cc(-c2ccn[nH]2)c2c(c1)C(c1ncc[nH]1)CC2 10.1016/j.bmcl.2008.03.070
CHEMBL256983 95384 0 None 6 3 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 250 2 2 2 2.9 c1cc(-c2ccn[nH]2)c2c(c1)C(c1ncc[nH]1)CC2 10.1016/j.bmcl.2008.03.070
22493347 119586 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 260 6 2 5 1.9 CCO/N=C(\C)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
CHEMBL346465 119586 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 260 6 2 5 1.9 CCO/N=C(\C)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
44281057 99647 0 None - 1 Human 5.3 pEC50 = 5.3 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 221 2 1 3 1.9 COc1ccc(OC)c2c1CCCC(N)C2 10.1021/jm00144a012
CHEMBL284486 99647 0 None - 1 Human 5.3 pEC50 = 5.3 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 221 2 1 3 1.9 COc1ccc(OC)c2c1CCCC(N)C2 10.1021/jm00144a012
9816461 10687 7 None 60 2 Human 7.3 pEC50 = 7.3 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1AAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1A
ChEMBL 253 4 2 5 0.5 CS(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL117094 10687 7 None 60 2 Human 7.3 pEC50 = 7.3 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1AAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1A
ChEMBL 253 4 2 5 0.5 CS(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL544290 10687 7 None 60 2 Human 7.3 pEC50 = 7.3 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1AAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1A
ChEMBL 253 4 2 5 0.5 CS(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
44574938 188890 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 214 2 0 3 2.2 COc1cccc(C2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.162
CHEMBL507755 188890 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 214 2 0 3 2.2 COc1cccc(C2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.162
44571888 183893 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 246 3 1 2 2.8 COCc1cc(F)cc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
CHEMBL481321 183893 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 246 3 1 2 2.8 COCc1cc(F)cc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
44343244 9920 0 None 5 2 Human 8.2 pEC50 = 8.2 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 241 3 3 4 2.0 Oc1ccc2cccc(NCC3=NCCN3)c2c1 10.1016/s0960-894x(02)00753-9
CHEMBL114669 9920 0 None 5 2 Human 8.2 pEC50 = 8.2 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 241 3 3 4 2.0 Oc1ccc2cccc(NCC3=NCCN3)c2c1 10.1016/s0960-894x(02)00753-9
44343236 111337 0 None 15 3 Human 8.2 pEC50 = 8.2 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 243 4 1 5 1.7 c1ccc(-c2ccno2)c(OCC2=NCCN2)c1 10.1016/s0960-894x(02)00753-9
CHEMBL327005 111337 0 None 15 3 Human 8.2 pEC50 = 8.2 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 243 4 1 5 1.7 c1ccc(-c2ccno2)c(OCC2=NCCN2)c1 10.1016/s0960-894x(02)00753-9
9903932 59480 0 None 501 2 Human 8.2 pEC50 = 8.2 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 284 5 2 6 1.9 CC(C)n1ncnc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
CHEMBL17151 59480 0 None 501 2 Human 8.2 pEC50 = 8.2 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 284 5 2 6 1.9 CC(C)n1ncnc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
44271932 65181 0 None 6 3 Human 8.2 pEC50 = 8.2 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 255 4 2 5 1.5 Cn1ccnc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
CHEMBL18256 65181 0 None 6 3 Human 8.2 pEC50 = 8.2 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 255 4 2 5 1.5 Cn1ccnc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
22493392 47125 0 None 3 3 Human 8.2 pEC50 = 8.2 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 252 4 2 4 2.2 c1ccc(-c2ccccc2NCC2=NCCN2)nc1 10.1016/s0960-894x(01)00822-8
CHEMBL154298 47125 0 None 3 3 Human 8.2 pEC50 = 8.2 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 252 4 2 4 2.2 c1ccc(-c2ccccc2NCC2=NCCN2)nc1 10.1016/s0960-894x(01)00822-8
9838192 111285 18 None -2 3 Rabbit 7.2 pEC50 = 7.2 Functional
Agonist activity at rabbit urethra adrenergic alpha1A receptorAgonist activity at rabbit urethra adrenergic alpha1A receptor
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1016/j.bmc.2008.02.091
CHEMBL326702 111285 18 None -2 3 Rabbit 7.2 pEC50 = 7.2 Functional
Agonist activity at rabbit urethra adrenergic alpha1A receptorAgonist activity at rabbit urethra adrenergic alpha1A receptor
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1016/j.bmc.2008.02.091
122184772 122495 0 None -1 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 424 9 4 6 2.3 CS(=O)(=O)Nc1cccc([C@@H](O)CNCCOc2ccc3c(Cl)n[nH]c3c2)c1 10.1021/acs.jmedchem.5b00638
CHEMBL3601203 122495 0 None -1 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 424 9 4 6 2.3 CS(=O)(=O)Nc1cccc([C@@H](O)CNCCOc2ccc3c(Cl)n[nH]c3c2)c1 10.1021/acs.jmedchem.5b00638
44574132 178565 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 280 2 0 4 2.8 Fc1cccc(-c2cncnc2)c1C1Cc2nccn2C1 10.1016/j.bmcl.2009.03.166
CHEMBL467259 178565 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 280 2 0 4 2.8 Fc1cccc(-c2cncnc2)c1C1Cc2nccn2C1 10.1016/j.bmcl.2009.03.166
44571842 179248 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 242 4 1 2 3.0 CCOCc1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
CHEMBL473043 179248 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 242 4 1 2 3.0 CCOCc1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
44571887 188392 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 246 3 1 2 2.8 COCc1c(F)ccc2c1CC[C@H]2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
CHEMBL502078 188392 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 246 3 1 2 2.8 COCc1c(F)ccc2c1CC[C@H]2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
44343243 9813 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 239 3 3 3 2.9 Oc1ccc2cccc(NCc3c[nH]cn3)c2c1 10.1016/s0960-894x(02)00753-9
CHEMBL114054 9813 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 239 3 3 3 2.9 Oc1ccc2cccc(NCc3c[nH]cn3)c2c1 10.1016/s0960-894x(02)00753-9
44343173 10989 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 272 6 2 3 2.5 CCN(CC)C(=O)c1ccccc1NCc1c[nH]cn1 10.1016/s0960-894x(02)00753-9
CHEMBL117482 10989 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 272 6 2 3 2.5 CCN(CC)C(=O)c1ccccc1NCc1c[nH]cn1 10.1016/s0960-894x(02)00753-9
9838294 59643 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 269 5 2 5 2.0 CCn1nccc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
CHEMBL17221 59643 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 269 5 2 5 2.0 CCn1nccc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
11079 2714 63 None 5 7 Human 7.2 pEC50 = 7.2 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1016/s0960-894x(01)00569-8
3369 2714 63 None 5 7 Human 7.2 pEC50 = 7.2 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1016/s0960-894x(01)00569-8
4436 2714 63 None 5 7 Human 7.2 pEC50 = 7.2 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1016/s0960-894x(01)00569-8
5509 2714 63 None 5 7 Human 7.2 pEC50 = 7.2 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1016/s0960-894x(01)00569-8
CHEMBL761 2714 63 None 5 7 Human 7.2 pEC50 = 7.2 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1016/s0960-894x(01)00569-8
DB06711 2714 63 None 5 7 Human 7.2 pEC50 = 7.2 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1016/s0960-894x(01)00569-8
11079 2714 63 None 5 7 Human 7.2 pEC50 = 7.2 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1016/s0960-894x(01)00822-8
3369 2714 63 None 5 7 Human 7.2 pEC50 = 7.2 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1016/s0960-894x(01)00822-8
4436 2714 63 None 5 7 Human 7.2 pEC50 = 7.2 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1016/s0960-894x(01)00822-8
5509 2714 63 None 5 7 Human 7.2 pEC50 = 7.2 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1016/s0960-894x(01)00822-8
CHEMBL761 2714 63 None 5 7 Human 7.2 pEC50 = 7.2 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1016/s0960-894x(01)00822-8
DB06711 2714 63 None 5 7 Human 7.2 pEC50 = 7.2 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1016/s0960-894x(01)00822-8
25154770 183628 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 246 3 1 2 2.8 COCc1ccc(F)c2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
CHEMBL480272 183628 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 246 3 1 2 2.8 COCc1ccc(F)c2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
22493325 119736 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 257 4 2 6 1.5 Cc1noc(-c2ccccc2NCC2=NCCN2)n1 10.1016/s0960-894x(01)00822-8
CHEMBL347920 119736 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 257 4 2 6 1.5 Cc1noc(-c2ccccc2NCC2=NCCN2)n1 10.1016/s0960-894x(01)00822-8
22493287 120067 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 320 4 2 4 3.2 FC(F)(F)c1cccnc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
CHEMBL350906 120067 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 320 4 2 4 3.2 FC(F)(F)c1cccnc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
11097789 102971 1 None -1 5 Human 8.1 pEC50 = 8.1 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 239 4 2 4 2.0 CSc1cc(F)ccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL306792 102971 1 None -1 5 Human 8.1 pEC50 = 8.1 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 239 4 2 4 2.0 CSc1cc(F)ccc1NCC1=NCCN1 10.1021/jm000542r
11140345 204148 0 None 2 5 Human 8.1 pEC50 = 8.1 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 239 4 2 4 2.0 CSc1c(F)cccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL70692 204148 0 None 2 5 Human 8.1 pEC50 = 8.1 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 239 4 2 4 2.0 CSc1c(F)cccc1NCC1=NCCN1 10.1021/jm000542r
9795167 107467 0 None 6 3 Human 8.1 pEC50 = 8.1 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 260 6 3 4 1.2 CCCNC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(02)00753-9
CHEMBL318544 107467 0 None 6 3 Human 8.1 pEC50 = 8.1 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 260 6 3 4 1.2 CCCNC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(02)00753-9
44352155 116782 0 None 7 5 Human 8.1 pEC50 = 8.1 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 251 4 2 3 2.8 c1ccc(-c2ccccc2NCC2=NCCN2)cc1 10.1016/s0960-894x(01)00764-8
CHEMBL337862 116782 0 None 7 5 Human 8.1 pEC50 = 8.1 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 251 4 2 3 2.8 c1ccc(-c2ccccc2NCC2=NCCN2)cc1 10.1016/s0960-894x(01)00764-8
9795167 107467 0 None 6 3 Human 8.1 pEC50 = 8.1 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 260 6 3 4 1.2 CCCNC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL318544 107467 0 None 6 3 Human 8.1 pEC50 = 8.1 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 260 6 3 4 1.2 CCCNC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
44329703 208139 0 None 7 2 Human 8.1 pEC50 = 8.1 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 275 4 2 5 2.1 CC(C)(C)OC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL98243 208139 0 None 7 2 Human 8.1 pEC50 = 8.1 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 275 4 2 5 2.1 CC(C)(C)OC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
44449304 95576 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 277 3 2 3 1.9 CS(=O)(=O)Nc1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL257800 95576 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 277 3 2 3 1.9 CS(=O)(=O)Nc1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
12764879 178399 0 None 100 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 184 1 0 2 2.2 c1ccc(C2Cc3nccn3C2)cc1 10.1016/j.bmcl.2009.03.162
CHEMBL465963 178399 0 None 100 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 184 1 0 2 2.2 c1ccc(C2Cc3nccn3C2)cc1 10.1016/j.bmcl.2009.03.162
172745 100095 7 None -234 2 Human 4.2 pEC50 = 4.2 Functional
Agonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortexAgonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortex
ChEMBL 187 2 4 4 0.2 NCC(O)c1ccc(O)c(O)c1F 10.1021/jm00118a019
CHEMBL287587 100095 7 None -234 2 Human 4.2 pEC50 = 4.2 Functional
Agonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortexAgonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortex
ChEMBL 187 2 4 4 0.2 NCC(O)c1ccc(O)c(O)c1F 10.1021/jm00118a019
1753 2487 28 None 2 4 Human 6.1 pEC50 = 6.1 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 10.1021/jm00144a012
483 2487 28 None 2 4 Human 6.1 pEC50 = 6.1 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 10.1021/jm00144a012
6082 2487 28 None 2 4 Human 6.1 pEC50 = 6.1 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 10.1021/jm00144a012
CHEMBL524 2487 28 None 2 4 Human 6.1 pEC50 = 6.1 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 10.1021/jm00144a012
DB00723 2487 28 None 2 4 Human 6.1 pEC50 = 6.1 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 10.1021/jm00144a012
12764880 178522 1 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 198 1 0 2 2.6 c1ccc(C2CCc3nccn3C2)cc1 10.1016/j.bmcl.2009.03.162
CHEMBL466914 178522 1 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 198 1 0 2 2.6 c1ccc(C2CCc3nccn3C2)cc1 10.1016/j.bmcl.2009.03.162
22493359 121662 0 None -1 2 Human 6.1 pEC50 = 6.1 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 257 4 2 6 1.5 Cc1nc(-c2ccccc2NCC2=NCCN2)no1 10.1016/s0960-894x(01)00822-8
CHEMBL358685 121662 0 None -1 2 Human 6.1 pEC50 = 6.1 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 257 4 2 6 1.5 Cc1nc(-c2ccccc2NCC2=NCCN2)no1 10.1016/s0960-894x(01)00822-8
12764879 178399 0 None 100 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 184 1 0 2 2.2 c1ccc(C2Cc3nccn3C2)cc1 10.1016/j.bmcl.2009.03.162
CHEMBL465963 178399 0 None 100 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 184 1 0 2 2.2 c1ccc(C2Cc3nccn3C2)cc1 10.1016/j.bmcl.2009.03.162
44593580 178518 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 242 3 1 2 2.8 COCc1ccccc1C1CCc2nc[nH]c2C1 10.1016/j.bmcl.2009.03.162
CHEMBL466876 178518 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 242 3 1 2 2.8 COCc1ccccc1C1CCc2nc[nH]c2C1 10.1016/j.bmcl.2009.03.162
44449303 95575 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 284 2 2 2 3.5 Clc1ccc2c(c1-c1cn[nH]c1)CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL257799 95575 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 284 2 2 2 3.5 Clc1ccc2c(c1-c1cn[nH]c1)CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
44449303 95575 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 284 2 2 2 3.5 Clc1ccc2c(c1-c1cn[nH]c1)CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
CHEMBL257799 95575 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 284 2 2 2 3.5 Clc1ccc2c(c1-c1cn[nH]c1)CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
9840212 62091 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 324 5 2 6 1.9 FC(F)(F)Cn1ncnc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
CHEMBL17764 62091 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 324 5 2 6 1.9 FC(F)(F)Cn1ncnc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
44329133 207678 0 None -6 3 Human 7.1 pEC50 = 7.1 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 274 6 3 4 1.5 CC(C)CNC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL95565 207678 0 None -6 3 Human 7.1 pEC50 = 7.1 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 274 6 3 4 1.5 CC(C)CNC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
22493408 61169 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 256 4 3 5 1.2 Cc1n[nH]c(-c2ccccc2NCC2=NCCN2)n1 10.1016/s0960-894x(03)00050-7
CHEMBL17657 61169 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 256 4 3 5 1.2 Cc1n[nH]c(-c2ccccc2NCC2=NCCN2)n1 10.1016/s0960-894x(03)00050-7
541604 165315 10 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortexAgonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortex
ChEMBL 201 3 4 4 0.5 CNCC(O)c1cc(O)c(O)cc1F 10.1021/jm00118a019
CHEMBL42359 165315 10 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortexAgonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortex
ChEMBL 201 3 4 4 0.5 CNCC(O)c1cc(O)c(O)cc1F 10.1021/jm00118a019
44574079 189285 0 None 8 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 261 2 0 3 3.3 c1ccc([C@@H]2Cc3nccn3C2)c(-c2ccncc2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL512289 189285 0 None 8 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 261 2 0 3 3.3 c1ccc([C@@H]2Cc3nccn3C2)c(-c2ccncc2)c1 10.1016/j.bmcl.2009.03.166
11522042 203656 1 None -1 2 Rat 6.1 pEC50 = 6.1 Functional
Vasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contractionVasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contraction
ChEMBL 284 2 0 3 3.2 Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1016/j.bmcl.2006.02.003
CHEMBL67457 203656 1 None -1 2 Rat 6.1 pEC50 = 6.1 Functional
Vasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contractionVasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contraction
ChEMBL 284 2 0 3 3.2 Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1016/j.bmcl.2006.02.003
45381933 122513 0 None -12 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 458 9 4 6 2.7 CS(=O)(=O)Nc1cccc([C@@H](O)CNCCOc2ccc3c(C(F)(F)F)n[nH]c3c2)c1 10.1021/acs.jmedchem.5b00638
CHEMBL3601308 122513 0 None -12 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 458 9 4 6 2.7 CS(=O)(=O)Nc1cccc([C@@H](O)CNCCOc2ccc3c(C(F)(F)F)n[nH]c3c2)c1 10.1021/acs.jmedchem.5b00638
44574989 189206 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 228 3 0 3 2.4 COCc1ccccc1C1Cc2nccn2C1 10.1016/j.bmcl.2009.03.162
CHEMBL511577 189206 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 228 3 0 3 2.4 COCc1ccccc1C1Cc2nccn2C1 10.1016/j.bmcl.2009.03.162
12764879 178399 0 None 100 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 184 1 0 2 2.2 c1ccc(C2Cc3nccn3C2)cc1 10.1016/j.bmcl.2009.03.162
CHEMBL465963 178399 0 None 100 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 184 1 0 2 2.2 c1ccc(C2Cc3nccn3C2)cc1 10.1016/j.bmcl.2009.03.162
44571840 188190 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 276 3 1 3 2.0 CS(=O)(=O)Cc1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
CHEMBL499180 188190 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 276 3 1 3 2.0 CS(=O)(=O)Cc1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
45381852 122496 0 None -60 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 418 10 4 6 2.2 CCc1n[nH]c2cc(OCCNC[C@H](O)c3cccc(NS(C)(=O)=O)c3)ccc12 10.1021/acs.jmedchem.5b00638
CHEMBL3601204 122496 0 None -60 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 418 10 4 6 2.2 CCc1n[nH]c2cc(OCCNC[C@H](O)c3cccc(NS(C)(=O)=O)c3)ccc12 10.1021/acs.jmedchem.5b00638
22493254 169064 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 260 6 2 5 1.9 CC/C(=N/OC)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
CHEMBL439822 169064 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 260 6 2 5 1.9 CC/C(=N/OC)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
44571845 189110 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 289 3 1 2 2.9 FC1(F)CN(Cc2cccc3c2CCC3c2ncc[nH]2)C1 10.1016/j.bmcl.2008.10.066
CHEMBL510613 189110 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 289 3 1 2 2.9 FC1(F)CN(Cc2cccc3c2CCC3c2ncc[nH]2)C1 10.1016/j.bmcl.2008.10.066
2803 952 58 None -6 14 Bovine 7.1 pEC50 = 7.1 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
516 952 58 None -6 14 Bovine 7.1 pEC50 = 7.1 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
704 952 58 None -6 14 Bovine 7.1 pEC50 = 7.1 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
CHEMBL134 952 58 None -6 14 Bovine 7.1 pEC50 = 7.1 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
DB00575 952 58 None -6 14 Bovine 7.1 pEC50 = 7.1 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
2146 3078 67 None 1 15 Bovine 8.1 pEC50 = 8.1 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O nan
485 3078 67 None 1 15 Bovine 8.1 pEC50 = 8.1 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O nan
6041 3078 67 None 1 15 Bovine 8.1 pEC50 = 8.1 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O nan
CHEMBL1215 3078 67 None 1 15 Bovine 8.1 pEC50 = 8.1 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O nan
DB00388 3078 67 None 1 15 Bovine 8.1 pEC50 = 8.1 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O nan
44574080 188922 0 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 264 2 0 4 2.6 Cn1cc(-c2ccccc2[C@@H]2Cc3nccn3C2)cn1 10.1016/j.bmcl.2009.03.166
CHEMBL508084 188922 0 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 264 2 0 4 2.6 Cn1cc(-c2ccccc2[C@@H]2Cc3nccn3C2)cn1 10.1016/j.bmcl.2009.03.166
9838192 111285 18 None 2 3 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1016/j.bmcl.2008.03.070
CHEMBL326702 111285 18 None 2 3 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1016/j.bmcl.2008.03.070
44571938 180049 0 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 300 3 1 3 3.0 Fc1ccn(Cc2c(F)ccc3c2CC[C@H]3c2ncc[nH]2)n1 10.1016/j.bmcl.2008.10.066
CHEMBL474796 180049 0 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 300 3 1 3 3.0 Fc1ccn(Cc2c(F)ccc3c2CC[C@H]3c2ncc[nH]2)n1 10.1016/j.bmcl.2008.10.066
1960 2838 67 None -2 19 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/acs.jmedchem.5b00638
439260 2838 67 None -2 19 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/acs.jmedchem.5b00638
505 2838 67 None -2 19 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/acs.jmedchem.5b00638
CHEMBL1437 2838 67 None -2 19 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/acs.jmedchem.5b00638
DB00368 2838 67 None -2 19 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/acs.jmedchem.5b00638
44571890 191952 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 265 3 1 4 2.1 c1cc(Cn2ccnn2)c2c(c1)C(c1ncc[nH]1)CC2 10.1016/j.bmcl.2008.10.066
CHEMBL520117 191952 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 265 3 1 4 2.1 c1cc(Cn2ccnn2)c2c(c1)C(c1ncc[nH]1)CC2 10.1016/j.bmcl.2008.10.066
44574076 172437 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 251 2 0 4 2.9 c1ccc([C@H]2Cc3nccn3C2)c(-c2ncco2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL448147 172437 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 251 2 0 4 2.9 c1ccc([C@H]2Cc3nccn3C2)c(-c2ncco2)c1 10.1016/j.bmcl.2009.03.166
44574985 188383 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 214 2 0 3 2.2 COc1ccc(C2Cc3nccn3C2)cc1 10.1016/j.bmcl.2009.03.162
CHEMBL501920 188383 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 214 2 0 3 2.2 COc1ccc(C2Cc3nccn3C2)cc1 10.1016/j.bmcl.2009.03.162
123562321 140486 0 None 1 3 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 443 12 3 6 2.9 COc1ccc(F)cc1OCCNC(C)Cc1cc(C(N)=O)c2c(ccn2CCCO)c1 10.1021/acs.jmedchem.5b02023
CHEMBL3810110 140486 0 None 1 3 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 443 12 3 6 2.9 COc1ccc(F)cc1OCCNC(C)Cc1cc(C(N)=O)c2c(ccn2CCCO)c1 10.1021/acs.jmedchem.5b02023
129211 3722 78 None -1 14 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human alpha1A receptor transfected in HEK293 cells co-transfected with Galpha16 assessed as reduction in intracellular calcium release incubated for 40 mins by Fluo-4AM dye based fluorescence assayAntagonist activity at human alpha1A receptor transfected in HEK293 cells co-transfected with Galpha16 assessed as reduction in intracellular calcium release incubated for 40 mins by Fluo-4AM dye based fluorescence assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.ejmech.2020.112616
2562 3722 78 None -1 14 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human alpha1A receptor transfected in HEK293 cells co-transfected with Galpha16 assessed as reduction in intracellular calcium release incubated for 40 mins by Fluo-4AM dye based fluorescence assayAntagonist activity at human alpha1A receptor transfected in HEK293 cells co-transfected with Galpha16 assessed as reduction in intracellular calcium release incubated for 40 mins by Fluo-4AM dye based fluorescence assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.ejmech.2020.112616
488 3722 78 None -1 14 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human alpha1A receptor transfected in HEK293 cells co-transfected with Galpha16 assessed as reduction in intracellular calcium release incubated for 40 mins by Fluo-4AM dye based fluorescence assayAntagonist activity at human alpha1A receptor transfected in HEK293 cells co-transfected with Galpha16 assessed as reduction in intracellular calcium release incubated for 40 mins by Fluo-4AM dye based fluorescence assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.ejmech.2020.112616
CHEMBL836 3722 78 None -1 14 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human alpha1A receptor transfected in HEK293 cells co-transfected with Galpha16 assessed as reduction in intracellular calcium release incubated for 40 mins by Fluo-4AM dye based fluorescence assayAntagonist activity at human alpha1A receptor transfected in HEK293 cells co-transfected with Galpha16 assessed as reduction in intracellular calcium release incubated for 40 mins by Fluo-4AM dye based fluorescence assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.ejmech.2020.112616
DB00706 3722 78 None -1 14 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human alpha1A receptor transfected in HEK293 cells co-transfected with Galpha16 assessed as reduction in intracellular calcium release incubated for 40 mins by Fluo-4AM dye based fluorescence assayAntagonist activity at human alpha1A receptor transfected in HEK293 cells co-transfected with Galpha16 assessed as reduction in intracellular calcium release incubated for 40 mins by Fluo-4AM dye based fluorescence assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.ejmech.2020.112616
499 4046 18 None - 1 Human 9.0 pIC50 = 9 Functional
Antagonist activity against human recombinant alpha1 receptor expressed in CHOK1 cells assessed as reduction in epinephrine-induced increase in intracellular Ca2+ levelsAntagonist activity against human recombinant alpha1 receptor expressed in CHOK1 cells assessed as reduction in epinephrine-induced increase in intracellular Ca2+ levels
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1016/j.ejmech.2014.12.045
5685 4046 18 None - 1 Human 9.0 pIC50 = 9 Functional
Antagonist activity against human recombinant alpha1 receptor expressed in CHOK1 cells assessed as reduction in epinephrine-induced increase in intracellular Ca2+ levelsAntagonist activity against human recombinant alpha1 receptor expressed in CHOK1 cells assessed as reduction in epinephrine-induced increase in intracellular Ca2+ levels
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1016/j.ejmech.2014.12.045
CHEMBL25554 4046 18 None - 1 Human 9.0 pIC50 = 9 Functional
Antagonist activity against human recombinant alpha1 receptor expressed in CHOK1 cells assessed as reduction in epinephrine-induced increase in intracellular Ca2+ levelsAntagonist activity against human recombinant alpha1 receptor expressed in CHOK1 cells assessed as reduction in epinephrine-induced increase in intracellular Ca2+ levels
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1016/j.ejmech.2014.12.045
499 4046 18 None - 1 Human 9.0 pIC50 = 9 Functional
Antagonist activity at human recombinant alpha1A adrenoceptor assessed as inhibition of epinephrine-induced intracellular Ca2+ releaseAntagonist activity at human recombinant alpha1A adrenoceptor assessed as inhibition of epinephrine-induced intracellular Ca2+ release
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm401895u
5685 4046 18 None - 1 Human 9.0 pIC50 = 9 Functional
Antagonist activity at human recombinant alpha1A adrenoceptor assessed as inhibition of epinephrine-induced intracellular Ca2+ releaseAntagonist activity at human recombinant alpha1A adrenoceptor assessed as inhibition of epinephrine-induced intracellular Ca2+ release
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm401895u
CHEMBL25554 4046 18 None - 1 Human 9.0 pIC50 = 9 Functional
Antagonist activity at human recombinant alpha1A adrenoceptor assessed as inhibition of epinephrine-induced intracellular Ca2+ releaseAntagonist activity at human recombinant alpha1A adrenoceptor assessed as inhibition of epinephrine-induced intracellular Ca2+ release
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm401895u
123854385 140491 0 None 72 3 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 527 13 3 6 4.3 CC(Cc1cc(C(N)=O)c2c(ccn2CCCO)c1)NCCOc1cc(Cl)ccc1OCC(F)(F)F 10.1021/acs.jmedchem.5b02023
CHEMBL3810145 140491 0 None 72 3 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 527 13 3 6 4.3 CC(Cc1cc(C(N)=O)c2c(ccn2CCCO)c1)NCCOc1cc(Cl)ccc1OCC(F)(F)F 10.1021/acs.jmedchem.5b02023
4151 3580 89 None 1 10 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/acs.jmedchem.6b01217
493 3580 89 None 1 10 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/acs.jmedchem.6b01217
5312125 3580 89 None 1 10 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/acs.jmedchem.6b01217
CHEMBL24778 3580 89 None 1 10 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/acs.jmedchem.6b01217
DB06207 3580 89 None 1 10 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/acs.jmedchem.6b01217
4151 3580 89 None 1 10 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/acs.jmedchem.5b02023
493 3580 89 None 1 10 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/acs.jmedchem.5b02023
5312125 3580 89 None 1 10 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/acs.jmedchem.5b02023
CHEMBL24778 3580 89 None 1 10 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/acs.jmedchem.5b02023
DB06207 3580 89 None 1 10 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/acs.jmedchem.5b02023
9913616 140358 6 None 8 3 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 493 13 3 6 3.7 CC(Cc1cc(C(N)=O)c2c(ccn2CCCO)c1)NCCOc1ccccc1OCC(F)(F)F 10.1021/acs.jmedchem.5b02023
CHEMBL3808572 140358 6 None 8 3 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 493 13 3 6 3.7 CC(Cc1cc(C(N)=O)c2c(ccn2CCCO)c1)NCCOc1ccccc1OCC(F)(F)F 10.1021/acs.jmedchem.5b02023
10160408 140415 0 None 1 3 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 439 13 3 6 3.1 CCOc1ccccc1OCCNC(C)Cc1cc(C(N)=O)c2c(ccn2CCCO)c1 10.1021/acs.jmedchem.5b02023
CHEMBL3809248 140415 0 None 1 3 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 439 13 3 6 3.1 CCOc1ccccc1OCCNC(C)Cc1cc(C(N)=O)c2c(ccn2CCCO)c1 10.1021/acs.jmedchem.5b02023
86344174 140443 0 None 251 3 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 507 13 3 6 4.0 Cc1ccc(OCC(F)(F)F)c(OCCN[C@H](C)Cc2cc(C(N)=O)c3c(ccn3CCCO)c2)c1 10.1021/acs.jmedchem.5b02023
CHEMBL3809490 140443 0 None 251 3 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 507 13 3 6 4.0 Cc1ccc(OCC(F)(F)F)c(OCCN[C@H](C)Cc2cc(C(N)=O)c3c(ccn3CCCO)c2)c1 10.1021/acs.jmedchem.5b02023
2389 3306 118 None -13 29 Human 8.0 pIC50 = 8 Functional
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.bmcl.2018.01.038
5073 3306 118 None -13 29 Human 8.0 pIC50 = 8 Functional
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.bmcl.2018.01.038
96 3306 118 None -13 29 Human 8.0 pIC50 = 8 Functional
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.bmcl.2018.01.038
CHEMBL85 3306 118 None -13 29 Human 8.0 pIC50 = 8 Functional
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.bmcl.2018.01.038
DB00734 3306 118 None -13 29 Human 8.0 pIC50 = 8 Functional
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.bmcl.2018.01.038
2389 3306 118 None -13 29 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.ejmech.2017.12.099
5073 3306 118 None -13 29 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.ejmech.2017.12.099
96 3306 118 None -13 29 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.ejmech.2017.12.099
CHEMBL85 3306 118 None -13 29 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.ejmech.2017.12.099
DB00734 3306 118 None -13 29 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.ejmech.2017.12.099
145946682 167550 0 None -10 3 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assayAntagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assay
ChEMBL 444 7 0 3 5.6 Fc1ccc(N2CCN(CCc3ccc(COc4ccc5c(c4)CCCC5)cc3)CC2)cc1 10.1016/j.bmcl.2018.03.070
CHEMBL4225239 167550 0 None -10 3 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assayAntagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assay
ChEMBL 444 7 0 3 5.6 Fc1ccc(N2CCN(CCc3ccc(COc4ccc5c(c4)CCCC5)cc3)CC2)cc1 10.1016/j.bmcl.2018.03.070
CHEMBL4300633 167550 0 None -10 3 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assayAntagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assay
ChEMBL 444 7 0 3 5.6 Fc1ccc(N2CCN(CCc3ccc(COc4ccc5c(c4)CCCC5)cc3)CC2)cc1 10.1016/j.bmcl.2018.03.070
145964299 164108 0 None -1 6 Human 8.0 pIC50 = 8.0 Functional
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 426 8 1 6 3.8 CNC(=O)c1cc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)ccn1 10.1016/j.bmcl.2018.01.038
CHEMBL4210030 164108 0 None -1 6 Human 8.0 pIC50 = 8.0 Functional
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 426 8 1 6 3.8 CNC(=O)c1cc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)ccn1 10.1016/j.bmcl.2018.01.038
76071739 142772 0 None -25 3 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 348 1 1 4 3.6 COc1ccc2[nH]c3c(c2c1)C[C@H]1c2cc4c(cc2CCN1C3)OCO4 10.1021/acs.jmedchem.6b01217
CHEMBL3892879 142772 0 None -25 3 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 348 1 1 4 3.6 COc1ccc2[nH]c3c(c2c1)C[C@H]1c2cc4c(cc2CCN1C3)OCO4 10.1021/acs.jmedchem.6b01217
145946986 167581 0 None -4 3 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assayAntagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assay
ChEMBL 460 7 0 3 6.2 Clc1cccc(N2CCN(CCc3ccc(COc4ccc5c(c4)CCCC5)cc3)CC2)c1 10.1016/j.bmcl.2018.03.070
CHEMBL4227241 167581 0 None -4 3 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assayAntagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assay
ChEMBL 460 7 0 3 6.2 Clc1cccc(N2CCN(CCc3ccc(COc4ccc5c(c4)CCCC5)cc3)CC2)c1 10.1016/j.bmcl.2018.03.070
CHEMBL4300995 167581 0 None -4 3 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assayAntagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assay
ChEMBL 460 7 0 3 6.2 Clc1cccc(N2CCN(CCc3ccc(COc4ccc5c(c4)CCCC5)cc3)CC2)c1 10.1016/j.bmcl.2018.03.070
145990794 166776 0 None -19 6 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assay
ChEMBL 437 6 0 5 3.8 O=C1[C@H]2[C@@H]3CC[C@@H](C3)[C@H]2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1 10.1016/j.ejmech.2017.12.099
CHEMBL4284346 166776 0 None -19 6 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assay
ChEMBL 437 6 0 5 3.8 O=C1[C@H]2[C@@H]3CC[C@@H](C3)[C@H]2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1 10.1016/j.ejmech.2017.12.099
131978695 150837 0 None 5 3 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 440 5 1 4 5.4 COc1ccc2[nH]c3c(c2c1)CC1c2cc(OCc4ccccc4)c(OC)cc2CCN1C3 10.1021/acs.jmedchem.6b01217
CHEMBL3957222 150837 0 None 5 3 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 440 5 1 4 5.4 COc1ccc2[nH]c3c(c2c1)CC1c2cc(OCc4ccccc4)c(OC)cc2CCN1C3 10.1021/acs.jmedchem.6b01217
134138882 147703 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 318 0 1 3 3.6 c1ccc2c3c([nH]c2c1)CN1CCc2cc4c(cc2C1C3)OCO4 10.1021/acs.jmedchem.6b01217
CHEMBL3932187 147703 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 318 0 1 3 3.6 c1ccc2c3c([nH]c2c1)CN1CCc2cc4c(cc2C1C3)OCO4 10.1021/acs.jmedchem.6b01217
44575544 173974 0 None -3 4 Human 7.9 pIC50 = 7.9 Functional
Inhibition of adrenergic receptor 1a expressed in HEK293 cells assessed as inhibition of calcium influx after 10 mins by Fluo-4-AM based fluorimetryInhibition of adrenergic receptor 1a expressed in HEK293 cells assessed as inhibition of calcium influx after 10 mins by Fluo-4-AM based fluorimetry
ChEMBL 794 5 5 13 3.0 CC(C)CC(=O)O[C@H]1/C=C/C=C/C(=O)O[C@H]2[C@@H](C)C[C@@H]3[C@]2(O)[C@H](O)[C@@]2(CO)O[C@H]2[C@H]2[C@H]4OC5(c6ccccc6)O[C@@H]([C@@H](C)[C@@]23O5)[C@@]4(O)[C@](C)(O)C[C@H]2CC[C@H]1[C@H]2C 10.1021/np3000359
CHEMBL454246 173974 0 None -3 4 Human 7.9 pIC50 = 7.9 Functional
Inhibition of adrenergic receptor 1a expressed in HEK293 cells assessed as inhibition of calcium influx after 10 mins by Fluo-4-AM based fluorimetryInhibition of adrenergic receptor 1a expressed in HEK293 cells assessed as inhibition of calcium influx after 10 mins by Fluo-4-AM based fluorimetry
ChEMBL 794 5 5 13 3.0 CC(C)CC(=O)O[C@H]1/C=C/C=C/C(=O)O[C@H]2[C@@H](C)C[C@@H]3[C@]2(O)[C@H](O)[C@@]2(CO)O[C@H]2[C@H]2[C@H]4OC5(c6ccccc6)O[C@@H]([C@@H](C)[C@@]23O5)[C@@]4(O)[C@](C)(O)C[C@H]2CC[C@H]1[C@H]2C 10.1021/np3000359
127044893 140383 0 None 2 3 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 411 11 3 5 2.4 Cc1ccccc1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2 10.1021/acs.jmedchem.5b02023
CHEMBL3808878 140383 0 None 2 3 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 411 11 3 5 2.4 Cc1ccccc1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2 10.1021/acs.jmedchem.5b02023
134157118 154178 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 332 0 0 4 3.6 Cn1c2c(c3ccccc31)CC1c3cc4c(cc3CCN1C2)OCO4 10.1021/acs.jmedchem.6b01217
CHEMBL3985901 154178 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 332 0 0 4 3.6 Cn1c2c(c3ccccc31)CC1c3cc4c(cc3CCN1C2)OCO4 10.1021/acs.jmedchem.6b01217
123141715 140510 0 None 2 3 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 459 12 3 6 3.4 COc1cc(Cl)ccc1OCCNC(C)Cc1cc(C(N)=O)c2c(ccn2CCCO)c1 10.1021/acs.jmedchem.5b02023
CHEMBL3810401 140510 0 None 2 3 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 459 12 3 6 3.4 COc1cc(Cl)ccc1OCCNC(C)Cc1cc(C(N)=O)c2c(ccn2CCCO)c1 10.1021/acs.jmedchem.5b02023
44347716 16276 0 None -3 3 Rat 4.8 pIC50 = 4.8 Functional
Antagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from ratAntagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from rat
ChEMBL 590 27 4 8 6.3 COc1cccc(CNCCCCCCNCCSSCCNCCCCCCNCc2ccccc2OC)c1 10.1021/jm000995w
CHEMBL122621 16276 0 None -3 3 Rat 4.8 pIC50 = 4.8 Functional
Antagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from ratAntagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from rat
ChEMBL 590 27 4 8 6.3 COc1cccc(CNCCCCCCNCCSSCCNCCCCCCNCc2ccccc2OC)c1 10.1021/jm000995w
145966333 164036 0 None -134 6 Human 6.8 pIC50 = 6.8 Functional
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 424 8 1 6 3.6 CNC(=O)c1cc(OCCCCN2CCN(c3cccc4sccc34)CC2)ccn1 10.1016/j.bmcl.2018.01.038
CHEMBL4209188 164036 0 None -134 6 Human 6.8 pIC50 = 6.8 Functional
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 424 8 1 6 3.6 CNC(=O)c1cc(OCCCCN2CCN(c3cccc4sccc34)CC2)ccn1 10.1016/j.bmcl.2018.01.038
123986550 140373 0 None 223 3 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 521 14 3 6 4.2 CCc1ccc(OCC(F)(F)F)c(OCCNC(C)Cc2cc(C(N)=O)c3c(ccn3CCCO)c2)c1 10.1021/acs.jmedchem.5b02023
CHEMBL3808717 140373 0 None 223 3 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 521 14 3 6 4.2 CCc1ccc(OCC(F)(F)F)c(OCCNC(C)Cc2cc(C(N)=O)c3c(ccn3CCCO)c2)c1 10.1021/acs.jmedchem.5b02023
134142282 145665 0 None 2 3 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 348 1 1 4 3.6 COc1ccc2[nH]c3c(c2c1)CC1c2cc4c(cc2CCN1C3)OCO4 10.1021/acs.jmedchem.6b01217
CHEMBL3916182 145665 0 None 2 3 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 348 1 1 4 3.6 COc1ccc2[nH]c3c(c2c1)CC1c2cc4c(cc2CCN1C3)OCO4 10.1021/acs.jmedchem.6b01217
242 469 124 None -120 33 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1016/j.ejmech.2017.12.099
34 469 124 None -120 33 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1016/j.ejmech.2017.12.099
60795 469 124 None -120 33 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1016/j.ejmech.2017.12.099
CHEMBL1112 469 124 None -120 33 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1016/j.ejmech.2017.12.099
DB01238 469 124 None -120 33 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1016/j.ejmech.2017.12.099
242 469 124 None -120 33 Human 6.8 pIC50 = 6.8 Functional
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1016/j.bmcl.2018.01.038
34 469 124 None -120 33 Human 6.8 pIC50 = 6.8 Functional
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1016/j.bmcl.2018.01.038
60795 469 124 None -120 33 Human 6.8 pIC50 = 6.8 Functional
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1016/j.bmcl.2018.01.038
CHEMBL1112 469 124 None -120 33 Human 6.8 pIC50 = 6.8 Functional
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1016/j.bmcl.2018.01.038
DB01238 469 124 None -120 33 Human 6.8 pIC50 = 6.8 Functional
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1016/j.bmcl.2018.01.038
145983928 166388 0 None -48 6 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assay
ChEMBL 435 6 0 5 3.6 O=C1[C@H]2[C@@H]3C=C[C@@H](C3)[C@H]2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1 10.1016/j.ejmech.2017.12.099
CHEMBL4277101 166388 0 None -48 6 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assay
ChEMBL 435 6 0 5 3.6 O=C1[C@H]2[C@@H]3C=C[C@@H](C3)[C@H]2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1 10.1016/j.ejmech.2017.12.099
10820251 96593 0 None -208 3 Rat 5.7 pIC50 = 5.7 Functional
Antagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from ratAntagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from rat
ChEMBL 1277 47 6 20 10.9 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccccc3CNCCCCCCNCCSSCCNCCCCCCNCc3ccccc3C(=O)N(C)CCCCCCN(C)c3nc(N)c4cc(OC)c(OC)cc4n3)nc(N)c2cc1OC 10.1021/jm000995w
CHEMBL1203233 96593 0 None -208 3 Rat 5.7 pIC50 = 5.7 Functional
Antagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from ratAntagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from rat
ChEMBL 1277 47 6 20 10.9 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccccc3CNCCCCCCNCCSSCCNCCCCCCNCc3ccccc3C(=O)N(C)CCCCCCN(C)c3nc(N)c4cc(OC)c(OC)cc4n3)nc(N)c2cc1OC 10.1021/jm000995w
CHEMBL263434 96593 0 None -208 3 Rat 5.7 pIC50 = 5.7 Functional
Antagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from ratAntagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from rat
ChEMBL 1277 47 6 20 10.9 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccccc3CNCCCCCCNCCSSCCNCCCCCCNCc3ccccc3C(=O)N(C)CCCCCCN(C)c3nc(N)c4cc(OC)c(OC)cc4n3)nc(N)c2cc1OC 10.1021/jm000995w
10606263 141526 0 None -81 3 Rat 5.7 pIC50 = 5.7 Functional
Antagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from ratAntagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from rat
ChEMBL 1161 33 6 20 7.3 COc1cc2nc(N3CCN(C(=O)c4ccc(CNCCCCCCNCCSSCCNCCCCCCNCc5ccc(C(=O)N6CCN(c7nc(N)c8cc(OC)c(OC)cc8n7)CC6)cc5)cc4)CC3)nc(N)c2cc1OC 10.1021/jm000995w
CHEMBL384790 141526 0 None -81 3 Rat 5.7 pIC50 = 5.7 Functional
Antagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from ratAntagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from rat
ChEMBL 1161 33 6 20 7.3 COc1cc2nc(N3CCN(C(=O)c4ccc(CNCCCCCCNCCSSCCNCCCCCCNCc5ccc(C(=O)N6CCN(c7nc(N)c8cc(OC)c(OC)cc8n7)CC6)cc5)cc4)CC3)nc(N)c2cc1OC 10.1021/jm000995w
123472560 140469 0 None 616 3 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 507 13 3 6 4.0 Cc1ccc(OCC(F)(F)F)c(OCCNC(C)Cc2cc(C(N)=O)c3c(ccn3CCCO)c2)c1 10.1021/acs.jmedchem.5b02023
CHEMBL3809840 140469 0 None 616 3 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 507 13 3 6 4.0 Cc1ccc(OCC(F)(F)F)c(OCCNC(C)Cc2cc(C(N)=O)c3c(ccn3CCCO)c2)c1 10.1021/acs.jmedchem.5b02023
129211 3722 78 None -1 14 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/acs.jmedchem.6b01217
2562 3722 78 None -1 14 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/acs.jmedchem.6b01217
488 3722 78 None -1 14 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/acs.jmedchem.6b01217
CHEMBL836 3722 78 None -1 14 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/acs.jmedchem.6b01217
DB00706 3722 78 None -1 14 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/acs.jmedchem.6b01217
123415538 140352 0 None 8 3 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 491 11 3 5 3.6 CC(Cc1cc(C(N)=O)c2c(ccn2CCCO)c1)NCCOc1ccc(F)cc1Br 10.1021/acs.jmedchem.5b02023
CHEMBL3808511 140352 0 None 8 3 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 491 11 3 5 3.6 CC(Cc1cc(C(N)=O)c2c(ccn2CCCO)c1)NCCOc1ccc(F)cc1Br 10.1021/acs.jmedchem.5b02023
123667086 140374 0 None -8 3 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 573 13 3 6 3.8 CC(Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1cc(Br)ccc1OCC(F)(F)F 10.1021/acs.jmedchem.5b02023
CHEMBL3808726 140374 0 None -8 3 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 573 13 3 6 3.8 CC(Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1cc(Br)ccc1OCC(F)(F)F 10.1021/acs.jmedchem.5b02023
127044912 140403 0 None -26 3 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 501 14 3 6 4.3 CC(Cc1cc(C(N)=O)c2c(ccn2CCCO)c1)NCCOc1ccccc1OCc1ccccc1 10.1021/acs.jmedchem.5b02023
CHEMBL3809093 140403 0 None -26 3 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 501 14 3 6 4.3 CC(Cc1cc(C(N)=O)c2c(ccn2CCCO)c1)NCCOc1ccccc1OCc1ccccc1 10.1021/acs.jmedchem.5b02023
117839022 140506 0 None 407 3 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 529 13 3 6 3.7 C[C@H](Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1cc(Cl)ccc1OCC(F)(F)F 10.1021/acs.jmedchem.5b02023
CHEMBL3810346 140506 0 None 407 3 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 529 13 3 6 3.7 C[C@H](Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1cc(Cl)ccc1OCC(F)(F)F 10.1021/acs.jmedchem.5b02023
124018870 140386 0 None -7 3 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 445 12 3 6 2.3 COc1ccc(F)cc1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2 10.1021/acs.jmedchem.5b02023
CHEMBL3808896 140386 0 None -7 3 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 445 12 3 6 2.3 COc1ccc(F)cc1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2 10.1021/acs.jmedchem.5b02023
123368349 140408 0 None 95 3 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 505 12 3 6 2.9 COc1cc(Br)ccc1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2 10.1021/acs.jmedchem.5b02023
CHEMBL3809175 140408 0 None 95 3 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 505 12 3 6 2.9 COc1cc(Br)ccc1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2 10.1021/acs.jmedchem.5b02023
123387804 140396 0 None -52 3 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 423 12 3 5 3.3 CCc1ccccc1OCCNC(C)Cc1cc(C(N)=O)c2c(ccn2CCCO)c1 10.1021/acs.jmedchem.5b02023
CHEMBL3808999 140396 0 None -52 3 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 423 12 3 5 3.3 CCc1ccccc1OCCNC(C)Cc1cc(C(N)=O)c2c(ccn2CCCO)c1 10.1021/acs.jmedchem.5b02023
156767236 182933 0 None 9 2 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human alpha1A receptor transfected in HEK293 cells co-transfected with Galpha16 assessed as reduction in intracellular calcium release incubated for 40 mins by Fluo-4AM dye based fluorescence assayAntagonist activity at human alpha1A receptor transfected in HEK293 cells co-transfected with Galpha16 assessed as reduction in intracellular calcium release incubated for 40 mins by Fluo-4AM dye based fluorescence assay
ChEMBL 449 11 1 5 4.7 COc1ccccc1N1CCN(CCCCn2cc(CCCC(=O)O)c3ccccc32)CC1 10.1016/j.ejmech.2020.112616
CHEMBL4792905 182933 0 None 9 2 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human alpha1A receptor transfected in HEK293 cells co-transfected with Galpha16 assessed as reduction in intracellular calcium release incubated for 40 mins by Fluo-4AM dye based fluorescence assayAntagonist activity at human alpha1A receptor transfected in HEK293 cells co-transfected with Galpha16 assessed as reduction in intracellular calcium release incubated for 40 mins by Fluo-4AM dye based fluorescence assay
ChEMBL 449 11 1 5 4.7 COc1ccccc1N1CCN(CCCCn2cc(CCCC(=O)O)c3ccccc32)CC1 10.1016/j.ejmech.2020.112616
134157566 154002 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 348 1 1 4 3.6 COc1cccc2[nH]c3c(c12)CC1c2cc4c(cc2CCN1C3)OCO4 10.1021/acs.jmedchem.6b01217
CHEMBL3984249 154002 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 348 1 1 4 3.6 COc1cccc2[nH]c3c(c12)CC1c2cc4c(cc2CCN1C3)OCO4 10.1021/acs.jmedchem.6b01217
134137522 143073 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 336 0 1 3 3.7 Fc1ccc2c3c([nH]c2c1)CN1CCc2cc4c(cc2C1C3)OCO4 10.1021/acs.jmedchem.6b01217
CHEMBL3895460 143073 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 336 0 1 3 3.7 Fc1ccc2c3c([nH]c2c1)CN1CCc2cc4c(cc2C1C3)OCO4 10.1021/acs.jmedchem.6b01217
123204312 140447 0 None 74 3 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 425 11 3 5 2.7 Cc1cccc(C)c1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2 10.1021/acs.jmedchem.5b02023
CHEMBL3809532 140447 0 None 74 3 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 425 11 3 5 2.7 Cc1cccc(C)c1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2 10.1021/acs.jmedchem.5b02023
134150827 152143 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 392 5 1 4 4.6 CCCOc1cc2c(cc1OC)CCN1Cc3[nH]c4ccc(OC)cc4c3CC21 10.1021/acs.jmedchem.6b01217
CHEMBL3968227 152143 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 392 5 1 4 4.6 CCCOc1cc2c(cc1OC)CCN1Cc3[nH]c4ccc(OC)cc4c3CC21 10.1021/acs.jmedchem.6b01217
134155537 150961 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 406 6 1 4 5.0 CCCCOc1cc2c(cc1OC)CCN1Cc3[nH]c4ccc(OC)cc4c3CC21 10.1021/acs.jmedchem.6b01217
CHEMBL3958316 150961 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 406 6 1 4 5.0 CCCCOc1cc2c(cc1OC)CCN1Cc3[nH]c4ccc(OC)cc4c3CC21 10.1021/acs.jmedchem.6b01217
123322716 140498 0 None 17 3 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 425 12 3 5 2.7 CCc1ccccc1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2 10.1021/acs.jmedchem.5b02023
CHEMBL3810198 140498 0 None 17 3 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 425 12 3 5 2.7 CCc1ccccc1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2 10.1021/acs.jmedchem.5b02023
134149598 148453 0 None 33 2 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 336 0 1 3 3.7 Fc1ccc2[nH]c3c(c2c1)CC1c2cc4c(cc2CCN1C3)OCO4 10.1021/acs.jmedchem.6b01217
CHEMBL3938121 148453 0 None 33 2 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 336 0 1 3 3.7 Fc1ccc2[nH]c3c(c2c1)CC1c2cc4c(cc2CCN1C3)OCO4 10.1021/acs.jmedchem.6b01217
123801568 140464 0 None 100 3 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 441 11 3 7 1.9 CC(Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccc2c(c1)OCO2 10.1021/acs.jmedchem.5b02023
CHEMBL3809781 140464 0 None 100 3 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 441 11 3 7 1.9 CC(Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccc2c(c1)OCO2 10.1021/acs.jmedchem.5b02023
134150128 152076 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 424 3 1 4 5.1 c1ccc(COc2ccc3[nH]c4c(c3c2)CC2c3cc5c(cc3CCN2C4)OCO5)cc1 10.1021/acs.jmedchem.6b01217
CHEMBL3967696 152076 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 424 3 1 4 5.1 c1ccc(COc2ccc3[nH]c4c(c3c2)CC2c3cc5c(cc3CCN2C4)OCO5)cc1 10.1021/acs.jmedchem.6b01217
9891967 107498 34 None 4 3 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 495 13 3 6 3.1 CC(Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccccc1OCC(F)(F)F 10.1021/acs.jmedchem.5b02023
CHEMBL3187195 107498 34 None 4 3 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 495 13 3 6 3.1 CC(Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccccc1OCC(F)(F)F 10.1021/acs.jmedchem.5b02023
123644751 140478 0 None 125 3 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 529 13 3 6 3.7 CC(Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1cc(Cl)ccc1OCC(F)(F)F 10.1021/acs.jmedchem.5b02023
CHEMBL3810005 140478 0 None 125 3 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 529 13 3 6 3.7 CC(Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1cc(Cl)ccc1OCC(F)(F)F 10.1021/acs.jmedchem.5b02023
123475619 140466 0 None 43 3 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 503 12 3 6 3.5 COc1cc(Br)ccc1OCCNC(C)Cc1cc(C(N)=O)c2c(ccn2CCCO)c1 10.1021/acs.jmedchem.5b02023
CHEMBL3809794 140466 0 None 43 3 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 503 12 3 6 3.5 COc1cc(Br)ccc1OCCNC(C)Cc1cc(C(N)=O)c2c(ccn2CCCO)c1 10.1021/acs.jmedchem.5b02023
76071859 150329 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 348 1 1 4 3.6 COc1ccc2[nH]c3c(c2c1)C[C@@H]1c2cc4c(cc2CCN1C3)OCO4 10.1021/acs.jmedchem.6b01217
CHEMBL3953156 150329 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 348 1 1 4 3.6 COc1ccc2[nH]c3c(c2c1)C[C@@H]1c2cc4c(cc2CCN1C3)OCO4 10.1021/acs.jmedchem.6b01217
156767234 182572 0 None 10 2 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human alpha1A receptor transfected in HEK293 cells co-transfected with Galpha16 assessed as reduction in intracellular calcium release incubated for 40 mins by Fluo-4AM dye based fluorescence assayAntagonist activity at human alpha1A receptor transfected in HEK293 cells co-transfected with Galpha16 assessed as reduction in intracellular calcium release incubated for 40 mins by Fluo-4AM dye based fluorescence assay
ChEMBL 467 11 1 4 5.7 O=C(O)CCCc1cn(CCCCCN2CCN(c3ccccc3Cl)CC2)c2ccccc12 10.1016/j.ejmech.2020.112616
CHEMBL4788144 182572 0 None 10 2 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human alpha1A receptor transfected in HEK293 cells co-transfected with Galpha16 assessed as reduction in intracellular calcium release incubated for 40 mins by Fluo-4AM dye based fluorescence assayAntagonist activity at human alpha1A receptor transfected in HEK293 cells co-transfected with Galpha16 assessed as reduction in intracellular calcium release incubated for 40 mins by Fluo-4AM dye based fluorescence assay
ChEMBL 467 11 1 4 5.7 O=C(O)CCCc1cn(CCCCCN2CCN(c3ccccc3Cl)CC2)c2ccccc12 10.1016/j.ejmech.2020.112616
123393714 140449 0 None 3 3 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 439 11 3 5 3.1 Cc1ccc(C)c(OCCNC(C)Cc2cc3c(c(C(N)=O)c2)N(CCCO)CC3)c1C 10.1021/acs.jmedchem.5b02023
CHEMBL3809543 140449 0 None 3 3 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 439 11 3 5 3.1 Cc1ccc(C)c(OCCNC(C)Cc2cc3c(c(C(N)=O)c2)N(CCCO)CC3)c1C 10.1021/acs.jmedchem.5b02023
145993493 167333 0 None -47 6 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assay
ChEMBL 439 6 0 5 4.5 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1 10.1016/j.ejmech.2017.12.099
CHEMBL4294617 167333 0 None -47 6 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assay
ChEMBL 439 6 0 5 4.5 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1 10.1016/j.ejmech.2017.12.099
145993117 166897 0 None -309 6 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assay
ChEMBL 427 7 0 5 4.4 CCC1(C)CC(=O)N(CCCCN2CCN(c3cccc4sccc34)CC2)C(=O)C1 10.1016/j.ejmech.2017.12.099
CHEMBL4286717 166897 0 None -309 6 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assay
ChEMBL 427 7 0 5 4.4 CCC1(C)CC(=O)N(CCCCN2CCN(c3cccc4sccc34)CC2)C(=O)C1 10.1016/j.ejmech.2017.12.099
123311113 140496 0 None 91 3 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 523 14 3 6 3.6 CCc1ccc(OCC(F)(F)F)c(OCCNC(C)Cc2cc3c(c(C(N)=O)c2)N(CCCO)CC3)c1 10.1021/acs.jmedchem.5b02023
CHEMBL3810187 140496 0 None 91 3 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 523 14 3 6 3.6 CCc1ccc(OCC(F)(F)F)c(OCCNC(C)Cc2cc3c(c(C(N)=O)c2)N(CCCO)CC3)c1 10.1021/acs.jmedchem.5b02023
10582125 81805 0 None -47 3 Rat 5.4 pIC50 = 5.4 Functional
Antagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from ratAntagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from rat
ChEMBL 1161 33 6 20 7.3 COc1cc2nc(N3CCN(C(=O)c4cccc(CNCCCCCCNCCSSCCNCCCCCCNCc5cccc(C(=O)N6CCN(c7nc(N)c8cc(OC)c(OC)cc8n7)CC6)c5)c4)CC3)nc(N)c2cc1OC 10.1021/jm000995w
CHEMBL216443 81805 0 None -47 3 Rat 5.4 pIC50 = 5.4 Functional
Antagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from ratAntagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from rat
ChEMBL 1161 33 6 20 7.3 COc1cc2nc(N3CCN(C(=O)c4cccc(CNCCCCCCNCCSSCCNCCCCCCNCc5cccc(C(=O)N6CCN(c7nc(N)c8cc(OC)c(OC)cc8n7)CC6)c5)c4)CC3)nc(N)c2cc1OC 10.1021/jm000995w
123688273 140456 0 None 36 3 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 513 13 3 6 3.2 CC(Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccc(F)cc1OCC(F)(F)F 10.1021/acs.jmedchem.5b02023
CHEMBL3809630 140456 0 None 36 3 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 513 13 3 6 3.2 CC(Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccc(F)cc1OCC(F)(F)F 10.1021/acs.jmedchem.5b02023
127044911 140423 0 None -10 3 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 425 12 3 6 2.7 COc1ccccc1OCCNC(C)Cc1cc(C(N)=O)c2c(ccn2CCCO)c1 10.1021/acs.jmedchem.5b02023
CHEMBL3809319 140423 0 None -10 3 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 425 12 3 6 2.7 COc1ccccc1OCCNC(C)Cc1cc(C(N)=O)c2c(ccn2CCCO)c1 10.1021/acs.jmedchem.5b02023
123183757 140452 0 None 10 3 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 445 12 3 6 2.3 COc1cc(F)ccc1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2 10.1021/acs.jmedchem.5b02023
CHEMBL3809600 140452 0 None 10 3 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 445 12 3 6 2.3 COc1cc(F)ccc1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2 10.1021/acs.jmedchem.5b02023
127044894 140342 0 None 3 3 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 427 12 3 6 2.1 COc1ccccc1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2 10.1021/acs.jmedchem.5b02023
CHEMBL3808408 140342 0 None 3 3 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 427 12 3 6 2.1 COc1ccccc1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2 10.1021/acs.jmedchem.5b02023
134147190 149774 0 None 3 3 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 334 0 2 4 3.3 Oc1ccc2[nH]c3c(c2c1)CC1c2cc4c(cc2CCN1C3)OCO4 10.1021/acs.jmedchem.6b01217
CHEMBL3948551 149774 0 None 3 3 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 334 0 2 4 3.3 Oc1ccc2[nH]c3c(c2c1)CC1c2cc4c(cc2CCN1C3)OCO4 10.1021/acs.jmedchem.6b01217
10034370 156968 0 None -10 3 Rat 7.3 pIC50 = 7.3 Functional
Antagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from ratAntagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from rat
ChEMBL 1277 47 6 20 10.9 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3cccc(CNCCCCCCNCCSSCCNCCCCCCNCc4cccc(C(=O)N(C)CCCCCCN(C)c5nc(N)c6cc(OC)c(OC)cc6n5)c4)c3)nc(N)c2cc1OC 10.1021/jm000995w
CHEMBL1203232 156968 0 None -10 3 Rat 7.3 pIC50 = 7.3 Functional
Antagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from ratAntagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from rat
ChEMBL 1277 47 6 20 10.9 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3cccc(CNCCCCCCNCCSSCCNCCCCCCNCc4cccc(C(=O)N(C)CCCCCCN(C)c5nc(N)c6cc(OC)c(OC)cc6n5)c4)c3)nc(N)c2cc1OC 10.1021/jm000995w
CHEMBL407315 156968 0 None -10 3 Rat 7.3 pIC50 = 7.3 Functional
Antagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from ratAntagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from rat
ChEMBL 1277 47 6 20 10.9 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3cccc(CNCCCCCCNCCSSCCNCCCCCCNCc4cccc(C(=O)N(C)CCCCCCN(C)c5nc(N)c6cc(OC)c(OC)cc6n5)c4)c3)nc(N)c2cc1OC 10.1021/jm000995w
127043026 140422 0 None 8 2 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 507 13 3 6 4.0 Cc1ccc(OCC(F)(F)F)c(OCCN[C@@H](C)Cc2cc(C(N)=O)c3c(ccn3CCCO)c2)c1 10.1021/acs.jmedchem.5b02023
CHEMBL3809314 140422 0 None 8 2 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 507 13 3 6 4.0 Cc1ccc(OCC(F)(F)F)c(OCCN[C@@H](C)Cc2cc(C(N)=O)c3c(ccn3CCCO)c2)c1 10.1021/acs.jmedchem.5b02023
16638286 149576 1 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 323 0 0 5 2.8 c1c2c(cc3c1OCO3)CN1CCc3cc4c(cc3C1C2)OCO4 10.1021/acs.jmedchem.6b01217
CHEMBL3946997 149576 1 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 323 0 0 5 2.8 c1c2c(cc3c1OCO3)CN1CCc3cc4c(cc3C1C2)OCO4 10.1021/acs.jmedchem.6b01217
10034371 165956 0 None -1479 3 Rat 5.3 pIC50 = 5.3 Functional
Antagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from ratAntagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from rat
ChEMBL 1277 47 6 20 10.9 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccc(CNCCCCCCNCCSSCCNCCCCCCNCc4ccc(C(=O)N(C)CCCCCCN(C)c5nc(N)c6cc(OC)c(OC)cc6n5)cc4)cc3)nc(N)c2cc1OC 10.1021/jm000995w
CHEMBL1203235 165956 0 None -1479 3 Rat 5.3 pIC50 = 5.3 Functional
Antagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from ratAntagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from rat
ChEMBL 1277 47 6 20 10.9 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccc(CNCCCCCCNCCSSCCNCCCCCCNCc4ccc(C(=O)N(C)CCCCCCN(C)c5nc(N)c6cc(OC)c(OC)cc6n5)cc4)cc3)nc(N)c2cc1OC 10.1021/jm000995w
CHEMBL425267 165956 0 None -1479 3 Rat 5.3 pIC50 = 5.3 Functional
Antagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from ratAntagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from rat
ChEMBL 1277 47 6 20 10.9 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccc(CNCCCCCCNCCSSCCNCCCCCCNCc4ccc(C(=O)N(C)CCCCCCN(C)c5nc(N)c6cc(OC)c(OC)cc6n5)cc4)cc3)nc(N)c2cc1OC 10.1021/jm000995w
10630100 96572 0 None -186 3 Rat 5.3 pIC50 = 5.3 Functional
Antagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from ratAntagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from rat
ChEMBL 1161 33 6 20 7.3 COc1cc2nc(N3CCN(C(=O)c4ccccc4CNCCCCCCNCCSSCCNCCCCCCNCc4ccccc4C(=O)N4CCN(c5nc(N)c6cc(OC)c(OC)cc6n5)CC4)CC3)nc(N)c2cc1OC 10.1021/jm000995w
CHEMBL263289 96572 0 None -186 3 Rat 5.3 pIC50 = 5.3 Functional
Antagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from ratAntagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from rat
ChEMBL 1161 33 6 20 7.3 COc1cc2nc(N3CCN(C(=O)c4ccccc4CNCCCCCCNCCSSCCNCCCCCCNCc4ccccc4C(=O)N4CCN(c5nc(N)c6cc(OC)c(OC)cc6n5)CC4)CC3)nc(N)c2cc1OC 10.1021/jm000995w
145947950 167709 0 None 1 3 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assayAntagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assay
ChEMBL 440 7 0 3 5.8 Cc1cccc(N2CCN(CCc3ccc(COc4ccc5c(c4)CCCC5)cc3)CC2)c1 10.1016/j.bmcl.2018.03.070
CHEMBL4224703 167709 0 None 1 3 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assayAntagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assay
ChEMBL 440 7 0 3 5.8 Cc1cccc(N2CCN(CCc3ccc(COc4ccc5c(c4)CCCC5)cc3)CC2)c1 10.1016/j.bmcl.2018.03.070
CHEMBL4302771 167709 0 None 1 3 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assayAntagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assay
ChEMBL 440 7 0 3 5.8 Cc1cccc(N2CCN(CCc3ccc(COc4ccc5c(c4)CCCC5)cc3)CC2)c1 10.1016/j.bmcl.2018.03.070
21171 186952 33 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 339 2 0 5 3.1 COc1ccc2c(c1OC)CN1CCc3cc4c(cc3[C@@H]1C2)OCO4 10.1021/acs.jmedchem.6b01217
CHEMBL490533 186952 33 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 339 2 0 5 3.1 COc1ccc2c(c1OC)CN1CCc3cc4c(cc3[C@@H]1C2)OCO4 10.1021/acs.jmedchem.6b01217
21823379 144701 2 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 304 1 1 2 3.8 COc1ccc2c(c1)CCN1Cc3[nH]c4ccccc4c3CC21 10.1021/acs.jmedchem.6b01217
CHEMBL3908813 144701 2 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 304 1 1 2 3.8 COc1ccc2c(c1)CCN1Cc3[nH]c4ccccc4c3CC21 10.1021/acs.jmedchem.6b01217
4418 34192 85 None -4 18 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assayAntagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assay
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1016/j.bmcl.2018.03.070
CHEMBL142635 34192 85 None -4 18 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assayAntagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assay
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1016/j.bmcl.2018.03.070
145947047 167611 0 None -1 3 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assayAntagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assay
ChEMBL 425 7 0 2 6.6 c1ccc(C2CCN(CCc3ccc(COc4ccc5c(c4)CCCC5)cc3)CC2)cc1 10.1016/j.bmcl.2018.03.070
CHEMBL4227513 167611 0 None -1 3 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assayAntagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assay
ChEMBL 425 7 0 2 6.6 c1ccc(C2CCN(CCc3ccc(COc4ccc5c(c4)CCCC5)cc3)CC2)cc1 10.1016/j.bmcl.2018.03.070
CHEMBL4301557 167611 0 None -1 3 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assayAntagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assay
ChEMBL 425 7 0 2 6.6 c1ccc(C2CCN(CCc3ccc(COc4ccc5c(c4)CCCC5)cc3)CC2)cc1 10.1016/j.bmcl.2018.03.070
123576734 140399 0 None 15 3 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 455 13 3 6 2.7 CCc1ccc(OCCNC(C)Cc2cc3c(c(C(N)=O)c2)N(CCCO)CC3)c(OC)c1 10.1021/acs.jmedchem.5b02023
CHEMBL3809032 140399 0 None 15 3 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 455 13 3 6 2.7 CCc1ccc(OCCNC(C)Cc2cc3c(c(C(N)=O)c2)N(CCCO)CC3)c(OC)c1 10.1021/acs.jmedchem.5b02023
76071738 148305 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 318 0 1 3 3.6 c1ccc2c3c([nH]c2c1)CN1CCc2cc4c(cc2[C@@H]1C3)OCO4 10.1021/acs.jmedchem.6b01217
CHEMBL3937032 148305 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 318 0 1 3 3.6 c1ccc2c3c([nH]c2c1)CN1CCc2cc4c(cc2[C@@H]1C3)OCO4 10.1021/acs.jmedchem.6b01217
145946630 167549 0 None 12 3 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assayAntagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assay
ChEMBL 456 8 0 4 5.5 COc1ccc(N2CCN(CCc3ccc(COc4ccc5c(c4)CCCC5)cc3)CC2)cc1 10.1016/j.bmcl.2018.03.070
CHEMBL4224794 167549 0 None 12 3 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assayAntagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assay
ChEMBL 456 8 0 4 5.5 COc1ccc(N2CCN(CCc3ccc(COc4ccc5c(c4)CCCC5)cc3)CC2)cc1 10.1016/j.bmcl.2018.03.070
CHEMBL4300618 167549 0 None 12 3 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assayAntagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assay
ChEMBL 456 8 0 4 5.5 COc1ccc(N2CCN(CCc3ccc(COc4ccc5c(c4)CCCC5)cc3)CC2)cc1 10.1016/j.bmcl.2018.03.070
123752717 140445 0 None 26 3 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 439 11 3 5 3.1 Cc1cc(C)c(OCCNC(C)Cc2cc3c(c(C(N)=O)c2)N(CCCO)CC3)c(C)c1 10.1021/acs.jmedchem.5b02023
CHEMBL3809500 140445 0 None 26 3 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 439 11 3 5 3.1 Cc1cc(C)c(OCCNC(C)Cc2cc3c(c(C(N)=O)c2)N(CCCO)CC3)c(C)c1 10.1021/acs.jmedchem.5b02023
134145079 150198 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 348 1 1 4 3.6 COc1ccc2c3c([nH]c2c1)CN1CCc2cc4c(cc2C1C3)OCO4 10.1021/acs.jmedchem.6b01217
CHEMBL3952204 150198 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 348 1 1 4 3.6 COc1ccc2c3c([nH]c2c1)CN1CCc2cc4c(cc2C1C3)OCO4 10.1021/acs.jmedchem.6b01217
127044906 140393 0 None 7 3 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 529 13 3 6 3.7 C[C@@H](Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1cc(Cl)ccc1OCC(F)(F)F 10.1021/acs.jmedchem.5b02023
CHEMBL3808981 140393 0 None 7 3 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 529 13 3 6 3.7 C[C@@H](Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1cc(Cl)ccc1OCC(F)(F)F 10.1021/acs.jmedchem.5b02023
123183788 140501 0 None 7 3 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 441 12 3 6 2.4 COc1cc(C)ccc1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2 10.1021/acs.jmedchem.5b02023
CHEMBL3810220 140501 0 None 7 3 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 441 12 3 6 2.4 COc1cc(C)ccc1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2 10.1021/acs.jmedchem.5b02023
123378354 140362 0 None 6 3 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 493 11 3 5 3.0 CC(Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccc(F)cc1Br 10.1021/acs.jmedchem.5b02023
CHEMBL3808595 140362 0 None 6 3 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 493 11 3 5 3.0 CC(Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccc(F)cc1Br 10.1021/acs.jmedchem.5b02023
145963961 164379 0 None -32 6 Human 7.2 pIC50 = 7.2 Functional
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 425 8 1 7 3.0 CNC(=O)c1cc(OCCCCN2CCN(c3nsc4ccccc34)CC2)ccn1 10.1016/j.bmcl.2018.01.038
CHEMBL4213342 164379 0 None -32 6 Human 7.2 pIC50 = 7.2 Functional
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 425 8 1 7 3.0 CNC(=O)c1cc(OCCCCN2CCN(c3nsc4ccccc34)CC2)ccn1 10.1016/j.bmcl.2018.01.038
134157568 154435 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 352 4 0 4 3.1 COc1cc2cc[n+]3c(c2cc1OC)Cc1ccc(OC)c(OC)c1C3 10.1021/acs.jmedchem.6b01217
CHEMBL3984336 154435 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 352 4 0 4 3.1 COc1cc2cc[n+]3c(c2cc1OC)Cc1ccc(OC)c(OC)c1C3 10.1021/acs.jmedchem.6b01217
CHEMBL3990197 154435 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 352 4 0 4 3.1 COc1cc2cc[n+]3c(c2cc1OC)Cc1ccc(OC)c(OC)c1C3 10.1021/acs.jmedchem.6b01217
127044916 140457 0 None 1 3 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 443 12 3 6 2.9 COc1cc(F)ccc1OCCNC(C)Cc1cc(C(N)=O)c2c(ccn2CCCO)c1 10.1021/acs.jmedchem.5b02023
CHEMBL3809676 140457 0 None 1 3 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 443 12 3 6 2.9 COc1cc(F)ccc1OCCNC(C)Cc1cc(C(N)=O)c2c(ccn2CCCO)c1 10.1021/acs.jmedchem.5b02023
123437117 140344 0 None 23 3 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 461 12 3 6 2.8 COc1cc(Cl)ccc1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2 10.1021/acs.jmedchem.5b02023
CHEMBL3808417 140344 0 None 23 3 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 461 12 3 6 2.8 COc1cc(Cl)ccc1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2 10.1021/acs.jmedchem.5b02023
127045050 140368 0 None -5 3 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 503 14 3 6 3.7 CC(Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccccc1OCc1ccccc1 10.1021/acs.jmedchem.5b02023
CHEMBL3808632 140368 0 None -5 3 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 503 14 3 6 3.7 CC(Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccccc1OCc1ccccc1 10.1021/acs.jmedchem.5b02023
118167692 164185 10 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at alpha1A adrenergic receptor (unknown origin)Antagonist activity at alpha1A adrenergic receptor (unknown origin)
ChEMBL 521 7 1 7 3.0 Cn1cnc(-c2cnc(O[C@H]3CCN(C(=O)Cc4ccc(OC(F)(F)F)cc4)C[C@H]3F)c(C(N)=O)c2)c1 10.1021/acs.jmedchem.8b00633
CHEMBL4210892 164185 10 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at alpha1A adrenergic receptor (unknown origin)Antagonist activity at alpha1A adrenergic receptor (unknown origin)
ChEMBL 521 7 1 7 3.0 Cn1cnc(-c2cnc(O[C@H]3CCN(C(=O)Cc4ccc(OC(F)(F)F)cc4)C[C@H]3F)c(C(N)=O)c2)c1 10.1021/acs.jmedchem.8b00633
134134752 144184 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 318 1 1 2 4.4 COc1ccc2c(c1)CCN1C(C)c3[nH]c4ccccc4c3CC21 10.1021/acs.jmedchem.6b01217
CHEMBL3904395 144184 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 318 1 1 2 4.4 COc1ccc2c(c1)CCN1C(C)c3[nH]c4ccccc4c3CC21 10.1021/acs.jmedchem.6b01217
10813278 106913 0 None - 0 Rabbit 10.7 pKd = 10.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 446 8 1 6 3.5 Cc1ccc(N2CCN(CCCNc3ncccc3C(=O)N(C)C)CC2)c(-n2cccc2)c1 10.1021/jm970166j
CHEMBL314880 106913 0 None - 0 Rabbit 10.7 pKd = 10.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 446 8 1 6 3.5 Cc1ccc(N2CCN(CCCNc3ncccc3C(=O)N(C)C)CC2)c(-n2cccc2)c1 10.1021/jm970166j
10697270 106151 0 None - 0 Rabbit 10.0 pKd = 10 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 519 9 2 8 3.2 CNC(=O)c1cnc2c(c(C)nn2C)c1NCCCN1CCN(c2ccccc2OCC(F)(F)F)CC1 10.1021/jm970166j
CHEMBL313775 106151 0 None - 0 Rabbit 10.0 pKd = 10 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 519 9 2 8 3.2 CNC(=O)c1cnc2c(c(C)nn2C)c1NCCCN1CCN(c2ccccc2OCC(F)(F)F)CC1 10.1021/jm970166j
10552132 112761 0 None - 0 Rabbit 10.0 pKd = 10 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 465 9 1 6 3.3 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2OCC(F)(F)F)CC1 10.1021/jm970166j
CHEMBL330579 112761 0 None - 0 Rabbit 10.0 pKd = 10 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 465 9 1 6 3.3 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2OCC(F)(F)F)CC1 10.1021/jm970166j
13305910 11804 1 None - 0 Rat 10.0 pKd = 10.0 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL1182155 11804 1 None - 0 Rat 10.0 pKd = 10.0 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL215421 11804 1 None - 0 Rat 10.0 pKd = 10.0 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL3741808 11804 1 None - 0 Rat 10.0 pKd = 10.0 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
13305910 11804 1 None - 0 Rat 10.0 pKd = 10.0 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL1182155 11804 1 None - 0 Rat 10.0 pKd = 10.0 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL215421 11804 1 None - 0 Rat 10.0 pKd = 10.0 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL3741808 11804 1 None - 0 Rat 10.0 pKd = 10.0 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1016/j.ejmech.2012.09.049
10506159 111373 0 None - 0 Rabbit 9.9 pKd = 9.9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 520 8 1 9 3.4 Cc1nn(C)c2ncc(C(=O)N(C)C)c(NCCCN3CCN(c4ccc(F)cc4-c4ncco4)CC3)c12 10.1021/jm970166j
CHEMBL327231 111373 0 None - 0 Rabbit 9.9 pKd = 9.9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 520 8 1 9 3.4 Cc1nn(C)c2ncc(C(=O)N(C)C)c(NCCCN3CCN(c4ccc(F)cc4-c4ncco4)CC3)c12 10.1021/jm970166j
10693231 202739 0 None - 0 Human 9.8 pKd = 9.8 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 416 4 1 6 2.2 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cc(C#N)ccc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL62033 202739 0 None - 0 Human 9.8 pKd = 9.8 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 416 4 1 6 2.2 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cc(C#N)ccc4c3=O)C[C@@H]21 10.1021/jm000541z
129211 3722 78 None - 14 Rabbit 9.8 pKd = 9.8 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970166j
2562 3722 78 None - 14 Rabbit 9.8 pKd = 9.8 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970166j
488 3722 78 None - 14 Rabbit 9.8 pKd = 9.8 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970166j
CHEMBL836 3722 78 None - 14 Rabbit 9.8 pKd = 9.8 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970166j
DB00706 3722 78 None - 14 Rabbit 9.8 pKd = 9.8 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970166j
10526964 206942 0 None - 0 Rabbit 9.8 pKd = 9.8 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 437 10 1 6 3.2 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2OCC2CC2)CC1 10.1021/jm970166j
CHEMBL91278 206942 0 None - 0 Rabbit 9.8 pKd = 9.8 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 437 10 1 6 3.2 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2OCC2CC2)CC1 10.1021/jm970166j
10764021 206968 0 None - 0 Rabbit 9.7 pKd = 9.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 409 9 1 5 3.4 CCCc1ccccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL91400 206968 0 None - 0 Rabbit 9.7 pKd = 9.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 409 9 1 5 3.4 CCCc1ccccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
24897950 56322 0 None - 0 Rat 9.6 pKd = 9.6 Functional
Antagonist activity at alpha1A adrenoceptor in Wistar rat vas deferens assessed as noradrenaline induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Wistar rat vas deferens assessed as noradrenaline induced contractions after 30 mins
ChEMBL 462 11 2 6 2.9 COc1ccc(C[C@@H](C)NCCOc2ccccc2OCC(F)(F)F)cc1S(N)(=O)=O 10.1016/j.ejmech.2010.09.042
CHEMBL1630940 56322 0 None - 0 Rat 9.6 pKd = 9.6 Functional
Antagonist activity at alpha1A adrenoceptor in Wistar rat vas deferens assessed as noradrenaline induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Wistar rat vas deferens assessed as noradrenaline induced contractions after 30 mins
ChEMBL 462 11 2 6 2.9 COc1ccc(C[C@@H](C)NCCOc2ccccc2OCC(F)(F)F)cc1S(N)(=O)=O 10.1016/j.ejmech.2010.09.042
71462043 84539 0 None - 0 Rat 9.6 pKd = 9.6 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 379 8 1 6 3.2 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(Cl)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153555 84539 0 None - 0 Rat 9.6 pKd = 9.6 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 379 8 1 6 3.2 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(Cl)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2220895 84539 0 None - 0 Rat 9.6 pKd = 9.6 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 379 8 1 6 3.2 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(Cl)c2O1 10.1016/j.ejmech.2012.09.049
129211 3722 78 None -1 14 Human 9.5 pKd = 9.5 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostateIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostate
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
2562 3722 78 None -1 14 Human 9.5 pKd = 9.5 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostateIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostate
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
488 3722 78 None -1 14 Human 9.5 pKd = 9.5 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostateIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostate
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
CHEMBL836 3722 78 None -1 14 Human 9.5 pKd = 9.5 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostateIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostate
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
DB00706 3722 78 None -1 14 Human 9.5 pKd = 9.5 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostateIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostate
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
129211 3722 78 None -1 14 Human 9.5 pKd = 9.5 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm000541z
2562 3722 78 None -1 14 Human 9.5 pKd = 9.5 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm000541z
488 3722 78 None -1 14 Human 9.5 pKd = 9.5 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm000541z
CHEMBL836 3722 78 None -1 14 Human 9.5 pKd = 9.5 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm000541z
DB00706 3722 78 None -1 14 Human 9.5 pKd = 9.5 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm000541z
499 4046 18 None - 1 Rat 9.5 pKd = 9.5 Functional
Antagonistic activity at ADRA1A in isolated rat prostatic vas deferensAntagonistic activity at ADRA1A in isolated rat prostatic vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1016/j.bmcl.2005.09.027
5685 4046 18 None - 1 Rat 9.5 pKd = 9.5 Functional
Antagonistic activity at ADRA1A in isolated rat prostatic vas deferensAntagonistic activity at ADRA1A in isolated rat prostatic vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1016/j.bmcl.2005.09.027
CHEMBL25554 4046 18 None - 1 Rat 9.5 pKd = 9.5 Functional
Antagonistic activity at ADRA1A in isolated rat prostatic vas deferensAntagonistic activity at ADRA1A in isolated rat prostatic vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1016/j.bmcl.2005.09.027
499 4046 18 None - 1 Rat 9.5 pKd = 9.5 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm011066n
5685 4046 18 None - 1 Rat 9.5 pKd = 9.5 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm011066n
CHEMBL25554 4046 18 None - 1 Rat 9.5 pKd = 9.5 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm011066n
10526831 111362 0 None - 0 Rabbit 9.5 pKd = 9.5 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 434 8 1 7 3.1 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2-c2ncco2)CC1 10.1021/jm970166j
CHEMBL327168 111362 0 None - 0 Rabbit 9.5 pKd = 9.5 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 434 8 1 7 3.1 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2-c2ncco2)CC1 10.1021/jm970166j
13305910 11804 1 None - 0 Rat 9.5 pKd = 9.5 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostateActivity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostate
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL1182155 11804 1 None - 0 Rat 9.5 pKd = 9.5 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostateActivity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostate
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL215421 11804 1 None - 0 Rat 9.5 pKd = 9.5 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostateActivity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostate
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL3741808 11804 1 None - 0 Rat 9.5 pKd = 9.5 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostateActivity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostate
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
13305910 11804 1 None - 0 Rat 9.5 pKd = 9.5 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL1182155 11804 1 None - 0 Rat 9.5 pKd = 9.5 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL215421 11804 1 None - 0 Rat 9.5 pKd = 9.5 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL3741808 11804 1 None - 0 Rat 9.5 pKd = 9.5 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1016/j.ejmech.2012.09.049
129211 3722 78 None - 14 Rat 9.5 pKd = 9.5 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferensIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferens
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
2562 3722 78 None - 14 Rat 9.5 pKd = 9.5 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferensIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferens
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
488 3722 78 None - 14 Rat 9.5 pKd = 9.5 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferensIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferens
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
CHEMBL836 3722 78 None - 14 Rat 9.5 pKd = 9.5 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferensIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferens
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
DB00706 3722 78 None - 14 Rat 9.5 pKd = 9.5 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferensIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferens
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
129211 3722 78 None - 14 Rat 9.5 pKd = 9.5 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm000541z
2562 3722 78 None - 14 Rat 9.5 pKd = 9.5 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm000541z
488 3722 78 None - 14 Rat 9.5 pKd = 9.5 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm000541z
CHEMBL836 3722 78 None - 14 Rat 9.5 pKd = 9.5 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm000541z
DB00706 3722 78 None - 14 Rat 9.5 pKd = 9.5 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm000541z
44289437 169839 0 None - 0 Rat 9.5 pKd = 9.5 Functional
Antagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptor
ChEMBL 431 9 1 5 4.7 COc1cccc(OC)c1OCCNCC1CC(c2ccccc2)c2ccccc2C1=O 10.1021/jm011066n
CHEMBL44403 169839 0 None - 0 Rat 9.5 pKd = 9.5 Functional
Antagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptor
ChEMBL 431 9 1 5 4.7 COc1cccc(OC)c1OCCNCC1CC(c2ccccc2)c2ccccc2C1=O 10.1021/jm011066n
10789770 100858 0 None - 0 Human 9.5 pKd = 9.5 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 451 6 1 7 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(OC)c(OC)ccc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL293695 100858 0 None - 0 Human 9.5 pKd = 9.5 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 451 6 1 7 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(OC)c(OC)ccc4c3=O)C[C@@H]21 10.1021/jm000541z
10645210 206456 0 None - 0 Rabbit 9.4 pKd = 9.4 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 409 8 1 5 3.5 CC(C)c1ccccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL88211 206456 0 None - 0 Rabbit 9.4 pKd = 9.4 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 409 8 1 5 3.5 CC(C)c1ccccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
499 4046 18 None - 1 Rat 9.4 pKd = 9.4 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm060358r
5685 4046 18 None - 1 Rat 9.4 pKd = 9.4 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm060358r
CHEMBL25554 4046 18 None - 1 Rat 9.4 pKd = 9.4 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm060358r
499 4046 18 None - 1 Rat 9.4 pKd = 9.4 Functional
Antagonistic activity against (-)-noradrenaline-induced contraction of rat prostatic vas deferens (Alpha-1A adrenergic receptor )Antagonistic activity against (-)-noradrenaline-induced contraction of rat prostatic vas deferens (Alpha-1A adrenergic receptor )
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm021078o
5685 4046 18 None - 1 Rat 9.4 pKd = 9.4 Functional
Antagonistic activity against (-)-noradrenaline-induced contraction of rat prostatic vas deferens (Alpha-1A adrenergic receptor )Antagonistic activity against (-)-noradrenaline-induced contraction of rat prostatic vas deferens (Alpha-1A adrenergic receptor )
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm021078o
CHEMBL25554 4046 18 None - 1 Rat 9.4 pKd = 9.4 Functional
Antagonistic activity against (-)-noradrenaline-induced contraction of rat prostatic vas deferens (Alpha-1A adrenergic receptor )Antagonistic activity against (-)-noradrenaline-induced contraction of rat prostatic vas deferens (Alpha-1A adrenergic receptor )
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm021078o
44289437 169839 0 None - 0 Rat 9.4 pKd = 9.4 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 431 9 1 5 4.7 COc1cccc(OC)c1OCCNCC1CC(c2ccccc2)c2ccccc2C1=O 10.1021/jm011066n
CHEMBL44403 169839 0 None - 0 Rat 9.4 pKd = 9.4 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 431 9 1 5 4.7 COc1cccc(OC)c1OCCNCC1CC(c2ccccc2)c2ccccc2C1=O 10.1021/jm011066n
10787790 105963 0 None - 0 Rabbit 9.3 pKd = 9.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 411 9 1 6 2.8 CCOc1ccccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL313157 105963 0 None - 0 Rabbit 9.3 pKd = 9.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 411 9 1 6 2.8 CCOc1ccccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
10744240 107007 0 None - 0 Rabbit 9.3 pKd = 9.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 508 9 2 7 2.8 COc1cc(F)ccc1N1CCN(CCCNc2c(C(=O)N(C)C)cnc3c(C(N)=O)cccc23)CC1 10.1021/jm970166j
CHEMBL315496 107007 0 None - 0 Rabbit 9.3 pKd = 9.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 508 9 2 7 2.8 COc1cc(F)ccc1N1CCN(CCCNc2c(C(=O)N(C)C)cnc3c(C(N)=O)cccc23)CC1 10.1021/jm970166j
10763212 168172 0 None - 0 Rabbit 9.3 pKd = 9.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 394 9 1 6 3.3 COc1ccccc1N1CCN(CCCNc2ncccc2C(=O)C2CC2)CC1 10.1021/jm970166j
CHEMBL433348 168172 0 None - 0 Rabbit 9.3 pKd = 9.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 394 9 1 6 3.3 COc1ccccc1N1CCN(CCCNc2ncccc2C(=O)C2CC2)CC1 10.1021/jm970166j
9893282 206446 0 None - 0 Rabbit 9.3 pKd = 9.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 533 9 1 8 3.5 Cc1nn(C)c2ncc(C(=O)N(C)C)c(NCCCN3CCN(c4ccccc4OCC(F)(F)F)CC3)c12 10.1021/jm970166j
CHEMBL88160 206446 0 None - 0 Rabbit 9.3 pKd = 9.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 533 9 1 8 3.5 Cc1nn(C)c2ncc(C(=O)N(C)C)c(NCCCN3CCN(c4ccccc4OCC(F)(F)F)CC3)c12 10.1021/jm970166j
44323795 206585 0 None - 0 Rabbit 9.3 pKd = 9.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 410 8 1 5 3.3 COc1ccccc1N1CCN(CCCNc2cc(C)ccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL89030 206585 0 None - 0 Rabbit 9.3 pKd = 9.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 410 8 1 5 3.3 COc1ccccc1N1CCN(CCCNc2cc(C)ccc2C(=O)N(C)C)CC1 10.1021/jm970166j
499 4046 18 None - 1 Rat 9.3 pKd = 9.3 Functional
Antagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptor
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm011066n
5685 4046 18 None - 1 Rat 9.3 pKd = 9.3 Functional
Antagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptor
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm011066n
CHEMBL25554 4046 18 None - 1 Rat 9.3 pKd = 9.3 Functional
Antagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptor
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm011066n
9824384 118761 1 None - 0 Rat 9.2 pKd = 9.2 Functional
Antagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochlorideAntagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochloride
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
CHEMBL342062 118761 1 None - 0 Rat 9.2 pKd = 9.2 Functional
Antagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochlorideAntagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochloride
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
10478121 170778 0 None - 0 Human 9.2 pKd = 9.2 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 435 6 0 7 3.1 COc1cc2ncn(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2cc1OC 10.1021/jm000541z
CHEMBL445325 170778 0 None - 0 Human 9.2 pKd = 9.2 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 435 6 0 7 3.1 COc1cc2ncn(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2cc1OC 10.1021/jm000541z
10743446 107044 0 None - 0 Rabbit 9.2 pKd = 9.2 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 483 8 1 8 2.8 COc1cc(F)ccc1N1CCN(CCCNc2c(C(=O)N(C)C)cnc3c2nc(C)n3C)CC1 10.1021/jm970166j
CHEMBL315785 107044 0 None - 0 Rabbit 9.2 pKd = 9.2 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 483 8 1 8 2.8 COc1cc(F)ccc1N1CCN(CCCNc2c(C(=O)N(C)C)cnc3c2nc(C)n3C)CC1 10.1021/jm970166j
10549680 112357 0 None - 0 Rabbit 9.2 pKd = 9.2 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 413 8 1 6 3.1 CSc1ccccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL329601 112357 0 None - 0 Rabbit 9.2 pKd = 9.2 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 413 8 1 6 3.1 CSc1ccccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
10647512 207002 0 None - 0 Rabbit 9.2 pKd = 9.2 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 456 8 2 6 1.6 COc1cc(F)ccc1N1CCN(CCCNc2c(C(=O)N(C)C)c[nH]c3ccn[n+]2-3)CC1 10.1021/jm970166j
CHEMBL91547 207002 0 None - 0 Rabbit 9.2 pKd = 9.2 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 456 8 2 6 1.6 COc1cc(F)ccc1N1CCN(CCCNc2c(C(=O)N(C)C)c[nH]c3ccn[n+]2-3)CC1 10.1021/jm970166j
10621397 207069 0 None - 0 Rabbit 9.2 pKd = 9.2 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 407 8 1 5 3.3 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2C2CC2)CC1 10.1021/jm970166j
CHEMBL91951 207069 0 None - 0 Rabbit 9.2 pKd = 9.2 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 407 8 1 5 3.3 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2C2CC2)CC1 10.1021/jm970166j
499 4046 18 None - 1 Rat 9.2 pKd = 9.2 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostateActivity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostate
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm060358r
5685 4046 18 None - 1 Rat 9.2 pKd = 9.2 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostateActivity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostate
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm060358r
CHEMBL25554 4046 18 None - 1 Rat 9.2 pKd = 9.2 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostateActivity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostate
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm060358r
10574245 111495 0 None - 0 Rabbit 9.1 pKd = 9.1 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 422 8 1 7 2.3 COc1ccccc1N1CCN(CCCNc2ncc(C#N)cc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL327872 111495 0 None - 0 Rabbit 9.1 pKd = 9.1 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 422 8 1 7 2.3 COc1ccccc1N1CCN(CCCNc2ncc(C#N)cc2C(=O)N(C)C)CC1 10.1021/jm970166j
10577066 112385 0 None - 0 Rabbit 9.1 pKd = 9.1 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 490 8 2 6 2.3 COc1cc(F)ccc1N1CCN(CCCNc2c(C(=O)N(C)C)c[nH]c3c(Cl)cn[n+]2-3)CC1 10.1021/jm970166j
CHEMBL329773 112385 0 None - 0 Rabbit 9.1 pKd = 9.1 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 490 8 2 6 2.3 COc1cc(F)ccc1N1CCN(CCCNc2c(C(=O)N(C)C)c[nH]c3c(Cl)cn[n+]2-3)CC1 10.1021/jm970166j
10530686 206880 0 None - 0 Rabbit 9.1 pKd = 9.1 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 549 9 1 6 5.2 CN(C)C(=O)c1cnc2c(Cl)cccc2c1NCCCN1CCN(c2ccccc2OCC(F)(F)F)CC1 10.1021/jm970166j
CHEMBL90878 206880 0 None - 0 Rabbit 9.1 pKd = 9.1 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 549 9 1 6 5.2 CN(C)C(=O)c1cnc2c(Cl)cccc2c1NCCCN1CCN(c2ccccc2OCC(F)(F)F)CC1 10.1021/jm970166j
11795906 207043 0 None - 0 Rabbit 9.1 pKd = 9.1 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 411 8 1 6 2.7 COc1cc(C)ccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL91785 207043 0 None - 0 Rabbit 9.1 pKd = 9.1 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 411 8 1 6 2.7 COc1cc(C)ccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
14423371 97426 1 None - 0 Rat 9.0 pKd = 9.0 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 441 11 1 8 3.6 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccco3)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL27013 97426 1 None - 0 Rat 9.0 pKd = 9.0 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 441 11 1 8 3.6 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccco3)nc(N)c2cc1OC 10.1021/jm9810654
71462043 84539 0 None - 0 Rat 9.0 pKd = 9.0 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 379 8 1 6 3.2 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(Cl)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153555 84539 0 None - 0 Rat 9.0 pKd = 9.0 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 379 8 1 6 3.2 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(Cl)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2220895 84539 0 None - 0 Rat 9.0 pKd = 9.0 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 379 8 1 6 3.2 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(Cl)c2O1 10.1016/j.ejmech.2012.09.049
14423371 97426 1 None - 0 Rat 9.0 pKd = 9.0 Functional
Antagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from ratAntagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from rat
ChEMBL 441 11 1 8 3.6 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccco3)nc(N)c2cc1OC 10.1016/s0960-894x(98)00217-0
CHEMBL27013 97426 1 None - 0 Rat 9.0 pKd = 9.0 Functional
Antagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from ratAntagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from rat
ChEMBL 441 11 1 8 3.6 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccco3)nc(N)c2cc1OC 10.1016/s0960-894x(98)00217-0
10456471 100505 0 None - 0 Human 9.0 pKd = 9.0 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 451 6 1 7 2.4 COc1cc2[nH]c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2cc1OC 10.1021/jm000541z
CHEMBL291303 100505 0 None - 0 Human 9.0 pKd = 9.0 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 451 6 1 7 2.4 COc1cc2[nH]c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2cc1OC 10.1021/jm000541z
10572854 112539 0 None - 0 Rabbit 9.0 pKd = 9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 396 8 1 5 3.0 COc1ccccc1N1CCN(CCCNc2ccccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL330060 112539 0 None - 0 Rabbit 9.0 pKd = 9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 396 8 1 5 3.0 COc1ccccc1N1CCN(CCCNc2ccccc2C(=O)N(C)C)CC1 10.1021/jm970166j
10786203 207246 0 None - 0 Rabbit 9.0 pKd = 9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 383 8 2 6 2.1 CNC(=O)c1cccnc1NCCCN1CCN(c2ccccc2OC)CC1 10.1021/jm970166j
CHEMBL93054 207246 0 None - 0 Rabbit 9.0 pKd = 9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 383 8 2 6 2.1 CNC(=O)c1cccnc1NCCCN1CCN(c2ccccc2OC)CC1 10.1021/jm970166j
11430491 62971 0 None - 0 Rat 9.0 pKd = 9 Functional
Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)
ChEMBL 435 5 1 9 2.4 COc1cc2nc(N3CCN(C(=O)CC4CCSS4)CC3)nc(N)c2cc1OC 10.1021/jm049153d
CHEMBL178673 62971 0 None - 0 Rat 9.0 pKd = 9 Functional
Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)
ChEMBL 435 5 1 9 2.4 COc1cc2nc(N3CCN(C(=O)CC4CCSS4)CC3)nc(N)c2cc1OC 10.1021/jm049153d
10527469 156241 3 None - 0 Human 9.0 pKd = 9 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostateIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostate
ChEMBL 448 4 1 7 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccnc54)c3=O)C[C@@H]21 10.1021/jm970364a
CHEMBL40650 156241 3 None - 0 Human 9.0 pKd = 9 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostateIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostate
ChEMBL 448 4 1 7 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccnc54)c3=O)C[C@@H]21 10.1021/jm970364a
4209 3141 75 None -1 17 Rat 9.0 pKd = 9.0 Functional
Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm049153d
4893 3141 75 None -1 17 Rat 9.0 pKd = 9.0 Functional
Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm049153d
503 3141 75 None -1 17 Rat 9.0 pKd = 9.0 Functional
Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm049153d
5385 3141 75 None -1 17 Rat 9.0 pKd = 9.0 Functional
Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm049153d
CHEMBL2 3141 75 None -1 17 Rat 9.0 pKd = 9.0 Functional
Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm049153d
DB00457 3141 75 None -1 17 Rat 9.0 pKd = 9.0 Functional
Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm049153d
10478121 170778 0 None - 0 Rat 9.0 pKd = 9.0 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 435 6 0 7 3.1 COc1cc2ncn(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2cc1OC 10.1021/jm000541z
CHEMBL445325 170778 0 None - 0 Rat 9.0 pKd = 9.0 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 435 6 0 7 3.1 COc1cc2ncn(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2cc1OC 10.1021/jm000541z
16121006 11809 0 None - 0 Rat 9.0 pKd = 9.0 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL1182182 11809 0 None - 0 Rat 9.0 pKd = 9.0 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL217469 11809 0 None - 0 Rat 9.0 pKd = 9.0 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
11742834 165746 0 None - 0 Rat 9.0 pKd = 9.0 Functional
Antagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptor
ChEMBL 419 9 1 5 4.7 COc1cccc(OC)c1OCCNC[C@@H]1C[C@H](c2ccccc2)c2ccccc2O1 10.1021/jm011066n
CHEMBL42472 165746 0 None - 0 Rat 9.0 pKd = 9.0 Functional
Antagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptor
ChEMBL 419 9 1 5 4.7 COc1cccc(OC)c1OCCNC[C@@H]1C[C@H](c2ccccc2)c2ccccc2O1 10.1021/jm011066n
10527469 156241 3 None - 0 Rat 8.9 pKd = 8.9 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferensIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferens
ChEMBL 448 4 1 7 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccnc54)c3=O)C[C@@H]21 10.1021/jm970364a
CHEMBL40650 156241 3 None - 0 Rat 8.9 pKd = 8.9 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferensIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferens
ChEMBL 448 4 1 7 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccnc54)c3=O)C[C@@H]21 10.1021/jm970364a
10834793 84550 0 None - 0 Rat 8.9 pKd = 8.9 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 363 8 1 6 2.7 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(F)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153557 84550 0 None - 0 Rat 8.9 pKd = 8.9 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 363 8 1 6 2.7 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(F)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2220925 84550 0 None - 0 Rat 8.9 pKd = 8.9 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 363 8 1 6 2.7 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(F)c2O1 10.1016/j.ejmech.2012.09.049
132266 1267 12 None - 0 Rat 8.9 pKd = 8.9 Functional
Antagonist activity at rat alpha1A adrenoceptor assessed as inhibition if norepinephrine-induced contraction of vas deferenceAntagonist activity at rat alpha1A adrenoceptor assessed as inhibition if norepinephrine-induced contraction of vas deference
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1021/jm8016046
486 1267 12 None - 0 Rat 8.9 pKd = 8.9 Functional
Antagonist activity at rat alpha1A adrenoceptor assessed as inhibition if norepinephrine-induced contraction of vas deferenceAntagonist activity at rat alpha1A adrenoceptor assessed as inhibition if norepinephrine-induced contraction of vas deference
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1021/jm8016046
CHEMBL423294 1267 12 None - 0 Rat 8.9 pKd = 8.9 Functional
Antagonist activity at rat alpha1A adrenoceptor assessed as inhibition if norepinephrine-induced contraction of vas deferenceAntagonist activity at rat alpha1A adrenoceptor assessed as inhibition if norepinephrine-induced contraction of vas deference
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1021/jm8016046
10505222 206642 0 None - 0 Rabbit 8.9 pKd = 8.9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 490 8 1 7 3.6 COc1cc(F)ccc1N1CCN(CCCNc2c(C(=O)N(C)C)cnc3c(C#N)cccc23)CC1 10.1021/jm970166j
CHEMBL89397 206642 0 None - 0 Rabbit 8.9 pKd = 8.9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 490 8 1 7 3.6 COc1cc(F)ccc1N1CCN(CCCNc2c(C(=O)N(C)C)cnc3c(C#N)cccc23)CC1 10.1021/jm970166j
10575254 206860 0 None - 0 Rabbit 8.9 pKd = 8.9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 443 8 1 5 4.1 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2-c2ccccc2)CC1 10.1021/jm970166j
CHEMBL90746 206860 0 None - 0 Rabbit 8.9 pKd = 8.9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 443 8 1 5 4.1 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2-c2ccccc2)CC1 10.1021/jm970166j
10814587 206869 0 None - 0 Rabbit 8.9 pKd = 8.9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 480 8 1 7 3.4 COc1cc(F)ccc1N1CCN(CCCNc2c(C(=O)N(C)C)cnc3nc(C)ccc23)CC1 10.1021/jm970166j
CHEMBL90810 206869 0 None - 0 Rabbit 8.9 pKd = 8.9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 480 8 1 7 3.4 COc1cc(F)ccc1N1CCN(CCCNc2c(C(=O)N(C)C)cnc3nc(C)ccc23)CC1 10.1021/jm970166j
10646065 206879 0 None - 0 Rabbit 8.9 pKd = 8.9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 425 8 2 6 3.2 COc1ccccc1N1CCN(CCCNc2ncccc2C(=O)NC(C)(C)C)CC1 10.1021/jm970166j
CHEMBL90874 206879 0 None - 0 Rabbit 8.9 pKd = 8.9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 425 8 2 6 3.2 COc1ccccc1N1CCN(CCCNc2ncccc2C(=O)NC(C)(C)C)CC1 10.1021/jm970166j
10624682 207015 0 None - 0 Rabbit 8.9 pKd = 8.9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 483 8 1 8 2.8 COc1cc(F)ccc1N1CCN(CCCNc2c(C(=O)N(C)C)cnc3c2c(C)nn3C)CC1 10.1021/jm970166j
CHEMBL91605 207015 0 None - 0 Rabbit 8.9 pKd = 8.9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 483 8 1 8 2.8 COc1cc(F)ccc1N1CCN(CCCNc2c(C(=O)N(C)C)cnc3c2c(C)nn3C)CC1 10.1021/jm970166j
10789770 100858 0 None - 0 Rat 8.9 pKd = 8.9 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 451 6 1 7 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(OC)c(OC)ccc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL293695 100858 0 None - 0 Rat 8.9 pKd = 8.9 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 451 6 1 7 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(OC)c(OC)ccc4c3=O)C[C@@H]21 10.1021/jm000541z
11742834 165746 0 None - 0 Rat 8.9 pKd = 8.9 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 419 9 1 5 4.7 COc1cccc(OC)c1OCCNC[C@@H]1C[C@H](c2ccccc2)c2ccccc2O1 10.1021/jm011066n
CHEMBL42472 165746 0 None - 0 Rat 8.9 pKd = 8.9 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 419 9 1 5 4.7 COc1cccc(OC)c1OCCNC[C@@H]1C[C@H](c2ccccc2)c2ccccc2O1 10.1021/jm011066n
10693231 202739 0 None - 0 Rat 8.8 pKd = 8.8 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 416 4 1 6 2.2 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cc(C#N)ccc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL62033 202739 0 None - 0 Rat 8.8 pKd = 8.8 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 416 4 1 6 2.2 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cc(C#N)ccc4c3=O)C[C@@H]21 10.1021/jm000541z
9865577 112282 2 None - 0 Rabbit 8.8 pKd = 8.8 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 397 8 1 6 2.4 COc1ccccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL329160 112282 2 None - 0 Rabbit 8.8 pKd = 8.8 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 397 8 1 6 2.4 COc1ccccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
10621790 163792 0 None - 0 Rabbit 8.8 pKd = 8.8 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 415 8 1 6 2.6 COc1cc(F)ccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL420620 163792 0 None - 0 Rabbit 8.8 pKd = 8.8 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 415 8 1 6 2.6 COc1cc(F)ccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
10839699 206728 0 None - 0 Rabbit 8.8 pKd = 8.8 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 520 9 1 8 3.8 Cc1noc2ncc(C(=O)N(C)C)c(NCCCN3CCN(c4ccccc4OCC(F)(F)F)CC3)c12 10.1021/jm970166j
CHEMBL90022 206728 0 None - 0 Rabbit 8.8 pKd = 8.8 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 520 9 1 8 3.8 Cc1noc2ncc(C(=O)N(C)C)c(NCCCN3CCN(c4ccccc4OCC(F)(F)F)CC3)c12 10.1021/jm970166j
10552164 206877 0 None - 0 Rabbit 8.8 pKd = 8.8 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 466 9 1 6 3.4 CN(C)C(=O)c1cccnc1N1CCC(NCCOc2ccccc2OCC(F)(F)F)CC1 10.1021/jm970166j
CHEMBL90869 206877 0 None - 0 Rabbit 8.8 pKd = 8.8 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 466 9 1 6 3.4 CN(C)C(=O)c1cccnc1N1CCC(NCCOc2ccccc2OCC(F)(F)F)CC1 10.1021/jm970166j
10549596 84576 1 None - 0 Rat 8.8 pKd = 8.8 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(OC)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153553 84576 1 None - 0 Rat 8.8 pKd = 8.8 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(OC)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2221147 84576 1 None - 0 Rat 8.8 pKd = 8.8 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(OC)c2O1 10.1016/j.ejmech.2012.09.049
10501886 111374 0 None - 0 Rabbit 8.7 pKd = 8.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 413 8 2 7 2.1 COc1ccccc1N1CCN(CCCNc2ncc(O)cc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL327232 111374 0 None - 0 Rabbit 8.7 pKd = 8.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 413 8 2 7 2.1 COc1ccccc1N1CCN(CCCNc2ncc(O)cc2C(=O)N(C)C)CC1 10.1021/jm970166j
10693071 206451 0 None - 0 Rabbit 8.7 pKd = 8.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 413 8 0 5 3.7 COc1ccccc1N1CCN(CCCSc2ccccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL88181 206451 0 None - 0 Rabbit 8.7 pKd = 8.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 413 8 0 5 3.7 COc1ccccc1N1CCN(CCCSc2ccccc2C(=O)N(C)C)CC1 10.1021/jm970166j
10833725 206488 0 None - 0 Rabbit 8.7 pKd = 8.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 381 7 1 5 2.7 Cc1ccccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL88435 206488 0 None - 0 Rabbit 8.7 pKd = 8.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 381 7 1 5 2.7 Cc1ccccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
10500734 206556 0 None - 0 Rabbit 8.7 pKd = 8.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 392 7 1 6 2.3 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2C#N)CC1 10.1021/jm970166j
CHEMBL88856 206556 0 None - 0 Rabbit 8.7 pKd = 8.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 392 7 1 6 2.3 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2C#N)CC1 10.1021/jm970166j
44324012 207226 0 None - 0 Rabbit 8.0 pKd = 8 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 397 8 2 6 2.4 COc1ccccc1N1CCN(CCCNc2nc(C)cc(C)c2C(N)=O)CC1 10.1021/jm970166j
CHEMBL92901 207226 0 None - 0 Rabbit 8.0 pKd = 8 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 397 8 2 6 2.4 COc1ccccc1N1CCN(CCCNc2nc(C)cc(C)c2C(N)=O)CC1 10.1021/jm970166j
11994673 12284 0 None - 0 Rat 8.0 pKd = 8.0 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 419 7 1 5 4.5 COc1ccc2ccccc2c1OCCNC[C@H]1COc2cc3c(cc2O1)CCCC3 10.1021/jm060358r
CHEMBL1185036 12284 0 None - 0 Rat 8.0 pKd = 8.0 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 419 7 1 5 4.5 COc1ccc2ccccc2c1OCCNC[C@H]1COc2cc3c(cc2O1)CCCC3 10.1021/jm060358r
CHEMBL385371 12284 0 None - 0 Rat 8.0 pKd = 8.0 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 419 7 1 5 4.5 COc1ccc2ccccc2c1OCCNC[C@H]1COc2cc3c(cc2O1)CCCC3 10.1021/jm060358r
10745791 36479 0 None - 0 Rat 8.0 pKd = 8.0 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 579 19 3 9 4.6 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccccc3CNCCCCCCN)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL144776 36479 0 None - 0 Rat 8.0 pKd = 8.0 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 579 19 3 9 4.6 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccccc3CNCCCCCCN)nc(N)c2cc1OC 10.1021/jm9810654
10394346 16931 0 None - 0 Rat 8.0 pKd = 8.0 Functional
Functional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferensFunctional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferens
ChEMBL 638 11 2 10 3.0 Cc1c(-c2ccccc2)oc2c(C(=O)NCCCN3CCN(c4ccccc4OCc4no[n+]([O-])c4C(N)=O)CC3)cccc2c1=O 10.1021/jm030825u
CHEMBL125365 16931 0 None - 0 Rat 8.0 pKd = 8.0 Functional
Functional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferensFunctional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferens
ChEMBL 638 11 2 10 3.0 Cc1c(-c2ccccc2)oc2c(C(=O)NCCCN3CCN(c4ccccc4OCc4no[n+]([O-])c4C(N)=O)CC3)cccc2c1=O 10.1021/jm030825u
52945071 17611 0 None - 0 Rat 6.0 pKd = 6.0 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 470 7 2 5 2.7 O=C1NC(=O)C(c2ccccc2)(c2ccccc2)N1CC(O)CN1CCN(c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
CHEMBL1258344 17611 0 None - 0 Rat 6.0 pKd = 6.0 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 470 7 2 5 2.7 O=C1NC(=O)C(c2ccccc2)(c2ccccc2)N1CC(O)CN1CCN(c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
11133868 155318 0 None - 0 Rat 7.0 pKd = 7.0 Functional
Antagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptor
ChEMBL 435 9 1 5 5.4 COc1cccc(OC)c1OCCNC[C@H]1C[C@H](c2ccccc2)c2ccccc2S1 10.1021/jm011066n
CHEMBL40325 155318 0 None - 0 Rat 7.0 pKd = 7.0 Functional
Antagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptor
ChEMBL 435 9 1 5 5.4 COc1cccc(OC)c1OCCNC[C@H]1C[C@H](c2ccccc2)c2ccccc2S1 10.1021/jm011066n
2419 692 28 None - 3 Rat 6.9 pKd = 6.9 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm9810654
9 692 28 None - 3 Rat 6.9 pKd = 6.9 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm9810654
CHEMBL13647 692 28 None - 3 Rat 6.9 pKd = 6.9 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm9810654
2419 692 28 None - 3 Rat 6.9 pKd = 6.9 Functional
Antagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from ratAntagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from rat
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/s0960-894x(98)00217-0
9 692 28 None - 3 Rat 6.9 pKd = 6.9 Functional
Antagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from ratAntagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from rat
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/s0960-894x(98)00217-0
CHEMBL13647 692 28 None - 3 Rat 6.9 pKd = 6.9 Functional
Antagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from ratAntagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from rat
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/s0960-894x(98)00217-0
3584 3748 64 None -25 11 Rat 7.9 pKd = 7.9 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile response
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmcl.2018.01.068
5401 3748 64 None -25 11 Rat 7.9 pKd = 7.9 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile response
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmcl.2018.01.068
7302 3748 64 None -25 11 Rat 7.9 pKd = 7.9 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile response
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmcl.2018.01.068
CHEMBL611 3748 64 None -25 11 Rat 7.9 pKd = 7.9 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile response
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmcl.2018.01.068
DB01162 3748 64 None -25 11 Rat 7.9 pKd = 7.9 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile response
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmcl.2018.01.068
10574889 106519 0 None - 0 Rabbit 7.9 pKd = 7.9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 435 7 1 5 3.4 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2C(F)(F)F)CC1 10.1021/jm970166j
CHEMBL314114 106519 0 None - 0 Rabbit 7.9 pKd = 7.9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 435 7 1 5 3.4 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2C(F)(F)F)CC1 10.1021/jm970166j
10787895 111393 0 None - 0 Rabbit 7.9 pKd = 7.9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 413 8 2 7 2.1 COc1cc(O)ccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL327351 111393 0 None - 0 Rabbit 7.9 pKd = 7.9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 413 8 2 7 2.1 COc1cc(O)ccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
10524875 207349 0 None - 0 Rabbit 7.9 pKd = 7.9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 397 8 1 6 2.4 COc1ccccc1N1CCN(CCCNc2ccncc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL93736 207349 0 None - 0 Rabbit 7.9 pKd = 7.9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 397 8 1 6 2.4 COc1ccccc1N1CCN(CCCNc2ccncc2C(=O)N(C)C)CC1 10.1021/jm970166j
52942664 17612 0 None - 0 Rat 6.9 pKd = 6.9 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 500 8 2 6 2.7 COc1ccccc1N1CCN(CC(O)CN2C(=O)NC(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
CHEMBL1258345 17612 0 None - 0 Rat 6.9 pKd = 6.9 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 500 8 2 6 2.7 COc1ccccc1N1CCN(CC(O)CN2C(=O)NC(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
52942591 17580 0 None - 0 Rat 5.9 pKd = 5.9 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 542 9 1 7 2.6 COC(=O)CN1C(=O)N(CC(O)CN2CCN(c3ccccc3)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
CHEMBL1258228 17580 0 None - 0 Rat 5.9 pKd = 5.9 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 542 9 1 7 2.6 COC(=O)CN1C(=O)N(CC(O)CN2CCN(c3ccccc3)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
44428846 92160 0 None - 0 Rat 6.9 pKd = 6.9 Functional
Antagonist activity against adrenergic alpha-1A receptor in rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractionAntagonist activity against adrenergic alpha-1A receptor in rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contraction
ChEMBL 467 5 1 9 3.1 COc1ccc(C(=O)N2CCN(c3nc(N)c4cc(OC)c(OC)cc4n3)[C@@H]3CCCC[C@@H]32)o1 10.1016/j.bmc.2007.01.028
CHEMBL242508 92160 0 None - 0 Rat 6.9 pKd = 6.9 Functional
Antagonist activity against adrenergic alpha-1A receptor in rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractionAntagonist activity against adrenergic alpha-1A receptor in rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contraction
ChEMBL 467 5 1 9 3.1 COc1ccc(C(=O)N2CCN(c3nc(N)c4cc(OC)c(OC)cc4n3)[C@@H]3CCCC[C@@H]32)o1 10.1016/j.bmc.2007.01.028
145971621 164581 0 None - 0 Rat 6.8 pKd = 6.8 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile response
ChEMBL 414 9 1 7 2.0 COC(=O)Cc1ccc(OCC(O)CN2CCN(c3ccccc3OC)CC2)cc1 10.1016/j.bmcl.2018.01.068
CHEMBL4215889 164581 0 None - 0 Rat 6.8 pKd = 6.8 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile response
ChEMBL 414 9 1 7 2.0 COC(=O)Cc1ccc(OCC(O)CN2CCN(c3ccccc3OC)CC2)cc1 10.1016/j.bmcl.2018.01.068
10506915 40209 0 None - 0 Rat 7.8 pKd = 7.8 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 552 13 1 9 4.5 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3cccc(CN4CCSC4)c3)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL148061 40209 0 None - 0 Rat 7.8 pKd = 7.8 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 552 13 1 9 4.5 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3cccc(CN4CCSC4)c3)nc(N)c2cc1OC 10.1021/jm9810654
69782867 161559 0 None - 0 Rat 6.8 pKd = 6.8 Functional
Antagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochlorideAntagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochloride
ChEMBL 549 8 1 9 4.4 COc1cc2nc(N3CCN(C(=O)COc4c(OC)cccc4C(C)C)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
CHEMBL4129291 161559 0 None - 0 Rat 6.8 pKd = 6.8 Functional
Antagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochlorideAntagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochloride
ChEMBL 549 8 1 9 4.4 COc1cc2nc(N3CCN(C(=O)COc4c(OC)cccc4C(C)C)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
25022505 188267 0 None - 0 Rat 6.8 pKd = 6.8 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 586 10 1 8 2.9 COC(=O)C(C)N1C(=O)N(CC(O)CN2CCN(c3ccccc3OC)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
CHEMBL500266 188267 0 None - 0 Rat 6.8 pKd = 6.8 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 586 10 1 8 2.9 COC(=O)C(C)N1C(=O)N(CC(O)CN2CCN(c3ccccc3OC)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
44586483 172443 0 None - 0 Rat 6.8 pKd = 6.8 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 600 11 1 8 3.3 CCOc1ccccc1N1CCN(CC(O)CN2C(=O)N(C(C)C(=O)OC)C(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
CHEMBL448198 172443 0 None - 0 Rat 6.8 pKd = 6.8 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 600 11 1 8 3.3 CCOc1ccccc1N1CCN(CC(O)CN2C(=O)N(C(C)C(=O)OC)C(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
44586429 184273 0 None - 0 Rat 6.8 pKd = 6.8 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 514 8 1 6 3.0 COc1ccccc1N1CCN(CC(O)CN2C(=O)N(C)C(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
CHEMBL484102 184273 0 None - 0 Rat 6.8 pKd = 6.8 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 514 8 1 6 3.0 COc1ccccc1N1CCN(CC(O)CN2C(=O)N(C)C(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
6603808 127496 3 None - 2 Rat 7.8 pKd = 7.8 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL214986 127496 3 None - 2 Rat 7.8 pKd = 7.8 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL36622 127496 3 None - 2 Rat 7.8 pKd = 7.8 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL3740374 127496 3 None - 2 Rat 7.8 pKd = 7.8 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
9891213 161478 0 None - 0 Rat 7.8 pKd = 7.8 Functional
Antagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochlorideAntagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochloride
ChEMBL 477 5 1 8 4.0 COc1cc2nc(N3CCN(C(=O)OCc4ccccc4)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
CHEMBL4128084 161478 0 None - 0 Rat 7.8 pKd = 7.8 Functional
Antagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochlorideAntagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochloride
ChEMBL 477 5 1 8 4.0 COc1cc2nc(N3CCN(C(=O)OCc4ccccc4)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
50905589 56324 0 None - 0 Rat 7.8 pKd = 7.8 Functional
Antagonist activity at alpha1A adrenoceptor in Wistar rat vas deferens assessed as noradrenaline induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Wistar rat vas deferens assessed as noradrenaline induced contractions after 30 mins
ChEMBL 406 7 2 6 2.1 COc1ccc(C[C@@H](C)NC[C@@H]2Oc3ccccc3O[C@@H]2C)cc1S(N)(=O)=O 10.1016/j.ejmech.2010.09.042
CHEMBL1630942 56324 0 None - 0 Rat 7.8 pKd = 7.8 Functional
Antagonist activity at alpha1A adrenoceptor in Wistar rat vas deferens assessed as noradrenaline induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Wistar rat vas deferens assessed as noradrenaline induced contractions after 30 mins
ChEMBL 406 7 2 6 2.1 COc1ccc(C[C@@H](C)NC[C@@H]2Oc3ccccc3O[C@@H]2C)cc1S(N)(=O)=O 10.1016/j.ejmech.2010.09.042
10530133 36986 1 None - 0 Rat 7.8 pKd = 7.8 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 525 12 1 10 4.2 COc1cc2nc(N(C)CCSSCCN(C)C(=O)c3ccc(CCl)o3)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL145181 36986 1 None - 0 Rat 7.8 pKd = 7.8 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 525 12 1 10 4.2 COc1cc2nc(N(C)CCSSCCN(C)C(=O)c3ccc(CCl)o3)nc(N)c2cc1OC 10.1021/jm9810654
132266 1267 12 None - 0 Rat 7.8 pKd = 7.8 Functional
Antagonist activity against adrenergic alpha-1A receptor in rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractionAntagonist activity against adrenergic alpha-1A receptor in rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contraction
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1016/j.bmc.2007.01.028
486 1267 12 None - 0 Rat 7.8 pKd = 7.8 Functional
Antagonist activity against adrenergic alpha-1A receptor in rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractionAntagonist activity against adrenergic alpha-1A receptor in rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contraction
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1016/j.bmc.2007.01.028
CHEMBL423294 1267 12 None - 0 Rat 7.8 pKd = 7.8 Functional
Antagonist activity against adrenergic alpha-1A receptor in rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractionAntagonist activity against adrenergic alpha-1A receptor in rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contraction
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1016/j.bmc.2007.01.028
132266 1267 12 None - 0 Rat 7.8 pKd = 7.8 Functional
Antagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochlorideAntagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochloride
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1016/j.bmc.2018.05.023
486 1267 12 None - 0 Rat 7.8 pKd = 7.8 Functional
Antagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochlorideAntagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochloride
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1016/j.bmc.2018.05.023
CHEMBL423294 1267 12 None - 0 Rat 7.8 pKd = 7.8 Functional
Antagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochlorideAntagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochloride
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1016/j.bmc.2018.05.023
71454865 84574 0 None - 0 Rat 6.8 pKd = 6.8 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 361 8 2 7 2.2 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(O)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153551 84574 0 None - 0 Rat 6.8 pKd = 6.8 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 361 8 2 7 2.2 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(O)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2221145 84574 0 None - 0 Rat 6.8 pKd = 6.8 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 361 8 2 7 2.2 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(O)c2O1 10.1016/j.ejmech.2012.09.049
44289261 164888 0 None - 0 Rat 6.8 pKd = 6.8 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 417 9 1 4 5.1 COc1cccc(OC)c1OCCNCC1Cc2ccccc2C(c2ccccc2)C1 10.1021/jm011066n
CHEMBL42231 164888 0 None - 0 Rat 6.8 pKd = 6.8 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 417 9 1 4 5.1 COc1cccc(OC)c1OCCNCC1Cc2ccccc2C(c2ccccc2)C1 10.1021/jm011066n
44277158 101618 0 None - 0 Rat 5.8 pKd = 5.8 Functional
Antagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from ratAntagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from rat
ChEMBL 449 11 3 10 3.0 COc1cc2nc(NCCSSCCNC(=O)c3ccco3)nc(N)c2cc1OC 10.1016/s0960-894x(98)00217-0
CHEMBL29907 101618 0 None - 0 Rat 5.8 pKd = 5.8 Functional
Antagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from ratAntagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from rat
ChEMBL 449 11 3 10 3.0 COc1cc2nc(NCCSSCCNC(=O)c3ccco3)nc(N)c2cc1OC 10.1016/s0960-894x(98)00217-0
11430126 60533 0 None - 0 Rat 7.7 pKd = 7.7 Functional
Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)
ChEMBL 421 4 1 9 2.0 COc1cc2nc(N3CCN(C(=O)C4CCSS4)CC3)nc(N)c2cc1OC 10.1021/jm049153d
CHEMBL175934 60533 0 None - 0 Rat 7.7 pKd = 7.7 Functional
Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)
ChEMBL 421 4 1 9 2.0 COc1cc2nc(N3CCN(C(=O)C4CCSS4)CC3)nc(N)c2cc1OC 10.1021/jm049153d
6603808 127496 3 None - 2 Rat 7.7 pKd = 7.7 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostateActivity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostate
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL214986 127496 3 None - 2 Rat 7.7 pKd = 7.7 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostateActivity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostate
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL36622 127496 3 None - 2 Rat 7.7 pKd = 7.7 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostateActivity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostate
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL3740374 127496 3 None - 2 Rat 7.7 pKd = 7.7 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostateActivity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostate
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
3584 3748 64 None - 11 Rabbit 7.7 pKd = 7.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970166j
5401 3748 64 None - 11 Rabbit 7.7 pKd = 7.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970166j
7302 3748 64 None - 11 Rabbit 7.7 pKd = 7.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970166j
CHEMBL611 3748 64 None - 11 Rabbit 7.7 pKd = 7.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970166j
DB01162 3748 64 None - 11 Rabbit 7.7 pKd = 7.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970166j
44323554 206436 0 None - 0 Rabbit 7.7 pKd = 7.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 446 8 1 7 2.9 CN(C)C(=O)c1cccnc1N1CCC(NCCOc2ccccc2-c2cncnc2)CC1 10.1021/jm970166j
CHEMBL88109 206436 0 None - 0 Rabbit 7.7 pKd = 7.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 446 8 1 7 2.9 CN(C)C(=O)c1cccnc1N1CCC(NCCOc2ccccc2-c2cncnc2)CC1 10.1021/jm970166j
10651334 29720 0 None - 0 Rat 6.7 pKd = 6.7 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 607 20 2 9 5.2 CNCCCCCCN(C)Cc1ccc(C(=O)N(C)CCCCCCN(C)c2nc(N)c3cc(OC)c(OC)cc3n2)cc1 10.1021/jm9810654
CHEMBL138681 29720 0 None - 0 Rat 6.7 pKd = 6.7 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 607 20 2 9 5.2 CNCCCCCCN(C)Cc1ccc(C(=O)N(C)CCCCCCN(C)c2nc(N)c3cc(OC)c(OC)cc3n2)cc1 10.1021/jm9810654
10673882 38695 0 None - 0 Rat 6.7 pKd = 6.7 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 534 13 1 11 3.5 COc1cc2nc(N(C)CCSSCCN(C)C(=O)c3ccc(CN(C)C)o3)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL146601 38695 0 None - 0 Rat 6.7 pKd = 6.7 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 534 13 1 11 3.5 COc1cc2nc(N(C)CCSSCCN(C)C(=O)c3ccc(CN(C)C)o3)nc(N)c2cc1OC 10.1021/jm9810654
45268939 196637 0 None - 0 Rat 6.7 pKd = 6.7 Functional
Antagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochlorideAntagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochloride
ChEMBL 505 4 1 9 3.0 COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
CHEMBL564481 196637 0 None - 0 Rat 6.7 pKd = 6.7 Functional
Antagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochlorideAntagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochloride
ChEMBL 505 4 1 9 3.0 COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
10786159 206617 1 None - 0 Rabbit 6.7 pKd = 6.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 382 7 1 6 2.1 Cc1cnccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL89222 206617 1 None - 0 Rabbit 6.7 pKd = 6.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 382 7 1 6 2.1 Cc1cnccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
3157 1458 71 None -2 22 Rat 8.7 pKd = 8.7 Functional
Antagonist activity at rat alpha1A adrenoceptor assessed as inhibition if norepinephrine-induced contraction of vas deferenceAntagonist activity at rat alpha1A adrenoceptor assessed as inhibition if norepinephrine-induced contraction of vas deference
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm8016046
7170 1458 71 None -2 22 Rat 8.7 pKd = 8.7 Functional
Antagonist activity at rat alpha1A adrenoceptor assessed as inhibition if norepinephrine-induced contraction of vas deferenceAntagonist activity at rat alpha1A adrenoceptor assessed as inhibition if norepinephrine-induced contraction of vas deference
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm8016046
954 1458 71 None -2 22 Rat 8.7 pKd = 8.7 Functional
Antagonist activity at rat alpha1A adrenoceptor assessed as inhibition if norepinephrine-induced contraction of vas deferenceAntagonist activity at rat alpha1A adrenoceptor assessed as inhibition if norepinephrine-induced contraction of vas deference
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm8016046
CHEMBL707 1458 71 None -2 22 Rat 8.7 pKd = 8.7 Functional
Antagonist activity at rat alpha1A adrenoceptor assessed as inhibition if norepinephrine-induced contraction of vas deferenceAntagonist activity at rat alpha1A adrenoceptor assessed as inhibition if norepinephrine-induced contraction of vas deference
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm8016046
DB00590 1458 71 None -2 22 Rat 8.7 pKd = 8.7 Functional
Antagonist activity at rat alpha1A adrenoceptor assessed as inhibition if norepinephrine-induced contraction of vas deferenceAntagonist activity at rat alpha1A adrenoceptor assessed as inhibition if norepinephrine-induced contraction of vas deference
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm8016046
3157 1458 71 None -2 22 Rat 8.7 pKd = 8.7 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm000541z
7170 1458 71 None -2 22 Rat 8.7 pKd = 8.7 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm000541z
954 1458 71 None -2 22 Rat 8.7 pKd = 8.7 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm000541z
CHEMBL707 1458 71 None -2 22 Rat 8.7 pKd = 8.7 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm000541z
DB00590 1458 71 None -2 22 Rat 8.7 pKd = 8.7 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm000541z
11039289 116814 0 None - 0 Rat 8.6 pKd = 8.6 Functional
Functional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferensFunctional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferens
ChEMBL 600 13 1 9 4.7 Cc1c(-c2ccccc2)oc2c(C(=O)NCCCN3CCN(c4ccccc4OCCCO[N+](=O)[O-])CC3)cccc2c1=O 10.1021/jm030825u
CHEMBL338029 116814 0 None - 0 Rat 8.6 pKd = 8.6 Functional
Functional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferensFunctional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferens
ChEMBL 600 13 1 9 4.7 Cc1c(-c2ccccc2)oc2c(C(=O)NCCCN3CCN(c4ccccc4OCCCO[N+](=O)[O-])CC3)cccc2c1=O 10.1021/jm030825u
4209 3141 75 None -1 17 Rat 8.6 pKd = 8.6 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm9810654
4893 3141 75 None -1 17 Rat 8.6 pKd = 8.6 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm9810654
503 3141 75 None -1 17 Rat 8.6 pKd = 8.6 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm9810654
5385 3141 75 None -1 17 Rat 8.6 pKd = 8.6 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm9810654
CHEMBL2 3141 75 None -1 17 Rat 8.6 pKd = 8.6 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm9810654
DB00457 3141 75 None -1 17 Rat 8.6 pKd = 8.6 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm9810654
10555166 206695 0 None - 0 Rabbit 8.6 pKd = 8.6 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 575 9 1 8 4.5 CN(C)C(=O)c1cnc2c(c(C(C)(C)C)nn2C)c1NCCCN1CCN(c2ccccc2OCC(F)(F)F)CC1 10.1021/jm970166j
CHEMBL89822 206695 0 None - 0 Rabbit 8.6 pKd = 8.6 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 575 9 1 8 4.5 CN(C)C(=O)c1cnc2c(c(C(C)(C)C)nn2C)c1NCCCN1CCN(c2ccccc2OCC(F)(F)F)CC1 10.1021/jm970166j
4209 3141 75 None -1 17 Rat 8.6 pKd = 8.6 Functional
Antagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from ratAntagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from rat
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/s0960-894x(98)00217-0
4893 3141 75 None -1 17 Rat 8.6 pKd = 8.6 Functional
Antagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from ratAntagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from rat
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/s0960-894x(98)00217-0
503 3141 75 None -1 17 Rat 8.6 pKd = 8.6 Functional
Antagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from ratAntagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from rat
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/s0960-894x(98)00217-0
5385 3141 75 None -1 17 Rat 8.6 pKd = 8.6 Functional
Antagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from ratAntagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from rat
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/s0960-894x(98)00217-0
CHEMBL2 3141 75 None -1 17 Rat 8.6 pKd = 8.6 Functional
Antagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from ratAntagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from rat
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/s0960-894x(98)00217-0
DB00457 3141 75 None -1 17 Rat 8.6 pKd = 8.6 Functional
Antagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from ratAntagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from rat
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/s0960-894x(98)00217-0
10549596 84576 1 None - 0 Rat 8.6 pKd = 8.6 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(OC)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153553 84576 1 None - 0 Rat 8.6 pKd = 8.6 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(OC)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2221147 84576 1 None - 0 Rat 8.6 pKd = 8.6 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(OC)c2O1 10.1016/j.ejmech.2012.09.049
10456471 100505 0 None - 0 Rat 8.5 pKd = 8.5 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 451 6 1 7 2.4 COc1cc2[nH]c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2cc1OC 10.1021/jm000541z
CHEMBL291303 100505 0 None - 0 Rat 8.5 pKd = 8.5 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 451 6 1 7 2.4 COc1cc2[nH]c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2cc1OC 10.1021/jm000541z
11133868 155318 0 None - 0 Rat 6.7 pKd = 6.7 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 435 9 1 5 5.4 COc1cccc(OC)c1OCCNC[C@H]1C[C@H](c2ccccc2)c2ccccc2S1 10.1021/jm011066n
CHEMBL40325 155318 0 None - 0 Rat 6.7 pKd = 6.7 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 435 9 1 5 5.4 COc1cccc(OC)c1OCCNC[C@H]1C[C@H](c2ccccc2)c2ccccc2S1 10.1021/jm011066n
115 342 71 None 14 5 Human 6.7 pKd = 6.7 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm000541z
2092 342 71 None 14 5 Human 6.7 pKd = 6.7 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm000541z
7109 342 71 None 14 5 Human 6.7 pKd = 6.7 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm000541z
CHEMBL709 342 71 None 14 5 Human 6.7 pKd = 6.7 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm000541z
DB00346 342 71 None 14 5 Human 6.7 pKd = 6.7 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm000541z
11751173 63396 0 None - 0 Rat 7.6 pKd = 7.6 Functional
Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)
ChEMBL 445 4 1 9 2.3 COc1cc2nc(N3CCN(C4=CC(=O)c5ccccc5C4=O)CC3)nc(N)c2cc1OC 10.1021/jm049153d
CHEMBL179743 63396 0 None - 0 Rat 7.6 pKd = 7.6 Functional
Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)
ChEMBL 445 4 1 9 2.3 COc1cc2nc(N3CCN(C4=CC(=O)c5ccccc5C4=O)CC3)nc(N)c2cc1OC 10.1021/jm049153d
44586479 188603 0 None - 0 Rat 6.7 pKd = 6.7 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 572 10 1 8 2.6 COC(=O)CN1C(=O)N(CC(O)CN2CCN(c3ccccc3OC)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
CHEMBL503007 188603 0 None - 0 Rat 6.7 pKd = 6.7 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 572 10 1 8 2.6 COC(=O)CN1C(=O)N(CC(O)CN2CCN(c3ccccc3OC)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
115 342 71 None - 5 Rat 7.6 pKd = 7.6 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm000541z
2092 342 71 None - 5 Rat 7.6 pKd = 7.6 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm000541z
7109 342 71 None - 5 Rat 7.6 pKd = 7.6 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm000541z
CHEMBL709 342 71 None - 5 Rat 7.6 pKd = 7.6 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm000541z
DB00346 342 71 None - 5 Rat 7.6 pKd = 7.6 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm000541z
10620831 206864 0 None - 0 Rabbit 7.6 pKd = 7.6 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 397 8 1 6 2.4 COc1ccccc1N1CCN(CCCNc2ccc(C(=O)N(C)C)cn2)CC1 10.1021/jm970166j
CHEMBL90778 206864 0 None - 0 Rabbit 7.6 pKd = 7.6 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 397 8 1 6 2.4 COc1ccccc1N1CCN(CCCNc2ccc(C(=O)N(C)C)cn2)CC1 10.1021/jm970166j
44586430 187006 0 None - 0 Rat 7.6 pKd = 7.6 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 528 9 1 6 3.4 CCOc1ccccc1N1CCN(CC(O)CN2C(=O)N(C)C(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
CHEMBL490865 187006 0 None - 0 Rat 7.6 pKd = 7.6 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 528 9 1 6 3.4 CCOc1ccccc1N1CCN(CC(O)CN2C(=O)N(C)C(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
3157 1458 71 None -38 22 Human 7.6 pKd = 7.6 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm000541z
7170 1458 71 None -38 22 Human 7.6 pKd = 7.6 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm000541z
954 1458 71 None -38 22 Human 7.6 pKd = 7.6 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm000541z
CHEMBL707 1458 71 None -38 22 Human 7.6 pKd = 7.6 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm000541z
DB00590 1458 71 None -38 22 Human 7.6 pKd = 7.6 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm000541z
135 2515 43 None -72 33 Human 6.6 pKd = 6.6 Functional
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm00370a011
1796 2515 43 None -72 33 Human 6.6 pKd = 6.6 Functional
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm00370a011
4184 2515 43 None -72 33 Human 6.6 pKd = 6.6 Functional
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm00370a011
CHEMBL6437 2515 43 None -72 33 Human 6.6 pKd = 6.6 Functional
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm00370a011
DB06148 2515 43 None -72 33 Human 6.6 pKd = 6.6 Functional
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm00370a011
11273296 170272 0 None - 0 Rat 6.6 pKd = 6.6 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 586 11 1 8 2.9 CCOC(=O)CN1C(=O)N(CC(O)CN2CCN(c3ccccc3OC)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
CHEMBL444648 170272 0 None - 0 Rat 6.6 pKd = 6.6 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 586 11 1 8 2.9 CCOC(=O)CN1C(=O)N(CC(O)CN2CCN(c3ccccc3OC)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
10834793 84550 0 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 363 8 1 6 2.7 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(F)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153557 84550 0 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 363 8 1 6 2.7 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(F)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2220925 84550 0 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 363 8 1 6 2.7 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(F)c2O1 10.1016/j.ejmech.2012.09.049
44289261 164888 0 None - 0 Rat 6.5 pKd = 6.5 Functional
Antagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptor
ChEMBL 417 9 1 4 5.1 COc1cccc(OC)c1OCCNCC1Cc2ccccc2C(c2ccccc2)C1 10.1021/jm011066n
CHEMBL42231 164888 0 None - 0 Rat 6.5 pKd = 6.5 Functional
Antagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptor
ChEMBL 417 9 1 4 5.1 COc1cccc(OC)c1OCCNCC1Cc2ccccc2C(c2ccccc2)C1 10.1021/jm011066n
10344976 101188 2 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 477 11 1 10 3.4 COc1cc2nc(N(C)CCSSCCN(C)C(=O)c3ccco3)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL29591 101188 2 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 477 11 1 10 3.4 COc1cc2nc(N(C)CCSSCCN(C)C(=O)c3ccco3)nc(N)c2cc1OC 10.1021/jm9810654
10363912 6506 0 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonistic activity against (-)-noradrenaline-induced contraction of rat prostatic vas deferens (alpha1A receptor)Antagonistic activity against (-)-noradrenaline-induced contraction of rat prostatic vas deferens (alpha1A receptor)
ChEMBL 405 9 1 5 4.0 COc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1021/jm021078o
CHEMBL1082862 6506 0 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonistic activity against (-)-noradrenaline-induced contraction of rat prostatic vas deferens (alpha1A receptor)Antagonistic activity against (-)-noradrenaline-induced contraction of rat prostatic vas deferens (alpha1A receptor)
ChEMBL 405 9 1 5 4.0 COc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1021/jm021078o
CHEMBL286003 6506 0 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonistic activity against (-)-noradrenaline-induced contraction of rat prostatic vas deferens (alpha1A receptor)Antagonistic activity against (-)-noradrenaline-induced contraction of rat prostatic vas deferens (alpha1A receptor)
ChEMBL 405 9 1 5 4.0 COc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1021/jm021078o
10344976 101188 2 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from ratAntagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from rat
ChEMBL 477 11 1 10 3.4 COc1cc2nc(N(C)CCSSCCN(C)C(=O)c3ccco3)nc(N)c2cc1OC 10.1016/s0960-894x(98)00217-0
CHEMBL29591 101188 2 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from ratAntagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from rat
ChEMBL 477 11 1 10 3.4 COc1cc2nc(N(C)CCSSCCN(C)C(=O)c3ccco3)nc(N)c2cc1OC 10.1016/s0960-894x(98)00217-0
10671310 206902 0 None - 0 Rabbit 8.5 pKd = 8.5 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 451 8 1 6 3.3 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2OC(F)(F)F)CC1 10.1021/jm970166j
CHEMBL91036 206902 0 None - 0 Rabbit 8.5 pKd = 8.5 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 451 8 1 6 3.3 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2OC(F)(F)F)CC1 10.1021/jm970166j
21473427 206954 0 None - 0 Rabbit 8.5 pKd = 8.5 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 410 8 1 5 3.3 COc1ccccc1N1CCN(CCCNc2c(C)cccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL91326 206954 0 None - 0 Rabbit 8.5 pKd = 8.5 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 410 8 1 5 3.3 COc1ccccc1N1CCN(CCCNc2c(C)cccc2C(=O)N(C)C)CC1 10.1021/jm970166j
148842 3915 27 None 12 2 Rat 8.4 pKd = 8.4 Functional
Functional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferensFunctional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferens
ChEMBL 511 8 1 6 4.7 COc1ccccc1N1CCN(CC1)CCCNC(=O)c1cccc2c1oc(c1ccccc1)c(c2=O)C 10.1021/jm030825u
496 3915 27 None 12 2 Rat 8.4 pKd = 8.4 Functional
Functional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferensFunctional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferens
ChEMBL 511 8 1 6 4.7 COc1ccccc1N1CCN(CC1)CCCNC(=O)c1cccc2c1oc(c1ccccc1)c(c2=O)C 10.1021/jm030825u
CHEMBL278865 3915 27 None 12 2 Rat 8.4 pKd = 8.4 Functional
Functional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferensFunctional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferens
ChEMBL 511 8 1 6 4.7 COc1ccccc1N1CCN(CC1)CCCNC(=O)c1cccc2c1oc(c1ccccc1)c(c2=O)C 10.1021/jm030825u
489 145 28 None - 1 Rabbit 8.4 pKd = 8.4 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm970166j
5640 145 28 None - 1 Rabbit 8.4 pKd = 8.4 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm970166j
CHEMBL420060 145 28 None - 1 Rabbit 8.4 pKd = 8.4 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm970166j
44323803 206524 0 None - 0 Rabbit 8.4 pKd = 8.4 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 398 8 1 7 1.8 COc1ccccc1N1CCN(CCCNc2cncnc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL88633 206524 0 None - 0 Rabbit 8.4 pKd = 8.4 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 398 8 1 7 1.8 COc1ccccc1N1CCN(CCCNc2cncnc2C(=O)N(C)C)CC1 10.1021/jm970166j
10596968 206955 0 None - 0 Rabbit 8.4 pKd = 8.4 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 397 8 0 5 3.0 COc1ccccc1N1CCN(CCCOc2ccccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL91338 206955 0 None - 0 Rabbit 8.4 pKd = 8.4 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 397 8 0 5 3.0 COc1ccccc1N1CCN(CCCOc2ccccc2C(=O)N(C)C)CC1 10.1021/jm970166j
10815708 207075 0 None - 0 Rabbit 8.4 pKd = 8.4 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 515 9 1 6 4.5 CN(C)C(=O)c1cnc2ccccc2c1NCCCN1CCN(c2ccccc2OCC(F)(F)F)CC1 10.1021/jm970166j
CHEMBL91989 207075 0 None - 0 Rabbit 8.4 pKd = 8.4 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 515 9 1 6 4.5 CN(C)C(=O)c1cnc2ccccc2c1NCCCN1CCN(c2ccccc2OCC(F)(F)F)CC1 10.1021/jm970166j
50905588 56323 0 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonist activity at alpha1A adrenoceptor in Wistar rat vas deferens assessed as noradrenaline induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Wistar rat vas deferens assessed as noradrenaline induced contractions after 30 mins
ChEMBL 406 7 2 6 2.1 COc1ccc(C[C@@H](C)NC[C@H]2Oc3ccccc3O[C@H]2C)cc1S(N)(=O)=O 10.1016/j.ejmech.2010.09.042
CHEMBL1630941 56323 0 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonist activity at alpha1A adrenoceptor in Wistar rat vas deferens assessed as noradrenaline induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Wistar rat vas deferens assessed as noradrenaline induced contractions after 30 mins
ChEMBL 406 7 2 6 2.1 COc1ccc(C[C@@H](C)NC[C@H]2Oc3ccccc3O[C@H]2C)cc1S(N)(=O)=O 10.1016/j.ejmech.2010.09.042
145971816 164508 0 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile response
ChEMBL 412 8 1 6 2.6 COC(=O)Cc1ccc(OC[C@@H](O)CN2CCN(c3cc(C)ccc3C)CC2)cc1 10.1016/j.bmcl.2018.01.068
CHEMBL4214992 164508 0 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile response
ChEMBL 412 8 1 6 2.6 COC(=O)Cc1ccc(OC[C@@H](O)CN2CCN(c3cc(C)ccc3C)CC2)cc1 10.1016/j.bmcl.2018.01.068
44428851 92289 0 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonist activity against adrenergic alpha-1A receptor in rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractionAntagonist activity against adrenergic alpha-1A receptor in rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contraction
ChEMBL 447 4 1 7 3.5 COc1cc2nc(N3CCN(C(=O)c4ccccc4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2007.01.028
CHEMBL242934 92289 0 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonist activity against adrenergic alpha-1A receptor in rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractionAntagonist activity against adrenergic alpha-1A receptor in rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contraction
ChEMBL 447 4 1 7 3.5 COc1cc2nc(N3CCN(C(=O)c4ccccc4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2007.01.028
145962817 161495 0 None - 0 Rat 5.5 pKd = 5.5 Functional
Antagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochlorideAntagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochloride
ChEMBL 385 3 1 7 2.2 COc1cc2nc(N3CCN(C(C)=O)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
CHEMBL4128311 161495 0 None - 0 Rat 5.5 pKd = 5.5 Functional
Antagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochlorideAntagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochloride
ChEMBL 385 3 1 7 2.2 COc1cc2nc(N3CCN(C(C)=O)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
10788615 206993 0 None - 0 Rabbit 7.5 pKd = 7.5 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 427 9 1 7 2.4 COc1ccc(N2CCN(CCCNc3ncccc3C(=O)N(C)C)CC2)c(OC)c1 10.1021/jm970166j
CHEMBL91480 206993 0 None - 0 Rabbit 7.5 pKd = 7.5 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 427 9 1 7 2.4 COc1ccc(N2CCN(CCCNc3ncccc3C(=O)N(C)C)CC2)c(OC)c1 10.1021/jm970166j
10598692 207121 0 None - 0 Rabbit 7.5 pKd = 7.5 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 429 9 1 5 4.6 COc1ccccc1N1CCN(CCCNc2ccccc2C(=O)c2ccccc2)CC1 10.1021/jm970166j
CHEMBL92259 207121 0 None - 0 Rabbit 7.5 pKd = 7.5 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 429 9 1 5 4.6 COc1ccccc1N1CCN(CCCNc2ccccc2C(=O)c2ccccc2)CC1 10.1021/jm970166j
4418 34192 85 None - 18 Rat 7.5 pKd = 7.5 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile response
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1016/j.bmcl.2018.01.068
CHEMBL142635 34192 85 None - 18 Rat 7.5 pKd = 7.5 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile response
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1016/j.bmcl.2018.01.068
132266 1267 12 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from ratAntagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from rat
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1016/s0960-894x(98)00217-0
486 1267 12 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from ratAntagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from rat
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1016/s0960-894x(98)00217-0
CHEMBL423294 1267 12 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from ratAntagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from rat
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1016/s0960-894x(98)00217-0
11133288 166009 0 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptor
ChEMBL 407 12 1 5 4.3 COc1cccc(OC)c1OCCNCCOc1ccccc1Cc1ccccc1 10.1021/jm011066n
CHEMBL42558 166009 0 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptor
ChEMBL 407 12 1 5 4.3 COc1cccc(OC)c1OCCNCCOc1ccccc1Cc1ccccc1 10.1021/jm011066n
16721032 92159 0 None - 0 Rat 6.5 pKd = 6.5 Functional
Antagonist activity against adrenergic alpha-1A receptor in rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractionAntagonist activity against adrenergic alpha-1A receptor in rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contraction
ChEMBL 451 4 1 8 3.4 COc1cc2nc(N3CCN(C(=O)c4ccc(C)o4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2007.01.028
CHEMBL242507 92159 0 None - 0 Rat 6.5 pKd = 6.5 Functional
Antagonist activity against adrenergic alpha-1A receptor in rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractionAntagonist activity against adrenergic alpha-1A receptor in rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contraction
ChEMBL 451 4 1 8 3.4 COc1cc2nc(N3CCN(C(=O)c4ccc(C)o4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2007.01.028
10348924 17913 0 None - 0 Rat 7.5 pKd = 7.5 Functional
Functional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferensFunctional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferens
ChEMBL 620 10 1 10 3.8 Cc1c(-c2ccccc2)oc2c(C(=O)NCCCN3CCN(c4ccccc4OCc4no[n+]([O-])c4C#N)CC3)cccc2c1=O 10.1021/jm030825u
CHEMBL125989 17913 0 None - 0 Rat 7.5 pKd = 7.5 Functional
Functional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferensFunctional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferens
ChEMBL 620 10 1 10 3.8 Cc1c(-c2ccccc2)oc2c(C(=O)NCCCN3CCN(c4ccccc4OCc4no[n+]([O-])c4C#N)CC3)cccc2c1=O 10.1021/jm030825u
44417706 11803 0 None - 0 Rat 5.5 pKd = 5.5 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 395 8 1 6 3.7 COc1cccc(OC)c1OCCNC[C@H]1COc2cc3ccccc3cc2O1 10.1021/jm060358r
CHEMBL1182152 11803 0 None - 0 Rat 5.5 pKd = 5.5 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 395 8 1 6 3.7 COc1cccc(OC)c1OCCNC[C@H]1COc2cc3ccccc3cc2O1 10.1021/jm060358r
CHEMBL215188 11803 0 None - 0 Rat 5.5 pKd = 5.5 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 395 8 1 6 3.7 COc1cccc(OC)c1OCCNC[C@H]1COc2cc3ccccc3cc2O1 10.1021/jm060358r
3584 3748 64 None -69 11 Human 7.4 pKd = 7.4 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostateIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostate
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
5401 3748 64 None -69 11 Human 7.4 pKd = 7.4 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostateIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostate
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
7302 3748 64 None -69 11 Human 7.4 pKd = 7.4 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostateIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostate
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
CHEMBL611 3748 64 None -69 11 Human 7.4 pKd = 7.4 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostateIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostate
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
DB01162 3748 64 None -69 11 Human 7.4 pKd = 7.4 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostateIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostate
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
3584 3748 64 None -69 11 Human 7.4 pKd = 7.4 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm000541z
5401 3748 64 None -69 11 Human 7.4 pKd = 7.4 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm000541z
7302 3748 64 None -69 11 Human 7.4 pKd = 7.4 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm000541z
CHEMBL611 3748 64 None -69 11 Human 7.4 pKd = 7.4 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm000541z
DB01162 3748 64 None -69 11 Human 7.4 pKd = 7.4 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm000541z
10072518 35875 0 None - 0 Rat 7.4 pKd = 7.4 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 451 11 1 7 4.0 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccccc3)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL144224 35875 0 None - 0 Rat 7.4 pKd = 7.4 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 451 11 1 7 4.0 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccccc3)nc(N)c2cc1OC 10.1021/jm9810654
10553385 119139 0 None - 0 Rat 7.4 pKd = 7.4 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 498 13 1 9 3.7 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccc(CN(C)C)o3)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL342997 119139 0 None - 0 Rat 7.4 pKd = 7.4 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 498 13 1 9 3.7 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccc(CN(C)C)o3)nc(N)c2cc1OC 10.1021/jm9810654
145964162 164312 0 None - 0 Rat 7.4 pKd = 7.4 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile response
ChEMBL 412 8 1 6 2.6 COC(=O)Cc1ccc(OCC(O)CN2CCN(c3cc(C)ccc3C)CC2)cc1 10.1016/j.bmcl.2018.01.068
CHEMBL4212528 164312 0 None - 0 Rat 7.4 pKd = 7.4 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile response
ChEMBL 412 8 1 6 2.6 COC(=O)Cc1ccc(OCC(O)CN2CCN(c3cc(C)ccc3C)CC2)cc1 10.1016/j.bmcl.2018.01.068
10621592 84542 0 None - 0 Rat 7.4 pKd = 7.4 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2c(OC)cccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153559 84542 0 None - 0 Rat 7.4 pKd = 7.4 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2c(OC)cccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2220898 84542 0 None - 0 Rat 7.4 pKd = 7.4 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2c(OC)cccc2O1 10.1016/j.ejmech.2012.09.049
9838192 111285 18 None - 3 Rat 5.4 pKd = 5.4 Functional
Antagonist activity at rat spleen adrenergic alpha1A receptorAntagonist activity at rat spleen adrenergic alpha1A receptor
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1016/j.bmc.2008.02.091
CHEMBL326702 111285 18 None - 3 Rat 5.4 pKd = 5.4 Functional
Antagonist activity at rat spleen adrenergic alpha1A receptorAntagonist activity at rat spleen adrenergic alpha1A receptor
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1016/j.bmc.2008.02.091
44289248 168952 0 None - 0 Rat 8.3 pKd = 8.3 Functional
Antagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptor
ChEMBL 435 9 1 5 5.4 COc1cccc(OC)c1OCCNCC1CC(c2ccccc2)c2ccccc2S1 10.1021/jm011066n
CHEMBL43905 168952 0 None - 0 Rat 8.3 pKd = 8.3 Functional
Antagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptor
ChEMBL 435 9 1 5 5.4 COc1cccc(OC)c1OCCNCC1CC(c2ccccc2)c2ccccc2S1 10.1021/jm011066n
10767688 36355 0 None - 0 Rat 6.4 pKd = 6.4 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 499 12 1 7 4.7 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccccc3CCl)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL144677 36355 0 None - 0 Rat 6.4 pKd = 6.4 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 499 12 1 7 4.7 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccccc3CCl)nc(N)c2cc1OC 10.1021/jm9810654
11994673 12284 0 None - 0 Rat 7.4 pKd = 7.4 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostateActivity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostate
ChEMBL 419 7 1 5 4.5 COc1ccc2ccccc2c1OCCNC[C@H]1COc2cc3c(cc2O1)CCCC3 10.1021/jm060358r
CHEMBL1185036 12284 0 None - 0 Rat 7.4 pKd = 7.4 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostateActivity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostate
ChEMBL 419 7 1 5 4.5 COc1ccc2ccccc2c1OCCNC[C@H]1COc2cc3c(cc2O1)CCCC3 10.1021/jm060358r
CHEMBL385371 12284 0 None - 0 Rat 7.4 pKd = 7.4 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostateActivity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostate
ChEMBL 419 7 1 5 4.5 COc1ccc2ccccc2c1OCCNC[C@H]1COc2cc3c(cc2O1)CCCC3 10.1021/jm060358r
10430193 161574 0 None - 0 Rat 7.4 pKd = 7.4 Functional
Antagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochlorideAntagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochloride
ChEMBL 385 3 1 7 2.2 COc1cc2nc(N3CCN(C(C)=O)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
CHEMBL4129461 161574 0 None - 0 Rat 7.4 pKd = 7.4 Functional
Antagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochlorideAntagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochloride
ChEMBL 385 3 1 7 2.2 COc1cc2nc(N3CCN(C(C)=O)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
10719536 121117 0 None - 0 Rat 7.3 pKd = 7.3 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 480 12 2 8 3.5 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3cccc(CN)c3)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL357669 121117 0 None - 0 Rat 7.3 pKd = 7.3 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 480 12 2 8 3.5 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3cccc(CN)c3)nc(N)c2cc1OC 10.1021/jm9810654
145978803 163814 0 None - 0 Rat 6.3 pKd = 6.3 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile response
ChEMBL 398 8 1 6 2.3 COC(=O)Cc1ccc(OCC(O)CN2CCN(c3ccccc3C)CC2)cc1 10.1016/j.bmcl.2018.01.068
CHEMBL4206435 163814 0 None - 0 Rat 6.3 pKd = 6.3 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile response
ChEMBL 398 8 1 6 2.3 COC(=O)Cc1ccc(OCC(O)CN2CCN(c3ccccc3C)CC2)cc1 10.1016/j.bmcl.2018.01.068
4209 3141 75 None - 17 Rabbit 8.3 pKd = 8.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm970166j
4893 3141 75 None - 17 Rabbit 8.3 pKd = 8.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm970166j
503 3141 75 None - 17 Rabbit 8.3 pKd = 8.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm970166j
5385 3141 75 None - 17 Rabbit 8.3 pKd = 8.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm970166j
CHEMBL2 3141 75 None - 17 Rabbit 8.3 pKd = 8.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm970166j
DB00457 3141 75 None - 17 Rabbit 8.3 pKd = 8.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm970166j
10643699 206528 0 None - 0 Rabbit 8.3 pKd = 8.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 383 7 2 6 2.1 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2O)CC1 10.1021/jm970166j
CHEMBL88664 206528 0 None - 0 Rabbit 8.3 pKd = 8.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 383 7 2 6 2.1 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2O)CC1 10.1021/jm970166j
44289262 101347 2 None - 0 Rat 8.2 pKd = 8.2 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 421 9 1 6 4.3 COc1cccc(OC)c1OCCNC[C@@H]1Oc2ccccc2O[C@H]1c1ccccc1 10.1021/jm011066n
CHEMBL297106 101347 2 None - 0 Rat 8.2 pKd = 8.2 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 421 9 1 6 4.3 COc1cccc(OC)c1OCCNC[C@@H]1Oc2ccccc2O[C@H]1c1ccccc1 10.1021/jm011066n
44289262 101347 2 None - 0 Rat 8.2 pKd = 8.2 Functional
Antagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptor
ChEMBL 421 9 1 6 4.3 COc1cccc(OC)c1OCCNC[C@@H]1Oc2ccccc2O[C@H]1c1ccccc1 10.1021/jm011066n
CHEMBL297106 101347 2 None - 0 Rat 8.2 pKd = 8.2 Functional
Antagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptor
ChEMBL 421 9 1 6 4.3 COc1cccc(OC)c1OCCNC[C@@H]1Oc2ccccc2O[C@H]1c1ccccc1 10.1021/jm011066n
71454865 84574 0 None - 0 Rat 7.3 pKd = 7.3 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 361 8 2 7 2.2 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(O)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153551 84574 0 None - 0 Rat 7.3 pKd = 7.3 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 361 8 2 7 2.2 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(O)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2221145 84574 0 None - 0 Rat 7.3 pKd = 7.3 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 361 8 2 7 2.2 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(O)c2O1 10.1016/j.ejmech.2012.09.049
3894573 3368 6 None - 0 Rabbit 7.3 pKd = 7.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 10.1021/jm970166j
495 3368 6 None - 0 Rabbit 7.3 pKd = 7.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 10.1021/jm970166j
CHEMBL88272 3368 6 None - 0 Rabbit 7.3 pKd = 7.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 10.1021/jm970166j
10621592 84542 0 None - 0 Rat 7.3 pKd = 7.3 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2c(OC)cccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153559 84542 0 None - 0 Rat 7.3 pKd = 7.3 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2c(OC)cccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2220898 84542 0 None - 0 Rat 7.3 pKd = 7.3 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2c(OC)cccc2O1 10.1016/j.ejmech.2012.09.049
10097792 118563 0 None - 0 Rat 7.3 pKd = 7.3 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 508 13 1 8 4.1 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3cccc(CN(C)C)c3)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL341665 118563 0 None - 0 Rat 7.3 pKd = 7.3 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 508 13 1 8 4.1 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3cccc(CN(C)C)c3)nc(N)c2cc1OC 10.1021/jm9810654
44417713 12390 0 None - 0 Rat 7.2 pKd = 7.2 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL1185884 12390 0 None - 0 Rat 7.2 pKd = 7.2 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL439346 12390 0 None - 0 Rat 7.2 pKd = 7.2 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
10602797 36470 0 None - 0 Rat 7.2 pKd = 7.2 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 552 13 1 9 4.5 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccc(CN4CCSC4)cc3)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL144768 36470 0 None - 0 Rat 7.2 pKd = 7.2 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 552 13 1 9 4.5 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccc(CN4CCSC4)cc3)nc(N)c2cc1OC 10.1021/jm9810654
11133288 166009 0 None - 0 Rat 7.2 pKd = 7.2 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 407 12 1 5 4.3 COc1cccc(OC)c1OCCNCCOc1ccccc1Cc1ccccc1 10.1021/jm011066n
CHEMBL42558 166009 0 None - 0 Rat 7.2 pKd = 7.2 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 407 12 1 5 4.3 COc1cccc(OC)c1OCCNCCOc1ccccc1Cc1ccccc1 10.1021/jm011066n
11994665 11802 0 None - 0 Rat 8.2 pKd = 8.2 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 391 8 1 5 4.2 COc1cccc(-c2ccccc2)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL1182151 11802 0 None - 0 Rat 8.2 pKd = 8.2 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 391 8 1 5 4.2 COc1cccc(-c2ccccc2)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL215151 11802 0 None - 0 Rat 8.2 pKd = 8.2 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 391 8 1 5 4.2 COc1cccc(-c2ccccc2)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
44289248 168952 0 None - 0 Rat 8.2 pKd = 8.2 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 435 9 1 5 5.4 COc1cccc(OC)c1OCCNCC1CC(c2ccccc2)c2ccccc2S1 10.1021/jm011066n
CHEMBL43905 168952 0 None - 0 Rat 8.2 pKd = 8.2 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 435 9 1 5 5.4 COc1cccc(OC)c1OCCNCC1CC(c2ccccc2)c2ccccc2S1 10.1021/jm011066n
10974101 116927 0 None - 0 Rat 8.2 pKd = 8.2 Functional
Functional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferensFunctional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferens
ChEMBL 609 10 1 9 4.2 Cc1c(-c2ccccc2)oc2c(C(=O)NCCCN3CCN(c4ccccc4OCc4no[n+]([O-])c4C)CC3)cccc2c1=O 10.1021/jm030825u
CHEMBL338608 116927 0 None - 0 Rat 8.2 pKd = 8.2 Functional
Functional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferensFunctional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferens
ChEMBL 609 10 1 9 4.2 Cc1c(-c2ccccc2)oc2c(C(=O)NCCCN3CCN(c4ccccc4OCc4no[n+]([O-])c4C)CC3)cccc2c1=O 10.1021/jm030825u
2142 3074 58 None - 18 Rabbit 8.2 pKd = 8.2 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm970166j
4920903 3074 58 None - 18 Rabbit 8.2 pKd = 8.2 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm970166j
502 3074 58 None - 18 Rabbit 8.2 pKd = 8.2 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm970166j
5775 3074 58 None - 18 Rabbit 8.2 pKd = 8.2 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm970166j
CHEMBL597 3074 58 None - 18 Rabbit 8.2 pKd = 8.2 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm970166j
DB00692 3074 58 None - 18 Rabbit 8.2 pKd = 8.2 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm970166j
10766280 111612 0 None - 0 Rabbit 8.2 pKd = 8.2 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 457 9 1 5 4.0 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2Cc2ccccc2)CC1 10.1021/jm970166j
CHEMBL328545 111612 0 None - 0 Rabbit 8.2 pKd = 8.2 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 457 9 1 5 4.0 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2Cc2ccccc2)CC1 10.1021/jm970166j
10642742 206772 0 None - 0 Rabbit 8.2 pKd = 8.2 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 367 7 1 5 2.4 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2)CC1 10.1021/jm970166j
CHEMBL90287 206772 0 None - 0 Rabbit 8.2 pKd = 8.2 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 367 7 1 5 2.4 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2)CC1 10.1021/jm970166j
10814913 35888 0 None - 0 Rat 8.2 pKd = 8.2 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 489 12 1 8 4.3 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccc(CCl)o3)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL144238 35888 0 None - 0 Rat 8.2 pKd = 8.2 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 489 12 1 8 4.3 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccc(CCl)o3)nc(N)c2cc1OC 10.1021/jm9810654
145975903 163797 0 None - 0 Rat 7.2 pKd = 7.2 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile response
ChEMBL 412 8 1 6 2.6 COC(=O)Cc1ccc(OC[C@H](O)CN2CCN(c3cc(C)ccc3C)CC2)cc1 10.1016/j.bmcl.2018.01.068
CHEMBL4206260 163797 0 None - 0 Rat 7.2 pKd = 7.2 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile response
ChEMBL 412 8 1 6 2.6 COC(=O)Cc1ccc(OC[C@H](O)CN2CCN(c3cc(C)ccc3C)CC2)cc1 10.1016/j.bmcl.2018.01.068
11169638 17162 0 None - 0 Rat 7.2 pKd = 7.2 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 600 11 1 8 3.3 CCOC(=O)C(C)N1C(=O)N(CC(O)CN2CCN(c3ccccc3OC)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
CHEMBL1256344 17162 0 None - 0 Rat 7.2 pKd = 7.2 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 600 11 1 8 3.3 CCOC(=O)C(C)N1C(=O)N(CC(O)CN2CCN(c3ccccc3OC)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
11454386 63077 0 None - 0 Rat 7.2 pKd = 7.2 Functional
Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)
ChEMBL 477 8 1 9 3.6 COc1cc2nc(N3CCN(C(=O)CCCCC4CCSS4)CC3)nc(N)c2cc1OC 10.1021/jm049153d
CHEMBL178923 63077 0 None - 0 Rat 7.2 pKd = 7.2 Functional
Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)
ChEMBL 477 8 1 9 3.6 COc1cc2nc(N3CCN(C(=O)CCCCC4CCSS4)CC3)nc(N)c2cc1OC 10.1021/jm049153d
10552704 163425 0 None - 0 Rabbit 8.1 pKd = 8.1 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 479 8 1 6 4.0 COc1cc(F)ccc1N1CCN(CCCNc2c(C(=O)N(C)C)cnc3c(C)cccc23)CC1 10.1021/jm970166j
CHEMBL419867 163425 0 None - 0 Rabbit 8.1 pKd = 8.1 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 479 8 1 6 4.0 COc1cc(F)ccc1N1CCN(CCCNc2c(C(=O)N(C)C)cnc3c(C)cccc23)CC1 10.1021/jm970166j
10767948 35919 0 None - 0 Rat 7.1 pKd = 7.1 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 508 13 1 8 4.1 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccc(CN(C)C)cc3)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL144263 35919 0 None - 0 Rat 7.1 pKd = 7.1 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 508 13 1 8 4.1 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccc(CN(C)C)cc3)nc(N)c2cc1OC 10.1021/jm9810654
11994915 11800 0 None - 0 Rat 6.1 pKd = 6.1 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 391 8 1 5 4.2 COc1cc(-c2ccccc2)ccc1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL1182145 11800 0 None - 0 Rat 6.1 pKd = 6.1 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 391 8 1 5 4.2 COc1cc(-c2ccccc2)ccc1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL214762 11800 0 None - 0 Rat 6.1 pKd = 6.1 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 391 8 1 5 4.2 COc1cc(-c2ccccc2)ccc1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
10743978 121277 0 None - 0 Rat 7.1 pKd = 7.1 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 499 12 1 7 4.7 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccc(CCl)cc3)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL358060 121277 0 None - 0 Rat 7.1 pKd = 7.1 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 499 12 1 7 4.7 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccc(CCl)cc3)nc(N)c2cc1OC 10.1021/jm9810654
69781970 161327 0 None - 0 Rat 6.1 pKd = 6.1 Functional
Antagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochlorideAntagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochloride
ChEMBL 477 5 1 8 4.0 COc1cc2nc(N3CCN(C(=O)OCc4ccccc4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
CHEMBL4125981 161327 0 None - 0 Rat 6.1 pKd = 6.1 Functional
Antagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochlorideAntagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochloride
ChEMBL 477 5 1 8 4.0 COc1cc2nc(N3CCN(C(=O)OCc4ccccc4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
10815228 37238 0 None - 0 Rat 7.1 pKd = 7.1 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 499 12 1 7 4.7 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3cccc(CCl)c3)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL145384 37238 0 None - 0 Rat 7.1 pKd = 7.1 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 499 12 1 7 4.7 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3cccc(CCl)c3)nc(N)c2cc1OC 10.1021/jm9810654
10531768 35622 0 None - 0 Rat 8.1 pKd = 8.1 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 607 20 2 9 5.2 CNCCCCCCN(C)Cc1cccc(C(=O)N(C)CCCCCCN(C)c2nc(N)c3cc(OC)c(OC)cc3n2)c1 10.1021/jm9810654
CHEMBL144000 35622 0 None - 0 Rat 8.1 pKd = 8.1 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 607 20 2 9 5.2 CNCCCCCCN(C)Cc1cccc(C(=O)N(C)CCCCCCN(C)c2nc(N)c3cc(OC)c(OC)cc3n2)c1 10.1021/jm9810654
52941981 17484 0 None - 0 Rat 6.1 pKd = 6.1 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 502 7 1 5 3.1 CN1C(=O)N(CC(O)CN2CCN(c3ccccc3F)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
CHEMBL1257883 17484 0 None - 0 Rat 6.1 pKd = 6.1 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 502 7 1 5 3.1 CN1C(=O)N(CC(O)CN2CCN(c3ccccc3F)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
3584 3748 64 None -25 11 Rat 8.0 pKd = 8.0 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of phenylephrine-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of phenylephrine-induced contractile response
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmcl.2018.01.068
5401 3748 64 None -25 11 Rat 8.0 pKd = 8.0 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of phenylephrine-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of phenylephrine-induced contractile response
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmcl.2018.01.068
7302 3748 64 None -25 11 Rat 8.0 pKd = 8.0 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of phenylephrine-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of phenylephrine-induced contractile response
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmcl.2018.01.068
CHEMBL611 3748 64 None -25 11 Rat 8.0 pKd = 8.0 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of phenylephrine-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of phenylephrine-induced contractile response
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmcl.2018.01.068
DB01162 3748 64 None -25 11 Rat 8.0 pKd = 8.0 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of phenylephrine-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of phenylephrine-induced contractile response
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmcl.2018.01.068
3584 3748 64 None -25 11 Rat 8.0 pKd = 8.0 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferensIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferens
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
5401 3748 64 None -25 11 Rat 8.0 pKd = 8.0 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferensIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferens
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
7302 3748 64 None -25 11 Rat 8.0 pKd = 8.0 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferensIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferens
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
CHEMBL611 3748 64 None -25 11 Rat 8.0 pKd = 8.0 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferensIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferens
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
DB01162 3748 64 None -25 11 Rat 8.0 pKd = 8.0 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferensIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferens
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
3584 3748 64 None -25 11 Rat 8.0 pKd = 8.0 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm000541z
5401 3748 64 None -25 11 Rat 8.0 pKd = 8.0 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm000541z
7302 3748 64 None -25 11 Rat 8.0 pKd = 8.0 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm000541z
CHEMBL611 3748 64 None -25 11 Rat 8.0 pKd = 8.0 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm000541z
DB01162 3748 64 None -25 11 Rat 8.0 pKd = 8.0 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm000541z
11994797 12282 0 None - 0 Rat 7.0 pKd = 7.0 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 369 7 1 5 3.4 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)CCCC2 10.1021/jm060358r
CHEMBL1185017 12282 0 None - 0 Rat 7.0 pKd = 7.0 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 369 7 1 5 3.4 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)CCCC2 10.1021/jm060358r
CHEMBL383938 12282 0 None - 0 Rat 7.0 pKd = 7.0 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 369 7 1 5 3.4 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)CCCC2 10.1021/jm060358r
10553687 38851 0 None - 0 Rat 7.0 pKd = 7.0 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 508 13 1 8 4.1 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccccc3CN(C)C)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL146724 38851 0 None - 0 Rat 7.0 pKd = 7.0 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 508 13 1 8 4.1 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccccc3CN(C)C)nc(N)c2cc1OC 10.1021/jm9810654
49800167 17649 0 None - 0 Rat 7.0 pKd = 7.0 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 514 9 2 6 3.1 CCOc1ccccc1N1CCN(CC(O)CN2C(=O)NC(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
CHEMBL1258457 17649 0 None - 0 Rat 7.0 pKd = 7.0 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 514 9 2 6 3.1 CCOc1ccccc1N1CCN(CC(O)CN2C(=O)NC(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
2419 692 28 None - 3 Rat 7.0 pKd = 7.0 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm011066n
9 692 28 None - 3 Rat 7.0 pKd = 7.0 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm011066n
CHEMBL13647 692 28 None - 3 Rat 7.0 pKd = 7.0 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm011066n
9827677 168398 0 None - 0 Human 9.7 pKi = 9.7 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 510 7 2 4 4.2 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
CHEMBL43491 168398 0 None - 0 Human 9.7 pKi = 9.7 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 510 7 2 4 4.2 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
44288945 168891 0 None - 0 Human 9.4 pKi = 9.4 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 485 7 2 3 4.4 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
CHEMBL43860 168891 0 None - 0 Human 9.4 pKi = 9.4 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 485 7 2 3 4.4 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
499 4046 18 None - 1 Human 9.4 pKi = 9.4 Functional
Antagonistic affinity tested against isolated Human recombinant Thoracic Aorta Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Human recombinant Thoracic Aorta Alpha-1A adrenergic receptor
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm011066n
5685 4046 18 None - 1 Human 9.4 pKi = 9.4 Functional
Antagonistic affinity tested against isolated Human recombinant Thoracic Aorta Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Human recombinant Thoracic Aorta Alpha-1A adrenergic receptor
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm011066n
CHEMBL25554 4046 18 None - 1 Human 9.4 pKi = 9.4 Functional
Antagonistic affinity tested against isolated Human recombinant Thoracic Aorta Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Human recombinant Thoracic Aorta Alpha-1A adrenergic receptor
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm011066n
44289100 100121 0 None - 0 Human 9.2 pKi = 9.2 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 499 7 1 3 4.7 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
CHEMBL287791 100121 0 None - 0 Human 9.2 pKi = 9.2 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 499 7 1 3 4.7 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
10436842 100228 0 None - 0 Human 9.1 pKi = 9.1 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 524 7 1 4 4.6 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
CHEMBL288772 100228 0 None - 0 Human 9.1 pKi = 9.1 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 524 7 1 4 4.6 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
44288874 101068 0 None - 0 Human 9.0 pKi = 9 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 528 7 2 4 4.2 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3F)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
CHEMBL295001 101068 0 None - 0 Human 9.0 pKi = 9 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 528 7 2 4 4.2 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3F)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
44289107 166156 0 None - 0 Human 9.0 pKi = 9 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 492 7 2 4 4.1 CC1=C(C(=O)NCCCN2CCC(c3ccccc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
CHEMBL42640 166156 0 None - 0 Human 9.0 pKi = 9 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 492 7 2 4 4.1 CC1=C(C(=O)NCCCN2CCC(c3ccccc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
44288769 101121 0 None - 0 Human 9.0 pKi = 9.0 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 542 7 1 4 4.5 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3F)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
CHEMBL295395 101121 0 None - 0 Human 9.0 pKi = 9.0 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 542 7 1 4 4.5 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3F)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
44288847 165285 0 None - 0 Human 8.9 pKi = 8.9 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 535 7 2 5 3.9 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
CHEMBL42335 165285 0 None - 0 Human 8.9 pKi = 8.9 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 535 7 2 5 3.9 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
44288917 100227 0 None - 0 Human 8.7 pKi = 8.7 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 510 7 2 4 4.0 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
CHEMBL288768 100227 0 None - 0 Human 8.7 pKi = 8.7 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 510 7 2 4 4.0 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
44289035 100486 0 None - 0 Human 8.7 pKi = 8.7 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 524 7 1 4 4.4 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
CHEMBL291166 100486 0 None - 0 Human 8.7 pKi = 8.7 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 524 7 1 4 4.4 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
53327992 63375 0 None - 0 Human 8.0 pKi = 8 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in HEK293 cells assessed as inhibition of norepinephrine-induced [3H]inositol phosphate hydrolysis by scintillation countingAntagonist activity at human adrenergic alpha1A receptor expressed in HEK293 cells assessed as inhibition of norepinephrine-induced [3H]inositol phosphate hydrolysis by scintillation counting
ChEMBL 461 7 0 5 3.6 COc1ccccc1N1CCN(CCCCN2C(=O)CC3(CCc4ccccc43)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796050 63375 0 None - 0 Human 8.0 pKi = 8 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in HEK293 cells assessed as inhibition of norepinephrine-induced [3H]inositol phosphate hydrolysis by scintillation countingAntagonist activity at human adrenergic alpha1A receptor expressed in HEK293 cells assessed as inhibition of norepinephrine-induced [3H]inositol phosphate hydrolysis by scintillation counting
ChEMBL 461 7 0 5 3.6 COc1ccccc1N1CCN(CCCCN2C(=O)CC3(CCc4ccccc43)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
71451044 80445 0 None - 0 Human 7.0 pKi = 7 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 410 7 0 5 4.3 CCCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2cccnc2c1=O 10.1016/j.bmc.2012.08.032
CHEMBL2146807 80445 0 None - 0 Human 7.0 pKi = 7 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 410 7 0 5 4.3 CCCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2cccnc2c1=O 10.1016/j.bmc.2012.08.032
25071930 19048 0 None - 0 Human 7.0 pKi = 7 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 366 2 1 4 3.7 O=C1OC2(CCN(c3nc4cc(F)ccc4[nH]3)CC2)CN1c1ccccc1 10.1016/j.bmcl.2010.09.064
CHEMBL1289039 19048 0 None - 0 Human 7.0 pKi = 7 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 366 2 1 4 3.7 O=C1OC2(CCN(c3nc4cc(F)ccc4[nH]3)CC2)CN1c1ccccc1 10.1016/j.bmcl.2010.09.064
25072242 19306 0 None - 0 Human 7.0 pKi = 7 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 416 2 1 4 4.6 O=C1OC2(CCN(c3nc4cc(C(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccc1 10.1016/j.bmcl.2010.09.064
CHEMBL1290706 19306 0 None - 0 Human 7.0 pKi = 7 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 416 2 1 4 4.6 O=C1OC2(CCN(c3nc4cc(C(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccc1 10.1016/j.bmcl.2010.09.064
25022356 19307 0 None - 0 Human 7.0 pKi = 7 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 348 2 1 4 3.6 O=C1OC2(CCN(c3nc4ccccc4[nH]3)CC2)CN1c1ccccc1 10.1016/j.bmcl.2010.09.064
CHEMBL1290707 19307 0 None - 0 Human 7.0 pKi = 7 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 348 2 1 4 3.6 O=C1OC2(CCN(c3nc4ccccc4[nH]3)CC2)CN1c1ccccc1 10.1016/j.bmcl.2010.09.064
71452871 80439 0 None - 0 Human 7.9 pKi = 7.9 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 412 7 0 6 3.1 COCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2cnccc2c1=O 10.1016/j.bmc.2012.08.032
CHEMBL2146801 80439 0 None - 0 Human 7.9 pKi = 7.9 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 412 7 0 6 3.1 COCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2cnccc2c1=O 10.1016/j.bmc.2012.08.032
71458203 80443 0 None - 0 Human 7.9 pKi = 7.9 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 368 4 0 5 3.1 CN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2cnccc2c1=O 10.1016/j.bmc.2012.08.032
CHEMBL2146805 80443 0 None - 0 Human 7.9 pKi = 7.9 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 368 4 0 5 3.1 CN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2cnccc2c1=O 10.1016/j.bmc.2012.08.032
25071310 19082 0 None - 0 Human 5.9 pKi = 5.9 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 431 3 1 4 5.5 O=C1O[C@]2(CC[C@H](c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccc1 10.1016/j.bmcl.2010.09.064
CHEMBL1289267 19082 0 None - 0 Human 5.9 pKi = 5.9 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 431 3 1 4 5.5 O=C1O[C@]2(CC[C@H](c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccc1 10.1016/j.bmcl.2010.09.064
25072876 19180 0 None - 0 Human 5.9 pKi = 5.9 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 416 2 1 4 5.0 O=C1O[C@]2(CC[C@H](c3nc4cc(C(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccn1 10.1016/j.bmcl.2010.09.064
CHEMBL1289936 19180 0 None - 0 Human 5.9 pKi = 5.9 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 416 2 1 4 5.0 O=C1O[C@]2(CC[C@H](c3nc4cc(C(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccn1 10.1016/j.bmcl.2010.09.064
44288843 168654 0 None - 0 Human 7.9 pKi = 7.9 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 531 7 1 5 4.1 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccccc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
CHEMBL43651 168654 0 None - 0 Human 7.9 pKi = 7.9 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 531 7 1 5 4.1 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccccc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
71461781 80440 0 None - 0 Human 7.8 pKi = 7.8 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 409 7 0 4 4.9 CCCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1016/j.bmc.2012.08.032
CHEMBL2146802 80440 0 None - 0 Human 7.8 pKi = 7.8 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 409 7 0 4 4.9 CCCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1016/j.bmc.2012.08.032
71458205 80449 0 None - 0 Human 6.8 pKi = 6.8 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 412 7 0 6 3.1 COCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ncccc2c1=O 10.1016/j.bmc.2012.08.032
CHEMBL2146811 80449 0 None - 0 Human 6.8 pKi = 6.8 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 412 7 0 6 3.1 COCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ncccc2c1=O 10.1016/j.bmc.2012.08.032
25072875 19135 0 None - 0 Human 5.8 pKi = 5.8 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 446 3 1 5 5.2 Cc1cccc(N2C[C@]3(CC[C@@H](c4nc5cc(OC(F)(F)F)ccc5[nH]4)CC3)OC2=O)n1 10.1016/j.bmcl.2010.09.064
CHEMBL1289609 19135 0 None - 0 Human 5.8 pKi = 5.8 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 446 3 1 5 5.2 Cc1cccc(N2C[C@]3(CC[C@@H](c4nc5cc(OC(F)(F)F)ccc5[nH]4)CC3)OC2=O)n1 10.1016/j.bmcl.2010.09.064
71456359 80441 0 None - 0 Human 7.7 pKi = 7.7 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 411 7 0 5 3.8 COCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1016/j.bmc.2012.08.032
CHEMBL2146803 80441 0 None - 0 Human 7.7 pKi = 7.7 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 411 7 0 5 3.8 COCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1016/j.bmc.2012.08.032
71449250 80442 0 None - 0 Human 7.7 pKi = 7.7 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 368 4 0 5 3.1 CN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccncc2c1=O 10.1016/j.bmc.2012.08.032
CHEMBL2146804 80442 0 None - 0 Human 7.7 pKi = 7.7 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 368 4 0 5 3.1 CN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccncc2c1=O 10.1016/j.bmc.2012.08.032
71458204 80447 0 None - 0 Human 6.7 pKi = 6.7 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 368 4 0 5 3.1 CN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ncccc2c1=O 10.1016/j.bmc.2012.08.032
CHEMBL2146809 80447 0 None - 0 Human 6.7 pKi = 6.7 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 368 4 0 5 3.1 CN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ncccc2c1=O 10.1016/j.bmc.2012.08.032
25071621 19068 0 None - 0 Human 6.7 pKi = 6.7 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 432 3 1 5 4.5 O=C1OC2(CCN(c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccc1 10.1016/j.bmcl.2010.09.064
CHEMBL1289154 19068 0 None - 0 Human 6.7 pKi = 6.7 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 432 3 1 5 4.5 O=C1OC2(CCN(c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccc1 10.1016/j.bmcl.2010.09.064
25073191 19119 0 None - 0 Human 5.7 pKi = 5.7 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 432 3 1 5 4.9 O=C1O[C@]2(CC[C@H](c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccn1 10.1016/j.bmcl.2010.09.064
CHEMBL1289503 19119 0 None - 0 Human 5.7 pKi = 5.7 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 432 3 1 5 4.9 O=C1O[C@]2(CC[C@H](c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccn1 10.1016/j.bmcl.2010.09.064
25071931 19169 0 None - 0 Human 5.7 pKi = 5.7 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 415 2 1 3 5.6 O=C1O[C@]2(CC[C@H](c3nc4cc(C(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccc1 10.1016/j.bmcl.2010.09.064
CHEMBL1289820 19169 0 None - 0 Human 5.7 pKi = 5.7 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 415 2 1 3 5.6 O=C1O[C@]2(CC[C@H](c3nc4cc(C(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccc1 10.1016/j.bmcl.2010.09.064
53327748 63358 0 None - 0 Human 8.6 pKi = 8.6 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in HEK293 cells assessed as inhibition of norepinephrine-induced [3H]inositol phosphate hydrolysis by scintillation countingAntagonist activity at human adrenergic alpha1A receptor expressed in HEK293 cells assessed as inhibition of norepinephrine-induced [3H]inositol phosphate hydrolysis by scintillation counting
ChEMBL 435 8 0 5 3.5 COc1ccccc1N1CCN(CCCCN2C(=O)CC(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796033 63358 0 None - 0 Human 8.6 pKi = 8.6 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in HEK293 cells assessed as inhibition of norepinephrine-induced [3H]inositol phosphate hydrolysis by scintillation countingAntagonist activity at human adrenergic alpha1A receptor expressed in HEK293 cells assessed as inhibition of norepinephrine-induced [3H]inositol phosphate hydrolysis by scintillation counting
ChEMBL 435 8 0 5 3.5 COc1ccccc1N1CCN(CCCCN2C(=O)CC(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
44288864 163438 0 None - 0 Human 6.6 pKi = 6.6 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 507 7 1 5 3.6 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccccn3)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
CHEMBL41996 163438 0 None - 0 Human 6.6 pKi = 6.6 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 507 7 1 5 3.6 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccccn3)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
44289103 155600 0 None - 0 Human 8.5 pKi = 8.5 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 506 7 1 4 4.4 CC1=C(C(=O)NCCCN2CCC(c3ccccc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
CHEMBL40464 155600 0 None - 0 Human 8.5 pKi = 8.5 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 506 7 1 4 4.4 CC1=C(C(=O)NCCCN2CCC(c3ccccc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
44288858 169131 0 None - 0 Human 8.5 pKi = 8.5 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 517 7 2 5 3.8 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccccc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
CHEMBL44042 169131 0 None - 0 Human 8.5 pKi = 8.5 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 517 7 2 5 3.8 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccccc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
49864841 15699 0 None - 0 Human 8.4 pKi = 8.4 Functional
Antagonist activity at human adrenergic alpha1A receptor assessed as intracellular calcium luminescence by cell based aequorin assayAntagonist activity at human adrenergic alpha1A receptor assessed as intracellular calcium luminescence by cell based aequorin assay
ChEMBL 266 1 1 4 1.6 C1=C(N2CCNCC2)c2nccn2Cc2ccccc21 10.1016/j.bmcl.2010.07.029
CHEMBL1222552 15699 0 None - 0 Human 8.4 pKi = 8.4 Functional
Antagonist activity at human adrenergic alpha1A receptor assessed as intracellular calcium luminescence by cell based aequorin assayAntagonist activity at human adrenergic alpha1A receptor assessed as intracellular calcium luminescence by cell based aequorin assay
ChEMBL 266 1 1 4 1.6 C1=C(N2CCNCC2)c2nccn2Cc2ccccc21 10.1016/j.bmcl.2010.07.029
53327991 63371 0 None - 0 Human 7.5 pKi = 7.5 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in HEK293 cells assessed as inhibition of norepinephrine-induced [3H]inositol phosphate hydrolysis by scintillation countingAntagonist activity at human adrenergic alpha1A receptor expressed in HEK293 cells assessed as inhibition of norepinephrine-induced [3H]inositol phosphate hydrolysis by scintillation counting
ChEMBL 449 8 0 5 3.7 COc1ccccc1N1CCN(CCCCN2C(=O)CC(C)(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796046 63371 0 None - 0 Human 7.5 pKi = 7.5 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in HEK293 cells assessed as inhibition of norepinephrine-induced [3H]inositol phosphate hydrolysis by scintillation countingAntagonist activity at human adrenergic alpha1A receptor expressed in HEK293 cells assessed as inhibition of norepinephrine-induced [3H]inositol phosphate hydrolysis by scintillation counting
ChEMBL 449 8 0 5 3.7 COc1ccccc1N1CCN(CCCCN2C(=O)CC(C)(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
15254720 61271 0 None - 0 Human 7.5 pKi = 7.5 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 367 4 0 4 3.7 CN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1016/j.bmc.2012.08.032
CHEMBL1767136 61271 0 None - 0 Human 7.5 pKi = 7.5 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 367 4 0 4 3.7 CN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1016/j.bmc.2012.08.032
24804150 80451 0 None - 0 Human 7.5 pKi = 7.5 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 641 14 0 7 7.2 O=c1c2ccncc2c(Cc2ccc(Cl)cc2)nn1C[C@H]1CCCN1CCCCc1ccc(OCCCN2CCCCCC2)cc1 10.1016/j.bmc.2012.08.032
CHEMBL2146813 80451 0 None - 0 Human 7.5 pKi = 7.5 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 641 14 0 7 7.2 O=c1c2ccncc2c(Cc2ccc(Cl)cc2)nn1C[C@H]1CCCN1CCCCc1ccc(OCCCN2CCCCCC2)cc1 10.1016/j.bmc.2012.08.032
71456360 80446 0 None - 0 Human 6.5 pKi = 6.5 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 412 7 0 6 3.1 COCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2cccnc2c1=O 10.1016/j.bmc.2012.08.032
CHEMBL2146808 80446 0 None - 0 Human 6.5 pKi = 6.5 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 412 7 0 6 3.1 COCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2cccnc2c1=O 10.1016/j.bmc.2012.08.032
2419 692 28 None - 3 Human 6.4 pKi = 6.4 Functional
Affinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assayAffinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm021078o
9 692 28 None - 3 Human 6.4 pKi = 6.4 Functional
Affinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assayAffinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm021078o
CHEMBL13647 692 28 None - 3 Human 6.4 pKi = 6.4 Functional
Affinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assayAffinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm021078o
17747460 61299 12 None - 2 Human 7.4 pKi = 7.4 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 640 14 0 6 7.8 O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C[C@H]1CCCN1CCCCc1ccc(OCCCN2CCCCCC2)cc1 10.1016/j.bmc.2012.08.032
CHEMBL1767164 61299 12 None - 2 Human 7.4 pKi = 7.4 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 640 14 0 6 7.8 O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C[C@H]1CCCN1CCCCc1ccc(OCCCN2CCCCCC2)cc1 10.1016/j.bmc.2012.08.032
25071929 19047 0 None - 0 Human 7.4 pKi = 7.4 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 426 2 1 4 4.3 O=C1OC2(CCN(c3nc4cc(Br)ccc4[nH]3)CC2)CN1c1ccccc1 10.1016/j.bmcl.2010.09.064
CHEMBL1289038 19047 0 None - 0 Human 7.4 pKi = 7.4 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 426 2 1 4 4.3 O=C1OC2(CCN(c3nc4cc(Br)ccc4[nH]3)CC2)CN1c1ccccc1 10.1016/j.bmcl.2010.09.064
71456361 80450 0 None - 0 Human 6.4 pKi = 6.4 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 369 4 0 6 2.5 CN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2nccnc2c1=O 10.1016/j.bmc.2012.08.032
CHEMBL2146812 80450 0 None - 0 Human 6.4 pKi = 6.4 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 369 4 0 6 2.5 CN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2nccnc2c1=O 10.1016/j.bmc.2012.08.032
44288729 163715 0 None - 0 Human 7.4 pKi = 7.4 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 507 7 2 5 3.5 CC1=C(C(=O)NCC(C)CN2CCC(C#N)(c3ccccn3)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
CHEMBL42053 163715 0 None - 0 Human 7.4 pKi = 7.4 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 507 7 2 5 3.5 CC1=C(C(=O)NCC(C)CN2CCC(C#N)(c3ccccn3)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
2267 557 71 None -45 14 Human 7.3 pKi = 7.3 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1016/j.bmc.2012.08.032
271 557 71 None -45 14 Human 7.3 pKi = 7.3 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1016/j.bmc.2012.08.032
7121 557 71 None -45 14 Human 7.3 pKi = 7.3 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1016/j.bmc.2012.08.032
CHEMBL639 557 71 None -45 14 Human 7.3 pKi = 7.3 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1016/j.bmc.2012.08.032
DB00972 557 71 None -45 14 Human 7.3 pKi = 7.3 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1016/j.bmc.2012.08.032
71454639 80448 0 None - 0 Human 7.3 pKi = 7.3 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 410 7 0 5 4.3 CCCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ncccc2c1=O 10.1016/j.bmc.2012.08.032
CHEMBL2146810 80448 0 None - 0 Human 7.3 pKi = 7.3 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 410 7 0 5 4.3 CCCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ncccc2c1=O 10.1016/j.bmc.2012.08.032
25073801 19152 0 None - 0 Human 6.3 pKi = 6.3 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 450 3 1 5 5.0 O=C1O[C@]2(CC[C@H](c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1cccc(F)n1 10.1016/j.bmcl.2010.09.064
CHEMBL1289714 19152 0 None - 0 Human 6.3 pKi = 6.3 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 450 3 1 5 5.0 O=C1O[C@]2(CC[C@H](c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1cccc(F)n1 10.1016/j.bmcl.2010.09.064
71461782 80444 0 None - 0 Human 8.2 pKi = 8.2 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 410 7 0 5 4.3 CCCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2cnccc2c1=O 10.1016/j.bmc.2012.08.032
CHEMBL2146806 80444 0 None - 0 Human 8.2 pKi = 8.2 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 410 7 0 5 4.3 CCCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2cnccc2c1=O 10.1016/j.bmc.2012.08.032
71452872 80405 0 None - 0 Human 6.2 pKi = 6.2 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 368 4 0 5 3.1 CN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2cccnc2c1=O 10.1016/j.bmc.2012.08.032
CHEMBL2146484 80405 0 None - 0 Human 6.2 pKi = 6.2 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 368 4 0 5 3.1 CN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2cccnc2c1=O 10.1016/j.bmc.2012.08.032
44288877 168575 0 None - 0 Human 8.2 pKi = 8.2 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 549 7 1 5 4.3 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
CHEMBL43594 168575 0 None - 0 Human 8.2 pKi = 8.2 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 549 7 1 5 4.3 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
25073189 19083 0 None - 0 Human 6.1 pKi = 6.1 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 449 3 1 4 5.7 O=C1O[C@]2(CC[C@H](c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccc1F 10.1016/j.bmcl.2010.09.064
CHEMBL1289268 19083 0 None - 0 Human 6.1 pKi = 6.1 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 449 3 1 4 5.7 O=C1O[C@]2(CC[C@H](c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccc1F 10.1016/j.bmcl.2010.09.064
25072880 19102 0 None - 0 Human 6.1 pKi = 6.1 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 449 3 1 4 5.7 O=C1O[C@]2(CC[C@H](c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1ccc(F)cc1 10.1016/j.bmcl.2010.09.064
CHEMBL1289386 19102 0 None - 0 Human 6.1 pKi = 6.1 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 449 3 1 4 5.7 O=C1O[C@]2(CC[C@H](c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1ccc(F)cc1 10.1016/j.bmcl.2010.09.064
135398745 2893 112 None -2 33 Rat 7.4 pA2 = 7.4 Functional
Measured as antagonism of phenylephrine-induced contraction of endothelium-denuded rat small mesenteric artery.Measured as antagonism of phenylephrine-induced contraction of endothelium-denuded rat small mesenteric artery.
Guide to Pharmacology 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 18542932
47 2893 112 None -2 33 Rat 7.4 pA2 = 7.4 Functional
Measured as antagonism of phenylephrine-induced contraction of endothelium-denuded rat small mesenteric artery.Measured as antagonism of phenylephrine-induced contraction of endothelium-denuded rat small mesenteric artery.
Guide to Pharmacology 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 18542932
CHEMBL715 2893 112 None -2 33 Rat 7.4 pA2 = 7.4 Functional
Measured as antagonism of phenylephrine-induced contraction of endothelium-denuded rat small mesenteric artery.Measured as antagonism of phenylephrine-induced contraction of endothelium-denuded rat small mesenteric artery.
Guide to Pharmacology 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 18542932
DB00334 2893 112 None -2 33 Rat 7.4 pA2 = 7.4 Functional
Measured as antagonism of phenylephrine-induced contraction of endothelium-denuded rat small mesenteric artery.Measured as antagonism of phenylephrine-induced contraction of endothelium-denuded rat small mesenteric artery.
Guide to Pharmacology 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 18542932
41835 217687 0 None -54 2 Human 6.1 pA2 = 6.1 Functional
NoneNone
Drug Central 372 8 4 6 1.9 CC(CCC1=CC2=C(OCO2)C=C1)NCC(O)C1=CC(C(N)=O)=C(O)C=C1 None
1753 2487 28 None 2 4 Human 8.3 pEC50 = 8.3 Functional
NoneNone
Drug Central 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC None
483 2487 28 None 2 4 Human 8.3 pEC50 = 8.3 Functional
NoneNone
Drug Central 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC None
6082 2487 28 None 2 4 Human 8.3 pEC50 = 8.3 Functional
NoneNone
Drug Central 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC None
CHEMBL524 2487 28 None 2 4 Human 8.3 pEC50 = 8.3 Functional
NoneNone
Drug Central 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC None
DB00723 2487 28 None 2 4 Human 8.3 pEC50 = 8.3 Functional
NoneNone
Drug Central 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC None
2435 719 100 None -25 10 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
395 719 100 None -25 10 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
520 719 100 None -25 10 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
5386 719 100 None -25 10 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
CHEMBL844 719 100 None -25 10 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
DB00484 719 100 None -25 10 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
521 1392 69 None -501 5 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C None
5311068 1392 69 None -501 5 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C None
835 1392 69 None -501 5 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C None
CHEMBL778 1392 69 None -501 5 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C None
DB00633 1392 69 None -501 5 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C None
2683 3805 60 None 1 6 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 None
5487 3805 60 None 1 6 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 None
7308 3805 60 None 1 6 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 None
CHEMBL1079 3805 60 None 1 6 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 None
DB00697 3805 60 None 1 6 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 None
2803 952 58 None -6 14 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
516 952 58 None -6 14 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
704 952 58 None -6 14 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
CHEMBL134 952 58 None -6 14 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
DB00575 952 58 None -6 14 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
1753 2487 28 None 2 4 Human 6.3 pEC50 = 6.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 20978120
1753 2487 28 None 2 4 Human 6.3 pEC50 = 6.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 28444738
1753 2487 28 None 2 4 Human 6.3 pEC50 = 6.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 34355529
483 2487 28 None 2 4 Human 6.3 pEC50 = 6.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 20978120
483 2487 28 None 2 4 Human 6.3 pEC50 = 6.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 28444738
483 2487 28 None 2 4 Human 6.3 pEC50 = 6.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 34355529
6082 2487 28 None 2 4 Human 6.3 pEC50 = 6.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 20978120
6082 2487 28 None 2 4 Human 6.3 pEC50 = 6.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 28444738
6082 2487 28 None 2 4 Human 6.3 pEC50 = 6.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 34355529
CHEMBL524 2487 28 None 2 4 Human 6.3 pEC50 = 6.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 20978120
CHEMBL524 2487 28 None 2 4 Human 6.3 pEC50 = 6.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 28444738
CHEMBL524 2487 28 None 2 4 Human 6.3 pEC50 = 6.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 34355529
DB00723 2487 28 None 2 4 Human 6.3 pEC50 = 6.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 20978120
DB00723 2487 28 None 2 4 Human 6.3 pEC50 = 6.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 28444738
DB00723 2487 28 None 2 4 Human 6.3 pEC50 = 6.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 34355529
2146 3078 67 None -20 15 Human 6.6 pEC50 = 6.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 20978120
2146 3078 67 None -20 15 Human 6.6 pEC50 = 6.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 28444738
2146 3078 67 None -20 15 Human 6.6 pEC50 = 6.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 34355529
485 3078 67 None -20 15 Human 6.6 pEC50 = 6.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 20978120
485 3078 67 None -20 15 Human 6.6 pEC50 = 6.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 28444738
485 3078 67 None -20 15 Human 6.6 pEC50 = 6.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 34355529
6041 3078 67 None -20 15 Human 6.6 pEC50 = 6.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 20978120
6041 3078 67 None -20 15 Human 6.6 pEC50 = 6.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 28444738
6041 3078 67 None -20 15 Human 6.6 pEC50 = 6.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 34355529
CHEMBL1215 3078 67 None -20 15 Human 6.6 pEC50 = 6.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 20978120
CHEMBL1215 3078 67 None -20 15 Human 6.6 pEC50 = 6.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 28444738
CHEMBL1215 3078 67 None -20 15 Human 6.6 pEC50 = 6.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 34355529
DB00388 3078 67 None -20 15 Human 6.6 pEC50 = 6.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 20978120
DB00388 3078 67 None -20 15 Human 6.6 pEC50 = 6.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 28444738
DB00388 3078 67 None -20 15 Human 6.6 pEC50 = 6.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 34355529
1960 2838 67 None -2 19 Human 7.1 pEC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 20978120
1960 2838 67 None -2 19 Human 7.1 pEC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 28444738
1960 2838 67 None -2 19 Human 7.1 pEC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 34355529
439260 2838 67 None -2 19 Human 7.1 pEC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 20978120
439260 2838 67 None -2 19 Human 7.1 pEC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 28444738
439260 2838 67 None -2 19 Human 7.1 pEC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 34355529
505 2838 67 None -2 19 Human 7.1 pEC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 20978120
505 2838 67 None -2 19 Human 7.1 pEC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 28444738
505 2838 67 None -2 19 Human 7.1 pEC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 34355529
CHEMBL1437 2838 67 None -2 19 Human 7.1 pEC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 20978120
CHEMBL1437 2838 67 None -2 19 Human 7.1 pEC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 28444738
CHEMBL1437 2838 67 None -2 19 Human 7.1 pEC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 34355529
DB00368 2838 67 None -2 19 Human 7.1 pEC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 20978120
DB00368 2838 67 None -2 19 Human 7.1 pEC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 28444738
DB00368 2838 67 None -2 19 Human 7.1 pEC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 34355529
1028 289 71 None 1 19 Human 7.4 pEC50 = 7.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 34355529
139148732 289 71 None 1 19 Human 7.4 pEC50 = 7.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 34355529
479 289 71 None 1 19 Human 7.4 pEC50 = 7.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 34355529
5816 289 71 None 1 19 Human 7.4 pEC50 = 7.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 34355529
CHEMBL679 289 71 None 1 19 Human 7.4 pEC50 = 7.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 34355529
DB00668 289 71 None 1 19 Human 7.4 pEC50 = 7.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 34355529
11079 2714 63 None 5 7 Human 7.8 pEC50 = 7.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 34355529
3369 2714 63 None 5 7 Human 7.8 pEC50 = 7.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 34355529
4436 2714 63 None 5 7 Human 7.8 pEC50 = 7.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 34355529
5509 2714 63 None 5 7 Human 7.8 pEC50 = 7.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 34355529
CHEMBL761 2714 63 None 5 7 Human 7.8 pEC50 = 7.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 34355529
DB06711 2714 63 None 5 7 Human 7.8 pEC50 = 7.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 34355529
2765 940 19 None 4 7 Human 8.1 pEC50 = 8.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 20978120
2765 940 19 None 4 7 Human 8.1 pEC50 = 8.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 34355529
515 940 19 None 4 7 Human 8.1 pEC50 = 8.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 20978120
515 940 19 None 4 7 Human 8.1 pEC50 = 8.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 34355529
CHEMBL13852 940 19 None 4 7 Human 8.1 pEC50 = 8.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 20978120
CHEMBL13852 940 19 None 4 7 Human 8.1 pEC50 = 8.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 34355529
DB09202 940 19 None 4 7 Human 8.1 pEC50 = 8.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 20978120
DB09202 940 19 None 4 7 Human 8.1 pEC50 = 8.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 34355529
124 2960 47 None -8 25 Human 8.3 pEC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 20978120
124 2960 47 None -8 25 Human 8.3 pEC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 28444738
124 2960 47 None -8 25 Human 8.3 pEC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 34355529
2032 2960 47 None -8 25 Human 8.3 pEC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 20978120
2032 2960 47 None -8 25 Human 8.3 pEC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 28444738
2032 2960 47 None -8 25 Human 8.3 pEC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 34355529
4636 2960 47 None -8 25 Human 8.3 pEC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 20978120
4636 2960 47 None -8 25 Human 8.3 pEC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 28444738
4636 2960 47 None -8 25 Human 8.3 pEC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 34355529
CHEMBL762 2960 47 None -8 25 Human 8.3 pEC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 20978120
CHEMBL762 2960 47 None -8 25 Human 8.3 pEC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 28444738
CHEMBL762 2960 47 None -8 25 Human 8.3 pEC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 34355529
DB00935 2960 47 None -8 25 Human 8.3 pEC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 20978120
DB00935 2960 47 None -8 25 Human 8.3 pEC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 28444738
DB00935 2960 47 None -8 25 Human 8.3 pEC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 34355529
4038180 204 14 None -1 6 Human 8.9 pEC50 = 8.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 20978120
4038180 204 14 None -1 6 Human 8.9 pEC50 = 8.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 28444738
4038180 204 14 None -1 6 Human 8.9 pEC50 = 8.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 34355529
4038180 204 14 None -1 6 Human 8.9 pEC50 = 8.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 7616455
480 204 14 None -1 6 Human 8.9 pEC50 = 8.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 20978120
480 204 14 None -1 6 Human 8.9 pEC50 = 8.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 28444738
480 204 14 None -1 6 Human 8.9 pEC50 = 8.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 34355529
480 204 14 None -1 6 Human 8.9 pEC50 = 8.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 7616455
CHEMBL109783 204 14 None -1 6 Human 8.9 pEC50 = 8.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 20978120
CHEMBL109783 204 14 None -1 6 Human 8.9 pEC50 = 8.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 28444738
CHEMBL109783 204 14 None -1 6 Human 8.9 pEC50 = 8.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 34355529
CHEMBL109783 204 14 None -1 6 Human 8.9 pEC50 = 8.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 7616455
135 2515 43 None -2 33 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
1796 2515 43 None -2 33 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
4184 2515 43 None -2 33 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
CHEMBL6437 2515 43 None -2 33 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
DB06148 2515 43 None -2 33 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
2398 951 62 None -2 36 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C None
2801 951 62 None -2 36 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C None
701 951 62 None -2 36 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C None
CHEMBL415 951 62 None -2 36 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C None
DB01242 951 62 None -2 36 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C None
1971 2846 38 None -6 32 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 None
2404 2846 38 None -6 32 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 None
4543 2846 38 None -6 32 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 None
CHEMBL445 2846 38 None -6 32 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 None
DB00540 2846 38 None -6 32 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 None
180 400 56 None -3 38 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C None
200 400 56 None -3 38 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C None
2160 400 56 None -3 38 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C None
CHEMBL629 400 56 None -3 38 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C None
DB00321 400 56 None -3 38 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C None
1225 1459 26 None -5 11 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 279 3 0 2 4.0 CN(CC/C=C\1/c2ccccc2OCc2c1cccc2)C None
3958 1459 26 None -5 11 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 279 3 0 2 4.0 CN(CC/C=C\1/c2ccccc2OCc2c1cccc2)C None
667477 1459 26 None -5 11 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 279 3 0 2 4.0 CN(CC/C=C\1/c2ccccc2OCc2c1cccc2)C None
CHEMBL860 1459 26 None -5 11 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 279 3 0 2 4.0 CN(CC/C=C\1/c2ccccc2OCc2c1cccc2)C None
DB01142 1459 26 None -5 11 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 279 3 0 2 4.0 CN(CC/C=C\1/c2ccccc2OCc2c1cccc2)C None
3823 50191 42 None 5 16 Rat 8.4 pIC50 = 8.4 Functional
NoneNone
Drug Central 530 7 0 7 4.2 CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 None
76973198 50191 42 None 5 16 Rat 8.4 pIC50 = 8.4 Functional
NoneNone
Drug Central 530 7 0 7 4.2 CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 None
CHEMBL157101 50191 42 None 5 16 Rat 8.4 pIC50 = 8.4 Functional
NoneNone
Drug Central 530 7 0 7 4.2 CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 None
2812 4747 101 None -3 44 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 344 4 0 2 5.4 Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 None
CHEMBL104 4747 101 None -3 44 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 344 4 0 2 5.4 Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 None
1016 3720 78 None -41 40 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 None
2561 3720 78 None -41 40 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 None
2733526 3720 78 None -41 40 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 None
5384 3720 78 None -41 40 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 None
CHEMBL83 3720 78 None -41 40 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 None
DB00675 3720 78 None -41 40 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 None
3198 205490 76 None -1 37 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 None
CHEMBL1201049 205490 76 None -1 37 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 None
CHEMBL808 205490 76 None -1 37 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 None
448537 160226 89 None 8 31 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 None
CHEMBL411 160226 89 None 8 31 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 None
441383 20301 57 None -2 20 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 531 8 0 8 4.5 CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 None
CHEMBL1306 20301 57 None -2 20 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 531 8 0 8 4.5 CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 None
10219 188772 37 None -1 10 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 None
CHEMBL493439 188772 37 None -1 10 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 None
CHEMBL50588 188772 37 None -1 10 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 None
1599 2326 50 None -97 21 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 None
3955 2326 50 None -97 21 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 None
7215 2326 50 None -97 21 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 None
CHEMBL841 2326 50 None -97 21 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 None
DB00836 2326 50 None -97 21 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 None
2291 3162 58 None -3 13 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O None
2561 3162 58 None -3 13 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O None
4932 3162 58 None -3 13 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O None
CHEMBL631 3162 58 None -3 13 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O None
DB01182 3162 58 None -3 13 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O None
1935 3707 97 None -1 12 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 198 0 1 2 2.7 Nc1c2CCCCc2nc2c1cccc2 None
2551 3707 97 None -1 12 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 198 0 1 2 2.7 Nc1c2CCCCc2nc2c1cccc2 None
6687 3707 97 None -1 12 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 198 0 1 2 2.7 Nc1c2CCCCc2nc2c1cccc2 None
CHEMBL95 3707 97 None -1 12 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 198 0 1 2 2.7 Nc1c2CCCCc2nc2c1cccc2 None
DB00382 3707 97 None -1 12 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 198 0 1 2 2.7 Nc1c2CCCCc2nc2c1cccc2 None
3191 102831 97 None -6 33 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 469 9 0 3 7.2 CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1 None
CHEMBL305660 102831 97 None -6 33 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 469 9 0 3 7.2 CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1 None
2351 3261 64 None -16 27 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O None
2820 3261 64 None -16 27 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O None
5035 3261 64 None -16 27 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O None
CHEMBL81 3261 64 None -16 27 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O None
DB00481 3261 64 None -16 27 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O None
2520 203985 70 None 1 20 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC None
CHEMBL1280 203985 70 None 1 20 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC None
CHEMBL6966 203985 70 None 1 20 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC None
2105 3032 37 None -22 25 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
47811 3032 37 None -22 25 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
48 3032 37 None -22 25 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
CHEMBL531 3032 37 None -22 25 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
DB01186 3032 37 None -22 25 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
1547484 937 74 None -1 26 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 None
654 937 74 None -1 26 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 None
9072 937 74 None -1 26 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 None
CHEMBL43064 937 74 None -1 26 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 None
DB00568 937 74 None -1 26 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 None
2771 194994 74 None 3 16 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 None
CHEMBL1200781 194994 74 None 3 16 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 None
CHEMBL549 194994 74 None 3 16 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 None
1343 1876 62 None -7 12 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
3519 1876 62 None -7 12 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
522 1876 62 None -7 12 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
CHEMBL862 1876 62 None -7 12 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
DB01018 1876 62 None -7 12 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
102 4096 48 None -12 20 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
3659 4096 48 None -12 20 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
8969 4096 48 None -12 20 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
CHEMBL15245 4096 48 None -12 20 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
DB01392 4096 48 None -12 20 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
4735 195092 96 None 7 14 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 340 10 4 4 2.9 N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1 None
CHEMBL361506 195092 96 None 7 14 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 340 10 4 4 2.9 N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1 None
CHEMBL55 195092 96 None 7 14 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 340 10 4 4 2.9 N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1 None
12488 1644 56 None -2 28 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F None
941361 1644 56 None -2 28 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F None
CHEMBL30008 1644 56 None -2 28 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F None
DB04841 1644 56 None -2 28 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F None
1028 289 71 None -3 19 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
139148732 289 71 None -3 19 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
479 289 71 None -3 19 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
5816 289 71 None -3 19 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
CHEMBL679 289 71 None -3 19 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
DB00668 289 71 None -3 19 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
4011 82379 49 None -7 26 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 277 4 1 1 4.2 CNCCCC12CCC(c3ccccc31)c1ccccc12 None
CHEMBL21731 82379 49 None -7 26 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 277 4 1 1 4.2 CNCCCC12CCC(c3ccccc31)c1ccccc12 None
3952 1875 38 None -5 21 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
5353646 1875 38 None -5 21 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
5443 1875 38 None -5 21 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
5702063 1875 38 None -5 21 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
CHEMBL1331786 1875 38 None -5 21 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
CHEMBL420 1875 38 None -5 21 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
191 402 98 None -7 36 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 None
201 402 98 None -7 36 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 None
2170 402 98 None -7 36 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 None
CHEMBL1113 402 98 None -7 36 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 None
DB00543 402 98 None -7 36 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 None
3151 1450 97 None -16 24 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 None
945 1450 97 None -16 24 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 None
965 1450 97 None -16 24 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 None
CHEMBL219916 1450 97 None -16 24 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 None
DB01184 1450 97 None -16 24 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 None
277 1289 62 None -40 29 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 None
2913 1289 62 None -40 29 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 None
765 1289 62 None -40 29 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 None
CHEMBL516 1289 62 None -40 29 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 None
DB00434 1289 62 None -40 29 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 None
6075 150084 42 None -1 20 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 310 2 0 3 4.6 CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1 None
CHEMBL395110 150084 42 None -1 20 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 310 2 0 3 4.6 CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1 None
1201549 594 24 None -15 26 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 None
333 594 24 None -15 26 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 None
7601 594 24 None -15 26 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 None
CHEMBL1201203 594 24 None -15 26 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 None
CHEMBL438151 594 24 None -15 26 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 None
DB00245 594 24 None -15 26 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 None
213 3824 55 None -3 22 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
2717 3824 55 None -3 22 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
5533 3824 55 None -3 22 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
CHEMBL621 3824 55 None -3 22 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
DB00656 3824 55 None -3 22 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
36811 1442 37 None 1 17 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O None
535 1442 37 None 1 17 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O None
937 1442 37 None 1 17 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O None
CHEMBL926 1442 37 None 1 17 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O None
DB00841 1442 37 None 1 17 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O None
3033538 1307 39 None -3 13 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 None
7155 1307 39 None -3 13 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 None
781 1307 39 None -3 13 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 None
CHEMBL1201216 1307 39 None -3 13 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 None
DB00298 1307 39 None -3 13 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 None
133 2479 52 None -66 28 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C None
1723 2479 52 None -66 28 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C None
28693 2479 52 None -66 28 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C None
CHEMBL19215 2479 52 None -66 28 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C None
DB13520 2479 52 None -66 28 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C None
2337 3232 77 None -4 29 Human 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
50 3232 77 None -4 29 Human 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
5002 3232 77 None -4 29 Human 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
CHEMBL716 3232 77 None -4 29 Human 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
DB01224 3232 77 None -4 29 Human 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
2337 3232 77 None -1 29 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
50 3232 77 None -1 29 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
5002 3232 77 None -1 29 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
CHEMBL716 3232 77 None -1 29 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
DB01224 3232 77 None -1 29 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
2286 3161 51 None -5 28 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C None
4927 3161 51 None -5 28 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C None
7282 3161 51 None -5 28 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C None
CHEMBL643 3161 51 None -5 28 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C None
DB01069 3161 51 None -5 28 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C None
135398745 2893 112 None -2 33 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
47 2893 112 None -2 33 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
CHEMBL715 2893 112 None -2 33 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
DB00334 2893 112 None -2 33 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
1531 2253 69 None -2 12 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O None
3869 2253 69 None -2 12 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O None
7207 2253 69 None -2 12 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O None
CHEMBL429 2253 69 None -2 12 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O None
DB00598 2253 69 None -2 12 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O None
2136 3073 30 None 1 21 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 None
4768 3073 30 None 1 21 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 None
7268 3073 30 None 1 21 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 None
CHEMBL753 3073 30 None 1 21 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 None
DB00925 3073 30 None 1 21 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 None
26987 946 33 None -16 34 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C None
6063 946 33 None -16 34 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C None
671 946 33 None -16 34 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C None
CHEMBL1626 946 33 None -16 34 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C None
DB00283 946 33 None -16 34 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C None
2274 3151 58 None 1 37 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
4917 3151 58 None 1 37 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
7279 3151 58 None 1 37 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
CHEMBL728 3151 58 None 1 37 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
DB00433 3151 58 None 1 37 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
1427 2000 54 None -112 30 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C None
357 2000 54 None -112 30 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C None
3696 2000 54 None -112 30 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C None
CHEMBL11 2000 54 None -112 30 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C None
DB00458 2000 54 None -112 30 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C None
2247 504 81 None 4 42 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 None
249 504 81 None 4 42 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 None
2603 504 81 None 4 42 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 None
CHEMBL296419 504 81 None 4 42 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 None
DB00637 504 81 None 4 42 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 None
1212 1649 50 None -6 35 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
204 1649 50 None -6 35 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
3372 1649 50 None -6 35 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
CHEMBL726 1649 50 None -6 35 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
DB00623 1649 50 None -6 35 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
1588 2311 27 None -77 23 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
28864 2311 27 None -77 23 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
43 2311 27 None -77 23 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
CHEMBL157138 2311 27 None -77 23 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
DB00589 2311 27 None -77 23 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
180 400 56 None -63 38 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C None
200 400 56 None -63 38 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C None
2160 400 56 None -63 38 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C None
CHEMBL629 400 56 None -63 38 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C None
DB00321 400 56 None -63 38 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C None
100 3776 58 None -8 38 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
2637 3776 58 None -8 38 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
5452 3776 58 None -8 38 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
CHEMBL479 3776 58 None -8 38 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
DB00679 3776 58 None -8 38 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
134551 357 27 None -15 17 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C None
271 357 27 None -15 17 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C None
885 357 27 None -15 17 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C None
CHEMBL1403281 357 27 None -15 17 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C None
2142 3074 58 None 1 18 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
4920903 3074 58 None 1 18 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
502 3074 58 None 1 18 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
5775 3074 58 None 1 18 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
CHEMBL597 3074 58 None 1 18 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
DB00692 3074 58 None 1 18 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
2284 3160 33 None -1 34 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C None
4926 3160 33 None -1 34 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C None
7281 3160 33 None -1 34 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C None
CHEMBL564 3160 33 None -1 34 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C None
DB00420 3160 33 None -1 34 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C None
2726 916 68 None -3 42 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
621 916 68 None -3 42 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
83 916 68 None -3 42 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
CHEMBL71 916 68 None -3 42 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
DB00477 916 68 None -3 42 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
11954224 215928 0 None -1 5 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 581 4 3 6 2.0 CC1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CN(C6CC7=CNC8=CC=CC(=C78)C6=C5)C None
2585 800 103 None -10 34 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
522 800 103 None -10 34 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
551 800 103 None -10 34 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
CHEMBL723 800 103 None -10 34 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
DB01136 800 103 None -10 34 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
31101 726 40 None -2 29 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
35 726 40 None -2 29 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
403 726 40 None -2 29 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
CHEMBL493 726 40 None -2 29 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
DB01200 726 40 None -2 29 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
100 3776 58 None -1 38 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
2637 3776 58 None -1 38 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
5452 3776 58 None -1 38 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
CHEMBL479 3776 58 None -1 38 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
DB00679 3776 58 None -1 38 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
6761 67770 19 None -3 17 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 401 5 1 4 4.5 NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1 None
CHEMBL1909072 67770 19 None -3 17 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 401 5 1 4 4.5 NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1 None
10531 1408 21 None -7 26 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O None
121 1408 21 None -7 26 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O None
888 1408 21 None -7 26 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O None
CHEMBL1732 1408 21 None -7 26 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O None
DB00320 1408 21 None -7 26 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O None
3168 9230 92 None -1 17 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 379 6 1 4 3.7 O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1 None
CHEMBL1108 9230 92 None -1 17 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 379 6 1 4 3.7 O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1 None
107715 200922 22 None -2 19 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 611 5 3 6 2.7 CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O None
CHEMBL1255837 200922 22 None -2 19 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 611 5 3 6 2.7 CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O None
CHEMBL601773 200922 22 None -2 19 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 611 5 3 6 2.7 CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O None
3157 1458 71 None -2 22 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 None
7170 1458 71 None -2 22 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 None
954 1458 71 None -2 22 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 None
CHEMBL707 1458 71 None -2 22 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 None
DB00590 1458 71 None -2 22 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 None
4151 3580 89 None -1 10 Rat 8.0 pIC50 = 8.0 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 mins
Drug Central 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N None
493 3580 89 None -1 10 Rat 8.0 pIC50 = 8.0 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 mins
Drug Central 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N None
5312125 3580 89 None -1 10 Rat 8.0 pIC50 = 8.0 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 mins
Drug Central 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N None
CHEMBL24778 3580 89 None -1 10 Rat 8.0 pIC50 = 8.0 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 mins
Drug Central 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N None
DB06207 3580 89 None -1 10 Rat 8.0 pIC50 = 8.0 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 mins
Drug Central 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N None
213 3824 55 None -18 22 Human 8.0 pIC50 = 8.0 Functional
NoneNone
Drug Central 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
2717 3824 55 None -18 22 Human 8.0 pIC50 = 8.0 Functional
NoneNone
Drug Central 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
5533 3824 55 None -18 22 Human 8.0 pIC50 = 8.0 Functional
NoneNone
Drug Central 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
CHEMBL621 3824 55 None -18 22 Human 8.0 pIC50 = 8.0 Functional
NoneNone
Drug Central 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
DB00656 3824 55 None -18 22 Human 8.0 pIC50 = 8.0 Functional
NoneNone
Drug Central 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
2995 204382 53 None -2 18 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 None
CHEMBL1696 204382 53 None -2 18 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 None
CHEMBL72 204382 53 None -2 18 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 None
4011 82379 49 None -8 26 Human 8.0 pIC50 = 8.0 Functional
NoneNone
Drug Central 277 4 1 1 4.2 CNCCCC12CCC(c3ccccc31)c1ccccc12 None
CHEMBL21731 82379 49 None -8 26 Human 8.0 pIC50 = 8.0 Functional
NoneNone
Drug Central 277 4 1 1 4.2 CNCCCC12CCC(c3ccccc31)c1ccccc12 None
1531 2253 69 None -1 12 Human 7.7 pIC50 = 7.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 34355529
3869 2253 69 None -1 12 Human 7.7 pIC50 = 7.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 34355529
7207 2253 69 None -1 12 Human 7.7 pIC50 = 7.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 34355529
CHEMBL429 2253 69 None -1 12 Human 7.7 pIC50 = 7.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 34355529
DB00598 2253 69 None -1 12 Human 7.7 pIC50 = 7.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 34355529




Ligands Receptor Assay information Chemical information
Sel. page Common
name
GPCRdb ID #Vendors Reference
ligand
Fold selectivity
(Affinity)
# tested GPCRs
(Affinity)
Species p-value
(-log)
Type Activity
Relation
Activity
Value
Assay Type Assay Description Source Mol
weight
Rot
Bonds
H don H acc LogP Smiles DOI
3294 1993 111 None -10 45 Human 8.7 pAC50 = 8.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1038/s41467-023-40064-9
71360 1993 111 None -10 45 Human 8.7 pAC50 = 8.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1038/s41467-023-40064-9
87 1993 111 None -10 45 Human 8.7 pAC50 = 8.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1038/s41467-023-40064-9
CHEMBL14376 1993 111 None -10 45 Human 8.7 pAC50 = 8.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1038/s41467-023-40064-9
DB04946 1993 111 None -10 45 Human 8.7 pAC50 = 8.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1038/s41467-023-40064-9
3584 3748 64 None -2 14 Human 8.0 pAC50 = 8.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
5401 3748 64 None -2 14 Human 8.0 pAC50 = 8.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
7302 3748 64 None -2 14 Human 8.0 pAC50 = 8.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
CHEMBL611 3748 64 None -2 14 Human 8.0 pAC50 = 8.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
DB01162 3748 64 None -2 14 Human 8.0 pAC50 = 8.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
31729 205761 10 None - 0 Human 5.0 pAC50 = 5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 287 6 4 4 2.4 CC(NCCc1ccc(O)cc1)C(O)c1ccc(O)cc1 10.1038/s41467-023-40064-9
CHEMBL83063 205761 10 None - 0 Human 5.0 pAC50 = 5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 287 6 4 4 2.4 CC(NCCc1ccc(O)cc1)C(O)c1ccc(O)cc1 10.1038/s41467-023-40064-9
1193 1643 108 None - 0 Human 6.0 pAC50 = 6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 281 3 2 2 4.1 OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F 10.1038/s41467-023-40064-9
2447 1643 108 None - 0 Human 6.0 pAC50 = 6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 281 3 2 2 4.1 OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F 10.1038/s41467-023-40064-9
3371 1643 108 None - 0 Human 6.0 pAC50 = 6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 281 3 2 2 4.1 OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F 10.1038/s41467-023-40064-9
CHEMBL23588 1643 108 None - 0 Human 6.0 pAC50 = 6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 281 3 2 2 4.1 OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F 10.1038/s41467-023-40064-9
DB02266 1643 108 None - 0 Human 6.0 pAC50 = 6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 281 3 2 2 4.1 OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F 10.1038/s41467-023-40064-9
5468 127202 85 None - 0 Human 5.0 pAC50 = 5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 260 4 1 3 3.2 CC(C(=O)O)c1ccc(C(=O)c2ccccc2)s1 10.1038/s41467-023-40064-9
CHEMBL365795 127202 85 None - 0 Human 5.0 pAC50 = 5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 260 4 1 3 3.2 CC(C(=O)O)c1ccc(C(=O)c2ccccc2)s1 10.1038/s41467-023-40064-9
5833 30453 74 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 416 1 0 5 4.9 CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34CCC(=O)O4)[C@H]12 10.1038/s41467-023-40064-9
CHEMBL1393 30453 74 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 416 1 0 5 4.9 CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34CCC(=O)O4)[C@H]12 10.1038/s41467-023-40064-9
1530 2169 50 None - 21 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 10.1038/s41467-023-40064-9
3827 2169 50 None - 21 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 10.1038/s41467-023-40064-9
7206 2169 50 None - 21 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 10.1038/s41467-023-40064-9
CHEMBL534 2169 50 None - 21 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 10.1038/s41467-023-40064-9
DB00920 2169 50 None - 21 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 10.1038/s41467-023-40064-9
202 1496 77 None - 33 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 10.1038/s41467-023-40064-9
60835 1496 77 None - 33 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 10.1038/s41467-023-40064-9
972 1496 77 None - 33 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL1175 1496 77 None - 33 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 10.1038/s41467-023-40064-9
DB00476 1496 77 None - 33 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 10.1038/s41467-023-40064-9
3339 203618 117 None - 5 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 360 6 0 4 4.7 CC(C)OC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1 10.1038/s41467-023-40064-9
CHEMBL672 203618 117 None - 5 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 360 6 0 4 4.7 CC(C)OC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1 10.1038/s41467-023-40064-9
4679 42731 89 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 7 1 6 2.9 COc1ccnc(C[S+]([O-])c2nc3cc(OC(F)F)ccc3[nH]2)c1OC 10.1038/s41467-023-40064-9
CHEMBL1502 42731 89 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 7 1 6 2.9 COc1ccnc(C[S+]([O-])c2nc3cc(OC(F)F)ccc3[nH]2)c1OC 10.1038/s41467-023-40064-9
2762 3834 31 None - 2 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 6 0 3 2.7 CN(CCN(c1ccccn1)Cc1ccccc1)C 10.1038/s41467-023-40064-9
5587 3834 31 None - 2 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 6 0 3 2.7 CN(CCN(c1ccccn1)Cc1ccccc1)C 10.1038/s41467-023-40064-9
7318 3834 31 None - 2 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 6 0 3 2.7 CN(CCN(c1ccccn1)Cc1ccccc1)C 10.1038/s41467-023-40064-9
CHEMBL1241 3834 31 None - 2 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 6 0 3 2.7 CN(CCN(c1ccccn1)Cc1ccccc1)C 10.1038/s41467-023-40064-9
DB00792 3834 31 None - 2 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 6 0 3 2.7 CN(CCN(c1ccccn1)Cc1ccccc1)C 10.1038/s41467-023-40064-9
154257 178595 67 None - 0 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 470 7 2 5 6.3 Cc1c(-c2ccc(O)cc2)n(Cc2ccc(OCCN3CCCCCC3)cc2)c2ccc(O)cc12 10.1038/s41467-023-40064-9
CHEMBL46740 178595 67 None - 0 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 470 7 2 5 6.3 Cc1c(-c2ccc(O)cc2)n(Cc2ccc(OCCN3CCCCCC3)cc2)c2ccc(O)cc12 10.1038/s41467-023-40064-9
165193 3165 68 None - 43 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 259 6 2 3 2.6 OC(COc1cccc2c1cccc2)CNC(C)C 10.1038/s41467-023-40064-9
2303 3165 68 None - 43 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 259 6 2 3 2.6 OC(COc1cccc2c1cccc2)CNC(C)C 10.1038/s41467-023-40064-9
4946 3165 68 None - 43 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 259 6 2 3 2.6 OC(COc1cccc2c1cccc2)CNC(C)C 10.1038/s41467-023-40064-9
564 3165 68 None - 43 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 259 6 2 3 2.6 OC(COc1cccc2c1cccc2)CNC(C)C 10.1038/s41467-023-40064-9
62882 3165 68 None - 43 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 259 6 2 3 2.6 OC(COc1cccc2c1cccc2)CNC(C)C 10.1038/s41467-023-40064-9
63 3165 68 None - 43 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 259 6 2 3 2.6 OC(COc1cccc2c1cccc2)CNC(C)C 10.1038/s41467-023-40064-9
66366 3165 68 None - 43 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 259 6 2 3 2.6 OC(COc1cccc2c1cccc2)CNC(C)C 10.1038/s41467-023-40064-9
91536 3165 68 None - 43 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 259 6 2 3 2.6 OC(COc1cccc2c1cccc2)CNC(C)C 10.1038/s41467-023-40064-9
CHEMBL27 3165 68 None - 43 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 259 6 2 3 2.6 OC(COc1cccc2c1cccc2)CNC(C)C 10.1038/s41467-023-40064-9
CHEMBL452861 3165 68 None - 43 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 259 6 2 3 2.6 OC(COc1cccc2c1cccc2)CNC(C)C 10.1038/s41467-023-40064-9
DB00571 3165 68 None - 43 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 259 6 2 3 2.6 OC(COc1cccc2c1cccc2)CNC(C)C 10.1038/s41467-023-40064-9
3121 7853 104 None - 0 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 144 5 1 1 2.3 CCCC(CCC)C(=O)O 10.1038/s41467-023-40064-9
CHEMBL109 7853 104 None - 0 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 144 5 1 1 2.3 CCCC(CCC)C(=O)O 10.1038/s41467-023-40064-9
CHEMBL433 7853 104 None - 0 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 144 5 1 1 2.3 CCCC(CCC)C(=O)O 10.1038/s41467-023-40064-9
1212 1649 50 None -16 66 Human 8.0 pAC50 = 8.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
204 1649 50 None -16 66 Human 8.0 pAC50 = 8.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
3372 1649 50 None -16 66 Human 8.0 pAC50 = 8.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
CHEMBL726 1649 50 None -16 66 Human 8.0 pAC50 = 8.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
DB00623 1649 50 None -16 66 Human 8.0 pAC50 = 8.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
5311507 194792 41 None - 1 Human 7.9 pAC50 = 7.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 400 5 1 4 4.2 OCCN1CCN(CC/C=C2/c3ccccc3Sc3ccc(Cl)cc32)CC1 10.1038/s41467-023-40064-9
CHEMBL53904 194792 41 None - 1 Human 7.9 pAC50 = 7.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 400 5 1 4 4.2 OCCN1CCN(CC/C=C2/c3ccccc3Sc3ccc(Cl)cc32)CC1 10.1038/s41467-023-40064-9
68602 205103 80 None - 8 Human 7.0 pAC50 = 7.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 200 2 1 1 3.2 Cc1cccc(C(C)c2c[nH]cn2)c1C 10.1038/s41467-023-40064-9
CHEMBL77921 205103 80 None - 8 Human 7.0 pAC50 = 7.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 200 2 1 1 3.2 Cc1cccc(C(C)c2c[nH]cn2)c1C 10.1038/s41467-023-40064-9
2771 194994 74 None - 27 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 10.1038/s41467-023-40064-9
CHEMBL1200781 194994 74 None - 27 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 10.1038/s41467-023-40064-9
CHEMBL549 194994 74 None - 27 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 10.1038/s41467-023-40064-9
3878 204680 122 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 1 2 5 2.0 Nc1nnc(-c2cccc(Cl)c2Cl)c(N)n1 10.1038/s41467-023-40064-9
CHEMBL741 204680 122 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 1 2 5 2.0 Nc1nnc(-c2cccc(Cl)c2Cl)c(N)n1 10.1038/s41467-023-40064-9
5666 102965 35 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 237 5 1 4 1.5 CCOc1ccccc1OCC1CNCCO1 10.1038/s41467-023-40064-9
CHEMBL306700 102965 35 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 237 5 1 4 1.5 CCOc1ccccc1OCC1CNCCO1 10.1038/s41467-023-40064-9
54477 84624 36 None - 23 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 370 6 1 4 2.7 CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(Br)c1OC 10.1038/s41467-023-40064-9
CHEMBL22242 84624 36 None - 23 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 370 6 1 4 2.7 CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(Br)c1OC 10.1038/s41467-023-40064-9
1971 2846 38 None -1 30 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1038/s41467-023-40064-9
2404 2846 38 None -1 30 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1038/s41467-023-40064-9
4543 2846 38 None -1 30 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL445 2846 38 None -1 30 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1038/s41467-023-40064-9
DB00540 2846 38 None -1 30 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1038/s41467-023-40064-9
1155 1616 53 None - 5 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
3343 1616 53 None - 5 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
557 1616 53 None - 5 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
CHEMBL32800 1616 53 None - 5 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
DB01288 1616 53 None - 5 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
3324 206415 115 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 321 7 1 9 0.5 CC(=O)OCC(CCn1cnc2cnc(N)nc21)COC(C)=O 10.1038/s41467-023-40064-9
CHEMBL880 206415 115 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 321 7 1 9 0.5 CC(=O)OCC(CCn1cnc2cnc(N)nc21)COC(C)=O 10.1038/s41467-023-40064-9
2795 14462 37 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 289 5 1 2 3.5 CN(C)CCC(O)(c1ccccc1)c1ccccc1Cl 10.1038/s41467-023-40064-9
CHEMBL1201313 14462 37 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 289 5 1 2 3.5 CN(C)CCC(O)(c1ccccc1)c1ccccc1Cl 10.1038/s41467-023-40064-9
2802 173065 36 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 315 2 1 4 3.0 O=C1CN=C(c2ccccc2Cl)c2cc([N+](=O)[O-])ccc2N1 10.1038/s41467-023-40064-9
CHEMBL452 173065 36 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 315 2 1 4 3.0 O=C1CN=C(c2ccccc2Cl)c2cc([N+](=O)[O-])ccc2N1 10.1038/s41467-023-40064-9
2372 106441 40 None - 0 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 345 10 2 5 2.6 COc1ccc(CCNCC(O)COc2cccc(C)c2)cc1OC 10.1038/s41467-023-40064-9
CHEMBL314010 106441 40 None - 0 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 345 10 2 5 2.6 COc1ccc(CCNCC(O)COc2cccc(C)c2)cc1OC 10.1038/s41467-023-40064-9
150 2492 21 None - 16 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO 10.1038/s41467-023-40064-9
1764 2492 21 None - 16 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO 10.1038/s41467-023-40064-9
8226 2492 21 None - 16 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO 10.1038/s41467-023-40064-9
CHEMBL1201356 2492 21 None - 16 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO 10.1038/s41467-023-40064-9
DB00353 2492 21 None - 16 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO 10.1038/s41467-023-40064-9
5770 205035 82 None - 7 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 608 8 1 10 4.2 COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC 10.1038/s41467-023-40064-9
CHEMBL772 205035 82 None - 7 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 608 8 1 10 4.2 COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC 10.1038/s41467-023-40064-9
2200 20171 61 None - 2 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 265 5 1 3 2.7 c1ccc(CN(CC2=NCCN2)c2ccccc2)cc1 10.1038/s41467-023-40064-9
CHEMBL1256819 20171 61 None - 2 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 265 5 1 3 2.7 c1ccc(CN(CC2=NCCN2)c2ccccc2)cc1 10.1038/s41467-023-40064-9
CHEMBL1305 20171 61 None - 2 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 265 5 1 3 2.7 c1ccc(CN(CC2=NCCN2)c2ccccc2)cc1 10.1038/s41467-023-40064-9
102 4096 48 None -346 50 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1038/s41467-023-40064-9
3659 4096 48 None -346 50 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1038/s41467-023-40064-9
8969 4096 48 None -346 50 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1038/s41467-023-40064-9
CHEMBL15245 4096 48 None -346 50 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1038/s41467-023-40064-9
DB01392 4096 48 None -346 50 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1038/s41467-023-40064-9
9931954 10902 76 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 323 3 3 2 3.0 CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1 10.1038/s41467-023-40064-9
CHEMBL1173055 10902 76 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 323 3 3 2 3.0 CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1 10.1038/s41467-023-40064-9
5591 157507 90 None - 2 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 441 5 2 6 4.4 Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2 10.1038/s41467-023-40064-9
CHEMBL408 157507 90 None - 2 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 441 5 2 6 4.4 Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2 10.1038/s41467-023-40064-9
2274 3151 58 None -3 32 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
4917 3151 58 None -3 32 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
7279 3151 58 None -3 32 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
CHEMBL728 3151 58 None -3 32 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
DB00433 3151 58 None -3 32 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
26757 207955 31 None - 2 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 187 4 0 1 2.2 C#CCN(C)[C@H](C)Cc1ccccc1 10.1038/s41467-023-40064-9
CHEMBL972 207955 31 None - 2 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 187 4 0 1 2.2 C#CCN(C)[C@H](C)Cc1ccccc1 10.1038/s41467-023-40064-9
3658 4076 53 None -9 8 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1038/s41467-023-40064-9
517 4076 53 None -9 8 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1038/s41467-023-40064-9
5709 4076 53 None -9 8 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1038/s41467-023-40064-9
CHEMBL312448 4076 53 None -9 8 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1038/s41467-023-40064-9
DB06694 4076 53 None -9 8 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1038/s41467-023-40064-9
3151 1450 97 None -8 27 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
945 1450 97 None -8 27 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
965 1450 97 None -8 27 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL219916 1450 97 None -8 27 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
DB01184 1450 97 None -8 27 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
3333 40138 111 None - 1 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 4 1 5 4.0 CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl 10.1038/s41467-023-40064-9
CHEMBL1480 40138 111 None - 1 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 4 1 5 4.0 CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl 10.1038/s41467-023-40064-9
12582 947 45 None - 5 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O 10.1038/s41467-023-40064-9
2783 947 45 None - 5 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O 10.1038/s41467-023-40064-9
CHEMBL49080 947 45 None - 5 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O 10.1038/s41467-023-40064-9
DB01407 947 45 None - 5 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O 10.1038/s41467-023-40064-9
56959 31526 103 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 427 9 2 6 2.3 COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1 10.1038/s41467-023-40064-9
CHEMBL1404 31526 103 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 427 9 2 6 2.3 COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1 10.1038/s41467-023-40064-9
CHEMBL1526084 31526 103 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 427 9 2 6 2.3 COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1 10.1038/s41467-023-40064-9
135398737 955 93 None -5 92 Human 7.9 pAC50 = 7.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
38 955 93 None -5 92 Human 7.9 pAC50 = 7.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
722 955 93 None -5 92 Human 7.9 pAC50 = 7.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL42 955 93 None -5 92 Human 7.9 pAC50 = 7.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
DB00363 955 93 None -5 92 Human 7.9 pAC50 = 7.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
2284 3160 33 None -3 29 Human 7.9 pAC50 = 7.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C 10.1038/s41467-023-40064-9
4926 3160 33 None -3 29 Human 7.9 pAC50 = 7.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C 10.1038/s41467-023-40064-9
7281 3160 33 None -3 29 Human 7.9 pAC50 = 7.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C 10.1038/s41467-023-40064-9
CHEMBL564 3160 33 None -3 29 Human 7.9 pAC50 = 7.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C 10.1038/s41467-023-40064-9
DB00420 3160 33 None -3 29 Human 7.9 pAC50 = 7.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C 10.1038/s41467-023-40064-9
2337 3232 77 None -5 63 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
50 3232 77 None -5 63 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
5002 3232 77 None -5 63 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL716 3232 77 None -5 63 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
DB01224 3232 77 None -5 63 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
1890 2739 49 None -1 16 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
4449 2739 49 None -1 16 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
7247 2739 49 None -1 16 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
CHEMBL623 2739 49 None -1 16 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
DB01149 2739 49 None -1 16 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
2218 15251 23 None - 0 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 322 8 0 2 4.4 CCN(CC)CCCN(c1ccccc1)C1Cc2ccccc2C1 10.1038/s41467-023-40064-9
CHEMBL1213033 15251 23 None - 0 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 322 8 0 2 4.4 CCN(CC)CCCN(c1ccccc1)C1Cc2ccccc2C1 10.1038/s41467-023-40064-9
25151352 140581 67 None - 0 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 417 5 2 4 5.2 FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1 10.1038/s41467-023-40064-9
CHEMBL3813873 140581 67 None - 0 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 417 5 2 4 5.2 FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1 10.1038/s41467-023-40064-9
2576 16411 62 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 260 7 2 4 2.0 CCCC(C)(COC(N)=O)COC(=O)NC(C)C 10.1038/s41467-023-40064-9
CHEMBL1233 16411 62 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 260 7 2 4 2.0 CCCC(C)(COC(N)=O)COC(=O)NC(C)C 10.1038/s41467-023-40064-9
5280343 188251 124 None - 32 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 10.1038/s41467-023-40064-9
CHEMBL1520590 188251 124 None - 32 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 10.1038/s41467-023-40064-9
CHEMBL50 188251 124 None - 32 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 10.1038/s41467-023-40064-9
2237 3140 79 None - 3 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 481 9 2 7 4.6 O=C(c1ccc(cc1)OCCCCc1ccccc1)Nc1cccc2c1oc(cc2=O)c1[nH]nnn1 10.1038/s41467-023-40064-9
3634 3140 79 None - 3 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 481 9 2 7 4.6 O=C(c1ccc(cc1)OCCCCc1ccccc1)Nc1cccc2c1oc(cc2=O)c1[nH]nnn1 10.1038/s41467-023-40064-9
4887 3140 79 None - 3 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 481 9 2 7 4.6 O=C(c1ccc(cc1)OCCCCc1ccccc1)Nc1cccc2c1oc(cc2=O)c1[nH]nnn1 10.1038/s41467-023-40064-9
CHEMBL21333 3140 79 None - 3 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 481 9 2 7 4.6 O=C(c1ccc(cc1)OCCCCc1ccccc1)Nc1cccc2c1oc(cc2=O)c1[nH]nnn1 10.1038/s41467-023-40064-9
DB01411 3140 79 None - 3 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 481 9 2 7 4.6 O=C(c1ccc(cc1)OCCCCc1ccccc1)Nc1cccc2c1oc(cc2=O)c1[nH]nnn1 10.1038/s41467-023-40064-9
2520 203985 70 None - 12 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC 10.1038/s41467-023-40064-9
CHEMBL1280 203985 70 None - 12 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC 10.1038/s41467-023-40064-9
CHEMBL6966 203985 70 None - 12 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC 10.1038/s41467-023-40064-9
135 2515 43 None -40 58 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
1796 2515 43 None -40 58 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
4184 2515 43 None -40 58 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
CHEMBL6437 2515 43 None -40 58 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
DB06148 2515 43 None -40 58 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
5482 14388 80 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 386 6 0 4 5.9 Clc1ccc(C(Cn2ccnc2)OCc2ccsc2Cl)c(Cl)c1 10.1038/s41467-023-40064-9
CHEMBL1200438 14388 80 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 386 6 0 4 5.9 Clc1ccc(C(Cn2ccnc2)OCc2ccsc2Cl)c(Cl)c1 10.1038/s41467-023-40064-9
1224 1420 83 None - 13 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 6 0 2 3.4 CN(CCOC(c1ccccc1)c1ccccc1)C 10.1038/s41467-023-40064-9
3100 1420 83 None - 13 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 6 0 2 3.4 CN(CCOC(c1ccccc1)c1ccccc1)C 10.1038/s41467-023-40064-9
8980 1420 83 None - 13 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 6 0 2 3.4 CN(CCOC(c1ccccc1)c1ccccc1)C 10.1038/s41467-023-40064-9
916 1420 83 None - 13 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 6 0 2 3.4 CN(CCOC(c1ccccc1)c1ccccc1)C 10.1038/s41467-023-40064-9
CHEMBL657 1420 83 None - 13 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 6 0 2 3.4 CN(CCOC(c1ccccc1)c1ccccc1)C 10.1038/s41467-023-40064-9
DB01075 1420 83 None - 13 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 6 0 2 3.4 CN(CCOC(c1ccccc1)c1ccccc1)C 10.1038/s41467-023-40064-9
5329 169452 119 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 253 3 2 5 1.4 Cc1cc(NS(=O)(=O)c2ccc(N)cc2)no1 10.1038/s41467-023-40064-9
CHEMBL443 169452 119 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 253 3 2 5 1.4 Cc1cc(NS(=O)(=O)c2ccc(N)cc2)no1 10.1038/s41467-023-40064-9
104850 3305 96 None - 6 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 462 4 1 4 5.9 Clc1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1 10.1038/s41467-023-40064-9
4150 3305 96 None - 6 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 462 4 1 4 5.9 Clc1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1 10.1038/s41467-023-40064-9
743 3305 96 None - 6 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 462 4 1 4 5.9 Clc1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1 10.1038/s41467-023-40064-9
CHEMBL111 3305 96 None - 6 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 462 4 1 4 5.9 Clc1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1 10.1038/s41467-023-40064-9
DB06155 3305 96 None - 6 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 462 4 1 4 5.9 Clc1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1 10.1038/s41467-023-40064-9
3463 175122 107 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 250 6 1 2 3.6 Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1 10.1038/s41467-023-40064-9
CHEMBL457 175122 107 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 250 6 1 2 3.6 Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1 10.1038/s41467-023-40064-9
2351 3261 64 None - 21 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O 10.1038/s41467-023-40064-9
2820 3261 64 None - 21 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O 10.1038/s41467-023-40064-9
5035 3261 64 None - 21 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O 10.1038/s41467-023-40064-9
CHEMBL81 3261 64 None - 21 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O 10.1038/s41467-023-40064-9
DB00481 3261 64 None - 21 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O 10.1038/s41467-023-40064-9
4775 39066 132 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 164 4 1 1 2.1 O=C(O)CCCc1ccccc1 10.1038/s41467-023-40064-9
CHEMBL1469 39066 132 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 164 4 1 1 2.1 O=C(O)CCCc1ccccc1 10.1038/s41467-023-40064-9
9417 133487 54 None - 0 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 363 6 1 4 3.3 OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1 10.1038/s41467-023-40064-9
CHEMBL1524185 133487 54 None - 0 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 363 6 1 4 3.3 OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1 10.1038/s41467-023-40064-9
CHEMBL370753 133487 54 None - 0 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 363 6 1 4 3.3 OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1 10.1038/s41467-023-40064-9
4659569 22299 101 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 273 3 2 5 2.5 Cc1ccc(C(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)cc1 10.1038/s41467-023-40064-9
CHEMBL1324 22299 101 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 273 3 2 5 2.5 Cc1ccc(C(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)cc1 10.1038/s41467-023-40064-9
1786 2503 85 None - 11 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
4171 2503 85 None - 11 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
553 2503 85 None - 11 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
CHEMBL13 2503 85 None - 11 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
DB00264 2503 85 None - 11 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
1830 2572 44 None 1 28 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 10.1038/s41467-023-40064-9
207 2572 44 None 1 28 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 10.1038/s41467-023-40064-9
23897 2572 44 None 1 28 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 10.1038/s41467-023-40064-9
CHEMBL460 2572 44 None 1 28 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 10.1038/s41467-023-40064-9
DB01618 2572 44 None 1 28 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 10.1038/s41467-023-40064-9
8249 59375 65 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 205 3 5 2 0.2 N=C(N)NC(=N)NCCc1ccccc1 10.1038/s41467-023-40064-9
CHEMBL1528839 59375 65 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 205 3 5 2 0.2 N=C(N)NC(=N)NCCc1ccccc1 10.1038/s41467-023-40064-9
CHEMBL170988 59375 65 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 205 3 5 2 0.2 N=C(N)NC(=N)NCCc1ccccc1 10.1038/s41467-023-40064-9
2200 20171 61 None - 2 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 265 5 1 3 2.7 c1ccc(CN(CC2=NCCN2)c2ccccc2)cc1 10.1038/s41467-023-40064-9
CHEMBL1256819 20171 61 None - 2 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 265 5 1 3 2.7 c1ccc(CN(CC2=NCCN2)c2ccccc2)cc1 10.1038/s41467-023-40064-9
CHEMBL1305 20171 61 None - 2 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 265 5 1 3 2.7 c1ccc(CN(CC2=NCCN2)c2ccccc2)cc1 10.1038/s41467-023-40064-9
31729 205761 10 None - 0 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 287 6 4 4 2.4 CC(NCCc1ccc(O)cc1)C(O)c1ccc(O)cc1 10.1038/s41467-023-40064-9
CHEMBL83063 205761 10 None - 0 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 287 6 4 4 2.4 CC(NCCc1ccc(O)cc1)C(O)c1ccc(O)cc1 10.1038/s41467-023-40064-9
5284616 161603 55 None - 0 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 914 6 3 13 6.2 CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C 10.1038/s41467-023-40064-9
CHEMBL413 161603 55 None - 0 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 914 6 3 13 6.2 CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C 10.1038/s41467-023-40064-9
191 402 98 None - 29 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 10.1038/s41467-023-40064-9
201 402 98 None - 29 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 10.1038/s41467-023-40064-9
2170 402 98 None - 29 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 10.1038/s41467-023-40064-9
CHEMBL1113 402 98 None - 29 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 10.1038/s41467-023-40064-9
DB00543 402 98 None - 29 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 10.1038/s41467-023-40064-9
100 3776 58 None - 56 Human 7.8 pAC50 = 7.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 10.1038/s41467-023-40064-9
2637 3776 58 None - 56 Human 7.8 pAC50 = 7.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 10.1038/s41467-023-40064-9
5452 3776 58 None - 56 Human 7.8 pAC50 = 7.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 10.1038/s41467-023-40064-9
CHEMBL479 3776 58 None - 56 Human 7.8 pAC50 = 7.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 10.1038/s41467-023-40064-9
DB00679 3776 58 None - 56 Human 7.8 pAC50 = 7.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 10.1038/s41467-023-40064-9
4499 59745 99 None - 2 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 388 6 1 7 3.2 COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1c1ccccc1[N+](=O)[O-] 10.1038/s41467-023-40064-9
CHEMBL1726 59745 99 None - 2 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 388 6 1 7 3.2 COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1c1ccccc1[N+](=O)[O-] 10.1038/s41467-023-40064-9
5280453 205948 74 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 416 6 3 3 5.7 C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)CCCC(C)(C)O)CC[C@@H]23)C[C@@H](O)C[C@@H]1O 10.1038/s41467-023-40064-9
CHEMBL846 205948 74 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 416 6 3 3 5.7 C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)CCCC(C)(C)O)CC[C@@H]23)C[C@@H](O)C[C@@H]1O 10.1038/s41467-023-40064-9
1577 3677 110 None - 26 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N 10.1038/s41467-023-40064-9
164512405 3677 110 None - 26 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N 10.1038/s41467-023-40064-9
2537 3677 110 None - 26 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N 10.1038/s41467-023-40064-9
5355 3677 110 None - 26 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N 10.1038/s41467-023-40064-9
5501 3677 110 None - 26 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N 10.1038/s41467-023-40064-9
643497 3677 110 None - 26 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N 10.1038/s41467-023-40064-9
688272 3677 110 None - 26 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N 10.1038/s41467-023-40064-9
958 3677 110 None - 26 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N 10.1038/s41467-023-40064-9
960 3677 110 None - 26 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N 10.1038/s41467-023-40064-9
CHEMBL196677 3677 110 None - 26 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N 10.1038/s41467-023-40064-9
CHEMBL26 3677 110 None - 26 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N 10.1038/s41467-023-40064-9
CHEMBL267044 3677 110 None - 26 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N 10.1038/s41467-023-40064-9
DB00391 3677 110 None - 26 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N 10.1038/s41467-023-40064-9
DB16021 3677 110 None - 26 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N 10.1038/s41467-023-40064-9
2286 3161 51 None - 30 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
4927 3161 51 None - 30 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
7282 3161 51 None - 30 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
CHEMBL643 3161 51 None - 30 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
DB01069 3161 51 None - 30 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
2220 3112 82 None - 14 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 295 0 0 2 4.4 CN1CCC(=C2c3ccsc3CCc3c2cccc3)CC1 10.1038/s41467-023-40064-9
27400 3112 82 None - 14 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 295 0 0 2 4.4 CN1CCC(=C2c3ccsc3CCc3c2cccc3)CC1 10.1038/s41467-023-40064-9
93 3112 82 None - 14 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 295 0 0 2 4.4 CN1CCC(=C2c3ccsc3CCc3c2cccc3)CC1 10.1038/s41467-023-40064-9
CHEMBL294951 3112 82 None - 14 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 295 0 0 2 4.4 CN1CCC(=C2c3ccsc3CCc3c2cccc3)CC1 10.1038/s41467-023-40064-9
DB06153 3112 82 None - 14 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 295 0 0 2 4.4 CN1CCC(=C2c3ccsc3CCc3c2cccc3)CC1 10.1038/s41467-023-40064-9
1400 1944 70 None - 3 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
3658 1944 70 None - 3 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
7199 1944 70 None - 3 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
91513 1944 70 None - 3 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL896 1944 70 None - 3 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
DB00557 1944 70 None - 3 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
1613 2333 53 None -2 45 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
205 2333 53 None -2 45 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
3964 2333 53 None -2 45 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
CHEMBL831 2333 53 None -2 45 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
DB00408 2333 53 None -2 45 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
176 397 66 None - 31 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 10.1038/s41467-023-40064-9
2157 397 66 None - 31 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 10.1038/s41467-023-40064-9
2566 397 66 None - 31 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 10.1038/s41467-023-40064-9
CHEMBL633 397 66 None - 31 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 10.1038/s41467-023-40064-9
DB01118 397 66 None - 31 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 10.1038/s41467-023-40064-9
1222 1651 49 None - 33 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
3396 1651 49 None - 33 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
85 1651 49 None - 33 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL46516 1651 49 None - 33 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
DB04842 1651 49 None - 33 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
2435 3563 83 None -16 49 Human 7.8 pAC50 = 7.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1038/s41467-023-40064-9
60149 3563 83 None -16 49 Human 7.8 pAC50 = 7.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1038/s41467-023-40064-9
98 3563 83 None -16 49 Human 7.8 pAC50 = 7.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1038/s41467-023-40064-9
CHEMBL12713 3563 83 None -16 49 Human 7.8 pAC50 = 7.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1038/s41467-023-40064-9
DB06144 3563 83 None -16 49 Human 7.8 pAC50 = 7.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1038/s41467-023-40064-9
2284 3160 33 None -3 29 Human 7.8 pAC50 = 7.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C 10.1038/s41467-023-40064-9
4926 3160 33 None -3 29 Human 7.8 pAC50 = 7.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C 10.1038/s41467-023-40064-9
7281 3160 33 None -3 29 Human 7.8 pAC50 = 7.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C 10.1038/s41467-023-40064-9
CHEMBL564 3160 33 None -3 29 Human 7.8 pAC50 = 7.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C 10.1038/s41467-023-40064-9
DB00420 3160 33 None -3 29 Human 7.8 pAC50 = 7.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C 10.1038/s41467-023-40064-9
2105 3032 37 None -9 33 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 10.1038/s41467-023-40064-9
47811 3032 37 None -9 33 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 10.1038/s41467-023-40064-9
48 3032 37 None -9 33 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 10.1038/s41467-023-40064-9
CHEMBL531 3032 37 None -9 33 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 10.1038/s41467-023-40064-9
DB01186 3032 37 None -9 33 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 10.1038/s41467-023-40064-9
37264 189398 24 None - 0 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 435 6 2 10 1.3 COc1cc2c(N)nc(N3CCN(C(=O)OCC(C)(C)O)CC3)nc2c(OC)c1OC 10.1038/s41467-023-40064-9
CHEMBL513301 189398 24 None - 0 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 435 6 2 10 1.3 COc1cc2c(N)nc(N3CCN(C(=O)OCC(C)(C)O)CC3)nc2c(OC)c1OC 10.1038/s41467-023-40064-9
5282230 161897 87 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 327 6 2 4 3.1 COc1ccc(/C=C/C(=O)Nc2ccccc2C(=O)O)cc1OC 10.1038/s41467-023-40064-9
CHEMBL415324 161897 87 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 327 6 2 4 3.1 COc1ccc(/C=C/C(=O)Nc2ccccc2C(=O)O)cc1OC 10.1038/s41467-023-40064-9
3584 3748 64 None -2 14 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
5401 3748 64 None -2 14 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
7302 3748 64 None -2 14 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
CHEMBL611 3748 64 None -2 14 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
DB01162 3748 64 None -2 14 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
2389 3306 118 None -11 68 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
5073 3306 118 None -11 68 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
96 3306 118 None -11 68 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
CHEMBL85 3306 118 None -11 68 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
DB00734 3306 118 None -11 68 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
19675 51640 43 None - 0 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 410 7 1 5 5.0 CC(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2 10.1038/s41467-023-40064-9
CHEMBL1584 51640 43 None - 0 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 410 7 1 5 5.0 CC(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2 10.1038/s41467-023-40064-9
213 3824 55 None - 44 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 10.1038/s41467-023-40064-9
2717 3824 55 None - 44 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 10.1038/s41467-023-40064-9
5533 3824 55 None - 44 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 10.1038/s41467-023-40064-9
CHEMBL621 3824 55 None - 44 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 10.1038/s41467-023-40064-9
DB00656 3824 55 None - 44 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 10.1038/s41467-023-40064-9
5329102 194703 86 None - 0 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 398 7 3 3 3.3 CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C 10.1038/s41467-023-40064-9
CHEMBL535 194703 86 None - 0 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 398 7 3 3 3.3 CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C 10.1038/s41467-023-40064-9
43815 186896 64 None - 25 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 329 4 1 4 3.3 Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1 10.1038/s41467-023-40064-9
CHEMBL1708 186896 64 None - 25 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 329 4 1 4 3.3 Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1 10.1038/s41467-023-40064-9
CHEMBL490 186896 64 None - 25 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 329 4 1 4 3.3 Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1 10.1038/s41467-023-40064-9
5039 63153 17 None - 1 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 314 10 2 7 1.5 CNC(=C[N+](=O)[O-])NCCSCc1ccc(CN(C)C)o1 10.1038/s41467-023-40064-9
CHEMBL1790041 63153 17 None - 1 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 314 10 2 7 1.5 CNC(=C[N+](=O)[O-])NCCSCc1ccc(CN(C)C)o1 10.1038/s41467-023-40064-9
2585 800 103 None -9 22 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
522 800 103 None -9 22 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
551 800 103 None -9 22 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
CHEMBL723 800 103 None -9 22 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
DB01136 800 103 None -9 22 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
2726 916 68 None -5 73 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
621 916 68 None -5 73 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
83 916 68 None -5 73 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
CHEMBL71 916 68 None -5 73 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
DB00477 916 68 None -5 73 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
2683 3805 60 None - 4 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 10.1038/s41467-023-40064-9
5487 3805 60 None - 4 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 10.1038/s41467-023-40064-9
7308 3805 60 None - 4 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 10.1038/s41467-023-40064-9
CHEMBL1079 3805 60 None - 4 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 10.1038/s41467-023-40064-9
DB00697 3805 60 None - 4 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 10.1038/s41467-023-40064-9
1353 1898 93 None -6 86 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
3559 1898 93 None -6 86 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
86 1898 93 None -6 86 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
CHEMBL54 1898 93 None -6 86 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
DB00502 1898 93 None -6 86 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
31101 726 40 None -12 36 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
35 726 40 None -12 36 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
403 726 40 None -12 36 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
CHEMBL493 726 40 None -12 36 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
DB01200 726 40 None -12 36 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
9915743 63512 93 None - 0 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 556 11 2 8 5.9 CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C 10.1038/s41467-023-40064-9
CHEMBL180022 63512 93 None - 0 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 556 11 2 8 5.9 CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C 10.1038/s41467-023-40064-9
4209 3141 75 None -3 34 Human 8.7 pAC50 = 8.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
4893 3141 75 None -3 34 Human 8.7 pAC50 = 8.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
503 3141 75 None -3 34 Human 8.7 pAC50 = 8.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
5385 3141 75 None -3 34 Human 8.7 pAC50 = 8.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
CHEMBL2 3141 75 None -3 34 Human 8.7 pAC50 = 8.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
DB00457 3141 75 None -3 34 Human 8.7 pAC50 = 8.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
4418 34192 85 None -1 7 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1038/s41467-023-40064-9
CHEMBL142635 34192 85 None -1 7 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1038/s41467-023-40064-9
4046 2466 33 None - 2 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 378 2 2 3 4.4 OC(c1cc(nc2c1cccc2C(F)(F)F)C(F)(F)F)C1CCCCN1 10.1038/s41467-023-40064-9
4252 2466 33 None - 2 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 378 2 2 3 4.4 OC(c1cc(nc2c1cccc2C(F)(F)F)C(F)(F)F)C1CCCCN1 10.1038/s41467-023-40064-9
CHEMBL416956 2466 33 None - 2 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 378 2 2 3 4.4 OC(c1cc(nc2c1cccc2C(F)(F)F)C(F)(F)F)C1CCCCN1 10.1038/s41467-023-40064-9
DB00358 2466 33 None - 2 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 378 2 2 3 4.4 OC(c1cc(nc2c1cccc2C(F)(F)F)C(F)(F)F)C1CCCCN1 10.1038/s41467-023-40064-9
3052776 206533 90 None - 1 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 171 2 1 1 1.9 C#CCN[C@@H]1CCc2ccccc21 10.1038/s41467-023-40064-9
CHEMBL887 206533 90 None - 1 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 171 2 1 1 1.9 C#CCN[C@@H]1CCc2ccccc21 10.1038/s41467-023-40064-9
135409453 3744 41 None - 2 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.1038/s41467-023-40064-9
226 3744 41 None - 2 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.1038/s41467-023-40064-9
CHEMBL76370 3744 41 None - 2 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.1038/s41467-023-40064-9
4034 55792 55 None - 1 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 390 5 0 2 5.6 Cc1cccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)c1 10.1038/s41467-023-40064-9
CHEMBL1623 55792 55 None - 1 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 390 5 0 2 5.6 Cc1cccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)c1 10.1038/s41467-023-40064-9
16362 3103 71 None -35 30 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
2172 3103 71 None -35 30 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
90 3103 71 None -35 30 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL1423 3103 71 None -35 30 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
DB01100 3103 71 None -35 30 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
2536 199342 40 None - 0 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 398 7 3 6 1.4 CN(C)C(=O)COC(=O)Cc1ccc(OC(=O)c2ccc(NC(=N)N)cc2)cc1 10.1038/s41467-023-40064-9
CHEMBL590799 199342 40 None - 0 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 398 7 3 6 1.4 CN(C)C(=O)COC(=O)Cc1ccc(OC(=O)c2ccc(NC(=N)N)cc2)cc1 10.1038/s41467-023-40064-9
3158 56237 27 None - 20 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 10.1038/s41467-023-40064-9
CHEMBL1628227 56237 27 None - 20 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 10.1038/s41467-023-40064-9
2803 952 58 None -8 19 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1038/s41467-023-40064-9
516 952 58 None -8 19 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1038/s41467-023-40064-9
704 952 58 None -8 19 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1038/s41467-023-40064-9
CHEMBL134 952 58 None -8 19 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1038/s41467-023-40064-9
DB00575 952 58 None -8 19 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1038/s41467-023-40064-9
47641 202848 32 None - 0 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 287 5 0 1 5.0 CN(C/C=C/c1ccccc1)Cc1cccc2ccccc12 10.1038/s41467-023-40064-9
CHEMBL626 202848 32 None - 0 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 287 5 0 1 5.0 CN(C/C=C/c1ccccc1)Cc1cccc2ccccc12 10.1038/s41467-023-40064-9
2419 3437 84 None - 6 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1038/s41467-023-40064-9
5152 3437 84 None - 6 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1038/s41467-023-40064-9
559 3437 84 None - 6 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1038/s41467-023-40064-9
CHEMBL1263 3437 84 None - 6 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1038/s41467-023-40064-9
DB00938 3437 84 None - 6 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1038/s41467-023-40064-9
21722 17960 31 None - 6 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 4 0 2 4.3 CN(C)CCCn1c2c(c3ccccc31)CCCCCC2 10.1038/s41467-023-40064-9
CHEMBL126224 17960 31 None - 6 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 4 0 2 4.3 CN(C)CCCn1c2c(c3ccccc31)CCCCCC2 10.1038/s41467-023-40064-9
4567 9916 34 None - 0 Human 7.6 pAC50 = 7.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 299 7 3 3 3.4 CC(CCc1ccccc1)NC(C)C(O)c1ccc(O)cc1 10.1038/s41467-023-40064-9
CHEMBL114655 9916 34 None - 0 Human 7.6 pAC50 = 7.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 299 7 3 3 3.4 CC(CCc1ccccc1)NC(C)C(O)c1ccc(O)cc1 10.1038/s41467-023-40064-9
4046 2466 33 None - 2 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 378 2 2 3 4.4 OC(c1cc(nc2c1cccc2C(F)(F)F)C(F)(F)F)C1CCCCN1 10.1038/s41467-023-40064-9
4252 2466 33 None - 2 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 378 2 2 3 4.4 OC(c1cc(nc2c1cccc2C(F)(F)F)C(F)(F)F)C1CCCCN1 10.1038/s41467-023-40064-9
CHEMBL416956 2466 33 None - 2 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 378 2 2 3 4.4 OC(c1cc(nc2c1cccc2C(F)(F)F)C(F)(F)F)C1CCCCN1 10.1038/s41467-023-40064-9
DB00358 2466 33 None - 2 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 378 2 2 3 4.4 OC(c1cc(nc2c1cccc2C(F)(F)F)C(F)(F)F)C1CCCCN1 10.1038/s41467-023-40064-9
2161 8701 121 None - 0 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 298 2 2 5 2.7 CC(C)c1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1 10.1038/s41467-023-40064-9
CHEMBL1096 8701 121 None - 0 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 298 2 2 5 2.7 CC(C)c1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1 10.1038/s41467-023-40064-9
135398735 136943 32 None - 0 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 822 4 6 15 4.3 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
136262914 136943 32 None - 0 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 822 4 6 15 4.3 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
CHEMBL374478 136943 32 None - 0 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 822 4 6 15 4.3 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
4756 16617 50 None - 0 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 213 2 2 5 2.7 Nc1ccc(/N=N/c2ccccc2)c(N)n1 10.1038/s41467-023-40064-9
CHEMBL1201022 16617 50 None - 0 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 213 2 2 5 2.7 Nc1ccc(/N=N/c2ccccc2)c(N)n1 10.1038/s41467-023-40064-9
CHEMBL1242 16617 50 None - 0 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 213 2 2 5 2.7 Nc1ccc(/N=N/c2ccccc2)c(N)n1 10.1038/s41467-023-40064-9
1427 2000 54 None - 27 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
357 2000 54 None - 27 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
3696 2000 54 None - 27 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
CHEMBL11 2000 54 None - 27 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
DB00458 2000 54 None - 27 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
154417 23149 60 None - 5 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 289 4 1 4 1.9 CN1[C@@H]2CC[C@H]1C[C@@H](OC(=O)[C@H](CO)c1ccccc1)C2 10.1038/s41467-023-40064-9
CHEMBL1331216 23149 60 None - 5 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 289 4 1 4 1.9 CN1[C@@H]2CC[C@H]1C[C@@H](OC(=O)[C@H](CO)c1ccccc1)C2 10.1038/s41467-023-40064-9
212 3777 47 None -7 25 Human 7.6 pAC50 = 7.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
2639 3777 47 None -7 25 Human 7.6 pAC50 = 7.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
941651 3777 47 None -7 25 Human 7.6 pAC50 = 7.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
CHEMBL1201 3777 47 None -7 25 Human 7.6 pAC50 = 7.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
DB01623 3777 47 None -7 25 Human 7.6 pAC50 = 7.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
3083544 26778 51 None - 5 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1038/s41467-023-40064-9
CHEMBL1200811 26778 51 None - 5 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1038/s41467-023-40064-9
CHEMBL1363 26778 51 None - 5 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1038/s41467-023-40064-9
CHEMBL1951071 26778 51 None - 5 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1038/s41467-023-40064-9
CHEMBL605993 26778 51 None - 5 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1038/s41467-023-40064-9
5280793 46307 65 None - 0 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 396 5 1 1 7.6 C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)/C=C/[C@H](C)C(C)C)CC[C@@H]12 10.1038/s41467-023-40064-9
CHEMBL1536 46307 65 None - 0 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 396 5 1 1 7.6 C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)/C=C/[C@H](C)C(C)C)CC[C@@H]12 10.1038/s41467-023-40064-9
209 3035 97 None -11 23 Human 7.6 pAC50 = 7.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
2113 3035 97 None -11 23 Human 7.6 pAC50 = 7.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
4748 3035 97 None -11 23 Human 7.6 pAC50 = 7.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
CHEMBL567 3035 97 None -11 23 Human 7.6 pAC50 = 7.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
DB00850 3035 97 None -11 23 Human 7.6 pAC50 = 7.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
10219 188772 37 None - 5 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 10.1038/s41467-023-40064-9
CHEMBL493439 188772 37 None - 5 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 10.1038/s41467-023-40064-9
CHEMBL50588 188772 37 None - 5 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 10.1038/s41467-023-40064-9
1228 3837 34 None - 4 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 278 4 0 2 3.9 Cc1ccc(cc1)/C(=C\CN1CCCC1)/c1ccccn1 10.1038/s41467-023-40064-9
2763 3837 34 None - 4 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 278 4 0 2 3.9 Cc1ccc(cc1)/C(=C\CN1CCCC1)/c1ccccn1 10.1038/s41467-023-40064-9
5282443 3837 34 None - 4 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 278 4 0 2 3.9 Cc1ccc(cc1)/C(=C\CN1CCCC1)/c1ccccn1 10.1038/s41467-023-40064-9
CHEMBL855 3837 34 None - 4 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 278 4 0 2 3.9 Cc1ccc(cc1)/C(=C\CN1CCCC1)/c1ccccn1 10.1038/s41467-023-40064-9
DB00427 3837 34 None - 4 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 278 4 0 2 3.9 Cc1ccc(cc1)/C(=C\CN1CCCC1)/c1ccccn1 10.1038/s41467-023-40064-9
5324346 205559 59 None - 10 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 318 9 1 4 3.2 COCCCC/C(=N\OCCN)c1ccc(C(F)(F)F)cc1 10.1038/s41467-023-40064-9
CHEMBL1409 205559 59 None - 10 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 318 9 1 4 3.2 COCCCC/C(=N\OCCN)c1ccc(C(F)(F)F)cc1 10.1038/s41467-023-40064-9
CHEMBL814 205559 59 None - 10 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 318 9 1 4 3.2 COCCCC/C(=N\OCCN)c1ccc(C(F)(F)F)cc1 10.1038/s41467-023-40064-9
36811 1442 37 None - 7 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
535 1442 37 None - 7 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
937 1442 37 None - 7 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
CHEMBL926 1442 37 None - 7 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
DB00841 1442 37 None - 7 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
1690 3036 19 None - 3 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 247 3 0 3 2.2 CCOC(=O)C1(CCN(CC1)C)c1ccccc1 10.1038/s41467-023-40064-9
4058 3036 19 None - 3 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 247 3 0 3 2.2 CCOC(=O)C1(CCN(CC1)C)c1ccccc1 10.1038/s41467-023-40064-9
5750 3036 19 None - 3 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 247 3 0 3 2.2 CCOC(=O)C1(CCN(CC1)C)c1ccccc1 10.1038/s41467-023-40064-9
7221 3036 19 None - 3 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 247 3 0 3 2.2 CCOC(=O)C1(CCN(CC1)C)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL607 3036 19 None - 3 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 247 3 0 3 2.2 CCOC(=O)C1(CCN(CC1)C)c1ccccc1 10.1038/s41467-023-40064-9
DB00454 3036 19 None - 3 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 247 3 0 3 2.2 CCOC(=O)C1(CCN(CC1)C)c1ccccc1 10.1038/s41467-023-40064-9
2895 203569 41 None - 8 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 275 3 0 1 4.6 CN(C)CCC=C1c2ccccc2C=Cc2ccccc21 10.1038/s41467-023-40064-9
CHEMBL669 203569 41 None - 8 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 275 3 0 1 4.6 CN(C)CCC=C1c2ccccc2C=Cc2ccccc21 10.1038/s41467-023-40064-9
102 4096 48 None -346 50 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1038/s41467-023-40064-9
3659 4096 48 None -346 50 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1038/s41467-023-40064-9
8969 4096 48 None -346 50 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1038/s41467-023-40064-9
CHEMBL15245 4096 48 None -346 50 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1038/s41467-023-40064-9
DB01392 4096 48 None -346 50 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1038/s41467-023-40064-9
135409453 3744 41 None - 2 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.1038/s41467-023-40064-9
226 3744 41 None - 2 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.1038/s41467-023-40064-9
CHEMBL76370 3744 41 None - 2 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.1038/s41467-023-40064-9
16231 207486 57 None - 17 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 229 1 5 6 -1.1 N=C(N)NC(=O)c1nc(Cl)c(N)nc1N 10.1038/s41467-023-40064-9
CHEMBL945 207486 57 None - 17 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 229 1 5 6 -1.1 N=C(N)NC(=O)c1nc(Cl)c(N)nc1N 10.1038/s41467-023-40064-9
2600 3750 74 None - 13 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O 10.1038/s41467-023-40064-9
2608 3750 74 None - 13 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O 10.1038/s41467-023-40064-9
5405 3750 74 None - 13 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O 10.1038/s41467-023-40064-9
CHEMBL17157 3750 74 None - 13 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O 10.1038/s41467-023-40064-9
DB00342 3750 74 None - 13 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O 10.1038/s41467-023-40064-9
2865 4112 73 None -14 54 Human 7.6 pAC50 = 7.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
59 4112 73 None -14 54 Human 7.6 pAC50 = 7.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
60854 4112 73 None -14 54 Human 7.6 pAC50 = 7.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL708 4112 73 None -14 54 Human 7.6 pAC50 = 7.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
DB00246 4112 73 None -14 54 Human 7.6 pAC50 = 7.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
22323 15267 32 None - 0 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 287 2 5 2 2.9 CC(C)NC(=N)NC(=N)Nc1ccc(Cl)c(Cl)c1 10.1038/s41467-023-40064-9
9571037 15267 32 None - 0 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 287 2 5 2 2.9 CC(C)NC(=N)NC(=N)Nc1ccc(Cl)c(Cl)c1 10.1038/s41467-023-40064-9
CHEMBL1213553 15267 32 None - 0 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 287 2 5 2 2.9 CC(C)NC(=N)NC(=N)Nc1ccc(Cl)c(Cl)c1 10.1038/s41467-023-40064-9
2705 3813 64 None - 10 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 325 7 1 2 5.3 Cc1ccc(c(c1)[C@@H](c1ccccc1)CCN(C(C)C)C(C)C)O 10.1038/s41467-023-40064-9
360 3813 64 None - 10 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 325 7 1 2 5.3 Cc1ccc(c(c1)[C@@H](c1ccccc1)CCN(C(C)C)C(C)C)O 10.1038/s41467-023-40064-9
443879 3813 64 None - 10 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 325 7 1 2 5.3 Cc1ccc(c(c1)[C@@H](c1ccccc1)CCN(C(C)C)C(C)C)O 10.1038/s41467-023-40064-9
CHEMBL1382 3813 64 None - 10 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 325 7 1 2 5.3 Cc1ccc(c(c1)[C@@H](c1ccccc1)CCN(C(C)C)C(C)C)O 10.1038/s41467-023-40064-9
DB01036 3813 64 None - 10 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 325 7 1 2 5.3 Cc1ccc(c(c1)[C@@H](c1ccccc1)CCN(C(C)C)C(C)C)O 10.1038/s41467-023-40064-9
2247 504 81 None - 42 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
249 504 81 None - 42 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
2603 504 81 None - 42 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
CHEMBL296419 504 81 None - 42 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
DB00637 504 81 None - 42 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
1024 1278 71 None - 1 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL None None None None 10.1038/s41467-023-40064-9
162639143 1278 71 None - 1 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL None None None None 10.1038/s41467-023-40064-9
5284373 1278 71 None - 1 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL None None None None 10.1038/s41467-023-40064-9
760 1278 71 None - 1 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL None None None None 10.1038/s41467-023-40064-9
CHEMBL160 1278 71 None - 1 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL None None None None 10.1038/s41467-023-40064-9
DB00091 1278 71 None - 1 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL None None None None 10.1038/s41467-023-40064-9
367 3795 12 None - 8 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 392 4 1 6 2.3 O=C(C(c1cccs1)(c1cccs1)O)OC1C[C@@H]2[C@@H]3[C@H]([C@H](C1)[N+]2(C)C)O3 10.1038/s41467-023-40064-9
5487427 3795 12 None - 8 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 392 4 1 6 2.3 O=C(C(c1cccs1)(c1cccs1)O)OC1C[C@@H]2[C@@H]3[C@H]([C@H](C1)[N+]2(C)C)O3 10.1038/s41467-023-40064-9
8592 3795 12 None - 8 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 392 4 1 6 2.3 O=C(C(c1cccs1)(c1cccs1)O)OC1C[C@@H]2[C@@H]3[C@H]([C@H](C1)[N+]2(C)C)O3 10.1038/s41467-023-40064-9
CHEMBL1900528 3795 12 None - 8 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 392 4 1 6 2.3 O=C(C(c1cccs1)(c1cccs1)O)OC1C[C@@H]2[C@@H]3[C@H]([C@H](C1)[N+]2(C)C)O3 10.1038/s41467-023-40064-9
CHEMBL3305968 3795 12 None - 8 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 392 4 1 6 2.3 O=C(C(c1cccs1)(c1cccs1)O)OC1C[C@@H]2[C@@H]3[C@H]([C@H](C1)[N+]2(C)C)O3 10.1038/s41467-023-40064-9
CHEMBL4650755 3795 12 None - 8 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 392 4 1 6 2.3 O=C(C(c1cccs1)(c1cccs1)O)OC1C[C@@H]2[C@@H]3[C@H]([C@H](C1)[N+]2(C)C)O3 10.1038/s41467-023-40064-9
DB01409 3795 12 None - 8 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 392 4 1 6 2.3 O=C(C(c1cccs1)(c1cccs1)O)OC1C[C@@H]2[C@@H]3[C@H]([C@H](C1)[N+]2(C)C)O3 10.1038/s41467-023-40064-9
135401907 38828 136 None - 1 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 136 0 2 3 -0.4 O=c1ncnc2[nH][nH]cc1-2 10.1038/s41467-023-40064-9
CHEMBL1467 38828 136 None - 1 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 136 0 2 3 -0.4 O=c1ncnc2[nH][nH]cc1-2 10.1038/s41467-023-40064-9
4940 14438 35 None - 0 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 340 5 0 4 4.8 CCC(=O)c1ccc2c(c1)N(CC(C)N(C)C)c1ccccc1S2 10.1038/s41467-023-40064-9
CHEMBL1201210 14438 35 None - 0 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 340 5 0 4 4.8 CCC(=O)c1ccc2c(c1)N(CC(C)N(C)C)c1ccccc1S2 10.1038/s41467-023-40064-9
180 400 56 None -12 40 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
200 400 56 None -12 40 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
2160 400 56 None -12 40 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
CHEMBL629 400 56 None -12 40 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
DB00321 400 56 None -12 40 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
1547484 937 74 None - 20 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
654 937 74 None - 20 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
9072 937 74 None - 20 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL43064 937 74 None - 20 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
DB00568 937 74 None - 20 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
5288783 14401 50 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 412 5 3 3 5.1 C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)/C=C/[C@@H](O)C4CC4)CC[C@@H]23)C[C@@H](O)C[C@@H]1O 10.1038/s41467-023-40064-9
CHEMBL1200666 14401 50 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 412 5 3 3 5.1 C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)/C=C/[C@@H](O)C4CC4)CC[C@@H]23)C[C@@H](O)C[C@@H]1O 10.1038/s41467-023-40064-9
119182 60377 92 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 303 2 3 8 -0.3 Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1F 10.1038/s41467-023-40064-9
CHEMBL1750 60377 92 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 303 2 3 8 -0.3 Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1F 10.1038/s41467-023-40064-9
55645 84341 8 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 395 7 2 4 2.1 CCCN1CC(NS(=O)(=O)N(CC)CC)CC2Cc3c(O)cccc3CC21 10.1038/s41467-023-40064-9
CHEMBL2218861 84341 8 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 395 7 2 4 2.1 CCCN1CC(NS(=O)(=O)N(CC)CC)CC2Cc3c(O)cccc3CC21 10.1038/s41467-023-40064-9
24958200 8542 76 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 320 3 2 4 2.6 NC(=O)c1cccc2cn(-c3ccc([C@@H]4CCCNC4)cc3)nc12 10.1038/s41467-023-40064-9
CHEMBL1094636 8542 76 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 320 3 2 4 2.6 NC(=O)c1cccc2cn(-c3ccc([C@@H]4CCCNC4)cc3)nc12 10.1038/s41467-023-40064-9
18283 208289 96 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 224 2 2 5 -0.7 Cc1cn([C@H]2C=C[C@@H](CO)O2)c(=O)[nH]c1=O 10.1038/s41467-023-40064-9
CHEMBL991 208289 96 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 224 2 2 5 -0.7 Cc1cn([C@H]2C=C[C@@H](CO)O2)c(=O)[nH]c1=O 10.1038/s41467-023-40064-9
4631 194949 29 None - 7 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 265 9 2 4 2.0 C=CCOc1ccccc1OCC(O)CNC(C)C 10.1038/s41467-023-40064-9
CHEMBL546 194949 29 None - 7 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 265 9 2 4 2.0 C=CCOc1ccccc1OCC(O)CNC(C)C 10.1038/s41467-023-40064-9
5906 14463 23 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 167 2 3 3 0.8 C[C@H](N)[C@H](O)c1cccc(O)c1 10.1038/s41467-023-40064-9
CHEMBL1201319 14463 23 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 167 2 3 3 0.8 C[C@H](N)[C@H](O)c1cccc(O)c1 10.1038/s41467-023-40064-9
103 4122 61 None -6 54 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
2875 4122 61 None -6 54 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
5736 4122 61 None -6 54 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
CHEMBL285802 4122 61 None -6 54 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
DB09225 4122 61 None -6 54 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
9429 202110 58 None - 5 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 446 6 0 6 3.2 CN1CCN(CCCN2c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1 10.1038/s41467-023-40064-9
CHEMBL609109 202110 58 None - 5 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 446 6 0 6 3.2 CN1CCN(CCCN2c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1 10.1038/s41467-023-40064-9
4209 3141 75 None -3 34 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
4893 3141 75 None -3 34 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
503 3141 75 None -3 34 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
5385 3141 75 None -3 34 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
CHEMBL2 3141 75 None -3 34 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
DB00457 3141 75 None -3 34 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
2389 3306 118 None -11 68 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
5073 3306 118 None -11 68 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
96 3306 118 None -11 68 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
CHEMBL85 3306 118 None -11 68 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
DB00734 3306 118 None -11 68 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
3157 1458 71 None -2 12 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
7170 1458 71 None -2 12 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
954 1458 71 None -2 12 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
CHEMBL707 1458 71 None -2 12 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
DB00590 1458 71 None -2 12 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
2286 3161 51 None - 30 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
4927 3161 51 None - 30 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
7282 3161 51 None - 30 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
CHEMBL643 3161 51 None - 30 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
DB01069 3161 51 None - 30 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
2169 44817 35 None - 0 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 380 9 3 6 1.4 COc1ccccc1OCCNCC(O)c1ccc(C)c(S(N)(=O)=O)c1 10.1038/s41467-023-40064-9
CHEMBL152231 44817 35 None - 0 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 380 9 3 6 1.4 COc1ccccc1OCCNCC(O)c1ccc(C)c(S(N)(=O)=O)c1 10.1038/s41467-023-40064-9
60065 84340 6 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 505 7 1 8 4.2 COC(=O)C1=C(C)NC(C)=C(C(=O)O[C@@H]2CCCN(Cc3ccccc3)C2)C1c1cccc([N+](=O)[O-])c1 10.1038/s41467-023-40064-9
CHEMBL2218858 84340 6 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 505 7 1 8 4.2 COC(=O)C1=C(C)NC(C)=C(C(=O)O[C@@H]2CCCN(Cc3ccccc3)C2)C1c1cccc([N+](=O)[O-])c1 10.1038/s41467-023-40064-9
5328940 100188 107 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 529 9 1 8 5.2 COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl 10.1038/s41467-023-40064-9
CHEMBL288441 100188 107 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 529 9 1 8 5.2 COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl 10.1038/s41467-023-40064-9
2865 4112 73 None -14 54 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
59 4112 73 None -14 54 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
60854 4112 73 None -14 54 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL708 4112 73 None -14 54 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
DB00246 4112 73 None -14 54 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
2470 3626 50 None -208 60 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
3300 3626 50 None -208 60 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
5265 3626 50 None -208 60 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
99 3626 50 None -208 60 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL267930 3626 50 None -208 60 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
5284550 41691 15 None 1 9 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 295 3 0 2 4.7 CN(C)CC/C=C1\c2ccccc2CSc2ccccc21 10.1038/s41467-023-40064-9
CHEMBL1492500 41691 15 None 1 9 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 295 3 0 2 4.7 CN(C)CC/C=C1\c2ccccc2CSc2ccccc21 10.1038/s41467-023-40064-9
3152 188387 103 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 379 6 0 4 4.4 COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2 10.1038/s41467-023-40064-9
CHEMBL502 188387 103 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 379 6 0 4 4.4 COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2 10.1038/s41467-023-40064-9
54671203 34980 53 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 444 2 6 9 -0.3 C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21 10.1038/s41467-023-40064-9
CHEMBL1433 34980 53 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 444 2 6 9 -0.3 C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21 10.1038/s41467-023-40064-9
1231 934 116 None - 8 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 252 5 3 4 0.6 N#CNC(=NC)NCCSCc1nc[nH]c1C 10.1038/s41467-023-40064-9
2756 934 116 None - 8 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 252 5 3 4 0.6 N#CNC(=NC)NCCSCc1nc[nH]c1C 10.1038/s41467-023-40064-9
645 934 116 None - 8 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 252 5 3 4 0.6 N#CNC(=NC)NCCSCc1nc[nH]c1C 10.1038/s41467-023-40064-9
CHEMBL30 934 116 None - 8 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 252 5 3 4 0.6 N#CNC(=NC)NCCSCc1nc[nH]c1C 10.1038/s41467-023-40064-9
DB00501 934 116 None - 8 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 252 5 3 4 0.6 N#CNC(=NC)NCCSCc1nc[nH]c1C 10.1038/s41467-023-40064-9
446598 60425 50 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 424 7 4 7 0.4 CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1 10.1038/s41467-023-40064-9
CHEMBL1753 60425 50 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 424 7 4 7 0.4 CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1 10.1038/s41467-023-40064-9
68617 205504 62 None 3 26 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 10.1038/s41467-023-40064-9
CHEMBL1709 205504 62 None 3 26 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 10.1038/s41467-023-40064-9
CHEMBL809 205504 62 None 3 26 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 10.1038/s41467-023-40064-9
CHEMBL3039583 210926 0 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL None None None NCCCC[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](c2ccccc2)NC(=O)[C@@H]2C[C@H](OC(=O)NCCN)CN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(OCc3ccccc3)cc2)NC1=O 10.1038/s41467-023-40064-9
5280954 57569 32 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 634 9 1 10 4.6 COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)/C=C/c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC 10.1038/s41467-023-40064-9
CHEMBL1668 57569 32 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 634 9 1 10 4.6 COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)/C=C/c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC 10.1038/s41467-023-40064-9
1155 1616 53 None - 5 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
3343 1616 53 None - 5 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
557 1616 53 None - 5 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
CHEMBL32800 1616 53 None - 5 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
DB01288 1616 53 None - 5 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
5360696 1394 30 None - 3 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 271 1 0 2 3.4 COc1ccc2c(c1)[C@@]13CCCC[C@@H]3[C@H](C2)N(CC1)C 10.1038/s41467-023-40064-9
6953 1394 30 None - 3 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 271 1 0 2 3.4 COc1ccc2c(c1)[C@@]13CCCC[C@@H]3[C@H](C2)N(CC1)C 10.1038/s41467-023-40064-9
842 1394 30 None - 3 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 271 1 0 2 3.4 COc1ccc2c(c1)[C@@]13CCCC[C@@H]3[C@H](C2)N(CC1)C 10.1038/s41467-023-40064-9
CHEMBL52440 1394 30 None - 3 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 271 1 0 2 3.4 COc1ccc2c(c1)[C@@]13CCCC[C@@H]3[C@H](C2)N(CC1)C 10.1038/s41467-023-40064-9
DB00514 1394 30 None - 3 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 271 1 0 2 3.4 COc1ccc2c(c1)[C@@]13CCCC[C@@H]3[C@H](C2)N(CC1)C 10.1038/s41467-023-40064-9
37 775 60 None -18 17 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 10.1038/s41467-023-40064-9
460 775 60 None -18 17 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 10.1038/s41467-023-40064-9
54746 775 60 None -18 17 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 10.1038/s41467-023-40064-9
CHEMBL1201087 775 60 None -18 17 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 10.1038/s41467-023-40064-9
DB00248 775 60 None -18 17 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 10.1038/s41467-023-40064-9
25271887 5128 84 None - 0 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 159 5 2 2 1.1 CC(C)C[C@H](CN)CC(=O)O 10.1038/s41467-023-40064-9
5486971 5128 84 None - 0 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 159 5 2 2 1.1 CC(C)C[C@H](CN)CC(=O)O 10.1038/s41467-023-40064-9
CHEMBL1059 5128 84 None - 0 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 159 5 2 2 1.1 CC(C)C[C@H](CN)CC(=O)O 10.1038/s41467-023-40064-9
10531 1408 21 None - 24 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
121 1408 21 None - 24 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
888 1408 21 None - 24 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
CHEMBL1732 1408 21 None - 24 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
DB00320 1408 21 None - 24 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
3152 188387 103 None - 0 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 379 6 0 4 4.4 COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2 10.1038/s41467-023-40064-9
CHEMBL502 188387 103 None - 0 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 379 6 0 4 4.4 COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2 10.1038/s41467-023-40064-9
242 469 124 None -14 52 Human 6.4 pAC50 = 6.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
34 469 124 None -14 52 Human 6.4 pAC50 = 6.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
60795 469 124 None -14 52 Human 6.4 pAC50 = 6.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
CHEMBL1112 469 124 None -14 52 Human 6.4 pAC50 = 6.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
DB01238 469 124 None -14 52 Human 6.4 pAC50 = 6.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
71109 78177 10 None - 0 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 272 4 1 4 2.9 OC(CN1CCCCC1)c1cc(-c2ccccc2)on1 10.1038/s41467-023-40064-9
CHEMBL2105453 78177 10 None - 0 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 272 4 1 4 2.9 OC(CN1CCCCC1)c1cc(-c2ccccc2)on1 10.1038/s41467-023-40064-9
124087 1377 114 None - 15 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 10.1038/s41467-023-40064-9
7157 1377 114 None - 15 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 10.1038/s41467-023-40064-9
814 1377 114 None - 15 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 10.1038/s41467-023-40064-9
CHEMBL1172 1377 114 None - 15 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 10.1038/s41467-023-40064-9
DB00967 1377 114 None - 15 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 10.1038/s41467-023-40064-9
2683 3805 60 None - 4 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 10.1038/s41467-023-40064-9
5487 3805 60 None - 4 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 10.1038/s41467-023-40064-9
7308 3805 60 None - 4 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 10.1038/s41467-023-40064-9
CHEMBL1079 3805 60 None - 4 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 10.1038/s41467-023-40064-9
DB00697 3805 60 None - 4 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 10.1038/s41467-023-40064-9
2176 3104 68 None - 27 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 10.1038/s41467-023-40064-9
4828 3104 68 None - 27 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 10.1038/s41467-023-40064-9
91 3104 68 None - 27 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 10.1038/s41467-023-40064-9
CHEMBL500 3104 68 None - 27 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 10.1038/s41467-023-40064-9
DB00960 3104 68 None - 27 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 10.1038/s41467-023-40064-9
5639 98867 75 None -1 5 Human 8.4 pAC50 = 8.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 387 7 1 8 0.7 COc1ccccc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1 10.1038/s41467-023-40064-9
CHEMBL279229 98867 75 None -1 5 Human 8.4 pAC50 = 8.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 387 7 1 8 0.7 COc1ccccc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1 10.1038/s41467-023-40064-9
4993 122331 110 None - 1 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 248 2 2 4 2.5 CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1 10.1038/s41467-023-40064-9
CHEMBL36 122331 110 None - 1 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 248 2 2 4 2.5 CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1 10.1038/s41467-023-40064-9
2099 9275 55 None - 1 Human 4.4 pAC50 = 4.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 294 2 1 3 2.4 Cc1[nH]cnc1CN1CCc2c(c3ccccc3n2C)C1=O 10.1038/s41467-023-40064-9
CHEMBL1110 9275 55 None - 1 Human 4.4 pAC50 = 4.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 294 2 1 3 2.4 Cc1[nH]cnc1CN1CCc2c(c3ccccc3n2C)C1=O 10.1038/s41467-023-40064-9
2351 4269 49 None - 0 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 366 10 0 3 4.8 CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1 10.1038/s41467-023-40064-9
CHEMBL1008 4269 49 None - 0 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 366 10 0 3 4.8 CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1 10.1038/s41467-023-40064-9
CHEMBL1257078 4269 49 None - 0 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 366 10 0 3 4.8 CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1 10.1038/s41467-023-40064-9
135398744 68633 86 None - 3 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 474 7 1 8 1.6 CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12 10.1038/s41467-023-40064-9
CHEMBL192 68633 86 None - 3 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 474 7 1 8 1.6 CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12 10.1038/s41467-023-40064-9
2142 3074 58 None -2 37 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
4920903 3074 58 None -2 37 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
502 3074 58 None -2 37 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
5775 3074 58 None -2 37 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
CHEMBL597 3074 58 None -2 37 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
DB00692 3074 58 None -2 37 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
2378 98659 103 None - 0 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 310 4 0 2 5.2 c1ccc(-c2ccc(C(c3ccccc3)n3ccnc3)cc2)cc1 10.1038/s41467-023-40064-9
CHEMBL277535 98659 103 None - 0 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 310 4 0 2 5.2 c1ccc(-c2ccc(C(c3ccccc3)n3ccnc3)cc2)cc1 10.1038/s41467-023-40064-9
1353 1898 93 None -6 86 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
3559 1898 93 None -6 86 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
86 1898 93 None -6 86 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
CHEMBL54 1898 93 None -6 86 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
DB00502 1898 93 None -6 86 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
2520 203985 70 None - 12 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC 10.1038/s41467-023-40064-9
CHEMBL1280 203985 70 None - 12 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC 10.1038/s41467-023-40064-9
CHEMBL6966 203985 70 None - 12 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC 10.1038/s41467-023-40064-9
68712 100310 60 None -8 5 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 10.1038/s41467-023-40064-9
CHEMBL289480 100310 60 None -8 5 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 10.1038/s41467-023-40064-9
2398 951 62 None 1 29 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
2801 951 62 None 1 29 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
701 951 62 None 1 29 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
CHEMBL415 951 62 None 1 29 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
DB01242 951 62 None 1 29 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
4034 55792 55 None - 1 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 390 5 0 2 5.6 Cc1cccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)c1 10.1038/s41467-023-40064-9
CHEMBL1623 55792 55 None - 1 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 390 5 0 2 5.6 Cc1cccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)c1 10.1038/s41467-023-40064-9
3157 1458 71 None -2 12 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
7170 1458 71 None -2 12 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
954 1458 71 None -2 12 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
CHEMBL707 1458 71 None -2 12 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
DB00590 1458 71 None -2 12 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
4976 203556 29 None - 12 Human 6.3 pAC50 = 6.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 263 4 1 1 4.3 CNCCCC1c2ccccc2C=Cc2ccccc21 10.1038/s41467-023-40064-9
CHEMBL668 203556 29 None - 12 Human 6.3 pAC50 = 6.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 263 4 1 1 4.3 CNCCCC1c2ccccc2C=Cc2ccccc21 10.1038/s41467-023-40064-9
135 2515 43 None -40 58 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
1796 2515 43 None -40 58 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
4184 2515 43 None -40 58 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
CHEMBL6437 2515 43 None -40 58 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
DB06148 2515 43 None -40 58 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
21722 17960 31 None - 6 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 4 0 2 4.3 CN(C)CCCn1c2c(c3ccccc31)CCCCCC2 10.1038/s41467-023-40064-9
CHEMBL126224 17960 31 None - 6 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 4 0 2 4.3 CN(C)CCCn1c2c(c3ccccc31)CCCCCC2 10.1038/s41467-023-40064-9
3365 5146 126 None - 0 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 306 5 1 7 0.7 OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F 10.1038/s41467-023-40064-9
CHEMBL106 5146 126 None - 0 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 306 5 1 7 0.7 OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F 10.1038/s41467-023-40064-9
135398737 955 93 None -5 92 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
38 955 93 None -5 92 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
722 955 93 None -5 92 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL42 955 93 None -5 92 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
DB00363 955 93 None -5 92 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
135398745 2893 112 None -39 66 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1038/s41467-023-40064-9
47 2893 112 None -39 66 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1038/s41467-023-40064-9
CHEMBL715 2893 112 None -39 66 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1038/s41467-023-40064-9
DB00334 2893 112 None -39 66 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1038/s41467-023-40064-9
5029 15513 92 None - 4 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 359 8 1 5 3.0 COCCCOc1ccnc(C[S+]([O-])c2nc3ccccc3[nH]2)c1C 10.1038/s41467-023-40064-9
CHEMBL1219 15513 92 None - 4 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 359 8 1 5 3.0 COCCCOc1ccnc(C[S+]([O-])c2nc3ccccc3[nH]2)c1C 10.1038/s41467-023-40064-9
3033 30121 102 None - 0 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 295 4 2 2 4.4 O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl 10.1038/s41467-023-40064-9
CHEMBL1034 30121 102 None - 0 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 295 4 2 2 4.4 O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl 10.1038/s41467-023-40064-9
CHEMBL139 30121 102 None - 0 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 295 4 2 2 4.4 O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl 10.1038/s41467-023-40064-9
11434515 261 6 None - 5 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 484 9 1 6 4.7 O=C(C(c1cccs1)(c1cccs1)O)O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2 10.1038/s41467-023-40064-9
11519741 261 6 None - 5 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 484 9 1 6 4.7 O=C(C(c1cccs1)(c1cccs1)O)O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2 10.1038/s41467-023-40064-9
4484 261 6 None - 5 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 484 9 1 6 4.7 O=C(C(c1cccs1)(c1cccs1)O)O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2 10.1038/s41467-023-40064-9
7449 261 6 None - 5 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 484 9 1 6 4.7 O=C(C(c1cccs1)(c1cccs1)O)O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2 10.1038/s41467-023-40064-9
CHEMBL1194325 261 6 None - 5 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 484 9 1 6 4.7 O=C(C(c1cccs1)(c1cccs1)O)O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2 10.1038/s41467-023-40064-9
DB08897 261 6 None - 5 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 484 9 1 6 4.7 O=C(C(c1cccs1)(c1cccs1)O)O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2 10.1038/s41467-023-40064-9
5340 168706 106 None - 0 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 3 2 5 1.5 Nc1ccc(S(=O)(=O)Nc2nccs2)cc1 10.1038/s41467-023-40064-9
CHEMBL437 168706 106 None - 0 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 3 2 5 1.5 Nc1ccc(S(=O)(=O)Nc2nccs2)cc1 10.1038/s41467-023-40064-9
1613 2333 53 None -2 45 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
205 2333 53 None -2 45 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
3964 2333 53 None -2 45 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
CHEMBL831 2333 53 None -2 45 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
DB00408 2333 53 None -2 45 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
1209 1645 75 None -1 32 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1038/s41467-023-40064-9
203 1645 75 None -1 32 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1038/s41467-023-40064-9
3386 1645 75 None -1 32 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1038/s41467-023-40064-9
CHEMBL41 1645 75 None -1 32 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1038/s41467-023-40064-9
DB00472 1645 75 None -1 32 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1038/s41467-023-40064-9
5360696 1394 30 None - 3 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 271 1 0 2 3.4 COc1ccc2c(c1)[C@@]13CCCC[C@@H]3[C@H](C2)N(CC1)C 10.1038/s41467-023-40064-9
6953 1394 30 None - 3 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 271 1 0 2 3.4 COc1ccc2c(c1)[C@@]13CCCC[C@@H]3[C@H](C2)N(CC1)C 10.1038/s41467-023-40064-9
842 1394 30 None - 3 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 271 1 0 2 3.4 COc1ccc2c(c1)[C@@]13CCCC[C@@H]3[C@H](C2)N(CC1)C 10.1038/s41467-023-40064-9
CHEMBL52440 1394 30 None - 3 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 271 1 0 2 3.4 COc1ccc2c(c1)[C@@]13CCCC[C@@H]3[C@H](C2)N(CC1)C 10.1038/s41467-023-40064-9
DB00514 1394 30 None - 3 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 271 1 0 2 3.4 COc1ccc2c(c1)[C@@]13CCCC[C@@H]3[C@H](C2)N(CC1)C 10.1038/s41467-023-40064-9
1209 1645 75 None -1 32 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1038/s41467-023-40064-9
203 1645 75 None -1 32 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1038/s41467-023-40064-9
3386 1645 75 None -1 32 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1038/s41467-023-40064-9
CHEMBL41 1645 75 None -1 32 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1038/s41467-023-40064-9
DB00472 1645 75 None -1 32 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1038/s41467-023-40064-9
3337 206344 27 None 13 41 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 10.1038/s41467-023-40064-9
65801 206344 27 None 13 41 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 10.1038/s41467-023-40064-9
66264 206344 27 None 13 41 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 10.1038/s41467-023-40064-9
91452 206344 27 None 13 41 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 10.1038/s41467-023-40064-9
CHEMBL87493 206344 27 None 13 41 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 10.1038/s41467-023-40064-9
214 3831 58 None -9 30 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
2740 3831 58 None -9 30 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
5566 3831 58 None -9 30 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
66064 3831 58 None -9 30 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
CHEMBL422 3831 58 None -9 30 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
DB00831 3831 58 None -9 30 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
4418 34192 85 None -1 7 Human 6.3 pAC50 = 6.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1038/s41467-023-40064-9
CHEMBL142635 34192 85 None -1 7 Human 6.3 pAC50 = 6.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1038/s41467-023-40064-9
242 469 124 None -14 52 Human 6.3 pAC50 = 6.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
34 469 124 None -14 52 Human 6.3 pAC50 = 6.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
60795 469 124 None -14 52 Human 6.3 pAC50 = 6.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
CHEMBL1112 469 124 None -14 52 Human 6.3 pAC50 = 6.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
DB01238 469 124 None -14 52 Human 6.3 pAC50 = 6.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
1400 1944 70 None - 3 Human 6.3 pAC50 = 6.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
3658 1944 70 None - 3 Human 6.3 pAC50 = 6.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
7199 1944 70 None - 3 Human 6.3 pAC50 = 6.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
91513 1944 70 None - 3 Human 6.3 pAC50 = 6.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL896 1944 70 None - 3 Human 6.3 pAC50 = 6.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
DB00557 1944 70 None - 3 Human 6.3 pAC50 = 6.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
155906370 34760 70 None - 0 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 129 0 4 2 -1.0 CN(C)C(=N)NC(=N)N 10.1038/s41467-023-40064-9
4091 34760 70 None - 0 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 129 0 4 2 -1.0 CN(C)C(=N)NC(=N)N 10.1038/s41467-023-40064-9
CHEMBL1431 34760 70 None - 0 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 129 0 4 2 -1.0 CN(C)C(=N)NC(=N)N 10.1038/s41467-023-40064-9
57469 18834 125 None - 3 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 240 2 1 4 2.8 CC(C)Cn1cnc2c(N)nc3ccccc3c21 10.1038/s41467-023-40064-9
CHEMBL1282 18834 125 None - 3 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 240 2 1 4 2.8 CC(C)Cn1cnc2c(N)nc3ccccc3c21 10.1038/s41467-023-40064-9
2727 188066 95 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 276 4 2 3 1.7 CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1 10.1038/s41467-023-40064-9
CHEMBL498 188066 95 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 276 4 2 3 1.7 CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1 10.1038/s41467-023-40064-9
65866 94235 73 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 611 12 1 8 6.5 COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)(C)CN(C)CCC(c2ccccc2)c2ccccc2)C1c1cccc([N+](=O)[O-])c1 10.1038/s41467-023-40064-9
CHEMBL250270 94235 73 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 611 12 1 8 6.5 COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)(C)CN(C)CCC(c2ccccc2)c2ccccc2)C1c1cccc([N+](=O)[O-])c1 10.1038/s41467-023-40064-9
2162 41484 100 None -3 6 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl 10.1038/s41467-023-40064-9
CHEMBL1491 41484 100 None -3 6 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl 10.1038/s41467-023-40064-9
27447 59773 63 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 347 4 3 5 0.4 CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1 10.1038/s41467-023-40064-9
6560168 59773 63 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 347 4 3 5 0.4 CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1 10.1038/s41467-023-40064-9
CHEMBL1727 59773 63 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 347 4 3 5 0.4 CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1 10.1038/s41467-023-40064-9
92727 204529 77 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 628 15 4 5 4.3 Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)N1CCCNC1=O 10.1038/s41467-023-40064-9
CHEMBL729 204529 77 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 628 15 4 5 4.3 Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)N1CCCNC1=O 10.1038/s41467-023-40064-9
1524 2168 96 None -5 52 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
197 2168 96 None -5 52 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
3822 2168 96 None -5 52 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
88 2168 96 None -5 52 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
CHEMBL51 2168 96 None -5 52 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
DB12465 2168 96 None -5 52 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
240 941 43 None - 25 Human 6.2 pAC50 = 6.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1038/s41467-023-40064-9
2769 941 43 None - 25 Human 6.2 pAC50 = 6.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1038/s41467-023-40064-9
44279790 941 43 None - 25 Human 6.2 pAC50 = 6.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1038/s41467-023-40064-9
660 941 43 None - 25 Human 6.2 pAC50 = 6.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1038/s41467-023-40064-9
CHEMBL1729 941 43 None - 25 Human 6.2 pAC50 = 6.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1038/s41467-023-40064-9
CHEMBL560739 941 43 None - 25 Human 6.2 pAC50 = 6.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1038/s41467-023-40064-9
DB00604 941 43 None - 25 Human 6.2 pAC50 = 6.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1038/s41467-023-40064-9
2337 3232 77 None -5 63 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
50 3232 77 None -5 63 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
5002 3232 77 None -5 63 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL716 3232 77 None -5 63 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
DB01224 3232 77 None -5 63 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
10219 188772 37 None - 5 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 10.1038/s41467-023-40064-9
CHEMBL493439 188772 37 None - 5 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 10.1038/s41467-023-40064-9
CHEMBL50588 188772 37 None - 5 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 10.1038/s41467-023-40064-9
2713 205248 82 None - 0 Human 6.2 pAC50 = 6.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
5353524 205248 82 None - 0 Human 6.2 pAC50 = 6.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
5360566 205248 82 None - 0 Human 6.2 pAC50 = 6.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
88536661 205248 82 None - 0 Human 6.2 pAC50 = 6.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
9552079 205248 82 None - 0 Human 6.2 pAC50 = 6.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
CHEMBL1330113 205248 82 None - 0 Human 6.2 pAC50 = 6.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
CHEMBL790 205248 82 None - 0 Human 6.2 pAC50 = 6.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
2771 194994 74 None - 27 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 10.1038/s41467-023-40064-9
CHEMBL1200781 194994 74 None - 27 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 10.1038/s41467-023-40064-9
CHEMBL549 194994 74 None - 27 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 10.1038/s41467-023-40064-9
2146 3078 67 None -2 9 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
485 3078 67 None -2 9 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
6041 3078 67 None -2 9 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
CHEMBL1215 3078 67 None -2 9 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
DB00388 3078 67 None -2 9 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
212 3777 47 None -7 25 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
2639 3777 47 None -7 25 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
941651 3777 47 None -7 25 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
CHEMBL1201 3777 47 None -7 25 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
DB01623 3777 47 None -7 25 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
1224 1420 83 None - 13 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 6 0 2 3.4 CN(CCOC(c1ccccc1)c1ccccc1)C 10.1038/s41467-023-40064-9
3100 1420 83 None - 13 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 6 0 2 3.4 CN(CCOC(c1ccccc1)c1ccccc1)C 10.1038/s41467-023-40064-9
8980 1420 83 None - 13 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 6 0 2 3.4 CN(CCOC(c1ccccc1)c1ccccc1)C 10.1038/s41467-023-40064-9
916 1420 83 None - 13 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 6 0 2 3.4 CN(CCOC(c1ccccc1)c1ccccc1)C 10.1038/s41467-023-40064-9
CHEMBL657 1420 83 None - 13 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 6 0 2 3.4 CN(CCOC(c1ccccc1)c1ccccc1)C 10.1038/s41467-023-40064-9
DB01075 1420 83 None - 13 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 6 0 2 3.4 CN(CCOC(c1ccccc1)c1ccccc1)C 10.1038/s41467-023-40064-9
39186 85906 54 None - 2 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 414 6 0 6 3.4 COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1 10.1038/s41467-023-40064-9
CHEMBL23 85906 54 None - 2 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 414 6 0 6 3.4 COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1 10.1038/s41467-023-40064-9
2247 504 81 None - 42 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
249 504 81 None - 42 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
2603 504 81 None - 42 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
CHEMBL296419 504 81 None - 42 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
DB00637 504 81 None - 42 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
5732 206912 59 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 307 3 0 3 3.2 Cc1ccc(-c2nc3ccc(C)cn3c2CC(=O)N(C)C)cc1 10.1038/s41467-023-40064-9
CHEMBL911 206912 59 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 307 3 0 3 3.2 Cc1ccc(-c2nc3ccc(C)cn3c2CC(=O)N(C)C)cc1 10.1038/s41467-023-40064-9
3158 56237 27 None - 20 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 10.1038/s41467-023-40064-9
CHEMBL1628227 56237 27 None - 20 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 10.1038/s41467-023-40064-9
5311017 120578 11 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 239 5 0 1 3.8 C[C@@H](Cc1ccccc1)N(C)Cc1ccccc1 10.1038/s41467-023-40064-9
CHEMBL3545985 120578 11 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 239 5 0 1 3.8 C[C@@H](Cc1ccccc1)N(C)Cc1ccccc1 10.1038/s41467-023-40064-9
2146 3078 67 None -2 9 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
485 3078 67 None -2 9 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
6041 3078 67 None -2 9 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
CHEMBL1215 3078 67 None -2 9 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
DB00388 3078 67 None -2 9 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
26987 946 33 None - 21 Human 8.1 pAC50 = 8.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C 10.1038/s41467-023-40064-9
6063 946 33 None - 21 Human 8.1 pAC50 = 8.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C 10.1038/s41467-023-40064-9
671 946 33 None - 21 Human 8.1 pAC50 = 8.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C 10.1038/s41467-023-40064-9
CHEMBL1626 946 33 None - 21 Human 8.1 pAC50 = 8.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C 10.1038/s41467-023-40064-9
DB00283 946 33 None - 21 Human 8.1 pAC50 = 8.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C 10.1038/s41467-023-40064-9
36811 1442 37 None - 7 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
535 1442 37 None - 7 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
937 1442 37 None - 7 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
CHEMBL926 1442 37 None - 7 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
DB00841 1442 37 None - 7 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
1210 915 51 None - 21 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
1213 915 51 None - 21 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
2725 915 51 None - 21 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
33036 915 51 None - 21 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
4411 915 51 None - 21 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
616 915 51 None - 21 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
6976 915 51 None - 21 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
716121 915 51 None - 21 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
90475904 915 51 None - 21 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
CHEMBL1201353 915 51 None - 21 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
CHEMBL1554789 915 51 None - 21 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
CHEMBL505 915 51 None - 21 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
DB01114 915 51 None - 21 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
DB13679 915 51 None - 21 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
5353627 84512 8 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 411 8 3 4 4.6 CC(C)n1c(/C=C/C(O)CC(O)CC(=O)O)c(-c2ccc(F)cc2)c2ccccc21 10.1038/s41467-023-40064-9
CHEMBL2220442 84512 8 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 411 8 3 4 4.6 CC(C)n1c(/C=C/C(O)CC(O)CC(=O)O)c(-c2ccc(F)cc2)c2ccccc21 10.1038/s41467-023-40064-9
135398745 2893 112 None -39 66 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1038/s41467-023-40064-9
47 2893 112 None -39 66 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1038/s41467-023-40064-9
CHEMBL715 2893 112 None -39 66 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1038/s41467-023-40064-9
DB00334 2893 112 None -39 66 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1038/s41467-023-40064-9
38853 175998 79 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 211 3 4 4 0.4 C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O 10.1038/s41467-023-40064-9
6919173 175998 79 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 211 3 4 4 0.4 C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O 10.1038/s41467-023-40064-9
CHEMBL459 175998 79 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 211 3 4 4 0.4 C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O 10.1038/s41467-023-40064-9
4212 198656 82 None - 4 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 444 12 8 10 -0.1 O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21 10.1038/s41467-023-40064-9
CHEMBL1417019 198656 82 None - 4 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 444 12 8 10 -0.1 O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21 10.1038/s41467-023-40064-9
CHEMBL58 198656 82 None - 4 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 444 12 8 10 -0.1 O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21 10.1038/s41467-023-40064-9
11626560 200914 94 None - 0 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 449 5 2 6 5.0 C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl 10.1038/s41467-023-40064-9
CHEMBL601719 200914 94 None - 0 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 449 5 2 6 5.0 C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl 10.1038/s41467-023-40064-9
16129706 209008 40 None - 5 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL None None None C[C@H](N)C(=O)NCC(=O)N[C@H]1CSSC[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC1=O 10.1038/s41467-023-40064-9
CHEMBL1823872 209008 40 None - 5 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL None None None C[C@H](N)C(=O)NCC(=O)N[C@H]1CSSC[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC1=O 10.1038/s41467-023-40064-9
26987 946 33 None - 21 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C 10.1038/s41467-023-40064-9
6063 946 33 None - 21 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C 10.1038/s41467-023-40064-9
671 946 33 None - 21 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C 10.1038/s41467-023-40064-9
CHEMBL1626 946 33 None - 21 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C 10.1038/s41467-023-40064-9
DB00283 946 33 None - 21 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C 10.1038/s41467-023-40064-9
1343 1876 62 None - 9 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 10.1038/s41467-023-40064-9
3519 1876 62 None - 9 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 10.1038/s41467-023-40064-9
522 1876 62 None - 9 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 10.1038/s41467-023-40064-9
CHEMBL862 1876 62 None - 9 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 10.1038/s41467-023-40064-9
DB01018 1876 62 None - 9 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 10.1038/s41467-023-40064-9
5472 205795 75 None - 3 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 263 2 0 2 4.0 Clc1ccccc1CN1CCc2sccc2C1 10.1038/s41467-023-40064-9
CHEMBL1717 205795 75 None - 3 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 263 2 0 2 4.0 Clc1ccccc1CN1CCc2sccc2C1 10.1038/s41467-023-40064-9
CHEMBL833 205795 75 None - 3 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 263 2 0 2 4.0 Clc1ccccc1CN1CCc2sccc2C1 10.1038/s41467-023-40064-9
1201549 594 24 None - 20 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
333 594 24 None - 20 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
7601 594 24 None - 20 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL1201203 594 24 None - 20 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL438151 594 24 None - 20 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
DB00245 594 24 None - 20 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
16362 3103 71 None -35 30 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
2172 3103 71 None -35 30 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
90 3103 71 None -35 30 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL1423 3103 71 None -35 30 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
DB01100 3103 71 None -35 30 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
115 342 71 None -3 7 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1038/s41467-023-40064-9
2092 342 71 None -3 7 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1038/s41467-023-40064-9
7109 342 71 None -3 7 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1038/s41467-023-40064-9
CHEMBL709 342 71 None -3 7 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1038/s41467-023-40064-9
DB00346 342 71 None -3 7 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1038/s41467-023-40064-9
1427 2000 54 None - 27 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
357 2000 54 None - 27 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
3696 2000 54 None - 27 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
CHEMBL11 2000 54 None - 27 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
DB00458 2000 54 None - 27 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
1593 2325 66 None - 4 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1038/s41467-023-40064-9
30668 2325 66 None - 4 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1038/s41467-023-40064-9
9868 2325 66 None - 4 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1038/s41467-023-40064-9
CHEMBL17860 2325 66 None - 4 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1038/s41467-023-40064-9
DB04948 2325 66 None - 4 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1038/s41467-023-40064-9
10100 15262 12 None - 0 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 339 8 0 3 4.3 CCC(=O)O[C@](Cc1ccccc1)(c1ccccc1)[C@H](C)CN(C)C 10.1038/s41467-023-40064-9
CHEMBL1213351 15262 12 None - 0 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 339 8 0 3 4.3 CCC(=O)O[C@](Cc1ccccc1)(c1ccccc1)[C@H](C)CN(C)C 10.1038/s41467-023-40064-9
191 402 98 None - 29 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 10.1038/s41467-023-40064-9
201 402 98 None - 29 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 10.1038/s41467-023-40064-9
2170 402 98 None - 29 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 10.1038/s41467-023-40064-9
CHEMBL1113 402 98 None - 29 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 10.1038/s41467-023-40064-9
DB00543 402 98 None - 29 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 10.1038/s41467-023-40064-9
1890 2739 49 None -1 16 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
4449 2739 49 None -1 16 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
7247 2739 49 None -1 16 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
CHEMBL623 2739 49 None -1 16 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
DB01149 2739 49 None -1 16 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
71398 106412 44 None - 0 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 302 5 4 4 3.6 C[C@@H](Cc1ccc(O)c(O)c1)[C@H](C)Cc1ccc(O)c(O)c1 10.1038/s41467-023-40064-9
CHEMBL313972 106412 44 None - 0 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 302 5 4 4 3.6 C[C@@H](Cc1ccc(O)c(O)c1)[C@H](C)Cc1ccc(O)c(O)c1 10.1038/s41467-023-40064-9
19861 207500 50 None - 1 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 290 0 0 2 3.7 CN1CCC(=C2c3ccccc3CCc3cccnc32)CC1 10.1038/s41467-023-40064-9
CHEMBL946 207500 50 None - 1 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 290 0 0 2 3.7 CN1CCC(=C2c3ccccc3CCc3cccnc32)CC1 10.1038/s41467-023-40064-9
9801 91556 35 None - 0 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 329 8 1 1 5.4 CC(Cc1ccccc1)NCCC(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL24072 91556 35 None - 0 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 329 8 1 1 5.4 CC(Cc1ccccc1)NCCC(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
65709 59851 39 None - 0 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 365 8 0 5 3.3 CCN(CC)CCn1c(=O)c(Cc2ccc(OC)cc2)nc2ccccc21 10.1038/s41467-023-40064-9
CHEMBL1729803 59851 39 None - 0 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 365 8 0 5 3.3 CCN(CC)CCn1c(=O)c(Cc2ccc(OC)cc2)nc2ccccc21 10.1038/s41467-023-40064-9
2585 800 103 None -9 22 Human 8.0 pAC50 = 8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
522 800 103 None -9 22 Human 8.0 pAC50 = 8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
551 800 103 None -9 22 Human 8.0 pAC50 = 8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
CHEMBL723 800 103 None -9 22 Human 8.0 pAC50 = 8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
DB01136 800 103 None -9 22 Human 8.0 pAC50 = 8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
319 1312 44 None - 9 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1038/s41467-023-40064-9
321 1312 44 None - 9 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1038/s41467-023-40064-9
444031 1312 44 None - 9 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1038/s41467-023-40064-9
784 1312 44 None - 9 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1038/s41467-023-40064-9
CHEMBL1346 1312 44 None - 9 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1038/s41467-023-40064-9
DB00496 1312 44 None - 9 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1038/s41467-023-40064-9
3337 206344 27 None 13 41 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 10.1038/s41467-023-40064-9
65801 206344 27 None 13 41 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 10.1038/s41467-023-40064-9
66264 206344 27 None 13 41 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 10.1038/s41467-023-40064-9
91452 206344 27 None 13 41 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 10.1038/s41467-023-40064-9
CHEMBL87493 206344 27 None 13 41 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 10.1038/s41467-023-40064-9
4614 5359 103 None - 0 Human 7.0 pAC50 = 7.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 293 5 1 3 4.0 O=C(O)CCc1nc(-c2ccccc2)c(-c2ccccc2)o1 10.1038/s41467-023-40064-9
CHEMBL1071 5359 103 None - 0 Human 7.0 pAC50 = 7.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 293 5 1 3 4.0 O=C(O)CCc1nc(-c2ccccc2)c(-c2ccccc2)o1 10.1038/s41467-023-40064-9
5329102 194703 86 None - 0 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 398 7 3 3 3.3 CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C 10.1038/s41467-023-40064-9
CHEMBL535 194703 86 None - 0 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 398 7 3 3 3.3 CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C 10.1038/s41467-023-40064-9
441074 19382 82 None - 0 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 324 4 1 4 3.2 C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12 10.1038/s41467-023-40064-9
CHEMBL1294 19382 82 None - 0 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 324 4 1 4 3.2 C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12 10.1038/s41467-023-40064-9
2880 97980 49 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 310 5 0 3 4.6 C=C(c1ccccc1OCc1cccc(Cl)c1)n1ccnc1 10.1038/s41467-023-40064-9
CHEMBL27289 97980 49 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 310 5 0 3 4.6 C=C(c1ccccc1OCc1cccc(Cl)c1)n1ccnc1 10.1038/s41467-023-40064-9
1499 2078 47 None - 17 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1038/s41467-023-40064-9
3779 2078 47 None - 17 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1038/s41467-023-40064-9
536 2078 47 None - 17 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1038/s41467-023-40064-9
CHEMBL434 2078 47 None - 17 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1038/s41467-023-40064-9
DB01064 2078 47 None - 17 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1038/s41467-023-40064-9
2540 4369 111 None - 4 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 610 10 1 11 6.3 CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1 10.1038/s41467-023-40064-9
CHEMBL1014 4369 111 None - 4 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 610 10 1 11 6.3 CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1 10.1038/s41467-023-40064-9
3180 14441 41 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 289 8 0 3 3.9 CCCCOc1ccc(C(=O)CCN2CCCCC2)cc1 10.1038/s41467-023-40064-9
CHEMBL1201217 14441 41 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 289 8 0 3 3.9 CCCCOc1ccc(C(=O)CCN2CCCCC2)cc1 10.1038/s41467-023-40064-9
4567 9916 34 None - 0 Human 7.0 pAC50 = 7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 299 7 3 3 3.4 CC(CCc1ccccc1)NC(C)C(O)c1ccc(O)cc1 10.1038/s41467-023-40064-9
CHEMBL114655 9916 34 None - 0 Human 7.0 pAC50 = 7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 299 7 3 3 3.4 CC(CCc1ccccc1)NC(C)C(O)c1ccc(O)cc1 10.1038/s41467-023-40064-9
2286 3161 51 None - 30 Human 7.0 pAC50 = 7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
4927 3161 51 None - 30 Human 7.0 pAC50 = 7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
7282 3161 51 None - 30 Human 7.0 pAC50 = 7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
CHEMBL643 3161 51 None - 30 Human 7.0 pAC50 = 7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
DB01069 3161 51 None - 30 Human 7.0 pAC50 = 7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
129211 3722 78 None -1 16 Human 10.2 pEC50 = 10.2 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmc.2016.09.017
2562 3722 78 None -1 16 Human 10.2 pEC50 = 10.2 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmc.2016.09.017
488 3722 78 None -1 16 Human 10.2 pEC50 = 10.2 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmc.2016.09.017
CHEMBL836 3722 78 None -1 16 Human 10.2 pEC50 = 10.2 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmc.2016.09.017
DB00706 3722 78 None -1 16 Human 10.2 pEC50 = 10.2 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmc.2016.09.017
132578519 149685 0 None - 0 Human 8.0 pEC50 = 8.0 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 484 10 1 5 4.3 CC(C)Oc1ccccc1OCCN1CCC(CNS(=O)(=O)c2cccc(Cl)c2F)CC1 10.1016/j.bmc.2016.09.017
CHEMBL3947830 149685 0 None - 0 Human 8.0 pEC50 = 8.0 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 484 10 1 5 4.3 CC(C)Oc1ccccc1OCCN1CCC(CNS(=O)(=O)c2cccc(Cl)c2F)CC1 10.1016/j.bmc.2016.09.017
134154987 150808 0 None - 0 Human 6.9 pEC50 = 6.9 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 438 9 1 5 3.4 COc1ccccc1OCCN1CCC(CNS(=O)(=O)c2cccc(Cl)c2)CC1 10.1016/j.bmc.2016.09.017
CHEMBL3956998 150808 0 None - 0 Human 6.9 pEC50 = 6.9 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 438 9 1 5 3.4 COc1ccccc1OCCN1CCC(CNS(=O)(=O)c2cccc(Cl)c2)CC1 10.1016/j.bmc.2016.09.017
9813756 8984 0 None - 3 Rabbit 5.9 pEC50 = 5.9 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 255 2 2 2 2.8 CC(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL109848 8984 0 None - 3 Rabbit 5.9 pEC50 = 5.9 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 255 2 2 2 2.8 CC(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
118727916 120668 0 None - 0 Human 6.9 pEC50 = 6.9 Binding
Antagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assayAntagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assay
ChEMBL 335 6 0 3 2.9 O=C1CCCN1CCCCN1CCN(c2ccccc2Cl)CC1 10.1016/j.bmc.2015.03.009
CHEMBL3400597 120668 0 None - 0 Human 6.9 pEC50 = 6.9 Binding
Antagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assayAntagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assay
ChEMBL 335 6 0 3 2.9 O=C1CCCN1CCCCN1CCN(c2ccccc2Cl)CC1 10.1016/j.bmc.2015.03.009
CHEMBL3547118 120668 0 None - 0 Human 6.9 pEC50 = 6.9 Binding
Antagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assayAntagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assay
ChEMBL 335 6 0 3 2.9 O=C1CCCN1CCCCN1CCN(c2ccccc2Cl)CC1 10.1016/j.bmc.2015.03.009
134156323 154233 0 None - 0 Human 6.9 pEC50 = 6.9 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 455 9 1 6 3.3 COc1ccccc1OCCN1CCC(CNS(=O)(=O)c2cncc3ccccc23)CC1 10.1016/j.bmc.2016.09.017
CHEMBL3986337 154233 0 None - 0 Human 6.9 pEC50 = 6.9 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 455 9 1 6 3.3 COc1ccccc1OCCN1CCC(CNS(=O)(=O)c2cncc3ccccc23)CC1 10.1016/j.bmc.2016.09.017
134148920 148425 0 None - 0 Human 6.8 pEC50 = 6.8 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 456 9 1 5 3.6 COc1ccccc1OCCN1CCC(CNS(=O)(=O)c2cc(Cl)ccc2F)CC1 10.1016/j.bmc.2016.09.017
CHEMBL3937911 148425 0 None - 0 Human 6.8 pEC50 = 6.8 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 456 9 1 5 3.6 COc1ccccc1OCCN1CCC(CNS(=O)(=O)c2cc(Cl)ccc2F)CC1 10.1016/j.bmc.2016.09.017
9944409 7581 0 None - 5 Rabbit 7.8 pEC50 = 7.8 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 307 3 3 4 2.0 CS(=O)(=O)Nc1c(O)ccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL108804 7581 0 None - 5 Rabbit 7.8 pEC50 = 7.8 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 307 3 3 4 2.0 CS(=O)(=O)Nc1c(O)ccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
134151231 152187 0 None - 0 Human 6.8 pEC50 = 6.8 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 464 11 1 7 2.8 COc1ccc(S(=O)(=O)NCC2CCN(CCOc3ccccc3OC)CC2)cc1OC 10.1016/j.bmc.2016.09.017
CHEMBL3968662 152187 0 None - 0 Human 6.8 pEC50 = 6.8 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 464 11 1 7 2.8 COc1ccc(S(=O)(=O)NCC2CCN(CCOc3ccccc3OC)CC2)cc1OC 10.1016/j.bmc.2016.09.017
76326541 85312 0 None - 4 Rabbit 6.8 pEC50 = 6.8 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 305 4 2 3 2.6 CCS(=O)(=O)Nc1cccc2c1CCC[C@H]2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL2261355 85312 0 None - 4 Rabbit 6.8 pEC50 = 6.8 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 305 4 2 3 2.6 CCS(=O)(=O)Nc1cccc2c1CCC[C@H]2c1c[nH]cn1 10.1007/s00044-004-0020-z
168290235 192944 0 None -16 20 Human 5.7 pEC50 = 5.7 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 315 6 4 3 1.1 C[C@@H](NC(=O)/N=C(\N)NCCCc1ncn[nH]1)c1ccccc1 10.1021/acs.jmedchem.1c00692
CHEMBL5201074 192944 0 None -16 20 Human 5.7 pEC50 = 5.7 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 315 6 4 3 1.1 C[C@@H](NC(=O)/N=C(\N)NCCCc1ncn[nH]1)c1ccccc1 10.1021/acs.jmedchem.1c00692
CHEMBL5222491 192944 0 None -16 20 Human 5.7 pEC50 = 5.7 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 315 6 4 3 1.1 C[C@@H](NC(=O)/N=C(\N)NCCCc1ncn[nH]1)c1ccccc1 10.1021/acs.jmedchem.1c00692
9815005 109634 0 None - 3 Rabbit 4.7 pEC50 = 4.7 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 305 3 2 3 2.6 CS(=O)(=O)Nc1cccc2c1CCCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL322492 109634 0 None - 3 Rabbit 4.7 pEC50 = 4.7 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 305 3 2 3 2.6 CS(=O)(=O)Nc1cccc2c1CCCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
134148037 149748 0 None - 0 Human 6.7 pEC50 = 6.7 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 450 10 1 7 2.5 COc1ccc(S(=O)(=O)NC2CCN(CCOc3ccccc3OC)CC2)cc1OC 10.1016/j.bmc.2016.09.017
CHEMBL3948333 149748 0 None - 0 Human 6.7 pEC50 = 6.7 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 450 10 1 7 2.5 COc1ccc(S(=O)(=O)NC2CCN(CCOc3ccccc3OC)CC2)cc1OC 10.1016/j.bmc.2016.09.017
164612037 185353 0 None -4 20 Human 5.7 pEC50 = 5.7 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 326 8 4 4 1.8 CCCCCNC(=O)/N=C(\N)NCCCc1sc(N)nc1C 10.1021/acs.jmedchem.1c00692
CHEMBL4860528 185353 0 None -4 20 Human 5.7 pEC50 = 5.7 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 326 8 4 4 1.8 CCCCCNC(=O)/N=C(\N)NCCCc1sc(N)nc1C 10.1021/acs.jmedchem.1c00692
146762 13278 6 None - 0 Human 7.6 pEC50 = 7.6 Binding
Effective concentration (EC50) against alpha-1-adrenoceptor in the isolated rabbit ear arteryEffective concentration (EC50) against alpha-1-adrenoceptor in the isolated rabbit ear artery
ChEMBL 244 5 3 4 0.5 CNCCc1ccc(O)c(NS(C)(=O)=O)c1 10.1021/jm00380a017
CHEMBL1191956 13278 6 None - 0 Human 7.6 pEC50 = 7.6 Binding
Effective concentration (EC50) against alpha-1-adrenoceptor in the isolated rabbit ear arteryEffective concentration (EC50) against alpha-1-adrenoceptor in the isolated rabbit ear artery
ChEMBL 244 5 3 4 0.5 CNCCc1ccc(O)c(NS(C)(=O)=O)c1 10.1021/jm00380a017
CHEMBL543126 13278 6 None - 0 Human 7.6 pEC50 = 7.6 Binding
Effective concentration (EC50) against alpha-1-adrenoceptor in the isolated rabbit ear arteryEffective concentration (EC50) against alpha-1-adrenoceptor in the isolated rabbit ear artery
ChEMBL 244 5 3 4 0.5 CNCCc1ccc(O)c(NS(C)(=O)=O)c1 10.1021/jm00380a017
9903797 9407 5 None - 4 Rabbit 5.6 pEC50 = 5.6 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 279 5 2 3 2.1 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1C 10.1007/s00044-004-0020-z
CHEMBL111734 9407 5 None - 4 Rabbit 5.6 pEC50 = 5.6 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 279 5 2 3 2.1 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1C 10.1007/s00044-004-0020-z
11183468 109845 2 None - 6 Rabbit 6.6 pEC50 = 6.6 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 213 1 2 2 2.5 Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL323402 109845 2 None - 6 Rabbit 6.6 pEC50 = 6.6 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 213 1 2 2 2.5 Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
9950711 109179 0 None - 4 Rabbit 5.6 pEC50 = 5.6 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 359 4 2 3 3.2 O=S(=O)(CC(F)(F)F)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL321644 109179 0 None - 4 Rabbit 5.6 pEC50 = 5.6 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 359 4 2 3 3.2 O=S(=O)(CC(F)(F)F)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
118727910 120656 0 None - 0 Human 6.5 pEC50 = 6.5 Binding
Antagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assayAntagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assay
ChEMBL 427 8 0 3 4.1 O=C1CCCN1CCCCN1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1 10.1016/j.bmc.2015.03.009
CHEMBL3400594 120656 0 None - 0 Human 6.5 pEC50 = 6.5 Binding
Antagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assayAntagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assay
ChEMBL 427 8 0 3 4.1 O=C1CCCN1CCCCN1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1 10.1016/j.bmc.2015.03.009
CHEMBL3547015 120656 0 None - 0 Human 6.5 pEC50 = 6.5 Binding
Antagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assayAntagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assay
ChEMBL 427 8 0 3 4.1 O=C1CCCN1CCCCN1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1 10.1016/j.bmc.2015.03.009
134136412 142929 0 None - 0 Human 7.5 pEC50 = 7.5 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 483 10 1 6 4.1 CC(C)Oc1ccccc1OCCN1CCC(CNS(=O)(=O)c2cccc3cccnc23)CC1 10.1016/j.bmc.2016.09.017
CHEMBL3894175 142929 0 None - 0 Human 7.5 pEC50 = 7.5 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 483 10 1 6 4.1 CC(C)Oc1ccccc1OCCN1CCC(CNS(=O)(=O)c2cccc3cccnc23)CC1 10.1016/j.bmc.2016.09.017
168294767 192995 0 None -4 20 Human 5.5 pEC50 = 5.5 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 313 8 4 5 0.9 CCCCCNC(=O)/N=C(\N)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
CHEMBL5207281 192995 0 None -4 20 Human 5.5 pEC50 = 5.5 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 313 8 4 5 0.9 CCCCCNC(=O)/N=C(\N)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
CHEMBL5222802 192995 0 None -4 20 Human 5.5 pEC50 = 5.5 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 313 8 4 5 0.9 CCCCCNC(=O)/N=C(\N)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
9904117 9370 3 None - 5 Rabbit 6.4 pEC50 = 6.4 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 291 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL111554 9370 3 None - 5 Rabbit 6.4 pEC50 = 6.4 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 291 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
3584 3748 64 None -2 14 Human 7.3 pEC50 = 7.3 Binding
Antagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assayAntagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmc.2015.03.009
5401 3748 64 None -2 14 Human 7.3 pEC50 = 7.3 Binding
Antagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assayAntagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmc.2015.03.009
7302 3748 64 None -2 14 Human 7.3 pEC50 = 7.3 Binding
Antagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assayAntagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmc.2015.03.009
CHEMBL611 3748 64 None -2 14 Human 7.3 pEC50 = 7.3 Binding
Antagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assayAntagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmc.2015.03.009
DB01162 3748 64 None -2 14 Human 7.3 pEC50 = 7.3 Binding
Antagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assayAntagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmc.2015.03.009
3584 3748 64 None -2 14 Human 7.3 pEC50 = 7.3 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmc.2016.09.017
5401 3748 64 None -2 14 Human 7.3 pEC50 = 7.3 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmc.2016.09.017
7302 3748 64 None -2 14 Human 7.3 pEC50 = 7.3 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmc.2016.09.017
CHEMBL611 3748 64 None -2 14 Human 7.3 pEC50 = 7.3 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmc.2016.09.017
DB01162 3748 64 None -2 14 Human 7.3 pEC50 = 7.3 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmc.2016.09.017
9796525 9375 0 None - 3 Rabbit 5.3 pEC50 = 5.3 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 305 3 1 4 2.3 Cn1cnc(C2CCCc3c(NS(C)(=O)=O)cccc32)c1 10.1007/s00044-004-0020-z
CHEMBL111584 9375 0 None - 3 Rabbit 5.3 pEC50 = 5.3 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 305 3 1 4 2.3 Cn1cnc(C2CCCc3c(NS(C)(=O)=O)cccc32)c1 10.1007/s00044-004-0020-z
2146 3078 67 None -2 9 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at alpha-1A adrenergic receptor (unknown origin) after 5 hrs by CCF4-AM staining-based cellular assayAgonist activity at alpha-1A adrenergic receptor (unknown origin) after 5 hrs by CCF4-AM staining-based cellular assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1016/j.bmc.2015.03.009
485 3078 67 None -2 9 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at alpha-1A adrenergic receptor (unknown origin) after 5 hrs by CCF4-AM staining-based cellular assayAgonist activity at alpha-1A adrenergic receptor (unknown origin) after 5 hrs by CCF4-AM staining-based cellular assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1016/j.bmc.2015.03.009
6041 3078 67 None -2 9 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at alpha-1A adrenergic receptor (unknown origin) after 5 hrs by CCF4-AM staining-based cellular assayAgonist activity at alpha-1A adrenergic receptor (unknown origin) after 5 hrs by CCF4-AM staining-based cellular assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1016/j.bmc.2015.03.009
CHEMBL1215 3078 67 None -2 9 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at alpha-1A adrenergic receptor (unknown origin) after 5 hrs by CCF4-AM staining-based cellular assayAgonist activity at alpha-1A adrenergic receptor (unknown origin) after 5 hrs by CCF4-AM staining-based cellular assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1016/j.bmc.2015.03.009
DB00388 3078 67 None -2 9 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at alpha-1A adrenergic receptor (unknown origin) after 5 hrs by CCF4-AM staining-based cellular assayAgonist activity at alpha-1A adrenergic receptor (unknown origin) after 5 hrs by CCF4-AM staining-based cellular assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1016/j.bmc.2015.03.009
2146 3078 67 None -2 9 Human 7.3 pEC50 = 7.3 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1016/j.bmc.2016.09.017
485 3078 67 None -2 9 Human 7.3 pEC50 = 7.3 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1016/j.bmc.2016.09.017
6041 3078 67 None -2 9 Human 7.3 pEC50 = 7.3 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1016/j.bmc.2016.09.017
CHEMBL1215 3078 67 None -2 9 Human 7.3 pEC50 = 7.3 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1016/j.bmc.2016.09.017
DB00388 3078 67 None -2 9 Human 7.3 pEC50 = 7.3 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1016/j.bmc.2016.09.017
10267873 110633 0 None - 2 Rabbit 5.3 pEC50 = 5.3 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 317 4 2 3 2.8 O=S(=O)(Nc1cccc2c1CCCC2c1c[nH]cn1)C1CC1 10.1007/s00044-004-0020-z
CHEMBL325897 110633 0 None - 2 Rabbit 5.3 pEC50 = 5.3 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 317 4 2 3 2.8 O=S(=O)(Nc1cccc2c1CCCC2c1c[nH]cn1)C1CC1 10.1007/s00044-004-0020-z
9838192 111285 18 None - 6 Human 6.2 pEC50 = 6.2 Binding
Effective concentration in vitro against rabbit urethra Alpha-1A adrenergic receptorEffective concentration in vitro against rabbit urethra Alpha-1A adrenergic receptor
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1021/jm025550h
CHEMBL326702 111285 18 None - 6 Human 6.2 pEC50 = 6.2 Binding
Effective concentration in vitro against rabbit urethra Alpha-1A adrenergic receptorEffective concentration in vitro against rabbit urethra Alpha-1A adrenergic receptor
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1021/jm025550h
9838192 111285 18 None - 6 Rabbit 6.2 pEC50 = 6.2 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1007/s00044-004-0020-z
CHEMBL326702 111285 18 None - 6 Rabbit 6.2 pEC50 = 6.2 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1007/s00044-004-0020-z
9926529 9357 2 None - 5 Rabbit 6.2 pEC50 = 6.2 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 305 4 2 3 2.6 CCS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL111496 9357 2 None - 5 Rabbit 6.2 pEC50 = 6.2 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 305 4 2 3 2.6 CCS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
9879119 9414 0 None - 5 Rabbit 7.2 pEC50 = 7.2 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 291 4 2 3 2.2 CCS(=O)(=O)Nc1cccc2c1CCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL111771 9414 0 None - 5 Rabbit 7.2 pEC50 = 7.2 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 291 4 2 3 2.2 CCS(=O)(=O)Nc1cccc2c1CCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
11301627 9366 0 None - 2 Rabbit 5.2 pEC50 = 5.2 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 319 4 2 3 3.0 CC(C)S(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL111537 9366 0 None - 2 Rabbit 5.2 pEC50 = 5.2 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 319 4 2 3 3.0 CC(C)S(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
43260 5450 65 None - 5 Rabbit 5.2 pEC50 = 5.2 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 197 4 2 4 0.7 COc1ccc(OC)c(C(O)CN)c1 10.1007/s00044-004-0020-z
CHEMBL1076 5450 65 None - 5 Rabbit 5.2 pEC50 = 5.2 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 197 4 2 4 0.7 COc1ccc(OC)c(C(O)CN)c1 10.1007/s00044-004-0020-z
43260 5450 65 None - 5 Human 5.2 pEC50 = 5.2 Binding
Effective concentration in vitro against rabbit urethra Alpha-1 adrenergic receptorEffective concentration in vitro against rabbit urethra Alpha-1 adrenergic receptor
ChEMBL 197 4 2 4 0.7 COc1ccc(OC)c(C(O)CN)c1 10.1021/jm025550h
CHEMBL1076 5450 65 None - 5 Human 5.2 pEC50 = 5.2 Binding
Effective concentration in vitro against rabbit urethra Alpha-1 adrenergic receptorEffective concentration in vitro against rabbit urethra Alpha-1 adrenergic receptor
ChEMBL 197 4 2 4 0.7 COc1ccc(OC)c(C(O)CN)c1 10.1021/jm025550h
134136428 143117 0 None - 0 Human 7.1 pEC50 = 7.1 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 456 9 1 5 3.6 COc1ccccc1OCCN1CCC(CNS(=O)(=O)c2cccc(Cl)c2F)CC1 10.1016/j.bmc.2016.09.017
CHEMBL3895815 143117 0 None - 0 Human 7.1 pEC50 = 7.1 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 456 9 1 5 3.6 COc1ccccc1OCCN1CCC(CNS(=O)(=O)c2cccc(Cl)c2F)CC1 10.1016/j.bmc.2016.09.017
168295528 193007 0 None -4 20 Human 6.1 pEC50 = 6.1 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 333 6 4 5 0.9 N/C(=N\C(=O)NCc1ccccc1)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
CHEMBL5206565 193007 0 None -4 20 Human 6.1 pEC50 = 6.1 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 333 6 4 5 0.9 N/C(=N\C(=O)NCc1ccccc1)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
CHEMBL5222872 193007 0 None -4 20 Human 6.1 pEC50 = 6.1 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 333 6 4 5 0.9 N/C(=N\C(=O)NCc1ccccc1)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
4038180 204 14 None -6 8 Human 8.0 pEC50 = 8.0 Binding
Effective concentration in vitro against rabbit urethra Alpha-1 adrenergic receptorEffective concentration in vitro against rabbit urethra Alpha-1 adrenergic receptor
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm025550h
480 204 14 None -6 8 Human 8.0 pEC50 = 8.0 Binding
Effective concentration in vitro against rabbit urethra Alpha-1 adrenergic receptorEffective concentration in vitro against rabbit urethra Alpha-1 adrenergic receptor
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm025550h
CHEMBL109783 204 14 None -6 8 Human 8.0 pEC50 = 8.0 Binding
Effective concentration in vitro against rabbit urethra Alpha-1 adrenergic receptorEffective concentration in vitro against rabbit urethra Alpha-1 adrenergic receptor
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm025550h
4038180 204 14 None - 8 Rabbit 8.0 pEC50 = 8.0 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
480 204 14 None - 8 Rabbit 8.0 pEC50 = 8.0 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
CHEMBL109783 204 14 None - 8 Rabbit 8.0 pEC50 = 8.0 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
132578518 148628 0 None - 0 Human 7.0 pEC50 = 7 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 441 8 1 6 3.1 COc1ccccc1OCCN1CCC(NS(=O)(=O)c2cncc3ccccc23)CC1 10.1016/j.bmc.2016.09.017
CHEMBL3939560 148628 0 None - 0 Human 7.0 pEC50 = 7 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 441 8 1 6 3.1 COc1ccccc1OCCN1CCC(NS(=O)(=O)c2cncc3ccccc23)CC1 10.1016/j.bmc.2016.09.017
3158 56237 27 None -295 20 Rat 11.0 pIC50 = 11 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 10.1021/jm9910369
CHEMBL1628227 56237 27 None -295 20 Rat 11.0 pIC50 = 11 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 10.1021/jm9910369
180 400 56 None -10 40 Rat 10.7 pIC50 = 10.7 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1021/jm9910369
200 400 56 None -10 40 Rat 10.7 pIC50 = 10.7 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1021/jm9910369
2160 400 56 None -10 40 Rat 10.7 pIC50 = 10.7 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1021/jm9910369
CHEMBL629 400 56 None -10 40 Rat 10.7 pIC50 = 10.7 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1021/jm9910369
DB00321 400 56 None -10 40 Rat 10.7 pIC50 = 10.7 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1021/jm9910369
2398 951 62 None -4 29 Rat 10.4 pIC50 = 10.4 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1021/jm9910369
2801 951 62 None -4 29 Rat 10.4 pIC50 = 10.4 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1021/jm9910369
701 951 62 None -4 29 Rat 10.4 pIC50 = 10.4 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1021/jm9910369
CHEMBL415 951 62 None -4 29 Rat 10.4 pIC50 = 10.4 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1021/jm9910369
DB01242 951 62 None -4 29 Rat 10.4 pIC50 = 10.4 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1021/jm9910369
1971 2846 38 None -24 30 Rat 10.4 pIC50 = 10.4 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1021/jm9910369
2404 2846 38 None -24 30 Rat 10.4 pIC50 = 10.4 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1021/jm9910369
4543 2846 38 None -24 30 Rat 10.4 pIC50 = 10.4 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1021/jm9910369
CHEMBL445 2846 38 None -24 30 Rat 10.4 pIC50 = 10.4 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1021/jm9910369
DB00540 2846 38 None -24 30 Rat 10.4 pIC50 = 10.4 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1021/jm9910369
135 2515 43 None -46 58 Rat 10.2 pIC50 = 10.2 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm9910369
1796 2515 43 None -46 58 Rat 10.2 pIC50 = 10.2 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm9910369
4184 2515 43 None -46 58 Rat 10.2 pIC50 = 10.2 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm9910369
CHEMBL6437 2515 43 None -46 58 Rat 10.2 pIC50 = 10.2 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm9910369
DB06148 2515 43 None -46 58 Rat 10.2 pIC50 = 10.2 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm9910369
4209 3141 75 None -3 34 Rat 9.7 pIC50 = 9.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
4893 3141 75 None -3 34 Rat 9.7 pIC50 = 9.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
503 3141 75 None -3 34 Rat 9.7 pIC50 = 9.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
5385 3141 75 None -3 34 Rat 9.7 pIC50 = 9.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
CHEMBL2 3141 75 None -3 34 Rat 9.7 pIC50 = 9.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
DB00457 3141 75 None -3 34 Rat 9.7 pIC50 = 9.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
2995 204382 53 None - 23 Rat 9.6 pIC50 = 9.6 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 10.1021/jm9910369
CHEMBL1696 204382 53 None - 23 Rat 9.6 pIC50 = 9.6 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 10.1021/jm9910369
CHEMBL72 204382 53 None - 23 Rat 9.6 pIC50 = 9.6 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 10.1021/jm9910369
4209 3141 75 None -3 34 Rat 9.6 pIC50 = 9.6 Binding
Displacement of [3H]prazosin from adrenergic alpha1A receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]prazosin from adrenergic alpha1A receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm900458r
4893 3141 75 None -3 34 Rat 9.6 pIC50 = 9.6 Binding
Displacement of [3H]prazosin from adrenergic alpha1A receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]prazosin from adrenergic alpha1A receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm900458r
503 3141 75 None -3 34 Rat 9.6 pIC50 = 9.6 Binding
Displacement of [3H]prazosin from adrenergic alpha1A receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]prazosin from adrenergic alpha1A receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm900458r
5385 3141 75 None -3 34 Rat 9.6 pIC50 = 9.6 Binding
Displacement of [3H]prazosin from adrenergic alpha1A receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]prazosin from adrenergic alpha1A receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm900458r
CHEMBL2 3141 75 None -3 34 Rat 9.6 pIC50 = 9.6 Binding
Displacement of [3H]prazosin from adrenergic alpha1A receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]prazosin from adrenergic alpha1A receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm900458r
DB00457 3141 75 None -3 34 Rat 9.6 pIC50 = 9.6 Binding
Displacement of [3H]prazosin from adrenergic alpha1A receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]prazosin from adrenergic alpha1A receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm900458r
11638677 84560 0 None -5 6 Rat 9.6 pIC50 = 9.6 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counterDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counter
ChEMBL 340 5 0 5 2.8 COc1ccccc1N1CCN(CCc2ccc3c(c2)OCO3)CC1 10.1016/j.ejmech.2011.04.032
CHEMBL2153423 84560 0 None -5 6 Rat 9.6 pIC50 = 9.6 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counterDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counter
ChEMBL 340 5 0 5 2.8 COc1ccccc1N1CCN(CCc2ccc3c(c2)OCO3)CC1 10.1016/j.ejmech.2011.04.032
CHEMBL2220978 84560 0 None -5 6 Rat 9.6 pIC50 = 9.6 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counterDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counter
ChEMBL 340 5 0 5 2.8 COc1ccccc1N1CCN(CCc2ccc3c(c2)OCO3)CC1 10.1016/j.ejmech.2011.04.032
10809876 102626 0 None - 0 Bovine 9.3 pIC50 = 9.3 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 381 5 0 5 2.4 COc1ccccc1N1CCN(CCc2ccc3c(c2)OCC(=O)N3C)CC1 10.1021/jm970298c
CHEMBL304438 102626 0 None - 0 Bovine 9.3 pIC50 = 9.3 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 381 5 0 5 2.4 COc1ccccc1N1CCN(CCc2ccc3c(c2)OCC(=O)N3C)CC1 10.1021/jm970298c
76071739 142772 0 None - 0 Rat 9.3 pIC50 = 9.3 Binding
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 mins
ChEMBL 348 1 1 4 3.6 COc1ccc2[nH]c3c(c2c1)C[C@H]1c2cc4c(cc2CCN1C3)OCO4 10.1021/acs.jmedchem.6b01217
CHEMBL3892879 142772 0 None - 0 Rat 9.3 pIC50 = 9.3 Binding
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 mins
ChEMBL 348 1 1 4 3.6 COc1ccc2[nH]c3c(c2c1)C[C@H]1c2cc4c(cc2CCN1C3)OCO4 10.1021/acs.jmedchem.6b01217
10547091 202075 0 None - 0 Bovine 9.2 pIC50 = 9.2 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 369 5 1 6 3.4 COc1ccccc1N1CCN(CCc2ccc3nc(O)sc3c2)CC1 10.1021/jm970298c
CHEMBL60885 202075 0 None - 0 Bovine 9.2 pIC50 = 9.2 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 369 5 1 6 3.4 COc1ccccc1N1CCN(CCc2ccc3nc(O)sc3c2)CC1 10.1021/jm970298c
122179430 121415 0 None -3 3 Human 9.2 pIC50 = 9.2 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 599 8 1 13 2.7 CCN(CC)c1ccc2cc(-n3cc(C(=O)N4CCN(c5nc(N)c6cc(OC)c(OC)cc6n5)CC4)nn3)c(=O)oc2c1 10.1021/ml5004298
CHEMBL3582270 121415 0 None -3 3 Human 9.2 pIC50 = 9.2 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 599 8 1 13 2.7 CCN(CC)c1ccc2cc(-n3cc(C(=O)N4CCN(c5nc(N)c6cc(OC)c(OC)cc6n5)CC4)nn3)c(=O)oc2c1 10.1021/ml5004298
4209 3141 75 None -3 34 Rat 9.2 pIC50 = 9.2 Binding
Displacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.01.025
4893 3141 75 None -3 34 Rat 9.2 pIC50 = 9.2 Binding
Displacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.01.025
503 3141 75 None -3 34 Rat 9.2 pIC50 = 9.2 Binding
Displacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.01.025
5385 3141 75 None -3 34 Rat 9.2 pIC50 = 9.2 Binding
Displacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.01.025
CHEMBL2 3141 75 None -3 34 Rat 9.2 pIC50 = 9.2 Binding
Displacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.01.025
DB00457 3141 75 None -3 34 Rat 9.2 pIC50 = 9.2 Binding
Displacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.01.025
3157 1458 71 None -1 12 Rat 9.1 pIC50 = 9.1 Binding
Displacement of [3H]-prazosin from rat alpha1A adrenergic receptor after 60 mins by scintillation counting analysisDisplacement of [3H]-prazosin from rat alpha1A adrenergic receptor after 60 mins by scintillation counting analysis
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1016/j.ejmech.2017.10.026
7170 1458 71 None -1 12 Rat 9.1 pIC50 = 9.1 Binding
Displacement of [3H]-prazosin from rat alpha1A adrenergic receptor after 60 mins by scintillation counting analysisDisplacement of [3H]-prazosin from rat alpha1A adrenergic receptor after 60 mins by scintillation counting analysis
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1016/j.ejmech.2017.10.026
954 1458 71 None -1 12 Rat 9.1 pIC50 = 9.1 Binding
Displacement of [3H]-prazosin from rat alpha1A adrenergic receptor after 60 mins by scintillation counting analysisDisplacement of [3H]-prazosin from rat alpha1A adrenergic receptor after 60 mins by scintillation counting analysis
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1016/j.ejmech.2017.10.026
CHEMBL707 1458 71 None -1 12 Rat 9.1 pIC50 = 9.1 Binding
Displacement of [3H]-prazosin from rat alpha1A adrenergic receptor after 60 mins by scintillation counting analysisDisplacement of [3H]-prazosin from rat alpha1A adrenergic receptor after 60 mins by scintillation counting analysis
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1016/j.ejmech.2017.10.026
DB00590 1458 71 None -1 12 Rat 9.1 pIC50 = 9.1 Binding
Displacement of [3H]-prazosin from rat alpha1A adrenergic receptor after 60 mins by scintillation counting analysisDisplacement of [3H]-prazosin from rat alpha1A adrenergic receptor after 60 mins by scintillation counting analysis
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1016/j.ejmech.2017.10.026
4151 3580 89 None - 3 Rat 9.1 pIC50 = 9.1 Binding
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 mins
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/acs.jmedchem.6b01217
493 3580 89 None - 3 Rat 9.1 pIC50 = 9.1 Binding
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 mins
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/acs.jmedchem.6b01217
5312125 3580 89 None - 3 Rat 9.1 pIC50 = 9.1 Binding
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 mins
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/acs.jmedchem.6b01217
CHEMBL24778 3580 89 None - 3 Rat 9.1 pIC50 = 9.1 Binding
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 mins
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/acs.jmedchem.6b01217
DB06207 3580 89 None - 3 Rat 9.1 pIC50 = 9.1 Binding
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 mins
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/acs.jmedchem.6b01217
10524876 203302 0 None - 0 Bovine 9.1 pIC50 = 9.1 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 397 7 1 6 4.2 COc1ccccc1N1CCN(CCCCc2ccc3nc(O)sc3c2)CC1 10.1021/jm970298c
CHEMBL64878 203302 0 None - 0 Bovine 9.1 pIC50 = 9.1 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 397 7 1 6 4.2 COc1ccccc1N1CCN(CCCCc2ccc3nc(O)sc3c2)CC1 10.1021/jm970298c
2389 3306 118 None -6 68 Rat 9.0 pIC50 = 9.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
5073 3306 118 None -6 68 Rat 9.0 pIC50 = 9.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
96 3306 118 None -6 68 Rat 9.0 pIC50 = 9.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
CHEMBL85 3306 118 None -6 68 Rat 9.0 pIC50 = 9.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
DB00734 3306 118 None -6 68 Rat 9.0 pIC50 = 9.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
10691383 100748 0 None - 0 Bovine 9.0 pIC50 = 9 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 383 6 1 6 3.8 COc1ccccc1N1CCN(CCCc2ccc3nc(O)sc3c2)CC1 10.1021/jm970298c
CHEMBL292935 100748 0 None - 0 Bovine 9.0 pIC50 = 9 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 383 6 1 6 3.8 COc1ccccc1N1CCN(CCCc2ccc3nc(O)sc3c2)CC1 10.1021/jm970298c
19972363 94377 0 None - 0 Rat 9.0 pIC50 = 9 Binding
Binding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptorBinding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptor
ChEMBL 539 9 1 6 5.5 Cc1c(-c2ccccc2)oc2c(C(=O)NCCCN3CCN(c4ccccc4OC(C)C)CC3)cccc2c1=O 10.1021/jm960697s
CHEMBL25098 94377 0 None - 0 Rat 9.0 pIC50 = 9 Binding
Binding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptorBinding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptor
ChEMBL 539 9 1 6 5.5 Cc1c(-c2ccccc2)oc2c(C(=O)NCCCN3CCN(c4ccccc4OC(C)C)CC3)cccc2c1=O 10.1021/jm960697s
44275384 98782 0 None - 0 Rat 9.0 pIC50 = 9 Binding
Binding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptorBinding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptor
ChEMBL 529 7 1 5 5.7 Cc1ccc(Cl)cc1N1CCN(CCCNC(=O)c2cccc3c(=O)c(C)c(-c4ccccc4)oc23)CC1 10.1021/jm960697s
CHEMBL278518 98782 0 None - 0 Rat 9.0 pIC50 = 9 Binding
Binding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptorBinding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptor
ChEMBL 529 7 1 5 5.7 Cc1ccc(Cl)cc1N1CCN(CCCNC(=O)c2cccc3c(=O)c(C)c(-c4ccccc4)oc23)CC1 10.1021/jm960697s
2142 3074 58 None -2 37 Human 9.0 pIC50 = 9.0 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/ml5004298
4920903 3074 58 None -2 37 Human 9.0 pIC50 = 9.0 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/ml5004298
502 3074 58 None -2 37 Human 9.0 pIC50 = 9.0 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/ml5004298
5775 3074 58 None -2 37 Human 9.0 pIC50 = 9.0 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/ml5004298
CHEMBL597 3074 58 None -2 37 Human 9.0 pIC50 = 9.0 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/ml5004298
DB00692 3074 58 None -2 37 Human 9.0 pIC50 = 9.0 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/ml5004298
19972428 98068 0 None - 0 Rat 8.8 pIC50 = 8.8 Binding
Binding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptorBinding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptor
ChEMBL 496 8 0 6 5.6 COc1ccccc1N1CCN(CCCC(=O)c2cccc3c(=O)c(C)c(-c4ccccc4)oc23)CC1 10.1021/jm960697s
CHEMBL27341 98068 0 None - 0 Rat 8.8 pIC50 = 8.8 Binding
Binding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptorBinding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptor
ChEMBL 496 8 0 6 5.6 COc1ccccc1N1CCN(CCCC(=O)c2cccc3c(=O)c(C)c(-c4ccccc4)oc23)CC1 10.1021/jm960697s
3157 1458 71 None -1 12 Rat 8.8 pIC50 = 8.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 nan
7170 1458 71 None -1 12 Rat 8.8 pIC50 = 8.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 nan
954 1458 71 None -1 12 Rat 8.8 pIC50 = 8.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 nan
CHEMBL707 1458 71 None -1 12 Rat 8.8 pIC50 = 8.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 nan
DB00590 1458 71 None -1 12 Rat 8.8 pIC50 = 8.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 nan
107715 200922 22 None -1 20 Rat 8.8 pIC50 = 8.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 611 5 3 6 2.7 CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O nan
CHEMBL1255837 200922 22 None -1 20 Rat 8.8 pIC50 = 8.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 611 5 3 6 2.7 CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O nan
CHEMBL601773 200922 22 None -1 20 Rat 8.8 pIC50 = 8.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 611 5 3 6 2.7 CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O nan
3168 9230 92 None 1 22 Rat 8.8 pIC50 = 8.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 379 6 1 4 3.7 O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1 nan
CHEMBL1108 9230 92 None 1 22 Rat 8.8 pIC50 = 8.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 379 6 1 4 3.7 O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1 nan
1427 2000 54 None - 27 Rat 8.8 pIC50 = 8.8 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1021/jm00172a035
357 2000 54 None - 27 Rat 8.8 pIC50 = 8.8 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1021/jm00172a035
3696 2000 54 None - 27 Rat 8.8 pIC50 = 8.8 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1021/jm00172a035
CHEMBL11 2000 54 None - 27 Rat 8.8 pIC50 = 8.8 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1021/jm00172a035
DB00458 2000 54 None - 27 Rat 8.8 pIC50 = 8.8 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1021/jm00172a035
9821397 100894 21 None - 0 Bovine 8.0 pIC50 = 8 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 383 5 0 6 3.0 COc1ccccc1N1CCN(CCc2ccc3c(c2)sc(=O)n3C)CC1 10.1021/jm970298c
CHEMBL293923 100894 21 None - 0 Bovine 8.0 pIC50 = 8 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 383 5 0 6 3.0 COc1ccccc1N1CCN(CCc2ccc3c(c2)sc(=O)n3C)CC1 10.1021/jm970298c
2389 3306 118 None -11 68 Human 8.0 pIC50 = 8 Binding
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.bmcl.2016.04.087
5073 3306 118 None -11 68 Human 8.0 pIC50 = 8 Binding
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.bmcl.2016.04.087
96 3306 118 None -11 68 Human 8.0 pIC50 = 8 Binding
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.bmcl.2016.04.087
CHEMBL85 3306 118 None -11 68 Human 8.0 pIC50 = 8 Binding
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.bmcl.2016.04.087
DB00734 3306 118 None -11 68 Human 8.0 pIC50 = 8 Binding
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.bmcl.2016.04.087
19972481 93480 0 None - 0 Rat 8.0 pIC50 = 8 Binding
Binding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptorBinding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptor
ChEMBL 498 9 0 6 5.8 COc1ccccc1N1CCN(CCCCOc2cccc3c(=O)c(C)c(-c4ccccc4)oc23)CC1 10.1021/jm960697s
CHEMBL24629 93480 0 None - 0 Rat 8.0 pIC50 = 8 Binding
Binding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptorBinding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptor
ChEMBL 498 9 0 6 5.8 COc1ccccc1N1CCN(CCCCOc2cccc3c(=O)c(C)c(-c4ccccc4)oc23)CC1 10.1021/jm960697s
119146 97122 18 None - 4 Rat 8.0 pIC50 = 8 Binding
Displacement of [3H]prazosin from rat cerebral cortex alpha1 adrenergic receptorDisplacement of [3H]prazosin from rat cerebral cortex alpha1 adrenergic receptor
ChEMBL 409 6 0 4 3.6 CN1CN(c2ccccc2)C2(CCN(CCCC(=O)c3ccc(F)cc3)CC2)C1=O 10.1021/acs.jmedchem.2c00633
CHEMBL267932 97122 18 None - 4 Rat 8.0 pIC50 = 8 Binding
Displacement of [3H]prazosin from rat cerebral cortex alpha1 adrenergic receptorDisplacement of [3H]prazosin from rat cerebral cortex alpha1 adrenergic receptor
ChEMBL 409 6 0 4 3.6 CN1CN(c2ccccc2)C2(CCN(CCCC(=O)c3ccc(F)cc3)CC2)C1=O 10.1021/acs.jmedchem.2c00633
10409553 18876 0 None - 0 Bovine 7.0 pIC50 = 7 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 414 5 1 5 3.1 CS(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3ccccc3)CC1)O2 10.1021/jm00099a028
CHEMBL1203299 18876 0 None - 0 Bovine 7.0 pIC50 = 7 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 414 5 1 5 3.1 CS(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3ccccc3)CC1)O2 10.1021/jm00099a028
CHEMBL128451 18876 0 None - 0 Bovine 7.0 pIC50 = 7 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 414 5 1 5 3.1 CS(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3ccccc3)CC1)O2 10.1021/jm00099a028
11198145 9783 2 None 1 5 Human 7.0 pIC50 = 7 Binding
Inhibition of Alpha-1 adrenergic receptorInhibition of Alpha-1 adrenergic receptor
ChEMBL 325 5 2 3 3.8 C[C@H]([C@@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1021/jm990199u
CHEMBL113830 9783 2 None 1 5 Human 7.0 pIC50 = 7 Binding
Inhibition of Alpha-1 adrenergic receptorInhibition of Alpha-1 adrenergic receptor
ChEMBL 325 5 2 3 3.8 C[C@H]([C@@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1021/jm990199u
13520310 163815 0 None - 0 Rat 7.0 pIC50 = 7 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 281 4 1 2 3.7 CN(C)CC(c1ccc(Cl)cc1)C1(O)CCCCC1 10.1021/jm00172a035
CHEMBL420644 163815 0 None - 0 Rat 7.0 pIC50 = 7 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 281 4 1 2 3.7 CN(C)CC(c1ccc(Cl)cc1)C1(O)CCCCC1 10.1021/jm00172a035
10072866 197452 0 None - 0 Bovine 6.0 pIC50 = 6 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 458 9 0 6 3.3 CCCN(CCCCN1C(=O)c2ccccc2S1(=O)=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL51561 197452 0 None - 0 Bovine 6.0 pIC50 = 6 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 458 9 0 6 3.3 CCCN(CCCCN1C(=O)c2ccccc2S1(=O)=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL56990 197452 0 None - 0 Bovine 6.0 pIC50 = 6 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 458 9 0 6 3.3 CCCN(CCCCN1C(=O)c2ccccc2S1(=O)=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10478362 20068 0 None - 0 Bovine 6.0 pIC50 = 6 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 439 5 1 6 3.0 CS(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3ccc(C#N)cc3)CC1)O2 10.1021/jm00099a028
CHEMBL1203297 20068 0 None - 0 Bovine 6.0 pIC50 = 6 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 439 5 1 6 3.0 CS(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3ccc(C#N)cc3)CC1)O2 10.1021/jm00099a028
CHEMBL130410 20068 0 None - 0 Bovine 6.0 pIC50 = 6 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 439 5 1 6 3.0 CS(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3ccc(C#N)cc3)CC1)O2 10.1021/jm00099a028
10048445 35247 4 None - 0 Rat 6.0 pIC50 = 6 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 432 5 1 3 4.6 Cc1ccc2c(c1)c(-c1ccc(F)cc1)c(C)n2C1=CCN(CCN2CCNC2=O)CC1 10.1021/jm00104a007
CHEMBL143617 35247 4 None - 0 Rat 6.0 pIC50 = 6 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 432 5 1 3 4.6 Cc1ccc2c(c1)c(-c1ccc(F)cc1)c(C)n2C1=CCN(CCN2CCNC2=O)CC1 10.1021/jm00104a007
10391177 189230 0 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 497 7 0 4 4.0 CN(CCCN1CCC2(CC1)OCc1ccccc12)C(=O)C(c1ccc(F)c(F)c1)N1CCCC1=O 10.1016/j.bmcl.2009.04.016
CHEMBL511747 189230 0 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 497 7 0 4 4.0 CN(CCCN1CCC2(CC1)OCc1ccccc12)C(=O)C(c1ccc(F)c(F)c1)N1CCCC1=O 10.1016/j.bmcl.2009.04.016
9978353 11221 0 None - 0 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 400 7 1 5 3.1 COc1cccc2c1CC(NCCCCN1C(=O)CC3(CCCC3)CC1=O)CO2 10.1021/jm00038a007
CHEMBL1178987 11221 0 None - 0 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 400 7 1 5 3.1 COc1cccc2c1CC(NCCCCN1C(=O)CC3(CCCC3)CC1=O)CO2 10.1021/jm00038a007
CHEMBL52785 11221 0 None - 0 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 400 7 1 5 3.1 COc1cccc2c1CC(NCCCCN1C(=O)CC3(CCCC3)CC1=O)CO2 10.1021/jm00038a007
11743327 98674 0 None - 1 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 428 8 1 5 3.9 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(O)c2C1 10.1021/jm00038a007
CHEMBL27763 98674 0 None - 1 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 428 8 1 5 3.9 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(O)c2C1 10.1021/jm00038a007
9975915 99708 0 None - 1 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 362 9 0 5 2.8 CCCN(CCCCN1CCOCC1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL284912 99708 0 None - 1 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 362 9 0 5 2.8 CCCN(CCCCN1CCOCC1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
11524225 188975 0 None - 1 Human 5.0 pIC50 = 5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 403 4 0 5 4.3 Cc1cccc2c(=O)n(C)c(-c3ccc(OC4CCN(C5CCC5)CC4)cc3)nc12 10.1016/j.bmcl.2008.10.034
CHEMBL508712 188975 0 None - 1 Human 5.0 pIC50 = 5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 403 4 0 5 4.3 Cc1cccc2c(=O)n(C)c(-c3ccc(OC4CCN(C5CCC5)CC4)cc3)nc12 10.1016/j.bmcl.2008.10.034
131001 98965 7 None - 1 Bovine 4.0 pIC50 = 4 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 249 5 1 3 2.8 CCCN(CCC)C1COc2cccc(O)c2C1 10.1021/jm00038a007
CHEMBL27995 98965 7 None - 1 Bovine 4.0 pIC50 = 4 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 249 5 1 3 2.8 CCCN(CCC)C1COc2cccc(O)c2C1 10.1021/jm00038a007
10364722 99057 0 None - 1 Bovine 4.0 pIC50 = 4 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 418 9 1 5 3.0 CCCN(CCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL280608 99057 0 None - 1 Bovine 4.0 pIC50 = 4 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 418 9 1 5 3.0 CCCN(CCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL51888 99057 0 None - 1 Bovine 4.0 pIC50 = 4 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 418 9 1 5 3.0 CCCN(CCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10199052 207931 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Concentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in humanConcentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in human
ChEMBL 258 5 3 4 1.0 O=C(NC1CC1)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL97044 207931 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Concentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in humanConcentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in human
ChEMBL 258 5 3 4 1.0 O=C(NC1CC1)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
3158 56237 27 None -295 20 Rat 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 nan
CHEMBL1628227 56237 27 None -295 20 Rat 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 nan
11108001 10840 2 None -3 6 Human 7.0 pIC50 = 7.0 Binding
In vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblastsIn vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblasts
ChEMBL 221 4 2 4 1.8 CSc1ccccc1NCC1=NCCN1 10.1016/s0960-894x(02)00753-9
CHEMBL117248 10840 2 None -3 6 Human 7.0 pIC50 = 7.0 Binding
In vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblastsIn vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblasts
ChEMBL 221 4 2 4 1.8 CSc1ccccc1NCC1=NCCN1 10.1016/s0960-894x(02)00753-9
CHEMBL540542 10840 2 None -3 6 Human 7.0 pIC50 = 7.0 Binding
In vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblastsIn vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblasts
ChEMBL 221 4 2 4 1.8 CSc1ccccc1NCC1=NCCN1 10.1016/s0960-894x(02)00753-9
12488 1644 56 None -77 23 Rat 6.0 pIC50 = 6.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F nan
941361 1644 56 None -77 23 Rat 6.0 pIC50 = 6.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F nan
CHEMBL30008 1644 56 None -77 23 Rat 6.0 pIC50 = 6.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F nan
DB04841 1644 56 None -77 23 Rat 6.0 pIC50 = 6.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F nan
5656 203043 87 None - 43 Rat 7.0 pIC50 = 7.0 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 277 5 1 3 3.0 COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1 10.1021/jm00172a035
CHEMBL637 203043 87 None - 43 Rat 7.0 pIC50 = 7.0 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 277 5 1 3 3.0 COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1 10.1021/jm00172a035
134551 357 27 None -3 21 Rat 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C nan
271 357 27 None -3 21 Rat 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C nan
885 357 27 None -3 21 Rat 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C nan
CHEMBL1403281 357 27 None -3 21 Rat 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C nan
2142 3074 58 None -2 37 Rat 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
4920903 3074 58 None -2 37 Rat 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
502 3074 58 None -2 37 Rat 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
5775 3074 58 None -2 37 Rat 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
CHEMBL597 3074 58 None -2 37 Rat 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
DB00692 3074 58 None -2 37 Rat 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
73453 29585 24 None -6 17 Rat 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 561 4 3 6 2.0 CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12 nan
CHEMBL1385840 29585 24 None -6 17 Rat 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 561 4 3 6 2.0 CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12 nan
10094822 164864 4 None - 0 Rat 8.0 pIC50 = 8.0 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 440 5 1 3 4.8 O=C1NCCN1CCN1CCC(n2cc(-c3ccc(F)cc3)c3ccc(Cl)cc32)CC1 10.1021/jm00104a007
CHEMBL422130 164864 4 None - 0 Rat 8.0 pIC50 = 8.0 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 440 5 1 3 4.8 O=C1NCCN1CCN1CCC(n2cc(-c3ccc(F)cc3)c3ccc(Cl)cc32)CC1 10.1021/jm00104a007
10595604 114110 0 None - 0 Rat 7.0 pIC50 = 7.0 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 374 5 0 4 4.1 Fc1ccc(-n2cc(OCCN3CCOCC3)c3cc(Cl)ccc32)cc1 10.1021/jm960159f
CHEMBL332913 114110 0 None - 0 Rat 7.0 pIC50 = 7.0 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 374 5 0 4 4.1 Fc1ccc(-n2cc(OCCN3CCOCC3)c3cc(Cl)ccc32)cc1 10.1021/jm960159f
36811 1442 37 None -2 7 Rat 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
535 1442 37 None -2 7 Rat 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
937 1442 37 None -2 7 Rat 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
CHEMBL926 1442 37 None -2 7 Rat 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
DB00841 1442 37 None -2 7 Rat 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
11668594 186650 0 None - 1 Human 6.0 pIC50 = 6.0 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 405 7 0 5 4.9 CC(C)n1c(-c2ccc(OCCCN3CCCCC3)cc2)nc2ccccc2c1=O 10.1016/j.bmcl.2008.10.034
CHEMBL488251 186650 0 None - 1 Human 6.0 pIC50 = 6.0 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 405 7 0 5 4.9 CC(C)n1c(-c2ccc(OCCCN3CCCCC3)cc2)nc2ccccc2c1=O 10.1016/j.bmcl.2008.10.034
44376958 57449 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 373 3 0 5 3.7 Cc1ccn2c(=O)c(CCN3CCc4oc5ccccc5c4C3)c(C)nc2c1 10.1016/s0960-894x(99)00591-0
CHEMBL165796 57449 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 373 3 0 5 3.7 Cc1ccn2c(=O)c(CCN3CCc4oc5ccccc5c4C3)c(C)nc2c1 10.1016/s0960-894x(99)00591-0
22120332 56015 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 389 4 0 6 3.4 COc1cccn2c(=O)c(CCN3CCc4oc5ccccc5c4C3)c(C)nc12 10.1016/s0960-894x(99)00591-0
CHEMBL162490 56015 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 389 4 0 6 3.4 COc1cccn2c(=O)c(CCN3CCc4oc5ccccc5c4C3)c(C)nc12 10.1016/s0960-894x(99)00591-0
10015132 163845 1 None - 0 Human 6.9 pIC50 = 6.9 Binding
Binding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptorBinding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptor
ChEMBL 253 4 1 4 2.1 c1ccc(-c2ccccc2OCC2=NCCN2)nc1 10.1016/s0960-894x(01)00764-8
CHEMBL420683 163845 1 None - 0 Human 6.9 pIC50 = 6.9 Binding
Binding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptorBinding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptor
ChEMBL 253 4 1 4 2.1 c1ccc(-c2ccccc2OCC2=NCCN2)nc1 10.1016/s0960-894x(01)00764-8
44573964 178630 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 483 7 0 4 4.5 CN(CCCN1CCC2(CC1)OCc1ccccc12)C(=O)C(c1ccc(F)c(F)c1)N1CCCC1 10.1016/j.bmcl.2009.04.016
CHEMBL467668 178630 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 483 7 0 4 4.5 CN(CCCN1CCC2(CC1)OCc1ccccc12)C(=O)C(c1ccc(F)c(F)c1)N1CCCC1 10.1016/j.bmcl.2009.04.016
213 3824 55 None -4 44 Rat 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
2717 3824 55 None -4 44 Rat 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
5533 3824 55 None -4 44 Rat 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
CHEMBL621 3824 55 None -4 44 Rat 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
DB00656 3824 55 None -4 44 Rat 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
10503470 164299 0 None - 0 Rat 7.9 pIC50 = 7.9 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 444 9 1 4 4.1 CCN(CCOc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12)CCN1CCNC1=O 10.1021/jm960159f
CHEMBL421239 164299 0 None - 0 Rat 7.9 pIC50 = 7.9 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 444 9 1 4 4.1 CCN(CCOc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12)CCN1CCNC1=O 10.1021/jm960159f
127049863 140227 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 443 8 1 5 4.5 CNC(=O)c1cc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)ccc1F 10.1016/j.bmcl.2016.04.087
CHEMBL3805518 140227 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 443 8 1 5 4.5 CNC(=O)c1cc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)ccc1F 10.1016/j.bmcl.2016.04.087
240 941 43 None -4 25 Rat 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
2769 941 43 None -4 25 Rat 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
44279790 941 43 None -4 25 Rat 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
660 941 43 None -4 25 Rat 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
CHEMBL1729 941 43 None -4 25 Rat 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
CHEMBL560739 941 43 None -4 25 Rat 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
DB00604 941 43 None -4 25 Rat 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
85469808 136605 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 439 7 0 4 3.8 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(Cc3ccccc3)CC2)cc1 10.1016/j.bmc.2015.11.020
CHEMBL3739900 136605 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 439 7 0 4 3.8 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(Cc3ccccc3)CC2)cc1 10.1016/j.bmc.2015.11.020
42 2050 57 None - 18 Bovine 5.9 pIC50 = 5.9 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 401 6 0 7 1.2 O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(CC1)c1ncccn1 10.1021/jm00038a007
56971 2050 57 None - 18 Bovine 5.9 pIC50 = 5.9 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 401 6 0 7 1.2 O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(CC1)c1ncccn1 10.1021/jm00038a007
CHEMBL8412 2050 57 None - 18 Bovine 5.9 pIC50 = 5.9 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 401 6 0 7 1.2 O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(CC1)c1ncccn1 10.1021/jm00038a007
4735 195092 96 None -77 10 Rat 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 340 10 4 4 2.9 N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1 nan
CHEMBL361506 195092 96 None -77 10 Rat 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 340 10 4 4 2.9 N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1 nan
CHEMBL55 195092 96 None -77 10 Rat 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 340 10 4 4 2.9 N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1 nan
102 4096 48 None -1258 50 Rat 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
3659 4096 48 None -1258 50 Rat 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
8969 4096 48 None -1258 50 Rat 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
CHEMBL15245 4096 48 None -1258 50 Rat 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
DB01392 4096 48 None -1258 50 Rat 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
13520332 4263 0 None - 0 Rat 6.9 pIC50 = 6.9 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 263 5 1 3 2.6 COc1ccc(C(CN(C)C)C2(O)CCCC2)cc1 10.1021/jm00172a035
CHEMBL100774 4263 0 None - 0 Rat 6.9 pIC50 = 6.9 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 263 5 1 3 2.6 COc1ccc(C(CN(C)C)C2(O)CCCC2)cc1 10.1021/jm00172a035
85469757 136714 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 468 6 0 5 3.9 N#Cc1ccc(N2CCN(CCc3ccc(CN4C(=O)c5ccccc5C4=O)cc3)CC2)c(F)c1 10.1016/j.bmc.2015.11.020
CHEMBL3740874 136714 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 468 6 0 5 3.9 N#Cc1ccc(N2CCN(CCc3ccc(CN4C(=O)c5ccccc5C4=O)cc3)CC2)c(F)c1 10.1016/j.bmc.2015.11.020
44362511 119322 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Binding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptorBinding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptor
ChEMBL 267 4 1 4 2.4 Cc1ccnc(-c2ccccc2OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
CHEMBL344294 119322 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Binding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptorBinding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptor
ChEMBL 267 4 1 4 2.4 Cc1ccnc(-c2ccccc2OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
10829244 16476 0 None - 0 Rat 6.9 pIC50 = 6.9 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 316 4 0 2 4.5 CN(C)CCc1cn(-c2ccc(F)cc2)c2cc(Cl)ccc12 10.1021/jm960159f
CHEMBL123640 16476 0 None - 0 Rat 6.9 pIC50 = 6.9 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 316 4 0 2 4.5 CN(C)CCc1cn(-c2ccc(F)cc2)c2cc(Cl)ccc12 10.1021/jm960159f
10265758 4446 4 None - 0 Rat 6.9 pIC50 = 6.9 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 281 4 1 2 3.7 CN(C)CC(c1cccc(Cl)c1)C1(O)CCCCC1 10.1021/jm00172a035
CHEMBL101899 4446 4 None - 0 Rat 6.9 pIC50 = 6.9 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 281 4 1 2 3.7 CN(C)CC(c1cccc(Cl)c1)C1(O)CCCCC1 10.1021/jm00172a035
2995 204382 53 None - 23 Rat 6.9 pIC50 = 6.9 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 10.1021/jm00172a035
CHEMBL1696 204382 53 None - 23 Rat 6.9 pIC50 = 6.9 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 10.1021/jm00172a035
CHEMBL72 204382 53 None - 23 Rat 6.9 pIC50 = 6.9 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 10.1021/jm00172a035
11689687 191255 0 None - 1 Human 5.9 pIC50 = 5.9 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 391 7 0 5 4.3 CCn1c(-c2ccc(OCCCN3CCCCC3)cc2)nc2ccccc2c1=O 10.1016/j.bmcl.2008.10.034
CHEMBL519067 191255 0 None - 1 Human 5.9 pIC50 = 5.9 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 391 7 0 5 4.3 CCn1c(-c2ccc(OCCCN3CCCCC3)cc2)nc2ccccc2c1=O 10.1016/j.bmcl.2008.10.034
45485061 198731 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 489 5 2 5 5.0 Cc1cc(N(C)C)nc(N[C@H]2CC[C@@H](NC(=O)c3cc(C(F)(F)F)cc(C(F)(F)F)c3)CC2)n1 10.1016/j.bmcl.2009.09.003
CHEMBL583014 198731 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 489 5 2 5 5.0 Cc1cc(N(C)C)nc(N[C@H]2CC[C@@H](NC(=O)c3cc(C(F)(F)F)cc(C(F)(F)F)c3)CC2)n1 10.1016/j.bmcl.2009.09.003
441383 20301 57 None -257 17 Rat 4.9 pIC50 = 4.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 531 8 0 8 4.5 CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
CHEMBL1306 20301 57 None -257 17 Rat 4.9 pIC50 = 4.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 531 8 0 8 4.5 CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
1343 1876 62 None -87 9 Rat 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
3519 1876 62 None -87 9 Rat 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
522 1876 62 None -87 9 Rat 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
CHEMBL862 1876 62 None -87 9 Rat 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
DB01018 1876 62 None -87 9 Rat 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
72197484 102467 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 330 4 2 4 3.5 c1ccc(Cc2nc3c(c(Nc4ccccc4)n2)CCNCC3)cc1 10.1016/j.ejmech.2013.02.020
CHEMBL2393243 102467 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 330 4 2 4 3.5 c1ccc(Cc2nc3c(c(Nc4ccccc4)n2)CCNCC3)cc1 10.1016/j.ejmech.2013.02.020
CHEMBL3040324 102467 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 330 4 2 4 3.5 c1ccc(Cc2nc3c(c(Nc4ccccc4)n2)CCNCC3)cc1 10.1016/j.ejmech.2013.02.020
10645487 15725 0 None - 0 Rat 7.9 pIC50 = 7.9 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 414 7 1 3 3.9 CN(CCc1cn(-c2ccc(F)cc2)c2cc(Cl)ccc12)CCN1CCNC1=O 10.1021/jm960159f
CHEMBL122269 15725 0 None - 0 Rat 7.9 pIC50 = 7.9 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 414 7 1 3 3.9 CN(CCc1cn(-c2ccc(F)cc2)c2cc(Cl)ccc12)CCN1CCNC1=O 10.1021/jm960159f
10788685 118434 0 None - 0 Rat 7.9 pIC50 = 7.9 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 428 8 1 3 4.3 CN(CCCN1CCNC1=O)CCc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12 10.1021/jm960159f
CHEMBL341229 118434 0 None - 0 Rat 7.9 pIC50 = 7.9 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 428 8 1 3 4.3 CN(CCCN1CCNC1=O)CCc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12 10.1021/jm960159f
19972519 94219 0 None - 0 Rat 7.9 pIC50 = 7.9 Binding
Binding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptorBinding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptor
ChEMBL 497 7 1 6 4.3 COc1ccccc1N1CCN(CCNC(=O)c2cccc3c(=O)c(C)c(-c4ccccc4)oc23)CC1 10.1021/jm960697s
CHEMBL25012 94219 0 None - 0 Rat 7.9 pIC50 = 7.9 Binding
Binding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptorBinding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptor
ChEMBL 497 7 1 6 4.3 COc1ccccc1N1CCN(CCNC(=O)c2cccc3c(=O)c(C)c(-c4ccccc4)oc23)CC1 10.1021/jm960697s
180 400 56 None -10 40 Rat 7.9 pIC50 = 7.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
200 400 56 None -10 40 Rat 7.9 pIC50 = 7.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
2160 400 56 None -10 40 Rat 7.9 pIC50 = 7.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
CHEMBL629 400 56 None -10 40 Rat 7.9 pIC50 = 7.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
DB00321 400 56 None -10 40 Rat 7.9 pIC50 = 7.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
85469809 136676 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 467 7 0 5 4.1 CC(=O)c1ccc(N2CCN(CCc3ccc(CN4C(=O)c5ccccc5C4=O)cc3)CC2)cc1 10.1016/j.bmc.2015.11.020
CHEMBL3740558 136676 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 467 7 0 5 4.1 CC(=O)c1ccc(N2CCN(CCc3ccc(CN4C(=O)c5ccccc5C4=O)cc3)CC2)cc1 10.1016/j.bmc.2015.11.020
10381889 107042 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Binding affinity against Alpha-1A adrenergic receptorBinding affinity against Alpha-1A adrenergic receptor
ChEMBL 328 2 0 3 4.1 CN(C)CC1CC2c3ccccc3Cc3ccc(Cl)cc3N2O1 10.1016/s0960-894x(02)00796-5
CHEMBL315772 107042 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Binding affinity against Alpha-1A adrenergic receptorBinding affinity against Alpha-1A adrenergic receptor
ChEMBL 328 2 0 3 4.1 CN(C)CC1CC2c3ccccc3Cc3ccc(Cl)cc3N2O1 10.1016/s0960-894x(02)00796-5
10381889 107042 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
ChEMBL 328 2 0 3 4.1 CN(C)CC1CC2c3ccccc3Cc3ccc(Cl)cc3N2O1 10.1016/s0960-894x(01)00721-1
CHEMBL315772 107042 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
ChEMBL 328 2 0 3 4.1 CN(C)CC1CC2c3ccccc3Cc3ccc(Cl)cc3N2O1 10.1016/s0960-894x(01)00721-1
5656 203043 87 None - 43 Rat 6.9 pIC50 = 6.9 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 277 5 1 3 3.0 COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1 10.1021/jm00172a035
CHEMBL637 203043 87 None - 43 Rat 6.9 pIC50 = 6.9 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 277 5 1 3 3.0 COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1 10.1021/jm00172a035
1201549 594 24 None -51 20 Rat 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
333 594 24 None -51 20 Rat 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
7601 594 24 None -51 20 Rat 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
CHEMBL1201203 594 24 None -51 20 Rat 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
CHEMBL438151 594 24 None -51 20 Rat 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
DB00245 594 24 None -51 20 Rat 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
6075 150084 42 None -11 16 Rat 6.8 pIC50 = 6.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 310 2 0 3 4.6 CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1 nan
CHEMBL395110 150084 42 None -11 16 Rat 6.8 pIC50 = 6.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 310 2 0 3 4.6 CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1 nan
11796106 15548 0 None - 0 Rat 7.8 pIC50 = 7.8 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 414 7 1 3 3.9 CN(CCc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12)CCN1CCNC1=O 10.1021/jm960159f
CHEMBL122113 15548 0 None - 0 Rat 7.8 pIC50 = 7.8 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 414 7 1 3 3.9 CN(CCc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12)CCN1CCNC1=O 10.1021/jm960159f
85469811 136859 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 459 6 0 4 4.5 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccccc3Cl)CC2)cc1 10.1016/j.bmc.2015.11.020
CHEMBL3742198 136859 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 459 6 0 4 4.5 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccccc3Cl)CC2)cc1 10.1016/j.bmc.2015.11.020
9886555 16463 0 None - 0 Rat 6.8 pIC50 = 6.8 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 387 5 0 4 4.0 CN1CCN(CCOc2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1 10.1021/jm960159f
CHEMBL123584 16463 0 None - 0 Rat 6.8 pIC50 = 6.8 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 387 5 0 4 4.0 CN1CCN(CCOc2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1 10.1021/jm960159f
13520317 4318 0 None - 0 Rat 6.8 pIC50 = 6.8 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 277 5 1 3 3.0 COc1cccc(C(CN(C)C)C2(O)CCCCC2)c1 10.1021/jm00172a035
CHEMBL101055 4318 0 None - 0 Rat 6.8 pIC50 = 6.8 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 277 5 1 3 3.0 COc1cccc(C(CN(C)C)C2(O)CCCCC2)c1 10.1021/jm00172a035
160023 19416 7 None - 0 Bovine 5.8 pIC50 = 5.8 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 456 5 1 8 2.6 CS(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3ccc4nonc4c3)CC1)O2 10.1021/jm00099a028
CHEMBL1204345 19416 7 None - 0 Bovine 5.8 pIC50 = 5.8 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 456 5 1 8 2.6 CS(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3ccc4nonc4c3)CC1)O2 10.1021/jm00099a028
CHEMBL129583 19416 7 None - 0 Bovine 5.8 pIC50 = 5.8 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 456 5 1 8 2.6 CS(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3ccc4nonc4c3)CC1)O2 10.1021/jm00099a028
10255678 117345 0 None - 0 Bovine 4.8 pIC50 = 4.8 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 507 7 2 7 2.5 CS(=O)(=O)Nc1ccc(CCN2CCC3(CC2)CC(=O)c2cc(NS(C)(=O)=O)ccc2O3)cc1 10.1021/jm00099a028
CHEMBL1203296 117345 0 None - 0 Bovine 4.8 pIC50 = 4.8 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 507 7 2 7 2.5 CS(=O)(=O)Nc1ccc(CCN2CCC3(CC2)CC(=O)c2cc(NS(C)(=O)=O)ccc2O3)cc1 10.1021/jm00099a028
CHEMBL339769 117345 0 None - 0 Bovine 4.8 pIC50 = 4.8 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 507 7 2 7 2.5 CS(=O)(=O)Nc1ccc(CCN2CCC3(CC2)CC(=O)c2cc(NS(C)(=O)=O)ccc2O3)cc1 10.1021/jm00099a028
85469698 136801 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 425 6 0 4 3.8 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccccc3)CC2)cc1 10.1016/j.bmc.2015.11.020
CHEMBL3741658 136801 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 425 6 0 4 3.8 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccccc3)CC2)cc1 10.1016/j.bmc.2015.11.020
5282322 78215 21 None - 1 Rat 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 785 11 4 15 2.4 CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O)/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]1O nan
CHEMBL2106399 78215 21 None - 1 Rat 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 785 11 4 15 2.4 CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O)/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]1O nan
135398737 955 93 None - 92 Bovine 6.8 pIC50 = 6.8 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm970298c
38 955 93 None - 92 Bovine 6.8 pIC50 = 6.8 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm970298c
722 955 93 None - 92 Bovine 6.8 pIC50 = 6.8 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm970298c
CHEMBL42 955 93 None - 92 Bovine 6.8 pIC50 = 6.8 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm970298c
DB00363 955 93 None - 92 Bovine 6.8 pIC50 = 6.8 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm970298c
2477 742 59 None - 29 Bovine 4.8 pIC50 = 4.8 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 10.1021/jm00038a007
36 742 59 None - 29 Bovine 4.8 pIC50 = 4.8 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 10.1021/jm00038a007
437 742 59 None - 29 Bovine 4.8 pIC50 = 4.8 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 10.1021/jm00038a007
CHEMBL49 742 59 None - 29 Bovine 4.8 pIC50 = 4.8 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 10.1021/jm00038a007
DB00490 742 59 None - 29 Bovine 4.8 pIC50 = 4.8 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 10.1021/jm00038a007
10246054 106517 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
ChEMBL 330 2 0 3 3.7 CN(C)CC1CC2c3cc(F)ccc3Cc3ccc(F)cc3N2O1 10.1016/s0960-894x(01)00721-1
CHEMBL314107 106517 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
ChEMBL 330 2 0 3 3.7 CN(C)CC1CC2c3cc(F)ccc3Cc3ccc(F)cc3N2O1 10.1016/s0960-894x(01)00721-1
44343410 11523 2 None - 0 Human 6.8 pIC50 = 6.8 Binding
In vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblastsIn vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblasts
ChEMBL 219 4 2 3 2.7 CSc1ccccc1NCc1c[nH]cn1 10.1016/s0960-894x(02)00753-9
CHEMBL118055 11523 2 None - 0 Human 6.8 pIC50 = 6.8 Binding
In vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblastsIn vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblasts
ChEMBL 219 4 2 3 2.7 CSc1ccccc1NCc1c[nH]cn1 10.1016/s0960-894x(02)00753-9
10592734 17049 0 None - 0 Rat 7.8 pIC50 = 7.8 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 332 5 0 3 4.4 CN(C)CCOc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12 10.1021/jm960159f
CHEMBL125483 17049 0 None - 0 Rat 7.8 pIC50 = 7.8 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 332 5 0 3 4.4 CN(C)CCOc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12 10.1021/jm960159f
8459 3273 4 None - 3 Bovine 7.8 pIC50 = 7.8 Binding
Binding affinity was tested on cloned bovine Alpha-1A adrenergic receptorBinding affinity was tested on cloned bovine Alpha-1A adrenergic receptor
ChEMBL 495 8 1 9 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)COc1c(OC)cccc1C(C)C 10.1021/jm960697s
9891980 3273 4 None - 3 Bovine 7.8 pIC50 = 7.8 Binding
Binding affinity was tested on cloned bovine Alpha-1A adrenergic receptorBinding affinity was tested on cloned bovine Alpha-1A adrenergic receptor
ChEMBL 495 8 1 9 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)COc1c(OC)cccc1C(C)C 10.1021/jm960697s
CHEMBL430717 3273 4 None - 3 Bovine 7.8 pIC50 = 7.8 Binding
Binding affinity was tested on cloned bovine Alpha-1A adrenergic receptorBinding affinity was tested on cloned bovine Alpha-1A adrenergic receptor
ChEMBL 495 8 1 9 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)COc1c(OC)cccc1C(C)C 10.1021/jm960697s
242 469 124 None -14 52 Human 6.8 pIC50 = 6.8 Binding
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1016/j.bmcl.2016.04.087
34 469 124 None -14 52 Human 6.8 pIC50 = 6.8 Binding
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1016/j.bmcl.2016.04.087
60795 469 124 None -14 52 Human 6.8 pIC50 = 6.8 Binding
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1016/j.bmcl.2016.04.087
CHEMBL1112 469 124 None -14 52 Human 6.8 pIC50 = 6.8 Binding
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1016/j.bmcl.2016.04.087
DB01238 469 124 None -14 52 Human 6.8 pIC50 = 6.8 Binding
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1016/j.bmcl.2016.04.087
10544602 117443 0 None - 0 Rat 6.8 pIC50 = 6.8 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 332 5 0 3 4.4 CN(C)CCOc1cn(-c2ccc(F)cc2)c2cc(Cl)ccc12 10.1021/jm960159f
CHEMBL339919 117443 0 None - 0 Rat 6.8 pIC50 = 6.8 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 332 5 0 3 4.4 CN(C)CCOc1cn(-c2ccc(F)cc2)c2cc(Cl)ccc12 10.1021/jm960159f
10739024 69804 0 None -33 6 Human 5.8 pIC50 = 5.8 Binding
Compound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the human prostate Alpha-1A adrenergic receptor subtype.Compound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the human prostate Alpha-1A adrenergic receptor subtype.
ChEMBL 388 4 3 8 0.9 COc1cc2nc(N3CCN[C@H](C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC 10.1021/jm980053f
CHEMBL19376 69804 0 None -33 6 Human 5.8 pIC50 = 5.8 Binding
Compound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the human prostate Alpha-1A adrenergic receptor subtype.Compound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the human prostate Alpha-1A adrenergic receptor subtype.
ChEMBL 388 4 3 8 0.9 COc1cc2nc(N3CCN[C@H](C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC 10.1021/jm980053f
2771 194994 74 None -8 27 Rat 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 nan
CHEMBL1200781 194994 74 None -8 27 Rat 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 nan
CHEMBL549 194994 74 None -8 27 Rat 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 nan
10518508 102025 1 None - 0 Rat 7.8 pIC50 = 7.8 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 302 3 0 2 4.5 CN(C)Cc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12 10.1021/jm960159f
CHEMBL301956 102025 1 None - 0 Rat 7.8 pIC50 = 7.8 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 302 3 0 2 4.5 CN(C)Cc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12 10.1021/jm960159f
11502343 186126 0 None - 1 Human 5.8 pIC50 = 5.8 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 405 8 0 5 4.7 CCCn1c(-c2ccc(OCCCN3CCCCC3)cc2)nc2ccccc2c1=O 10.1016/j.bmcl.2008.10.034
CHEMBL487230 186126 0 None - 1 Human 5.8 pIC50 = 5.8 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 405 8 0 5 4.7 CCCn1c(-c2ccc(OCCCN3CCCCC3)cc2)nc2ccccc2c1=O 10.1016/j.bmcl.2008.10.034
10477439 35976 4 None - 0 Rat 7.7 pIC50 = 7.7 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 424 5 1 3 4.2 O=C1NCCN1CCN1CCC(n2cc(-c3ccc(F)cc3)c3cc(F)ccc32)CC1 10.1021/jm00104a007
CHEMBL144318 35976 4 None - 0 Rat 7.7 pIC50 = 7.7 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 424 5 1 3 4.2 O=C1NCCN1CCN1CCC(n2cc(-c3ccc(F)cc3)c3cc(F)ccc32)CC1 10.1021/jm00104a007
10426286 119327 0 None - 0 Rat 6.7 pIC50 = 6.7 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 322 2 0 2 5.0 Cc1ccc2c(c1)c(-c1ccc(F)cc1)cn2C1CCN(C)CC1 10.1021/jm00104a007
CHEMBL344335 119327 0 None - 0 Rat 6.7 pIC50 = 6.7 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 322 2 0 2 5.0 Cc1ccc2c(c1)c(-c1ccc(F)cc1)cn2C1CCN(C)CC1 10.1021/jm00104a007
10254306 120849 4 None - 0 Rat 6.7 pIC50 = 6.7 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 474 5 1 3 5.1 O=C1NCCN1CCN1CCC(n2cc(-c3ccc(F)cc3)c3cc(C(F)(F)F)ccc32)CC1 10.1021/jm00104a007
CHEMBL355917 120849 4 None - 0 Rat 6.7 pIC50 = 6.7 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 474 5 1 3 5.1 O=C1NCCN1CCN1CCC(n2cc(-c3ccc(F)cc3)c3cc(C(F)(F)F)ccc32)CC1 10.1021/jm00104a007
13520327 208342 0 None - 0 Rat 6.7 pIC50 = 6.7 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 355 5 1 3 3.8 COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1Br 10.1021/jm00172a035
CHEMBL99503 208342 0 None - 0 Rat 6.7 pIC50 = 6.7 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 355 5 1 3 3.8 COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1Br 10.1021/jm00172a035
19426635 205570 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
ChEMBL 280 2 1 3 3.1 CNCC1CC2c3ccccc3Cc3ccccc3N2O1 10.1016/s0960-894x(01)00721-1
CHEMBL81485 205570 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
ChEMBL 280 2 1 3 3.1 CNCC1CC2c3ccccc3Cc3ccccc3N2O1 10.1016/s0960-894x(01)00721-1
22493269 46796 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cellsIn vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cells
ChEMBL 256 4 2 5 2.1 Cc1ncoc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
CHEMBL154023 46796 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cellsIn vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cells
ChEMBL 256 4 2 5 2.1 Cc1ncoc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
22493289 49658 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cellsIn vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cells
ChEMBL 253 4 2 5 1.6 c1cnc(-c2ccccc2NCC2=NCCN2)nc1 10.1016/s0960-894x(01)00822-8
CHEMBL156661 49658 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cellsIn vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cells
ChEMBL 253 4 2 5 1.6 c1cnc(-c2ccccc2NCC2=NCCN2)nc1 10.1016/s0960-894x(01)00822-8
9934955 72247 0 None -489 6 Human 5.7 pIC50 = 5.7 Binding
Compound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the human prostate Alpha-1A adrenergic receptor subtypeCompound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the human prostate Alpha-1A adrenergic receptor subtype
ChEMBL 482 5 2 9 2.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@H](C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC 10.1021/jm980053f
CHEMBL19826 72247 0 None -489 6 Human 5.7 pIC50 = 5.7 Binding
Compound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the human prostate Alpha-1A adrenergic receptor subtypeCompound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the human prostate Alpha-1A adrenergic receptor subtype
ChEMBL 482 5 2 9 2.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@H](C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC 10.1021/jm980053f
25014630 83510 1 None - 0 Human 5.7 pIC50 = 5.7 Binding
Inhibition of alpha1A adrenergic receptorInhibition of alpha1A adrenergic receptor
ChEMBL 326 3 3 4 3.3 N=C(Nc1ccc2c(c1)CCN2C1CCNCC1)c1cccs1 10.1016/j.ejmech.2012.07.006
CHEMBL2203713 83510 1 None - 0 Human 5.7 pIC50 = 5.7 Binding
Inhibition of alpha1A adrenergic receptorInhibition of alpha1A adrenergic receptor
ChEMBL 326 3 3 4 3.3 N=C(Nc1ccc2c(c1)CCN2C1CCNCC1)c1cccs1 10.1016/j.ejmech.2012.07.006
44461606 105968 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
ChEMBL 308 3 0 3 3.8 CN(C)CCC1CC2c3ccccc3Cc3ccccc3N2O1 10.1016/s0960-894x(01)00721-1
CHEMBL313189 105968 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
ChEMBL 308 3 0 3 3.8 CN(C)CCC1CC2c3ccccc3Cc3ccccc3N2O1 10.1016/s0960-894x(01)00721-1
10073934 187466 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 481 7 0 6 3.5 CN(CCCN1CCC2(CC1)OCc1ccccc12)C(=O)C(c1ccc(F)c(F)c1)n1cncn1 10.1016/j.bmcl.2009.04.016
CHEMBL494155 187466 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 481 7 0 6 3.5 CN(CCCN1CCC2(CC1)OCc1ccccc12)C(=O)C(c1ccc(F)c(F)c1)n1cncn1 10.1016/j.bmcl.2009.04.016
44573932 187467 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 482 7 0 7 2.9 CN(CCCN1CCC2(CC1)OCc1ccccc12)C(=O)C(c1ccc(F)c(F)c1)n1cnnn1 10.1016/j.bmcl.2009.04.016
CHEMBL494156 187467 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 482 7 0 7 2.9 CN(CCCN1CCC2(CC1)OCc1ccccc12)C(=O)C(c1ccc(F)c(F)c1)n1cnnn1 10.1016/j.bmcl.2009.04.016
1547484 937 74 None -125 20 Rat 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
654 937 74 None -125 20 Rat 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
9072 937 74 None -125 20 Rat 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
CHEMBL43064 937 74 None -125 20 Rat 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
DB00568 937 74 None -125 20 Rat 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
10345121 187429 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 481 7 0 6 3.5 CN(CCCN1CCC2(CC1)OCc1ccccc12)C(=O)C(c1ccc(F)c(F)c1)n1ccnn1 10.1016/j.bmcl.2009.04.016
CHEMBL493967 187429 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 481 7 0 6 3.5 CN(CCCN1CCC2(CC1)OCc1ccccc12)C(=O)C(c1ccc(F)c(F)c1)n1ccnn1 10.1016/j.bmcl.2009.04.016
2105 3032 37 None -1258 33 Rat 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
47811 3032 37 None -1258 33 Rat 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
48 3032 37 None -1258 33 Rat 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
CHEMBL531 3032 37 None -1258 33 Rat 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
DB01186 3032 37 None -1258 33 Rat 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
448537 160226 89 None -1584 25 Rat 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 nan
CHEMBL411 160226 89 None -1584 25 Rat 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 nan
9837963 62941 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibitory concentration against radioligand binding to human Alpha-1A adrenergic receptor, expressed in rat 1 fibroblast cellsInhibitory concentration against radioligand binding to human Alpha-1A adrenergic receptor, expressed in rat 1 fibroblast cells
ChEMBL 255 4 2 5 1.5 Cn1nccc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
CHEMBL17851 62941 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibitory concentration against radioligand binding to human Alpha-1A adrenergic receptor, expressed in rat 1 fibroblast cellsInhibitory concentration against radioligand binding to human Alpha-1A adrenergic receptor, expressed in rat 1 fibroblast cells
ChEMBL 255 4 2 5 1.5 Cn1nccc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
148842 3915 27 None -8 5 Rat 8.7 pIC50 = 8.7 Binding
Binding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptorBinding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptor
ChEMBL 511 8 1 6 4.7 COc1ccccc1N1CCN(CC1)CCCNC(=O)c1cccc2c1oc(c1ccccc1)c(c2=O)C 10.1021/jm960697s
496 3915 27 None -8 5 Rat 8.7 pIC50 = 8.7 Binding
Binding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptorBinding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptor
ChEMBL 511 8 1 6 4.7 COc1ccccc1N1CCN(CC1)CCCNC(=O)c1cccc2c1oc(c1ccccc1)c(c2=O)C 10.1021/jm960697s
CHEMBL278865 3915 27 None -8 5 Rat 8.7 pIC50 = 8.7 Binding
Binding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptorBinding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptor
ChEMBL 511 8 1 6 4.7 COc1ccccc1N1CCN(CC1)CCCNC(=O)c1cccc2c1oc(c1ccccc1)c(c2=O)C 10.1021/jm960697s
85469933 136623 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 439 6 0 4 4.2 Cc1ccc(N2CCN(CCc3ccc(CN4C(=O)c5ccccc5C4=O)cc3)CC2)cc1 10.1016/j.bmc.2015.11.020
CHEMBL3740019 136623 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 439 6 0 4 4.2 Cc1ccc(N2CCN(CCc3ccc(CN4C(=O)c5ccccc5C4=O)cc3)CC2)cc1 10.1016/j.bmc.2015.11.020
56961506 121413 0 None - 1 Human 8.6 pIC50 = 8.6 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 544 5 2 13 1.6 COc1cc2nc(N3CCN(C(=O)c4cn(-c5cc6ccc(O)cc6oc5=O)nn4)CC3)nc(N)c2cc1OC 10.1021/ml5004298
CHEMBL3582269 121413 0 None - 1 Human 8.6 pIC50 = 8.6 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 544 5 2 13 1.6 COc1cc2nc(N3CCN(C(=O)c4cn(-c5cc6ccc(O)cc6oc5=O)nn4)CC3)nc(N)c2cc1OC 10.1021/ml5004298
137380627 162642 3 None - 0 Rat 8.6 pIC50 = 8.6 Binding
Displacement of [3H]-prazosin from rat alpha1A adrenergic receptor after 60 mins by scintillation counting analysisDisplacement of [3H]-prazosin from rat alpha1A adrenergic receptor after 60 mins by scintillation counting analysis
ChEMBL 772 17 2 14 4.7 COc1cc2nc(N3CCN(C(=O)CCCCCCCCCCC(=O)N4CCN(c5nc(N)c6cc(OC)c(OC)cc6n5)CC4)CC3)nc(N)c2cc1OC 10.1016/j.ejmech.2017.10.026
CHEMBL4170029 162642 3 None - 0 Rat 8.6 pIC50 = 8.6 Binding
Displacement of [3H]-prazosin from rat alpha1A adrenergic receptor after 60 mins by scintillation counting analysisDisplacement of [3H]-prazosin from rat alpha1A adrenergic receptor after 60 mins by scintillation counting analysis
ChEMBL 772 17 2 14 4.7 COc1cc2nc(N3CCN(C(=O)CCCCCCCCCCC(=O)N4CCN(c5nc(N)c6cc(OC)c(OC)cc6n5)CC4)CC3)nc(N)c2cc1OC 10.1016/j.ejmech.2017.10.026
1353 1898 93 None - 86 Bovine 7.7 pIC50 = 7.7 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1021/jm970298c
3559 1898 93 None - 86 Bovine 7.7 pIC50 = 7.7 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1021/jm970298c
86 1898 93 None - 86 Bovine 7.7 pIC50 = 7.7 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1021/jm970298c
CHEMBL54 1898 93 None - 86 Bovine 7.7 pIC50 = 7.7 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1021/jm970298c
DB00502 1898 93 None - 86 Bovine 7.7 pIC50 = 7.7 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1021/jm970298c
10573576 200409 0 None - 0 Bovine 7.7 pIC50 = 7.7 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 409 7 0 5 3.2 COc1ccccc1N1CCN(CCCCc2ccc3c(c2)OCC(=O)N3C)CC1 10.1021/jm970298c
CHEMBL59823 200409 0 None - 0 Bovine 7.7 pIC50 = 7.7 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 409 7 0 5 3.2 COc1ccccc1N1CCN(CCCCc2ccc3c(c2)OCC(=O)N3C)CC1 10.1021/jm970298c
10671211 202704 0 None - 0 Bovine 6.7 pIC50 = 6.7 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 449 6 0 5 4.8 Cn1c(=O)sc2cc(CCCCN3CCN(c4cccc(C(F)(F)F)c4)CC3)ccc21 10.1021/jm970298c
CHEMBL61818 202704 0 None - 0 Bovine 6.7 pIC50 = 6.7 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 449 6 0 5 4.8 Cn1c(=O)sc2cc(CCCCN3CCN(c4cccc(C(F)(F)F)c4)CC3)ccc21 10.1021/jm970298c
10319624 98959 0 None - 1 Bovine 5.7 pIC50 = 5.7 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 414 10 1 4 4.1 CCCN(CCCCNC(=O)c1ccc(F)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL27991 98959 0 None - 1 Bovine 5.7 pIC50 = 5.7 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 414 10 1 4 4.1 CCCN(CCCCNC(=O)c1ccc(F)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL298534 98959 0 None - 1 Bovine 5.7 pIC50 = 5.7 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 414 10 1 4 4.1 CCCN(CCCCNC(=O)c1ccc(F)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10265863 193300 0 None - 0 Bovine 5.7 pIC50 = 5.7 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 283 5 0 2 4.3 CCCN(CCC)C1COc2ccc3ccccc3c2C1 10.1021/jm00038a007
CHEMBL52438 193300 0 None - 0 Bovine 5.7 pIC50 = 5.7 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 283 5 0 2 4.3 CCCN(CCC)C1COc2ccc3ccccc3c2C1 10.1021/jm00038a007
9934955 72247 0 None -165 6 Rat 5.7 pIC50 = 5.7 Binding
Compound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the rat prostate Alpha-1A adrenergic receptor subtypeCompound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the rat prostate Alpha-1A adrenergic receptor subtype
ChEMBL 482 5 2 9 2.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@H](C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC 10.1021/jm980053f
CHEMBL19826 72247 0 None -165 6 Rat 5.7 pIC50 = 5.7 Binding
Compound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the rat prostate Alpha-1A adrenergic receptor subtypeCompound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the rat prostate Alpha-1A adrenergic receptor subtype
ChEMBL 482 5 2 9 2.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@H](C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC 10.1021/jm980053f
121852 10134 7 None - 1 Bovine 4.7 pIC50 = 4.7 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 442 9 0 5 4.2 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL11592 10134 7 None - 1 Bovine 4.7 pIC50 = 4.7 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 442 9 0 5 4.2 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL301060 10134 7 None - 1 Bovine 4.7 pIC50 = 4.7 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 442 9 0 5 4.2 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
44376975 55956 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 435 5 0 5 4.6 O=c1c(CCN2CCc3oc4ccccc4c3C2)c(Cc2ccccc2)nc2ccccn12 10.1016/s0960-894x(99)00591-0
CHEMBL162436 55956 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 435 5 0 5 4.6 O=c1c(CCN2CCc3oc4ccccc4c3C2)c(Cc2ccccc2)nc2ccccn12 10.1016/s0960-894x(99)00591-0
9903313 172654 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Concentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in humanConcentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in human
ChEMBL 260 5 2 4 1.2 CCN(C)C(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL450018 172654 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Concentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in humanConcentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in human
ChEMBL 260 5 2 4 1.2 CCN(C)C(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
14739944 208377 0 None - 0 Rat 6.7 pIC50 = 6.7 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 261 4 1 2 3.3 Cc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1 10.1021/jm00172a035
CHEMBL99670 208377 0 None - 0 Rat 6.7 pIC50 = 6.7 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 261 4 1 2 3.3 Cc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1 10.1021/jm00172a035
2520 203985 70 None -147 12 Rat 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC nan
CHEMBL1280 203985 70 None -147 12 Rat 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC nan
CHEMBL6966 203985 70 None -147 12 Rat 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC nan
3198 205490 76 None -1698 34 Rat 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
CHEMBL1201049 205490 76 None -1698 34 Rat 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
CHEMBL808 205490 76 None -1698 34 Rat 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
9951544 57346 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 375 3 0 5 3.8 Cc1nc2ccccn2c(=O)c1CCN1CCc2sc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL165181 57346 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 375 3 0 5 3.8 Cc1nc2ccccn2c(=O)c1CCN1CCc2sc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
10198532 207673 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Concentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in humanConcentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in human
ChEMBL 232 4 3 4 0.5 CNC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL95523 207673 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Concentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in humanConcentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in human
ChEMBL 232 4 3 4 0.5 CNC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
11581337 186648 0 None - 3 Human 5.7 pIC50 = 5.7 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 363 6 0 5 3.5 Cn1c(-c2ccc(OCCCN3CCCC3)cc2)nc2ccccc2c1=O 10.1016/j.bmcl.2008.10.034
CHEMBL488248 186648 0 None - 3 Human 5.7 pIC50 = 5.7 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 363 6 0 5 3.5 Cn1c(-c2ccc(OCCCN3CCCC3)cc2)nc2ccccc2c1=O 10.1016/j.bmcl.2008.10.034
CHEMBL557214 186648 0 None - 3 Human 5.7 pIC50 = 5.7 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 363 6 0 5 3.5 Cn1c(-c2ccc(OCCCN3CCCC3)cc2)nc2ccccc2c1=O 10.1016/j.bmcl.2008.10.034
2351 3261 64 None -138 21 Rat 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
2820 3261 64 None -138 21 Rat 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
5035 3261 64 None -138 21 Rat 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
CHEMBL81 3261 64 None -138 21 Rat 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
DB00481 3261 64 None -138 21 Rat 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
1016 3720 78 None -1737 35 Rat 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
2561 3720 78 None -1737 35 Rat 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
2733526 3720 78 None -1737 35 Rat 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
5384 3720 78 None -1737 35 Rat 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
CHEMBL83 3720 78 None -1737 35 Rat 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
DB00675 3720 78 None -1737 35 Rat 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
44329797 108079 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Concentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in humanConcentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in human
ChEMBL 261 5 2 5 1.7 CC(C)OC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL319553 108079 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Concentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in humanConcentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in human
ChEMBL 261 5 2 5 1.7 CC(C)OC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
135 2515 43 None -46 58 Rat 6.7 pIC50 = 6.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
1796 2515 43 None -46 58 Rat 6.7 pIC50 = 6.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
4184 2515 43 None -46 58 Rat 6.7 pIC50 = 6.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
CHEMBL6437 2515 43 None -46 58 Rat 6.7 pIC50 = 6.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
DB06148 2515 43 None -46 58 Rat 6.7 pIC50 = 6.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
85469870 136625 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 439 6 0 4 4.2 Cc1ccccc1N1CCN(CCc2ccc(CN3C(=O)c4ccccc4C3=O)cc2)CC1 10.1016/j.bmc.2015.11.020
CHEMBL3740042 136625 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 439 6 0 4 4.2 Cc1ccccc1N1CCN(CCc2ccc(CN3C(=O)c4ccccc4C3=O)cc2)CC1 10.1016/j.bmc.2015.11.020
85469934 136710 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 443 6 0 4 4.0 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccc(F)cc3)CC2)cc1 10.1016/j.bmc.2015.11.020
CHEMBL3740847 136710 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 443 6 0 4 4.0 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccc(F)cc3)CC2)cc1 10.1016/j.bmc.2015.11.020
10834872 15533 0 None - 0 Rat 7.6 pIC50 = 7.6 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 400 6 1 3 3.9 CN(CCN1CCNC1=O)Cc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12 10.1021/jm960159f
CHEMBL122018 15533 0 None - 0 Rat 7.6 pIC50 = 7.6 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 400 6 1 3 3.9 CN(CCN1CCNC1=O)Cc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12 10.1021/jm960159f
1588 2311 27 None -26 44 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
28864 2311 27 None -26 44 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
43 2311 27 None -26 44 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
CHEMBL157138 2311 27 None -26 44 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
DB00589 2311 27 None -26 44 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
10047772 36641 0 None - 0 Rat 7.6 pIC50 = 7.6 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 420 5 1 3 4.4 Cc1cccc2c(-c3ccc(F)cc3)cn(C3CCN(CCN4CCNC4=O)CC3)c12 10.1021/jm00104a007
CHEMBL144901 36641 0 None - 0 Rat 7.6 pIC50 = 7.6 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 420 5 1 3 4.4 Cc1cccc2c(-c3ccc(F)cc3)cn(C3CCN(CCN4CCNC4=O)CC3)c12 10.1021/jm00104a007
44573821 192709 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 503 6 0 2 6.8 Cc1ccc(N(C(=O)N(C)CCCN2CCC3(CCc4ccccc43)CC2)c2ccc(F)c(F)c2)cc1 10.1016/j.bmcl.2009.04.016
CHEMBL522037 192709 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 503 6 0 2 6.8 Cc1ccc(N(C(=O)N(C)CCCN2CCC3(CCc4ccccc43)CC2)c2ccc(F)c(F)c2)cc1 10.1016/j.bmcl.2009.04.016
3082597 99531 8 None - 1 Bovine 5.6 pIC50 = 5.6 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 263 6 0 3 3.1 CCCN(CCC)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL283606 99531 8 None - 1 Bovine 5.6 pIC50 = 5.6 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 263 6 0 3 3.1 CCCN(CCC)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
11753909 18936 0 None - 0 Bovine 5.6 pIC50 = 5.6 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 458 5 2 8 2.5 CS(=O)(=O)Nc1ccc2c(c1)C(O)CC1(CCN(CCc3ccc4nonc4c3)CC1)O2 10.1021/jm00099a028
CHEMBL1203301 18936 0 None - 0 Bovine 5.6 pIC50 = 5.6 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 458 5 2 8 2.5 CS(=O)(=O)Nc1ccc2c(c1)C(O)CC1(CCN(CCc3ccc4nonc4c3)CC1)O2 10.1021/jm00099a028
CHEMBL128745 18936 0 None - 0 Bovine 5.6 pIC50 = 5.6 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 458 5 2 8 2.5 CS(=O)(=O)Nc1ccc2c(c1)C(O)CC1(CCN(CCc3ccc4nonc4c3)CC1)O2 10.1021/jm00099a028
9845791 119205 4 None - 0 Rat 5.6 pIC50 = 5.6 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 434 5 1 3 4.7 Cc1ccc2c(c1)c(-c1ccc(F)cc1)c(C)n2C1CCN(CCN2CCNC2=O)CC1 10.1021/jm00104a007
CHEMBL343444 119205 4 None - 0 Rat 5.6 pIC50 = 5.6 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 434 5 1 3 4.7 Cc1ccc2c(c1)c(-c1ccc(F)cc1)c(C)n2C1CCN(CCN2CCNC2=O)CC1 10.1021/jm00104a007
44376954 55710 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 387 3 0 5 4.0 Cc1cc(C)n2c(=O)c(CCN3CCc4oc5ccccc5c4C3)c(C)nc2c1 10.1016/s0960-894x(99)00591-0
CHEMBL162232 55710 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 387 3 0 5 4.0 Cc1cc(C)n2c(=O)c(CCN3CCc4oc5ccccc5c4C3)c(C)nc2c1 10.1016/s0960-894x(99)00591-0
2247 504 81 None -5 42 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
249 504 81 None -5 42 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
2603 504 81 None -5 42 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
CHEMBL296419 504 81 None -5 42 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
DB00637 504 81 None -5 42 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
1212 1649 50 None -19 66 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
204 1649 50 None -19 66 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
3372 1649 50 None -19 66 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
CHEMBL726 1649 50 None -19 66 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
DB00623 1649 50 None -19 66 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
3584 3748 64 None -2 14 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
5401 3748 64 None -2 14 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
7302 3748 64 None -2 14 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
CHEMBL611 3748 64 None -2 14 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
DB01162 3748 64 None -2 14 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
9931837 119147 4 None - 0 Rat 7.6 pIC50 = 7.6 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 418 5 1 3 4.3 Cc1ccc2c(c1)c(-c1ccc(F)cc1)cn2C1=CCN(CCN2CCNC2=O)CC1 10.1021/jm00104a007
CHEMBL343034 119147 4 None - 0 Rat 7.6 pIC50 = 7.6 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 418 5 1 3 4.3 Cc1ccc2c(c1)c(-c1ccc(F)cc1)cn2C1=CCN(CCN2CCNC2=O)CC1 10.1021/jm00104a007
44563063 186001 0 None - 1 Human 5.6 pIC50 = 5.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 439 7 0 5 5.3 O=c1c2ccccc2nc(-c2ccc(OCCCN3CCCCC3)cc2)n1-c1ccccc1 10.1016/j.bmcl.2008.10.034
CHEMBL487060 186001 0 None - 1 Human 5.6 pIC50 = 5.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 439 7 0 5 5.3 O=c1c2ccccc2nc(-c2ccc(OCCCN3CCCCC3)cc2)n1-c1ccccc1 10.1016/j.bmcl.2008.10.034
277 1289 62 None -117 46 Rat 6.6 pIC50 = 6.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
2913 1289 62 None -117 46 Rat 6.6 pIC50 = 6.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
765 1289 62 None -117 46 Rat 6.6 pIC50 = 6.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
CHEMBL516 1289 62 None -117 46 Rat 6.6 pIC50 = 6.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
DB00434 1289 62 None -117 46 Rat 6.6 pIC50 = 6.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
44376900 56238 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 375 3 1 6 3.1 Cc1nc2c(O)cccn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL162826 56238 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 375 3 1 6 3.1 Cc1nc2c(O)cccn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
11292933 56364 45 None - 9 Rat 7.6 pIC50 = 7.6 Binding
Inhibition of rat adrenergic alpha1A receptorInhibition of rat adrenergic alpha1A receptor
ChEMBL 415 5 1 4 3.4 Cc1ccc2c(N3CCN(CCc4cccc(N5CCNC5=O)c4)CC3)cccc2n1 10.1021/jm100714c
CHEMBL1631540 56364 45 None - 9 Rat 7.6 pIC50 = 7.6 Binding
Inhibition of rat adrenergic alpha1A receptorInhibition of rat adrenergic alpha1A receptor
ChEMBL 415 5 1 4 3.4 Cc1ccc2c(N3CCN(CCc4cccc(N5CCNC5=O)c4)CC3)cccc2n1 10.1021/jm100714c
22493258 98636 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibitory concentration against radioligand binding to human Alpha-1A adrenergic receptor, expressed in rat 1 fibroblast cellsInhibitory concentration against radioligand binding to human Alpha-1A adrenergic receptor, expressed in rat 1 fibroblast cells
ChEMBL 241 4 3 4 1.5 c1ccc(-c2cc[nH]n2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(03)00050-7
CHEMBL277375 98636 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibitory concentration against radioligand binding to human Alpha-1A adrenergic receptor, expressed in rat 1 fibroblast cellsInhibitory concentration against radioligand binding to human Alpha-1A adrenergic receptor, expressed in rat 1 fibroblast cells
ChEMBL 241 4 3 4 1.5 c1ccc(-c2cc[nH]n2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(03)00050-7
73603034 125926 29 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at alpha 1a adrenergic receptor (unknown origin)Antagonist activity at alpha 1a adrenergic receptor (unknown origin)
ChEMBL 465 4 3 8 2.9 Cn1ncc(NC(=O)c2nc(-c3c(F)cccc3F)sc2N)c1N1CC[C@@H](N)[C@H](F)CC1 10.1021/acs.jmedchem.8b01857
CHEMBL3648680 125926 29 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at alpha 1a adrenergic receptor (unknown origin)Antagonist activity at alpha 1a adrenergic receptor (unknown origin)
ChEMBL 465 4 3 8 2.9 Cn1ncc(NC(=O)c2nc(-c3c(F)cccc3F)sc2N)c1N1CC[C@@H](N)[C@H](F)CC1 10.1021/acs.jmedchem.8b01857
44376993 56454 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 427 3 0 5 4.7 Cc1nc2c(Cl)cc(Cl)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL163247 56454 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 427 3 0 5 4.7 Cc1nc2c(Cl)cc(Cl)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
14739954 109083 0 None - 0 Rat 6.6 pIC50 = 6.6 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 325 4 1 2 3.8 CN(C)CC(c1ccccc1Br)C1(O)CCCCC1 10.1021/jm00172a035
CHEMBL321364 109083 0 None - 0 Rat 6.6 pIC50 = 6.6 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 325 4 1 2 3.8 CN(C)CC(c1ccccc1Br)C1(O)CCCCC1 10.1021/jm00172a035
3191 102831 97 None -204 25 Rat 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 469 9 0 3 7.2 CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1 nan
CHEMBL305660 102831 97 None -204 25 Rat 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 469 9 0 3 7.2 CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1 nan
2812 4747 101 None -2238 34 Rat 4.6 pIC50 = 4.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 344 4 0 2 5.4 Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 nan
CHEMBL104 4747 101 None -2238 34 Rat 4.6 pIC50 = 4.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 344 4 0 2 5.4 Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 nan
10341964 33040 0 None - 0 Rat 7.6 pIC50 = 7.6 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 418 5 1 3 4.3 Cc1cccc2c(-c3ccc(F)cc3)cn(C3=CCN(CCN4CCNC4=O)CC3)c12 10.1021/jm00104a007
CHEMBL141667 33040 0 None - 0 Rat 7.6 pIC50 = 7.6 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 418 5 1 3 4.3 Cc1cccc2c(-c3ccc(F)cc3)cn(C3=CCN(CCN4CCNC4=O)CC3)c12 10.1021/jm00104a007
44269124 28787 1 None - 0 Human 7.6 pIC50 = 7.6 Binding
Binding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptorBinding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptor
ChEMBL 252 4 1 3 2.7 c1ccc(-c2ccccc2OCC2=NCCN2)cc1 10.1016/s0960-894x(01)00764-8
CHEMBL13789 28787 1 None - 0 Human 7.6 pIC50 = 7.6 Binding
Binding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptorBinding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptor
ChEMBL 252 4 1 3 2.7 c1ccc(-c2ccccc2OCC2=NCCN2)cc1 10.1016/s0960-894x(01)00764-8
10427137 36020 4 None -1 2 Rat 5.6 pIC50 = 5.6 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 336 2 0 2 5.3 Cc1ccc2c(c1)c(-c1ccc(F)cc1)c(C)n2C1CCN(C)CC1 10.1021/jm00104a007
CHEMBL144362 36020 4 None -1 2 Rat 5.6 pIC50 = 5.6 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 336 2 0 2 5.3 Cc1ccc2c(c1)c(-c1ccc(F)cc1)c(C)n2C1CCN(C)CC1 10.1021/jm00104a007
127046693 139642 0 None -2 2 Human 5.6 pIC50 = 5.6 Binding
Selectivity interaction (Binding assay) EUB0000341aCl ADRA1ASelectivity interaction (Binding assay) EUB0000341aCl ADRA1A
ChEMBL 300 3 2 4 2.2 C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N 10.6019/CHEMBL5212743
CHEMBL3797887 139642 0 None -2 2 Human 5.6 pIC50 = 5.6 Binding
Selectivity interaction (Binding assay) EUB0000341aCl ADRA1ASelectivity interaction (Binding assay) EUB0000341aCl ADRA1A
ChEMBL 300 3 2 4 2.2 C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N 10.6019/CHEMBL5212743
CHEMBL4762646 139642 0 None -2 2 Human 5.6 pIC50 = 5.6 Binding
Selectivity interaction (Binding assay) EUB0000341aCl ADRA1ASelectivity interaction (Binding assay) EUB0000341aCl ADRA1A
ChEMBL 300 3 2 4 2.2 C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N 10.6019/CHEMBL5212743
1935 3707 97 None -190 6 Rat 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 198 0 1 2 2.7 Nc1c2CCCCc2nc2c1cccc2 nan
2551 3707 97 None -190 6 Rat 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 198 0 1 2 2.7 Nc1c2CCCCc2nc2c1cccc2 nan
6687 3707 97 None -190 6 Rat 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 198 0 1 2 2.7 Nc1c2CCCCc2nc2c1cccc2 nan
CHEMBL95 3707 97 None -190 6 Rat 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 198 0 1 2 2.7 Nc1c2CCCCc2nc2c1cccc2 nan
DB00382 3707 97 None -190 6 Rat 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 198 0 1 2 2.7 Nc1c2CCCCc2nc2c1cccc2 nan
45485062 197145 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 367 5 2 5 3.3 Cc1cccc(C(=O)N[C@H]2CC[C@@H](Nc3ncc(C)c(N(C)C)n3)CC2)c1 10.1016/j.bmcl.2009.09.003
CHEMBL567993 197145 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 367 5 2 5 3.3 Cc1cccc(C(=O)N[C@H]2CC[C@@H](Nc3ncc(C)c(N(C)C)n3)CC2)c1 10.1016/j.bmcl.2009.09.003
9956013 37607 4 None - 0 Rat 6.6 pIC50 = 6.6 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 462 6 0 3 5.5 Cc1ccc2c(c1)c(-c1ccc(F)cc1)cn2C1CCN(CCN2CCN(C(C)C)C2=O)CC1 10.1021/jm00104a007
CHEMBL145712 37607 4 None - 0 Rat 6.6 pIC50 = 6.6 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 462 6 0 3 5.5 Cc1ccc2c(c1)c(-c1ccc(F)cc1)cn2C1CCN(CCN2CCN(C(C)C)C2=O)CC1 10.1021/jm00104a007
44377007 57118 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 393 3 0 5 4.0 Cc1nc2ccccn2c(=O)c1CCN1CCc2oc3c(Cl)cccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL164612 57118 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 393 3 0 5 4.0 Cc1nc2ccccn2c(=O)c1CCN1CCc2oc3c(Cl)cccc3c2C1 10.1016/s0960-894x(99)00591-0
9795167 107467 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
In vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblastsIn vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblasts
ChEMBL 260 6 3 4 1.2 CCCNC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(02)00753-9
CHEMBL318544 107467 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
In vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblastsIn vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblasts
ChEMBL 260 6 3 4 1.2 CCCNC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(02)00753-9
10399043 120136 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
In vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cellsIn vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cells
ChEMBL 232 5 2 5 1.1 CO/N=C/c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
CHEMBL351542 120136 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
In vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cellsIn vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cells
ChEMBL 232 5 2 5 1.1 CO/N=C/c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
3151 1450 97 None -147 27 Rat 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
945 1450 97 None -147 27 Rat 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
965 1450 97 None -147 27 Rat 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
CHEMBL219916 1450 97 None -147 27 Rat 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
DB01184 1450 97 None -147 27 Rat 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
22120322 55891 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 373 3 0 5 3.7 Cc1ccc2nc(C)c(CCN3CCc4oc5ccccc5c4C3)c(=O)n2c1 10.1016/s0960-894x(99)00591-0
CHEMBL162370 55891 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 373 3 0 5 3.7 Cc1ccc2nc(C)c(CCN3CCc4oc5ccccc5c4C3)c(=O)n2c1 10.1016/s0960-894x(99)00591-0
12575 1975 30 None - 17 Human 5.5 pIC50 = 5.5 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1016/s0960-894x(99)00591-0
54459 1975 30 None - 17 Human 5.5 pIC50 = 5.5 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1016/s0960-894x(99)00591-0
CHEMBL10316 1975 30 None - 17 Human 5.5 pIC50 = 5.5 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1016/s0960-894x(99)00591-0
11516386 186007 0 None - 1 Human 5.5 pIC50 = 5.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 377 6 0 5 3.9 Cn1c(-c2ccc(OCCCN3CCCCC3)cc2)nc2ccccc2c1=O 10.1016/j.bmcl.2008.10.034
CHEMBL487064 186007 0 None - 1 Human 5.5 pIC50 = 5.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 377 6 0 5 3.9 Cn1c(-c2ccc(OCCCN3CCCCC3)cc2)nc2ccccc2c1=O 10.1016/j.bmcl.2008.10.034
2435 3563 83 None - 49 Rat 8.5 pIC50 = 8.5 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm960159f
60149 3563 83 None - 49 Rat 8.5 pIC50 = 8.5 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm960159f
98 3563 83 None - 49 Rat 8.5 pIC50 = 8.5 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm960159f
CHEMBL12713 3563 83 None - 49 Rat 8.5 pIC50 = 8.5 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm960159f
DB06144 3563 83 None - 49 Rat 8.5 pIC50 = 8.5 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm960159f
2435 3563 83 None - 49 Rat 8.5 pIC50 = 8.5 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm00104a007
60149 3563 83 None - 49 Rat 8.5 pIC50 = 8.5 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm00104a007
98 3563 83 None - 49 Rat 8.5 pIC50 = 8.5 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm00104a007
CHEMBL12713 3563 83 None - 49 Rat 8.5 pIC50 = 8.5 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm00104a007
DB06144 3563 83 None - 49 Rat 8.5 pIC50 = 8.5 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm00104a007
56961460 121412 0 None - 1 Human 8.4 pIC50 = 8.4 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 477 4 2 10 2.0 COc1cc2nc(N3CCN(C(=O)c4cc5ccc(O)cc5oc4=O)CC3)nc(N)c2cc1OC 10.1021/ml5004298
CHEMBL3582268 121412 0 None - 1 Human 8.4 pIC50 = 8.4 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 477 4 2 10 2.0 COc1cc2nc(N3CCN(C(=O)c4cc5ccc(O)cc5oc4=O)CC3)nc(N)c2cc1OC 10.1021/ml5004298
10809238 201118 0 None - 0 Bovine 7.5 pIC50 = 7.5 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 371 4 0 5 3.1 Cn1c(=O)sc2cc(CCN3CCN(c4ccc(F)cc4)CC3)ccc21 10.1021/jm970298c
CHEMBL60318 201118 0 None - 0 Bovine 7.5 pIC50 = 7.5 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 371 4 0 5 3.1 Cn1c(=O)sc2cc(CCN3CCN(c4ccc(F)cc4)CC3)ccc21 10.1021/jm970298c
10501785 202705 0 None - 0 Bovine 7.5 pIC50 = 7.5 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 411 7 0 6 3.8 COc1ccccc1N1CCN(CCCCc2ccc3c(c2)sc(=O)n3C)CC1 10.1021/jm970298c
CHEMBL61819 202705 0 None - 0 Bovine 7.5 pIC50 = 7.5 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 411 7 0 6 3.8 COc1ccccc1N1CCN(CCCCc2ccc3c(c2)sc(=O)n3C)CC1 10.1021/jm970298c
10718277 203239 0 None - 0 Bovine 7.5 pIC50 = 7.5 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 447 6 0 4 4.2 CN1C(=O)COc2cc(CCCCN3CCN(c4cccc(C(F)(F)F)c4)CC3)ccc21 10.1021/jm970298c
CHEMBL64610 203239 0 None - 0 Bovine 7.5 pIC50 = 7.5 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 447 6 0 4 4.2 CN1C(=O)COc2cc(CCCCN3CCN(c4cccc(C(F)(F)F)c4)CC3)ccc21 10.1021/jm970298c
85469932 136761 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 455 7 0 5 3.9 COc1ccccc1N1CCN(CCc2ccc(CN3C(=O)c4ccccc4C3=O)cc2)CC1 10.1016/j.bmc.2015.11.020
CHEMBL3741318 136761 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 455 7 0 5 3.9 COc1ccccc1N1CCN(CCc2ccc(CN3C(=O)c4ccccc4C3=O)cc2)CC1 10.1016/j.bmc.2015.11.020
1305 510 14 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 425 5 2 5 4.1 O=C(c1ccc(c(c1)F)F)N[C@@H]1CC[C@@H](CC1)Nc1nc2ccccc2c(n1)N(C)C 10.1016/j.bmcl.2009.09.003
9934033 510 14 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 425 5 2 5 4.1 O=C(c1ccc(c(c1)F)F)N[C@@H]1CC[C@@H](CC1)Nc1nc2ccccc2c(n1)N(C)C 10.1016/j.bmcl.2009.09.003
CHEMBL182150 510 14 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 425 5 2 5 4.1 O=C(c1ccc(c(c1)F)F)N[C@@H]1CC[C@@H](CC1)Nc1nc2ccccc2c(n1)N(C)C 10.1016/j.bmcl.2009.09.003
138753277 177271 1 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibition of adrenergic receptor alpha1a (unknown origin)Inhibition of adrenergic receptor alpha1a (unknown origin)
ChEMBL 303 1 2 3 3.3 Cc1cc(Br)c(NC2=NCCN2)c2ccccc12 10.1021/acs.jmedchem.9b01870
CHEMBL4636550 177271 1 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibition of adrenergic receptor alpha1a (unknown origin)Inhibition of adrenergic receptor alpha1a (unknown origin)
ChEMBL 303 1 2 3 3.3 Cc1cc(Br)c(NC2=NCCN2)c2ccccc12 10.1021/acs.jmedchem.9b01870
13520336 4319 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 291 5 1 3 3.4 COc1ccc(C(CN(C)C)C2(O)CCCCCC2)cc1 10.1021/jm00172a035
CHEMBL101056 4319 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 291 5 1 3 3.4 COc1ccc(C(CN(C)C)C2(O)CCCCCC2)cc1 10.1021/jm00172a035
3501942 9433 55 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 263 5 2 3 2.7 CNCC(c1ccc(OC)cc1)C1(O)CCCCC1 10.1021/jm00172a035
CHEMBL1119 9433 55 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 263 5 2 3 2.7 CNCC(c1ccc(OC)cc1)C1(O)CCCCC1 10.1021/jm00172a035
CHEMBL1628258 9433 55 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 263 5 2 3 2.7 CNCC(c1ccc(OC)cc1)C1(O)CCCCC1 10.1021/jm00172a035
13520306 208212 12 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 247 4 1 2 3.0 CN(C)CC(c1ccccc1)C1(O)CCCCC1 10.1021/jm00172a035
CHEMBL98660 208212 12 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 247 4 1 2 3.0 CN(C)CC(c1ccccc1)C1(O)CCCCC1 10.1021/jm00172a035
10251234 11213 0 None - 0 Bovine 5.5 pIC50 = 5.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 414 9 0 5 3.3 CCCN(CCCCN1C(=O)C2CCCC2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL1178932 11213 0 None - 0 Bovine 5.5 pIC50 = 5.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 414 9 0 5 3.3 CCCN(CCCCN1C(=O)C2CCCC2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL50530 11213 0 None - 0 Bovine 5.5 pIC50 = 5.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 414 9 0 5 3.3 CCCN(CCCCN1C(=O)C2CCCC2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10476735 13699 0 None - 0 Bovine 5.5 pIC50 = 5.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 411 9 0 7 3.5 CCCN(CCCCn1c(=O)oc2cccnc21)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL1195096 13699 0 None - 0 Bovine 5.5 pIC50 = 5.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 411 9 0 7 3.5 CCCN(CCCCn1c(=O)oc2cccnc21)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL553833 13699 0 None - 0 Bovine 5.5 pIC50 = 5.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 411 9 0 7 3.5 CCCN(CCCCn1c(=O)oc2cccnc21)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
9981024 96068 0 None - 1 Bovine 5.5 pIC50 = 5.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 446 11 1 5 3.8 CCCN(CCCCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL26018 96068 0 None - 1 Bovine 5.5 pIC50 = 5.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 446 11 1 5 3.8 CCCN(CCCCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL300735 96068 0 None - 1 Bovine 5.5 pIC50 = 5.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 446 11 1 5 3.8 CCCN(CCCCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
9980269 99055 0 None - 1 Bovine 5.5 pIC50 = 5.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 432 10 1 5 3.4 CCCN(CCCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL280586 99055 0 None - 1 Bovine 5.5 pIC50 = 5.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 432 10 1 5 3.4 CCCN(CCCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL54266 99055 0 None - 1 Bovine 5.5 pIC50 = 5.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 432 10 1 5 3.4 CCCN(CCCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10342423 99441 0 None - 1 Bovine 5.5 pIC50 = 5.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 426 11 1 5 3.9 CCCN(CCCCNC(=O)c1ccccc1OC)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL28312 99441 0 None - 1 Bovine 5.5 pIC50 = 5.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 426 11 1 5 3.9 CCCN(CCCCNC(=O)c1ccccc1OC)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL48925 99441 0 None - 1 Bovine 5.5 pIC50 = 5.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 426 11 1 5 3.9 CCCN(CCCCNC(=O)c1ccccc1OC)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10366072 116871 0 None - 0 Bovine 5.5 pIC50 = 5.5 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 442 5 1 7 3.0 CS(=O)(=O)Nc1ccc2c(c1)CCC1(CCN(CCc3ccc4nonc4c3)CC1)O2 10.1021/jm00099a028
CHEMBL1203300 116871 0 None - 0 Bovine 5.5 pIC50 = 5.5 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 442 5 1 7 3.0 CS(=O)(=O)Nc1ccc2c(c1)CCC1(CCN(CCc3ccc4nonc4c3)CC1)O2 10.1021/jm00099a028
CHEMBL338361 116871 0 None - 0 Bovine 5.5 pIC50 = 5.5 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 442 5 1 7 3.0 CS(=O)(=O)Nc1ccc2c(c1)CCC1(CCN(CCc3ccc4nonc4c3)CC1)O2 10.1021/jm00099a028
23027245 197105 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 387 5 2 5 3.7 Cc1cc(N(C)C)nc(N[C@H]2CC[C@@H](NC(=O)c3ccc(Cl)cc3)CC2)n1 10.1016/j.bmcl.2009.09.003
CHEMBL567791 197105 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 387 5 2 5 3.7 Cc1cc(N(C)C)nc(N[C@H]2CC[C@@H](NC(=O)c3ccc(Cl)cc3)CC2)n1 10.1016/j.bmcl.2009.09.003
1220 187 55 None - 45 Bovine 4.5 pIC50 = 4.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm00038a007
31 187 55 None - 45 Bovine 4.5 pIC50 = 4.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm00038a007
7 187 55 None - 45 Bovine 4.5 pIC50 = 4.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm00038a007
CHEMBL56 187 55 None - 45 Bovine 4.5 pIC50 = 4.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm00038a007
44343257 10468 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
In vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblastsIn vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblasts
ChEMBL 250 4 1 2 3.7 c1ccc(-c2ccccc2OCc2c[nH]cn2)cc1 10.1016/s0960-894x(02)00753-9
CHEMBL116700 10468 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
In vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblastsIn vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblasts
ChEMBL 250 4 1 2 3.7 c1ccc(-c2ccccc2OCc2c[nH]cn2)cc1 10.1016/s0960-894x(02)00753-9
1971 2846 38 None -24 30 Rat 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 nan
2404 2846 38 None -24 30 Rat 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 nan
4543 2846 38 None -24 30 Rat 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 nan
CHEMBL445 2846 38 None -24 30 Rat 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 nan
DB00540 2846 38 None -24 30 Rat 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 nan
10497675 16065 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 344 6 0 2 5.3 CN(C)CCCCc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12 10.1021/jm960159f
CHEMBL122384 16065 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 344 6 0 2 5.3 CN(C)CCCCc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12 10.1021/jm960159f
1816 2523 102 None - 18 Human 5.5 pIC50 = 5.5 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10.1016/s0960-894x(99)00591-0
4205 2523 102 None - 18 Human 5.5 pIC50 = 5.5 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10.1016/s0960-894x(99)00591-0
7241 2523 102 None - 18 Human 5.5 pIC50 = 5.5 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10.1016/s0960-894x(99)00591-0
CHEMBL654 2523 102 None - 18 Human 5.5 pIC50 = 5.5 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10.1016/s0960-894x(99)00591-0
DB00370 2523 102 None - 18 Human 5.5 pIC50 = 5.5 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10.1016/s0960-894x(99)00591-0
10499570 16900 0 None - 0 Rat 7.5 pIC50 = 7.5 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 372 5 0 3 5.3 Fc1ccc(-n2cc(OCCN3CCCCC3)c3cc(Cl)ccc32)cc1 10.1021/jm960159f
CHEMBL125291 16900 0 None - 0 Rat 7.5 pIC50 = 7.5 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 372 5 0 3 5.3 Fc1ccc(-n2cc(OCCN3CCCCC3)c3cc(Cl)ccc32)cc1 10.1021/jm960159f
2274 3151 58 None -6 32 Rat 7.5 pIC50 = 7.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
4917 3151 58 None -6 32 Rat 7.5 pIC50 = 7.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
7279 3151 58 None -6 32 Rat 7.5 pIC50 = 7.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
CHEMBL728 3151 58 None -6 32 Rat 7.5 pIC50 = 7.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
DB00433 3151 58 None -6 32 Rat 7.5 pIC50 = 7.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
44362195 121063 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Binding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptorBinding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptor
ChEMBL 241 4 2 3 2.1 c1c[nH]c(-c2ccccc2OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
CHEMBL357129 121063 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Binding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptorBinding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptor
ChEMBL 241 4 2 3 2.1 c1c[nH]c(-c2ccccc2OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
85469812 136661 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 469 8 0 5 4.2 CCOc1ccccc1N1CCN(CCc2ccc(CN3C(=O)c4ccccc4C3=O)cc2)CC1 10.1016/j.bmc.2015.11.020
CHEMBL3740351 136661 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 469 8 0 5 4.2 CCOc1ccccc1N1CCN(CCc2ccc(CN3C(=O)c4ccccc4C3=O)cc2)CC1 10.1016/j.bmc.2015.11.020
15987265 196864 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 503 6 2 5 5.3 Cc1cnc(N[C@H]2CC[C@@H](CNC(=O)c3cc(C(F)(F)F)cc(C(F)(F)F)c3)CC2)nc1N(C)C 10.1016/j.bmcl.2009.09.003
CHEMBL566075 196864 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 503 6 2 5 5.3 Cc1cnc(N[C@H]2CC[C@@H](CNC(=O)c3cc(C(F)(F)F)cc(C(F)(F)F)c3)CC2)nc1N(C)C 10.1016/j.bmcl.2009.09.003
196129 67769 17 None -1698 15 Rat 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 917 13 4 16 4.3 CO[C@H]1C[C@@H](O[C@H]2C[C@H]([C@H]3O[C@](C)(O)[C@H](C)C[C@@H]3C)O[C@H]2[C@]2(C)CC[C@H]([C@]3(C)CC[C@]4(C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H]5O[C@](O)(CC(=O)O)[C@@H](C)[C@H](OC)[C@H]5OC)O4)O3)O2)O[C@@H](C)[C@@H]1OC nan
CHEMBL1909065 67769 17 None -1698 15 Rat 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 917 13 4 16 4.3 CO[C@H]1C[C@@H](O[C@H]2C[C@H]([C@H]3O[C@](C)(O)[C@H](C)C[C@@H]3C)O[C@H]2[C@]2(C)CC[C@H]([C@]3(C)CC[C@]4(C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H]5O[C@](O)(CC(=O)O)[C@@H](C)[C@H](OC)[C@H]5OC)O4)O3)O2)O[C@@H](C)[C@@H]1OC nan
10409893 119090 0 None - 0 Rat 7.5 pIC50 = 7.5 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 420 5 1 3 4.4 Cc1cccc2c1c(-c1ccc(F)cc1)cn2C1CCN(CCN2CCNC2=O)CC1 10.1021/jm00104a007
CHEMBL342730 119090 0 None - 0 Rat 7.5 pIC50 = 7.5 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 420 5 1 3 4.4 Cc1cccc2c1c(-c1ccc(F)cc1)cn2C1CCN(CCN2CCNC2=O)CC1 10.1021/jm00104a007
85469930 136849 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 473 6 0 4 4.8 Cc1ccc(Cl)cc1N1CCN(CCc2ccc(CN3C(=O)c4ccccc4C3=O)cc2)CC1 10.1016/j.bmc.2015.11.020
CHEMBL3742103 136849 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 473 6 0 4 4.8 Cc1ccc(Cl)cc1N1CCN(CCc2ccc(CN3C(=O)c4ccccc4C3=O)cc2)CC1 10.1016/j.bmc.2015.11.020
10060965 35204 1 None - 0 Human 7.5 pIC50 = 7.5 Binding
Binding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptorBinding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptor
ChEMBL 256 4 1 4 2.6 Cc1ccoc1-c1ccccc1OCC1=NCCN1 10.1016/s0960-894x(01)00764-8
CHEMBL143562 35204 1 None - 0 Human 7.5 pIC50 = 7.5 Binding
Binding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptorBinding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptor
ChEMBL 256 4 1 4 2.6 Cc1ccoc1-c1ccccc1OCC1=NCCN1 10.1016/s0960-894x(01)00764-8
506 2239 39 None -97 6 Rat 6.5 pIC50 = 6.5 Binding
Compound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the rat prostate Alpha-1A adrenergic receptor subtype.Compound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the rat prostate Alpha-1A adrenergic receptor subtype.
ChEMBL 522 6 2 9 3.0 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H](C1)C(=O)NC(C)(C)C)C(=O)OCc1ccccc1 10.1021/jm980053f
6603904 2239 39 None -97 6 Rat 6.5 pIC50 = 6.5 Binding
Compound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the rat prostate Alpha-1A adrenergic receptor subtype.Compound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the rat prostate Alpha-1A adrenergic receptor subtype.
ChEMBL 522 6 2 9 3.0 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H](C1)C(=O)NC(C)(C)C)C(=O)OCc1ccccc1 10.1021/jm980053f
CHEMBL19476 2239 39 None -97 6 Rat 6.5 pIC50 = 6.5 Binding
Compound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the rat prostate Alpha-1A adrenergic receptor subtype.Compound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the rat prostate Alpha-1A adrenergic receptor subtype.
ChEMBL 522 6 2 9 3.0 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H](C1)C(=O)NC(C)(C)C)C(=O)OCc1ccccc1 10.1021/jm980053f
44574357 178683 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 471 6 1 2 6.4 Cc1ccc(N(C(=O)NCCCN2CCC3(CCc4ccccc43)CC2)c2ccc(F)cc2)cc1 10.1016/j.bmcl.2009.04.016
CHEMBL468298 178683 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 471 6 1 2 6.4 Cc1ccc(N(C(=O)NCCCN2CCC3(CCc4ccccc43)CC2)c2ccc(F)cc2)cc1 10.1016/j.bmcl.2009.04.016
85469753 136736 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 503 6 0 4 4.6 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccc(Br)cc3)CC2)cc1 10.1016/j.bmc.2015.11.020
CHEMBL3741079 136736 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 503 6 0 4 4.6 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccc(Br)cc3)CC2)cc1 10.1016/j.bmc.2015.11.020
3045401 56029 32 None - 0 Human 6.5 pIC50 = 6.5 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 359 3 0 5 3.4 Cc1nc2ccccn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL162501 56029 32 None - 0 Human 6.5 pIC50 = 6.5 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 359 3 0 5 3.4 Cc1nc2ccccn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
2477 742 59 None -218 29 Rat 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 nan
36 742 59 None -218 29 Rat 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 nan
437 742 59 None -218 29 Rat 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 nan
CHEMBL49 742 59 None -218 29 Rat 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 nan
DB00490 742 59 None -218 29 Rat 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 nan
127049862 140232 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 425 8 1 5 4.4 CNC(=O)c1cccc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)c1 10.1016/j.bmcl.2016.04.087
CHEMBL3805559 140232 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 425 8 1 5 4.4 CNC(=O)c1cccc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)c1 10.1016/j.bmcl.2016.04.087
22493280 48245 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
In vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cellsIn vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cells
ChEMBL 242 4 2 5 1.8 c1ccc(-c2ccno2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
CHEMBL155327 48245 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
In vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cellsIn vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cells
ChEMBL 242 4 2 5 1.8 c1ccc(-c2ccno2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
44573820 193244 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 489 6 1 2 6.5 Cc1ccc(N(C(=O)NCCCN2CCC3(CCc4ccccc43)CC2)c2ccc(F)c(F)c2)cc1 10.1016/j.bmcl.2009.04.016
CHEMBL523882 193244 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 489 6 1 2 6.5 Cc1ccc(N(C(=O)NCCCN2CCC3(CCc4ccccc43)CC2)c2ccc(F)c(F)c2)cc1 10.1016/j.bmcl.2009.04.016
3082597 99531 8 None - 1 Bovine 5.5 pIC50 = 5.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 263 6 0 3 3.1 CCCN(CCC)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL283606 99531 8 None - 1 Bovine 5.5 pIC50 = 5.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 263 6 0 3 3.1 CCCN(CCC)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
191 402 98 None -107 29 Rat 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
201 402 98 None -107 29 Rat 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
2170 402 98 None -107 29 Rat 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
CHEMBL1113 402 98 None -107 29 Rat 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
DB00543 402 98 None -107 29 Rat 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
3823 50191 42 None -3019 11 Rat 4.5 pIC50 = 4.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 530 7 0 7 4.2 CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
76973198 50191 42 None -3019 11 Rat 4.5 pIC50 = 4.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 530 7 0 7 4.2 CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
CHEMBL157101 50191 42 None -3019 11 Rat 4.5 pIC50 = 4.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 530 7 0 7 4.2 CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
127041710 136591 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 450 6 0 4 4.4 [C-]#[N+]c1ccccc1N1CCN(CCc2ccc(CN3C(=O)c4ccccc4C3=O)cc2)CC1 10.1016/j.bmc.2015.11.020
CHEMBL3739762 136591 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 450 6 0 4 4.4 [C-]#[N+]c1ccccc1N1CCN(CCc2ccc(CN3C(=O)c4ccccc4C3=O)cc2)CC1 10.1016/j.bmc.2015.11.020
10403428 208374 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 315 4 1 2 4.0 CN(C)CC(c1cccc(C(F)(F)F)c1)C1(O)CCCCC1 10.1021/jm00172a035
CHEMBL99653 208374 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 315 4 1 2 4.0 CN(C)CC(c1cccc(C(F)(F)F)c1)C1(O)CCCCC1 10.1021/jm00172a035
45484995 198496 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 403 6 2 5 3.5 Cc1cnc(N[C@H]2CC[C@@H](CNC(=O)c3ccc(F)c(F)c3)CC2)nc1N(C)C 10.1016/j.bmcl.2009.09.003
CHEMBL577904 198496 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 403 6 2 5 3.5 Cc1cnc(N[C@H]2CC[C@@H](CNC(=O)c3ccc(F)c(F)c3)CC2)nc1N(C)C 10.1016/j.bmcl.2009.09.003
44573931 187428 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 479 7 0 4 5.6 CN(CCCC1CCC2(CC1)OCc1ccccc12)C(=O)C(c1ccc(F)c(F)c1)n1cccn1 10.1016/j.bmcl.2009.04.016
CHEMBL493962 187428 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 479 7 0 4 5.6 CN(CCCC1CCC2(CC1)OCc1ccccc12)C(=O)C(c1ccc(F)c(F)c1)n1cccn1 10.1016/j.bmcl.2009.04.016
146431 208253 1 None - 0 Rat 7.4 pIC50 = 7.4 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 315 4 1 2 4.3 CN(C)CC(c1ccc(Cl)c(Cl)c1)C1(O)CCCCC1 10.1021/jm00172a035
CHEMBL98894 208253 1 None - 0 Rat 7.4 pIC50 = 7.4 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 315 4 1 2 4.3 CN(C)CC(c1ccc(Cl)c(Cl)c1)C1(O)CCCCC1 10.1021/jm00172a035
2803 952 58 None -3 19 Rat 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
516 952 58 None -3 19 Rat 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
704 952 58 None -3 19 Rat 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
CHEMBL134 952 58 None -3 19 Rat 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
DB00575 952 58 None -3 19 Rat 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
135398737 955 93 None -5 92 Rat 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
38 955 93 None -5 92 Rat 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
722 955 93 None -5 92 Rat 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
CHEMBL42 955 93 None -5 92 Rat 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
DB00363 955 93 None -5 92 Rat 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
124 2960 47 None -13 33 Rat 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
2032 2960 47 None -13 33 Rat 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
4636 2960 47 None -13 33 Rat 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
CHEMBL762 2960 47 None -13 33 Rat 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
DB00935 2960 47 None -13 33 Rat 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
85469873 136567 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 493 6 0 4 4.9 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccccc3C(F)(F)F)CC2)cc1 10.1016/j.bmc.2015.11.020
CHEMBL3739542 136567 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 493 6 0 4 4.9 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccccc3C(F)(F)F)CC2)cc1 10.1016/j.bmc.2015.11.020
3952 1875 38 None -26 12 Rat 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
5353646 1875 38 None -26 12 Rat 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
5443 1875 38 None -26 12 Rat 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
5702063 1875 38 None -26 12 Rat 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
CHEMBL1331786 1875 38 None -26 12 Rat 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
CHEMBL420 1875 38 None -26 12 Rat 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
10108561 112917 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding affinity against Alpha-1A adrenergic receptorBinding affinity against Alpha-1A adrenergic receptor
ChEMBL 295 2 0 4 2.8 CN(C)CC1CC2c3ccccc3Cc3ccncc3N2O1 10.1016/s0960-894x(02)00796-5
CHEMBL331077 112917 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding affinity against Alpha-1A adrenergic receptorBinding affinity against Alpha-1A adrenergic receptor
ChEMBL 295 2 0 4 2.8 CN(C)CC1CC2c3ccccc3Cc3ccncc3N2O1 10.1016/s0960-894x(02)00796-5
44376923 56397 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 373 3 0 5 3.7 Cc1nc2cccc(C)n2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL163190 56397 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 373 3 0 5 3.7 Cc1nc2cccc(C)n2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
137399257 162426 0 None - 0 Rat 8.4 pIC50 = 8.4 Binding
Displacement of [3H]-prazosin from rat alpha1A adrenergic receptor after 60 mins by scintillation counting analysisDisplacement of [3H]-prazosin from rat alpha1A adrenergic receptor after 60 mins by scintillation counting analysis
ChEMBL 513 8 1 8 3.7 COc1cc2nc(N3CCN(C(=O)Cc4ccc(OCc5ccccc5)cc4)CC3)nc(N)c2cc1OC 10.1016/j.ejmech.2017.10.026
CHEMBL4166644 162426 0 None - 0 Rat 8.4 pIC50 = 8.4 Binding
Displacement of [3H]-prazosin from rat alpha1A adrenergic receptor after 60 mins by scintillation counting analysisDisplacement of [3H]-prazosin from rat alpha1A adrenergic receptor after 60 mins by scintillation counting analysis
ChEMBL 513 8 1 8 3.7 COc1cc2nc(N3CCN(C(=O)Cc4ccc(OCc5ccccc5)cc4)CC3)nc(N)c2cc1OC 10.1016/j.ejmech.2017.10.026
10734233 113717 0 None - 0 Rat 7.4 pIC50 = 7.4 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 316 4 0 2 4.5 CN(C)CCc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12 10.1021/jm960159f
CHEMBL332365 113717 0 None - 0 Rat 7.4 pIC50 = 7.4 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 316 4 0 2 4.5 CN(C)CCc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12 10.1021/jm960159f
10717072 163219 0 None - 0 Bovine 6.4 pIC50 = 6.4 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 421 4 0 5 4.0 Cn1c(=O)sc2cc(CCN3CCN(c4cccc(C(F)(F)F)c4)CC3)ccc21 10.1021/jm970298c
CHEMBL418499 163219 0 None - 0 Bovine 6.4 pIC50 = 6.4 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 421 4 0 5 4.0 Cn1c(=O)sc2cc(CCN3CCN(c4cccc(C(F)(F)F)c4)CC3)ccc21 10.1021/jm970298c
10527817 113041 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 456 8 0 3 5.0 CC(C)N1CCN(CCN(C)CCc2cn(-c3ccc(F)cc3)c3cc(Cl)ccc23)C1=O 10.1021/jm960159f
CHEMBL331193 113041 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 456 8 0 3 5.0 CC(C)N1CCN(CCN(C)CCc2cn(-c3ccc(F)cc3)c3cc(Cl)ccc23)C1=O 10.1021/jm960159f
10070029 165393 0 None - 1 Bovine 5.4 pIC50 = 5.4 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 408 8 0 5 3.4 CCCN(CCCN1C(=O)c2ccccc2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL423841 165393 0 None - 1 Bovine 5.4 pIC50 = 5.4 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 408 8 0 5 3.4 CCCN(CCCN1C(=O)c2ccccc2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL54089 165393 0 None - 1 Bovine 5.4 pIC50 = 5.4 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 408 8 0 5 3.4 CCCN(CCCN1C(=O)c2ccccc2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
121852 10134 7 None - 1 Bovine 4.4 pIC50 = 4.4 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 442 9 0 5 4.2 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL11592 10134 7 None - 1 Bovine 4.4 pIC50 = 4.4 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 442 9 0 5 4.2 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL301060 10134 7 None - 1 Bovine 4.4 pIC50 = 4.4 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 442 9 0 5 4.2 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10014217 99720 0 None - 1 Bovine 4.4 pIC50 = 4.4 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 233 2 0 3 2.1 COc1cccc2c1CC(N1CCCC1)CO2 10.1021/jm00038a007
CHEMBL285010 99720 0 None - 1 Bovine 4.4 pIC50 = 4.4 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 233 2 0 3 2.1 COc1cccc2c1CC(N1CCCC1)CO2 10.1021/jm00038a007
135 2515 43 None -40 58 Human 6.4 pIC50 = 6.4 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1016/s0960-894x(01)00721-1
1796 2515 43 None -40 58 Human 6.4 pIC50 = 6.4 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1016/s0960-894x(01)00721-1
4184 2515 43 None -40 58 Human 6.4 pIC50 = 6.4 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1016/s0960-894x(01)00721-1
CHEMBL6437 2515 43 None -40 58 Human 6.4 pIC50 = 6.4 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1016/s0960-894x(01)00721-1
DB06148 2515 43 None -40 58 Human 6.4 pIC50 = 6.4 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1016/s0960-894x(01)00721-1
10550615 114560 0 None - 0 Rat 7.4 pIC50 = 7.4 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 430 8 1 4 3.8 CN(CCOc1cn(-c2ccc(F)cc2)c2cc(Cl)ccc12)CCN1CCNC1=O 10.1021/jm960159f
CHEMBL333774 114560 0 None - 0 Rat 7.4 pIC50 = 7.4 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 430 8 1 4 3.8 CN(CCOc1cn(-c2ccc(F)cc2)c2cc(Cl)ccc12)CCN1CCNC1=O 10.1021/jm960159f
44318842 206085 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
ChEMBL 308 2 0 3 3.7 Cc1ccc2c(c1)N1OC(CN(C)C)CC1c1ccccc1C2 10.1016/s0960-894x(01)00721-1
CHEMBL85735 206085 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
ChEMBL 308 2 0 3 3.7 Cc1ccc2c(c1)N1OC(CN(C)C)CC1c1ccccc1C2 10.1016/s0960-894x(01)00721-1
11517341 173715 0 None - 1 Human 5.4 pIC50 = 5.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 419 5 0 6 4.0 COc1cccc2nc(-c3ccc(OC4CCN(C5CCC5)CC4)cc3)n(C)c(=O)c12 10.1016/j.bmcl.2008.10.034
CHEMBL453653 173715 0 None - 1 Human 5.4 pIC50 = 5.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 419 5 0 6 4.0 COc1cccc2nc(-c3ccc(OC4CCN(C5CCC5)CC4)cc3)n(C)c(=O)c12 10.1016/j.bmcl.2008.10.034
10812487 15539 0 None - 0 Rat 7.4 pIC50 = 7.4 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 428 8 1 3 4.3 CN(CCCc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12)CCN1CCNC1=O 10.1021/jm960159f
CHEMBL122042 15539 0 None - 0 Rat 7.4 pIC50 = 7.4 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 428 8 1 3 4.3 CN(CCCc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12)CCN1CCNC1=O 10.1021/jm960159f
10361439 109606 0 None - 1 Human 7.4 pIC50 = 7.4 Binding
Inhibition of alpha 1A adrenergic receptor (unknown origin)Inhibition of alpha 1A adrenergic receptor (unknown origin)
ChEMBL 364 6 0 3 4.7 COc1cccc2c1CCCC2CCCN1CCN(c2ccccc2)CC1 10.1021/acs.jmedchem.2c00633
CHEMBL322275 109606 0 None - 1 Human 7.4 pIC50 = 7.4 Binding
Inhibition of alpha 1A adrenergic receptor (unknown origin)Inhibition of alpha 1A adrenergic receptor (unknown origin)
ChEMBL 364 6 0 3 4.7 COc1cccc2c1CCCC2CCCN1CCN(c2ccccc2)CC1 10.1021/acs.jmedchem.2c00633
CHEMBL5206987 109606 0 None - 1 Human 7.4 pIC50 = 7.4 Binding
Inhibition of alpha 1A adrenergic receptor (unknown origin)Inhibition of alpha 1A adrenergic receptor (unknown origin)
ChEMBL 364 6 0 3 4.7 COc1cccc2c1CCCC2CCCN1CCN(c2ccccc2)CC1 10.1021/acs.jmedchem.2c00633
13520334 112518 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 297 4 1 2 3.0 CN(C)CC(c1ccc(Br)cc1)C1(O)CCC1 10.1021/jm00172a035
CHEMBL329923 112518 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 297 4 1 2 3.0 CN(C)CC(c1ccc(Br)cc1)C1(O)CCC1 10.1021/jm00172a035
44318454 205986 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
ChEMBL 312 2 0 3 3.5 CN(C)CC1CC2c3ccccc3Cc3ccc(F)cc3N2O1 10.1016/s0960-894x(01)00721-1
CHEMBL84931 205986 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
ChEMBL 312 2 0 3 3.5 CN(C)CC1CC2c3ccccc3Cc3ccc(F)cc3N2O1 10.1016/s0960-894x(01)00721-1
78243717 137325 53 None - 0 Human 6.4 pIC50 = 6.4 Binding
Selectivity interaction (CEREP panel (cellular receptors and 30 other enzymes)) EUB0000199c ADRA1ASelectivity interaction (CEREP panel (cellular receptors and 30 other enzymes)) EUB0000199c ADRA1A
ChEMBL 321 4 1 5 2.4 O=C(/C=C/N1C[C@H]2C[C@@H]1CN2c1ccccn1)c1ccccc1O 10.6019/CHEMBL5212743
CHEMBL3752911 137325 53 None - 0 Human 6.4 pIC50 = 6.4 Binding
Selectivity interaction (CEREP panel (cellular receptors and 30 other enzymes)) EUB0000199c ADRA1ASelectivity interaction (CEREP panel (cellular receptors and 30 other enzymes)) EUB0000199c ADRA1A
ChEMBL 321 4 1 5 2.4 O=C(/C=C/N1C[C@H]2C[C@@H]1CN2c1ccccn1)c1ccccc1O 10.6019/CHEMBL5212743
10789000 203295 0 None - 0 Bovine 7.4 pIC50 = 7.4 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 435 6 1 5 5.2 Oc1nc2ccc(CCCCN3CCN(c4cccc(C(F)(F)F)c4)CC3)cc2s1 10.1021/jm970298c
CHEMBL64845 203295 0 None - 0 Bovine 7.4 pIC50 = 7.4 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 435 6 1 5 5.2 Oc1nc2ccc(CCCCN3CCN(c4cccc(C(F)(F)F)c4)CC3)cc2s1 10.1021/jm970298c
134142282 145665 0 None - 0 Rat 7.3 pIC50 = 7.3 Binding
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 mins
ChEMBL 348 1 1 4 3.6 COc1ccc2[nH]c3c(c2c1)CC1c2cc4c(cc2CCN1C3)OCO4 10.1021/acs.jmedchem.6b01217
CHEMBL3916182 145665 0 None - 0 Rat 7.3 pIC50 = 7.3 Binding
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 mins
ChEMBL 348 1 1 4 3.6 COc1ccc2[nH]c3c(c2c1)CC1c2cc4c(cc2CCN1C3)OCO4 10.1021/acs.jmedchem.6b01217
22493352 48244 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
In vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cellsIn vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cells
ChEMBL 242 4 2 5 1.8 c1ccc(-c2ncco2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
CHEMBL155326 48244 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
In vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cellsIn vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cells
ChEMBL 242 4 2 5 1.8 c1ccc(-c2ncco2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
11502381 174120 0 None - 1 Human 5.4 pIC50 = 5.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 407 4 0 5 4.1 Cn1c(-c2ccc(OC3CCN(C4CCC4)CC3)cc2)nc2c(F)cccc2c1=O 10.1016/j.bmcl.2008.10.034
CHEMBL454642 174120 0 None - 1 Human 5.4 pIC50 = 5.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 407 4 0 5 4.1 Cn1c(-c2ccc(OC3CCN(C4CCC4)CC3)cc2)nc2c(F)cccc2c1=O 10.1016/j.bmcl.2008.10.034
9794803 10974 2 None - 0 Human 6.3 pIC50 = 6.3 Binding
In vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cellsIn vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cells
ChEMBL 242 4 2 5 1.8 c1ccc(-c2cnco2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
CHEMBL117381 10974 2 None - 0 Human 6.3 pIC50 = 6.3 Binding
In vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cellsIn vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cells
ChEMBL 242 4 2 5 1.8 c1ccc(-c2cnco2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
85469754 136870 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 503 7 0 6 3.3 CS(=O)(=O)c1ccccc1N1CCN(CCc2ccc(CN3C(=O)c4ccccc4C3=O)cc2)CC1 10.1016/j.bmc.2015.11.020
CHEMBL3742276 136870 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 503 7 0 6 3.3 CS(=O)(=O)c1ccccc1N1CCN(CCc2ccc(CN3C(=O)c4ccccc4C3=O)cc2)CC1 10.1016/j.bmc.2015.11.020
10378649 108566 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Concentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in humanConcentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in human
ChEMBL 274 7 3 4 1.6 CCCCNC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL320419 108566 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Concentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in humanConcentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in human
ChEMBL 274 7 3 4 1.6 CCCCNC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
5074 3307 80 None - 30 Rat 7.3 pIC50 = 7.3 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 477 5 0 5 5.5 Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F 10.1021/jm960159f
97 3307 80 None - 30 Rat 7.3 pIC50 = 7.3 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 477 5 0 5 5.5 Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F 10.1021/jm960159f
CHEMBL267777 3307 80 None - 30 Rat 7.3 pIC50 = 7.3 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 477 5 0 5 5.5 Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F 10.1021/jm960159f
DB12693 3307 80 None - 30 Rat 7.3 pIC50 = 7.3 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 477 5 0 5 5.5 Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F 10.1021/jm960159f
5074 3307 80 None - 30 Rat 7.3 pIC50 = 7.3 Binding
Compound was tested for i the displacement of [3H]prazosin from alpha-1 adrenergic receptorCompound was tested for i the displacement of [3H]prazosin from alpha-1 adrenergic receptor
ChEMBL 477 5 0 5 5.5 Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F 10.1021/jm00104a007
97 3307 80 None - 30 Rat 7.3 pIC50 = 7.3 Binding
Compound was tested for i the displacement of [3H]prazosin from alpha-1 adrenergic receptorCompound was tested for i the displacement of [3H]prazosin from alpha-1 adrenergic receptor
ChEMBL 477 5 0 5 5.5 Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F 10.1021/jm00104a007
CHEMBL267777 3307 80 None - 30 Rat 7.3 pIC50 = 7.3 Binding
Compound was tested for i the displacement of [3H]prazosin from alpha-1 adrenergic receptorCompound was tested for i the displacement of [3H]prazosin from alpha-1 adrenergic receptor
ChEMBL 477 5 0 5 5.5 Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F 10.1021/jm00104a007
DB12693 3307 80 None - 30 Rat 7.3 pIC50 = 7.3 Binding
Compound was tested for i the displacement of [3H]prazosin from alpha-1 adrenergic receptorCompound was tested for i the displacement of [3H]prazosin from alpha-1 adrenergic receptor
ChEMBL 477 5 0 5 5.5 Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F 10.1021/jm00104a007
5074 3307 80 None - 30 Rat 7.3 pIC50 = 7.3 Binding
Compound was tested for the displacement of [3H]prazosin from alpha-1 adrenergic receptor of rat striatal membranesCompound was tested for the displacement of [3H]prazosin from alpha-1 adrenergic receptor of rat striatal membranes
ChEMBL 477 5 0 5 5.5 Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F 10.1021/jm00104a006
97 3307 80 None - 30 Rat 7.3 pIC50 = 7.3 Binding
Compound was tested for the displacement of [3H]prazosin from alpha-1 adrenergic receptor of rat striatal membranesCompound was tested for the displacement of [3H]prazosin from alpha-1 adrenergic receptor of rat striatal membranes
ChEMBL 477 5 0 5 5.5 Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F 10.1021/jm00104a006
CHEMBL267777 3307 80 None - 30 Rat 7.3 pIC50 = 7.3 Binding
Compound was tested for the displacement of [3H]prazosin from alpha-1 adrenergic receptor of rat striatal membranesCompound was tested for the displacement of [3H]prazosin from alpha-1 adrenergic receptor of rat striatal membranes
ChEMBL 477 5 0 5 5.5 Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F 10.1021/jm00104a006
DB12693 3307 80 None - 30 Rat 7.3 pIC50 = 7.3 Binding
Compound was tested for the displacement of [3H]prazosin from alpha-1 adrenergic receptor of rat striatal membranesCompound was tested for the displacement of [3H]prazosin from alpha-1 adrenergic receptor of rat striatal membranes
ChEMBL 477 5 0 5 5.5 Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F 10.1021/jm00104a006
44573822 187441 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 505 6 0 3 6.4 Cc1ccc(N(C(=O)N(C)CCCN2CCC3(CC2)OCc2ccccc23)c2ccc(F)c(F)c2)cc1 10.1016/j.bmcl.2009.04.016
CHEMBL494009 187441 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 505 6 0 3 6.4 Cc1ccc(N(C(=O)N(C)CCCN2CCC3(CC2)OCc2ccccc23)c2ccc(F)c(F)c2)cc1 10.1016/j.bmcl.2009.04.016
44376984 56193 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 485 3 0 5 4.0 Cc1nc2ccc(I)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL162682 56193 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 485 3 0 5 4.0 Cc1nc2ccc(I)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
85469869 136566 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 426 6 0 5 3.2 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccccn3)CC2)cc1 10.1016/j.bmc.2015.11.020
CHEMBL3739533 136566 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 426 6 0 5 3.2 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccccn3)CC2)cc1 10.1016/j.bmc.2015.11.020
44574359 178711 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 471 6 1 2 6.4 Cc1ccc(N(C(=O)NCCCN2CCC3(CCc4ccccc43)CC2)c2cccc(F)c2)cc1 10.1016/j.bmcl.2009.04.016
CHEMBL468509 178711 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 471 6 1 2 6.4 Cc1ccc(N(C(=O)NCCCN2CCC3(CCc4ccccc43)CC2)c2cccc(F)c2)cc1 10.1016/j.bmcl.2009.04.016
10531 1408 21 None -5 24 Rat 8.3 pIC50 = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
121 1408 21 None -5 24 Rat 8.3 pIC50 = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
888 1408 21 None -5 24 Rat 8.3 pIC50 = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
CHEMBL1732 1408 21 None -5 24 Rat 8.3 pIC50 = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
DB00320 1408 21 None -5 24 Rat 8.3 pIC50 = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
100 3776 58 None 1 56 Rat 8.3 pIC50 = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
2637 3776 58 None 1 56 Rat 8.3 pIC50 = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
5452 3776 58 None 1 56 Rat 8.3 pIC50 = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
CHEMBL479 3776 58 None 1 56 Rat 8.3 pIC50 = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
DB00679 3776 58 None 1 56 Rat 8.3 pIC50 = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
6761 67770 19 None 1 18 Rat 8.3 pIC50 = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 401 5 1 4 4.5 NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1 nan
CHEMBL1909072 67770 19 None 1 18 Rat 8.3 pIC50 = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 401 5 1 4 4.5 NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1 nan
9802796 164306 0 None - 0 Rat 8.2 pIC50 = 8.2 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 430 8 1 4 3.8 CN(CCOc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12)CCN1CCNC1=O 10.1021/jm960159f
CHEMBL421244 164306 0 None - 0 Rat 8.2 pIC50 = 8.2 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 430 8 1 4 3.8 CN(CCOc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12)CCN1CCNC1=O 10.1021/jm960159f
44362185 121003 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Binding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptorBinding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptor
ChEMBL 253 4 1 4 2.1 c1cncc(-c2ccccc2OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
CHEMBL356605 121003 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Binding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptorBinding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptor
ChEMBL 253 4 1 4 2.1 c1cncc(-c2ccccc2OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
10364538 4354 0 None - 1 Bovine 6.3 pIC50 = 6.3 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 415 5 1 6 2.5 CS(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3ccccn3)CC1)O2 10.1021/jm00099a028
CHEMBL101322 4354 0 None - 1 Bovine 6.3 pIC50 = 6.3 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 415 5 1 6 2.5 CS(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3ccccn3)CC1)O2 10.1021/jm00099a028
CHEMBL1204312 4354 0 None - 1 Bovine 6.3 pIC50 = 6.3 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 415 5 1 6 2.5 CS(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3ccccn3)CC1)O2 10.1021/jm00099a028
10245637 33104 2 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 323 2 0 3 3.6 Cc1ccc2c(c1)c(-c1ccc(F)cc1)cn2N1CCN(C)CC1 10.1021/jm00104a007
CHEMBL141721 33104 2 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 323 2 0 3 3.6 Cc1ccc2c(c1)c(-c1ccc(F)cc1)cn2N1CCN(C)CC1 10.1021/jm00104a007
9885114 119578 5 None -47 12 Rat 6.3 pIC50 = 6.3 Binding
Inhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary glandInhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 357 3 1 4 3.0 O=C1COc2cc(CN3CCN(c4ccc(Cl)cc4)CC3)ccc2N1 10.1021/jm990277d
CHEMBL346389 119578 5 None -47 12 Rat 6.3 pIC50 = 6.3 Binding
Inhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary glandInhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 357 3 1 4 3.0 O=C1COc2cc(CN3CCN(c4ccc(Cl)cc4)CC3)ccc2N1 10.1021/jm990277d
59271992 118022 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibition of alpha-adrenoceptor 1A (unknown origin)Inhibition of alpha-adrenoceptor 1A (unknown origin)
ChEMBL 513 13 2 7 3.5 COCCCOc1cc(C(=O)N(C[C@@H]2CNC[C@H]2OC(=O)NCc2ccccc2)C(C)C)ccc1OC 10.1016/j.bmcl.2015.02.040
CHEMBL3403995 118022 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibition of alpha-adrenoceptor 1A (unknown origin)Inhibition of alpha-adrenoceptor 1A (unknown origin)
ChEMBL 513 13 2 7 3.5 COCCCOc1cc(C(=O)N(C[C@@H]2CNC[C@H]2OC(=O)NCc2ccccc2)C(C)C)ccc1OC 10.1016/j.bmcl.2015.02.040
10092409 12014 0 None - 0 Bovine 5.3 pIC50 = 5.3 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 400 9 0 4 3.7 CCCN(CCCCN1CC2CCCC2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL1183479 12014 0 None - 0 Bovine 5.3 pIC50 = 5.3 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 400 9 0 4 3.7 CCCN(CCCCN1CC2CCCC2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL299561 12014 0 None - 0 Bovine 5.3 pIC50 = 5.3 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 400 9 0 4 3.7 CCCN(CCCCN1CC2CCCC2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10095594 12336 0 None - 0 Bovine 5.3 pIC50 = 5.3 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 456 10 0 5 4.6 CCCN(CCCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL1185501 12336 0 None - 0 Bovine 5.3 pIC50 = 5.3 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 456 10 0 5 4.6 CCCN(CCCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL417550 12336 0 None - 0 Bovine 5.3 pIC50 = 5.3 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 456 10 0 5 4.6 CCCN(CCCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10251673 99462 0 None - 1 Bovine 5.3 pIC50 = 5.3 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 422 9 0 5 3.8 CCCN(CCCCN1C(=O)c2ccccc2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL283207 99462 0 None - 1 Bovine 5.3 pIC50 = 5.3 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 422 9 0 5 3.8 CCCN(CCCCN1C(=O)c2ccccc2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL52396 99462 0 None - 1 Bovine 5.3 pIC50 = 5.3 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 422 9 0 5 3.8 CCCN(CCCCN1C(=O)c2ccccc2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10338595 162475 0 None - 1 Bovine 5.3 pIC50 = 5.3 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 360 9 0 4 4.0 CCCN(CCCCN1CCCCC1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL416747 162475 0 None - 1 Bovine 5.3 pIC50 = 5.3 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 360 9 0 4 4.0 CCCN(CCCCN1CCCCC1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
13520313 107724 0 None - 0 Rat 7.3 pIC50 = 7.3 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 325 4 1 2 3.8 CN(C)CC(c1cccc(Br)c1)C1(O)CCCCC1 10.1021/jm00172a035
CHEMBL319142 107724 0 None - 0 Rat 7.3 pIC50 = 7.3 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 325 4 1 2 3.8 CN(C)CC(c1cccc(Br)c1)C1(O)CCCCC1 10.1021/jm00172a035
122179431 121417 0 None -1 3 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 585 9 1 13 3.1 CCN(CC)c1ccc2cc(-n3cc(CN4CCN(c5nc(N)c6cc(OC)c(OC)cc6n5)CC4)nn3)c(=O)oc2c1 10.1021/ml5004298
CHEMBL3582272 121417 0 None -1 3 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 585 9 1 13 3.1 CCN(CC)c1ccc2cc(-n3cc(CN4CCN(c5nc(N)c6cc(OC)c(OC)cc6n5)CC4)nn3)c(=O)oc2c1 10.1021/ml5004298
132499 107217 8 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 281 4 1 2 3.7 CN(C)CC(c1ccccc1Cl)C1(O)CCCCC1 10.1021/jm00172a035
CHEMBL316862 107217 8 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 281 4 1 2 3.7 CN(C)CC(c1ccccc1Cl)C1(O)CCCCC1 10.1021/jm00172a035
44376845 55515 1 None - 0 Human 5.3 pIC50 = 5.3 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 419 5 0 7 3.4 COc1cc2nc(C)c(CCN3CCc4oc5ccccc5c4C3)c(=O)n2cc1OC 10.1016/s0960-894x(99)00591-0
CHEMBL162058 55515 1 None - 0 Human 5.3 pIC50 = 5.3 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 419 5 0 7 3.4 COc1cc2nc(C)c(CCN3CCc4oc5ccccc5c4C3)c(=O)n2cc1OC 10.1016/s0960-894x(99)00591-0
26987 946 33 None -75 21 Rat 7.3 pIC50 = 7.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
6063 946 33 None -75 21 Rat 7.3 pIC50 = 7.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
671 946 33 None -75 21 Rat 7.3 pIC50 = 7.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
CHEMBL1626 946 33 None -75 21 Rat 7.3 pIC50 = 7.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
DB00283 946 33 None -75 21 Rat 7.3 pIC50 = 7.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
9904205 205827 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding affinity against Alpha-1A adrenergic receptorBinding affinity against Alpha-1A adrenergic receptor
ChEMBL 294 2 0 3 3.4 CN(C)CC1CC2c3ccccc3Cc3ccccc3N2O1 10.1016/s0960-894x(02)00796-5
CHEMBL83658 205827 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding affinity against Alpha-1A adrenergic receptorBinding affinity against Alpha-1A adrenergic receptor
ChEMBL 294 2 0 3 3.4 CN(C)CC1CC2c3ccccc3Cc3ccccc3N2O1 10.1016/s0960-894x(02)00796-5
9904205 205827 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
ChEMBL 294 2 0 3 3.4 CN(C)CC1CC2c3ccccc3Cc3ccccc3N2O1 10.1016/s0960-894x(01)00721-1
CHEMBL83658 205827 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
ChEMBL 294 2 0 3 3.4 CN(C)CC1CC2c3ccccc3Cc3ccccc3N2O1 10.1016/s0960-894x(01)00721-1
10432755 113769 0 None - 0 Rat 7.3 pIC50 = 7.3 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 428 8 1 3 4.3 CN(CCCN1CCNC1=O)CCc1cn(-c2ccc(F)cc2)c2cc(Cl)ccc12 10.1021/jm960159f
CHEMBL332425 113769 0 None - 0 Rat 7.3 pIC50 = 7.3 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 428 8 1 3 4.3 CN(CCCN1CCNC1=O)CCc1cn(-c2ccc(F)cc2)c2cc(Cl)ccc12 10.1021/jm960159f
10047887 121023 0 None - 0 Rat 7.3 pIC50 = 7.3 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 422 5 1 3 4.7 CNC(=O)N(C)CCN1CCC(n2cc(-c3ccc(F)cc3)c3cc(C)ccc32)CC1 10.1021/jm00104a007
CHEMBL356799 121023 0 None - 0 Rat 7.3 pIC50 = 7.3 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 422 5 1 3 4.7 CNC(=O)N(C)CCN1CCC(n2cc(-c3ccc(F)cc3)c3cc(C)ccc32)CC1 10.1021/jm00104a007
4452 2742 19 None - 19 Rat 6.3 pIC50 = 6.3 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 387 6 2 4 3.8 COc1cc(NC)c(cc1C(=O)NC1CCN(C1C)Cc1ccccc1)Cl 10.1021/jm960159f
983 2742 19 None - 19 Rat 6.3 pIC50 = 6.3 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 387 6 2 4 3.8 COc1cc(NC)c(cc1C(=O)NC1CCN(C1C)Cc1ccccc1)Cl 10.1021/jm960159f
CHEMBL20734 2742 19 None - 19 Rat 6.3 pIC50 = 6.3 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 387 6 2 4 3.8 COc1cc(NC)c(cc1C(=O)NC1CCN(C1C)Cc1ccccc1)Cl 10.1021/jm960159f
44574358 178684 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 467 6 1 2 6.5 Cc1ccc(N(C(=O)NCCCN2CCC3(CCc4ccccc43)CC2)c2ccc(C)cc2)cc1 10.1016/j.bmcl.2009.04.016
CHEMBL468299 178684 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 467 6 1 2 6.5 Cc1ccc(N(C(=O)NCCCN2CCC3(CCc4ccccc43)CC2)c2ccc(C)cc2)cc1 10.1016/j.bmcl.2009.04.016
85469872 136780 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 459 6 0 4 4.5 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccc(Cl)cc3)CC2)cc1 10.1016/j.bmc.2015.11.020
CHEMBL3741483 136780 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 459 6 0 4 4.5 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccc(Cl)cc3)CC2)cc1 10.1016/j.bmc.2015.11.020
4418 34192 85 None -1 7 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1016/j.bmc.2015.11.020
CHEMBL142635 34192 85 None -1 7 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1016/j.bmc.2015.11.020
44596863 198904 0 None - 0 Rat 7.3 pIC50 = 7.3 Binding
Displacement of [3H]prazosin from adrenergic alpha1A receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]prazosin from adrenergic alpha1A receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 367 6 1 6 2.3 C=Cc1c(C)nn(CCCN2CCN(c3ccc(C)cc3)CC2)c(=O)c1N 10.1021/jm900458r
CHEMBL584606 198904 0 None - 0 Rat 7.3 pIC50 = 7.3 Binding
Displacement of [3H]prazosin from adrenergic alpha1A receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]prazosin from adrenergic alpha1A receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 367 6 1 6 2.3 C=Cc1c(C)nn(CCCN2CCN(c3ccc(C)cc3)CC2)c(=O)c1N 10.1021/jm900458r
4011 82379 49 None -125 24 Rat 6.3 pIC50 = 6.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 277 4 1 1 4.2 CNCCCC12CCC(c3ccccc31)c1ccccc12 nan
CHEMBL21731 82379 49 None -125 24 Rat 6.3 pIC50 = 6.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 277 4 1 1 4.2 CNCCCC12CCC(c3ccccc31)c1ccccc12 nan
1531 2253 69 None -3 16 Rat 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O nan
3869 2253 69 None -3 16 Rat 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O nan
7207 2253 69 None -3 16 Rat 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O nan
CHEMBL429 2253 69 None -3 16 Rat 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O nan
DB00598 2253 69 None -3 16 Rat 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O nan
44376927 55607 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 461 3 0 5 5.0 Cc1nc2c(Cl)cc(C(F)(F)F)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL162147 55607 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 461 3 0 5 5.0 Cc1nc2c(Cl)cc(C(F)(F)F)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
506 2239 39 None -81 6 Human 6.2 pIC50 = 6.2 Binding
Compound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the human prostate Alpha-1A adrenergic receptor subtypeCompound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the human prostate Alpha-1A adrenergic receptor subtype
ChEMBL 522 6 2 9 3.0 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H](C1)C(=O)NC(C)(C)C)C(=O)OCc1ccccc1 10.1021/jm980053f
6603904 2239 39 None -81 6 Human 6.2 pIC50 = 6.2 Binding
Compound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the human prostate Alpha-1A adrenergic receptor subtypeCompound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the human prostate Alpha-1A adrenergic receptor subtype
ChEMBL 522 6 2 9 3.0 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H](C1)C(=O)NC(C)(C)C)C(=O)OCc1ccccc1 10.1021/jm980053f
CHEMBL19476 2239 39 None -81 6 Human 6.2 pIC50 = 6.2 Binding
Compound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the human prostate Alpha-1A adrenergic receptor subtypeCompound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the human prostate Alpha-1A adrenergic receptor subtype
ChEMBL 522 6 2 9 3.0 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H](C1)C(=O)NC(C)(C)C)C(=O)OCc1ccccc1 10.1021/jm980053f
11502638 173719 0 None - 1 Human 5.2 pIC50 = 5.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 419 5 0 6 4.0 COc1ccc2nc(-c3ccc(OC4CCN(C5CCC5)CC4)cc3)n(C)c(=O)c2c1 10.1016/j.bmcl.2008.10.034
CHEMBL453654 173719 0 None - 1 Human 5.2 pIC50 = 5.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 419 5 0 6 4.0 COc1ccc2nc(-c3ccc(OC4CCN(C5CCC5)CC4)cc3)n(C)c(=O)c2c1 10.1016/j.bmcl.2008.10.034
10644514 101030 0 None - 0 Bovine 8.2 pIC50 = 8.2 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 397 6 0 6 3.4 COc1ccccc1N1CCN(CCCc2ccc3c(c2)sc(=O)n3C)CC1 10.1021/jm970298c
CHEMBL294730 101030 0 None - 0 Bovine 8.2 pIC50 = 8.2 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 397 6 0 6 3.4 COc1ccccc1N1CCN(CCCc2ccc3c(c2)sc(=O)n3C)CC1 10.1021/jm970298c
10409070 121898 4 None - 0 Rat 8.2 pIC50 = 8.2 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 406 5 1 3 4.1 O=C1NCCN1CCN1CCC(n2cc(-c3ccc(F)cc3)c3ccccc32)CC1 10.1021/jm00104a007
CHEMBL359031 121898 4 None - 0 Rat 8.2 pIC50 = 8.2 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 406 5 1 3 4.1 O=C1NCCN1CCN1CCC(n2cc(-c3ccc(F)cc3)c3ccccc32)CC1 10.1021/jm00104a007
31101 726 40 None -4 36 Rat 8.2 pIC50 = 8.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
35 726 40 None -4 36 Rat 8.2 pIC50 = 8.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
403 726 40 None -4 36 Rat 8.2 pIC50 = 8.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
CHEMBL493 726 40 None -4 36 Rat 8.2 pIC50 = 8.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
DB01200 726 40 None -4 36 Rat 8.2 pIC50 = 8.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
125017 9419 99 None - 0 Rat 7.2 pIC50 = 7.2 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 263 4 2 3 2.7 CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1 10.1021/jm00172a035
CHEMBL1118 9419 99 None - 0 Rat 7.2 pIC50 = 7.2 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 263 4 2 3 2.7 CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1 10.1021/jm00172a035
10528455 15540 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 472 9 0 4 4.9 CC(C)N1CCN(CCN(C)CCOc2cn(-c3ccc(F)cc3)c3cc(Cl)ccc23)C1=O 10.1021/jm960159f
CHEMBL122047 15540 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 472 9 0 4 4.9 CC(C)N1CCN(CCN(C)CCOc2cn(-c3ccc(F)cc3)c3cc(Cl)ccc23)C1=O 10.1021/jm960159f
10413283 187444 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 490 7 0 3 5.5 CN(CCCN1CCC2(CC1)OCc1ccccc12)C(=O)C(c1ccccc1)c1ccc(F)c(F)c1 10.1016/j.bmcl.2009.04.016
CHEMBL494016 187444 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 490 7 0 3 5.5 CN(CCCN1CCC2(CC1)OCc1ccccc12)C(=O)C(c1ccccc1)c1ccc(F)c(F)c1 10.1016/j.bmcl.2009.04.016
121852 10134 7 None - 1 Bovine 5.2 pIC50 = 5.2 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 442 9 0 5 4.2 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL11592 10134 7 None - 1 Bovine 5.2 pIC50 = 5.2 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 442 9 0 5 4.2 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL301060 10134 7 None - 1 Bovine 5.2 pIC50 = 5.2 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 442 9 0 5 4.2 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10024943 97361 0 None - 1 Bovine 5.2 pIC50 = 5.2 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 416 9 0 5 3.7 CCCN(CCCCN1C(=O)CC(C)(C)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL26975 97361 0 None - 1 Bovine 5.2 pIC50 = 5.2 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 416 9 0 5 3.7 CCCN(CCCCN1C(=O)CC(C)(C)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL52485 97361 0 None - 1 Bovine 5.2 pIC50 = 5.2 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 416 9 0 5 3.7 CCCN(CCCCN1C(=O)CC(C)(C)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
2291 3162 58 None -446 12 Rat 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O nan
2561 3162 58 None -446 12 Rat 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O nan
4932 3162 58 None -446 12 Rat 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O nan
CHEMBL631 3162 58 None -446 12 Rat 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O nan
DB01182 3162 58 None -446 12 Rat 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O nan
14183742 208299 0 None - 0 Rat 7.2 pIC50 = 7.2 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 325 4 1 2 3.8 CN(C)CC(c1ccc(Br)cc1)C1(O)CCCCC1 10.1021/jm00172a035
CHEMBL99175 208299 0 None - 0 Rat 7.2 pIC50 = 7.2 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 325 4 1 2 3.8 CN(C)CC(c1ccc(Br)cc1)C1(O)CCCCC1 10.1021/jm00172a035
119081417 151635 38 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [3H]prazosin from recombinant human adrenergic A1a receptor after 60 mins by scintillation counting methodDisplacement of [3H]prazosin from recombinant human adrenergic A1a receptor after 60 mins by scintillation counting method
ChEMBL 488 10 0 7 5.2 CCCOc1ccc(CCc2nc3cc(-c4c(C)noc4C)ccc3n2CCN2CCOCC2)cc1 10.1021/acs.jmedchem.6b01839
CHEMBL3963965 151635 38 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [3H]prazosin from recombinant human adrenergic A1a receptor after 60 mins by scintillation counting methodDisplacement of [3H]prazosin from recombinant human adrenergic A1a receptor after 60 mins by scintillation counting method
ChEMBL 488 10 0 7 5.2 CCCOc1ccc(CCc2nc3cc(-c4c(C)noc4C)ccc3n2CCN2CCOCC2)cc1 10.1021/acs.jmedchem.6b01839
11567596 174558 0 None - 1 Human 5.2 pIC50 = 5.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 403 4 0 5 4.4 Cn1c(-c2ccc(OC3CCN(C4CCCC4)CC3)cc2)nc2ccccc2c1=O 10.1016/j.bmcl.2008.10.034
CHEMBL455681 174558 0 None - 1 Human 5.2 pIC50 = 5.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 403 4 0 5 4.4 Cn1c(-c2ccc(OC3CCN(C4CCCC4)CC3)cc2)nc2ccccc2c1=O 10.1016/j.bmcl.2008.10.034
1599 2326 50 None -3019 16 Rat 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 nan
3955 2326 50 None -3019 16 Rat 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 nan
7215 2326 50 None -3019 16 Rat 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 nan
CHEMBL841 2326 50 None -3019 16 Rat 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 nan
DB00836 2326 50 None -3019 16 Rat 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 nan
1028 289 71 None -47 30 Rat 6.2 pIC50 = 6.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
139148732 289 71 None -47 30 Rat 6.2 pIC50 = 6.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
479 289 71 None -47 30 Rat 6.2 pIC50 = 6.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
5816 289 71 None -47 30 Rat 6.2 pIC50 = 6.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
CHEMBL679 289 71 None -47 30 Rat 6.2 pIC50 = 6.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
DB00668 289 71 None -47 30 Rat 6.2 pIC50 = 6.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
11618024 186649 0 None - 1 Human 5.2 pIC50 = 5.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 389 4 0 5 4.0 Cn1c(-c2ccc(OC3CCN(C4CCC4)CC3)cc2)nc2ccccc2c1=O 10.1016/j.bmcl.2008.10.034
CHEMBL488249 186649 0 None - 1 Human 5.2 pIC50 = 5.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 389 4 0 5 4.0 Cn1c(-c2ccc(OC3CCN(C4CCC4)CC3)cc2)nc2ccccc2c1=O 10.1016/j.bmcl.2008.10.034
2435 719 100 None -436 12 Rat 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
395 719 100 None -436 12 Rat 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
520 719 100 None -436 12 Rat 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
5386 719 100 None -436 12 Rat 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
CHEMBL844 719 100 None -436 12 Rat 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
DB00484 719 100 None -436 12 Rat 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
135398745 2893 112 None -13 66 Rat 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
47 2893 112 None -13 66 Rat 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
CHEMBL715 2893 112 None -13 66 Rat 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
DB00334 2893 112 None -13 66 Rat 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
10647075 16863 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 446 8 1 4 4.5 CN(CCSc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12)CCN1CCNC1=O 10.1021/jm960159f
CHEMBL125072 16863 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 446 8 1 4 4.5 CN(CCSc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12)CCN1CCNC1=O 10.1021/jm960159f
11618702 173820 0 None - 1 Human 5.2 pIC50 = 5.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 423 4 0 5 4.7 Cn1c(-c2ccc(OC3CCN(C4CCC4)CC3)cc2)nc2c(Cl)cccc2c1=O 10.1016/j.bmcl.2008.10.034
CHEMBL453893 173820 0 None - 1 Human 5.2 pIC50 = 5.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 423 4 0 5 4.7 Cn1c(-c2ccc(OC3CCN(C4CCC4)CC3)cc2)nc2c(Cl)cccc2c1=O 10.1016/j.bmcl.2008.10.034
23151199 186004 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 377 6 0 5 3.9 Cc1nc2ccccc2c(=O)n1-c1ccc(OCCCN2CCCCC2)cc1 10.1016/j.bmcl.2008.10.034
CHEMBL487063 186004 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 377 6 0 5 3.9 Cc1nc2ccccc2c(=O)n1-c1ccc(OCCCN2CCCCC2)cc1 10.1016/j.bmcl.2008.10.034
10219 188772 37 None -467 5 Rat 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 nan
CHEMBL493439 188772 37 None -467 5 Rat 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 nan
CHEMBL50588 188772 37 None -467 5 Rat 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 nan
44269124 28787 1 None - 0 Human 7.2 pIC50 = 7.2 Binding
In vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblastsIn vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblasts
ChEMBL 252 4 1 3 2.7 c1ccc(-c2ccccc2OCC2=NCCN2)cc1 10.1016/s0960-894x(02)00753-9
CHEMBL13789 28787 1 None - 0 Human 7.2 pIC50 = 7.2 Binding
In vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblastsIn vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblasts
ChEMBL 252 4 1 3 2.7 c1ccc(-c2ccccc2OCC2=NCCN2)cc1 10.1016/s0960-894x(02)00753-9
85469931 136867 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 493 6 0 4 4.9 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccc(C(F)(F)F)cc3)CC2)cc1 10.1016/j.bmc.2015.11.020
CHEMBL3742253 136867 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 493 6 0 4 4.9 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccc(C(F)(F)F)cc3)CC2)cc1 10.1016/j.bmc.2015.11.020
10003405 121049 4 None - 0 Rat 7.2 pIC50 = 7.2 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 440 5 1 3 4.8 O=C1NCCN1CCN1CCC(n2cc(-c3ccc(F)cc3)c3cc(Cl)ccc32)CC1 10.1021/jm00104a007
CHEMBL357019 121049 4 None - 0 Rat 7.2 pIC50 = 7.2 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 440 5 1 3 4.8 O=C1NCCN1CCN1CCC(n2cc(-c3ccc(F)cc3)c3cc(Cl)ccc32)CC1 10.1021/jm00104a007
1353 1898 93 None -10 86 Rat 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
3559 1898 93 None -10 86 Rat 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
86 1898 93 None -10 86 Rat 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
CHEMBL54 1898 93 None -10 86 Rat 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
DB00502 1898 93 None -10 86 Rat 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
44377035 120104 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 373 3 0 5 3.7 Cc1nc2c(C)cccn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL351200 120104 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 373 3 0 5 3.7 Cc1nc2c(C)cccn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
2585 800 103 None -5 22 Rat 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
522 800 103 None -5 22 Rat 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
551 800 103 None -5 22 Rat 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
CHEMBL723 800 103 None -5 22 Rat 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
DB01136 800 103 None -5 22 Rat 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
9826570 113285 0 None - 0 Rat 7.2 pIC50 = 7.2 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 482 6 0 3 5.7 CC(C)N1CCN(CCN2CCC(c3cn(-c4ccc(F)cc4)c4cc(Cl)ccc34)CC2)C1=O 10.1021/jm960159f
CHEMBL331545 113285 0 None - 0 Rat 7.2 pIC50 = 7.2 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 482 6 0 3 5.7 CC(C)N1CCN(CCN2CCC(c3cn(-c4ccc(F)cc4)c4cc(Cl)ccc34)CC2)C1=O 10.1021/jm960159f
9826570 113285 0 None - 0 Rat 7.2 pIC50 = 7.2 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 482 6 0 3 5.7 CC(C)N1CCN(CCN2CCC(c3cn(-c4ccc(F)cc4)c4cc(Cl)ccc34)CC2)C1=O 10.1021/jm00104a007
CHEMBL331545 113285 0 None - 0 Rat 7.2 pIC50 = 7.2 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 482 6 0 3 5.7 CC(C)N1CCN(CCN2CCC(c3cn(-c4ccc(F)cc4)c4cc(Cl)ccc34)CC2)C1=O 10.1021/jm00104a007
14739952 4442 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 307 6 1 4 3.0 COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1OC 10.1021/jm00172a035
CHEMBL101819 4442 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 307 6 1 4 3.0 COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1OC 10.1021/jm00172a035
10251234 11213 0 None - 0 Bovine 5.2 pIC50 = 5.2 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 414 9 0 5 3.3 CCCN(CCCCN1C(=O)C2CCCC2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL1178932 11213 0 None - 0 Bovine 5.2 pIC50 = 5.2 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 414 9 0 5 3.3 CCCN(CCCCN1C(=O)C2CCCC2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL50530 11213 0 None - 0 Bovine 5.2 pIC50 = 5.2 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 414 9 0 5 3.3 CCCN(CCCCN1C(=O)C2CCCC2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
9981024 96068 0 None - 1 Bovine 5.2 pIC50 = 5.2 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 446 11 1 5 3.8 CCCN(CCCCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL26018 96068 0 None - 1 Bovine 5.2 pIC50 = 5.2 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 446 11 1 5 3.8 CCCN(CCCCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL300735 96068 0 None - 1 Bovine 5.2 pIC50 = 5.2 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 446 11 1 5 3.8 CCCN(CCCCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10047322 97111 0 None - 1 Bovine 5.2 pIC50 = 5.2 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 412 8 0 4 4.2 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2ccccc2C1 10.1021/jm00038a007
CHEMBL26783 97111 0 None - 1 Bovine 5.2 pIC50 = 5.2 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 412 8 0 4 4.2 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2ccccc2C1 10.1021/jm00038a007
CHEMBL50993 97111 0 None - 1 Bovine 5.2 pIC50 = 5.2 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 412 8 0 4 4.2 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2ccccc2C1 10.1021/jm00038a007
10008463 11217 0 None - 0 Bovine 4.2 pIC50 = 4.2 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 457 9 0 4 4.3 CCC[N+](C)(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL1178971 11217 0 None - 0 Bovine 4.2 pIC50 = 4.2 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 457 9 0 4 4.3 CCC[N+](C)(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL51985 11217 0 None - 0 Bovine 4.2 pIC50 = 4.2 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 457 9 0 4 4.3 CCC[N+](C)(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10364835 36467 4 None - 0 Rat 7.2 pIC50 = 7.2 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 420 5 1 3 4.4 Cc1ccc2c(c1)c(-c1ccc(F)cc1)cn2C1CCN(CCN2CCNC2=O)CC1 10.1021/jm00104a007
CHEMBL144767 36467 4 None - 0 Rat 7.2 pIC50 = 7.2 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 420 5 1 3 4.4 Cc1ccc2c(c1)c(-c1ccc(F)cc1)cn2C1CCN(CCN2CCNC2=O)CC1 10.1021/jm00104a007
11641036 185999 0 None - 1 Human 5.1 pIC50 = 5.1 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 453 8 0 5 5.4 O=c1c2ccccc2nc(-c2ccc(OCCCN3CCCCC3)cc2)n1Cc1ccccc1 10.1016/j.bmcl.2008.10.034
CHEMBL487059 185999 0 None - 1 Human 5.1 pIC50 = 5.1 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 453 8 0 5 5.4 O=c1c2ccccc2nc(-c2ccc(OCCCN3CCCCC3)cc2)n1Cc1ccccc1 10.1016/j.bmcl.2008.10.034
44377036 120130 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 393 3 0 5 4.0 Cc1nc2ccc(Cl)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL351483 120130 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 393 3 0 5 4.0 Cc1nc2ccc(Cl)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
10544460 16378 0 None - 0 Rat 7.1 pIC50 = 7.1 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 330 5 0 2 4.9 CN(C)CCCc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12 10.1021/jm960159f
CHEMBL123094 16378 0 None - 0 Rat 7.1 pIC50 = 7.1 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 330 5 0 2 4.9 CN(C)CCCc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12 10.1021/jm960159f
42636941 178925 0 None - 1 Human 7.1 pIC50 = 7.1 Binding
Displacement of [3H]prazosin form human recombinant alpha1A adrenergic receptorDisplacement of [3H]prazosin form human recombinant alpha1A adrenergic receptor
ChEMBL 343 5 0 5 4.4 CCCN1CCC(COc2nc3scc(C)c3n3cccc23)CC1 10.1016/j.bmc.2008.11.045
CHEMBL470432 178925 0 None - 1 Human 7.1 pIC50 = 7.1 Binding
Displacement of [3H]prazosin form human recombinant alpha1A adrenergic receptorDisplacement of [3H]prazosin form human recombinant alpha1A adrenergic receptor
ChEMBL 343 5 0 5 4.4 CCCN1CCC(COc2nc3scc(C)c3n3cccc23)CC1 10.1016/j.bmc.2008.11.045
23027527 196769 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 371 5 2 5 3.1 Cc1cnc(N[C@H]2CC[C@@H](NC(=O)c3ccc(F)cc3)CC2)nc1N(C)C 10.1016/j.bmcl.2009.09.003
CHEMBL565551 196769 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 371 5 2 5 3.1 Cc1cnc(N[C@H]2CC[C@@H](NC(=O)c3ccc(F)cc3)CC2)nc1N(C)C 10.1016/j.bmcl.2009.09.003
44343247 110608 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
In vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblastsIn vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblasts
ChEMBL 258 6 3 3 2.2 CCCNC(=O)c1ccccc1NCc1c[nH]cn1 10.1016/s0960-894x(02)00753-9
CHEMBL325745 110608 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
In vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblastsIn vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblasts
ChEMBL 258 6 3 3 2.2 CCCNC(=O)c1ccccc1NCc1c[nH]cn1 10.1016/s0960-894x(02)00753-9
2286 3161 51 None -10 30 Rat 7.1 pIC50 = 7.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
4927 3161 51 None -10 30 Rat 7.1 pIC50 = 7.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
7282 3161 51 None -10 30 Rat 7.1 pIC50 = 7.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
CHEMBL643 3161 51 None -10 30 Rat 7.1 pIC50 = 7.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
DB01069 3161 51 None -10 30 Rat 7.1 pIC50 = 7.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
1043 1569 14 None -35 29 Rat 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
149 1569 14 None -35 29 Rat 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
8223 1569 14 None -35 29 Rat 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
CHEMBL442 1569 14 None -35 29 Rat 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
DB00696 1569 14 None -35 29 Rat 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
2726 916 68 None -2 73 Rat 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
621 916 68 None -2 73 Rat 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
83 916 68 None -2 73 Rat 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
CHEMBL71 916 68 None -2 73 Rat 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
DB00477 916 68 None -2 73 Rat 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
56961507 121416 0 None 1 3 Human 8.1 pIC50 = 8.1 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 678 6 4 11 5.0 COc1cc2nc(N3CCN(C(=S)Nc4ccc(-c5c6ccc(=O)cc-6oc6cc(O)ccc56)c(C(=O)O)c4)CC3)nc(N)c2cc1OC 10.1021/ml5004298
CHEMBL3582271 121416 0 None 1 3 Human 8.1 pIC50 = 8.1 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 678 6 4 11 5.0 COc1cc2nc(N3CCN(C(=S)Nc4ccc(-c5c6ccc(=O)cc-6oc6cc(O)ccc56)c(C(=O)O)c4)CC3)nc(N)c2cc1OC 10.1021/ml5004298
10251234 11213 0 None - 0 Bovine 5.1 pIC50 = 5.1 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 414 9 0 5 3.3 CCCN(CCCCN1C(=O)C2CCCC2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL1178932 11213 0 None - 0 Bovine 5.1 pIC50 = 5.1 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 414 9 0 5 3.3 CCCN(CCCCN1C(=O)C2CCCC2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL50530 11213 0 None - 0 Bovine 5.1 pIC50 = 5.1 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 414 9 0 5 3.3 CCCN(CCCCN1C(=O)C2CCCC2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10252000 98519 0 None - 1 Bovine 5.1 pIC50 = 5.1 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 428 8 0 5 3.8 CCCN(CCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL27650 98519 0 None - 1 Bovine 5.1 pIC50 = 5.1 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 428 8 0 5 3.8 CCCN(CCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL50188 98519 0 None - 1 Bovine 5.1 pIC50 = 5.1 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 428 8 0 5 3.8 CCCN(CCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
3082597 99531 8 None - 1 Bovine 4.1 pIC50 = 4.1 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 263 6 0 3 3.1 CCCN(CCC)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL283606 99531 8 None - 1 Bovine 4.1 pIC50 = 4.1 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 263 6 0 3 3.1 CCCN(CCC)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
22493392 47125 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
In vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cellsIn vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cells
ChEMBL 252 4 2 4 2.2 c1ccc(-c2ccccc2NCC2=NCCN2)nc1 10.1016/s0960-894x(01)00822-8
CHEMBL154298 47125 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
In vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cellsIn vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cells
ChEMBL 252 4 2 4 2.2 c1ccc(-c2ccccc2NCC2=NCCN2)nc1 10.1016/s0960-894x(01)00822-8
44376936 57444 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 373 4 0 5 3.7 Cc1nc2ccccn2c(=O)c1CCCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL165776 57444 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 373 4 0 5 3.7 Cc1nc2ccccn2c(=O)c1CCCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
46182745 57297 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Inhibition of radioligand binding to human adrenergic alpha1a receptorInhibition of radioligand binding to human adrenergic alpha1a receptor
ChEMBL 461 6 1 3 6.2 O=C(O)c1cc(-c2cccc(COc3ccc4c(c3)CN(C3CCCC3)C4=O)c2)ccc1Cl 10.1021/jm3005306
CHEMBL1651208 57297 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Inhibition of radioligand binding to human adrenergic alpha1a receptorInhibition of radioligand binding to human adrenergic alpha1a receptor
ChEMBL 461 6 1 3 6.2 O=C(O)c1cc(-c2cccc(COc3ccc4c(c3)CN(C3CCCC3)C4=O)c2)ccc1Cl 10.1021/jm3005306
10736518 16361 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 348 5 0 3 5.1 CN(C)CCSc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12 10.1021/jm960159f
CHEMBL123027 16361 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 348 5 0 3 5.1 CN(C)CCSc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12 10.1021/jm960159f
10788207 200744 0 None - 0 Bovine 7.1 pIC50 = 7.1 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 419 4 0 4 3.4 CN1C(=O)COc2cc(CCN3CCN(c4cccc(C(F)(F)F)c4)CC3)ccc21 10.1021/jm970298c
CHEMBL60047 200744 0 None - 0 Bovine 7.1 pIC50 = 7.1 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 419 4 0 4 3.4 CN1C(=O)COc2cc(CCN3CCN(c4cccc(C(F)(F)F)c4)CC3)ccc21 10.1021/jm970298c
9816986 164115 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Concentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in humanConcentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in human
ChEMBL 274 6 2 4 1.6 CCN(CC)C(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL421011 164115 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Concentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in humanConcentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in human
ChEMBL 274 6 2 4 1.6 CCN(CC)C(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
2337 3232 77 None -3 63 Rat 7.1 pIC50 = 7.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
50 3232 77 None -3 63 Rat 7.1 pIC50 = 7.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
5002 3232 77 None -3 63 Rat 7.1 pIC50 = 7.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
CHEMBL716 3232 77 None -3 63 Rat 7.1 pIC50 = 7.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
DB01224 3232 77 None -3 63 Rat 7.1 pIC50 = 7.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
10551704 116812 0 None - 0 Rat 7.1 pIC50 = 7.1 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 454 9 1 4 3.8 C#CCN(CCOc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12)CCN1CCNC1=O 10.1021/jm960159f
CHEMBL338022 116812 0 None - 0 Rat 7.1 pIC50 = 7.1 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 454 9 1 4 3.8 C#CCN(CCOc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12)CCN1CCNC1=O 10.1021/jm960159f
13520319 163381 0 None - 0 Rat 7.1 pIC50 = 7.1 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 315 4 1 2 4.0 CN(C)CC(c1ccc(C(F)(F)F)cc1)C1(O)CCCCC1 10.1021/jm00172a035
CHEMBL419533 163381 0 None - 0 Rat 7.1 pIC50 = 7.1 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 315 4 1 2 4.0 CN(C)CC(c1ccc(C(F)(F)F)cc1)C1(O)CCCCC1 10.1021/jm00172a035
85469756 136562 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 455 7 0 5 3.9 COc1ccc(N2CCN(CCc3ccc(CN4C(=O)c5ccccc5C4=O)cc3)CC2)cc1 10.1016/j.bmc.2015.11.020
CHEMBL3739513 136562 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 455 7 0 5 3.9 COc1ccc(N2CCN(CCc3ccc(CN4C(=O)c5ccccc5C4=O)cc3)CC2)cc1 10.1016/j.bmc.2015.11.020
10093723 36406 0 None - 0 Rat 7.1 pIC50 = 7.1 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 422 5 1 3 4.7 Cc1ccc2c(c1)c(-c1ccc(F)cc1)cn2C1CCN(CCNC(=O)N(C)C)CC1 10.1021/jm00104a007
CHEMBL144710 36406 0 None - 0 Rat 7.1 pIC50 = 7.1 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 422 5 1 3 4.7 Cc1ccc2c(c1)c(-c1ccc(F)cc1)cn2C1CCN(CCNC(=O)N(C)C)CC1 10.1021/jm00104a007
85469868 136755 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 450 6 0 5 3.7 N#Cc1ccc(N2CCN(CCc3ccc(CN4C(=O)c5ccccc5C4=O)cc3)CC2)cc1 10.1016/j.bmc.2015.11.020
CHEMBL3741260 136755 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 450 6 0 5 3.7 N#Cc1ccc(N2CCN(CCc3ccc(CN4C(=O)c5ccccc5C4=O)cc3)CC2)cc1 10.1016/j.bmc.2015.11.020
85469755 136744 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 461 6 0 4 4.1 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccc(F)cc3F)CC2)cc1 10.1016/j.bmc.2015.11.020
CHEMBL3741161 136744 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 461 6 0 4 4.1 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccc(F)cc3F)CC2)cc1 10.1016/j.bmc.2015.11.020
44377200 57390 1 None - 0 Human 6.1 pIC50 = 6.1 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 437 3 0 5 4.1 Cc1nc2ccc(Br)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL165350 57390 1 None - 0 Human 6.1 pIC50 = 6.1 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 437 3 0 5 4.1 Cc1nc2ccc(Br)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
2284 3160 33 None -1 29 Rat 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
4926 3160 33 None -1 29 Rat 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
7281 3160 33 None -1 29 Rat 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
CHEMBL564 3160 33 None -1 29 Rat 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
DB00420 3160 33 None -1 29 Rat 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
10645076 200287 0 None - 0 Bovine 7.1 pIC50 = 7.1 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 407 4 1 5 4.4 Oc1nc2ccc(CCN3CCN(c4cccc(C(F)(F)F)c4)CC3)cc2s1 10.1021/jm970298c
CHEMBL59741 200287 0 None - 0 Bovine 7.1 pIC50 = 7.1 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 407 4 1 5 4.4 Oc1nc2ccc(CCN3CCN(c4cccc(C(F)(F)F)c4)CC3)cc2s1 10.1021/jm970298c
5656 203043 87 None - 43 Rat 7.1 pIC50 = 7.1 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 277 5 1 3 3.0 COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1 10.1021/jm00172a035
CHEMBL637 203043 87 None - 43 Rat 7.1 pIC50 = 7.1 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 277 5 1 3 3.0 COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1 10.1021/jm00172a035
10321964 18819 0 None - 0 Bovine 6.1 pIC50 = 6.1 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor determined in a filtration-based assay using [3H]prazosin as the radioligand.Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor determined in a filtration-based assay using [3H]prazosin as the radioligand.
ChEMBL 459 6 1 7 3.0 CS(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3ccc([N+](=O)[O-])cc3)CC1)O2 10.1021/jm00099a028
CHEMBL1203302 18819 0 None - 0 Bovine 6.1 pIC50 = 6.1 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor determined in a filtration-based assay using [3H]prazosin as the radioligand.Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor determined in a filtration-based assay using [3H]prazosin as the radioligand.
ChEMBL 459 6 1 7 3.0 CS(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3ccc([N+](=O)[O-])cc3)CC1)O2 10.1021/jm00099a028
CHEMBL128132 18819 0 None - 0 Bovine 6.1 pIC50 = 6.1 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor determined in a filtration-based assay using [3H]prazosin as the radioligand.Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor determined in a filtration-based assay using [3H]prazosin as the radioligand.
ChEMBL 459 6 1 7 3.0 CS(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3ccc([N+](=O)[O-])cc3)CC1)O2 10.1021/jm00099a028
9795857 208125 59 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 249 4 2 3 2.4 COc1ccc(C(CN)C2(O)CCCCC2)cc1 10.1021/jm00172a035
CHEMBL98158 208125 59 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 249 4 2 3 2.4 COc1ccc(C(CN)C2(O)CCCCC2)cc1 10.1021/jm00172a035
10321248 99398 0 None - 1 Bovine 5.1 pIC50 = 5.1 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 444 9 0 6 3.7 CCCN(CCCON1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL28287 99398 0 None - 1 Bovine 5.1 pIC50 = 5.1 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 444 9 0 6 3.7 CCCN(CCCON1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL50722 99398 0 None - 1 Bovine 5.1 pIC50 = 5.1 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 444 9 0 6 3.7 CCCN(CCCON1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
53246941 69393 42 None - 0 Human 6.0 pIC50 = 6.0 Binding
Selectivity interaction (Enzyme panel (receptors, ion channels, other enzymes)) EUB0000679a ADRA1ASelectivity interaction (Enzyme panel (receptors, ion channels, other enzymes)) EUB0000679a ADRA1A
ChEMBL 458 6 2 6 3.9 C[C@@H]1CCNC(=O)c2cc3ccc(C(=O)Nc4nc5ccccc5n4CCCN(C)C)cc3n21 10.6019/CHEMBL5212743
CHEMBL1933288 69393 42 None - 0 Human 6.0 pIC50 = 6.0 Binding
Selectivity interaction (Enzyme panel (receptors, ion channels, other enzymes)) EUB0000679a ADRA1ASelectivity interaction (Enzyme panel (receptors, ion channels, other enzymes)) EUB0000679a ADRA1A
ChEMBL 458 6 2 6 3.9 C[C@@H]1CCNC(=O)c2cc3ccc(C(=O)Nc4nc5ccccc5n4CCCN(C)C)cc3n21 10.6019/CHEMBL5212743
44573823 193210 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 491 6 0 3 6.1 CN(CCCN1CCC2(CC1)OCc1ccccc12)C(=O)N(c1ccccc1)c1ccc(F)c(F)c1 10.1016/j.bmcl.2009.04.016
CHEMBL523697 193210 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 491 6 0 3 6.1 CN(CCCN1CCC2(CC1)OCc1ccccc12)C(=O)N(c1ccccc1)c1ccc(F)c(F)c1 10.1016/j.bmcl.2009.04.016
3033538 1307 39 None -7 9 Rat 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 nan
7155 1307 39 None -7 9 Rat 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 nan
781 1307 39 None -7 9 Rat 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 nan
CHEMBL1201216 1307 39 None -7 9 Rat 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 nan
DB00298 1307 39 None -7 9 Rat 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 nan
133 2479 52 None -70 43 Rat 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
1723 2479 52 None -70 43 Rat 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
28693 2479 52 None -70 43 Rat 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
CHEMBL19215 2479 52 None -70 43 Rat 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
DB13520 2479 52 None -70 43 Rat 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
14739950 208243 0 None - 0 Rat 7.0 pIC50 = 7.0 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 263 5 1 3 2.6 COc1cccc(C(CN(C)C)C2(O)CCCC2)c1 10.1021/jm00172a035
CHEMBL98842 208243 0 None - 0 Rat 7.0 pIC50 = 7.0 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 263 5 1 3 2.6 COc1cccc(C(CN(C)C)C2(O)CCCC2)c1 10.1021/jm00172a035
19063108 93455 0 None - 0 Bovine 6.0 pIC50 = 6.0 Binding
Binding affinity was tested on cloned bovine Alpha-1A adrenergic receptorBinding affinity was tested on cloned bovine Alpha-1A adrenergic receptor
ChEMBL 546 9 1 10 4.6 COc1ccc(CC2c3cc(OC)c(OC)cc3CCN2c2nc(N)c3cc(OC)c(OC)cc3n2)cc1OC 10.1021/jm960697s
CHEMBL24619 93455 0 None - 0 Bovine 6.0 pIC50 = 6.0 Binding
Binding affinity was tested on cloned bovine Alpha-1A adrenergic receptorBinding affinity was tested on cloned bovine Alpha-1A adrenergic receptor
ChEMBL 546 9 1 10 4.6 COc1ccc(CC2c3cc(OC)c(OC)cc3CCN2c2nc(N)c3cc(OC)c(OC)cc3n2)cc1OC 10.1021/jm960697s
85469871 136559 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 443 6 0 4 4.0 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccccc3F)CC2)cc1 10.1016/j.bmc.2015.11.020
CHEMBL3739505 136559 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 443 6 0 4 4.0 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccccc3F)CC2)cc1 10.1016/j.bmc.2015.11.020
2398 951 62 None -4 29 Rat 7.0 pIC50 = 7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C nan
2801 951 62 None -4 29 Rat 7.0 pIC50 = 7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C nan
701 951 62 None -4 29 Rat 7.0 pIC50 = 7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C nan
CHEMBL415 951 62 None -4 29 Rat 7.0 pIC50 = 7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C nan
DB01242 951 62 None -4 29 Rat 7.0 pIC50 = 7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C nan
4209 3141 75 None -3 34 Rat 9.8 pKd = 9.8 Binding
Partial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic stripsPartial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic strips
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00025a012
4893 3141 75 None -3 34 Rat 9.8 pKd = 9.8 Binding
Partial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic stripsPartial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic strips
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00025a012
503 3141 75 None -3 34 Rat 9.8 pKd = 9.8 Binding
Partial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic stripsPartial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic strips
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00025a012
5385 3141 75 None -3 34 Rat 9.8 pKd = 9.8 Binding
Partial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic stripsPartial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic strips
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00025a012
CHEMBL2 3141 75 None -3 34 Rat 9.8 pKd = 9.8 Binding
Partial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic stripsPartial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic strips
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00025a012
DB00457 3141 75 None -3 34 Rat 9.8 pKd = 9.8 Binding
Partial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic stripsPartial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic strips
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00025a012
164612037 185353 0 None -4 20 Human 9.6 pKd = 9.6 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 326 8 4 4 1.8 CCCCCNC(=O)/N=C(\N)NCCCc1sc(N)nc1C 10.1021/acs.jmedchem.1c00692
CHEMBL4860528 185353 0 None -4 20 Human 9.6 pKd = 9.6 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 326 8 4 4 1.8 CCCCCNC(=O)/N=C(\N)NCCCc1sc(N)nc1C 10.1021/acs.jmedchem.1c00692
168290235 192944 0 None -16 20 Human 9.6 pKd = 9.6 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 315 6 4 3 1.1 C[C@@H](NC(=O)/N=C(\N)NCCCc1ncn[nH]1)c1ccccc1 10.1021/acs.jmedchem.1c00692
CHEMBL5201074 192944 0 None -16 20 Human 9.6 pKd = 9.6 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 315 6 4 3 1.1 C[C@@H](NC(=O)/N=C(\N)NCCCc1ncn[nH]1)c1ccccc1 10.1021/acs.jmedchem.1c00692
CHEMBL5222491 192944 0 None -16 20 Human 9.6 pKd = 9.6 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 315 6 4 3 1.1 C[C@@H](NC(=O)/N=C(\N)NCCCc1ncn[nH]1)c1ccccc1 10.1021/acs.jmedchem.1c00692
168294767 192995 0 None -4 20 Human 9.6 pKd = 9.6 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 313 8 4 5 0.9 CCCCCNC(=O)/N=C(\N)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
CHEMBL5207281 192995 0 None -4 20 Human 9.6 pKd = 9.6 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 313 8 4 5 0.9 CCCCCNC(=O)/N=C(\N)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
CHEMBL5222802 192995 0 None -4 20 Human 9.6 pKd = 9.6 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 313 8 4 5 0.9 CCCCCNC(=O)/N=C(\N)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
168295528 193007 0 None -4 20 Human 9.6 pKd = 9.6 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 333 6 4 5 0.9 N/C(=N\C(=O)NCc1ccccc1)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
CHEMBL5206565 193007 0 None -4 20 Human 9.6 pKd = 9.6 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 333 6 4 5 0.9 N/C(=N\C(=O)NCc1ccccc1)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
CHEMBL5222872 193007 0 None -4 20 Human 9.6 pKd = 9.6 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 333 6 4 5 0.9 N/C(=N\C(=O)NCc1ccccc1)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
44363762 40120 0 None - 1 Rat 9.2 pKd = 9.2 Binding
Partial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic stripsPartial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic strips
ChEMBL 497 6 1 11 1.8 COc1cc2nc(N3CCN(S(=O)(=O)c4nonc4-c4ccccc4)CC3)nc(N)c2cc1OC 10.1021/jm00025a012
CHEMBL147984 40120 0 None - 1 Rat 9.2 pKd = 9.2 Binding
Partial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic stripsPartial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic strips
ChEMBL 497 6 1 11 1.8 COc1cc2nc(N3CCN(S(=O)(=O)c4nonc4-c4ccccc4)CC3)nc(N)c2cc1OC 10.1021/jm00025a012
10250895 190318 0 None 1 5 Human 9.1 pKd = 9.1 Binding
Binding affinity to alpha-1A adrenergic receptor (unknown origin)Binding affinity to alpha-1A adrenergic receptor (unknown origin)
ChEMBL 408 7 0 6 3.7 COc1ccccc1N1CCN(CCCOc2ccc3c(C)cc(=O)oc3c2)CC1 10.1021/jm400408r
CHEMBL51767 190318 0 None 1 5 Human 9.1 pKd = 9.1 Binding
Binding affinity to alpha-1A adrenergic receptor (unknown origin)Binding affinity to alpha-1A adrenergic receptor (unknown origin)
ChEMBL 408 7 0 6 3.7 COc1ccccc1N1CCN(CCCOc2ccc3c(C)cc(=O)oc3c2)CC1 10.1021/jm400408r
10250895 190318 0 None -1 5 Rat 9.1 pKd = 9.1 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 408 7 0 6 3.7 COc1ccccc1N1CCN(CCCOc2ccc3c(C)cc(=O)oc3c2)CC1 10.1016/s0960-894x(02)00933-2
CHEMBL51767 190318 0 None -1 5 Rat 9.1 pKd = 9.1 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 408 7 0 6 3.7 COc1ccccc1N1CCN(CCCOc2ccc3c(C)cc(=O)oc3c2)CC1 10.1016/s0960-894x(02)00933-2
44364207 37767 0 None - 1 Rat 9.0 pKd = 9.0 Binding
Partial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic stripsPartial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic strips
ChEMBL 513 6 1 11 1.0 COc1cc2nc(N3CCN(S(=O)(=O)c4no[n+]([O-])c4-c4ccccc4)CC3)nc(N)c2cc1OC 10.1021/jm00025a012
CHEMBL145838 37767 0 None - 1 Rat 9.0 pKd = 9.0 Binding
Partial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic stripsPartial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic strips
ChEMBL 513 6 1 11 1.0 COc1cc2nc(N3CCN(S(=O)(=O)c4no[n+]([O-])c4-c4ccccc4)CC3)nc(N)c2cc1OC 10.1021/jm00025a012
71817386 102559 0 None -6 7 Rat 8.7 pKd = 8.7 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 355 7 1 6 3.3 COc1ccc2ccoc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
CHEMBL2419769 102559 0 None -6 7 Rat 8.7 pKd = 8.7 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 355 7 1 6 3.3 COc1ccc2ccoc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
CHEMBL3040851 102559 0 None -6 7 Rat 8.7 pKd = 8.7 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 355 7 1 6 3.3 COc1ccc2ccoc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
2419 692 28 None -288 12 Rat 6.0 pKd = 6.0 Binding
In vitro functional activity at Alpha-1A adrenergic receptor in rat vas deferensIn vitro functional activity at Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/s0960-894x(01)00159-7
9 692 28 None -288 12 Rat 6.0 pKd = 6.0 Binding
In vitro functional activity at Alpha-1A adrenergic receptor in rat vas deferensIn vitro functional activity at Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/s0960-894x(01)00159-7
CHEMBL13647 692 28 None -288 12 Rat 6.0 pKd = 6.0 Binding
In vitro functional activity at Alpha-1A adrenergic receptor in rat vas deferensIn vitro functional activity at Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/s0960-894x(01)00159-7
10317514 192505 0 None -14 6 Rat 7.9 pKd = 7.9 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 378 6 0 5 3.7 Cc1cc(=O)oc2cc(OCCCN3CCN(c4ccccc4)CC3)ccc12 10.1016/s0960-894x(02)00933-2
CHEMBL52096 192505 0 None -14 6 Rat 7.9 pKd = 7.9 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 378 6 0 5 3.7 Cc1cc(=O)oc2cc(OCCCN3CCN(c4ccccc4)CC3)ccc12 10.1016/s0960-894x(02)00933-2
2419 692 28 None -288 12 Rat 6.9 pKd = 6.9 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm400867d
9 692 28 None -288 12 Rat 6.9 pKd = 6.9 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm400867d
CHEMBL13647 692 28 None -288 12 Rat 6.9 pKd = 6.9 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm400867d
3584 3748 64 None -2 14 Rat 7.9 pKd = 7.9 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.ejmech.2015.04.005
5401 3748 64 None -2 14 Rat 7.9 pKd = 7.9 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.ejmech.2015.04.005
7302 3748 64 None -2 14 Rat 7.9 pKd = 7.9 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.ejmech.2015.04.005
CHEMBL611 3748 64 None -2 14 Rat 7.9 pKd = 7.9 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.ejmech.2015.04.005
DB01162 3748 64 None -2 14 Rat 7.9 pKd = 7.9 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.ejmech.2015.04.005
73437674 118505 0 None -2 3 Rat 7.9 pKd = 7.9 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 434 10 2 4 3.8 COc1ccccc1N1CCN(CCCNC(=O)CCCc2c[nH]c3ccccc23)CC1 10.1016/j.ejmech.2015.04.005
CHEMBL3415014 118505 0 None -2 3 Rat 7.9 pKd = 7.9 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 434 10 2 4 3.8 COc1ccccc1N1CCN(CCCNC(=O)CCCc2c[nH]c3ccccc23)CC1 10.1016/j.ejmech.2015.04.005
14348818 109747 0 None 5 3 Rat 4.9 pKd = 4.9 Binding
The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.
ChEMBL 415 7 4 7 2.9 C/C(=N\OCC(O)CNC(C)(C)C)c1cc(Cl)c(NC2=NCCN2)c(Cl)c1 10.1021/jm00115a008
CHEMBL323176 109747 0 None 5 3 Rat 4.9 pKd = 4.9 Binding
The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.
ChEMBL 415 7 4 7 2.9 C/C(=N\OCC(O)CNC(C)(C)C)c1cc(Cl)c(NC2=NCCN2)c(Cl)c1 10.1021/jm00115a008
71817545 92095 0 None -2 7 Rat 7.9 pKd = 7.9 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 354 7 2 5 3.0 COc1ccc2cc[nH]c2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
CHEMBL2419765 92095 0 None -2 7 Rat 7.9 pKd = 7.9 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 354 7 2 5 3.0 COc1ccc2cc[nH]c2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
71817547 102551 0 None -81 7 Rat 7.9 pKd = 7.9 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 357 7 1 6 2.4 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)OCC2 10.1021/jm400867d
CHEMBL2419771 102551 0 None -81 7 Rat 7.9 pKd = 7.9 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 357 7 1 6 2.4 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)OCC2 10.1021/jm400867d
CHEMBL3040800 102551 0 None -81 7 Rat 7.9 pKd = 7.9 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 357 7 1 6 2.4 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)OCC2 10.1021/jm400867d
76308474 106207 0 None -162 5 Rat 6.9 pKd = 6.9 Binding
Competitive antagonist activity at alpha1A adrenergic receptor in Rattus norvegicus (rat) vas deferens assessed as inhibition of (-)-noradrenaline-induced contractionCompetitive antagonist activity at alpha1A adrenergic receptor in Rattus norvegicus (rat) vas deferens assessed as inhibition of (-)-noradrenaline-induced contraction
ChEMBL 467 5 1 9 3.1 COc1ccc(C(=O)N2CCN(c3nc(N)c4cc(OC)c(OC)cc4n3)[C@H]3CCCC[C@@H]32)o1 10.1007/s00044-004-0024-8
CHEMBL2261607 106207 0 None -162 5 Rat 6.9 pKd = 6.9 Binding
Competitive antagonist activity at alpha1A adrenergic receptor in Rattus norvegicus (rat) vas deferens assessed as inhibition of (-)-noradrenaline-induced contractionCompetitive antagonist activity at alpha1A adrenergic receptor in Rattus norvegicus (rat) vas deferens assessed as inhibition of (-)-noradrenaline-induced contraction
ChEMBL 467 5 1 9 3.1 COc1ccc(C(=O)N2CCN(c3nc(N)c4cc(OC)c(OC)cc4n3)[C@H]3CCCC[C@@H]32)o1 10.1007/s00044-004-0024-8
CHEMBL3138856 106207 0 None -162 5 Rat 6.9 pKd = 6.9 Binding
Competitive antagonist activity at alpha1A adrenergic receptor in Rattus norvegicus (rat) vas deferens assessed as inhibition of (-)-noradrenaline-induced contractionCompetitive antagonist activity at alpha1A adrenergic receptor in Rattus norvegicus (rat) vas deferens assessed as inhibition of (-)-noradrenaline-induced contraction
ChEMBL 467 5 1 9 3.1 COc1ccc(C(=O)N2CCN(c3nc(N)c4cc(OC)c(OC)cc4n3)[C@H]3CCCC[C@@H]32)o1 10.1007/s00044-004-0024-8
10252540 85328 1 None -83 6 Rat 7.8 pKd = 7.8 Binding
Antagonist activity at alpha1A adrenoreceptor in Rattus norvegicus (rat) small mesenteric arteryAntagonist activity at alpha1A adrenoreceptor in Rattus norvegicus (rat) small mesenteric artery
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1007/s00044-004-0024-8
CHEMBL2261604 85328 1 None -83 6 Rat 7.8 pKd = 7.8 Binding
Antagonist activity at alpha1A adrenoreceptor in Rattus norvegicus (rat) small mesenteric arteryAntagonist activity at alpha1A adrenoreceptor in Rattus norvegicus (rat) small mesenteric artery
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1007/s00044-004-0024-8
10252540 85328 1 None -83 6 Rat 7.8 pKd = 7.8 Binding
Competitive antagonist activity at alpha1A adrenergic receptor in Rattus norvegicus (rat) vas deferens assessed as inhibition of (-)-noradrenaline-induced contractionCompetitive antagonist activity at alpha1A adrenergic receptor in Rattus norvegicus (rat) vas deferens assessed as inhibition of (-)-noradrenaline-induced contraction
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1007/s00044-004-0024-8
CHEMBL2261604 85328 1 None -83 6 Rat 7.8 pKd = 7.8 Binding
Competitive antagonist activity at alpha1A adrenergic receptor in Rattus norvegicus (rat) vas deferens assessed as inhibition of (-)-noradrenaline-induced contractionCompetitive antagonist activity at alpha1A adrenergic receptor in Rattus norvegicus (rat) vas deferens assessed as inhibition of (-)-noradrenaline-induced contraction
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1007/s00044-004-0024-8
1353 1898 93 None -10 86 Rat 7.8 pKd = 7.8 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1016/s0960-894x(02)00933-2
3559 1898 93 None -10 86 Rat 7.8 pKd = 7.8 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1016/s0960-894x(02)00933-2
86 1898 93 None -10 86 Rat 7.8 pKd = 7.8 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1016/s0960-894x(02)00933-2
CHEMBL54 1898 93 None -10 86 Rat 7.8 pKd = 7.8 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1016/s0960-894x(02)00933-2
DB00502 1898 93 None -10 86 Rat 7.8 pKd = 7.8 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1016/s0960-894x(02)00933-2
155559152 174756 0 None -21 3 Rat 5.7 pKd = 5.7 Binding
Antagonistic activity at alpha1A adrenoceptor in Sprague-Dawley rat vas deferens assessed as inhibition of noradrenaline-induced contractions after 0.5 hrs in presence of alpha2/beta adrenoceptor blocker yohimbine, propranolol by Schild plot analysisAntagonistic activity at alpha1A adrenoceptor in Sprague-Dawley rat vas deferens assessed as inhibition of noradrenaline-induced contractions after 0.5 hrs in presence of alpha2/beta adrenoceptor blocker yohimbine, propranolol by Schild plot analysis
ChEMBL 431 7 2 5 3.9 COc1ccc(N2CCN(CC(O)COc3cccc4[nH]c5ccccc5c34)CC2)cc1 10.1016/j.bmc.2016.09.010
CHEMBL4561614 174756 0 None -21 3 Rat 5.7 pKd = 5.7 Binding
Antagonistic activity at alpha1A adrenoceptor in Sprague-Dawley rat vas deferens assessed as inhibition of noradrenaline-induced contractions after 0.5 hrs in presence of alpha2/beta adrenoceptor blocker yohimbine, propranolol by Schild plot analysisAntagonistic activity at alpha1A adrenoceptor in Sprague-Dawley rat vas deferens assessed as inhibition of noradrenaline-induced contractions after 0.5 hrs in presence of alpha2/beta adrenoceptor blocker yohimbine, propranolol by Schild plot analysis
ChEMBL 431 7 2 5 3.9 COc1ccc(N2CCN(CC(O)COc3cccc4[nH]c5ccccc5c34)CC2)cc1 10.1016/j.bmc.2016.09.010
44294972 183994 0 None -1 2 Rat 6.7 pKd = 6.7 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 395 7 0 7 2.8 COc1cc(=O)oc2cc(OCCCN3CCN(c4ccccn4)CC3)ccc12 10.1016/s0960-894x(02)00933-2
CHEMBL48205 183994 0 None -1 2 Rat 6.7 pKd = 6.7 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 395 7 0 7 2.8 COc1cc(=O)oc2cc(OCCCN3CCN(c4ccccn4)CC3)ccc12 10.1016/s0960-894x(02)00933-2
73437673 118504 0 None -5 3 Rat 6.7 pKd = 6.7 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 420 9 2 4 3.4 COc1ccccc1N1CCN(CCCNC(=O)CCc2c[nH]c3ccccc23)CC1 10.1016/j.ejmech.2015.04.005
CHEMBL3415013 118504 0 None -5 3 Rat 6.7 pKd = 6.7 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 420 9 2 4 3.4 COc1ccccc1N1CCN(CCCNC(=O)CCc2c[nH]c3ccccc23)CC1 10.1016/j.ejmech.2015.04.005
10527913 121498 0 None - 1 Rat 8.6 pKd = 8.6 Binding
Partial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic stripsPartial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic strips
ChEMBL 459 5 1 12 -0.4 COC(=O)c1c(C(=O)N2CCN(c3nc(N)c4cc(OC)c(OC)cc4n3)CC2)no[n+]1[O-] 10.1021/jm00025a012
CHEMBL358498 121498 0 None - 1 Rat 8.6 pKd = 8.6 Binding
Partial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic stripsPartial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic strips
ChEMBL 459 5 1 12 -0.4 COC(=O)c1c(C(=O)N2CCN(c3nc(N)c4cc(OC)c(OC)cc4n3)CC2)no[n+]1[O-] 10.1021/jm00025a012
155567902 175970 0 None -6 3 Rat 6.7 pKd = 6.7 Binding
Antagonist activity at alpha-1a adrenergic receptor in SPF rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractionsAntagonist activity at alpha-1a adrenergic receptor in SPF rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions
ChEMBL 448 7 1 8 0.9 COc1cc2c(cc1OCC(O)CN1CCN(C(=O)C3CCCO3)CC1)C(=O)C(C)OC2 10.1016/j.bmc.2019.05.004
CHEMBL4589115 175970 0 None -6 3 Rat 6.7 pKd = 6.7 Binding
Antagonist activity at alpha-1a adrenergic receptor in SPF rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractionsAntagonist activity at alpha-1a adrenergic receptor in SPF rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions
ChEMBL 448 7 1 8 0.9 COc1cc2c(cc1OCC(O)CN1CCN(C(=O)C3CCCO3)CC1)C(=O)C(C)OC2 10.1016/j.bmc.2019.05.004
92766 106515 35 None 1 6 Human 6.6 pKd = 6.6 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12 10.1021/jm00370a011
CHEMBL31410 106515 35 None 1 6 Human 6.6 pKd = 6.6 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12 10.1021/jm00370a011
2803 952 58 None -3 19 Rat 6.6 pKd = 6.6 Binding
The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm00115a008
516 952 58 None -3 19 Rat 6.6 pKd = 6.6 Binding
The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm00115a008
704 952 58 None -3 19 Rat 6.6 pKd = 6.6 Binding
The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm00115a008
CHEMBL134 952 58 None -3 19 Rat 6.6 pKd = 6.6 Binding
The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm00115a008
DB00575 952 58 None -3 19 Rat 6.6 pKd = 6.6 Binding
The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm00115a008
73438500 118502 0 None -2 3 Rat 7.6 pKd = 7.6 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 392 7 2 4 3.1 COc1ccccc1N1CCN(CCCNC(=O)c2ccc3[nH]ccc3c2)CC1 10.1016/j.ejmech.2015.04.005
CHEMBL3415011 118502 0 None -2 3 Rat 7.6 pKd = 7.6 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 392 7 2 4 3.1 COc1ccccc1N1CCN(CCCNC(=O)c2ccc3[nH]ccc3c2)CC1 10.1016/j.ejmech.2015.04.005
44294683 189843 0 None -3 2 Rat 6.6 pKd = 6.6 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 379 6 0 6 3.1 Cc1cc(=O)oc2cc(OCCCN3CCN(c4ccccn4)CC3)ccc12 10.1016/s0960-894x(02)00933-2
CHEMBL51681 189843 0 None -3 2 Rat 6.6 pKd = 6.6 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 379 6 0 6 3.1 Cc1cc(=O)oc2cc(OCCCN3CCN(c4ccccn4)CC3)ccc12 10.1016/s0960-894x(02)00933-2
44364190 39735 0 None - 1 Rat 8.5 pKd = 8.5 Binding
Partial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic stripsPartial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic strips
ChEMBL 539 6 1 11 1.4 COc1cc2nc(N3CCN(S(=O)(=O)c4no[n+]([O-])c4C4=C/C=C\C=C/C=C\4)CC3)nc(N)c2cc1OC 10.1021/jm00025a012
CHEMBL147624 39735 0 None - 1 Rat 8.5 pKd = 8.5 Binding
Partial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic stripsPartial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic strips
ChEMBL 539 6 1 11 1.4 COc1cc2nc(N3CCN(S(=O)(=O)c4no[n+]([O-])c4C4=C/C=C\C=C/C=C\4)CC3)nc(N)c2cc1OC 10.1021/jm00025a012
71817549 102553 0 None -7 7 Rat 8.4 pKd = 8.4 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 356 7 2 6 2.5 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)NCC2 10.1021/jm400867d
CHEMBL3040803 102553 0 None -7 7 Rat 8.4 pKd = 8.4 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 356 7 2 6 2.5 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)NCC2 10.1021/jm400867d
CHEMBL3216590 102553 0 None -7 7 Rat 8.4 pKd = 8.4 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 356 7 2 6 2.5 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)NCC2 10.1021/jm400867d
2142 3074 58 None -2 37 Human 7.5 pKd = 7.5 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00370a011
4920903 3074 58 None -2 37 Human 7.5 pKd = 7.5 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00370a011
502 3074 58 None -2 37 Human 7.5 pKd = 7.5 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00370a011
5775 3074 58 None -2 37 Human 7.5 pKd = 7.5 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00370a011
CHEMBL597 3074 58 None -2 37 Human 7.5 pKd = 7.5 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00370a011
DB00692 3074 58 None -2 37 Human 7.5 pKd = 7.5 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00370a011
4418 34192 85 None -10 7 Rat 7.5 pKd = 7.5 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1016/j.ejmech.2015.04.005
CHEMBL142635 34192 85 None -10 7 Rat 7.5 pKd = 7.5 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1016/j.ejmech.2015.04.005
71817547 102551 0 None -81 7 Rat 7.5 pKd = 7.5 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 357 7 1 6 2.4 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)OCC2 10.1021/jm400867d
CHEMBL2419771 102551 0 None -81 7 Rat 7.5 pKd = 7.5 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 357 7 1 6 2.4 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)OCC2 10.1021/jm400867d
CHEMBL3040800 102551 0 None -81 7 Rat 7.5 pKd = 7.5 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 357 7 1 6 2.4 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)OCC2 10.1021/jm400867d
44294973 183977 0 None 1 2 Rat 6.5 pKd = 6.5 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 394 7 0 6 3.4 COc1cc(=O)oc2cc(OCCCN3CCN(c4ccccc4)CC3)ccc12 10.1016/s0960-894x(02)00933-2
CHEMBL48194 183977 0 None 1 2 Rat 6.5 pKd = 6.5 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 394 7 0 6 3.4 COc1cc(=O)oc2cc(OCCCN3CCN(c4ccccc4)CC3)ccc12 10.1016/s0960-894x(02)00933-2
135398737 955 93 None -5 92 Human 7.4 pKd = 7.4 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm00370a011
38 955 93 None -5 92 Human 7.4 pKd = 7.4 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm00370a011
722 955 93 None -5 92 Human 7.4 pKd = 7.4 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm00370a011
CHEMBL42 955 93 None -5 92 Human 7.4 pKd = 7.4 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm00370a011
DB00363 955 93 None -5 92 Human 7.4 pKd = 7.4 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm00370a011
86288949 112598 0 None -5 5 Rat 7.4 pKd = 7.4 Binding
Antagonist activity at alpha1A adrenoceptor in Wistar (Krf:(WI) WU) rat endothelium-denuded tail artery assessed as inhibition of noradrenaline-induced contraction after 30 minsAntagonist activity at alpha1A adrenoceptor in Wistar (Krf:(WI) WU) rat endothelium-denuded tail artery assessed as inhibition of noradrenaline-induced contraction after 30 mins
ChEMBL 434 8 0 4 3.8 CN1C(=O)N(CCCCCN2CCN(c3ccccc3)CC2)C(C)(c2ccccc2)C1=O 10.1016/j.ejmech.2014.01.065
CHEMBL3233665 112598 0 None -5 5 Rat 7.4 pKd = 7.4 Binding
Antagonist activity at alpha1A adrenoceptor in Wistar (Krf:(WI) WU) rat endothelium-denuded tail artery assessed as inhibition of noradrenaline-induced contraction after 30 minsAntagonist activity at alpha1A adrenoceptor in Wistar (Krf:(WI) WU) rat endothelium-denuded tail artery assessed as inhibition of noradrenaline-induced contraction after 30 mins
ChEMBL 434 8 0 4 3.8 CN1C(=O)N(CCCCCN2CCN(c3ccccc3)CC2)C(C)(c2ccccc2)C1=O 10.1016/j.ejmech.2014.01.065
CHEMBL3302599 112598 0 None -5 5 Rat 7.4 pKd = 7.4 Binding
Antagonist activity at alpha1A adrenoceptor in Wistar (Krf:(WI) WU) rat endothelium-denuded tail artery assessed as inhibition of noradrenaline-induced contraction after 30 minsAntagonist activity at alpha1A adrenoceptor in Wistar (Krf:(WI) WU) rat endothelium-denuded tail artery assessed as inhibition of noradrenaline-induced contraction after 30 mins
ChEMBL 434 8 0 4 3.8 CN1C(=O)N(CCCCCN2CCN(c3ccccc3)CC2)C(C)(c2ccccc2)C1=O 10.1016/j.ejmech.2014.01.065
2419 692 28 None -288 12 Human 6.4 pKd = 6.4 Binding
Affinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptorAffinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm011066n
9 692 28 None -288 12 Human 6.4 pKd = 6.4 Binding
Affinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptorAffinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm011066n
CHEMBL13647 692 28 None -288 12 Human 6.4 pKd = 6.4 Binding
Affinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptorAffinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm011066n
102 4096 48 None -346 50 Human 6.4 pKd = 6.4 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00370a011
3659 4096 48 None -346 50 Human 6.4 pKd = 6.4 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00370a011
8969 4096 48 None -346 50 Human 6.4 pKd = 6.4 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00370a011
CHEMBL15245 4096 48 None -346 50 Human 6.4 pKd = 6.4 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00370a011
DB01392 4096 48 None -346 50 Human 6.4 pKd = 6.4 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00370a011
15112598 9289 0 None -2 3 Rat 5.4 pKd = 5.4 Binding
The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.
ChEMBL 444 9 3 7 3.3 C/C(=N\OCC(O)CNC(C)(C)C)c1cc(Cl)c(OC(C)C2=NCCN2)c(Cl)c1 10.1021/jm00115a008
CHEMBL111090 9289 0 None -2 3 Rat 5.4 pKd = 5.4 Binding
The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.
ChEMBL 444 9 3 7 3.3 C/C(=N\OCC(O)CNC(C)(C)C)c1cc(Cl)c(OC(C)C2=NCCN2)c(Cl)c1 10.1021/jm00115a008
134149596 148441 0 None -10 4 Rat 8.4 pKd = 8.4 Binding
Competitive antagonist activity at alpha1A-adrenoceptor in Wistar rat prostatic vas deference assessed as inhibition of (-)-NE-induced contractions preincubated for 60 mins before (-)-NE challenge measured after 45 mins by Schild plot analysisCompetitive antagonist activity at alpha1A-adrenoceptor in Wistar rat prostatic vas deference assessed as inhibition of (-)-NE-induced contractions preincubated for 60 mins before (-)-NE challenge measured after 45 mins by Schild plot analysis
ChEMBL 368 6 0 5 3.6 CC(C)Oc1ccccc1N1CCN(CCc2ccc3c(c2)OCO3)CC1 10.1016/j.ejmech.2016.06.052
CHEMBL3938038 148441 0 None -10 4 Rat 8.4 pKd = 8.4 Binding
Competitive antagonist activity at alpha1A-adrenoceptor in Wistar rat prostatic vas deference assessed as inhibition of (-)-NE-induced contractions preincubated for 60 mins before (-)-NE challenge measured after 45 mins by Schild plot analysisCompetitive antagonist activity at alpha1A-adrenoceptor in Wistar rat prostatic vas deference assessed as inhibition of (-)-NE-induced contractions preincubated for 60 mins before (-)-NE challenge measured after 45 mins by Schild plot analysis
ChEMBL 368 6 0 5 3.6 CC(C)Oc1ccccc1N1CCN(CCc2ccc3c(c2)OCO3)CC1 10.1016/j.ejmech.2016.06.052
491 192 9 None -44 12 Rat 8.4 pKd = 8.4 Binding
In vitro functional activity at Alpha-1A adrenergic receptor in rat vas deferensIn vitro functional activity at Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 10.1016/s0960-894x(01)00159-7
9891167 192 9 None -44 12 Rat 8.4 pKd = 8.4 Binding
In vitro functional activity at Alpha-1A adrenergic receptor in rat vas deferensIn vitro functional activity at Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 10.1016/s0960-894x(01)00159-7
CHEMBL13856 192 9 None -44 12 Rat 8.4 pKd = 8.4 Binding
In vitro functional activity at Alpha-1A adrenergic receptor in rat vas deferensIn vitro functional activity at Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 10.1016/s0960-894x(01)00159-7
71817545 92095 0 None -2 7 Rat 8.3 pKd = 8.3 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 354 7 2 5 3.0 COc1ccc2cc[nH]c2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
CHEMBL2419765 92095 0 None -2 7 Rat 8.3 pKd = 8.3 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 354 7 2 5 3.0 COc1ccc2cc[nH]c2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
14348818 109747 0 None 5 3 Rat 5.4 pKd = 5.4 Binding
The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.
ChEMBL 415 7 4 7 2.9 C/C(=N\OCC(O)CNC(C)(C)C)c1cc(Cl)c(NC2=NCCN2)c(Cl)c1 10.1021/jm00115a008
CHEMBL323176 109747 0 None 5 3 Rat 5.4 pKd = 5.4 Binding
The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.
ChEMBL 415 7 4 7 2.9 C/C(=N\OCC(O)CNC(C)(C)C)c1cc(Cl)c(NC2=NCCN2)c(Cl)c1 10.1021/jm00115a008
44294687 96878 0 None 7 2 Rat 7.4 pKd = 7.4 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 380 6 0 7 2.5 Cc1cc(=O)oc2cc(OCCCN3CCN(c4ncccn4)CC3)ccc12 10.1016/s0960-894x(02)00933-2
CHEMBL265805 96878 0 None 7 2 Rat 7.4 pKd = 7.4 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 380 6 0 7 2.5 Cc1cc(=O)oc2cc(OCCCN3CCN(c4ncccn4)CC3)ccc12 10.1016/s0960-894x(02)00933-2
155534921 171963 0 None -5 3 Rat 6.4 pKd = 6.4 Binding
Antagonistic activity at alpha1A adrenoceptor in Sprague-Dawley rat vas deferens assessed as inhibition of noradrenaline-induced contractions after 0.5 hrs in presence of alpha2/beta adrenoceptor blocker yohimbine, propranolol by Schild plot analysisAntagonistic activity at alpha1A adrenoceptor in Sprague-Dawley rat vas deferens assessed as inhibition of noradrenaline-induced contractions after 0.5 hrs in presence of alpha2/beta adrenoceptor blocker yohimbine, propranolol by Schild plot analysis
ChEMBL 461 8 2 6 3.9 COc1ccc(OC)c(N2CCN(CC(O)COc3cccc4[nH]c5ccccc5c34)CC2)c1 10.1016/j.bmc.2016.09.010
CHEMBL4471070 171963 0 None -5 3 Rat 6.4 pKd = 6.4 Binding
Antagonistic activity at alpha1A adrenoceptor in Sprague-Dawley rat vas deferens assessed as inhibition of noradrenaline-induced contractions after 0.5 hrs in presence of alpha2/beta adrenoceptor blocker yohimbine, propranolol by Schild plot analysisAntagonistic activity at alpha1A adrenoceptor in Sprague-Dawley rat vas deferens assessed as inhibition of noradrenaline-induced contractions after 0.5 hrs in presence of alpha2/beta adrenoceptor blocker yohimbine, propranolol by Schild plot analysis
ChEMBL 461 8 2 6 3.9 COc1ccc(OC)c(N2CCN(CC(O)COc3cccc4[nH]c5ccccc5c34)CC2)c1 10.1016/j.bmc.2016.09.010
44294988 193236 0 None 1 2 Rat 7.4 pKd = 7.4 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 396 7 0 8 2.2 COc1cc(=O)oc2cc(OCCCN3CCN(c4ncccn4)CC3)ccc12 10.1016/s0960-894x(02)00933-2
CHEMBL52384 193236 0 None 1 2 Rat 7.4 pKd = 7.4 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 396 7 0 8 2.2 COc1cc(=O)oc2cc(OCCCN3CCN(c4ncccn4)CC3)ccc12 10.1016/s0960-894x(02)00933-2
73437729 118509 0 None -2 3 Rat 7.3 pKd = 7.3 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 426 7 2 4 3.8 COc1ccccc1N1CCN(CCCNC(=O)c2cc3cc(Cl)ccc3[nH]2)CC1 10.1016/j.ejmech.2015.04.005
CHEMBL3415018 118509 0 None -2 3 Rat 7.3 pKd = 7.3 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 426 7 2 4 3.8 COc1ccccc1N1CCN(CCCNC(=O)c2cc3cc(Cl)ccc3[nH]2)CC1 10.1016/j.ejmech.2015.04.005
86288950 112616 0 None -15 6 Rat 7.3 pKd = 7.3 Binding
Antagonist activity at alpha1A adrenoceptor in Wistar (Krf:(WI) WU) rat endothelium-denuded tail artery assessed as inhibition of noradrenaline-induced contraction after 30 minsAntagonist activity at alpha1A adrenoceptor in Wistar (Krf:(WI) WU) rat endothelium-denuded tail artery assessed as inhibition of noradrenaline-induced contraction after 30 mins
ChEMBL 452 8 0 4 3.9 CN1C(=O)N(CCCCCN2CCN(c3ccccc3F)CC2)C(C)(c2ccccc2)C1=O 10.1016/j.ejmech.2014.01.065
CHEMBL3233666 112616 0 None -15 6 Rat 7.3 pKd = 7.3 Binding
Antagonist activity at alpha1A adrenoceptor in Wistar (Krf:(WI) WU) rat endothelium-denuded tail artery assessed as inhibition of noradrenaline-induced contraction after 30 minsAntagonist activity at alpha1A adrenoceptor in Wistar (Krf:(WI) WU) rat endothelium-denuded tail artery assessed as inhibition of noradrenaline-induced contraction after 30 mins
ChEMBL 452 8 0 4 3.9 CN1C(=O)N(CCCCCN2CCN(c3ccccc3F)CC2)C(C)(c2ccccc2)C1=O 10.1016/j.ejmech.2014.01.065
CHEMBL3302931 112616 0 None -15 6 Rat 7.3 pKd = 7.3 Binding
Antagonist activity at alpha1A adrenoceptor in Wistar (Krf:(WI) WU) rat endothelium-denuded tail artery assessed as inhibition of noradrenaline-induced contraction after 30 minsAntagonist activity at alpha1A adrenoceptor in Wistar (Krf:(WI) WU) rat endothelium-denuded tail artery assessed as inhibition of noradrenaline-induced contraction after 30 mins
ChEMBL 452 8 0 4 3.9 CN1C(=O)N(CCCCCN2CCN(c3ccccc3F)CC2)C(C)(c2ccccc2)C1=O 10.1016/j.ejmech.2014.01.065
71817386 102559 0 None -6 7 Rat 8.3 pKd = 8.3 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 355 7 1 6 3.3 COc1ccc2ccoc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
CHEMBL2419769 102559 0 None -6 7 Rat 8.3 pKd = 8.3 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 355 7 1 6 3.3 COc1ccc2ccoc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
CHEMBL3040851 102559 0 None -6 7 Rat 8.3 pKd = 8.3 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 355 7 1 6 3.3 COc1ccc2ccoc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
10694582 38537 0 None - 1 Rat 8.3 pKd = 8.3 Binding
Partial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic stripsPartial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic strips
ChEMBL 444 5 2 11 -1.1 COc1cc2nc(N3CCN(C(=O)c4no[n+]([O-])c4C(N)=O)CC3)nc(N)c2cc1OC 10.1021/jm00025a012
CHEMBL146481 38537 0 None - 1 Rat 8.3 pKd = 8.3 Binding
Partial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic stripsPartial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic strips
ChEMBL 444 5 2 11 -1.1 COc1cc2nc(N3CCN(C(=O)c4no[n+]([O-])c4C(N)=O)CC3)nc(N)c2cc1OC 10.1021/jm00025a012
73437677 118510 0 None -9 3 Rat 7.3 pKd = 7.3 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 406 7 1 5 3.1 COc1ccccc1N1CCN(CCCNC(=O)c2cn(C)c3ccccc23)CC1 10.1016/j.ejmech.2015.04.005
CHEMBL3415019 118510 0 None -9 3 Rat 7.3 pKd = 7.3 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 406 7 1 5 3.1 COc1ccccc1N1CCN(CCCNC(=O)c2cn(C)c3ccccc23)CC1 10.1016/j.ejmech.2015.04.005
73437675 118506 0 None -2 3 Rat 7.3 pKd = 7.3 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 408 7 3 5 2.8 COc1ccccc1N1CCN(CCCNC(=O)c2cc3cc(O)ccc3[nH]2)CC1 10.1016/j.ejmech.2015.04.005
CHEMBL3415015 118506 0 None -2 3 Rat 7.3 pKd = 7.3 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 408 7 3 5 2.8 COc1ccccc1N1CCN(CCCNC(=O)c2cc3cc(O)ccc3[nH]2)CC1 10.1016/j.ejmech.2015.04.005
73437730 118507 0 None -2 3 Rat 7.2 pKd = 7.2 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 437 8 2 6 3.0 COc1ccccc1N1CCN(CCCNC(=O)c2cc3cccc([N+](=O)[O-])c3[nH]2)CC1 10.1016/j.ejmech.2015.04.005
CHEMBL3415016 118507 0 None -2 3 Rat 7.2 pKd = 7.2 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 437 8 2 6 3.0 COc1ccccc1N1CCN(CCCNC(=O)c2cc3cccc([N+](=O)[O-])c3[nH]2)CC1 10.1016/j.ejmech.2015.04.005
73437678 118508 0 None -4 3 Rat 7.2 pKd = 7.2 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 470 7 2 4 3.9 COc1ccccc1N1CCN(CCCNC(=O)c2cc3ccc(Br)cc3[nH]2)CC1 10.1016/j.ejmech.2015.04.005
CHEMBL3415017 118508 0 None -4 3 Rat 7.2 pKd = 7.2 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 470 7 2 4 3.9 COc1ccccc1N1CCN(CCCNC(=O)c2cc3ccc(Br)cc3[nH]2)CC1 10.1016/j.ejmech.2015.04.005
9871544 14184 3 None -141 11 Human 6.2 pKd = 6.2 Binding
Binding affinity to Alpha-1A adrenergic receptorBinding affinity to Alpha-1A adrenergic receptor
ChEMBL 526 7 0 5 4.6 COc1ccc(C[C@H](C)CN2C[C@@H](C(=O)N3CCN(c4ccc(F)c(F)c4)CC3)[C@H]3CCCC[C@H]3C2)cn1 10.1016/j.bmcl.2010.01.063
CHEMBL1076624 14184 3 None -141 11 Human 6.2 pKd = 6.2 Binding
Binding affinity to Alpha-1A adrenergic receptorBinding affinity to Alpha-1A adrenergic receptor
ChEMBL 526 7 0 5 4.6 COc1ccc(C[C@H](C)CN2C[C@@H](C(=O)N3CCN(c4ccc(F)c(F)c4)CC3)[C@H]3CCCC[C@H]3C2)cn1 10.1016/j.bmcl.2010.01.063
CHEMBL1198948 14184 3 None -141 11 Human 6.2 pKd = 6.2 Binding
Binding affinity to Alpha-1A adrenergic receptorBinding affinity to Alpha-1A adrenergic receptor
ChEMBL 526 7 0 5 4.6 COc1ccc(C[C@H](C)CN2C[C@@H](C(=O)N3CCN(c4ccc(F)c(F)c4)CC3)[C@H]3CCCC[C@H]3C2)cn1 10.1016/j.bmcl.2010.01.063
118733023 118511 0 None -2 3 Rat 8.1 pKd = 8.1 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 482 9 1 5 4.6 COc1ccccc1N1CCN(CCCNC(=O)c2cc3ccccc3n2Cc2ccccc2)CC1 10.1016/j.ejmech.2015.04.005
CHEMBL3415020 118511 0 None -2 3 Rat 8.1 pKd = 8.1 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 482 9 1 5 4.6 COc1ccccc1N1CCN(CCCNC(=O)c2cc3ccccc3n2Cc2ccccc2)CC1 10.1016/j.ejmech.2015.04.005
73438501 118503 0 None -1 3 Rat 8.1 pKd = 8.1 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 406 8 2 4 3.0 COc1ccccc1N1CCN(CCCNC(=O)Cc2c[nH]c3ccccc23)CC1 10.1016/j.ejmech.2015.04.005
CHEMBL3415012 118503 0 None -1 3 Rat 8.1 pKd = 8.1 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 406 8 2 4 3.0 COc1ccccc1N1CCN(CCCNC(=O)Cc2c[nH]c3ccccc23)CC1 10.1016/j.ejmech.2015.04.005
44294991 101496 0 None 2 2 Rat 8.1 pKd = 8.1 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 424 8 0 7 3.4 COc1ccccc1N1CCN(CCCOc2ccc3c(OC)cc(=O)oc3c2)CC1 10.1016/s0960-894x(02)00933-2
CHEMBL298108 101496 0 None 2 2 Rat 8.1 pKd = 8.1 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 424 8 0 7 3.4 COc1ccccc1N1CCN(CCCOc2ccc3c(OC)cc(=O)oc3c2)CC1 10.1016/s0960-894x(02)00933-2
73437676 118470 0 None -1 3 Rat 7.1 pKd = 7.1 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 422 8 2 5 3.1 COc1ccc2[nH]c(C(=O)NCCCN3CCN(c4ccccc4OC)CC3)cc2c1 10.1016/j.ejmech.2015.04.005
CHEMBL3414578 118470 0 None -1 3 Rat 7.1 pKd = 7.1 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 422 8 2 5 3.1 COc1ccc2[nH]c(C(=O)NCCCN3CCN(c4ccccc4OC)CC3)cc2c1 10.1016/j.ejmech.2015.04.005
14348818 109747 0 None 5 3 Rat 5.1 pKd = 5.1 Binding
The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.
ChEMBL 415 7 4 7 2.9 C/C(=N\OCC(O)CNC(C)(C)C)c1cc(Cl)c(NC2=NCCN2)c(Cl)c1 10.1021/jm00115a008
CHEMBL323176 109747 0 None 5 3 Rat 5.1 pKd = 5.1 Binding
The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.
ChEMBL 415 7 4 7 2.9 C/C(=N\OCC(O)CNC(C)(C)C)c1cc(Cl)c(NC2=NCCN2)c(Cl)c1 10.1021/jm00115a008
490 191 8 None -36 12 Rat 8.1 pKd = 8.1 Binding
In vitro functional activity at Alpha-1A adrenergic receptor in rat vas deferensIn vitro functional activity at Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 10.1016/s0960-894x(01)00159-7
9890547 191 8 None -36 12 Rat 8.1 pKd = 8.1 Binding
In vitro functional activity at Alpha-1A adrenergic receptor in rat vas deferensIn vitro functional activity at Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 10.1016/s0960-894x(01)00159-7
CHEMBL268758 191 8 None -36 12 Rat 8.1 pKd = 8.1 Binding
In vitro functional activity at Alpha-1A adrenergic receptor in rat vas deferensIn vitro functional activity at Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 10.1016/s0960-894x(01)00159-7
10550345 119168 0 None - 1 Rat 8.0 pKd = 8.0 Binding
Partial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic stripsPartial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic strips
ChEMBL 426 4 1 11 -0.3 COc1cc2nc(N3CCN(C(=O)c4no[n+]([O-])c4C#N)CC3)nc(N)c2cc1OC 10.1021/jm00025a012
CHEMBL343188 119168 0 None - 1 Rat 8.0 pKd = 8.0 Binding
Partial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic stripsPartial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic strips
ChEMBL 426 4 1 11 -0.3 COc1cc2nc(N3CCN(C(=O)c4no[n+]([O-])c4C#N)CC3)nc(N)c2cc1OC 10.1021/jm00025a012
71817549 102553 0 None -7 7 Rat 8.0 pKd = 8.0 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 356 7 2 6 2.5 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)NCC2 10.1021/jm400867d
CHEMBL3040803 102553 0 None -7 7 Rat 8.0 pKd = 8.0 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 356 7 2 6 2.5 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)NCC2 10.1021/jm400867d
CHEMBL3216590 102553 0 None -7 7 Rat 8.0 pKd = 8.0 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 356 7 2 6 2.5 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)NCC2 10.1021/jm400867d
10531157 37772 0 None 2290 3 Human 11.0 pKi = 11 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 572 8 2 8 3.3 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3[N+](=O)[O-])CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL145843 37772 0 None 2290 3 Human 11.0 pKi = 11 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 572 8 2 8 3.3 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3[N+](=O)[O-])CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
60820 4277 14 None 1 13 Human 10.7 pKi = 10.7 Binding
Binding affinity to adrenergic alpha1A receptorBinding affinity to adrenergic alpha1A receptor
ChEMBL 421 6 0 4 4.4 CC(C)Oc1ccccc1N1CCN(Cc2cccc(C(=O)N3CCCCC3)c2)CC1 10.1016/j.bmc.2008.02.091
CHEMBL10085 4277 14 None 1 13 Human 10.7 pKi = 10.7 Binding
Binding affinity to adrenergic alpha1A receptorBinding affinity to adrenergic alpha1A receptor
ChEMBL 421 6 0 4 4.4 CC(C)Oc1ccccc1N1CCN(Cc2cccc(C(=O)N3CCCCC3)c2)CC1 10.1016/j.bmc.2008.02.091
10745901 37434 0 None 1698 3 Human 10.7 pKi = 10.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 586 8 2 8 3.7 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3[N+](=O)[O-])C[C@@H]2C)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL145547 37434 0 None 1698 3 Human 10.7 pKi = 10.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 586 8 2 8 3.7 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3[N+](=O)[O-])C[C@@H]2C)C1c1ccc(F)c(F)c1 10.1021/jm990202+
129211 3722 78 None -1 16 Human 10.5 pKi = 10.5 Binding
Binding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligandBinding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
2562 3722 78 None -1 16 Human 10.5 pKi = 10.5 Binding
Binding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligandBinding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
488 3722 78 None -1 16 Human 10.5 pKi = 10.5 Binding
Binding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligandBinding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
CHEMBL836 3722 78 None -1 16 Human 10.5 pKi = 10.5 Binding
Binding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligandBinding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
DB00706 3722 78 None -1 16 Human 10.5 pKi = 10.5 Binding
Binding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligandBinding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
164089 110326 24 None -1 5 Bovine 10.5 pKi = 10.5 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 395 5 1 7 3.4 COc1cc2c(cc1OC)CN(c1cc(N)c3cc(OC)c(OC)cc3n1)CC2 10.1021/jm00018a001
CHEMBL324090 110326 24 None -1 5 Bovine 10.5 pKi = 10.5 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 395 5 1 7 3.4 COc1cc2c(cc1OC)CN(c1cc(N)c3cc(OC)c(OC)cc3n1)CC2 10.1021/jm00018a001
129211 3722 78 None -2 16 Rat 10.5 pKi = 10.5 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm990567u
2562 3722 78 None -2 16 Rat 10.5 pKi = 10.5 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm990567u
488 3722 78 None -2 16 Rat 10.5 pKi = 10.5 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm990567u
CHEMBL836 3722 78 None -2 16 Rat 10.5 pKi = 10.5 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm990567u
DB00706 3722 78 None -2 16 Rat 10.5 pKi = 10.5 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm990567u
4151 3580 89 None 33 3 Human 10.4 pKi = 10.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1016/j.bmcl.2004.11.032
493 3580 89 None 33 3 Human 10.4 pKi = 10.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1016/j.bmcl.2004.11.032
5312125 3580 89 None 33 3 Human 10.4 pKi = 10.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1016/j.bmcl.2004.11.032
CHEMBL24778 3580 89 None 33 3 Human 10.4 pKi = 10.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1016/j.bmcl.2004.11.032
DB06207 3580 89 None 33 3 Human 10.4 pKi = 10.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1016/j.bmcl.2004.11.032
4151 3580 89 None 33 3 Human 10.4 pKi = 10.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/jm960697s
493 3580 89 None 33 3 Human 10.4 pKi = 10.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/jm960697s
5312125 3580 89 None 33 3 Human 10.4 pKi = 10.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/jm960697s
CHEMBL24778 3580 89 None 33 3 Human 10.4 pKi = 10.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/jm960697s
DB06207 3580 89 None 33 3 Human 10.4 pKi = 10.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/jm960697s
44298611 100625 0 None 125 3 Human 10.4 pKi = 10.4 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 440 7 1 6 2.3 Cc1[nH]c(=O)n(CCCN2CCN(c3ccccc3OCC(F)(F)F)CC2)c(=O)c1C 10.1016/s0960-894x(03)00305-6
CHEMBL292189 100625 0 None 125 3 Human 10.4 pKi = 10.4 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 440 7 1 6 2.3 Cc1[nH]c(=O)n(CCCN2CCN(c3ccccc3OCC(F)(F)F)CC2)c(=O)c1C 10.1016/s0960-894x(03)00305-6
164089 110326 24 None -1 5 Human 10.4 pKi = 10.4 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 395 5 1 7 3.4 COc1cc2c(cc1OC)CN(c1cc(N)c3cc(OC)c(OC)cc3n1)CC2 10.1021/jm00018a001
CHEMBL324090 110326 24 None -1 5 Human 10.4 pKi = 10.4 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 395 5 1 7 3.4 COc1cc2c(cc1OC)CN(c1cc(N)c3cc(OC)c(OC)cc3n1)CC2 10.1021/jm00018a001
10789770 100858 0 None 1 5 Rat 10.4 pKi = 10.4 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 451 6 1 7 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(OC)c(OC)ccc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL293695 100858 0 None 1 5 Rat 10.4 pKi = 10.4 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 451 6 1 7 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(OC)c(OC)ccc4c3=O)C[C@@H]21 10.1021/jm000541z
10622402 202737 0 None 6 3 Rat 10.4 pKi = 10.4 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 427 5 1 7 2.4 COc1cc2[nH]c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2s1 10.1021/jm000541z
CHEMBL62028 202737 0 None 6 3 Rat 10.4 pKi = 10.4 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 427 5 1 7 2.4 COc1cc2[nH]c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2s1 10.1021/jm000541z
4209 3141 75 None -3 34 Human 10.4 pKi = 10.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.ejmech.2014.12.045
4893 3141 75 None -3 34 Human 10.4 pKi = 10.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.ejmech.2014.12.045
503 3141 75 None -3 34 Human 10.4 pKi = 10.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.ejmech.2014.12.045
5385 3141 75 None -3 34 Human 10.4 pKi = 10.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.ejmech.2014.12.045
CHEMBL2 3141 75 None -3 34 Human 10.4 pKi = 10.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.ejmech.2014.12.045
DB00457 3141 75 None -3 34 Human 10.4 pKi = 10.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.ejmech.2014.12.045
4209 3141 75 None -3 34 Human 10.4 pKi = 10.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm401895u
4893 3141 75 None -3 34 Human 10.4 pKi = 10.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm401895u
503 3141 75 None -3 34 Human 10.4 pKi = 10.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm401895u
5385 3141 75 None -3 34 Human 10.4 pKi = 10.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm401895u
CHEMBL2 3141 75 None -3 34 Human 10.4 pKi = 10.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm401895u
DB00457 3141 75 None -3 34 Human 10.4 pKi = 10.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm401895u
76333279 84787 0 None - 1 Human 10.3 pKi = 10.3 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 405 8 1 5 4.6 COc1cccc(OC)c1OCCN[C@H]1C[C@@H](c2ccccc2)c2ccccc2O1 10.1007/s00044-010-9379-1
CHEMBL2234441 84787 0 None - 1 Human 10.3 pKi = 10.3 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 405 8 1 5 4.6 COc1cccc(OC)c1OCCN[C@H]1C[C@@H](c2ccccc2)c2ccccc2O1 10.1007/s00044-010-9379-1
10698570 118732 0 None 257 3 Human 10.3 pKi = 10.3 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 586 8 2 8 3.7 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3[N+](=O)[O-])C[C@H]2C)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL341849 118732 0 None 257 3 Human 10.3 pKi = 10.3 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 586 8 2 8 3.7 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3[N+](=O)[O-])C[C@H]2C)C1c1ccc(F)c(F)c1 10.1021/jm990202+
11742834 165746 0 None -1 7 Human 10.3 pKi = 10.3 Binding
Affinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptorAffinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptor
ChEMBL 419 9 1 5 4.7 COc1cccc(OC)c1OCCNC[C@@H]1C[C@H](c2ccccc2)c2ccccc2O1 10.1021/jm011066n
CHEMBL42472 165746 0 None -1 7 Human 10.3 pKi = 10.3 Binding
Affinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptorAffinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptor
ChEMBL 419 9 1 5 4.7 COc1cccc(OC)c1OCCNC[C@@H]1C[C@H](c2ccccc2)c2ccccc2O1 10.1021/jm011066n
76333279 84787 0 None - 1 Human 10.3 pKi = 10.3 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 405 8 1 5 4.6 COc1cccc(OC)c1OCCN[C@H]1C[C@@H](c2ccccc2)c2ccccc2O1 10.1007/s00044-010-9379-1
CHEMBL2234441 84787 0 None - 1 Human 10.3 pKi = 10.3 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 405 8 1 5 4.6 COc1cccc(OC)c1OCCN[C@H]1C[C@@H](c2ccccc2)c2ccccc2O1 10.1007/s00044-010-9379-1
129211 3722 78 None -1 16 Human 10.3 pKi = 10.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.ejmech.2010.09.042
2562 3722 78 None -1 16 Human 10.3 pKi = 10.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.ejmech.2010.09.042
488 3722 78 None -1 16 Human 10.3 pKi = 10.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.ejmech.2010.09.042
CHEMBL836 3722 78 None -1 16 Human 10.3 pKi = 10.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.ejmech.2010.09.042
DB00706 3722 78 None -1 16 Human 10.3 pKi = 10.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.ejmech.2010.09.042
19085858 104125 0 None 173 3 Human 10.2 pKi = 10.2 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in CHO cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in CHO cells
ChEMBL 501 7 0 8 3.6 CSc1ccc2c(c1)C(=O)N(CCCCN1CCC(n3c(=O)oc4ccccc43)CC1)S2(=O)=O 10.1016/s0960-894x(98)00446-6
CHEMBL309518 104125 0 None 173 3 Human 10.2 pKi = 10.2 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in CHO cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in CHO cells
ChEMBL 501 7 0 8 3.6 CSc1ccc2c(c1)C(=O)N(CCCCN1CCC(n3c(=O)oc4ccccc43)CC1)S2(=O)=O 10.1016/s0960-894x(98)00446-6
10817365 36683 0 None 501 3 Human 10.2 pKi = 10.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 599 9 2 7 3.9 COCC1=C(C(=O)OC)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3)CC2)C(=O)N1 10.1021/jm990201h
CHEMBL144933 36683 0 None 501 3 Human 10.2 pKi = 10.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 599 9 2 7 3.9 COCC1=C(C(=O)OC)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3)CC2)C(=O)N1 10.1021/jm990201h
10651636 37831 0 None 1318 3 Human 10.2 pKi = 10.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 630 8 2 5 6.3 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(c3ccc(C)cc3)(c3ccccc3C)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL145894 37831 0 None 1318 3 Human 10.2 pKi = 10.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 630 8 2 5 6.3 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(c3ccc(C)cc3)(c3ccccc3C)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
44298664 197263 0 None 31 3 Human 10.2 pKi = 10.2 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 462 7 1 6 2.8 O=c1[nH]c2ccccc2c(=O)n1CCCN1CCN(c2ccccc2OCC(F)(F)F)CC1 10.1016/s0960-894x(03)00305-6
CHEMBL56863 197263 0 None 31 3 Human 10.2 pKi = 10.2 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 462 7 1 6 2.8 O=c1[nH]c2ccccc2c(=O)n1CCCN1CCN(c2ccccc2OCC(F)(F)F)CC1 10.1016/s0960-894x(03)00305-6
19085914 205802 0 None 234 3 Human 10.2 pKi = 10.2 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 485 7 0 8 2.9 COc1ccc2c(c1)C(=O)N(CCCCN1CCC(n3c(=O)oc4ccccc43)CC1)S2(=O)=O 10.1016/s0960-894x(98)00446-6
CHEMBL83340 205802 0 None 234 3 Human 10.2 pKi = 10.2 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 485 7 0 8 2.9 COc1ccc2c(c1)C(=O)N(CCCCN1CCC(n3c(=O)oc4ccccc43)CC1)S2(=O)=O 10.1016/s0960-894x(98)00446-6
49781233 17893 0 None 5 3 Bovine 10.2 pKi = 10.2 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 392 2 0 7 2.9 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4nnnn4C)cc32)CC1 10.1021/jm100652h
CHEMBL1259217 17893 0 None 5 3 Bovine 10.2 pKi = 10.2 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 392 2 0 7 2.9 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4nnnn4C)cc32)CC1 10.1021/jm100652h
44324405 206738 0 None 117 3 Human 10.2 pKi = 10.2 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 511 7 2 4 3.9 CN1C=C(C(=O)NCCCN2CCC(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)NC1=O 10.1021/jm990612y
CHEMBL90086 206738 0 None 117 3 Human 10.2 pKi = 10.2 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 511 7 2 4 3.9 CN1C=C(C(=O)NCCCN2CCC(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)NC1=O 10.1021/jm990612y
10767606 207428 0 None 371 3 Human 10.2 pKi = 10.2 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 497 7 3 4 3.6 N#Cc1cc(F)ccc1C1CCN(CCCNC(=O)C2=CNC(=O)N[C@@H]2c2ccc(F)c(F)c2)CC1 10.1016/j.ejmech.2017.03.025
CHEMBL94188 207428 0 None 371 3 Human 10.2 pKi = 10.2 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 497 7 3 4 3.6 N#Cc1cc(F)ccc1C1CCN(CCCNC(=O)C2=CNC(=O)N[C@@H]2c2ccc(F)c(F)c2)CC1 10.1016/j.ejmech.2017.03.025
10767606 207428 0 None 371 3 Human 10.2 pKi = 10.2 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 497 7 3 4 3.6 N#Cc1cc(F)ccc1C1CCN(CCCNC(=O)C2=CNC(=O)N[C@@H]2c2ccc(F)c(F)c2)CC1 10.1021/jm990612y
CHEMBL94188 207428 0 None 371 3 Human 10.2 pKi = 10.2 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 497 7 3 4 3.6 N#Cc1cc(F)ccc1C1CCN(CCCNC(=O)C2=CNC(=O)N[C@@H]2c2ccc(F)c(F)c2)CC1 10.1021/jm990612y
4209 3141 75 None -3 34 Rat 10.2 pKi = 10.2 Binding
Inhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary glandInhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm990277d
4893 3141 75 None -3 34 Rat 10.2 pKi = 10.2 Binding
Inhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary glandInhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm990277d
503 3141 75 None -3 34 Rat 10.2 pKi = 10.2 Binding
Inhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary glandInhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm990277d
5385 3141 75 None -3 34 Rat 10.2 pKi = 10.2 Binding
Inhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary glandInhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm990277d
CHEMBL2 3141 75 None -3 34 Rat 10.2 pKi = 10.2 Binding
Inhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary glandInhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm990277d
DB00457 3141 75 None -3 34 Rat 10.2 pKi = 10.2 Binding
Inhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary glandInhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm990277d
9913449 106425 1 None 13 3 Human 10.1 pKi = 10.1 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 489 6 0 7 3.5 O=C1c2cc(Cl)ccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
CHEMBL313990 106425 1 None 13 3 Human 10.1 pKi = 10.1 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 489 6 0 7 3.5 O=C1c2cc(Cl)ccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
10526964 206942 0 None 1 3 Bovine 10.1 pKi = 10.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 437 10 1 6 3.2 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2OCC2CC2)CC1 10.1021/jm970166j
CHEMBL91278 206942 0 None 1 3 Bovine 10.1 pKi = 10.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 437 10 1 6 3.2 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2OCC2CC2)CC1 10.1021/jm970166j
76315111 84789 0 None - 1 Human 10.1 pKi = 10.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 421 8 1 5 5.3 COc1cccc(OC)c1OCCN[C@H]1C[C@@H](c2ccccc2)c2ccccc2S1 10.1007/s00044-010-9379-1
CHEMBL2234443 84789 0 None - 1 Human 10.1 pKi = 10.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 421 8 1 5 5.3 COc1cccc(OC)c1OCCN[C@H]1C[C@@H](c2ccccc2)c2ccccc2S1 10.1007/s00044-010-9379-1
10699164 36998 0 None 151 3 Human 10.1 pKi = 10.1 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 552 7 2 7 3.3 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C#N)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL145190 36998 0 None 151 3 Human 10.1 pKi = 10.1 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 552 7 2 7 3.3 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C#N)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
499 4046 18 None -1 15 Rat 10.1 pKi = 10.1 Binding
Overall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary glandOverall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm00018a001
5685 4046 18 None -1 15 Rat 10.1 pKi = 10.1 Binding
Overall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary glandOverall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm00018a001
CHEMBL25554 4046 18 None -1 15 Rat 10.1 pKi = 10.1 Binding
Overall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary glandOverall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm00018a001
52942381 17860 0 None -2 4 Bovine 10.1 pKi = 10.1 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 339 2 1 4 3.1 CN1CCN(C2Cc3ccccc3Sc3ccc(CN)cc32)CC1 10.1021/jm100652h
CHEMBL1259113 17860 0 None -2 4 Bovine 10.1 pKi = 10.1 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 339 2 1 4 3.1 CN1CCN(C2Cc3ccccc3Sc3ccc(CN)cc32)CC1 10.1021/jm100652h
19085876 205791 0 None 87 3 Human 10.1 pKi = 10.1 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 473 6 0 7 3.0 O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3cc(F)ccc32)CC1 10.1016/s0960-894x(98)00446-6
CHEMBL83272 205791 0 None 87 3 Human 10.1 pKi = 10.1 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 473 6 0 7 3.0 O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3cc(F)ccc32)CC1 10.1016/s0960-894x(98)00446-6
49781447 17812 0 None 3 4 Bovine 10.1 pKi = 10.1 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 391 2 0 6 3.5 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4ncn(C)n4)cc32)CC1 10.1021/jm100652h
CHEMBL1258988 17812 0 None 3 4 Bovine 10.1 pKi = 10.1 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 391 2 0 6 3.5 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4ncn(C)n4)cc32)CC1 10.1021/jm100652h
4209 3141 75 None -3 34 Rat 10.1 pKi = 10.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
4893 3141 75 None -3 34 Rat 10.1 pKi = 10.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
503 3141 75 None -3 34 Rat 10.1 pKi = 10.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
5385 3141 75 None -3 34 Rat 10.1 pKi = 10.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
CHEMBL2 3141 75 None -3 34 Rat 10.1 pKi = 10.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
DB00457 3141 75 None -3 34 Rat 10.1 pKi = 10.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
49781892 17869 0 None -1 4 Bovine 10.1 pKi = 10.1 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 381 3 1 4 3.3 CC(=O)NCc1ccc2c(c1)C(N1CCN(C)CC1)Cc1ccccc1S2 10.1021/jm100652h
CHEMBL1259144 17869 0 None -1 4 Bovine 10.1 pKi = 10.1 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 381 3 1 4 3.3 CC(=O)NCc1ccc2c(c1)C(N1CCN(C)CC1)Cc1ccccc1S2 10.1021/jm100652h
44289248 168952 0 None 4 7 Human 10.1 pKi = 10.1 Binding
Affinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptorAffinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptor
ChEMBL 435 9 1 5 5.4 COc1cccc(OC)c1OCCNCC1CC(c2ccccc2)c2ccccc2S1 10.1021/jm011066n
CHEMBL43905 168952 0 None 4 7 Human 10.1 pKi = 10.1 Binding
Affinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptorAffinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptor
ChEMBL 435 9 1 5 5.4 COc1cccc(OC)c1OCCNCC1CC(c2ccccc2)c2ccccc2S1 10.1021/jm011066n
76315111 84789 0 None - 1 Human 10.1 pKi = 10.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 421 8 1 5 5.3 COc1cccc(OC)c1OCCN[C@H]1C[C@@H](c2ccccc2)c2ccccc2S1 10.1007/s00044-010-9379-1
CHEMBL2234443 84789 0 None - 1 Human 10.1 pKi = 10.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 421 8 1 5 5.3 COc1cccc(OC)c1OCCN[C@H]1C[C@@H](c2ccccc2)c2ccccc2S1 10.1007/s00044-010-9379-1
10716965 167936 0 None 10 3 Rat 10.1 pKi = 10.1 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 419 4 1 5 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(C)c(C)ccc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL431720 167936 0 None 10 3 Rat 10.1 pKi = 10.1 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 419 4 1 5 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(C)c(C)ccc4c3=O)C[C@@H]21 10.1021/jm000541z
10812130 199158 0 None 2 3 Rat 10.1 pKi = 10.1 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 421 5 1 6 2.4 COc1ccc2c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)[nH]c2c1 10.1021/jm000541z
CHEMBL58956 199158 0 None 2 3 Rat 10.1 pKi = 10.1 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 421 5 1 6 2.4 COc1ccc2c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)[nH]c2c1 10.1021/jm000541z
10693231 202739 0 None -2 5 Rat 10.1 pKi = 10.1 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 416 4 1 6 2.2 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cc(C#N)ccc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL62033 202739 0 None -2 5 Rat 10.1 pKi = 10.1 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 416 4 1 6 2.2 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cc(C#N)ccc4c3=O)C[C@@H]21 10.1021/jm000541z
11039289 116814 0 None 12 5 Human 10.0 pKi = 10.0 Binding
Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)
ChEMBL 600 13 1 9 4.7 Cc1c(-c2ccccc2)oc2c(C(=O)NCCCN3CCN(c4ccccc4OCCCO[N+](=O)[O-])CC3)cccc2c1=O 10.1021/jm030825u
CHEMBL338029 116814 0 None 12 5 Human 10.0 pKi = 10.0 Binding
Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)
ChEMBL 600 13 1 9 4.7 Cc1c(-c2ccccc2)oc2c(C(=O)NCCCN3CCN(c4ccccc4OCCCO[N+](=O)[O-])CC3)cccc2c1=O 10.1021/jm030825u
34580 17859 2 None -1 4 Bovine 10.0 pKi = 10.0 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 335 1 0 4 3.6 CN1CCN(C2Cc3ccccc3Sc3ccc(C#N)cc32)CC1 10.1021/jm100652h
CHEMBL1259112 17859 2 None -1 4 Bovine 10.0 pKi = 10.0 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 335 1 0 4 3.6 CN1CCN(C2Cc3ccccc3Sc3ccc(C#N)cc32)CC1 10.1021/jm100652h
19085926 205520 0 None 199 3 Human 10.0 pKi = 10 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 469 6 0 7 3.2 Cc1ccc2c(c1)C(=O)N(CCCCN1CCC(n3c(=O)oc4ccccc43)CC1)S2(=O)=O 10.1016/s0960-894x(98)00446-6
CHEMBL81006 205520 0 None 199 3 Human 10.0 pKi = 10 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 469 6 0 7 3.2 Cc1ccc2c(c1)C(=O)N(CCCCN1CCC(n3c(=O)oc4ccccc43)CC1)S2(=O)=O 10.1016/s0960-894x(98)00446-6
9959671 32641 0 None 363 3 Human 10.0 pKi = 10 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 567 10 0 7 5.6 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL141322 32641 0 None 363 3 Human 10.0 pKi = 10 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 567 10 0 7 5.6 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
10721751 34600 0 None 1412 3 Human 10.0 pKi = 10 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 569 10 1 6 4.9 COC(=O)C1=C(C)NC(=O)N(CCCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL142981 34600 0 None 1412 3 Human 10.0 pKi = 10 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 569 10 1 6 4.9 COC(=O)C1=C(C)NC(=O)N(CCCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
10031709 37281 0 None 2511 3 Human 10.0 pKi = 10 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 613 10 0 5 8.1 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(c3ccc(C)cc3)(c3ccccc3C)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL145411 37281 0 None 2511 3 Human 10.0 pKi = 10 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 613 10 0 5 8.1 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(c3ccc(C)cc3)(c3ccccc3C)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
10651219 33708 0 None 1000 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 600 10 3 8 2.1 COCC1=C(C(=O)OC)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C(=O)N1 10.1021/jm990202+
CHEMBL142236 33708 0 None 1000 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 600 10 3 8 2.1 COCC1=C(C(=O)OC)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C(=O)N1 10.1021/jm990202+
10650726 33728 0 None 87 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 571 9 2 7 3.8 CCOc1ccccc1N1CCN(CCCNC(=O)N2C(=O)NC(C)=C(C(=O)OC)C2c2ccc(F)c(F)c2)CC1 10.1021/jm990202+
CHEMBL142251 33728 0 None 87 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 571 9 2 7 3.8 CCOc1ccccc1N1CCN(CCCNC(=O)N2C(=O)NC(C)=C(C(=O)OC)C2c2ccc(F)c(F)c2)CC1 10.1021/jm990202+
10531476 34315 0 None 269 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 590 8 2 10 3.0 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc2nonc2c1 10.1021/jm990200p
CHEMBL142743 34315 0 None 269 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 590 8 2 10 3.0 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc2nonc2c1 10.1021/jm990200p
10747201 36852 0 None 1288 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 618 10 3 8 2.3 COCC1=C(C(=O)OC)C(c2cc(F)c(F)cc2F)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C(=O)N1 10.1021/jm990202+
CHEMBL145072 36852 0 None 1288 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 618 10 3 8 2.3 COCC1=C(C(=O)OC)C(c2cc(F)c(F)cc2F)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C(=O)N1 10.1021/jm990202+
10699164 36998 0 None 151 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 552 7 2 7 3.3 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C#N)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL145190 36998 0 None 151 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 552 7 2 7 3.3 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C#N)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
10745380 38761 0 None 177 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 557 8 2 7 3.4 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3OC)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL146654 38761 0 None 177 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 557 8 2 7 3.4 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3OC)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
10438280 101571 0 None 446 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 584 8 2 7 3.8 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990200p
CHEMBL298713 101571 0 None 446 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 584 8 2 7 3.8 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990200p
11802456 170936 0 None 316 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 584 9 3 7 2.9 CCC1=C(C(=O)OC)C(c2ccc(F)cc2F)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C(=O)N1 10.1021/jm990202+
CHEMBL445577 170936 0 None 316 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 584 9 3 7 2.9 CCC1=C(C(=O)OC)C(c2ccc(F)cc2F)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C(=O)N1 10.1021/jm990202+
10627090 34531 0 None 1288 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 581 9 2 7 3.8 COCC1=C(C(=O)OC)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C#N)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990201h
CHEMBL142929 34531 0 None 1288 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 581 9 2 7 3.8 COCC1=C(C(=O)OC)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C#N)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990201h
10721751 34600 0 None 1412 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 569 10 1 6 4.9 COC(=O)C1=C(C)NC(=O)N(CCCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL142981 34600 0 None 1412 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 569 10 1 6 4.9 COC(=O)C1=C(C)NC(=O)N(CCCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
10438280 101571 0 None 446 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 584 8 2 7 3.8 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL298713 101571 0 None 446 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 584 8 2 7 3.8 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
10578715 102648 0 None 144 3 Human 10.0 pKi = 10.0 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 556 10 1 7 4.2 COc1ccc(N2C(=O)c3ccc(C(=O)NCCCN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc1 10.1021/jm9905918
CHEMBL304591 102648 0 None 144 3 Human 10.0 pKi = 10.0 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 556 10 1 7 4.2 COc1ccc(N2C(=O)c3ccc(C(=O)NCCCN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc1 10.1021/jm9905918
10815593 207016 0 None 436 3 Human 9.9 pKi = 9.9 Binding
Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 511 7 2 4 3.7 CN1C=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)NC1=O 10.1021/jm990612y
CHEMBL91616 207016 0 None 436 3 Human 9.9 pKi = 9.9 Binding
Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 511 7 2 4 3.7 CN1C=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)NC1=O 10.1021/jm990612y
19085866 105390 0 None 117 3 Human 9.9 pKi = 9.9 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 455 6 0 7 2.9 O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
CHEMBL311890 105390 0 None 117 3 Human 9.9 pKi = 9.9 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 455 6 0 7 2.9 O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
49781893 17870 0 None 1 4 Bovine 9.9 pKi = 9.9 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 409 4 1 4 4.0 CC(C)C(=O)NCc1ccc2c(c1)C(N1CCN(C)CC1)Cc1ccccc1S2 10.1021/jm100652h
CHEMBL1259145 17870 0 None 1 4 Bovine 9.9 pKi = 9.9 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 409 4 1 4 4.0 CC(C)C(=O)NCc1ccc2c(c1)C(N1CCN(C)CC1)Cc1ccccc1S2 10.1021/jm100652h
10673657 206710 0 None 1071 3 Human 9.9 pKi = 9.9 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 525 7 2 4 4.3 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1C 10.1021/jm990612y
CHEMBL89927 206710 0 None 1071 3 Human 9.9 pKi = 9.9 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 525 7 2 4 4.3 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1C 10.1021/jm990612y
9985476 37254 0 None 912 3 Human 9.9 pKi = 9.9 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 570 8 3 7 2.5 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL145394 37254 0 None 912 3 Human 9.9 pKi = 9.9 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 570 8 3 7 2.5 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
4209 3141 75 None -4 34 Bovine 9.9 pKi = 9.9 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm970166j
4893 3141 75 None -4 34 Bovine 9.9 pKi = 9.9 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm970166j
503 3141 75 None -4 34 Bovine 9.9 pKi = 9.9 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm970166j
5385 3141 75 None -4 34 Bovine 9.9 pKi = 9.9 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm970166j
CHEMBL2 3141 75 None -4 34 Bovine 9.9 pKi = 9.9 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm970166j
DB00457 3141 75 None -4 34 Bovine 9.9 pKi = 9.9 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm970166j
129211 3722 78 None -7 16 Bovine 9.9 pKi = 9.9 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970166j
2562 3722 78 None -7 16 Bovine 9.9 pKi = 9.9 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970166j
488 3722 78 None -7 16 Bovine 9.9 pKi = 9.9 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970166j
CHEMBL836 3722 78 None -7 16 Bovine 9.9 pKi = 9.9 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970166j
DB00706 3722 78 None -7 16 Bovine 9.9 pKi = 9.9 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970166j
10499343 206502 0 None 79 2 Bovine 9.9 pKi = 9.9 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 369 8 2 6 1.8 COc1ccccc1N1CCN(CCCNc2ncccc2C(N)=O)CC1 10.1021/jm970166j
CHEMBL88512 206502 0 None 79 2 Bovine 9.9 pKi = 9.9 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 369 8 2 6 1.8 COc1ccccc1N1CCN(CCCNc2ncccc2C(N)=O)CC1 10.1021/jm970166j
19085820 205781 0 None 1023 3 Human 9.9 pKi = 9.9 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 500 7 0 9 2.8 O=C1c2cc([N+](=O)[O-])ccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
CHEMBL83226 205781 0 None 1023 3 Human 9.9 pKi = 9.9 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 500 7 0 9 2.8 O=C1c2cc([N+](=O)[O-])ccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
129211 3722 78 None -1 16 Human 9.9 pKi = 9.9 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm9905918
2562 3722 78 None -1 16 Human 9.9 pKi = 9.9 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm9905918
488 3722 78 None -1 16 Human 9.9 pKi = 9.9 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm9905918
CHEMBL836 3722 78 None -1 16 Human 9.9 pKi = 9.9 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm9905918
DB00706 3722 78 None -1 16 Human 9.9 pKi = 9.9 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm9905918
10576661 206835 0 None 1230 3 Human 9.9 pKi = 9.9 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 479 7 3 4 3.5 N#Cc1ccccc1C1CCN(CCCNC(=O)C2=CNC(=O)N[C@@H]2c2ccc(F)c(F)c2)CC1 10.1016/j.ejmech.2017.03.025
CHEMBL90652 206835 0 None 1230 3 Human 9.9 pKi = 9.9 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 479 7 3 4 3.5 N#Cc1ccccc1C1CCN(CCCNC(=O)C2=CNC(=O)N[C@@H]2c2ccc(F)c(F)c2)CC1 10.1016/j.ejmech.2017.03.025
129211 3722 78 None -2 16 Rat 9.9 pKi = 9.9 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counterDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counter
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.ejmech.2011.04.032
2562 3722 78 None -2 16 Rat 9.9 pKi = 9.9 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counterDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counter
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.ejmech.2011.04.032
488 3722 78 None -2 16 Rat 9.9 pKi = 9.9 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counterDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counter
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.ejmech.2011.04.032
CHEMBL836 3722 78 None -2 16 Rat 9.9 pKi = 9.9 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counterDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counter
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.ejmech.2011.04.032
DB00706 3722 78 None -2 16 Rat 9.9 pKi = 9.9 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counterDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counter
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.ejmech.2011.04.032
10576661 206835 0 None 1230 3 Human 9.9 pKi = 9.9 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 479 7 3 4 3.5 N#Cc1ccccc1C1CCN(CCCNC(=O)C2=CNC(=O)N[C@@H]2c2ccc(F)c(F)c2)CC1 10.1021/jm990612y
CHEMBL90652 206835 0 None 1230 3 Human 9.9 pKi = 9.9 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 479 7 3 4 3.5 N#Cc1ccccc1C1CCN(CCCNC(=O)C2=CNC(=O)N[C@@H]2c2ccc(F)c(F)c2)CC1 10.1021/jm990612y
10649481 206795 0 None 123 3 Human 9.9 pKi = 9.9 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 514 7 1 3 4.8 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)N(C)C(=O)N1C 10.1016/j.ejmech.2017.03.025
CHEMBL90420 206795 0 None 123 3 Human 9.9 pKi = 9.9 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 514 7 1 3 4.8 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)N(C)C(=O)N1C 10.1016/j.ejmech.2017.03.025
11638677 84560 0 None -5 6 Rat 9.9 pKi = 9.9 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counterDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counter
ChEMBL 340 5 0 5 2.8 COc1ccccc1N1CCN(CCc2ccc3c(c2)OCO3)CC1 10.1016/j.ejmech.2011.04.032
CHEMBL2153423 84560 0 None -5 6 Rat 9.9 pKi = 9.9 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counterDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counter
ChEMBL 340 5 0 5 2.8 COc1ccccc1N1CCN(CCc2ccc3c(c2)OCO3)CC1 10.1016/j.ejmech.2011.04.032
CHEMBL2220978 84560 0 None -5 6 Rat 9.9 pKi = 9.9 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counterDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counter
ChEMBL 340 5 0 5 2.8 COc1ccccc1N1CCN(CCc2ccc3c(c2)OCO3)CC1 10.1016/j.ejmech.2011.04.032
10840194 111801 0 None 245 3 Human 9.9 pKi = 9.9 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 541 9 3 5 3.6 COCC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1021/jm990612y
CHEMBL328763 111801 0 None 245 3 Human 9.9 pKi = 9.9 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 541 9 3 5 3.6 COCC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1021/jm990612y
10815240 206829 0 None 33 3 Human 9.9 pKi = 9.9 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 500 7 2 3 4.5 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)N(C)C(=O)N1 10.1021/jm990612y
CHEMBL90606 206829 0 None 33 3 Human 9.9 pKi = 9.9 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 500 7 2 3 4.5 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)N(C)C(=O)N1 10.1021/jm990612y
4209 3141 75 None -3 34 Human 9.8 pKi = 9.8 Binding
Displacement of [3H]prazosin from alpha1-adrenoceptor (unknown origin) in cerebral cortex membranes after 60 mins by TopCount scintillation counting methodDisplacement of [3H]prazosin from alpha1-adrenoceptor (unknown origin) in cerebral cortex membranes after 60 mins by TopCount scintillation counting method
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.ejmech.2017.12.063
4893 3141 75 None -3 34 Human 9.8 pKi = 9.8 Binding
Displacement of [3H]prazosin from alpha1-adrenoceptor (unknown origin) in cerebral cortex membranes after 60 mins by TopCount scintillation counting methodDisplacement of [3H]prazosin from alpha1-adrenoceptor (unknown origin) in cerebral cortex membranes after 60 mins by TopCount scintillation counting method
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.ejmech.2017.12.063
503 3141 75 None -3 34 Human 9.8 pKi = 9.8 Binding
Displacement of [3H]prazosin from alpha1-adrenoceptor (unknown origin) in cerebral cortex membranes after 60 mins by TopCount scintillation counting methodDisplacement of [3H]prazosin from alpha1-adrenoceptor (unknown origin) in cerebral cortex membranes after 60 mins by TopCount scintillation counting method
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.ejmech.2017.12.063
5385 3141 75 None -3 34 Human 9.8 pKi = 9.8 Binding
Displacement of [3H]prazosin from alpha1-adrenoceptor (unknown origin) in cerebral cortex membranes after 60 mins by TopCount scintillation counting methodDisplacement of [3H]prazosin from alpha1-adrenoceptor (unknown origin) in cerebral cortex membranes after 60 mins by TopCount scintillation counting method
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.ejmech.2017.12.063
CHEMBL2 3141 75 None -3 34 Human 9.8 pKi = 9.8 Binding
Displacement of [3H]prazosin from alpha1-adrenoceptor (unknown origin) in cerebral cortex membranes after 60 mins by TopCount scintillation counting methodDisplacement of [3H]prazosin from alpha1-adrenoceptor (unknown origin) in cerebral cortex membranes after 60 mins by TopCount scintillation counting method
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.ejmech.2017.12.063
DB00457 3141 75 None -3 34 Human 9.8 pKi = 9.8 Binding
Displacement of [3H]prazosin from alpha1-adrenoceptor (unknown origin) in cerebral cortex membranes after 60 mins by TopCount scintillation counting methodDisplacement of [3H]prazosin from alpha1-adrenoceptor (unknown origin) in cerebral cortex membranes after 60 mins by TopCount scintillation counting method
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.ejmech.2017.12.063
463 1393 22 None 5 13 Human 9.8 pKi = 9.8 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm960697s
6918097 1393 22 None 5 13 Human 9.8 pKi = 9.8 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm960697s
837 1393 22 None 5 13 Human 9.8 pKi = 9.8 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm960697s
CHEMBL2051956 1393 22 None 5 13 Human 9.8 pKi = 9.8 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm960697s
DB14068 1393 22 None 5 13 Human 9.8 pKi = 9.8 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm960697s
499 4046 18 None 1 15 Human 9.8 pKi = 9.8 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm960697s
5685 4046 18 None 1 15 Human 9.8 pKi = 9.8 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm960697s
CHEMBL25554 4046 18 None 1 15 Human 9.8 pKi = 9.8 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm960697s
44298624 195684 0 None 63 2 Human 9.8 pKi = 9.8 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 458 8 1 6 2.5 Cc1c[nH]c(=O)n(CCCCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)c1=O 10.1016/s0960-894x(03)00305-6
CHEMBL55695 195684 0 None 63 2 Human 9.8 pKi = 9.8 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 458 8 1 6 2.5 Cc1c[nH]c(=O)n(CCCCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)c1=O 10.1016/s0960-894x(03)00305-6
487 3607 21 None -1 12 Human 9.8 pKi = 9.8 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00010a001
60602 3607 21 None -1 12 Human 9.8 pKi = 9.8 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00010a001
CHEMBL405355 3607 21 None -1 12 Human 9.8 pKi = 9.8 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00010a001
DB09239 3607 21 None -1 12 Human 9.8 pKi = 9.8 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00010a001
19085881 205745 0 None 478 3 Human 9.8 pKi = 9.8 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in CHO cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in CHO cells
ChEMBL 500 7 0 9 2.8 O=C1c2ccc([N+](=O)[O-])cc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
CHEMBL82877 205745 0 None 478 3 Human 9.8 pKi = 9.8 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in CHO cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in CHO cells
ChEMBL 500 7 0 9 2.8 O=C1c2ccc([N+](=O)[O-])cc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
10530491 102578 0 None 234 2 Human 9.8 pKi = 9.8 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 540 9 1 6 4.5 Cc1ccc(N2C(=O)c3ccc(C(=O)NCCCN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc1 10.1021/jm9905918
CHEMBL304132 102578 0 None 234 2 Human 9.8 pKi = 9.8 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 540 9 1 6 4.5 Cc1ccc(N2C(=O)c3ccc(C(=O)NCCCN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc1 10.1021/jm9905918
487 3607 21 None -1 12 Human 9.8 pKi = 9.8 Binding
Binding affinity towards recombinant human alpha-1A adrenergic receptorBinding affinity towards recombinant human alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm030480f
60602 3607 21 None -1 12 Human 9.8 pKi = 9.8 Binding
Binding affinity towards recombinant human alpha-1A adrenergic receptorBinding affinity towards recombinant human alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm030480f
CHEMBL405355 3607 21 None -1 12 Human 9.8 pKi = 9.8 Binding
Binding affinity towards recombinant human alpha-1A adrenergic receptorBinding affinity towards recombinant human alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm030480f
DB09239 3607 21 None -1 12 Human 9.8 pKi = 9.8 Binding
Binding affinity towards recombinant human alpha-1A adrenergic receptorBinding affinity towards recombinant human alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm030480f
487 3607 21 None -1 12 Human 9.8 pKi = 9.8 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1016/j.bmcl.2004.11.032
60602 3607 21 None -1 12 Human 9.8 pKi = 9.8 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1016/j.bmcl.2004.11.032
CHEMBL405355 3607 21 None -1 12 Human 9.8 pKi = 9.8 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1016/j.bmcl.2004.11.032
DB09239 3607 21 None -1 12 Human 9.8 pKi = 9.8 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1016/j.bmcl.2004.11.032
137659584 159358 0 None - 1 Human 9.8 pKi = 9.8 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 548 9 3 6 3.2 COCC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(C#N)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1016/j.ejmech.2017.03.025
CHEMBL4100620 159358 0 None - 1 Human 9.8 pKi = 9.8 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 548 9 3 6 3.2 COCC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(C#N)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1016/j.ejmech.2017.03.025
499 4046 18 None 1 15 Human 9.8 pKi = 9.8 Binding
Displacement of [3H]prazosin from human recombinant adrenergic alpha-1A receptor expressed in CHO cell membranes incubated for 60 minsDisplacement of [3H]prazosin from human recombinant adrenergic alpha-1A receptor expressed in CHO cell membranes incubated for 60 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/acs.jmedchem.9b01465
5685 4046 18 None 1 15 Human 9.8 pKi = 9.8 Binding
Displacement of [3H]prazosin from human recombinant adrenergic alpha-1A receptor expressed in CHO cell membranes incubated for 60 minsDisplacement of [3H]prazosin from human recombinant adrenergic alpha-1A receptor expressed in CHO cell membranes incubated for 60 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/acs.jmedchem.9b01465
CHEMBL25554 4046 18 None 1 15 Human 9.8 pKi = 9.8 Binding
Displacement of [3H]prazosin from human recombinant adrenergic alpha-1A receptor expressed in CHO cell membranes incubated for 60 minsDisplacement of [3H]prazosin from human recombinant adrenergic alpha-1A receptor expressed in CHO cell membranes incubated for 60 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/acs.jmedchem.9b01465
71508712 87039 0 None 40 5 Bovine 9.8 pKi = 9.8 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 389 3 0 5 4.4 CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4ncn(C)n4)cc23)CC1 10.1016/j.bmc.2012.10.049
CHEMBL2326175 87039 0 None 40 5 Bovine 9.8 pKi = 9.8 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 389 3 0 5 4.4 CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4ncn(C)n4)cc23)CC1 10.1016/j.bmc.2012.10.049
49782998 17885 0 None 1 6 Bovine 9.8 pKi = 9.8 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 409 4 1 4 4.0 CC(C)C(=O)NCc1ccc2c(c1)[C@@H](N1CCN(C)CC1)Cc1ccccc1S2 10.1021/jm100652h
CHEMBL1259190 17885 0 None 1 6 Bovine 9.8 pKi = 9.8 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 409 4 1 4 4.0 CC(C)C(=O)NCc1ccc2c(c1)[C@@H](N1CCN(C)CC1)Cc1ccccc1S2 10.1021/jm100652h
10696866 206910 0 None 6165 3 Human 9.8 pKi = 9.8 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 504 7 3 5 3.1 N#Cc1ccccc1C1(C#N)CCN(CCCNC(=O)C2=CNC(=O)N[C@@H]2c2ccc(F)c(F)c2)CC1 10.1021/jm990612y
CHEMBL91091 206910 0 None 6165 3 Human 9.8 pKi = 9.8 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 504 7 3 5 3.1 N#Cc1ccccc1C1(C#N)CCN(CCCNC(=O)C2=CNC(=O)N[C@@H]2c2ccc(F)c(F)c2)CC1 10.1021/jm990612y
10974101 116927 0 None 10 5 Human 9.8 pKi = 9.8 Binding
Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)
ChEMBL 609 10 1 9 4.2 Cc1c(-c2ccccc2)oc2c(C(=O)NCCCN3CCN(c4ccccc4OCc4no[n+]([O-])c4C)CC3)cccc2c1=O 10.1021/jm030825u
CHEMBL338608 116927 0 None 10 5 Human 9.8 pKi = 9.8 Binding
Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)
ChEMBL 609 10 1 9 4.2 Cc1c(-c2ccccc2)oc2c(C(=O)NCCCN3CCN(c4ccccc4OCc4no[n+]([O-])c4C)CC3)cccc2c1=O 10.1021/jm030825u
14423371 97426 1 None -1 7 Human 9.8 pKi = 9.8 Binding
Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.
ChEMBL 441 11 1 8 3.6 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccco3)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL27013 97426 1 None -1 7 Human 9.8 pKi = 9.8 Binding
Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.
ChEMBL 441 11 1 8 3.6 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccco3)nc(N)c2cc1OC 10.1021/jm9810654
4209 3141 75 None -4 34 Bovine 9.8 pKi = 9.8 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
4893 3141 75 None -4 34 Bovine 9.8 pKi = 9.8 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
503 3141 75 None -4 34 Bovine 9.8 pKi = 9.8 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
5385 3141 75 None -4 34 Bovine 9.8 pKi = 9.8 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
CHEMBL2 3141 75 None -4 34 Bovine 9.8 pKi = 9.8 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
DB00457 3141 75 None -4 34 Bovine 9.8 pKi = 9.8 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
9830741 207833 1 None 1 7 Human 9.8 pKi = 9.8 Binding
Binding affinity towards Alpha1A human adrenergic receptors, using [125I]-HEAT as radioligand.Binding affinity towards Alpha1A human adrenergic receptors, using [125I]-HEAT as radioligand.
ChEMBL 475 6 1 4 5.0 C[C@@H]1OC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1021/jm000085e
CHEMBL96467 207833 1 None 1 7 Human 9.8 pKi = 9.8 Binding
Binding affinity towards Alpha1A human adrenergic receptors, using [125I]-HEAT as radioligand.Binding affinity towards Alpha1A human adrenergic receptors, using [125I]-HEAT as radioligand.
ChEMBL 475 6 1 4 5.0 C[C@@H]1OC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1021/jm000085e
9830741 207833 1 None 1 7 Human 9.8 pKi = 9.8 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 475 6 1 4 5.0 C[C@@H]1OC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1016/j.bmcl.2004.11.032
CHEMBL96467 207833 1 None 1 7 Human 9.8 pKi = 9.8 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 475 6 1 4 5.0 C[C@@H]1OC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1016/j.bmcl.2004.11.032
9913449 106425 1 None 13 3 Human 9.8 pKi = 9.8 Binding
Compound was evaluated for its affinity for alpha 1a receptor in human prostate tissue preparationsCompound was evaluated for its affinity for alpha 1a receptor in human prostate tissue preparations
ChEMBL 489 6 0 7 3.5 O=C1c2cc(Cl)ccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
CHEMBL313990 106425 1 None 13 3 Human 9.8 pKi = 9.8 Binding
Compound was evaluated for its affinity for alpha 1a receptor in human prostate tissue preparationsCompound was evaluated for its affinity for alpha 1a receptor in human prostate tissue preparations
ChEMBL 489 6 0 7 3.5 O=C1c2cc(Cl)ccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
137637836 156057 0 None - 1 Human 9.8 pKi = 9.8 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 509 9 3 6 3.1 COCC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)cc2)NCN1 10.1016/j.ejmech.2017.03.025
CHEMBL4062896 156057 0 None - 1 Human 9.8 pKi = 9.8 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 509 9 3 6 3.1 COCC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)cc2)NCN1 10.1016/j.ejmech.2017.03.025
10719222 207424 0 None 141 3 Human 9.8 pKi = 9.8 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 472 7 3 3 3.7 O=C1NC=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)N1 10.1016/j.ejmech.2017.03.025
CHEMBL94167 207424 0 None 141 3 Human 9.8 pKi = 9.8 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 472 7 3 3 3.7 O=C1NC=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)N1 10.1016/j.ejmech.2017.03.025
49781232 17892 0 None -1 5 Bovine 9.8 pKi = 9.8 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 392 2 0 7 2.9 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4nnn(C)n4)cc32)CC1 10.1021/jm100652h
CHEMBL1259216 17892 0 None -1 5 Bovine 9.8 pKi = 9.8 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 392 2 0 7 2.9 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4nnn(C)n4)cc32)CC1 10.1021/jm100652h
10767607 107102 0 None 831 3 Human 9.8 pKi = 9.8 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 497 7 3 4 3.4 N#CC1(c2ccc(F)cc2)CCN(CCCNC(=O)C2=CNC(=O)N[C@@H]2c2ccc(F)c(F)c2)CC1 10.1021/jm990612y
CHEMBL316100 107102 0 None 831 3 Human 9.8 pKi = 9.8 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 497 7 3 4 3.4 N#CC1(c2ccc(F)cc2)CCN(CCCNC(=O)C2=CNC(=O)N[C@@H]2c2ccc(F)c(F)c2)CC1 10.1021/jm990612y
10791844 207134 0 None 512 3 Human 9.8 pKi = 9.8 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 511 7 3 4 4.0 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1021/jm990612y
CHEMBL92328 207134 0 None 512 3 Human 9.8 pKi = 9.8 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 511 7 3 4 4.0 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1021/jm990612y
10719222 207424 0 None 141 3 Human 9.8 pKi = 9.8 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 472 7 3 3 3.7 O=C1NC=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)N1 10.1021/jm990612y
CHEMBL94167 207424 0 None 141 3 Human 9.8 pKi = 9.8 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 472 7 3 3 3.7 O=C1NC=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)N1 10.1021/jm990612y
9830741 207833 1 None 1 7 Human 9.8 pKi = 9.8 Binding
Tested for binding affinity against recombinant human Alpha-1A adrenergic receptor using [125I]HEAT in competition binding assayTested for binding affinity against recombinant human Alpha-1A adrenergic receptor using [125I]HEAT in competition binding assay
ChEMBL 475 6 1 4 5.0 C[C@@H]1OC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1016/s0960-894x(00)00524-2
CHEMBL96467 207833 1 None 1 7 Human 9.8 pKi = 9.8 Binding
Tested for binding affinity against recombinant human Alpha-1A adrenergic receptor using [125I]HEAT in competition binding assayTested for binding affinity against recombinant human Alpha-1A adrenergic receptor using [125I]HEAT in competition binding assay
ChEMBL 475 6 1 4 5.0 C[C@@H]1OC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1016/s0960-894x(00)00524-2
10649481 206795 0 None 123 3 Human 9.7 pKi = 9.7 Binding
Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 514 7 1 3 4.8 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)N(C)C(=O)N1C 10.1021/jm990612y
CHEMBL90420 206795 0 None 123 3 Human 9.7 pKi = 9.7 Binding
Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 514 7 1 3 4.8 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)N(C)C(=O)N1C 10.1021/jm990612y
10839105 206796 0 None 660 3 Human 9.7 pKi = 9.7 Binding
Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 500 7 2 3 4.5 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1C 10.1021/jm990612y
CHEMBL90421 206796 0 None 660 3 Human 9.7 pKi = 9.7 Binding
Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 500 7 2 3 4.5 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1C 10.1021/jm990612y
CHEMBL179334 63273 0 None 977 6 Human 9.7 pKi = 9.7 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 608 10 2 7 6.4 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)[C@H]1c1ccc([N+](=O)[O-])cc1 10.1021/jm00010a001
10674564 203914 0 None 83 3 Human 9.7 pKi = 9.7 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 569 10 1 7 4.3 CC(C)Oc1ccccc1N1CCN(CCCNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(N(C)C)cc2)C3=O)CC1 10.1021/jm9905918
CHEMBL69264 203914 0 None 83 3 Human 9.7 pKi = 9.7 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 569 10 1 7 4.3 CC(C)Oc1ccccc1N1CCN(CCCNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(N(C)C)cc2)C3=O)CC1 10.1021/jm9905918
10074286 205481 0 None 2 4 Human 9.7 pKi = 9.7 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 489 9 1 8 3.5 COc1ccccc1N1CCN(CCNc2c(C(=O)C(C)C)c(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
CHEMBL80730 205481 0 None 2 4 Human 9.7 pKi = 9.7 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 489 9 1 8 3.5 COc1ccccc1N1CCN(CCNc2c(C(=O)C(C)C)c(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
CHEMBL179334 63273 0 None 977 6 Human 9.7 pKi = 9.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 608 10 2 7 6.4 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)[C@H]1c1ccc([N+](=O)[O-])cc1 10.1016/j.bmcl.2004.11.032
137646446 157648 0 None - 1 Human 9.7 pKi = 9.7 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 518 7 2 3 4.6 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)c(F)c3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1C 10.1016/j.ejmech.2017.03.025
CHEMBL4081581 157648 0 None - 1 Human 9.7 pKi = 9.7 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 518 7 2 3 4.6 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)c(F)c3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1C 10.1016/j.ejmech.2017.03.025
9932698 17877 0 None 3 6 Bovine 9.7 pKi = 9.7 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 435 6 2 4 3.4 NCc1ccc2c(c1)c(C1CCN(CCN3CCNC3=O)CC1)cn2-c1ccc(F)cc1 10.1021/jm100652h
CHEMBL1259172 17877 0 None 3 6 Bovine 9.7 pKi = 9.7 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 435 6 2 4 3.4 NCc1ccc2c(c1)c(C1CCN(CCN3CCNC3=O)CC1)cn2-c1ccc(F)cc1 10.1021/jm100652h
10697623 107140 0 None 2398 3 Human 9.7 pKi = 9.7 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 536 7 2 5 3.6 CN1C=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)NC1=O 10.1021/jm990612y
CHEMBL316358 107140 0 None 2398 3 Human 9.7 pKi = 9.7 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 536 7 2 5 3.6 CN1C=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)NC1=O 10.1021/jm990612y
13911290 28140 0 None 1 6 Bovine 9.7 pKi = 9.7 Binding
Binding affinity towards bovine Alpha-1A adrenergic receptorBinding affinity towards bovine Alpha-1A adrenergic receptor
ChEMBL 386 5 1 7 1.6 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3sccc3c2=O)CC1 10.1016/s0960-894x(01)00159-7
CHEMBL13735 28140 0 None 1 6 Bovine 9.7 pKi = 9.7 Binding
Binding affinity towards bovine Alpha-1A adrenergic receptorBinding affinity towards bovine Alpha-1A adrenergic receptor
ChEMBL 386 5 1 7 1.6 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3sccc3c2=O)CC1 10.1016/s0960-894x(01)00159-7
129211 3722 78 None -1 16 Human 9.7 pKi = 9.7 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2007.04.008
2562 3722 78 None -1 16 Human 9.7 pKi = 9.7 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2007.04.008
488 3722 78 None -1 16 Human 9.7 pKi = 9.7 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2007.04.008
CHEMBL836 3722 78 None -1 16 Human 9.7 pKi = 9.7 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2007.04.008
DB00706 3722 78 None -1 16 Human 9.7 pKi = 9.7 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2007.04.008
129211 3722 78 None -1 16 Human 9.7 pKi = 9.7 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2007.04.098
2562 3722 78 None -1 16 Human 9.7 pKi = 9.7 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2007.04.098
488 3722 78 None -1 16 Human 9.7 pKi = 9.7 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2007.04.098
CHEMBL836 3722 78 None -1 16 Human 9.7 pKi = 9.7 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2007.04.098
DB00706 3722 78 None -1 16 Human 9.7 pKi = 9.7 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2007.04.098
10005161 205226 0 None 1 4 Human 9.7 pKi = 9.7 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 475 9 1 8 3.3 CCC(=O)c1c(-c2ccccc2)nn(C)c(=O)c1NCCN1CCN(c2ccccc2OC)CC1 10.1021/jm0009336
CHEMBL78874 205226 0 None 1 4 Human 9.7 pKi = 9.7 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 475 9 1 8 3.3 CCC(=O)c1c(-c2ccccc2)nn(C)c(=O)c1NCCN1CCN(c2ccccc2OC)CC1 10.1021/jm0009336
129211 3722 78 None -1 16 Human 9.7 pKi = 9.7 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2007.11.068
2562 3722 78 None -1 16 Human 9.7 pKi = 9.7 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2007.11.068
488 3722 78 None -1 16 Human 9.7 pKi = 9.7 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2007.11.068
CHEMBL836 3722 78 None -1 16 Human 9.7 pKi = 9.7 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2007.11.068
DB00706 3722 78 None -1 16 Human 9.7 pKi = 9.7 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2007.11.068
49781450 17825 0 None 1 4 Bovine 9.7 pKi = 9.7 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 387 2 0 4 4.7 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4cccnc4)cc32)CC1 10.1021/jm100652h
CHEMBL1259023 17825 0 None 1 4 Bovine 9.7 pKi = 9.7 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 387 2 0 4 4.7 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4cccnc4)cc32)CC1 10.1021/jm100652h
9916549 121538 0 None 1 4 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of humanIn vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of human
ChEMBL 592 10 3 8 3.1 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
CHEMBL358595 121538 0 None 1 4 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of humanIn vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of human
ChEMBL 592 10 3 8 3.1 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
463 1393 22 None 5 13 Human 9.7 pKi = 9.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm960697s
6918097 1393 22 None 5 13 Human 9.7 pKi = 9.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm960697s
837 1393 22 None 5 13 Human 9.7 pKi = 9.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm960697s
CHEMBL2051956 1393 22 None 5 13 Human 9.7 pKi = 9.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm960697s
DB14068 1393 22 None 5 13 Human 9.7 pKi = 9.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm960697s
4209 3141 75 None -3 34 Human 9.7 pKi = 9.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm960697s
4893 3141 75 None -3 34 Human 9.7 pKi = 9.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm960697s
503 3141 75 None -3 34 Human 9.7 pKi = 9.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm960697s
5385 3141 75 None -3 34 Human 9.7 pKi = 9.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm960697s
CHEMBL2 3141 75 None -3 34 Human 9.7 pKi = 9.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm960697s
DB00457 3141 75 None -3 34 Human 9.7 pKi = 9.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm960697s
129211 3722 78 None -1 16 Human 9.7 pKi = 9.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm960697s
2562 3722 78 None -1 16 Human 9.7 pKi = 9.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm960697s
488 3722 78 None -1 16 Human 9.7 pKi = 9.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm960697s
CHEMBL836 3722 78 None -1 16 Human 9.7 pKi = 9.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm960697s
DB00706 3722 78 None -1 16 Human 9.7 pKi = 9.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm960697s
9872851 97056 3 None 79 3 Human 9.7 pKi = 9.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 571 10 1 7 4.6 COc1ccc(CCN2CCC(c3nc(COCC(F)(F)F)c(-c4ccc(F)cc4)o3)CC2)cc1S(N)(=O)=O 10.1021/jm960697s
CHEMBL267336 97056 3 None 79 3 Human 9.7 pKi = 9.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 571 10 1 7 4.6 COc1ccc(CCN2CCC(c3nc(COCC(F)(F)F)c(-c4ccc(F)cc4)o3)CC2)cc1S(N)(=O)=O 10.1021/jm960697s
9809007 172540 8 None 134 6 Human 9.7 pKi = 9.7 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm9902032
CHEMBL448620 172540 8 None 134 6 Human 9.7 pKi = 9.7 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm9902032
60820 4277 14 None -10 13 Rat 9.7 pKi = 9.7 Binding
Binding affinity towards alpha-1A adrenergic receptors using alpha-1A ligand WB-4101Binding affinity towards alpha-1A adrenergic receptors using alpha-1A ligand WB-4101
ChEMBL 421 6 0 4 4.4 CC(C)Oc1ccccc1N1CCN(Cc2cccc(C(=O)N3CCCCC3)c2)CC1 10.1021/jm00034a003
CHEMBL10085 4277 14 None -10 13 Rat 9.7 pKi = 9.7 Binding
Binding affinity towards alpha-1A adrenergic receptors using alpha-1A ligand WB-4101Binding affinity towards alpha-1A adrenergic receptors using alpha-1A ligand WB-4101
ChEMBL 421 6 0 4 4.4 CC(C)Oc1ccccc1N1CCN(Cc2cccc(C(=O)N3CCCCC3)c2)CC1 10.1021/jm00034a003
10674055 204193 0 None 50 3 Human 9.7 pKi = 9.7 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 542 9 2 7 3.9 CC(C)Oc1ccccc1N1CCN(CCCNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(O)cc2)C3=O)CC1 10.1021/jm9905918
CHEMBL70892 204193 0 None 50 3 Human 9.7 pKi = 9.7 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 542 9 2 7 3.9 CC(C)Oc1ccccc1N1CCN(CCCNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(O)cc2)C3=O)CC1 10.1021/jm9905918
129211 3722 78 None -1 16 Human 9.7 pKi = 9.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2004.11.032
2562 3722 78 None -1 16 Human 9.7 pKi = 9.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2004.11.032
488 3722 78 None -1 16 Human 9.7 pKi = 9.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2004.11.032
CHEMBL836 3722 78 None -1 16 Human 9.7 pKi = 9.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2004.11.032
DB00706 3722 78 None -1 16 Human 9.7 pKi = 9.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2004.11.032
44390739 64312 1 None - 1 Human 9.7 pKi = 9.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 361 8 1 6 3.2 COc1cccc(OC)c1OCCNC[C@H]1CSc2ccccc2O1 10.1016/j.bmcl.2004.11.032
CHEMBL181215 64312 1 None - 1 Human 9.7 pKi = 9.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 361 8 1 6 3.2 COc1cccc(OC)c1OCCNC[C@H]1CSc2ccccc2O1 10.1016/j.bmcl.2004.11.032
10099811 120997 4 None 676 4 Human 9.7 pKi = 9.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 583 9 3 6 3.5 CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1016/j.bmcl.2004.11.032
CHEMBL356584 120997 4 None 676 4 Human 9.7 pKi = 9.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 583 9 3 6 3.5 CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1016/j.bmcl.2004.11.032
18738386 204015 0 None 125 3 Human 9.7 pKi = 9.7 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 413 7 0 5 4.0 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCC3=O)cs2)CC1 10.1016/s0960-894x(02)00347-5
CHEMBL69848 204015 0 None 125 3 Human 9.7 pKi = 9.7 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 413 7 0 5 4.0 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCC3=O)cs2)CC1 10.1016/s0960-894x(02)00347-5
11984570 92775 0 None 2 3 Human 9.7 pKi = 9.7 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 465 5 0 5 4.3 CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4cccc(F)c4C3=O)CC2)CC1 10.1016/j.bmcl.2006.12.111
CHEMBL243694 92775 0 None 2 3 Human 9.7 pKi = 9.7 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 465 5 0 5 4.3 CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4cccc(F)c4C3=O)CC2)CC1 10.1016/j.bmcl.2006.12.111
49781452 17834 0 None -1 4 Bovine 9.7 pKi = 9.7 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 388 2 0 5 4.1 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4cncnc4)cc32)CC1 10.1021/jm100652h
CHEMBL1259042 17834 0 None -1 4 Bovine 9.7 pKi = 9.7 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 388 2 0 5 4.1 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4cncnc4)cc32)CC1 10.1021/jm100652h
10722045 32785 0 None 436 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 584 8 2 7 3.8 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)cc1F 10.1021/jm990200p
CHEMBL141444 32785 0 None 436 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 584 8 2 7 3.8 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)cc1F 10.1021/jm990200p
10626726 33914 0 None 70 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 561 7 2 6 4.1 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3Cl)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL142398 33914 0 None 70 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 561 7 2 6 4.1 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3Cl)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
10371061 36671 0 None 1380 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 583 9 3 6 3.5 CCC1=C(C(N)=O)C(c2ccc(F)cc2F)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
CHEMBL144925 36671 0 None 1380 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 583 9 3 6 3.5 CCC1=C(C(N)=O)C(c2ccc(F)cc2F)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
10627155 37189 0 None 125 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 585 8 2 8 3.2 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C(=O)OC)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL145338 37189 0 None 125 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 585 8 2 8 3.2 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C(=O)OC)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
10554140 119091 0 None 38 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 527 7 2 6 3.4 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL342731 119091 0 None 38 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 527 7 2 6 3.4 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
10099811 120997 4 None 676 4 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 583 9 3 6 3.5 CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
10099811 120997 4 None 676 4 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 583 9 3 6 3.5 CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990202+
CHEMBL356584 120997 4 None 676 4 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 583 9 3 6 3.5 CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
CHEMBL356584 120997 4 None 676 4 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 583 9 3 6 3.5 CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990202+
9916549 121538 0 None 1 4 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 592 10 3 8 3.1 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
CHEMBL358595 121538 0 None 1 4 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 592 10 3 8 3.1 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
10371061 36671 0 None 1380 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 583 9 3 6 3.5 CCC1=C(C(N)=O)C(c2ccc(F)cc2F)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990201h
CHEMBL144925 36671 0 None 1380 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 583 9 3 6 3.5 CCC1=C(C(N)=O)C(c2ccc(F)cc2F)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990201h
10745870 36688 0 None 3090 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 584 9 2 7 2.8 COC(=O)C1=C(C)NC(=O)N(CC(=O)NCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL144938 36688 0 None 3090 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 584 9 2 7 2.8 COC(=O)C1=C(C)NC(=O)N(CC(=O)NCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
10720893 37338 0 None 181 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 526 7 2 5 4.5 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL145459 37338 0 None 181 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 526 7 2 5 4.5 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
10675068 96421 0 None 758 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 599 9 2 7 3.9 COCC1=C(C(=O)OC)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C#N)(c3cccc(F)c3)CC2)C(=O)N1 10.1021/jm990201h
CHEMBL262217 96421 0 None 758 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 599 9 2 7 3.9 COCC1=C(C(=O)OC)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C#N)(c3cccc(F)c3)CC2)C(=O)N1 10.1021/jm990201h
10508330 118768 0 None 99 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 638 8 2 5 5.9 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)(c3ccc(F)cc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL342126 118768 0 None 99 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 638 8 2 5 5.9 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)(c3ccc(F)cc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
10099811 120997 4 None 676 4 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 583 9 3 6 3.5 CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990201h
CHEMBL356584 120997 4 None 676 4 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 583 9 3 6 3.5 CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990201h
10507500 121668 0 None 1258 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 582 6 2 7 3.7 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC3(CC2)OC(=O)Cc2ccccc23)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL358785 121668 0 None 1258 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 582 6 2 7 3.7 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC3(CC2)OC(=O)Cc2ccccc23)C1c1ccc(F)c(F)c1 10.1021/jm990201h
10555024 121863 0 None 2454 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 568 6 2 6 4.1 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC3(CC2)OCCc2ccccc23)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL359012 121863 0 None 2454 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 568 6 2 6 4.1 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC3(CC2)OCCc2ccccc23)C1c1ccc(F)c(F)c1 10.1021/jm990201h
10099811 120997 4 None 676 4 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity radioligandIn vitro binding affinity radioligand
ChEMBL 583 9 3 6 3.5 CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
CHEMBL356584 120997 4 None 676 4 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity radioligandIn vitro binding affinity radioligand
ChEMBL 583 9 3 6 3.5 CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
4013695 101988 20 None 1 5 Rat 9.7 pKi = 9.7 Binding
Binding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranesBinding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranes
ChEMBL 419 5 2 6 2.0 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c([nH]c4ccccc43)c2=O)CC1 10.1021/jm00110a014
CHEMBL301707 101988 20 None 1 5 Rat 9.7 pKi = 9.7 Binding
Binding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranesBinding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranes
ChEMBL 419 5 2 6 2.0 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c([nH]c4ccccc43)c2=O)CC1 10.1021/jm00110a014
10099811 120997 4 None 676 4 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of humanIn vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of human
ChEMBL 583 9 3 6 3.5 CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
CHEMBL356584 120997 4 None 676 4 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of humanIn vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of human
ChEMBL 583 9 3 6 3.5 CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
10527469 156241 3 None 1 16 Human 9.7 pKi = 9.7 Binding
Binding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligandBinding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligand
ChEMBL 448 4 1 7 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccnc54)c3=O)C[C@@H]21 10.1021/jm970364a
CHEMBL40650 156241 3 None 1 16 Human 9.7 pKi = 9.7 Binding
Binding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligandBinding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligand
ChEMBL 448 4 1 7 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccnc54)c3=O)C[C@@H]21 10.1021/jm970364a
10916771 105187 0 None 9 4 Human 9.7 pKi = 9.7 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 419 7 1 7 2.7 COc1ccccc1N1CCN(CCNc2cc(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
CHEMBL311479 105187 0 None 9 4 Human 9.7 pKi = 9.7 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 419 7 1 7 2.7 COc1ccccc1N1CCN(CCNc2cc(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
10527469 156241 3 None 1 16 Human 9.7 pKi = 9.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 448 4 1 7 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccnc54)c3=O)C[C@@H]21 10.1016/j.bmcl.2004.11.032
CHEMBL40650 156241 3 None 1 16 Human 9.7 pKi = 9.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 448 4 1 7 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccnc54)c3=O)C[C@@H]21 10.1016/j.bmcl.2004.11.032
9828476 206901 0 None 58 6 Human 9.6 pKi = 9.6 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 532 9 2 7 5.2 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
CHEMBL91022 206901 0 None 58 6 Human 9.6 pKi = 9.6 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 532 9 2 7 5.2 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
9828476 85253 0 None - 1 Human 9.6 pKi = 9.6 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 532 9 2 7 4.4 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
CHEMBL2260360 85253 0 None - 1 Human 9.6 pKi = 9.6 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 532 9 2 7 4.4 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
9830741 207833 1 None 1 7 Human 9.6 pKi = 9.6 Binding
Binding affinity towards Alpha1A dog adrenergic receptors, using [125I]HEAT as radioligand.Binding affinity towards Alpha1A dog adrenergic receptors, using [125I]HEAT as radioligand.
ChEMBL 475 6 1 4 5.0 C[C@@H]1OC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1021/jm000085e
CHEMBL96467 207833 1 None 1 7 Human 9.6 pKi = 9.6 Binding
Binding affinity towards Alpha1A dog adrenergic receptors, using [125I]HEAT as radioligand.Binding affinity towards Alpha1A dog adrenergic receptors, using [125I]HEAT as radioligand.
ChEMBL 475 6 1 4 5.0 C[C@@H]1OC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1021/jm000085e
10626910 203761 0 None 537 2 Human 9.6 pKi = 9.6 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 572 10 2 8 3.2 COc1ccc(N2C(=O)c3ccc(C(=O)NC[C@H](O)CN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc1 10.1021/jm9905918
CHEMBL68203 203761 0 None 537 2 Human 9.6 pKi = 9.6 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 572 10 2 8 3.2 COc1ccc(N2C(=O)c3ccc(C(=O)NC[C@H](O)CN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc1 10.1021/jm9905918
9826801 107910 0 None 4 12 Bovine 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 488 6 1 7 3.2 Cn1nnc(-c2ccc3c(c2)c(C2CCN(CCN4CCNC4=O)CC2)cn3-c2ccc(F)cc2)n1 10.1021/jm020938y
CHEMBL319352 107910 0 None 4 12 Bovine 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 488 6 1 7 3.2 Cn1nnc(-c2ccc3c(c2)c(C2CCN(CCN4CCNC4=O)CC2)cn3-c2ccc(F)cc2)n1 10.1021/jm020938y
135418497 63009 0 None 1 4 Rat 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranesDisplacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranes
ChEMBL 391 4 1 5 2.5 COc1ccccc1N1CCN(C[C@H]2CN=C3c4ccccc4NC(=O)N32)CC1 10.1021/jm970159v
CHEMBL1788222 63009 0 None 1 4 Rat 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranesDisplacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranes
ChEMBL 391 4 1 5 2.5 COc1ccccc1N1CCN(C[C@H]2CN=C3c4ccccc4NC(=O)N32)CC1 10.1021/jm970159v
4209 3141 75 None -3 34 Rat 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2006.05.002
4893 3141 75 None -3 34 Rat 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2006.05.002
503 3141 75 None -3 34 Rat 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2006.05.002
5385 3141 75 None -3 34 Rat 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2006.05.002
CHEMBL2 3141 75 None -3 34 Rat 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2006.05.002
DB00457 3141 75 None -3 34 Rat 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2006.05.002
9826801 107910 0 None 4 12 Bovine 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 488 6 1 7 3.2 Cn1nnc(-c2ccc3c(c2)c(C2CCN(CCN4CCNC4=O)CC2)cn3-c2ccc(F)cc2)n1 10.1016/j.bmc.2012.10.049
CHEMBL319352 107910 0 None 4 12 Bovine 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 488 6 1 7 3.2 Cn1nnc(-c2ccc3c(c2)c(C2CCN(CCN4CCNC4=O)CC2)cn3-c2ccc(F)cc2)n1 10.1016/j.bmc.2012.10.049
9826801 107910 0 None 4 12 Bovine 9.6 pKi = 9.6 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 488 6 1 7 3.2 Cn1nnc(-c2ccc3c(c2)c(C2CCN(CCN4CCNC4=O)CC2)cn3-c2ccc(F)cc2)n1 10.1021/jm100652h
CHEMBL319352 107910 0 None 4 12 Bovine 9.6 pKi = 9.6 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 488 6 1 7 3.2 Cn1nnc(-c2ccc3c(c2)c(C2CCN(CCN4CCNC4=O)CC2)cn3-c2ccc(F)cc2)n1 10.1021/jm100652h
9809007 172540 8 None 134 6 Human 9.6 pKi = 9.6 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm960697s
CHEMBL448620 172540 8 None 134 6 Human 9.6 pKi = 9.6 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm960697s
10369288 207235 0 None 169 3 Human 9.6 pKi = 9.6 Binding
Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 516 9 3 4 3.7 COCC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1021/jm990612y
CHEMBL92951 207235 0 None 169 3 Human 9.6 pKi = 9.6 Binding
Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 516 9 3 4 3.7 COCC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1021/jm990612y
10456471 100505 0 None 1 5 Rat 9.6 pKi = 9.6 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 451 6 1 7 2.4 COc1cc2[nH]c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2cc1OC 10.1021/jm000541z
CHEMBL291303 100505 0 None 1 5 Rat 9.6 pKi = 9.6 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 451 6 1 7 2.4 COc1cc2[nH]c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2cc1OC 10.1021/jm000541z
9913449 106425 1 None 13 3 Human 9.6 pKi = 9.6 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog prostate tissue preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog prostate tissue preparations
ChEMBL 489 6 0 7 3.5 O=C1c2cc(Cl)ccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
CHEMBL313990 106425 1 None 13 3 Human 9.6 pKi = 9.6 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog prostate tissue preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog prostate tissue preparations
ChEMBL 489 6 0 7 3.5 O=C1c2cc(Cl)ccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
44300165 101824 0 None 66 3 Human 9.6 pKi = 9.6 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 607 7 2 7 4.5 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@@H]2CC[C@H](N3CCC(c4ccccc4C#N)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
CHEMBL300540 101824 0 None 66 3 Human 9.6 pKi = 9.6 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 607 7 2 7 4.5 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@@H]2CC[C@H](N3CCC(c4ccccc4C#N)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
10369288 207235 0 None 169 3 Human 9.6 pKi = 9.6 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 516 9 3 4 3.7 COCC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1016/j.ejmech.2017.03.025
CHEMBL92951 207235 0 None 169 3 Human 9.6 pKi = 9.6 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 516 9 3 4 3.7 COCC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1016/j.ejmech.2017.03.025
49781236 17811 0 None -1 4 Bovine 9.6 pKi = 9.6 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 390 2 0 5 4.1 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4cnn(C)c4)cc32)CC1 10.1021/jm100652h
CHEMBL1258987 17811 0 None -1 4 Bovine 9.6 pKi = 9.6 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 390 2 0 5 4.1 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4cnn(C)c4)cc32)CC1 10.1021/jm100652h
49781449 17819 0 None 2 4 Bovine 9.6 pKi = 9.6 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 387 2 0 4 4.7 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4ccccn4)cc32)CC1 10.1021/jm100652h
CHEMBL1259006 17819 0 None 2 4 Bovine 9.6 pKi = 9.6 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 387 2 0 4 4.7 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4ccccn4)cc32)CC1 10.1021/jm100652h
9847196 30150 0 None 1 5 Bovine 9.6 pKi = 9.6 Binding
Binding affinity towards bovine Alpha-1A adrenergic receptorBinding affinity towards bovine Alpha-1A adrenergic receptor
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3sc(-c4ccccc4)cc3c2=O)CC1 10.1016/s0960-894x(01)00159-7
CHEMBL13903 30150 0 None 1 5 Bovine 9.6 pKi = 9.6 Binding
Binding affinity towards bovine Alpha-1A adrenergic receptorBinding affinity towards bovine Alpha-1A adrenergic receptor
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3sc(-c4ccccc4)cc3c2=O)CC1 10.1016/s0960-894x(01)00159-7
10606670 199069 0 None 13 3 Rat 9.6 pKi = 9.6 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 465 6 0 8 2.4 COc1cc2c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)n(C)c2cc1OC 10.1021/jm000541z
CHEMBL58862 199069 0 None 13 3 Rat 9.6 pKi = 9.6 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 465 6 0 8 2.4 COc1cc2c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)n(C)c2cc1OC 10.1021/jm000541z
3567002 3362 9 None 58 3 Human 9.6 pKi = 9.6 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 426 7 1 6 2.0 O=c1[nH]cc(c(=O)n1CCCN1CCN(CC1)c1ccccc1OCC(F)(F)F)C 10.1016/j.bmcl.2004.11.032
7381 3362 9 None 58 3 Human 9.6 pKi = 9.6 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 426 7 1 6 2.0 O=c1[nH]cc(c(=O)n1CCCN1CCN(CC1)c1ccccc1OCC(F)(F)F)C 10.1016/j.bmcl.2004.11.032
CHEMBL56331 3362 9 None 58 3 Human 9.6 pKi = 9.6 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 426 7 1 6 2.0 O=c1[nH]cc(c(=O)n1CCCN1CCN(CC1)c1ccccc1OCC(F)(F)F)C 10.1016/j.bmcl.2004.11.032
10624993 111660 0 None 630 3 Human 9.6 pKi = 9.6 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 493 7 3 4 3.9 CC1=C(C(=O)NCCCN2CCC(c3ccccc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1021/jm990612y
CHEMBL328658 111660 0 None 630 3 Human 9.6 pKi = 9.6 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 493 7 3 4 3.9 CC1=C(C(=O)NCCCN2CCC(c3ccccc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1021/jm990612y
11626704 72425 0 None -5 4 Human 9.6 pKi = 9.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 457 13 1 6 5.0 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1cccc(Cl)c1 10.1007/s00044-010-9379-1
CHEMBL198860 72425 0 None -5 4 Human 9.6 pKi = 9.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 457 13 1 6 5.0 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1cccc(Cl)c1 10.1007/s00044-010-9379-1
44289437 169839 0 None -1 7 Human 9.6 pKi = 9.6 Binding
Affinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptorAffinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptor
ChEMBL 431 9 1 5 4.7 COc1cccc(OC)c1OCCNCC1CC(c2ccccc2)c2ccccc2C1=O 10.1021/jm011066n
CHEMBL44403 169839 0 None -1 7 Human 9.6 pKi = 9.6 Binding
Affinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptorAffinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptor
ChEMBL 431 9 1 5 4.7 COc1cccc(OC)c1OCCNCC1CC(c2ccccc2)c2ccccc2C1=O 10.1021/jm011066n
11626704 72425 0 None -5 4 Human 9.6 pKi = 9.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 457 13 1 6 5.0 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1cccc(Cl)c1 10.1007/s00044-010-9379-1
CHEMBL198860 72425 0 None -5 4 Human 9.6 pKi = 9.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 457 13 1 6 5.0 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1cccc(Cl)c1 10.1007/s00044-010-9379-1
11626704 72425 0 None -5 4 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 457 13 1 6 5.0 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1cccc(Cl)c1 10.1021/jm0580398
CHEMBL198860 72425 0 None -5 4 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 457 13 1 6 5.0 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1cccc(Cl)c1 10.1021/jm0580398
11583392 72885 1 None -7 4 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 457 13 1 6 5.0 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccc(Cl)cc1 10.1021/jm0580398
CHEMBL200446 72885 1 None -7 4 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 457 13 1 6 5.0 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccc(Cl)cc1 10.1021/jm0580398
3567002 3362 9 None 58 3 Human 9.6 pKi = 9.6 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 426 7 1 6 2.0 O=c1[nH]cc(c(=O)n1CCCN1CCN(CC1)c1ccccc1OCC(F)(F)F)C 10.1016/s0960-894x(03)00305-6
7381 3362 9 None 58 3 Human 9.6 pKi = 9.6 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 426 7 1 6 2.0 O=c1[nH]cc(c(=O)n1CCCN1CCN(CC1)c1ccccc1OCC(F)(F)F)C 10.1016/s0960-894x(03)00305-6
CHEMBL56331 3362 9 None 58 3 Human 9.6 pKi = 9.6 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 426 7 1 6 2.0 O=c1[nH]cc(c(=O)n1CCCN1CCN(CC1)c1ccccc1OCC(F)(F)F)C 10.1016/s0960-894x(03)00305-6
44298650 163131 0 None 100 3 Human 9.6 pKi = 9.6 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 448 7 1 6 2.0 O=c1[nH]cc(F)c(=O)n1CCCN1CCN(c2ccc(F)cc2OCC(F)(F)F)CC1 10.1016/s0960-894x(03)00305-6
CHEMBL417954 163131 0 None 100 3 Human 9.6 pKi = 9.6 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 448 7 1 6 2.0 O=c1[nH]cc(F)c(=O)n1CCCN1CCN(c2ccc(F)cc2OCC(F)(F)F)CC1 10.1016/s0960-894x(03)00305-6
4431 2710 25 None 1 12 Human 9.6 pKi = 9.6 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 393 7 0 5 2.9 COc1ccccc1N1CCN(CC1)CCCCN1C(=O)c2c(C1=O)cccc2 10.1016/j.bmcl.2006.12.111
73 2710 25 None 1 12 Human 9.6 pKi = 9.6 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 393 7 0 5 2.9 COc1ccccc1N1CCN(CC1)CCCCN1C(=O)c2c(C1=O)cccc2 10.1016/j.bmcl.2006.12.111
CHEMBL8618 2710 25 None 1 12 Human 9.6 pKi = 9.6 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 393 7 0 5 2.9 COc1ccccc1N1CCN(CC1)CCCCN1C(=O)c2c(C1=O)cccc2 10.1016/j.bmcl.2006.12.111
132891 5280 14 None 2 5 Rat 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranesDisplacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranes
ChEMBL 391 4 1 5 2.5 COc1ccccc1N1CCN(CC2CN=C3c4ccccc4NC(=O)N32)CC1 10.1021/jm970159v
CHEMBL106737 5280 14 None 2 5 Rat 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranesDisplacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranes
ChEMBL 391 4 1 5 2.5 COc1ccccc1N1CCN(CC2CN=C3c4ccccc4NC(=O)N32)CC1 10.1021/jm970159v
49781235 17898 0 None -1 4 Bovine 9.6 pKi = 9.6 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 390 2 0 5 4.1 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4ccn(C)n4)cc32)CC1 10.1021/jm100652h
CHEMBL1259232 17898 0 None -1 4 Bovine 9.6 pKi = 9.6 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 390 2 0 5 4.1 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4ccn(C)n4)cc32)CC1 10.1021/jm100652h
9985476 37254 0 None 912 3 Human 9.6 pKi = 9.6 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 570 8 3 7 2.5 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL145394 37254 0 None 912 3 Human 9.6 pKi = 9.6 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 570 8 3 7 2.5 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
52949448 16629 0 None 3 4 Human 9.6 pKi = 9.6 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 430 6 0 5 4.1 COc1ccccc1N1CCN(CC2OCC(c3ccccc3)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
CHEMBL1242352 16629 0 None 3 4 Human 9.6 pKi = 9.6 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 430 6 0 5 4.1 COc1ccccc1N1CCN(CC2OCC(c3ccccc3)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
57393527 71529 0 None 3 4 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 430 6 0 5 4.1 COc1ccccc1N1CCN(CC2COC(c3ccccc3)(c3ccccc3)O2)CC1 10.1021/jm200421e
CHEMBL1946777 71529 0 None 3 4 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 430 6 0 5 4.1 COc1ccccc1N1CCN(CC2COC(c3ccccc3)(c3ccccc3)O2)CC1 10.1021/jm200421e
CHEMBL1963046 71529 0 None 3 4 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 430 6 0 5 4.1 COc1ccccc1N1CCN(CC2COC(c3ccccc3)(c3ccccc3)O2)CC1 10.1021/jm200421e
4013695 101988 20 None -1 5 Human 9.6 pKi = 9.6 Binding
Binding affinity to adrenergic alpha1A receptorBinding affinity to adrenergic alpha1A receptor
ChEMBL 419 5 2 6 2.0 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c([nH]c4ccccc43)c2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL301707 101988 20 None -1 5 Human 9.6 pKi = 9.6 Binding
Binding affinity to adrenergic alpha1A receptorBinding affinity to adrenergic alpha1A receptor
ChEMBL 419 5 2 6 2.0 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c([nH]c4ccccc43)c2=O)CC1 10.1016/j.ejmech.2011.03.054
4013695 101988 20 None -1 5 Human 9.6 pKi = 9.6 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 419 5 2 6 2.0 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c([nH]c4ccccc43)c2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL301707 101988 20 None -1 5 Human 9.6 pKi = 9.6 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 419 5 2 6 2.0 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c([nH]c4ccccc43)c2=O)CC1 10.1016/j.ejmech.2011.03.054
4209 3141 75 None -3 34 Human 9.6 pKi = 9.6 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00010a001
4893 3141 75 None -3 34 Human 9.6 pKi = 9.6 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00010a001
503 3141 75 None -3 34 Human 9.6 pKi = 9.6 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00010a001
5385 3141 75 None -3 34 Human 9.6 pKi = 9.6 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00010a001
CHEMBL2 3141 75 None -3 34 Human 9.6 pKi = 9.6 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00010a001
DB00457 3141 75 None -3 34 Human 9.6 pKi = 9.6 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00010a001
19085829 205823 0 None 186 3 Human 9.6 pKi = 9.6 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in HEK cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in HEK cells
ChEMBL 473 6 0 7 3.0 O=C1c2cc(F)ccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
CHEMBL83592 205823 0 None 186 3 Human 9.6 pKi = 9.6 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in HEK cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in HEK cells
ChEMBL 473 6 0 7 3.0 O=C1c2cc(F)ccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
10647175 131429 0 None 2 3 Rat 9.6 pKi = 9.6 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 449 5 1 7 2.1 COC(=O)c1ccc2c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)[nH]c2c1 10.1021/jm000541z
CHEMBL369154 131429 0 None 2 3 Rat 9.6 pKi = 9.6 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 449 5 1 7 2.1 COC(=O)c1ccc2c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)[nH]c2c1 10.1021/jm000541z
10478121 170778 0 None 1 5 Rat 9.6 pKi = 9.6 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 435 6 0 7 3.1 COc1cc2ncn(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2cc1OC 10.1021/jm000541z
CHEMBL445325 170778 0 None 1 5 Rat 9.6 pKi = 9.6 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 435 6 0 7 3.1 COc1cc2ncn(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2cc1OC 10.1021/jm000541z
10527469 156241 3 None -1 16 Rat 9.6 pKi = 9.6 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 448 4 1 7 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccnc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL40650 156241 3 None -1 16 Rat 9.6 pKi = 9.6 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 448 4 1 7 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccnc54)c3=O)C[C@@H]21 10.1021/jm990567u
490 191 8 None -2 12 Bovine 9.6 pKi = 9.6 Binding
Binding affinity towards bovine Alpha-1A adrenergic receptorBinding affinity towards bovine Alpha-1A adrenergic receptor
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 10.1016/s0960-894x(01)00159-7
9890547 191 8 None -2 12 Bovine 9.6 pKi = 9.6 Binding
Binding affinity towards bovine Alpha-1A adrenergic receptorBinding affinity towards bovine Alpha-1A adrenergic receptor
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 10.1016/s0960-894x(01)00159-7
CHEMBL268758 191 8 None -2 12 Bovine 9.6 pKi = 9.6 Binding
Binding affinity towards bovine Alpha-1A adrenergic receptorBinding affinity towards bovine Alpha-1A adrenergic receptor
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 10.1016/s0960-894x(01)00159-7
18187410 104871 0 None 10 3 Human 9.6 pKi = 9.6 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 418 6 1 6 3.5 O=C1c2ccccc2C(=O)N1CCCCN1CCC(n2c(O)nc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
CHEMBL311247 104871 0 None 10 3 Human 9.6 pKi = 9.6 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 418 6 1 6 3.5 O=C1c2ccccc2C(=O)N1CCCCN1CCC(n2c(O)nc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
11092254 205443 0 None 1 4 Human 9.6 pKi = 9.6 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 495 8 1 8 3.5 COc1ccc(Cl)cc1N1CCN(CCNc2c(C(C)=O)c(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
CHEMBL80458 205443 0 None 1 4 Human 9.6 pKi = 9.6 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 495 8 1 8 3.5 COc1ccc(Cl)cc1N1CCN(CCNc2c(C(C)=O)c(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
4209 3141 75 None -3 34 Rat 9.6 pKi = 9.6 Binding
Displacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.01.025
4893 3141 75 None -3 34 Rat 9.6 pKi = 9.6 Binding
Displacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.01.025
503 3141 75 None -3 34 Rat 9.6 pKi = 9.6 Binding
Displacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.01.025
5385 3141 75 None -3 34 Rat 9.6 pKi = 9.6 Binding
Displacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.01.025
CHEMBL2 3141 75 None -3 34 Rat 9.6 pKi = 9.6 Binding
Displacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.01.025
DB00457 3141 75 None -3 34 Rat 9.6 pKi = 9.6 Binding
Displacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.01.025
9843389 87028 0 None 245 2 Bovine 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 390 3 0 6 3.8 CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4nnn(C)n4)cc23)CC1 10.1016/j.bmc.2012.10.049
CHEMBL2325935 87028 0 None 245 2 Bovine 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 390 3 0 6 3.8 CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4nnn(C)n4)cc23)CC1 10.1016/j.bmc.2012.10.049
12765746 102253 4 None -3 10 Bovine 9.6 pKi = 9.6 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 344 1 0 3 4.3 CN1CCN([C@H]2Cc3ccccc3Sc3ccc(Cl)cc32)CC1 10.1021/jm100652h
CHEMBL303313 102253 4 None -3 10 Bovine 9.6 pKi = 9.6 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 344 1 0 3 4.3 CN1CCN([C@H]2Cc3ccccc3Sc3ccc(Cl)cc32)CC1 10.1021/jm100652h
10698013 100412 0 None 2 3 Rat 9.6 pKi = 9.6 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 518 5 1 7 3.3 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccc(C(=O)N(C)C)cc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL290519 100412 0 None 2 3 Rat 9.6 pKi = 9.6 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 518 5 1 7 3.3 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccc(C(=O)N(C)C)cc54)c3=O)C[C@@H]21 10.1021/jm990567u
4013695 101988 20 None -1 5 Human 9.5 pKi = 9.5 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 419 5 2 6 2.0 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c([nH]c4ccccc43)c2=O)CC1 10.1016/j.bmcl.2006.09.034
CHEMBL301707 101988 20 None -1 5 Human 9.5 pKi = 9.5 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 419 5 2 6 2.0 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c([nH]c4ccccc43)c2=O)CC1 10.1016/j.bmcl.2006.09.034
11430491 62971 0 None 1 6 Human 9.5 pKi = 9.5 Binding
Equilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cellsEquilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cells
ChEMBL 435 5 1 9 2.4 COc1cc2nc(N3CCN(C(=O)CC4CCSS4)CC3)nc(N)c2cc1OC 10.1021/jm049153d
CHEMBL178673 62971 0 None 1 6 Human 9.5 pKi = 9.5 Binding
Equilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cellsEquilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cells
ChEMBL 435 5 1 9 2.4 COc1cc2nc(N3CCN(C(=O)CC4CCSS4)CC3)nc(N)c2cc1OC 10.1021/jm049153d
10792897 167890 0 None 186 2 Human 9.5 pKi = 9.5 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 556 9 2 7 3.5 Cc1ccc(N2C(=O)c3ccc(C(=O)NC[C@H](O)CN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc1 10.1021/jm9905918
CHEMBL431362 167890 0 None 186 2 Human 9.5 pKi = 9.5 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 556 9 2 7 3.5 Cc1ccc(N2C(=O)c3ccc(C(=O)NC[C@H](O)CN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc1 10.1021/jm9905918
10673690 100474 0 None -1 3 Rat 9.5 pKi = 9.5 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 490 5 2 7 2.7 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cc(C(N)=O)ccc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL291073 100474 0 None -1 3 Rat 9.5 pKi = 9.5 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 490 5 2 7 2.7 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cc(C(N)=O)ccc54)c3=O)C[C@@H]21 10.1021/jm990567u
10721171 37680 0 None 398 3 Human 9.5 pKi = 9.5 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 539 10 0 6 6.2 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(c3ccccc3OC)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL145770 37680 0 None 398 3 Human 9.5 pKi = 9.5 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 539 10 0 6 6.2 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(c3ccccc3OC)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
11134424 104704 0 None -1 4 Human 9.5 pKi = 9.5 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 465 7 1 7 3.5 CC(=O)c1c(-c2ccccc2)nn(C)c(=O)c1NCCN1CCN(c2ccccc2Cl)CC1 10.1021/jm0009336
CHEMBL310599 104704 0 None -1 4 Human 9.5 pKi = 9.5 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 465 7 1 7 3.5 CC(=O)c1c(-c2ccccc2)nn(C)c(=O)c1NCCN1CCN(c2ccccc2Cl)CC1 10.1021/jm0009336
4209 3141 75 None -3 34 Rat 9.5 pKi = 9.5 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm980053f
4893 3141 75 None -3 34 Rat 9.5 pKi = 9.5 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm980053f
503 3141 75 None -3 34 Rat 9.5 pKi = 9.5 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm980053f
5385 3141 75 None -3 34 Rat 9.5 pKi = 9.5 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm980053f
CHEMBL2 3141 75 None -3 34 Rat 9.5 pKi = 9.5 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm980053f
DB00457 3141 75 None -3 34 Rat 9.5 pKi = 9.5 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm980053f
10836245 102720 0 None 10 5 Human 9.5 pKi = 9.5 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 427 7 0 5 4.4 CC(C)Oc1ccccc1N1CCN(Cc2ccc(CN3CCCCC3=O)s2)CC1 10.1016/s0960-894x(02)00347-5
CHEMBL305029 102720 0 None 10 5 Human 9.5 pKi = 9.5 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 427 7 0 5 4.4 CC(C)Oc1ccccc1N1CCN(Cc2ccc(CN3CCCCC3=O)s2)CC1 10.1016/s0960-894x(02)00347-5
CHEMBL552830 102720 0 None 10 5 Human 9.5 pKi = 9.5 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 427 7 0 5 4.4 CC(C)Oc1ccccc1N1CCN(Cc2ccc(CN3CCCCC3=O)s2)CC1 10.1016/s0960-894x(02)00347-5
122179430 121415 0 None -3 3 Human 9.5 pKi = 9.5 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 599 8 1 13 2.7 CCN(CC)c1ccc2cc(-n3cc(C(=O)N4CCN(c5nc(N)c6cc(OC)c(OC)cc6n5)CC4)nn3)c(=O)oc2c1 10.1021/ml5004298
CHEMBL3582270 121415 0 None -3 3 Human 9.5 pKi = 9.5 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 599 8 1 13 2.7 CCN(CC)c1ccc2cc(-n3cc(C(=O)N4CCN(c5nc(N)c6cc(OC)c(OC)cc6n5)CC4)nn3)c(=O)oc2c1 10.1021/ml5004298
44447061 154344 0 None -1 4 Rat 9.5 pKi = 9.5 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 474 5 1 5 4.3 O=C(NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21)C(F)(F)F 10.1016/j.bmcl.2007.11.106
CHEMBL398711 154344 0 None -1 4 Rat 9.5 pKi = 9.5 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 474 5 1 5 4.3 O=C(NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21)C(F)(F)F 10.1016/j.bmcl.2007.11.106
10626493 207364 0 None 239 3 Human 9.5 pKi = 9.5 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 550 7 1 5 4.0 CN1C=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)N(C)C1=O 10.1021/jm990612y
CHEMBL93843 207364 0 None 239 3 Human 9.5 pKi = 9.5 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 550 7 1 5 4.0 CN1C=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)N(C)C1=O 10.1021/jm990612y
10770007 34564 0 None 50 3 Human 9.5 pKi = 9.5 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 607 10 2 9 3.8 CCOC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm990200p
CHEMBL142957 34564 0 None 50 3 Human 9.5 pKi = 9.5 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 607 10 2 9 3.8 CCOC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm990200p
10768829 119358 0 None 32 3 Human 9.5 pKi = 9.5 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 541 7 2 6 3.7 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL344525 119358 0 None 32 3 Human 9.5 pKi = 9.5 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 541 7 2 6 3.7 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
10722099 121068 0 None 190 3 Human 9.5 pKi = 9.5 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 588 8 3 7 2.6 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C1c1cc(F)c(F)c(F)c1 10.1021/jm990202+
CHEMBL357172 121068 0 None 190 3 Human 9.5 pKi = 9.5 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 588 8 3 7 2.6 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C1c1cc(F)c(F)c(F)c1 10.1021/jm990202+
10721476 36969 0 None 691 3 Human 9.5 pKi = 9.5 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 554 6 2 6 4.1 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC3(CC2)OCc2ccccc23)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL145170 36969 0 None 691 3 Human 9.5 pKi = 9.5 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 554 6 2 6 4.1 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC3(CC2)OCc2ccccc23)C1c1ccc(F)c(F)c1 10.1021/jm990201h
10769621 118967 0 None 2290 3 Human 9.5 pKi = 9.5 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 584 8 2 7 4.1 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(OC(C)=O)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL342543 118967 0 None 2290 3 Human 9.5 pKi = 9.5 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 584 8 2 7 4.1 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(OC(C)=O)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
11712470 71976 0 None -5 4 Human 9.5 pKi = 9.5 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 468 14 1 8 4.2 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1cccc([N+](=O)[O-])c1 10.1007/s00044-010-9379-1
CHEMBL197442 71976 0 None -5 4 Human 9.5 pKi = 9.5 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 468 14 1 8 4.2 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1cccc([N+](=O)[O-])c1 10.1007/s00044-010-9379-1
11712470 71976 0 None -5 4 Human 9.5 pKi = 9.5 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 468 14 1 8 4.2 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1cccc([N+](=O)[O-])c1 10.1007/s00044-010-9379-1
CHEMBL197442 71976 0 None -5 4 Human 9.5 pKi = 9.5 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 468 14 1 8 4.2 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1cccc([N+](=O)[O-])c1 10.1007/s00044-010-9379-1
11712470 71976 0 None -5 4 Human 9.5 pKi = 9.5 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 468 14 1 8 4.2 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1cccc([N+](=O)[O-])c1 10.1021/jm0580398
CHEMBL197442 71976 0 None -5 4 Human 9.5 pKi = 9.5 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 468 14 1 8 4.2 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1cccc([N+](=O)[O-])c1 10.1021/jm0580398
44298626 195454 0 None 25 3 Human 9.5 pKi = 9.5 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 427 7 1 7 1.4 Cc1n[nH]c(=O)n(CCCN2CCN(c3ccccc3OCC(F)(F)F)CC2)c1=O 10.1016/s0960-894x(03)00305-6
CHEMBL55290 195454 0 None 25 3 Human 9.5 pKi = 9.5 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 427 7 1 7 1.4 Cc1n[nH]c(=O)n(CCCN2CCN(c3ccccc3OCC(F)(F)F)CC2)c1=O 10.1016/s0960-894x(03)00305-6
9960497 100448 0 None 154 6 Human 9.5 pKi = 9.5 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.9 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)OCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00010a001
CHEMBL290860 100448 0 None 154 6 Human 9.5 pKi = 9.5 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.9 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)OCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00010a001
3416533 194966 6 None 4 2 Rat 9.5 pKi = 9.5 Binding
Binding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranesBinding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranes
ChEMBL 447 5 0 8 2.0 COc1ccccc1N1CCN(CCn2c(=O)c3c(c4ccccc4n3C)n(C)c2=O)CC1 10.1021/jm00110a014
CHEMBL54716 194966 6 None 4 2 Rat 9.5 pKi = 9.5 Binding
Binding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranesBinding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranes
ChEMBL 447 5 0 8 2.0 COc1ccccc1N1CCN(CCn2c(=O)c3c(c4ccccc4n3C)n(C)c2=O)CC1 10.1021/jm00110a014
10961351 163477 0 None 1 4 Human 9.5 pKi = 9.5 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 449 7 1 7 3.0 CC(=O)c1c(-c2ccccc2)nn(C)c(=O)c1NCCN1CCN(c2ccccc2F)CC1 10.1021/jm0009336
CHEMBL420205 163477 0 None 1 4 Human 9.5 pKi = 9.5 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 449 7 1 7 3.0 CC(=O)c1c(-c2ccccc2)nn(C)c(=O)c1NCCN1CCN(c2ccccc2F)CC1 10.1021/jm0009336
71508640 87018 0 None 46 2 Bovine 9.5 pKi = 9.5 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 388 3 0 4 5.0 CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4ccnn4C)cc23)CC1 10.1016/j.bmc.2012.10.049
CHEMBL2325926 87018 0 None 46 2 Bovine 9.5 pKi = 9.5 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 388 3 0 4 5.0 CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4ccnn4C)cc23)CC1 10.1016/j.bmc.2012.10.049
10097792 118563 0 None -1 8 Human 9.5 pKi = 9.5 Binding
Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.
ChEMBL 508 13 1 8 4.1 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3cccc(CN(C)C)c3)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL341665 118563 0 None -1 8 Human 9.5 pKi = 9.5 Binding
Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.
ChEMBL 508 13 1 8 4.1 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3cccc(CN(C)C)c3)nc(N)c2cc1OC 10.1021/jm9810654
90645597 112462 0 None -2 3 Human 9.5 pKi = 9.5 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 654 12 3 9 4.2 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)CCCC(=O)NCc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
CHEMBL3298750 112462 0 None -2 3 Human 9.5 pKi = 9.5 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 654 12 3 9 4.2 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)CCCC(=O)NCc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
10841070 37649 0 None 2 4 Human 9.5 pKi = 9.5 Binding
Binding affinity against isolated human prostate using [3H]- prazosin.Binding affinity against isolated human prostate using [3H]- prazosin.
ChEMBL 585 10 0 5 7.4 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL145746 37649 0 None 2 4 Human 9.5 pKi = 9.5 Binding
Binding affinity against isolated human prostate using [3H]- prazosin.Binding affinity against isolated human prostate using [3H]- prazosin.
ChEMBL 585 10 0 5 7.4 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
10504673 202650 0 None -1 3 Rat 9.5 pKi = 9.5 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 473 5 1 6 4.1 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(-c5ccccc5)csc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL61483 202650 0 None -1 3 Rat 9.5 pKi = 9.5 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 473 5 1 6 4.1 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(-c5ccccc5)csc4c3=O)C[C@@H]21 10.1021/jm000541z
9894665 103786 1 None 30 8 Human 9.5 pKi = 9.5 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 585 10 2 8 3.3 CC(C)Oc1ccccc1N1CCN(C[C@@H](O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(N(C)C)cc2)C3=O)CC1 10.1021/jm9905918
CHEMBL309106 103786 1 None 30 8 Human 9.5 pKi = 9.5 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 585 10 2 8 3.3 CC(C)Oc1ccccc1N1CCN(C[C@@H](O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(N(C)C)cc2)C3=O)CC1 10.1021/jm9905918
10474042 170229 0 None -1 6 Human 9.5 pKi = 9.5 Binding
Binding affinity was determined on human cloned Alpha-1A adrenoceptorBinding affinity was determined on human cloned Alpha-1A adrenoceptor
ChEMBL 365 6 0 4 4.1 COc1cccc2c1CCCC2CCCN1CCN(c2ccccn2)CC1 10.1021/jm010866v
CHEMBL444590 170229 0 None -1 6 Human 9.5 pKi = 9.5 Binding
Binding affinity was determined on human cloned Alpha-1A adrenoceptorBinding affinity was determined on human cloned Alpha-1A adrenoceptor
ChEMBL 365 6 0 4 4.1 COc1cccc2c1CCCC2CCCN1CCN(c2ccccn2)CC1 10.1021/jm010866v
9955302 100139 0 None -1 3 Rat 9.5 pKi = 9.5 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 448 4 1 7 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccncc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL287965 100139 0 None -1 3 Rat 9.5 pKi = 9.5 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 448 4 1 7 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccncc54)c3=O)C[C@@H]21 10.1021/jm990567u
50905381 56320 0 None -1 4 Human 9.5 pKi = 9.5 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 422 11 2 6 2.7 COc1ccc(C[C@@H](C)NCCOc2ccccc2OC(C)C)cc1S(N)(=O)=O 10.1016/j.ejmech.2010.09.042
CHEMBL1630938 56320 0 None -1 4 Human 9.5 pKi = 9.5 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 422 11 2 6 2.7 COc1ccc(C[C@@H](C)NCCOc2ccccc2OC(C)C)cc1S(N)(=O)=O 10.1016/j.ejmech.2010.09.042
49782792 17879 0 None 1 6 Bovine 9.5 pKi = 9.5 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 381 3 1 4 3.3 CC(=O)NCc1ccc2c(c1)[C@@H](N1CCN(C)CC1)Cc1ccccc1S2 10.1021/jm100652h
CHEMBL1259174 17879 0 None 1 6 Bovine 9.5 pKi = 9.5 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 381 3 1 4 3.3 CC(=O)NCc1ccc2c(c1)[C@@H](N1CCN(C)CC1)Cc1ccccc1S2 10.1021/jm100652h
148842 3915 27 None 8 5 Human 9.5 pKi = 9.5 Binding
Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)
ChEMBL 511 8 1 6 4.7 COc1ccccc1N1CCN(CC1)CCCNC(=O)c1cccc2c1oc(c1ccccc1)c(c2=O)C 10.1021/jm030825u
496 3915 27 None 8 5 Human 9.5 pKi = 9.5 Binding
Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)
ChEMBL 511 8 1 6 4.7 COc1ccccc1N1CCN(CC1)CCCNC(=O)c1cccc2c1oc(c1ccccc1)c(c2=O)C 10.1021/jm030825u
CHEMBL278865 3915 27 None 8 5 Human 9.5 pKi = 9.5 Binding
Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)
ChEMBL 511 8 1 6 4.7 COc1ccccc1N1CCN(CC1)CCCNC(=O)c1cccc2c1oc(c1ccccc1)c(c2=O)C 10.1021/jm030825u
13911290 28140 0 None -1 6 Human 9.5 pKi = 9.5 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 386 5 1 7 1.6 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3sccc3c2=O)CC1 10.1016/s0960-894x(01)00159-7
CHEMBL13735 28140 0 None -1 6 Human 9.5 pKi = 9.5 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 386 5 1 7 1.6 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3sccc3c2=O)CC1 10.1016/s0960-894x(01)00159-7
9809007 172540 8 None 134 6 Human 9.5 pKi = 9.5 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
CHEMBL448620 172540 8 None 134 6 Human 9.5 pKi = 9.5 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
9809007 172540 8 None 134 6 Human 9.5 pKi = 9.5 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
CHEMBL448620 172540 8 None 134 6 Human 9.5 pKi = 9.5 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
50905585 56321 0 None -1 3 Human 9.5 pKi = 9.5 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 470 12 2 6 3.5 COc1ccc(C[C@@H](C)NCCOc2ccccc2OCc2ccccc2)cc1S(N)(=O)=O 10.1016/j.ejmech.2010.09.042
CHEMBL1630939 56321 0 None -1 3 Human 9.5 pKi = 9.5 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 470 12 2 6 3.5 COc1ccc(C[C@@H](C)NCCOc2ccccc2OCc2ccccc2)cc1S(N)(=O)=O 10.1016/j.ejmech.2010.09.042
491 192 9 None -4 12 Bovine 9.5 pKi = 9.5 Binding
Binding affinity towards bovine Alpha-1A adrenergic receptorBinding affinity towards bovine Alpha-1A adrenergic receptor
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 10.1016/s0960-894x(01)00159-7
9891167 192 9 None -4 12 Bovine 9.5 pKi = 9.5 Binding
Binding affinity towards bovine Alpha-1A adrenergic receptorBinding affinity towards bovine Alpha-1A adrenergic receptor
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 10.1016/s0960-894x(01)00159-7
CHEMBL13856 192 9 None -4 12 Bovine 9.5 pKi = 9.5 Binding
Binding affinity towards bovine Alpha-1A adrenergic receptorBinding affinity towards bovine Alpha-1A adrenergic receptor
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 10.1016/s0960-894x(01)00159-7
9809007 172540 8 None 134 6 Human 9.5 pKi = 9.5 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00010a001
CHEMBL448620 172540 8 None 134 6 Human 9.5 pKi = 9.5 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00010a001
499 4046 18 None -1 15 Bovine 9.5 pKi = 9.5 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm00018a001
5685 4046 18 None -1 15 Bovine 9.5 pKi = 9.5 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm00018a001
CHEMBL25554 4046 18 None -1 15 Bovine 9.5 pKi = 9.5 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm00018a001
9809007 172540 8 None 134 6 Human 9.5 pKi = 9.5 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1016/s0960-894x(99)00484-9
CHEMBL448620 172540 8 None 134 6 Human 9.5 pKi = 9.5 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1016/s0960-894x(99)00484-9
10599007 204492 0 None -1 8 Bovine 9.5 pKi = 9.5 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligand
ChEMBL 435 9 1 6 4.6 COc1cccc(OC)c1OCCNC[C@@H]1Oc2ccccc2O[C@H]1c1ccc(C)cc1 10.1021/jm960069a
CHEMBL72657 204492 0 None -1 8 Bovine 9.5 pKi = 9.5 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligand
ChEMBL 435 9 1 6 4.6 COc1cccc(OC)c1OCCNC[C@@H]1Oc2ccccc2O[C@H]1c1ccc(C)cc1 10.1021/jm960069a
10599007 204492 0 None 1 8 Human 9.5 pKi = 9.5 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 435 9 1 6 4.6 COc1cccc(OC)c1OCCNC[C@@H]1Oc2ccccc2O[C@H]1c1ccc(C)cc1 10.1016/j.bmcl.2004.11.032
CHEMBL72657 204492 0 None 1 8 Human 9.5 pKi = 9.5 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 435 9 1 6 4.6 COc1cccc(OC)c1OCCNC[C@@H]1Oc2ccccc2O[C@H]1c1ccc(C)cc1 10.1016/j.bmcl.2004.11.032
10917953 207965 0 None 1 10 Bovine 9.5 pKi = 9.5 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 489 6 0 8 3.6 Cn1nnc(-c2ccc3c(c2)c(C2CCN(CCN4CCOC4=O)CC2)cn3-c2ccc(F)cc2)n1 10.1021/jm020938y
CHEMBL97242 207965 0 None 1 10 Bovine 9.5 pKi = 9.5 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 489 6 0 8 3.6 Cn1nnc(-c2ccc3c(c2)c(C2CCN(CCN4CCOC4=O)CC2)cn3-c2ccc(F)cc2)n1 10.1021/jm020938y
10743310 169208 0 None 3 3 Rat 9.5 pKi = 9.5 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 479 5 1 9 2.4 COc1cnc2sc3c(=O)n(CCN4C[C@@H]5CCc6c(OC)cccc6[C@@H]5C4)c(=O)[nH]c3c2n1 10.1021/jm990567u
CHEMBL441032 169208 0 None 3 3 Rat 9.5 pKi = 9.5 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 479 5 1 9 2.4 COc1cnc2sc3c(=O)n(CCN4C[C@@H]5CCc6c(OC)cccc6[C@@H]5C4)c(=O)[nH]c3c2n1 10.1021/jm990567u
9830741 207833 1 None -1 7 Rat 9.4 pKi = 9.4 Binding
Binding affinity towards Alpha1A rat adrenergic receptors, using [125I]HEAT as radioligand.Binding affinity towards Alpha1A rat adrenergic receptors, using [125I]HEAT as radioligand.
ChEMBL 475 6 1 4 5.0 C[C@@H]1OC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1021/jm000085e
CHEMBL96467 207833 1 None -1 7 Rat 9.4 pKi = 9.4 Binding
Binding affinity towards Alpha1A rat adrenergic receptors, using [125I]HEAT as radioligand.Binding affinity towards Alpha1A rat adrenergic receptors, using [125I]HEAT as radioligand.
ChEMBL 475 6 1 4 5.0 C[C@@H]1OC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1021/jm000085e
44275505 96772 0 None - 1 Human 9.4 pKi = 9.4 Binding
Binding affinity towards recombinant human alpha-1A adrenergic receptorBinding affinity towards recombinant human alpha-1A adrenergic receptor
ChEMBL 556 10 2 7 2.6 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)C(C(=O)NCCCN2CCC(c3ccccn3)CC2)C(=O)N1 10.1021/jm030480f
CHEMBL265001 96772 0 None - 1 Human 9.4 pKi = 9.4 Binding
Binding affinity towards recombinant human alpha-1A adrenergic receptorBinding affinity towards recombinant human alpha-1A adrenergic receptor
ChEMBL 556 10 2 7 2.6 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)C(C(=O)NCCCN2CCC(c3ccccn3)CC2)C(=O)N1 10.1021/jm030480f
9874983 65437 18 None - 1 Human 9.4 pKi = 9.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 557 9 2 7 3.5 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(c3ccccn3)CC2)C(=O)N1 10.1016/j.bmcl.2004.11.032
CHEMBL182998 65437 18 None - 1 Human 9.4 pKi = 9.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 557 9 2 7 3.5 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(c3ccccn3)CC2)C(=O)N1 10.1016/j.bmcl.2004.11.032
499 4046 18 None 1 15 Human 9.4 pKi = 9.4 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm00018a001
5685 4046 18 None 1 15 Human 9.4 pKi = 9.4 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm00018a001
CHEMBL25554 4046 18 None 1 15 Human 9.4 pKi = 9.4 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm00018a001
9830292 168165 0 None 562 3 Human 9.4 pKi = 9.4 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 607 7 2 7 4.3 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@@H]2CC[C@@H](N3CCC(C#N)(c4ccccc4)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
CHEMBL433284 168165 0 None 562 3 Human 9.4 pKi = 9.4 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 607 7 2 7 4.3 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@@H]2CC[C@@H](N3CCC(C#N)(c4ccccc4)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
2435 3563 83 None -3 49 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm020938y
60149 3563 83 None -3 49 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm020938y
98 3563 83 None -3 49 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm020938y
CHEMBL12713 3563 83 None -3 49 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm020938y
DB06144 3563 83 None -3 49 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm020938y
2435 3563 83 None -3 49 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1016/j.bmc.2012.10.049
60149 3563 83 None -3 49 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1016/j.bmc.2012.10.049
98 3563 83 None -3 49 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1016/j.bmc.2012.10.049
CHEMBL12713 3563 83 None -3 49 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1016/j.bmc.2012.10.049
DB06144 3563 83 None -3 49 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1016/j.bmc.2012.10.049
2435 3563 83 None -3 49 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm100652h
60149 3563 83 None -3 49 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm100652h
98 3563 83 None -3 49 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm100652h
CHEMBL12713 3563 83 None -3 49 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm100652h
DB06144 3563 83 None -3 49 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm100652h
9847845 28422 0 None -1 6 Bovine 9.4 pKi = 9.4 Binding
Binding affinity towards bovine Alpha-1A adrenergic receptorBinding affinity towards bovine Alpha-1A adrenergic receptor
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3sc(C)c(-c4ccccc4)c3c2=O)CC1 10.1016/s0960-894x(01)00159-7
CHEMBL13754 28422 0 None -1 6 Bovine 9.4 pKi = 9.4 Binding
Binding affinity towards bovine Alpha-1A adrenergic receptorBinding affinity towards bovine Alpha-1A adrenergic receptor
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3sc(C)c(-c4ccccc4)c3c2=O)CC1 10.1016/s0960-894x(01)00159-7
487 3607 21 None 1 12 Bovine 9.4 pKi = 9.4 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligand
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm960069a
60602 3607 21 None 1 12 Bovine 9.4 pKi = 9.4 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligand
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm960069a
CHEMBL405355 3607 21 None 1 12 Bovine 9.4 pKi = 9.4 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligand
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm960069a
DB09239 3607 21 None 1 12 Bovine 9.4 pKi = 9.4 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligand
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm960069a
44300129 167404 0 None 912 3 Human 9.4 pKi = 9.4 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 583 7 2 7 4.0 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@@H]2CC[C@@H](N3CCC(c4ccccn4)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
CHEMBL429697 167404 0 None 912 3 Human 9.4 pKi = 9.4 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 583 7 2 7 4.0 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@@H]2CC[C@@H](N3CCC(c4ccccn4)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
10838523 101173 0 None 1 3 Rat 9.4 pKi = 9.4 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
ChEMBL 482 4 1 7 3.6 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccc(Cl)nc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL295741 101173 0 None 1 3 Rat 9.4 pKi = 9.4 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
ChEMBL 482 4 1 7 3.6 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccc(Cl)nc54)c3=O)C[C@@H]21 10.1021/jm990567u
134149596 148441 0 None 4 4 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 368 6 0 5 3.6 CC(C)Oc1ccccc1N1CCN(CCc2ccc3c(c2)OCO3)CC1 10.1016/j.ejmech.2016.06.052
CHEMBL3938038 148441 0 None 4 4 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 368 6 0 5 3.6 CC(C)Oc1ccccc1N1CCN(CCc2ccc3c(c2)OCO3)CC1 10.1016/j.ejmech.2016.06.052
10767264 206971 0 None 102 3 Human 9.4 pKi = 9.4 Binding
Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 486 7 3 3 4.1 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1021/jm990612y
CHEMBL91405 206971 0 None 102 3 Human 9.4 pKi = 9.4 Binding
Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 486 7 3 3 4.1 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1021/jm990612y
4209 3141 75 None -3 34 Human 9.4 pKi = 9.4 Binding
Compound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptorCompound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm980053f
4893 3141 75 None -3 34 Human 9.4 pKi = 9.4 Binding
Compound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptorCompound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm980053f
503 3141 75 None -3 34 Human 9.4 pKi = 9.4 Binding
Compound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptorCompound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm980053f
5385 3141 75 None -3 34 Human 9.4 pKi = 9.4 Binding
Compound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptorCompound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm980053f
CHEMBL2 3141 75 None -3 34 Human 9.4 pKi = 9.4 Binding
Compound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptorCompound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm980053f
DB00457 3141 75 None -3 34 Human 9.4 pKi = 9.4 Binding
Compound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptorCompound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm980053f
10839825 206718 0 None 2818 3 Human 9.4 pKi = 9.4 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 525 7 2 4 4.1 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1C 10.1021/jm990612y
CHEMBL89965 206718 0 None 2818 3 Human 9.4 pKi = 9.4 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 525 7 2 4 4.1 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1C 10.1021/jm990612y
10552608 100390 0 None 8 3 Rat 9.4 pKi = 9.4 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 477 4 1 8 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5nc(C)c(C)nc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL290243 100390 0 None 8 3 Rat 9.4 pKi = 9.4 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 477 4 1 8 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5nc(C)c(C)nc54)c3=O)C[C@@H]21 10.1021/jm990567u
11133288 166009 0 None 7 7 Human 9.4 pKi = 9.4 Binding
Affinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptorAffinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptor
ChEMBL 407 12 1 5 4.3 COc1cccc(OC)c1OCCNCCOc1ccccc1Cc1ccccc1 10.1021/jm011066n
CHEMBL42558 166009 0 None 7 7 Human 9.4 pKi = 9.4 Binding
Affinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptorAffinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptor
ChEMBL 407 12 1 5 4.3 COc1cccc(OC)c1OCCNCCOc1ccccc1Cc1ccccc1 10.1021/jm011066n
9865801 94695 10 None 3 3 Human 9.4 pKi = 9.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 401 8 2 5 5.0 COc1c(C)c(C)c(O)c(C)c1CN(C)CCOc1cc(C)c(O)cc1C(C)C 10.1021/jm960697s
CHEMBL25300 94695 10 None 3 3 Human 9.4 pKi = 9.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 401 8 2 5 5.0 COc1c(C)c(C)c(O)c(C)c1CN(C)CCOc1cc(C)c(O)cc1C(C)C 10.1021/jm960697s
11633517 72496 0 None -1 4 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 437 13 1 6 4.6 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1cccc(C)c1 10.1021/jm0580398
CHEMBL199080 72496 0 None -1 4 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 437 13 1 6 4.6 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1cccc(C)c1 10.1021/jm0580398
10572854 112539 0 None 2 3 Bovine 9.4 pKi = 9.4 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 396 8 1 5 3.0 COc1ccccc1N1CCN(CCCNc2ccccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL330060 112539 0 None 2 3 Bovine 9.4 pKi = 9.4 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 396 8 1 5 3.0 COc1ccccc1N1CCN(CCCNc2ccccc2C(=O)N(C)C)CC1 10.1021/jm970166j
10525639 207122 0 None 15 2 Bovine 9.4 pKi = 9.4 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 410 8 1 6 3.9 COc1ccccc1N1CCN(CCCNc2ncccc2C(=O)C(C)(C)C)CC1 10.1021/jm970166j
CHEMBL92261 207122 0 None 15 2 Bovine 9.4 pKi = 9.4 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 410 8 1 6 3.9 COc1ccccc1N1CCN(CCCNc2ncccc2C(=O)C(C)(C)C)CC1 10.1021/jm970166j
10554957 32963 0 None 1000 3 Human 9.4 pKi = 9.4 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 564 11 0 7 5.5 COCC1=C(C(=O)OC)C(c2ccc(F)c(F)c2)N(CCCCCN2CCC(C#N)(c3ccccc3)CC2)C(C)=N1 10.1021/jm9902032
CHEMBL141604 32963 0 None 1000 3 Human 9.4 pKi = 9.4 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 564 11 0 7 5.5 COCC1=C(C(=O)OC)C(c2ccc(F)c(F)c2)N(CCCCCN2CCC(C#N)(c3ccccc3)CC2)C(C)=N1 10.1021/jm9902032
10626772 36206 0 None 776 3 Human 9.4 pKi = 9.4 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 564 11 0 7 5.5 COCC1=NC(C)=C(C(=O)OC)C(c2ccc(F)c(F)c2)N1CCCCCN1CCC(C#N)(c2ccccc2)CC1 10.1021/jm9902032
CHEMBL144534 36206 0 None 776 3 Human 9.4 pKi = 9.4 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 564 11 0 7 5.5 COCC1=NC(C)=C(C(=O)OC)C(c2ccc(F)c(F)c2)N1CCCCCN1CCC(C#N)(c2ccccc2)CC1 10.1021/jm9902032
10650129 37478 0 None 162 3 Human 9.4 pKi = 9.4 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 540 10 0 7 5.2 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCN(c3ccccc3OC)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL145587 37478 0 None 162 3 Human 9.4 pKi = 9.4 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 540 10 0 7 5.2 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCN(c3ccccc3OC)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
10841070 37649 0 None 2 4 Human 9.4 pKi = 9.4 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 585 10 0 5 7.4 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL145746 37649 0 None 2 4 Human 9.4 pKi = 9.4 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 585 10 0 5 7.4 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
10815549 121988 0 None 234 3 Human 9.4 pKi = 9.4 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 509 9 0 5 6.2 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL359421 121988 0 None 234 3 Human 9.4 pKi = 9.4 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 509 9 0 5 6.2 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
10032383 110083 0 None 194 6 Human 9.4 pKi = 9.4 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 666 15 4 8 4.2 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
136680387 110083 0 None 194 6 Human 9.4 pKi = 9.4 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 666 15 4 8 4.2 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
CHEMBL323579 110083 0 None 194 6 Human 9.4 pKi = 9.4 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 666 15 4 8 4.2 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
44390708 64241 0 None 630 3 Human 9.4 pKi = 9.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 666 15 4 8 4.2 CCC1=C(C(N)=O)[C@H](c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN)N1 10.1016/j.bmcl.2004.11.032
CHEMBL180932 64241 0 None 630 3 Human 9.4 pKi = 9.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 666 15 4 8 4.2 CCC1=C(C(N)=O)[C@H](c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN)N1 10.1016/j.bmcl.2004.11.032
9865801 94695 10 None 3 3 Human 9.4 pKi = 9.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 401 8 2 5 5.0 COc1c(C)c(C)c(O)c(C)c1CN(C)CCOc1cc(C)c(O)cc1C(C)C 10.1016/j.bmcl.2004.11.032
CHEMBL25300 94695 10 None 3 3 Human 9.4 pKi = 9.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 401 8 2 5 5.0 COc1c(C)c(C)c(O)c(C)c1CN(C)CCOc1cc(C)c(O)cc1C(C)C 10.1016/j.bmcl.2004.11.032
2389 3306 118 None -6 68 Rat 9.4 pKi = 9.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
5073 3306 118 None -6 68 Rat 9.4 pKi = 9.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
96 3306 118 None -6 68 Rat 9.4 pKi = 9.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
CHEMBL85 3306 118 None -6 68 Rat 9.4 pKi = 9.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
DB00734 3306 118 None -6 68 Rat 9.4 pKi = 9.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
44300111 100833 0 None 794 3 Human 9.4 pKi = 9.4 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 583 7 2 7 4.0 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@@H]2CC[C@H](N3CCC(c4ccccn4)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
CHEMBL293515 100833 0 None 794 3 Human 9.4 pKi = 9.4 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 583 7 2 7 4.0 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@@H]2CC[C@H](N3CCC(c4ccccn4)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
44431194 92531 0 None 1 3 Human 9.4 pKi = 9.4 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 448 5 0 6 3.6 CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4ccncc4C3=O)CC2)CC1 10.1016/j.bmcl.2006.12.111
CHEMBL243229 92531 0 None 1 3 Human 9.4 pKi = 9.4 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 448 5 0 6 3.6 CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4ccncc4C3=O)CC2)CC1 10.1016/j.bmcl.2006.12.111
9959689 101786 0 None 281 3 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 568 7 2 7 3.1 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc(F)c(F)c2)CC1 10.1016/s0960-894x(99)00653-8
CHEMBL300222 101786 0 None 281 3 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 568 7 2 7 3.1 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc(F)c(F)c2)CC1 10.1016/s0960-894x(99)00653-8
10393665 33892 0 None 47 3 Human 9.4 pKi = 9.4 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 593 9 2 9 3.4 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm990200p
CHEMBL142383 33892 0 None 47 3 Human 9.4 pKi = 9.4 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 593 9 2 9 3.4 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm990200p
10556164 121670 0 None 549 3 Human 9.4 pKi = 9.4 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 572 8 3 6 3.1 CC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C1c1cc(F)c(F)c(F)c1 10.1021/jm990202+
CHEMBL358795 121670 0 None 549 3 Human 9.4 pKi = 9.4 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 572 8 3 6 3.1 CC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C1c1cc(F)c(F)c(F)c1 10.1021/jm990202+
9809007 172540 8 None 134 6 Human 9.4 pKi = 9.4 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm990200p
CHEMBL448620 172540 8 None 134 6 Human 9.4 pKi = 9.4 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm990200p
10816815 119329 0 None 776 3 Human 9.4 pKi = 9.4 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 566 6 2 5 4.9 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC3(CCCc4ccccc43)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL344339 119329 0 None 776 3 Human 9.4 pKi = 9.4 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 566 6 2 5 4.9 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC3(CCCc4ccccc43)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
10839391 157346 0 None 1 3 Rat 9.4 pKi = 9.4 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 472 4 1 7 3.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cc(C#N)ccc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL40780 157346 0 None 1 3 Rat 9.4 pKi = 9.4 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 472 4 1 7 3.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cc(C#N)ccc54)c3=O)C[C@@H]21 10.1021/jm990567u
101333429 117050 0 None 588 6 Human 9.4 pKi = 9.4 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1cccc([N+](=O)[O-])c1 10.1021/jm00019a001
CHEMBL3392247 117050 0 None 588 6 Human 9.4 pKi = 9.4 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1cccc([N+](=O)[O-])c1 10.1021/jm00019a001
13305910 11804 1 None -2 9 Human 9.4 pKi = 9.4 Binding
Antagonist activity at human alpha A1 adrenoreceptor expressed in CHO cellsAntagonist activity at human alpha A1 adrenoreceptor expressed in CHO cells
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1016/j.ejmech.2020.112419
CHEMBL1182155 11804 1 None -2 9 Human 9.4 pKi = 9.4 Binding
Antagonist activity at human alpha A1 adrenoreceptor expressed in CHO cellsAntagonist activity at human alpha A1 adrenoreceptor expressed in CHO cells
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1016/j.ejmech.2020.112419
CHEMBL215421 11804 1 None -2 9 Human 9.4 pKi = 9.4 Binding
Antagonist activity at human alpha A1 adrenoreceptor expressed in CHO cellsAntagonist activity at human alpha A1 adrenoreceptor expressed in CHO cells
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1016/j.ejmech.2020.112419
CHEMBL3741808 11804 1 None -2 9 Human 9.4 pKi = 9.4 Binding
Antagonist activity at human alpha A1 adrenoreceptor expressed in CHO cellsAntagonist activity at human alpha A1 adrenoreceptor expressed in CHO cells
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1016/j.ejmech.2020.112419
13305910 11804 1 None -2 9 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL1182155 11804 1 None -2 9 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL215421 11804 1 None -2 9 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL3741808 11804 1 None -2 9 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
13305910 11804 1 None -2 9 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
CHEMBL1182155 11804 1 None -2 9 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
CHEMBL215421 11804 1 None -2 9 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
CHEMBL3741808 11804 1 None -2 9 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
13305910 11804 1 None -2 9 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL1182155 11804 1 None -2 9 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL215421 11804 1 None -2 9 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL3741808 11804 1 None -2 9 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1016/j.ejmech.2012.09.049
13305910 11804 1 None -2 9 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm301525w
CHEMBL1182155 11804 1 None -2 9 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm301525w
CHEMBL215421 11804 1 None -2 9 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm301525w
CHEMBL3741808 11804 1 None -2 9 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm301525w
13305910 11804 1 None -2 9 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1039/C4MD00484A
CHEMBL1182155 11804 1 None -2 9 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1039/C4MD00484A
CHEMBL215421 11804 1 None -2 9 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1039/C4MD00484A
CHEMBL3741808 11804 1 None -2 9 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1039/C4MD00484A
10624165 100534 0 None 3 3 Rat 9.4 pKi = 9.4 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 469 6 1 7 3.6 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(C(C)C)c(OC)sc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL291528 100534 0 None 3 3 Rat 9.4 pKi = 9.4 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 469 6 1 7 3.6 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(C(C)C)c(OC)sc4c3=O)C[C@@H]21 10.1021/jm000541z
10506729 203676 0 None 53 3 Human 9.4 pKi = 9.4 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 544 9 1 6 4.4 CC(C)Oc1ccccc1N1CCN(CCCNC(=O)c2ccc3c(c2)C(=O)N(c2cccc(F)c2)C3=O)CC1 10.1021/jm9905918
CHEMBL67552 203676 0 None 53 3 Human 9.4 pKi = 9.4 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 544 9 1 6 4.4 CC(C)Oc1ccccc1N1CCN(CCCNC(=O)c2ccc3c(c2)C(=O)N(c2cccc(F)c2)C3=O)CC1 10.1021/jm9905918
49781234 17897 0 None -1 4 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 390 2 0 5 4.1 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4ccnn4C)cc32)CC1 10.1021/jm100652h
CHEMBL1259231 17897 0 None -1 4 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 390 2 0 5 4.1 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4ccnn4C)cc32)CC1 10.1021/jm100652h
10344976 101188 2 None 1 6 Human 9.4 pKi = 9.4 Binding
Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.
ChEMBL 477 11 1 10 3.4 COc1cc2nc(N(C)CCSSCCN(C)C(=O)c3ccco3)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL29591 101188 2 None 1 6 Human 9.4 pKi = 9.4 Binding
Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.
ChEMBL 477 11 1 10 3.4 COc1cc2nc(N(C)CCSSCCN(C)C(=O)c3ccco3)nc(N)c2cc1OC 10.1021/jm9810654
49782791 17878 0 None 2 6 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 381 3 1 4 3.3 CC(=O)NCc1ccc2c(c1)[C@H](N1CCN(C)CC1)Cc1ccccc1S2 10.1021/jm100652h
CHEMBL1259173 17878 0 None 2 6 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 381 3 1 4 3.3 CC(=O)NCc1ccc2c(c1)[C@H](N1CCN(C)CC1)Cc1ccccc1S2 10.1021/jm100652h
10506222 111459 0 None 691 3 Human 9.4 pKi = 9.4 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 523 9 3 5 3.5 COCC1=C(C(=O)NCCCN2CCC(c3ccccc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1021/jm990612y
CHEMBL327716 111459 0 None 691 3 Human 9.4 pKi = 9.4 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 523 9 3 5 3.5 COCC1=C(C(=O)NCCCN2CCC(c3ccccc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1021/jm990612y
499 4046 18 None 1 15 Human 9.4 pKi = 9.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1007/s00044-010-9379-1
5685 4046 18 None 1 15 Human 9.4 pKi = 9.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1007/s00044-010-9379-1
CHEMBL25554 4046 18 None 1 15 Human 9.4 pKi = 9.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1007/s00044-010-9379-1
499 4046 18 None 1 15 Human 9.4 pKi = 9.4 Binding
Affinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assayAffinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm021078o
5685 4046 18 None 1 15 Human 9.4 pKi = 9.4 Binding
Affinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assayAffinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm021078o
CHEMBL25554 4046 18 None 1 15 Human 9.4 pKi = 9.4 Binding
Affinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assayAffinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm021078o
499 4046 18 None 1 15 Human 9.4 pKi = 9.4 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm030952q
5685 4046 18 None 1 15 Human 9.4 pKi = 9.4 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm030952q
CHEMBL25554 4046 18 None 1 15 Human 9.4 pKi = 9.4 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm030952q
499 4046 18 None 1 15 Human 9.4 pKi = 9.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1007/s00044-010-9379-1
5685 4046 18 None 1 15 Human 9.4 pKi = 9.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1007/s00044-010-9379-1
CHEMBL25554 4046 18 None 1 15 Human 9.4 pKi = 9.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1007/s00044-010-9379-1
499 4046 18 None 1 15 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1016/j.bmc.2010.08.002
5685 4046 18 None 1 15 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1016/j.bmc.2010.08.002
CHEMBL25554 4046 18 None 1 15 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1016/j.bmc.2010.08.002
499 4046 18 None 1 15 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptorDisplacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptor
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm991065j
5685 4046 18 None 1 15 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptorDisplacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptor
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm991065j
CHEMBL25554 4046 18 None 1 15 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptorDisplacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptor
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm991065j
499 4046 18 None 1 15 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm800461k
5685 4046 18 None 1 15 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm800461k
CHEMBL25554 4046 18 None 1 15 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm800461k
499 4046 18 None 1 15 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm301525w
5685 4046 18 None 1 15 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm301525w
CHEMBL25554 4046 18 None 1 15 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm301525w
10527466 202664 0 None -1 3 Rat 9.4 pKi = 9.4 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 448 5 2 6 2.3 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cc(NC(C)=O)ccc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL61598 202664 0 None -1 3 Rat 9.4 pKi = 9.4 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 448 5 2 6 2.3 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cc(NC(C)=O)ccc4c3=O)C[C@@H]21 10.1021/jm000541z
49782794 17884 0 None -1 6 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 409 4 1 4 4.0 CC(C)C(=O)NCc1ccc2c(c1)[C@H](N1CCN(C)CC1)Cc1ccccc1S2 10.1021/jm100652h
CHEMBL1259189 17884 0 None -1 6 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 409 4 1 4 4.0 CC(C)C(=O)NCc1ccc2c(c1)[C@H](N1CCN(C)CC1)Cc1ccccc1S2 10.1021/jm100652h
9891166 33582 0 None 1 5 Bovine 9.4 pKi = 9.4 Binding
Binding affinity towards bovine Alpha-1A adrenergic receptorBinding affinity towards bovine Alpha-1A adrenergic receptor
ChEMBL 476 6 0 8 3.3 COc1ccccc1N1CCN(CCn2c(=O)c3c(-c4ccccc4)csc3n(C)c2=O)CC1 10.1016/s0960-894x(01)00159-7
CHEMBL14213 33582 0 None 1 5 Bovine 9.4 pKi = 9.4 Binding
Binding affinity towards bovine Alpha-1A adrenergic receptorBinding affinity towards bovine Alpha-1A adrenergic receptor
ChEMBL 476 6 0 8 3.3 COc1ccccc1N1CCN(CCn2c(=O)c3c(-c4ccccc4)csc3n(C)c2=O)CC1 10.1016/s0960-894x(01)00159-7
10994812 205073 0 None 3 4 Human 9.4 pKi = 9.4 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 509 9 1 8 3.9 COc1ccc(Cl)cc1N1CCN(CCCNc2c(C(C)=O)c(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
CHEMBL77618 205073 0 None 3 4 Human 9.4 pKi = 9.4 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 509 9 1 8 3.9 COc1ccc(Cl)cc1N1CCN(CCCNc2c(C(C)=O)c(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
44299974 101867 0 None 89 3 Human 9.4 pKi = 9.4 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 608 7 2 8 3.4 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4C#N)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
CHEMBL300821 101867 0 None 89 3 Human 9.4 pKi = 9.4 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 608 7 2 8 3.4 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4C#N)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
10553935 161796 0 None -1 3 Rat 9.4 pKi = 9.4 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 481 4 1 6 4.2 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccc(Cl)cc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL41444 161796 0 None -1 3 Rat 9.4 pKi = 9.4 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 481 4 1 6 4.2 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccc(Cl)cc54)c3=O)C[C@@H]21 10.1021/jm990567u
10529370 206916 0 None 524 3 Human 9.4 pKi = 9.4 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 499 9 3 5 3.0 COCC1=C(C(=O)NCCCN2CCC(c3ccccn3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1016/j.ejmech.2017.03.025
CHEMBL91125 206916 0 None 524 3 Human 9.4 pKi = 9.4 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 499 9 3 5 3.0 COCC1=C(C(=O)NCCCN2CCC(c3ccccn3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1016/j.ejmech.2017.03.025
44447063 94555 0 None -1 3 Rat 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 434 6 1 5 4.2 CCC(=O)NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21 10.1016/j.bmcl.2007.11.106
CHEMBL252031 94555 0 None -1 3 Rat 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 434 6 1 5 4.2 CCC(=O)NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21 10.1016/j.bmcl.2007.11.106
10529370 206916 0 None 524 3 Human 9.4 pKi = 9.4 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 499 9 3 5 3.0 COCC1=C(C(=O)NCCCN2CCC(c3ccccn3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1021/jm990612y
CHEMBL91125 206916 0 None 524 3 Human 9.4 pKi = 9.4 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 499 9 3 5 3.0 COCC1=C(C(=O)NCCCN2CCC(c3ccccn3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1021/jm990612y
10602912 102711 0 None 301 2 Human 9.3 pKi = 9.3 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 558 9 3 8 2.9 CC(C)Oc1ccccc1N1CCN(C[C@@H](O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(O)cc2)C3=O)CC1 10.1021/jm9905918
CHEMBL304977 102711 0 None 301 2 Human 9.3 pKi = 9.3 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 558 9 3 8 2.9 CC(C)Oc1ccccc1N1CCN(C[C@@H](O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(O)cc2)C3=O)CC1 10.1021/jm9905918
44300087 96392 0 None 67 3 Human 9.3 pKi = 9.3 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 607 7 2 7 4.5 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@@H]2CC[C@@H](N3CCC(c4ccccc4C#N)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
CHEMBL262002 96392 0 None 67 3 Human 9.3 pKi = 9.3 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 607 7 2 7 4.5 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@@H]2CC[C@@H](N3CCC(c4ccccc4C#N)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
10364994 167861 0 None -6 4 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 423 13 1 6 4.3 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccccc1 10.1021/jm0580398
CHEMBL43116 167861 0 None -6 4 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 423 13 1 6 4.3 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccccc1 10.1021/jm0580398
10364994 167861 0 None -6 4 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 423 13 1 6 4.3 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
CHEMBL43116 167861 0 None -6 4 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 423 13 1 6 4.3 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
10095156 78514 0 None 1 3 Rat 9.3 pKi = 9.3 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 447 4 1 6 3.6 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccccc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL2112073 78514 0 None 1 3 Rat 9.3 pKi = 9.3 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 447 4 1 6 3.6 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccccc54)c3=O)C[C@@H]21 10.1021/jm990567u
10678154 170577 0 None 1 3 Rat 9.3 pKi = 9.3 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 397 4 1 6 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cscc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL445071 170577 0 None 1 3 Rat 9.3 pKi = 9.3 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 397 4 1 6 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cscc4c3=O)C[C@@H]21 10.1021/jm000541z
10414908 202741 0 None 204 3 Human 9.3 pKi = 9.3 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 539 7 0 4 5.9 Cc1ccc(C2(c3ccc(C)cc3)CC(=O)N(CCCN3CCC(C#N)(c4ccccc4Cl)CC3)C2=O)cc1 10.1016/s0960-894x(01)00320-1
CHEMBL62045 202741 0 None 204 3 Human 9.3 pKi = 9.3 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 539 7 0 4 5.9 Cc1ccc(C2(c3ccc(C)cc3)CC(=O)N(CCCN3CCC(C#N)(c4ccccc4Cl)CC3)C2=O)cc1 10.1016/s0960-894x(01)00320-1
71817386 102559 0 None 1 7 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 355 7 1 6 3.3 COc1ccc2ccoc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
CHEMBL2419769 102559 0 None 1 7 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 355 7 1 6 3.3 COc1ccc2ccoc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
CHEMBL3040851 102559 0 None 1 7 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 355 7 1 6 3.3 COc1ccc2ccoc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
11049209 207382 0 None 8 9 Bovine 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 486 6 1 5 4.4 Cn1ccc(-c2ccc3c(c2)c(C2CCN(CCN4CCNC4=O)CC2)cn3-c2ccc(F)cc2)n1 10.1021/jm020938y
CHEMBL93923 207382 0 None 8 9 Bovine 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 486 6 1 5 4.4 Cn1ccc(-c2ccc3c(c2)c(C2CCN(CCN4CCNC4=O)CC2)cn3-c2ccc(F)cc2)n1 10.1021/jm020938y
44447068 154099 0 None 1 3 Rat 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 448 6 1 5 4.4 CC(C)C(=O)NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21 10.1016/j.bmcl.2007.11.106
CHEMBL398525 154099 0 None 1 3 Rat 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 448 6 1 5 4.4 CC(C)C(=O)NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21 10.1016/j.bmcl.2007.11.106
10647790 101364 0 None 4 3 Rat 9.3 pKi = 9.3 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 463 4 1 8 2.7 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5nc(C)cnc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL297218 101364 0 None 4 3 Rat 9.3 pKi = 9.3 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 463 4 1 8 2.7 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5nc(C)cnc54)c3=O)C[C@@H]21 10.1021/jm990567u
10507220 121250 0 None 316 3 Human 9.3 pKi = 9.3 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 567 10 0 7 5.6 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)cc1F 10.1021/jm9902032
CHEMBL357842 121250 0 None 316 3 Human 9.3 pKi = 9.3 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 567 10 0 7 5.6 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)cc1F 10.1021/jm9902032
10626843 168641 0 None 67 3 Human 9.3 pKi = 9.3 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 568 10 0 8 5.0 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCN(c3ccccc3C(=O)OC)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL436407 168641 0 None 67 3 Human 9.3 pKi = 9.3 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 568 10 0 8 5.0 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCN(c3ccccc3C(=O)OC)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
10032383 110083 0 None 194 6 Human 9.3 pKi = 9.3 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 666 15 4 8 4.2 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
136680387 110083 0 None 194 6 Human 9.3 pKi = 9.3 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 666 15 4 8 4.2 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
CHEMBL323579 110083 0 None 194 6 Human 9.3 pKi = 9.3 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 666 15 4 8 4.2 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
18738385 203701 0 None 181 3 Human 9.3 pKi = 9.3 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 427 7 0 5 4.4 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCC3=O)cs2)CC1 10.1016/s0960-894x(02)00347-5
CHEMBL67713 203701 0 None 181 3 Human 9.3 pKi = 9.3 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 427 7 0 5 4.4 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCC3=O)cs2)CC1 10.1016/s0960-894x(02)00347-5
122065 189525 3 None 2 8 Rat 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranesDisplacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranes
ChEMBL 380 5 1 6 1.5 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1 10.1021/jm970159v
CHEMBL51433 189525 3 None 2 8 Rat 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranesDisplacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranes
ChEMBL 380 5 1 6 1.5 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1 10.1021/jm970159v
2865 4112 73 None -4 54 Rat 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1016/j.bmcl.2007.11.106
59 4112 73 None -4 54 Rat 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1016/j.bmcl.2007.11.106
60854 4112 73 None -4 54 Rat 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1016/j.bmcl.2007.11.106
CHEMBL708 4112 73 None -4 54 Rat 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1016/j.bmcl.2007.11.106
DB00246 4112 73 None -4 54 Rat 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1016/j.bmcl.2007.11.106
49781453 17835 0 None -1 4 Bovine 9.3 pKi = 9.3 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 386 2 0 3 5.3 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4ccccc4)cc32)CC1 10.1021/jm100652h
CHEMBL1259043 17835 0 None -1 4 Bovine 9.3 pKi = 9.3 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 386 2 0 3 5.3 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4ccccc4)cc32)CC1 10.1021/jm100652h
10393665 33892 0 None 47 3 Human 9.3 pKi = 9.3 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 593 9 2 9 3.4 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm990200p
CHEMBL142383 33892 0 None 47 3 Human 9.3 pKi = 9.3 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 593 9 2 9 3.4 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm990200p
9916549 121538 0 None 1 4 Human 9.3 pKi = 9.3 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 592 10 3 8 3.1 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
CHEMBL358595 121538 0 None 1 4 Human 9.3 pKi = 9.3 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 592 10 3 8 3.1 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
11757736 33717 0 None 870 4 Human 9.3 pKi = 9.3 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 570 9 2 6 4.3 COCC1=C(C(=O)OC)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990201h
CHEMBL142243 33717 0 None 870 4 Human 9.3 pKi = 9.3 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 570 9 2 6 4.3 COCC1=C(C(=O)OC)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990201h
10840177 38086 0 None 537 3 Human 9.3 pKi = 9.3 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 540 7 2 5 4.6 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL146109 38086 0 None 537 3 Human 9.3 pKi = 9.3 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 540 7 2 5 4.6 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
9891213 161478 0 None -12 6 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 477 5 1 8 4.0 COc1cc2nc(N3CCN(C(=O)OCc4ccccc4)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
CHEMBL4128084 161478 0 None -12 6 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 477 5 1 8 4.0 COc1cc2nc(N3CCN(C(=O)OCc4ccccc4)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
489 145 28 None -4 13 Bovine 9.3 pKi = 9.3 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm970166j
5640 145 28 None -4 13 Bovine 9.3 pKi = 9.3 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm970166j
CHEMBL420060 145 28 None -4 13 Bovine 9.3 pKi = 9.3 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm970166j
44298447 100772 0 None 5 3 Human 9.3 pKi = 9.3 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 430 6 1 6 1.7 Cc1c[nH]c(=O)n(CCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)c1=O 10.1016/s0960-894x(03)00305-6
CHEMBL293149 100772 0 None 5 3 Human 9.3 pKi = 9.3 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 430 6 1 6 1.7 Cc1c[nH]c(=O)n(CCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)c1=O 10.1016/s0960-894x(03)00305-6
4209 3141 75 None -3 34 Human 9.3 pKi = 9.3 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
4893 3141 75 None -3 34 Human 9.3 pKi = 9.3 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
503 3141 75 None -3 34 Human 9.3 pKi = 9.3 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
5385 3141 75 None -3 34 Human 9.3 pKi = 9.3 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
CHEMBL2 3141 75 None -3 34 Human 9.3 pKi = 9.3 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
DB00457 3141 75 None -3 34 Human 9.3 pKi = 9.3 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
10029146 205668 0 None 331 3 Human 9.3 pKi = 9.3 Binding
Binding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assayBinding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assay
ChEMBL 504 8 0 6 3.9 CCOC(=O)[C@@H]1CN(CCCCN2C(=O)c3cc(Cl)ccc3S2(=O)=O)CC[C@@H]1c1ccccc1 10.1016/s0960-894x(98)00451-x
CHEMBL82267 205668 0 None 331 3 Human 9.3 pKi = 9.3 Binding
Binding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assayBinding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assay
ChEMBL 504 8 0 6 3.9 CCOC(=O)[C@@H]1CN(CCCCN2C(=O)c3cc(Cl)ccc3S2(=O)=O)CC[C@@H]1c1ccccc1 10.1016/s0960-894x(98)00451-x
11800077 100484 0 None 2 3 Rat 9.3 pKi = 9.3 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 481 4 1 6 4.2 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccc(Cl)c54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL291154 100484 0 None 2 3 Rat 9.3 pKi = 9.3 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 481 4 1 6 4.2 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccc(Cl)c54)c3=O)C[C@@H]21 10.1021/jm990567u
44289261 164888 0 None 12 7 Human 9.3 pKi = 9.3 Binding
Affinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptorAffinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptor
ChEMBL 417 9 1 4 5.1 COc1cccc(OC)c1OCCNCC1Cc2ccccc2C(c2ccccc2)C1 10.1021/jm011066n
CHEMBL42231 164888 0 None 12 7 Human 9.3 pKi = 9.3 Binding
Affinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptorAffinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptor
ChEMBL 417 9 1 4 5.1 COc1cccc(OC)c1OCCNCC1Cc2ccccc2C(c2ccccc2)C1 10.1021/jm011066n
52942395 17889 0 None 3 6 Bovine 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 386 3 0 4 5.0 CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4cncnc4)cc23)CC1 10.1016/j.bmc.2012.10.049
CHEMBL1259203 17889 0 None 3 6 Bovine 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 386 3 0 4 5.0 CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4cncnc4)cc23)CC1 10.1016/j.bmc.2012.10.049
49781448 17818 0 None 1 4 Bovine 9.3 pKi = 9.3 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 406 2 0 4 5.7 Cc1ccc(-c2ccc3c(c2)C(N2CCN(C)CC2)Cc2ccccc2S3)s1 10.1021/jm100652h
CHEMBL1259005 17818 0 None 1 4 Bovine 9.3 pKi = 9.3 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 406 2 0 4 5.7 Cc1ccc(-c2ccc3c(c2)C(N2CCN(C)CC2)Cc2ccccc2S3)s1 10.1021/jm100652h
52942395 17889 0 None 3 6 Bovine 9.3 pKi = 9.3 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 386 3 0 4 5.0 CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4cncnc4)cc23)CC1 10.1021/jm100652h
CHEMBL1259203 17889 0 None 3 6 Bovine 9.3 pKi = 9.3 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 386 3 0 4 5.0 CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4cncnc4)cc23)CC1 10.1021/jm100652h
10744687 100398 0 None -1 3 Rat 9.3 pKi = 9.3 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 490 5 2 7 2.7 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccc(C(N)=O)cc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL290388 100398 0 None -1 3 Rat 9.3 pKi = 9.3 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 490 5 2 7 2.7 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccc(C(N)=O)cc54)c3=O)C[C@@H]21 10.1021/jm990567u
13911290 28140 0 None -2 6 Rat 9.3 pKi = 9.3 Binding
Binding affinity towards rat Alpha-1A adrenergic receptorBinding affinity towards rat Alpha-1A adrenergic receptor
ChEMBL 386 5 1 7 1.6 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3sccc3c2=O)CC1 10.1016/s0960-894x(01)00159-7
CHEMBL13735 28140 0 None -2 6 Rat 9.3 pKi = 9.3 Binding
Binding affinity towards rat Alpha-1A adrenergic receptorBinding affinity towards rat Alpha-1A adrenergic receptor
ChEMBL 386 5 1 7 1.6 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3sccc3c2=O)CC1 10.1016/s0960-894x(01)00159-7
10769331 111506 0 None 79 6 Human 9.3 pKi = 9.3 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 566 9 2 7 5.9 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc(Cl)c([N+](=O)[O-])c1 10.1021/jm980077m
CHEMBL327931 111506 0 None 79 6 Human 9.3 pKi = 9.3 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 566 9 2 7 5.9 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc(Cl)c([N+](=O)[O-])c1 10.1021/jm980077m
10769331 85263 0 None - 1 Human 9.3 pKi = 9.3 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 566 9 2 7 5.0 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc(Cl)c([N+](=O)[O-])c1 10.1007/s00044-004-0120-9
CHEMBL2260370 85263 0 None - 1 Human 9.3 pKi = 9.3 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 566 9 2 7 5.0 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc(Cl)c([N+](=O)[O-])c1 10.1007/s00044-004-0120-9
15054191 197728 0 None 4 2 Rat 9.3 pKi = 9.3 Binding
Binding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranesBinding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranes
ChEMBL 423 4 2 5 2.6 O=c1[nH]c2c([nH]c3ccccc32)c(=O)n1CCN1CCN(c2ccccc2Cl)CC1 10.1021/jm00110a014
CHEMBL57163 197728 0 None 4 2 Rat 9.3 pKi = 9.3 Binding
Binding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranesBinding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranes
ChEMBL 423 4 2 5 2.6 O=c1[nH]c2c([nH]c3ccccc32)c(=O)n1CCN1CCN(c2ccccc2Cl)CC1 10.1021/jm00110a014
10917316 205464 0 None 10 4 Human 9.3 pKi = 9.3 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 447 8 1 8 2.6 COc1ccc(Cl)cc1N1CCN(CCCNc2c(C(C)=O)c(C)nn(C)c2=O)CC1 10.1021/jm0009336
CHEMBL80599 205464 0 None 10 4 Human 9.3 pKi = 9.3 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 447 8 1 8 2.6 COc1ccc(Cl)cc1N1CCN(CCCNc2c(C(C)=O)c(C)nn(C)c2=O)CC1 10.1021/jm0009336
10411384 157140 0 None -1 3 Rat 9.3 pKi = 9.3 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 448 4 1 7 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cnccc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL40754 157140 0 None -1 3 Rat 9.3 pKi = 9.3 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 448 4 1 7 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cnccc54)c3=O)C[C@@H]21 10.1021/jm990567u
3157 1458 71 None -2 12 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm0580398
7170 1458 71 None -2 12 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm0580398
954 1458 71 None -2 12 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm0580398
CHEMBL707 1458 71 None -2 12 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm0580398
DB00590 1458 71 None -2 12 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm0580398
3157 1458 71 None -2 12 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm8016046
7170 1458 71 None -2 12 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm8016046
954 1458 71 None -2 12 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm8016046
CHEMBL707 1458 71 None -2 12 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm8016046
DB00590 1458 71 None -2 12 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm8016046
71508713 87040 0 None 295 2 Bovine 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 388 3 0 4 5.0 CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4ccn(C)n4)cc23)CC1 10.1016/j.bmc.2012.10.049
CHEMBL2326176 87040 0 None 295 2 Bovine 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 388 3 0 4 5.0 CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4ccn(C)n4)cc23)CC1 10.1016/j.bmc.2012.10.049
44358574 119343 0 None -2 5 Human 9.3 pKi = 9.3 Binding
Binding affinity was determined on human cloned Alpha-1A adrenoceptorBinding affinity was determined on human cloned Alpha-1A adrenoceptor
ChEMBL 340 9 1 4 4.0 COc1cccc2c1CCCC2CCCNCCOc1ccccn1 10.1021/jm010866v
CHEMBL344432 119343 0 None -2 5 Human 9.3 pKi = 9.3 Binding
Binding affinity was determined on human cloned Alpha-1A adrenoceptorBinding affinity was determined on human cloned Alpha-1A adrenoceptor
ChEMBL 340 9 1 4 4.0 COc1cccc2c1CCCC2CCCNCCOc1ccccn1 10.1021/jm010866v
44431607 147570 0 None 42 4 Human 9.3 pKi = 9.3 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 509 7 1 5 4.7 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3cccc(Cl)c3F)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL393105 147570 0 None 42 4 Human 9.3 pKi = 9.3 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 509 7 1 5 4.7 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3cccc(Cl)c3F)CC2)CC1 10.1016/j.bmcl.2007.04.008
12765746 102253 4 None -3 10 Bovine 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 344 1 0 3 4.3 CN1CCN([C@H]2Cc3ccccc3Sc3ccc(Cl)cc32)CC1 10.1021/jm020938y
CHEMBL303313 102253 4 None -3 10 Bovine 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 344 1 0 3 4.3 CN1CCN([C@H]2Cc3ccccc3Sc3ccc(Cl)cc32)CC1 10.1021/jm020938y
11092112 207605 0 None 3 9 Bovine 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 485 6 0 6 4.9 O=C1OCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4ncccn4)cc23)CC1 10.1021/jm020938y
CHEMBL95175 207605 0 None 3 9 Bovine 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 485 6 0 6 4.9 O=C1OCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4ncccn4)cc23)CC1 10.1021/jm020938y
10844296 201392 0 None -1 3 Rat 9.2 pKi = 9.2 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 425 4 1 5 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cc(Cl)ccc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL60471 201392 0 None -1 3 Rat 9.2 pKi = 9.2 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 425 4 1 5 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cc(Cl)ccc4c3=O)C[C@@H]21 10.1021/jm000541z
9847196 30150 0 None -2 5 Rat 9.2 pKi = 9.2 Binding
Binding affinity towards rat Alpha-1A adrenergic receptorBinding affinity towards rat Alpha-1A adrenergic receptor
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3sc(-c4ccccc4)cc3c2=O)CC1 10.1016/s0960-894x(01)00159-7
CHEMBL13903 30150 0 None -2 5 Rat 9.2 pKi = 9.2 Binding
Binding affinity towards rat Alpha-1A adrenergic receptorBinding affinity towards rat Alpha-1A adrenergic receptor
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3sc(-c4ccccc4)cc3c2=O)CC1 10.1016/s0960-894x(01)00159-7
4209 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Binding affinity against human Alpha-1A adrenergic receptorBinding affinity against human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/s0960-894x(99)00484-9
4893 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Binding affinity against human Alpha-1A adrenergic receptorBinding affinity against human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/s0960-894x(99)00484-9
503 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Binding affinity against human Alpha-1A adrenergic receptorBinding affinity against human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/s0960-894x(99)00484-9
5385 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Binding affinity against human Alpha-1A adrenergic receptorBinding affinity against human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/s0960-894x(99)00484-9
CHEMBL2 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Binding affinity against human Alpha-1A adrenergic receptorBinding affinity against human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/s0960-894x(99)00484-9
DB00457 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Binding affinity against human Alpha-1A adrenergic receptorBinding affinity against human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/s0960-894x(99)00484-9
4209 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm980506g
4893 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm980506g
503 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm980506g
5385 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm980506g
CHEMBL2 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm980506g
DB00457 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm980506g
9916549 121538 0 None -1 4 Rat 9.2 pKi = 9.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of ratIn vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of rat
ChEMBL 592 10 3 8 3.1 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
CHEMBL358595 121538 0 None -1 4 Rat 9.2 pKi = 9.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of ratIn vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of rat
ChEMBL 592 10 3 8 3.1 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
4209 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
The compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cellsThe compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm981006q
4893 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
The compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cellsThe compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm981006q
503 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
The compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cellsThe compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm981006q
5385 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
The compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cellsThe compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm981006q
CHEMBL2 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
The compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cellsThe compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm981006q
DB00457 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
The compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cellsThe compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm981006q
4209 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1007/s00044-010-9379-1
4893 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1007/s00044-010-9379-1
503 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1007/s00044-010-9379-1
5385 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1007/s00044-010-9379-1
CHEMBL2 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1007/s00044-010-9379-1
DB00457 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1007/s00044-010-9379-1
4209 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm9810654
4893 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm9810654
503 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm9810654
5385 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm9810654
CHEMBL2 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm9810654
DB00457 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm9810654
4209 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm030952q
4893 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm030952q
503 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm030952q
5385 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm030952q
CHEMBL2 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm030952q
DB00457 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm030952q
4209 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1007/s00044-010-9379-1
4893 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1007/s00044-010-9379-1
503 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1007/s00044-010-9379-1
5385 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1007/s00044-010-9379-1
CHEMBL2 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1007/s00044-010-9379-1
DB00457 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1007/s00044-010-9379-1
9824384 118761 1 None -14 8 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
CHEMBL342062 118761 1 None -14 8 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
4209 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.ejmech.2017.05.003
4893 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.ejmech.2017.05.003
503 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.ejmech.2017.05.003
5385 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.ejmech.2017.05.003
CHEMBL2 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.ejmech.2017.05.003
DB00457 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.ejmech.2017.05.003
4209 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Equilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cellsEquilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm049153d
4893 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Equilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cellsEquilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm049153d
503 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Equilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cellsEquilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm049153d
5385 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Equilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cellsEquilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm049153d
CHEMBL2 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Equilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cellsEquilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm049153d
DB00457 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Equilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cellsEquilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm049153d
4209 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.12.024
4893 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.12.024
503 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.12.024
5385 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.12.024
CHEMBL2 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.12.024
DB00457 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.12.024
10718317 100498 0 None 1 3 Rat 9.2 pKi = 9.2 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 448 4 1 7 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ncccc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL291262 100498 0 None 1 3 Rat 9.2 pKi = 9.2 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 448 4 1 7 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ncccc54)c3=O)C[C@@H]21 10.1021/jm990567u
10437624 121245 0 None 398 3 Human 9.2 pKi = 9.2 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 553 10 1 7 4.3 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCN(c3ccccc3C(N)=O)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL357828 121245 0 None 398 3 Human 9.2 pKi = 9.2 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 553 10 1 7 4.3 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCN(c3ccccc3C(N)=O)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
499 4046 18 None -1 15 Bovine 9.2 pKi = 9.2 Binding
Binding affinity of compound towards Alpha-1 adrenergic receptor using [3H]prazosin 0.5 nM ligand in frontal cortex calf was determinedBinding affinity of compound towards Alpha-1 adrenergic receptor using [3H]prazosin 0.5 nM ligand in frontal cortex calf was determined
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm950759z
5685 4046 18 None -1 15 Bovine 9.2 pKi = 9.2 Binding
Binding affinity of compound towards Alpha-1 adrenergic receptor using [3H]prazosin 0.5 nM ligand in frontal cortex calf was determinedBinding affinity of compound towards Alpha-1 adrenergic receptor using [3H]prazosin 0.5 nM ligand in frontal cortex calf was determined
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm950759z
CHEMBL25554 4046 18 None -1 15 Bovine 9.2 pKi = 9.2 Binding
Binding affinity of compound towards Alpha-1 adrenergic receptor using [3H]prazosin 0.5 nM ligand in frontal cortex calf was determinedBinding affinity of compound towards Alpha-1 adrenergic receptor using [3H]prazosin 0.5 nM ligand in frontal cortex calf was determined
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm950759z
3894573 3368 6 None -1 5 Human 9.2 pKi = 9.2 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 10.1016/j.bmcl.2004.11.032
495 3368 6 None -1 5 Human 9.2 pKi = 9.2 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 10.1016/j.bmcl.2004.11.032
CHEMBL88272 3368 6 None -1 5 Human 9.2 pKi = 9.2 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 10.1016/j.bmcl.2004.11.032
44300107 100659 0 None 114 3 Human 9.2 pKi = 9.2 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 607 7 2 7 4.5 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4C#N)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
CHEMBL292365 100659 0 None 114 3 Human 9.2 pKi = 9.2 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 607 7 2 7 4.5 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4C#N)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
44294957 191020 0 None 295 3 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 556 7 2 8 2.7 O=C1OCC2=C1C(c1ccc(F)c(F)c1)N(C(=O)NCCCN1CCN(c3ccccc3[N+](=O)[O-])CC1)C(=O)N2 10.1016/s0960-894x(99)00653-8
CHEMBL51871 191020 0 None 295 3 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 556 7 2 8 2.7 O=C1OCC2=C1C(c1ccc(F)c(F)c1)N(C(=O)NCCCN1CCN(c3ccccc3[N+](=O)[O-])CC1)C(=O)N2 10.1016/s0960-894x(99)00653-8
2142 3074 58 None -2 37 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/ml5004298
4920903 3074 58 None -2 37 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/ml5004298
502 3074 58 None -2 37 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/ml5004298
5775 3074 58 None -2 37 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/ml5004298
CHEMBL597 3074 58 None -2 37 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/ml5004298
DB00692 3074 58 None -2 37 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/ml5004298
10697912 206969 0 None - 1 Human 9.2 pKi = 9.2 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 550 7 2 5 4.0 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1C 10.1021/jm990612y
CHEMBL91403 206969 0 None - 1 Human 9.2 pKi = 9.2 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 550 7 2 5 4.0 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1C 10.1021/jm990612y
10530552 33215 0 None 26 3 Human 9.2 pKi = 9.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 543 7 3 7 3.1 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3O)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL141821 33215 0 None 26 3 Human 9.2 pKi = 9.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 543 7 3 7 3.1 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3O)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
4209 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm990201h
4893 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm990201h
503 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm990201h
5385 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm990201h
CHEMBL2 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm990201h
DB00457 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm990201h
24897950 56322 0 None -2 6 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 462 11 2 6 2.9 COc1ccc(C[C@@H](C)NCCOc2ccccc2OCC(F)(F)F)cc1S(N)(=O)=O 10.1016/j.ejmech.2010.09.042
CHEMBL1630940 56322 0 None -2 6 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 462 11 2 6 2.9 COc1ccc(C[C@@H](C)NCCOc2ccccc2OCC(F)(F)F)cc1S(N)(=O)=O 10.1016/j.ejmech.2010.09.042
4209 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm0009336
4893 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm0009336
503 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm0009336
5385 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm0009336
CHEMBL2 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm0009336
DB00457 3141 75 None -3 34 Human 9.2 pKi = 9.2 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm0009336
499 4046 18 None -1 15 Bovine 9.2 pKi = 9.2 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligand
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm960069a
5685 4046 18 None -1 15 Bovine 9.2 pKi = 9.2 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligand
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm960069a
CHEMBL25554 4046 18 None -1 15 Bovine 9.2 pKi = 9.2 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligand
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm960069a
11016418 106095 0 None 5 9 Bovine 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 488 6 0 7 4.2 Cn1cnc(-c2ccc3c(c2)c(C2CCN(CCN4CCOC4=O)CC2)cn3-c2ccc(F)cc2)n1 10.1021/jm020938y
CHEMBL313424 106095 0 None 5 9 Bovine 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 488 6 0 7 4.2 Cn1cnc(-c2ccc3c(c2)c(C2CCN(CCN4CCOC4=O)CC2)cn3-c2ccc(F)cc2)n1 10.1021/jm020938y
3157 1458 71 None -1 12 Rat 9.2 pKi = 9.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 nan
7170 1458 71 None -1 12 Rat 9.2 pKi = 9.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 nan
954 1458 71 None -1 12 Rat 9.2 pKi = 9.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 nan
CHEMBL707 1458 71 None -1 12 Rat 9.2 pKi = 9.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 nan
DB00590 1458 71 None -1 12 Rat 9.2 pKi = 9.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 nan
10434440 205471 0 None -4 4 Human 9.2 pKi = 9.2 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 461 8 1 8 2.9 COc1ccccc1N1CCN(CCNc2c(C(C)=O)c(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
CHEMBL80641 205471 0 None -4 4 Human 9.2 pKi = 9.2 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 461 8 1 8 2.9 COc1ccccc1N1CCN(CCNc2c(C(C)=O)c(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
489 145 28 None -3 13 Human 9.2 pKi = 9.2 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm960697s
5640 145 28 None -3 13 Human 9.2 pKi = 9.2 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm960697s
CHEMBL420060 145 28 None -3 13 Human 9.2 pKi = 9.2 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm960697s
3894573 3368 6 None -1 5 Human 9.2 pKi = 9.2 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 10.1021/jm960697s
495 3368 6 None -1 5 Human 9.2 pKi = 9.2 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 10.1021/jm960697s
CHEMBL88272 3368 6 None -1 5 Human 9.2 pKi = 9.2 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 10.1021/jm960697s
46934643 16645 0 None 6 4 Human 9.2 pKi = 9.2 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 479 7 0 6 3.5 COc1ccccc1N1CCN(C[C@H]2CO[C@@](CN3CCCCCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
CHEMBL1242632 16645 0 None 6 4 Human 9.2 pKi = 9.2 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 479 7 0 6 3.5 COc1ccccc1N1CCN(C[C@H]2CO[C@@](CN3CCCCCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
145956955 162077 0 None -2 3 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 397 5 2 8 2.2 COc1cc2nc(N3CCC[C@H](NC(=O)c4ccco4)C3)nc(N)c2cc1OC 10.1016/j.ejmech.2017.05.003
CHEMBL4161165 162077 0 None -2 3 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 397 5 2 8 2.2 COc1cc2nc(N3CCC[C@H](NC(=O)c4ccco4)C3)nc(N)c2cc1OC 10.1016/j.ejmech.2017.05.003
10742076 100290 0 None -1 3 Rat 9.2 pKi = 9.2 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 447 4 1 6 3.6 COc1cccc2c1CCC1CN(CCn3c(=O)[nH]c4c(sc5ccccc54)c3=O)CC21 10.1021/jm990567u
CHEMBL289361 100290 0 None -1 3 Rat 9.2 pKi = 9.2 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 447 4 1 6 3.6 COc1cccc2c1CCC1CN(CCn3c(=O)[nH]c4c(sc5ccccc54)c3=O)CC21 10.1021/jm990567u
44390708 64241 0 None 630 3 Human 9.2 pKi = 9.2 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 666 15 4 8 4.2 CCC1=C(C(N)=O)[C@H](c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN)N1 10.1021/jm960697s
CHEMBL180932 64241 0 None 630 3 Human 9.2 pKi = 9.2 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 666 15 4 8 4.2 CCC1=C(C(N)=O)[C@H](c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN)N1 10.1021/jm960697s
10834793 84550 0 None -1 7 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 363 8 1 6 2.7 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(F)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153557 84550 0 None -1 7 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 363 8 1 6 2.7 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(F)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2220925 84550 0 None -1 7 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 363 8 1 6 2.7 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(F)c2O1 10.1016/j.ejmech.2012.09.049
56946573 71497 0 None 6 4 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 428 6 0 4 4.9 COc1ccccc1N1CCN(CC2CCC(c3ccccc3)(c3ccccc3)O2)CC1 10.1021/jm200421e
CHEMBL1946780 71497 0 None 6 4 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 428 6 0 4 4.9 COc1ccccc1N1CCN(CC2CCC(c3ccccc3)(c3ccccc3)O2)CC1 10.1021/jm200421e
CHEMBL1962870 71497 0 None 6 4 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 428 6 0 4 4.9 COc1ccccc1N1CCN(CC2CCC(c3ccccc3)(c3ccccc3)O2)CC1 10.1021/jm200421e
9866614 14683 1 None 120 3 Human 9.2 pKi = 9.2 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 416 9 1 5 2.1 CC(C)Oc1ccccc1N1CCN(CCCNC(=O)CN2CCCCC2=O)CC1 10.1016/j.bmcl.2004.11.032
CHEMBL12062 14683 1 None 120 3 Human 9.2 pKi = 9.2 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 416 9 1 5 2.1 CC(C)Oc1ccccc1N1CCN(CCCNC(=O)CN2CCCCC2=O)CC1 10.1016/j.bmcl.2004.11.032
135559170 102033 0 None 8 7 Rat 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranesDisplacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranes
ChEMBL 391 4 1 5 2.5 COc1ccccc1N1CCN(CC2CN3C(=O)Nc4ccccc4C3=N2)CC1 10.1021/jm970159v
CHEMBL302021 102033 0 None 8 7 Rat 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranesDisplacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranes
ChEMBL 391 4 1 5 2.5 COc1ccccc1N1CCN(CC2CN3C(=O)Nc4ccccc4C3=N2)CC1 10.1021/jm970159v
107715 200922 22 None -1 20 Rat 9.2 pKi = 9.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 611 5 3 6 2.7 CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O nan
CHEMBL1255837 200922 22 None -1 20 Rat 9.2 pKi = 9.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 611 5 3 6 2.7 CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O nan
CHEMBL601773 200922 22 None -1 20 Rat 9.2 pKi = 9.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 611 5 3 6 2.7 CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O nan
9866614 14683 1 None 120 3 Human 9.2 pKi = 9.2 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 416 9 1 5 2.1 CC(C)Oc1ccccc1N1CCN(CCCNC(=O)CN2CCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
CHEMBL12062 14683 1 None 120 3 Human 9.2 pKi = 9.2 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 416 9 1 5 2.1 CC(C)Oc1ccccc1N1CCN(CCCNC(=O)CN2CCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
10792898 203922 0 None 93 2 Human 9.2 pKi = 9.2 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 556 9 2 7 3.5 Cc1ccc(N2C(=O)c3ccc(C(=O)NCC(O)CN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc1 10.1021/jm9905918
CHEMBL69295 203922 0 None 93 2 Human 9.2 pKi = 9.2 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 556 9 2 7 3.5 Cc1ccc(N2C(=O)c3ccc(C(=O)NCC(O)CN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc1 10.1021/jm9905918
9913988 17883 0 None -1 4 Bovine 9.2 pKi = 9.2 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 502 7 1 7 3.1 Cn1nnc(Cc2ccc3c(c2)c(C2CCN(CCN4CCNC4=O)CC2)cn3-c2ccc(F)cc2)n1 10.1021/jm100652h
CHEMBL1259188 17883 0 None -1 4 Bovine 9.2 pKi = 9.2 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 502 7 1 7 3.1 Cn1nnc(Cc2ccc3c(c2)c(C2CCN(CCN4CCNC4=O)CC2)cn3-c2ccc(F)cc2)n1 10.1021/jm100652h
1238 203151 24 None -3 17 Bovine 9.2 pKi = 9.2 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 344 1 0 3 4.3 CN1CCN(C2Cc3ccccc3Sc3ccc(Cl)cc32)CC1 10.1021/jm100652h
CHEMBL64249 203151 24 None -3 17 Bovine 9.2 pKi = 9.2 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 344 1 0 3 4.3 CN1CCN(C2Cc3ccccc3Sc3ccc(Cl)cc32)CC1 10.1021/jm100652h
10552656 161288 0 None 1 3 Rat 9.2 pKi = 9.2 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 478 5 1 8 3.0 COc1ccc2sc3c(=O)n(CCN4C[C@@H]5CCc6c(OC)cccc6[C@@H]5C4)c(=O)[nH]c3c2n1 10.1021/jm990567u
CHEMBL41234 161288 0 None 1 3 Rat 9.2 pKi = 9.2 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 478 5 1 8 3.0 COc1ccc2sc3c(=O)n(CCN4C[C@@H]5CCc6c(OC)cccc6[C@@H]5C4)c(=O)[nH]c3c2n1 10.1021/jm990567u
9895338 94416 0 None 223 3 Human 9.2 pKi = 9.2 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 622 11 2 7 6.8 CCC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)/C(=C(\O)OC)C(C)=N1 10.1021/jm960697s
CHEMBL25121 94416 0 None 223 3 Human 9.2 pKi = 9.2 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 622 11 2 7 6.8 CCC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)/C(=C(\O)OC)C(C)=N1 10.1021/jm960697s
3168 9230 92 None 1 22 Rat 9.2 pKi = 9.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 379 6 1 4 3.7 O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1 nan
CHEMBL1108 9230 92 None 1 22 Rat 9.2 pKi = 9.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 379 6 1 4 3.7 O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1 nan
10763038 202652 0 None -1 3 Rat 9.2 pKi = 9.2 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 391 4 1 5 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4ccccc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL61491 202652 0 None -1 3 Rat 9.2 pKi = 9.2 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 391 4 1 5 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4ccccc4c3=O)C[C@@H]21 10.1021/jm000541z
52946023 17882 0 None 2 6 Bovine 9.2 pKi = 9.2 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 477 7 2 4 3.6 CC(=O)NCc1ccc2c(c1)c(C1CCN(CCN3CCNC3=O)CC1)cn2-c1ccc(F)cc1 10.1021/jm100652h
CHEMBL1259187 17882 0 None 2 6 Bovine 9.2 pKi = 9.2 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 477 7 2 4 3.6 CC(=O)NCc1ccc2c(c1)c(C1CCN(CCN3CCNC3=O)CC1)cn2-c1ccc(F)cc1 10.1021/jm100652h
10718348 100217 0 None 3 3 Rat 9.2 pKi = 9.2 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 449 4 1 8 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ncncc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL288678 100217 0 None 3 3 Rat 9.2 pKi = 9.2 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 449 4 1 8 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ncncc54)c3=O)C[C@@H]21 10.1021/jm990567u
10415038 4407 0 None 3 4 Human 9.2 pKi = 9.2 Binding
Ability to displace [125I]HEAT from cloned human Alpha-1A adrenergic receptor stably expressed in CHO cellsAbility to displace [125I]HEAT from cloned human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 545 6 1 7 5.3 Cc1noc(C)c1S(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3cccc4ccccc34)CC1)O2 10.1016/s0960-894x(98)00732-x
CHEMBL101610 4407 0 None 3 4 Human 9.2 pKi = 9.2 Binding
Ability to displace [125I]HEAT from cloned human Alpha-1A adrenergic receptor stably expressed in CHO cellsAbility to displace [125I]HEAT from cloned human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 545 6 1 7 5.3 Cc1noc(C)c1S(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3cccc4ccccc34)CC1)O2 10.1016/s0960-894x(98)00732-x
10368033 100397 0 None 5 4 Rat 9.2 pKi = 9.2 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 483 4 1 8 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ncc(Cl)nc54)c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL290387 100397 0 None 5 4 Rat 9.2 pKi = 9.2 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 483 4 1 8 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ncc(Cl)nc54)c3=O)C[C@@H]21 10.1021/jm000541z
10368033 100397 0 None 5 4 Rat 9.2 pKi = 9.2 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
ChEMBL 483 4 1 8 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ncc(Cl)nc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL290387 100397 0 None 5 4 Rat 9.2 pKi = 9.2 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
ChEMBL 483 4 1 8 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ncc(Cl)nc54)c3=O)C[C@@H]21 10.1021/jm990567u
6603950 203301 9 None -3 9 Bovine 9.2 pKi = 9.2 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 344 1 0 3 4.3 CN1CCN([C@@H]2Cc3ccccc3Sc3ccc(Cl)cc32)CC1 10.1021/jm100652h
CHEMBL64875 203301 9 None -3 9 Bovine 9.2 pKi = 9.2 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 344 1 0 3 4.3 CN1CCN([C@@H]2Cc3ccccc3Sc3ccc(Cl)cc32)CC1 10.1021/jm100652h
10554913 37316 0 None 11 3 Human 9.2 pKi = 9.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 561 7 2 6 4.1 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3cccc(Cl)c3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL145443 37316 0 None 11 3 Human 9.2 pKi = 9.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 561 7 2 6 4.1 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3cccc(Cl)c3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
10745766 37454 0 None 141 3 Human 9.2 pKi = 9.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 578 9 3 8 2.7 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC(C)=C(C(N)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm990200p
CHEMBL145562 37454 0 None 141 3 Human 9.2 pKi = 9.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 578 9 3 8 2.7 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC(C)=C(C(N)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm990200p
10674333 37464 0 None 239 3 Human 9.2 pKi = 9.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 554 8 3 6 2.9 CC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL145574 37464 0 None 239 3 Human 9.2 pKi = 9.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 554 8 3 6 2.9 CC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
10415156 121112 0 None 870 4 Human 9.2 pKi = 9.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 550 8 3 5 3.8 CCC1=C(C(N)=O)C(c2ccc(F)cc2F)N(C(=O)NCCCN2CCC(C#N)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990201h
CHEMBL357628 121112 0 None 870 4 Human 9.2 pKi = 9.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 550 8 3 5 3.8 CCC1=C(C(N)=O)C(c2ccc(F)cc2F)N(C(=O)NCCCN2CCC(C#N)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990201h
489 145 28 None -2 13 Rat 9.2 pKi = 9.2 Binding
Overall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary glandOverall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm00018a001
5640 145 28 None -2 13 Rat 9.2 pKi = 9.2 Binding
Overall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary glandOverall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm00018a001
CHEMBL420060 145 28 None -2 13 Rat 9.2 pKi = 9.2 Binding
Overall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary glandOverall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm00018a001
10741071 169193 0 None -1 3 Rat 9.2 pKi = 9.2 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 425 4 1 5 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cccc(Cl)c4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL440865 169193 0 None -1 3 Rat 9.2 pKi = 9.2 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 425 4 1 5 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cccc(Cl)c4c3=O)C[C@@H]21 10.1021/jm000541z
10478895 100199 0 None 2 3 Rat 9.1 pKi = 9.1 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 449 4 1 8 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5nccnc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL288530 100199 0 None 2 3 Rat 9.1 pKi = 9.1 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 449 4 1 8 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5nccnc54)c3=O)C[C@@H]21 10.1021/jm990567u
20215436 28484 3 None -1 3 Rat 9.1 pKi = 9.1 Binding
The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.
ChEMBL 355 4 1 8 2.1 COc1cc2nc(N3CCN(c4ccco4)CC3)nc(N)c2cc1OC 10.1021/jm9805337
CHEMBL137598 28484 3 None -1 3 Rat 9.1 pKi = 9.1 Binding
The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.
ChEMBL 355 4 1 8 2.1 COc1cc2nc(N3CCN(c4ccco4)CC3)nc(N)c2cc1OC 10.1021/jm9805337
4209 3141 75 None -4 34 Bovine 9.1 pKi = 9.1 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm960510x
4893 3141 75 None -4 34 Bovine 9.1 pKi = 9.1 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm960510x
503 3141 75 None -4 34 Bovine 9.1 pKi = 9.1 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm960510x
5385 3141 75 None -4 34 Bovine 9.1 pKi = 9.1 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm960510x
CHEMBL2 3141 75 None -4 34 Bovine 9.1 pKi = 9.1 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm960510x
DB00457 3141 75 None -4 34 Bovine 9.1 pKi = 9.1 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm960510x
44431551 87182 0 None 33 4 Human 9.1 pKi = 9.1 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 475 7 1 5 4.0 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3cccc(F)c3)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL232780 87182 0 None 33 4 Human 9.1 pKi = 9.1 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 475 7 1 5 4.0 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3cccc(F)c3)CC2)CC1 10.1016/j.bmcl.2007.04.008
44447067 94586 0 None -1 3 Rat 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 446 6 1 5 4.2 O=C(NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21)C1CC1 10.1016/j.bmcl.2007.11.106
CHEMBL252230 94586 0 None -1 3 Rat 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 446 6 1 5 4.2 O=C(NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21)C1CC1 10.1016/j.bmcl.2007.11.106
10348924 17913 0 None 3 5 Human 9.1 pKi = 9.1 Binding
Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)
ChEMBL 620 10 1 10 3.8 Cc1c(-c2ccccc2)oc2c(C(=O)NCCCN3CCN(c4ccccc4OCc4no[n+]([O-])c4C#N)CC3)cccc2c1=O 10.1021/jm030825u
CHEMBL125989 17913 0 None 3 5 Human 9.1 pKi = 9.1 Binding
Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)
ChEMBL 620 10 1 10 3.8 Cc1c(-c2ccccc2)oc2c(C(=O)NCCCN3CCN(c4ccccc4OCc4no[n+]([O-])c4C#N)CC3)cccc2c1=O 10.1021/jm030825u
10721564 207327 0 None 33 3 Human 9.1 pKi = 9.1 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 558 7 1 5 4.9 COC(=O)N1C(=O)N(C)C(C)=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1016/j.ejmech.2017.03.025
CHEMBL93623 207327 0 None 33 3 Human 9.1 pKi = 9.1 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 558 7 1 5 4.9 COC(=O)N1C(=O)N(C)C(C)=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1016/j.ejmech.2017.03.025
10721564 207327 0 None 33 3 Human 9.1 pKi = 9.1 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 558 7 1 5 4.9 COC(=O)N1C(=O)N(C)C(C)=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1021/jm990612y
CHEMBL93623 207327 0 None 33 3 Human 9.1 pKi = 9.1 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 558 7 1 5 4.9 COC(=O)N1C(=O)N(C)C(C)=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1021/jm990612y
10627003 204317 0 None 53 3 Human 9.1 pKi = 9.1 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 576 9 2 7 3.8 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2cccc(Cl)c2)C3=O)CC1 10.1021/jm9905918
CHEMBL71580 204317 0 None 53 3 Human 9.1 pKi = 9.1 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 576 9 2 7 3.8 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2cccc(Cl)c2)C3=O)CC1 10.1021/jm9905918
44431546 88113 0 None 3 4 Human 9.1 pKi = 9.1 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 482 7 1 6 3.8 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccccc3C#N)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL234680 88113 0 None 3 4 Human 9.1 pKi = 9.1 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 482 7 1 6 3.8 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccccc3C#N)CC2)CC1 10.1016/j.bmcl.2007.04.008
10626911 102193 0 None 66 2 Human 9.1 pKi = 9.1 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 572 10 2 8 3.2 COc1ccc(N2C(=O)c3ccc(C(=O)NCC(O)CN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc1 10.1021/jm9905918
CHEMBL302940 102193 0 None 66 2 Human 9.1 pKi = 9.1 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 572 10 2 8 3.2 COc1ccc(N2C(=O)c3ccc(C(=O)NCC(O)CN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc1 10.1021/jm9905918
10625617 161672 0 None 1 3 Rat 9.1 pKi = 9.1 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 477 5 1 7 3.6 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccc(OC)c54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL41344 161672 0 None 1 3 Rat 9.1 pKi = 9.1 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 477 5 1 7 3.6 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccc(OC)c54)c3=O)C[C@@H]21 10.1021/jm990567u
3157 1458 71 None -2 12 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1016/j.ejmech.2017.05.003
7170 1458 71 None -2 12 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1016/j.ejmech.2017.05.003
954 1458 71 None -2 12 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1016/j.ejmech.2017.05.003
CHEMBL707 1458 71 None -2 12 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1016/j.ejmech.2017.05.003
DB00590 1458 71 None -2 12 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1016/j.ejmech.2017.05.003
10648335 100134 0 None 1 3 Rat 9.1 pKi = 9.1 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 478 5 1 8 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5c(OC)ccnc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL287928 100134 0 None 1 3 Rat 9.1 pKi = 9.1 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 478 5 1 8 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5c(OC)ccnc54)c3=O)C[C@@H]21 10.1021/jm990567u
10765077 100234 0 None -1 3 Rat 9.1 pKi = 9.1 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 430 4 2 5 2.8 COc1cccc2c1CCC1CN(CCn3c(=O)[nH]c4c([nH]c5ccccc54)c3=O)CC21 10.1021/jm990567u
CHEMBL288809 100234 0 None -1 3 Rat 9.1 pKi = 9.1 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 430 4 2 5 2.8 COc1cccc2c1CCC1CN(CCn3c(=O)[nH]c4c([nH]c5ccccc54)c3=O)CC21 10.1021/jm990567u
2142 3074 58 None -1 37 Bovine 9.1 pKi = 9.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm970166j
4920903 3074 58 None -1 37 Bovine 9.1 pKi = 9.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm970166j
502 3074 58 None -1 37 Bovine 9.1 pKi = 9.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm970166j
5775 3074 58 None -1 37 Bovine 9.1 pKi = 9.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm970166j
CHEMBL597 3074 58 None -1 37 Bovine 9.1 pKi = 9.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm970166j
DB00692 3074 58 None -1 37 Bovine 9.1 pKi = 9.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm970166j
3894573 3368 6 None 1 5 Bovine 9.1 pKi = 9.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 10.1021/jm970166j
495 3368 6 None 1 5 Bovine 9.1 pKi = 9.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 10.1021/jm970166j
CHEMBL88272 3368 6 None 1 5 Bovine 9.1 pKi = 9.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 10.1021/jm970166j
10833725 206488 0 None 2 3 Bovine 9.1 pKi = 9.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 381 7 1 5 2.7 Cc1ccccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL88435 206488 0 None 2 3 Bovine 9.1 pKi = 9.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 381 7 1 5 2.7 Cc1ccccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
10647341 206911 0 None 63 2 Bovine 9.1 pKi = 9.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 453 9 1 6 3.8 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2OCC(C)(C)C)CC1 10.1021/jm970166j
CHEMBL91093 206911 0 None 63 2 Bovine 9.1 pKi = 9.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 453 9 1 6 3.8 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2OCC(C)(C)C)CC1 10.1021/jm970166j
10550225 207059 0 None 25 2 Bovine 9.1 pKi = 9.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 423 8 1 6 3.0 COc1ccccc1N1CCN(CCCNc2ncccc2C(=O)N2CCCC2)CC1 10.1021/jm970166j
CHEMBL91876 207059 0 None 25 2 Bovine 9.1 pKi = 9.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 423 8 1 6 3.0 COc1ccccc1N1CCN(CCCNc2ncccc2C(=O)N2CCCC2)CC1 10.1021/jm970166j
10524875 207349 0 None 15 3 Bovine 9.1 pKi = 9.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 397 8 1 6 2.4 COc1ccccc1N1CCN(CCCNc2ccncc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL93736 207349 0 None 15 3 Bovine 9.1 pKi = 9.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 397 8 1 6 2.4 COc1ccccc1N1CCN(CCCNc2ccncc2C(=O)N(C)C)CC1 10.1021/jm970166j
9891937 194725 0 None 31 3 Human 9.1 pKi = 9.1 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 458 8 1 6 2.4 CCc1c[nH]c(=O)n(CCCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)c1=O 10.1016/s0960-894x(03)00305-6
CHEMBL53675 194725 0 None 31 3 Human 9.1 pKi = 9.1 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 458 8 1 6 2.4 CCc1c[nH]c(=O)n(CCCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)c1=O 10.1016/s0960-894x(03)00305-6
44298746 195609 0 None 19 3 Human 9.1 pKi = 9.1 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 452 7 1 6 2.4 Cc1c[nH]c(=O)n(CC2(CN3CCN(c4ccccc4OCC(F)(F)F)CC3)CC2)c1=O 10.1016/s0960-894x(03)00305-6
CHEMBL55629 195609 0 None 19 3 Human 9.1 pKi = 9.1 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 452 7 1 6 2.4 Cc1c[nH]c(=O)n(CC2(CN3CCN(c4ccccc4OCC(F)(F)F)CC3)CC2)c1=O 10.1016/s0960-894x(03)00305-6
9865577 112282 2 None 1 3 Bovine 9.1 pKi = 9.1 Binding
The compound was screened in vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorThe compound was screened in vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 397 8 1 6 2.4 COc1ccccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL329160 112282 2 None 1 3 Bovine 9.1 pKi = 9.1 Binding
The compound was screened in vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorThe compound was screened in vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 397 8 1 6 2.4 COc1ccccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
10674840 203693 0 None 50 2 Human 9.1 pKi = 9.1 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 585 10 2 8 3.3 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(N(C)C)cc2)C3=O)CC1 10.1021/jm9905918
CHEMBL67648 203693 0 None 50 2 Human 9.1 pKi = 9.1 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 585 10 2 8 3.3 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(N(C)C)cc2)C3=O)CC1 10.1021/jm9905918
44431192 92530 0 None 1 3 Human 9.1 pKi = 9.1 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 448 5 0 6 3.6 CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4cccnc4C3=O)CC2)CC1 10.1016/j.bmcl.2006.12.111
CHEMBL243228 92530 0 None 1 3 Human 9.1 pKi = 9.1 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 448 5 0 6 3.6 CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4cccnc4C3=O)CC2)CC1 10.1016/j.bmcl.2006.12.111
10917920 111419 0 None 7 10 Bovine 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 487 6 1 6 3.8 Cn1cnc(-c2ccc3c(c2)c(C2CCN(CCN4CCNC4=O)CC2)cn3-c2ccc(F)cc2)n1 10.1021/jm020938y
CHEMBL327527 111419 0 None 7 10 Bovine 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 487 6 1 6 3.8 Cn1cnc(-c2ccc3c(c2)c(C2CCN(CCN4CCNC4=O)CC2)cn3-c2ccc(F)cc2)n1 10.1021/jm020938y
56944383 112092 0 None -1 12 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells
ChEMBL 487 8 1 6 5.1 O=S(=O)(NCCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1cc2ccccc2s1 10.1021/jm401895u
CHEMBL3290012 112092 0 None -1 12 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells
ChEMBL 487 8 1 6 5.1 O=S(=O)(NCCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1cc2ccccc2s1 10.1021/jm401895u
10603739 16357 0 None 46 3 Human 9.1 pKi = 9.1 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 607 10 2 9 3.8 CCC1=C(C(=O)OC)C(c2ccc([N+](=O)[O-])cc2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
CHEMBL123012 16357 0 None 46 3 Human 9.1 pKi = 9.1 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 607 10 2 9 3.8 CCC1=C(C(=O)OC)C(c2ccc([N+](=O)[O-])cc2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
10698141 33795 0 None 21 3 Human 9.1 pKi = 9.1 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 561 7 2 6 4.1 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccc(Cl)cc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL142307 33795 0 None 21 3 Human 9.1 pKi = 9.1 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 561 7 2 6 4.1 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccc(Cl)cc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
11430126 60533 0 None -1 6 Human 9.1 pKi = 9.1 Binding
Equilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cellsEquilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cells
ChEMBL 421 4 1 9 2.0 COc1cc2nc(N3CCN(C(=O)C4CCSS4)CC3)nc(N)c2cc1OC 10.1021/jm049153d
CHEMBL175934 60533 0 None -1 6 Human 9.1 pKi = 9.1 Binding
Equilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cellsEquilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cells
ChEMBL 421 4 1 9 2.0 COc1cc2nc(N3CCN(C(=O)C4CCSS4)CC3)nc(N)c2cc1OC 10.1021/jm049153d
3584 3748 64 None -2 14 Rat 9.1 pKi = 9.1 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990567u
5401 3748 64 None -2 14 Rat 9.1 pKi = 9.1 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990567u
7302 3748 64 None -2 14 Rat 9.1 pKi = 9.1 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990567u
CHEMBL611 3748 64 None -2 14 Rat 9.1 pKi = 9.1 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990567u
DB01162 3748 64 None -2 14 Rat 9.1 pKi = 9.1 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990567u
10793261 121027 0 None 2290 4 Human 9.1 pKi = 9.1 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 575 10 3 8 3.0 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(N)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
CHEMBL356829 121027 0 None 2290 4 Human 9.1 pKi = 9.1 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 575 10 3 8 3.0 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(N)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
57402366 69286 0 None -1 5 Pig 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 1033 32 2 17 5.4 COc1ccccc1N1CCN(CCCCNC(=O)c2cnn3ccc(COCCOCCOCCOCCOCc4ccn5ncc(C(=O)NCCCCN6CCN(c7ccccc7OC)CC6)c5c4)cc23)CC1 10.1016/j.bmc.2011.10.063
CHEMBL1928139 69286 0 None -1 5 Pig 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 1033 32 2 17 5.4 COc1ccccc1N1CCN(CCCCNC(=O)c2cnn3ccc(COCCOCCOCCOCCOCc4ccn5ncc(C(=O)NCCCCN6CCN(c7ccccc7OC)CC6)c5c4)cc23)CC1 10.1016/j.bmc.2011.10.063
10740866 102068 0 None 1 3 Rat 9.1 pKi = 9.1 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 421 5 1 6 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(OC)cccc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL302203 102068 0 None 1 3 Rat 9.1 pKi = 9.1 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 421 5 1 6 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(OC)cccc4c3=O)C[C@@H]21 10.1021/jm000541z
10740369 201840 0 None -1 3 Rat 9.1 pKi = 9.1 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 411 4 1 6 2.7 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(C)csc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL60721 201840 0 None -1 3 Rat 9.1 pKi = 9.1 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 411 4 1 6 2.7 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(C)csc4c3=O)C[C@@H]21 10.1021/jm000541z
9847196 30150 0 None -3 5 Human 9.1 pKi = 9.1 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3sc(-c4ccccc4)cc3c2=O)CC1 10.1016/s0960-894x(01)00159-7
CHEMBL13903 30150 0 None -3 5 Human 9.1 pKi = 9.1 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3sc(-c4ccccc4)cc3c2=O)CC1 10.1016/s0960-894x(01)00159-7
49781676 17840 0 None 1 4 Bovine 9.1 pKi = 9.1 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 400 2 0 3 5.7 Cc1ccccc1-c1ccc2c(c1)C(N1CCN(C)CC1)Cc1ccccc1S2 10.1021/jm100652h
CHEMBL1259062 17840 0 None 1 4 Bovine 9.1 pKi = 9.1 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 400 2 0 3 5.7 Cc1ccccc1-c1ccc2c(c1)C(N1CCN(C)CC1)Cc1ccccc1S2 10.1021/jm100652h
46934639 16638 0 None 6 4 Human 9.1 pKi = 9.1 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 465 7 0 6 3.1 COc1ccccc1N1CCN(C[C@H]2CO[C@@](CN3CCCCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
CHEMBL1242541 16638 0 None 6 4 Human 9.1 pKi = 9.1 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 465 7 0 6 3.1 COc1ccccc1N1CCN(C[C@H]2CO[C@@](CN3CCCCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
69782867 161559 0 None -5 6 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 549 8 1 9 4.4 COc1cc2nc(N3CCN(C(=O)COc4c(OC)cccc4C(C)C)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
CHEMBL4129291 161559 0 None -5 6 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 549 8 1 9 4.4 COc1cc2nc(N3CCN(C(=O)COc4c(OC)cccc4C(C)C)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
44431547 88114 0 None 34 4 Human 9.1 pKi = 9.1 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 475 7 1 5 4.0 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccccc3F)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL234681 88114 0 None 34 4 Human 9.1 pKi = 9.1 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 475 7 1 5 4.0 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccccc3F)CC2)CC1 10.1016/j.bmcl.2007.04.008
10721568 203827 0 None 32 2 Human 9.1 pKi = 9.1 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 558 9 3 8 2.9 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(O)cc2)C3=O)CC1 10.1021/jm9905918
CHEMBL68604 203827 0 None 32 2 Human 9.1 pKi = 9.1 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 558 9 3 8 2.9 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(O)cc2)C3=O)CC1 10.1021/jm9905918
2389 3306 118 None -6 68 Rat 9.1 pKi = 9.1 Binding
Receptor Binding Assay: Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) on rat cortical membrane preparation using [3H]-prazosine (0.22-0.37 nM) as ligand. The non-specific binding was determined in the presence of 10 μM phentolamine.Receptor Binding Assay: Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) on rat cortical membrane preparation using [3H]-prazosine (0.22-0.37 nM) as ligand. The non-specific binding was determined in the presence of 10 μM phentolamine.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
5073 3306 118 None -6 68 Rat 9.1 pKi = 9.1 Binding
Receptor Binding Assay: Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) on rat cortical membrane preparation using [3H]-prazosine (0.22-0.37 nM) as ligand. The non-specific binding was determined in the presence of 10 μM phentolamine.Receptor Binding Assay: Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) on rat cortical membrane preparation using [3H]-prazosine (0.22-0.37 nM) as ligand. The non-specific binding was determined in the presence of 10 μM phentolamine.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
96 3306 118 None -6 68 Rat 9.1 pKi = 9.1 Binding
Receptor Binding Assay: Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) on rat cortical membrane preparation using [3H]-prazosine (0.22-0.37 nM) as ligand. The non-specific binding was determined in the presence of 10 μM phentolamine.Receptor Binding Assay: Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) on rat cortical membrane preparation using [3H]-prazosine (0.22-0.37 nM) as ligand. The non-specific binding was determined in the presence of 10 μM phentolamine.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
CHEMBL85 3306 118 None -6 68 Rat 9.1 pKi = 9.1 Binding
Receptor Binding Assay: Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) on rat cortical membrane preparation using [3H]-prazosine (0.22-0.37 nM) as ligand. The non-specific binding was determined in the presence of 10 μM phentolamine.Receptor Binding Assay: Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) on rat cortical membrane preparation using [3H]-prazosine (0.22-0.37 nM) as ligand. The non-specific binding was determined in the presence of 10 μM phentolamine.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
DB00734 3306 118 None -6 68 Rat 9.1 pKi = 9.1 Binding
Receptor Binding Assay: Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) on rat cortical membrane preparation using [3H]-prazosine (0.22-0.37 nM) as ligand. The non-specific binding was determined in the presence of 10 μM phentolamine.Receptor Binding Assay: Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) on rat cortical membrane preparation using [3H]-prazosine (0.22-0.37 nM) as ligand. The non-specific binding was determined in the presence of 10 μM phentolamine.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
10949698 205264 0 None 1 4 Human 9.1 pKi = 9.1 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 413 8 1 8 1.9 COc1ccccc1N1CCN(CCCNc2c(C(C)=O)c(C)nn(C)c2=O)CC1 10.1021/jm0009336
CHEMBL79161 205264 0 None 1 4 Human 9.1 pKi = 9.1 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 413 8 1 8 1.9 COc1ccccc1N1CCN(CCCNc2c(C(C)=O)c(C)nn(C)c2=O)CC1 10.1021/jm0009336
71462043 84539 0 None -1 7 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 379 8 1 6 3.2 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(Cl)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153555 84539 0 None -1 7 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 379 8 1 6 3.2 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(Cl)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2220895 84539 0 None -1 7 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 379 8 1 6 3.2 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(Cl)c2O1 10.1016/j.ejmech.2012.09.049
44431564 87613 0 None 34 4 Human 9.1 pKi = 9.1 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 501 8 1 6 4.2 COc1ccc(C)cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL233623 87613 0 None 34 4 Human 9.1 pKi = 9.1 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 501 8 1 6 4.2 COc1ccc(C)cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
9872440 102239 0 None 81 2 Human 9.1 pKi = 9.1 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 556 9 2 7 3.5 Cc1cccc(N2C(=O)c3ccc(C(=O)NCC(O)CN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)c1 10.1021/jm9905918
CHEMBL303248 102239 0 None 81 2 Human 9.1 pKi = 9.1 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 556 9 2 7 3.5 Cc1cccc(N2C(=O)c3ccc(C(=O)NCC(O)CN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)c1 10.1021/jm9905918
10506673 203902 0 None 72 2 Human 9.1 pKi = 9.1 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 542 9 2 7 3.2 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccccc2)C3=O)CC1 10.1021/jm9905918
CHEMBL69143 203902 0 None 72 2 Human 9.1 pKi = 9.1 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 542 9 2 7 3.2 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccccc2)C3=O)CC1 10.1021/jm9905918
10047430 104734 0 None 117 3 Human 9.1 pKi = 9.1 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 414 7 0 6 3.4 CC(C)Oc1ccccc1N1CCN(Cc2nc(CN3CCCC3=O)cs2)CC1 10.1016/s0960-894x(02)00436-5
CHEMBL310768 104734 0 None 117 3 Human 9.1 pKi = 9.1 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 414 7 0 6 3.4 CC(C)Oc1ccccc1N1CCN(Cc2nc(CN3CCCC3=O)cs2)CC1 10.1016/s0960-894x(02)00436-5
44299973 197429 0 None 6 3 Human 9.1 pKi = 9.1 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 608 7 2 8 3.4 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@@H]2CC[C@@H](N3CCN(c4ccccc4C#N)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
CHEMBL56974 197429 0 None 6 3 Human 9.1 pKi = 9.1 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 608 7 2 8 3.4 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@@H]2CC[C@@H](N3CCN(c4ccccc4C#N)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
44295192 101695 0 None 338 3 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 574 7 2 10 2.4 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc3nonc3c2)CC1 10.1016/s0960-894x(99)00653-8
CHEMBL299539 101695 0 None 338 3 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 574 7 2 10 2.4 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc3nonc3c2)CC1 10.1016/s0960-894x(99)00653-8
9959689 101786 0 None 281 3 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 568 7 2 7 3.1 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc(F)c(F)c2)CC1 10.1016/s0960-894x(99)00653-8
CHEMBL300222 101786 0 None 281 3 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 568 7 2 7 3.1 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc(F)c(F)c2)CC1 10.1016/s0960-894x(99)00653-8
44447065 94583 0 None -1 3 Rat 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 448 7 1 5 4.6 CCCC(=O)NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21 10.1016/j.bmcl.2007.11.106
CHEMBL252228 94583 0 None -1 3 Rat 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 448 7 1 5 4.6 CCCC(=O)NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21 10.1016/j.bmcl.2007.11.106
71452768 79542 0 None 53 3 Human 9.1 pKi = 9.1 Binding
Tested for binding affinity against recombinant human Alpha-1A adrenergic receptor using [125I]HEAT in competition binding assayTested for binding affinity against recombinant human Alpha-1A adrenergic receptor using [125I]HEAT in competition binding assay
ChEMBL 475 6 1 4 5.0 C[C@H]1OC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1016/s0960-894x(00)00524-2
CHEMBL2114249 79542 0 None 53 3 Human 9.1 pKi = 9.1 Binding
Tested for binding affinity against recombinant human Alpha-1A adrenergic receptor using [125I]HEAT in competition binding assayTested for binding affinity against recombinant human Alpha-1A adrenergic receptor using [125I]HEAT in competition binding assay
ChEMBL 475 6 1 4 5.0 C[C@H]1OC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1016/s0960-894x(00)00524-2
10503057 102594 0 None 1 3 Rat 9.0 pKi = 9.0 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 436 5 1 7 2.3 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cc([N+](=O)[O-])ccc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL304215 102594 0 None 1 3 Rat 9.0 pKi = 9.0 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 436 5 1 7 2.3 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cc([N+](=O)[O-])ccc4c3=O)C[C@@H]21 10.1021/jm000541z
11519153 85720 0 None 2 4 Human 9.0 pKi = 9.0 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 514 9 1 6 4.7 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OC4CC4)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
CHEMBL229085 85720 0 None 2 4 Human 9.0 pKi = 9.0 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 514 9 1 6 4.7 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OC4CC4)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
11519153 85720 0 None 2 4 Human 9.0 pKi = 9.0 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 514 9 1 6 4.7 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OC4CC4)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
CHEMBL229085 85720 0 None 2 4 Human 9.0 pKi = 9.0 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 514 9 1 6 4.7 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OC4CC4)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
44289525 165971 0 None 4 9 Bovine 9.0 pKi = 9.0 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]-prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]-prazosin as radioligand
ChEMBL 435 9 1 6 4.6 COc1cccc(OC)c1OCCNCC1Oc2ccccc2OC1c1ccc(C)cc1 10.1021/jm960069a
CHEMBL42539 165971 0 None 4 9 Bovine 9.0 pKi = 9.0 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]-prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]-prazosin as radioligand
ChEMBL 435 9 1 6 4.6 COc1cccc(OC)c1OCCNCC1Oc2ccccc2OC1c1ccc(C)cc1 10.1021/jm960069a
10601065 112281 0 None 173 3 Human 9.0 pKi = 9.0 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 488 7 4 4 2.8 O=C1NC=C(C(=O)NCCCN2CCC(O)(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)N1 10.1021/jm990612y
CHEMBL329143 112281 0 None 173 3 Human 9.0 pKi = 9.0 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 488 7 4 4 2.8 O=C1NC=C(C(=O)NCCCN2CCC(O)(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)N1 10.1021/jm990612y
90645605 112411 0 None -1 3 Human 9.0 pKi = 9.0 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 666 13 2 9 5.2 COc1ccccc1N1CCN(CCn2c(C)nc3c(sc4ccc(NC(=O)CCCC(=O)NCCc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
CHEMBL3298023 112411 0 None -1 3 Human 9.0 pKi = 9.0 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 666 13 2 9 5.2 COc1ccccc1N1CCN(CCn2c(C)nc3c(sc4ccc(NC(=O)CCCC(=O)NCCc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
10549596 84576 1 None -3 7 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(OC)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153553 84576 1 None -3 7 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(OC)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2221147 84576 1 None -3 7 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(OC)c2O1 10.1016/j.ejmech.2012.09.049
4209 3141 75 None -4 34 Bovine 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm020938y
4893 3141 75 None -4 34 Bovine 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm020938y
503 3141 75 None -4 34 Bovine 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm020938y
5385 3141 75 None -4 34 Bovine 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm020938y
CHEMBL2 3141 75 None -4 34 Bovine 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm020938y
DB00457 3141 75 None -4 34 Bovine 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm020938y
9931976 60288 1 None 4 4 Rat 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranesDisplacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranes
ChEMBL 421 4 0 7 3.3 COc1ccccc1N1CCN(CC2CN=C3c4ccccc4N=C(SC)N32)CC1 10.1021/jm970159v
CHEMBL1744044 60288 1 None 4 4 Rat 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranesDisplacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranes
ChEMBL 421 4 0 7 3.3 COc1ccccc1N1CCN(CC2CN=C3c4ccccc4N=C(SC)N32)CC1 10.1021/jm970159v
4209 3141 75 None -3 34 Rat 9.0 pKi = 9.0 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm960510x
4893 3141 75 None -3 34 Rat 9.0 pKi = 9.0 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm960510x
503 3141 75 None -3 34 Rat 9.0 pKi = 9.0 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm960510x
5385 3141 75 None -3 34 Rat 9.0 pKi = 9.0 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm960510x
CHEMBL2 3141 75 None -3 34 Rat 9.0 pKi = 9.0 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm960510x
DB00457 3141 75 None -3 34 Rat 9.0 pKi = 9.0 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm960510x
13155 3396 0 None -16 3 Human 9.0 pKi = 9.0 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 668 12 2 9 4.5 CN(C(CCCC(=O)NC=1C=CC2=C(C1)C=3NC(N(C(C3S2)=O)CCN4CCN(CC4)C5=C(C=CC=C5)OC)=O)=O)CC6=CC=CC=C6 10.1016/j.ejmech.2014.06.057
90645598 3396 0 None -16 3 Human 9.0 pKi = 9.0 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 668 12 2 9 4.5 CN(C(CCCC(=O)NC=1C=CC2=C(C1)C=3NC(N(C(C3S2)=O)CCN4CCN(CC4)C5=C(C=CC=C5)OC)=O)=O)CC6=CC=CC=C6 10.1016/j.ejmech.2014.06.057
CHEMBL3297829 3396 0 None -16 3 Human 9.0 pKi = 9.0 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 668 12 2 9 4.5 CN(C(CCCC(=O)NC=1C=CC2=C(C1)C=3NC(N(C(C3S2)=O)CCN4CCN(CC4)C5=C(C=CC=C5)OC)=O)=O)CC6=CC=CC=C6 10.1016/j.ejmech.2014.06.057
10650843 203826 0 None 57 3 Human 9.0 pKi = 9.0 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 576 9 2 7 3.8 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(Cl)cc2)C3=O)CC1 10.1021/jm9905918
CHEMBL68601 203826 0 None 57 3 Human 9.0 pKi = 9.0 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 576 9 2 7 3.8 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(Cl)cc2)C3=O)CC1 10.1021/jm9905918
49781677 17841 0 None -1 4 Bovine 9.0 pKi = 9.0 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 400 2 0 3 5.7 Cc1cccc(-c2ccc3c(c2)C(N2CCN(C)CC2)Cc2ccccc2S3)c1 10.1021/jm100652h
CHEMBL1259063 17841 0 None -1 4 Bovine 9.0 pKi = 9.0 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 400 2 0 3 5.7 Cc1cccc(-c2ccc3c(c2)C(N2CCN(C)CC2)Cc2ccccc2S3)c1 10.1021/jm100652h
10841070 37649 0 None -2 4 Rat 9.0 pKi = 9.0 Binding
Binding affinity against isolated rat prostate using [3H]- prazosin.Binding affinity against isolated rat prostate using [3H]- prazosin.
ChEMBL 585 10 0 5 7.4 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL145746 37649 0 None -2 4 Rat 9.0 pKi = 9.0 Binding
Binding affinity against isolated rat prostate using [3H]- prazosin.Binding affinity against isolated rat prostate using [3H]- prazosin.
ChEMBL 585 10 0 5 7.4 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
57390116 69269 0 None -1 5 Pig 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 925 30 2 13 5.9 COc1ccccc1N1CCN(CCCCNC(=O)c2cccc(OCCOCCOCCOCCOc3cccc(C(=O)NCCCCN4CCN(c5ccccc5OC)CC4)c3)c2)CC1 10.1016/j.bmc.2011.10.063
CHEMBL1928122 69269 0 None -1 5 Pig 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 925 30 2 13 5.9 COc1ccccc1N1CCN(CCCCNC(=O)c2cccc(OCCOCCOCCOCCOc3cccc(C(=O)NCCCCN4CCN(c5ccccc5OC)CC4)c3)c2)CC1 10.1016/j.bmc.2011.10.063
10793720 204048 0 None 57 2 Human 9.0 pKi = 9.0 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 602 11 2 9 3.2 COc1ccc(N2C(=O)c3ccc(C(=O)NCC(O)CN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc1OC 10.1021/jm9905918
CHEMBL70095 204048 0 None 57 2 Human 9.0 pKi = 9.0 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 602 11 2 9 3.2 COc1ccc(N2C(=O)c3ccc(C(=O)NCC(O)CN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc1OC 10.1021/jm9905918
9910451 164106 0 None 3 7 Bovine 9.0 pKi = 9 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 428 5 0 6 4.7 Cn1cnc(-c2ccc3c(c2)c(C2CCN(CCC#N)CC2)cn3-c2ccc(F)cc2)n1 10.1021/jm020938y
CHEMBL420997 164106 0 None 3 7 Bovine 9.0 pKi = 9 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 428 5 0 6 4.7 Cn1cnc(-c2ccc3c(c2)c(C2CCN(CCC#N)CC2)cn3-c2ccc(F)cc2)n1 10.1021/jm020938y
10481087 169442 0 None 281 3 Human 9.0 pKi = 9 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 499 8 1 3 6.2 Cc1ccc(C(C(=O)NCCCN2CCC(C#N)(c3ccccc3Cl)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
CHEMBL44294 169442 0 None 281 3 Human 9.0 pKi = 9 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 499 8 1 3 6.2 Cc1ccc(C(C(=O)NCCCN2CCC(C#N)(c3ccccc3Cl)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
9959671 32641 0 None 363 3 Human 9.0 pKi = 9 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 567 10 0 7 5.6 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL141322 32641 0 None 363 3 Human 9.0 pKi = 9 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 567 10 0 7 5.6 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
10506484 36768 0 None 489 3 Human 9.0 pKi = 9 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 534 9 0 6 5.9 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(C#N)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL145001 36768 0 None 489 3 Human 9.0 pKi = 9 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 534 9 0 6 5.9 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(C#N)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
9894818 98897 0 None 83 7 Human 9.0 pKi = 9 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
CHEMBL279436 98897 0 None 83 7 Human 9.0 pKi = 9 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
9894818 98897 0 None 83 7 Human 9.0 pKi = 9 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1007/s00044-004-0120-9
CHEMBL279436 98897 0 None 83 7 Human 9.0 pKi = 9 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1007/s00044-004-0120-9
44431548 87022 0 None 26 4 Human 9.0 pKi = 9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 502 8 1 7 3.8 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccccc3[N+](=O)[O-])CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL232593 87022 0 None 26 4 Human 9.0 pKi = 9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 502 8 1 7 3.8 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccccc3[N+](=O)[O-])CC2)CC1 10.1016/j.bmcl.2007.04.008
17753379 87774 0 None -1 4 Human 9.0 pKi = 9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 521 8 1 6 4.5 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL233816 87774 0 None -1 4 Human 9.0 pKi = 9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 521 8 1 6 4.5 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
44431594 87990 0 None 17 4 Human 9.0 pKi = 9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 532 9 1 8 3.8 COc1ccc([N+](=O)[O-])cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL234422 87990 0 None 17 4 Human 9.0 pKi = 9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 532 9 1 8 3.8 COc1ccc([N+](=O)[O-])cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
10928520 205571 0 None 1 4 Human 9.0 pKi = 9 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 453 7 1 7 3.3 COc1ccc(Cl)cc1N1CCN(CCNc2cc(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
CHEMBL81486 205571 0 None 1 4 Human 9.0 pKi = 9 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 453 7 1 7 3.3 COc1ccc(Cl)cc1N1CCN(CCNc2cc(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
497 3340 8 None 61 3 Human 9.0 pKi = 9 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 444 7 1 6 2.1 Fc1ccc(c(c1)OCC(F)(F)F)N1CCN(CC1)CCCn1c(=O)[nH]cc(c1=O)C 10.1021/jm960697s
9872515 3340 8 None 61 3 Human 9.0 pKi = 9 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 444 7 1 6 2.1 Fc1ccc(c(c1)OCC(F)(F)F)N1CCN(CC1)CCCn1c(=O)[nH]cc(c1=O)C 10.1021/jm960697s
CHEMBL24777 3340 8 None 61 3 Human 9.0 pKi = 9 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 444 7 1 6 2.1 Fc1ccc(c(c1)OCC(F)(F)F)N1CCN(CC1)CCCn1c(=O)[nH]cc(c1=O)C 10.1021/jm960697s
148842 3915 27 None 8 5 Human 9.0 pKi = 9 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 511 8 1 6 4.7 COc1ccccc1N1CCN(CC1)CCCNC(=O)c1cccc2c1oc(c1ccccc1)c(c2=O)C 10.1021/jm960697s
496 3915 27 None 8 5 Human 9.0 pKi = 9 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 511 8 1 6 4.7 COc1ccccc1N1CCN(CC1)CCCNC(=O)c1cccc2c1oc(c1ccccc1)c(c2=O)C 10.1021/jm960697s
CHEMBL278865 3915 27 None 8 5 Human 9.0 pKi = 9 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 511 8 1 6 4.7 COc1ccccc1N1CCN(CC1)CCCNC(=O)c1cccc2c1oc(c1ccccc1)c(c2=O)C 10.1021/jm960697s
148842 3915 27 None 8 5 Human 9.0 pKi = 9 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 511 8 1 6 4.7 COc1ccccc1N1CCN(CC1)CCCNC(=O)c1cccc2c1oc(c1ccccc1)c(c2=O)C 10.1016/j.bmcl.2004.11.032
496 3915 27 None 8 5 Human 9.0 pKi = 9 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 511 8 1 6 4.7 COc1ccccc1N1CCN(CC1)CCCNC(=O)c1cccc2c1oc(c1ccccc1)c(c2=O)C 10.1016/j.bmcl.2004.11.032
CHEMBL278865 3915 27 None 8 5 Human 9.0 pKi = 9 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 511 8 1 6 4.7 COc1ccccc1N1CCN(CC1)CCCNC(=O)c1cccc2c1oc(c1ccccc1)c(c2=O)C 10.1016/j.bmcl.2004.11.032
609483 123636 15 None - 1 Human 9.0 pKi = 9 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 407 5 0 5 2.8 COc1ccccc1N1CCN(CCN2C(=O)c3ccccc3C(C)(C)C2=O)CC1 10.1016/j.bmcl.2004.11.032
CHEMBL362051 123636 15 None - 1 Human 9.0 pKi = 9 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 407 5 0 5 2.8 COc1ccccc1N1CCN(CCN2C(=O)c3ccccc3C(C)(C)C2=O)CC1 10.1016/j.bmcl.2004.11.032
90645606 112412 0 None 2 3 Human 9.0 pKi = 9 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 652 12 2 9 4.8 COc1ccccc1N1CCN(CCn2c(C)nc3c(sc4ccc(NC(=O)CCCNC(=O)Cc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
CHEMBL3298024 112412 0 None 2 3 Human 9.0 pKi = 9 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 652 12 2 9 4.8 COc1ccccc1N1CCN(CCn2c(C)nc3c(sc4ccc(NC(=O)CCCNC(=O)Cc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
56668277 63150 0 None 616 3 Human 9.0 pKi = 9 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 607 7 2 7 4.3 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@@H]2CC[C@H](N3CCC(C#N)(c4ccccc4)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
CHEMBL1789975 63150 0 None 616 3 Human 9.0 pKi = 9 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 607 7 2 7 4.3 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@@H]2CC[C@H](N3CCC(C#N)(c4ccccc4)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
11984570 92775 0 None 2 3 Human 9.0 pKi = 9 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 465 5 0 5 4.3 CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4cccc(F)c4C3=O)CC2)CC1 10.1016/j.bmcl.2006.12.111
CHEMBL243694 92775 0 None 2 3 Human 9.0 pKi = 9 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 465 5 0 5 4.3 CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4cccc(F)c4C3=O)CC2)CC1 10.1016/j.bmcl.2006.12.111
49781680 17853 0 None 4 4 Bovine 9.0 pKi = 9 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 414 2 0 3 6.0 Cc1cccc(C)c1-c1ccc2c(c1)C(N1CCN(C)CC1)Cc1ccccc1S2 10.1021/jm100652h
CHEMBL1259097 17853 0 None 4 4 Bovine 9.0 pKi = 9 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 414 2 0 3 6.0 Cc1cccc(C)c1-c1ccc2c(c1)C(N1CCN(C)CC1)Cc1ccccc1S2 10.1021/jm100652h
10626610 36722 0 None 251 3 Human 9.0 pKi = 9 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 556 8 2 6 4.2 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL144965 36722 0 None 251 3 Human 9.0 pKi = 9 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 556 8 2 6 4.2 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
44298770 101584 0 None 10 3 Human 9.0 pKi = 9 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 464 7 1 6 2.5 O=c1[nH]cc(Cl)c(=O)n1CCCN1CCN(c2ccc(F)cc2OCC(F)(F)F)CC1 10.1016/s0960-894x(03)00305-6
CHEMBL298838 101584 0 None 10 3 Human 9.0 pKi = 9 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 464 7 1 6 2.5 O=c1[nH]cc(Cl)c(=O)n1CCCN1CCN(c2ccc(F)cc2OCC(F)(F)F)CC1 10.1016/s0960-894x(03)00305-6
15840661 199439 0 None 31 3 Human 9.0 pKi = 9 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 432 7 1 5 2.2 O=C1CCNC(=O)N1CCCN1CCN(c2ccc(F)cc2OCC(F)(F)F)CC1 10.1016/s0960-894x(03)00305-6
CHEMBL59153 199439 0 None 31 3 Human 9.0 pKi = 9 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 432 7 1 5 2.2 O=C1CCNC(=O)N1CCCN1CCN(c2ccc(F)cc2OCC(F)(F)F)CC1 10.1016/s0960-894x(03)00305-6
10717073 202602 0 None 1 3 Rat 9.0 pKi = 9.0 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 421 5 1 6 2.4 COc1ccc2[nH]c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2c1 10.1021/jm000541z
CHEMBL61225 202602 0 None 1 3 Rat 9.0 pKi = 9.0 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 421 5 1 6 2.4 COc1ccc2[nH]c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2c1 10.1021/jm000541z
10507089 102301 0 None 186 2 Human 9.0 pKi = 9.0 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 560 9 2 7 3.3 CC(C)Oc1ccccc1N1CCN(C[C@@H](O)CNC(=O)c2ccc3c(c2)C(=O)N(c2cccc(F)c2)C3=O)CC1 10.1021/jm9905918
CHEMBL303627 102301 0 None 186 2 Human 9.0 pKi = 9.0 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 560 9 2 7 3.3 CC(C)Oc1ccccc1N1CCN(C[C@@H](O)CNC(=O)c2ccc3c(c2)C(=O)N(c2cccc(F)c2)C3=O)CC1 10.1021/jm9905918
10644505 100737 0 None -1 3 Rat 9.0 pKi = 9.0 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 397 4 1 6 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4sccc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL292881 100737 0 None -1 3 Rat 9.0 pKi = 9.0 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 397 4 1 6 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4sccc4c3=O)C[C@@H]21 10.1021/jm000541z
4209 3141 75 None -3 34 Rat 9.0 pKi = 9.0 Binding
Compound was tested for its binding affinity towards Alpha-1A adrenergic receptor using [3H]prazosin from rat submaxillary glandCompound was tested for its binding affinity towards Alpha-1A adrenergic receptor using [3H]prazosin from rat submaxillary gland
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm970740r
4893 3141 75 None -3 34 Rat 9.0 pKi = 9.0 Binding
Compound was tested for its binding affinity towards Alpha-1A adrenergic receptor using [3H]prazosin from rat submaxillary glandCompound was tested for its binding affinity towards Alpha-1A adrenergic receptor using [3H]prazosin from rat submaxillary gland
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm970740r
503 3141 75 None -3 34 Rat 9.0 pKi = 9.0 Binding
Compound was tested for its binding affinity towards Alpha-1A adrenergic receptor using [3H]prazosin from rat submaxillary glandCompound was tested for its binding affinity towards Alpha-1A adrenergic receptor using [3H]prazosin from rat submaxillary gland
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm970740r
5385 3141 75 None -3 34 Rat 9.0 pKi = 9.0 Binding
Compound was tested for its binding affinity towards Alpha-1A adrenergic receptor using [3H]prazosin from rat submaxillary glandCompound was tested for its binding affinity towards Alpha-1A adrenergic receptor using [3H]prazosin from rat submaxillary gland
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm970740r
CHEMBL2 3141 75 None -3 34 Rat 9.0 pKi = 9.0 Binding
Compound was tested for its binding affinity towards Alpha-1A adrenergic receptor using [3H]prazosin from rat submaxillary glandCompound was tested for its binding affinity towards Alpha-1A adrenergic receptor using [3H]prazosin from rat submaxillary gland
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm970740r
DB00457 3141 75 None -3 34 Rat 9.0 pKi = 9.0 Binding
Compound was tested for its binding affinity towards Alpha-1A adrenergic receptor using [3H]prazosin from rat submaxillary glandCompound was tested for its binding affinity towards Alpha-1A adrenergic receptor using [3H]prazosin from rat submaxillary gland
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm970740r
9895326 207004 0 None 177 6 Human 9.0 pKi = 9.0 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 621 12 3 6 5.7 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(CC)N1 10.1021/jm980077m
CHEMBL91550 207004 0 None 177 6 Human 9.0 pKi = 9.0 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 621 12 3 6 5.7 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(CC)N1 10.1021/jm980077m
9895326 207004 0 None 177 6 Human 9.0 pKi = 9.0 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 621 12 3 6 5.7 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(CC)N1 10.1007/s00044-004-0120-9
CHEMBL91550 207004 0 None 177 6 Human 9.0 pKi = 9.0 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 621 12 3 6 5.7 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(CC)N1 10.1007/s00044-004-0120-9
10742076 100290 0 None -1 3 Rat 9.0 pKi = 9.0 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 447 4 1 6 3.6 COc1cccc2c1CCC1CN(CCn3c(=O)[nH]c4c(sc5ccccc54)c3=O)CC21 10.1021/jm990567u
CHEMBL289361 100290 0 None -1 3 Rat 9.0 pKi = 9.0 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 447 4 1 6 3.6 COc1cccc2c1CCC1CN(CCn3c(=O)[nH]c4c(sc5ccccc54)c3=O)CC21 10.1021/jm990567u
10606661 100912 0 None 1 3 Rat 9.0 pKi = 9.0 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 441 5 1 7 2.7 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(C)c(OC)sc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL294027 100912 0 None 1 3 Rat 9.0 pKi = 9.0 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 441 5 1 7 2.7 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(C)c(OC)sc4c3=O)C[C@@H]21 10.1021/jm000541z
90645592 112457 0 None -1 3 Human 9.0 pKi = 9.0 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 555 7 2 8 4.0 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)c5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
CHEMBL3298745 112457 0 None -1 3 Human 9.0 pKi = 9.0 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 555 7 2 8 4.0 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)c5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
90645596 112461 0 None -2 3 Human 9.0 pKi = 9.0 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 640 11 3 9 3.8 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)CCC(=O)NCc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
CHEMBL3298749 112461 0 None -2 3 Human 9.0 pKi = 9.0 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 640 11 3 9 3.8 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)CCC(=O)NCc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
10507411 34152 0 None 457 3 Human 9.0 pKi = 9.0 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 577 9 0 5 7.3 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(c3ccccc3C(F)(F)F)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL142606 34152 0 None 457 3 Human 9.0 pKi = 9.0 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 577 9 0 5 7.3 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(c3ccccc3C(F)(F)F)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
10318686 104256 0 None 60 3 Human 9.0 pKi = 9.0 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 398 7 0 6 2.9 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCC3=O)no2)CC1 10.1016/s0960-894x(02)00436-5
CHEMBL309969 104256 0 None 60 3 Human 9.0 pKi = 9.0 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 398 7 0 6 2.9 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCC3=O)no2)CC1 10.1016/s0960-894x(02)00436-5
44295046 101906 0 None 117 3 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 577 8 2 9 2.8 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1016/s0960-894x(99)00653-8
CHEMBL301077 101906 0 None 117 3 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 577 8 2 9 2.8 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1016/s0960-894x(99)00653-8
57390118 69273 0 None -1 5 Pig 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 953 32 2 13 6.2 COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(COCCOCCOCCOCCOCc3ccc(C(=O)NCCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1 10.1016/j.bmc.2011.10.063
CHEMBL1928126 69273 0 None -1 5 Pig 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 953 32 2 13 6.2 COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(COCCOCCOCCOCCOCc3ccc(C(=O)NCCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1 10.1016/j.bmc.2011.10.063
57393628 69284 0 None -3 5 Pig 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 1005 30 2 17 5.2 COc1ccccc1N1CCN(CCCCNC(=O)c2cnn3ccc(OCCOCCOCCOCCOc4ccn5ncc(C(=O)NCCCCN6CCN(c7ccccc7OC)CC6)c5c4)cc23)CC1 10.1016/j.bmc.2011.10.063
CHEMBL1928137 69284 0 None -3 5 Pig 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 1005 30 2 17 5.2 COc1ccccc1N1CCN(CCCCNC(=O)c2cnn3ccc(OCCOCCOCCOCCOc4ccn5ncc(C(=O)NCCCCN6CCN(c7ccccc7OC)CC6)c5c4)cc23)CC1 10.1016/j.bmc.2011.10.063
49781678 17846 0 None -1 4 Bovine 9.0 pKi = 9.0 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 400 2 0 3 5.7 Cc1ccc(-c2ccc3c(c2)C(N2CCN(C)CC2)Cc2ccccc2S3)cc1 10.1021/jm100652h
CHEMBL1259079 17846 0 None -1 4 Bovine 9.0 pKi = 9.0 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 400 2 0 3 5.7 Cc1ccc(-c2ccc3c(c2)C(N2CCN(C)CC2)Cc2ccccc2S3)cc1 10.1021/jm100652h
10555288 34710 0 None 45 3 Human 9.0 pKi = 9.0 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 582 8 2 7 4.2 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1cccc(Cl)c1 10.1021/jm990200p
CHEMBL143066 34710 0 None 45 3 Human 9.0 pKi = 9.0 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 582 8 2 7 4.2 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1cccc(Cl)c1 10.1021/jm990200p
10769058 165654 0 None 208 3 Human 9.0 pKi = 9.0 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 552 6 2 5 4.6 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC3(CCc4ccccc43)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL424494 165654 0 None 208 3 Human 9.0 pKi = 9.0 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 552 6 2 5 4.6 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC3(CCc4ccccc43)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
44289321 161944 0 None 6 3 Human 9.0 pKi = 9.0 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 455 8 1 3 5.1 Cc1ccc(C(C(=O)NCCCN2CCN(c3ccccc3C)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
CHEMBL415887 161944 0 None 6 3 Human 9.0 pKi = 9.0 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 455 8 1 3 5.1 Cc1ccc(C(C(=O)NCCCN2CCN(c3ccccc3C)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
9982050 101907 0 None 2 4 Human 9.0 pKi = 9.0 Binding
The compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cellsThe compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 467 6 1 9 2.5 COc1ccccc1N1CCN(CCNc2ccc3c4c(=O)n(C)nc(Cl)c4cn3n2)CC1 10.1021/jm981006q
CHEMBL301078 101907 0 None 2 4 Human 9.0 pKi = 9.0 Binding
The compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cellsThe compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 467 6 1 9 2.5 COc1ccccc1N1CCN(CCNc2ccc3c4c(=O)n(C)nc(Cl)c4cn3n2)CC1 10.1021/jm981006q
10531766 206974 0 None 199 6 Human 9.0 pKi = 9.0 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 607 9 2 7 6.3 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2 10.1021/jm980077m
CHEMBL91415 206974 0 None 199 6 Human 9.0 pKi = 9.0 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 607 9 2 7 6.3 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2 10.1021/jm980077m
10531766 85259 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 607 9 2 7 5.4 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2 10.1007/s00044-004-0120-9
CHEMBL2260366 85259 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 607 9 2 7 5.4 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2 10.1007/s00044-004-0120-9
52942152 17035 0 None -2 4 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 438 13 1 7 4.2 COc1cccc([N+](=O)[O-])c1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
CHEMBL1254743 17035 0 None -2 4 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 438 13 1 7 4.2 COc1cccc([N+](=O)[O-])c1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
71659980 145868 0 None 1 3 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 354 6 0 5 3.2 CCOc1ccccc1N1CCN(CCc2ccc3c(c2)OCO3)CC1 10.1016/j.ejmech.2016.06.052
CHEMBL3917716 145868 0 None 1 3 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 354 6 0 5 3.2 CCOc1ccccc1N1CCN(CCc2ccc3c(c2)OCO3)CC1 10.1016/j.ejmech.2016.06.052
78815633 147491 2 None 1 3 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 340 7 0 4 3.5 CCOc1ccccc1N1CCN(CCc2ccc(OC)cc2)CC1 10.1016/j.ejmech.2016.06.052
CHEMBL3930616 147491 2 None 1 3 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 340 7 0 4 3.5 CCOc1ccccc1N1CCN(CCc2ccc(OC)cc2)CC1 10.1016/j.ejmech.2016.06.052
10621309 202752 0 None -1 3 Rat 8.9 pKi = 8.9 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 405 4 1 5 2.7 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cccc(C)c4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL62110 202752 0 None -1 3 Rat 8.9 pKi = 8.9 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 405 4 1 5 2.7 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cccc(C)c4c3=O)C[C@@H]21 10.1021/jm000541z
9851486 206676 0 None 223 6 Human 8.9 pKi = 8.9 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 592 10 2 6 6.0 CC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
CHEMBL89685 206676 0 None 223 6 Human 8.9 pKi = 8.9 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 592 10 2 6 6.0 CC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
9851486 206676 0 None 223 6 Human 8.9 pKi = 8.9 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 592 10 2 6 6.0 CC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
CHEMBL89685 206676 0 None 223 6 Human 8.9 pKi = 8.9 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 592 10 2 6 6.0 CC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
10409038 85213 0 None 41 4 Rat 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from adrenergic alpha1A receptor in rat brain membraneDisplacement of [3H]prazosin from adrenergic alpha1A receptor in rat brain membrane
ChEMBL 405 2 2 5 3.6 COc1cc2c(cc1O)C[C@H]1c3c(c(Br)c(O)c(OC)c3-2)CCN1C 10.1021/np990433j
CHEMBL225853 85213 0 None 41 4 Rat 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from adrenergic alpha1A receptor in rat brain membraneDisplacement of [3H]prazosin from adrenergic alpha1A receptor in rat brain membrane
ChEMBL 405 2 2 5 3.6 COc1cc2c(cc1O)C[C@H]1c3c(c(Br)c(O)c(OC)c3-2)CCN1C 10.1021/np990433j
10620533 201841 0 None 1 3 Rat 8.9 pKi = 8.9 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 392 4 1 6 1.8 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4ncccc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL60722 201841 0 None 1 3 Rat 8.9 pKi = 8.9 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 392 4 1 6 1.8 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4ncccc4c3=O)C[C@@H]21 10.1021/jm000541z
10770057 102045 0 None 42 3 Human 8.9 pKi = 8.9 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 610 9 2 7 4.5 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(Cl)c(Cl)c2)C3=O)CC1 10.1021/jm9905918
CHEMBL302092 102045 0 None 42 3 Human 8.9 pKi = 8.9 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 610 9 2 7 4.5 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(Cl)c(Cl)c2)C3=O)CC1 10.1021/jm9905918
19085869 168101 0 None 30 3 Human 8.9 pKi = 8.9 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 469 6 0 7 3.2 Cc1ccc2oc(=O)n(C3CCN(CCCCN4C(=O)c5ccccc5S4(=O)=O)CC3)c2c1 10.1016/s0960-894x(98)00446-6
CHEMBL432947 168101 0 None 30 3 Human 8.9 pKi = 8.9 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 469 6 0 7 3.2 Cc1ccc2oc(=O)n(C3CCN(CCCCN4C(=O)c5ccccc5S4(=O)=O)CC3)c2c1 10.1016/s0960-894x(98)00446-6
10578548 36982 0 None 398 3 Human 8.9 pKi = 8.9 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 548 9 0 6 6.2 COC(=O)C1=C(C)N=C(C)N(CCC[C@H](C)CN2CCC(C#N)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL145178 36982 0 None 398 3 Human 8.9 pKi = 8.9 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 548 9 0 6 6.2 COC(=O)C1=C(C)N=C(C)N(CCC[C@H](C)CN2CCC(C#N)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
10643502 100922 0 None 1 3 Rat 8.9 pKi = 8.9 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 380 4 2 5 1.7 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4[nH]ccc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL294098 100922 0 None 1 3 Rat 8.9 pKi = 8.9 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 380 4 2 5 1.7 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4[nH]ccc4c3=O)C[C@@H]21 10.1021/jm000541z
11505007 168899 0 None -3 4 Human 8.9 pKi = 8.9 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 557 9 1 7 4.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4OCC(F)(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
CHEMBL438673 168899 0 None -3 4 Human 8.9 pKi = 8.9 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 557 9 1 7 4.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4OCC(F)(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
44431616 88047 0 None 3 4 Human 8.9 pKi = 8.9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 471 8 1 5 4.0 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL234649 88047 0 None 3 4 Human 8.9 pKi = 8.9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 471 8 1 5 4.0 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
10342554 104755 0 None 33 3 Human 8.9 pKi = 8.9 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 428 7 0 6 3.8 CC(C)Oc1ccccc1N1CCN(Cc2nc(CN3CCCCC3=O)cs2)CC1 10.1016/s0960-894x(02)00436-5
CHEMBL310890 104755 0 None 33 3 Human 8.9 pKi = 8.9 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 428 7 0 6 3.8 CC(C)Oc1ccccc1N1CCN(Cc2nc(CN3CCCCC3=O)cs2)CC1 10.1016/s0960-894x(02)00436-5
57400556 69281 0 None -1 5 Pig 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 495 13 1 8 3.1 CCOCCOc1ccn2ncc(C(=O)NCCCCN3CCN(c4ccccc4OC)CC3)c2c1 10.1016/j.bmc.2011.10.063
CHEMBL1928134 69281 0 None -1 5 Pig 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 495 13 1 8 3.1 CCOCCOc1ccn2ncc(C(=O)NCCCCN3CCN(c4ccccc4OC)CC3)c2c1 10.1016/j.bmc.2011.10.063
57400557 69283 0 None -1 5 Pig 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 509 14 1 8 3.2 CCOCCOCc1ccn2ncc(C(=O)NCCCCN3CCN(c4ccccc4OC)CC3)c2c1 10.1016/j.bmc.2011.10.063
CHEMBL1928136 69283 0 None -1 5 Pig 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 509 14 1 8 3.2 CCOCCOCc1ccn2ncc(C(=O)NCCCCN3CCN(c4ccccc4OC)CC3)c2c1 10.1016/j.bmc.2011.10.063
10650633 37507 0 None 64 3 Human 8.9 pKi = 8.9 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 566 8 2 7 3.6 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)cc1 10.1021/jm990200p
CHEMBL145610 37507 0 None 64 3 Human 8.9 pKi = 8.9 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 566 8 2 7 3.6 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)cc1 10.1021/jm990200p
10603727 37660 0 None 114 3 Human 8.9 pKi = 8.9 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 606 10 3 8 3.4 CCC1=C(C(=O)NC)C(c2ccc([N+](=O)[O-])cc2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
CHEMBL145752 37660 0 None 114 3 Human 8.9 pKi = 8.9 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 606 10 3 8 3.4 CCC1=C(C(=O)NC)C(c2ccc([N+](=O)[O-])cc2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
11994665 11802 0 None -1 7 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 391 8 1 5 4.2 COc1cccc(-c2ccccc2)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL1182151 11802 0 None -1 7 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 391 8 1 5 4.2 COc1cccc(-c2ccccc2)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL215151 11802 0 None -1 7 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 391 8 1 5 4.2 COc1cccc(-c2ccccc2)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
10770317 203868 0 None 123 2 Human 8.9 pKi = 8.9 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 632 12 2 10 3.2 COc1cc(N2C(=O)c3ccc(C(=O)NCC(O)CN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc(OC)c1OC 10.1021/jm9905918
CHEMBL68913 203868 0 None 123 2 Human 8.9 pKi = 8.9 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 632 12 2 10 3.2 COc1cc(N2C(=O)c3ccc(C(=O)NCC(O)CN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc(OC)c1OC 10.1021/jm9905918
44268966 33407 0 None 5 6 Bovine 8.9 pKi = 8.9 Binding
Binding affinity towards bovine Alpha-1A adrenergic receptorBinding affinity towards bovine Alpha-1A adrenergic receptor
ChEMBL 476 7 1 7 3.6 COc1ccccc1N1CCN(CCCn2c(=O)[nH]c3scc(-c4ccccc4)c3c2=O)CC1 10.1016/s0960-894x(01)00159-7
CHEMBL14199 33407 0 None 5 6 Bovine 8.9 pKi = 8.9 Binding
Binding affinity towards bovine Alpha-1A adrenergic receptorBinding affinity towards bovine Alpha-1A adrenergic receptor
ChEMBL 476 7 1 7 3.6 COc1ccccc1N1CCN(CCCn2c(=O)[nH]c3scc(-c4ccccc4)c3c2=O)CC1 10.1016/s0960-894x(01)00159-7
44275255 98576 0 None 223 3 Human 8.9 pKi = 8.9 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 636 12 2 7 7.2 CCC1=NC(CC)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)/C1=C(\O)OC 10.1021/jm960697s
CHEMBL276932 98576 0 None 223 3 Human 8.9 pKi = 8.9 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 636 12 2 7 7.2 CCC1=NC(CC)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)/C1=C(\O)OC 10.1021/jm960697s
11554541 71779 0 None -25 4 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 468 14 1 8 4.2 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccc([N+](=O)[O-])cc1 10.1021/jm0580398
CHEMBL196817 71779 0 None -25 4 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 468 14 1 8 4.2 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccc([N+](=O)[O-])cc1 10.1021/jm0580398
11751173 63396 0 None -1 6 Human 8.9 pKi = 8.9 Binding
Equilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cellsEquilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cells
ChEMBL 445 4 1 9 2.3 COc1cc2nc(N3CCN(C4=CC(=O)c5ccccc5C4=O)CC3)nc(N)c2cc1OC 10.1021/jm049153d
CHEMBL179743 63396 0 None -1 6 Human 8.9 pKi = 8.9 Binding
Equilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cellsEquilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cells
ChEMBL 445 4 1 9 2.3 COc1cc2nc(N3CCN(C4=CC(=O)c5ccccc5C4=O)CC3)nc(N)c2cc1OC 10.1021/jm049153d
497 3340 8 None 61 3 Human 8.9 pKi = 8.9 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 444 7 1 6 2.1 Fc1ccc(c(c1)OCC(F)(F)F)N1CCN(CC1)CCCn1c(=O)[nH]cc(c1=O)C 10.1016/s0960-894x(03)00305-6
9872515 3340 8 None 61 3 Human 8.9 pKi = 8.9 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 444 7 1 6 2.1 Fc1ccc(c(c1)OCC(F)(F)F)N1CCN(CC1)CCCn1c(=O)[nH]cc(c1=O)C 10.1016/s0960-894x(03)00305-6
CHEMBL24777 3340 8 None 61 3 Human 8.9 pKi = 8.9 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 444 7 1 6 2.1 Fc1ccc(c(c1)OCC(F)(F)F)N1CCN(CC1)CCCn1c(=O)[nH]cc(c1=O)C 10.1016/s0960-894x(03)00305-6
9804599 101673 0 None 25 3 Human 8.9 pKi = 8.9 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 430 7 1 6 1.8 O=c1cc[nH]c(=O)n1CCCN1CCN(c2ccc(F)cc2OCC(F)(F)F)CC1 10.1016/s0960-894x(03)00305-6
CHEMBL299452 101673 0 None 25 3 Human 8.9 pKi = 8.9 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 430 7 1 6 1.8 O=c1cc[nH]c(=O)n1CCCN1CCN(c2ccc(F)cc2OCC(F)(F)F)CC1 10.1016/s0960-894x(03)00305-6
10506361 157681 0 None 1 3 Rat 8.9 pKi = 8.9 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 492 5 1 8 3.5 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccc([N+](=O)[O-])cc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL40819 157681 0 None 1 3 Rat 8.9 pKi = 8.9 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 492 5 1 8 3.5 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccc([N+](=O)[O-])cc54)c3=O)C[C@@H]21 10.1021/jm990567u
499 4046 18 None -1 15 Rat 8.9 pKi = 8.9 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligand
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm960069a
5685 4046 18 None -1 15 Rat 8.9 pKi = 8.9 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligand
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm960069a
CHEMBL25554 4046 18 None -1 15 Rat 8.9 pKi = 8.9 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligand
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm960069a
10696645 144097 0 None -1 3 Rat 8.9 pKi = 8.9 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 461 4 1 6 3.9 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccc(C)c54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL39037 144097 0 None -1 3 Rat 8.9 pKi = 8.9 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 461 4 1 6 3.9 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccc(C)c54)c3=O)C[C@@H]21 10.1021/jm990567u
44431554 166654 0 None 20 4 Human 8.9 pKi = 8.9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 475 7 1 5 4.0 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccc(F)cc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL428197 166654 0 None 20 4 Human 8.9 pKi = 8.9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 475 7 1 5 4.0 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccc(F)cc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
11857710 142338 0 None 1 4 Human 8.9 pKi = 8.9 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 518 8 1 5 5.4 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCC(c3ccccc3OC3CC3)CC2)CC1 10.1016/j.bmcl.2007.04.098
CHEMBL388897 142338 0 None 1 4 Human 8.9 pKi = 8.9 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 518 8 1 5 5.4 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCC(c3ccccc3OC3CC3)CC2)CC1 10.1016/j.bmcl.2007.04.098
497 3340 8 None 61 3 Human 8.9 pKi = 8.9 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 444 7 1 6 2.1 Fc1ccc(c(c1)OCC(F)(F)F)N1CCN(CC1)CCCn1c(=O)[nH]cc(c1=O)C 10.1016/j.bmcl.2004.11.032
9872515 3340 8 None 61 3 Human 8.9 pKi = 8.9 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 444 7 1 6 2.1 Fc1ccc(c(c1)OCC(F)(F)F)N1CCN(CC1)CCCn1c(=O)[nH]cc(c1=O)C 10.1016/j.bmcl.2004.11.032
CHEMBL24777 3340 8 None 61 3 Human 8.9 pKi = 8.9 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 444 7 1 6 2.1 Fc1ccc(c(c1)OCC(F)(F)F)N1CCN(CC1)CCCn1c(=O)[nH]cc(c1=O)C 10.1016/j.bmcl.2004.11.032
56961506 121413 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 544 5 2 13 1.6 COc1cc2nc(N3CCN(C(=O)c4cn(-c5cc6ccc(O)cc6oc5=O)nn4)CC3)nc(N)c2cc1OC 10.1021/ml5004298
CHEMBL3582269 121413 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 544 5 2 13 1.6 COc1cc2nc(N3CCN(C(=O)c4cn(-c5cc6ccc(O)cc6oc5=O)nn4)CC3)nc(N)c2cc1OC 10.1021/ml5004298
10973768 107533 0 None -3 10 Bovine 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 563 6 1 8 4.4 Cn1cnc(-c2ccc3c(c2)c(C2CCN(CCn4c(=O)[nH]c5ccccc5c4=O)CC2)cn3-c2ccc(F)cc2)n1 10.1021/jm020938y
CHEMBL318901 107533 0 None -3 10 Bovine 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 563 6 1 8 4.4 Cn1cnc(-c2ccc3c(c2)c(C2CCN(CCn4c(=O)[nH]c5ccccc5c4=O)CC2)cn3-c2ccc(F)cc2)n1 10.1021/jm020938y
49781894 17874 0 None -3 4 Bovine 8.9 pKi = 8.9 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 423 3 1 4 4.3 CN1CCN(C2Cc3ccccc3Sc3ccc(CNC(=O)C(C)(C)C)cc32)CC1 10.1021/jm100652h
CHEMBL1259158 17874 0 None -3 4 Bovine 8.9 pKi = 8.9 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 423 3 1 4 4.3 CN1CCN(C2Cc3ccccc3Sc3ccc(CNC(=O)C(C)(C)C)cc32)CC1 10.1021/jm100652h
10099811 120997 4 None 676 4 Human 8.9 pKi = 8.9 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of dogIn vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of dog
ChEMBL 583 9 3 6 3.5 CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
CHEMBL356584 120997 4 None 676 4 Human 8.9 pKi = 8.9 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of dogIn vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of dog
ChEMBL 583 9 3 6 3.5 CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
10841851 34285 0 None 562 3 Human 8.9 pKi = 8.9 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 569 9 4 6 2.2 CCC1=C(C(N)=O)C(c2ccc(F)cc2F)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C(=O)N1 10.1021/jm990202+
CHEMBL142718 34285 0 None 562 3 Human 8.9 pKi = 8.9 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 569 9 4 6 2.2 CCC1=C(C(N)=O)C(c2ccc(F)cc2F)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C(=O)N1 10.1021/jm990202+
9894818 98897 0 None 83 7 Human 8.9 pKi = 8.9 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm00019a001
CHEMBL279436 98897 0 None 83 7 Human 8.9 pKi = 8.9 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm00019a001
9809007 172540 8 None 134 6 Human 8.9 pKi = 8.9 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00019a001
CHEMBL448620 172540 8 None 134 6 Human 8.9 pKi = 8.9 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00019a001
9982585 101489 0 None 281 3 Human 8.9 pKi = 8.9 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 479 8 1 3 5.8 Cc1ccc(C(C(=O)NCCCN2CCC(C#N)(c3ccccc3C)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
CHEMBL298058 101489 0 None 281 3 Human 8.9 pKi = 8.9 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 479 8 1 3 5.8 Cc1ccc(C(C(=O)NCCCN2CCC(C#N)(c3ccccc3C)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
16721110 83660 0 None -7 3 Human 8.9 pKi = 8.9 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 451 5 1 6 3.7 COc1ccc(Cl)cc1N1CCN(CCn2c(C)nc3c([nH]c4ccccc43)c2=O)CC1 10.1016/j.bmcl.2006.09.034
CHEMBL220515 83660 0 None -7 3 Human 8.9 pKi = 8.9 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 451 5 1 6 3.7 COc1ccc(Cl)cc1N1CCN(CCn2c(C)nc3c([nH]c4ccccc43)c2=O)CC1 10.1016/j.bmcl.2006.09.034
11384634 94669 0 None -134 4 Rat 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 420 5 1 5 3.8 CC(=O)NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21 10.1016/j.bmcl.2007.11.106
CHEMBL252818 94669 0 None -134 4 Rat 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 420 5 1 5 3.8 CC(=O)NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21 10.1016/j.bmcl.2007.11.106
10480509 142306 0 None 89 2 Rat 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from adrenergic alpha1A receptor in rat brain membraneDisplacement of [3H]prazosin from adrenergic alpha1A receptor in rat brain membrane
ChEMBL 483 2 2 5 4.4 COc1cc2c(c(Br)c1O)C[C@H]1c3c(c(Br)c(O)c(OC)c3-2)CCN1C 10.1021/np990433j
CHEMBL388564 142306 0 None 89 2 Rat 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from adrenergic alpha1A receptor in rat brain membraneDisplacement of [3H]prazosin from adrenergic alpha1A receptor in rat brain membrane
ChEMBL 483 2 2 5 4.4 COc1cc2c(c(Br)c1O)C[C@H]1c3c(c(Br)c(O)c(OC)c3-2)CCN1C 10.1021/np990433j
136806217 207676 0 None 12 3 Human 8.9 pKi = 8.9 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 576 13 4 8 2.7 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)CC2)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
44328806 207676 0 None 12 3 Human 8.9 pKi = 8.9 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 576 13 4 8 2.7 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)CC2)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
CHEMBL95548 207676 0 None 12 3 Human 8.9 pKi = 8.9 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 576 13 4 8 2.7 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)CC2)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
10627021 107068 0 None 194 6 Human 8.9 pKi = 8.9 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 577 9 2 5 6.8 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(C)cc1 10.1021/jm980077m
CHEMBL315914 107068 0 None 194 6 Human 8.9 pKi = 8.9 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 577 9 2 5 6.8 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(C)cc1 10.1021/jm980077m
10627021 85258 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 577 9 2 5 6.0 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(C)cc1 10.1007/s00044-004-0120-9
CHEMBL2260365 85258 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 577 9 2 5 6.0 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(C)cc1 10.1007/s00044-004-0120-9
10606657 201465 0 None -1 3 Rat 8.9 pKi = 8.9 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 419 4 1 5 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cc(C)c(C)cc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL60510 201465 0 None -1 3 Rat 8.9 pKi = 8.9 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 419 4 1 5 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cc(C)c(C)cc4c3=O)C[C@@H]21 10.1021/jm000541z
52942047 16633 0 None 5 4 Human 8.9 pKi = 8.9 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 451 7 0 6 2.7 COc1ccccc1N1CCN(C[C@H]2CO[C@](CN3CCCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
CHEMBL1242444 16633 0 None 5 4 Human 8.9 pKi = 8.9 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 451 7 0 6 2.7 COc1ccccc1N1CCN(C[C@H]2CO[C@](CN3CCCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
44447039 154362 0 None -2 4 Rat 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 472 6 1 6 4.7 O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1ccco1 10.1016/j.bmcl.2007.11.106
CHEMBL398744 154362 0 None -2 4 Rat 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 472 6 1 6 4.7 O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1ccco1 10.1016/j.bmcl.2007.11.106
71454559 79615 0 None -1 3 Rat 8.9 pKi = 8.9 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 397 4 1 6 2.4 COc1cccc2c1CCC1CN(CCn3c(=O)[nH]c4ccsc4c3=O)CC21 10.1021/jm000541z
CHEMBL2115086 79615 0 None -1 3 Rat 8.9 pKi = 8.9 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 397 4 1 6 2.4 COc1cccc2c1CCC1CN(CCn3c(=O)[nH]c4ccsc4c3=O)CC21 10.1021/jm000541z
10692195 100578 0 None -1 3 Rat 8.9 pKi = 8.9 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 397 4 1 6 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4ccsc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL291839 100578 0 None -1 3 Rat 8.9 pKi = 8.9 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 397 4 1 6 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4ccsc4c3=O)C[C@@H]21 10.1021/jm000541z
20215436 28484 3 None -3 3 Human 8.9 pKi = 8.9 Binding
The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.
ChEMBL 355 4 1 8 2.1 COc1cc2nc(N3CCN(c4ccco4)CC3)nc(N)c2cc1OC 10.1021/jm9805337
CHEMBL137598 28484 3 None -3 3 Human 8.9 pKi = 8.9 Binding
The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.
ChEMBL 355 4 1 8 2.1 COc1cc2nc(N3CCN(c4ccco4)CC3)nc(N)c2cc1OC 10.1021/jm9805337
11857639 85719 1 None 56 4 Human 8.9 pKi = 8.9 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 492 7 1 4 5.2 CC(C)Oc1ccccc1C1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccc(F)c(F)c3)CC2)CC1 10.1016/j.bmcl.2007.04.098
CHEMBL229084 85719 1 None 56 4 Human 8.9 pKi = 8.9 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 492 7 1 4 5.2 CC(C)Oc1ccccc1C1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccc(F)c(F)c3)CC2)CC1 10.1016/j.bmcl.2007.04.098
6603950 203301 9 None -3 9 Bovine 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 344 1 0 3 4.3 CN1CCN([C@@H]2Cc3ccccc3Sc3ccc(Cl)cc32)CC1 10.1021/jm020938y
CHEMBL64875 203301 9 None -3 9 Bovine 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 344 1 0 3 4.3 CN1CCN([C@@H]2Cc3ccccc3Sc3ccc(Cl)cc32)CC1 10.1021/jm020938y
56837636 69268 0 None 7 5 Pig 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 897 28 2 13 5.1 COc1ccccc1N1CCN(CCCNC(=O)c2cccc(OCCOCCOCCOCCOc3cccc(C(=O)NCCCN4CCN(c5ccccc5OC)CC4)c3)c2)CC1 10.1016/j.bmc.2011.10.063
CHEMBL1928121 69268 0 None 7 5 Pig 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 897 28 2 13 5.1 COc1ccccc1N1CCN(CCCNC(=O)c2cccc(OCCOCCOCCOCCOc3cccc(C(=O)NCCCN4CCN(c5ccccc5OC)CC4)c3)c2)CC1 10.1016/j.bmc.2011.10.063
10095044 102277 0 None 1 3 Human 8.9 pKi = 8.9 Binding
In vitro binding affinity at human Alpha-1A adrenergic receptor.In vitro binding affinity at human Alpha-1A adrenergic receptor.
ChEMBL 445 6 0 8 3.2 COc1ccccc1N1CCN(CCn2nc(-c3ccccc3)c3c(C)onc3c2=O)CC1 10.1021/jm0307741
CHEMBL303464 102277 0 None 1 3 Human 8.9 pKi = 8.9 Binding
In vitro binding affinity at human Alpha-1A adrenergic receptor.In vitro binding affinity at human Alpha-1A adrenergic receptor.
ChEMBL 445 6 0 8 3.2 COc1ccccc1N1CCN(CCn2nc(-c3ccccc3)c3c(C)onc3c2=O)CC1 10.1021/jm0307741
11189150 131907 0 None - 1 Human 8.9 pKi = 8.9 Binding
Inhibition of [3H]prazosin binding to human adrenergic alpha-1A receptor expressed in CHO-K1 cell membranesInhibition of [3H]prazosin binding to human adrenergic alpha-1A receptor expressed in CHO-K1 cell membranes
ChEMBL 413 7 1 6 3.2 O=C(NCCCCN1CCN(c2csc3cc(F)ccc23)CC1)c1cnccn1 10.1021/jm0491804
CHEMBL369520 131907 0 None - 1 Human 8.9 pKi = 8.9 Binding
Inhibition of [3H]prazosin binding to human adrenergic alpha-1A receptor expressed in CHO-K1 cell membranesInhibition of [3H]prazosin binding to human adrenergic alpha-1A receptor expressed in CHO-K1 cell membranes
ChEMBL 413 7 1 6 3.2 O=C(NCCCCN1CCN(c2csc3cc(F)ccc23)CC1)c1cnccn1 10.1021/jm0491804
10691912 167996 0 None 1 3 Rat 8.9 pKi = 8.9 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 392 4 1 6 1.8 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cnccc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL432147 167996 0 None 1 3 Rat 8.9 pKi = 8.9 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 392 4 1 6 1.8 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cnccc4c3=O)C[C@@H]21 10.1021/jm000541z
46224879 201524 3 None -6 7 Human 8.9 pKi = 8.9 Binding
Binding affinity to adrenergic alpha1A receptor by radioligand displacement assayBinding affinity to adrenergic alpha1A receptor by radioligand displacement assay
ChEMBL 302 2 0 2 4.6 Cc1ccc2c(c1)c1c(n2/C=C\c2ccccc2)CCN(C)C1 10.1016/j.bmcl.2009.11.037
CHEMBL605405 201524 3 None -6 7 Human 8.9 pKi = 8.9 Binding
Binding affinity to adrenergic alpha1A receptor by radioligand displacement assayBinding affinity to adrenergic alpha1A receptor by radioligand displacement assay
ChEMBL 302 2 0 2 4.6 Cc1ccc2c(c1)c1c(n2/C=C\c2ccccc2)CCN(C)C1 10.1016/j.bmcl.2009.11.037
11712250 72971 0 None -5 4 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 457 13 1 6 5.0 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccccc1Cl 10.1021/jm0580398
CHEMBL200839 72971 0 None -5 4 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 457 13 1 6 5.0 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccccc1Cl 10.1021/jm0580398
11454386 63077 0 None -1 6 Human 8.9 pKi = 8.9 Binding
Equilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cellsEquilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cells
ChEMBL 477 8 1 9 3.6 COc1cc2nc(N3CCN(C(=O)CCCCC4CCSS4)CC3)nc(N)c2cc1OC 10.1021/jm049153d
CHEMBL178923 63077 0 None -1 6 Human 8.9 pKi = 8.9 Binding
Equilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cellsEquilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cells
ChEMBL 477 8 1 9 3.6 COc1cc2nc(N3CCN(C(=O)CCCCC4CCSS4)CC3)nc(N)c2cc1OC 10.1021/jm049153d
11270912 199569 0 None -2 5 Human 8.8 pKi = 8.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 451 6 0 4 4.6 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1007/s00044-010-9379-1
CHEMBL59262 199569 0 None -2 5 Human 8.8 pKi = 8.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 451 6 0 4 4.6 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1007/s00044-010-9379-1
11270912 199569 0 None -2 5 Human 8.8 pKi = 8.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 451 6 0 4 4.6 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1007/s00044-010-9379-1
CHEMBL59262 199569 0 None -2 5 Human 8.8 pKi = 8.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 451 6 0 4 4.6 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1007/s00044-010-9379-1
10578990 203818 0 None 48 3 Human 8.8 pKi = 8.8 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 572 10 2 8 3.2 COc1ccccc1N1C(=O)c2ccc(C(=O)NCC(O)CN3CCN(c4ccccc4OC(C)C)CC3)cc2C1=O 10.1021/jm9905918
CHEMBL68565 203818 0 None 48 3 Human 8.8 pKi = 8.8 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 572 10 2 8 3.2 COc1ccccc1N1C(=O)c2ccc(C(=O)NCC(O)CN3CCN(c4ccccc4OC(C)C)CC3)cc2C1=O 10.1021/jm9905918
10508332 105964 0 None 109 6 Human 8.8 pKi = 8.8 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 638 11 2 8 6.4 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])c(OC)c1 10.1021/jm980077m
CHEMBL313160 105964 0 None 109 6 Human 8.8 pKi = 8.8 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 638 11 2 8 6.4 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])c(OC)c1 10.1021/jm980077m
10508332 85261 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 638 11 2 8 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])c(OC)c1 10.1007/s00044-004-0120-9
CHEMBL2260368 85261 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 638 11 2 8 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])c(OC)c1 10.1007/s00044-004-0120-9
44420428 83465 0 None -3 3 Human 8.8 pKi = 8.8 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 434 5 0 7 3.8 COc1ccccc1N1CCN(CCn2c(C)nc3c(sc4ccccc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
CHEMBL220221 83465 0 None -3 3 Human 8.8 pKi = 8.8 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 434 5 0 7 3.8 COc1ccccc1N1CCN(CCn2c(C)nc3c(sc4ccccc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
90645593 112458 0 None -1 3 Human 8.8 pKi = 8.8 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 569 8 2 8 3.9 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)Cc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
CHEMBL3298746 112458 0 None -1 3 Human 8.8 pKi = 8.8 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 569 8 2 8 3.9 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)Cc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
44420428 83465 0 None -3 3 Human 8.8 pKi = 8.8 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 434 5 0 7 3.8 COc1ccccc1N1CCN(CCn2c(C)nc3c(sc4ccccc43)c2=O)CC1 10.1016/j.bmcl.2006.09.034
CHEMBL220221 83465 0 None -3 3 Human 8.8 pKi = 8.8 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 434 5 0 7 3.8 COc1ccccc1N1CCN(CCn2c(C)nc3c(sc4ccccc43)c2=O)CC1 10.1016/j.bmcl.2006.09.034
10678161 100788 0 None -1 3 Rat 8.8 pKi = 8.8 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 455 5 1 8 2.2 COC(=O)c1cc2[nH]c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2s1 10.1021/jm000541z
CHEMBL293236 100788 0 None -1 3 Rat 8.8 pKi = 8.8 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 455 5 1 8 2.2 COC(=O)c1cc2[nH]c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2s1 10.1021/jm000541z
10256583 28801 0 None 1 3 Rat 8.8 pKi = 8.8 Binding
The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.
ChEMBL 497 7 1 7 4.1 COc1cc2nc(N3CCN(C(=O)CC(c4ccccc4)c4ccccc4)CC3)nc(N)c2cc1OC 10.1021/jm9805337
CHEMBL137903 28801 0 None 1 3 Rat 8.8 pKi = 8.8 Binding
The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.
ChEMBL 497 7 1 7 4.1 COc1cc2nc(N3CCN(C(=O)CC(c4ccccc4)c4ccccc4)CC3)nc(N)c2cc1OC 10.1021/jm9805337
44431599 88035 0 None 10 4 Human 8.8 pKi = 8.8 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 505 7 1 5 4.8 Cc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1Cl 10.1016/j.bmcl.2007.04.008
CHEMBL234609 88035 0 None 10 4 Human 8.8 pKi = 8.8 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 505 7 1 5 4.8 Cc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1Cl 10.1016/j.bmcl.2007.04.008
9915831 102077 0 None 50 2 Human 8.8 pKi = 8.8 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 560 9 2 7 3.3 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2cccc(F)c2)C3=O)CC1 10.1021/jm9905918
CHEMBL302246 102077 0 None 50 2 Human 8.8 pKi = 8.8 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 560 9 2 7 3.3 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2cccc(F)c2)C3=O)CC1 10.1021/jm9905918
9850782 103572 0 None 72 2 Human 8.8 pKi = 8.8 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 560 9 2 7 3.3 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(F)cc2)C3=O)CC1 10.1021/jm9905918
CHEMBL308671 103572 0 None 72 2 Human 8.8 pKi = 8.8 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 560 9 2 7 3.3 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(F)cc2)C3=O)CC1 10.1021/jm9905918
9931977 63010 0 None -1 4 Rat 8.8 pKi = 8.8 Binding
Displacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranesDisplacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranes
ChEMBL 421 4 0 7 3.3 COc1ccccc1N1CCN(C[C@H]2CN=C3c4ccccc4N=C(SC)N32)CC1 10.1021/jm970159v
CHEMBL1788223 63010 0 None -1 4 Rat 8.8 pKi = 8.8 Binding
Displacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranesDisplacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranes
ChEMBL 421 4 0 7 3.3 COc1ccccc1N1CCN(C[C@H]2CN=C3c4ccccc4N=C(SC)N32)CC1 10.1021/jm970159v
49781451 17826 0 None -2 4 Bovine 8.8 pKi = 8.8 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 387 2 0 4 4.7 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4ccncc4)cc32)CC1 10.1021/jm100652h
CHEMBL1259024 17826 0 None -2 4 Bovine 8.8 pKi = 8.8 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 387 2 0 4 4.7 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4ccncc4)cc32)CC1 10.1021/jm100652h
49781679 17847 0 None -1 4 Bovine 8.8 pKi = 8.8 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 414 2 0 3 6.0 Cc1cccc(-c2ccc3c(c2)C(N2CCN(C)CC2)Cc2ccccc2S3)c1C 10.1021/jm100652h
CHEMBL1259080 17847 0 None -1 4 Bovine 8.8 pKi = 8.8 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 414 2 0 3 6.0 Cc1cccc(-c2ccc3c(c2)C(N2CCN(C)CC2)Cc2ccccc2S3)c1C 10.1021/jm100652h
10531022 121043 0 None 44 3 Human 8.8 pKi = 8.8 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 566 8 2 7 3.6 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1cccc(F)c1 10.1021/jm990200p
CHEMBL356978 121043 0 None 44 3 Human 8.8 pKi = 8.8 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 566 8 2 7 3.6 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1cccc(F)c1 10.1021/jm990200p
11123606 205412 0 None 2 4 Human 8.8 pKi = 8.8 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 475 9 1 8 3.3 COc1ccccc1N1CCN(CCCNc2c(C(C)=O)c(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
CHEMBL80260 205412 0 None 2 4 Human 8.8 pKi = 8.8 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 475 9 1 8 3.3 COc1ccccc1N1CCN(CCCNc2c(C(C)=O)c(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
16121006 11809 0 None -75 8 Human 8.8 pKi = 8.8 Binding
Antagonist activity at human alpha A1 adrenoreceptor expressed in CHO cellsAntagonist activity at human alpha A1 adrenoreceptor expressed in CHO cells
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@H]1COc2ccccc2O1 10.1016/j.ejmech.2020.112419
CHEMBL1182182 11809 0 None -75 8 Human 8.8 pKi = 8.8 Binding
Antagonist activity at human alpha A1 adrenoreceptor expressed in CHO cellsAntagonist activity at human alpha A1 adrenoreceptor expressed in CHO cells
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@H]1COc2ccccc2O1 10.1016/j.ejmech.2020.112419
CHEMBL217469 11809 0 None -75 8 Human 8.8 pKi = 8.8 Binding
Antagonist activity at human alpha A1 adrenoreceptor expressed in CHO cellsAntagonist activity at human alpha A1 adrenoreceptor expressed in CHO cells
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@H]1COc2ccccc2O1 10.1016/j.ejmech.2020.112419
11539392 141217 0 None -12 4 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 437 13 1 6 4.6 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccccc1C 10.1021/jm0580398
CHEMBL382972 141217 0 None -12 4 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 437 13 1 6 4.6 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccccc1C 10.1021/jm0580398
16121006 11809 0 None -75 8 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL1182182 11809 0 None -75 8 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL217469 11809 0 None -75 8 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
16121006 11809 0 None -75 8 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
CHEMBL1182182 11809 0 None -75 8 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
CHEMBL217469 11809 0 None -75 8 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
10716502 206552 0 None 39 2 Bovine 8.8 pKi = 8.8 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 410 7 1 5 2.5 COc1ccccc1N1CCN(CCC(=O)Nc2ccccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL88820 206552 0 None 39 2 Bovine 8.8 pKi = 8.8 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 410 7 1 5 2.5 COc1ccccc1N1CCN(CCC(=O)Nc2ccccc2C(=O)N(C)C)CC1 10.1021/jm970166j
10789868 206707 0 None 158 2 Bovine 8.8 pKi = 8.8 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 453 10 1 6 4.0 COc1ccccc1N1CCN(CCCNc2ccncc2C(=O)N(C(C)C)C(C)C)CC1 10.1021/jm970166j
CHEMBL89916 206707 0 None 158 2 Bovine 8.8 pKi = 8.8 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 453 10 1 6 4.0 COc1ccccc1N1CCN(CCCNc2ccncc2C(=O)N(C(C)C)C(C)C)CC1 10.1021/jm970166j
10552164 206877 0 None -1 3 Bovine 8.8 pKi = 8.8 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 466 9 1 6 3.4 CN(C)C(=O)c1cccnc1N1CCC(NCCOc2ccccc2OCC(F)(F)F)CC1 10.1021/jm970166j
CHEMBL90869 206877 0 None -1 3 Bovine 8.8 pKi = 8.8 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 466 9 1 6 3.4 CN(C)C(=O)c1cccnc1N1CCC(NCCOc2ccccc2OCC(F)(F)F)CC1 10.1021/jm970166j
10646065 206879 0 None -1 3 Bovine 8.8 pKi = 8.8 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 425 8 2 6 3.2 COc1ccccc1N1CCN(CCCNc2ncccc2C(=O)NC(C)(C)C)CC1 10.1021/jm970166j
CHEMBL90874 206879 0 None -1 3 Bovine 8.8 pKi = 8.8 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 425 8 2 6 3.2 COc1ccccc1N1CCN(CCCNc2ncccc2C(=O)NC(C)(C)C)CC1 10.1021/jm970166j
44324012 207226 0 None 6 3 Bovine 8.8 pKi = 8.8 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 397 8 2 6 2.4 COc1ccccc1N1CCN(CCCNc2nc(C)cc(C)c2C(N)=O)CC1 10.1021/jm970166j
CHEMBL92901 207226 0 None 6 3 Bovine 8.8 pKi = 8.8 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 397 8 2 6 2.4 COc1ccccc1N1CCN(CCCNc2nc(C)cc(C)c2C(N)=O)CC1 10.1021/jm970166j
44298671 163152 0 None 19 3 Human 8.8 pKi = 8.8 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 460 8 1 7 1.8 COc1c[nH]c(=O)n(CCCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)c1=O 10.1016/s0960-894x(03)00305-6
CHEMBL418112 163152 0 None 19 3 Human 8.8 pKi = 8.8 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 460 8 1 7 1.8 COc1c[nH]c(=O)n(CCCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)c1=O 10.1016/s0960-894x(03)00305-6
44298734 196685 0 None 31 3 Human 8.8 pKi = 8.8 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 444 7 1 6 2.1 Cc1cc(=O)n(CCCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)c(=O)[nH]1 10.1016/s0960-894x(03)00305-6
CHEMBL56489 196685 0 None 31 3 Human 8.8 pKi = 8.8 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 444 7 1 6 2.1 Cc1cc(=O)n(CCCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)c(=O)[nH]1 10.1016/s0960-894x(03)00305-6
10256583 28801 0 None -1 3 Human 8.8 pKi = 8.8 Binding
The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.
ChEMBL 497 7 1 7 4.1 COc1cc2nc(N3CCN(C(=O)CC(c4ccccc4)c4ccccc4)CC3)nc(N)c2cc1OC 10.1021/jm9805337
CHEMBL137903 28801 0 None -1 3 Human 8.8 pKi = 8.8 Binding
The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.
ChEMBL 497 7 1 7 4.1 COc1cc2nc(N3CCN(C(=O)CC(c4ccccc4)c4ccccc4)CC3)nc(N)c2cc1OC 10.1021/jm9805337
10627094 121065 0 None 269 3 Human 8.8 pKi = 8.8 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 581 10 0 7 5.8 COC(=O)C1=C(C)N=C(C)N(CCC[C@H](C)CN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL357131 121065 0 None 269 3 Human 8.8 pKi = 8.8 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 581 10 0 7 5.8 COC(=O)C1=C(C)N=C(C)N(CCC[C@H](C)CN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
44431587 87805 0 None -1 4 Human 8.8 pKi = 8.8 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 565 8 1 6 4.7 COc1ccc(Br)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL233849 87805 0 None -1 4 Human 8.8 pKi = 8.8 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 565 8 1 6 4.7 COc1ccc(Br)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
44431560 145553 0 None -2 4 Human 8.8 pKi = 8.8 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 517 9 1 7 3.9 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.008
CHEMBL391530 145553 0 None -2 4 Human 8.8 pKi = 8.8 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 517 9 1 7 3.9 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.008
44431602 147569 0 None 5 4 Human 8.8 pKi = 8.8 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 525 7 1 5 5.2 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccc(Cl)cc3Cl)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL393104 147569 0 None 5 4 Human 8.8 pKi = 8.8 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 525 7 1 5 5.2 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccc(Cl)cc3Cl)CC2)CC1 10.1016/j.bmcl.2007.04.008
44299975 101861 0 None 4 3 Human 8.8 pKi = 8.8 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 608 7 2 8 3.4 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@@H]2CC[C@H](N3CCN(c4ccccc4C#N)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
CHEMBL300766 101861 0 None 4 3 Human 8.8 pKi = 8.8 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 608 7 2 8 3.4 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@@H]2CC[C@H](N3CCN(c4ccccc4C#N)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
155552185 174037 0 None -2 16 Human 8.8 pKi = 8.8 Binding
Displacement of [3H] prazosin from alpha1A adrenergic receptor (unknown origin)Displacement of [3H] prazosin from alpha1A adrenergic receptor (unknown origin)
ChEMBL 491 10 2 5 4.3 COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccc(F)cc2)c2ccccc2)CC1 10.1021/acs.jmedchem.9b01085
CHEMBL4544086 174037 0 None -2 16 Human 8.8 pKi = 8.8 Binding
Displacement of [3H] prazosin from alpha1A adrenergic receptor (unknown origin)Displacement of [3H] prazosin from alpha1A adrenergic receptor (unknown origin)
ChEMBL 491 10 2 5 4.3 COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccc(F)cc2)c2ccccc2)CC1 10.1021/acs.jmedchem.9b01085
9959689 101786 0 None 281 3 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 568 7 2 7 3.1 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc(F)c(F)c2)CC1 10.1016/s0960-894x(99)00653-8
CHEMBL300222 101786 0 None 281 3 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 568 7 2 7 3.1 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc(F)c(F)c2)CC1 10.1016/s0960-894x(99)00653-8
11046644 30673 0 None -4 6 Human 8.8 pKi = 8.8 Binding
Binding affinity was determined on human cloned Alpha-1A adrenoceptorBinding affinity was determined on human cloned Alpha-1A adrenoceptor
ChEMBL 361 6 0 4 4.0 COc1cccc2c(CCCN3CCN(c4ccccn4)CC3)cccc12 10.1021/jm010866v
CHEMBL139505 30673 0 None -4 6 Human 8.8 pKi = 8.8 Binding
Binding affinity was determined on human cloned Alpha-1A adrenoceptorBinding affinity was determined on human cloned Alpha-1A adrenoceptor
ChEMBL 361 6 0 4 4.0 COc1cccc2c(CCCN3CCN(c4ccccn4)CC3)cccc12 10.1021/jm010866v
10813408 158329 0 None 2 3 Rat 8.8 pKi = 8.8 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 449 4 1 8 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cncnc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL40896 158329 0 None 2 3 Rat 8.8 pKi = 8.8 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 449 4 1 8 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cncnc54)c3=O)C[C@@H]21 10.1021/jm990567u
90645599 112405 0 None -1 3 Human 8.8 pKi = 8.8 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 668 13 3 9 4.2 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)CCCC(=O)NCCc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
CHEMBL3298017 112405 0 None -1 3 Human 8.8 pKi = 8.8 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 668 13 3 9 4.2 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)CCCC(=O)NCCc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
10767959 160922 0 None -2 3 Rat 8.8 pKi = 8.8 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 472 4 1 7 3.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccc(C#N)cc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL41155 160922 0 None -2 3 Rat 8.8 pKi = 8.8 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 472 4 1 7 3.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccc(C#N)cc54)c3=O)C[C@@H]21 10.1021/jm990567u
132266 1267 12 None -18 9 Rat 8.8 pKi = 8.8 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1021/jm960510x
486 1267 12 None -18 9 Rat 8.8 pKi = 8.8 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1021/jm960510x
CHEMBL423294 1267 12 None -18 9 Rat 8.8 pKi = 8.8 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1021/jm960510x
90645601 112407 0 None -1 3 Human 8.8 pKi = 8.8 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 564 10 2 9 3.0 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)CCCN(C)C)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
CHEMBL3298019 112407 0 None -1 3 Human 8.8 pKi = 8.8 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 564 10 2 9 3.0 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)CCCN(C)C)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
136680383 167978 0 None 21 3 Human 8.8 pKi = 8.8 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 666 15 4 8 4.2 CCC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)C(C(N)=O)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
44328800 167978 0 None 21 3 Human 8.8 pKi = 8.8 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 666 15 4 8 4.2 CCC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)C(C(N)=O)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
CHEMBL432026 167978 0 None 21 3 Human 8.8 pKi = 8.8 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 666 15 4 8 4.2 CCC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)C(C(N)=O)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
16041629 95417 0 None 1 4 Human 8.8 pKi = 8.8 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 472 6 2 4 5.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3cc(F)ccc3F)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL257097 95417 0 None 1 4 Human 8.8 pKi = 8.8 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 472 6 2 4 5.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3cc(F)ccc3F)CC2)CC1 10.1016/j.bmcl.2007.11.068
155515982 169986 0 None -6 17 Human 8.8 pKi = 8.8 Binding
Displacement of [3H] prazosin from alpha1A adrenergic receptor (unknown origin)Displacement of [3H] prazosin from alpha1A adrenergic receptor (unknown origin)
ChEMBL 473 10 2 5 4.1 COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccccc2)c2ccccc2)CC1 10.1021/acs.jmedchem.9b01085
CHEMBL4442460 169986 0 None -6 17 Human 8.8 pKi = 8.8 Binding
Displacement of [3H] prazosin from alpha1A adrenergic receptor (unknown origin)Displacement of [3H] prazosin from alpha1A adrenergic receptor (unknown origin)
ChEMBL 473 10 2 5 4.1 COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccccc2)c2ccccc2)CC1 10.1021/acs.jmedchem.9b01085
10580182 37443 0 None 1862 3 Human 8.8 pKi = 8.8 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 658 7 1 8 4.0 COCC1=C(C(=O)OC)C(c2cc(F)c(F)c(F)c2)N(C(=O)N2CCC(N3CCC(C(=O)OC)(c4ccccc4)CC3)CC2)C(=O)N1 10.1021/jm990201h
CHEMBL145553 37443 0 None 1862 3 Human 8.8 pKi = 8.8 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 658 7 1 8 4.0 COCC1=C(C(=O)OC)C(c2cc(F)c(F)c(F)c2)N(C(=O)N2CCC(N3CCC(C(=O)OC)(c4ccccc4)CC3)CC2)C(=O)N1 10.1021/jm990201h
9984150 101742 0 None 891 3 Human 8.8 pKi = 8.8 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 519 7 0 4 5.6 Cc1ccc(C2(c3ccc(C)cc3)CC(=O)N(CCCN3CCC(C#N)(c4ccccc4C)CC3)C2=O)cc1 10.1016/s0960-894x(01)00320-1
CHEMBL299914 101742 0 None 891 3 Human 8.8 pKi = 8.8 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 519 7 0 4 5.6 Cc1ccc(C2(c3ccc(C)cc3)CC(=O)N(CCCN3CCC(C#N)(c4ccccc4C)CC3)C2=O)cc1 10.1016/s0960-894x(01)00320-1
10599007 204492 0 None -5 8 Rat 8.8 pKi = 8.8 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligand
ChEMBL 435 9 1 6 4.6 COc1cccc(OC)c1OCCNC[C@@H]1Oc2ccccc2O[C@H]1c1ccc(C)cc1 10.1021/jm960069a
CHEMBL72657 204492 0 None -5 8 Rat 8.8 pKi = 8.8 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligand
ChEMBL 435 9 1 6 4.6 COc1cccc(OC)c1OCCNC[C@@H]1Oc2ccccc2O[C@H]1c1ccc(C)cc1 10.1021/jm960069a
10793665 106925 0 None 69 6 Human 8.8 pKi = 8.8 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 597 9 2 5 7.2 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(Cl)cc1 10.1021/jm980077m
CHEMBL314960 106925 0 None 69 6 Human 8.8 pKi = 8.8 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 597 9 2 5 7.2 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(Cl)cc1 10.1021/jm980077m
10793665 85252 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 597 9 2 5 6.3 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(Cl)cc1 10.1007/s00044-004-0120-9
CHEMBL2260359 85252 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 597 9 2 5 6.3 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(Cl)cc1 10.1007/s00044-004-0120-9
15054187 191642 0 None - 1 Rat 8.7 pKi = 8.7 Binding
Binding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranesBinding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranes
ChEMBL 389 4 2 5 2.0 O=c1[nH]c2c([nH]c3ccccc32)c(=O)n1CCN1CCN(c2ccccc2)CC1 10.1021/jm00110a014
CHEMBL51963 191642 0 None - 1 Rat 8.7 pKi = 8.7 Binding
Binding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranesBinding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranes
ChEMBL 389 4 2 5 2.0 O=c1[nH]c2c([nH]c3ccccc32)c(=O)n1CCN1CCN(c2ccccc2)CC1 10.1021/jm00110a014
11857709 85599 0 None 1 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 556 9 1 6 5.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OCC(F)(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
CHEMBL228334 85599 0 None 1 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 556 9 1 6 5.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OCC(F)(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
11857638 143785 0 None -1 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 516 9 1 6 5.0 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
CHEMBL390129 143785 0 None -1 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 516 9 1 6 5.0 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
11857711 85592 0 None 1 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 506 7 1 4 5.5 O=S(=O)(N[C@H]1CC[C@@H](N2CCC(c3ccccc3OC3CC3)CC2)CC1)c1cc(Cl)ccc1F 10.1016/j.bmcl.2007.04.098
CHEMBL228280 85592 0 None 1 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 506 7 1 4 5.5 O=S(=O)(N[C@H]1CC[C@@H](N2CCC(c3ccccc3OC3CC3)CC2)CC1)c1cc(Cl)ccc1F 10.1016/j.bmcl.2007.04.098
11857709 85599 0 None 1 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 556 9 1 6 5.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OCC(F)(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
CHEMBL228334 85599 0 None 1 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 556 9 1 6 5.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OCC(F)(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
9808529 203849 0 None 20 2 Human 8.7 pKi = 8.7 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 587 10 2 9 3.1 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc([N+](=O)[O-])cc2)C3=O)CC1 10.1021/jm9905918
CHEMBL68746 203849 0 None 20 2 Human 8.7 pKi = 8.7 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 587 10 2 9 3.1 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc([N+](=O)[O-])cc2)C3=O)CC1 10.1021/jm9905918
18738384 164353 0 None 25 3 Human 8.7 pKi = 8.7 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 441 7 0 5 4.8 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCCC3=O)cs2)CC1 10.1016/s0960-894x(02)00347-5
CHEMBL421297 164353 0 None 25 3 Human 8.7 pKi = 8.7 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 441 7 0 5 4.8 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCCC3=O)cs2)CC1 10.1016/s0960-894x(02)00347-5
44431180 92820 0 None -9 3 Human 8.7 pKi = 8.7 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 497 5 0 5 5.4 CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4ccc5ccccc5c4C3=O)CC2)CC1 10.1016/j.bmcl.2006.12.111
CHEMBL243864 92820 0 None -9 3 Human 8.7 pKi = 8.7 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 497 5 0 5 5.4 CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4ccc5ccccc5c4C3=O)CC2)CC1 10.1016/j.bmcl.2006.12.111
10793023 121496 0 None 60 3 Human 8.7 pKi = 8.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 562 8 2 7 3.8 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1cccc(C)c1 10.1021/jm990200p
CHEMBL358489 121496 0 None 60 3 Human 8.7 pKi = 8.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 562 8 2 7 3.8 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1cccc(C)c1 10.1021/jm990200p
10394346 16931 0 None -1 5 Human 8.7 pKi = 8.7 Binding
Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)
ChEMBL 638 11 2 10 3.0 Cc1c(-c2ccccc2)oc2c(C(=O)NCCCN3CCN(c4ccccc4OCc4no[n+]([O-])c4C(N)=O)CC3)cccc2c1=O 10.1021/jm030825u
CHEMBL125365 16931 0 None -1 5 Human 8.7 pKi = 8.7 Binding
Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)
ChEMBL 638 11 2 10 3.0 Cc1c(-c2ccccc2)oc2c(C(=O)NCCCN3CCN(c4ccccc4OCc4no[n+]([O-])c4C(N)=O)CC3)cccc2c1=O 10.1021/jm030825u
487 3607 21 None -1 12 Human 8.7 pKi = 8.7 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00019a001
60602 3607 21 None -1 12 Human 8.7 pKi = 8.7 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00019a001
CHEMBL405355 3607 21 None -1 12 Human 8.7 pKi = 8.7 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00019a001
DB09239 3607 21 None -1 12 Human 8.7 pKi = 8.7 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00019a001
11270912 199569 0 None -2 5 Rat 8.7 pKi = 8.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 451 6 0 4 4.6 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
CHEMBL59262 199569 0 None -2 5 Rat 8.7 pKi = 8.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 451 6 0 4 4.6 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
10674896 206621 0 None 83 6 Human 8.7 pKi = 8.7 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 588 9 2 6 6.4 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(C#N)cc1 10.1021/jm980077m
CHEMBL89243 206621 0 None 83 6 Human 8.7 pKi = 8.7 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 588 9 2 6 6.4 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(C#N)cc1 10.1021/jm980077m
10674896 85243 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 588 9 2 6 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(C#N)cc1 10.1007/s00044-004-0120-9
CHEMBL2260149 85243 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 588 9 2 6 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(C#N)cc1 10.1007/s00044-004-0120-9
53327748 63358 0 None 2 3 Human 8.7 pKi = 8.7 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 435 8 0 5 3.5 COc1ccccc1N1CCN(CCCCN2C(=O)CC(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796033 63358 0 None 2 3 Human 8.7 pKi = 8.7 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 435 8 0 5 3.5 COc1ccccc1N1CCN(CCCCN2C(=O)CC(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
9894818 98897 0 None 83 7 Human 8.7 pKi = 8.7 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
CHEMBL279436 98897 0 None 83 7 Human 8.7 pKi = 8.7 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
10651654 111456 0 None 61 6 Human 8.7 pKi = 8.7 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 631 9 2 5 7.8 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(Cl)c(Cl)c1 10.1021/jm980077m
CHEMBL327712 111456 0 None 61 6 Human 8.7 pKi = 8.7 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 631 9 2 5 7.8 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(Cl)c(Cl)c1 10.1021/jm980077m
10651654 85260 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 631 9 2 5 7.0 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(Cl)c(Cl)c1 10.1007/s00044-004-0120-9
CHEMBL2260367 85260 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 631 9 2 5 7.0 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(Cl)c(Cl)c1 10.1007/s00044-004-0120-9
9894818 98897 0 None 83 7 Human 8.7 pKi = 8.7 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1007/s00044-004-0120-9
CHEMBL279436 98897 0 None 83 7 Human 8.7 pKi = 8.7 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1007/s00044-004-0120-9
44390749 63880 0 None 173 6 Human 8.7 pKi = 8.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 607 11 3 6 5.3 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm960697s
CHEMBL180561 63880 0 None 173 6 Human 8.7 pKi = 8.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 607 11 3 6 5.3 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm960697s
4209 3141 75 None -3 34 Human 8.7 pKi = 8.7 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.12.024
4893 3141 75 None -3 34 Human 8.7 pKi = 8.7 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.12.024
503 3141 75 None -3 34 Human 8.7 pKi = 8.7 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.12.024
5385 3141 75 None -3 34 Human 8.7 pKi = 8.7 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.12.024
CHEMBL2 3141 75 None -3 34 Human 8.7 pKi = 8.7 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.12.024
DB00457 3141 75 None -3 34 Human 8.7 pKi = 8.7 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.12.024
145962342 161399 0 None -29 4 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 521 9 0 8 5.1 CCCN(CCC)c1nc(N2CCN(C(=O)c3ccco3)[C@@H]3CCCC[C@@H]32)nc2cc(OC)c(OC)cc12 10.1016/j.bmc.2018.05.023
CHEMBL4126860 161399 0 None -29 4 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 521 9 0 8 5.1 CCCN(CCC)c1nc(N2CCN(C(=O)c3ccco3)[C@@H]3CCCC[C@@H]32)nc2cc(OC)c(OC)cc12 10.1016/j.bmc.2018.05.023
10767981 196239 0 None -1 3 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 509 11 1 9 3.5 COc1cc2nc(N(C)CCCCCCN(C)C(=O)C3COc4ccccc4O3)nc(N)c2cc1OC 10.1021/jm8016046
CHEMBL561851 196239 0 None -1 3 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 509 11 1 9 3.5 COc1cc2nc(N(C)CCCCCCN(C)C(=O)C3COc4ccccc4O3)nc(N)c2cc1OC 10.1021/jm8016046
44390749 63880 0 None 173 6 Human 8.7 pKi = 8.7 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 607 11 3 6 5.3 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1016/s0960-894x(99)00484-9
CHEMBL180561 63880 0 None 173 6 Human 8.7 pKi = 8.7 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 607 11 3 6 5.3 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1016/s0960-894x(99)00484-9
9894818 98897 0 None 83 7 Human 8.7 pKi = 8.7 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980506g
CHEMBL279436 98897 0 None 83 7 Human 8.7 pKi = 8.7 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980506g
44447059 94520 0 None -23 4 Rat 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 473 6 1 7 4.1 O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1ccno1 10.1016/j.bmcl.2007.11.106
CHEMBL251834 94520 0 None -23 4 Rat 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 473 6 1 7 4.1 O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1ccno1 10.1016/j.bmcl.2007.11.106
10742417 202750 0 None 1 3 Rat 8.7 pKi = 8.7 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 455 5 1 6 3.0 COc1cc2[nH]c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2cc1Cl 10.1021/jm000541z
CHEMBL62109 202750 0 None 1 3 Rat 8.7 pKi = 8.7 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 455 5 1 6 3.0 COc1cc2[nH]c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2cc1Cl 10.1021/jm000541z
10793503 119689 0 None 616 3 Human 8.7 pKi = 8.7 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 588 11 2 8 4.5 CCOC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(C)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
CHEMBL347499 119689 0 None 616 3 Human 8.7 pKi = 8.7 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 588 11 2 8 4.5 CCOC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(C)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
44390749 63880 0 None 173 6 Human 8.7 pKi = 8.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 607 11 3 6 5.3 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1016/j.bmcl.2004.11.032
CHEMBL180561 63880 0 None 173 6 Human 8.7 pKi = 8.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 607 11 3 6 5.3 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1016/j.bmcl.2004.11.032
57391895 69272 0 None 14 5 Pig 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 925 30 2 13 5.4 COc1ccccc1N1CCN(CCCNC(=O)c2ccc(COCCOCCOCCOCCOCc3ccc(C(=O)NCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1 10.1016/j.bmc.2011.10.063
CHEMBL1928125 69272 0 None 14 5 Pig 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 925 30 2 13 5.4 COc1ccccc1N1CCN(CCCNC(=O)c2ccc(COCCOCCOCCOCCOCc3ccc(C(=O)NCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1 10.1016/j.bmc.2011.10.063
9916549 121538 0 None 1 4 Human 8.7 pKi = 8.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of dogIn vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of dog
ChEMBL 592 10 3 8 3.1 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
CHEMBL358595 121538 0 None 1 4 Human 8.7 pKi = 8.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of dogIn vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of dog
ChEMBL 592 10 3 8 3.1 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
9916549 121538 0 None 1 4 Human 8.7 pKi = 8.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 592 10 3 8 3.1 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
CHEMBL358595 121538 0 None 1 4 Human 8.7 pKi = 8.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 592 10 3 8 3.1 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
10531675 36751 0 None 19 3 Human 8.7 pKi = 8.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 602 8 2 5 5.7 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL144989 36751 0 None 19 3 Human 8.7 pKi = 8.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 602 8 2 5 5.7 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
10793503 119689 0 None 616 3 Human 8.7 pKi = 8.7 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 588 11 2 8 4.5 CCOC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(C)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1007/s00044-004-0120-9
CHEMBL347499 119689 0 None 616 3 Human 8.7 pKi = 8.7 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 588 11 2 8 4.5 CCOC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(C)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1007/s00044-004-0120-9
44446999 94668 0 None 2 3 Rat 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 474 5 1 5 4.3 O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)C(F)(F)F 10.1016/j.bmcl.2007.11.106
CHEMBL252816 94668 0 None 2 3 Rat 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 474 5 1 5 4.3 O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)C(F)(F)F 10.1016/j.bmcl.2007.11.106
10048729 189119 0 None 3 4 Human 8.7 pKi = 8.7 Binding
The compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cellsThe compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 437 5 1 8 2.5 Cn1nc(Cl)c2cn3nc(NCCN4CCN(c5ccccc5)CC4)ccc3c2c1=O 10.1021/jm981006q
CHEMBL51074 189119 0 None 3 4 Human 8.7 pKi = 8.7 Binding
The compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cellsThe compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 437 5 1 8 2.5 Cn1nc(Cl)c2cn3nc(NCCN4CCN(c5ccccc5)CC4)ccc3c2c1=O 10.1021/jm981006q
9847845 28422 0 None -7 6 Rat 8.7 pKi = 8.7 Binding
Binding affinity towards rat Alpha-1A adrenergic receptorBinding affinity towards rat Alpha-1A adrenergic receptor
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3sc(C)c(-c4ccccc4)c3c2=O)CC1 10.1016/s0960-894x(01)00159-7
CHEMBL13754 28422 0 None -7 6 Rat 8.7 pKi = 8.7 Binding
Binding affinity towards rat Alpha-1A adrenergic receptorBinding affinity towards rat Alpha-1A adrenergic receptor
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3sc(C)c(-c4ccccc4)c3c2=O)CC1 10.1016/s0960-894x(01)00159-7
11604548 72859 0 None -31 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 437 13 1 6 4.6 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccc(C)cc1 10.1007/s00044-010-9379-1
CHEMBL200366 72859 0 None -31 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 437 13 1 6 4.6 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccc(C)cc1 10.1007/s00044-010-9379-1
11532563 166355 0 None -6 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 453 14 1 7 4.3 COc1cccc(COc2ccccc2OCCNCCOc2c(OC)cccc2OC)c1 10.1007/s00044-010-9379-1
CHEMBL427552 166355 0 None -6 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 453 14 1 7 4.3 COc1cccc(COc2ccccc2OCCNCCOc2c(OC)cccc2OC)c1 10.1007/s00044-010-9379-1
11604548 72859 0 None -31 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 437 13 1 6 4.6 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccc(C)cc1 10.1007/s00044-010-9379-1
CHEMBL200366 72859 0 None -31 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 437 13 1 6 4.6 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccc(C)cc1 10.1007/s00044-010-9379-1
11532563 166355 0 None -6 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 453 14 1 7 4.3 COc1cccc(COc2ccccc2OCCNCCOc2c(OC)cccc2OC)c1 10.1007/s00044-010-9379-1
CHEMBL427552 166355 0 None -6 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 453 14 1 7 4.3 COc1cccc(COc2ccccc2OCCNCCOc2c(OC)cccc2OC)c1 10.1007/s00044-010-9379-1
9809007 172540 8 None 134 6 Human 8.7 pKi = 8.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm960697s
CHEMBL448620 172540 8 None 134 6 Human 8.7 pKi = 8.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm960697s
11705133 72301 0 None 1 4 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 453 14 1 7 4.3 COc1ccccc1COc1ccccc1OCCNCCOc1c(OC)cccc1OC 10.1021/jm0580398
CHEMBL198431 72301 0 None 1 4 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 453 14 1 7 4.3 COc1ccccc1COc1ccccc1OCCNCCOc1c(OC)cccc1OC 10.1021/jm0580398
11604548 72859 0 None -31 4 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 437 13 1 6 4.6 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccc(C)cc1 10.1021/jm0580398
CHEMBL200366 72859 0 None -31 4 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 437 13 1 6 4.6 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccc(C)cc1 10.1021/jm0580398
11669646 72919 0 None -19 4 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 453 14 1 7 4.3 COc1ccc(COc2ccccc2OCCNCCOc2c(OC)cccc2OC)cc1 10.1021/jm0580398
CHEMBL200580 72919 0 None -19 4 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 453 14 1 7 4.3 COc1ccc(COc2ccccc2OCCNCCOc2c(OC)cccc2OC)cc1 10.1021/jm0580398
11532563 166355 0 None -6 4 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 453 14 1 7 4.3 COc1cccc(COc2ccccc2OCCNCCOc2c(OC)cccc2OC)c1 10.1021/jm0580398
CHEMBL427552 166355 0 None -6 4 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 453 14 1 7 4.3 COc1cccc(COc2ccccc2OCCNCCOc2c(OC)cccc2OC)c1 10.1021/jm0580398
52941004 17059 0 None 1 4 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 407 13 1 5 4.7 CCOc1ccccc1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
CHEMBL1254914 17059 0 None 1 4 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 407 13 1 5 4.7 CCOc1ccccc1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
71817547 102551 0 None -7 7 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 357 7 1 6 2.4 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)OCC2 10.1021/jm400867d
CHEMBL2419771 102551 0 None -7 7 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 357 7 1 6 2.4 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)OCC2 10.1021/jm400867d
CHEMBL3040800 102551 0 None -7 7 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 357 7 1 6 2.4 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)OCC2 10.1021/jm400867d
134139869 146175 0 None -1 3 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 384 8 0 5 3.9 COc1ccc(CCN2CCN(c3ccccc3OC(C)C)CC2)cc1OC 10.1016/j.ejmech.2016.06.052
CHEMBL3920110 146175 0 None -1 3 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 384 8 0 5 3.9 COc1ccc(CCN2CCN(c3ccccc3OC(C)C)CC2)cc1OC 10.1016/j.ejmech.2016.06.052
10642742 206772 0 None 3 3 Bovine 8.7 pKi = 8.7 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 367 7 1 5 2.4 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2)CC1 10.1021/jm970166j
CHEMBL90287 206772 0 None 3 3 Bovine 8.7 pKi = 8.7 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 367 7 1 5 2.4 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2)CC1 10.1021/jm970166j
44298694 100664 0 None 9 3 Human 8.7 pKi = 8.7 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 426 7 1 6 2.0 Cc1cn(CCCN2CCN(c3ccccc3OCC(F)(F)F)CC2)c(=O)[nH]c1=O 10.1016/s0960-894x(03)00305-6
CHEMBL292403 100664 0 None 9 3 Human 8.7 pKi = 8.7 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 426 7 1 6 2.0 Cc1cn(CCCN2CCN(c3ccccc3OCC(F)(F)F)CC2)c(=O)[nH]c1=O 10.1016/s0960-894x(03)00305-6
CHEMBL5272464 194602 0 None -11 3 Human 8.0 pKi = 8 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 480 10 1 5 4.4 CCCNC(=O)CCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
CHEMBL5315453 194602 0 None -11 3 Human 8.0 pKi = 8 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 480 10 1 5 4.4 CCCNC(=O)CCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
10415038 4407 0 None 3 4 Human 8.0 pKi = 8 Binding
Binding affinity against Alpha-1A adrenergic receptor in human prostatic tissueBinding affinity against Alpha-1A adrenergic receptor in human prostatic tissue
ChEMBL 545 6 1 7 5.3 Cc1noc(C)c1S(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3cccc4ccccc34)CC1)O2 10.1016/s0960-894x(98)00732-x
CHEMBL101610 4407 0 None 3 4 Human 8.0 pKi = 8 Binding
Binding affinity against Alpha-1A adrenergic receptor in human prostatic tissueBinding affinity against Alpha-1A adrenergic receptor in human prostatic tissue
ChEMBL 545 6 1 7 5.3 Cc1noc(C)c1S(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3cccc4ccccc34)CC1)O2 10.1016/s0960-894x(98)00732-x
10415038 4407 0 None -3 4 Rat 8.0 pKi = 8 Binding
Binding affinity against Alpha-1A adrenergic receptor in rat prostatic tissueBinding affinity against Alpha-1A adrenergic receptor in rat prostatic tissue
ChEMBL 545 6 1 7 5.3 Cc1noc(C)c1S(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3cccc4ccccc34)CC1)O2 10.1016/s0960-894x(98)00732-x
CHEMBL101610 4407 0 None -3 4 Rat 8.0 pKi = 8 Binding
Binding affinity against Alpha-1A adrenergic receptor in rat prostatic tissueBinding affinity against Alpha-1A adrenergic receptor in rat prostatic tissue
ChEMBL 545 6 1 7 5.3 Cc1noc(C)c1S(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3cccc4ccccc34)CC1)O2 10.1016/s0960-894x(98)00732-x
135398737 955 93 None -5 92 Human 8.0 pKi = 8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1039/C2MD00311B
38 955 93 None -5 92 Human 8.0 pKi = 8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1039/C2MD00311B
722 955 93 None -5 92 Human 8.0 pKi = 8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1039/C2MD00311B
CHEMBL42 955 93 None -5 92 Human 8.0 pKi = 8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1039/C2MD00311B
DB00363 955 93 None -5 92 Human 8.0 pKi = 8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1039/C2MD00311B
2389 3306 118 None -11 68 Human 8.0 pKi = 8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1039/C2MD00311B
5073 3306 118 None -11 68 Human 8.0 pKi = 8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1039/C2MD00311B
96 3306 118 None -11 68 Human 8.0 pKi = 8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1039/C2MD00311B
CHEMBL85 3306 118 None -11 68 Human 8.0 pKi = 8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1039/C2MD00311B
DB00734 3306 118 None -11 68 Human 8.0 pKi = 8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1039/C2MD00311B
52937631 61277 0 None -50 3 Human 8.0 pKi = 8 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 347 4 0 4 3.4 Cc1ccc(Cc2nn(C[C@H]3CCCN3C)c(=O)c3ccccc23)cc1 10.1021/jm1013874
CHEMBL1767141 61277 0 None -50 3 Human 8.0 pKi = 8 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 347 4 0 4 3.4 Cc1ccc(Cc2nn(C[C@H]3CCCN3C)c(=O)c3ccccc23)cc1 10.1021/jm1013874
44431587 167128 0 None 3 4 Human 8.0 pKi = 8 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 565 8 1 6 4.7 COc1ccc(Br)cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL429076 167128 0 None 3 4 Human 8.0 pKi = 8 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 565 8 1 6 4.7 COc1ccc(Br)cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
11857792 143878 0 None 3 4 Human 8.0 pKi = 8 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 560 8 1 5 5.8 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1 10.1016/j.bmcl.2007.04.098
CHEMBL390192 143878 0 None 3 4 Human 8.0 pKi = 8 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 560 8 1 5 5.8 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1 10.1016/j.bmcl.2007.04.098
1524 2168 96 None -7 52 Rat 8.0 pKi = 8 Binding
Binding affinity to rat forebrain homogenate membrane alpha 1 adrenergic receptor incubated for 10 minsBinding affinity to rat forebrain homogenate membrane alpha 1 adrenergic receptor incubated for 10 mins
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1021/acs.jmedchem.2c00633
197 2168 96 None -7 52 Rat 8.0 pKi = 8 Binding
Binding affinity to rat forebrain homogenate membrane alpha 1 adrenergic receptor incubated for 10 minsBinding affinity to rat forebrain homogenate membrane alpha 1 adrenergic receptor incubated for 10 mins
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1021/acs.jmedchem.2c00633
3822 2168 96 None -7 52 Rat 8.0 pKi = 8 Binding
Binding affinity to rat forebrain homogenate membrane alpha 1 adrenergic receptor incubated for 10 minsBinding affinity to rat forebrain homogenate membrane alpha 1 adrenergic receptor incubated for 10 mins
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1021/acs.jmedchem.2c00633
88 2168 96 None -7 52 Rat 8.0 pKi = 8 Binding
Binding affinity to rat forebrain homogenate membrane alpha 1 adrenergic receptor incubated for 10 minsBinding affinity to rat forebrain homogenate membrane alpha 1 adrenergic receptor incubated for 10 mins
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1021/acs.jmedchem.2c00633
CHEMBL51 2168 96 None -7 52 Rat 8.0 pKi = 8 Binding
Binding affinity to rat forebrain homogenate membrane alpha 1 adrenergic receptor incubated for 10 minsBinding affinity to rat forebrain homogenate membrane alpha 1 adrenergic receptor incubated for 10 mins
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1021/acs.jmedchem.2c00633
DB12465 2168 96 None -7 52 Rat 8.0 pKi = 8 Binding
Binding affinity to rat forebrain homogenate membrane alpha 1 adrenergic receptor incubated for 10 minsBinding affinity to rat forebrain homogenate membrane alpha 1 adrenergic receptor incubated for 10 mins
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1021/acs.jmedchem.2c00633
115 342 71 None -3 7 Human 8.0 pKi = 8 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm960697s
2092 342 71 None -3 7 Human 8.0 pKi = 8 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm960697s
7109 342 71 None -3 7 Human 8.0 pKi = 8 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm960697s
CHEMBL709 342 71 None -3 7 Human 8.0 pKi = 8 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm960697s
DB00346 342 71 None -3 7 Human 8.0 pKi = 8 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm960697s
46934793 16597 0 None -7 4 Human 8.0 pKi = 8 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 533 7 0 7 3.8 COc1ccccc1N1CCN(C[C@@H]2CO[C@@](CN3C(=O)CC4(CCCC4)CC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
CHEMBL1241557 16597 0 None -7 4 Human 8.0 pKi = 8 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 533 7 0 7 3.8 COc1ccccc1N1CCN(C[C@@H]2CO[C@@](CN3C(=O)CC4(CCCC4)CC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
52941056 17091 0 None -1 4 Human 8.0 pKi = 8 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 363 11 1 4 4.3 c1ccc(COc2ccccc2OCCNCCOc2ccccc2)cc1 10.1016/j.bmc.2010.08.002
CHEMBL1255086 17091 0 None -1 4 Human 8.0 pKi = 8 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 363 11 1 4 4.3 c1ccc(COc2ccccc2OCCNCCOc2ccccc2)cc1 10.1016/j.bmc.2010.08.002
11668565 16040 0 None -3 3 Human 8.0 pKi = 8 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 404 8 1 4 4.9 Fc1ccccc1N1CCN(CCCCNc2ccc(-c3ccccc3)cn2)CC1 10.1016/j.bmcl.2010.07.096
CHEMBL1223799 16040 0 None -3 3 Human 8.0 pKi = 8 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 404 8 1 4 4.9 Fc1ccccc1N1CCN(CCCCNc2ccc(-c3ccccc3)cn2)CC1 10.1016/j.bmcl.2010.07.096
71508685 87023 0 None 2 2 Bovine 8.0 pKi = 8 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 385 3 0 3 5.6 CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4ccncc4)cc23)CC1 10.1016/j.bmc.2012.10.049
CHEMBL2325930 87023 0 None 2 2 Bovine 8.0 pKi = 8 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 385 3 0 3 5.6 CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4ccncc4)cc23)CC1 10.1016/j.bmc.2012.10.049
10555223 37095 0 None 158 3 Human 8.0 pKi = 8 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 579 9 3 8 3.3 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC(C)=C(C(=O)O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm990200p
CHEMBL145267 37095 0 None 158 3 Human 8.0 pKi = 8 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 579 9 3 8 3.3 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC(C)=C(C(=O)O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm990200p
53328685 63369 0 None 5 3 Human 8.0 pKi = 8.0 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 435 7 0 5 3.3 COc1ccccc1N1CCN(CCCN2C(=O)CC(C)(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796044 63369 0 None 5 3 Human 8.0 pKi = 8.0 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 435 7 0 5 3.3 COc1ccccc1N1CCN(CCCN2C(=O)CC(C)(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
118716707 114975 0 None 1 4 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 519 5 0 6 3.9 COc1ccccc1N1CCN(CC2COC3(CCN(C(=O)c4ccc(C(F)(F)F)cc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342860 114975 0 None 1 4 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 519 5 0 6 3.9 COc1ccccc1N1CCN(CC2COC3(CCN(C(=O)c4ccc(C(F)(F)F)cc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
44447013 169379 0 None -4 4 Rat 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 500 6 1 5 5.2 O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1ccc(F)cc1 10.1016/j.bmcl.2007.11.106
CHEMBL442290 169379 0 None -4 4 Rat 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 500 6 1 5 5.2 O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1ccc(F)cc1 10.1016/j.bmcl.2007.11.106
127028034 137625 0 None 3 3 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 404 9 0 4 5.2 COc1ccccc1N1CCN(CCCCCOc2ccc3ccccc3c2)CC1 10.1016/j.bmcl.2015.12.068
CHEMBL3758368 137625 0 None 3 3 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 404 9 0 4 5.2 COc1ccccc1N1CCN(CCCCCOc2ccc3ccccc3c2)CC1 10.1016/j.bmcl.2015.12.068
44447028 94578 0 None -10 4 Rat 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 510 8 1 5 5.4 O=C(CCc1ccccc1)NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21 10.1016/j.bmcl.2007.11.106
CHEMBL252201 94578 0 None -10 4 Rat 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 510 8 1 5 5.4 O=C(CCc1ccccc1)NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21 10.1016/j.bmcl.2007.11.106
8459 3273 4 None -10 3 Human 8.0 pKi = 8.0 Binding
The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.
ChEMBL 495 8 1 9 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)COc1c(OC)cccc1C(C)C 10.1021/jm9805337
9891980 3273 4 None -10 3 Human 8.0 pKi = 8.0 Binding
The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.
ChEMBL 495 8 1 9 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)COc1c(OC)cccc1C(C)C 10.1021/jm9805337
CHEMBL430717 3273 4 None -10 3 Human 8.0 pKi = 8.0 Binding
The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.
ChEMBL 495 8 1 9 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)COc1c(OC)cccc1C(C)C 10.1021/jm9805337
44428849 143604 0 None -6 3 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 436 4 2 7 2.8 COc1cc2nc(N3CCN(C(=O)c4ccc[nH]4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2007.01.028
CHEMBL389978 143604 0 None -6 3 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 436 4 2 7 2.8 COc1cc2nc(N3CCN(C(=O)c4ccc[nH]4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2007.01.028
118716706 114973 0 None 1 4 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 451 5 0 6 2.9 COc1ccccc1N1CCN(CC2COC3(CCN(C(=O)c4ccccc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342859 114973 0 None 1 4 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 451 5 0 6 2.9 COc1ccccc1N1CCN(CC2COC3(CCN(C(=O)c4ccccc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
11474937 197151 0 None -9 4 Rat 8.0 pKi = 8.0 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 395 5 0 4 3.4 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2C2CC2)CC1 10.1021/jm030944+
CHEMBL56804 197151 0 None -9 4 Rat 8.0 pKi = 8.0 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 395 5 0 4 3.4 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2C2CC2)CC1 10.1021/jm030944+
44447008 94738 0 None -2 4 Rat 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 482 6 1 5 5.1 O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1ccccc1 10.1016/j.bmcl.2007.11.106
CHEMBL253233 94738 0 None -2 4 Rat 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 482 6 1 5 5.1 O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1ccccc1 10.1016/j.bmcl.2007.11.106
9867616 168302 0 None -2 3 Rat 8.0 pKi = 8.0 Binding
The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.
ChEMBL 435 6 1 8 2.2 COc1cc2nc(N3CCN(C(=O)CC(=O)c4ccccc4)CC3)nc(N)c2cc1OC 10.1021/jm9805337
CHEMBL434228 168302 0 None -2 3 Rat 8.0 pKi = 8.0 Binding
The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.
ChEMBL 435 6 1 8 2.2 COc1cc2nc(N3CCN(C(=O)CC(=O)c4ccccc4)CC3)nc(N)c2cc1OC 10.1021/jm9805337
44318081 163289 0 None 3 3 Human 7.0 pKi = 7 Binding
Binding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assayBinding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assay
ChEMBL 504 8 0 6 3.9 CCOC(=O)[C@H]1CN(CCCCN2C(=O)c3cc(Cl)ccc3S2(=O)=O)CC[C@@H]1c1ccccc1 10.1016/s0960-894x(98)00451-x
CHEMBL418926 163289 0 None 3 3 Human 7.0 pKi = 7 Binding
Binding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assayBinding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assay
ChEMBL 504 8 0 6 3.9 CCOC(=O)[C@H]1CN(CCCCN2C(=O)c3cc(Cl)ccc3S2(=O)=O)CC[C@@H]1c1ccccc1 10.1016/s0960-894x(98)00451-x
9822477 199429 0 None -34 5 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 403 4 0 4 3.5 Cc1ccc(Cl)c(N2CCN(CCN3C(=O)CC4(CCCC4)CC3=O)CC2)c1 10.1007/s00044-010-9379-1
CHEMBL59149 199429 0 None -34 5 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 403 4 0 4 3.5 Cc1ccc(Cl)c(N2CCN(CCN3C(=O)CC4(CCCC4)CC3=O)CC2)c1 10.1007/s00044-010-9379-1
242 469 124 None -14 52 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1039/C2MD00311B
34 469 124 None -14 52 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1039/C2MD00311B
60795 469 124 None -14 52 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1039/C2MD00311B
CHEMBL1112 469 124 None -14 52 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1039/C2MD00311B
DB01238 469 124 None -14 52 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1039/C2MD00311B
2337 3232 77 None -5 63 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1039/C2MD00311B
50 3232 77 None -5 63 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1039/C2MD00311B
5002 3232 77 None -5 63 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1039/C2MD00311B
CHEMBL716 3232 77 None -5 63 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1039/C2MD00311B
DB01224 3232 77 None -5 63 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1039/C2MD00311B
52937119 61290 0 None -15 3 Human 7.0 pKi = 7 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 367 4 0 4 3.6 CN1CCC(Cn2nc(Cc3ccc(Cl)cc3)c3ccccc3c2=O)C1 10.1021/jm1013874
CHEMBL1767155 61290 0 None -15 3 Human 7.0 pKi = 7 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 367 4 0 4 3.6 CN1CCC(Cn2nc(Cc3ccc(Cl)cc3)c3ccccc3c2=O)C1 10.1021/jm1013874
24803641 61294 0 None -199 4 Human 7.0 pKi = 7 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 612 10 0 6 7.5 O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C1CCCN(Cc2ccc(OCCCN3CCCCCC3)cc2)CC1 10.1021/jm1013874
CHEMBL1767159 61294 0 None -199 4 Human 7.0 pKi = 7 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 612 10 0 6 7.5 O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C1CCCN(Cc2ccc(OCCCN3CCCCCC3)cc2)CC1 10.1021/jm1013874
24803639 61301 0 None -251 4 Human 7.0 pKi = 7 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 622 14 1 7 6.8 O=c1c2ccccc2c(Cc2ccc(O)cc2)nn1C[C@H]1CCCN1CCCCc1ccc(OCCCN2CCCCCC2)cc1 10.1021/jm1013874
CHEMBL1767166 61301 0 None -251 4 Human 7.0 pKi = 7 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 622 14 1 7 6.8 O=c1c2ccccc2c(Cc2ccc(O)cc2)nn1C[C@H]1CCCN1CCCCc1ccc(OCCCN2CCCCCC2)cc1 10.1021/jm1013874
44431557 146647 0 None -1 4 Human 7.0 pKi = 7 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 541 8 1 6 4.8 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccc(OC(F)(F)F)cc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL392377 146647 0 None -1 4 Human 7.0 pKi = 7 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 541 8 1 6 4.8 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccc(OC(F)(F)F)cc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
10362296 95059 0 None - 1 Human 7.0 pKi = 7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 378 8 1 3 3.6 CC(=O)CC(=O)NCCCN1CCC(c2ccccc2)(c2ccccc2)CC1 10.1021/jm960697s
CHEMBL25537 95059 0 None - 1 Human 7.0 pKi = 7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 378 8 1 3 3.6 CC(=O)CC(=O)NCCCN1CCC(c2ccccc2)(c2ccccc2)CC1 10.1021/jm960697s
44417715 11806 0 None 2 4 Human 7.0 pKi = 7 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 399 8 1 6 3.4 COc1cccc(OC)c1OCCNC[C@@H]1COc2cc3c(cc2O1)CCCC3 10.1021/jm060358r
CHEMBL1182160 11806 0 None 2 4 Human 7.0 pKi = 7 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 399 8 1 6 3.4 COc1cccc(OC)c1OCCNC[C@@H]1COc2cc3c(cc2O1)CCCC3 10.1021/jm060358r
CHEMBL215857 11806 0 None 2 4 Human 7.0 pKi = 7 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 399 8 1 6 3.4 COc1cccc(OC)c1OCCNC[C@@H]1COc2cc3c(cc2O1)CCCC3 10.1021/jm060358r
11135150 7571 0 None -1 5 Human 7.0 pKi = 7 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 435 10 1 6 4.0 COc1cccc(OC)c1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.bmcl.2010.01.030
CHEMBL1087942 7571 0 None -1 5 Human 7.0 pKi = 7 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 435 10 1 6 4.0 COc1cccc(OC)c1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.bmcl.2010.01.030
CHEMBL287686 7571 0 None -1 5 Human 7.0 pKi = 7 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 435 10 1 6 4.0 COc1cccc(OC)c1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.bmcl.2010.01.030
9822477 199429 0 None -34 5 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 403 4 0 4 3.5 Cc1ccc(Cl)c(N2CCN(CCN3C(=O)CC4(CCCC4)CC3=O)CC2)c1 10.1007/s00044-010-9379-1
CHEMBL59149 199429 0 None -34 5 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 403 4 0 4 3.5 Cc1ccc(Cl)c(N2CCN(CCN3C(=O)CC4(CCCC4)CC3=O)CC2)c1 10.1007/s00044-010-9379-1
9908478 195613 1 None -7079 8 Human 6.0 pKi = 6 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 391 4 0 4 2.8 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(F)ccc2F)CC1 10.1021/jm0491391
CHEMBL556313 195613 1 None -7079 8 Human 6.0 pKi = 6 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 391 4 0 4 2.8 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(F)ccc2F)CC1 10.1021/jm0491391
135398745 2893 112 None -39 66 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1039/C2MD00311B
47 2893 112 None -39 66 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1039/C2MD00311B
CHEMBL715 2893 112 None -39 66 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1039/C2MD00311B
DB00334 2893 112 None -39 66 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1039/C2MD00311B
9923249 5565 0 None - 1 Rat 6.0 pKi = 6 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 323 4 2 4 2.8 CCS(=O)(=O)Nc1cccc2c1SCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL107726 5565 0 None - 1 Rat 6.0 pKi = 6 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 323 4 2 4 2.8 CCS(=O)(=O)Nc1cccc2c1SCCC2c1c[nH]cn1 10.1021/jm030551a
16041451 97780 0 None -5 4 Human 7.0 pKi = 7 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 500 7 2 5 5.4 COc1ccc(Cl)cc1NC(=O)NC1CCC(N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL271913 97780 0 None -5 4 Human 7.0 pKi = 7 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 500 7 2 5 5.4 COc1ccc(Cl)cc1NC(=O)NC1CCC(N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.11.068
16756753 92099 1 None -37 3 Human 6.0 pKi = 6 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptor
ChEMBL 478 7 1 3 7.0 Cc1ccc(C2CCN(Cc3ccc(Oc4ccc(F)c(F)c4)cc3)CC2)cc1NC(=O)C(C)C 10.1021/jm060383x
CHEMBL242003 92099 1 None -37 3 Human 6.0 pKi = 6 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptor
ChEMBL 478 7 1 3 7.0 Cc1ccc(C2CCN(Cc3ccc(Oc4ccc(F)c(F)c4)cc3)CC2)cc1NC(=O)C(C)C 10.1021/jm060383x
44417709 12388 0 None 2 4 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 395 8 1 6 3.7 COc1cccc(OC)c1OCCNC[C@@H]1COc2cc3ccccc3cc2O1 10.1021/jm060358r
CHEMBL1185857 12388 0 None 2 4 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 395 8 1 6 3.7 COc1cccc(OC)c1OCCNC[C@@H]1COc2cc3ccccc3cc2O1 10.1021/jm060358r
CHEMBL436955 12388 0 None 2 4 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 395 8 1 6 3.7 COc1cccc(OC)c1OCCNC[C@@H]1COc2cc3ccccc3cc2O1 10.1021/jm060358r
127025275 137657 0 None -263 3 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 474 9 2 5 4.7 CCOC(=O)Nc1cccc(N2CCN(CCCCNC(=O)c3ccc4ccccc4c3)CC2)c1 10.1016/j.bmcl.2015.12.068
CHEMBL3758665 137657 0 None -263 3 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 474 9 2 5 4.7 CCOC(=O)Nc1cccc(N2CCN(CCCCNC(=O)c3ccc4ccccc4c3)CC2)c1 10.1016/j.bmcl.2015.12.068
19085921 104882 0 None 1 3 Human 6.0 pKi = 6.0 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 513 7 0 9 2.6 COC(=O)c1ccc2c(c1)oc(=O)n2C1CCN(CCCCN2C(=O)c3ccccc3S2(=O)=O)CC1 10.1016/s0960-894x(98)00446-6
CHEMBL311290 104882 0 None 1 3 Human 6.0 pKi = 6.0 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 513 7 0 9 2.6 COC(=O)c1ccc2c(c1)oc(=O)n2C1CCN(CCCCN2C(=O)c3ccccc3S2(=O)=O)CC1 10.1016/s0960-894x(98)00446-6
10939408 47393 0 None -181 6 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 455 7 1 3 5.5 O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
CHEMBL154508 47393 0 None -181 6 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 455 7 1 3 5.5 O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
25022505 188267 0 None 2 3 Rat 7.0 pKi = 7.0 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 586 10 1 8 2.9 COC(=O)C(C)N1C(=O)N(CC(O)CN2CCN(c3ccccc3OC)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
CHEMBL500266 188267 0 None 2 3 Rat 7.0 pKi = 7.0 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 586 10 1 8 2.9 COC(=O)C(C)N1C(=O)N(CC(O)CN2CCN(c3ccccc3OC)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
3191 102831 97 None -204 25 Rat 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 469 9 0 3 7.2 CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1 nan
CHEMBL305660 102831 97 None -204 25 Rat 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 469 9 0 3 7.2 CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1 nan
102 4096 48 None -346 50 Human 6.0 pKi = 6.0 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00019a001
3659 4096 48 None -346 50 Human 6.0 pKi = 6.0 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00019a001
8969 4096 48 None -346 50 Human 6.0 pKi = 6.0 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00019a001
CHEMBL15245 4096 48 None -346 50 Human 6.0 pKi = 6.0 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00019a001
DB01392 4096 48 None -346 50 Human 6.0 pKi = 6.0 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00019a001
127046693 139642 0 None -2 2 Human 6.0 pKi = 6.0 Binding
Selectivity interaction (GPCR panel (PDSP screen)) EUB0000341aCl ADRA1ASelectivity interaction (GPCR panel (PDSP screen)) EUB0000341aCl ADRA1A
ChEMBL 300 3 2 4 2.2 C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N 10.6019/CHEMBL5212743
CHEMBL3797887 139642 0 None -2 2 Human 6.0 pKi = 6.0 Binding
Selectivity interaction (GPCR panel (PDSP screen)) EUB0000341aCl ADRA1ASelectivity interaction (GPCR panel (PDSP screen)) EUB0000341aCl ADRA1A
ChEMBL 300 3 2 4 2.2 C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N 10.6019/CHEMBL5212743
CHEMBL4762646 139642 0 None -2 2 Human 6.0 pKi = 6.0 Binding
Selectivity interaction (GPCR panel (PDSP screen)) EUB0000341aCl ADRA1ASelectivity interaction (GPCR panel (PDSP screen)) EUB0000341aCl ADRA1A
ChEMBL 300 3 2 4 2.2 C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N 10.6019/CHEMBL5212743
2812 4747 101 None -2238 34 Rat 5.0 pKi = 5.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 344 4 0 2 5.4 Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 nan
CHEMBL104 4747 101 None -2238 34 Rat 5.0 pKi = 5.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 344 4 0 2 5.4 Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 nan
9844321 100834 0 None -588 5 Rat 7.0 pKi = 7.0 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 407 4 0 4 3.3 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(F)ccc2Cl)CC1 10.1021/jm030944+
CHEMBL293539 100834 0 None -588 5 Rat 7.0 pKi = 7.0 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 407 4 0 4 3.3 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(F)ccc2Cl)CC1 10.1021/jm030944+
10669270 166265 0 None -28 2 Rat 7.0 pKi = 7.0 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 410 5 0 4 2.6 O=C1C2CCCN2C(=O)N1CCCN1CCN(c2cccc(C(F)(F)F)c2)CC1 10.1021/jm970216k
CHEMBL42706 166265 0 None -28 2 Rat 7.0 pKi = 7.0 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 410 5 0 4 2.6 O=C1C2CCCN2C(=O)N1CCCN1CCN(c2cccc(C(F)(F)F)c2)CC1 10.1021/jm970216k
14004040 51605 0 None -6 2 Bovine 7.0 pKi = 7.0 Binding
Compound was evaluated for log 1/Ki at alpha-1 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-1 adrenergic receptor
ChEMBL 227 0 0 2 3.5 c1ccc2c3c(oc2c1)C1CCCCN1CC3 10.1021/jm00398a025
CHEMBL158371 51605 0 None -6 2 Bovine 7.0 pKi = 7.0 Binding
Compound was evaluated for log 1/Ki at alpha-1 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-1 adrenergic receptor
ChEMBL 227 0 0 2 3.5 c1ccc2c3c(oc2c1)C1CCCCN1CC3 10.1021/jm00398a025
145951352 162736 0 None -2 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 397 5 2 8 2.2 COc1cc2nc(N3CCC[C@@H](NC(=O)c4ccco4)C3)nc(N)c2cc1OC 10.1016/j.ejmech.2017.05.003
CHEMBL4171710 162736 0 None -2 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 397 5 2 8 2.2 COc1cc2nc(N3CCC[C@@H](NC(=O)c4ccco4)C3)nc(N)c2cc1OC 10.1016/j.ejmech.2017.05.003
56945164 71485 0 None -338 4 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 417 9 2 4 4.4 COc1ccccc1OCCNC[C@H]1CCC(c2ccccc2)(c2ccccc2)[C@@H]1O 10.1021/jm200421e
CHEMBL1946786 71485 0 None -338 4 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 417 9 2 4 4.4 COc1ccccc1OCCNC[C@H]1CCC(c2ccccc2)(c2ccccc2)[C@@H]1O 10.1021/jm200421e
CHEMBL1962756 71485 0 None -338 4 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 417 9 2 4 4.4 COc1ccccc1OCCNC[C@H]1CCC(c2ccccc2)(c2ccccc2)[C@@H]1O 10.1021/jm200421e
14004039 119535 3 None -5 2 Bovine 6.0 pKi = 6.0 Binding
Compound was evaluated for log 1/Ki at alpha-1 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-1 adrenergic receptor
ChEMBL 193 0 0 2 2.8 c1cc2c(s1)C1CCCCN1CC2 10.1021/jm00398a025
CHEMBL346016 119535 3 None -5 2 Bovine 6.0 pKi = 6.0 Binding
Compound was evaluated for log 1/Ki at alpha-1 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-1 adrenergic receptor
ChEMBL 193 0 0 2 2.8 c1cc2c(s1)C1CCCCN1CC2 10.1021/jm00398a025
10744391 207340 0 None 7 3 Human 8.0 pKi = 8.0 Binding
Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 514 7 1 3 4.8 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H](c2ccc(F)c(F)c2)N(C)C(=O)N1C 10.1021/jm990612y
CHEMBL93693 207340 0 None 7 3 Human 8.0 pKi = 8.0 Binding
Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 514 7 1 3 4.8 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H](c2ccc(F)c(F)c2)N(C)C(=O)N1C 10.1021/jm990612y
1353 1898 93 None -6 86 Human 8.0 pKi = 8.0 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
3559 1898 93 None -6 86 Human 8.0 pKi = 8.0 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
86 1898 93 None -6 86 Human 8.0 pKi = 8.0 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
CHEMBL54 1898 93 None -6 86 Human 8.0 pKi = 8.0 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
DB00502 1898 93 None -6 86 Human 8.0 pKi = 8.0 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
10092649 193049 56 None 1 9 Human 8.0 pKi = 8.0 Binding
Binding affinity to human adrenergic alpha1A receptor by radioligand displacement assayBinding affinity to human adrenergic alpha1A receptor by radioligand displacement assay
ChEMBL 404 4 1 4 3.9 Cc1ccccc1CN1CCC(N2CCC(n3c(=O)[nH]c4ccccc43)CC2)CC1 10.1021/jm100697g
CHEMBL522460 193049 56 None 1 9 Human 8.0 pKi = 8.0 Binding
Binding affinity to human adrenergic alpha1A receptor by radioligand displacement assayBinding affinity to human adrenergic alpha1A receptor by radioligand displacement assay
ChEMBL 404 4 1 4 3.9 Cc1ccccc1CN1CCC(N2CCC(n3c(=O)[nH]c4ccccc43)CC2)CC1 10.1021/jm100697g
11519153 85590 0 None 3 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 514 9 1 6 4.7 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OC4CC4)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
CHEMBL228278 85590 0 None 3 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 514 9 1 6 4.7 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OC4CC4)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
11857861 194757 0 None -1 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 520 10 1 6 4.5 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OCCF)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
CHEMBL538397 194757 0 None -1 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 520 10 1 6 4.5 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OCCF)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
44431611 87456 0 None -7 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 509 7 1 5 4.7 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccc(Cl)cc3F)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL233410 87456 0 None -7 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 509 7 1 5 4.7 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccc(Cl)cc3F)CC2)CC1 10.1016/j.bmcl.2007.04.008
17753379 87774 0 None -1 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 521 8 1 6 4.5 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL233816 87774 0 None -1 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 521 8 1 6 4.5 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
44431599 87991 0 None 1 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 505 7 1 5 4.8 Cc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1Cl 10.1016/j.bmcl.2007.04.008
CHEMBL234423 87991 0 None 1 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 505 7 1 5 4.8 Cc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1Cl 10.1016/j.bmcl.2007.04.008
44431574 146245 0 None 6 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 505 8 1 6 4.0 COc1ccc(F)cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL392066 146245 0 None 6 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 505 8 1 6 4.0 COc1ccc(F)cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
11519153 85590 0 None 3 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 514 9 1 6 4.7 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OC4CC4)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
CHEMBL228278 85590 0 None 3 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 514 9 1 6 4.7 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OC4CC4)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
16041091 95192 0 None 1 4 Human 8.0 pKi = 8.0 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 468 7 2 4 4.5 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)NCc3cccc(F)c3)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL256041 95192 0 None 1 4 Human 8.0 pKi = 8.0 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 468 7 2 4 4.5 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)NCc3cccc(F)c3)CC2)CC1 10.1016/j.bmcl.2007.11.068
16041263 95418 0 None -1 4 Human 8.0 pKi = 8.0 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 470 6 2 4 5.4 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3ccccc3Cl)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL257098 95418 0 None -1 4 Human 8.0 pKi = 8.0 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 470 6 2 4 5.4 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3ccccc3Cl)CC2)CC1 10.1016/j.bmcl.2007.11.068
145946966 167573 0 None -5 5 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 354 7 0 4 3.9 COc1ccccc1N1CCN(CCCOc2ccc(C)cc2C)CC1 10.1016/j.bmcl.2018.04.059
CHEMBL4209888 167573 0 None -5 5 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 354 7 0 4 3.9 COc1ccccc1N1CCN(CCCOc2ccc(C)cc2C)CC1 10.1016/j.bmcl.2018.04.059
CHEMBL4300899 167573 0 None -5 5 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 354 7 0 4 3.9 COc1ccccc1N1CCN(CCCOc2ccc(C)cc2C)CC1 10.1016/j.bmcl.2018.04.059
6603808 127496 3 None -1 9 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL214986 127496 3 None -1 9 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL36622 127496 3 None -1 9 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL3740374 127496 3 None -1 9 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
6603808 127496 3 None -1 9 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL214986 127496 3 None -1 9 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL36622 127496 3 None -1 9 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL3740374 127496 3 None -1 9 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1016/j.ejmech.2012.09.049
6603808 127496 3 None -1 9 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm301525w
CHEMBL214986 127496 3 None -1 9 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm301525w
CHEMBL36622 127496 3 None -1 9 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm301525w
CHEMBL3740374 127496 3 None -1 9 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm301525w
6603808 127496 3 None -1 9 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1039/C4MD00484A
CHEMBL214986 127496 3 None -1 9 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1039/C4MD00484A
CHEMBL36622 127496 3 None -1 9 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1039/C4MD00484A
CHEMBL3740374 127496 3 None -1 9 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1039/C4MD00484A
46934637 16639 0 None -7 4 Human 7.9 pKi = 7.9 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 465 7 0 6 3.1 COc1ccccc1N1CCN(C[C@@H]2CO[C@@](CN3CCCCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
CHEMBL1242542 16639 0 None -7 4 Human 7.9 pKi = 7.9 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 465 7 0 6 3.1 COc1ccccc1N1CCN(C[C@@H]2CO[C@@](CN3CCCCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
11994551 11808 0 None 1 4 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 369 7 1 5 3.4 COc1ccc2c(c1OCCNC[C@@H]1COc3ccccc3O1)CCCC2 10.1021/jm060358r
CHEMBL1182179 11808 0 None 1 4 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 369 7 1 5 3.4 COc1ccc2c(c1OCCNC[C@@H]1COc3ccccc3O1)CCCC2 10.1021/jm060358r
CHEMBL217143 11808 0 None 1 4 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 369 7 1 5 3.4 COc1ccc2c(c1OCCNC[C@@H]1COc3ccccc3O1)CCCC2 10.1021/jm060358r
50905589 56324 0 None 1 5 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 406 7 2 6 2.1 COc1ccc(C[C@@H](C)NC[C@@H]2Oc3ccccc3O[C@@H]2C)cc1S(N)(=O)=O 10.1016/j.ejmech.2010.09.042
CHEMBL1630942 56324 0 None 1 5 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 406 7 2 6 2.1 COc1ccc(C[C@@H](C)NC[C@@H]2Oc3ccccc3O[C@@H]2C)cc1S(N)(=O)=O 10.1016/j.ejmech.2010.09.042
44328920 108614 0 None 15 6 Human 7.9 pKi = 7.9 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 705 14 3 7 5.9 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCC(F)(F)F)N1 10.1016/s0960-894x(99)00484-9
CHEMBL320736 108614 0 None 15 6 Human 7.9 pKi = 7.9 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 705 14 3 7 5.9 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCC(F)(F)F)N1 10.1016/s0960-894x(99)00484-9
118716710 114978 0 None 2 4 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 444 5 1 7 1.3 COc1ccccc1N1CCN(CC2COC3(CCN(C(=O)C4CCCN4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342863 114978 0 None 2 4 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 444 5 1 7 1.3 COc1ccccc1N1CCN(CC2COC3(CCN(C(=O)C4CCCN4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
14004040 51605 0 None -6 2 Bovine 7.0 pKi = 7.0 Binding
Affinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranesAffinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranes
ChEMBL 227 0 0 2 3.5 c1ccc2c3c(oc2c1)C1CCCCN1CC3 10.1021/jm00398a025
CHEMBL158371 51605 0 None -6 2 Bovine 7.0 pKi = 7.0 Binding
Affinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranesAffinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranes
ChEMBL 227 0 0 2 3.5 c1ccc2c3c(oc2c1)C1CCCCN1CC3 10.1021/jm00398a025
10254390 71659 0 None -851 8 Rat 7.0 pKi = 7.0 Binding
Binding affinity for rat Alpha-1A adrenergic receptor using [11C] radiotracerBinding affinity for rat Alpha-1A adrenergic receptor using [11C] radiotracer
ChEMBL 475 8 1 5 5.1 COc1cccc2cc(C(=O)NCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)oc12 10.1021/jm050171k
CHEMBL196476 71659 0 None -851 8 Rat 7.0 pKi = 7.0 Binding
Binding affinity for rat Alpha-1A adrenergic receptor using [11C] radiotracerBinding affinity for rat Alpha-1A adrenergic receptor using [11C] radiotracer
ChEMBL 475 8 1 5 5.1 COc1cccc2cc(C(=O)NCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)oc12 10.1021/jm050171k
16041090 95364 0 None -1 4 Human 7.0 pKi = 7.0 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 496 8 2 6 4.7 COc1ccc(NC(=O)NC2CCC(N3CCN(c4ccccc4OC(C)C)CC3)CC2)c(OC)c1 10.1016/j.bmcl.2007.11.068
CHEMBL256853 95364 0 None -1 4 Human 7.0 pKi = 7.0 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 496 8 2 6 4.7 COc1ccc(NC(=O)NC2CCC(N3CCN(c4ccccc4OC(C)C)CC3)CC2)c(OC)c1 10.1016/j.bmcl.2007.11.068
13938361 185339 0 None -141 2 Bovine 7.0 pKi = 7.0 Binding
Evaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortexEvaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortex
ChEMBL 364 4 1 5 1.7 CN([C@@H]1CCN2CCc3c(oc4ccccc34)[C@@H]2C1)S(=O)(=O)CCO 10.1021/jm00150a002
CHEMBL48603 185339 0 None -141 2 Bovine 7.0 pKi = 7.0 Binding
Evaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortexEvaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortex
ChEMBL 364 4 1 5 1.7 CN([C@@H]1CCN2CCc3c(oc4ccccc34)[C@@H]2C1)S(=O)(=O)CCO 10.1021/jm00150a002
14004039 119535 3 None -5 2 Bovine 6.0 pKi = 6.0 Binding
Affinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranesAffinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranes
ChEMBL 193 0 0 2 2.8 c1cc2c(s1)C1CCCCN1CC2 10.1021/jm00398a025
CHEMBL346016 119535 3 None -5 2 Bovine 6.0 pKi = 6.0 Binding
Affinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranesAffinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranes
ChEMBL 193 0 0 2 2.8 c1cc2c(s1)C1CCCCN1CC2 10.1021/jm00398a025
10242469 31411 0 None - 1 Bovine 6.0 pKi = 6.0 Binding
In Vitro Alpha-1 adrenergic receptor binding affinity on calf frontal cortex membrane preparationIn Vitro Alpha-1 adrenergic receptor binding affinity on calf frontal cortex membrane preparation
ChEMBL 217 1 1 4 0.9 CN1CC(C2=NCCN2)Oc2ccccc21 10.1021/jm021050c
CHEMBL14028 31411 0 None - 1 Bovine 6.0 pKi = 6.0 Binding
In Vitro Alpha-1 adrenergic receptor binding affinity on calf frontal cortex membrane preparationIn Vitro Alpha-1 adrenergic receptor binding affinity on calf frontal cortex membrane preparation
ChEMBL 217 1 1 4 0.9 CN1CC(C2=NCCN2)Oc2ccccc21 10.1021/jm021050c
9887884 119259 51 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of alpha1A adrenergic receptor (unknown origin)Inhibition of alpha1A adrenergic receptor (unknown origin)
ChEMBL 412 4 0 3 5.1 O=C1c2ccccc2C(Cc2ccnc(F)c2)(Cc2ccnc(F)c2)c2ccccc21 10.1016/j.bmcl.2019.126681
CHEMBL343822 119259 51 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of alpha1A adrenergic receptor (unknown origin)Inhibition of alpha1A adrenergic receptor (unknown origin)
ChEMBL 412 4 0 3 5.1 O=C1c2ccccc2C(Cc2ccnc(F)c2)(Cc2ccnc(F)c2)c2ccccc21 10.1016/j.bmcl.2019.126681
10577609 26955 0 None -75 3 Human 6.0 pKi = 6.0 Binding
The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.
ChEMBL 509 8 1 9 3.5 COc1cc2nc(N3CCN(C(=O)C(C)Oc4c(OC)cccc4C(C)C)CC3)nc(N)c2cc1OC 10.1021/jm9805337
CHEMBL136458 26955 0 None -75 3 Human 6.0 pKi = 6.0 Binding
The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.
ChEMBL 509 8 1 9 3.5 COc1cc2nc(N3CCN(C(=O)C(C)Oc4c(OC)cccc4C(C)C)CC3)nc(N)c2cc1OC 10.1021/jm9805337
1935 3707 97 None -190 6 Rat 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 198 0 1 2 2.7 Nc1c2CCCCc2nc2c1cccc2 nan
2551 3707 97 None -190 6 Rat 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 198 0 1 2 2.7 Nc1c2CCCCc2nc2c1cccc2 nan
6687 3707 97 None -190 6 Rat 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 198 0 1 2 2.7 Nc1c2CCCCc2nc2c1cccc2 nan
CHEMBL95 3707 97 None -190 6 Rat 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 198 0 1 2 2.7 Nc1c2CCCCc2nc2c1cccc2 nan
DB00382 3707 97 None -190 6 Rat 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 198 0 1 2 2.7 Nc1c2CCCCc2nc2c1cccc2 nan
118717460 115116 0 None -2 4 Human 7.0 pKi = 7.0 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 412 10 2 4 6.9 Cc1ccc2c(NCCCCCCCNc3ccnc4cc(C)ccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
CHEMBL3343982 115116 0 None -2 4 Human 7.0 pKi = 7.0 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 412 10 2 4 6.9 Cc1ccc2c(NCCCCCCCNc3ccnc4cc(C)ccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
2419 692 28 None -288 12 Rat 7.0 pKi = 7.0 Binding
Binding affinity towards rat Alpha-1A adrenergic receptorBinding affinity towards rat Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/s0960-894x(01)00159-7
9 692 28 None -288 12 Rat 7.0 pKi = 7.0 Binding
Binding affinity towards rat Alpha-1A adrenergic receptorBinding affinity towards rat Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/s0960-894x(01)00159-7
CHEMBL13647 692 28 None -288 12 Rat 7.0 pKi = 7.0 Binding
Binding affinity towards rat Alpha-1A adrenergic receptorBinding affinity towards rat Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/s0960-894x(01)00159-7
118717460 115116 0 None -2 4 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 412 10 2 4 6.9 Cc1ccc2c(NCCCCCCCNc3ccnc4cc(C)ccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
CHEMBL3343982 115116 0 None -2 4 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 412 10 2 4 6.9 Cc1ccc2c(NCCCCCCCNc3ccnc4cc(C)ccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
481 2872 7 None 4 3 Human 6.0 pKi = 6.0 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 248 4 3 4 0.2 NC[C@@H](c1cc(ccc1F)NS(=O)(=O)C)O 10.1021/jm000542r
9838763 2872 7 None 4 3 Human 6.0 pKi = 6.0 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 248 4 3 4 0.2 NC[C@@H](c1cc(ccc1F)NS(=O)(=O)C)O 10.1021/jm000542r
CHEMBL72958 2872 7 None 4 3 Human 6.0 pKi = 6.0 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 248 4 3 4 0.2 NC[C@@H](c1cc(ccc1F)NS(=O)(=O)C)O 10.1021/jm000542r
131829 204704 15 None -173 6 Human 6.0 pKi = 6.0 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 295 1 4 5 1.7 Brc1c(NC2=NCCN2)ccc2c1NCCN2 10.1016/0960-894X(95)00391-6
CHEMBL74283 204704 15 None -173 6 Human 6.0 pKi = 6.0 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 295 1 4 5 1.7 Brc1c(NC2=NCCN2)ccc2c1NCCN2 10.1016/0960-894X(95)00391-6
34458 98315 68 None - 1 Rat 6.0 pKi = 6.0 Binding
Displacement of [125I]-BE2254 from Wistar rat alpha1A adrenoceptor after 20 minsDisplacement of [125I]-BE2254 from Wistar rat alpha1A adrenoceptor after 20 mins
ChEMBL 339 2 0 5 3.1 COc1ccc2c(c1OC)CN1CCc3cc4c(cc3C1C2)OCO4 10.1021/acs.jmedchem.6b01217
CHEMBL275097 98315 68 None - 1 Rat 6.0 pKi = 6.0 Binding
Displacement of [125I]-BE2254 from Wistar rat alpha1A adrenoceptor after 20 minsDisplacement of [125I]-BE2254 from Wistar rat alpha1A adrenoceptor after 20 mins
ChEMBL 339 2 0 5 3.1 COc1ccc2c(c1OC)CN1CCc3cc4c(cc3C1C2)OCO4 10.1021/acs.jmedchem.6b01217
9892644 197323 0 None -30 4 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 511 4 0 4 4.0 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(Br)ccc2Br)CC1 10.1021/jm030944+
CHEMBL56899 197323 0 None -30 4 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 511 4 0 4 4.0 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(Br)ccc2Br)CC1 10.1021/jm030944+
9906978 42681 2 None -2 12 Human 6.9 pKi = 6.9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptor by radioligand binding assayBinding affinity to human cloned adrenergic alpha-1A receptor by radioligand binding assay
ChEMBL 361 6 1 3 4.0 O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)C1)c1ccc(F)cc1 10.1016/j.bmcl.2006.03.057
CHEMBL150161 42681 2 None -2 12 Human 6.9 pKi = 6.9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptor by radioligand binding assayBinding affinity to human cloned adrenergic alpha-1A receptor by radioligand binding assay
ChEMBL 361 6 1 3 4.0 O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)C1)c1ccc(F)cc1 10.1016/j.bmcl.2006.03.057
10775000 107367 2 None -30 5 Bovine 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assay
ChEMBL 214 1 2 2 2.6 Oc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL317912 107367 2 None -30 5 Bovine 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assay
ChEMBL 214 1 2 2 2.6 Oc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
11301627 9366 0 None 1 2 Rat 5.9 pKi = 5.9 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 319 4 2 3 3.0 CC(C)S(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL111537 9366 0 None 1 2 Rat 5.9 pKi = 5.9 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 319 4 2 3 3.0 CC(C)S(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
11301627 9366 0 None 1 2 Rat 5.9 pKi = 5.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 319 4 2 3 3.0 CC(C)S(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL111537 9366 0 None 1 2 Rat 5.9 pKi = 5.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 319 4 2 3 3.0 CC(C)S(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
9922027 115384 0 None 1 3 Rat 5.9 pKi = 5.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 289 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCC=C2c1c[nH]cn1 10.1021/jm030551a
CHEMBL3350265 115384 0 None 1 3 Rat 5.9 pKi = 5.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 289 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCC=C2c1c[nH]cn1 10.1021/jm030551a
10835395 206786 0 None -7 2 Rat 6.9 pKi = 6.9 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 410 6 0 4 3.7 FC(F)(F)c1cccc(N2CCN(CCCCN3CC4CCCCN4C3)CC2)c1 10.1021/jm970216k
CHEMBL90384 206786 0 None -7 2 Rat 6.9 pKi = 6.9 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 410 6 0 4 3.7 FC(F)(F)c1cccc(N2CCN(CCCCN3CC4CCCCN4C3)CC2)c1 10.1021/jm970216k
3151 1450 97 None -147 27 Rat 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
945 1450 97 None -147 27 Rat 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
965 1450 97 None -147 27 Rat 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
CHEMBL219916 1450 97 None -147 27 Rat 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
DB01184 1450 97 None -147 27 Rat 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
127027974 137736 0 None -9 3 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 396 8 1 4 3.4 COc1ccccc1N1CCN(CCCCNC(=O)N(C)c2ccccc2)CC1 10.1016/j.bmcl.2015.12.068
CHEMBL3759312 137736 0 None -9 3 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 396 8 1 4 3.4 COc1ccccc1N1CCN(CCCCNC(=O)N(C)c2ccccc2)CC1 10.1016/j.bmcl.2015.12.068
46881493 6956 0 None -14 4 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 389 8 1 4 4.3 Cc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.bmcl.2010.01.030
CHEMBL1084658 6956 0 None -14 4 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 389 8 1 4 4.3 Cc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.bmcl.2010.01.030
9845172 169085 0 None -79 4 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 422 4 0 3 4.9 O=C1CC2(CCCC2)CC(=O)N1CCN1CCC(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
CHEMBL440118 169085 0 None -79 4 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 422 4 0 3 4.9 O=C1CC2(CCCC2)CC(=O)N1CCN1CCC(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
11584530 16067 0 None -158 3 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 454 8 1 4 5.8 FC(F)(F)c1cccc(N2CCN(CCCCNc3cc(-c4ccccc4)ccn3)CC2)c1 10.1016/j.bmcl.2010.07.096
CHEMBL1223857 16067 0 None -158 3 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 454 8 1 4 5.8 FC(F)(F)c1cccc(N2CCN(CCCCNc3cc(-c4ccccc4)ccn3)CC2)c1 10.1016/j.bmcl.2010.07.096
9929936 167888 0 None -11 5 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 383 4 0 4 3.1 Cc1ccc(C)c(N2CCN(CCN3C(=O)CC4(CCCC4)CC3=O)CC2)c1 10.1021/jm030944+
CHEMBL431354 167888 0 None -11 5 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 383 4 0 4 3.1 Cc1ccc(C)c(N2CCN(CCN3C(=O)CC4(CCCC4)CC3=O)CC2)c1 10.1021/jm030944+
9822812 195849 0 None -45 3 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 409 4 0 4 3.4 O=C1CC2(CCC2)CC(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
CHEMBL55882 195849 0 None -45 3 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 409 4 0 4 3.4 O=C1CC2(CCC2)CC(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
11857862 142029 0 None -2 4 Human 7.9 pKi = 7.9 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 538 10 1 6 4.8 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OCC(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
CHEMBL387833 142029 0 None -2 4 Human 7.9 pKi = 7.9 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 538 10 1 6 4.8 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OCC(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
44431607 87455 0 None -1 4 Human 7.9 pKi = 7.9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 509 7 1 5 4.7 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3cccc(Cl)c3F)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL233407 87455 0 None -1 4 Human 7.9 pKi = 7.9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 509 7 1 5 4.7 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3cccc(Cl)c3F)CC2)CC1 10.1016/j.bmcl.2007.04.008
11857794 85639 0 None 5 4 Human 7.9 pKi = 7.9 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 562 9 1 5 5.7 O=S(=O)(N[C@H]1CC[C@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1cccc(OC(F)F)c1 10.1016/j.bmcl.2007.04.098
CHEMBL228553 85639 0 None 5 4 Human 7.9 pKi = 7.9 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 562 9 1 5 5.7 O=S(=O)(N[C@H]1CC[C@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1cccc(OC(F)F)c1 10.1016/j.bmcl.2007.04.098
11857862 142029 0 None -2 4 Human 7.9 pKi = 7.9 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 538 10 1 6 4.8 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OCC(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
CHEMBL387833 142029 0 None -2 4 Human 7.9 pKi = 7.9 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 538 10 1 6 4.8 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OCC(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
4038180 204 14 None 2 8 Rat 7.9 pKi = 7.9 Binding
Binding affinity towards rat submaxillary gland Alpha-1 adrenergic receptor; value ranges from (0.009 - 0.015)Binding affinity towards rat submaxillary gland Alpha-1 adrenergic receptor; value ranges from (0.009 - 0.015)
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm025550h
480 204 14 None 2 8 Rat 7.9 pKi = 7.9 Binding
Binding affinity towards rat submaxillary gland Alpha-1 adrenergic receptor; value ranges from (0.009 - 0.015)Binding affinity towards rat submaxillary gland Alpha-1 adrenergic receptor; value ranges from (0.009 - 0.015)
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm025550h
CHEMBL109783 204 14 None 2 8 Rat 7.9 pKi = 7.9 Binding
Binding affinity towards rat submaxillary gland Alpha-1 adrenergic receptor; value ranges from (0.009 - 0.015)Binding affinity towards rat submaxillary gland Alpha-1 adrenergic receptor; value ranges from (0.009 - 0.015)
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm025550h
44308466 203766 0 None 1 3 Human 7.9 pKi = 7.9 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 429 7 0 7 3.2 COC(=O)[C@@H]1CCCN1Cc1ccc(CN2CCN(c3ccccc3OC)CC2)s1 10.1016/s0960-894x(02)00347-5
CHEMBL68241 203766 0 None 1 3 Human 7.9 pKi = 7.9 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 429 7 0 7 3.2 COC(=O)[C@@H]1CCCN1Cc1ccc(CN2CCN(c3ccccc3OC)CC2)s1 10.1016/s0960-894x(02)00347-5
68604 78176 29 None -28 6 Rat 7.9 pKi = 7.9 Binding
Displacement of [3H]-WB4101 from rat forebrain homogenate alpha 1 adrenergic receptorDisplacement of [3H]-WB4101 from rat forebrain homogenate alpha 1 adrenergic receptor
ChEMBL 401 5 0 6 2.9 Cc1nc2n(c(=O)c1CCN1CCC(C(=O)c3ccc(F)cc3)CC1)CCS2 10.1021/acs.jmedchem.2c00633
CHEMBL2105437 78176 29 None -28 6 Rat 7.9 pKi = 7.9 Binding
Displacement of [3H]-WB4101 from rat forebrain homogenate alpha 1 adrenergic receptorDisplacement of [3H]-WB4101 from rat forebrain homogenate alpha 1 adrenergic receptor
ChEMBL 401 5 0 6 2.9 Cc1nc2n(c(=O)c1CCN1CCC(C(=O)c3ccc(F)cc3)CC1)CCS2 10.1021/acs.jmedchem.2c00633
11590801 16018 0 None -7 3 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 428 7 1 4 5.3 FC(F)(F)c1cccc(N2CCN(CCCCNc3ccc4ccccc4n3)CC2)c1 10.1016/j.bmcl.2010.07.096
CHEMBL1223747 16018 0 None -7 3 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 428 7 1 4 5.3 FC(F)(F)c1cccc(N2CCN(CCCCNc3ccc4ccccc4n3)CC2)c1 10.1016/j.bmcl.2010.07.096
2142 3074 58 None -2 37 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1016/j.bmcl.2018.04.059
4920903 3074 58 None -2 37 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1016/j.bmcl.2018.04.059
502 3074 58 None -2 37 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1016/j.bmcl.2018.04.059
5775 3074 58 None -2 37 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1016/j.bmcl.2018.04.059
CHEMBL597 3074 58 None -2 37 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1016/j.bmcl.2018.04.059
DB00692 3074 58 None -2 37 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1016/j.bmcl.2018.04.059
10745664 121990 0 None 12 3 Human 7.9 pKi = 7.9 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 572 8 2 8 3.3 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3cccc([N+](=O)[O-])c3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL359433 121990 0 None 12 3 Human 7.9 pKi = 7.9 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 572 8 2 8 3.3 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3cccc([N+](=O)[O-])c3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
44289344 168522 0 None 1 3 Human 7.9 pKi = 7.9 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 441 8 1 3 4.8 Cc1ccc(C(C(=O)NCCCN2CCN(c3ccccc3)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
CHEMBL435576 168522 0 None 1 3 Human 7.9 pKi = 7.9 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 441 8 1 3 4.8 Cc1ccc(C(C(=O)NCCCN2CCN(c3ccccc3)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
3039881 174233 10 None -19 3 Human 7.9 pKi = 7.9 Binding
The compound was tested for binding affinity against Alpha-1 adrenergic receptor using WB-4101 as radioligandThe compound was tested for binding affinity against Alpha-1 adrenergic receptor using WB-4101 as radioligand
ChEMBL 337 1 0 1 5.0 CN(C)C1C=CC2(CC1)c1ccccc1CCc1ccc(Cl)cc12 10.1021/jm00109a026
CHEMBL45491 174233 10 None -19 3 Human 7.9 pKi = 7.9 Binding
The compound was tested for binding affinity against Alpha-1 adrenergic receptor using WB-4101 as radioligandThe compound was tested for binding affinity against Alpha-1 adrenergic receptor using WB-4101 as radioligand
ChEMBL 337 1 0 1 5.0 CN(C)C1C=CC2(CC1)c1ccccc1CCc1ccc(Cl)cc12 10.1021/jm00109a026
1443 2015 34 None -2 11 Bovine 7.9 pKi = 7.9 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm00018a001
33625 2015 34 None -2 11 Bovine 7.9 pKi = 7.9 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm00018a001
501 2015 34 None -2 11 Bovine 7.9 pKi = 7.9 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm00018a001
CHEMBL279516 2015 34 None -2 11 Bovine 7.9 pKi = 7.9 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm00018a001
DB08950 2015 34 None -2 11 Bovine 7.9 pKi = 7.9 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm00018a001
4038180 204 14 None 2 8 Rat 7.9 pKi = 7.9 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
480 204 14 None 2 8 Rat 7.9 pKi = 7.9 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
CHEMBL109783 204 14 None 2 8 Rat 7.9 pKi = 7.9 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
118716721 114989 0 None 1 4 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 466 5 1 6 3.3 COc1ccccc1N1CCN(CC2COC3(CCN(C(=O)Nc4ccccc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342874 114989 0 None 1 4 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 466 5 1 6 3.3 COc1ccccc1N1CCN(CC2COC3(CCN(C(=O)Nc4ccccc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
4038180 204 14 None 2 8 Rat 7.9 pKi = 7.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm030551a
480 204 14 None 2 8 Rat 7.9 pKi = 7.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm030551a
CHEMBL109783 204 14 None 2 8 Rat 7.9 pKi = 7.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm030551a
10644955 166163 7 None -1 3 Rat 7.9 pKi = 7.9 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 404 6 0 4 3.1 O=C1C2CCCCN2C(=O)N1CCCCN1CCN(c2cccc(Cl)c2)CC1 10.1021/jm970216k
CHEMBL42644 166163 7 None -1 3 Rat 7.9 pKi = 7.9 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 404 6 0 4 3.1 O=C1C2CCCCN2C(=O)N1CCCCN1CCN(c2cccc(Cl)c2)CC1 10.1021/jm970216k
9824384 118761 1 None -14 8 Human 7.9 pKi = 7.9 Binding
Compound was tested for binding affinity against human hippocampus Alpha-1A adrenergic receptor using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against human hippocampus Alpha-1A adrenergic receptor using radioligand ([3H]prazosin) binding assay
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1021/jm960510x
CHEMBL342062 118761 1 None -14 8 Human 7.9 pKi = 7.9 Binding
Compound was tested for binding affinity against human hippocampus Alpha-1A adrenergic receptor using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against human hippocampus Alpha-1A adrenergic receptor using radioligand ([3H]prazosin) binding assay
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1021/jm960510x
10252540 85328 1 None -58 6 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptorDisplacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1007/s00044-004-0024-8
CHEMBL2261604 85328 1 None -58 6 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptorDisplacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1007/s00044-004-0024-8
132266 1267 12 None -28 9 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1016/j.bmc.2007.01.028
486 1267 12 None -28 9 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1016/j.bmc.2007.01.028
CHEMBL423294 1267 12 None -28 9 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1016/j.bmc.2007.01.028
132266 1267 12 None -28 9 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1016/j.bmc.2018.05.023
486 1267 12 None -28 9 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1016/j.bmc.2018.05.023
CHEMBL423294 1267 12 None -28 9 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1016/j.bmc.2018.05.023
52948119 16634 0 None -2 4 Human 7.9 pKi = 7.9 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 451 7 0 6 2.7 COc1ccccc1N1CCN(C[C@@H]2CO[C@](CN3CCCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
CHEMBL1242445 16634 0 None -2 4 Human 7.9 pKi = 7.9 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 451 7 0 6 2.7 COc1ccccc1N1CCN(C[C@@H]2CO[C@](CN3CCCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
118716723 114991 0 None 2 4 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 446 4 1 6 2.5 COc1ccccc1N1CCN(CC2COC3(CCN(C(=O)NC(C)(C)C)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342876 114991 0 None 2 4 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 446 4 1 6 2.5 COc1ccccc1N1CCN(CC2COC3(CCN(C(=O)NC(C)(C)C)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
44288162 168975 0 None -2 3 Rat 7.9 pKi = 7.9 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 447 4 1 6 3.6 COc1ccc2c(c1)C1CN(CCn3c(=O)[nH]c4c(sc5ccccc54)c3=O)CC1CC2 10.1021/jm990567u
CHEMBL43921 168975 0 None -2 3 Rat 7.9 pKi = 7.9 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 447 4 1 6 3.6 COc1ccc2c(c1)C1CN(CCn3c(=O)[nH]c4c(sc5ccccc54)c3=O)CC1CC2 10.1021/jm990567u
10622830 102399 0 None 5 3 Rat 7.9 pKi = 7.9 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 437 6 1 6 3.2 COc1cc2c(cc1OC)C(=O)N(CCN1C[C@@H]3CCc4c(OC)cccc4[C@@H]3C1)CN2 10.1021/jm000541z
CHEMBL303988 102399 0 None 5 3 Rat 7.9 pKi = 7.9 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 437 6 1 6 3.2 COc1cc2c(cc1OC)C(=O)N(CCN1C[C@@H]3CCc4c(OC)cccc4[C@@H]3C1)CN2 10.1021/jm000541z
118717456 115110 0 None -2 4 Human 6.9 pKi = 6.9 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 342 5 2 4 4.9 Cc1ccc2c(NCCNc3ccnc4cc(C)ccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
CHEMBL3343977 115110 0 None -2 4 Human 6.9 pKi = 6.9 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 342 5 2 4 4.9 Cc1ccc2c(NCCNc3ccnc4cc(C)ccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
9797396 12849 0 None -39 3 Rat 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 325 5 1 2 4.2 c1ccc2c(C3CCN(CCCN4CCCCC4)CC3)c[nH]c2c1 10.1016/j.bmcl.2006.05.002
CHEMBL1188811 12849 0 None -39 3 Rat 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 325 5 1 2 4.2 c1ccc2c(C3CCN(CCCN4CCCCC4)CC3)c[nH]c2c1 10.1016/j.bmcl.2006.05.002
CHEMBL537428 12849 0 None -39 3 Rat 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 325 5 1 2 4.2 c1ccc2c(C3CCN(CCCN4CCCCC4)CC3)c[nH]c2c1 10.1016/j.bmcl.2006.05.002
9797396 12849 0 None -39 3 Rat 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 325 5 1 2 4.2 c1ccc2c(C3CCN(CCCN4CCCCC4)CC3)c[nH]c2c1 10.1016/j.bmcl.2015.07.046
CHEMBL1188811 12849 0 None -39 3 Rat 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 325 5 1 2 4.2 c1ccc2c(C3CCN(CCCN4CCCCC4)CC3)c[nH]c2c1 10.1016/j.bmcl.2015.07.046
CHEMBL537428 12849 0 None -39 3 Rat 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 325 5 1 2 4.2 c1ccc2c(C3CCN(CCCN4CCCCC4)CC3)c[nH]c2c1 10.1016/j.bmcl.2015.07.046
44586430 187006 0 None 3 3 Rat 6.9 pKi = 6.9 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 528 9 1 6 3.4 CCOc1ccccc1N1CCN(CC(O)CN2C(=O)N(C)C(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
CHEMBL490865 187006 0 None 3 3 Rat 6.9 pKi = 6.9 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 528 9 1 6 3.4 CCOc1ccccc1N1CCN(CC(O)CN2C(=O)N(C)C(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
155525650 176614 0 None -22 4 Human 6.9 pKi = 6.9 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 389 9 1 4 4.2 c1ccc(OCCNC[C@H]2CO[C@H](C(c3ccccc3)c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
CHEMBL4457585 176614 0 None -22 4 Human 6.9 pKi = 6.9 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 389 9 1 4 4.2 c1ccc(OCCNC[C@H]2CO[C@H](C(c3ccccc3)c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
CHEMBL4597956 176614 0 None -22 4 Human 6.9 pKi = 6.9 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 389 9 1 4 4.2 c1ccc(OCCNC[C@H]2CO[C@H](C(c3ccccc3)c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
118717456 115110 0 None -2 4 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 342 5 2 4 4.9 Cc1ccc2c(NCCNc3ccnc4cc(C)ccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
CHEMBL3343977 115110 0 None -2 4 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 342 5 2 4 4.9 Cc1ccc2c(NCCNc3ccnc4cc(C)ccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
145949210 162725 0 None -4 3 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 459 5 2 9 2.8 COc1cc2nc(N3CCC[C@@H](NC4=CC(=O)c5ccccc5C4=O)C3)nc(N)c2cc1OC 10.1016/j.ejmech.2017.05.003
CHEMBL4171491 162725 0 None -4 3 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 459 5 2 9 2.8 COc1cc2nc(N3CCC[C@@H](NC4=CC(=O)c5ccccc5C4=O)C3)nc(N)c2cc1OC 10.1016/j.ejmech.2017.05.003
145946292 167480 0 None -19 2 Human 5.9 pKi = 5.9 Binding
Displacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting methodDisplacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting method
ChEMBL 382 6 2 5 2.9 CNc1ccc2c(c1)[C@H](NCCOc1cc(F)ccc1F)CCS2(=O)=O 10.1016/j.ejmech.2017.07.071
CHEMBL4210954 167480 0 None -19 2 Human 5.9 pKi = 5.9 Binding
Displacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting methodDisplacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting method
ChEMBL 382 6 2 5 2.9 CNc1ccc2c(c1)[C@H](NCCOc1cc(F)ccc1F)CCS2(=O)=O 10.1016/j.ejmech.2017.07.071
CHEMBL4299802 167480 0 None -19 2 Human 5.9 pKi = 5.9 Binding
Displacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting methodDisplacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting method
ChEMBL 382 6 2 5 2.9 CNc1ccc2c(c1)[C@H](NCCOc1cc(F)ccc1F)CCS2(=O)=O 10.1016/j.ejmech.2017.07.071
12909389 60339 0 None 64 2 Bovine 5.9 pKi = 5.9 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 320 1 1 3 3.7 CN1CCC(=C2c3cc(C(=O)O)ccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
CHEMBL174649 60339 0 None 64 2 Bovine 5.9 pKi = 5.9 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 320 1 1 3 3.7 CN1CCC(=C2c3cc(C(=O)O)ccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
10221004 204208 0 None -1 5 Human 5.9 pKi = 5.9 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 267 5 2 5 0.9 CCS(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL70973 204208 0 None -1 5 Human 5.9 pKi = 5.9 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 267 5 2 5 0.9 CCS(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
9953974 77804 0 None 5 3 Rat 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranesDisplacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranes
ChEMBL 421 4 0 7 3.3 COc1ccccc1N1CCN(C[C@@H]2CN=C3c4ccccc4N=C(SC)N32)CC1 10.1021/jm970159v
CHEMBL2092927 77804 0 None 5 3 Rat 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranesDisplacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranes
ChEMBL 421 4 0 7 3.3 COc1ccccc1N1CCN(C[C@@H]2CN=C3c4ccccc4N=C(SC)N32)CC1 10.1021/jm970159v
10694274 198999 0 None 1 3 Rat 6.9 pKi = 6.9 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 437 6 1 5 3.7 COc1cc2c(cc1OC)NC(=O)N(CCN1C[C@@H]3CCc4c(OC)cccc4[C@@H]3C1)C2 10.1021/jm000541z
CHEMBL58585 198999 0 None 1 3 Rat 6.9 pKi = 6.9 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 437 6 1 5 3.7 COc1cc2c(cc1OC)NC(=O)N(CCN1C[C@@H]3CCc4c(OC)cccc4[C@@H]3C1)C2 10.1021/jm000541z
1971 2846 38 None -24 30 Rat 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 nan
2404 2846 38 None -24 30 Rat 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 nan
4543 2846 38 None -24 30 Rat 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 nan
CHEMBL445 2846 38 None -24 30 Rat 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 nan
DB00540 2846 38 None -24 30 Rat 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 nan
9950711 109179 0 None 5 4 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 359 4 2 3 3.2 O=S(=O)(CC(F)(F)F)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL321644 109179 0 None 5 4 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 359 4 2 3 3.2 O=S(=O)(CC(F)(F)F)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
16655023 107414 2 None -102 7 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from human cloned alpha-1A receptorDisplacement of [3H]prazosin from human cloned alpha-1A receptor
ChEMBL 481 7 0 7 3.7 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccc(F)cc4)CC3)[C@@H]1CO2 10.1016/j.bmc.2007.03.053
CHEMBL318235 107414 2 None -102 7 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from human cloned alpha-1A receptorDisplacement of [3H]prazosin from human cloned alpha-1A receptor
ChEMBL 481 7 0 7 3.7 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccc(F)cc4)CC3)[C@@H]1CO2 10.1016/j.bmc.2007.03.053
9822477 199429 0 None -43 5 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 403 4 0 4 3.5 Cc1ccc(Cl)c(N2CCN(CCN3C(=O)CC4(CCCC4)CC3=O)CC2)c1 10.1021/jm030944+
CHEMBL59149 199429 0 None -43 5 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 403 4 0 4 3.5 Cc1ccc(Cl)c(N2CCN(CCN3C(=O)CC4(CCCC4)CC3=O)CC2)c1 10.1021/jm030944+
11183468 109845 2 None -2 6 Rat 6.9 pKi = 6.9 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 213 1 2 2 2.5 Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL323402 109845 2 None -2 6 Rat 6.9 pKi = 6.9 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 213 1 2 2 2.5 Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
52937526 61272 0 None -1258 4 Human 6.9 pKi = 6.9 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 363 5 0 5 3.1 COc1ccc(Cc2nn(C[C@H]3CCCN3C)c(=O)c3ccccc23)cc1 10.1021/jm1013874
CHEMBL1767137 61272 0 None -1258 4 Human 6.9 pKi = 6.9 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 363 5 0 5 3.1 COc1ccc(Cc2nn(C[C@H]3CCCN3C)c(=O)c3ccccc23)cc1 10.1021/jm1013874
24803798 61295 0 None -501 4 Human 6.9 pKi = 6.9 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 640 12 0 6 7.9 O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C1CCCN(CCCc2ccc(OCCCN3CCCCCC3)cc2)CC1 10.1021/jm1013874
CHEMBL1767160 61295 0 None -501 4 Human 6.9 pKi = 6.9 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 640 12 0 6 7.9 O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C1CCCN(CCCc2ccc(OCCCN3CCCCCC3)cc2)CC1 10.1021/jm1013874
218362 204777 5 None -75 4 Human 6.9 pKi = 6.9 Binding
Binding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 216 1 1 3 2.0 c1ccc2c(c1)CCCC2NC1=NCCO1 10.1016/0960-894X(94)85032-1
CHEMBL75030 204777 5 None -75 4 Human 6.9 pKi = 6.9 Binding
Binding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 216 1 1 3 2.0 c1ccc2c(c1)CCCC2NC1=NCCO1 10.1016/0960-894X(94)85032-1
151779 194681 2 None 1 4 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 384 10 2 4 6.3 c1ccc2c(NCCCCCCCNc3ccnc4ccccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
CHEMBL533979 194681 2 None 1 4 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 384 10 2 4 6.3 c1ccc2c(NCCCCCCCNc3ccnc4ccccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
127040061 136901 0 None -33 5 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNC[C@H]2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1039/C4MD00484A
CHEMBL3739932 136901 0 None -33 5 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNC[C@H]2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1039/C4MD00484A
CHEMBL3742489 136901 0 None -33 5 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNC[C@H]2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1039/C4MD00484A
127036186 137389 0 None -39 19 Human 5.9 pKi = 5.9 Binding
Binding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 254 7 1 1 3.7 C=CCN(CC=C)CCc1c[nH]c2ccc(C)cc12 10.1016/j.bmcl.2015.12.053
CHEMBL3753318 137389 0 None -39 19 Human 5.9 pKi = 5.9 Binding
Binding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 254 7 1 1 3.7 C=CCN(CC=C)CCc1c[nH]c2ccc(C)cc12 10.1016/j.bmcl.2015.12.053
127026052 137528 0 None -75 19 Human 5.9 pKi = 5.9 Binding
Binding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 258 7 1 1 3.5 C=CCN(CC=C)CCc1c[nH]c2ccc(F)cc12 10.1016/j.bmcl.2015.12.053
CHEMBL3754496 137528 0 None -75 19 Human 5.9 pKi = 5.9 Binding
Binding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 258 7 1 1 3.5 C=CCN(CC=C)CCc1c[nH]c2ccc(F)cc12 10.1016/j.bmcl.2015.12.053
183528 168677 6 None -16 2 Human 4.9 pKi = 4.9 Binding
Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)
ChEMBL 420 3 4 3 4.7 O=C(c1nc(-c2c[nH]c3cc(Br)ccc23)c[nH]1)c1c[nH]c2cc(O)ccc12 10.1016/0960-894X(96)00376-9
CHEMBL436760 168677 6 None -16 2 Human 4.9 pKi = 4.9 Binding
Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)
ChEMBL 420 3 4 3 4.7 O=C(c1nc(-c2c[nH]c3cc(Br)ccc23)c[nH]1)c1c[nH]c2cc(O)ccc12 10.1016/0960-894X(96)00376-9
151779 194681 2 None 1 4 Human 6.9 pKi = 6.9 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 384 10 2 4 6.3 c1ccc2c(NCCCCCCCNc3ccnc4ccccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
CHEMBL533979 194681 2 None 1 4 Human 6.9 pKi = 6.9 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 384 10 2 4 6.3 c1ccc2c(NCCCCCCCNc3ccnc4ccccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
44328739 207628 0 None 1 3 Human 6.9 pKi = 6.9 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 691 16 3 6 7.5 CCCCCC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCC)=C(CC)N1 10.1016/s0960-894x(99)00484-9
CHEMBL95263 207628 0 None 1 3 Human 6.9 pKi = 6.9 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 691 16 3 6 7.5 CCCCCC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCC)=C(CC)N1 10.1016/s0960-894x(99)00484-9
1376848 203733 8 None -1 3 Human 6.9 pKi = 6.9 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 366 4 0 4 3.8 COc1ccccc1N1CCN(Cc2ccc(Br)s2)CC1 10.1016/s0960-894x(02)00347-5
CHEMBL67932 203733 8 None -1 3 Human 6.9 pKi = 6.9 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 366 4 0 4 3.8 COc1ccccc1N1CCN(Cc2ccc(Br)s2)CC1 10.1016/s0960-894x(02)00347-5
9954092 196623 0 None -1000 6 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 423 4 0 4 3.8 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
CHEMBL56438 196623 0 None -1000 6 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 423 4 0 4 3.8 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
9903797 9407 5 None 18 4 Rat 6.9 pKi = 6.9 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 279 5 2 3 2.1 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1C 10.1007/s00044-004-0020-z
CHEMBL111734 9407 5 None 18 4 Rat 6.9 pKi = 6.9 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 279 5 2 3 2.1 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1C 10.1007/s00044-004-0020-z
25181489 187333 0 None -158 4 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 389 8 1 4 4.0 c1ccc(OCCNC[C@@H]2COCC(c3ccccc3)(c3ccccc3)O2)cc1 10.1021/jm301525w
CHEMBL493285 187333 0 None -158 4 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 389 8 1 4 4.0 c1ccc(OCCNC[C@@H]2COCC(c3ccccc3)(c3ccccc3)O2)cc1 10.1021/jm301525w
9903797 9407 5 None 18 4 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 279 5 2 3 2.1 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1C 10.1021/jm030551a
CHEMBL111734 9407 5 None 18 4 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 279 5 2 3 2.1 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1C 10.1021/jm030551a
11747739 13203 0 None -1 4 Human 5.9 pKi = 5.9 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 237 4 2 4 0.8 C[S+]([O-])c1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL1191324 13203 0 None -1 4 Human 5.9 pKi = 5.9 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 237 4 2 4 0.8 C[S+]([O-])c1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL542402 13203 0 None -1 4 Human 5.9 pKi = 5.9 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 237 4 2 4 0.8 C[S+]([O-])c1ccccc1NCC1=NCCN1 10.1021/jm000542r
44267890 16475 0 None 41 3 Human 6.9 pKi = 6.9 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 460 8 1 5 2.0 O=C(CN1CCCCC1=O)NCCN1CCN(c2ccc(F)cc2OCC(F)(F)F)CC1 10.1016/s0960-894x(00)00169-4
CHEMBL12364 16475 0 None 41 3 Human 6.9 pKi = 6.9 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 460 8 1 5 2.0 O=C(CN1CCCCC1=O)NCCN1CCN(c2ccc(F)cc2OCC(F)(F)F)CC1 10.1016/s0960-894x(00)00169-4
44460394 205355 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 398 7 0 6 2.9 CC(C)Oc1ccccc1N1CCN(Cc2nc(CN3CCCC3=O)co2)CC1 10.1016/s0960-894x(02)00436-5
CHEMBL79940 205355 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 398 7 0 6 2.9 CC(C)Oc1ccccc1N1CCN(Cc2nc(CN3CCCC3=O)co2)CC1 10.1016/s0960-894x(02)00436-5
9959671 32641 0 None 363 3 Human 7.9 pKi = 7.9 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 567 10 0 7 5.6 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL141322 32641 0 None 363 3 Human 7.9 pKi = 7.9 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 567 10 0 7 5.6 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
15054189 195561 0 None 23 3 Rat 7.9 pKi = 7.9 Binding
Binding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranesBinding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranes
ChEMBL 433 6 2 6 2.4 COc1ccccc1N1CCN(CCCn2c(=O)[nH]c3c([nH]c4ccccc43)c2=O)CC1 10.1021/jm00110a014
CHEMBL55528 195561 0 None 23 3 Rat 7.9 pKi = 7.9 Binding
Binding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranesBinding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranes
ChEMBL 433 6 2 6 2.4 COc1ccccc1N1CCN(CCCn2c(=O)[nH]c3c([nH]c4ccccc43)c2=O)CC1 10.1021/jm00110a014
2389 3306 118 None -6 68 Rat 7.9 pKi = 7.9 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1021/jm9810396
5073 3306 118 None -6 68 Rat 7.9 pKi = 7.9 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1021/jm9810396
96 3306 118 None -6 68 Rat 7.9 pKi = 7.9 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1021/jm9810396
CHEMBL85 3306 118 None -6 68 Rat 7.9 pKi = 7.9 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1021/jm9810396
DB00734 3306 118 None -6 68 Rat 7.9 pKi = 7.9 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1021/jm9810396
10623356 168105 0 None -8 3 Human 7.9 pKi = 7.9 Binding
Binding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constantBinding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constant
ChEMBL 448 7 0 5 4.0 COc1ccccc1N1CCN(CCN(C(=O)c2ccc(F)c(C)c2)c2ccccn2)CC1 10.1021/acs.jmedchem.2c00633
CHEMBL1910243 168105 0 None -8 3 Human 7.9 pKi = 7.9 Binding
Binding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constantBinding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constant
ChEMBL 448 7 0 5 4.0 COc1ccccc1N1CCN(CCN(C(=O)c2ccc(F)c(C)c2)c2ccccn2)CC1 10.1021/acs.jmedchem.2c00633
CHEMBL43297 168105 0 None -8 3 Human 7.9 pKi = 7.9 Binding
Binding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constantBinding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constant
ChEMBL 448 7 0 5 4.0 COc1ccccc1N1CCN(CCN(C(=O)c2ccc(F)c(C)c2)c2ccccn2)CC1 10.1021/acs.jmedchem.2c00633
2274 3151 58 None -6 32 Rat 7.9 pKi = 7.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
4917 3151 58 None -6 32 Rat 7.9 pKi = 7.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
7279 3151 58 None -6 32 Rat 7.9 pKi = 7.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
CHEMBL728 3151 58 None -6 32 Rat 7.9 pKi = 7.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
DB00433 3151 58 None -6 32 Rat 7.9 pKi = 7.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
44331136 109654 0 None 1 3 Human 7.9 pKi = 7.9 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 540 7 1 5 5.8 O=C1CC2(CCN(CCc3cccc4ccccc34)CC2)Oc2ccc(NS(=O)(=O)Cc3ccccc3)cc21 10.1016/s0960-894x(98)00732-x
CHEMBL322688 109654 0 None 1 3 Human 7.9 pKi = 7.9 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 540 7 1 5 5.8 O=C1CC2(CCN(CCc3cccc4ccccc34)CC2)Oc2ccc(NS(=O)(=O)Cc3ccccc3)cc21 10.1016/s0960-894x(98)00732-x
13141184 165866 0 None 17 2 Bovine 7.9 pKi = 7.9 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 376 1 0 3 5.6 CN1CCC(=C2c3cc(SC(F)(F)F)ccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
CHEMBL424967 165866 0 None 17 2 Bovine 7.9 pKi = 7.9 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 376 1 0 3 5.6 CN1CCC(=C2c3cc(SC(F)(F)F)ccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
57402365 69266 0 None 10 5 Pig 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 441 12 1 6 3.1 CCOCCOc1cccc(C(=O)NCCCN2CCN(c3ccccc3OC)CC2)c1 10.1016/j.bmc.2011.10.063
CHEMBL1928119 69266 0 None 10 5 Pig 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 441 12 1 6 3.1 CCOCCOc1cccc(C(=O)NCCCN2CCN(c3ccccc3OC)CC2)c1 10.1016/j.bmc.2011.10.063
11393666 192962 0 None -33 19 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from recombinant human alpha1A receptor measured after 60 mins by scintillation counting analysisDisplacement of [3H]prazosin from recombinant human alpha1A receptor measured after 60 mins by scintillation counting analysis
ChEMBL 340 2 1 2 4.6 CC1(C)CN([C@@H]2C[C@@H](c3ccccc3)c3ccc(Cl)cc32)CCN1 10.1016/j.bmcl.2022.128879
CHEMBL5201983 192962 0 None -33 19 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from recombinant human alpha1A receptor measured after 60 mins by scintillation counting analysisDisplacement of [3H]prazosin from recombinant human alpha1A receptor measured after 60 mins by scintillation counting analysis
ChEMBL 340 2 1 2 4.6 CC1(C)CN([C@@H]2C[C@@H](c3ccccc3)c3ccc(Cl)cc32)CCN1 10.1016/j.bmcl.2022.128879
CHEMBL5222597 192962 0 None -33 19 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from recombinant human alpha1A receptor measured after 60 mins by scintillation counting analysisDisplacement of [3H]prazosin from recombinant human alpha1A receptor measured after 60 mins by scintillation counting analysis
ChEMBL 340 2 1 2 4.6 CC1(C)CN([C@@H]2C[C@@H](c3ccccc3)c3ccc(Cl)cc32)CCN1 10.1016/j.bmcl.2022.128879
53779053 78408 0 None 5 3 Human 7.9 pKi = 7.9 Binding
Tested for binding affinity against recombinant human Alpha-1A adrenergic receptor using [125I]HEAT in competition binding assayTested for binding affinity against recombinant human Alpha-1A adrenergic receptor using [125I]HEAT in competition binding assay
ChEMBL 475 6 1 4 5.0 C[C@H]1OC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H]1c1ccc(F)c(F)c1 10.1016/s0960-894x(00)00524-2
CHEMBL2111563 78408 0 None 5 3 Human 7.9 pKi = 7.9 Binding
Tested for binding affinity against recombinant human Alpha-1A adrenergic receptor using [125I]HEAT in competition binding assayTested for binding affinity against recombinant human Alpha-1A adrenergic receptor using [125I]HEAT in competition binding assay
ChEMBL 475 6 1 4 5.0 C[C@H]1OC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H]1c1ccc(F)c(F)c1 10.1016/s0960-894x(00)00524-2
124 2960 47 None -14 33 Bovine 7.9 pKi = 7.9 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
2032 2960 47 None -14 33 Bovine 7.9 pKi = 7.9 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
4636 2960 47 None -14 33 Bovine 7.9 pKi = 7.9 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
CHEMBL762 2960 47 None -14 33 Bovine 7.9 pKi = 7.9 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
DB00935 2960 47 None -14 33 Bovine 7.9 pKi = 7.9 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
10623356 168105 0 None -8 3 Human 7.9 pKi = 7.9 Binding
Binding affinity to alpha1A receptorBinding affinity to alpha1A receptor
ChEMBL 448 7 0 5 4.0 COc1ccccc1N1CCN(CCN(C(=O)c2ccc(F)c(C)c2)c2ccccn2)CC1 10.1016/j.ejmech.2011.06.023
CHEMBL1910243 168105 0 None -8 3 Human 7.9 pKi = 7.9 Binding
Binding affinity to alpha1A receptorBinding affinity to alpha1A receptor
ChEMBL 448 7 0 5 4.0 COc1ccccc1N1CCN(CCN(C(=O)c2ccc(F)c(C)c2)c2ccccn2)CC1 10.1016/j.ejmech.2011.06.023
CHEMBL43297 168105 0 None -8 3 Human 7.9 pKi = 7.9 Binding
Binding affinity to alpha1A receptorBinding affinity to alpha1A receptor
ChEMBL 448 7 0 5 4.0 COc1ccccc1N1CCN(CCN(C(=O)c2ccc(F)c(C)c2)c2ccccn2)CC1 10.1016/j.ejmech.2011.06.023
44431618 144879 0 None 3 4 Human 7.9 pKi = 7.9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 488 8 1 7 3.3 COc1ccncc1S(=O)(=O)N[C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL391017 144879 0 None 3 4 Human 7.9 pKi = 7.9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 488 8 1 7 3.3 COc1ccncc1S(=O)(=O)N[C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
2470 3626 50 None -316 60 Bovine 7.9 pKi = 7.9 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1021/jm960510x
3300 3626 50 None -316 60 Bovine 7.9 pKi = 7.9 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1021/jm960510x
5265 3626 50 None -316 60 Bovine 7.9 pKi = 7.9 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1021/jm960510x
99 3626 50 None -316 60 Bovine 7.9 pKi = 7.9 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1021/jm960510x
CHEMBL267930 3626 50 None -316 60 Bovine 7.9 pKi = 7.9 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1021/jm960510x
44447010 154216 0 None -4 4 Rat 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 496 6 1 5 5.4 Cc1ccc(C(=O)NC2CCc3ccc(CCN4CCN(c5nsc6ccccc56)CC4)cc32)cc1 10.1016/j.bmcl.2007.11.106
CHEMBL398618 154216 0 None -4 4 Rat 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 496 6 1 5 5.4 Cc1ccc(C(=O)NC2CCc3ccc(CCN4CCN(c5nsc6ccccc56)CC4)cc32)cc1 10.1016/j.bmcl.2007.11.106
44431545 144995 0 None -2 4 Human 7.9 pKi = 7.9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 457 7 1 5 3.9 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL391107 144995 0 None -2 4 Human 7.9 pKi = 7.9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 457 7 1 5 3.9 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
2419 692 28 None -288 12 Human 6.9 pKi = 6.9 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/s0960-894x(01)00159-7
9 692 28 None -288 12 Human 6.9 pKi = 6.9 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/s0960-894x(01)00159-7
CHEMBL13647 692 28 None -288 12 Human 6.9 pKi = 6.9 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/s0960-894x(01)00159-7
9954092 196623 0 None -1000 6 Human 6.9 pKi = 6.9 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 423 4 0 4 3.8 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1016/j.bmcl.2004.11.032
CHEMBL56438 196623 0 None -1000 6 Human 6.9 pKi = 6.9 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 423 4 0 4 3.8 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1016/j.bmcl.2004.11.032
13156 3421 0 None -416 3 Human 6.9 pKi = 6.9 Binding
Displacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting methodDisplacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting method
ChEMBL 382 6 2 5 2.9 FC1=C(OCCN[C@H]2CCS(C3=CC=C(C=C23)NC)(=O)=O)C=C(C=C1)F 10.1016/j.ejmech.2017.07.071
145946376 3421 0 None -416 3 Human 6.9 pKi = 6.9 Binding
Displacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting methodDisplacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting method
ChEMBL 382 6 2 5 2.9 FC1=C(OCCN[C@H]2CCS(C3=CC=C(C=C23)NC)(=O)=O)C=C(C=C1)F 10.1016/j.ejmech.2017.07.071
CHEMBL4299993 3421 0 None -416 3 Human 6.9 pKi = 6.9 Binding
Displacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting methodDisplacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting method
ChEMBL 382 6 2 5 2.9 FC1=C(OCCN[C@H]2CCS(C3=CC=C(C=C23)NC)(=O)=O)C=C(C=C1)F 10.1016/j.ejmech.2017.07.071
12909383 130677 1 None 5 2 Bovine 6.9 pKi = 6.9 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 278 0 0 2 3.6 CN1CCC(=C2c3ccccc3CCn3cccc32)CC1 10.1021/jm00361a008
CHEMBL368413 130677 1 None 5 2 Bovine 6.9 pKi = 6.9 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 278 0 0 2 3.6 CN1CCC(=C2c3ccccc3CCn3cccc32)CC1 10.1021/jm00361a008
9929458 123036 0 None -61 2 Rat 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 373 5 1 2 4.8 c1ccc2c(c1)CCN(CCCN1CCC(c3c[nH]c4ccccc34)CC1)C2 10.1016/j.bmcl.2015.07.046
CHEMBL3609359 123036 0 None -61 2 Rat 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 373 5 1 2 4.8 c1ccc2c(c1)CCN(CCCN1CCC(c3c[nH]c4ccccc34)CC1)C2 10.1016/j.bmcl.2015.07.046
11169638 17162 0 None -1 3 Rat 6.9 pKi = 6.9 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 600 11 1 8 3.3 CCOC(=O)C(C)N1C(=O)N(CC(O)CN2CCN(c3ccccc3OC)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
CHEMBL1256344 17162 0 None -1 3 Rat 6.9 pKi = 6.9 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 600 11 1 8 3.3 CCOC(=O)C(C)N1C(=O)N(CC(O)CN2CCN(c3ccccc3OC)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
9838192 111285 18 None -2 6 Rat 6.9 pKi = 6.9 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1007/s00044-004-0020-z
CHEMBL326702 111285 18 None -2 6 Rat 6.9 pKi = 6.9 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1007/s00044-004-0020-z
118717455 115109 0 None -7 4 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 342 5 2 4 4.9 Cc1ccc2nccc(NCCNc3ccnc4ccc(C)cc34)c2c1 10.1016/j.bmc.2014.09.017
CHEMBL3343976 115109 0 None -7 4 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 342 5 2 4 4.9 Cc1ccc2nccc(NCCNc3ccnc4ccc(C)cc34)c2c1 10.1016/j.bmc.2014.09.017
9838192 111285 18 None -2 6 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1021/jm030551a
CHEMBL326702 111285 18 None -2 6 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1021/jm030551a
13149 2528 36 None -22 17 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]prazosin from human recombinant adrenergic alpha-1A receptor expressed in CHO cell membranes incubated for 60 minsDisplacement of [3H]prazosin from human recombinant adrenergic alpha-1A receptor expressed in CHO cell membranes incubated for 60 mins
ChEMBL 398 5 1 5 3.8 CC[C@@H]1CN2CCC3=C([C@@H]2C[C@@H]1/C(=C\OC)/C(=O)OC)NC4=C3C(=CC=C4)OC 10.1021/acs.jmedchem.9b01465
3034396 2528 36 None -22 17 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]prazosin from human recombinant adrenergic alpha-1A receptor expressed in CHO cell membranes incubated for 60 minsDisplacement of [3H]prazosin from human recombinant adrenergic alpha-1A receptor expressed in CHO cell membranes incubated for 60 mins
ChEMBL 398 5 1 5 3.8 CC[C@@H]1CN2CCC3=C([C@@H]2C[C@@H]1/C(=C\OC)/C(=O)OC)NC4=C3C(=CC=C4)OC 10.1021/acs.jmedchem.9b01465
CHEMBL299031 2528 36 None -22 17 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]prazosin from human recombinant adrenergic alpha-1A receptor expressed in CHO cell membranes incubated for 60 minsDisplacement of [3H]prazosin from human recombinant adrenergic alpha-1A receptor expressed in CHO cell membranes incubated for 60 mins
ChEMBL 398 5 1 5 3.8 CC[C@@H]1CN2CCC3=C([C@@H]2C[C@@H]1/C(=C\OC)/C(=O)OC)NC4=C3C(=CC=C4)OC 10.1021/acs.jmedchem.9b01465
9815005 109634 0 None 1 3 Rat 5.9 pKi = 5.9 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 305 3 2 3 2.6 CS(=O)(=O)Nc1cccc2c1CCCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL322492 109634 0 None 1 3 Rat 5.9 pKi = 5.9 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 305 3 2 3 2.6 CS(=O)(=O)Nc1cccc2c1CCCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL4576555 213994 5 None -1 19 Human 5.9 pKi = 5.9 Binding
GPCRScan assay: inhibition of Alpha1AGPCRScan assay: inhibition of Alpha1A
ChEMBL None None None CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5cc(C(C)(C)C)cc(C(C)(C)C)c5)ccc4n3)cc2)CC1 10.6019/CHEMBL4507307
9815005 109634 0 None 1 3 Rat 5.9 pKi = 5.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 305 3 2 3 2.6 CS(=O)(=O)Nc1cccc2c1CCCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL322492 109634 0 None 1 3 Rat 5.9 pKi = 5.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 305 3 2 3 2.6 CS(=O)(=O)Nc1cccc2c1CCCCC2c1c[nH]cn1 10.1021/jm030551a
118717455 115109 0 None -7 4 Human 6.9 pKi = 6.9 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 342 5 2 4 4.9 Cc1ccc2nccc(NCCNc3ccnc4ccc(C)cc34)c2c1 10.1016/j.bmc.2014.09.017
CHEMBL3343976 115109 0 None -7 4 Human 6.9 pKi = 6.9 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 342 5 2 4 4.9 Cc1ccc2nccc(NCCNc3ccnc4ccc(C)cc34)c2c1 10.1016/j.bmc.2014.09.017
9908478 195613 1 None -954 8 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 391 4 0 4 2.8 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(F)ccc2F)CC1 10.1021/jm030944+
CHEMBL556313 195613 1 None -954 8 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 391 4 0 4 2.8 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(F)ccc2F)CC1 10.1021/jm030944+
196129 67769 17 None -1698 15 Rat 5.9 pKi = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 917 13 4 16 4.3 CO[C@H]1C[C@@H](O[C@H]2C[C@H]([C@H]3O[C@](C)(O)[C@H](C)C[C@@H]3C)O[C@H]2[C@]2(C)CC[C@H]([C@]3(C)CC[C@]4(C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H]5O[C@](O)(CC(=O)O)[C@@H](C)[C@H](OC)[C@H]5OC)O4)O3)O2)O[C@@H](C)[C@@H]1OC nan
CHEMBL1909065 67769 17 None -1698 15 Rat 5.9 pKi = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 917 13 4 16 4.3 CO[C@H]1C[C@@H](O[C@H]2C[C@H]([C@H]3O[C@](C)(O)[C@H](C)C[C@@H]3C)O[C@H]2[C@]2(C)CC[C@H]([C@]3(C)CC[C@]4(C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H]5O[C@](O)(CC(=O)O)[C@@H](C)[C@H](OC)[C@H]5OC)O4)O3)O2)O[C@@H](C)[C@@H]1OC nan
9938248 102179 0 None -1 3 Rat 6.9 pKi = 6.9 Binding
Binding affinity was determined against Alpha-1a adrenergic receptorBinding affinity was determined against Alpha-1a adrenergic receptor
ChEMBL 580 2 4 3 6.0 CN1C[C@H](c2c[nH]c3c(Br)c(Br)cc(O)c23)NC[C@H]1c1c[nH]c2cc(Br)ccc12 10.1016/0960-894X(96)00376-9
CHEMBL302882 102179 0 None -1 3 Rat 6.9 pKi = 6.9 Binding
Binding affinity was determined against Alpha-1a adrenergic receptorBinding affinity was determined against Alpha-1a adrenergic receptor
ChEMBL 580 2 4 3 6.0 CN1C[C@H](c2c[nH]c3c(Br)c(Br)cc(O)c23)NC[C@H]1c1c[nH]c2cc(Br)ccc12 10.1016/0960-894X(96)00376-9
11183468 109845 2 None -2 6 Bovine 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assay
ChEMBL 213 1 2 2 2.5 Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL323402 109845 2 None -2 6 Bovine 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assay
ChEMBL 213 1 2 2 2.5 Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
6918539 144194 2 None - 1 Rat 5.9 pKi = 5.9 Binding
Displacement of [125I]-BE2254 from Wistar rat alpha1A adrenoceptor after 20 minsDisplacement of [125I]-BE2254 from Wistar rat alpha1A adrenoceptor after 20 mins
ChEMBL 361 2 2 5 3.4 COc1cc2c(cc1O)[C@@H]1Cc3c(Cl)cc(OC)c(O)c3CN1CC2 10.1021/acs.jmedchem.6b01217
CHEMBL3904484 144194 2 None - 1 Rat 5.9 pKi = 5.9 Binding
Displacement of [125I]-BE2254 from Wistar rat alpha1A adrenoceptor after 20 minsDisplacement of [125I]-BE2254 from Wistar rat alpha1A adrenoceptor after 20 mins
ChEMBL 361 2 2 5 3.4 COc1cc2c(cc1O)[C@@H]1Cc3c(Cl)cc(OC)c(O)c3CN1CC2 10.1021/acs.jmedchem.6b01217
11173600 163356 0 None - 1 Rat 5.9 pKi = 5.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 282 5 2 3 2.1 CCS(=O)(=O)Nc1cccc2c1CCCC2CNC 10.1021/jm030551a
CHEMBL419369 163356 0 None - 1 Rat 5.9 pKi = 5.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 282 5 2 3 2.1 CCS(=O)(=O)Nc1cccc2c1CCCC2CNC 10.1021/jm030551a
CHEMBL4752561 214015 0 None 3 2 Human 5.9 pKi = 5.9 Binding
Selectivity interaction (GPCR panel (PDSP screen)) EUB0000739a ADRA1ASelectivity interaction (GPCR panel (PDSP screen)) EUB0000739a ADRA1A
ChEMBL None None None COc1cc(-c2cn([C@H]3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1 10.6019/CHEMBL5212743
CHEMBL4576555 213994 5 None -1 19 Human 5.9 pKi = 5.9 Binding
GPCRScan assay: inhibition of Alpha1AGPCRScan assay: inhibition of Alpha1A
ChEMBL None None None CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5cc(C(C)(C)C)cc(C(C)(C)C)c5)ccc4n3)cc2)CC1 10.6019/CHEMBL4507307
10745566 34288 0 None 61 3 Human 7.9 pKi = 7.9 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 566 10 1 6 5.1 CNC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)cc1F 10.1021/jm9902032
CHEMBL142719 34288 0 None 61 3 Human 7.9 pKi = 7.9 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 566 10 1 6 5.1 CNC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)cc1F 10.1021/jm9902032
44431553 87555 0 None -10 4 Human 7.9 pKi = 7.9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 525 7 1 5 4.9 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3cccc(C(F)(F)F)c3)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL233592 87555 0 None -10 4 Human 7.9 pKi = 7.9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 525 7 1 5 4.9 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3cccc(C(F)(F)F)c3)CC2)CC1 10.1016/j.bmcl.2007.04.008
44426404 85598 0 None 4 4 Human 7.9 pKi = 7.9 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 498 7 1 6 4.4 O=S(=O)(N[C@H]1CC[C@H](N2CCC(c3ccccc3OC3CC3)CC2)CC1)c1ccc2c(c1)OCO2 10.1016/j.bmcl.2007.04.098
CHEMBL228333 85598 0 None 4 4 Human 7.9 pKi = 7.9 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 498 7 1 6 4.4 O=S(=O)(N[C@H]1CC[C@H](N2CCC(c3ccccc3OC3CC3)CC2)CC1)c1ccc2c(c1)OCO2 10.1016/j.bmcl.2007.04.098
18738387 163474 0 None -1 2 Human 7.9 pKi = 7.9 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 399 6 0 5 3.6 COc1ccccc1N1CCN(Cc2ccc(CN3CCCCC3=O)s2)CC1 10.1016/s0960-894x(02)00347-5
CHEMBL420184 163474 0 None -1 2 Human 7.9 pKi = 7.9 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 399 6 0 5 3.6 COc1ccccc1N1CCN(Cc2ccc(CN3CCCCC3=O)s2)CC1 10.1016/s0960-894x(02)00347-5
16041628 155326 0 None -1 4 Human 7.9 pKi = 7.9 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 472 6 2 4 5.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3ccc(F)cc3F)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL403280 155326 0 None -1 4 Human 7.9 pKi = 7.9 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 472 6 2 4 5.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3ccc(F)cc3F)CC2)CC1 10.1016/j.bmcl.2007.11.068
49865640 16002 0 None 2 3 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 324 7 1 4 3.4 Cc1ccccc1N1CCN(CCCCNc2ccccn2)CC1 10.1016/j.bmcl.2010.07.096
CHEMBL1223681 16002 0 None 2 3 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 324 7 1 4 3.4 Cc1ccccc1N1CCN(CCCCNc2ccccn2)CC1 10.1016/j.bmcl.2010.07.096
57390117 69270 0 None 16 5 Pig 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 455 13 1 6 3.2 CCOCCOCc1ccc(C(=O)NCCCN2CCN(c3ccccc3OC)CC2)cc1 10.1016/j.bmc.2011.10.063
CHEMBL1928123 69270 0 None 16 5 Pig 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 455 13 1 6 3.2 CCOCCOCc1ccc(C(=O)NCCCN2CCN(c3ccccc3OC)CC2)cc1 10.1016/j.bmc.2011.10.063
145946714 167534 0 None 2 6 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 398 9 0 5 3.8 COc1ccccc1N1CCN(CCOCCOc2cc(C)cc(C)c2C)CC1 10.1016/j.bmcl.2018.04.059
CHEMBL4213352 167534 0 None 2 6 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 398 9 0 5 3.8 COc1ccccc1N1CCN(CCOCCOc2cc(C)cc(C)c2C)CC1 10.1016/j.bmcl.2018.04.059
CHEMBL4300399 167534 0 None 2 6 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 398 9 0 5 3.8 COc1ccccc1N1CCN(CCOCCOc2cc(C)cc(C)c2C)CC1 10.1016/j.bmcl.2018.04.059
10578735 121094 0 None 28 3 Human 7.9 pKi = 7.9 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 557 8 2 7 3.4 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccc(OC)cc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL357439 121094 0 None 28 3 Human 7.9 pKi = 7.9 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 557 8 2 7 3.4 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccc(OC)cc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
53328508 63367 0 None 4 3 Human 7.9 pKi = 7.9 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 466 8 0 7 3.0 COc1ccccc1N1CCN(CCCN2C(=O)CC(c3ccc([N+](=O)[O-])cc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796042 63367 0 None 4 3 Human 7.9 pKi = 7.9 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 466 8 0 7 3.0 COc1ccccc1N1CCN(CCCN2C(=O)CC(c3ccc([N+](=O)[O-])cc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
44431620 87038 0 None -102 4 Human 7.8 pKi = 7.8 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 570 7 1 6 4.7 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3cnc(Cl)c(Br)c3)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL232609 87038 0 None -102 4 Human 7.8 pKi = 7.8 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 570 7 1 6 4.7 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3cnc(Cl)c(Br)c3)CC2)CC1 10.1016/j.bmcl.2007.04.008
11782656 29052 0 None -75 6 Human 7.8 pKi = 7.8 Binding
Binding affinity was determined on human cloned Alpha-1A adrenoceptorBinding affinity was determined on human cloned Alpha-1A adrenoceptor
ChEMBL 336 9 1 4 3.8 COc1cccc2c(CCCNCCOc3ccccn3)cccc12 10.1021/jm010866v
CHEMBL138109 29052 0 None -75 6 Human 7.8 pKi = 7.8 Binding
Binding affinity was determined on human cloned Alpha-1A adrenoceptorBinding affinity was determined on human cloned Alpha-1A adrenoceptor
ChEMBL 336 9 1 4 3.8 COc1cccc2c(CCCNCCOc3ccccn3)cccc12 10.1021/jm010866v
10793963 99644 0 None 9 6 Human 7.8 pKi = 7.8 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 622 11 2 7 6.8 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
CHEMBL284470 99644 0 None 9 6 Human 7.8 pKi = 7.8 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 622 11 2 7 6.8 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
10793963 85241 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 622 11 2 7 6.0 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
CHEMBL2260147 85241 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 622 11 2 7 6.0 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
9838192 111285 18 None -2 6 Rat 6.9 pKi = 6.9 Binding
Binding affinity towards rat submaxillary gland Alpha-1 adrenergic receptor; value ranges from (0.12 - 0.15)Binding affinity towards rat submaxillary gland Alpha-1 adrenergic receptor; value ranges from (0.12 - 0.15)
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1021/jm025550h
CHEMBL326702 111285 18 None -2 6 Rat 6.9 pKi = 6.9 Binding
Binding affinity towards rat submaxillary gland Alpha-1 adrenergic receptor; value ranges from (0.12 - 0.15)Binding affinity towards rat submaxillary gland Alpha-1 adrenergic receptor; value ranges from (0.12 - 0.15)
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1021/jm025550h
9938248 102179 0 None -1 3 Human 6.9 pKi = 6.9 Binding
Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)
ChEMBL 580 2 4 3 6.0 CN1C[C@H](c2c[nH]c3c(Br)c(Br)cc(O)c23)NC[C@H]1c1c[nH]c2cc(Br)ccc12 10.1016/0960-894X(96)00376-9
CHEMBL302882 102179 0 None -1 3 Human 6.9 pKi = 6.9 Binding
Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)
ChEMBL 580 2 4 3 6.0 CN1C[C@H](c2c[nH]c3c(Br)c(Br)cc(O)c23)NC[C@H]1c1c[nH]c2cc(Br)ccc12 10.1016/0960-894X(96)00376-9
12909388 61026 0 None 14 2 Bovine 6.9 pKi = 6.9 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 303 0 0 3 3.4 CN1CCC(=C2c3cc(C#N)ccc3CCn3cccc32)CC1 10.1021/jm00361a008
CHEMBL176365 61026 0 None 14 2 Bovine 6.9 pKi = 6.9 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 303 0 0 3 3.4 CN1CCC(=C2c3cc(C#N)ccc3CCn3cccc32)CC1 10.1021/jm00361a008
6604117 187823 6 None -1 6 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from alpha-1A adrenergic receptor (unknown origin)Displacement of [3H]prazosin from alpha-1A adrenergic receptor (unknown origin)
ChEMBL 325 5 2 3 3.8 C[C@@H]([C@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1021/acs.jmedchem.0c01912
CHEMBL2062340 187823 6 None -1 6 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from alpha-1A adrenergic receptor (unknown origin)Displacement of [3H]prazosin from alpha-1A adrenergic receptor (unknown origin)
ChEMBL 325 5 2 3 3.8 C[C@@H]([C@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1021/acs.jmedchem.0c01912
CHEMBL49623 187823 6 None -1 6 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from alpha-1A adrenergic receptor (unknown origin)Displacement of [3H]prazosin from alpha-1A adrenergic receptor (unknown origin)
ChEMBL 325 5 2 3 3.8 C[C@@H]([C@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1021/acs.jmedchem.0c01912
122187555 123029 0 None -3 2 Rat 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 324 5 1 1 5.7 c1ccc2c(C3CCN(CCCC4CCCCC4)CC3)c[nH]c2c1 10.1016/j.bmcl.2015.07.046
CHEMBL3609352 123029 0 None -3 2 Rat 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 324 5 1 1 5.7 c1ccc2c(C3CCN(CCCC4CCCCC4)CC3)c[nH]c2c1 10.1016/j.bmcl.2015.07.046
9845181 208138 3 None -1445 14 Human 4.9 pKi = 4.9 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 423 4 0 4 3.3 C[C@H](CN1CCN(c2cc(F)c(F)cc2F)CC1)N1C(=O)CC2(CCCC2)CC1=O 10.1021/jm0491391
CHEMBL98241 208138 3 None -1445 14 Human 4.9 pKi = 4.9 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 423 4 0 4 3.3 C[C@H](CN1CCN(c2cc(F)c(F)cc2F)CC1)N1C(=O)CC2(CCCC2)CC1=O 10.1021/jm0491391
44314198 104385 0 None -95 4 Human 6.9 pKi = 6.9 Binding
Binding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 210 3 1 3 2.3 CCC[C@H]1CCCCC1NC1=NCCO1 10.1016/0960-894X(94)85032-1
CHEMBL310335 104385 0 None -95 4 Human 6.9 pKi = 6.9 Binding
Binding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 210 3 1 3 2.3 CCC[C@H]1CCCCC1NC1=NCCO1 10.1016/0960-894X(94)85032-1
155557696 176415 0 None -30 4 Human 6.9 pKi = 6.9 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 377 11 2 4 3.8 OCC(CNCCOc1ccccc1)OC(c1ccccc1)c1ccccc1 10.1016/j.ejmech.2019.05.024
CHEMBL4558985 176415 0 None -30 4 Human 6.9 pKi = 6.9 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 377 11 2 4 3.8 OCC(CNCCOc1ccccc1)OC(c1ccccc1)c1ccccc1 10.1016/j.ejmech.2019.05.024
CHEMBL4596295 176415 0 None -30 4 Human 6.9 pKi = 6.9 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 377 11 2 4 3.8 OCC(CNCCOc1ccccc1)OC(c1ccccc1)c1ccccc1 10.1016/j.ejmech.2019.05.024
2477 742 59 None -218 29 Rat 5.9 pKi = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 nan
36 742 59 None -218 29 Rat 5.9 pKi = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 nan
437 742 59 None -218 29 Rat 5.9 pKi = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 nan
CHEMBL49 742 59 None -218 29 Rat 5.9 pKi = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 nan
DB00490 742 59 None -218 29 Rat 5.9 pKi = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 nan
44311789 204712 0 None -1 5 Human 4.9 pKi = 4.9 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 345 1 2 5 3.1 Brc1c(NC2=N[C@@H]3CCCC[C@@H]3N2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
CHEMBL74342 204712 0 None -1 5 Human 4.9 pKi = 4.9 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 345 1 2 5 3.1 Brc1c(NC2=N[C@@H]3CCCC[C@@H]3N2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
92766 106515 35 None 1 6 Human 6.9 pKi = 6.9 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12 10.1021/jm00019a001
CHEMBL31410 106515 35 None 1 6 Human 6.9 pKi = 6.9 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12 10.1021/jm00019a001
191 402 98 None -107 29 Rat 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
201 402 98 None -107 29 Rat 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
2170 402 98 None -107 29 Rat 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
CHEMBL1113 402 98 None -107 29 Rat 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
DB00543 402 98 None -107 29 Rat 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
10804826 23583 2 None -1 4 Bovine 5.8 pKi = 5.8 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 309 3 3 5 1.2 CS(=O)(=O)Nc1c(O)ccc2c1CCC[C@@H]2C1=NCCN1 10.1021/jm960354u
CHEMBL133451 23583 2 None -1 4 Bovine 5.8 pKi = 5.8 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 309 3 3 5 1.2 CS(=O)(=O)Nc1c(O)ccc2c1CCC[C@@H]2C1=NCCN1 10.1021/jm960354u
3823 50191 42 None -3019 11 Rat 4.8 pKi = 4.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 530 7 0 7 4.2 CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
76973198 50191 42 None -3019 11 Rat 4.8 pKi = 4.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 530 7 0 7 4.2 CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
CHEMBL157101 50191 42 None -3019 11 Rat 4.8 pKi = 4.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 530 7 0 7 4.2 CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
44582676 189755 0 None -1 17 Human 6.8 pKi = 6.8 Binding
Inhibition of human cloned alpha1A adrenergic receptor by competitive binding experimentInhibition of human cloned alpha1A adrenergic receptor by competitive binding experiment
ChEMBL 403 9 0 4 4.3 COc1c(OCCF)cccc1C(=O)C1CCN(CCc2ccc(F)cc2)CC1 10.1016/j.bmc.2009.03.021
CHEMBL516088 189755 0 None -1 17 Human 6.8 pKi = 6.8 Binding
Inhibition of human cloned alpha1A adrenergic receptor by competitive binding experimentInhibition of human cloned alpha1A adrenergic receptor by competitive binding experiment
ChEMBL 403 9 0 4 4.3 COc1c(OCCF)cccc1C(=O)C1CCN(CCc2ccc(F)cc2)CC1 10.1016/j.bmc.2009.03.021
19085836 205642 0 None 6 3 Human 6.8 pKi = 6.8 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 469 6 0 7 3.2 Cc1cccc2oc(=O)n(C3CCN(CCCCN4C(=O)c5ccccc5S4(=O)=O)CC3)c12 10.1016/s0960-894x(98)00446-6
CHEMBL82056 205642 0 None 6 3 Human 6.8 pKi = 6.8 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 469 6 0 7 3.2 Cc1cccc2oc(=O)n(C3CCN(CCCCN4C(=O)c5ccccc5S4(=O)=O)CC3)c12 10.1016/s0960-894x(98)00446-6
11140345 204148 0 None 1 6 Human 6.8 pKi = 6.8 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 239 4 2 4 2.0 CSc1c(F)cccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL70692 204148 0 None 1 6 Human 6.8 pKi = 6.8 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 239 4 2 4 2.0 CSc1c(F)cccc1NCC1=NCCN1 10.1021/jm000542r
9900133 8953 0 None -1 4 Bovine 6.8 pKi = 6.8 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assay
ChEMBL 271 2 2 3 3.1 COC(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL109827 8953 0 None -1 4 Bovine 6.8 pKi = 6.8 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assay
ChEMBL 271 2 2 3 3.1 COC(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
185076 187066 5 None -389 7 Human 5.8 pKi = 5.8 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 227 1 2 5 1.3 Cc1c(NC2=NCCN2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
CHEMBL49137 187066 5 None -389 7 Human 5.8 pKi = 5.8 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 227 1 2 5 1.3 Cc1c(NC2=NCCN2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
13298529 101192 57 None -134 2 Bovine 5.8 pKi = 5.8 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 241 1 1 3 1.3 Brc1cccnc1N1CCNCC1 10.1021/jm00366a007
CHEMBL295921 101192 57 None -134 2 Bovine 5.8 pKi = 5.8 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 241 1 1 3 1.3 Brc1cccnc1N1CCNCC1 10.1021/jm00366a007
11464777 101778 0 None -363 5 Human 6.8 pKi = 6.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 437 4 0 4 4.2 CC(CN1CCN(c2cc(Cl)ccc2Cl)CC1)N1C(=O)CC2(CCCC2)CC1=O 10.1007/s00044-010-9379-1
CHEMBL300152 101778 0 None -363 5 Human 6.8 pKi = 6.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 437 4 0 4 4.2 CC(CN1CCN(c2cc(Cl)ccc2Cl)CC1)N1C(=O)CC2(CCCC2)CC1=O 10.1007/s00044-010-9379-1
9845181 208138 3 None -1445 14 Human 4.8 pKi = 4.8 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 423 4 0 4 3.3 C[C@H](CN1CCN(c2cc(F)c(F)cc2F)CC1)N1C(=O)CC2(CCCC2)CC1=O 10.1016/s0960-894x(01)00159-7
CHEMBL98241 208138 3 None -1445 14 Human 4.8 pKi = 4.8 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 423 4 0 4 3.3 C[C@H](CN1CCN(c2cc(F)c(F)cc2F)CC1)N1C(=O)CC2(CCCC2)CC1=O 10.1016/s0960-894x(01)00159-7
44433348 167325 0 None 1 4 Human 7.8 pKi = 7.8 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 545 10 0 7 4.6 CCN([C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1)S(=O)(=O)c1ccc(OC)c(OC)c1 10.1016/j.bmcl.2007.09.051
CHEMBL429453 167325 0 None 1 4 Human 7.8 pKi = 7.8 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 545 10 0 7 4.6 CCN([C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1)S(=O)(=O)c1ccc(OC)c(OC)c1 10.1016/j.bmcl.2007.09.051
135398737 955 93 None -5 92 Rat 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
38 955 93 None -5 92 Rat 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
722 955 93 None -5 92 Rat 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
CHEMBL42 955 93 None -5 92 Rat 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
DB00363 955 93 None -5 92 Rat 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
44460423 205593 0 None 11 3 Human 7.8 pKi = 7.8 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 446 7 0 6 4.3 O=C1CCCCN1Cc1cc(CN2CCN(c3ccccc3Oc3ccccc3)CC2)on1 10.1016/s0960-894x(02)00436-5
CHEMBL81661 205593 0 None 11 3 Human 7.8 pKi = 7.8 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 446 7 0 6 4.3 O=C1CCCCN1Cc1cc(CN2CCN(c3ccccc3Oc3ccccc3)CC2)on1 10.1016/s0960-894x(02)00436-5
44431184 92821 0 None -2 3 Human 7.8 pKi = 7.8 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 515 5 0 5 5.5 CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4ccc5ccc(F)cc5c4C3=O)CC2)CC1 10.1016/j.bmcl.2006.12.111
CHEMBL243866 92821 0 None -2 3 Human 7.8 pKi = 7.8 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 515 5 0 5 5.5 CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4ccc5ccc(F)cc5c4C3=O)CC2)CC1 10.1016/j.bmcl.2006.12.111
44295218 189078 0 None 22 3 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 582 8 2 7 3.5 COC(=O)C1(c2ccccc2)CCN(CCCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc(F)c(F)c2)CC1 10.1016/s0960-894x(99)00653-8
CHEMBL51019 189078 0 None 22 3 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 582 8 2 7 3.5 COC(=O)C1(c2ccccc2)CCN(CCCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc(F)c(F)c2)CC1 10.1016/s0960-894x(99)00653-8
145947937 167699 0 None -3 6 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 398 9 0 5 3.8 COc1ccccc1N1CCN(CCOCCOc2c(C)cc(C)cc2C)CC1 10.1016/j.bmcl.2018.04.059
CHEMBL4207653 167699 0 None -3 6 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 398 9 0 5 3.8 COc1ccccc1N1CCN(CCOCCOc2c(C)cc(C)cc2C)CC1 10.1016/j.bmcl.2018.04.059
CHEMBL4302655 167699 0 None -3 6 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 398 9 0 5 3.8 COc1ccccc1N1CCN(CCOCCOc2c(C)cc(C)cc2C)CC1 10.1016/j.bmcl.2018.04.059
44447070 94616 0 None -9 4 Rat 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 500 6 1 5 5.2 O=C(NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21)c1ccc(F)cc1 10.1016/j.bmcl.2007.11.106
CHEMBL252429 94616 0 None -9 4 Rat 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 500 6 1 5 5.2 O=C(NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21)c1ccc(F)cc1 10.1016/j.bmcl.2007.11.106
124 2960 47 None -19 33 Human 7.8 pKi = 7.8 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm000542r
2032 2960 47 None -19 33 Human 7.8 pKi = 7.8 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm000542r
4636 2960 47 None -19 33 Human 7.8 pKi = 7.8 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm000542r
CHEMBL762 2960 47 None -19 33 Human 7.8 pKi = 7.8 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm000542r
DB00935 2960 47 None -19 33 Human 7.8 pKi = 7.8 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm000542r
CHEMBL5270515 194586 0 None -39 3 Human 7.8 pKi = 7.8 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 452 8 1 5 3.6 CCC(=O)NCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
CHEMBL5315265 194586 0 None -39 3 Human 7.8 pKi = 7.8 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 452 8 1 5 3.6 CCC(=O)NCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
52937222 61291 0 None -15 4 Human 7.8 pKi = 7.8 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 367 3 0 4 3.9 CN1CCC(n2nc(Cc3ccc(Cl)cc3)c3ccccc3c2=O)CC1 10.1021/jm1013874
CHEMBL1767156 61291 0 None -15 4 Human 7.8 pKi = 7.8 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 367 3 0 4 3.9 CN1CCC(n2nc(Cc3ccc(Cl)cc3)c3ccccc3c2=O)CC1 10.1021/jm1013874
10089254 99953 0 None 12 3 Human 7.8 pKi = 7.8 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 350 7 1 3 3.5 O=C(CCCN1CCC(NC(=O)c2ccccc2)CC1)c1ccccc1 10.1021/jm960697s
CHEMBL286591 99953 0 None 12 3 Human 7.8 pKi = 7.8 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 350 7 1 3 3.5 O=C(CCCN1CCC(NC(=O)c2ccccc2)CC1)c1ccccc1 10.1021/jm960697s
53328314 63359 0 None 1 3 Human 7.8 pKi = 7.8 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 439 7 0 4 4.2 O=C1CC(c2ccccc2)CC(=O)N1CCCCN1CCN(c2ccccc2Cl)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796034 63359 0 None 1 3 Human 7.8 pKi = 7.8 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 439 7 0 4 4.2 O=C1CC(c2ccccc2)CC(=O)N1CCCCN1CCN(c2ccccc2Cl)CC1 10.1016/j.ejmech.2011.03.054
144096995 164472 0 None -17 3 Human 6.8 pKi = 6.8 Binding
Displacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting methodDisplacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting method
ChEMBL 371 8 1 4 3.1 CS(=O)(=O)c1ccccc1CCNCCOc1cc(F)ccc1Cl 10.1016/j.ejmech.2017.07.071
CHEMBL4214499 164472 0 None -17 3 Human 6.8 pKi = 6.8 Binding
Displacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting methodDisplacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting method
ChEMBL 371 8 1 4 3.1 CS(=O)(=O)c1ccccc1CCNCCOc1cc(F)ccc1Cl 10.1016/j.ejmech.2017.07.071
173712 124295 20 None -8 3 Human 6.8 pKi = 6.8 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptor
ChEMBL 391 6 1 3 4.9 O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(Cl)cc1 10.1021/jm060383x
CHEMBL363548 124295 20 None -8 3 Human 6.8 pKi = 6.8 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptor
ChEMBL 391 6 1 3 4.9 O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(Cl)cc1 10.1021/jm060383x
1862 161 18 None -1 7 Human 5.8 pKi = 5.8 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
ChEMBL 187 2 4 4 0.2 NCC(c1cc(O)c(cc1F)O)O 10.1021/jm00118a019
510 161 18 None -1 7 Human 5.8 pKi = 5.8 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
ChEMBL 187 2 4 4 0.2 NCC(c1cc(O)c(cc1F)O)O 10.1021/jm00118a019
CHEMBL281232 161 18 None -1 7 Human 5.8 pKi = 5.8 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
ChEMBL 187 2 4 4 0.2 NCC(c1cc(O)c(cc1F)O)O 10.1021/jm00118a019
1960 2838 67 None -57 26 Human 5.8 pKi = 5.8 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
439260 2838 67 None -57 26 Human 5.8 pKi = 5.8 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
505 2838 67 None -57 26 Human 5.8 pKi = 5.8 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
CHEMBL1437 2838 67 None -57 26 Human 5.8 pKi = 5.8 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
DB00368 2838 67 None -57 26 Human 5.8 pKi = 5.8 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
18738412 205386 0 None 2 3 Human 5.8 pKi = 5.8 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 365 6 1 6 3.3 OCc1cc(CN2CCN(c3ccccc3Oc3ccccc3)CC2)on1 10.1016/s0960-894x(02)00436-5
CHEMBL80125 205386 0 None 2 3 Human 5.8 pKi = 5.8 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 365 6 1 6 3.3 OCc1cc(CN2CCN(c3ccccc3Oc3ccccc3)CC2)on1 10.1016/s0960-894x(02)00436-5
6603915 99954 30 None -446 3 Human 6.8 pKi = 6.8 Binding
Binding affinity to alpha1A receptorBinding affinity to alpha1A receptor
ChEMBL 434 7 0 5 3.7 COc1ccccc1N1CCN(CCN(C(=O)c2ccc(F)cc2)c2ccccn2)CC1 10.1016/j.ejmech.2011.06.023
CHEMBL1775000 99954 30 None -446 3 Human 6.8 pKi = 6.8 Binding
Binding affinity to alpha1A receptorBinding affinity to alpha1A receptor
ChEMBL 434 7 0 5 3.7 COc1ccccc1N1CCN(CCN(C(=O)c2ccc(F)cc2)c2ccccn2)CC1 10.1016/j.ejmech.2011.06.023
CHEMBL286607 99954 30 None -446 3 Human 6.8 pKi = 6.8 Binding
Binding affinity to alpha1A receptorBinding affinity to alpha1A receptor
ChEMBL 434 7 0 5 3.7 COc1ccccc1N1CCN(CCN(C(=O)c2ccc(F)cc2)c2ccccn2)CC1 10.1016/j.ejmech.2011.06.023
2803 952 58 None -3 19 Rat 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
516 952 58 None -3 19 Rat 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
704 952 58 None -3 19 Rat 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
CHEMBL134 952 58 None -3 19 Rat 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
DB00575 952 58 None -3 19 Rat 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
11464777 101778 0 None -363 5 Human 6.8 pKi = 6.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 437 4 0 4 4.2 CC(CN1CCN(c2cc(Cl)ccc2Cl)CC1)N1C(=O)CC2(CCCC2)CC1=O 10.1007/s00044-010-9379-1
CHEMBL300152 101778 0 None -363 5 Human 6.8 pKi = 6.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 437 4 0 4 4.2 CC(CN1CCN(c2cc(Cl)ccc2Cl)CC1)N1C(=O)CC2(CCCC2)CC1=O 10.1007/s00044-010-9379-1
1220 187 55 None -407 45 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1016/j.bmcl.2010.01.030
31 187 55 None -407 45 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1016/j.bmcl.2010.01.030
7 187 55 None -407 45 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1016/j.bmcl.2010.01.030
CHEMBL56 187 55 None -407 45 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1016/j.bmcl.2010.01.030
1220 187 55 None -407 45 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm200421e
31 187 55 None -407 45 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm200421e
7 187 55 None -407 45 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm200421e
CHEMBL56 187 55 None -407 45 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm200421e
11201573 197634 0 None -3 2 Rat 5.8 pKi = 5.8 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 442 5 0 6 1.6 COc1ccccc1N1CCN(CCN2C(=O)CC3(CCN(C(C)=O)CC3)CC2=O)CC1 10.1021/jm030944+
CHEMBL57097 197634 0 None -3 2 Rat 5.8 pKi = 5.8 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 442 5 0 6 1.6 COc1ccccc1N1CCN(CCN2C(=O)CC3(CCN(C(C)=O)CC3)CC2=O)CC1 10.1021/jm030944+
127027077 137755 0 None -7585 3 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 403 7 2 4 3.9 O=C(NCCCCN1CCN(c2cccc(O)c2)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
CHEMBL3759491 137755 0 None -7585 3 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 403 7 2 4 3.9 O=C(NCCCCN1CCN(c2cccc(O)c2)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
10768423 101300 0 None 1 3 Rat 6.8 pKi = 6.8 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 525 5 1 8 4.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5nc(-c6ccccc6)cnc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL296711 101300 0 None 1 3 Rat 6.8 pKi = 6.8 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 525 5 1 8 4.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5nc(-c6ccccc6)cnc54)c3=O)C[C@@H]21 10.1021/jm990567u
16040907 97855 0 None -2 4 Human 6.8 pKi = 6.8 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 466 7 2 5 4.7 COc1ccccc1NC(=O)NC1CCC(N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL272340 97855 0 None -2 4 Human 6.8 pKi = 6.8 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 466 7 2 5 4.7 COc1ccccc1NC(=O)NC1CCC(N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.11.068
10577609 26955 0 None -10 3 Rat 6.8 pKi = 6.8 Binding
The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.
ChEMBL 509 8 1 9 3.5 COc1cc2nc(N3CCN(C(=O)C(C)Oc4c(OC)cccc4C(C)C)CC3)nc(N)c2cc1OC 10.1021/jm9805337
CHEMBL136458 26955 0 None -10 3 Rat 6.8 pKi = 6.8 Binding
The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.
ChEMBL 509 8 1 9 3.5 COc1cc2nc(N3CCN(C(=O)C(C)Oc4c(OC)cccc4C(C)C)CC3)nc(N)c2cc1OC 10.1021/jm9805337
3952 1875 38 None -26 12 Rat 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
5353646 1875 38 None -26 12 Rat 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
5443 1875 38 None -26 12 Rat 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
5702063 1875 38 None -26 12 Rat 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
CHEMBL1331786 1875 38 None -26 12 Rat 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
CHEMBL420 1875 38 None -26 12 Rat 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
127027080 137828 0 None -45 3 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 443 7 3 4 3.3 O=C(NCCCCN1CCN(c2cccc3[nH]c(=O)[nH]c23)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
CHEMBL3760110 137828 0 None -45 3 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 443 7 3 4 3.3 O=C(NCCCCN1CCN(c2cccc3[nH]c(=O)[nH]c23)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
11152823 165235 0 None -1 3 Human 6.8 pKi = 6.8 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 367 5 2 6 2.6 COc1cc2nc3c(c(N)c2cc1OC)CC(CNC(=O)c1ccco1)C3 10.1021/jm030952q
CHEMBL423018 165235 0 None -1 3 Human 6.8 pKi = 6.8 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 367 5 2 6 2.6 COc1cc2nc3c(c(N)c2cc1OC)CC(CNC(=O)c1ccco1)C3 10.1021/jm030952q
76333281 84796 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 367 5 2 6 2.6 COc1cc2nc3c(c(N)c2cc1OC)CC(CNC(=O)c1ccoc1)C3 10.1007/s00044-010-9379-1
CHEMBL2234450 84796 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 367 5 2 6 2.6 COc1cc2nc3c(c(N)c2cc1OC)CC(CNC(=O)c1ccoc1)C3 10.1007/s00044-010-9379-1
11273296 170272 0 None 6 3 Rat 6.8 pKi = 6.8 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 586 11 1 8 2.9 CCOC(=O)CN1C(=O)N(CC(O)CN2CCN(c3ccccc3OC)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
CHEMBL444648 170272 0 None 6 3 Rat 6.8 pKi = 6.8 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 586 11 1 8 2.9 CCOC(=O)CN1C(=O)N(CC(O)CN2CCN(c3ccccc3OC)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
203096 61269 3 None -630 3 Human 6.8 pKi = 6.8 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 341 5 0 4 3.2 CN(C)CCn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/jm1013874
CHEMBL1767134 61269 3 None -630 3 Human 6.8 pKi = 6.8 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 341 5 0 4 3.2 CN(C)CCn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/jm1013874
45358442 61293 0 None -63 3 Human 6.8 pKi = 6.8 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 381 3 0 4 4.3 CN1CCCCC(n2nc(Cc3ccc(Cl)cc3)c3ccccc3c2=O)C1 10.1021/jm1013874
CHEMBL1767158 61293 0 None -63 3 Human 6.8 pKi = 6.8 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 381 3 0 4 4.3 CN1CCCCC(n2nc(Cc3ccc(Cl)cc3)c3ccccc3c2=O)C1 10.1021/jm1013874
24803799 61296 0 None -79 4 Human 6.8 pKi = 6.8 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 654 13 0 6 8.3 O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C1CCCN(CCCCc2ccc(OCCCN3CCCCCC3)cc2)CC1 10.1021/jm1013874
CHEMBL1767161 61296 0 None -79 4 Human 6.8 pKi = 6.8 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 654 13 0 6 8.3 O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C1CCCN(CCCCc2ccc(OCCCN3CCCCCC3)cc2)CC1 10.1021/jm1013874
25130875 187603 0 None -4 4 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 343 8 1 5 2.8 COc1ccccc1OCCNC[C@@H]1CO[C@@H](c2ccccc2)CO1 10.1021/jm800461k
CHEMBL494908 187603 0 None -4 4 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 343 8 1 5 2.8 COc1ccccc1OCCNC[C@@H]1CO[C@@H](c2ccccc2)CO1 10.1021/jm800461k
52937730 61282 0 None -794 3 Human 5.8 pKi = 5.8 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 363 5 0 5 3.1 COc1cccc(Cc2nn(C[C@H]3CCCN3C)c(=O)c3ccccc23)c1 10.1021/jm1013874
CHEMBL1767147 61282 0 None -794 3 Human 5.8 pKi = 5.8 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 363 5 0 5 3.1 COc1cccc(Cc2nn(C[C@H]3CCCN3C)c(=O)c3ccccc23)c1 10.1021/jm1013874
24803480 61298 0 None -199 3 Human 5.8 pKi = 5.8 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 614 15 0 6 7.2 CN(CCCCc1ccc(OCCCN2CCCCCC2)cc1)CCn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/jm1013874
CHEMBL1767163 61298 0 None -199 3 Human 5.8 pKi = 5.8 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 614 15 0 6 7.2 CN(CCCCc1ccc(OCCCN2CCCCCC2)cc1)CCn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/jm1013874
153287574 175223 0 None -21 10 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]-Prazosin from human recombinant adrenergic alpha1A receptor expressed in cells after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Prazosin from human recombinant adrenergic alpha1A receptor expressed in cells after 90 mins by microbeta scintillation counting method
ChEMBL 266 2 1 2 4.0 CC[C@H]1c2ccccc2N(c2ccccc2)C[C@@]1(C)N 10.1021/acsmedchemlett.9b00225
CHEMBL4572167 175223 0 None -21 10 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]-Prazosin from human recombinant adrenergic alpha1A receptor expressed in cells after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Prazosin from human recombinant adrenergic alpha1A receptor expressed in cells after 90 mins by microbeta scintillation counting method
ChEMBL 266 2 1 2 4.0 CC[C@H]1c2ccccc2N(c2ccccc2)C[C@@]1(C)N 10.1021/acsmedchemlett.9b00225
11857863 85649 0 None -1 4 Human 7.8 pKi = 7.8 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 534 9 1 6 5.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccc(F)cc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
CHEMBL228608 85649 0 None -1 4 Human 7.8 pKi = 7.8 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 534 9 1 6 5.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccc(F)cc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
44426404 142541 0 None -1 4 Human 7.8 pKi = 7.8 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 498 7 1 6 4.4 O=S(=O)(N[C@H]1CC[C@@H](N2CCC(c3ccccc3OC3CC3)CC2)CC1)c1ccc2c(c1)OCO2 10.1016/j.bmcl.2007.04.098
CHEMBL389104 142541 0 None -1 4 Human 7.8 pKi = 7.8 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 498 7 1 6 4.4 O=S(=O)(N[C@H]1CC[C@@H](N2CCC(c3ccccc3OC3CC3)CC2)CC1)c1ccc2c(c1)OCO2 10.1016/j.bmcl.2007.04.098
124 2960 47 None -13 33 Rat 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
2032 2960 47 None -13 33 Rat 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
4636 2960 47 None -13 33 Rat 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
CHEMBL762 2960 47 None -13 33 Rat 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
DB00935 2960 47 None -13 33 Rat 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
67753767 123028 1 None -1 2 Rat 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 318 5 1 1 5.0 c1ccc(CCCN2CCC(c3c[nH]c4ccccc34)CC2)cc1 10.1016/j.bmcl.2015.07.046
CHEMBL3609351 123028 1 None -1 2 Rat 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 318 5 1 1 5.0 c1ccc(CCCN2CCC(c3c[nH]c4ccccc34)CC2)cc1 10.1016/j.bmcl.2015.07.046
56649648 67826 0 None -47 8 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assayDisplacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assay
ChEMBL 474 8 0 5 3.0 COc1ccccc1N1CCN(CCN(C(=O)C23C4C5C2C2C3C4C52CF)c2ccccn2)CC1 10.1016/j.ejmech.2011.06.023
CHEMBL1910139 67826 0 None -47 8 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assayDisplacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assay
ChEMBL 474 8 0 5 3.0 COc1ccccc1N1CCN(CCN(C(=O)C23C4C5C2C2C3C4C52CF)c2ccccn2)CC1 10.1016/j.ejmech.2011.06.023
10816903 37663 0 None 32 3 Human 7.8 pKi = 7.8 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 571 8 2 7 3.7 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccc(OC)cc3C)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL145756 37663 0 None 32 3 Human 7.8 pKi = 7.8 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 571 8 2 7 3.7 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccc(OC)cc3C)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
13507646 119588 0 None -3 2 Bovine 7.8 pKi = 7.8 Binding
Affinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranesAffinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranes
ChEMBL 243 0 0 2 4.0 c1ccc2c3c(sc2c1)C1CCCCN1CC3 10.1021/jm00398a025
CHEMBL346492 119588 0 None -3 2 Bovine 7.8 pKi = 7.8 Binding
Affinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranesAffinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranes
ChEMBL 243 0 0 2 4.0 c1ccc2c3c(sc2c1)C1CCCCN1CC3 10.1021/jm00398a025
11801828 206521 0 None 35 6 Human 7.8 pKi = 7.8 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 606 9 3 6 5.0 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2 10.1021/jm980077m
CHEMBL88628 206521 0 None 35 6 Human 7.8 pKi = 7.8 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 606 9 3 6 5.0 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2 10.1021/jm980077m
11801828 206521 0 None 35 6 Human 7.8 pKi = 7.8 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 606 9 3 6 5.0 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2 10.1007/s00044-004-0120-9
CHEMBL88628 206521 0 None 35 6 Human 7.8 pKi = 7.8 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 606 9 3 6 5.0 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2 10.1007/s00044-004-0120-9
13507646 119588 0 None -3 2 Bovine 7.8 pKi = 7.8 Binding
Compound was evaluated for log 1/Ki at alpha-1 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-1 adrenergic receptor
ChEMBL 243 0 0 2 4.0 c1ccc2c3c(sc2c1)C1CCCCN1CC3 10.1021/jm00398a025
CHEMBL346492 119588 0 None -3 2 Bovine 7.8 pKi = 7.8 Binding
Compound was evaluated for log 1/Ki at alpha-1 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-1 adrenergic receptor
ChEMBL 243 0 0 2 4.0 c1ccc2c3c(sc2c1)C1CCCCN1CC3 10.1021/jm00398a025
11994669 11798 0 None 3 4 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 391 8 1 5 4.2 COc1ccc(-c2ccccc2)cc1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL1182141 11798 0 None 3 4 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 391 8 1 5 4.2 COc1ccc(-c2ccccc2)cc1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL214552 11798 0 None 3 4 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 391 8 1 5 4.2 COc1ccc(-c2ccccc2)cc1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
52942664 17612 0 None 1 3 Rat 7.8 pKi = 7.8 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 500 8 2 6 2.7 COc1ccccc1N1CCN(CC(O)CN2C(=O)NC(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
CHEMBL1258345 17612 0 None 1 3 Rat 7.8 pKi = 7.8 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 500 8 2 6 2.7 COc1ccccc1N1CCN(CC(O)CN2C(=O)NC(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
10621590 84577 0 None -1 4 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2cccc(OC)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153554 84577 0 None -1 4 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2cccc(OC)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2221148 84577 0 None -1 4 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2cccc(OC)c2O1 10.1016/j.ejmech.2012.09.049
25181488 187358 0 None -33 4 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 419 9 1 5 4.0 COc1ccccc1OCCNC[C@@H]1COCC(c2ccccc2)(c2ccccc2)O1 10.1021/jm301525w
CHEMBL493486 187358 0 None -33 4 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 419 9 1 5 4.0 COc1ccccc1OCCNC[C@@H]1COCC(c2ccccc2)(c2ccccc2)O1 10.1021/jm301525w
71151588 118232 0 None -169 10 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in CHO cells
ChEMBL 518 9 1 7 3.6 NC(=O)c1ccccc1OCCCN1CCN(c2cccc3c2ccn3S(=O)(=O)c2ccccc2)CC1 10.1016/j.ejmech.2014.12.045
CHEMBL3409256 118232 0 None -169 10 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in CHO cells
ChEMBL 518 9 1 7 3.6 NC(=O)c1ccccc1OCCCN1CCN(c2cccc3c2ccn3S(=O)(=O)c2ccccc2)CC1 10.1016/j.ejmech.2014.12.045
14468881 176259 0 None -14 4 Human 7.8 pKi = 7.8 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 347 10 1 3 4.5 c1ccc(OCCNCCOC(c2ccccc2)c2ccccc2)cc1 10.1016/j.ejmech.2019.05.024
CHEMBL4462600 176259 0 None -14 4 Human 7.8 pKi = 7.8 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 347 10 1 3 4.5 c1ccc(OCCNCCOC(c2ccccc2)c2ccccc2)cc1 10.1016/j.ejmech.2019.05.024
CHEMBL4595111 176259 0 None -14 4 Human 7.8 pKi = 7.8 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 347 10 1 3 4.5 c1ccc(OCCNCCOC(c2ccccc2)c2ccccc2)cc1 10.1016/j.ejmech.2019.05.024
71817859 102552 0 None 1 4 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 357 7 1 6 2.4 COc1ccc2c(c1OCCNC[C@@H]1COc3ccccc3O1)OCC2 10.1021/jm400867d
CHEMBL2419772 102552 0 None 1 4 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 357 7 1 6 2.4 COc1ccc2c(c1OCCNC[C@@H]1COc3ccccc3O1)OCC2 10.1021/jm400867d
CHEMBL3040801 102552 0 None 1 4 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 357 7 1 6 2.4 COc1ccc2c(c1OCCNC[C@@H]1COc3ccccc3O1)OCC2 10.1021/jm400867d
145962945 161319 0 None -14 4 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 511 5 1 7 4.6 COc1cc2nc(N3CCN(C(=O)Cc4ccc5ccccc5c4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
CHEMBL4125846 161319 0 None -14 4 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 511 5 1 7 4.6 COc1cc2nc(N3CCN(C(=O)Cc4ccc5ccccc5c4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
118716699 114805 0 None 1 4 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 348 4 0 6 1.7 COc1ccccc1N1CCN(CC2COC3(CCOCC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3341769 114805 0 None 1 4 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 348 4 0 6 1.7 COc1ccccc1N1CCN(CC2COC3(CCOCC3)O2)CC1 10.1016/j.ejmech.2014.09.070
12203911 188259 22 None -54 2 Bovine 6.8 pKi = 6.8 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 255 1 0 3 1.6 CN1CCN(c2ncccc2Br)CC1 10.1021/jm00366a007
CHEMBL50017 188259 22 None -54 2 Bovine 6.8 pKi = 6.8 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 255 1 0 3 1.6 CN1CCN(c2ncccc2Br)CC1 10.1021/jm00366a007
415628 208169 95 None -13 5 Bovine 6.8 pKi = 6.8 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 196 1 1 2 1.8 Clc1ccccc1N1CCNCC1 10.1021/jm00366a007
CHEMBL9841 208169 95 None -13 5 Bovine 6.8 pKi = 6.8 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 196 1 1 2 1.8 Clc1ccccc1N1CCNCC1 10.1021/jm00366a007
127027384 137653 0 None -100 3 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 480 9 2 5 3.5 CS(=O)(=O)Nc1cccc(N2CCN(CCCCNC(=O)c3ccc4ccccc4c3)CC2)c1 10.1016/j.bmcl.2015.12.068
CHEMBL3758610 137653 0 None -100 3 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 480 9 2 5 3.5 CS(=O)(=O)Nc1cccc(N2CCN(CCCCNC(=O)c3ccc4ccccc4c3)CC2)c1 10.1016/j.bmcl.2015.12.068
11500225 101174 61 None -38 2 Bovine 5.8 pKi = 5.8 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 289 1 1 3 1.1 Ic1cccnc1N1CCNCC1 10.1021/jm00366a007
CHEMBL295764 101174 61 None -38 2 Bovine 5.8 pKi = 5.8 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 289 1 1 3 1.1 Ic1cccnc1N1CCNCC1 10.1021/jm00366a007
44586429 184273 0 None -1 3 Rat 6.8 pKi = 6.8 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 514 8 1 6 3.0 COc1ccccc1N1CCN(CC(O)CN2C(=O)N(C)C(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
CHEMBL484102 184273 0 None -1 3 Rat 6.8 pKi = 6.8 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 514 8 1 6 3.0 COc1ccccc1N1CCN(CC(O)CN2C(=O)N(C)C(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
44361064 31585 0 None -6 6 Bovine 6.8 pKi = 6.8 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 338 7 2 4 4.5 N=CCC(O)CC1CCN(c2ccccc2Oc2ccccc2)CC1 10.1021/jm960510x
CHEMBL140450 31585 0 None -6 6 Bovine 6.8 pKi = 6.8 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 338 7 2 4 4.5 N=CCC(O)CC1CCN(c2ccccc2Oc2ccccc2)CC1 10.1021/jm960510x
11732516 205187 0 None 1 2 Human 6.8 pKi = 6.8 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 418 5 0 7 3.0 COc1ccccc1N1CCN(c2c(C(C)=O)c(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
CHEMBL78584 205187 0 None 1 2 Human 6.8 pKi = 6.8 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 418 5 0 7 3.0 COc1ccccc1N1CCN(c2c(C(C)=O)c(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
9817256 204215 0 None 2 4 Human 5.8 pKi = 5.8 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 283 5 2 6 0.5 COc1ccc(S(C)(=O)=O)c(NCC2=NCCN2)c1 10.1021/jm000542r
CHEMBL71001 204215 0 None 2 4 Human 5.8 pKi = 5.8 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 283 5 2 6 0.5 COc1ccc(S(C)(=O)=O)c(NCC2=NCCN2)c1 10.1021/jm000542r
44586483 172443 0 None 1 3 Rat 6.8 pKi = 6.8 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 600 11 1 8 3.3 CCOc1ccccc1N1CCN(CC(O)CN2C(=O)N(C(C)C(=O)OC)C(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
CHEMBL448198 172443 0 None 1 3 Rat 6.8 pKi = 6.8 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 600 11 1 8 3.3 CCOc1ccccc1N1CCN(CC(O)CN2C(=O)N(C(C)C(=O)OC)C(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
24894141 187385 0 None -30 4 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 449 10 1 6 4.0 COc1cccc(OC)c1OCCNC[C@@H]1COCC(c2ccccc2)(c2ccccc2)O1 10.1021/jm301525w
CHEMBL493697 187385 0 None -30 4 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 449 10 1 6 4.0 COc1cccc(OC)c1OCCNC[C@@H]1COCC(c2ccccc2)(c2ccccc2)O1 10.1021/jm301525w
9944467 9219 0 None 1 4 Rat 6.8 pKi = 6.8 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 309 2 2 2 3.4 O=C(Nc1cccc2c1CCCC2c1c[nH]cn1)C(F)(F)F 10.1021/jm030551a
CHEMBL110751 9219 0 None 1 4 Rat 6.8 pKi = 6.8 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 309 2 2 2 3.4 O=C(Nc1cccc2c1CCCC2c1c[nH]cn1)C(F)(F)F 10.1021/jm030551a
10420352 168716 10 None -63 4 Human 4.8 pKi = 4.8 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
ChEMBL 201 3 4 4 0.5 CNCC(O)c1ccc(O)c(O)c1F 10.1021/jm00118a019
CHEMBL43711 168716 10 None -63 4 Human 4.8 pKi = 4.8 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
ChEMBL 201 3 4 4 0.5 CNCC(O)c1ccc(O)c(O)c1F 10.1021/jm00118a019
24839550 137290 14 None -26 15 Human 5.8 pKi = 5.8 Binding
Binding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 240 7 1 1 3.4 C=CCN(CC=C)CCc1c[nH]c2ccccc12 10.1016/j.bmcl.2015.12.053
CHEMBL3752576 137290 14 None -26 15 Human 5.8 pKi = 5.8 Binding
Binding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 240 7 1 1 3.4 C=CCN(CC=C)CCc1c[nH]c2ccccc12 10.1016/j.bmcl.2015.12.053
127024960 137691 0 None -15 3 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 421 7 1 3 4.8 O=C(NCCCCN1CCN(c2ccc(Cl)cc2)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
CHEMBL3758920 137691 0 None -15 3 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 421 7 1 3 4.8 O=C(NCCCCN1CCN(c2ccc(Cl)cc2)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
11742585 163324 0 None 1 2 Human 5.8 pKi = 5.8 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 415 5 1 6 2.5 CS(=O)(=O)Nc1ccc2c(c1)OC1(CCN(CCc3ccccn3)CC1)CC2=O 10.1016/s0960-894x(98)00732-x
CHEMBL419164 163324 0 None 1 2 Human 5.8 pKi = 5.8 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 415 5 1 6 2.5 CS(=O)(=O)Nc1ccc2c(c1)OC1(CCN(CCc3ccccn3)CC1)CC2=O 10.1016/s0960-894x(98)00732-x
CHEMBL4576555 213994 5 None -1 19 Human 5.8 pKi = 5.8 Binding
Selectivity interaction (GPCR panel (PDSP screen)) EUB0000705a ADRA1ASelectivity interaction (GPCR panel (PDSP screen)) EUB0000705a ADRA1A
ChEMBL None None None CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5cc(C(C)(C)C)cc(C(C)(C)C)c5)ccc4n3)cc2)CC1 10.6019/CHEMBL5212743
76322411 84785 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 375 7 1 4 4.0 c1ccc(OCCNC2COCC(c3ccccc3)(c3ccccc3)O2)cc1 10.1007/s00044-010-9379-1
CHEMBL2234439 84785 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 375 7 1 4 4.0 c1ccc(OCCNC2COCC(c3ccccc3)(c3ccccc3)O2)cc1 10.1007/s00044-010-9379-1
11176459 101610 0 None -181 5 Human 6.8 pKi = 6.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 380 4 0 5 2.4 N#Cc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1007/s00044-010-9379-1
CHEMBL299022 101610 0 None -181 5 Human 6.8 pKi = 6.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 380 4 0 5 2.4 N#Cc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1007/s00044-010-9379-1
155536203 176383 0 None -2 4 Human 6.8 pKi = 6.8 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 403 10 1 4 4.6 c1ccc(OCCNCC[C@@H]2CO[C@H](C(c3ccccc3)c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
CHEMBL4473623 176383 0 None -2 4 Human 6.8 pKi = 6.8 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 403 10 1 4 4.6 c1ccc(OCCNCC[C@@H]2CO[C@H](C(c3ccccc3)c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
CHEMBL4596045 176383 0 None -2 4 Human 6.8 pKi = 6.8 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 403 10 1 4 4.6 c1ccc(OCCNCC[C@@H]2CO[C@H](C(c3ccccc3)c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
25131198 86231 0 None -288 4 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assayDisplacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assay
ChEMBL 389 8 1 4 4.0 c1ccc(OCCNCC2COCC(c3ccccc3)(c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.02.056
CHEMBL2312537 86231 0 None -288 4 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assayDisplacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assay
ChEMBL 389 8 1 4 4.0 c1ccc(OCCNCC2COCC(c3ccccc3)(c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.02.056
25181489 187333 0 None -158 4 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 389 8 1 4 4.0 c1ccc(OCCNC[C@@H]2COCC(c3ccccc3)(c3ccccc3)O2)cc1 10.1021/jm800461k
CHEMBL493285 187333 0 None -158 4 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 389 8 1 4 4.0 c1ccc(OCCNC[C@@H]2COCC(c3ccccc3)(c3ccccc3)O2)cc1 10.1021/jm800461k
25131198 86231 0 None -288 4 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 389 8 1 4 4.0 c1ccc(OCCNCC2COCC(c3ccccc3)(c3ccccc3)O2)cc1 10.1021/jm301525w
CHEMBL2312537 86231 0 None -288 4 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 389 8 1 4 4.0 c1ccc(OCCNCC2COCC(c3ccccc3)(c3ccccc3)O2)cc1 10.1021/jm301525w
76307951 84797 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 453 9 2 8 3.6 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNCOc1c(OC)cccc1OC)C3 10.1007/s00044-010-9379-1
CHEMBL2234451 84797 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 453 9 2 8 3.6 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNCOc1c(OC)cccc1OC)C3 10.1007/s00044-010-9379-1
11784634 36484 0 None -7 3 Human 5.8 pKi = 5.8 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 468 10 2 8 3.7 COc1cc2nc3c(c(O)c2cc1OC)CCC(CNCCOc1c(OC)cccc1OC)C3 10.1021/jm030952q
CHEMBL144779 36484 0 None -7 3 Human 5.8 pKi = 5.8 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 468 10 2 8 3.7 COc1cc2nc3c(c(O)c2cc1OC)CCC(CNCCOc1c(OC)cccc1OC)C3 10.1021/jm030952q
76307951 84797 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 453 9 2 8 3.6 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNCOc1c(OC)cccc1OC)C3 10.1007/s00044-010-9379-1
CHEMBL2234451 84797 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 453 9 2 8 3.6 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNCOc1c(OC)cccc1OC)C3 10.1007/s00044-010-9379-1
9818490 9345 0 None - 1 Rat 5.8 pKi = 5.8 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 319 5 2 3 3.0 CCCS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL111391 9345 0 None - 1 Rat 5.8 pKi = 5.8 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 319 5 2 3 3.0 CCCS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
53328503 63362 0 None -15 3 Human 5.8 pKi = 5.8 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 441 6 0 5 3.4 COc1ccccc1N1CCN(CCN2C(=O)CC(c3ccc(Cl)cc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796037 63362 0 None -15 3 Human 5.8 pKi = 5.8 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 441 6 0 5 3.4 COc1ccccc1N1CCN(CCN2C(=O)CC(c3ccc(Cl)cc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
9818490 9345 0 None - 1 Rat 5.8 pKi = 5.8 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 319 5 2 3 3.0 CCCS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL111391 9345 0 None - 1 Rat 5.8 pKi = 5.8 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 319 5 2 3 3.0 CCCS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
9966903 169389 0 None - 1 Rat 5.8 pKi = 5.8 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 321 4 2 4 2.3 COc1ccc(NS(C)(=O)=O)c2c1C(c1c[nH]cn1)CCC2 10.1021/jm030551a
CHEMBL442394 169389 0 None - 1 Rat 5.8 pKi = 5.8 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 321 4 2 4 2.3 COc1ccc(NS(C)(=O)=O)c2c1C(c1c[nH]cn1)CCC2 10.1021/jm030551a
44431562 87945 0 None 3 4 Human 7.8 pKi = 7.8 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 517 9 1 7 3.9 COc1ccc(OC)c(S(=O)(=O)N[C@H]2CC[C@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)c1 10.1016/j.bmcl.2007.04.008
CHEMBL234194 87945 0 None 3 4 Human 7.8 pKi = 7.8 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 517 9 1 7 3.9 COc1ccc(OC)c(S(=O)(=O)N[C@H]2CC[C@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)c1 10.1016/j.bmcl.2007.04.008
44431557 89249 0 None -8 4 Human 7.8 pKi = 7.8 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 541 8 1 6 4.8 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccc(OC(F)(F)F)cc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL236830 89249 0 None -8 4 Human 7.8 pKi = 7.8 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 541 8 1 6 4.8 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccc(OC(F)(F)F)cc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
49865639 16001 0 None -1 3 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 328 7 1 4 3.2 Fc1ccccc1N1CCN(CCCCNc2ccccn2)CC1 10.1016/j.bmcl.2010.07.096
CHEMBL1223680 16001 0 None -1 3 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 328 7 1 4 3.2 Fc1ccccc1N1CCN(CCCCNc2ccccn2)CC1 10.1016/j.bmcl.2010.07.096
44288485 162496 0 None 29 3 Human 7.8 pKi = 7.8 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 498 9 1 4 5.1 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C(c2ccc(C)cc2)c2ccc(C)cc2)CC1 10.1016/s0960-894x(01)00320-1
CHEMBL41677 162496 0 None 29 3 Human 7.8 pKi = 7.8 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 498 9 1 4 5.1 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C(c2ccc(C)cc2)c2ccc(C)cc2)CC1 10.1016/s0960-894x(01)00320-1
44288359 155722 0 None -2 3 Rat 7.8 pKi = 7.8 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 461 5 1 6 4.0 COc1cccc2c1CCC1CN(CCCn3c(=O)[nH]c4c(sc5ccccc54)c3=O)CC21 10.1021/jm990567u
CHEMBL40564 155722 0 None -2 3 Rat 7.8 pKi = 7.8 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 461 5 1 6 4.0 COc1cccc2c1CCC1CN(CCCn3c(=O)[nH]c4c(sc5ccccc54)c3=O)CC21 10.1021/jm990567u
44447072 94617 0 None -25 4 Rat 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 483 6 1 6 4.5 O=C(NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21)c1cccnc1 10.1016/j.bmcl.2007.11.106
CHEMBL252430 94617 0 None -25 4 Rat 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 483 6 1 6 4.5 O=C(NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21)c1cccnc1 10.1016/j.bmcl.2007.11.106
6604803 116492 2 None -7 4 Bovine 7.8 pKi = 7.8 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 309 3 3 5 1.2 CS(=O)(=O)Nc1c(O)ccc2c1CCC[C@H]2C1=NCCN1 10.1021/jm960354u
CHEMBL336161 116492 2 None -7 4 Bovine 7.8 pKi = 7.8 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 309 3 3 5 1.2 CS(=O)(=O)Nc1c(O)ccc2c1CCC[C@H]2C1=NCCN1 10.1021/jm960354u
118716705 114972 0 None -1 4 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 424 5 0 7 2.6 COc1ccccc1N1CCN(CC2COC3(CCN(c4ccccn4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342858 114972 0 None -1 4 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 424 5 0 7 2.6 COc1ccccc1N1CCN(CC2COC3(CCN(c4ccccn4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
11176459 101610 0 None -181 5 Human 6.8 pKi = 6.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 380 4 0 5 2.4 N#Cc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1007/s00044-010-9379-1
CHEMBL299022 101610 0 None -181 5 Human 6.8 pKi = 6.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 380 4 0 5 2.4 N#Cc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1007/s00044-010-9379-1
9934955 72247 0 None -489 6 Human 5.8 pKi = 5.8 Binding
Compound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptorCompound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor
ChEMBL 482 5 2 9 2.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@H](C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC 10.1021/jm980053f
CHEMBL19826 72247 0 None -489 6 Human 5.8 pKi = 5.8 Binding
Compound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptorCompound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor
ChEMBL 482 5 2 9 2.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@H](C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC 10.1021/jm980053f
11098175 204147 0 None -1 5 Human 6.8 pKi = 6.8 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 251 5 2 5 1.8 COc1ccc(SC)c(NCC2=NCCN2)c1 10.1021/jm000542r
CHEMBL70691 204147 0 None -1 5 Human 6.8 pKi = 6.8 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 251 5 2 5 1.8 COc1ccc(SC)c(NCC2=NCCN2)c1 10.1021/jm000542r
1220 187 55 None -407 45 Human 5.8 pKi = 5.8 Binding
Binding affinity was determined on human cloned Alpha-1A adrenoceptorBinding affinity was determined on human cloned Alpha-1A adrenoceptor
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm010866v
31 187 55 None -407 45 Human 5.8 pKi = 5.8 Binding
Binding affinity was determined on human cloned Alpha-1A adrenoceptorBinding affinity was determined on human cloned Alpha-1A adrenoceptor
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm010866v
7 187 55 None -407 45 Human 5.8 pKi = 5.8 Binding
Binding affinity was determined on human cloned Alpha-1A adrenoceptorBinding affinity was determined on human cloned Alpha-1A adrenoceptor
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm010866v
CHEMBL56 187 55 None -407 45 Human 5.8 pKi = 5.8 Binding
Binding affinity was determined on human cloned Alpha-1A adrenoceptorBinding affinity was determined on human cloned Alpha-1A adrenoceptor
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm010866v
1220 187 55 None -407 45 Human 5.8 pKi = 5.8 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm0009336
31 187 55 None -407 45 Human 5.8 pKi = 5.8 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm0009336
7 187 55 None -407 45 Human 5.8 pKi = 5.8 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm0009336
CHEMBL56 187 55 None -407 45 Human 5.8 pKi = 5.8 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm0009336
53248365 62056 0 None -186 7 Human 6.8 pKi = 6.8 Binding
Inhibition of adrenergic alpha1A receptorInhibition of adrenergic alpha1A receptor
ChEMBL 554 6 1 5 2.9 O=C(N(CCN1CCN(c2ccccc2O)CC1)c1ccccn1)C12C3C4C1C1C2C3C41I 10.1021/jm1009956
CHEMBL1774995 62056 0 None -186 7 Human 6.8 pKi = 6.8 Binding
Inhibition of adrenergic alpha1A receptorInhibition of adrenergic alpha1A receptor
ChEMBL 554 6 1 5 2.9 O=C(N(CCN1CCN(c2ccccc2O)CC1)c1ccccn1)C12C3C4C1C1C2C3C41I 10.1021/jm1009956
71817545 92095 0 None -58 7 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 354 7 2 5 3.0 COc1ccc2cc[nH]c2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
CHEMBL2419765 92095 0 None -58 7 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 354 7 2 5 3.0 COc1ccc2cc[nH]c2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
126720252 164651 0 None -63 12 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]-Prazosin from human adrenergic alpha1A receptor after 90 mins by scintillation counting methodDisplacement of [3H]-Prazosin from human adrenergic alpha1A receptor after 90 mins by scintillation counting method
ChEMBL 697 15 2 6 9.2 NCCCCCCn1cc(CCCCN2CCC(c3ccc(-c4cc(C(=O)O)cc5cc(-c6ccc(C(F)(F)F)cc6)ccc45)cc3)CC2)nn1 10.1021/acs.jmedchem.8b00168
CHEMBL4216870 164651 0 None -63 12 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]-Prazosin from human adrenergic alpha1A receptor after 90 mins by scintillation counting methodDisplacement of [3H]-Prazosin from human adrenergic alpha1A receptor after 90 mins by scintillation counting method
ChEMBL 697 15 2 6 9.2 NCCCCCCn1cc(CCCCN2CCC(c3ccc(-c4cc(C(=O)O)cc5cc(-c6ccc(C(F)(F)F)cc6)ccc45)cc3)CC2)nn1 10.1021/acs.jmedchem.8b00168
18738382 15235 0 None 33 3 Human 7.8 pKi = 7.8 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 399 8 0 5 2.7 CC(C)Oc1ccccc1N1CCN(C/C=C/C(=O)CN2CCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
CHEMBL12127 15235 0 None 33 3 Human 7.8 pKi = 7.8 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 399 8 0 5 2.7 CC(C)Oc1ccccc1N1CCN(C/C=C/C(=O)CN2CCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
9888164 17919 1 None 25 3 Human 7.8 pKi = 7.8 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 416 8 1 5 2.1 CC(C)Oc1ccccc1N1CCN(CCNC(=O)CN2CCCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
CHEMBL12603 17919 1 None 25 3 Human 7.8 pKi = 7.8 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 416 8 1 5 2.1 CC(C)Oc1ccccc1N1CCN(CCNC(=O)CN2CCCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
289 242 12 None -1 14 Human 7.8 pKi = 7.8 Binding
Binding affinity to human adrenergic alpha1A receptor by radioligand displacement assayBinding affinity to human adrenergic alpha1A receptor by radioligand displacement assay
ChEMBL 301 8 0 2 4.9 CCCCC1CCN(CC1)CCCC(=O)c1ccccc1C 10.1021/jm100697g
9948320 242 12 None -1 14 Human 7.8 pKi = 7.8 Binding
Binding affinity to human adrenergic alpha1A receptor by radioligand displacement assayBinding affinity to human adrenergic alpha1A receptor by radioligand displacement assay
ChEMBL 301 8 0 2 4.9 CCCCC1CCN(CC1)CCCC(=O)c1ccccc1C 10.1021/jm100697g
CHEMBL1242950 242 12 None -1 14 Human 7.8 pKi = 7.8 Binding
Binding affinity to human adrenergic alpha1A receptor by radioligand displacement assayBinding affinity to human adrenergic alpha1A receptor by radioligand displacement assay
ChEMBL 301 8 0 2 4.9 CCCCC1CCN(CC1)CCCC(=O)c1ccccc1C 10.1021/jm100697g
44431564 148335 0 None -2 4 Human 7.8 pKi = 7.8 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 501 8 1 6 4.2 COc1ccc(C)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL393725 148335 0 None -2 4 Human 7.8 pKi = 7.8 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 501 8 1 6 4.2 COc1ccc(C)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
44308443 203930 0 None -1 2 Human 7.8 pKi = 7.8 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 413 6 0 5 4.0 COc1ccccc1N1CCN(Cc2ccc(CN3CCCCCC3=O)s2)CC1 10.1016/s0960-894x(02)00347-5
CHEMBL69339 203930 0 None -1 2 Human 7.8 pKi = 7.8 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 413 6 0 5 4.0 COc1ccccc1N1CCN(Cc2ccc(CN3CCCCCC3=O)s2)CC1 10.1016/s0960-894x(02)00347-5
9864676 127782 0 None -1 5 Bovine 7.8 pKi = 7.8 Binding
Inhibition of [3H]prazosin binding to Alpha-1 adrenergic receptor in bovine frontal cortexInhibition of [3H]prazosin binding to Alpha-1 adrenergic receptor in bovine frontal cortex
ChEMBL 380 6 0 3 4.5 O=C(CCCN1CCN(C2CCCc3ccccc32)CC1)c1ccc(F)cc1 10.1021/jm950759z
CHEMBL366388 127782 0 None -1 5 Bovine 7.8 pKi = 7.8 Binding
Inhibition of [3H]prazosin binding to Alpha-1 adrenergic receptor in bovine frontal cortexInhibition of [3H]prazosin binding to Alpha-1 adrenergic receptor in bovine frontal cortex
ChEMBL 380 6 0 3 4.5 O=C(CCCN1CCN(C2CCCc3ccccc32)CC1)c1ccc(F)cc1 10.1021/jm950759z
145950240 162677 0 None 2 3 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 465 5 2 9 2.2 COc1cc2nc(N3CCC[C@H](NC(=O)[C@H]4COc5ccccc5O4)C3)nc(N)c2cc1OC 10.1016/j.ejmech.2017.05.003
CHEMBL4170675 162677 0 None 2 3 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 465 5 2 9 2.2 COc1cc2nc(N3CCC[C@H](NC(=O)[C@H]4COc5ccccc5O4)C3)nc(N)c2cc1OC 10.1016/j.ejmech.2017.05.003
10787126 84541 0 None -2 4 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 363 8 1 6 2.7 COc1cccc(OC)c1OCCNC[C@@H]1COc2cccc(F)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153558 84541 0 None -2 4 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 363 8 1 6 2.7 COc1cccc(OC)c1OCCNC[C@@H]1COc2cccc(F)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2220897 84541 0 None -2 4 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 363 8 1 6 2.7 COc1cccc(OC)c1OCCNC[C@@H]1COc2cccc(F)c2O1 10.1016/j.ejmech.2012.09.049
10893672 205389 0 None -1 4 Human 7.7 pKi = 7.7 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 357 6 1 7 1.3 COc1ccccc1N1CCN(CCNc2cc(C)nn(C)c2=O)CC1 10.1021/jm0009336
CHEMBL80132 205389 0 None -1 4 Human 7.7 pKi = 7.7 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 357 6 1 7 1.3 COc1ccccc1N1CCN(CCNc2cc(C)nn(C)c2=O)CC1 10.1021/jm0009336
11109088 204157 0 None -3 6 Human 7.7 pKi = 7.7 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 255 4 2 4 2.5 CSc1ccc(Cl)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL70751 204157 0 None -3 6 Human 7.7 pKi = 7.7 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 255 4 2 4 2.5 CSc1ccc(Cl)cc1NCC1=NCCN1 10.1021/jm000542r
9824384 118761 1 None -17 8 Rat 7.7 pKi = 7.7 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1021/jm960510x
CHEMBL342062 118761 1 None -17 8 Rat 7.7 pKi = 7.7 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1021/jm960510x
10252540 85328 1 None -83 6 Rat 7.7 pKi = 7.7 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) CEC-treated hippocampusBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) CEC-treated hippocampus
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1007/s00044-004-0024-8
CHEMBL2261604 85328 1 None -83 6 Rat 7.7 pKi = 7.7 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) CEC-treated hippocampusBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) CEC-treated hippocampus
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1007/s00044-004-0024-8
3251 4041 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1016/j.ejmech.2010.05.023
5684 4041 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1016/j.ejmech.2010.05.023
80 4041 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1016/j.ejmech.2010.05.023
CHEMBL31354 4041 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1016/j.ejmech.2010.05.023
3251 4041 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1016/j.ejmech.2019.05.024
5684 4041 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1016/j.ejmech.2019.05.024
80 4041 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1016/j.ejmech.2019.05.024
CHEMBL31354 4041 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1016/j.ejmech.2019.05.024
3251 4041 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assayDisplacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assay
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1016/j.ejmech.2019.02.056
5684 4041 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assayDisplacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assay
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1016/j.ejmech.2019.02.056
80 4041 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assayDisplacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assay
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1016/j.ejmech.2019.02.056
CHEMBL31354 4041 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assayDisplacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assay
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1016/j.ejmech.2019.02.056
3251 4041 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1021/jm200421e
5684 4041 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1021/jm200421e
80 4041 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1021/jm200421e
CHEMBL31354 4041 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1021/jm200421e
118716720 114988 0 None 1 4 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 425 5 0 7 1.0 COc1ccccc1N1CCN(CC2COC3(CCN(S(C)(=O)=O)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342873 114988 0 None 1 4 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 425 5 0 7 1.0 COc1ccccc1N1CCN(CC2COC3(CCN(S(C)(=O)=O)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
10575664 119182 0 None -2 3 Rat 7.7 pKi = 7.7 Binding
The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.
ChEMBL 453 7 1 9 2.0 COc1cc2nc(N3CCN(C(=O)COc4ccccc4OC)CC3)nc(N)c2cc1OC 10.1021/jm9805337
CHEMBL343283 119182 0 None -2 3 Rat 7.7 pKi = 7.7 Binding
The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.
ChEMBL 453 7 1 9 2.0 COc1cc2nc(N3CCN(C(=O)COc4ccccc4OC)CC3)nc(N)c2cc1OC 10.1021/jm9805337
10575664 119182 0 None -2 3 Human 7.7 pKi = 7.7 Binding
The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.
ChEMBL 453 7 1 9 2.0 COc1cc2nc(N3CCN(C(=O)COc4ccccc4OC)CC3)nc(N)c2cc1OC 10.1021/jm9805337
CHEMBL343283 119182 0 None -2 3 Human 7.7 pKi = 7.7 Binding
The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.
ChEMBL 453 7 1 9 2.0 COc1cc2nc(N3CCN(C(=O)COc4ccccc4OC)CC3)nc(N)c2cc1OC 10.1021/jm9805337
16756754 92100 27 None -81 3 Human 6.8 pKi = 6.8 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptor
ChEMBL 478 7 1 3 7.0 Cc1ccc(NC(=O)C(C)C)cc1C1CCN(Cc2ccc(Oc3ccc(F)c(F)c3)cc2)CC1 10.1021/jm060383x
CHEMBL242004 92100 27 None -81 3 Human 6.8 pKi = 6.8 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptor
ChEMBL 478 7 1 3 7.0 Cc1ccc(NC(=O)C(C)C)cc1C1CCN(Cc2ccc(Oc3ccc(F)c(F)c3)cc2)CC1 10.1021/jm060383x
11412944 101482 69 None -223 2 Bovine 5.8 pKi = 5.8 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 197 1 1 3 1.1 Clc1cccnc1N1CCNCC1 10.1021/jm00366a007
CHEMBL298004 101482 69 None -223 2 Bovine 5.8 pKi = 5.8 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 197 1 1 3 1.1 Clc1cccnc1N1CCNCC1 10.1021/jm00366a007
70820518 167503 0 None -104 3 Human 5.8 pKi = 5.8 Binding
Displacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting methodDisplacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting method
ChEMBL 391 7 1 4 3.7 CS(=O)(=O)c1ccc(Cl)cc1CNCCOc1cc(F)ccc1Cl 10.1016/j.ejmech.2017.07.071
CHEMBL4213747 167503 0 None -104 3 Human 5.8 pKi = 5.8 Binding
Displacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting methodDisplacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting method
ChEMBL 391 7 1 4 3.7 CS(=O)(=O)c1ccc(Cl)cc1CNCCOc1cc(F)ccc1Cl 10.1016/j.ejmech.2017.07.071
CHEMBL4300105 167503 0 None -104 3 Human 5.8 pKi = 5.8 Binding
Displacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting methodDisplacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting method
ChEMBL 391 7 1 4 3.7 CS(=O)(=O)c1ccc(Cl)cc1CNCCOc1cc(F)ccc1Cl 10.1016/j.ejmech.2017.07.071
57400562 69289 0 None -1 5 Pig 5.8 pKi = 5.8 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 469 14 1 6 3.6 CCOCCOCc1ccc(N2CCN(CCCCNC(=O)c3ccccc3)CC2)c(OC)c1 10.1016/j.bmc.2011.10.063
CHEMBL1928247 69289 0 None -1 5 Pig 5.8 pKi = 5.8 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 469 14 1 6 3.6 CCOCCOCc1ccc(N2CCN(CCCCNC(=O)c3ccccc3)CC2)c(OC)c1 10.1016/j.bmc.2011.10.063
44420419 83402 0 None 2 3 Human 6.7 pKi = 6.7 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 485 4 0 7 3.3 Cn1c(=O)n(CCN2CCN(c3ccc(Cl)c(Cl)c3)CC2)c(=O)c2c1c1ccccc1n2C 10.1016/j.bmcl.2006.09.034
CHEMBL219719 83402 0 None 2 3 Human 6.7 pKi = 6.7 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 485 4 0 7 3.3 Cn1c(=O)n(CCN2CCN(c3ccc(Cl)c(Cl)c3)CC2)c(=O)c2c1c1ccccc1n2C 10.1016/j.bmcl.2006.09.034
10198248 187425 40 None -83 6 Human 4.7 pKi = 4.7 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 213 1 2 5 1.0 c1cnc2cc(NC3=NCCN3)ccc2n1 10.1016/0960-894X(95)00391-6
CHEMBL49395 187425 40 None -83 6 Human 4.7 pKi = 4.7 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 213 1 2 5 1.0 c1cnc2cc(NC3=NCCN3)ccc2n1 10.1016/0960-894X(95)00391-6
134149777 148487 0 None -199 4 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting method
ChEMBL 353 7 1 5 4.2 COc1ccccc1OCCNCC1CSC2(CCCCC2)S1 10.1016/j.ejmech.2016.09.050
CHEMBL3938383 148487 0 None -199 4 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting method
ChEMBL 353 7 1 5 4.2 COc1ccccc1OCCNCC1CSC2(CCCCC2)S1 10.1016/j.ejmech.2016.09.050
11464777 101778 0 None -457 5 Rat 6.7 pKi = 6.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 437 4 0 4 4.2 CC(CN1CCN(c2cc(Cl)ccc2Cl)CC1)N1C(=O)CC2(CCCC2)CC1=O 10.1021/jm030944+
CHEMBL300152 101778 0 None -457 5 Rat 6.7 pKi = 6.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 437 4 0 4 4.2 CC(CN1CCN(c2cc(Cl)ccc2Cl)CC1)N1C(=O)CC2(CCCC2)CC1=O 10.1021/jm030944+
44431613 87553 0 None -2 4 Human 6.7 pKi = 6.7 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 529 10 1 7 3.9 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4OCC4CC4)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.008
CHEMBL233584 87553 0 None -2 4 Human 6.7 pKi = 6.7 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 529 10 1 7 3.9 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4OCC4CC4)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.008
10792536 206753 0 None 14 3 Human 7.7 pKi = 7.7 Binding
Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 540 7 3 3 4.7 O=C1NC(C(F)(F)F)=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)N1 10.1021/jm990612y
CHEMBL90184 206753 0 None 14 3 Human 7.7 pKi = 7.7 Binding
Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 540 7 3 3 4.7 O=C1NC(C(F)(F)F)=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)N1 10.1021/jm990612y
135398737 955 93 None -5 92 Human 7.7 pKi = 7.7 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
38 955 93 None -5 92 Human 7.7 pKi = 7.7 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
722 955 93 None -5 92 Human 7.7 pKi = 7.7 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
CHEMBL42 955 93 None -5 92 Human 7.7 pKi = 7.7 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
DB00363 955 93 None -5 92 Human 7.7 pKi = 7.7 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
44431614 88008 0 None 2 4 Human 7.7 pKi = 7.7 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 533 9 1 6 4.5 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OCC3CC3)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL234474 88008 0 None 2 4 Human 7.7 pKi = 7.7 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 533 9 1 6 4.5 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OCC3CC3)CC2)CC1 10.1016/j.bmcl.2007.04.008
13141182 130867 1 None 10 2 Bovine 7.7 pKi = 7.7 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 354 0 0 2 4.7 CN1CCC(=C2c3cc(Br)ccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
CHEMBL368578 130867 1 None 10 2 Bovine 7.7 pKi = 7.7 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 354 0 0 2 4.7 CN1CCC(=C2c3cc(Br)ccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
127027078 137802 0 None -14 3 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 426 7 2 3 4.7 O=C(NCCCCN1CCN(c2cccc3[nH]ccc23)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
CHEMBL3759865 137802 0 None -14 3 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 426 7 2 3 4.7 O=C(NCCCCN1CCN(c2cccc3[nH]ccc23)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
57395341 69282 0 None 2 5 Pig 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 495 13 1 8 2.8 CCOCCOCc1ccn2ncc(C(=O)NCCCN3CCN(c4ccccc4OC)CC3)c2c1 10.1016/j.bmc.2011.10.063
CHEMBL1928135 69282 0 None 2 5 Pig 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 495 13 1 8 2.8 CCOCCOCc1ccn2ncc(C(=O)NCCCN3CCN(c4ccccc4OC)CC3)c2c1 10.1016/j.bmc.2011.10.063
71508682 87019 0 None 45 2 Bovine 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 371 3 0 5 4.2 CN1CCC(c2cn(-c3ccncc3)c3ccc(-c4ccnn4C)cc23)CC1 10.1016/j.bmc.2012.10.049
CHEMBL2325927 87019 0 None 45 2 Bovine 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 371 3 0 5 4.2 CN1CCC(c2cn(-c3ccncc3)c3ccc(-c4ccnn4C)cc23)CC1 10.1016/j.bmc.2012.10.049
71508711 87027 0 None 43 2 Bovine 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 369 3 0 5 4.3 CN1CCC(c2cn(-c3ccncc3)c3ccc(-c4cncnc4)cc23)CC1 10.1016/j.bmc.2012.10.049
CHEMBL2325934 87027 0 None 43 2 Bovine 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 369 3 0 5 4.3 CN1CCC(c2cn(-c3ccncc3)c3ccc(-c4cncnc4)cc23)CC1 10.1016/j.bmc.2012.10.049
10698974 91093 0 None 102 3 Human 7.7 pKi = 7.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 610 5 1 7 4.3 COC(=O)C1=C(C)NC(=O)N(C(=O)N2CCC(N3CCC(C(=O)OC)(c4ccccc4)CC3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL239806 91093 0 None 102 3 Human 7.7 pKi = 7.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 610 5 1 7 4.3 COC(=O)C1=C(C)NC(=O)N(C(=O)N2CCC(N3CCC(C(=O)OC)(c4ccccc4)CC3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
135398737 955 93 None -5 92 Human 7.7 pKi = 7.7 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm401958n
38 955 93 None -5 92 Human 7.7 pKi = 7.7 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm401958n
722 955 93 None -5 92 Human 7.7 pKi = 7.7 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm401958n
CHEMBL42 955 93 None -5 92 Human 7.7 pKi = 7.7 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm401958n
DB00363 955 93 None -5 92 Human 7.7 pKi = 7.7 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm401958n
42631003 199595 13 None -97 8 Human 7.7 pKi = 7.7 Binding
Binding affinity to adrenergic alpha1A receptor by radioligand displacement assayBinding affinity to adrenergic alpha1A receptor by radioligand displacement assay
ChEMBL 304 3 0 2 4.2 Cc1ccc2c(c1)c1c(n2CCc2ccccc2)CCN(C)C1 10.1016/j.bmcl.2009.11.037
CHEMBL592752 199595 13 None -97 8 Human 7.7 pKi = 7.7 Binding
Binding affinity to adrenergic alpha1A receptor by radioligand displacement assayBinding affinity to adrenergic alpha1A receptor by radioligand displacement assay
ChEMBL 304 3 0 2 4.2 Cc1ccc2c(c1)c1c(n2CCc2ccccc2)CCN(C)C1 10.1016/j.bmcl.2009.11.037
50905588 56323 0 None -1 6 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 406 7 2 6 2.1 COc1ccc(C[C@@H](C)NC[C@H]2Oc3ccccc3O[C@H]2C)cc1S(N)(=O)=O 10.1016/j.ejmech.2010.09.042
CHEMBL1630941 56323 0 None -1 6 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 406 7 2 6 2.1 COc1ccc(C[C@@H](C)NC[C@H]2Oc3ccccc3O[C@H]2C)cc1S(N)(=O)=O 10.1016/j.ejmech.2010.09.042
10575494 165723 0 None -4 3 Human 7.7 pKi = 7.7 Binding
The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.
ChEMBL 449 7 1 8 2.5 COc1cc2nc(N3CCN(C(=O)CCC(=O)c4ccccc4)CC3)nc(N)c2cc1OC 10.1021/jm9805337
CHEMBL424658 165723 0 None -4 3 Human 7.7 pKi = 7.7 Binding
The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.
ChEMBL 449 7 1 8 2.5 COc1cc2nc(N3CCN(C(=O)CCC(=O)c4ccccc4)CC3)nc(N)c2cc1OC 10.1021/jm9805337
44329027 4137 0 None 9 6 Human 7.7 pKi = 7.7 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 637 13 3 7 4.9 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COC)N1 10.1016/s0960-894x(99)00484-9
CHEMBL100045 4137 0 None 9 6 Human 7.7 pKi = 7.7 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 637 13 3 7 4.9 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COC)N1 10.1016/s0960-894x(99)00484-9
10363912 6506 0 None -36 7 Human 7.7 pKi = 7.7 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 405 9 1 5 4.0 COc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
CHEMBL1082862 6506 0 None -36 7 Human 7.7 pKi = 7.7 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 405 9 1 5 4.0 COc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
CHEMBL286003 6506 0 None -36 7 Human 7.7 pKi = 7.7 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 405 9 1 5 4.0 COc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
10363912 6506 0 None -36 7 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 405 9 1 5 4.0 COc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.bmcl.2010.01.030
CHEMBL1082862 6506 0 None -36 7 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 405 9 1 5 4.0 COc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.bmcl.2010.01.030
CHEMBL286003 6506 0 None -36 7 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 405 9 1 5 4.0 COc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.bmcl.2010.01.030
10363912 6506 0 None -36 7 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 405 9 1 5 4.0 COc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1021/jm200421e
CHEMBL1082862 6506 0 None -36 7 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 405 9 1 5 4.0 COc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1021/jm200421e
CHEMBL286003 6506 0 None -36 7 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 405 9 1 5 4.0 COc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1021/jm200421e
11653915 123986 0 None -5 6 Human 7.7 pKi = 7.7 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
ChEMBL 296 4 2 5 2.6 COc1cccc(N(NC2=NCCN2)c2ccc(C)cc2)c1 10.1016/j.bmcl.2005.07.083
CHEMBL362954 123986 0 None -5 6 Human 7.7 pKi = 7.7 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
ChEMBL 296 4 2 5 2.6 COc1cccc(N(NC2=NCCN2)c2ccc(C)cc2)c1 10.1016/j.bmcl.2005.07.083
52945156 17026 0 None -7 4 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 455 13 1 6 4.1 COc1cccc(OC)c1[S+]([O-])CCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
CHEMBL1254660 17026 0 None -7 4 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 455 13 1 6 4.1 COc1cccc(OC)c1[S+]([O-])CCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
118716722 114990 0 None -1 4 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 446 7 1 6 2.5 CCCCNC(=O)N1CCC2(CC1)OCC(CN1CCN(c3ccccc3OC)CC1)O2 10.1016/j.ejmech.2014.09.070
CHEMBL3342875 114990 0 None -1 4 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 446 7 1 6 2.5 CCCCNC(=O)N1CCC2(CC1)OCC(CN1CCN(c3ccccc3OC)CC1)O2 10.1016/j.ejmech.2014.09.070
44298747 101981 0 None -3 2 Human 7.7 pKi = 7.7 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 480 7 1 6 2.7 O=c1[nH]cc(C(F)(F)F)c(=O)n1CCCN1CCN(c2ccccc2OCC(F)(F)F)CC1 10.1016/s0960-894x(03)00305-6
CHEMBL301650 101981 0 None -3 2 Human 7.7 pKi = 7.7 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 480 7 1 6 2.7 O=c1[nH]cc(C(F)(F)F)c(=O)n1CCCN1CCN(c2ccccc2OCC(F)(F)F)CC1 10.1016/s0960-894x(03)00305-6
9887458 195650 0 None -512 4 Rat 6.7 pKi = 6.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 403 4 0 4 3.5 Cc1ccc(Cl)cc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1021/jm030944+
CHEMBL55654 195650 0 None -512 4 Rat 6.7 pKi = 6.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 403 4 0 4 3.5 Cc1ccc(Cl)cc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1021/jm030944+
53328313 63357 0 None 1 3 Human 6.7 pKi = 6.7 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 455 7 0 5 3.8 COc1ccc(Cl)cc1N1CCN(CCCN2C(=O)CC(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796032 63357 0 None 1 3 Human 6.7 pKi = 6.7 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 455 7 0 5 3.8 COc1ccc(Cl)cc1N1CCN(CCCN2C(=O)CC(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
145958538 162241 0 None -6 3 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 303 3 2 7 1.2 COc1cc2nc(N3CCC[C@H](N)C3)nc(N)c2cc1OC 10.1016/j.ejmech.2017.05.003
CHEMBL4163810 162241 0 None -6 3 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 303 3 2 7 1.2 COc1cc2nc(N3CCC[C@H](N)C3)nc(N)c2cc1OC 10.1016/j.ejmech.2017.05.003
9905929 12781 0 None -26 2 Rat 5.7 pKi = 5.7 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 339 5 1 2 4.5 Cc1[nH]c2ccccc2c1C1CCN(CCCN2CCCCC2)CC1 10.1016/j.bmcl.2006.05.002
CHEMBL1188265 12781 0 None -26 2 Rat 5.7 pKi = 5.7 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 339 5 1 2 4.5 Cc1[nH]c2ccccc2c1C1CCN(CCCN2CCCCC2)CC1 10.1016/j.bmcl.2006.05.002
CHEMBL535837 12781 0 None -26 2 Rat 5.7 pKi = 5.7 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 339 5 1 2 4.5 Cc1[nH]c2ccccc2c1C1CCN(CCCN2CCCCC2)CC1 10.1016/j.bmcl.2006.05.002
9904117 9370 3 None -1 5 Rat 6.7 pKi = 6.7 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 291 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL111554 9370 3 None -1 5 Rat 6.7 pKi = 6.7 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 291 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
44531812 194659 0 None 1 4 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 374 7 2 6 4.3 COc1cccc2c(NCCNc3ccnc4c(OC)cccc34)ccnc12 10.1016/j.bmc.2014.09.017
CHEMBL532818 194659 0 None 1 4 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 374 7 2 6 4.3 COc1cccc2c(NCCNc3ccnc4c(OC)cccc34)ccnc12 10.1016/j.bmc.2014.09.017
9904117 9370 3 None -1 5 Rat 6.7 pKi = 6.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 291 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL111554 9370 3 None -1 5 Rat 6.7 pKi = 6.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 291 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
44314200 102925 0 None -81 4 Human 5.7 pKi = 5.7 Binding
Binding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 230 1 1 3 2.4 c1ccc2c(c1)CCCC2NC1=NCCCO1 10.1016/0960-894X(94)85032-1
CHEMBL306377 102925 0 None -81 4 Human 5.7 pKi = 5.7 Binding
Binding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 230 1 1 3 2.4 c1ccc2c(c1)CCCC2NC1=NCCCO1 10.1016/0960-894X(94)85032-1
44531812 194659 0 None 1 4 Human 6.7 pKi = 6.7 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 374 7 2 6 4.3 COc1cccc2c(NCCNc3ccnc4c(OC)cccc34)ccnc12 10.1016/j.bmc.2014.09.017
CHEMBL532818 194659 0 None 1 4 Human 6.7 pKi = 6.7 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 374 7 2 6 4.3 COc1cccc2c(NCCNc3ccnc4c(OC)cccc34)ccnc12 10.1016/j.bmc.2014.09.017
CHEMBL5291469 194617 0 None -70 2 Human 6.7 pKi = 6.7 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 508 8 1 6 3.6 O=C(NCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O)C1CCOCC1 10.1021/acsmedchemlett.7b00112
CHEMBL5315702 194617 0 None -70 2 Human 6.7 pKi = 6.7 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 508 8 1 6 3.6 O=C(NCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O)C1CCOCC1 10.1021/acsmedchemlett.7b00112
44586479 188603 0 None 1 3 Rat 6.7 pKi = 6.7 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 572 10 1 8 2.6 COC(=O)CN1C(=O)N(CC(O)CN2CCN(c3ccccc3OC)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
CHEMBL503007 188603 0 None 1 3 Rat 6.7 pKi = 6.7 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 572 10 1 8 2.6 COC(=O)CN1C(=O)N(CC(O)CN2CCN(c3ccccc3OC)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
52937732 61284 0 None -794 3 Human 6.7 pKi = 6.7 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 369 4 0 4 3.4 CN1CCC[C@@H]1Cn1nc(Cc2ccc(F)c(F)c2)c2ccccc2c1=O 10.1021/jm1013874
CHEMBL1767149 61284 0 None -794 3 Human 6.7 pKi = 6.7 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 369 4 0 4 3.4 CN1CCC[C@@H]1Cn1nc(Cc2ccc(F)c(F)c2)c2ccccc2c1=O 10.1021/jm1013874
52937828 61287 0 None -6 3 Human 6.7 pKi = 6.7 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 347 5 0 4 3.3 CN1CCC[C@@H]1Cn1nc(CCc2ccccc2)c2ccccc2c1=O 10.1021/jm1013874
CHEMBL1767152 61287 0 None -6 3 Human 6.7 pKi = 6.7 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 347 5 0 4 3.3 CN1CCC[C@@H]1Cn1nc(CCc2ccccc2)c2ccccc2c1=O 10.1021/jm1013874
25130879 173213 0 None -47 4 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 343 8 1 5 2.8 COc1ccccc1OCCNC[C@@H]1COC[C@H](c2ccccc2)O1 10.1021/jm800461k
CHEMBL452437 173213 0 None -47 4 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 343 8 1 5 2.8 COc1ccccc1OCCNC[C@@H]1COC[C@H](c2ccccc2)O1 10.1021/jm800461k
134138438 147318 0 None -66 4 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting method
ChEMBL 378 4 0 5 4.3 COc1ccccc1N1CCN(CC2CSC3(CCCCC3)S2)CC1 10.1016/j.ejmech.2016.09.050
CHEMBL3929328 147318 0 None -66 4 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting method
ChEMBL 378 4 0 5 4.3 COc1ccccc1N1CCN(CC2CSC3(CCCCC3)S2)CC1 10.1016/j.ejmech.2016.09.050
25025581 201973 0 None -3 8 Human 6.7 pKi = 6.7 Binding
Inhibition of adrenergic alpha1A receptorInhibition of adrenergic alpha1A receptor
ChEMBL 285 4 1 2 3.1 CCOC[C@H]1[C@@H]2CNC[C@@]21c1ccc(Cl)c(Cl)c1 10.1021/jm901818u
CHEMBL608151 201973 0 None -3 8 Human 6.7 pKi = 6.7 Binding
Inhibition of adrenergic alpha1A receptorInhibition of adrenergic alpha1A receptor
ChEMBL 285 4 1 2 3.1 CCOC[C@H]1[C@@H]2CNC[C@@]21c1ccc(Cl)c(Cl)c1 10.1021/jm901818u
43260 5450 65 None -1 5 Rat 5.7 pKi = 5.7 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 197 4 2 4 0.7 COc1ccc(OC)c(C(O)CN)c1 10.1007/s00044-004-0020-z
CHEMBL1076 5450 65 None -1 5 Rat 5.7 pKi = 5.7 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 197 4 2 4 0.7 COc1ccc(OC)c(C(O)CN)c1 10.1007/s00044-004-0020-z
294234 102866 3 None -512 4 Human 5.7 pKi = 5.7 Binding
Binding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 182 1 1 3 1.7 C1CCCC(NC2=NCCO2)CC1 10.1016/0960-894X(94)85032-1
CHEMBL305928 102866 3 None -512 4 Human 5.7 pKi = 5.7 Binding
Binding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 182 1 1 3 1.7 C1CCCC(NC2=NCCO2)CC1 10.1016/0960-894X(94)85032-1
25164129 161136 0 None -3715 4 Rat 5.7 pKi = 5.7 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptorDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptor
ChEMBL 447 12 1 5 4.1 CCCCc1cc(OC2CCN(CCCCNS(=O)(=O)CC)CC2)c2ncccc2c1 10.1016/j.bmcl.2017.09.020
CHEMBL4088036 161136 0 None -3715 4 Rat 5.7 pKi = 5.7 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptorDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptor
ChEMBL 447 12 1 5 4.1 CCCCc1cc(OC2CCN(CCCCNS(=O)(=O)CC)CC2)c2ncccc2c1 10.1016/j.bmcl.2017.09.020
CHEMBL4117406 161136 0 None -3715 4 Rat 5.7 pKi = 5.7 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptorDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptor
ChEMBL 447 12 1 5 4.1 CCCCc1cc(OC2CCN(CCCCNS(=O)(=O)CC)CC2)c2ncccc2c1 10.1016/j.bmcl.2017.09.020
43260 5450 65 None -1 5 Rat 5.7 pKi = 5.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 197 4 2 4 0.7 COc1ccc(OC)c(C(O)CN)c1 10.1021/jm030551a
CHEMBL1076 5450 65 None -1 5 Rat 5.7 pKi = 5.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 197 4 2 4 0.7 COc1ccc(OC)c(C(O)CN)c1 10.1021/jm030551a
3584 3748 64 None -2 14 Human 8.7 pKi = 8.7 Binding
Binding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligandBinding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligand
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
5401 3748 64 None -2 14 Human 8.7 pKi = 8.7 Binding
Binding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligandBinding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligand
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
7302 3748 64 None -2 14 Human 8.7 pKi = 8.7 Binding
Binding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligandBinding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligand
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
CHEMBL611 3748 64 None -2 14 Human 8.7 pKi = 8.7 Binding
Binding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligandBinding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligand
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
DB01162 3748 64 None -2 14 Human 8.7 pKi = 8.7 Binding
Binding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligandBinding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligand
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
44431560 145553 0 None -2 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 517 9 1 7 3.9 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
CHEMBL391530 145553 0 None -2 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 517 9 1 7 3.9 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
11081136 205203 0 None 1 3 Human 8.7 pKi = 8.7 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 467 8 1 7 3.7 COc1ccc(Cl)cc1N1CCN(CCCNc2cc(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
CHEMBL78676 205203 0 None 1 3 Human 8.7 pKi = 8.7 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 467 8 1 7 3.7 COc1ccc(Cl)cc1N1CCN(CCCNc2cc(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
4431 2710 25 None 1 12 Human 8.7 pKi = 8.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 393 7 0 5 2.9 COc1ccccc1N1CCN(CC1)CCCCN1C(=O)c2c(C1=O)cccc2 10.1016/j.bmcl.2004.11.032
73 2710 25 None 1 12 Human 8.7 pKi = 8.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 393 7 0 5 2.9 COc1ccccc1N1CCN(CC1)CCCCN1C(=O)c2c(C1=O)cccc2 10.1016/j.bmcl.2004.11.032
CHEMBL8618 2710 25 None 1 12 Human 8.7 pKi = 8.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 393 7 0 5 2.9 COc1ccccc1N1CCN(CC1)CCCCN1C(=O)c2c(C1=O)cccc2 10.1016/j.bmcl.2004.11.032
9909211 94179 1 None 1 3 Human 8.7 pKi = 8.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 404 8 2 7 1.9 COc1ccc(Cl)cc1N1CCN(CCCNc2nccc(C(N)=O)n2)CC1 10.1016/j.bmcl.2004.11.032
CHEMBL24981 94179 1 None 1 3 Human 8.7 pKi = 8.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 404 8 2 7 1.9 COc1ccc(Cl)cc1N1CCN(CCCNc2nccc(C(N)=O)n2)CC1 10.1016/j.bmcl.2004.11.032
3584 3748 64 None -2 14 Human 8.7 pKi = 8.7 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog aorta preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog aorta preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
5401 3748 64 None -2 14 Human 8.7 pKi = 8.7 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog aorta preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog aorta preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
7302 3748 64 None -2 14 Human 8.7 pKi = 8.7 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog aorta preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog aorta preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
CHEMBL611 3748 64 None -2 14 Human 8.7 pKi = 8.7 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog aorta preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog aorta preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
DB01162 3748 64 None -2 14 Human 8.7 pKi = 8.7 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog aorta preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog aorta preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
181743 178548 5 None 24 22 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]Prazosin from human adrenergic alpha1A receptorDisplacement of [3H]Prazosin from human adrenergic alpha1A receptor
ChEMBL 339 2 0 5 3.2 COc1cc2c3c(c1OC)-c1cc4c(cc1CC3N(C)CC2)OCO4 10.1016/j.bmcl.2009.11.053
CHEMBL467094 178548 5 None 24 22 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]Prazosin from human adrenergic alpha1A receptorDisplacement of [3H]Prazosin from human adrenergic alpha1A receptor
ChEMBL 339 2 0 5 3.2 COc1cc2c3c(c1OC)-c1cc4c(cc1CC3N(C)CC2)OCO4 10.1016/j.bmcl.2009.11.053
49781681 17854 0 None -1 4 Bovine 8.7 pKi = 8.7 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 428 2 0 3 6.3 Cc1cc(C)c(-c2ccc3c(c2)C(N2CCN(C)CC2)Cc2ccccc2S3)c(C)c1 10.1021/jm100652h
CHEMBL1259098 17854 0 None -1 4 Bovine 8.7 pKi = 8.7 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 428 2 0 3 6.3 Cc1cc(C)c(-c2ccc3c(c2)C(N2CCN(C)CC2)Cc2ccccc2S3)c(C)c1 10.1021/jm100652h
10097317 200061 0 None 288 3 Human 8.7 pKi = 8.7 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 495 8 2 4 4.9 Cc1ccc(C(O)(C(=O)NCCCN2CCC(C#N)(c3ccccc3C)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(01)00320-1
CHEMBL59590 200061 0 None 288 3 Human 8.7 pKi = 8.7 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 495 8 2 4 4.9 Cc1ccc(C(O)(C(=O)NCCCN2CCC(C#N)(c3ccccc3C)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(01)00320-1
10026936 163434 0 None 114 3 Human 8.7 pKi = 8.7 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 453 8 1 3 5.1 Cc1ccccc1C1(C#N)CCN(CCCNC(=O)C(c2ccc(F)c(F)c2)C(C)C)CC1 10.1016/s0960-894x(00)00307-3
CHEMBL41994 163434 0 None 114 3 Human 8.7 pKi = 8.7 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 453 8 1 3 5.1 Cc1ccccc1C1(C#N)CCN(CCCNC(=O)C(c2ccc(F)c(F)c2)C(C)C)CC1 10.1016/s0960-894x(00)00307-3
11200086 196401 0 None -1 4 Rat 8.7 pKi = 8.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 388 4 0 3 4.2 O=C1CC2(CCCC2)CC(=O)N1CCN1CCC(c2ccccc2Cl)CC1 10.1021/jm030944+
CHEMBL56292 196401 0 None -1 4 Rat 8.7 pKi = 8.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 388 4 0 3 4.2 O=C1CC2(CCCC2)CC(=O)N1CCN1CCC(c2ccccc2Cl)CC1 10.1021/jm030944+
44312563 204897 2 None -1 7 Bovine 8.7 pKi = 8.7 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]-prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]-prazosin as radioligand
ChEMBL 401 7 1 8 1.0 COc1ccc(C)cc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1 10.1021/jm960069a
CHEMBL76168 204897 2 None -1 7 Bovine 8.7 pKi = 8.7 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]-prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]-prazosin as radioligand
ChEMBL 401 7 1 8 1.0 COc1ccc(C)cc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1 10.1021/jm960069a
10531 1408 21 None -5 24 Rat 8.7 pKi = 8.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
121 1408 21 None -5 24 Rat 8.7 pKi = 8.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
888 1408 21 None -5 24 Rat 8.7 pKi = 8.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
CHEMBL1732 1408 21 None -5 24 Rat 8.7 pKi = 8.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
DB00320 1408 21 None -5 24 Rat 8.7 pKi = 8.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
46934945 16666 0 None 1 4 Human 8.7 pKi = 8.7 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 533 7 0 7 3.8 COc1ccccc1N1CCN(C[C@H]2CO[C@@](CN3C(=O)CC4(CCCC4)CC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
CHEMBL1242912 16666 0 None 1 4 Human 8.7 pKi = 8.7 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 533 7 0 7 3.8 COc1ccccc1N1CCN(C[C@H]2CO[C@@](CN3C(=O)CC4(CCCC4)CC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
100 3776 58 None 1 56 Rat 8.7 pKi = 8.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
2637 3776 58 None 1 56 Rat 8.7 pKi = 8.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
5452 3776 58 None 1 56 Rat 8.7 pKi = 8.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
CHEMBL479 3776 58 None 1 56 Rat 8.7 pKi = 8.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
DB00679 3776 58 None 1 56 Rat 8.7 pKi = 8.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
6761 67770 19 None 1 18 Rat 8.7 pKi = 8.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 401 5 1 4 4.5 NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1 nan
CHEMBL1909072 67770 19 None 1 18 Rat 8.7 pKi = 8.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 401 5 1 4 4.5 NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1 nan
46882034 5769 0 None -1 4 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 433 10 1 5 4.8 CC(C)Oc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.bmcl.2010.01.030
CHEMBL1078773 5769 0 None -1 4 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 433 10 1 5 4.8 CC(C)Oc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.bmcl.2010.01.030
121102 143941 2 None -3 3 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 370 8 0 5 3.5 CCOc1ccccc1N1CCN(CCc2ccc(OC)c(OC)c2)CC1 10.1016/j.ejmech.2016.06.052
CHEMBL3902626 143941 2 None -3 3 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 370 8 0 5 3.5 CCOc1ccccc1N1CCN(CCc2ccc(OC)c(OC)c2)CC1 10.1016/j.ejmech.2016.06.052
11801214 102194 0 None 25 2 Human 8.7 pKi = 8.7 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 572 10 2 8 3.2 COc1ccc(N2C(=O)c3ccc(C(=O)NC[C@@H](O)CN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc1 10.1021/jm9905918
CHEMBL302942 102194 0 None 25 2 Human 8.7 pKi = 8.7 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 572 10 2 8 3.2 COc1ccc(N2C(=O)c3ccc(C(=O)NC[C@@H](O)CN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc1 10.1021/jm9905918
9844511 104569 0 None 85 3 Human 8.7 pKi = 8.7 Binding
Compound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptorCompound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptor
ChEMBL 411 7 1 5 3.0 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCC3=O)n[nH]2)CC1 10.1016/s0960-894x(00)00472-8
CHEMBL310471 104569 0 None 85 3 Human 8.7 pKi = 8.7 Binding
Compound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptorCompound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptor
ChEMBL 411 7 1 5 3.0 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCC3=O)n[nH]2)CC1 10.1016/s0960-894x(00)00472-8
56961460 121412 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 477 4 2 10 2.0 COc1cc2nc(N3CCN(C(=O)c4cc5ccc(O)cc5oc4=O)CC3)nc(N)c2cc1OC 10.1021/ml5004298
CHEMBL3582268 121412 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 477 4 2 10 2.0 COc1cc2nc(N3CCN(C(=O)c4cc5ccc(O)cc5oc4=O)CC3)nc(N)c2cc1OC 10.1021/ml5004298
10393665 33892 0 None 47 3 Human 8.7 pKi = 8.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 593 9 2 9 3.4 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm990200p
CHEMBL142383 33892 0 None 47 3 Human 8.7 pKi = 8.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 593 9 2 9 3.4 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm990200p
10627279 37183 0 None 47 3 Human 8.7 pKi = 8.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 592 9 3 8 3.0 CNC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm990200p
CHEMBL145334 37183 0 None 47 3 Human 8.7 pKi = 8.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 592 9 3 8 3.0 CNC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm990200p
10767626 155299 0 None -2 3 Rat 8.7 pKi = 8.7 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 461 4 1 6 3.9 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccc(C)cc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL40310 155299 0 None -2 3 Rat 8.7 pKi = 8.7 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 461 4 1 6 3.9 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccc(C)cc54)c3=O)C[C@@H]21 10.1021/jm990567u
10502807 163121 0 None -3 3 Rat 8.7 pKi = 8.7 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 431 4 1 6 3.1 COc1cccc2c1CCC1CN(CCn3c(=O)[nH]c4c(oc5ccccc54)c3=O)CC21 10.1021/jm990567u
CHEMBL417890 163121 0 None -3 3 Rat 8.7 pKi = 8.7 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 431 4 1 6 3.1 COc1cccc2c1CCC1CN(CCn3c(=O)[nH]c4c(oc5ccccc54)c3=O)CC21 10.1021/jm990567u
71454865 84574 0 None -2 7 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 361 8 2 7 2.2 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(O)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153551 84574 0 None -2 7 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 361 8 2 7 2.2 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(O)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2221145 84574 0 None -2 7 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 361 8 2 7 2.2 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(O)c2O1 10.1016/j.ejmech.2012.09.049
10698630 44403 0 None 1230 3 Human 8.7 pKi = 8.7 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 589 11 3 8 3.4 CCOC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(N)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
CHEMBL151878 44403 0 None 1230 3 Human 8.7 pKi = 8.7 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 589 11 3 8 3.4 CCOC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(N)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
11857791 85611 0 None 10 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 554 7 1 6 4.9 O=S(=O)(N[C@H]1CC[C@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1ccc2c(c1)OCCO2 10.1016/j.bmcl.2007.04.098
CHEMBL228390 85611 0 None 10 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 554 7 1 6 4.9 O=S(=O)(N[C@H]1CC[C@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1ccc2c(c1)OCCO2 10.1016/j.bmcl.2007.04.098
11857638 143785 0 None -1 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 516 9 1 6 5.0 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
CHEMBL390129 143785 0 None -1 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 516 9 1 6 5.0 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
10792591 206800 0 None 15 3 Human 8.7 pKi = 8.7 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 542 7 1 4 4.7 CC(=O)N1C(=O)N(C)C(C)=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1016/j.ejmech.2017.03.025
CHEMBL90453 206800 0 None 15 3 Human 8.7 pKi = 8.7 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 542 7 1 4 4.7 CC(=O)N1C(=O)N(C)C(C)=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1016/j.ejmech.2017.03.025
11071135 207985 0 None 3 8 Bovine 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 500 6 0 6 4.6 CN1CCC(CCN2CCC(c3cn(-c4ccc(F)cc4)c4ccc(-c5ncn(C)n5)cc34)CC2)C1=O 10.1021/jm020938y
CHEMBL97333 207985 0 None 3 8 Bovine 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 500 6 0 6 4.6 CN1CCC(CCN2CCC(c3cn(-c4ccc(F)cc4)c4ccc(-c5ncn(C)n5)cc34)CC2)C1=O 10.1021/jm020938y
56837419 69275 0 None -9 5 Pig 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 997 35 2 14 6.2 COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1 10.1016/j.bmc.2011.10.063
CHEMBL1928128 69275 0 None -9 5 Pig 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 997 35 2 14 6.2 COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1 10.1016/j.bmc.2011.10.063
10792591 206800 0 None 15 3 Human 8.7 pKi = 8.7 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 542 7 1 4 4.7 CC(=O)N1C(=O)N(C)C(C)=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1021/jm990612y
CHEMBL90453 206800 0 None 15 3 Human 8.7 pKi = 8.7 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 542 7 1 4 4.7 CC(=O)N1C(=O)N(C)C(C)=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1021/jm990612y
44447005 94697 0 None -7 4 Rat 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 446 6 1 5 4.2 O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)C1CC1 10.1016/j.bmcl.2007.11.106
CHEMBL253024 94697 0 None -7 4 Rat 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 446 6 1 5 4.2 O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)C1CC1 10.1016/j.bmcl.2007.11.106
6604803 116492 2 None 7 4 Rat 8.7 pKi = 8.7 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 309 3 3 5 1.2 CS(=O)(=O)Nc1c(O)ccc2c1CCC[C@H]2C1=NCCN1 10.1021/jm960354u
CHEMBL336161 116492 2 None 7 4 Rat 8.7 pKi = 8.7 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 309 3 3 5 1.2 CS(=O)(=O)Nc1c(O)ccc2c1CCC[C@H]2C1=NCCN1 10.1021/jm960354u
10406315 193301 0 None 120 2 Rat 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from adrenergic alpha1A receptor in rat brain membraneDisplacement of [3H]prazosin from adrenergic alpha1A receptor in rat brain membrane
ChEMBL 361 2 2 5 3.5 COc1cc2c(cc1O)C[C@H]1c3c(c(Cl)c(O)c(OC)c3-2)CCN1C 10.1021/np990433j
CHEMBL524439 193301 0 None 120 2 Rat 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from adrenergic alpha1A receptor in rat brain membraneDisplacement of [3H]prazosin from adrenergic alpha1A receptor in rat brain membrane
ChEMBL 361 2 2 5 3.5 COc1cc2c(cc1O)C[C@H]1c3c(c(Cl)c(O)c(OC)c3-2)CCN1C 10.1021/np990433j
134152568 153063 0 None 1 3 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 354 7 0 4 3.8 COc1ccc(CCN2CCN(c3ccccc3OC(C)C)CC2)cc1 10.1016/j.ejmech.2016.06.052
CHEMBL3976144 153063 0 None 1 3 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 354 7 0 4 3.8 COc1ccc(CCN2CCN(c3ccccc3OC(C)C)CC2)cc1 10.1016/j.ejmech.2016.06.052
11014848 205101 0 None 1 4 Human 8.6 pKi = 8.6 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 399 7 1 8 1.5 COc1ccccc1N1CCN(CCNc2c(C(C)=O)c(C)nn(C)c2=O)CC1 10.1021/jm0009336
CHEMBL77901 205101 0 None 1 4 Human 8.6 pKi = 8.6 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 399 7 1 8 1.5 COc1ccccc1N1CCN(CCNc2c(C(C)=O)c(C)nn(C)c2=O)CC1 10.1021/jm0009336
10791843 163376 0 None 138 3 Human 8.6 pKi = 8.6 Binding
Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 511 7 2 4 3.7 CN1C=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3)CC2)[C@H](c2ccc(F)c(F)c2)NC1=O 10.1021/jm990612y
CHEMBL419497 163376 0 None 138 3 Human 8.6 pKi = 8.6 Binding
Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 511 7 2 4 3.7 CN1C=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3)CC2)[C@H](c2ccc(F)c(F)c2)NC1=O 10.1021/jm990612y
2389 3306 118 None -11 68 Human 8.6 pKi = 8.6 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
5073 3306 118 None -11 68 Human 8.6 pKi = 8.6 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
96 3306 118 None -11 68 Human 8.6 pKi = 8.6 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
CHEMBL85 3306 118 None -11 68 Human 8.6 pKi = 8.6 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
DB00734 3306 118 None -11 68 Human 8.6 pKi = 8.6 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
44299945 101899 0 None 41 3 Human 8.6 pKi = 8.6 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 607 7 2 7 4.3 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@H]2CC[C@H](N3CCC(C#N)(c4ccccc4)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
CHEMBL301024 101899 0 None 41 3 Human 8.6 pKi = 8.6 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 607 7 2 7 4.3 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@H]2CC[C@H](N3CCC(C#N)(c4ccccc4)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
44294958 188307 0 None 151 3 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 554 7 3 7 1.9 NC(=O)c1ccccc1N1CCN(CCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc(F)c(F)c2)CC1 10.1016/s0960-894x(99)00653-8
CHEMBL50081 188307 0 None 151 3 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 554 7 3 7 1.9 NC(=O)c1ccccc1N1CCN(CCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc(F)c(F)c2)CC1 10.1016/s0960-894x(99)00653-8
71508687 87025 0 None 33 2 Bovine 8.6 pKi = 8.6 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 385 3 0 3 5.6 CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4cccnc4)cc23)CC1 10.1016/j.bmc.2012.10.049
CHEMBL2325932 87025 0 None 33 2 Bovine 8.6 pKi = 8.6 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 385 3 0 3 5.6 CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4cccnc4)cc23)CC1 10.1016/j.bmc.2012.10.049
489 145 28 None -3 13 Human 8.6 pKi = 8.6 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm00018a001
5640 145 28 None -3 13 Human 8.6 pKi = 8.6 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm00018a001
CHEMBL420060 145 28 None -3 13 Human 8.6 pKi = 8.6 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm00018a001
76333280 84788 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 421 8 1 5 5.3 COc1cccc(OC)c1OCCN[C@H]1C[C@H](c2ccccc2)c2ccccc2S1 10.1007/s00044-010-9379-1
CHEMBL2234442 84788 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 421 8 1 5 5.3 COc1cccc(OC)c1OCCN[C@H]1C[C@H](c2ccccc2)c2ccccc2S1 10.1007/s00044-010-9379-1
11133868 155318 0 None 4 7 Human 8.6 pKi = 8.6 Binding
Affinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptorAffinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptor
ChEMBL 435 9 1 5 5.4 COc1cccc(OC)c1OCCNC[C@H]1C[C@H](c2ccccc2)c2ccccc2S1 10.1021/jm011066n
CHEMBL40325 155318 0 None 4 7 Human 8.6 pKi = 8.6 Binding
Affinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptorAffinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptor
ChEMBL 435 9 1 5 5.4 COc1cccc(OC)c1OCCNC[C@H]1C[C@H](c2ccccc2)c2ccccc2S1 10.1021/jm011066n
76333280 84788 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 421 8 1 5 5.3 COc1cccc(OC)c1OCCN[C@H]1C[C@H](c2ccccc2)c2ccccc2S1 10.1007/s00044-010-9379-1
CHEMBL2234442 84788 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 421 8 1 5 5.3 COc1cccc(OC)c1OCCN[C@H]1C[C@H](c2ccccc2)c2ccccc2S1 10.1007/s00044-010-9379-1
132266 1267 12 None -7 9 Bovine 8.6 pKi = 8.6 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1021/jm960510x
486 1267 12 None -7 9 Bovine 8.6 pKi = 8.6 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1021/jm960510x
CHEMBL423294 1267 12 None -7 9 Bovine 8.6 pKi = 8.6 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1021/jm960510x
19085894 205536 0 None 2 3 Human 8.6 pKi = 8.6 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in COS-7 cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in COS-7 cells
ChEMBL 533 7 0 9 2.3 CS(=O)(=O)c1ccc2c(c1)S(=O)(=O)N(CCCCN1CCC(n3c(=O)oc4ccccc43)CC1)C2=O 10.1016/s0960-894x(98)00446-6
CHEMBL81173 205536 0 None 2 3 Human 8.6 pKi = 8.6 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in COS-7 cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in COS-7 cells
ChEMBL 533 7 0 9 2.3 CS(=O)(=O)c1ccc2c(c1)S(=O)(=O)N(CCCCN1CCC(n3c(=O)oc4ccccc43)CC1)C2=O 10.1016/s0960-894x(98)00446-6
3037308 44049 27 None 2 6 Rat 8.6 pKi = 8.6 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
ChEMBL 452 7 1 7 4.2 O=c1c(CO)coc2cc(OCCCN3CCC(c4noc5cc(F)ccc45)CC3)ccc12 10.1021/jm9810396
CHEMBL151475 44049 27 None 2 6 Rat 8.6 pKi = 8.6 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
ChEMBL 452 7 1 7 4.2 O=c1c(CO)coc2cc(OCCCN3CCC(c4noc5cc(F)ccc45)CC3)ccc12 10.1021/jm9810396
3584 3748 64 None -2 14 Human 8.6 pKi = 8.6 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in human aorta preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in human aorta preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
5401 3748 64 None -2 14 Human 8.6 pKi = 8.6 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in human aorta preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in human aorta preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
7302 3748 64 None -2 14 Human 8.6 pKi = 8.6 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in human aorta preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in human aorta preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
CHEMBL611 3748 64 None -2 14 Human 8.6 pKi = 8.6 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in human aorta preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in human aorta preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
DB01162 3748 64 None -2 14 Human 8.6 pKi = 8.6 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in human aorta preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in human aorta preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
44300159 101808 0 None 275 3 Human 8.6 pKi = 8.6 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 607 7 2 7 4.3 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@H]2CC[C@@H](N3CCC(C#N)(c4ccccc4)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
CHEMBL300355 101808 0 None 275 3 Human 8.6 pKi = 8.6 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 607 7 2 7 4.3 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@H]2CC[C@@H](N3CCC(C#N)(c4ccccc4)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
44300170 168236 0 None 4 3 Human 8.6 pKi = 8.6 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 607 7 2 7 4.5 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4C#N)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
CHEMBL433832 168236 0 None 4 3 Human 8.6 pKi = 8.6 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 607 7 2 7 4.5 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4C#N)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
10793261 121027 0 None 2290 4 Human 8.6 pKi = 8.6 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 575 10 3 8 3.0 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(N)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm990200p
CHEMBL356829 121027 0 None 2290 4 Human 8.6 pKi = 8.6 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 575 10 3 8 3.0 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(N)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm990200p
10326069 39266 1 None 23 9 Human 8.6 pKi = 8.6 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 589 10 3 8 3.3 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980506g
CHEMBL147077 39266 1 None 23 9 Human 8.6 pKi = 8.6 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 589 10 3 8 3.3 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980506g
490 191 8 None -36 12 Rat 8.6 pKi = 8.6 Binding
Binding affinity towards rat Alpha-1A adrenergic receptorBinding affinity towards rat Alpha-1A adrenergic receptor
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 10.1016/s0960-894x(01)00159-7
9890547 191 8 None -36 12 Rat 8.6 pKi = 8.6 Binding
Binding affinity towards rat Alpha-1A adrenergic receptorBinding affinity towards rat Alpha-1A adrenergic receptor
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 10.1016/s0960-894x(01)00159-7
CHEMBL268758 191 8 None -36 12 Rat 8.6 pKi = 8.6 Binding
Binding affinity towards rat Alpha-1A adrenergic receptorBinding affinity towards rat Alpha-1A adrenergic receptor
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 10.1016/s0960-894x(01)00159-7
10647424 206758 0 None 741 2 Human 8.6 pKi = 8.6 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 455 7 3 4 3.0 O=C1NC=C(C(=O)NCCCN2CCC(c3ccccn3)CC2)[C@@H](c2ccc(F)c(F)c2)N1 10.1021/jm990612y
CHEMBL90210 206758 0 None 741 2 Human 8.6 pKi = 8.6 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 455 7 3 4 3.0 O=C1NC=C(C(=O)NCCCN2CCC(c3ccccn3)CC2)[C@@H](c2ccc(F)c(F)c2)N1 10.1021/jm990612y
9909211 94179 1 None 1 3 Human 8.6 pKi = 8.6 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 404 8 2 7 1.9 COc1ccc(Cl)cc1N1CCN(CCCNc2nccc(C(N)=O)n2)CC1 10.1021/jm960697s
CHEMBL24981 94179 1 None 1 3 Human 8.6 pKi = 8.6 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 404 8 2 7 1.9 COc1ccc(Cl)cc1N1CCN(CCCNc2nccc(C(N)=O)n2)CC1 10.1021/jm960697s
52940951 17047 0 None -3 4 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 427 12 1 5 5.0 COc1cccc(Cl)c1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
CHEMBL1254828 17047 0 None -3 4 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 427 12 1 5 5.0 COc1cccc(Cl)c1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
52943356 17048 0 None -2 4 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 407 12 1 5 4.6 COc1cccc(C)c1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
CHEMBL1254829 17048 0 None -2 4 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 407 12 1 5 4.6 COc1cccc(C)c1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
3584 3748 64 None -3 14 Bovine 8.6 pKi = 8.6 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970166j
5401 3748 64 None -3 14 Bovine 8.6 pKi = 8.6 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970166j
7302 3748 64 None -3 14 Bovine 8.6 pKi = 8.6 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970166j
CHEMBL611 3748 64 None -3 14 Bovine 8.6 pKi = 8.6 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970166j
DB01162 3748 64 None -3 14 Bovine 8.6 pKi = 8.6 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970166j
44298735 198437 0 None 39 2 Human 8.6 pKi = 8.6 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 472 8 1 6 3.0 CC(C)c1c[nH]c(=O)n(CCCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)c1=O 10.1016/s0960-894x(03)00305-6
CHEMBL57740 198437 0 None 39 2 Human 8.6 pKi = 8.6 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 472 8 1 6 3.0 CC(C)c1c[nH]c(=O)n(CCCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)c1=O 10.1016/s0960-894x(03)00305-6
10674647 38946 0 None 457 3 Human 8.6 pKi = 8.6 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 574 10 2 8 4.1 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(C)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1007/s00044-004-0120-9
CHEMBL146815 38946 0 None 457 3 Human 8.6 pKi = 8.6 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 574 10 2 8 4.1 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(C)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1007/s00044-004-0120-9
10674647 38946 0 None 457 3 Human 8.6 pKi = 8.6 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 574 10 2 8 4.1 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(C)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
CHEMBL146815 38946 0 None 457 3 Human 8.6 pKi = 8.6 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 574 10 2 8 4.1 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(C)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
11144555 205215 0 None 2 4 Human 8.6 pKi = 8.6 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 433 8 1 7 3.1 COc1ccccc1N1CCN(CCCNc2cc(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
CHEMBL78785 205215 0 None 2 4 Human 8.6 pKi = 8.6 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 433 8 1 7 3.1 COc1ccccc1N1CCN(CCCNc2cc(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
3157 1458 71 None -2 12 Human 8.6 pKi = 8.6 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm00018a001
7170 1458 71 None -2 12 Human 8.6 pKi = 8.6 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm00018a001
954 1458 71 None -2 12 Human 8.6 pKi = 8.6 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm00018a001
CHEMBL707 1458 71 None -2 12 Human 8.6 pKi = 8.6 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm00018a001
DB00590 1458 71 None -2 12 Human 8.6 pKi = 8.6 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm00018a001
490 191 8 None -25 12 Human 8.6 pKi = 8.6 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 10.1016/j.bmcl.2004.11.032
9890547 191 8 None -25 12 Human 8.6 pKi = 8.6 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 10.1016/j.bmcl.2004.11.032
CHEMBL268758 191 8 None -25 12 Human 8.6 pKi = 8.6 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 10.1016/j.bmcl.2004.11.032
10576280 111390 0 None - 1 Human 8.6 pKi = 8.6 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 469 7 3 4 3.4 CC1=C(C(=O)NCCCN2CCC(c3ccccn3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1021/jm990612y
CHEMBL327327 111390 0 None - 1 Human 8.6 pKi = 8.6 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 469 7 3 4 3.4 CC1=C(C(=O)NCCCN2CCC(c3ccccn3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1021/jm990612y
9891166 33582 0 None -6 5 Rat 8.6 pKi = 8.6 Binding
Binding affinity towards rat Alpha-1A adrenergic receptorBinding affinity towards rat Alpha-1A adrenergic receptor
ChEMBL 476 6 0 8 3.3 COc1ccccc1N1CCN(CCn2c(=O)c3c(-c4ccccc4)csc3n(C)c2=O)CC1 10.1016/s0960-894x(01)00159-7
CHEMBL14213 33582 0 None -6 5 Rat 8.6 pKi = 8.6 Binding
Binding affinity towards rat Alpha-1A adrenergic receptorBinding affinity towards rat Alpha-1A adrenergic receptor
ChEMBL 476 6 0 8 3.3 COc1ccccc1N1CCN(CCn2c(=O)c3c(-c4ccccc4)csc3n(C)c2=O)CC1 10.1016/s0960-894x(01)00159-7
490 191 8 None -25 12 Human 8.6 pKi = 8.6 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 10.1016/s0960-894x(01)00159-7
9890547 191 8 None -25 12 Human 8.6 pKi = 8.6 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 10.1016/s0960-894x(01)00159-7
CHEMBL268758 191 8 None -25 12 Human 8.6 pKi = 8.6 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 10.1016/s0960-894x(01)00159-7
9847845 28422 0 None -10 6 Human 8.6 pKi = 8.6 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3sc(C)c(-c4ccccc4)c3c2=O)CC1 10.1016/s0960-894x(01)00159-7
CHEMBL13754 28422 0 None -10 6 Human 8.6 pKi = 8.6 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3sc(C)c(-c4ccccc4)c3c2=O)CC1 10.1016/s0960-894x(01)00159-7
155532148 171677 0 None -1 7 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assayDisplacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assay
ChEMBL 444 6 0 5 4.2 COc1ccccc1N1CCN(CC2COCC(c3ccccc3)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2019.02.056
CHEMBL4466677 171677 0 None -1 7 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assayDisplacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assay
ChEMBL 444 6 0 5 4.2 COc1ccccc1N1CCN(CC2COCC(c3ccccc3)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2019.02.056
44431545 88052 0 None 12 4 Human 8.6 pKi = 8.6 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 457 7 1 5 3.9 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL234669 88052 0 None 12 4 Human 8.6 pKi = 8.6 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 457 7 1 5 3.9 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
44431174 92774 0 None -8 3 Human 8.6 pKi = 8.6 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 515 5 0 5 5.5 CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4cc(Cl)c(Cl)cc4C3=O)CC2)CC1 10.1016/j.bmcl.2006.12.111
CHEMBL243692 92774 0 None -8 3 Human 8.6 pKi = 8.6 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 515 5 0 5 5.5 CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4cc(Cl)c(Cl)cc4C3=O)CC2)CC1 10.1016/j.bmcl.2006.12.111
71508683 87020 0 None 56 2 Bovine 8.6 pKi = 8.6 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 388 3 0 4 5.0 CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4cnn(C)c4)cc23)CC1 10.1016/j.bmc.2012.10.049
CHEMBL2325928 87020 0 None 56 2 Bovine 8.6 pKi = 8.6 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 388 3 0 4 5.0 CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4cnn(C)c4)cc23)CC1 10.1016/j.bmc.2012.10.049
44447001 155449 0 None -30 4 Rat 8.6 pKi = 8.6 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 378 4 1 5 3.6 NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21 10.1016/j.bmcl.2007.11.106
CHEMBL404000 155449 0 None -30 4 Rat 8.6 pKi = 8.6 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 378 4 1 5 3.6 NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21 10.1016/j.bmcl.2007.11.106
10716964 100564 0 None 1 3 Rat 8.6 pKi = 8.6 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 419 4 1 5 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(C)cc(C)cc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL291769 100564 0 None 1 3 Rat 8.6 pKi = 8.6 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 419 4 1 5 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(C)cc(C)cc4c3=O)C[C@@H]21 10.1021/jm000541z
11655728 16612 8 None -39 6 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor by filtration binding assayDisplacement of [3H]prazosin from human adrenergic alpha1A receptor by filtration binding assay
ChEMBL 468 5 1 7 3.1 Cc1ccc2c(N3CCN(CCc4cccc5c4OCc4c(C(N)=O)ncn4-5)CC3)cccc2n1 10.1021/jm100482n
CHEMBL1241913 16612 8 None -39 6 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor by filtration binding assayDisplacement of [3H]prazosin from human adrenergic alpha1A receptor by filtration binding assay
ChEMBL 468 5 1 7 3.1 Cc1ccc2c(N3CCN(CCc4cccc5c4OCc4c(C(N)=O)ncn4-5)CC3)cccc2n1 10.1021/jm100482n
134147055 149550 0 None -2 3 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 354 7 0 4 3.8 COc1cccc(CCN2CCN(c3ccccc3OC(C)C)CC2)c1 10.1016/j.ejmech.2016.06.052
CHEMBL3946843 149550 0 None -2 3 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 354 7 0 4 3.8 COc1cccc(CCN2CCN(c3ccccc3OC(C)C)CC2)c1 10.1016/j.ejmech.2016.06.052
2389 3306 118 None -11 68 Human 8.6 pKi = 8.6 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.bmcl.2004.11.032
5073 3306 118 None -11 68 Human 8.6 pKi = 8.6 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.bmcl.2004.11.032
96 3306 118 None -11 68 Human 8.6 pKi = 8.6 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.bmcl.2004.11.032
CHEMBL85 3306 118 None -11 68 Human 8.6 pKi = 8.6 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.bmcl.2004.11.032
DB00734 3306 118 None -11 68 Human 8.6 pKi = 8.6 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.bmcl.2004.11.032
31101 726 40 None -4 36 Rat 8.6 pKi = 8.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
35 726 40 None -4 36 Rat 8.6 pKi = 8.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
403 726 40 None -4 36 Rat 8.6 pKi = 8.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
CHEMBL493 726 40 None -4 36 Rat 8.6 pKi = 8.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
DB01200 726 40 None -4 36 Rat 8.6 pKi = 8.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
11154198 201591 0 None -5 5 Human 8.6 pKi = 8.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 413 6 0 5 3.3 CC(C)Oc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1007/s00044-010-9379-1
CHEMBL60583 201591 0 None -5 5 Human 8.6 pKi = 8.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 413 6 0 5 3.3 CC(C)Oc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1007/s00044-010-9379-1
11994797 12282 0 None 1 7 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 369 7 1 5 3.4 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)CCCC2 10.1021/jm060358r
CHEMBL1185017 12282 0 None 1 7 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 369 7 1 5 3.4 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)CCCC2 10.1021/jm060358r
CHEMBL383938 12282 0 None 1 7 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 369 7 1 5 3.4 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)CCCC2 10.1021/jm060358r
45268939 196637 0 None -4 5 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 505 4 1 9 3.0 COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1021/jm8016046
CHEMBL564481 196637 0 None -4 5 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 505 4 1 9 3.0 COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1021/jm8016046
11154198 201591 0 None -5 5 Human 8.6 pKi = 8.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 413 6 0 5 3.3 CC(C)Oc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1007/s00044-010-9379-1
CHEMBL60583 201591 0 None -5 5 Human 8.6 pKi = 8.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 413 6 0 5 3.3 CC(C)Oc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1007/s00044-010-9379-1
11487449 195466 0 None -1 4 Rat 8.5 pKi = 8.5 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 437 5 0 4 4.2 O=C1CC2(CCCC2)CC(=O)N1CCCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
CHEMBL55319 195466 0 None -1 4 Rat 8.5 pKi = 8.5 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 437 5 0 4 4.2 O=C1CC2(CCCC2)CC(=O)N1CCCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
10506674 119698 0 None 354 3 Human 8.5 pKi = 8.5 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 542 9 3 7 3.4 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(C#N)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980506g
CHEMBL347559 119698 0 None 354 3 Human 8.5 pKi = 8.5 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 542 9 3 7 3.4 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(C#N)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980506g
46934787 16654 0 None 1 4 Human 8.5 pKi = 8.5 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 465 7 0 7 2.2 COc1ccccc1N1CCN(C[C@H]2CO[C@@](CN3C(=O)CCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
CHEMBL1242724 16654 0 None 1 4 Human 8.5 pKi = 8.5 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 465 7 0 7 2.2 COc1ccccc1N1CCN(C[C@H]2CO[C@@](CN3C(=O)CCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
3584 3748 64 None -2 14 Human 8.5 pKi = 8.5 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in human prostate tissue preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in human prostate tissue preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
5401 3748 64 None -2 14 Human 8.5 pKi = 8.5 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in human prostate tissue preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in human prostate tissue preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
7302 3748 64 None -2 14 Human 8.5 pKi = 8.5 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in human prostate tissue preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in human prostate tissue preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
CHEMBL611 3748 64 None -2 14 Human 8.5 pKi = 8.5 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in human prostate tissue preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in human prostate tissue preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
DB01162 3748 64 None -2 14 Human 8.5 pKi = 8.5 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in human prostate tissue preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in human prostate tissue preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
134147929 149617 0 None -1 3 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 340 7 0 4 3.5 CCOc1ccccc1N1CCN(CCc2cccc(OC)c2)CC1 10.1016/j.ejmech.2016.06.052
CHEMBL3947302 149617 0 None -1 3 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 340 7 0 4 3.5 CCOc1ccccc1N1CCN(CCc2cccc(OC)c2)CC1 10.1016/j.ejmech.2016.06.052
11145007 164069 0 None -2 4 Human 8.5 pKi = 8.5 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 461 9 1 8 3.0 COc1ccc(Cl)cc1N1CCN(CCCCNc2c(C(C)=O)c(C)nn(C)c2=O)CC1 10.1021/jm0009336
CHEMBL420959 164069 0 None -2 4 Human 8.5 pKi = 8.5 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 461 9 1 8 3.0 COc1ccc(Cl)cc1N1CCN(CCCCNc2c(C(C)=O)c(C)nn(C)c2=O)CC1 10.1021/jm0009336
19085832 163752 0 None 5 3 Human 7.7 pKi = 7.7 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 483 6 0 7 3.5 Cc1cc(C)c2oc(=O)n(C3CCN(CCCCN4C(=O)c5ccccc5S4(=O)=O)CC3)c2c1 10.1016/s0960-894x(98)00446-6
CHEMBL420578 163752 0 None 5 3 Human 7.7 pKi = 7.7 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 483 6 0 7 3.5 Cc1cc(C)c2oc(=O)n(C3CCN(CCCCN4C(=O)c5ccccc5S4(=O)=O)CC3)c2c1 10.1016/s0960-894x(98)00446-6
2337 3232 77 None -5 63 Human 7.7 pKi = 7.7 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
50 3232 77 None -5 63 Human 7.7 pKi = 7.7 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
5002 3232 77 None -5 63 Human 7.7 pKi = 7.7 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
CHEMBL716 3232 77 None -5 63 Human 7.7 pKi = 7.7 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
DB01224 3232 77 None -5 63 Human 7.7 pKi = 7.7 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
10578926 118940 0 None 75 3 Human 7.7 pKi = 7.7 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 567 10 1 7 4.5 COC(=O)C1=C(C)N=C(C)N(CCC[C@@H](C)CN2CCN(c3ccccc3C(N)=O)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL342347 118940 0 None 75 3 Human 7.7 pKi = 7.7 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 567 10 1 7 4.5 COC(=O)C1=C(C)N=C(C)N(CCC[C@@H](C)CN2CCN(c3ccccc3C(N)=O)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
9890459 16899 0 None 13 3 Human 7.7 pKi = 7.7 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 460 10 1 7 1.3 CCOC(=O)C1CCC(=O)N1CC(=O)NCCN1CCN(c2ccccc2OC(C)C)CC1 10.1016/s0960-894x(00)00169-4
CHEMBL12529 16899 0 None 13 3 Human 7.7 pKi = 7.7 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 460 10 1 7 1.3 CCOC(=O)C1CCC(=O)N1CC(=O)NCCN1CCN(c2ccccc2OC(C)C)CC1 10.1016/s0960-894x(00)00169-4
45560410 1081 0 None -891 4 Human 7.7 pKi = 7.7 Binding
Binding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constantBinding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constant
ChEMBL 340 6 1 5 1.6 COc1ccccc1N1CCN(CC1)CCNC(=O)c1ccccn1 10.1021/acs.jmedchem.2c00633
9825 1081 0 None -891 4 Human 7.7 pKi = 7.7 Binding
Binding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constantBinding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constant
ChEMBL 340 6 1 5 1.6 COc1ccccc1N1CCN(CC1)CCNC(=O)c1ccccn1 10.1021/acs.jmedchem.2c00633
CHEMBL4205290 1081 0 None -891 4 Human 7.7 pKi = 7.7 Binding
Binding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constantBinding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constant
ChEMBL 340 6 1 5 1.6 COc1ccccc1N1CCN(CC1)CCNC(=O)c1ccccn1 10.1021/acs.jmedchem.2c00633
10640907 4880 1 None -21 5 Human 7.7 pKi = 7.7 Binding
Binding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constantBinding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constant
ChEMBL 340 6 1 5 1.6 COc1ccccc1N1CCN(CCNC(=O)c2ccncc2)CC1 10.1021/acs.jmedchem.2c00633
CHEMBL104593 4880 1 None -21 5 Human 7.7 pKi = 7.7 Binding
Binding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constantBinding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constant
ChEMBL 340 6 1 5 1.6 COc1ccccc1N1CCN(CCNC(=O)c2ccncc2)CC1 10.1021/acs.jmedchem.2c00633
56971026 69213 0 None -12 4 Human 7.7 pKi = 7.7 Binding
Binding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constantBinding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constant
ChEMBL 378 7 1 6 2.1 COc1ccccc1N1CCN(CCCN/C(=N\C#N)c2ccccn2)CC1 10.1021/acs.jmedchem.2c00633
CHEMBL1927088 69213 0 None -12 4 Human 7.7 pKi = 7.7 Binding
Binding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constantBinding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constant
ChEMBL 378 7 1 6 2.1 COc1ccccc1N1CCN(CCCN/C(=N\C#N)c2ccccn2)CC1 10.1021/acs.jmedchem.2c00633
CHEMBL5172506 69213 0 None -12 4 Human 7.7 pKi = 7.7 Binding
Binding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constantBinding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constant
ChEMBL 378 7 1 6 2.1 COc1ccccc1N1CCN(CCCN/C(=N\C#N)c2ccccn2)CC1 10.1021/acs.jmedchem.2c00633
44431553 87457 0 None 1 4 Human 7.7 pKi = 7.7 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 525 7 1 5 4.9 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3cccc(C(F)(F)F)c3)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL233416 87457 0 None 1 4 Human 7.7 pKi = 7.7 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 525 7 1 5 4.9 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3cccc(C(F)(F)F)c3)CC2)CC1 10.1016/j.bmcl.2007.04.008
44390704 64523 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 445 7 2 10 -0.2 Cn1c(NCCCN2CCN(c3ccc4c(c3)OCC(CO)O4)CC2)cc(=O)n(C)c1=O 10.1016/j.bmcl.2004.11.032
CHEMBL181475 64523 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 445 7 2 10 -0.2 Cn1c(NCCCN2CCN(c3ccc4c(c3)OCC(CO)O4)CC2)cc(=O)n(C)c1=O 10.1016/j.bmcl.2004.11.032
44331090 208370 0 None 6 3 Human 7.7 pKi = 7.7 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 464 5 1 5 4.3 CS(=O)(=O)Nc1ccc2c(c1)OC1(CCN(CCc3cccc4ccccc34)CC1)CC2=O 10.1016/s0960-894x(98)00732-x
CHEMBL99614 208370 0 None 6 3 Human 7.7 pKi = 7.7 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 464 5 1 5 4.3 CS(=O)(=O)Nc1ccc2c(c1)OC1(CCN(CCc3cccc4ccccc34)CC1)CC2=O 10.1016/s0960-894x(98)00732-x
13141183 161939 1 None 15 2 Bovine 7.7 pKi = 7.7 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 310 0 0 2 4.6 CN1CCC(=C2c3cc(Cl)ccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
CHEMBL415761 161939 1 None 15 2 Bovine 7.7 pKi = 7.7 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 310 0 0 2 4.6 CN1CCC(=C2c3cc(Cl)ccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
3251 4041 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assayDisplacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assay
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1016/j.ejmech.2011.06.023
5684 4041 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assayDisplacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assay
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1016/j.ejmech.2011.06.023
80 4041 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assayDisplacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assay
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1016/j.ejmech.2011.06.023
CHEMBL31354 4041 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assayDisplacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assay
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1016/j.ejmech.2011.06.023
10839106 111568 0 None 5 3 Human 7.7 pKi = 7.7 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 500 7 2 3 4.5 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H](c2ccc(F)c(F)c2)NC(=O)N1C 10.1021/jm990612y
CHEMBL328268 111568 0 None 5 3 Human 7.7 pKi = 7.7 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 500 7 2 3 4.5 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H](c2ccc(F)c(F)c2)NC(=O)N1C 10.1021/jm990612y
11800744 207308 0 None 10 3 Human 7.7 pKi = 7.7 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 547 7 3 4 4.4 N#Cc1ccccc1C1CCN(CCCNC(=O)C2=C(C(F)(F)F)NC(=O)N[C@@H]2c2ccc(F)c(F)c2)CC1 10.1021/jm990612y
CHEMBL93523 207308 0 None 10 3 Human 7.7 pKi = 7.7 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 547 7 3 4 4.4 N#Cc1ccccc1C1CCN(CCCNC(=O)C2=C(C(F)(F)F)NC(=O)N[C@@H]2c2ccc(F)c(F)c2)CC1 10.1021/jm990612y
24854106 161037 1 None 2 8 Human 7.7 pKi = 7.7 Binding
Inhibition of adrenergic alpha-1 receptorInhibition of adrenergic alpha-1 receptor
ChEMBL 367 6 1 3 3.9 O=C1Nc2ccc(F)cc2C1CCCCN1CCN(c2ccccc2)CC1 10.1021/jm070279v
CHEMBL411663 161037 1 None 2 8 Human 7.7 pKi = 7.7 Binding
Inhibition of adrenergic alpha-1 receptorInhibition of adrenergic alpha-1 receptor
ChEMBL 367 6 1 3 3.9 O=C1Nc2ccc(F)cc2C1CCCCN1CCN(c2ccccc2)CC1 10.1021/jm070279v
3251 4041 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Inhibition of adrenergic alpha1A receptorInhibition of adrenergic alpha1A receptor
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1021/jm1009956
5684 4041 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Inhibition of adrenergic alpha1A receptorInhibition of adrenergic alpha1A receptor
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1021/jm1009956
80 4041 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Inhibition of adrenergic alpha1A receptorInhibition of adrenergic alpha1A receptor
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1021/jm1009956
CHEMBL31354 4041 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Inhibition of adrenergic alpha1A receptorInhibition of adrenergic alpha1A receptor
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1021/jm1009956
10603951 206493 0 None 11 6 Human 7.7 pKi = 7.7 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 622 10 1 7 6.8 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)N(C)CCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
CHEMBL88448 206493 0 None 11 6 Human 7.7 pKi = 7.7 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 622 10 1 7 6.8 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)N(C)CCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
10603951 85242 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 622 10 1 7 5.9 COC(=O)C1=C(C)NC(C)=C(C(=O)N(C)CCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
CHEMBL2260148 85242 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 622 10 1 7 5.9 COC(=O)C1=C(C)NC(C)=C(C(=O)N(C)CCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
11097789 102971 1 None -4 6 Human 7.7 pKi = 7.7 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 239 4 2 4 2.0 CSc1cc(F)ccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL306792 102971 1 None -4 6 Human 7.7 pKi = 7.7 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 239 4 2 4 2.0 CSc1cc(F)ccc1NCC1=NCCN1 10.1021/jm000542r
10934575 204463 0 None -1 6 Human 7.7 pKi = 7.7 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 235 4 2 4 2.1 CSc1ccc(C)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL72441 204463 0 None -1 6 Human 7.7 pKi = 7.7 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 235 4 2 4 2.1 CSc1ccc(C)cc1NCC1=NCCN1 10.1021/jm000542r
9894818 98897 0 None 83 7 Human 7.7 pKi = 7.7 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
CHEMBL279436 98897 0 None 83 7 Human 7.7 pKi = 7.7 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
9894818 98897 0 None 83 7 Human 7.7 pKi = 7.7 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1007/s00044-004-0120-9
CHEMBL279436 98897 0 None 83 7 Human 7.7 pKi = 7.7 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1007/s00044-004-0120-9
53328684 63368 0 None 2 3 Human 7.7 pKi = 7.7 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 480 9 0 7 3.4 COc1ccccc1N1CCN(CCCCN2C(=O)CC(c3ccc([N+](=O)[O-])cc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796043 63368 0 None 2 3 Human 7.7 pKi = 7.7 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 480 9 0 7 3.4 COc1ccccc1N1CCN(CCCCN2C(=O)CC(c3ccc([N+](=O)[O-])cc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
46881494 6576 0 None -20 4 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 421 9 1 5 4.7 COc1ccccc1OCCNCC1CSC(c2ccccc2)(c2ccccc2)O1 10.1016/j.bmcl.2010.01.030
CHEMBL1083182 6576 0 None -20 4 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 421 9 1 5 4.7 COc1ccccc1OCCNCC1CSC(c2ccccc2)(c2ccccc2)O1 10.1016/j.bmcl.2010.01.030
10106205 207114 1 None -12 4 Human 6.7 pKi = 6.7 Binding
Binding affinity towards alpha-1-adrenergic receptorBinding affinity towards alpha-1-adrenergic receptor
ChEMBL 251 2 2 3 3.0 Cc1c(NC2=NCCN2)cccc1-c1ccccc1 10.1021/jm030030n
CHEMBL92221 207114 1 None -12 4 Human 6.7 pKi = 6.7 Binding
Binding affinity towards alpha-1-adrenergic receptorBinding affinity towards alpha-1-adrenergic receptor
ChEMBL 251 2 2 3 3.0 Cc1c(NC2=NCCN2)cccc1-c1ccccc1 10.1021/jm030030n
10183297 93283 0 None -109 3 Human 6.7 pKi = 6.7 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptor
ChEMBL 464 7 1 3 6.7 CC(C)C(=O)Nc1cccc(C2CCN(Cc3ccc(Oc4ccc(F)c(F)c4)cc3)CC2)c1 10.1021/jm060383x
CHEMBL245231 93283 0 None -109 3 Human 6.7 pKi = 6.7 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptor
ChEMBL 464 7 1 3 6.7 CC(C)C(=O)Nc1cccc(C2CCN(Cc3ccc(Oc4ccc(F)c(F)c4)cc3)CC2)c1 10.1021/jm060383x
102 4096 48 None -85 50 Bovine 6.7 pKi = 6.7 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00375a017
3659 4096 48 None -85 50 Bovine 6.7 pKi = 6.7 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00375a017
8969 4096 48 None -85 50 Bovine 6.7 pKi = 6.7 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00375a017
CHEMBL15245 4096 48 None -85 50 Bovine 6.7 pKi = 6.7 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00375a017
DB01392 4096 48 None -85 50 Bovine 6.7 pKi = 6.7 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00375a017
57393634 69290 0 None -1 5 Pig 6.7 pKi = 6.7 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 953 32 2 13 6.2 COc1cc(COCCOCCOCCOCCOCc2ccc(N3CCN(CCCCNC(=O)c4ccccc4)CC3)c(OC)c2)ccc1N1CCN(CCCCNC(=O)c2ccccc2)CC1 10.1016/j.bmc.2011.10.063
CHEMBL1928248 69290 0 None -1 5 Pig 6.7 pKi = 6.7 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 953 32 2 13 6.2 COc1cc(COCCOCCOCCOCCOCc2ccc(N3CCN(CCCCNC(=O)c4ccccc4)CC3)c(OC)c2)ccc1N1CCN(CCCCNC(=O)c2ccccc2)CC1 10.1016/j.bmc.2011.10.063
2737203 183900 83 None -141 2 Bovine 5.7 pKi = 5.7 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 188 1 1 4 0.4 N#Cc1cccnc1N1CCNCC1 10.1021/jm00366a007
CHEMBL48137 183900 83 None -141 2 Bovine 5.7 pKi = 5.7 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 188 1 1 4 0.4 N#Cc1cccnc1N1CCNCC1 10.1021/jm00366a007
1028 289 71 None -48 30 Human 5.7 pKi = 5.7 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
139148732 289 71 None -48 30 Human 5.7 pKi = 5.7 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
479 289 71 None -48 30 Human 5.7 pKi = 5.7 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
5816 289 71 None -48 30 Human 5.7 pKi = 5.7 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
CHEMBL679 289 71 None -48 30 Human 5.7 pKi = 5.7 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
DB00668 289 71 None -48 30 Human 5.7 pKi = 5.7 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
43260 5450 65 None -1 5 Rat 5.7 pKi = 5.7 Binding
Binding affinity towards rat submaxillary gland Alpha-1 adrenergic receptor; value ranges from (1.6 -2.5)Binding affinity towards rat submaxillary gland Alpha-1 adrenergic receptor; value ranges from (1.6 -2.5)
ChEMBL 197 4 2 4 0.7 COc1ccc(OC)c(C(O)CN)c1 10.1021/jm025550h
CHEMBL1076 5450 65 None -1 5 Rat 5.7 pKi = 5.7 Binding
Binding affinity towards rat submaxillary gland Alpha-1 adrenergic receptor; value ranges from (1.6 -2.5)Binding affinity towards rat submaxillary gland Alpha-1 adrenergic receptor; value ranges from (1.6 -2.5)
ChEMBL 197 4 2 4 0.7 COc1ccc(OC)c(C(O)CN)c1 10.1021/jm025550h
10892762 78792 0 None -52 6 Human 6.7 pKi = 6.7 Binding
Binding affinity was determined on human cloned Alpha-1A adrenoceptorBinding affinity was determined on human cloned Alpha-1A adrenoceptor
ChEMBL 326 7 1 4 3.8 COc1cccc(C2CCC(NCCOc3ccccn3)CC2)c1 10.1021/jm010866v
CHEMBL2112774 78792 0 None -52 6 Human 6.7 pKi = 6.7 Binding
Binding affinity was determined on human cloned Alpha-1A adrenoceptorBinding affinity was determined on human cloned Alpha-1A adrenoceptor
ChEMBL 326 7 1 4 3.8 COc1cccc(C2CCC(NCCOc3ccccn3)CC2)c1 10.1021/jm010866v
12134995 102115 0 None -1 3 Human 6.7 pKi = 6.7 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 318 5 1 5 2.6 COc1ccccc1N1CCN(Cc2ccc(CO)s2)CC1 10.1016/s0960-894x(02)00347-5
CHEMBL302495 102115 0 None -1 3 Human 6.7 pKi = 6.7 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 318 5 1 5 2.6 COc1ccccc1N1CCN(Cc2ccc(CO)s2)CC1 10.1016/s0960-894x(02)00347-5
9885114 119578 5 None -47 12 Rat 6.7 pKi = 6.7 Binding
Inhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary glandInhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 357 3 1 4 3.0 O=C1COc2cc(CN3CCN(c4ccc(Cl)cc4)CC3)ccc2N1 10.1021/jm990277d
CHEMBL346389 119578 5 None -47 12 Rat 6.7 pKi = 6.7 Binding
Inhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary glandInhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 357 3 1 4 3.0 O=C1COc2cc(CN3CCN(c4ccc(Cl)cc4)CC3)ccc2N1 10.1021/jm990277d
218362 204777 5 None -75 4 Human 6.7 pKi = 6.7 Binding
Binding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 216 1 1 3 2.0 c1ccc2c(c1)CCCC2NC1=NCCO1 10.1016/0960-894X(94)85032-1
CHEMBL75030 204777 5 None -75 4 Human 6.7 pKi = 6.7 Binding
Binding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 216 1 1 3 2.0 c1ccc2c(c1)CCCC2NC1=NCCO1 10.1016/0960-894X(94)85032-1
9904606 9354 0 None -2 4 Rat 6.7 pKi = 6.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 305 3 1 3 2.3 CN(c1cccc2c1CCCC2c1c[nH]cn1)S(C)(=O)=O 10.1021/jm030551a
CHEMBL111463 9354 0 None -2 4 Rat 6.7 pKi = 6.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 305 3 1 3 2.3 CN(c1cccc2c1CCCC2c1c[nH]cn1)S(C)(=O)=O 10.1021/jm030551a
11347303 111353 0 None -91 5 Bovine 5.7 pKi = 5.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assay
ChEMBL 305 4 2 3 2.6 CCS(=O)(=O)Nc1ccc2c(c1)C(c1c[nH]cn1)CCC2 10.1021/jm030551a
CHEMBL327116 111353 0 None -91 5 Bovine 5.7 pKi = 5.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assay
ChEMBL 305 4 2 3 2.6 CCS(=O)(=O)Nc1ccc2c(c1)C(c1c[nH]cn1)CCC2 10.1021/jm030551a
1220 187 55 None -1659 45 Rat 5.7 pKi = 5.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm030944+
31 187 55 None -1659 45 Rat 5.7 pKi = 5.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm030944+
7 187 55 None -1659 45 Rat 5.7 pKi = 5.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm030944+
CHEMBL56 187 55 None -1659 45 Rat 5.7 pKi = 5.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm030944+
11857709 85610 0 None 1 4 Human 7.7 pKi = 7.7 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 556 9 1 6 5.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OCC(F)(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
CHEMBL228389 85610 0 None 1 4 Human 7.7 pKi = 7.7 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 556 9 1 6 5.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OCC(F)(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
11857709 85610 0 None 1 4 Human 7.7 pKi = 7.7 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 556 9 1 6 5.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OCC(F)(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
CHEMBL228389 85610 0 None 1 4 Human 7.7 pKi = 7.7 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 556 9 1 6 5.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OCC(F)(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
26987 946 33 None -75 21 Rat 7.7 pKi = 7.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
6063 946 33 None -75 21 Rat 7.7 pKi = 7.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
671 946 33 None -75 21 Rat 7.7 pKi = 7.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
CHEMBL1626 946 33 None -75 21 Rat 7.7 pKi = 7.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
DB00283 946 33 None -75 21 Rat 7.7 pKi = 7.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
9798183 13108 0 None -33 3 Rat 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 343 5 1 2 4.4 Fc1ccc2c(C3CCN(CCCN4CCCCC4)CC3)c[nH]c2c1 10.1016/j.bmcl.2006.05.002
CHEMBL1190579 13108 0 None -33 3 Rat 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 343 5 1 2 4.4 Fc1ccc2c(C3CCN(CCCN4CCCCC4)CC3)c[nH]c2c1 10.1016/j.bmcl.2006.05.002
CHEMBL541129 13108 0 None -33 3 Rat 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 343 5 1 2 4.4 Fc1ccc2c(C3CCN(CCCN4CCCCC4)CC3)c[nH]c2c1 10.1016/j.bmcl.2006.05.002
11496213 16042 0 None -35 3 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 454 8 1 4 6.1 Clc1cccc(N2CCN(CCCCNc3ccc(-c4ccccc4)cn3)CC2)c1Cl 10.1016/j.bmcl.2010.07.096
CHEMBL1223800 16042 0 None -35 3 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 454 8 1 4 6.1 Clc1cccc(N2CCN(CCCCNc3ccc(-c4ccccc4)cn3)CC2)c1Cl 10.1016/j.bmcl.2010.07.096
46934789 16659 0 None -2 4 Human 7.7 pKi = 7.7 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 479 7 0 7 2.6 COc1ccccc1N1CCN(C[C@@H]2CO[C@@](CN3C(=O)CCCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
CHEMBL1242819 16659 0 None -2 4 Human 7.7 pKi = 7.7 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 479 7 0 7 2.6 COc1ccccc1N1CCN(C[C@@H]2CO[C@@](CN3C(=O)CCCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
118716708 114976 0 None 1 4 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 441 5 0 7 2.5 COc1ccccc1N1CCN(CC2COC3(CCN(C(=O)c4ccco4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342861 114976 0 None 1 4 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 441 5 0 7 2.5 COc1ccccc1N1CCN(CC2COC3(CCN(C(=O)c4ccco4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
73346042 91805 5 None -213 17 Human 7.7 pKi = 7.7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 405 9 0 8 0.9 Cn1c(=O)cnn(CCCCN2CCN(c3ccccc3OCCF)CC2)c1=O 10.1016/j.bmc.2013.05.050
CHEMBL2413153 91805 5 None -213 17 Human 7.7 pKi = 7.7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 405 9 0 8 0.9 Cn1c(=O)cnn(CCCCN2CCN(c3ccccc3OCCF)CC2)c1=O 10.1016/j.bmc.2013.05.050
73346042 91805 5 None -213 17 Human 7.7 pKi = 7.7 Binding
Binding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constantBinding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constant
ChEMBL 405 9 0 8 0.9 Cn1c(=O)cnn(CCCCN2CCN(c3ccccc3OCCF)CC2)c1=O 10.1021/acs.jmedchem.2c00633
CHEMBL2413153 91805 5 None -213 17 Human 7.7 pKi = 7.7 Binding
Binding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constantBinding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constant
ChEMBL 405 9 0 8 0.9 Cn1c(=O)cnn(CCCCN2CCN(c3ccccc3OCCF)CC2)c1=O 10.1021/acs.jmedchem.2c00633
53328316 63361 0 None 1 3 Human 7.7 pKi = 7.7 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 449 9 0 5 3.9 COc1ccccc1N1CCN(CCCCCN2C(=O)CC(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796036 63361 0 None 1 3 Human 7.7 pKi = 7.7 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 449 9 0 5 3.9 COc1ccccc1N1CCN(CCCCCN2C(=O)CC(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
13938356 185054 0 None -154 2 Bovine 6.7 pKi = 6.7 Binding
Evaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortexEvaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortex
ChEMBL 364 4 1 5 1.7 CN(C1CCN2CCc3c(oc4ccccc34)C2C1)S(=O)(=O)CCO 10.1021/jm00150a002
CHEMBL48558 185054 0 None -154 2 Bovine 6.7 pKi = 6.7 Binding
Evaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortexEvaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortex
ChEMBL 364 4 1 5 1.7 CN(C1CCN2CCc3c(oc4ccccc34)C2C1)S(=O)(=O)CCO 10.1021/jm00150a002
127027079 137751 0 None -416 3 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 442 7 2 4 3.7 O=C1Cc2c(cccc2N2CCN(CCCCNC(=O)c3ccc4ccccc4c3)CC2)N1 10.1016/j.bmcl.2015.12.068
CHEMBL3759441 137751 0 None -416 3 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 442 7 2 4 3.7 O=C1Cc2c(cccc2N2CCN(CCCCNC(=O)c3ccc4ccccc4c3)CC2)N1 10.1016/j.bmcl.2015.12.068
145946733 167556 0 None -14 5 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 368 7 0 4 4.2 COc1ccc(N2CCN(CCCOc3c(C)cc(C)cc3C)CC2)cc1 10.1016/j.bmcl.2018.04.059
CHEMBL4205526 167556 0 None -14 5 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 368 7 0 4 4.2 COc1ccc(N2CCN(CCCOc3c(C)cc(C)cc3C)CC2)cc1 10.1016/j.bmcl.2018.04.059
CHEMBL4300710 167556 0 None -14 5 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 368 7 0 4 4.2 COc1ccc(N2CCN(CCCOc3c(C)cc(C)cc3C)CC2)cc1 10.1016/j.bmcl.2018.04.059
11176459 101610 0 None -229 5 Rat 6.7 pKi = 6.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 380 4 0 5 2.4 N#Cc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1021/jm030944+
CHEMBL299022 101610 0 None -229 5 Rat 6.7 pKi = 6.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 380 4 0 5 2.4 N#Cc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1021/jm030944+
44312037 204596 1 None -2 6 Human 4.7 pKi = 4.7 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 308 1 1 5 2.9 Brc1c(NC2=NCCS2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
CHEMBL73392 204596 1 None -2 6 Human 4.7 pKi = 4.7 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 308 1 1 5 2.9 Brc1c(NC2=NCCS2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
179268 102139 6 None -4 2 Human 5.7 pKi = 5.7 Binding
Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)
ChEMBL 454 2 3 1 6.2 Brc1ccc2c(-c3c[nH]c(-c4c[nH]c5cc(Br)ccc45)n3)c[nH]c2c1 10.1016/0960-894X(96)00376-9
CHEMBL302637 102139 6 None -4 2 Human 5.7 pKi = 5.7 Binding
Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)
ChEMBL 454 2 3 1 6.2 Brc1ccc2c(-c3c[nH]c(-c4c[nH]c5cc(Br)ccc45)n3)c[nH]c2c1 10.1016/0960-894X(96)00376-9
11959098 179512 56 None -79 2 Bovine 6.7 pKi = 6.7 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 211 1 0 3 1.5 CN1CCN(c2ncccc2Cl)CC1 10.1021/jm00366a007
CHEMBL47415 179512 56 None -79 2 Bovine 6.7 pKi = 6.7 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 211 1 0 3 1.5 CN1CCN(c2ncccc2Cl)CC1 10.1021/jm00366a007
10737133 206638 0 None -15 2 Rat 6.7 pKi = 6.7 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 358 6 0 5 2.3 COc1ccccc1N1CCN(CCCN2CC3CCCCN3C2)CC1 10.1021/jm970216k
CHEMBL89380 206638 0 None -15 2 Rat 6.7 pKi = 6.7 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 358 6 0 5 2.3 COc1ccccc1N1CCN(CCCN2CC3CCCCN3C2)CC1 10.1021/jm970216k
10028436 3506 5 None -109 12 Human 6.7 pKi = 6.7 Binding
Compound was tested for its binding affinity for Alpha 1B adrenergic receptorCompound was tested for its binding affinity for Alpha 1B adrenergic receptor
ChEMBL 487 7 1 4 4.9 Clc1ccc(cc1)OC1CCN(CC1)CC[C@H]1CCCN1S(=O)(=O)c1ccc2c(c1)[nH]cc2 10.1016/s0960-894x(02)00690-x
3237 3506 5 None -109 12 Human 6.7 pKi = 6.7 Binding
Compound was tested for its binding affinity for Alpha 1B adrenergic receptorCompound was tested for its binding affinity for Alpha 1B adrenergic receptor
ChEMBL 487 7 1 4 4.9 Clc1ccc(cc1)OC1CCN(CC1)CC[C@H]1CCCN1S(=O)(=O)c1ccc2c(c1)[nH]cc2 10.1016/s0960-894x(02)00690-x
CHEMBL95104 3506 5 None -109 12 Human 6.7 pKi = 6.7 Binding
Compound was tested for its binding affinity for Alpha 1B adrenergic receptorCompound was tested for its binding affinity for Alpha 1B adrenergic receptor
ChEMBL 487 7 1 4 4.9 Clc1ccc(cc1)OC1CCN(CC1)CC[C@H]1CCCN1S(=O)(=O)c1ccc2c(c1)[nH]cc2 10.1016/s0960-894x(02)00690-x
10903226 13738 0 None -2 4 Human 5.7 pKi = 5.7 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 281 6 2 5 1.3 CCCS(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL1195368 13738 0 None -2 4 Human 5.7 pKi = 5.7 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 281 6 2 5 1.3 CCCS(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL554416 13738 0 None -2 4 Human 5.7 pKi = 5.7 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 281 6 2 5 1.3 CCCS(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
44314200 102925 0 None -81 4 Human 5.7 pKi = 5.7 Binding
Binding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 230 1 1 3 2.4 c1ccc2c(c1)CCCC2NC1=NCCCO1 10.1016/0960-894X(94)85032-1
CHEMBL306377 102925 0 None -81 4 Human 5.7 pKi = 5.7 Binding
Binding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 230 1 1 3 2.4 c1ccc2c(c1)CCCC2NC1=NCCCO1 10.1016/0960-894X(94)85032-1
10626453 121989 0 None 72 3 Human 7.7 pKi = 7.7 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 548 9 0 6 6.2 COC(=O)C1=C(C)N=C(C)N(CCC[C@@H](C)CN2CCC(C#N)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL359430 121989 0 None 72 3 Human 7.7 pKi = 7.7 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 548 9 0 6 6.2 COC(=O)C1=C(C)N=C(C)N(CCC[C@@H](C)CN2CCC(C#N)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
135398737 955 93 None -5 92 Rat 7.7 pKi = 7.7 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm9810396
38 955 93 None -5 92 Rat 7.7 pKi = 7.7 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm9810396
722 955 93 None -5 92 Rat 7.7 pKi = 7.7 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm9810396
CHEMBL42 955 93 None -5 92 Rat 7.7 pKi = 7.7 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm9810396
DB00363 955 93 None -5 92 Rat 7.7 pKi = 7.7 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm9810396
10768610 203747 0 None 24 2 Human 7.7 pKi = 7.7 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 532 8 2 7 2.5 COc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2cccc(F)c2)C3=O)CC1 10.1021/jm9905918
CHEMBL68045 203747 0 None 24 2 Human 7.7 pKi = 7.7 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 532 8 2 7 2.5 COc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2cccc(F)c2)C3=O)CC1 10.1021/jm9905918
9888164 17919 1 None 25 3 Human 7.7 pKi = 7.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 416 8 1 5 2.1 CC(C)Oc1ccccc1N1CCN(CCNC(=O)CN2CCCCCC2=O)CC1 10.1016/j.bmcl.2004.11.032
CHEMBL12603 17919 1 None 25 3 Human 7.7 pKi = 7.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 416 8 1 5 2.1 CC(C)Oc1ccccc1N1CCN(CCNC(=O)CN2CCCCCC2=O)CC1 10.1016/j.bmcl.2004.11.032
16041264 95414 0 None -1 4 Human 7.7 pKi = 7.7 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 470 6 2 4 5.4 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3cccc(Cl)c3)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL257077 95414 0 None -1 4 Human 7.7 pKi = 7.7 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 470 6 2 4 5.4 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3cccc(Cl)c3)CC2)CC1 10.1016/j.bmcl.2007.11.068
71508710 87026 0 None 50 2 Bovine 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 368 3 0 4 4.9 CN1CCC(c2cn(-c3ccncc3)c3ccc(-c4cccnc4)cc23)CC1 10.1016/j.bmc.2012.10.049
CHEMBL2325933 87026 0 None 50 2 Bovine 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 368 3 0 4 4.9 CN1CCC(c2cn(-c3ccncc3)c3ccc(-c4cccnc4)cc23)CC1 10.1016/j.bmc.2012.10.049
44289026 166362 0 None 87 3 Human 7.7 pKi = 7.7 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 533 8 1 3 6.5 Cc1ccc(C(C(=O)NCCCN2CCC(C#N)(c3ccccc3C(F)(F)F)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
CHEMBL42763 166362 0 None 87 3 Human 7.7 pKi = 7.7 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 533 8 1 3 6.5 Cc1ccc(C(C(=O)NCCCN2CCC(C#N)(c3ccccc3C(F)(F)F)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
9879119 9414 0 None 4 5 Rat 7.7 pKi = 7.7 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 291 4 2 3 2.2 CCS(=O)(=O)Nc1cccc2c1CCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL111771 9414 0 None 4 5 Rat 7.7 pKi = 7.7 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 291 4 2 3 2.2 CCS(=O)(=O)Nc1cccc2c1CCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
53327991 63371 0 None -9 3 Human 7.7 pKi = 7.7 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 449 8 0 5 3.7 COc1ccccc1N1CCN(CCCCN2C(=O)CC(C)(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796046 63371 0 None -9 3 Human 7.7 pKi = 7.7 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 449 8 0 5 3.7 COc1ccccc1N1CCN(CCCCN2C(=O)CC(C)(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
145962368 161433 0 None -74 3 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 521 9 0 8 5.1 CCCN(CCC)c1nc(N2CCN(C(=O)c3ccco3)[C@H]3CCCC[C@H]32)nc2cc(OC)c(OC)cc12 10.1016/j.bmc.2018.05.023
CHEMBL4127483 161433 0 None -74 3 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 521 9 0 8 5.1 CCCN(CCC)c1nc(N2CCN(C(=O)c3ccco3)[C@H]3CCCC[C@H]32)nc2cc(OC)c(OC)cc12 10.1016/j.bmc.2018.05.023
9879119 9414 0 None 4 5 Rat 7.7 pKi = 7.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 291 4 2 3 2.2 CCS(=O)(=O)Nc1cccc2c1CCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL111771 9414 0 None 4 5 Rat 7.7 pKi = 7.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 291 4 2 3 2.2 CCS(=O)(=O)Nc1cccc2c1CCC2c1c[nH]cn1 10.1021/jm030551a
102 4096 48 None -85 50 Bovine 6.7 pKi = 6.7 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00366a007
3659 4096 48 None -85 50 Bovine 6.7 pKi = 6.7 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00366a007
8969 4096 48 None -85 50 Bovine 6.7 pKi = 6.7 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00366a007
CHEMBL15245 4096 48 None -85 50 Bovine 6.7 pKi = 6.7 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00366a007
DB01392 4096 48 None -85 50 Bovine 6.7 pKi = 6.7 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00366a007
145947545 167670 0 None -199 3 Human 6.7 pKi = 6.7 Binding
Displacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting methodDisplacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting method
ChEMBL 341 4 2 4 3.1 CSc1ccc(Cl)cc1Cn1cc(Cl)cc(C(N)=O)c1=N 10.1016/j.ejmech.2017.07.071
CHEMBL4208816 167670 0 None -199 3 Human 6.7 pKi = 6.7 Binding
Displacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting methodDisplacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting method
ChEMBL 341 4 2 4 3.1 CSc1ccc(Cl)cc1Cn1cc(Cl)cc(C(N)=O)c1=N 10.1016/j.ejmech.2017.07.071
CHEMBL4302269 167670 0 None -199 3 Human 6.7 pKi = 6.7 Binding
Displacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting methodDisplacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting method
ChEMBL 341 4 2 4 3.1 CSc1ccc(Cl)cc1Cn1cc(Cl)cc(C(N)=O)c1=N 10.1016/j.ejmech.2017.07.071
102 4096 48 None -85 50 Bovine 6.7 pKi = 6.7 Binding
Evaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortexEvaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortex
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00150a002
3659 4096 48 None -85 50 Bovine 6.7 pKi = 6.7 Binding
Evaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortexEvaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortex
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00150a002
8969 4096 48 None -85 50 Bovine 6.7 pKi = 6.7 Binding
Evaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortexEvaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortex
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00150a002
CHEMBL15245 4096 48 None -85 50 Bovine 6.7 pKi = 6.7 Binding
Evaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortexEvaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortex
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00150a002
DB01392 4096 48 None -85 50 Bovine 6.7 pKi = 6.7 Binding
Evaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortexEvaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortex
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00150a002
44301572 201352 0 None - 1 Human 6.7 pKi = 6.7 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 555 7 0 4 6.8 Cc1ccc(C2(c3ccc(C)cc3)CC(=S)N(CCCN3CCC(C#N)(c4ccccc4Cl)CC3)C2=O)cc1 10.1016/s0960-894x(01)00320-1
CHEMBL60452 201352 0 None - 1 Human 6.7 pKi = 6.7 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 555 7 0 4 6.8 Cc1ccc(C2(c3ccc(C)cc3)CC(=S)N(CCCN3CCC(C#N)(c4ccccc4Cl)CC3)C2=O)cc1 10.1016/s0960-894x(01)00320-1
3303 2231 46 None -3235 15 Human 5.7 pKi = 5.7 Binding
Inhibition of alpha1C adrenergic receptor (unknown origin)Inhibition of alpha1C adrenergic receptor (unknown origin)
ChEMBL 326 3 1 3 3.5 Clc1ccc(cc1)N1CCN(CC1)Cc1c[nH]c2c1cccn2 10.1021/acs.jmedchem.7b00151
5311200 2231 46 None -3235 15 Human 5.7 pKi = 5.7 Binding
Inhibition of alpha1C adrenergic receptor (unknown origin)Inhibition of alpha1C adrenergic receptor (unknown origin)
ChEMBL 326 3 1 3 3.5 Clc1ccc(cc1)N1CCN(CC1)Cc1c[nH]c2c1cccn2 10.1021/acs.jmedchem.7b00151
CHEMBL267014 2231 46 None -3235 15 Human 5.7 pKi = 5.7 Binding
Inhibition of alpha1C adrenergic receptor (unknown origin)Inhibition of alpha1C adrenergic receptor (unknown origin)
ChEMBL 326 3 1 3 3.5 Clc1ccc(cc1)N1CCN(CC1)Cc1c[nH]c2c1cccn2 10.1021/acs.jmedchem.7b00151
76307952 84801 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 375 7 1 4 4.0 c1ccc(OCCNC2COC(c3ccccc3)(c3ccccc3)CO2)cc1 10.1007/s00044-010-9379-1
CHEMBL2234455 84801 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 375 7 1 4 4.0 c1ccc(OCCNC2COC(c3ccccc3)(c3ccccc3)CO2)cc1 10.1007/s00044-010-9379-1
145962817 161495 0 None -74 6 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 385 3 1 7 2.2 COc1cc2nc(N3CCN(C(C)=O)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
CHEMBL4128311 161495 0 None -74 6 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 385 3 1 7 2.2 COc1cc2nc(N3CCN(C(C)=O)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
44568818 187681 0 None -6 4 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 389 8 1 4 4.0 c1ccc(OCCNC[C@@H]2COC(c3ccccc3)(c3ccccc3)CO2)cc1 10.1021/jm800461k
CHEMBL495289 187681 0 None -6 4 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 389 8 1 4 4.0 c1ccc(OCCNC[C@@H]2COC(c3ccccc3)(c3ccccc3)CO2)cc1 10.1021/jm800461k
6917970 3665 61 None -512 34 Rat 5.7 pKi = 5.7 Binding
Displacement of [125I]-BE2254 from Wistar rat alpha1A adrenoceptor after 20 minsDisplacement of [125I]-BE2254 from Wistar rat alpha1A adrenoceptor after 20 mins
ChEMBL 327 2 2 5 2.8 COc1cc2CCN3[C@H](c2cc1O)Cc1c(C3)c(OC)c(cc1)O 10.1021/acs.jmedchem.6b01217
8370 3665 61 None -512 34 Rat 5.7 pKi = 5.7 Binding
Displacement of [125I]-BE2254 from Wistar rat alpha1A adrenoceptor after 20 minsDisplacement of [125I]-BE2254 from Wistar rat alpha1A adrenoceptor after 20 mins
ChEMBL 327 2 2 5 2.8 COc1cc2CCN3[C@H](c2cc1O)Cc1c(C3)c(OC)c(cc1)O 10.1021/acs.jmedchem.6b01217
CHEMBL487387 3665 61 None -512 34 Rat 5.7 pKi = 5.7 Binding
Displacement of [125I]-BE2254 from Wistar rat alpha1A adrenoceptor after 20 minsDisplacement of [125I]-BE2254 from Wistar rat alpha1A adrenoceptor after 20 mins
ChEMBL 327 2 2 5 2.8 COc1cc2CCN3[C@H](c2cc1O)Cc1c(C3)c(OC)c(cc1)O 10.1021/acs.jmedchem.6b01217
44271903 63254 0 None - 1 Bovine 5.7 pKi = 5.7 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 208 1 0 2 2.5 CN1CC=C(c2ncccc2Cl)CC1 10.1021/jm00375a017
CHEMBL17926 63254 0 None - 1 Bovine 5.7 pKi = 5.7 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 208 1 0 2 2.5 CN1CC=C(c2ncccc2Cl)CC1 10.1021/jm00375a017
11655403 16043 0 None -208 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 454 8 1 4 5.8 FC(F)(F)c1cccc(N2CCN(CCCCNc3ccc(-c4ccccc4)cn3)CC2)c1 10.1016/j.bmcl.2010.07.096
CHEMBL1223801 16043 0 None -208 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 454 8 1 4 5.8 FC(F)(F)c1cccc(N2CCN(CCCCNc3ccc(-c4ccccc4)cn3)CC2)c1 10.1016/j.bmcl.2010.07.096
73347826 92513 0 None -1 7 Human 5.6 pKi = 5.6 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin) by PDSP assayInhibition of adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 266 4 1 2 2.4 c1ccc(CCN[C@H]2C3C4CC5C6C4CC3C6C52)nc1 10.1016/j.bmc.2013.07.045
CHEMBL2432049 92513 0 None -1 7 Human 5.6 pKi = 5.6 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin) by PDSP assayInhibition of adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 266 4 1 2 2.4 c1ccc(CCN[C@H]2C3C4CC5C6C4CC3C6C52)nc1 10.1016/j.bmc.2013.07.045
134157330 153680 0 None -75 4 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting method
ChEMBL 321 7 1 5 2.7 COc1ccccc1OCCNCC1COC2(CCCCC2)O1 10.1016/j.ejmech.2016.09.050
CHEMBL3981480 153680 0 None -75 4 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting method
ChEMBL 321 7 1 5 2.7 COc1ccccc1OCCNCC1COC2(CCCCC2)O1 10.1016/j.ejmech.2016.09.050
115 342 71 None -2 7 Bovine 7.6 pKi = 7.6 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm00018a001
2092 342 71 None -2 7 Bovine 7.6 pKi = 7.6 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm00018a001
7109 342 71 None -2 7 Bovine 7.6 pKi = 7.6 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm00018a001
CHEMBL709 342 71 None -2 7 Bovine 7.6 pKi = 7.6 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm00018a001
DB00346 342 71 None -2 7 Bovine 7.6 pKi = 7.6 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm00018a001
44431560 89135 0 None 1 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 517 9 1 7 3.9 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
CHEMBL236621 89135 0 None 1 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 517 9 1 7 3.9 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
44433348 90234 0 None -8 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 545 10 0 7 4.6 CCN([C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1)S(=O)(=O)c1ccc(OC)c(OC)c1 10.1016/j.bmcl.2007.09.051
CHEMBL238401 90234 0 None -8 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 545 10 0 7 4.6 CCN([C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1)S(=O)(=O)c1ccc(OC)c(OC)c1 10.1016/j.bmcl.2007.09.051
44431560 89135 0 None 1 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 517 9 1 7 3.9 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.008
CHEMBL236621 89135 0 None 1 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 517 9 1 7 3.9 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.008
11857863 85654 0 None 2 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 534 9 1 6 5.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccc(F)cc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
CHEMBL228658 85654 0 None 2 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 534 9 1 6 5.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccc(F)cc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
1531 2253 69 None -3 16 Rat 7.6 pKi = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O nan
3869 2253 69 None -3 16 Rat 7.6 pKi = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O nan
7207 2253 69 None -3 16 Rat 7.6 pKi = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O nan
CHEMBL429 2253 69 None -3 16 Rat 7.6 pKi = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O nan
DB00598 2253 69 None -3 16 Rat 7.6 pKi = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O nan
49865599 15988 0 None -28 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 340 8 1 5 3.1 COc1ccccc1N1CCN(CCCCNc2ccccn2)CC1 10.1016/j.bmcl.2010.07.096
CHEMBL1223615 15988 0 None -28 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 340 8 1 5 3.1 COc1ccccc1N1CCN(CCCCNc2ccccn2)CC1 10.1016/j.bmcl.2010.07.096
11303180 198203 0 None -7 5 Human 7.6 pKi = 7.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 369 5 0 4 3.1 COc1ccccc1N1CCN(CCN2C=CC3(CCCC3)CC2=O)CC1 10.1007/s00044-010-9379-1
CHEMBL57540 198203 0 None -7 5 Human 7.6 pKi = 7.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 369 5 0 4 3.1 COc1ccccc1N1CCN(CCN2C=CC3(CCCC3)CC2=O)CC1 10.1007/s00044-010-9379-1
11303180 198203 0 None -7 5 Human 7.6 pKi = 7.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 369 5 0 4 3.1 COc1ccccc1N1CCN(CCN2C=CC3(CCCC3)CC2=O)CC1 10.1007/s00044-010-9379-1
CHEMBL57540 198203 0 None -7 5 Human 7.6 pKi = 7.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 369 5 0 4 3.1 COc1ccccc1N1CCN(CCN2C=CC3(CCCC3)CC2=O)CC1 10.1007/s00044-010-9379-1
76323010 106221 0 None -26 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptorDisplacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 451 4 1 8 3.4 COc1cc2nc(N3CCN(C(=O)c4ccc(C)o4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1007/s00044-004-0024-8
CHEMBL2261606 106221 0 None -26 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptorDisplacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 451 4 1 8 3.4 COc1cc2nc(N3CCN(C(=O)c4ccc(C)o4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1007/s00044-004-0024-8
CHEMBL3138929 106221 0 None -26 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptorDisplacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 451 4 1 8 3.4 COc1cc2nc(N3CCN(C(=O)c4ccc(C)o4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1007/s00044-004-0024-8
16721032 92159 0 None -26 6 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 451 4 1 8 3.4 COc1cc2nc(N3CCN(C(=O)c4ccc(C)o4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2007.01.028
CHEMBL242507 92159 0 None -26 6 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 451 4 1 8 3.4 COc1cc2nc(N3CCN(C(=O)c4ccc(C)o4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2007.01.028
10790988 116074 0 None -2 3 Human 7.6 pKi = 7.6 Binding
The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.
ChEMBL 483 8 1 10 2.0 COc1cc2nc(N3CCN(C(=O)COc4c(OC)cccc4OC)CC3)nc(N)c2cc1OC 10.1021/jm9805337
CHEMBL335731 116074 0 None -2 3 Human 7.6 pKi = 7.6 Binding
The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.
ChEMBL 483 8 1 10 2.0 COc1cc2nc(N3CCN(C(=O)COc4c(OC)cccc4OC)CC3)nc(N)c2cc1OC 10.1021/jm9805337
10621592 84542 0 None -4 7 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2c(OC)cccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153559 84542 0 None -4 7 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2c(OC)cccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2220898 84542 0 None -4 7 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2c(OC)cccc2O1 10.1016/j.ejmech.2012.09.049
4011 82379 49 None -125 24 Rat 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 277 4 1 1 4.2 CNCCCC12CCC(c3ccccc31)c1ccccc12 nan
CHEMBL21731 82379 49 None -125 24 Rat 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 277 4 1 1 4.2 CNCCCC12CCC(c3ccccc31)c1ccccc12 nan
127025258 137669 0 None -173 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 415 7 1 3 4.8 Cc1cccc(N2CCN(CCCCNC(=O)c3ccc4ccccc4c3)CC2)c1C 10.1016/j.bmcl.2015.12.068
CHEMBL3758741 137669 0 None -173 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 415 7 1 3 4.8 Cc1cccc(N2CCN(CCCCNC(=O)c3ccc4ccccc4c3)CC2)c1C 10.1016/j.bmcl.2015.12.068
9844022 123035 0 None -32 2 Rat 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 401 6 1 2 5.6 c1ccc(C2CCN(CCCN3CCC(c4c[nH]c5ccccc45)CC3)CC2)cc1 10.1016/j.bmcl.2015.07.046
CHEMBL3609358 123035 0 None -32 2 Rat 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 401 6 1 2 5.6 c1ccc(C2CCN(CCCN3CCC(c4c[nH]c5ccccc45)CC3)CC2)cc1 10.1016/j.bmcl.2015.07.046
12134991 205690 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 412 7 0 6 3.3 CC(C)Oc1ccccc1N1CCN(Cc2nc(CN3CCCCC3=O)co2)CC1 10.1016/s0960-894x(02)00436-5
CHEMBL82480 205690 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 412 7 0 6 3.3 CC(C)Oc1ccccc1N1CCN(Cc2nc(CN3CCCCC3=O)co2)CC1 10.1016/s0960-894x(02)00436-5
11486511 101557 0 None -691 5 Human 6.6 pKi = 6.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 403 4 0 4 3.6 O=C1CC2(CCCC2)CC(=O)N1CCN1CCCN(c2ccccc2Cl)CC1 10.1007/s00044-010-9379-1
CHEMBL298595 101557 0 None -691 5 Human 6.6 pKi = 6.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 403 4 0 4 3.6 O=C1CC2(CCCC2)CC(=O)N1CCN1CCCN(c2ccccc2Cl)CC1 10.1007/s00044-010-9379-1
11994671 11797 0 None 1 4 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 391 8 1 5 4.2 COc1cc(-c2ccccc2)ccc1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL1182138 11797 0 None 1 4 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 391 8 1 5 4.2 COc1cc(-c2ccccc2)ccc1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL214506 11797 0 None 1 4 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 391 8 1 5 4.2 COc1cc(-c2ccccc2)ccc1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
2162 41484 100 None -3 6 Human 5.6 pKi = 5.6 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl 10.1016/s0960-894x(99)00484-9
CHEMBL1491 41484 100 None -3 6 Human 5.6 pKi = 5.6 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl 10.1016/s0960-894x(99)00484-9
11486511 101557 0 None -691 5 Human 6.6 pKi = 6.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 403 4 0 4 3.6 O=C1CC2(CCCC2)CC(=O)N1CCN1CCCN(c2ccccc2Cl)CC1 10.1007/s00044-010-9379-1
CHEMBL298595 101557 0 None -691 5 Human 6.6 pKi = 6.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 403 4 0 4 3.6 O=C1CC2(CCCC2)CC(=O)N1CCN1CCCN(c2ccccc2Cl)CC1 10.1007/s00044-010-9379-1
21509921 104431 0 None -234 24 Human 5.6 pKi = 5.6 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 288 0 0 2 3.7 CN1CCc2c(c3cccc4c3n2-c2ccccc2CC4)C1 10.1016/j.bmcl.2013.12.024
CHEMBL3104091 104431 0 None -234 24 Human 5.6 pKi = 5.6 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 288 0 0 2 3.7 CN1CCc2c(c3cccc4c3n2-c2ccccc2CC4)C1 10.1016/j.bmcl.2013.12.024
21509921 104431 0 None -234 24 Human 5.6 pKi = 5.6 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 288 0 0 2 3.7 CN1CCc2c(c3cccc4c3n2-c2ccccc2CC4)C1 10.1016/j.bmcl.2013.12.024
CHEMBL3104091 104431 0 None -234 24 Human 5.6 pKi = 5.6 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 288 0 0 2 3.7 CN1CCc2c(c3cccc4c3n2-c2ccccc2CC4)C1 10.1016/j.bmcl.2013.12.024
14004033 49202 5 None -2 2 Bovine 4.6 pKi = 4.6 Binding
Compound was evaluated for log 1/Ki at alpha-1 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-1 adrenergic receptor
ChEMBL 177 0 1 2 1.5 c1[nH]nc2c1CCN1CCCCC21 10.1021/jm00398a025
CHEMBL156283 49202 5 None -2 2 Bovine 4.6 pKi = 4.6 Binding
Compound was evaluated for log 1/Ki at alpha-1 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-1 adrenergic receptor
ChEMBL 177 0 1 2 1.5 c1[nH]nc2c1CCN1CCCCC21 10.1021/jm00398a025
13151 978 0 None -151 4 Rat 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 391 5 1 2 4.9 FC1=CC=C2C(=CNC2=C1)C3CCN(CC3)CCCN4CC5=CC=CC=C5CC4 10.1016/j.bmcl.2015.07.046
9930376 978 0 None -151 4 Rat 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 391 5 1 2 4.9 FC1=CC=C2C(=CNC2=C1)C3CCN(CC3)CCCN4CC5=CC=CC=C5CC4 10.1016/j.bmcl.2015.07.046
CHEMBL3609360 978 0 None -151 4 Rat 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 391 5 1 2 4.9 FC1=CC=C2C(=CNC2=C1)C3CCN(CC3)CCCN4CC5=CC=CC=C5CC4 10.1016/j.bmcl.2015.07.046
71508686 87024 0 None 10 2 Bovine 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 368 3 0 4 4.9 CN1CCC(c2cn(-c3ccncc3)c3ccc(-c4ccncc4)cc23)CC1 10.1016/j.bmc.2012.10.049
CHEMBL2325931 87024 0 None 10 2 Bovine 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 368 3 0 4 4.9 CN1CCC(c2cn(-c3ccncc3)c3ccc(-c4ccncc4)cc23)CC1 10.1016/j.bmc.2012.10.049
44288995 162860 0 None 39 3 Human 7.6 pKi = 7.6 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 435 8 1 3 4.9 Cc1ccccc1C1(C#N)CCN(CCCNC(=O)C(c2ccc(F)cc2)C(C)C)CC1 10.1016/s0960-894x(00)00307-3
CHEMBL417350 162860 0 None 39 3 Human 7.6 pKi = 7.6 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 435 8 1 3 4.9 Cc1ccccc1C1(C#N)CCN(CCCNC(=O)C(c2ccc(F)cc2)C(C)C)CC1 10.1016/s0960-894x(00)00307-3
10962489 11158 0 None -1 2 Human 7.6 pKi = 7.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 404 8 0 3 4.5 C[N+](C)(CCOc1ccccc1)CC1COC(c2ccccc2)(c2ccccc2)O1 10.1007/s00044-010-9379-1
CHEMBL1178679 11158 0 None -1 2 Human 7.6 pKi = 7.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 404 8 0 3 4.5 C[N+](C)(CCOc1ccccc1)CC1COC(c2ccccc2)(c2ccccc2)O1 10.1007/s00044-010-9379-1
CHEMBL37212 11158 0 None -1 2 Human 7.6 pKi = 7.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 404 8 0 3 4.5 C[N+](C)(CCOc1ccccc1)CC1COC(c2ccccc2)(c2ccccc2)O1 10.1007/s00044-010-9379-1
10363912 6506 0 None -36 7 Human 7.6 pKi = 7.6 Binding
Affinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assayAffinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay
ChEMBL 405 9 1 5 4.0 COc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1021/jm021078o
CHEMBL1082862 6506 0 None -36 7 Human 7.6 pKi = 7.6 Binding
Affinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assayAffinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay
ChEMBL 405 9 1 5 4.0 COc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1021/jm021078o
CHEMBL286003 6506 0 None -36 7 Human 7.6 pKi = 7.6 Binding
Affinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assayAffinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay
ChEMBL 405 9 1 5 4.0 COc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1021/jm021078o
155532835 176430 0 None -31 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 419 9 1 5 4.4 COc1ccccc1OCCNCC1CCOC(c2ccccc2)(c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
CHEMBL4467585 176430 0 None -31 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 419 9 1 5 4.4 COc1ccccc1OCCNCC1CCOC(c2ccccc2)(c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
CHEMBL4596417 176430 0 None -31 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 419 9 1 5 4.4 COc1ccccc1OCCNCC1CCOC(c2ccccc2)(c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
10386062 206749 0 None -19 2 Rat 6.6 pKi = 6.6 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 396 6 0 4 3.3 FC(F)(F)c1cccc(N2CCN(CCCCN3CC4CCCN4C3)CC2)c1 10.1021/jm970216k
CHEMBL90165 206749 0 None -19 2 Rat 6.6 pKi = 6.6 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 396 6 0 4 3.3 FC(F)(F)c1cccc(N2CCN(CCCCN3CC4CCCN4C3)CC2)c1 10.1021/jm970216k
9817327 123030 0 None -50 2 Rat 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 285 5 1 2 3.3 CN(C)CCCN1CCC(c2c[nH]c3ccccc23)CC1 10.1016/j.bmcl.2015.07.046
CHEMBL3609353 123030 0 None -50 2 Rat 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 285 5 1 2 3.3 CN(C)CCCN1CCC(c2c[nH]c3ccccc23)CC1 10.1016/j.bmcl.2015.07.046
44289089 164561 0 None 3 3 Human 6.6 pKi = 6.6 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 453 10 1 6 3.2 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)CCc2ccc([N+](=O)[O-])cc2)CC1 10.1016/s0960-894x(00)00307-3
CHEMBL42156 164561 0 None 3 3 Human 6.6 pKi = 6.6 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 453 10 1 6 3.2 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)CCc2ccc([N+](=O)[O-])cc2)CC1 10.1016/s0960-894x(00)00307-3
94459 64244 127 None -64 2 Bovine 5.6 pKi = 5.6 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 163 1 1 3 0.5 c1ccc(N2CCNCC2)nc1 10.1021/jm00366a007
CHEMBL18094 64244 127 None -64 2 Bovine 5.6 pKi = 5.6 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 163 1 1 3 0.5 c1ccc(N2CCNCC2)nc1 10.1021/jm00366a007
94459 64244 127 None -64 2 Bovine 5.6 pKi = 5.6 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 163 1 1 3 0.5 c1ccc(N2CCNCC2)nc1 10.1021/jm00375a017
CHEMBL18094 64244 127 None -64 2 Bovine 5.6 pKi = 5.6 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 163 1 1 3 0.5 c1ccc(N2CCNCC2)nc1 10.1021/jm00375a017
14004033 49202 5 None -2 2 Bovine 4.6 pKi = 4.6 Binding
Affinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranesAffinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranes
ChEMBL 177 0 1 2 1.5 c1[nH]nc2c1CCN1CCCCC21 10.1021/jm00398a025
CHEMBL156283 49202 5 None -2 2 Bovine 4.6 pKi = 4.6 Binding
Affinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranesAffinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranes
ChEMBL 177 0 1 2 1.5 c1[nH]nc2c1CCN1CCCCC21 10.1021/jm00398a025
165413025 190343 2 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]-prazosin from human adrenergic alpha1A receptor expressed in human HEK293 cellsDisplacement of [3H]-prazosin from human adrenergic alpha1A receptor expressed in human HEK293 cells
ChEMBL 364 6 2 6 1.3 NC(CCOc1ccc(S(N)(=O)=O)cc1)C1COc2ccccc2O1 10.1021/acs.jmedchem.2c01192
CHEMBL5177166 190343 2 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]-prazosin from human adrenergic alpha1A receptor expressed in human HEK293 cellsDisplacement of [3H]-prazosin from human adrenergic alpha1A receptor expressed in human HEK293 cells
ChEMBL 364 6 2 6 1.3 NC(CCOc1ccc(S(N)(=O)=O)cc1)C1COc2ccccc2O1 10.1021/acs.jmedchem.2c01192
2291 3162 58 None -446 12 Rat 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O nan
2561 3162 58 None -446 12 Rat 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O nan
4932 3162 58 None -446 12 Rat 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O nan
CHEMBL631 3162 58 None -446 12 Rat 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O nan
DB01182 3162 58 None -446 12 Rat 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O nan
44431590 87951 0 None -13 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 555 8 1 6 4.9 COc1ccc(C(F)(F)F)cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL234232 87951 0 None -13 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 555 8 1 6 4.9 COc1ccc(C(F)(F)F)cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
44289346 168021 0 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 466 8 1 4 4.9 Cc1ccc(C(C(=O)NCCCN2CCC(C#N)(c3ccccn3)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
CHEMBL432302 168021 0 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 466 8 1 4 4.9 Cc1ccc(C(C(=O)NCCCN2CCC(C#N)(c3ccccn3)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
135398745 2893 112 None -13 66 Rat 7.6 pKi = 7.6 Binding
Receptor Binding Assay: Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) on rat cortical membrane preparation using [3H]-prazosine (0.22-0.37 nM) as ligand. The non-specific binding was determined in the presence of 10 μM phentolamine.Receptor Binding Assay: Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) on rat cortical membrane preparation using [3H]-prazosine (0.22-0.37 nM) as ligand. The non-specific binding was determined in the presence of 10 μM phentolamine.
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
47 2893 112 None -13 66 Rat 7.6 pKi = 7.6 Binding
Receptor Binding Assay: Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) on rat cortical membrane preparation using [3H]-prazosine (0.22-0.37 nM) as ligand. The non-specific binding was determined in the presence of 10 μM phentolamine.Receptor Binding Assay: Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) on rat cortical membrane preparation using [3H]-prazosine (0.22-0.37 nM) as ligand. The non-specific binding was determined in the presence of 10 μM phentolamine.
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
CHEMBL715 2893 112 None -13 66 Rat 7.6 pKi = 7.6 Binding
Receptor Binding Assay: Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) on rat cortical membrane preparation using [3H]-prazosine (0.22-0.37 nM) as ligand. The non-specific binding was determined in the presence of 10 μM phentolamine.Receptor Binding Assay: Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) on rat cortical membrane preparation using [3H]-prazosine (0.22-0.37 nM) as ligand. The non-specific binding was determined in the presence of 10 μM phentolamine.
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
DB00334 2893 112 None -13 66 Rat 7.6 pKi = 7.6 Binding
Receptor Binding Assay: Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) on rat cortical membrane preparation using [3H]-prazosine (0.22-0.37 nM) as ligand. The non-specific binding was determined in the presence of 10 μM phentolamine.Receptor Binding Assay: Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) on rat cortical membrane preparation using [3H]-prazosine (0.22-0.37 nM) as ligand. The non-specific binding was determined in the presence of 10 μM phentolamine.
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
11281005 11811 0 None 13 6 Human 7.6 pKi = 7.6 Binding
Antagonist activity at human alpha A1 adrenoreceptor expressed in CHO cellsAntagonist activity at human alpha A1 adrenoreceptor expressed in CHO cells
ChEMBL 399 8 1 6 3.4 COc1cccc(OC)c1OCCNC[C@H]1COc2cc3c(cc2O1)CCCC3 10.1016/j.ejmech.2020.112419
CHEMBL1182191 11811 0 None 13 6 Human 7.6 pKi = 7.6 Binding
Antagonist activity at human alpha A1 adrenoreceptor expressed in CHO cellsAntagonist activity at human alpha A1 adrenoreceptor expressed in CHO cells
ChEMBL 399 8 1 6 3.4 COc1cccc(OC)c1OCCNC[C@H]1COc2cc3c(cc2O1)CCCC3 10.1016/j.ejmech.2020.112419
CHEMBL218079 11811 0 None 13 6 Human 7.6 pKi = 7.6 Binding
Antagonist activity at human alpha A1 adrenoreceptor expressed in CHO cellsAntagonist activity at human alpha A1 adrenoreceptor expressed in CHO cells
ChEMBL 399 8 1 6 3.4 COc1cccc(OC)c1OCCNC[C@H]1COc2cc3c(cc2O1)CCCC3 10.1016/j.ejmech.2020.112419
15254720 61271 0 None -204 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 367 4 0 4 3.7 CN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/jm1013874
CHEMBL1767136 61271 0 None -204 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 367 4 0 4 3.7 CN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/jm1013874
24803483 61302 0 None -63 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 654 15 0 6 8.2 O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C[C@H]1CCCN1CCCCCc1ccc(OCCCN2CCCCCC2)cc1 10.1021/jm1013874
CHEMBL1767167 61302 0 None -63 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 654 15 0 6 8.2 O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C[C@H]1CCCN1CCCCCc1ccc(OCCCN2CCCCCC2)cc1 10.1021/jm1013874
132266 1267 12 None -28 9 Human 7.6 pKi = 7.6 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1021/jm960697s
486 1267 12 None -28 9 Human 7.6 pKi = 7.6 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1021/jm960697s
CHEMBL423294 1267 12 None -28 9 Human 7.6 pKi = 7.6 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1021/jm960697s
126225 94947 5 None -13 8 Human 7.6 pKi = 7.6 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 263 1 0 2 4.2 C=Cc1sc2ccc(Cl)c3c2c1CN(C)CC3 10.1021/jm960697s
CHEMBL25467 94947 5 None -13 8 Human 7.6 pKi = 7.6 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 263 1 0 2 4.2 C=Cc1sc2ccc(Cl)c3c2c1CN(C)CC3 10.1021/jm960697s
11281005 11811 0 None 13 6 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 399 8 1 6 3.4 COc1cccc(OC)c1OCCNC[C@H]1COc2cc3c(cc2O1)CCCC3 10.1021/jm060358r
CHEMBL1182191 11811 0 None 13 6 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 399 8 1 6 3.4 COc1cccc(OC)c1OCCNC[C@H]1COc2cc3c(cc2O1)CCCC3 10.1021/jm060358r
CHEMBL218079 11811 0 None 13 6 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 399 8 1 6 3.4 COc1cccc(OC)c1OCCNC[C@H]1COc2cc3c(cc2O1)CCCC3 10.1021/jm060358r
76326562 106179 0 None -18 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptorDisplacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 479 5 1 9 3.3 COc1cc2nc(N3CCN(C(=O)c4ccc(C(C)=O)o4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1007/s00044-004-0024-8
CHEMBL2261608 106179 0 None -18 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptorDisplacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 479 5 1 9 3.3 COc1cc2nc(N3CCN(C(=O)c4ccc(C(C)=O)o4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1007/s00044-004-0024-8
CHEMBL3138761 106179 0 None -18 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptorDisplacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 479 5 1 9 3.3 COc1cc2nc(N3CCN(C(=O)c4ccc(C(C)=O)o4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1007/s00044-004-0024-8
44428847 92264 0 None -18 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 479 5 1 9 3.3 COc1cc2nc(N3CCN(C(=O)c4ccc(C(C)=O)o4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2007.01.028
CHEMBL242723 92264 0 None -18 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 479 5 1 9 3.3 COc1cc2nc(N3CCN(C(=O)c4ccc(C(C)=O)o4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2007.01.028
12841596 117434 20 None -3 2 Bovine 6.6 pKi = 6.6 Binding
Binding affinity against alpha-1 adrenergic receptor was determined in calf cerebral cortex homogenates using [3H]prazosin as radioligandBinding affinity against alpha-1 adrenergic receptor was determined in calf cerebral cortex homogenates using [3H]prazosin as radioligand
ChEMBL 237 1 1 5 0.8 Clc1cn2ccnc2c(N2CCNCC2)n1 10.1021/jm00099a012
CHEMBL2448004 117434 20 None -3 2 Bovine 6.6 pKi = 6.6 Binding
Binding affinity against alpha-1 adrenergic receptor was determined in calf cerebral cortex homogenates using [3H]prazosin as radioligandBinding affinity against alpha-1 adrenergic receptor was determined in calf cerebral cortex homogenates using [3H]prazosin as radioligand
ChEMBL 237 1 1 5 0.8 Clc1cn2ccnc2c(N2CCNCC2)n1 10.1021/jm00099a012
CHEMBL339883 117434 20 None -3 2 Bovine 6.6 pKi = 6.6 Binding
Binding affinity against alpha-1 adrenergic receptor was determined in calf cerebral cortex homogenates using [3H]prazosin as radioligandBinding affinity against alpha-1 adrenergic receptor was determined in calf cerebral cortex homogenates using [3H]prazosin as radioligand
ChEMBL 237 1 1 5 0.8 Clc1cn2ccnc2c(N2CCNCC2)n1 10.1021/jm00099a012
2419 692 28 None -288 12 Human 6.6 pKi = 6.6 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/j.bmcl.2004.11.032
9 692 28 None -288 12 Human 6.6 pKi = 6.6 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/j.bmcl.2004.11.032
CHEMBL13647 692 28 None -288 12 Human 6.6 pKi = 6.6 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/j.bmcl.2004.11.032
134987 186657 47 None -309 2 Bovine 5.6 pKi = 5.6 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 181 1 1 3 0.6 Fc1cccnc1N1CCNCC1 10.1021/jm00366a007
CHEMBL48833 186657 47 None -309 2 Bovine 5.6 pKi = 5.6 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 181 1 1 3 0.6 Fc1cccnc1N1CCNCC1 10.1021/jm00366a007
3386873 64545 4 None - 1 Human 5.6 pKi = 5.6 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 338 6 2 3 3.9 N=C(CC(O)COc1ccccc1-c1ccccc1)N1CCCCC1 10.1016/j.bmcl.2004.11.032
CHEMBL181583 64545 4 None - 1 Human 5.6 pKi = 5.6 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 338 6 2 3 3.9 N=C(CC(O)COc1ccccc1-c1ccccc1)N1CCCCC1 10.1016/j.bmcl.2004.11.032
44271616 59646 0 None - 1 Bovine 5.6 pKi = 5.6 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 188 1 0 2 2.1 Cc1cccnc1C1=CCN(C)CC1 10.1021/jm00375a017
CHEMBL17223 59646 0 None - 1 Bovine 5.6 pKi = 5.6 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 188 1 0 2 2.1 Cc1cccnc1C1=CCN(C)CC1 10.1021/jm00375a017
15357024 60649 3 None - 1 Bovine 5.6 pKi = 5.6 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 174 1 0 2 1.8 CN1CC=C(c2ccccn2)CC1 10.1021/jm00375a017
CHEMBL17605 60649 3 None - 1 Bovine 5.6 pKi = 5.6 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 174 1 0 2 1.8 CN1CC=C(c2ccccn2)CC1 10.1021/jm00375a017
3020566 61046 14 None - 1 Bovine 5.6 pKi = 5.6 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 176 1 0 2 1.9 CN1CCC(c2ccccn2)CC1 10.1021/jm00375a017
CHEMBL17648 61046 14 None - 1 Bovine 5.6 pKi = 5.6 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 176 1 0 2 1.9 CN1CCC(c2ccccn2)CC1 10.1021/jm00375a017
2419 692 28 None -288 12 Human 6.6 pKi = 6.6 Binding
In vitro binding affinity at human Alpha-1A adrenergic receptor.In vitro binding affinity at human Alpha-1A adrenergic receptor.
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm0307741
9 692 28 None -288 12 Human 6.6 pKi = 6.6 Binding
In vitro binding affinity at human Alpha-1A adrenergic receptor.In vitro binding affinity at human Alpha-1A adrenergic receptor.
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm0307741
CHEMBL13647 692 28 None -288 12 Human 6.6 pKi = 6.6 Binding
In vitro binding affinity at human Alpha-1A adrenergic receptor.In vitro binding affinity at human Alpha-1A adrenergic receptor.
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm0307741
9950711 109179 0 None 5 4 Rat 6.6 pKi = 6.6 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 359 4 2 3 3.2 O=S(=O)(CC(F)(F)F)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL321644 109179 0 None 5 4 Rat 6.6 pKi = 6.6 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 359 4 2 3 3.2 O=S(=O)(CC(F)(F)F)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
52937527 61273 0 None -1584 4 Human 6.6 pKi = 6.6 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 349 4 1 5 2.8 CN1CCC[C@@H]1Cn1nc(Cc2ccc(O)cc2)c2ccccc2c1=O 10.1021/jm1013874
CHEMBL1767138 61273 0 None -1584 4 Human 6.6 pKi = 6.6 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 349 4 1 5 2.8 CN1CCC[C@@H]1Cn1nc(Cc2ccc(O)cc2)c2ccccc2c1=O 10.1021/jm1013874
2419 692 28 None -288 12 Human 6.6 pKi = 6.6 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm960697s
9 692 28 None -288 12 Human 6.6 pKi = 6.6 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm960697s
CHEMBL13647 692 28 None -288 12 Human 6.6 pKi = 6.6 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm960697s
119204 184245 40 None 2 3 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]-HEAT from human adrenergic alpha1A receptor expressed in rat-1 cellsDisplacement of [125I]-HEAT from human adrenergic alpha1A receptor expressed in rat-1 cells
ChEMBL 279 0 0 3 3.2 CN1CCc2cc3c(c4c2[C@H]1Cc1ccccc1-4)OCO3 10.1039/C7MD00629B
CHEMBL483825 184245 40 None 2 3 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]-HEAT from human adrenergic alpha1A receptor expressed in rat-1 cellsDisplacement of [125I]-HEAT from human adrenergic alpha1A receptor expressed in rat-1 cells
ChEMBL 279 0 0 3 3.2 CN1CCc2cc3c(c4c2[C@H]1Cc1ccccc1-4)OCO3 10.1039/C7MD00629B
10337773 101558 0 None -63 10 Human 4.6 pKi = 4.6 Binding
Binding affinity against Alpha-1A adrenergic receptorBinding affinity against Alpha-1A adrenergic receptor
ChEMBL 311 3 1 4 1.6 Cn1cc(C(=O)C(=O)N[C@@H]2CN3CCC2CC3)c2ccccc21 10.1016/0960-894X(95)00308-G
CHEMBL298612 101558 0 None -63 10 Human 4.6 pKi = 4.6 Binding
Binding affinity against Alpha-1A adrenergic receptorBinding affinity against Alpha-1A adrenergic receptor
ChEMBL 311 3 1 4 1.6 Cn1cc(C(=O)C(=O)N[C@@H]2CN3CCC2CC3)c2ccccc21 10.1016/0960-894X(95)00308-G
11800278 39161 0 None 15 3 Human 5.6 pKi = 5.6 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 527 10 3 8 2.4 CCOC(=O)C1CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(=O)NC)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
CHEMBL146983 39161 0 None 15 3 Human 5.6 pKi = 5.6 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 527 10 3 8 2.4 CCOC(=O)C1CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(=O)NC)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
1599 2326 50 None -3019 16 Rat 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 nan
3955 2326 50 None -3019 16 Rat 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 nan
7215 2326 50 None -3019 16 Rat 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 nan
CHEMBL841 2326 50 None -3019 16 Rat 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 nan
DB00836 2326 50 None -3019 16 Rat 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 nan
1028 289 71 None -47 30 Rat 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
139148732 289 71 None -47 30 Rat 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
479 289 71 None -47 30 Rat 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
5816 289 71 None -47 30 Rat 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
CHEMBL679 289 71 None -47 30 Rat 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
DB00668 289 71 None -47 30 Rat 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
2435 719 100 None -436 12 Rat 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
395 719 100 None -436 12 Rat 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
520 719 100 None -436 12 Rat 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
5386 719 100 None -436 12 Rat 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
CHEMBL844 719 100 None -436 12 Rat 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
DB00484 719 100 None -436 12 Rat 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
118717461 115117 0 None -7 4 Human 6.6 pKi = 6.6 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 444 12 2 6 6.3 COc1ccc2c(NCCCCCCCNc3ccnc4cc(OC)ccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
CHEMBL3343983 115117 0 None -7 4 Human 6.6 pKi = 6.6 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 444 12 2 6 6.3 COc1ccc2c(NCCCCCCCNc3ccnc4cc(OC)ccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
118717461 115117 0 None -7 4 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 444 12 2 6 6.3 COc1ccc2c(NCCCCCCCNc3ccnc4cc(OC)ccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
CHEMBL3343983 115117 0 None -7 4 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 444 12 2 6 6.3 COc1ccc2c(NCCCCCCCNc3ccnc4cc(OC)ccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
56852956 112016 1 None -66 9 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from human adrenergic-alpha1A receptor by PDSP assayDisplacement of [3H]prazosin from human adrenergic-alpha1A receptor by PDSP assay
ChEMBL 339 5 0 6 2.8 c1cnc(N2CCN(CCCc3nc4ccccc4s3)CC2)nc1 10.1016/j.bmc.2014.04.026
CHEMBL3289656 112016 1 None -66 9 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from human adrenergic-alpha1A receptor by PDSP assayDisplacement of [3H]prazosin from human adrenergic-alpha1A receptor by PDSP assay
ChEMBL 339 5 0 6 2.8 c1cnc(N2CCN(CCCc3nc4ccccc4s3)CC2)nc1 10.1016/j.bmc.2014.04.026
137640201 156937 2 None -204 13 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from human recombinant alpha-1A adrenergic receptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from human recombinant alpha-1A adrenergic receptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 362 6 0 2 4.3 O=C1CCc2ccccc2N1CCCN1CCC(Cc2ccccc2)CC1 10.1021/acs.jmedchem.8b00265
CHEMBL4072818 156937 2 None -204 13 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from human recombinant alpha-1A adrenergic receptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from human recombinant alpha-1A adrenergic receptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 362 6 0 2 4.3 O=C1CCc2ccccc2N1CCCN1CCC(Cc2ccccc2)CC1 10.1021/acs.jmedchem.8b00265
71521479 86230 0 None -831 4 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 419 9 1 5 4.0 COc1ccccc1OCCNC[C@H]1COCC(c2ccccc2)(c2ccccc2)O1 10.1021/jm301525w
CHEMBL2312536 86230 0 None -831 4 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 419 9 1 5 4.0 COc1ccccc1OCCNC[C@H]1COCC(c2ccccc2)(c2ccccc2)O1 10.1021/jm301525w
11164948 37713 0 None -8 3 Human 5.6 pKi = 5.6 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 382 5 2 6 3.1 COc1cc2nc3c(c(O)c2cc1OC)CCC(CNC(=O)c1ccco1)C3 10.1021/jm030952q
CHEMBL145793 37713 0 None -8 3 Human 5.6 pKi = 5.6 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 382 5 2 6 3.1 COc1cc2nc3c(c(O)c2cc1OC)CCC(CNC(=O)c1ccco1)C3 10.1021/jm030952q
76318763 84795 0 None - 1 Human 5.6 pKi = 5.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 381 5 2 6 3.0 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNC(=O)c1ccoc1)C3 10.1007/s00044-010-9379-1
CHEMBL2234449 84795 0 None - 1 Human 5.6 pKi = 5.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 381 5 2 6 3.0 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNC(=O)c1ccoc1)C3 10.1007/s00044-010-9379-1
56852956 112016 1 None -66 9 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from human adrenergic-alpha1A receptor by PDSP assayDisplacement of [3H]prazosin from human adrenergic-alpha1A receptor by PDSP assay
ChEMBL 339 5 0 6 2.8 c1cnc(N2CCN(CCCc3nc4ccccc4s3)CC2)nc1 10.1016/j.bmc.2014.04.026
CHEMBL3289656 112016 1 None -66 9 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from human adrenergic-alpha1A receptor by PDSP assayDisplacement of [3H]prazosin from human adrenergic-alpha1A receptor by PDSP assay
ChEMBL 339 5 0 6 2.8 c1cnc(N2CCN(CCCc3nc4ccccc4s3)CC2)nc1 10.1016/j.bmc.2014.04.026
242 469 124 None -14 52 Human 7.6 pKi = 7.6 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl nan
34 469 124 None -14 52 Human 7.6 pKi = 7.6 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl nan
60795 469 124 None -14 52 Human 7.6 pKi = 7.6 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl nan
CHEMBL1112 469 124 None -14 52 Human 7.6 pKi = 7.6 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl nan
DB01238 469 124 None -14 52 Human 7.6 pKi = 7.6 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl nan
3584 3748 64 None -3 14 Bovine 7.6 pKi = 7.6 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00018a001
5401 3748 64 None -3 14 Bovine 7.6 pKi = 7.6 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00018a001
7302 3748 64 None -3 14 Bovine 7.6 pKi = 7.6 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00018a001
CHEMBL611 3748 64 None -3 14 Bovine 7.6 pKi = 7.6 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00018a001
DB01162 3748 64 None -3 14 Bovine 7.6 pKi = 7.6 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00018a001
180707 115108 2 None 1 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 314 5 2 4 4.3 c1ccc2c(NCCNc3ccnc4ccccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
CHEMBL3343975 115108 2 None 1 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 314 5 2 4 4.3 c1ccc2c(NCCNc3ccnc4ccccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
135398745 2893 112 None -13 66 Rat 7.6 pKi = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
47 2893 112 None -13 66 Rat 7.6 pKi = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
CHEMBL715 2893 112 None -13 66 Rat 7.6 pKi = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
DB00334 2893 112 None -13 66 Rat 7.6 pKi = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
16041629 95417 0 None 1 4 Human 7.6 pKi = 7.6 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 472 6 2 4 5.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3cc(F)ccc3F)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL257097 95417 0 None 1 4 Human 7.6 pKi = 7.6 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 472 6 2 4 5.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3cc(F)ccc3F)CC2)CC1 10.1016/j.bmcl.2007.11.068
180707 115108 2 None 1 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 314 5 2 4 4.3 c1ccc2c(NCCNc3ccnc4ccccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
CHEMBL3343975 115108 2 None 1 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 314 5 2 4 4.3 c1ccc2c(NCCNc3ccnc4ccccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
9883506 70535 0 None -2 6 Human 7.6 pKi = 7.6 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
ChEMBL 282 3 3 5 2.3 Cc1ccc(N(NC2=NCCN2)c2cccc(O)c2)cc1 10.1016/j.bmcl.2005.07.083
CHEMBL194849 70535 0 None -2 6 Human 7.6 pKi = 7.6 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
ChEMBL 282 3 3 5 2.3 Cc1ccc(N(NC2=NCCN2)c2cccc(O)c2)cc1 10.1016/j.bmcl.2005.07.083
46934641 16646 0 None -10 4 Human 7.6 pKi = 7.6 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 479 7 0 6 3.5 COc1ccccc1N1CCN(C[C@@H]2CO[C@@](CN3CCCCCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
CHEMBL1242633 16646 0 None -10 4 Human 7.6 pKi = 7.6 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 479 7 0 6 3.5 COc1ccccc1N1CCN(C[C@@H]2CO[C@@](CN3CCCCCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
56946474 71487 0 None -32 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 403 9 1 4 4.8 COc1ccccc1OCCNCC1CCC(c2ccccc2)(c2ccccc2)O1 10.1021/jm200421e
CHEMBL1946779 71487 0 None -32 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 403 9 1 4 4.8 COc1ccccc1OCCNCC1CCC(c2ccccc2)(c2ccccc2)O1 10.1021/jm200421e
CHEMBL1962769 71487 0 None -32 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 403 9 1 4 4.8 COc1ccccc1OCCNCC1CCC(c2ccccc2)(c2ccccc2)O1 10.1021/jm200421e
44207909 16667 3 None 2 9 Human 6.6 pKi = 6.6 Binding
Binding affinity to human adrenergic alpha1A receptor by radioligand displacement assayBinding affinity to human adrenergic alpha1A receptor by radioligand displacement assay
ChEMBL 407 7 1 4 2.6 O=C(Cc1ccccc1)NC1CCN(CCCN2C(=O)COc3ccccc32)CC1 10.1021/jm100697g
CHEMBL1242923 16667 3 None 2 9 Human 6.6 pKi = 6.6 Binding
Binding affinity to human adrenergic alpha1A receptor by radioligand displacement assayBinding affinity to human adrenergic alpha1A receptor by radioligand displacement assay
ChEMBL 407 7 1 4 2.6 O=C(Cc1ccccc1)NC1CCN(CCCN2C(=O)COc3ccccc32)CC1 10.1021/jm100697g
44538690 109824 0 None -295 7 Human 6.6 pKi = 6.6 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
ChEMBL 380 5 0 4 3.9 O=C(CCCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCO3)c1ccc(F)cc1 10.1021/jm401958n
CHEMBL3233432 109824 0 None -295 7 Human 6.6 pKi = 6.6 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
ChEMBL 380 5 0 4 3.9 O=C(CCCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCO3)c1ccc(F)cc1 10.1021/jm401958n
CHEMBL4795065 214029 25 None 1 2 Human 5.6 pKi = 5.6 Binding
GPCRScan assay: inhibition of Alpha1AGPCRScan assay: inhibition of Alpha1A
ChEMBL None None None C=CC(=O)Nc1ccc2[nH]c(=O)n(C3CCN(Cc4ccc(-c5nc6cc[nH]c(=O)c6cc5-c5ccccc5)cc4)CC3)c2c1 10.6019/CHEMBL4800730
10219 188772 37 None -467 5 Rat 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 nan
CHEMBL493439 188772 37 None -467 5 Rat 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 nan
CHEMBL50588 188772 37 None -467 5 Rat 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 nan
CHEMBL4795065 214029 25 None 1 2 Human 5.6 pKi = 5.6 Binding
GPCRScan assay: inhibition of Alpha1AGPCRScan assay: inhibition of Alpha1A
ChEMBL None None None C=CC(=O)Nc1ccc2[nH]c(=O)n(C3CCN(Cc4ccc(-c5nc6cc[nH]c(=O)c6cc5-c5ccccc5)cc4)CC3)c2c1 10.6019/CHEMBL4800730
12840734 100902 3 None -630 5 Human 5.6 pKi = 5.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 355 4 0 4 2.5 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2)CC1 10.1007/s00044-010-9379-1
CHEMBL293968 100902 3 None -630 5 Human 5.6 pKi = 5.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 355 4 0 4 2.5 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2)CC1 10.1007/s00044-010-9379-1
134133829 143800 0 None -120 4 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting method
ChEMBL 337 7 1 5 3.5 COc1ccccc1OCCNCC1CSC2(CCCCC2)O1 10.1016/j.ejmech.2016.09.050
CHEMBL3901382 143800 0 None -120 4 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting method
ChEMBL 337 7 1 5 3.5 COc1ccccc1OCCNCC1CSC2(CCCCC2)O1 10.1016/j.ejmech.2016.09.050
10221830 9389 0 None 1 3 Rat 6.6 pKi = 6.6 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 387 5 2 3 4.7 CCS(=O)(=O)Nc1cc(C2CCCCC2)cc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL111685 9389 0 None 1 3 Rat 6.6 pKi = 6.6 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 387 5 2 3 4.7 CCS(=O)(=O)Nc1cc(C2CCCCC2)cc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
11811395 204678 0 None -2 4 Human 5.6 pKi = 5.6 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 281 5 2 5 1.3 CC(C)S(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL74071 204678 0 None -2 4 Human 5.6 pKi = 5.6 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 281 5 2 5 1.3 CC(C)S(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
12840734 100902 3 None -630 5 Human 5.6 pKi = 5.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 355 4 0 4 2.5 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2)CC1 10.1007/s00044-010-9379-1
CHEMBL293968 100902 3 None -630 5 Human 5.6 pKi = 5.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 355 4 0 4 2.5 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2)CC1 10.1007/s00044-010-9379-1
10721586 119695 0 None 141 3 Human 7.6 pKi = 7.6 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 559 10 3 7 3.4 CC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(N)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
CHEMBL347522 119695 0 None 141 3 Human 7.6 pKi = 7.6 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 559 10 3 7 3.4 CC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(N)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
11198145 9783 2 None 1 5 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from alpha-1A adrenergic receptor (unknown origin)Displacement of [3H]prazosin from alpha-1A adrenergic receptor (unknown origin)
ChEMBL 325 5 2 3 3.8 C[C@H]([C@@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1021/acs.jmedchem.0c01912
CHEMBL113830 9783 2 None 1 5 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from alpha-1A adrenergic receptor (unknown origin)Displacement of [3H]prazosin from alpha-1A adrenergic receptor (unknown origin)
ChEMBL 325 5 2 3 3.8 C[C@H]([C@@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1021/acs.jmedchem.0c01912
44289047 100355 0 None 25 3 Human 7.6 pKi = 7.6 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 441 8 1 3 5.2 Cc1ccc(C(C(=O)NCCCN2CCC(c3ccccn3)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
CHEMBL289916 100355 0 None 25 3 Human 7.6 pKi = 7.6 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 441 8 1 3 5.2 Cc1ccc(C(C(=O)NCCCN2CCC(c3ccccn3)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
9822705 100660 0 None -19 4 Rat 7.6 pKi = 7.6 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 407 4 0 3 4.4 O=C1CC2(C=CN1CCN1CCN(c3cc(Cl)ccc3Cl)CC1)CCCC2 10.1021/jm030944+
CHEMBL292366 100660 0 None -19 4 Rat 7.6 pKi = 7.6 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 407 4 0 3 4.4 O=C1CC2(C=CN1CCN1CCN(c3cc(Cl)ccc3Cl)CC1)CCCC2 10.1021/jm030944+
25131876 86163 0 None -41 7 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assayDisplacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assay
ChEMBL 419 9 1 5 4.0 COc1ccccc1OCCNCC1COCC(c2ccccc2)(c2ccccc2)O1 10.1016/j.ejmech.2019.02.056
CHEMBL2312227 86163 0 None -41 7 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assayDisplacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assay
ChEMBL 419 9 1 5 4.0 COc1ccccc1OCCNCC1COCC(c2ccccc2)(c2ccccc2)O1 10.1016/j.ejmech.2019.02.056
76308474 106207 0 None -31 5 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptorDisplacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 467 5 1 9 3.1 COc1ccc(C(=O)N2CCN(c3nc(N)c4cc(OC)c(OC)cc4n3)[C@H]3CCCC[C@@H]32)o1 10.1007/s00044-004-0024-8
CHEMBL2261607 106207 0 None -31 5 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptorDisplacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 467 5 1 9 3.1 COc1ccc(C(=O)N2CCN(c3nc(N)c4cc(OC)c(OC)cc4n3)[C@H]3CCCC[C@@H]32)o1 10.1007/s00044-004-0024-8
CHEMBL3138856 106207 0 None -31 5 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptorDisplacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 467 5 1 9 3.1 COc1ccc(C(=O)N2CCN(c3nc(N)c4cc(OC)c(OC)cc4n3)[C@H]3CCCC[C@@H]32)o1 10.1007/s00044-004-0024-8
44428846 92160 0 None -31 5 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 467 5 1 9 3.1 COc1ccc(C(=O)N2CCN(c3nc(N)c4cc(OC)c(OC)cc4n3)[C@@H]3CCCC[C@@H]32)o1 10.1016/j.bmc.2007.01.028
CHEMBL242508 92160 0 None -31 5 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 467 5 1 9 3.1 COc1ccc(C(=O)N2CCN(c3nc(N)c4cc(OC)c(OC)cc4n3)[C@@H]3CCCC[C@@H]32)o1 10.1016/j.bmc.2007.01.028
25181488 187358 0 None -33 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 419 9 1 5 4.0 COc1ccccc1OCCNC[C@@H]1COCC(c2ccccc2)(c2ccccc2)O1 10.1021/jm800461k
CHEMBL493486 187358 0 None -33 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 419 9 1 5 4.0 COc1ccccc1OCCNC[C@@H]1COCC(c2ccccc2)(c2ccccc2)O1 10.1021/jm800461k
25131876 86163 0 None -41 7 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 419 9 1 5 4.0 COc1ccccc1OCCNCC1COCC(c2ccccc2)(c2ccccc2)O1 10.1021/jm301525w
CHEMBL2312227 86163 0 None -41 7 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 419 9 1 5 4.0 COc1ccccc1OCCNCC1COCC(c2ccccc2)(c2ccccc2)O1 10.1021/jm301525w
10427137 36020 4 None -1 2 Rat 5.6 pKi = 5.6 Binding
Displacement of [3H]prazosin from rat whole brain alpha1 adrenergic receptorDisplacement of [3H]prazosin from rat whole brain alpha1 adrenergic receptor
ChEMBL 336 2 0 2 5.3 Cc1ccc2c(c1)c(-c1ccc(F)cc1)c(C)n2C1CCN(C)CC1 10.1021/acs.jmedchem.2c00633
CHEMBL144362 36020 4 None -1 2 Rat 5.6 pKi = 5.6 Binding
Displacement of [3H]prazosin from rat whole brain alpha1 adrenergic receptorDisplacement of [3H]prazosin from rat whole brain alpha1 adrenergic receptor
ChEMBL 336 2 0 2 5.3 Cc1ccc2c(c1)c(-c1ccc(F)cc1)c(C)n2C1CCN(C)CC1 10.1021/acs.jmedchem.2c00633
11711943 16068 0 None -28 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 444 8 1 5 5.4 FC(F)(F)c1cccc(N2CCN(CCCCNc3ncc(-c4ccccc4)o3)CC2)c1 10.1016/j.bmcl.2010.07.096
CHEMBL1223858 16068 0 None -28 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 444 8 1 5 5.4 FC(F)(F)c1cccc(N2CCN(CCCCNc3ncc(-c4ccccc4)o3)CC2)c1 10.1016/j.bmcl.2010.07.096
71062646 149519 0 None -4466 13 Mouse 5.6 pKi = 5.6 Binding
Radioligand Binding Assay: The detailed experimental protocols for the radioligand and functional receptor assays are available on the NIMH PDSP website at http://pdsp.med.unc.edu/UNC-CH %20Protocol %20Book.pdf. A. Serotonin receptors: 5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E, 5-HT2A, 5-HT2B, 5-HT2C, 5-HT3, 5-HT5A, 5-HT6 and 5-HT7. Assay Buffer: Standard Binding Buffer (50 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, pH 7.4) Membrane Fraction Source: Transiently or stably transfected cell lines (e.g., HEK293, COS, CHO, NIH3T3). Protocol adapted from Roth et al. (1986), J. Pharmacol. Exp. Ther., 238(2): 480-485; and Roth et al. (1994), J. Pharmacol. Exp. Ther., 268(3): 1403-1410. Adrenergic Receptors: alpha1A, alpha1B, alpha2A, alpha2B, alpha2C, beta1, beta2, beta3 Assay Buffers: For alpha1 receptors, alpha1 Binding Buffer (20 mM Tris-HCl, 145 mM NaCl, pH 7.4); for alpha2 receptors, alpha2 Binding Buffer (50 mM Tris-HCl, 5 mM MgCl2, pH 7.7); for beta receptors.Radioligand Binding Assay: The detailed experimental protocols for the radioligand and functional receptor assays are available on the NIMH PDSP website at http://pdsp.med.unc.edu/UNC-CH %20Protocol %20Book.pdf. A. Serotonin receptors: 5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E, 5-HT2A, 5-HT2B, 5-HT2C, 5-HT3, 5-HT5A, 5-HT6 and 5-HT7. Assay Buffer: Standard Binding Buffer (50 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, pH 7.4) Membrane Fraction Source: Transiently or stably transfected cell lines (e.g., HEK293, COS, CHO, NIH3T3). Protocol adapted from Roth et al. (1986), J. Pharmacol. Exp. Ther., 238(2): 480-485; and Roth et al. (1994), J. Pharmacol. Exp. Ther., 268(3): 1403-1410. Adrenergic Receptors: alpha1A, alpha1B, alpha2A, alpha2B, alpha2C, beta1, beta2, beta3 Assay Buffers: For alpha1 receptors, alpha1 Binding Buffer (20 mM Tris-HCl, 145 mM NaCl, pH 7.4); for alpha2 receptors, alpha2 Binding Buffer (50 mM Tris-HCl, 5 mM MgCl2, pH 7.7); for beta receptors.
ChEMBL 338 6 0 4 2.8 c1ccc(OC[C@@H]2CN(CCN3CCc4ccccc43)CCO2)cc1 nan
CHEMBL3946661 149519 0 None -4466 13 Mouse 5.6 pKi = 5.6 Binding
Radioligand Binding Assay: The detailed experimental protocols for the radioligand and functional receptor assays are available on the NIMH PDSP website at http://pdsp.med.unc.edu/UNC-CH %20Protocol %20Book.pdf. A. Serotonin receptors: 5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E, 5-HT2A, 5-HT2B, 5-HT2C, 5-HT3, 5-HT5A, 5-HT6 and 5-HT7. Assay Buffer: Standard Binding Buffer (50 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, pH 7.4) Membrane Fraction Source: Transiently or stably transfected cell lines (e.g., HEK293, COS, CHO, NIH3T3). Protocol adapted from Roth et al. (1986), J. Pharmacol. Exp. Ther., 238(2): 480-485; and Roth et al. (1994), J. Pharmacol. Exp. Ther., 268(3): 1403-1410. Adrenergic Receptors: alpha1A, alpha1B, alpha2A, alpha2B, alpha2C, beta1, beta2, beta3 Assay Buffers: For alpha1 receptors, alpha1 Binding Buffer (20 mM Tris-HCl, 145 mM NaCl, pH 7.4); for alpha2 receptors, alpha2 Binding Buffer (50 mM Tris-HCl, 5 mM MgCl2, pH 7.7); for beta receptors.Radioligand Binding Assay: The detailed experimental protocols for the radioligand and functional receptor assays are available on the NIMH PDSP website at http://pdsp.med.unc.edu/UNC-CH %20Protocol %20Book.pdf. A. Serotonin receptors: 5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E, 5-HT2A, 5-HT2B, 5-HT2C, 5-HT3, 5-HT5A, 5-HT6 and 5-HT7. Assay Buffer: Standard Binding Buffer (50 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, pH 7.4) Membrane Fraction Source: Transiently or stably transfected cell lines (e.g., HEK293, COS, CHO, NIH3T3). Protocol adapted from Roth et al. (1986), J. Pharmacol. Exp. Ther., 238(2): 480-485; and Roth et al. (1994), J. Pharmacol. Exp. Ther., 268(3): 1403-1410. Adrenergic Receptors: alpha1A, alpha1B, alpha2A, alpha2B, alpha2C, beta1, beta2, beta3 Assay Buffers: For alpha1 receptors, alpha1 Binding Buffer (20 mM Tris-HCl, 145 mM NaCl, pH 7.4); for alpha2 receptors, alpha2 Binding Buffer (50 mM Tris-HCl, 5 mM MgCl2, pH 7.7); for beta receptors.
ChEMBL 338 6 0 4 2.8 c1ccc(OC[C@@H]2CN(CCN3CCc4ccccc43)CCO2)cc1 nan
9796525 9375 0 None 5 3 Rat 6.6 pKi = 6.6 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 305 3 1 4 2.3 Cn1cnc(C2CCCc3c(NS(C)(=O)=O)cccc32)c1 10.1007/s00044-004-0020-z
CHEMBL111584 9375 0 None 5 3 Rat 6.6 pKi = 6.6 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 305 3 1 4 2.3 Cn1cnc(C2CCCc3c(NS(C)(=O)=O)cccc32)c1 10.1007/s00044-004-0020-z
9796525 9375 0 None 5 3 Rat 6.6 pKi = 6.6 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 305 3 1 4 2.3 Cn1cnc(C2CCCc3c(NS(C)(=O)=O)cccc32)c1 10.1021/jm030551a
CHEMBL111584 9375 0 None 5 3 Rat 6.6 pKi = 6.6 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 305 3 1 4 2.3 Cn1cnc(C2CCCc3c(NS(C)(=O)=O)cccc32)c1 10.1021/jm030551a
10763305 106935 0 None -11 2 Rat 6.6 pKi = 6.6 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 396 5 0 4 3.3 FC(F)(F)c1cccc(N2CCN(CCCN3CC4CCCCN4C3)CC2)c1 10.1021/jm970216k
CHEMBL314997 106935 0 None -11 2 Rat 6.6 pKi = 6.6 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 396 5 0 4 3.3 FC(F)(F)c1cccc(N2CCN(CCCN3CC4CCCCN4C3)CC2)c1 10.1021/jm970216k
18738380 11909 0 None 8 3 Human 7.6 pKi = 7.6 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 417 9 1 6 1.9 CC(C)Oc1ccccc1N1CCN(CC(O)CC(=O)CN2CCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
CHEMBL11828 11909 0 None 8 3 Human 7.6 pKi = 7.6 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 417 9 1 6 1.9 CC(C)Oc1ccccc1N1CCN(CC(O)CC(=O)CN2CCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
11857638 142130 0 None 1 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 516 9 1 6 5.0 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
CHEMBL388361 142130 0 None 1 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 516 9 1 6 5.0 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
11857638 142130 0 None 1 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 516 9 1 6 5.0 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
CHEMBL388361 142130 0 None 1 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 516 9 1 6 5.0 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
1353 1898 93 None -10 86 Rat 7.6 pKi = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
3559 1898 93 None -10 86 Rat 7.6 pKi = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
86 1898 93 None -10 86 Rat 7.6 pKi = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
CHEMBL54 1898 93 None -10 86 Rat 7.6 pKi = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
DB00502 1898 93 None -10 86 Rat 7.6 pKi = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
44460477 205384 0 None 1 2 Human 7.6 pKi = 7.6 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 432 7 0 6 3.9 O=C1CCCN1Cc1cc(CN2CCN(c3ccccc3Oc3ccccc3)CC2)on1 10.1016/s0960-894x(02)00436-5
CHEMBL80109 205384 0 None 1 2 Human 7.6 pKi = 7.6 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 432 7 0 6 3.9 O=C1CCCN1Cc1cc(CN2CCN(c3ccccc3Oc3ccccc3)CC2)on1 10.1016/s0960-894x(02)00436-5
145987771 167065 0 None -8 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from alpha1-adrenoceptor (unknown origin) in cerebral cortex membranes after 60 mins by TopCount scintillation counting methodDisplacement of [3H]prazosin from alpha1-adrenoceptor (unknown origin) in cerebral cortex membranes after 60 mins by TopCount scintillation counting method
ChEMBL 431 6 1 2 5.9 Fc1ccc(N2CCN(CCCc3c[nH]c4ccc(F)cc34)CC2)c(-c2ccccc2)c1 10.1016/j.ejmech.2017.12.063
CHEMBL4289783 167065 0 None -8 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from alpha1-adrenoceptor (unknown origin) in cerebral cortex membranes after 60 mins by TopCount scintillation counting methodDisplacement of [3H]prazosin from alpha1-adrenoceptor (unknown origin) in cerebral cortex membranes after 60 mins by TopCount scintillation counting method
ChEMBL 431 6 1 2 5.9 Fc1ccc(N2CCN(CCCc3c[nH]c4ccc(F)cc34)CC2)c(-c2ccccc2)c1 10.1016/j.ejmech.2017.12.063
44288740 101328 0 None 29 3 Human 7.6 pKi = 7.6 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 437 8 1 3 4.9 N#CC1(c2ccccc2)CCN(CCCNC(=O)C(c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(00)00307-3
CHEMBL296965 101328 0 None 29 3 Human 7.6 pKi = 7.6 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 437 8 1 3 4.9 N#CC1(c2ccccc2)CCN(CCCNC(=O)C(c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(00)00307-3
53328505 63364 0 None 2 3 Human 7.6 pKi = 7.6 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 455 7 0 5 3.8 COc1ccccc1N1CCN(CCCN2C(=O)CC(c3ccc(Cl)cc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796039 63364 0 None 2 3 Human 7.6 pKi = 7.6 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 455 7 0 5 3.8 COc1ccccc1N1CCN(CCCN2C(=O)CC(c3ccc(Cl)cc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
76322412 84793 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 354 5 0 5 2.9 COc1ccccc1N1CCN(CC2CO[C@H](c3ccccc3)O2)CC1 10.1007/s00044-010-9379-1
CHEMBL2234447 84793 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 354 5 0 5 2.9 COc1ccccc1N1CCN(CC2CO[C@H](c3ccccc3)O2)CC1 10.1007/s00044-010-9379-1
14004037 53741 2 None -8 2 Bovine 5.6 pKi = 5.6 Binding
Affinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranesAffinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranes
ChEMBL 209 0 1 4 1.8 Nc1nc2c(s1)CCN1CCCCC21 10.1021/jm00398a025
CHEMBL160388 53741 2 None -8 2 Bovine 5.6 pKi = 5.6 Binding
Affinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranesAffinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranes
ChEMBL 209 0 1 4 1.8 Nc1nc2c(s1)CCN1CCCCC21 10.1021/jm00398a025
1960 2838 67 None -57 26 Rat 6.6 pKi = 6.6 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
439260 2838 67 None -57 26 Rat 6.6 pKi = 6.6 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
505 2838 67 None -57 26 Rat 6.6 pKi = 6.6 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
CHEMBL1437 2838 67 None -57 26 Rat 6.6 pKi = 6.6 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
DB00368 2838 67 None -57 26 Rat 6.6 pKi = 6.6 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
2435 719 100 None -21 12 Human 5.6 pKi = 5.6 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1016/0960-894X(95)00391-6
395 719 100 None -21 12 Human 5.6 pKi = 5.6 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1016/0960-894X(95)00391-6
520 719 100 None -21 12 Human 5.6 pKi = 5.6 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1016/0960-894X(95)00391-6
5386 719 100 None -21 12 Human 5.6 pKi = 5.6 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1016/0960-894X(95)00391-6
CHEMBL844 719 100 None -21 12 Human 5.6 pKi = 5.6 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1016/0960-894X(95)00391-6
DB00484 719 100 None -21 12 Human 5.6 pKi = 5.6 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1016/0960-894X(95)00391-6
14004037 53741 2 None -8 2 Bovine 5.6 pKi = 5.6 Binding
Compound was evaluated for log 1/Ki at alpha-1 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-1 adrenergic receptor
ChEMBL 209 0 1 4 1.8 Nc1nc2c(s1)CCN1CCCCC21 10.1021/jm00398a025
CHEMBL160388 53741 2 None -8 2 Bovine 5.6 pKi = 5.6 Binding
Compound was evaluated for log 1/Ki at alpha-1 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-1 adrenergic receptor
ChEMBL 209 0 1 4 1.8 Nc1nc2c(s1)CCN1CCCCC21 10.1021/jm00398a025
127027076 137662 0 None -257 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 455 7 1 3 5.2 O=C(NCCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
CHEMBL3758711 137662 0 None -257 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 455 7 1 3 5.2 O=C(NCCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
2777786 174953 82 None -29 2 Bovine 5.5 pKi = 5.5 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 231 1 1 3 1.5 FC(F)(F)c1cccnc1N1CCNCC1 10.1021/jm00366a007
CHEMBL45663 174953 82 None -29 2 Bovine 5.5 pKi = 5.5 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 231 1 1 3 1.5 FC(F)(F)c1cccnc1N1CCNCC1 10.1021/jm00366a007
73213196 104433 4 None -2 13 Human 6.5 pKi = 6.5 Binding
Binding affinity to adrenergic alpha 1A receptor (unknown origin)Binding affinity to adrenergic alpha 1A receptor (unknown origin)
ChEMBL 288 0 0 2 3.9 CN1CCc2c(c3cccc4c3n2CCc2ccccc2-4)C1 10.1016/j.bmcl.2014.05.016
CHEMBL3104093 104433 4 None -2 13 Human 6.5 pKi = 6.5 Binding
Binding affinity to adrenergic alpha 1A receptor (unknown origin)Binding affinity to adrenergic alpha 1A receptor (unknown origin)
ChEMBL 288 0 0 2 3.9 CN1CCc2c(c3cccc4c3n2CCc2ccccc2-4)C1 10.1016/j.bmcl.2014.05.016
73213196 104433 4 None -2 13 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 288 0 0 2 3.9 CN1CCc2c(c3cccc4c3n2CCc2ccccc2-4)C1 10.1016/j.bmcl.2013.12.024
CHEMBL3104093 104433 4 None -2 13 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 288 0 0 2 3.9 CN1CCc2c(c3cccc4c3n2CCc2ccccc2-4)C1 10.1016/j.bmcl.2013.12.024
11282574 37702 0 None -38 3 Human 6.5 pKi = 6.5 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 459 5 2 5 4.4 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNC(=O)c1ccccc1C(F)(F)F)C3 10.1021/jm030952q
CHEMBL145785 37702 0 None -38 3 Human 6.5 pKi = 6.5 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 459 5 2 5 4.4 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNC(=O)c1ccccc1C(F)(F)F)C3 10.1021/jm030952q
76319344 85308 0 None 29 3 Rat 6.5 pKi = 6.5 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 289 2 3 5 2.0 COC(=O)Nc1c(O)ccc2c1CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
CHEMBL2261351 85308 0 None 29 3 Rat 6.5 pKi = 6.5 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 289 2 3 5 2.0 COC(=O)Nc1c(O)ccc2c1CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
73213196 104433 4 None -2 13 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 288 0 0 2 3.9 CN1CCc2c(c3cccc4c3n2CCc2ccccc2-4)C1 10.1016/j.bmcl.2013.12.024
CHEMBL3104093 104433 4 None -2 13 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 288 0 0 2 3.9 CN1CCc2c(c3cccc4c3n2CCc2ccccc2-4)C1 10.1016/j.bmcl.2013.12.024
155552821 176659 0 None -12 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 389 8 1 4 4.2 c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)OC2)cc1 10.1016/j.ejmech.2019.05.024
CHEMBL4544457 176659 0 None -12 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 389 8 1 4 4.2 c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)OC2)cc1 10.1016/j.ejmech.2019.05.024
CHEMBL4598345 176659 0 None -12 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 389 8 1 4 4.2 c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)OC2)cc1 10.1016/j.ejmech.2019.05.024
92766 106515 35 None 1 6 Human 7.5 pKi = 7.5 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12 10.1016/j.bmcl.2004.11.032
CHEMBL31410 106515 35 None 1 6 Human 7.5 pKi = 7.5 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12 10.1016/j.bmcl.2004.11.032
12909385 60399 1 None 7 2 Bovine 7.5 pKi = 7.5 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 276 0 0 2 4.0 CN1CCC(=C2c3ccccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
CHEMBL175154 60399 1 None 7 2 Bovine 7.5 pKi = 7.5 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 276 0 0 2 4.0 CN1CCC(=C2c3ccccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
11303180 198203 0 None -9 5 Rat 7.5 pKi = 7.5 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 369 5 0 4 3.1 COc1ccccc1N1CCN(CCN2C=CC3(CCCC3)CC2=O)CC1 10.1021/jm030944+
CHEMBL57540 198203 0 None -9 5 Rat 7.5 pKi = 7.5 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 369 5 0 4 3.1 COc1ccccc1N1CCN(CCN2C=CC3(CCCC3)CC2=O)CC1 10.1021/jm030944+
122179431 121417 0 None -1 3 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 585 9 1 13 3.1 CCN(CC)c1ccc2cc(-n3cc(CN4CCN(c5nc(N)c6cc(OC)c(OC)cc6n5)CC4)nn3)c(=O)oc2c1 10.1021/ml5004298
CHEMBL3582272 121417 0 None -1 3 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 585 9 1 13 3.1 CCN(CC)c1ccc2cc(-n3cc(CN4CCN(c5nc(N)c6cc(OC)c(OC)cc6n5)CC4)nn3)c(=O)oc2c1 10.1021/ml5004298
11384664 83083 0 None -35 4 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 421 7 1 3 4.8 O=C(NCCCCN1CCN(c2ccccc2Cl)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
CHEMBL218203 83083 0 None -35 4 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 421 7 1 3 4.8 O=C(NCCCCN1CCN(c2ccccc2Cl)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
127026123 137686 0 None -41 3 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 401 7 1 3 4.5 Cc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1 10.1016/j.bmcl.2015.12.068
CHEMBL3758881 137686 0 None -41 3 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 401 7 1 3 4.5 Cc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1 10.1016/j.bmcl.2015.12.068
2419 692 28 None -288 12 Human 6.5 pKi = 6.5 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm0491391
9 692 28 None -288 12 Human 6.5 pKi = 6.5 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm0491391
CHEMBL13647 692 28 None -288 12 Human 6.5 pKi = 6.5 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm0491391
9845181 208138 3 None -1445 14 Human 6.5 pKi = 6.5 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 423 4 0 4 3.3 C[C@H](CN1CCN(c2cc(F)c(F)cc2F)CC1)N1C(=O)CC2(CCCC2)CC1=O 10.1016/j.bmcl.2004.11.032
CHEMBL98241 208138 3 None -1445 14 Human 6.5 pKi = 6.5 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 423 4 0 4 3.3 C[C@H](CN1CCN(c2cc(F)c(F)cc2F)CC1)N1C(=O)CC2(CCCC2)CC1=O 10.1016/j.bmcl.2004.11.032
10643994 77227 0 None -2 3 Rat 5.5 pKi = 5.5 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 388 4 3 8 0.9 COc1cc2nc(N3CCN[C@@H](C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC 10.1021/jm980053f
CHEMBL2079655 77227 0 None -2 3 Rat 5.5 pKi = 5.5 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 388 4 3 8 0.9 COc1cc2nc(N3CCN[C@@H](C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC 10.1021/jm980053f
146025727 171661 0 None -107 27 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]-prazosin from recombinant human alpha1A adrenergic receptor measured after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-prazosin from recombinant human alpha1A adrenergic receptor measured after 90 mins by microbeta scintillation counting method
ChEMBL 411 3 0 5 6.4 FC(F)(F)c1cc(Oc2nccc3ccsc23)ccc1-c1cccc2nccn12 10.1021/acs.jmedchem.9b00351
CHEMBL4466483 171661 0 None -107 27 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]-prazosin from recombinant human alpha1A adrenergic receptor measured after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-prazosin from recombinant human alpha1A adrenergic receptor measured after 90 mins by microbeta scintillation counting method
ChEMBL 411 3 0 5 6.4 FC(F)(F)c1cc(Oc2nccc3ccsc23)ccc1-c1cccc2nccn12 10.1021/acs.jmedchem.9b00351
2419 692 28 None -288 12 Human 6.5 pKi = 6.5 Binding
Compound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor (n >= 2)Compound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor (n >= 2)
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm980053f
9 692 28 None -288 12 Human 6.5 pKi = 6.5 Binding
Compound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor (n >= 2)Compound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor (n >= 2)
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm980053f
CHEMBL13647 692 28 None -288 12 Human 6.5 pKi = 6.5 Binding
Compound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor (n >= 2)Compound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor (n >= 2)
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm980053f
9845181 208138 3 None -1445 14 Human 6.5 pKi = 6.5 Binding
In vitro binding affinity at human Alpha-1A adrenergic receptor.In vitro binding affinity at human Alpha-1A adrenergic receptor.
ChEMBL 423 4 0 4 3.3 C[C@H](CN1CCN(c2cc(F)c(F)cc2F)CC1)N1C(=O)CC2(CCCC2)CC1=O 10.1021/jm0307741
CHEMBL98241 208138 3 None -1445 14 Human 6.5 pKi = 6.5 Binding
In vitro binding affinity at human Alpha-1A adrenergic receptor.In vitro binding affinity at human Alpha-1A adrenergic receptor.
ChEMBL 423 4 0 4 3.3 C[C@H](CN1CCN(c2cc(F)c(F)cc2F)CC1)N1C(=O)CC2(CCCC2)CC1=O 10.1021/jm0307741
11191047 201794 0 None -8 3 Rat 6.5 pKi = 6.5 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 490 7 0 6 3.2 COc1ccccc1N1CCN(CCN2C(=O)CC3(CCN(Cc4ccccc4)CC3)CC2=O)CC1 10.1021/jm030944+
CHEMBL60699 201794 0 None -8 3 Rat 6.5 pKi = 6.5 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 490 7 0 6 3.2 COc1ccccc1N1CCN(CCN2C(=O)CC3(CCN(Cc4ccccc4)CC3)CC2=O)CC1 10.1021/jm030944+
11486511 101557 0 None -870 5 Rat 6.5 pKi = 6.5 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 403 4 0 4 3.6 O=C1CC2(CCCC2)CC(=O)N1CCN1CCCN(c2ccccc2Cl)CC1 10.1021/jm030944+
CHEMBL298595 101557 0 None -870 5 Rat 6.5 pKi = 6.5 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 403 4 0 4 3.6 O=C1CC2(CCCC2)CC(=O)N1CCN1CCCN(c2ccccc2Cl)CC1 10.1021/jm030944+
11346205 9244 0 None -8 2 Rat 5.5 pKi = 5.5 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 268 4 3 5 0.8 CCS(=O)(=O)Nc1cccc(NC2=NCCN2)c1 10.1021/jm030551a
CHEMBL110852 9244 0 None -8 2 Rat 5.5 pKi = 5.5 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 268 4 3 5 0.8 CCS(=O)(=O)Nc1cccc(NC2=NCCN2)c1 10.1021/jm030551a
44460522 205364 0 None 3 2 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 460 7 0 7 3.6 CC(C)Oc1ccccc1N1CCN(Cc2nc(CN3C(=O)c4ccccc4C3=O)co2)CC1 10.1016/s0960-894x(02)00436-5
CHEMBL79990 205364 0 None 3 2 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 460 7 0 7 3.6 CC(C)Oc1ccccc1N1CCN(Cc2nc(CN3C(=O)c4ccccc4C3=O)co2)CC1 10.1016/s0960-894x(02)00436-5
136680385 207627 0 None 85 3 Human 8.5 pKi = 8.5 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 694 16 4 8 4.9 CCNC(=O)C1=C(COCCN)NC(CC)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1016/s0960-894x(99)00484-9
44328824 207627 0 None 85 3 Human 8.5 pKi = 8.5 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 694 16 4 8 4.9 CCNC(=O)C1=C(COCCN)NC(CC)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1016/s0960-894x(99)00484-9
CHEMBL95253 207627 0 None 85 3 Human 8.5 pKi = 8.5 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 694 16 4 8 4.9 CCNC(=O)C1=C(COCCN)NC(CC)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1016/s0960-894x(99)00484-9
44213782 10508 0 None 309 3 Human 8.5 pKi = 8.5 Binding
Binding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assayBinding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assay
ChEMBL 504 8 0 6 3.9 CCOC(=O)C1CN(CCCCN2C(=O)c3cc(Cl)ccc3S2(=O)=O)CCC1c1ccccc1 10.1016/s0960-894x(98)00451-x
CHEMBL1169493 10508 0 None 309 3 Human 8.5 pKi = 8.5 Binding
Binding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assayBinding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assay
ChEMBL 504 8 0 6 3.9 CCOC(=O)C1CN(CCCCN2C(=O)c3cc(Cl)ccc3S2(=O)=O)CCC1c1ccccc1 10.1016/s0960-894x(98)00451-x
44431611 87552 0 None 6 4 Human 8.5 pKi = 8.5 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 509 7 1 5 4.7 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccc(Cl)cc3F)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL233582 87552 0 None 6 4 Human 8.5 pKi = 8.5 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 509 7 1 5 4.7 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccc(Cl)cc3F)CC2)CC1 10.1016/j.bmcl.2007.04.008
11857639 143859 1 None 2 4 Human 8.5 pKi = 8.5 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 492 7 1 4 5.2 CC(C)Oc1ccccc1C1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccc(F)c(F)c3)CC2)CC1 10.1016/j.bmcl.2007.04.098
CHEMBL390184 143859 1 None 2 4 Human 8.5 pKi = 8.5 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 492 7 1 4 5.2 CC(C)Oc1ccccc1C1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccc(F)c(F)c3)CC2)CC1 10.1016/j.bmcl.2007.04.098
9848303 111553 0 None 1 10 Bovine 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 487 6 1 6 3.8 Cn1cc(-c2ccc3c(c2)c(C2CCN(CCN4CCNC4=O)CC2)cn3-c2ccc(F)cc2)nn1 10.1016/j.bmc.2012.10.049
CHEMBL328187 111553 0 None 1 10 Bovine 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 487 6 1 6 3.8 Cn1cc(-c2ccc3c(c2)c(C2CCN(CCN4CCNC4=O)CC2)cn3-c2ccc(F)cc2)nn1 10.1016/j.bmc.2012.10.049
9848303 111553 0 None 1 10 Bovine 8.5 pKi = 8.5 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 487 6 1 6 3.8 Cn1cc(-c2ccc3c(c2)c(C2CCN(CCN4CCNC4=O)CC2)cn3-c2ccc(F)cc2)nn1 10.1021/jm100652h
CHEMBL328187 111553 0 None 1 10 Bovine 8.5 pKi = 8.5 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 487 6 1 6 3.8 Cn1cc(-c2ccc3c(c2)c(C2CCN(CCN4CCNC4=O)CC2)cn3-c2ccc(F)cc2)nn1 10.1021/jm100652h
10971791 208295 0 None -7 3 Human 8.5 pKi = 8.5 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 417 5 1 7 3.4 COc1ccccc1N1CCN(CCn2c(C)nc3c4ccccc4nc-3c2O)CC1 10.1016/j.bmcl.2006.09.034
CHEMBL99142 208295 0 None -7 3 Human 8.5 pKi = 8.5 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 417 5 1 7 3.4 COc1ccccc1N1CCN(CCn2c(C)nc3c4ccccc4nc-3c2O)CC1 10.1016/j.bmcl.2006.09.034
118716718 114986 0 None -3 4 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 532 7 0 9 2.3 COc1ccccc1N1CCN(CC2COC3(CCN(S(=O)(=O)c4cccc([N+](=O)[O-])c4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342871 114986 0 None -3 4 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 532 7 0 9 2.3 COc1ccccc1N1CCN(CC2COC3(CCN(S(=O)(=O)c4cccc([N+](=O)[O-])c4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
44447002 94696 0 None -301 4 Rat 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 434 6 1 5 4.2 CCC(=O)NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21 10.1016/j.bmcl.2007.11.106
CHEMBL253022 94696 0 None -301 4 Rat 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 434 6 1 5 4.2 CCC(=O)NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21 10.1016/j.bmcl.2007.11.106
9960311 203841 0 None 25 2 Human 8.5 pKi = 8.5 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 598 9 2 7 4.5 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(C(C)(C)C)cc2)C3=O)CC1 10.1021/jm9905918
CHEMBL68699 203841 0 None 25 2 Human 8.5 pKi = 8.5 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 598 9 2 7 4.5 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(C(C)(C)C)cc2)C3=O)CC1 10.1021/jm9905918
19085839 205759 0 None 97 3 Human 8.5 pKi = 8.5 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 469 6 0 7 3.2 Cc1ccc2c(c1)oc(=O)n2C1CCN(CCCCN2C(=O)c3ccccc3S2(=O)=O)CC1 10.1016/s0960-894x(98)00446-6
CHEMBL83041 205759 0 None 97 3 Human 8.5 pKi = 8.5 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 469 6 0 7 3.2 Cc1ccc2c(c1)oc(=O)n2C1CCN(CCCCN2C(=O)c3ccccc3S2(=O)=O)CC1 10.1016/s0960-894x(98)00446-6
4188516 100350 8 None 1 2 Rat 8.5 pKi = 8.5 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 372 6 0 5 1.6 COc1ccccc1N1CCN(CCCN2C(=O)C3CCCN3C2=O)CC1 10.1021/jm970216k
CHEMBL289873 100350 8 None 1 2 Rat 8.5 pKi = 8.5 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 372 6 0 5 1.6 COc1ccccc1N1CCN(CCCN2C(=O)C3CCCN3C2=O)CC1 10.1021/jm970216k
9891166 33582 0 None -7 5 Human 8.5 pKi = 8.5 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 476 6 0 8 3.3 COc1ccccc1N1CCN(CCn2c(=O)c3c(-c4ccccc4)csc3n(C)c2=O)CC1 10.1016/s0960-894x(01)00159-7
CHEMBL14213 33582 0 None -7 5 Human 8.5 pKi = 8.5 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 476 6 0 8 3.3 COc1ccccc1N1CCN(CCn2c(=O)c3c(-c4ccccc4)csc3n(C)c2=O)CC1 10.1016/s0960-894x(01)00159-7
16041628 155326 0 None -1 4 Human 8.5 pKi = 8.5 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 472 6 2 4 5.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3ccc(F)cc3F)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL403280 155326 0 None -1 4 Human 8.5 pKi = 8.5 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 472 6 2 4 5.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3ccc(F)cc3F)CC2)CC1 10.1016/j.bmcl.2007.11.068
10841387 99590 0 None 91 6 Human 8.5 pKi = 8.5 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 607 10 3 6 5.2 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00019a001
CHEMBL284103 99590 0 None 91 6 Human 8.5 pKi = 8.5 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 607 10 3 6 5.2 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00019a001
10624665 100304 0 None 1 3 Rat 8.5 pKi = 8.5 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 482 4 1 7 3.6 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5c(Cl)ccnc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL289437 100304 0 None 1 3 Rat 8.5 pKi = 8.5 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 482 4 1 7 3.6 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5c(Cl)ccnc54)c3=O)C[C@@H]21 10.1021/jm990567u
10416624 109623 0 None 263 3 Human 8.5 pKi = 8.5 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 634 14 4 10 2.0 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(COCCN)NC(C)=C(C(N)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1016/s0960-894x(99)00484-9
136806219 109623 0 None 263 3 Human 8.5 pKi = 8.5 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 634 14 4 10 2.0 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(COCCN)NC(C)=C(C(N)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1016/s0960-894x(99)00484-9
CHEMBL322405 109623 0 None 263 3 Human 8.5 pKi = 8.5 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 634 14 4 10 2.0 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(COCCN)NC(C)=C(C(N)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1016/s0960-894x(99)00484-9
2585 800 103 None -5 22 Rat 8.5 pKi = 8.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
522 800 103 None -5 22 Rat 8.5 pKi = 8.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
551 800 103 None -5 22 Rat 8.5 pKi = 8.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
CHEMBL723 800 103 None -5 22 Rat 8.5 pKi = 8.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
DB01136 800 103 None -5 22 Rat 8.5 pKi = 8.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
3157 1458 71 None -2 12 Human 8.5 pKi = 8.5 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm960697s
7170 1458 71 None -2 12 Human 8.5 pKi = 8.5 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm960697s
954 1458 71 None -2 12 Human 8.5 pKi = 8.5 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm960697s
CHEMBL707 1458 71 None -2 12 Human 8.5 pKi = 8.5 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm960697s
DB00590 1458 71 None -2 12 Human 8.5 pKi = 8.5 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm960697s
10841387 99590 0 None 91 6 Human 8.5 pKi = 8.5 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 607 10 3 6 5.2 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm960697s
CHEMBL284103 99590 0 None 91 6 Human 8.5 pKi = 8.5 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 607 10 3 6 5.2 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm960697s
52947579 17018 0 None -17 4 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 439 13 1 6 5.0 COc1cccc(OC)c1SCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
CHEMBL1254582 17018 0 None -17 4 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 439 13 1 6 5.0 COc1cccc(OC)c1SCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
52945803 17034 0 None -8 4 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 451 15 1 6 5.1 CCOc1cccc(OCC)c1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
CHEMBL1254742 17034 0 None -8 4 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 451 15 1 6 5.1 CCOc1cccc(OCC)c1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
52941624 17060 0 None -1 4 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 393 12 1 5 4.3 COc1ccccc1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
CHEMBL1254915 17060 0 None -1 4 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 393 12 1 5 4.3 COc1ccccc1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
10693026 105926 0 None 5 2 Bovine 8.5 pKi = 8.5 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 412 9 1 6 2.8 CCOc1ccccc1OCCNC1CCN(c2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL312935 105926 0 None 5 2 Bovine 8.5 pKi = 8.5 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 412 9 1 6 2.8 CCOc1ccccc1OCCNC1CCN(c2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
25032525 94554 0 None -9 4 Rat 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 420 5 1 5 3.8 CC(=O)NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21 10.1016/j.bmcl.2007.11.106
CHEMBL252030 94554 0 None -9 4 Rat 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 420 5 1 5 3.8 CC(=O)NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21 10.1016/j.bmcl.2007.11.106
10769037 37178 0 None 70 3 Human 8.5 pKi = 8.5 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 551 7 2 6 4.1 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C#N)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL145332 37178 0 None 70 3 Human 8.5 pKi = 8.5 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 551 7 2 6 4.1 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C#N)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
1043 1569 14 None -35 29 Rat 8.5 pKi = 8.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
149 1569 14 None -35 29 Rat 8.5 pKi = 8.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
8223 1569 14 None -35 29 Rat 8.5 pKi = 8.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
CHEMBL442 1569 14 None -35 29 Rat 8.5 pKi = 8.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
DB00696 1569 14 None -35 29 Rat 8.5 pKi = 8.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
15853467 208111 0 None 29 6 Human 8.5 pKi = 8.5 Binding
Binding affinity against human Alpha-1A adrenergic receptorBinding affinity against human Alpha-1A adrenergic receptor
ChEMBL 692 16 3 8 5.6 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN=[N+]=[N-])N1 10.1016/s0960-894x(99)00484-9
CHEMBL98063 208111 0 None 29 6 Human 8.5 pKi = 8.5 Binding
Binding affinity against human Alpha-1A adrenergic receptorBinding affinity against human Alpha-1A adrenergic receptor
ChEMBL 692 16 3 8 5.6 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN=[N+]=[N-])N1 10.1016/s0960-894x(99)00484-9
11857864 85655 0 None -2 4 Human 8.5 pKi = 8.5 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 534 9 1 6 5.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4cc(F)ccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
CHEMBL228659 85655 0 None -2 4 Human 8.5 pKi = 8.5 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 534 9 1 6 5.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4cc(F)ccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
10553701 100268 0 None 1 3 Rat 8.5 pKi = 8.5 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 472 4 1 7 3.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccc(C#N)c54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL289166 100268 0 None 1 3 Rat 8.5 pKi = 8.5 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 472 4 1 7 3.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccc(C#N)c54)c3=O)C[C@@H]21 10.1021/jm990567u
9960497 117049 0 None 25 6 Human 8.5 pKi = 8.5 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(C)=C(C(=O)OCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00019a001
CHEMBL3392246 117049 0 None 25 6 Human 8.5 pKi = 8.5 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(C)=C(C(=O)OCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00019a001
44447015 154217 0 None -3 4 Rat 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 483 6 1 6 4.5 O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1cccnc1 10.1016/j.bmcl.2007.11.106
CHEMBL398619 154217 0 None -3 4 Rat 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 483 6 1 6 4.5 O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1cccnc1 10.1016/j.bmcl.2007.11.106
10071710 84103 0 None -2 3 Human 8.5 pKi = 8.5 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 436 5 1 7 2.7 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccccc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
CHEMBL220781 84103 0 None -2 3 Human 8.5 pKi = 8.5 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 436 5 1 7 2.7 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccccc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
10071710 84103 0 None -2 3 Human 8.5 pKi = 8.5 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 436 5 1 7 2.7 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccccc43)c2=O)CC1 10.1016/j.bmcl.2006.09.034
CHEMBL220781 84103 0 None -2 3 Human 8.5 pKi = 8.5 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 436 5 1 7 2.7 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccccc43)c2=O)CC1 10.1016/j.bmcl.2006.09.034
45268939 196637 0 None -4 5 Human 8.5 pKi = 8.5 Binding
Binding affinity to alpha1A adrenergic receptor (unknown origin)Binding affinity to alpha1A adrenergic receptor (unknown origin)
ChEMBL 505 4 1 9 3.0 COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
CHEMBL564481 196637 0 None -4 5 Human 8.5 pKi = 8.5 Binding
Binding affinity to alpha1A adrenergic receptor (unknown origin)Binding affinity to alpha1A adrenergic receptor (unknown origin)
ChEMBL 505 4 1 9 3.0 COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
90645603 112409 0 None -1 3 Human 8.5 pKi = 8.5 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 567 8 1 8 4.9 COc1ccccc1N1CCN(CCn2c(C)nc3c(sc4ccc(NC(=O)Cc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
CHEMBL3298021 112409 0 None -1 3 Human 8.5 pKi = 8.5 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 567 8 1 8 4.9 COc1ccccc1N1CCN(CCn2c(C)nc3c(sc4ccc(NC(=O)Cc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
24894147 195858 0 None -6 3 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 505 4 1 9 3.0 COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1021/jm8016046
CHEMBL558890 195858 0 None -6 3 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 505 4 1 9 3.0 COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1021/jm8016046
11465618 102371 23 None -12 19 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from recombinant human alpha1A receptor measured after 60 mins by scintillation counting analysisDisplacement of [3H]prazosin from recombinant human alpha1A receptor measured after 60 mins by scintillation counting analysis
ChEMBL 354 2 0 2 4.9 CN1CCN([C@@H]2C[C@@H](c3ccccc3)c3ccc(Cl)cc32)CC1(C)C 10.1016/j.bmcl.2022.128879
CHEMBL3039528 102371 23 None -12 19 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from recombinant human alpha1A receptor measured after 60 mins by scintillation counting analysisDisplacement of [3H]prazosin from recombinant human alpha1A receptor measured after 60 mins by scintillation counting analysis
ChEMBL 354 2 0 2 4.9 CN1CCN([C@@H]2C[C@@H](c3ccccc3)c3ccc(Cl)cc32)CC1(C)C 10.1016/j.bmcl.2022.128879
CHEMBL5191141 102371 23 None -12 19 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from recombinant human alpha1A receptor measured after 60 mins by scintillation counting analysisDisplacement of [3H]prazosin from recombinant human alpha1A receptor measured after 60 mins by scintillation counting analysis
ChEMBL 354 2 0 2 4.9 CN1CCN([C@@H]2C[C@@H](c3ccccc3)c3ccc(Cl)cc32)CC1(C)C 10.1016/j.bmcl.2022.128879
44289034 165929 0 None 199 3 Human 8.5 pKi = 8.5 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 435 8 1 3 4.9 Cc1ccccc1C1(C#N)CCN(CCCNC(=O)C(c2cccc(F)c2)C(C)C)CC1 10.1016/s0960-894x(00)00307-3
CHEMBL42514 165929 0 None 199 3 Human 8.5 pKi = 8.5 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 435 8 1 3 4.9 Cc1ccccc1C1(C#N)CCN(CCCNC(=O)C(c2cccc(F)c2)C(C)C)CC1 10.1016/s0960-894x(00)00307-3
2726 916 68 None -2 73 Rat 8.5 pKi = 8.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
621 916 68 None -2 73 Rat 8.5 pKi = 8.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
83 916 68 None -2 73 Rat 8.5 pKi = 8.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
CHEMBL71 916 68 None -2 73 Rat 8.5 pKi = 8.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
DB00477 916 68 None -2 73 Rat 8.5 pKi = 8.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
44420431 84708 0 None -4 3 Human 8.5 pKi = 8.5 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 468 5 0 7 4.4 COc1ccc(Cl)cc1N1CCN(CCn2c(C)nc3c(sc4ccccc43)c2=O)CC1 10.1016/j.bmcl.2006.09.034
CHEMBL222896 84708 0 None -4 3 Human 8.5 pKi = 8.5 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 468 5 0 7 4.4 COc1ccc(Cl)cc1N1CCN(CCn2c(C)nc3c(sc4ccccc43)c2=O)CC1 10.1016/j.bmcl.2006.09.034
76330229 106208 0 None -11 4 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptorDisplacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 515 4 1 8 3.9 COc1cc2nc(N3CCN(C(=O)c4ccc(Br)o4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1007/s00044-004-0024-8
CHEMBL2261605 106208 0 None -11 4 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptorDisplacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 515 4 1 8 3.9 COc1cc2nc(N3CCN(C(=O)c4ccc(Br)o4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1007/s00044-004-0024-8
CHEMBL3138857 106208 0 None -11 4 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptorDisplacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 515 4 1 8 3.9 COc1cc2nc(N3CCN(C(=O)c4ccc(Br)o4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1007/s00044-004-0024-8
44428845 142337 0 None -11 4 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 515 4 1 8 3.9 COc1cc2nc(N3CCN(C(=O)c4ccc(Br)o4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2007.01.028
CHEMBL388884 142337 0 None -11 4 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 515 4 1 8 3.9 COc1cc2nc(N3CCN(C(=O)c4ccc(Br)o4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2007.01.028
11638677 84560 0 None -138 6 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 340 5 0 5 2.8 COc1ccccc1N1CCN(CCc2ccc3c(c2)OCO3)CC1 10.1016/j.ejmech.2016.06.052
CHEMBL2153423 84560 0 None -138 6 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 340 5 0 5 2.8 COc1ccccc1N1CCN(CCc2ccc3c(c2)OCO3)CC1 10.1016/j.ejmech.2016.06.052
CHEMBL2220978 84560 0 None -138 6 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 340 5 0 5 2.8 COc1ccccc1N1CCN(CCc2ccc3c(c2)OCO3)CC1 10.1016/j.ejmech.2016.06.052
491 192 9 None -44 12 Rat 8.5 pKi = 8.5 Binding
Binding affinity towards rat Alpha-1A adrenergic receptorBinding affinity towards rat Alpha-1A adrenergic receptor
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 10.1016/s0960-894x(01)00159-7
9891167 192 9 None -44 12 Rat 8.5 pKi = 8.5 Binding
Binding affinity towards rat Alpha-1A adrenergic receptorBinding affinity towards rat Alpha-1A adrenergic receptor
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 10.1016/s0960-894x(01)00159-7
CHEMBL13856 192 9 None -44 12 Rat 8.5 pKi = 8.5 Binding
Binding affinity towards rat Alpha-1A adrenergic receptorBinding affinity towards rat Alpha-1A adrenergic receptor
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 10.1016/s0960-894x(01)00159-7
10816832 121478 0 None 234 3 Human 8.5 pKi = 8.5 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 567 10 1 7 4.5 COC(=O)C1=C(C)N=C(C)N(CCC[C@H](C)CN2CCN(c3ccccc3C(N)=O)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL358313 121478 0 None 234 3 Human 8.5 pKi = 8.5 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 567 10 1 7 4.5 COC(=O)C1=C(C)N=C(C)N(CCC[C@H](C)CN2CCN(c3ccccc3C(N)=O)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
44431551 87181 0 None -1 4 Human 8.5 pKi = 8.5 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 475 7 1 5 4.0 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3cccc(F)c3)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL232779 87181 0 None -1 4 Human 8.5 pKi = 8.5 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 475 7 1 5 4.0 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3cccc(F)c3)CC2)CC1 10.1016/j.bmcl.2007.04.008
44431620 87769 0 None 4 4 Human 8.5 pKi = 8.5 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 570 7 1 6 4.7 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3cnc(Cl)c(Br)c3)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL233790 87769 0 None 4 4 Human 8.5 pKi = 8.5 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 570 7 1 6 4.7 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3cnc(Cl)c(Br)c3)CC2)CC1 10.1016/j.bmcl.2007.04.008
56837635 69279 0 None -11 5 Pig 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 1129 44 2 17 6.2 COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1 10.1016/j.bmc.2011.10.063
CHEMBL1928132 69279 0 None -11 5 Pig 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 1129 44 2 17 6.2 COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1 10.1016/j.bmc.2011.10.063
57398875 69285 0 None 1 5 Pig 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 1005 30 2 17 4.7 COc1ccccc1N1CCN(CCCNC(=O)c2cnn3ccc(COCCOCCOCCOCCOCc4ccn5ncc(C(=O)NCCCN6CCN(c7ccccc7OC)CC6)c5c4)cc23)CC1 10.1016/j.bmc.2011.10.063
CHEMBL1928138 69285 0 None 1 5 Pig 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 1005 30 2 17 4.7 COc1ccccc1N1CCN(CCCNC(=O)c2cnn3ccc(COCCOCCOCCOCCOCc4ccn5ncc(C(=O)NCCCN6CCN(c7ccccc7OC)CC6)c5c4)cc23)CC1 10.1016/j.bmc.2011.10.063
11154198 201591 0 None -6 5 Rat 8.5 pKi = 8.5 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 413 6 0 5 3.3 CC(C)Oc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1021/jm030944+
CHEMBL60583 201591 0 None -6 5 Rat 8.5 pKi = 8.5 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 413 6 0 5 3.3 CC(C)Oc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1021/jm030944+
11801562 85255 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 590 10 2 9 3.7 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
CHEMBL2260362 85255 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 590 10 2 9 3.7 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
90645604 112410 0 None 1 3 Human 8.5 pKi = 8.5 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 652 12 2 9 5.2 COc1ccccc1N1CCN(CCn2c(C)nc3c(sc4ccc(NC(=O)CCCC(=O)NCc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
CHEMBL3298022 112410 0 None 1 3 Human 8.5 pKi = 8.5 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 652 12 2 9 5.2 COc1ccccc1N1CCN(CCn2c(C)nc3c(sc4ccc(NC(=O)CCCC(=O)NCc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
10582623 101741 0 None -1 3 Rat 8.5 pKi = 8.5 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 392 4 1 6 1.8 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cccnc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL299907 101741 0 None -1 3 Rat 8.5 pKi = 8.5 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 392 4 1 6 1.8 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cccnc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL41844 163208 0 None 194 4 Human 8.5 pKi = 8.5 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 590 10 2 9 4.6 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)N=C(C)/C(=C(/O)OC)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
10745305 37106 0 None 120 3 Human 8.4 pKi = 8.4 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 553 9 0 7 5.2 COC(=O)C1=C(C)N=C(C)N(CCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL145278 37106 0 None 120 3 Human 8.4 pKi = 8.4 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 553 9 0 7 5.2 COC(=O)C1=C(C)N=C(C)N(CCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
102 4096 48 None -85 50 Bovine 8.4 pKi = 8.4 Binding
Compound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pineal
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00018a001
3659 4096 48 None -85 50 Bovine 8.4 pKi = 8.4 Binding
Compound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pineal
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00018a001
8969 4096 48 None -85 50 Bovine 8.4 pKi = 8.4 Binding
Compound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pineal
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00018a001
CHEMBL15245 4096 48 None -85 50 Bovine 8.4 pKi = 8.4 Binding
Compound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pineal
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00018a001
DB01392 4096 48 None -85 50 Bovine 8.4 pKi = 8.4 Binding
Compound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pineal
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00018a001
16041092 95351 0 None -1 4 Human 8.4 pKi = 8.4 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 472 6 2 4 5.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3ccc(F)c(F)c3)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL256804 95351 0 None -1 4 Human 8.4 pKi = 8.4 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 472 6 2 4 5.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3ccc(F)c(F)c3)CC2)CC1 10.1016/j.bmcl.2007.11.068
136048765 63306 0 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of [3H]prazosin binding to human adrenergic alpha-1A receptor expressed in CHO-K1 cell membranesInhibition of [3H]prazosin binding to human adrenergic alpha-1A receptor expressed in CHO-K1 cell membranes
ChEMBL 502 9 3 8 4.9 COc1ccccc1N1CCN(CCCNc2cc(O)nc(Nc3c(Cl)cccc3Cl)n2)CC1 10.1021/jm0491804
CHEMBL179401 63306 0 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of [3H]prazosin binding to human adrenergic alpha-1A receptor expressed in CHO-K1 cell membranesInhibition of [3H]prazosin binding to human adrenergic alpha-1A receptor expressed in CHO-K1 cell membranes
ChEMBL 502 9 3 8 4.9 COc1ccccc1N1CCN(CCCNc2cc(O)nc(Nc3c(Cl)cccc3Cl)n2)CC1 10.1021/jm0491804
CHEMBL41844 163208 0 None 194 4 Human 8.4 pKi = 8.4 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 590 10 2 9 4.6 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)N=C(C)/C(=C(/O)OC)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1016/s0960-894x(00)00307-3
44447007 154773 0 None -4 4 Rat 8.4 pKi = 8.4 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 448 6 1 5 4.4 CC(C)C(=O)NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21 10.1016/j.bmcl.2007.11.106
CHEMBL400236 154773 0 None -4 4 Rat 8.4 pKi = 8.4 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 448 6 1 5 4.4 CC(C)C(=O)NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21 10.1016/j.bmcl.2007.11.106
10817661 85257 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 620 12 3 10 3.1 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(=O)OCCO)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1007/s00044-004-0120-9
CHEMBL2260364 85257 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 620 12 3 10 3.1 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(=O)OCCO)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1007/s00044-004-0120-9
CHEMBL347501 119690 0 None 436 3 Human 8.4 pKi = 8.4 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 620 12 3 10 3.9 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)N=C(C)/C(=C(/O)OCCO)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
4418 34192 85 None -1 7 Human 8.4 pKi = 8.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1016/j.bmcl.2004.11.032
CHEMBL142635 34192 85 None -1 7 Human 8.4 pKi = 8.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1016/j.bmcl.2004.11.032
44316098 169142 0 None 14 3 Human 8.4 pKi = 8.4 Binding
Compound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptorCompound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptor
ChEMBL 425 7 0 6 3.0 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCC3=O)n(C)n2)CC1 10.1016/s0960-894x(00)00472-8
CHEMBL440499 169142 0 None 14 3 Human 8.4 pKi = 8.4 Binding
Compound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptorCompound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptor
ChEMBL 425 7 0 6 3.0 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCC3=O)n(C)n2)CC1 10.1016/s0960-894x(00)00472-8
1443 2015 34 None 1 11 Human 8.4 pKi = 8.4 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm00018a001
33625 2015 34 None 1 11 Human 8.4 pKi = 8.4 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm00018a001
501 2015 34 None 1 11 Human 8.4 pKi = 8.4 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm00018a001
CHEMBL279516 2015 34 None 1 11 Human 8.4 pKi = 8.4 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm00018a001
DB08950 2015 34 None 1 11 Human 8.4 pKi = 8.4 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm00018a001
10555618 85256 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 604 11 2 9 4.1 CCOC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
CHEMBL2260363 85256 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 604 11 2 9 4.1 CCOC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
4418 34192 85 None -1 7 Human 8.4 pKi = 8.4 Binding
Displacement of [125I-HEAT from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes incubated for 60 minsDisplacement of [125I-HEAT from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes incubated for 60 mins
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1016/j.bmcl.2018.01.068
CHEMBL142635 34192 85 None -1 7 Human 8.4 pKi = 8.4 Binding
Displacement of [125I-HEAT from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes incubated for 60 minsDisplacement of [125I-HEAT from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes incubated for 60 mins
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1016/j.bmcl.2018.01.068
CHEMBL346649 119603 0 None 104 3 Human 8.4 pKi = 8.4 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 604 11 2 9 4.9 CCO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980506g
2284 3160 33 None -1 29 Rat 8.4 pKi = 8.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
4926 3160 33 None -1 29 Rat 8.4 pKi = 8.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
7281 3160 33 None -1 29 Rat 8.4 pKi = 8.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
CHEMBL564 3160 33 None -1 29 Rat 8.4 pKi = 8.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
DB00420 3160 33 None -1 29 Rat 8.4 pKi = 8.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
10526419 199025 0 None 7 3 Rat 8.4 pKi = 8.4 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 425 7 2 6 2.7 COc1cc(N)c(C(=O)NCCN2C[C@@H]3CCc4c(OC)cccc4[C@@H]3C2)cc1OC 10.1021/jm000541z
CHEMBL58612 199025 0 None 7 3 Rat 8.4 pKi = 8.4 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 425 7 2 6 2.7 COc1cc(N)c(C(=O)NCCN2C[C@@H]3CCc4c(OC)cccc4[C@@H]3C2)cc1OC 10.1021/jm000541z
44328654 107158 0 None 47 6 Human 8.4 pKi = 8.4 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 663 14 3 6 6.7 CCCC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCC)=C(CC)N1 10.1016/s0960-894x(99)00484-9
CHEMBL316495 107158 0 None 47 6 Human 8.4 pKi = 8.4 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 663 14 3 6 6.7 CCCC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCC)=C(CC)N1 10.1016/s0960-894x(99)00484-9
136806212 207709 0 None 47 3 Human 8.4 pKi = 8.4 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 636 13 4 7 4.6 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(CCCN)N1 10.1016/s0960-894x(99)00484-9
44328639 207709 0 None 47 3 Human 8.4 pKi = 8.4 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 636 13 4 7 4.6 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(CCCN)N1 10.1016/s0960-894x(99)00484-9
CHEMBL95736 207709 0 None 47 3 Human 8.4 pKi = 8.4 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 636 13 4 7 4.6 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(CCCN)N1 10.1016/s0960-894x(99)00484-9
17753379 88034 0 None 2 4 Human 8.4 pKi = 8.4 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 521 8 1 6 4.5 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL234607 88034 0 None 2 4 Human 8.4 pKi = 8.4 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 521 8 1 6 4.5 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
11857711 85597 0 None 8 4 Human 8.4 pKi = 8.4 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 506 7 1 4 5.5 O=S(=O)(N[C@H]1CC[C@H](N2CCC(c3ccccc3OC3CC3)CC2)CC1)c1cc(Cl)ccc1F 10.1016/j.bmcl.2007.04.098
CHEMBL228332 85597 0 None 8 4 Human 8.4 pKi = 8.4 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 506 7 1 4 5.5 O=S(=O)(N[C@H]1CC[C@H](N2CCC(c3ccccc3OC3CC3)CC2)CC1)c1cc(Cl)ccc1F 10.1016/j.bmcl.2007.04.098
12134986 164370 0 None 70 3 Human 8.4 pKi = 8.4 Binding
Compound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptorCompound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptor
ChEMBL 412 7 0 6 3.3 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCC3=O)on2)CC1 10.1016/s0960-894x(00)00472-8
CHEMBL421324 164370 0 None 70 3 Human 8.4 pKi = 8.4 Binding
Compound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptorCompound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptor
ChEMBL 412 7 0 6 3.3 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCC3=O)on2)CC1 10.1016/s0960-894x(00)00472-8
71817549 102553 0 None -4 7 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 356 7 2 6 2.5 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)NCC2 10.1021/jm400867d
CHEMBL3040803 102553 0 None -4 7 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 356 7 2 6 2.5 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)NCC2 10.1021/jm400867d
CHEMBL3216590 102553 0 None -4 7 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 356 7 2 6 2.5 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)NCC2 10.1021/jm400867d
2894 208048 6 None -8 6 Rat 8.4 pKi = 8.4 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)C4CCCCC43)nc(N)c2cc1OC 10.1021/jm960510x
CHEMBL97698 208048 6 None -8 6 Rat 8.4 pKi = 8.4 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)C4CCCCC43)nc(N)c2cc1OC 10.1021/jm960510x
90645602 112408 0 None 1 3 Human 8.4 pKi = 8.4 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 553 7 1 8 5.0 COc1ccccc1N1CCN(CCn2c(C)nc3c(sc4ccc(NC(=O)c5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
CHEMBL3298020 112408 0 None 1 3 Human 8.4 pKi = 8.4 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 553 7 1 8 5.0 COc1ccccc1N1CCN(CCn2c(C)nc3c(sc4ccc(NC(=O)c5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
44431616 88048 0 None 3 4 Human 8.4 pKi = 8.4 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 471 8 1 5 4.0 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL234650 88048 0 None 3 4 Human 8.4 pKi = 8.4 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 471 8 1 5 4.0 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
3584 3748 64 None -2 14 Rat 8.4 pKi = 8.4 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980053f
5401 3748 64 None -2 14 Rat 8.4 pKi = 8.4 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980053f
7302 3748 64 None -2 14 Rat 8.4 pKi = 8.4 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980053f
CHEMBL611 3748 64 None -2 14 Rat 8.4 pKi = 8.4 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980053f
DB01162 3748 64 None -2 14 Rat 8.4 pKi = 8.4 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980053f
44431184 92821 0 None -2 3 Human 8.4 pKi = 8.4 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 515 5 0 5 5.5 CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4ccc5ccc(F)cc5c4C3=O)CC2)CC1 10.1016/j.bmcl.2006.12.111
CHEMBL243866 92821 0 None -2 3 Human 8.4 pKi = 8.4 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 515 5 0 5 5.5 CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4ccc5ccc(F)cc5c4C3=O)CC2)CC1 10.1016/j.bmcl.2006.12.111
10310103 107285 0 None 1 9 Bovine 8.4 pKi = 8.4 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 425 5 0 5 5.3 N#CCCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4ncccn4)cc23)CC1 10.1021/jm020938y
CHEMBL317333 107285 0 None 1 9 Bovine 8.4 pKi = 8.4 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 425 5 0 5 5.3 N#CCCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4ncccn4)cc23)CC1 10.1021/jm020938y
10602180 168957 0 None 5 3 Rat 8.4 pKi = 8.4 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 525 5 1 8 4.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ncc(-c6ccccc6)nc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL43909 168957 0 None 5 3 Rat 8.4 pKi = 8.4 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 525 5 1 8 4.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ncc(-c6ccccc6)nc54)c3=O)C[C@@H]21 10.1021/jm990567u
10326069 39266 1 None 23 9 Human 8.4 pKi = 8.4 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 589 10 3 8 3.3 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980506g
CHEMBL147077 39266 1 None 23 9 Human 8.4 pKi = 8.4 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 589 10 3 8 3.3 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980506g
44447003 154772 0 None -8 4 Rat 8.4 pKi = 8.4 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 448 7 1 5 4.6 CCCC(=O)NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21 10.1016/j.bmcl.2007.11.106
CHEMBL400235 154772 0 None -8 4 Rat 8.4 pKi = 8.4 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 448 7 1 5 4.6 CCCC(=O)NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21 10.1016/j.bmcl.2007.11.106
CHEMBL5275284 194631 0 None -5 3 Human 8.4 pKi = 8.4 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 466 8 1 5 3.9 CC(C)C(=O)NCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
CHEMBL5315872 194631 0 None -5 3 Human 8.4 pKi = 8.4 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 466 8 1 5 3.9 CC(C)C(=O)NCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
10326069 39266 1 None 23 9 Human 8.4 pKi = 8.4 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 589 10 3 8 3.3 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
CHEMBL147077 39266 1 None 23 9 Human 8.4 pKi = 8.4 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 589 10 3 8 3.3 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
1443 2015 34 None 1 11 Human 8.4 pKi = 8.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm960697s
33625 2015 34 None 1 11 Human 8.4 pKi = 8.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm960697s
501 2015 34 None 1 11 Human 8.4 pKi = 8.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm960697s
CHEMBL279516 2015 34 None 1 11 Human 8.4 pKi = 8.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm960697s
DB08950 2015 34 None 1 11 Human 8.4 pKi = 8.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm960697s
129211 3722 78 None -1 16 Human 8.4 pKi = 8.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm960697s
2562 3722 78 None -1 16 Human 8.4 pKi = 8.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm960697s
488 3722 78 None -1 16 Human 8.4 pKi = 8.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm960697s
CHEMBL836 3722 78 None -1 16 Human 8.4 pKi = 8.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm960697s
DB00706 3722 78 None -1 16 Human 8.4 pKi = 8.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm960697s
9817640 99302 0 None 9 3 Human 8.4 pKi = 8.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 295 6 1 2 3.6 COc1ccc(CCNCC2CCc3ccccc3C2)cc1 10.1021/jm960697s
CHEMBL282214 99302 0 None 9 3 Human 8.4 pKi = 8.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 295 6 1 2 3.6 COc1ccc(CCNCC2CCc3ccccc3C2)cc1 10.1021/jm960697s
44298644 163103 0 None 31 3 Human 8.4 pKi = 8.4 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 454 7 1 6 2.6 Cc1c[nH]c(=O)n(CC(C)(C)CN2CCN(c3ccccc3OCC(F)(F)F)CC2)c1=O 10.1016/s0960-894x(03)00305-6
CHEMBL417758 163103 0 None 31 3 Human 8.4 pKi = 8.4 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 454 7 1 6 2.6 Cc1c[nH]c(=O)n(CC(C)(C)CN2CCN(c3ccccc3OCC(F)(F)F)CC2)c1=O 10.1016/s0960-894x(03)00305-6
12909387 62607 0 None 33 2 Bovine 7.5 pKi = 7.5 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 301 0 0 3 3.8 CN1CCC(=C2c3cc(C#N)ccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
CHEMBL178376 62607 0 None 33 2 Bovine 7.5 pKi = 7.5 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 301 0 0 3 3.8 CN1CCC(=C2c3cc(C#N)ccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
102012413 78627 0 None 2 2 Human 7.5 pKi = 7.5 Binding
Tested for binding affinity against recombinant human Alpha-1A adrenergic receptor using [125I]HEAT in competition binding assayTested for binding affinity against recombinant human Alpha-1A adrenergic receptor using [125I]HEAT in competition binding assay
ChEMBL 475 6 1 4 5.0 C[C@@H]1OC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H]1c1ccc(F)c(F)c1 10.1016/s0960-894x(00)00524-2
CHEMBL2112365 78627 0 None 2 2 Human 7.5 pKi = 7.5 Binding
Tested for binding affinity against recombinant human Alpha-1A adrenergic receptor using [125I]HEAT in competition binding assayTested for binding affinity against recombinant human Alpha-1A adrenergic receptor using [125I]HEAT in competition binding assay
ChEMBL 475 6 1 4 5.0 C[C@@H]1OC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H]1c1ccc(F)c(F)c1 10.1016/s0960-894x(00)00524-2
240 941 43 None -4 25 Rat 7.5 pKi = 7.5 Binding
The ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brainThe ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brain
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1021/jm00086a019
2769 941 43 None -4 25 Rat 7.5 pKi = 7.5 Binding
The ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brainThe ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brain
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1021/jm00086a019
44279790 941 43 None -4 25 Rat 7.5 pKi = 7.5 Binding
The ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brainThe ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brain
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1021/jm00086a019
660 941 43 None -4 25 Rat 7.5 pKi = 7.5 Binding
The ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brainThe ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brain
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1021/jm00086a019
CHEMBL1729 941 43 None -4 25 Rat 7.5 pKi = 7.5 Binding
The ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brainThe ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brain
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1021/jm00086a019
CHEMBL560739 941 43 None -4 25 Rat 7.5 pKi = 7.5 Binding
The ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brainThe ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brain
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1021/jm00086a019
DB00604 941 43 None -4 25 Rat 7.5 pKi = 7.5 Binding
The ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brainThe ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brain
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1021/jm00086a019
4038180 204 14 None -2 8 Bovine 7.5 pKi = 7.5 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm960354u
480 204 14 None -2 8 Bovine 7.5 pKi = 7.5 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm960354u
CHEMBL109783 204 14 None -2 8 Bovine 7.5 pKi = 7.5 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm960354u
44420423 83976 0 None -4 3 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 455 4 1 5 4.3 Cc1nc2c([nH]c3ccccc32)c(=O)n1CCN1CCN(c2ccc(Cl)c(Cl)c2)CC1 10.1016/j.bmcl.2006.09.034
CHEMBL220717 83976 0 None -4 3 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 455 4 1 5 4.3 Cc1nc2c([nH]c3ccccc32)c(=O)n1CCN1CCN(c2ccc(Cl)c(Cl)c2)CC1 10.1016/j.bmcl.2006.09.034
127040157 136902 0 None -10 5 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNC[C@@H]2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1039/C4MD00484A
CHEMBL3739897 136902 0 None -10 5 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNC[C@@H]2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1039/C4MD00484A
CHEMBL3742490 136902 0 None -10 5 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNC[C@@H]2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1039/C4MD00484A
155563002 176644 0 None -15 4 Human 7.5 pKi = 7.5 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 419 10 1 5 4.2 COc1ccccc1OCCNC[C@H]1CO[C@H](C(c2ccccc2)c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
CHEMBL4570387 176644 0 None -15 4 Human 7.5 pKi = 7.5 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 419 10 1 5 4.2 COc1ccccc1OCCNC[C@H]1CO[C@H](C(c2ccccc2)c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
CHEMBL4598207 176644 0 None -15 4 Human 7.5 pKi = 7.5 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 419 10 1 5 4.2 COc1ccccc1OCCNC[C@H]1CO[C@H](C(c2ccccc2)c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
118716709 114977 0 None -1 4 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 457 5 0 6 3.1 COc1ccccc1N1CCN(CC2COC3(CCN(C(=O)C4CCCCC4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342862 114977 0 None -1 4 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 457 5 0 6 3.1 COc1ccccc1N1CCN(CC2COC3(CCN(C(=O)C4CCCCC4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
44388493 63075 0 None - 1 Human 6.5 pKi = 6.5 Binding
Inhibition of [3H]prazosin binding to human adrenergic alpha-1A receptor expressed in CHO-K1 cell membranesInhibition of [3H]prazosin binding to human adrenergic alpha-1A receptor expressed in CHO-K1 cell membranes
ChEMBL 500 8 0 6 4.3 Clc1ccc(C2(Cn3ccnc3)OCC(CN3CCN(CCc4ccccc4)CC3)O2)c(Cl)c1 10.1021/jm0491804
CHEMBL178921 63075 0 None - 1 Human 6.5 pKi = 6.5 Binding
Inhibition of [3H]prazosin binding to human adrenergic alpha-1A receptor expressed in CHO-K1 cell membranesInhibition of [3H]prazosin binding to human adrenergic alpha-1A receptor expressed in CHO-K1 cell membranes
ChEMBL 500 8 0 6 4.3 Clc1ccc(C2(Cn3ccnc3)OCC(CN3CCN(CCc4ccccc4)CC3)O2)c(Cl)c1 10.1021/jm0491804
46882086 5784 0 None 1 2 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 435 10 1 6 4.0 COc1cc(OC)cc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)c1 10.1016/j.bmcl.2010.01.030
CHEMBL1078954 5784 0 None 1 2 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 435 10 1 6 4.0 COc1cc(OC)cc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)c1 10.1016/j.bmcl.2010.01.030
9796667 109439 0 None 9 2 Rat 6.5 pKi = 6.5 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 309 3 2 3 2.4 CS(=O)(=O)Nc1ccc(F)c2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL322042 109439 0 None 9 2 Rat 6.5 pKi = 6.5 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 309 3 2 3 2.4 CS(=O)(=O)Nc1ccc(F)c2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
11857862 85648 0 None 2 4 Human 7.5 pKi = 7.5 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 538 10 1 6 4.8 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OCC(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
CHEMBL228607 85648 0 None 2 4 Human 7.5 pKi = 7.5 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 538 10 1 6 4.8 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OCC(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
11857862 85648 0 None 2 4 Human 7.5 pKi = 7.5 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 538 10 1 6 4.8 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OCC(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
CHEMBL228607 85648 0 None 2 4 Human 7.5 pKi = 7.5 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 538 10 1 6 4.8 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OCC(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
44331174 4138 0 None 1 3 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 355 3 0 2 4.9 O=C1c2ccccc2CC12CCN(CCc1cccc3ccccc13)CC2 10.1016/s0960-894x(98)00732-x
CHEMBL100052 4138 0 None 1 3 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 355 3 0 2 4.9 O=C1c2ccccc2CC12CCN(CCc1cccc3ccccc13)CC2 10.1016/s0960-894x(98)00732-x
CHEMBL5269671 194577 0 None -44 3 Human 7.5 pKi = 7.5 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 466 9 1 5 4.0 CCCC(=O)NCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
CHEMBL5315170 194577 0 None -44 3 Human 7.5 pKi = 7.5 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 466 9 1 5 4.0 CCCC(=O)NCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
CHEMBL5284242 194592 0 None -56 3 Human 7.5 pKi = 7.5 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 510 11 0 6 4.0 COCCCC(=O)N(C)CCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
CHEMBL5315342 194592 0 None -56 3 Human 7.5 pKi = 7.5 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 510 11 0 6 4.0 COCCCC(=O)N(C)CCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
9981635 36880 0 None -2 3 Human 7.5 pKi = 7.5 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 459 5 2 5 4.4 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNC(=O)c1cccc(C(F)(F)F)c1)C3 10.1021/jm030952q
CHEMBL145098 36880 0 None -2 3 Human 7.5 pKi = 7.5 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 459 5 2 5 4.4 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNC(=O)c1cccc(C(F)(F)F)c1)C3 10.1021/jm030952q
CHEMBL2112853 36880 0 None -2 3 Human 7.5 pKi = 7.5 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 459 5 2 5 4.4 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNC(=O)c1cccc(C(F)(F)F)c1)C3 10.1021/jm030952q
24803797 61050 0 None -7 4 Human 7.5 pKi = 7.5 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 626 11 0 6 7.6 O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C1CCCN(CCc2ccc(OCCCN3CCCCCC3)cc2)CC1 10.1021/jm1013874
CHEMBL1765111 61050 0 None -7 4 Human 7.5 pKi = 7.5 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 626 11 0 6 7.6 O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C1CCCN(CCc2ccc(OCCCN3CCCCCC3)cc2)CC1 10.1021/jm1013874
24803482 61303 0 None -125 4 Human 7.5 pKi = 7.5 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 640 14 0 6 7.8 O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C[C@@H]1CCCN1CCCCc1ccc(OCCCN2CCCCCC2)cc1 10.1021/jm1013874
CHEMBL1767168 61303 0 None -125 4 Human 7.5 pKi = 7.5 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 640 14 0 6 7.8 O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C[C@@H]1CCCN1CCCCc1ccc(OCCCN2CCCCCC2)cc1 10.1021/jm1013874
71817861 102379 0 None 2 4 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 356 7 2 6 2.5 COc1ccc2c(c1OCCNC[C@@H]1COc3ccccc3O1)NCC2 10.1021/jm400867d
CHEMBL3039699 102379 0 None 2 4 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 356 7 2 6 2.5 COc1ccc2c(c1OCCNC[C@@H]1COc3ccccc3O1)NCC2 10.1021/jm400867d
CHEMBL3217244 102379 0 None 2 4 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 356 7 2 6 2.5 COc1ccc2c(c1OCCNC[C@@H]1COc3ccccc3O1)NCC2 10.1021/jm400867d
3826471 97450 13 None -17 4 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 296 5 0 3 3.1 COc1ccccc1N1CCN(CCc2ccccc2)CC1 10.1016/j.ejmech.2016.06.052
CHEMBL27021 97450 13 None -17 4 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 296 5 0 3 3.1 COc1ccccc1N1CCN(CCc2ccccc2)CC1 10.1016/j.ejmech.2016.06.052
702235 53182 97 None -7 4 Rat 5.5 pKi = 5.5 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 200 1 2 1 2.6 c1ccc2c(C3CCNCC3)c[nH]c2c1 10.1016/j.bmcl.2015.07.046
CHEMBL15988 53182 97 None -7 4 Rat 5.5 pKi = 5.5 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 200 1 2 1 2.6 c1ccc2c(C3CCNCC3)c[nH]c2c1 10.1016/j.bmcl.2015.07.046
CHEMBL2011564 53182 97 None -7 4 Rat 5.5 pKi = 5.5 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 200 1 2 1 2.6 c1ccc2c(C3CCNCC3)c[nH]c2c1 10.1016/j.bmcl.2015.07.046
10397358 174963 44 None -70 2 Bovine 4.5 pKi = 4.5 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 178 1 2 4 0.1 Nc1cccnc1N1CCNCC1 10.1021/jm00366a007
CHEMBL45665 174963 44 None -70 2 Bovine 4.5 pKi = 4.5 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 178 1 2 4 0.1 Nc1cccnc1N1CCNCC1 10.1021/jm00366a007
132060812 162012 0 None -831 10 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]-Prazosin from human adrenergic alpha1A receptor after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Prazosin from human adrenergic alpha1A receptor after 90 mins by microbeta scintillation counting method
ChEMBL 329 4 0 2 4.9 COc1cccc(-c2ccc3c(c2)CCN(Cc2ccccc2)C3)c1 10.1016/j.ejmech.2018.02.024
CHEMBL4160064 162012 0 None -831 10 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]-Prazosin from human adrenergic alpha1A receptor after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Prazosin from human adrenergic alpha1A receptor after 90 mins by microbeta scintillation counting method
ChEMBL 329 4 0 2 4.9 COc1cccc(-c2ccc3c(c2)CCN(Cc2ccccc2)C3)c1 10.1016/j.ejmech.2018.02.024
10287924 109806 0 None -95 5 Human 6.5 pKi = 6.5 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
ChEMBL 388 4 0 5 3.9 CN1CCN2c3c(cccc31)[C@@H]1CN(CCCc3noc4ccccc34)CC[C@@H]12 10.1021/jm401958n
CHEMBL3233411 109806 0 None -95 5 Human 6.5 pKi = 6.5 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
ChEMBL 388 4 0 5 3.9 CN1CCN2c3c(cccc31)[C@@H]1CN(CCCc3noc4ccccc34)CC[C@@H]12 10.1021/jm401958n
155770281 177723 0 None -3 9 Human 5.5 pKi = 5.5 Binding
Binding affinity to alpha1a (unknown origin)Binding affinity to alpha1a (unknown origin)
ChEMBL 517 4 1 2 7.6 CC(=O)N1CCC(c2ccc(-c3cc(C(=O)O)cc4cc(-c5ccc(C(F)(F)F)cc5)ccc34)cc2)CC1 10.1021/acs.jmedchem.1c00164
CHEMBL4642592 177723 0 None -3 9 Human 5.5 pKi = 5.5 Binding
Binding affinity to alpha1a (unknown origin)Binding affinity to alpha1a (unknown origin)
ChEMBL 517 4 1 2 7.6 CC(=O)N1CCC(c2ccc(-c3cc(C(=O)O)cc4cc(-c5ccc(C(F)(F)F)cc5)ccc34)cc2)CC1 10.1021/acs.jmedchem.1c00164
118717459 115115 0 None -2 4 Human 6.5 pKi = 6.5 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 444 12 2 6 6.3 COc1ccc2nccc(NCCCCCCCNc3ccnc4ccc(OC)cc34)c2c1 10.1016/j.bmc.2014.09.017
CHEMBL3343981 115115 0 None -2 4 Human 6.5 pKi = 6.5 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 444 12 2 6 6.3 COc1ccc2nccc(NCCCCCCCNc3ccnc4ccc(OC)cc34)c2c1 10.1016/j.bmc.2014.09.017
10579368 105977 0 None -1 6 Human 6.5 pKi = 6.5 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 593 9 3 6 5.3 CC1=C(C(=O)O)C(c2ccc3c(c2)OCO3)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
CHEMBL313251 105977 0 None -1 6 Human 6.5 pKi = 6.5 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 593 9 3 6 5.3 CC1=C(C(=O)O)C(c2ccc3c(c2)OCO3)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
10579368 105977 0 None -1 6 Human 6.5 pKi = 6.5 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 593 9 3 6 5.3 CC1=C(C(=O)O)C(c2ccc3c(c2)OCO3)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1007/s00044-004-0120-9
CHEMBL313251 105977 0 None -1 6 Human 6.5 pKi = 6.5 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 593 9 3 6 5.3 CC1=C(C(=O)O)C(c2ccc3c(c2)OCO3)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1007/s00044-004-0120-9
52937018 61270 0 None -31 4 Human 6.5 pKi = 6.5 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 355 6 0 4 3.6 CN(C)CCCn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/jm1013874
CHEMBL1767135 61270 0 None -31 4 Human 6.5 pKi = 6.5 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 355 6 0 4 3.6 CN(C)CCCn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/jm1013874
52937223 61292 23 None -5 4 Human 6.5 pKi = 6.5 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 381 5 0 4 4.1 CN1CCCC1CCn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/jm1013874
CHEMBL1767157 61292 23 None -5 4 Human 6.5 pKi = 6.5 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 381 5 0 4 4.1 CN1CCCC1CCn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/jm1013874
24803316 61297 0 None -794 4 Human 6.5 pKi = 6.5 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 600 15 1 6 6.9 O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1CCNCCCCc1ccc(OCCCN2CCCCCC2)cc1 10.1021/jm1013874
CHEMBL1767162 61297 0 None -794 4 Human 6.5 pKi = 6.5 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 600 15 1 6 6.9 O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1CCNCCCCc1ccc(OCCCN2CCCCCC2)cc1 10.1021/jm1013874
250 3361 8 None -8912 13 Human 6.5 pKi = 6.5 Binding
Compound was evaluated for binding affinity against Alpha-1C adrenergic receptor using radioligand binding assayCompound was evaluated for binding affinity against Alpha-1C adrenergic receptor using radioligand binding assay
ChEMBL 502 10 1 7 5.0 COc1cc(CCCN2CCC(CC2)CCC(=O)c2cc(Cl)c(c3c2OCCO3)N)ccc1OC 10.1016/0960-894X(95)00358-Z
5311416 3361 8 None -8912 13 Human 6.5 pKi = 6.5 Binding
Compound was evaluated for binding affinity against Alpha-1C adrenergic receptor using radioligand binding assayCompound was evaluated for binding affinity against Alpha-1C adrenergic receptor using radioligand binding assay
ChEMBL 502 10 1 7 5.0 COc1cc(CCCN2CCC(CC2)CCC(=O)c2cc(Cl)c(c3c2OCCO3)N)ccc1OC 10.1016/0960-894X(95)00358-Z
CHEMBL69733 3361 8 None -8912 13 Human 6.5 pKi = 6.5 Binding
Compound was evaluated for binding affinity against Alpha-1C adrenergic receptor using radioligand binding assayCompound was evaluated for binding affinity against Alpha-1C adrenergic receptor using radioligand binding assay
ChEMBL 502 10 1 7 5.0 COc1cc(CCCN2CCC(CC2)CCC(=O)c2cc(Cl)c(c3c2OCCO3)N)ccc1OC 10.1016/0960-894X(95)00358-Z
118717459 115115 0 None -2 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 444 12 2 6 6.3 COc1ccc2nccc(NCCCCCCCNc3ccnc4ccc(OC)cc34)c2c1 10.1016/j.bmc.2014.09.017
CHEMBL3343981 115115 0 None -2 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 444 12 2 6 6.3 COc1ccc2nccc(NCCCCCCCNc3ccnc4ccc(OC)cc34)c2c1 10.1016/j.bmc.2014.09.017
3584 3748 64 None -2 14 Human 7.5 pKi = 7.5 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog prostate tissue preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog prostate tissue preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
5401 3748 64 None -2 14 Human 7.5 pKi = 7.5 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog prostate tissue preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog prostate tissue preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
7302 3748 64 None -2 14 Human 7.5 pKi = 7.5 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog prostate tissue preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog prostate tissue preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
CHEMBL611 3748 64 None -2 14 Human 7.5 pKi = 7.5 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog prostate tissue preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog prostate tissue preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
DB01162 3748 64 None -2 14 Human 7.5 pKi = 7.5 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog prostate tissue preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog prostate tissue preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
2286 3161 51 None -10 30 Rat 7.5 pKi = 7.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
4927 3161 51 None -10 30 Rat 7.5 pKi = 7.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
7282 3161 51 None -10 30 Rat 7.5 pKi = 7.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
CHEMBL643 3161 51 None -10 30 Rat 7.5 pKi = 7.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
DB01069 3161 51 None -10 30 Rat 7.5 pKi = 7.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
10043148 206517 0 None -26 2 Rat 6.5 pKi = 6.5 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 344 6 0 5 1.9 COc1ccccc1N1CCN(CCCN2CC3CCCN3C2)CC1 10.1021/jm970216k
CHEMBL88594 206517 0 None -26 2 Rat 6.5 pKi = 6.5 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 344 6 0 5 1.9 COc1ccccc1N1CCN(CCCN2CC3CCCN3C2)CC1 10.1021/jm970216k
11995036 11812 0 None 1 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 419 7 1 5 4.5 COc1ccc2ccccc2c1OCCNC[C@@H]1COc2cc3c(cc2O1)CCCC3 10.1021/jm060358r
CHEMBL1182196 11812 0 None 1 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 419 7 1 5 4.5 COc1ccc2ccccc2c1OCCNC[C@@H]1COc2cc3c(cc2O1)CCCC3 10.1021/jm060358r
CHEMBL218732 11812 0 None 1 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 419 7 1 5 4.5 COc1ccc2ccccc2c1OCCNC[C@@H]1COc2cc3c(cc2O1)CCCC3 10.1021/jm060358r
14004032 119808 2 None -1 2 Bovine 5.5 pKi = 5.5 Binding
Compound was evaluated for log 1/Ki at alpha-1 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-1 adrenergic receptor
ChEMBL 188 0 0 2 2.2 c1cnc2c(c1)CCN1CCCCC21 10.1021/jm00398a025
CHEMBL348538 119808 2 None -1 2 Bovine 5.5 pKi = 5.5 Binding
Compound was evaluated for log 1/Ki at alpha-1 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-1 adrenergic receptor
ChEMBL 188 0 0 2 2.2 c1cnc2c(c1)CCN1CCCCC21 10.1021/jm00398a025
53328116 63354 0 None -5 3 Human 5.5 pKi = 5.5 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 411 5 0 4 3.4 O=C1CC(c2ccccc2)CC(=O)N1CCN1CCN(c2ccccc2Cl)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796029 63354 0 None -5 3 Human 5.5 pKi = 5.5 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 411 5 0 4 3.4 O=C1CC(c2ccccc2)CC(=O)N1CCN1CCN(c2ccccc2Cl)CC1 10.1016/j.ejmech.2011.03.054
14004032 119808 2 None -1 2 Bovine 5.5 pKi = 5.5 Binding
Affinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranesAffinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranes
ChEMBL 188 0 0 2 2.2 c1cnc2c(c1)CCN1CCCCC21 10.1021/jm00398a025
CHEMBL348538 119808 2 None -1 2 Bovine 5.5 pKi = 5.5 Binding
Affinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranesAffinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranes
ChEMBL 188 0 0 2 2.2 c1cnc2c(c1)CCN1CCCCC21 10.1021/jm00398a025
11732785 163696 0 None -38 6 Rat 7.5 pKi = 7.5 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 432 7 0 5 3.7 COc1ccccc1N1CCN(CCCCN2CCn3c(cc4ccccc43)C2=O)CC1 10.1021/jm0211220
CHEMBL420510 163696 0 None -38 6 Rat 7.5 pKi = 7.5 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 432 7 0 5 3.7 COc1ccccc1N1CCN(CCCCN2CCn3c(cc4ccccc43)C2=O)CC1 10.1021/jm0211220
10020855 78794 0 None -165 6 Human 7.5 pKi = 7.5 Binding
Binding affinity was determined on human cloned Alpha-1A adrenoceptorBinding affinity was determined on human cloned Alpha-1A adrenoceptor
ChEMBL 351 4 0 4 3.9 COc1cccc(C2CCC(N3CCN(c4ccccn4)CC3)CC2)c1 10.1021/jm010866v
CHEMBL2112778 78794 0 None -165 6 Human 7.5 pKi = 7.5 Binding
Binding affinity was determined on human cloned Alpha-1A adrenoceptorBinding affinity was determined on human cloned Alpha-1A adrenoceptor
ChEMBL 351 4 0 4 3.9 COc1cccc(C2CCC(N3CCN(c4ccccn4)CC3)CC2)c1 10.1021/jm010866v
16041265 95308 0 None -1 4 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 504 6 2 4 6.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3c(Cl)cccc3Cl)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL256597 95308 0 None -1 4 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 504 6 2 4 6.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3c(Cl)cccc3Cl)CC2)CC1 10.1016/j.bmcl.2007.11.068
49865600 15989 0 None -83 3 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 378 7 1 4 4.4 Clc1cccc(N2CCN(CCCCNc3ccccn3)CC2)c1Cl 10.1016/j.bmcl.2010.07.096
CHEMBL1223616 15989 0 None -83 3 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 378 7 1 4 4.4 Clc1cccc(N2CCN(CCCCNc3ccccn3)CC2)c1Cl 10.1016/j.bmcl.2010.07.096
122295 9836 7 None 1 9 Human 7.5 pKi = 7.5 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 279 3 0 2 3.7 CC(C)=CCOc1ccc(Cl)c2c1CCN(C)CC2 10.1021/jm00019a001
CHEMBL114166 9836 7 None 1 9 Human 7.5 pKi = 7.5 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 279 3 0 2 3.7 CC(C)=CCOc1ccc(Cl)c2c1CCN(C)CC2 10.1021/jm00019a001
11140347 204510 1 None -5 6 Human 7.5 pKi = 7.5 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 239 4 2 4 2.0 CSc1ccc(F)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL72768 204510 1 None -5 6 Human 7.5 pKi = 7.5 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 239 4 2 4 2.0 CSc1ccc(F)cc1NCC1=NCCN1 10.1021/jm000542r
9824384 118761 1 None -177 8 Bovine 7.5 pKi = 7.5 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1021/jm960510x
CHEMBL342062 118761 1 None -177 8 Bovine 7.5 pKi = 7.5 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1021/jm960510x
145963755 162010 0 None -4 3 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 465 5 2 9 2.2 COc1cc2nc(N3CCC[C@H](NC(=O)[C@@H]4COc5ccccc5O4)C3)nc(N)c2cc1OC 10.1016/j.ejmech.2017.05.003
CHEMBL4160032 162010 0 None -4 3 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 465 5 2 9 2.2 COc1cc2nc(N3CCC[C@H](NC(=O)[C@@H]4COc5ccccc5O4)C3)nc(N)c2cc1OC 10.1016/j.ejmech.2017.05.003
10962489 11158 0 None -1 2 Human 7.5 pKi = 7.5 Binding
Affinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assayAffinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay
ChEMBL 404 8 0 3 4.5 C[N+](C)(CCOc1ccccc1)CC1COC(c2ccccc2)(c2ccccc2)O1 10.1021/jm021078o
CHEMBL1178679 11158 0 None -1 2 Human 7.5 pKi = 7.5 Binding
Affinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assayAffinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay
ChEMBL 404 8 0 3 4.5 C[N+](C)(CCOc1ccccc1)CC1COC(c2ccccc2)(c2ccccc2)O1 10.1021/jm021078o
CHEMBL37212 11158 0 None -1 2 Human 7.5 pKi = 7.5 Binding
Affinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assayAffinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay
ChEMBL 404 8 0 3 4.5 C[N+](C)(CCOc1ccccc1)CC1COC(c2ccccc2)(c2ccccc2)O1 10.1021/jm021078o
44417706 11803 0 None 5 7 Human 7.5 pKi = 7.5 Binding
Antagonist activity at human alpha A1 adrenoreceptor expressed in CHO cellsAntagonist activity at human alpha A1 adrenoreceptor expressed in CHO cells
ChEMBL 395 8 1 6 3.7 COc1cccc(OC)c1OCCNC[C@H]1COc2cc3ccccc3cc2O1 10.1016/j.ejmech.2020.112419
CHEMBL1182152 11803 0 None 5 7 Human 7.5 pKi = 7.5 Binding
Antagonist activity at human alpha A1 adrenoreceptor expressed in CHO cellsAntagonist activity at human alpha A1 adrenoreceptor expressed in CHO cells
ChEMBL 395 8 1 6 3.7 COc1cccc(OC)c1OCCNC[C@H]1COc2cc3ccccc3cc2O1 10.1016/j.ejmech.2020.112419
CHEMBL215188 11803 0 None 5 7 Human 7.5 pKi = 7.5 Binding
Antagonist activity at human alpha A1 adrenoreceptor expressed in CHO cellsAntagonist activity at human alpha A1 adrenoreceptor expressed in CHO cells
ChEMBL 395 8 1 6 3.7 COc1cccc(OC)c1OCCNC[C@H]1COc2cc3ccccc3cc2O1 10.1016/j.ejmech.2020.112419
10962489 11158 0 None -1 2 Human 7.5 pKi = 7.5 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 404 8 0 3 4.5 C[N+](C)(CCOc1ccccc1)CC1COC(c2ccccc2)(c2ccccc2)O1 10.1007/s00044-010-9379-1
CHEMBL1178679 11158 0 None -1 2 Human 7.5 pKi = 7.5 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 404 8 0 3 4.5 C[N+](C)(CCOc1ccccc1)CC1COC(c2ccccc2)(c2ccccc2)O1 10.1007/s00044-010-9379-1
CHEMBL37212 11158 0 None -1 2 Human 7.5 pKi = 7.5 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 404 8 0 3 4.5 C[N+](C)(CCOc1ccccc1)CC1COC(c2ccccc2)(c2ccccc2)O1 10.1007/s00044-010-9379-1
11049096 11164 0 None 1 2 Human 7.5 pKi = 7.5 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 389 8 0 4 4.3 CN(CCOc1ccccc1)CC1COC(c2ccccc2)(c2ccccc2)O1 10.1007/s00044-010-9379-1
CHEMBL1178700 11164 0 None 1 2 Human 7.5 pKi = 7.5 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 389 8 0 4 4.3 CN(CCOc1ccccc1)CC1COC(c2ccccc2)(c2ccccc2)O1 10.1007/s00044-010-9379-1
CHEMBL37962 11164 0 None 1 2 Human 7.5 pKi = 7.5 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 389 8 0 4 4.3 CN(CCOc1ccccc1)CC1COC(c2ccccc2)(c2ccccc2)O1 10.1007/s00044-010-9379-1
9822814 101922 0 None -346 5 Human 7.5 pKi = 7.5 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 409 4 0 3 4.3 O=C1CC2(CCCC2)CCN1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1007/s00044-010-9379-1
CHEMBL301224 101922 0 None -346 5 Human 7.5 pKi = 7.5 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 409 4 0 3 4.3 O=C1CC2(CCCC2)CCN1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1007/s00044-010-9379-1
155567201 176204 0 None -20 4 Human 7.5 pKi = 7.5 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 419 9 1 5 4.2 COc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)OC1 10.1016/j.ejmech.2019.05.024
CHEMBL4588223 176204 0 None -20 4 Human 7.5 pKi = 7.5 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 419 9 1 5 4.2 COc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)OC1 10.1016/j.ejmech.2019.05.024
CHEMBL4594654 176204 0 None -20 4 Human 7.5 pKi = 7.5 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 419 9 1 5 4.2 COc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)OC1 10.1016/j.ejmech.2019.05.024
44417706 11803 0 None 5 7 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 395 8 1 6 3.7 COc1cccc(OC)c1OCCNC[C@H]1COc2cc3ccccc3cc2O1 10.1021/jm060358r
CHEMBL1182152 11803 0 None 5 7 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 395 8 1 6 3.7 COc1cccc(OC)c1OCCNC[C@H]1COc2cc3ccccc3cc2O1 10.1021/jm060358r
CHEMBL215188 11803 0 None 5 7 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 395 8 1 6 3.7 COc1cccc(OC)c1OCCNC[C@H]1COc2cc3ccccc3cc2O1 10.1021/jm060358r
9822814 101922 0 None -346 5 Human 7.5 pKi = 7.5 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 409 4 0 3 4.3 O=C1CC2(CCCC2)CCN1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1007/s00044-010-9379-1
CHEMBL301224 101922 0 None -346 5 Human 7.5 pKi = 7.5 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 409 4 0 3 4.3 O=C1CC2(CCCC2)CCN1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1007/s00044-010-9379-1
44435219 91763 0 None 6 4 Human 6.5 pKi = 6.5 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by PDSP assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 367 2 0 2 6.2 O=C(Cc1ccc2ccccc2c1)N1c2ccccc2Sc2ccccc21 10.1016/j.bmcl.2013.04.082
CHEMBL241115 91763 0 None 6 4 Human 6.5 pKi = 6.5 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by PDSP assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 367 2 0 2 6.2 O=C(Cc1ccc2ccccc2c1)N1c2ccccc2Sc2ccccc21 10.1016/j.bmcl.2013.04.082
9932835 100766 0 None -151 4 Rat 6.5 pKi = 6.5 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 437 4 0 4 4.2 O=C1CC2(CCCCC2)CC(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
CHEMBL293111 100766 0 None -151 4 Rat 6.5 pKi = 6.5 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 437 4 0 4 4.2 O=C1CC2(CCCCC2)CC(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
518 3585 1 None -234 6 Human 5.5 pKi = 5.5 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 299 0 0 2 3.8 CN1CCc2c3c(C1)c(Br)oc3ccc2Cl 10.1016/j.bmcl.2004.11.032
9839317 3585 1 None -234 6 Human 5.5 pKi = 5.5 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 299 0 0 2 3.8 CN1CCc2c3c(C1)c(Br)oc3ccc2Cl 10.1016/j.bmcl.2004.11.032
CHEMBL123138 3585 1 None -234 6 Human 5.5 pKi = 5.5 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 299 0 0 2 3.8 CN1CCc2c3c(C1)c(Br)oc3ccc2Cl 10.1016/j.bmcl.2004.11.032
44271624 64745 3 None - 1 Bovine 5.5 pKi = 5.5 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 192 1 0 2 1.9 CN1CC=C(c2ncccc2F)CC1 10.1021/jm00375a017
CHEMBL18194 64745 3 None - 1 Bovine 5.5 pKi = 5.5 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 192 1 0 2 1.9 CN1CC=C(c2ncccc2F)CC1 10.1021/jm00375a017
518 3585 1 None -234 6 Human 5.5 pKi = 5.5 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 299 0 0 2 3.8 CN1CCc2c3c(C1)c(Br)oc3ccc2Cl 10.1021/jm00019a001
9839317 3585 1 None -234 6 Human 5.5 pKi = 5.5 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 299 0 0 2 3.8 CN1CCc2c3c(C1)c(Br)oc3ccc2Cl 10.1021/jm00019a001
CHEMBL123138 3585 1 None -234 6 Human 5.5 pKi = 5.5 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 299 0 0 2 3.8 CN1CCc2c3c(C1)c(Br)oc3ccc2Cl 10.1021/jm00019a001
20750645 102280 0 None 1 2 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 346 6 1 5 3.4 CC(C)Oc1ccccc1N1CCN(Cc2cc(CO)cs2)CC1 10.1016/s0960-894x(02)00347-5
CHEMBL303485 102280 0 None 1 2 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 346 6 1 5 3.4 CC(C)Oc1ccccc1N1CCN(Cc2cc(CO)cs2)CC1 10.1016/s0960-894x(02)00347-5
127035062 136426 0 None -11 19 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]Prazosin from human recombinant alpha 1A receptor after 90 mins by scintillation counting methodDisplacement of [3H]Prazosin from human recombinant alpha 1A receptor after 90 mins by scintillation counting method
ChEMBL 447 12 0 5 5.2 COc1ccc(CCN(CCCc2ccccc2)CCc2ccc3c(c2)OCO3)cc1OC 10.1039/C4MD00418C
CHEMBL3735756 136426 0 None -11 19 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]Prazosin from human recombinant alpha 1A receptor after 90 mins by scintillation counting methodDisplacement of [3H]Prazosin from human recombinant alpha 1A receptor after 90 mins by scintillation counting method
ChEMBL 447 12 0 5 5.2 COc1ccc(CCN(CCCc2ccccc2)CCc2ccc3c(c2)OCO3)cc1OC 10.1039/C4MD00418C
44582675 189677 0 None -5 15 Human 6.5 pKi = 6.5 Binding
Inhibition of human cloned alpha1A adrenergic receptor by competitive binding experimentInhibition of human cloned alpha1A adrenergic receptor by competitive binding experiment
ChEMBL 405 9 1 4 4.2 COc1c(OCCF)cccc1[C@H](O)C1CCN(CCc2ccc(F)cc2)CC1 10.1016/j.bmc.2009.03.021
CHEMBL515472 189677 0 None -5 15 Human 6.5 pKi = 6.5 Binding
Inhibition of human cloned alpha1A adrenergic receptor by competitive binding experimentInhibition of human cloned alpha1A adrenergic receptor by competitive binding experiment
ChEMBL 405 9 1 4 4.2 COc1c(OCCF)cccc1[C@H](O)C1CCN(CCc2ccc(F)cc2)CC1 10.1016/j.bmc.2009.03.021
12840734 100902 3 None -794 5 Rat 5.5 pKi = 5.5 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 355 4 0 4 2.5 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2)CC1 10.1021/jm030944+
CHEMBL293968 100902 3 None -794 5 Rat 5.5 pKi = 5.5 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 355 4 0 4 2.5 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2)CC1 10.1021/jm030944+
76318762 84786 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 435 9 1 6 4.0 COc1cccc(OC)c1OCCNC1COCC(c2ccccc2)(c2ccccc2)O1 10.1007/s00044-010-9379-1
CHEMBL2234440 84786 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 435 9 1 6 4.0 COc1cccc(OC)c1OCCNC1COCC(c2ccccc2)(c2ccccc2)O1 10.1007/s00044-010-9379-1
25131193 86161 0 None -239 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assayDisplacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assay
ChEMBL 449 10 1 6 4.0 COc1cccc(OC)c1OCCNCC1COCC(c2ccccc2)(c2ccccc2)O1 10.1016/j.ejmech.2019.02.056
CHEMBL2312225 86161 0 None -239 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assayDisplacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assay
ChEMBL 449 10 1 6 4.0 COc1cccc(OC)c1OCCNCC1COCC(c2ccccc2)(c2ccccc2)O1 10.1016/j.ejmech.2019.02.056
24894141 187385 0 None -30 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 449 10 1 6 4.0 COc1cccc(OC)c1OCCNC[C@@H]1COCC(c2ccccc2)(c2ccccc2)O1 10.1021/jm800461k
CHEMBL493697 187385 0 None -30 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 449 10 1 6 4.0 COc1cccc(OC)c1OCCNC[C@@H]1COCC(c2ccccc2)(c2ccccc2)O1 10.1021/jm800461k
25131193 86161 0 None -239 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 449 10 1 6 4.0 COc1cccc(OC)c1OCCNCC1COCC(c2ccccc2)(c2ccccc2)O1 10.1021/jm301525w
CHEMBL2312225 86161 0 None -239 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 449 10 1 6 4.0 COc1cccc(OC)c1OCCNCC1COCC(c2ccccc2)(c2ccccc2)O1 10.1021/jm301525w
53328872 63373 0 None -3 3 Human 5.5 pKi = 5.5 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 433 5 0 5 2.9 COc1ccccc1N1CCN(CCN2C(=O)CC3(CCc4ccccc43)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796048 63373 0 None -3 3 Human 5.5 pKi = 5.5 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 433 5 0 5 2.9 COc1ccccc1N1CCN(CCN2C(=O)CC3(CCc4ccccc43)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
9906978 42681 2 None -2 12 Human 7.5 pKi = 7.5 Binding
Binding affinity to human cloned adrenergic alpha-1A receptor by radioligand binding assayBinding affinity to human cloned adrenergic alpha-1A receptor by radioligand binding assay
ChEMBL 361 6 1 3 4.0 O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)C1)c1ccc(F)cc1 10.1016/j.bmcl.2006.03.057
CHEMBL150161 42681 2 None -2 12 Human 7.5 pKi = 7.5 Binding
Binding affinity to human cloned adrenergic alpha-1A receptor by radioligand binding assayBinding affinity to human cloned adrenergic alpha-1A receptor by radioligand binding assay
ChEMBL 361 6 1 3 4.0 O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)C1)c1ccc(F)cc1 10.1016/j.bmcl.2006.03.057
16041451 97780 0 None -5 4 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 500 7 2 5 5.4 COc1ccc(Cl)cc1NC(=O)NC1CCC(N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL271913 97780 0 None -5 4 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 500 7 2 5 5.4 COc1ccc(Cl)cc1NC(=O)NC1CCC(N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.11.068
168270256 190043 0 None -8 2 Rat 7.5 pKi = 7.5 Binding
Displacement of [3H]-prazosin from rat whole cortex membrane homogenate alpha 1 adrenergic receptorDisplacement of [3H]-prazosin from rat whole cortex membrane homogenate alpha 1 adrenergic receptor
ChEMBL 415 3 0 3 3.7 CCN(CC)C(=O)[C@@H]1C=C2c3cccc4c3c(c(Br)n4C)CC2N(C)C1 10.1021/acs.jmedchem.2c00633
CHEMBL5172469 190043 0 None -8 2 Rat 7.5 pKi = 7.5 Binding
Displacement of [3H]-prazosin from rat whole cortex membrane homogenate alpha 1 adrenergic receptorDisplacement of [3H]-prazosin from rat whole cortex membrane homogenate alpha 1 adrenergic receptor
ChEMBL 415 3 0 3 3.7 CCN(CC)C(=O)[C@@H]1C=C2c3cccc4c3c(c(Br)n4C)CC2N(C)C1 10.1021/acs.jmedchem.2c00633
53328686 63370 0 None 2 3 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 469 7 0 5 4.0 COc1ccc(Cl)cc1N1CCN(CCCN2C(=O)CC(C)(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796045 63370 0 None 2 3 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 469 7 0 5 4.0 COc1ccc(Cl)cc1N1CCN(CCCN2C(=O)CC(C)(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
2337 3232 77 None -3 63 Rat 7.5 pKi = 7.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
50 3232 77 None -3 63 Rat 7.5 pKi = 7.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
5002 3232 77 None -3 63 Rat 7.5 pKi = 7.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
CHEMBL716 3232 77 None -3 63 Rat 7.5 pKi = 7.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
DB01224 3232 77 None -3 63 Rat 7.5 pKi = 7.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
75201901 166401 19 None -251 24 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]-prazosin from recombinant human alpha1A adrenergic receptor measured after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-prazosin from recombinant human alpha1A adrenergic receptor measured after 90 mins by microbeta scintillation counting method
ChEMBL 356 3 0 6 4.9 Cc1cc(Oc2nccc3occc23)ccc1-c1c(C)ncc2nccn12 10.1021/acs.jmedchem.9b00351
CHEMBL4277264 166401 19 None -251 24 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]-prazosin from recombinant human alpha1A adrenergic receptor measured after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-prazosin from recombinant human alpha1A adrenergic receptor measured after 90 mins by microbeta scintillation counting method
ChEMBL 356 3 0 6 4.9 Cc1cc(Oc2nccc3occc23)ccc1-c1c(C)ncc2nccn12 10.1021/acs.jmedchem.9b00351
16756752 142566 0 None -4168 3 Human 4.5 pKi = 4.5 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptor
ChEMBL 496 7 1 3 7.8 CC(C)C(=O)Nc1cccc(C2CCN(Cc3ccc(Oc4ccc(Cl)c(Cl)c4)cc3)CC2)c1 10.1021/jm060383x
CHEMBL389129 142566 0 None -4168 3 Human 4.5 pKi = 4.5 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptor
ChEMBL 496 7 1 3 7.8 CC(C)C(=O)Nc1cccc(C2CCN(Cc3ccc(Oc4ccc(Cl)c(Cl)c4)cc3)CC2)c1 10.1021/jm060383x
44460449 205851 0 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 426 7 0 6 3.7 CC(C)Oc1ccccc1N1CCN(Cc2nc(CN3CCCCCC3=O)co2)CC1 10.1016/s0960-894x(02)00436-5
CHEMBL83791 205851 0 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 426 7 0 6 3.7 CC(C)Oc1ccccc1N1CCN(Cc2nc(CN3CCCCCC3=O)co2)CC1 10.1016/s0960-894x(02)00436-5
53328115 63353 0 None -2 3 Human 5.5 pKi = 5.5 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 407 6 0 5 2.8 COc1ccccc1N1CCN(CCN2C(=O)CC(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796028 63353 0 None -2 3 Human 5.5 pKi = 5.5 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 407 6 0 5 2.8 COc1ccccc1N1CCN(CCN2C(=O)CC(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
132060776 162378 0 None -11 16 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]-Prazosin from human adrenergic alpha1A receptor after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Prazosin from human adrenergic alpha1A receptor after 90 mins by microbeta scintillation counting method
ChEMBL 419 4 0 4 4.4 O=C(OCc1ccccc1)N1CCc2ccc(N3CCN(C4CCCC4)CC3)cc2C1 10.1016/j.ejmech.2018.02.024
CHEMBL4165863 162378 0 None -11 16 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]-Prazosin from human adrenergic alpha1A receptor after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Prazosin from human adrenergic alpha1A receptor after 90 mins by microbeta scintillation counting method
ChEMBL 419 4 0 4 4.4 O=C(OCc1ccccc1)N1CCc2ccc(N3CCN(C4CCCC4)CC3)cc2C1 10.1016/j.ejmech.2018.02.024
44295193 101751 0 None 11 3 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 576 7 2 9 2.6 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc3c(c2)OCO3)CC1 10.1016/s0960-894x(99)00653-8
CHEMBL299984 101751 0 None 11 3 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 576 7 2 9 2.6 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc3c(c2)OCO3)CC1 10.1016/s0960-894x(99)00653-8
46881382 7292 0 None -275 4 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 437 9 1 5 5.4 COc1ccccc1OCCNCC1CSC(c2ccccc2)(c2ccccc2)S1 10.1016/j.bmcl.2010.01.030
CHEMBL1086156 7292 0 None -275 4 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 437 9 1 5 5.4 COc1ccccc1OCCNCC1CSC(c2ccccc2)(c2ccccc2)S1 10.1016/j.bmcl.2010.01.030
49832191 167515 0 None -407 3 Human 6.5 pKi = 6.5 Binding
Displacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting methodDisplacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting method
ChEMBL 382 6 2 5 2.9 CNc1ccc2c(c1)C(NCCOc1cc(F)ccc1F)CCS2(=O)=O 10.1016/j.ejmech.2017.07.071
CHEMBL4218307 167515 0 None -407 3 Human 6.5 pKi = 6.5 Binding
Displacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting methodDisplacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting method
ChEMBL 382 6 2 5 2.9 CNc1ccc2c(c1)C(NCCOc1cc(F)ccc1F)CCS2(=O)=O 10.1016/j.ejmech.2017.07.071
CHEMBL4300210 167515 0 None -407 3 Human 6.5 pKi = 6.5 Binding
Displacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting methodDisplacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting method
ChEMBL 382 6 2 5 2.9 CNc1ccc2c(c1)C(NCCOc1cc(F)ccc1F)CCS2(=O)=O 10.1016/j.ejmech.2017.07.071
1346 83 117 None -2884 9 Rat 5.5 pKi = 5.5 Binding
Binding affinity measured for alpha-1 adrenergic receptor by displacement of [3H]prazosin from rat cortical membranesBinding affinity measured for alpha-1 adrenergic receptor by displacement of [3H]prazosin from rat cortical membranes
ChEMBL 192 2 1 3 1.1 COc1ccccc1N1CCNCC1 10.1021/jm00110a014
280 83 117 None -2884 9 Rat 5.5 pKi = 5.5 Binding
Binding affinity measured for alpha-1 adrenergic receptor by displacement of [3H]prazosin from rat cortical membranesBinding affinity measured for alpha-1 adrenergic receptor by displacement of [3H]prazosin from rat cortical membranes
ChEMBL 192 2 1 3 1.1 COc1ccccc1N1CCNCC1 10.1021/jm00110a014
9899402 83 117 None -2884 9 Rat 5.5 pKi = 5.5 Binding
Binding affinity measured for alpha-1 adrenergic receptor by displacement of [3H]prazosin from rat cortical membranesBinding affinity measured for alpha-1 adrenergic receptor by displacement of [3H]prazosin from rat cortical membranes
ChEMBL 192 2 1 3 1.1 COc1ccccc1N1CCNCC1 10.1021/jm00110a014
CHEMBL9666 83 117 None -2884 9 Rat 5.5 pKi = 5.5 Binding
Binding affinity measured for alpha-1 adrenergic receptor by displacement of [3H]prazosin from rat cortical membranesBinding affinity measured for alpha-1 adrenergic receptor by displacement of [3H]prazosin from rat cortical membranes
ChEMBL 192 2 1 3 1.1 COc1ccccc1N1CCNCC1 10.1021/jm00110a014
155515301 169943 0 None -29 7 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assayDisplacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assay
ChEMBL 444 6 0 5 4.2 COc1ccccc1N1CCN(C[C@H]2OCCOC2(c2ccccc2)c2ccccc2)CC1 10.1016/j.ejmech.2019.02.056
CHEMBL4441888 169943 0 None -29 7 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assayDisplacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assay
ChEMBL 444 6 0 5 4.2 COc1ccccc1N1CCN(C[C@H]2OCCOC2(c2ccccc2)c2ccccc2)CC1 10.1016/j.ejmech.2019.02.056
10092819 16741 0 None -34 12 Rat 7.4 pKi = 7.4 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 407 8 1 5 3.8 COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3o2)CC1 10.1021/jm0211220
CHEMBL124444 16741 0 None -34 12 Rat 7.4 pKi = 7.4 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 407 8 1 5 3.8 COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3o2)CC1 10.1021/jm0211220
44431590 87950 0 None -2 4 Human 7.4 pKi = 7.4 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 555 8 1 6 4.9 COc1ccc(C(F)(F)F)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL234231 87950 0 None -2 4 Human 7.4 pKi = 7.4 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 555 8 1 6 4.9 COc1ccc(C(F)(F)F)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
44431615 88009 0 None 1 4 Human 7.4 pKi = 7.4 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 521 8 1 5 4.7 O=S(=O)(N[C@H]1CC[C@@H](N2CCN(c3ccccc3OCC3CC3)CC2)CC1)c1cc(Cl)ccc1F 10.1016/j.bmcl.2007.04.008
CHEMBL234476 88009 0 None 1 4 Human 7.4 pKi = 7.4 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 521 8 1 5 4.7 O=S(=O)(N[C@H]1CC[C@@H](N2CCN(c3ccccc3OCC3CC3)CC2)CC1)c1cc(Cl)ccc1F 10.1016/j.bmcl.2007.04.008
13141187 130690 0 None 9 2 Bovine 7.4 pKi = 7.4 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 378 1 0 3 5.2 CN1CCC(=C2c3cc(SC(F)(F)F)ccc3CCn3cccc32)CC1 10.1021/jm00361a008
CHEMBL368475 130690 0 None 9 2 Bovine 7.4 pKi = 7.4 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 378 1 0 3 5.2 CN1CCC(=C2c3cc(SC(F)(F)F)ccc3CCn3cccc32)CC1 10.1021/jm00361a008
56649650 67829 0 None -41 8 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assayDisplacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assay
ChEMBL 466 8 0 5 4.2 COc1ccccc1N1CCN(CCN(C(=O)C23CCC(CF)(CC2)C3)c2ccccn2)CC1 10.1016/j.ejmech.2011.06.023
CHEMBL1910141 67829 0 None -41 8 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assayDisplacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assay
ChEMBL 466 8 0 5 4.2 COc1ccccc1N1CCN(CCN(C(=O)C23CCC(CF)(CC2)C3)c2ccccn2)CC1 10.1016/j.ejmech.2011.06.023
145946527 167546 0 None 5 5 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 382 10 0 4 3.6 Cc1cccc(OCCOCCN2CCN(CCc3ccccc3)CC2)c1C 10.1016/j.bmcl.2018.04.059
CHEMBL4217761 167546 0 None 5 5 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 382 10 0 4 3.6 Cc1cccc(OCCOCCN2CCN(CCc3ccccc3)CC2)c1C 10.1016/j.bmcl.2018.04.059
CHEMBL4300609 167546 0 None 5 5 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 382 10 0 4 3.6 Cc1cccc(OCCOCCN2CCN(CCc3ccccc3)CC2)c1C 10.1016/j.bmcl.2018.04.059
126225 94947 5 None -13 8 Human 7.4 pKi = 7.4 Binding
In vitro binding affinity at human Alpha-1A adrenergic receptor.In vitro binding affinity at human Alpha-1A adrenergic receptor.
ChEMBL 263 1 0 2 4.2 C=Cc1sc2ccc(Cl)c3c2c1CN(C)CC3 10.1021/jm0307741
CHEMBL25467 94947 5 None -13 8 Human 7.4 pKi = 7.4 Binding
In vitro binding affinity at human Alpha-1A adrenergic receptor.In vitro binding affinity at human Alpha-1A adrenergic receptor.
ChEMBL 263 1 0 2 4.2 C=Cc1sc2ccc(Cl)c3c2c1CN(C)CC3 10.1021/jm0307741
126225 94947 5 None -13 8 Human 7.4 pKi = 7.4 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 263 1 0 2 4.2 C=Cc1sc2ccc(Cl)c3c2c1CN(C)CC3 10.1021/jm00019a001
CHEMBL25467 94947 5 None -13 8 Human 7.4 pKi = 7.4 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 263 1 0 2 4.2 C=Cc1sc2ccc(Cl)c3c2c1CN(C)CC3 10.1021/jm00019a001
3038603 101838 8 None -48 3 Human 7.4 pKi = 7.4 Binding
The compound was tested for binding affinity against Alpha-1 adrenergic receptor using WB-4101 as radioligandThe compound was tested for binding affinity against Alpha-1 adrenergic receptor using WB-4101 as radioligand
ChEMBL 335 1 0 1 5.4 CN(C)C1C=CC2(CC1)c1ccccc1C=Cc1ccc(Cl)cc12 10.1021/jm00109a026
CHEMBL300647 101838 8 None -48 3 Human 7.4 pKi = 7.4 Binding
The compound was tested for binding affinity against Alpha-1 adrenergic receptor using WB-4101 as radioligandThe compound was tested for binding affinity against Alpha-1 adrenergic receptor using WB-4101 as radioligand
ChEMBL 335 1 0 1 5.4 CN(C)C1C=CC2(CC1)c1ccccc1C=Cc1ccc(Cl)cc12 10.1021/jm00109a026
10790988 116074 0 None -3 3 Rat 7.4 pKi = 7.4 Binding
The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.
ChEMBL 483 8 1 10 2.0 COc1cc2nc(N3CCN(C(=O)COc4c(OC)cccc4OC)CC3)nc(N)c2cc1OC 10.1021/jm9805337
CHEMBL335731 116074 0 None -3 3 Rat 7.4 pKi = 7.4 Binding
The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.
ChEMBL 483 8 1 10 2.0 COc1cc2nc(N3CCN(C(=O)COc4c(OC)cccc4OC)CC3)nc(N)c2cc1OC 10.1021/jm9805337
76307950 84791 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 404 5 0 5 4.1 COc1ccccc1N1CCN(CC2CO[C@@H](c3cccc4ccccc34)O2)CC1 10.1007/s00044-010-9379-1
CHEMBL2234445 84791 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 404 5 0 5 4.1 COc1ccccc1N1CCN(CC2CO[C@@H](c3cccc4ccccc34)O2)CC1 10.1007/s00044-010-9379-1
10508016 207133 0 None 3 6 Human 7.4 pKi = 7.4 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 613 9 2 5 7.7 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2ccccc2c1 10.1021/jm980077m
CHEMBL92322 207133 0 None 3 6 Human 7.4 pKi = 7.4 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 613 9 2 5 7.7 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2ccccc2c1 10.1021/jm980077m
10508016 85262 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 613 9 2 5 6.8 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2ccccc2c1 10.1007/s00044-004-0120-9
CHEMBL2260369 85262 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 613 9 2 5 6.8 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2ccccc2c1 10.1007/s00044-004-0120-9
76307950 84791 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 404 5 0 5 4.1 COc1ccccc1N1CCN(CC2CO[C@@H](c3cccc4ccccc34)O2)CC1 10.1007/s00044-010-9379-1
CHEMBL2234445 84791 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 404 5 0 5 4.1 COc1ccccc1N1CCN(CC2CO[C@@H](c3cccc4ccccc34)O2)CC1 10.1007/s00044-010-9379-1
9944409 7581 0 None 1 5 Rat 7.4 pKi = 7.4 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 307 3 3 4 2.0 CS(=O)(=O)Nc1c(O)ccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL108804 7581 0 None 1 5 Rat 7.4 pKi = 7.4 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 307 3 3 4 2.0 CS(=O)(=O)Nc1c(O)ccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
53328315 63360 0 None 1 3 Human 7.4 pKi = 7.4 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 469 8 0 5 4.2 COc1ccc(Cl)cc1N1CCN(CCCCN2C(=O)CC(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796035 63360 0 None 1 3 Human 7.4 pKi = 7.4 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 469 8 0 5 4.2 COc1ccc(Cl)cc1N1CCN(CCCCN2C(=O)CC(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
10617200 26402 0 None -6 5 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptorDisplacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptor
ChEMBL 341 5 2 5 2.4 O[C@@H]1[C@H](NC[C@H]2COc3ccccc3O2)CC[C@H]1Oc1ccccc1 10.1021/jm991065j
CHEMBL135973 26402 0 None -6 5 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptorDisplacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptor
ChEMBL 341 5 2 5 2.4 O[C@@H]1[C@H](NC[C@H]2COc3ccccc3O2)CC[C@H]1Oc1ccccc1 10.1021/jm991065j
9944409 7581 0 None 1 5 Rat 7.4 pKi = 7.4 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 307 3 3 4 2.0 CS(=O)(=O)Nc1c(O)ccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL108804 7581 0 None 1 5 Rat 7.4 pKi = 7.4 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 307 3 3 4 2.0 CS(=O)(=O)Nc1c(O)ccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
71719108 86022 1 None -141 4 Human 6.4 pKi = 6.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 895 16 6 11 3.5 N=C(N)NCCC[C@@H](NC(=O)CC1(CC(=O)N2CCN(C3c4ccccc4NC(=O)c4ccccc43)CC2)CCCC1)C(=O)NCCn1c(=O)n(-c2ccccc2)n(-c2ccccc2)c1=O 10.1016/j.bmcl.2013.11.061
CHEMBL2307889 86022 1 None -141 4 Human 6.4 pKi = 6.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 895 16 6 11 3.5 N=C(N)NCCC[C@@H](NC(=O)CC1(CC(=O)N2CCN(C3c4ccccc4NC(=O)c4ccccc43)CC2)CCCC1)C(=O)NCCn1c(=O)n(-c2ccccc2)n(-c2ccccc2)c1=O 10.1016/j.bmcl.2013.11.061
10619916 206715 0 None -12 2 Rat 6.4 pKi = 6.4 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 382 5 0 4 3.0 FC(F)(F)c1cccc(N2CCN(CCCN3CC4CCCN4C3)CC2)c1 10.1021/jm970216k
CHEMBL89950 206715 0 None -12 2 Rat 6.4 pKi = 6.4 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 382 5 0 4 3.0 FC(F)(F)c1cccc(N2CCN(CCCN3CC4CCCN4C3)CC2)c1 10.1021/jm970216k
9909389 165287 6 None -524 2 Human 6.4 pKi = 6.4 Binding
Binding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constantBinding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constant
ChEMBL 408 6 1 5 3.5 O=C(C1CCCCC1)N(CCN1CCN(c2ccccc2O)CC1)c1ccccn1 10.1021/acs.jmedchem.2c00633
CHEMBL423361 165287 6 None -524 2 Human 6.4 pKi = 6.4 Binding
Binding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constantBinding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constant
ChEMBL 408 6 1 5 3.5 O=C(C1CCCCC1)N(CCN1CCN(c2ccccc2O)CC1)c1ccccn1 10.1021/acs.jmedchem.2c00633
9809007 172540 8 None 134 6 Human 7.4 pKi = 7.4 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00010a001
CHEMBL448620 172540 8 None 134 6 Human 7.4 pKi = 7.4 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00010a001
9976756 6575 0 None -10 5 Human 7.4 pKi = 7.4 Binding
Affinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assayAffinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1021/jm021078o
CHEMBL1083181 6575 0 None -10 5 Human 7.4 pKi = 7.4 Binding
Affinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assayAffinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1021/jm021078o
CHEMBL37883 6575 0 None -10 5 Human 7.4 pKi = 7.4 Binding
Affinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assayAffinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1021/jm021078o
9976756 6575 0 None -10 5 Human 7.4 pKi = 7.4 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
CHEMBL1083181 6575 0 None -10 5 Human 7.4 pKi = 7.4 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
CHEMBL37883 6575 0 None -10 5 Human 7.4 pKi = 7.4 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
9976756 6575 0 None -10 5 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1016/j.bmcl.2010.01.030
CHEMBL1083181 6575 0 None -10 5 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1016/j.bmcl.2010.01.030
CHEMBL37883 6575 0 None -10 5 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1016/j.bmcl.2010.01.030
9976756 6575 0 None -10 5 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1039/C4MD00484A
CHEMBL1083181 6575 0 None -10 5 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1039/C4MD00484A
CHEMBL37883 6575 0 None -10 5 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1039/C4MD00484A
9976756 6575 0 None -10 5 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1021/jm200421e
CHEMBL1083181 6575 0 None -10 5 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1021/jm200421e
CHEMBL37883 6575 0 None -10 5 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1021/jm200421e
44431173 92773 0 None -1 3 Human 7.4 pKi = 7.4 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 519 5 0 5 4.8 CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4c(F)c(F)c(F)c(F)c4C3=O)CC2)CC1 10.1016/j.bmcl.2006.12.111
CHEMBL243690 92773 0 None -1 3 Human 7.4 pKi = 7.4 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 519 5 0 5 4.8 CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4c(F)c(F)c(F)c(F)c4C3=O)CC2)CC1 10.1016/j.bmcl.2006.12.111
12613159 187302 11 None -1 4 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from alpha-1A adrenergic receptor (unknown origin)Displacement of [3H]prazosin from alpha-1A adrenergic receptor (unknown origin)
ChEMBL 325 5 2 3 3.8 C[C@H]([C@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1021/acs.jmedchem.0c01912
CHEMBL493054 187302 11 None -1 4 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from alpha-1A adrenergic receptor (unknown origin)Displacement of [3H]prazosin from alpha-1A adrenergic receptor (unknown origin)
ChEMBL 325 5 2 3 3.8 C[C@H]([C@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1021/acs.jmedchem.0c01912
10084076 97888 0 None -20 9 Human 6.4 pKi = 6.4 Binding
Binding affinity towards alpha-1-adrenergic receptorBinding affinity towards alpha-1-adrenergic receptor
ChEMBL 262 0 1 2 2.8 CN1CCc2ccc3c4c2[C@H]1Cc1cccc(c1-4)[C@@H]3N 10.1021/jm030030n
CHEMBL27251 97888 0 None -20 9 Human 6.4 pKi = 6.4 Binding
Binding affinity towards alpha-1-adrenergic receptorBinding affinity towards alpha-1-adrenergic receptor
ChEMBL 262 0 1 2 2.8 CN1CCc2ccc3c4c2[C@H]1Cc1cccc(c1-4)[C@@H]3N 10.1021/jm030030n
3024499 175449 73 None -20 2 Bovine 6.4 pKi = 6.4 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 197 1 1 3 1.1 Clc1cccc(N2CCNCC2)n1 10.1021/jm00366a007
CHEMBL45773 175449 73 None -20 2 Bovine 6.4 pKi = 6.4 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 197 1 1 3 1.1 Clc1cccc(N2CCNCC2)n1 10.1021/jm00366a007
11384983 197279 0 None -295 4 Rat 6.4 pKi = 6.4 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 433 4 0 4 3.3 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2Br)CC1 10.1021/jm030944+
CHEMBL56869 197279 0 None -295 4 Rat 6.4 pKi = 6.4 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 433 4 0 4 3.3 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2Br)CC1 10.1021/jm030944+
10651027 121037 0 None 11 3 Human 5.4 pKi = 5.4 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 588 11 3 7 3.7 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(CN(C)C)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980506g
CHEMBL356923 121037 0 None 11 3 Human 5.4 pKi = 5.4 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 588 11 3 7 3.7 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(CN(C)C)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980506g
98358 119460 8 None 1 2 Bovine 7.4 pKi = 7.4 Binding
Affinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranesAffinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranes
ChEMBL 226 0 1 1 3.3 c1ccc2c3c([nH]c2c1)C1CCCCN1CC3 10.1021/jm00398a025
CHEMBL345349 119460 8 None 1 2 Bovine 7.4 pKi = 7.4 Binding
Affinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranesAffinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranes
ChEMBL 226 0 1 1 3.3 c1ccc2c3c([nH]c2c1)C1CCCCN1CC3 10.1021/jm00398a025
44267884 15535 0 None 2 3 Human 7.4 pKi = 7.4 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 403 8 0 6 2.2 CC(C)Oc1ccccc1N1CCN(CCOC(=O)CN2CCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
CHEMBL12202 15535 0 None 2 3 Human 7.4 pKi = 7.4 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 403 8 0 6 2.2 CC(C)Oc1ccccc1N1CCN(CCOC(=O)CN2CCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
44426405 85640 0 None 2 4 Human 7.4 pKi = 7.4 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 562 9 1 5 5.7 O=S(=O)(N[C@H]1CC[C@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1ccc(OC(F)F)cc1 10.1016/j.bmcl.2007.04.098
CHEMBL228554 85640 0 None 2 4 Human 7.4 pKi = 7.4 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 562 9 1 5 5.7 O=S(=O)(N[C@H]1CC[C@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1ccc(OC(F)F)cc1 10.1016/j.bmcl.2007.04.098
60785 205870 48 None -309 7 Rat 7.4 pKi = 7.4 Binding
Binding affinity to rat cerebral cortex homogenate alpha 1 adrenergic receptor assessed as inhibition constantBinding affinity to rat cerebral cortex homogenate alpha 1 adrenergic receptor assessed as inhibition constant
ChEMBL 425 5 0 4 3.7 O=S1(=O)c2cccc3cccc(c23)N1CCCN1CCN(c2ccc(F)cc2)CC1 10.1021/acs.jmedchem.2c00633
CHEMBL83894 205870 48 None -309 7 Rat 7.4 pKi = 7.4 Binding
Binding affinity to rat cerebral cortex homogenate alpha 1 adrenergic receptor assessed as inhibition constantBinding affinity to rat cerebral cortex homogenate alpha 1 adrenergic receptor assessed as inhibition constant
ChEMBL 425 5 0 4 3.7 O=S1(=O)c2cccc3cccc(c23)N1CCCN1CCN(c2ccc(F)cc2)CC1 10.1021/acs.jmedchem.2c00633
133 2479 52 None -70 43 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
1723 2479 52 None -70 43 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
28693 2479 52 None -70 43 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
CHEMBL19215 2479 52 None -70 43 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
DB13520 2479 52 None -70 43 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
16040907 97855 0 None -2 4 Human 7.4 pKi = 7.4 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 466 7 2 5 4.7 COc1ccccc1NC(=O)NC1CCC(N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL272340 97855 0 None -2 4 Human 7.4 pKi = 7.4 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 466 7 2 5 4.7 COc1ccccc1NC(=O)NC1CCC(N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.11.068
71508684 87021 0 None 169 2 Bovine 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 371 3 0 5 4.2 CN1CCC(c2cn(-c3ccncc3)c3ccc(-c4cnn(C)c4)cc23)CC1 10.1016/j.bmc.2012.10.049
CHEMBL2325929 87021 0 None 169 2 Bovine 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 371 3 0 5 4.2 CN1CCC(c2cn(-c3ccncc3)c3ccc(-c4cnn(C)c4)cc23)CC1 10.1016/j.bmc.2012.10.049
2470 3626 50 None -398 60 Rat 7.4 pKi = 7.4 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1021/jm960510x
3300 3626 50 None -398 60 Rat 7.4 pKi = 7.4 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1021/jm960510x
5265 3626 50 None -398 60 Rat 7.4 pKi = 7.4 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1021/jm960510x
99 3626 50 None -398 60 Rat 7.4 pKi = 7.4 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1021/jm960510x
CHEMBL267930 3626 50 None -398 60 Rat 7.4 pKi = 7.4 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1021/jm960510x
98358 119460 8 None 1 2 Bovine 7.4 pKi = 7.4 Binding
Compound was evaluated for log 1/Ki at alpha-1 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-1 adrenergic receptor
ChEMBL 226 0 1 1 3.3 c1ccc2c3c([nH]c2c1)C1CCCCN1CC3 10.1021/jm00398a025
CHEMBL345349 119460 8 None 1 2 Bovine 7.4 pKi = 7.4 Binding
Compound was evaluated for log 1/Ki at alpha-1 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-1 adrenergic receptor
ChEMBL 226 0 1 1 3.3 c1ccc2c3c([nH]c2c1)C1CCCCN1CC3 10.1021/jm00398a025
44288469 161666 0 None 1 3 Rat 7.4 pKi = 7.4 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 447 4 1 6 3.6 COc1ccc2c(c1)CCC1CN(CCn3c(=O)[nH]c4c(sc5ccccc54)c3=O)CC21 10.1021/jm990567u
CHEMBL41332 161666 0 None 1 3 Rat 7.4 pKi = 7.4 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 447 4 1 6 3.6 COc1ccc2c(c1)CCC1CN(CCn3c(=O)[nH]c4c(sc5ccccc54)c3=O)CC21 10.1021/jm990567u
127024959 137776 0 None -30 3 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 405 7 1 3 4.3 O=C(NCCCCN1CCN(c2ccccc2F)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
CHEMBL3759607 137776 0 None -30 3 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 405 7 1 3 4.3 O=C(NCCCCN1CCN(c2ccccc2F)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
155562125 176319 0 None -20 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 389 8 1 4 4.4 c1ccc(OCCNCC2CCOC(c3ccccc3)(c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
CHEMBL4582160 176319 0 None -20 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 389 8 1 4 4.4 c1ccc(OCCNCC2CCOC(c3ccccc3)(c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
CHEMBL4595563 176319 0 None -20 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 389 8 1 4 4.4 c1ccc(OCCNCC2CCOC(c3ccccc3)(c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
56945165 71489 0 None -69 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 442 6 1 4 4.6 COc1ccccc1N1CCN(C[C@H]2CCC(c3ccccc3)(c3ccccc3)[C@H]2O)CC1 10.1021/jm200421e
CHEMBL1946787 71489 0 None -69 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 442 6 1 4 4.6 COc1ccccc1N1CCN(C[C@H]2CCC(c3ccccc3)(c3ccccc3)[C@H]2O)CC1 10.1021/jm200421e
CHEMBL1962770 71489 0 None -69 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 442 6 1 4 4.6 COc1ccccc1N1CCN(C[C@H]2CCC(c3ccccc3)(c3ccccc3)[C@H]2O)CC1 10.1021/jm200421e
44288492 163390 0 None 3 2 Human 6.4 pKi = 6.4 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 439 9 1 6 2.9 COC(=O)C1(c2ccccc2)CCN(CCNC(=O)CCc2ccc([N+](=O)[O-])cc2)CC1 10.1016/s0960-894x(00)00307-3
CHEMBL41959 163390 0 None 3 2 Human 6.4 pKi = 6.4 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 439 9 1 6 2.9 COC(=O)C1(c2ccccc2)CCN(CCNC(=O)CCc2ccc([N+](=O)[O-])cc2)CC1 10.1016/s0960-894x(00)00307-3
2419 692 28 None -288 12 Human 6.4 pKi = 6.4 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/j.ejmech.2010.05.023
9 692 28 None -288 12 Human 6.4 pKi = 6.4 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/j.ejmech.2010.05.023
CHEMBL13647 692 28 None -288 12 Human 6.4 pKi = 6.4 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/j.ejmech.2010.05.023
2419 692 28 None -288 12 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assayDisplacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assay
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/j.ejmech.2019.02.056
9 692 28 None -288 12 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assayDisplacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assay
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/j.ejmech.2019.02.056
CHEMBL13647 692 28 None -288 12 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assayDisplacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assay
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/j.ejmech.2019.02.056
2419 692 28 None -288 12 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/j.bmcl.2010.01.030
9 692 28 None -288 12 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/j.bmcl.2010.01.030
CHEMBL13647 692 28 None -288 12 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/j.bmcl.2010.01.030
2419 692 28 None -288 12 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptorDisplacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm991065j
9 692 28 None -288 12 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptorDisplacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm991065j
CHEMBL13647 692 28 None -288 12 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptorDisplacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm991065j
2419 692 28 None -288 12 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm800461k
9 692 28 None -288 12 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm800461k
CHEMBL13647 692 28 None -288 12 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm800461k
2419 692 28 None -288 12 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm301525w
9 692 28 None -288 12 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm301525w
CHEMBL13647 692 28 None -288 12 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm301525w
2419 692 28 None -288 12 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm200421e
9 692 28 None -288 12 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm200421e
CHEMBL13647 692 28 None -288 12 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm200421e
3778834 101293 78 None -144 2 Bovine 5.4 pKi = 5.4 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 208 2 1 5 0.4 O=[N+]([O-])c1cccnc1N1CCNCC1 10.1021/jm00366a007
CHEMBL296653 101293 78 None -144 2 Bovine 5.4 pKi = 5.4 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 208 2 1 5 0.4 O=[N+]([O-])c1cccnc1N1CCNCC1 10.1021/jm00366a007
11338314 171346 0 None -676 4 Human 5.4 pKi = 5.4 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 391 4 0 4 2.8 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccc(F)cc2F)CC1 10.1021/jm0491391
CHEMBL446180 171346 0 None -676 4 Human 5.4 pKi = 5.4 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 391 4 0 4 2.8 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccc(F)cc2F)CC1 10.1021/jm0491391
294234 102866 3 None -512 4 Human 5.4 pKi = 5.4 Binding
Binding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 182 1 1 3 1.7 C1CCCC(NC2=NCCO2)CC1 10.1016/0960-894X(94)85032-1
CHEMBL305928 102866 3 None -512 4 Human 5.4 pKi = 5.4 Binding
Binding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 182 1 1 3 1.7 C1CCCC(NC2=NCCO2)CC1 10.1016/0960-894X(94)85032-1
10640982 26403 0 None -467 5 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptorDisplacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptor
ChEMBL 341 5 2 5 2.4 O[C@H]1[C@@H](NC[C@H]2COc3ccccc3O2)CC[C@@H]1Oc1ccccc1 10.1021/jm991065j
CHEMBL135974 26403 0 None -467 5 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptorDisplacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptor
ChEMBL 341 5 2 5 2.4 O[C@H]1[C@@H](NC[C@H]2COc3ccccc3O2)CC[C@@H]1Oc1ccccc1 10.1021/jm991065j
2419 692 28 None -288 12 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting method
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/j.ejmech.2016.09.050
9 692 28 None -288 12 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting method
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/j.ejmech.2016.09.050
CHEMBL13647 692 28 None -288 12 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting method
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/j.ejmech.2016.09.050
9796526 109857 0 None 6 2 Rat 6.4 pKi = 6.4 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 305 3 2 3 2.6 Cc1ccc(NS(C)(=O)=O)c2c1C(c1c[nH]cn1)CCC2 10.1021/jm030551a
CHEMBL323440 109857 0 None 6 2 Rat 6.4 pKi = 6.4 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 305 3 2 3 2.6 Cc1ccc(NS(C)(=O)=O)c2c1C(c1c[nH]cn1)CCC2 10.1021/jm030551a
71455083 81801 0 None -64 7 Human 7.4 pKi = 7.4 Binding
Binding affinity to adrenergic alpha1A receptor by radioligand binding assayBinding affinity to adrenergic alpha1A receptor by radioligand binding assay
ChEMBL 389 6 0 3 4.8 O=C(C1CCCCC1)N(CCN1CC=C(c2ccccc2)CC1)c1ccccn1 10.1016/j.bmcl.2012.05.119
CHEMBL2164354 81801 0 None -64 7 Human 7.4 pKi = 7.4 Binding
Binding affinity to adrenergic alpha1A receptor by radioligand binding assayBinding affinity to adrenergic alpha1A receptor by radioligand binding assay
ChEMBL 389 6 0 3 4.8 O=C(C1CCCCC1)N(CCN1CC=C(c2ccccc2)CC1)c1ccccn1 10.1016/j.bmcl.2012.05.119
3033538 1307 39 None -7 9 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 nan
7155 1307 39 None -7 9 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 nan
781 1307 39 None -7 9 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 nan
CHEMBL1201216 1307 39 None -7 9 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 nan
DB00298 1307 39 None -7 9 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 nan
13091268 78195 0 None -42 14 Human 7.4 pKi = 7.4 Binding
Binding affinity to human cloned adrenergic alpha-1A receptor by radioligand binding assayBinding affinity to human cloned adrenergic alpha-1A receptor by radioligand binding assay
ChEMBL 401 6 1 3 5.0 O=C(CCCN1C2CCC1CC(O)(c1ccc(Cl)cc1)C2)c1ccc(F)cc1 10.1016/j.bmcl.2006.03.057
CHEMBL210578 78195 0 None -42 14 Human 7.4 pKi = 7.4 Binding
Binding affinity to human cloned adrenergic alpha-1A receptor by radioligand binding assayBinding affinity to human cloned adrenergic alpha-1A receptor by radioligand binding assay
ChEMBL 401 6 1 3 5.0 O=C(CCCN1C2CCC1CC(O)(c1ccc(Cl)cc1)C2)c1ccc(F)cc1 10.1016/j.bmcl.2006.03.057
52937830 61289 0 None -125 3 Human 7.4 pKi = 7.4 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 367 4 0 4 3.7 CN1CCC[C@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/jm1013874
CHEMBL1767154 61289 0 None -125 3 Human 7.4 pKi = 7.4 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 367 4 0 4 3.7 CN1CCC[C@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/jm1013874
17747460 61299 12 None -158 4 Human 7.4 pKi = 7.4 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 640 14 0 6 7.8 O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C[C@H]1CCCN1CCCCc1ccc(OCCCN2CCCCCC2)cc1 10.1021/jm1013874
CHEMBL1767164 61299 12 None -158 4 Human 7.4 pKi = 7.4 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 640 14 0 6 7.8 O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C[C@H]1CCCN1CCCCc1ccc(OCCCN2CCCCCC2)cc1 10.1021/jm1013874
3584 3748 64 None -2 14 Human 7.4 pKi = 7.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm960697s
5401 3748 64 None -2 14 Human 7.4 pKi = 7.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm960697s
7302 3748 64 None -2 14 Human 7.4 pKi = 7.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm960697s
CHEMBL611 3748 64 None -2 14 Human 7.4 pKi = 7.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm960697s
DB01162 3748 64 None -2 14 Human 7.4 pKi = 7.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm960697s
56946579 71484 0 None -11 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 440 6 0 4 4.8 COc1ccccc1N1CCN(CC2CCC(c3ccccc3)(c3ccccc3)C2=O)CC1 10.1021/jm200421e
CHEMBL1946783 71484 0 None -11 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 440 6 0 4 4.8 COc1ccccc1N1CCN(CC2CCC(c3ccccc3)(c3ccccc3)C2=O)CC1 10.1021/jm200421e
CHEMBL1962755 71484 0 None -11 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 440 6 0 4 4.8 COc1ccccc1N1CCN(CC2CCC(c3ccccc3)(c3ccccc3)C2=O)CC1 10.1021/jm200421e
52937729 61281 0 None -251 3 Human 6.4 pKi = 6.4 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 367 4 0 4 3.7 CN1CCC[C@@H]1Cn1nc(Cc2cccc(Cl)c2)c2ccccc2c1=O 10.1021/jm1013874
CHEMBL1767146 61281 0 None -251 3 Human 6.4 pKi = 6.4 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 367 4 0 4 3.7 CN1CCC[C@@H]1Cn1nc(Cc2cccc(Cl)c2)c2ccccc2c1=O 10.1021/jm1013874
11857791 168973 0 None -1 4 Human 8.4 pKi = 8.4 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 554 7 1 6 4.9 O=S(=O)(N[C@H]1CC[C@@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1ccc2c(c1)OCCO2 10.1016/j.bmcl.2007.04.098
CHEMBL439197 168973 0 None -1 4 Human 8.4 pKi = 8.4 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 554 7 1 6 4.9 O=S(=O)(N[C@H]1CC[C@@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1ccc2c(c1)OCCO2 10.1016/j.bmcl.2007.04.098
3584 3748 64 None -2 14 Human 8.4 pKi = 8.4 Binding
In vitro binding affinity radioligandIn vitro binding affinity radioligand
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990200p
5401 3748 64 None -2 14 Human 8.4 pKi = 8.4 Binding
In vitro binding affinity radioligandIn vitro binding affinity radioligand
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990200p
7302 3748 64 None -2 14 Human 8.4 pKi = 8.4 Binding
In vitro binding affinity radioligandIn vitro binding affinity radioligand
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990200p
CHEMBL611 3748 64 None -2 14 Human 8.4 pKi = 8.4 Binding
In vitro binding affinity radioligandIn vitro binding affinity radioligand
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990200p
DB01162 3748 64 None -2 14 Human 8.4 pKi = 8.4 Binding
In vitro binding affinity radioligandIn vitro binding affinity radioligand
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990200p
44289525 165971 0 None -4 9 Human 8.4 pKi = 8.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 435 9 1 6 4.6 COc1cccc(OC)c1OCCNCC1Oc2ccccc2OC1c1ccc(C)cc1 10.1016/j.bmcl.2004.11.032
CHEMBL42539 165971 0 None -4 9 Human 8.4 pKi = 8.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 435 9 1 6 4.6 COc1cccc(OC)c1OCCNCC1Oc2ccccc2OC1c1ccc(C)cc1 10.1016/j.bmcl.2004.11.032
57402787 69166 0 None -1 5 Pig 8.4 pKi = 8.4 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 977 28 2 17 4.4 COc1ccccc1N1CCN(CCCNC(=O)c2cnn3ccc(OCCOCCOCCOCCOc4ccn5ncc(C(=O)NCCCN6CCN(c7ccccc7OC)CC6)c5c4)cc23)CC1 10.1016/j.bmc.2011.10.063
CHEMBL1926700 69166 0 None -1 5 Pig 8.4 pKi = 8.4 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 977 28 2 17 4.4 COc1ccccc1N1CCN(CCCNC(=O)c2cnn3ccc(OCCOCCOCCOCCOc4ccn5ncc(C(=O)NCCCN6CCN(c7ccccc7OC)CC6)c5c4)cc23)CC1 10.1016/j.bmc.2011.10.063
2142 3074 58 None -2 37 Human 8.4 pKi = 8.4 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1016/j.bmcl.2005.07.083
4920903 3074 58 None -2 37 Human 8.4 pKi = 8.4 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1016/j.bmcl.2005.07.083
502 3074 58 None -2 37 Human 8.4 pKi = 8.4 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1016/j.bmcl.2005.07.083
5775 3074 58 None -2 37 Human 8.4 pKi = 8.4 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1016/j.bmcl.2005.07.083
CHEMBL597 3074 58 None -2 37 Human 8.4 pKi = 8.4 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1016/j.bmcl.2005.07.083
DB00692 3074 58 None -2 37 Human 8.4 pKi = 8.4 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1016/j.bmcl.2005.07.083
10555134 40767 0 None 173 3 Human 8.4 pKi = 8.4 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 573 9 2 8 4.0 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(C)=O)C2c2ccc3c(c2)OCO3)CC1 10.1007/s00044-004-0120-9
CHEMBL148552 40767 0 None 173 3 Human 8.4 pKi = 8.4 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 573 9 2 8 4.0 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(C)=O)C2c2ccc3c(c2)OCO3)CC1 10.1007/s00044-004-0120-9
44428851 92289 0 None -8 4 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 447 4 1 7 3.5 COc1cc2nc(N3CCN(C(=O)c4ccccc4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2007.01.028
CHEMBL242934 92289 0 None -8 4 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 447 4 1 7 3.5 COc1cc2nc(N3CCN(C(=O)c4ccccc4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2007.01.028
491 192 9 None -50 12 Human 8.4 pKi = 8.4 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 10.1016/s0960-894x(01)00159-7
9891167 192 9 None -50 12 Human 8.4 pKi = 8.4 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 10.1016/s0960-894x(01)00159-7
CHEMBL13856 192 9 None -50 12 Human 8.4 pKi = 8.4 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 10.1016/s0960-894x(01)00159-7
10555134 40767 0 None 173 3 Human 8.4 pKi = 8.4 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 573 9 2 8 4.0 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(C)=O)C2c2ccc3c(c2)OCO3)CC1 10.1021/jm980506g
CHEMBL148552 40767 0 None 173 3 Human 8.4 pKi = 8.4 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 573 9 2 8 4.0 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(C)=O)C2c2ccc3c(c2)OCO3)CC1 10.1021/jm980506g
3584 3748 64 None -2 14 Human 8.4 pKi = 8.4 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
5401 3748 64 None -2 14 Human 8.4 pKi = 8.4 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
7302 3748 64 None -2 14 Human 8.4 pKi = 8.4 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
CHEMBL611 3748 64 None -2 14 Human 8.4 pKi = 8.4 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
DB01162 3748 64 None -2 14 Human 8.4 pKi = 8.4 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
10554745 37202 0 None 97 3 Human 8.4 pKi = 8.4 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 552 10 1 6 4.9 COC(=O)C1(c2ccccc2)CCN(CCCCCN2C(C)=NC(C)=C(C(N)=O)C2c2ccc(F)cc2F)CC1 10.1021/jm9902032
CHEMBL145353 37202 0 None 97 3 Human 8.4 pKi = 8.4 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 552 10 1 6 4.9 COC(=O)C1(c2ccccc2)CCN(CCCCCN2C(C)=NC(C)=C(C(N)=O)C2c2ccc(F)cc2F)CC1 10.1021/jm9902032
491 192 9 None -50 12 Human 8.4 pKi = 8.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 10.1016/j.bmcl.2004.11.032
9891167 192 9 None -50 12 Human 8.4 pKi = 8.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 10.1016/j.bmcl.2004.11.032
CHEMBL13856 192 9 None -50 12 Human 8.4 pKi = 8.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 10.1016/j.bmcl.2004.11.032
3584 3748 64 None -2 14 Human 8.4 pKi = 8.4 Binding
Compound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptorCompound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980053f
5401 3748 64 None -2 14 Human 8.4 pKi = 8.4 Binding
Compound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptorCompound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980053f
7302 3748 64 None -2 14 Human 8.4 pKi = 8.4 Binding
Compound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptorCompound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980053f
CHEMBL611 3748 64 None -2 14 Human 8.4 pKi = 8.4 Binding
Compound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptorCompound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980053f
DB01162 3748 64 None -2 14 Human 8.4 pKi = 8.4 Binding
Compound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptorCompound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980053f
57390119 69274 0 None 9 5 Pig 8.4 pKi = 8.4 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 969 33 2 14 5.4 COc1ccccc1N1CCN(CCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1 10.1016/j.bmc.2011.10.063
CHEMBL1928127 69274 0 None 9 5 Pig 8.4 pKi = 8.4 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 969 33 2 14 5.4 COc1ccccc1N1CCN(CCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1 10.1016/j.bmc.2011.10.063
10603030 207440 0 None 47 3 Human 8.4 pKi = 8.4 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 565 7 3 4 4.5 N#Cc1cc(F)ccc1C1CCN(CCCNC(=O)C2=C(C(F)(F)F)NC(=O)N[C@@H]2c2ccc(F)c(F)c2)CC1 10.1021/jm990612y
CHEMBL94259 207440 0 None 47 3 Human 8.4 pKi = 8.4 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 565 7 3 4 4.5 N#Cc1cc(F)ccc1C1CCN(CCCNC(=O)C2=C(C(F)(F)F)NC(=O)N[C@@H]2c2ccc(F)c(F)c2)CC1 10.1021/jm990612y
44362633 121521 0 None 95 3 Human 8.4 pKi = 8.4 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 597 9 3 6 3.9 CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCC(C)N2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990201h
CHEMBL358590 121521 0 None 95 3 Human 8.4 pKi = 8.4 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 597 9 3 6 3.9 CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCC(C)N2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990201h
10674133 163396 0 None 32 2 Human 8.4 pKi = 8.4 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 546 9 2 7 2.9 CCOc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2cccc(F)c2)C3=O)CC1 10.1021/jm9905918
CHEMBL419624 163396 0 None 32 2 Human 8.4 pKi = 8.4 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 546 9 2 7 2.9 CCOc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2cccc(F)c2)C3=O)CC1 10.1021/jm9905918
44428848 92265 0 None -17 4 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 453 4 1 8 3.6 COc1cc2nc(N3CCN(C(=O)c4cccs4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2007.01.028
CHEMBL242724 92265 0 None -17 4 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 453 4 1 8 3.6 COc1cc2nc(N3CCN(C(=O)c4cccs4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2007.01.028
134551 357 27 None -3 21 Rat 8.4 pKi = 8.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C nan
271 357 27 None -3 21 Rat 8.4 pKi = 8.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C nan
885 357 27 None -3 21 Rat 8.4 pKi = 8.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C nan
CHEMBL1403281 357 27 None -3 21 Rat 8.4 pKi = 8.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C nan
44431594 167386 0 None -1 4 Human 8.4 pKi = 8.4 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 532 9 1 8 3.8 COc1ccc([N+](=O)[O-])cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL429623 167386 0 None -1 4 Human 8.4 pKi = 8.4 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 532 9 1 8 3.8 COc1ccc([N+](=O)[O-])cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
136806211 207660 0 None 61 3 Human 8.4 pKi = 8.4 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 650 14 4 7 5.0 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(CCCCN)N1 10.1016/s0960-894x(99)00484-9
44328738 207660 0 None 61 3 Human 8.4 pKi = 8.4 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 650 14 4 7 5.0 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(CCCCN)N1 10.1016/s0960-894x(99)00484-9
CHEMBL95434 207660 0 None 61 3 Human 8.4 pKi = 8.4 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 650 14 4 7 5.0 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(CCCCN)N1 10.1016/s0960-894x(99)00484-9
9817640 99302 0 None 9 3 Human 8.4 pKi = 8.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 295 6 1 2 3.6 COc1ccc(CCNCC2CCc3ccccc3C2)cc1 10.1016/j.bmcl.2004.11.032
CHEMBL282214 99302 0 None 9 3 Human 8.4 pKi = 8.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 295 6 1 2 3.6 COc1ccc(CCNCC2CCc3ccccc3C2)cc1 10.1016/j.bmcl.2004.11.032
489 145 28 None -4 13 Bovine 8.4 pKi = 8.4 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm00018a001
5640 145 28 None -4 13 Bovine 8.4 pKi = 8.4 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm00018a001
CHEMBL420060 145 28 None -4 13 Bovine 8.4 pKi = 8.4 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm00018a001
10841387 99590 0 None 91 6 Human 8.4 pKi = 8.4 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 607 10 3 6 5.2 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
CHEMBL284103 99590 0 None 91 6 Human 8.4 pKi = 8.4 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 607 10 3 6 5.2 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
10841387 99590 0 None 91 6 Human 8.4 pKi = 8.4 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 607 10 3 6 5.2 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
CHEMBL284103 99590 0 None 91 6 Human 8.4 pKi = 8.4 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 607 10 3 6 5.2 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
73453 29585 24 None -6 17 Rat 8.4 pKi = 8.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 561 4 3 6 2.0 CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12 nan
CHEMBL1385840 29585 24 None -6 17 Rat 8.4 pKi = 8.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 561 4 3 6 2.0 CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12 nan
136680384 207632 0 None 104 6 Human 8.4 pKi = 8.4 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 694 16 4 8 4.9 CCNC(=O)C1=C(CC)NC(COCCN)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1016/s0960-894x(99)00484-9
44328799 207632 0 None 104 6 Human 8.4 pKi = 8.4 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 694 16 4 8 4.9 CCNC(=O)C1=C(CC)NC(COCCN)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1016/s0960-894x(99)00484-9
CHEMBL95290 207632 0 None 104 6 Human 8.4 pKi = 8.4 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 694 16 4 8 4.9 CCNC(=O)C1=C(CC)NC(COCCN)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1016/s0960-894x(99)00484-9
44431602 144916 0 None -6 4 Human 8.4 pKi = 8.4 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 525 7 1 5 5.2 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccc(Cl)cc3Cl)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL391035 144916 0 None -6 4 Human 8.4 pKi = 8.4 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 525 7 1 5 5.2 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccc(Cl)cc3Cl)CC2)CC1 10.1016/j.bmcl.2007.04.008
11857710 85591 0 None 10 4 Human 8.4 pKi = 8.4 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 518 8 1 5 5.4 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCC(c3ccccc3OC3CC3)CC2)CC1 10.1016/j.bmcl.2007.04.098
CHEMBL228279 85591 0 None 10 4 Human 8.4 pKi = 8.4 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 518 8 1 5 5.4 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCC(c3ccccc3OC3CC3)CC2)CC1 10.1016/j.bmcl.2007.04.098
10674791 38141 0 None 10 3 Human 8.4 pKi = 8.4 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 582 8 2 7 4.2 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(Cl)cc1 10.1021/jm990200p
CHEMBL146163 38141 0 None 10 3 Human 8.4 pKi = 8.4 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 582 8 2 7 4.2 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(Cl)cc1 10.1021/jm990200p
10674544 118765 0 None 331 3 Human 8.4 pKi = 8.4 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 568 6 2 7 3.5 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC3(CC2)C(=O)Oc2ccccc23)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL342111 118765 0 None 331 3 Human 8.4 pKi = 8.4 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 568 6 2 7 3.5 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC3(CC2)C(=O)Oc2ccccc23)C1c1ccc(F)c(F)c1 10.1021/jm990201h
44417713 12390 0 None 2 8 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL1185884 12390 0 None 2 8 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL439346 12390 0 None 2 8 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
118716714 114982 0 None 1 4 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 501 6 0 7 2.7 COc1ccccc1N1CCN(CC2COC3(CCN(S(=O)(=O)c4ccc(C)cc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342867 114982 0 None 1 4 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 501 6 0 7 2.7 COc1ccccc1N1CCN(CC2COC3(CCN(S(=O)(=O)c4ccc(C)cc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
56837634 69277 0 None -10 5 Pig 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 1041 38 2 15 6.2 COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1 10.1016/j.bmc.2011.10.063
CHEMBL1928130 69277 0 None -10 5 Pig 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 1041 38 2 15 6.2 COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1 10.1016/j.bmc.2011.10.063
44362867 37617 0 None 165 3 Human 8.3 pKi = 8.3 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 658 8 2 5 6.9 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(c3cc(C)cc(C)c3)(c3cc(C)cc(C)c3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL145719 37617 0 None 165 3 Human 8.3 pKi = 8.3 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 658 8 2 5 6.9 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(c3cc(C)cc(C)c3)(c3cc(C)cc(C)c3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
2142 3074 58 None -2 37 Rat 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
4920903 3074 58 None -2 37 Rat 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
502 3074 58 None -2 37 Rat 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
5775 3074 58 None -2 37 Rat 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
CHEMBL597 3074 58 None -2 37 Rat 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
DB00692 3074 58 None -2 37 Rat 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
44312563 204897 2 None -3 7 Rat 8.3 pKi = 8.3 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampus (+ 10 uM) CES membrane using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampus (+ 10 uM) CES membrane using [3H]prazosin as radioligand
ChEMBL 401 7 1 8 1.0 COc1ccc(C)cc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1 10.1021/jm960069a
CHEMBL76168 204897 2 None -3 7 Rat 8.3 pKi = 8.3 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampus (+ 10 uM) CES membrane using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampus (+ 10 uM) CES membrane using [3H]prazosin as radioligand
ChEMBL 401 7 1 8 1.0 COc1ccc(C)cc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1 10.1021/jm960069a
463 1393 22 None 5 13 Human 8.3 pKi = 8.3 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00010a001
6918097 1393 22 None 5 13 Human 8.3 pKi = 8.3 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00010a001
837 1393 22 None 5 13 Human 8.3 pKi = 8.3 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00010a001
CHEMBL2051956 1393 22 None 5 13 Human 8.3 pKi = 8.3 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00010a001
DB14068 1393 22 None 5 13 Human 8.3 pKi = 8.3 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00010a001
44299835 198379 0 None 61 3 Human 8.3 pKi = 8.3 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 583 7 2 7 4.0 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccn4)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
CHEMBL57691 198379 0 None 61 3 Human 8.3 pKi = 8.3 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 583 7 2 7 4.0 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccn4)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
56961507 121416 0 None 1 3 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 678 6 4 11 5.0 COc1cc2nc(N3CCN(C(=S)Nc4ccc(-c5c6ccc(=O)cc-6oc6cc(O)ccc56)c(C(=O)O)c4)CC3)nc(N)c2cc1OC 10.1021/ml5004298
CHEMBL3582271 121416 0 None 1 3 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 678 6 4 11 5.0 COc1cc2nc(N3CCN(C(=S)Nc4ccc(-c5c6ccc(=O)cc-6oc6cc(O)ccc56)c(C(=O)O)c4)CC3)nc(N)c2cc1OC 10.1021/ml5004298
10554492 168543 0 None -1 3 Rat 8.3 pKi = 8.3 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 505 5 1 8 3.4 COC(=O)c1ccc2sc3c(=O)n(CCN4C[C@@H]5CCc6c(OC)cccc6[C@@H]5C4)c(=O)[nH]c3c2c1 10.1021/jm990567u
CHEMBL43573 168543 0 None -1 3 Rat 8.3 pKi = 8.3 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 505 5 1 8 3.4 COC(=O)c1ccc2sc3c(=O)n(CCN4C[C@@H]5CCc6c(OC)cccc6[C@@H]5C4)c(=O)[nH]c3c2c1 10.1021/jm990567u
44294569 101992 0 None -5 4 Human 8.3 pKi = 8.3 Binding
The compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cellsThe compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 447 7 1 8 2.5 COc1ccccc1N1CCN(CCn2nc(-c3ccccc3)c(C(C)=O)c(N)c2=O)CC1 10.1021/jm981006q
CHEMBL301726 101992 0 None -5 4 Human 8.3 pKi = 8.3 Binding
The compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cellsThe compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 447 7 1 8 2.5 COc1ccccc1N1CCN(CCn2nc(-c3ccccc3)c(C(C)=O)c(N)c2=O)CC1 10.1021/jm981006q
10532044 85254 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 629 12 2 10 4.0 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(=O)OCCC#N)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1007/s00044-004-0120-9
136901434 85254 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 629 12 2 10 4.0 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(=O)OCCC#N)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1007/s00044-004-0120-9
CHEMBL2260361 85254 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 629 12 2 10 4.0 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(=O)OCCC#N)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1007/s00044-004-0120-9
10603688 121120 0 None 645 3 Human 8.3 pKi = 8.3 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 603 11 3 8 3.7 CCNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
CHEMBL357681 121120 0 None 645 3 Human 8.3 pKi = 8.3 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 603 11 3 8 3.7 CCNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
CHEMBL151825 44345 0 None 109 3 Human 8.3 pKi = 8.3 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 629 12 2 10 4.8 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)N=C(C)/C(=C(/O)OCCC#N)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
136680386 207680 0 None 60 6 Human 8.3 pKi = 8.3 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 680 16 4 8 4.6 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCCN)N1 10.1016/s0960-894x(99)00484-9
44328801 207680 0 None 60 6 Human 8.3 pKi = 8.3 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 680 16 4 8 4.6 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCCN)N1 10.1016/s0960-894x(99)00484-9
CHEMBL95578 207680 0 None 60 6 Human 8.3 pKi = 8.3 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 680 16 4 8 4.6 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCCN)N1 10.1016/s0960-894x(99)00484-9
44431555 89133 0 None -1 4 Human 8.3 pKi = 8.3 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 535 8 1 7 3.3 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccc(S(C)(=O)=O)cc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL236617 89133 0 None -1 4 Human 8.3 pKi = 8.3 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 535 8 1 7 3.3 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccc(S(C)(=O)=O)cc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
11857793 85629 0 None 7 4 Human 8.3 pKi = 8.3 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 548 7 1 4 5.9 O=S(=O)(N[C@H]1CC[C@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1cc(Cl)ccc1F 10.1016/j.bmcl.2007.04.098
CHEMBL228494 85629 0 None 7 4 Human 8.3 pKi = 8.3 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 548 7 1 4 5.9 O=S(=O)(N[C@H]1CC[C@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1cc(Cl)ccc1F 10.1016/j.bmcl.2007.04.098
44273916 98801 0 None 1 3 Human 8.3 pKi = 8.3 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 608 7 2 8 3.4 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@H]2CC[C@H](N3CCN(c4ccccc4C#N)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
CHEMBL278716 98801 0 None 1 3 Human 8.3 pKi = 8.3 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 608 7 2 8 3.4 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@H]2CC[C@H](N3CCN(c4ccccc4C#N)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
10603688 121120 0 None 645 3 Human 8.3 pKi = 8.3 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 603 11 3 8 3.7 CCNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980506g
CHEMBL357681 121120 0 None 645 3 Human 8.3 pKi = 8.3 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 603 11 3 8 3.7 CCNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980506g
10154 142104 59 None 58 4 Rat 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from adrenergic alpha1A receptor in rat brain membraneDisplacement of [3H]prazosin from adrenergic alpha1A receptor in rat brain membrane
ChEMBL 327 2 2 5 2.9 COc1cc2c(cc1O)C[C@H]1c3c(cc(O)c(OC)c3-2)CCN1C 10.1021/np990433j
CHEMBL388342 142104 59 None 58 4 Rat 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from adrenergic alpha1A receptor in rat brain membraneDisplacement of [3H]prazosin from adrenergic alpha1A receptor in rat brain membrane
ChEMBL 327 2 2 5 2.9 COc1cc2c(cc1O)C[C@H]1c3c(cc(O)c(OC)c3-2)CCN1C 10.1021/np990433j
44431618 87037 0 None 1 4 Human 8.3 pKi = 8.3 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 488 8 1 7 3.3 COc1ccncc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL232607 87037 0 None 1 4 Human 8.3 pKi = 8.3 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 488 8 1 7 3.3 COc1ccncc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
10627329 37413 0 None 8 3 Human 8.3 pKi = 8.3 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 595 7 2 6 4.4 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3cccc(C(F)(F)F)c3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL145525 37413 0 None 8 3 Human 8.3 pKi = 8.3 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 595 7 2 6 4.4 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3cccc(C(F)(F)F)c3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
10091187 78795 1 None -23 6 Human 8.3 pKi = 8.3 Binding
Binding affinity was determined on human cloned Alpha-1A adrenoceptorBinding affinity was determined on human cloned Alpha-1A adrenoceptor
ChEMBL 380 5 0 4 4.6 COc1cccc(C2CCC(N3CCN(c4ccccc4OC)CC3)CC2)c1 10.1021/jm010866v
CHEMBL2112779 78795 1 None -23 6 Human 8.3 pKi = 8.3 Binding
Binding affinity was determined on human cloned Alpha-1A adrenoceptorBinding affinity was determined on human cloned Alpha-1A adrenoceptor
ChEMBL 380 5 0 4 4.6 COc1cccc(C2CCC(N3CCN(c4ccccc4OC)CC3)CC2)c1 10.1021/jm010866v
10430183 205605 0 None -398 7 Human 7.4 pKi = 7.4 Binding
Binding affinity to human alpha 1A adrenergic receptor expressed in CHO cells assessed as inhibition constantBinding affinity to human alpha 1A adrenergic receptor expressed in CHO cells assessed as inhibition constant
ChEMBL 385 5 1 5 2.1 O=C(NCCN1CCN(c2cccc3c2OCCO3)CC1)c1ccc(F)cc1 10.1021/acs.jmedchem.2c00633
CHEMBL81728 205605 0 None -398 7 Human 7.4 pKi = 7.4 Binding
Binding affinity to human alpha 1A adrenergic receptor expressed in CHO cells assessed as inhibition constantBinding affinity to human alpha 1A adrenergic receptor expressed in CHO cells assessed as inhibition constant
ChEMBL 385 5 1 5 2.1 O=C(NCCN1CCN(c2cccc3c2OCCO3)CC1)c1ccc(F)cc1 10.1021/acs.jmedchem.2c00633
2398 951 62 None -4 29 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C nan
2801 951 62 None -4 29 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C nan
701 951 62 None -4 29 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C nan
CHEMBL415 951 62 None -4 29 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C nan
DB01242 951 62 None -4 29 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C nan
12134996 204064 0 None -1 2 Human 7.4 pKi = 7.4 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 385 6 0 5 3.2 COc1ccccc1N1CCN(Cc2ccc(CN3CCCC3=O)s2)CC1 10.1016/s0960-894x(02)00347-5
CHEMBL70178 204064 0 None -1 2 Human 7.4 pKi = 7.4 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 385 6 0 5 3.2 COc1ccccc1N1CCN(Cc2ccc(CN3CCCC3=O)s2)CC1 10.1016/s0960-894x(02)00347-5
11520239 3605 11 None -144 4 Human 7.4 pKi = 7.4 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptor
ChEMBL 613 10 3 7 4.0 COCC1=C(C(=O)OC)[C@@H](N(C(=O)N1)C(=O)NCCCN1CCC(CC1)c1cccc(c1)NC(=O)C)c1ccc(c(c1)F)F 10.1021/jm060383x
1313 3605 11 None -144 4 Human 7.4 pKi = 7.4 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptor
ChEMBL 613 10 3 7 4.0 COCC1=C(C(=O)OC)[C@@H](N(C(=O)N1)C(=O)NCCCN1CCC(CC1)c1cccc(c1)NC(=O)C)c1ccc(c(c1)F)F 10.1021/jm060383x
CHEMBL185271 3605 11 None -144 4 Human 7.4 pKi = 7.4 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptor
ChEMBL 613 10 3 7 4.0 COCC1=C(C(=O)OC)[C@@H](N(C(=O)N1)C(=O)NCCCN1CCC(CC1)c1cccc(c1)NC(=O)C)c1ccc(c(c1)F)F 10.1021/jm060383x
49865641 16003 0 None -3 3 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 338 7 1 4 3.7 Cc1cccc(N2CCN(CCCCNc3ccccn3)CC2)c1C 10.1016/j.bmcl.2010.07.096
CHEMBL1223682 16003 0 None -3 3 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 338 7 1 4 3.7 Cc1cccc(N2CCN(CCCCNc3ccccn3)CC2)c1C 10.1016/j.bmcl.2010.07.096
10320782 99949 0 None -4 7 Rat 7.4 pKi = 7.4 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligand
ChEMBL 435 9 1 6 4.6 COc1cccc(OC)c1OCCNC[C@H]1Oc2ccccc2O[C@@H]1c1ccc(C)cc1 10.1021/jm960069a
CHEMBL286565 99949 0 None -4 7 Rat 7.4 pKi = 7.4 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligand
ChEMBL 435 9 1 6 4.6 COc1cccc(OC)c1OCCNC[C@H]1Oc2ccccc2O[C@@H]1c1ccc(C)cc1 10.1021/jm960069a
46934645 16655 0 None -2 4 Human 7.4 pKi = 7.4 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 465 7 0 7 2.2 COc1ccccc1N1CCN(C[C@@H]2CO[C@@](CN3C(=O)CCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
CHEMBL1242725 16655 0 None -2 4 Human 7.4 pKi = 7.4 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 465 7 0 7 2.2 COc1ccccc1N1CCN(C[C@@H]2CO[C@@](CN3C(=O)CCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
15166842 98832 23 None - 1 Bovine 5.4 pKi = 5.4 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 160 1 1 2 1.5 C1=C(c2ccccn2)CCNC1 10.1021/jm00375a017
CHEMBL278934 98832 23 None - 1 Bovine 5.4 pKi = 5.4 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 160 1 1 2 1.5 C1=C(c2ccccn2)CCNC1 10.1021/jm00375a017
9823115 198580 0 None -2041 5 Human 6.4 pKi = 6.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 414 4 0 5 3.0 N#Cc1ccc(Cl)cc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1007/s00044-010-9379-1
CHEMBL57868 198580 0 None -2041 5 Human 6.4 pKi = 6.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 414 4 0 5 3.0 N#Cc1ccc(Cl)cc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1007/s00044-010-9379-1
76311538 84799 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 299 6 1 4 2.8 c1ccc(OCCN[C@H]2COC[C@H](c3ccccc3)O2)cc1 10.1007/s00044-010-9379-1
CHEMBL2234453 84799 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 299 6 1 4 2.8 c1ccc(OCCN[C@H]2COC[C@H](c3ccccc3)O2)cc1 10.1007/s00044-010-9379-1
9823115 198580 0 None -2041 5 Human 6.4 pKi = 6.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 414 4 0 5 3.0 N#Cc1ccc(Cl)cc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1007/s00044-010-9379-1
CHEMBL57868 198580 0 None -2041 5 Human 6.4 pKi = 6.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 414 4 0 5 3.0 N#Cc1ccc(Cl)cc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1007/s00044-010-9379-1
25132565 187247 0 None -7 3 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 313 7 1 4 2.8 c1ccc(OCCNC[C@@H]2COC[C@@H](c3ccccc3)O2)cc1 10.1021/jm800461k
CHEMBL492785 187247 0 None -7 3 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 313 7 1 4 2.8 c1ccc(OCCNC[C@@H]2COC[C@@H](c3ccccc3)O2)cc1 10.1021/jm800461k
22629308 64277 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 425 3 2 5 3.6 N=C(Nc1ccccc1)N1CCN(/C=C2/N=C(c3cccc4ccccc34)OC2=O)CC1 10.1016/j.bmcl.2004.11.032
CHEMBL181071 64277 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 425 3 2 5 3.6 N=C(Nc1ccccc1)N1CCN(/C=C2/N=C(c3cccc4ccccc34)OC2=O)CC1 10.1016/j.bmcl.2004.11.032
9865254 68646 0 None -512 6 Human 5.4 pKi = 5.4 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 391 4 0 4 2.8 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccc(F)c(F)c2)CC1 10.1021/jm0491391
CHEMBL192099 68646 0 None -512 6 Human 5.4 pKi = 5.4 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 391 4 0 4 2.8 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccc(F)c(F)c2)CC1 10.1021/jm0491391
11948707 166143 0 None -128 13 Human 6.4 pKi = 6.4 Binding
Binding affinity to alpha 1A adrenergic receptor by radioligand binding assayBinding affinity to alpha 1A adrenergic receptor by radioligand binding assay
ChEMBL 373 7 0 8 0.6 COc1cccc(N2CCN(CCCCn3ncc(=O)n(C)c3=O)CC2)c1 10.1016/j.bmcl.2006.01.052
CHEMBL426317 166143 0 None -128 13 Human 6.4 pKi = 6.4 Binding
Binding affinity to alpha 1A adrenergic receptor by radioligand binding assayBinding affinity to alpha 1A adrenergic receptor by radioligand binding assay
ChEMBL 373 7 0 8 0.6 COc1cccc(N2CCN(CCCCn3ncc(=O)n(C)c3=O)CC2)c1 10.1016/j.bmcl.2006.01.052
11395842 100663 0 None -21 3 Rat 6.4 pKi = 6.4 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 412 7 0 4 4.0 CN(CCOc1cc(Cl)ccc1Cl)CCN1C(=O)CC2(CCCC2)CC1=O 10.1021/jm030944+
CHEMBL292399 100663 0 None -21 3 Rat 6.4 pKi = 6.4 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 412 7 0 4 4.0 CN(CCOc1cc(Cl)ccc1Cl)CCN1C(=O)CC2(CCCC2)CC1=O 10.1021/jm030944+
11058166 204682 0 None -1 5 Human 6.4 pKi = 6.4 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1cccc(F)c1NCC1=NCCN1 10.1021/jm000542r
CHEMBL74114 204682 0 None -1 5 Human 6.4 pKi = 6.4 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1cccc(F)c1NCC1=NCCN1 10.1021/jm000542r
52942591 17580 0 None 4 3 Rat 6.4 pKi = 6.4 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 542 9 1 7 2.6 COC(=O)CN1C(=O)N(CC(O)CN2CCN(c3ccccc3)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
CHEMBL1258228 17580 0 None 4 3 Rat 6.4 pKi = 6.4 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 542 9 1 7 2.6 COC(=O)CN1C(=O)N(CC(O)CN2CCN(c3ccccc3)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
12039032 98234 0 None 14 3 Human 6.4 pKi = 6.4 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 415 9 0 6 2.1 CC(C)Oc1ccccc1N1CCN(CC(=O)CC(=O)CN2CCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
CHEMBL274529 98234 0 None 14 3 Human 6.4 pKi = 6.4 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 415 9 0 6 2.1 CC(C)Oc1ccccc1N1CCN(CC(=O)CC(=O)CN2CCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
127025279 137630 0 None -3 2 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 347 9 1 4 2.8 COc1ccccc1N1CCN(CCCCNC(=O)CC(C)C)CC1 10.1016/j.bmcl.2015.12.068
CHEMBL3758403 137630 0 None -3 2 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 347 9 1 4 2.8 COc1ccccc1N1CCN(CCCCNC(=O)CC(C)C)CC1 10.1016/j.bmcl.2015.12.068
44308654 203561 0 None -3 3 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 401 6 1 6 3.4 COc1ccccc1N1CCN(Cc2ccc(CN3CCCCC3O)s2)CC1 10.1016/s0960-894x(02)00347-5
CHEMBL66823 203561 0 None -3 3 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 401 6 1 6 3.4 COc1ccccc1N1CCN(Cc2ccc(CN3CCCCC3O)s2)CC1 10.1016/s0960-894x(02)00347-5
9822814 101922 0 None -346 5 Human 7.4 pKi = 7.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 409 4 0 3 4.3 O=C1CC2(CCCC2)CCN1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1016/j.bmcl.2004.11.032
CHEMBL301224 101922 0 None -346 5 Human 7.4 pKi = 7.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 409 4 0 3 4.3 O=C1CC2(CCCC2)CCN1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1016/j.bmcl.2004.11.032
11589069 96218 0 None -25 8 Human 7.4 pKi = 7.4 Binding
Inhibition of adrenergic alpha-1 receptorInhibition of adrenergic alpha-1 receptor
ChEMBL 383 6 1 3 4.4 O=C1Nc2ccccc2C1CCCCN1CCN(c2ccc(Cl)cc2)CC1 10.1021/jm070279v
CHEMBL260994 96218 0 None -25 8 Human 7.4 pKi = 7.4 Binding
Inhibition of adrenergic alpha-1 receptorInhibition of adrenergic alpha-1 receptor
ChEMBL 383 6 1 3 4.4 O=C1Nc2ccccc2C1CCCCN1CCN(c2ccc(Cl)cc2)CC1 10.1021/jm070279v
9822814 101922 0 None -389 5 Rat 7.4 pKi = 7.4 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 409 4 0 3 4.3 O=C1CC2(CCCC2)CCN1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
CHEMBL301224 101922 0 None -389 5 Rat 7.4 pKi = 7.4 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 409 4 0 3 4.3 O=C1CC2(CCCC2)CCN1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
2419 692 28 None -288 12 Human 7.4 pKi = 7.4 Binding
Binding affinity to adrenergic alpha1A receptorBinding affinity to adrenergic alpha1A receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/j.ejmech.2011.03.054
9 692 28 None -288 12 Human 7.4 pKi = 7.4 Binding
Binding affinity to adrenergic alpha1A receptorBinding affinity to adrenergic alpha1A receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/j.ejmech.2011.03.054
CHEMBL13647 692 28 None -288 12 Human 7.4 pKi = 7.4 Binding
Binding affinity to adrenergic alpha1A receptorBinding affinity to adrenergic alpha1A receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/j.ejmech.2011.03.054
506 2239 39 None -81 6 Human 6.4 pKi = 6.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 522 6 2 9 3.0 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H](C1)C(=O)NC(C)(C)C)C(=O)OCc1ccccc1 10.1016/j.bmcl.2004.11.032
6603904 2239 39 None -81 6 Human 6.4 pKi = 6.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 522 6 2 9 3.0 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H](C1)C(=O)NC(C)(C)C)C(=O)OCc1ccccc1 10.1016/j.bmcl.2004.11.032
CHEMBL19476 2239 39 None -81 6 Human 6.4 pKi = 6.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 522 6 2 9 3.0 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H](C1)C(=O)NC(C)(C)C)C(=O)OCc1ccccc1 10.1016/j.bmcl.2004.11.032
506 2239 39 None -81 6 Human 6.4 pKi = 6.4 Binding
Compound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptorCompound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor
ChEMBL 522 6 2 9 3.0 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H](C1)C(=O)NC(C)(C)C)C(=O)OCc1ccccc1 10.1021/jm980053f
6603904 2239 39 None -81 6 Human 6.4 pKi = 6.4 Binding
Compound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptorCompound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor
ChEMBL 522 6 2 9 3.0 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H](C1)C(=O)NC(C)(C)C)C(=O)OCc1ccccc1 10.1021/jm980053f
CHEMBL19476 2239 39 None -81 6 Human 6.4 pKi = 6.4 Binding
Compound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptorCompound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor
ChEMBL 522 6 2 9 3.0 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H](C1)C(=O)NC(C)(C)C)C(=O)OCc1ccccc1 10.1021/jm980053f
11315660 167964 0 None -144 4 Rat 6.4 pKi = 6.4 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 403 4 0 4 3.6 O=C1CC2(CCCCC2)CC(=O)N1CCN1CCN(c2ccccc2Cl)CC1 10.1021/jm030944+
CHEMBL431943 167964 0 None -144 4 Rat 6.4 pKi = 6.4 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 403 4 0 4 3.6 O=C1CC2(CCCCC2)CC(=O)N1CCN1CCN(c2ccccc2Cl)CC1 10.1021/jm030944+
155529118 176540 0 None -37 4 Human 6.4 pKi = 6.4 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 389 9 1 4 4.2 c1ccc(OCCNC[C@@H]2CO[C@H](C(c3ccccc3)c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
CHEMBL4462768 176540 0 None -37 4 Human 6.4 pKi = 6.4 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 389 9 1 4 4.2 c1ccc(OCCNC[C@@H]2CO[C@H](C(c3ccccc3)c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
CHEMBL4597358 176540 0 None -37 4 Human 6.4 pKi = 6.4 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 389 9 1 4 4.2 c1ccc(OCCNC[C@@H]2CO[C@H](C(c3ccccc3)c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
44420418 83401 0 None -13 3 Human 5.4 pKi = 5.4 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 474 4 1 6 4.0 O=c1[nH]c2c(sc3ccccc32)c(=O)n1CCN1CCN(c2ccc(Cl)c(Cl)c2)CC1 10.1016/j.bmcl.2006.09.034
CHEMBL219718 83401 0 None -13 3 Human 5.4 pKi = 5.4 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 474 4 1 6 4.0 O=c1[nH]c2c(sc3ccccc32)c(=O)n1CCN1CCN(c2ccc(Cl)c(Cl)c2)CC1 10.1016/j.bmcl.2006.09.034
135 2515 43 None -9 58 Bovine 7.4 pKi = 7.4 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm00366a007
1796 2515 43 None -9 58 Bovine 7.4 pKi = 7.4 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm00366a007
4184 2515 43 None -9 58 Bovine 7.4 pKi = 7.4 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm00366a007
CHEMBL6437 2515 43 None -9 58 Bovine 7.4 pKi = 7.4 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm00366a007
DB06148 2515 43 None -9 58 Bovine 7.4 pKi = 7.4 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm00366a007
11857864 144224 0 None 1 4 Human 7.4 pKi = 7.4 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 534 9 1 6 5.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4cc(F)ccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
CHEMBL390473 144224 0 None 1 4 Human 7.4 pKi = 7.4 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 534 9 1 6 5.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4cc(F)ccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
2419 692 28 None -52 12 Bovine 7.4 pKi = 7.4 Binding
Binding affinity towards bovine Alpha-1A adrenergic receptorBinding affinity towards bovine Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/s0960-894x(01)00159-7
9 692 28 None -52 12 Bovine 7.4 pKi = 7.4 Binding
Binding affinity towards bovine Alpha-1A adrenergic receptorBinding affinity towards bovine Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/s0960-894x(01)00159-7
CHEMBL13647 692 28 None -52 12 Bovine 7.4 pKi = 7.4 Binding
Binding affinity towards bovine Alpha-1A adrenergic receptorBinding affinity towards bovine Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/s0960-894x(01)00159-7
3158 56237 27 None -295 20 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 nan
CHEMBL1628227 56237 27 None -295 20 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 nan
135 2515 43 None -9 58 Bovine 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm00375a017
1796 2515 43 None -9 58 Bovine 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm00375a017
4184 2515 43 None -9 58 Bovine 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm00375a017
CHEMBL6437 2515 43 None -9 58 Bovine 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm00375a017
DB06148 2515 43 None -9 58 Bovine 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm00375a017
11372228 101640 0 None -51 5 Human 7.4 pKi = 7.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 373 4 0 3 3.8 O=C1CC2(C=CN1CCN1CCN(c3ccccc3Cl)CC1)CCCC2 10.1007/s00044-010-9379-1
CHEMBL299253 101640 0 None -51 5 Human 7.4 pKi = 7.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 373 4 0 3 3.8 O=C1CC2(C=CN1CCN1CCN(c3ccccc3Cl)CC1)CCCC2 10.1007/s00044-010-9379-1
11108001 10840 2 None -3 6 Human 7.4 pKi = 7.4 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 221 4 2 4 1.8 CSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL117248 10840 2 None -3 6 Human 7.4 pKi = 7.4 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 221 4 2 4 1.8 CSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL540542 10840 2 None -3 6 Human 7.4 pKi = 7.4 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 221 4 2 4 1.8 CSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
11000184 13020 0 None 1 6 Human 7.4 pKi = 7.4 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 235 5 2 4 2.2 CCSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL1190038 13020 0 None 1 6 Human 7.4 pKi = 7.4 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 235 5 2 4 2.2 CCSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL540035 13020 0 None 1 6 Human 7.4 pKi = 7.4 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 235 5 2 4 2.2 CCSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
11372228 101640 0 None -51 5 Human 7.4 pKi = 7.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 373 4 0 3 3.8 O=C1CC2(C=CN1CCN1CCN(c3ccccc3Cl)CC1)CCCC2 10.1007/s00044-010-9379-1
CHEMBL299253 101640 0 None -51 5 Human 7.4 pKi = 7.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 373 4 0 3 3.8 O=C1CC2(C=CN1CCN1CCN(c3ccccc3Cl)CC1)CCCC2 10.1007/s00044-010-9379-1
9802999 195651 0 None -2 3 Rat 7.4 pKi = 7.4 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 434 5 0 6 3.1 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc([N+](=O)[O-])ccc2Cl)CC1 10.1021/jm030944+
CHEMBL55655 195651 0 None -2 3 Rat 7.4 pKi = 7.4 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 434 5 0 6 3.1 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc([N+](=O)[O-])ccc2Cl)CC1 10.1021/jm030944+
197001 63317 20 None - 1 Human 6.4 pKi = 6.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 339 2 0 5 3.2 COc1cc2c3c(c1OC)-c1cc4c(cc1C[C@@H]3N(C)CC2)OCO4 10.1016/j.bmcl.2004.11.032
CHEMBL179440 63317 20 None - 1 Human 6.4 pKi = 6.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 339 2 0 5 3.2 COc1cc2c3c(c1OC)-c1cc4c(cc1C[C@@H]3N(C)CC2)OCO4 10.1016/j.bmcl.2004.11.032
10840781 36903 0 None 3 3 Human 6.4 pKi = 6.4 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 569 8 2 7 3.6 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccc(C(C)=O)cc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL145122 36903 0 None 3 3 Human 6.4 pKi = 6.4 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 569 8 2 7 3.6 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccc(C(C)=O)cc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
44292470 101608 5 None -57 2 Bovine 5.4 pKi = 5.4 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 211 1 1 3 1.5 Cc1ccnc(N2CCNCC2)c1Cl 10.1021/jm00366a007
CHEMBL299007 101608 5 None -57 2 Bovine 5.4 pKi = 5.4 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 211 1 1 3 1.5 Cc1ccnc(N2CCNCC2)c1Cl 10.1021/jm00366a007
10646816 43351 0 None 7 3 Human 5.4 pKi = 5.4 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 441 8 3 6 2.3 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCCCC2)=C(C)N1 10.1021/jm980506g
CHEMBL150743 43351 0 None 7 3 Human 5.4 pKi = 5.4 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 441 8 3 6 2.3 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCCCC2)=C(C)N1 10.1021/jm980506g
2419 692 28 None -288 12 Human 6.4 pKi = 6.4 Binding
Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm9810654
9 692 28 None -288 12 Human 6.4 pKi = 6.4 Binding
Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm9810654
CHEMBL13647 692 28 None -288 12 Human 6.4 pKi = 6.4 Binding
Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm9810654
71817857 92096 0 None 3 4 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 354 7 2 5 3.0 COc1ccc2cc[nH]c2c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm400867d
CHEMBL2419766 92096 0 None 3 4 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 354 7 2 5 3.0 COc1ccc2cc[nH]c2c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm400867d
25130876 192601 0 None -125 4 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 343 8 1 5 2.8 COc1ccccc1OCCNC[C@@H]1CO[C@H](c2ccccc2)CO1 10.1021/jm800461k
CHEMBL521665 192601 0 None -125 4 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 343 8 1 5 2.8 COc1ccccc1OCCNC[C@@H]1CO[C@H](c2ccccc2)CO1 10.1021/jm800461k
10236758 115746 5 None -446 13 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human recombinant alpha-1A adrenergic receptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from human recombinant alpha-1A adrenergic receptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 328 7 0 2 4.3 CCCCC1CCN(CCCN2C(=O)CCc3ccccc32)CC1 10.1021/acs.jmedchem.8b00265
CHEMBL3354065 115746 5 None -446 13 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human recombinant alpha-1A adrenergic receptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from human recombinant alpha-1A adrenergic receptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 328 7 0 2 4.3 CCCCC1CCN(CCCN2C(=O)CCc3ccccc32)CC1 10.1021/acs.jmedchem.8b00265
71521480 86232 0 None -1096 4 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 389 8 1 4 4.0 c1ccc(OCCNC[C@H]2COCC(c3ccccc3)(c3ccccc3)O2)cc1 10.1021/jm301525w
CHEMBL2312538 86232 0 None -1096 4 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 389 8 1 4 4.0 c1ccc(OCCNC[C@H]2COCC(c3ccccc3)(c3ccccc3)O2)cc1 10.1021/jm301525w
44462130 205309 0 None 45 3 Human 7.4 pKi = 7.4 Binding
Binding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assayBinding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assay
ChEMBL 490 7 0 6 3.5 COC(=O)C1(c2ccccc2)CCN(CCCCN2C(=O)c3cc(Cl)ccc3S2(=O)=O)CC1 10.1016/s0960-894x(98)00451-x
CHEMBL79532 205309 0 None 45 3 Human 7.4 pKi = 7.4 Binding
Binding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assayBinding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assay
ChEMBL 490 7 0 6 3.5 COC(=O)C1(c2ccccc2)CCN(CCCCN2C(=O)c3cc(Cl)ccc3S2(=O)=O)CC1 10.1016/s0960-894x(98)00451-x
13141185 60458 0 None 9 2 Bovine 7.4 pKi = 7.4 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 356 0 0 2 4.3 CN1CCC(=C2c3cc(Br)ccc3CCn3cccc32)CC1 10.1021/jm00361a008
CHEMBL175508 60458 0 None 9 2 Bovine 7.4 pKi = 7.4 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 356 0 0 2 4.3 CN1CCC(=C2c3cc(Br)ccc3CCn3cccc32)CC1 10.1021/jm00361a008
155533100 176320 0 None -6 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 377 11 1 4 4.5 COc1ccccc1OCCNCCOC(c1ccccc1)c1ccccc1 10.1016/j.ejmech.2019.05.024
CHEMBL4468507 176320 0 None -6 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 377 11 1 4 4.5 COc1ccccc1OCCNCCOC(c1ccccc1)c1ccccc1 10.1016/j.ejmech.2019.05.024
CHEMBL4595564 176320 0 None -6 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 377 11 1 4 4.5 COc1ccccc1OCCNCCOC(c1ccccc1)c1ccccc1 10.1016/j.ejmech.2019.05.024
56945167 71486 0 None -56 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 442 6 1 4 4.6 COc1ccccc1N1CCN(C[C@H]2CCC(c3ccccc3)(c3ccccc3)[C@@H]2O)CC1 10.1021/jm200421e
CHEMBL1946788 71486 0 None -56 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 442 6 1 4 4.6 COc1ccccc1N1CCN(C[C@H]2CCC(c3ccccc3)(c3ccccc3)[C@@H]2O)CC1 10.1021/jm200421e
CHEMBL1962757 71486 0 None -56 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 442 6 1 4 4.6 COc1ccccc1N1CCN(C[C@H]2CCC(c3ccccc3)(c3ccccc3)[C@@H]2O)CC1 10.1021/jm200421e
12488 1644 56 None -77 23 Rat 6.4 pKi = 6.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F nan
941361 1644 56 None -77 23 Rat 6.4 pKi = 6.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F nan
CHEMBL30008 1644 56 None -77 23 Rat 6.4 pKi = 6.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F nan
DB04841 1644 56 None -77 23 Rat 6.4 pKi = 6.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F nan
9931327 69781 1 None -2290 6 Human 5.4 pKi = 5.4 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 409 4 0 4 2.9 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(F)c(F)cc2F)CC1 10.1021/jm0491391
CHEMBL193620 69781 1 None -2290 6 Human 5.4 pKi = 5.4 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 409 4 0 4 2.9 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(F)c(F)cc2F)CC1 10.1021/jm0491391
136 3267 32 None -6918 16 Human 5.4 pKi = 5.4 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00019a001
223 3267 32 None -6918 16 Human 5.4 pKi = 5.4 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00019a001
643606 3267 32 None -6918 16 Human 5.4 pKi = 5.4 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00019a001
CHEMBL10347 3267 32 None -6918 16 Human 5.4 pKi = 5.4 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00019a001
1960 2838 67 None -10 26 Bovine 6.4 pKi = 6.4 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
439260 2838 67 None -10 26 Bovine 6.4 pKi = 6.4 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
505 2838 67 None -10 26 Bovine 6.4 pKi = 6.4 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
CHEMBL1437 2838 67 None -10 26 Bovine 6.4 pKi = 6.4 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
DB00368 2838 67 None -10 26 Bovine 6.4 pKi = 6.4 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
9905391 109459 0 None 6 2 Rat 6.4 pKi = 6.4 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 325 3 2 3 2.9 CS(=O)(=O)Nc1ccc(Cl)c2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL322082 109459 0 None 6 2 Rat 6.4 pKi = 6.4 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 325 3 2 3 2.9 CS(=O)(=O)Nc1ccc(Cl)c2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
123981 16427 22 None -245 8 Human 6.4 pKi = 6.4 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 195 0 0 1 2.4 CN1CCc2cccc(Cl)c2CC1 10.1021/jm00019a001
CHEMBL123349 16427 22 None -245 8 Human 6.4 pKi = 6.4 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 195 0 0 1 2.4 CN1CCc2cccc(Cl)c2CC1 10.1021/jm00019a001
CHEMBL536803 16427 22 None -245 8 Human 6.4 pKi = 6.4 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 195 0 0 1 2.4 CN1CCc2cccc(Cl)c2CC1 10.1021/jm00019a001
11740041 206536 0 None -8 2 Rat 7.4 pKi = 7.4 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 372 7 0 5 2.7 COc1ccccc1N1CCN(CCCCN2CC3CCCCN3C2)CC1 10.1021/jm970216k
CHEMBL88715 206536 0 None -8 2 Rat 7.4 pKi = 7.4 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 372 7 0 5 2.7 COc1ccccc1N1CCN(CCCCN2CC3CCCCN3C2)CC1 10.1021/jm970216k
44431612 148840 0 None -2 4 Human 7.4 pKi = 7.4 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 509 7 1 5 4.7 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3cc(Cl)ccc3F)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL394139 148840 0 None -2 4 Human 7.4 pKi = 7.4 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 509 7 1 5 4.7 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3cc(Cl)ccc3F)CC2)CC1 10.1016/j.bmcl.2007.04.008
36811 1442 37 None -2 7 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
535 1442 37 None -2 7 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
937 1442 37 None -2 7 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
CHEMBL926 1442 37 None -2 7 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
DB00841 1442 37 None -2 7 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
44330880 208128 0 None 1 3 Human 7.4 pKi = 7.4 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 371 3 0 3 4.6 O=C1OC2(CCN(CCc3cccc4ccccc34)CC2)Cc2ccccc21 10.1016/s0960-894x(98)00732-x
CHEMBL98168 208128 0 None 1 3 Human 7.4 pKi = 7.4 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 371 3 0 3 4.6 O=C1OC2(CCN(CCc3cccc4ccccc34)CC2)Cc2ccccc21 10.1016/s0960-894x(98)00732-x
10132012 109718 0 None 7 2 Rat 7.3 pKi = 7.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 339 4 2 3 3.3 CCS(=O)(=O)Nc1cc(Cl)cc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL323004 109718 0 None 7 2 Rat 7.3 pKi = 7.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 339 4 2 3 3.3 CCS(=O)(=O)Nc1cc(Cl)cc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
136806214 208106 0 None 60 3 Human 6.3 pKi = 6.3 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 633 15 4 9 2.4 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(CN(C)C)(c3ccccc3)CC2)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
44329028 208106 0 None 60 3 Human 6.3 pKi = 6.3 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 633 15 4 9 2.4 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(CN(C)C)(c3ccccc3)CC2)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
CHEMBL98038 208106 0 None 60 3 Human 6.3 pKi = 6.3 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 633 15 4 9 2.4 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(CN(C)C)(c3ccccc3)CC2)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
10916464 204130 0 None 1 5 Human 6.3 pKi = 6.3 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 287 4 2 5 1.2 CS(=O)(=O)c1cc(Cl)ccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL70563 204130 0 None 1 5 Human 6.3 pKi = 6.3 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 287 4 2 5 1.2 CS(=O)(=O)c1cc(Cl)ccc1NCC1=NCCN1 10.1021/jm000542r
11312410 8870 0 None 9 3 Rat 6.3 pKi = 6.3 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 293 3 2 4 1.5 CS(=O)(=O)Nc1cccc2c1CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
CHEMBL109755 8870 0 None 9 3 Rat 6.3 pKi = 6.3 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 293 3 2 4 1.5 CS(=O)(=O)Nc1cccc2c1CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
11312410 8870 0 None 9 3 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 293 3 2 4 1.5 CS(=O)(=O)Nc1cccc2c1CCCC2C1=NCCN1 10.1021/jm030551a
CHEMBL109755 8870 0 None 9 3 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 293 3 2 4 1.5 CS(=O)(=O)Nc1cccc2c1CCCC2C1=NCCN1 10.1021/jm030551a
11511026 16004 0 None -75 4 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 428 7 1 4 5.6 Clc1cccc(N2CCN(CCCCNc3ccc4ccccc4n3)CC2)c1Cl 10.1016/j.bmcl.2010.07.096
CHEMBL1223683 16004 0 None -75 4 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 428 7 1 4 5.6 Clc1cccc(N2CCN(CCCCNc3ccc4ccccc4n3)CC2)c1Cl 10.1016/j.bmcl.2010.07.096
127024958 137620 0 None -3 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 403 7 2 4 3.9 O=C(NCCCCN1CCN(c2ccccc2O)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
CHEMBL3758330 137620 0 None -3 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 403 7 2 4 3.9 O=C(NCCCCN1CCN(c2ccccc2O)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
76326541 85312 0 None 28 4 Rat 7.3 pKi = 7.3 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 305 4 2 3 2.6 CCS(=O)(=O)Nc1cccc2c1CCC[C@H]2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL2261355 85312 0 None 28 4 Rat 7.3 pKi = 7.3 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 305 4 2 3 2.6 CCS(=O)(=O)Nc1cccc2c1CCC[C@H]2c1c[nH]cn1 10.1007/s00044-004-0020-z
53328311 63355 0 None -1 3 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 421 7 0 5 3.1 COc1ccccc1N1CCN(CCCN2C(=O)CC(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796030 63355 0 None -1 3 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 421 7 0 5 3.1 COc1ccccc1N1CCN(CCCN2C(=O)CC(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
9926529 9357 2 None 1 5 Rat 7.3 pKi = 7.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 305 4 2 3 2.6 CCS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL111496 9357 2 None 1 5 Rat 7.3 pKi = 7.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 305 4 2 3 2.6 CCS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
10698608 43297 0 None 40 3 Human 6.3 pKi = 6.3 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 588 10 3 7 2.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(C(=O)N(C)C)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980506g
CHEMBL150696 43297 0 None 40 3 Human 6.3 pKi = 6.3 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 588 10 3 7 2.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(C(=O)N(C)C)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980506g
76318764 84800 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 359 8 1 6 2.8 COc1cccc(OC)c1OCCN[C@H]1COC[C@H](c2ccccc2)O1 10.1007/s00044-010-9379-1
CHEMBL2234454 84800 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 359 8 1 6 2.8 COc1cccc(OC)c1OCCN[C@H]1COC[C@H](c2ccccc2)O1 10.1007/s00044-010-9379-1
25131192 187301 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 373 9 1 6 2.8 COc1cccc(OC)c1OCCNC[C@@H]1COC[C@H](c2ccccc2)O1 10.1021/jm800461k
CHEMBL493043 187301 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 373 9 1 6 2.8 COc1cccc(OC)c1OCCNC[C@@H]1COC[C@H](c2ccccc2)O1 10.1021/jm800461k
213 3824 55 None -4 44 Rat 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
2717 3824 55 None -4 44 Rat 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
5533 3824 55 None -4 44 Rat 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
CHEMBL621 3824 55 None -4 44 Rat 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
DB00656 3824 55 None -4 44 Rat 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
44288754 170492 0 None 36 3 Human 7.3 pKi = 7.3 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 453 9 1 6 3.4 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C(C)c2ccc([N+](=O)[O-])cc2)CC1 10.1016/s0960-894x(00)00307-3
CHEMBL44496 170492 0 None 36 3 Human 7.3 pKi = 7.3 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 453 9 1 6 3.4 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C(C)c2ccc([N+](=O)[O-])cc2)CC1 10.1016/s0960-894x(00)00307-3
53328312 63356 0 None -1 3 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 425 6 0 4 3.8 O=C1CC(c2ccccc2)CC(=O)N1CCCN1CCN(c2ccccc2Cl)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796031 63356 0 None -1 3 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 425 6 0 4 3.8 O=C1CC(c2ccccc2)CC(=O)N1CCCN1CCN(c2ccccc2Cl)CC1 10.1016/j.ejmech.2011.03.054
118567543 171344 0 None -4 3 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]-prazosin from human alpha1A adrenoreceptor expressed in enriched membranes incubated for 90 mins by liquid scintillation counting methodDisplacement of [3H]-prazosin from human alpha1A adrenoreceptor expressed in enriched membranes incubated for 90 mins by liquid scintillation counting method
ChEMBL 463 4 0 4 4.2 O=C1N(c2cccnc2C(F)(F)F)CC2(CCN(CCc3ccccc3F)CC2)OC12CC2 10.1021/acs.jmedchem.9b01256
CHEMBL4461774 171344 0 None -4 3 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]-prazosin from human alpha1A adrenoreceptor expressed in enriched membranes incubated for 90 mins by liquid scintillation counting methodDisplacement of [3H]-prazosin from human alpha1A adrenoreceptor expressed in enriched membranes incubated for 90 mins by liquid scintillation counting method
ChEMBL 463 4 0 4 4.2 O=C1N(c2cccnc2C(F)(F)F)CC2(CCN(CCc3ccccc3F)CC2)OC12CC2 10.1021/acs.jmedchem.9b01256
71450550 83778 0 None 1 16 Human 6.3 pKi = 6.3 Binding
Binding affinity to alpha1A adrenergicBinding affinity to alpha1A adrenergic
ChEMBL 309 4 1 3 2.0 COc1ccccc1CCN1C2C3C4CC5C6C4C2C6C1(O)C53 10.1016/j.bmcl.2012.08.046
CHEMBL2205836 83778 0 None 1 16 Human 6.3 pKi = 6.3 Binding
Binding affinity to alpha1A adrenergicBinding affinity to alpha1A adrenergic
ChEMBL 309 4 1 3 2.0 COc1ccccc1CCN1C2C3C4CC5C6C4C2C6C1(O)C53 10.1016/j.bmcl.2012.08.046
72457 102247 14 None -4 2 Human 5.3 pKi = 5.3 Binding
Compound was tested for its binding affinity towards Rat-1 cells stably expressing hamster alpha-1b adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)Compound was tested for its binding affinity towards Rat-1 cells stably expressing hamster alpha-1b adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)
ChEMBL 342 3 4 3 4.0 O=C(c1nc(-c2c[nH]c3ccccc23)c[nH]1)c1c[nH]c2cc(O)ccc12 10.1016/0960-894X(96)00376-9
CHEMBL303282 102247 14 None -4 2 Human 5.3 pKi = 5.3 Binding
Compound was tested for its binding affinity towards Rat-1 cells stably expressing hamster alpha-1b adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)Compound was tested for its binding affinity towards Rat-1 cells stably expressing hamster alpha-1b adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)
ChEMBL 342 3 4 3 4.0 O=C(c1nc(-c2c[nH]c3ccccc23)c[nH]1)c1c[nH]c2cc(O)ccc12 10.1016/0960-894X(96)00376-9
9814617 9302 0 None 2 2 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 293 3 2 4 1.7 CS(=O)(=O)Nc1cccc2c1OCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL111151 9302 0 None 2 2 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 293 3 2 4 1.7 CS(=O)(=O)Nc1cccc2c1OCCC2c1c[nH]cn1 10.1021/jm030551a
9958160 198831 0 None -31 4 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 515 4 0 4 3.8 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(I)ccc2Cl)CC1 10.1021/jm030944+
CHEMBL58384 198831 0 None -31 4 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 515 4 0 4 3.8 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(I)ccc2Cl)CC1 10.1021/jm030944+
16041263 95418 0 None -1 4 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 470 6 2 4 5.4 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3ccccc3Cl)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL257098 95418 0 None -1 4 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 470 6 2 4 5.4 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3ccccc3Cl)CC2)CC1 10.1016/j.bmcl.2007.11.068
53328506 63365 0 None 1 3 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 459 6 0 4 4.4 O=C1CC(c2ccc(Cl)cc2)CC(=O)N1CCCN1CCN(c2ccccc2Cl)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796040 63365 0 None 1 3 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 459 6 0 4 4.4 O=C1CC(c2ccc(Cl)cc2)CC(=O)N1CCCN1CCN(c2ccccc2Cl)CC1 10.1016/j.ejmech.2011.03.054
44428850 92266 0 None -8 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 448 4 1 8 2.9 COc1cc2nc(N3CCN(C(=O)c4ccccn4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2007.01.028
CHEMBL242725 92266 0 None -8 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 448 4 1 8 2.9 COc1cc2nc(N3CCN(C(=O)c4ccccn4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2007.01.028
46881444 7583 0 None -6 4 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 403 9 1 4 4.5 COc1ccccc1CCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.bmcl.2010.01.030
CHEMBL1088072 7583 0 None -6 4 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 403 9 1 4 4.5 COc1ccccc1CCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.bmcl.2010.01.030
118716703 114970 0 None -1 4 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 347 4 1 6 1.3 COc1ccccc1N1CCN(CC2COC3(CCNCC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342856 114970 0 None -1 4 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 347 4 1 6 1.3 COc1ccccc1N1CCN(CC2COC3(CCNCC3)O2)CC1 10.1016/j.ejmech.2014.09.070
44414173 12857 0 None -7 2 Rat 6.3 pKi = 6.3 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 339 5 0 3 4.2 Cn1cc(C2CCN(CCCN3CCCCC3)CC2)c2ccccc21 10.1016/j.bmcl.2006.05.002
CHEMBL1188901 12857 0 None -7 2 Rat 6.3 pKi = 6.3 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 339 5 0 3 4.2 Cn1cc(C2CCN(CCCN3CCCCC3)CC2)c2ccccc21 10.1016/j.bmcl.2006.05.002
CHEMBL537650 12857 0 None -7 2 Rat 6.3 pKi = 6.3 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 339 5 0 3 4.2 Cn1cc(C2CCN(CCCN3CCCCC3)CC2)c2ccccc21 10.1016/j.bmcl.2006.05.002
21670271 65209 3 None - 1 Bovine 5.3 pKi = 5.3 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 174 1 0 2 1.8 CN1CC=C(c2cccnc2)CC1 10.1021/jm00375a017
CHEMBL18270 65209 3 None - 1 Bovine 5.3 pKi = 5.3 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 174 1 0 2 1.8 CN1CC=C(c2cccnc2)CC1 10.1021/jm00375a017
46846073 5768 0 None -223 3 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 451 9 1 4 5.6 c1ccc(-c2ccccc2OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1016/j.bmcl.2010.01.030
CHEMBL1078772 5768 0 None -223 3 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 451 9 1 4 5.6 c1ccc(-c2ccccc2OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1016/j.bmcl.2010.01.030
240 941 43 None -4 25 Rat 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
2769 941 43 None -4 25 Rat 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
44279790 941 43 None -4 25 Rat 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
660 941 43 None -4 25 Rat 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
CHEMBL1729 941 43 None -4 25 Rat 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
CHEMBL560739 941 43 None -4 25 Rat 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
DB00604 941 43 None -4 25 Rat 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
13298530 99044 20 None -97 2 Bovine 6.3 pKi = 6.3 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 195 1 0 3 1.0 CN1CCN(c2ncccc2F)CC1 10.1021/jm00366a007
CHEMBL280514 99044 20 None -97 2 Bovine 6.3 pKi = 6.3 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 195 1 0 3 1.0 CN1CCN(c2ncccc2F)CC1 10.1021/jm00366a007
6603710 123921 10 None - 1 Human 6.3 pKi = 6.3 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 345 5 2 3 3.9 CCS(=O)(=O)Nc1cccc(C(=C2CCCCC2)c2c[nH]cn2)c1 10.1016/j.bmcl.2004.11.032
CHEMBL362863 123921 10 None - 1 Human 6.3 pKi = 6.3 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 345 5 2 3 3.9 CCS(=O)(=O)Nc1cccc(C(=C2CCCCC2)c2c[nH]cn2)c1 10.1016/j.bmcl.2004.11.032
13298530 99044 20 None -97 2 Bovine 6.3 pKi = 6.3 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 195 1 0 3 1.0 CN1CCN(c2ncccc2F)CC1 10.1021/jm00375a017
CHEMBL280514 99044 20 None -97 2 Bovine 6.3 pKi = 6.3 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 195 1 0 3 1.0 CN1CCN(c2ncccc2F)CC1 10.1021/jm00375a017
4735 195092 96 None -77 10 Rat 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 340 10 4 4 2.9 N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1 nan
CHEMBL361506 195092 96 None -77 10 Rat 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 340 10 4 4 2.9 N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1 nan
CHEMBL55 195092 96 None -77 10 Rat 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 340 10 4 4 2.9 N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1 nan
2419 692 28 None -288 12 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm030944+
9 692 28 None -288 12 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm030944+
CHEMBL13647 692 28 None -288 12 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm030944+
19085827 104836 0 None 3 3 Human 6.3 pKi = 6.3 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 485 7 0 8 2.9 COc1ccc2c(c1)oc(=O)n2C1CCN(CCCCN2C(=O)c3ccccc3S2(=O)=O)CC1 10.1016/s0960-894x(98)00446-6
CHEMBL311014 104836 0 None 3 3 Human 6.3 pKi = 6.3 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 485 7 0 8 2.9 COc1ccc2c(c1)oc(=O)n2C1CCN(CCCCN2C(=O)c3ccccc3S2(=O)=O)CC1 10.1016/s0960-894x(98)00446-6
44571938 180049 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to adrenergic alpha1A receptorBinding affinity to adrenergic alpha1A receptor
ChEMBL 300 3 1 3 3.0 Fc1ccn(Cc2c(F)ccc3c2CC[C@H]3c2ncc[nH]2)n1 10.1016/j.bmcl.2008.10.066
CHEMBL474796 180049 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to adrenergic alpha1A receptorBinding affinity to adrenergic alpha1A receptor
ChEMBL 300 3 1 3 3.0 Fc1ccn(Cc2c(F)ccc3c2CC[C@H]3c2ncc[nH]2)n1 10.1016/j.bmcl.2008.10.066
44431617 88313 0 None 3 4 Human 8.3 pKi = 8.3 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 458 7 1 6 3.3 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL234854 88313 0 None 3 4 Human 8.3 pKi = 8.3 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 458 7 1 6 3.3 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
44390740 122912 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 478 7 3 7 0.9 C[C@@]1(O)C(=O)N(CCCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)C(=O)N[C@@H]1O 10.1016/j.bmcl.2004.11.032
CHEMBL360688 122912 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 478 7 3 7 0.9 C[C@@]1(O)C(=O)N(CCCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)C(=O)N[C@@H]1O 10.1016/j.bmcl.2004.11.032
3033677 202921 40 None -25 9 Rat 8.3 pKi = 8.3 Binding
Displacement of [3H]-WB4101 from rat forebrain alpha 1 adrenergic receptorsDisplacement of [3H]-WB4101 from rat forebrain alpha 1 adrenergic receptors
ChEMBL 411 5 1 5 3.8 O=C(c1ccc(F)cc1)C1CCN(CCn2c(=S)[nH]c3ccccc3c2=O)CC1 10.1021/acs.jmedchem.2c00633
CHEMBL2355519 202921 40 None -25 9 Rat 8.3 pKi = 8.3 Binding
Displacement of [3H]-WB4101 from rat forebrain alpha 1 adrenergic receptorsDisplacement of [3H]-WB4101 from rat forebrain alpha 1 adrenergic receptors
ChEMBL 411 5 1 5 3.8 O=C(c1ccc(F)cc1)C1CCN(CCn2c(=S)[nH]c3ccccc3c2=O)CC1 10.1021/acs.jmedchem.2c00633
CHEMBL62919 202921 40 None -25 9 Rat 8.3 pKi = 8.3 Binding
Displacement of [3H]-WB4101 from rat forebrain alpha 1 adrenergic receptorsDisplacement of [3H]-WB4101 from rat forebrain alpha 1 adrenergic receptors
ChEMBL 411 5 1 5 3.8 O=C(c1ccc(F)cc1)C1CCN(CCn2c(=S)[nH]c3ccccc3c2=O)CC1 10.1021/acs.jmedchem.2c00633
127025276 137702 0 None -3 3 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 416 8 2 4 4.1 COc1ccccc1N1CCN(CCCCNC(=O)Nc2cccc(Cl)c2)CC1 10.1016/j.bmcl.2015.12.068
CHEMBL3758991 137702 0 None -3 3 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 416 8 2 4 4.1 COc1ccccc1N1CCN(CCCCNC(=O)Nc2cccc(Cl)c2)CC1 10.1016/j.bmcl.2015.12.068
10579632 35555 0 None 5 3 Human 8.3 pKi = 8.3 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 611 9 2 7 5.3 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm990200p
CHEMBL143940 35555 0 None 5 3 Human 8.3 pKi = 8.3 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 611 9 2 7 5.3 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm990200p
52944674 17090 0 None 2 4 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 395 11 3 6 3.7 Oc1cccc(O)c1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
CHEMBL1255085 17090 0 None 2 4 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 395 11 3 6 3.7 Oc1cccc(O)c1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
134150497 152068 0 None -1 3 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 324 6 0 3 3.8 CC(C)Oc1ccccc1N1CCN(CCc2ccccc2)CC1 10.1016/j.ejmech.2016.06.052
CHEMBL3967641 152068 0 None -1 3 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 324 6 0 3 3.8 CC(C)Oc1ccccc1N1CCN(CCc2ccccc2)CC1 10.1016/j.ejmech.2016.06.052
44298780 196525 0 None 25 3 Human 8.3 pKi = 8.3 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 478 7 3 7 0.9 C[C@]1(O)C(=O)N(CCCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)C(=O)N[C@H]1O 10.1016/s0960-894x(03)00305-6
CHEMBL56375 196525 0 None 25 3 Human 8.3 pKi = 8.3 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 478 7 3 7 0.9 C[C@]1(O)C(=O)N(CCCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)C(=O)N[C@H]1O 10.1016/s0960-894x(03)00305-6
44329026 208402 0 None 19 6 Human 8.3 pKi = 8.3 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 679 16 3 7 6.1 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(CCCCOC)N1 10.1016/s0960-894x(99)00484-9
CHEMBL99864 208402 0 None 19 6 Human 8.3 pKi = 8.3 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 679 16 3 7 6.1 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(CCCCOC)N1 10.1016/s0960-894x(99)00484-9
16041264 95414 0 None -1 4 Human 8.3 pKi = 8.3 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 470 6 2 4 5.4 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3cccc(Cl)c3)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL257077 95414 0 None -1 4 Human 8.3 pKi = 8.3 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 470 6 2 4 5.4 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3cccc(Cl)c3)CC2)CC1 10.1016/j.bmcl.2007.11.068
2894 208048 6 None -12 6 Bovine 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)C4CCCCC43)nc(N)c2cc1OC 10.1021/jm020938y
CHEMBL97698 208048 6 None -12 6 Bovine 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)C4CCCCC43)nc(N)c2cc1OC 10.1021/jm020938y
44288485 162496 0 None 29 3 Human 8.3 pKi = 8.3 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 498 9 1 4 5.1 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C(c2ccc(C)cc2)c2ccc(C)cc2)CC1 10.1016/s0960-894x(00)00307-3
CHEMBL41677 162496 0 None 29 3 Human 8.3 pKi = 8.3 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 498 9 1 4 5.1 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C(c2ccc(C)cc2)c2ccc(C)cc2)CC1 10.1016/s0960-894x(00)00307-3
10746137 36924 0 None 138 3 Human 8.3 pKi = 8.3 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 599 9 2 7 3.9 COCC1=C(C(=O)OC)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C#N)(c3ccccc3F)CC2)C(=O)N1 10.1021/jm990201h
CHEMBL145134 36924 0 None 138 3 Human 8.3 pKi = 8.3 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 599 9 2 7 3.9 COCC1=C(C(=O)OC)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C#N)(c3ccccc3F)CC2)C(=O)N1 10.1021/jm990201h
90645595 112460 0 None -4 3 Human 8.3 pKi = 8.3 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 611 11 2 8 5.1 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)CCCCc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
CHEMBL3298748 112460 0 None -4 3 Human 8.3 pKi = 8.3 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 611 11 2 8 5.1 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)CCCCc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
118716717 114985 0 None 1 4 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 532 7 0 9 2.3 COc1ccccc1N1CCN(CC2COC3(CCN(S(=O)(=O)c4ccc([N+](=O)[O-])cc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342870 114985 0 None 1 4 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 532 7 0 9 2.3 COc1ccccc1N1CCN(CC2COC3(CCN(S(=O)(=O)c4ccc([N+](=O)[O-])cc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
44404321 70263 0 None -1 2 Human 8.3 pKi = 8.3 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
ChEMBL 297 4 1 5 3.0 COc1cccc(N(NC2=NCCO2)c2ccc(C)cc2)c1 10.1016/j.bmcl.2005.07.083
CHEMBL194323 70263 0 None -1 2 Human 8.3 pKi = 8.3 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
ChEMBL 297 4 1 5 3.0 COc1cccc(N(NC2=NCCO2)c2ccc(C)cc2)c1 10.1016/j.bmcl.2005.07.083
44404326 133499 0 None -1 2 Human 8.3 pKi = 8.3 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
ChEMBL 283 3 2 5 2.7 Cc1ccc(N(NC2=NCCO2)c2cccc(O)c2)cc1 10.1016/j.bmcl.2005.07.083
CHEMBL370818 133499 0 None -1 2 Human 8.3 pKi = 8.3 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
ChEMBL 283 3 2 5 2.7 Cc1ccc(N(NC2=NCCO2)c2cccc(O)c2)cc1 10.1016/j.bmcl.2005.07.083
44447018 94835 0 None -131 4 Rat 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 496 7 1 5 5.0 O=C(Cc1ccccc1)NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21 10.1016/j.bmcl.2007.11.106
CHEMBL253878 94835 0 None -131 4 Rat 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 496 7 1 5 5.0 O=C(Cc1ccccc1)NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21 10.1016/j.bmcl.2007.11.106
44288468 168357 0 None 1 3 Rat 8.3 pKi = 8.3 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 447 4 1 6 3.6 COc1cccc2c1C1CN(CCn3c(=O)[nH]c4c(sc5ccccc54)c3=O)CC1CC2 10.1021/jm990567u
CHEMBL434591 168357 0 None 1 3 Rat 8.3 pKi = 8.3 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 447 4 1 6 3.6 COc1cccc2c1C1CN(CCn3c(=O)[nH]c4c(sc5ccccc54)c3=O)CC1CC2 10.1021/jm990567u
16041630 97519 0 None -2 4 Human 8.3 pKi = 8.3 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 472 6 2 4 5.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3c(F)cccc3F)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL270589 97519 0 None -2 4 Human 8.3 pKi = 8.3 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 472 6 2 4 5.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3c(F)cccc3F)CC2)CC1 10.1016/j.bmcl.2007.11.068
44289525 165971 0 None -5 9 Rat 8.3 pKi = 8.3 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampus (+ 10 uM) CES membrane using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampus (+ 10 uM) CES membrane using [3H]prazosin as radioligand
ChEMBL 435 9 1 6 4.6 COc1cccc(OC)c1OCCNCC1Oc2ccccc2OC1c1ccc(C)cc1 10.1021/jm960069a
CHEMBL42539 165971 0 None -5 9 Rat 8.3 pKi = 8.3 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampus (+ 10 uM) CES membrane using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampus (+ 10 uM) CES membrane using [3H]prazosin as radioligand
ChEMBL 435 9 1 6 4.6 COc1cccc(OC)c1OCCNCC1Oc2ccccc2OC1c1ccc(C)cc1 10.1021/jm960069a
44426405 142028 0 None -1 4 Human 8.3 pKi = 8.3 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 562 9 1 5 5.7 O=S(=O)(N[C@H]1CC[C@@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1ccc(OC(F)F)cc1 10.1016/j.bmcl.2007.04.098
CHEMBL387832 142028 0 None -1 4 Human 8.3 pKi = 8.3 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 562 9 1 5 5.7 O=S(=O)(N[C@H]1CC[C@@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1ccc(OC(F)F)cc1 10.1016/j.bmcl.2007.04.098
10746433 121057 0 None 295 3 Human 8.3 pKi = 8.3 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 619 13 3 9 3.0 COCCOC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(N)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
CHEMBL357061 121057 0 None 295 3 Human 8.3 pKi = 8.3 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 619 13 3 9 3.0 COCCOC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(N)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
69781970 161327 0 None -14 5 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 477 5 1 8 4.0 COc1cc2nc(N3CCN(C(=O)OCc4ccccc4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
CHEMBL4125981 161327 0 None -14 5 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 477 5 1 8 4.0 COc1cc2nc(N3CCN(C(=O)OCc4ccccc4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
132266 1267 12 None -28 9 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1021/jm8016046
486 1267 12 None -28 9 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1021/jm8016046
CHEMBL423294 1267 12 None -28 9 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1021/jm8016046
180 400 56 None -10 40 Rat 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
200 400 56 None -10 40 Rat 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
2160 400 56 None -10 40 Rat 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
CHEMBL629 400 56 None -10 40 Rat 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
DB00321 400 56 None -10 40 Rat 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
44431554 88314 0 None -1 4 Human 8.3 pKi = 8.3 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 475 7 1 5 4.0 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccc(F)cc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL234874 88314 0 None -1 4 Human 8.3 pKi = 8.3 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 475 7 1 5 4.0 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccc(F)cc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
44431547 154580 0 None -2 4 Human 8.3 pKi = 8.3 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 475 7 1 5 4.0 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccccc3F)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL399195 154580 0 None -2 4 Human 8.3 pKi = 8.3 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 475 7 1 5 4.0 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccccc3F)CC2)CC1 10.1016/j.bmcl.2007.04.008
11994667 11799 0 None 1 6 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 391 8 1 5 4.2 COc1ccc(-c2ccccc2)cc1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL1182143 11799 0 None 1 6 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 391 8 1 5 4.2 COc1ccc(-c2ccccc2)cc1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL214694 11799 0 None 1 6 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 391 8 1 5 4.2 COc1ccc(-c2ccccc2)cc1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
71458492 84540 0 None -1 4 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 379 8 1 6 3.2 COc1cccc(OC)c1OCCNC[C@@H]1COc2cccc(Cl)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153556 84540 0 None -1 4 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 379 8 1 6 3.2 COc1cccc(OC)c1OCCNC[C@@H]1COc2cccc(Cl)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2220896 84540 0 None -1 4 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 379 8 1 6 3.2 COc1cccc(OC)c1OCCNC[C@@H]1COc2cccc(Cl)c2O1 10.1016/j.ejmech.2012.09.049
44447012 94770 0 None -56 4 Rat 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 516 6 1 5 5.7 O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1ccc(Cl)cc1 10.1016/j.bmcl.2007.11.106
CHEMBL253439 94770 0 None -56 4 Rat 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 516 6 1 5 5.7 O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1ccc(Cl)cc1 10.1016/j.bmcl.2007.11.106
10575494 165723 0 None -1 3 Rat 8.3 pKi = 8.3 Binding
The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.
ChEMBL 449 7 1 8 2.5 COc1cc2nc(N3CCN(C(=O)CCC(=O)c4ccccc4)CC3)nc(N)c2cc1OC 10.1021/jm9805337
CHEMBL424658 165723 0 None -1 3 Rat 8.3 pKi = 8.3 Binding
The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.
ChEMBL 449 7 1 8 2.5 COc1cc2nc(N3CCN(C(=O)CCC(=O)c4ccccc4)CC3)nc(N)c2cc1OC 10.1021/jm9805337
44301681 202671 0 None 309 3 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 481 8 2 4 4.6 Cc1ccc(C(O)(C(=O)NCCCN2CCC(C#N)(c3ccccc3)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(01)00320-1
CHEMBL61643 202671 0 None 309 3 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 481 8 2 4 4.6 Cc1ccc(C(O)(C(=O)NCCCN2CCC(C#N)(c3ccccc3)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(01)00320-1
145953314 161405 0 None -6 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 441 7 1 7 3.8 CCCCCC(=O)N1CCN(c2nc(N)c3cc(OC)c(OC)cc3n2)[C@@H]2CCCC[C@@H]21 10.1016/j.bmc.2018.05.023
CHEMBL4127078 161405 0 None -6 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 441 7 1 7 3.8 CCCCCC(=O)N1CCN(c2nc(N)c3cc(OC)c(OC)cc3n2)[C@@H]2CCCC[C@@H]21 10.1016/j.bmc.2018.05.023
10895039 18488 0 None -11 8 Rat 8.2 pKi = 8.2 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 418 8 1 5 3.6 COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3cn2)CC1 10.1021/jm0211220
CHEMBL127400 18488 0 None -11 8 Rat 8.2 pKi = 8.2 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 418 8 1 5 3.6 COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3cn2)CC1 10.1021/jm0211220
CHEMBL129022 18488 0 None -11 8 Rat 8.2 pKi = 8.2 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 418 8 1 5 3.6 COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3cn2)CC1 10.1021/jm0211220
44431617 144876 0 None -1 4 Human 8.2 pKi = 8.2 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 458 7 1 6 3.3 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL391016 144876 0 None -1 4 Human 8.2 pKi = 8.2 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 458 7 1 6 3.3 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
44295044 101553 0 None 169 3 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 535 6 2 6 3.5 N#CC1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc(F)c(F)c2)CC1 10.1016/s0960-894x(99)00653-8
CHEMBL298579 101553 0 None 169 3 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 535 6 2 6 3.5 N#CC1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc(F)c(F)c2)CC1 10.1016/s0960-894x(99)00653-8
4418 34192 85 None -1 7 Human 8.2 pKi = 8.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1007/s00044-010-9379-1
CHEMBL142635 34192 85 None -1 7 Human 8.2 pKi = 8.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1007/s00044-010-9379-1
4418 34192 85 None -1 7 Human 8.2 pKi = 8.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1007/s00044-010-9379-1
CHEMBL142635 34192 85 None -1 7 Human 8.2 pKi = 8.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1007/s00044-010-9379-1
10793963 99644 0 None 9 6 Human 8.2 pKi = 8.2 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 622 11 2 7 6.8 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm960697s
CHEMBL284470 99644 0 None 9 6 Human 8.2 pKi = 8.2 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 622 11 2 7 6.8 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm960697s
10032383 110083 0 None 194 6 Human 8.2 pKi = 8.2 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 666 15 4 8 4.2 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
136680387 110083 0 None 194 6 Human 8.2 pKi = 8.2 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 666 15 4 8 4.2 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
CHEMBL323579 110083 0 None 194 6 Human 8.2 pKi = 8.2 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 666 15 4 8 4.2 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
11857793 85621 0 None -6 4 Human 8.2 pKi = 8.2 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 548 7 1 4 5.9 O=S(=O)(N[C@H]1CC[C@@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1cc(Cl)ccc1F 10.1016/j.bmcl.2007.04.098
CHEMBL228445 85621 0 None -6 4 Human 8.2 pKi = 8.2 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 548 7 1 4 5.9 O=S(=O)(N[C@H]1CC[C@@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1cc(Cl)ccc1F 10.1016/j.bmcl.2007.04.098
10743042 188128 0 None 2 4 Human 8.2 pKi = 8.2 Binding
The compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cellsThe compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 471 5 1 8 3.1 Cn1nc(Cl)c2cn3nc(NCCN4CCN(c5ccccc5Cl)CC4)ccc3c2c1=O 10.1021/jm981006q
CHEMBL49851 188128 0 None 2 4 Human 8.2 pKi = 8.2 Binding
The compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cellsThe compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 471 5 1 8 3.1 Cn1nc(Cl)c2cn3nc(NCCN4CCN(c5ccccc5Cl)CC4)ccc3c2c1=O 10.1021/jm981006q
10651706 121488 0 None 25 3 Human 8.2 pKi = 8.2 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 637 11 3 8 4.5 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(C(=O)Oc3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980506g
CHEMBL358406 121488 0 None 25 3 Human 8.2 pKi = 8.2 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 637 11 3 8 4.5 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(C(=O)Oc3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980506g
144096985 164070 0 None -5 3 Human 7.3 pKi = 7.3 Binding
Displacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting methodDisplacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting method
ChEMBL 385 9 1 4 3.5 CS(=O)(=O)c1ccccc1CCCNCCOc1cc(F)ccc1Cl 10.1016/j.ejmech.2017.07.071
CHEMBL4209590 164070 0 None -5 3 Human 7.3 pKi = 7.3 Binding
Displacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting methodDisplacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting method
ChEMBL 385 9 1 4 3.5 CS(=O)(=O)c1ccccc1CCCNCCOc1cc(F)ccc1Cl 10.1016/j.ejmech.2017.07.071
9841781 123034 0 None -13 2 Rat 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 359 5 1 2 4.8 c1ccc2c(c1)CN(CCCN1CCC(c3c[nH]c4ccccc34)CC1)C2 10.1016/j.bmcl.2015.07.046
CHEMBL3609357 123034 0 None -13 2 Rat 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 359 5 1 2 4.8 c1ccc2c(c1)CN(CCCN1CCC(c3c[nH]c4ccccc34)CC1)C2 10.1016/j.bmcl.2015.07.046
44288794 162052 0 None 39 3 Human 7.3 pKi = 7.3 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 429 8 1 3 5.0 N#CC1(c2ccccc2)CCN(CCCNC(=O)C(c2ccccc2)C2CCCC2)CC1 10.1016/s0960-894x(00)00307-3
CHEMBL416073 162052 0 None 39 3 Human 7.3 pKi = 7.3 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 429 8 1 3 5.0 N#CC1(c2ccccc2)CCN(CCCNC(=O)C(c2ccccc2)C2CCCC2)CC1 10.1016/s0960-894x(00)00307-3
10026936 163434 0 None 114 3 Human 7.3 pKi = 7.3 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 453 8 1 3 5.1 Cc1ccccc1C1(C#N)CCN(CCCNC(=O)C(c2ccc(F)c(F)c2)C(C)C)CC1 10.1016/s0960-894x(00)00307-3
CHEMBL41994 163434 0 None 114 3 Human 7.3 pKi = 7.3 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 453 8 1 3 5.1 Cc1ccccc1C1(C#N)CCN(CCCNC(=O)C(c2ccc(F)c(F)c2)C(C)C)CC1 10.1016/s0960-894x(00)00307-3
2267 557 71 None -15 7 Human 7.3 pKi = 7.3 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1021/acsmedchemlett.7b00112
271 557 71 None -15 7 Human 7.3 pKi = 7.3 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1021/acsmedchemlett.7b00112
7121 557 71 None -15 7 Human 7.3 pKi = 7.3 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1021/acsmedchemlett.7b00112
CHEMBL639 557 71 None -15 7 Human 7.3 pKi = 7.3 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1021/acsmedchemlett.7b00112
DB00972 557 71 None -15 7 Human 7.3 pKi = 7.3 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1021/acsmedchemlett.7b00112
24824726 161085 1 None -64 6 Human 7.3 pKi = 7.3 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 496 11 1 6 3.6 COCCCC(=O)NCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
CHEMBL4060529 161085 1 None -64 6 Human 7.3 pKi = 7.3 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 496 11 1 6 3.6 COCCCC(=O)NCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
CHEMBL4117079 161085 1 None -64 6 Human 7.3 pKi = 7.3 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 496 11 1 6 3.6 COCCCC(=O)NCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
CHEMBL5282336 161085 1 None -64 6 Human 7.3 pKi = 7.3 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 496 11 1 6 3.6 COCCCC(=O)NCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
CHEMBL5286389 161085 1 None -64 6 Human 7.3 pKi = 7.3 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 496 11 1 6 3.6 COCCCC(=O)NCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
CHEMBL5273244 194593 0 None -100 3 Human 7.3 pKi = 7.3 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 468 9 1 6 2.9 COCC(=O)NCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
CHEMBL5315364 194593 0 None -100 3 Human 7.3 pKi = 7.3 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 468 9 1 6 2.9 COCC(=O)NCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
2267 557 71 None -15 7 Human 7.3 pKi = 7.3 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1021/jm1013874
271 557 71 None -15 7 Human 7.3 pKi = 7.3 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1021/jm1013874
7121 557 71 None -15 7 Human 7.3 pKi = 7.3 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1021/jm1013874
CHEMBL639 557 71 None -15 7 Human 7.3 pKi = 7.3 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1021/jm1013874
DB00972 557 71 None -15 7 Human 7.3 pKi = 7.3 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1021/jm1013874
52937728 61280 0 None -100 4 Human 7.3 pKi = 7.3 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 351 4 0 4 3.2 CN1CCC[C@@H]1Cn1nc(Cc2cccc(F)c2)c2ccccc2c1=O 10.1021/jm1013874
CHEMBL1767145 61280 0 None -100 4 Human 7.3 pKi = 7.3 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 351 4 0 4 3.2 CN1CCC[C@@H]1Cn1nc(Cc2cccc(F)c2)c2ccccc2c1=O 10.1021/jm1013874
155565449 176307 0 None -3 4 Human 7.3 pKi = 7.3 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 433 11 1 5 4.6 COc1ccccc1OCCNCC[C@@H]1CO[C@H](C(c2ccccc2)c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
CHEMBL4579802 176307 0 None -3 4 Human 7.3 pKi = 7.3 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 433 11 1 5 4.6 COc1ccccc1OCCNCC[C@@H]1CO[C@H](C(c2ccccc2)c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
CHEMBL4595447 176307 0 None -3 4 Human 7.3 pKi = 7.3 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 433 11 1 5 4.6 COc1ccccc1OCCNCC[C@@H]1CO[C@H](C(c2ccccc2)c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
2267 557 71 None -15 7 Rat 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptorDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptor
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1016/j.bmcl.2017.09.020
271 557 71 None -15 7 Rat 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptorDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptor
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1016/j.bmcl.2017.09.020
7121 557 71 None -15 7 Rat 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptorDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptor
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1016/j.bmcl.2017.09.020
CHEMBL639 557 71 None -15 7 Rat 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptorDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptor
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1016/j.bmcl.2017.09.020
DB00972 557 71 None -15 7 Rat 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptorDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptor
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1016/j.bmcl.2017.09.020
19608536 137757 0 None -10 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 421 7 1 3 4.8 O=C(NCCCCN1CCN(c2cccc(Cl)c2)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
CHEMBL3759513 137757 0 None -10 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 421 7 1 3 4.8 O=C(NCCCCN1CCN(c2cccc(Cl)c2)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
12575 1975 30 None -331 17 Bovine 6.3 pKi = 6.3 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1021/jm00366a007
54459 1975 30 None -331 17 Bovine 6.3 pKi = 6.3 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1021/jm00366a007
CHEMBL10316 1975 30 None -331 17 Bovine 6.3 pKi = 6.3 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1021/jm00366a007
506 2239 39 None -97 6 Rat 6.3 pKi = 6.3 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 522 6 2 9 3.0 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H](C1)C(=O)NC(C)(C)C)C(=O)OCc1ccccc1 10.1021/jm980053f
6603904 2239 39 None -97 6 Rat 6.3 pKi = 6.3 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 522 6 2 9 3.0 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H](C1)C(=O)NC(C)(C)C)C(=O)OCc1ccccc1 10.1021/jm980053f
CHEMBL19476 2239 39 None -97 6 Rat 6.3 pKi = 6.3 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 522 6 2 9 3.0 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H](C1)C(=O)NC(C)(C)C)C(=O)OCc1ccccc1 10.1021/jm980053f
102 4096 48 None -1258 50 Rat 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
3659 4096 48 None -1258 50 Rat 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
8969 4096 48 None -1258 50 Rat 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
CHEMBL15245 4096 48 None -1258 50 Rat 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
DB01392 4096 48 None -1258 50 Rat 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
10792152 206928 0 None - 1 Human 6.3 pKi = 6.3 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 523 7 3 4 3.9 O=C1NC(C(F)(F)F)=C(C(=O)NCCCN2CCC(c3ccccn3)CC2)[C@@H](c2ccc(F)c(F)c2)N1 10.1021/jm990612y
CHEMBL91179 206928 0 None - 1 Human 6.3 pKi = 6.3 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 523 7 3 4 3.9 O=C1NC(C(F)(F)F)=C(C(=O)NCCCN2CCC(c3ccccn3)CC2)[C@@H](c2ccc(F)c(F)c2)N1 10.1021/jm990612y
75306277 109227 0 None -251 23 Human 6.3 pKi = 6.3 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 308 0 0 3 4.2 CN1CCC2C(C1)c1cccc3c1N2c1ccccc1CS3 10.1039/C2MD00311B
CHEMBL3217984 109227 0 None -251 23 Human 6.3 pKi = 6.3 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 308 0 0 3 4.2 CN1CCC2C(C1)c1cccc3c1N2c1ccccc1CS3 10.1039/C2MD00311B
52937731 61283 0 None -630 4 Human 6.3 pKi = 6.3 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 347 4 0 4 3.4 Cc1cccc(Cc2nn(C[C@H]3CCCN3C)c(=O)c3ccccc23)c1 10.1021/jm1013874
CHEMBL1767148 61283 0 None -630 4 Human 6.3 pKi = 6.3 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 347 4 0 4 3.4 Cc1cccc(Cc2nn(C[C@H]3CCCN3C)c(=O)c3ccccc23)c1 10.1021/jm1013874
52937829 61288 0 None -316 3 Human 6.3 pKi = 6.3 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 313 6 0 4 3.2 CCCCCc1nn(C[C@H]2CCCN2C)c(=O)c2ccccc12 10.1021/jm1013874
CHEMBL1767153 61288 0 None -316 3 Human 6.3 pKi = 6.3 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 313 6 0 4 3.2 CCCCCc1nn(C[C@H]2CCCN2C)c(=O)c2ccccc12 10.1021/jm1013874
11736917 9245 2 None 1 2 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 254 4 2 3 1.5 CCS(=O)(=O)Nc1cccc(C2CCNC2)c1 10.1021/jm030551a
CHEMBL110859 9245 2 None 1 2 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 254 4 2 3 1.5 CCS(=O)(=O)Nc1cccc(C2CCNC2)c1 10.1021/jm030551a
9880162 9270 0 None -1 3 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 321 4 2 4 2.3 COc1ccc2c(c1NS(C)(=O)=O)CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL110976 9270 0 None -1 3 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 321 4 2 4 2.3 COc1ccc2c(c1NS(C)(=O)=O)CCCC2c1c[nH]cn1 10.1021/jm030551a
9823115 198580 0 None -2511 5 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 414 4 0 5 3.0 N#Cc1ccc(Cl)cc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1021/jm030944+
CHEMBL57868 198580 0 None -2511 5 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 414 4 0 5 3.0 N#Cc1ccc(Cl)cc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1021/jm030944+
16041449 95191 0 None -1 4 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 538 6 2 4 6.7 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3c(Cl)cc(Cl)cc3Cl)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL256040 95191 0 None -1 4 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 538 6 2 4 6.7 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3c(Cl)cc(Cl)cc3Cl)CC2)CC1 10.1016/j.bmcl.2007.11.068
16041092 95351 0 None -1 4 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 472 6 2 4 5.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3ccc(F)c(F)c3)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL256804 95351 0 None -1 4 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 472 6 2 4 5.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3ccc(F)c(F)c3)CC2)CC1 10.1016/j.bmcl.2007.11.068
9820229 123033 0 None -6 2 Rat 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 359 5 1 2 4.8 c1ccc2c(c1)CCN2CCCN1CCC(c2c[nH]c3ccccc23)CC1 10.1016/j.bmcl.2015.07.046
CHEMBL3609356 123033 0 None -6 2 Rat 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 359 5 1 2 4.8 c1ccc2c(c1)CCN2CCCN1CCC(c2c[nH]c3ccccc23)CC1 10.1016/j.bmcl.2015.07.046
10739024 69804 0 None -20 6 Rat 6.3 pKi = 6.3 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 388 4 3 8 0.9 COc1cc2nc(N3CCN[C@H](C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC 10.1021/jm980053f
CHEMBL19376 69804 0 None -20 6 Rat 6.3 pKi = 6.3 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 388 4 3 8 0.9 COc1cc2nc(N3CCN[C@H](C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC 10.1021/jm980053f
10961938 119513 0 None -8511 8 Rat 5.3 pKi = 5.3 Binding
Binding affinity for rat Alpha-1A adrenergic receptor using [11C] radiotracerBinding affinity for rat Alpha-1A adrenergic receptor using [11C] radiotracer
ChEMBL 485 8 1 4 5.5 COc1c(C(=O)NCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)ccc2ccccc12 10.1021/jm050171k
CHEMBL345820 119513 0 None -8511 8 Rat 5.3 pKi = 5.3 Binding
Binding affinity for rat Alpha-1A adrenergic receptor using [11C] radiotracerBinding affinity for rat Alpha-1A adrenergic receptor using [11C] radiotracer
ChEMBL 485 8 1 4 5.5 COc1c(C(=O)NCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)ccc2ccccc12 10.1021/jm050171k
76322413 84798 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 359 8 1 6 2.8 COc1cccc(OC)c1OCCN[C@H]1CO[C@H](c2ccccc2)CO1 10.1007/s00044-010-9379-1
CHEMBL2234452 84798 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 359 8 1 6 2.8 COc1cccc(OC)c1OCCN[C@H]1CO[C@H](c2ccccc2)CO1 10.1007/s00044-010-9379-1
2803 952 58 None -8 19 Human 6.3 pKi = 6.3 Binding
Binding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
516 952 58 None -8 19 Human 6.3 pKi = 6.3 Binding
Binding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
704 952 58 None -8 19 Human 6.3 pKi = 6.3 Binding
Binding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
CHEMBL134 952 58 None -8 19 Human 6.3 pKi = 6.3 Binding
Binding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
DB00575 952 58 None -8 19 Human 6.3 pKi = 6.3 Binding
Binding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
25132564 187378 0 None -2 2 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 373 9 1 6 2.8 COc1cccc(OC)c1OCCNC[C@@H]1CO[C@@H](c2ccccc2)CO1 10.1021/jm800461k
CHEMBL493661 187378 0 None -2 2 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 373 9 1 6 2.8 COc1cccc(OC)c1OCCNC[C@@H]1CO[C@@H](c2ccccc2)CO1 10.1021/jm800461k
3086326 204508 22 None -138 6 Human 5.3 pKi = 5.3 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 247 1 2 5 1.7 Clc1c(NC2=NCCN2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
CHEMBL72753 204508 22 None -138 6 Human 5.3 pKi = 5.3 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 247 1 2 5 1.7 Clc1c(NC2=NCCN2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
16041630 97519 0 None -2 4 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 472 6 2 4 5.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3c(F)cccc3F)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL270589 97519 0 None -2 4 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 472 6 2 4 5.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3c(F)cccc3F)CC2)CC1 10.1016/j.bmcl.2007.11.068
49783209 17577 0 None -912 27 Human 6.3 pKi = 6.3 Binding
Binding affinity to human adrenergic alpha1A receptorBinding affinity to human adrenergic alpha1A receptor
ChEMBL 396 7 1 6 3.8 CCCCN1CCC(COC(=O)c2cc(Cl)c(NC)c3c2OCCO3)CC1 10.1021/jm100668r
CHEMBL1258223 17577 0 None -912 27 Human 6.3 pKi = 6.3 Binding
Binding affinity to human adrenergic alpha1A receptorBinding affinity to human adrenergic alpha1A receptor
ChEMBL 396 7 1 6 3.8 CCCCN1CCC(COC(=O)c2cc(Cl)c(NC)c3c2OCCO3)CC1 10.1021/jm100668r
127036932 137323 0 None -17 22 Human 6.3 pKi = 6.3 Binding
Binding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 274 7 1 1 4.0 C=CCN(CC=C)CCc1c[nH]c2ccc(Cl)cc12 10.1016/j.bmcl.2015.12.053
CHEMBL3752900 137323 0 None -17 22 Human 6.3 pKi = 6.3 Binding
Binding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 274 7 1 1 4.0 C=CCN(CC=C)CCc1c[nH]c2ccc(Cl)cc12 10.1016/j.bmcl.2015.12.053
9813756 8984 0 None 1 3 Rat 6.3 pKi = 6.3 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 255 2 2 2 2.8 CC(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL109848 8984 0 None 1 3 Rat 6.3 pKi = 6.3 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 255 2 2 2 2.8 CC(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
9813756 8984 0 None 1 3 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 255 2 2 2 2.8 CC(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL109848 8984 0 None 1 3 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 255 2 2 2 2.8 CC(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
15546405 97129 0 None 12 3 Human 7.3 pKi = 7.3 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 416 8 0 5 2.1 CC(C)Oc1ccccc1N1CCN(CCN(C)C(=O)CN2CCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
CHEMBL268030 97129 0 None 12 3 Human 7.3 pKi = 7.3 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 416 8 0 5 2.1 CC(C)Oc1ccccc1N1CCN(CCN(C)C(=O)CN2CCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
44331277 4444 0 None -1 3 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 371 3 0 3 4.9 O=C1CC2(CCN(CCc3cccc4ccccc34)CC2)Oc2ccccc21 10.1016/s0960-894x(98)00732-x
CHEMBL101869 4444 0 None -1 3 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 371 3 0 3 4.9 O=C1CC2(CCN(CCc3cccc4ccccc34)CC2)Oc2ccccc21 10.1016/s0960-894x(98)00732-x
9800400 123031 1 None -7 2 Rat 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 387 5 1 3 4.0 O=C1c2ccccc2C(=O)N1CCCN1CCC(c2c[nH]c3ccccc23)CC1 10.1016/j.bmcl.2015.07.046
CHEMBL3609354 123031 1 None -7 2 Rat 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 387 5 1 3 4.0 O=C1c2ccccc2C(=O)N1CCCN1CCC(c2c[nH]c3ccccc23)CC1 10.1016/j.bmcl.2015.07.046
10818003 106394 0 None 3 6 Human 7.3 pKi = 7.3 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 649 12 3 6 6.2 CC(C)C1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C(C)C)N1 10.1021/jm980077m
CHEMBL313953 106394 0 None 3 6 Human 7.3 pKi = 7.3 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 649 12 3 6 6.2 CC(C)C1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C(C)C)N1 10.1021/jm980077m
10818003 106394 0 None 3 6 Human 7.3 pKi = 7.3 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 649 12 3 6 6.2 CC(C)C1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C(C)C)N1 10.1007/s00044-004-0120-9
CHEMBL313953 106394 0 None 3 6 Human 7.3 pKi = 7.3 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 649 12 3 6 6.2 CC(C)C1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C(C)C)N1 10.1007/s00044-004-0120-9
44420412 84767 0 None -3 3 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 470 5 1 7 3.4 COc1ccc(Cl)cc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccccc43)c2=O)CC1 10.1016/j.bmcl.2006.09.034
CHEMBL223289 84767 0 None -3 3 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 470 5 1 7 3.4 COc1ccc(Cl)cc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccccc43)c2=O)CC1 10.1016/j.bmcl.2006.09.034
14925759 158014 6 None -18 13 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from human recombinant alpha-1A adrenergic receptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from human recombinant alpha-1A adrenergic receptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 349 5 0 3 3.2 O=C1CCc2ccccc2N1CCCN1CCN(c2ccccc2)CC1 10.1021/acs.jmedchem.8b00265
CHEMBL4085780 158014 6 None -18 13 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from human recombinant alpha-1A adrenergic receptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from human recombinant alpha-1A adrenergic receptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 349 5 0 3 3.2 O=C1CCc2ccccc2N1CCCN1CCN(c2ccccc2)CC1 10.1021/acs.jmedchem.8b00265
56946472 71482 0 None -26 4 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 373 8 1 3 4.8 c1ccc(OCCNCC2CCC(c3ccccc3)(c3ccccc3)O2)cc1 10.1021/jm200421e
CHEMBL1946778 71482 0 None -26 4 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 373 8 1 3 4.8 c1ccc(OCCNCC2CCC(c3ccccc3)(c3ccccc3)O2)cc1 10.1021/jm200421e
CHEMBL1962753 71482 0 None -26 4 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 373 8 1 3 4.8 c1ccc(OCCNCC2CCC(c3ccccc3)(c3ccccc3)O2)cc1 10.1021/jm200421e
11372228 101640 0 None -64 5 Rat 7.3 pKi = 7.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 373 4 0 3 3.8 O=C1CC2(C=CN1CCN1CCN(c3ccccc3Cl)CC1)CCCC2 10.1021/jm030944+
CHEMBL299253 101640 0 None -64 5 Rat 7.3 pKi = 7.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 373 4 0 3 3.8 O=C1CC2(C=CN1CCN1CCN(c3ccccc3Cl)CC1)CCCC2 10.1021/jm030944+
11771731 108219 2 None -1 3 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]prazosin from alpha-1A adrenergic receptor (unknown origin)Displacement of [3H]prazosin from alpha-1A adrenergic receptor (unknown origin)
ChEMBL 325 5 2 3 3.8 C[C@@H]([C@@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1021/acs.jmedchem.0c01912
CHEMBL319706 108219 2 None -1 3 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]prazosin from alpha-1A adrenergic receptor (unknown origin)Displacement of [3H]prazosin from alpha-1A adrenergic receptor (unknown origin)
ChEMBL 325 5 2 3 3.8 C[C@@H]([C@@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1021/acs.jmedchem.0c01912
9947861 204139 0 None 4 4 Human 6.3 pKi = 6.3 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 287 4 2 5 1.2 CS(=O)(=O)c1ccc(Cl)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL70634 204139 0 None 4 4 Human 6.3 pKi = 6.3 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 287 4 2 5 1.2 CS(=O)(=O)c1ccc(Cl)cc1NCC1=NCCN1 10.1021/jm000542r
76311539 84803 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 299 6 1 4 2.8 c1ccc(OCCN[C@H]2CO[C@H](c3ccccc3)CO2)cc1 10.1007/s00044-010-9379-1
CHEMBL2234457 84803 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 299 6 1 4 2.8 c1ccc(OCCN[C@H]2CO[C@H](c3ccccc3)CO2)cc1 10.1007/s00044-010-9379-1
10267873 110633 0 None 5 2 Rat 6.3 pKi = 6.3 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 317 4 2 3 2.8 O=S(=O)(Nc1cccc2c1CCCC2c1c[nH]cn1)C1CC1 10.1007/s00044-004-0020-z
CHEMBL325897 110633 0 None 5 2 Rat 6.3 pKi = 6.3 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 317 4 2 3 2.8 O=S(=O)(Nc1cccc2c1CCCC2c1c[nH]cn1)C1CC1 10.1007/s00044-004-0020-z
14004035 119493 0 None 1 2 Bovine 6.3 pKi = 6.3 Binding
Compound was evaluated for log 1/Ki at alpha-1 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-1 adrenergic receptor
ChEMBL 227 0 1 2 2.6 c1cnc2[nH]c3c(c2c1)CCN1CCCCC31 10.1021/jm00398a025
CHEMBL345621 119493 0 None 1 2 Bovine 6.3 pKi = 6.3 Binding
Compound was evaluated for log 1/Ki at alpha-1 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-1 adrenergic receptor
ChEMBL 227 0 1 2 2.6 c1cnc2[nH]c3c(c2c1)CCN1CCCCC31 10.1021/jm00398a025
25131196 192608 0 None -3 2 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 313 7 1 4 2.8 c1ccc(OCCNC[C@@H]2CO[C@@H](c3ccccc3)CO2)cc1 10.1021/jm800461k
CHEMBL521694 192608 0 None -3 2 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 313 7 1 4 2.8 c1ccc(OCCNC[C@@H]2CO[C@@H](c3ccccc3)CO2)cc1 10.1021/jm800461k
10267873 110633 0 None 5 2 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 317 4 2 3 2.8 O=S(=O)(Nc1cccc2c1CCCC2c1c[nH]cn1)C1CC1 10.1021/jm030551a
CHEMBL325897 110633 0 None 5 2 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 317 4 2 3 2.8 O=S(=O)(Nc1cccc2c1CCCC2c1c[nH]cn1)C1CC1 10.1021/jm030551a
441383 20301 57 None -257 17 Rat 5.3 pKi = 5.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 531 8 0 8 4.5 CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
CHEMBL1306 20301 57 None -257 17 Rat 5.3 pKi = 5.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 531 8 0 8 4.5 CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
11505007 90235 0 None -6 4 Human 7.3 pKi = 7.3 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 557 9 1 7 4.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCN(c4ccccc4OCC(F)(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
CHEMBL238402 90235 0 None -6 4 Human 7.3 pKi = 7.3 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 557 9 1 7 4.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCN(c4ccccc4OCC(F)(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
11303253 198574 0 None -147 4 Rat 7.3 pKi = 7.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 371 5 0 4 3.0 COc1ccccc1N1CCN(CCN2CCC3(CCCC3)CC2=O)CC1 10.1021/jm030944+
CHEMBL57859 198574 0 None -147 4 Rat 7.3 pKi = 7.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 371 5 0 4 3.0 COc1ccccc1N1CCN(CCN2CCC3(CCCC3)CC2=O)CC1 10.1021/jm030944+
9909471 196883 0 None -17 4 Human 7.3 pKi = 7.3 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 409 4 0 4 3.4 O=C1CC2(CCCC2)C(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1007/s00044-010-9379-1
CHEMBL56620 196883 0 None -17 4 Human 7.3 pKi = 7.3 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 409 4 0 4 3.4 O=C1CC2(CCCC2)C(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1007/s00044-010-9379-1
9909471 196883 0 None -17 4 Human 7.3 pKi = 7.3 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 409 4 0 4 3.4 O=C1CC2(CCCC2)C(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1007/s00044-010-9379-1
CHEMBL56620 196883 0 None -17 4 Human 7.3 pKi = 7.3 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 409 4 0 4 3.4 O=C1CC2(CCCC2)C(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1007/s00044-010-9379-1
14004035 119493 0 None 1 2 Bovine 6.3 pKi = 6.3 Binding
Affinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranesAffinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranes
ChEMBL 227 0 1 2 2.6 c1cnc2[nH]c3c(c2c1)CCN1CCCCC31 10.1021/jm00398a025
CHEMBL345621 119493 0 None 1 2 Bovine 6.3 pKi = 6.3 Binding
Affinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranesAffinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranes
ChEMBL 227 0 1 2 2.6 c1cnc2[nH]c3c(c2c1)CCN1CCCCC31 10.1021/jm00398a025
1343 1876 62 None -87 9 Rat 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
3519 1876 62 None -87 9 Rat 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
522 1876 62 None -87 9 Rat 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
CHEMBL862 1876 62 None -87 9 Rat 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
DB01018 1876 62 None -87 9 Rat 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
10411237 117456 0 None -3019 4 Rat 6.3 pKi = 6.3 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 444 7 2 3 4.8 O=C(NCCCCN1CCN(c2ccc(Cl)cc2Cl)CC1)c1cc2ccccc2[nH]1 10.1021/jm0211220
CHEMBL339960 117456 0 None -3019 4 Rat 6.3 pKi = 6.3 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 444 7 2 3 4.8 O=C(NCCCCN1CCN(c2ccc(Cl)cc2Cl)CC1)c1cc2ccccc2[nH]1 10.1021/jm0211220
CHEMBL4287055 117456 0 None -3019 4 Rat 6.3 pKi = 6.3 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 444 7 2 3 4.8 O=C(NCCCCN1CCN(c2ccc(Cl)cc2Cl)CC1)c1cc2ccccc2[nH]1 10.1021/jm0211220
11090351 163367 0 None -2 4 Human 6.3 pKi = 6.3 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1c(F)cccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL419448 163367 0 None -2 4 Human 6.3 pKi = 6.3 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1c(F)cccc1NCC1=NCCN1 10.1021/jm000542r
76330200 85311 0 None 2 3 Rat 5.3 pKi = 5.3 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 323 3 2 5 1.2 CN(c1c(O)ccc2c1CCCC2C1=NCCN1)S(C)(=O)=O 10.1007/s00044-004-0020-z
CHEMBL2261354 85311 0 None 2 3 Rat 5.3 pKi = 5.3 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 323 3 2 5 1.2 CN(c1c(O)ccc2c1CCCC2C1=NCCN1)S(C)(=O)=O 10.1007/s00044-004-0020-z
135423051 77803 0 None 2 3 Rat 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranesDisplacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranes
ChEMBL 391 4 1 5 2.5 COc1ccccc1N1CCN(C[C@@H]2CN=C3c4ccccc4NC(=O)N32)CC1 10.1021/jm970159v
CHEMBL2092926 77803 0 None 2 3 Rat 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranesDisplacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranes
ChEMBL 391 4 1 5 2.5 COc1ccccc1N1CCN(C[C@@H]2CN=C3c4ccccc4NC(=O)N32)CC1 10.1021/jm970159v
456386 202980 6 None -3 2 Human 6.3 pKi = 6.3 Binding
Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)
ChEMBL 376 2 3 1 5.5 Brc1ccc2c(-c3c[nH]c(-c4c[nH]c5ccccc45)n3)c[nH]c2c1 10.1016/0960-894X(96)00376-9
CHEMBL63208 202980 6 None -3 2 Human 6.3 pKi = 6.3 Binding
Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)
ChEMBL 376 2 3 1 5.5 Brc1ccc2c(-c3c[nH]c(-c4c[nH]c5ccccc45)n3)c[nH]c2c1 10.1016/0960-894X(96)00376-9
44300018 198270 0 None -660 4 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 389 4 0 4 3.2 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2Cl)CC1 10.1021/jm030944+
CHEMBL57593 198270 0 None -660 4 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 389 4 0 4 3.2 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2Cl)CC1 10.1021/jm030944+
44331198 4427 0 None -1 3 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 357 3 0 2 5.2 c1ccc2c(c1)CCC1(CCN(CCc3cccc4ccccc34)CC1)O2 10.1016/s0960-894x(98)00732-x
CHEMBL101739 4427 0 None -1 3 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 357 3 0 2 5.2 c1ccc2c(c1)CCC1(CCN(CCc3cccc4ccccc34)CC1)O2 10.1016/s0960-894x(98)00732-x
9797995 13915 0 None -51 2 Rat 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 339 6 1 2 4.6 c1ccc2c(C3CCN(CCCCN4CCCCC4)CC3)c[nH]c2c1 10.1016/j.bmcl.2006.05.002
CHEMBL1196601 13915 0 None -51 2 Rat 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 339 6 1 2 4.6 c1ccc2c(C3CCN(CCCCN4CCCCC4)CC3)c[nH]c2c1 10.1016/j.bmcl.2006.05.002
CHEMBL557584 13915 0 None -51 2 Rat 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 339 6 1 2 4.6 c1ccc2c(C3CCN(CCCCN4CCCCC4)CC3)c[nH]c2c1 10.1016/j.bmcl.2006.05.002
10626982 111468 0 None 2 6 Human 7.3 pKi = 7.3 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 575 9 2 6 5.9 CC1=C(C#N)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
CHEMBL327775 111468 0 None 2 6 Human 7.3 pKi = 7.3 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 575 9 2 6 5.9 CC1=C(C#N)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
10626982 111468 0 None 2 6 Human 7.3 pKi = 7.3 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 575 9 2 6 5.9 CC1=C(C#N)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1007/s00044-004-0120-9
CHEMBL327775 111468 0 None 2 6 Human 7.3 pKi = 7.3 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 575 9 2 6 5.9 CC1=C(C#N)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1007/s00044-004-0120-9
52941981 17484 0 None -2 3 Rat 6.3 pKi = 6.3 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 502 7 1 5 3.1 CN1C(=O)N(CC(O)CN2CCN(c3ccccc3F)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
CHEMBL1257883 17484 0 None -2 3 Rat 6.3 pKi = 6.3 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 502 7 1 5 3.1 CN1C(=O)N(CC(O)CN2CCN(c3ccccc3F)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
44314198 104385 0 None -95 4 Human 6.3 pKi = 6.3 Binding
Binding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 210 3 1 3 2.3 CCC[C@H]1CCCCC1NC1=NCCO1 10.1016/0960-894X(94)85032-1
CHEMBL310335 104385 0 None -95 4 Human 6.3 pKi = 6.3 Binding
Binding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 210 3 1 3 2.3 CCC[C@H]1CCCCC1NC1=NCCO1 10.1016/0960-894X(94)85032-1
1201549 594 24 None -51 20 Rat 7.2 pKi = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
333 594 24 None -51 20 Rat 7.2 pKi = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
7601 594 24 None -51 20 Rat 7.2 pKi = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
CHEMBL1201203 594 24 None -51 20 Rat 7.2 pKi = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
CHEMBL438151 594 24 None -51 20 Rat 7.2 pKi = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
DB00245 594 24 None -51 20 Rat 7.2 pKi = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
18001206 12754 0 None -4 2 Rat 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 327 5 0 4 3.9 c1ccc2c(C3CCN(CCCN4CCCCC4)CC3)noc2c1 10.1016/j.bmcl.2006.05.002
CHEMBL1188049 12754 0 None -4 2 Rat 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 327 5 0 4 3.9 c1ccc2c(C3CCN(CCCN4CCCCC4)CC3)noc2c1 10.1016/j.bmcl.2006.05.002
CHEMBL534943 12754 0 None -4 2 Rat 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 327 5 0 4 3.9 c1ccc2c(C3CCN(CCCN4CCCCC4)CC3)noc2c1 10.1016/j.bmcl.2006.05.002
9798656 12858 0 None -38 3 Rat 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 353 7 1 2 5.0 c1ccc2c(C3CCN(CCCCCN4CCCCC4)CC3)c[nH]c2c1 10.1016/j.bmcl.2006.05.002
CHEMBL1188902 12858 0 None -38 3 Rat 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 353 7 1 2 5.0 c1ccc2c(C3CCN(CCCCCN4CCCCC4)CC3)c[nH]c2c1 10.1016/j.bmcl.2006.05.002
CHEMBL537651 12858 0 None -38 3 Rat 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 353 7 1 2 5.0 c1ccc2c(C3CCN(CCCCCN4CCCCC4)CC3)c[nH]c2c1 10.1016/j.bmcl.2006.05.002
10859076 13650 0 None 1 6 Human 7.2 pKi = 7.2 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 249 5 2 4 2.6 CC(C)Sc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL1194763 13650 0 None 1 6 Human 7.2 pKi = 7.2 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 249 5 2 4 2.6 CC(C)Sc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL553276 13650 0 None 1 6 Human 7.2 pKi = 7.2 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 249 5 2 4 2.6 CC(C)Sc1ccccc1NCC1=NCCN1 10.1021/jm000542r
134137025 142713 0 None -11 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting method
ChEMBL 362 4 0 5 3.6 COc1ccccc1N1CCN(CC2CSC3(CCCCC3)O2)CC1 10.1016/j.ejmech.2016.09.050
CHEMBL3892434 142713 0 None -11 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting method
ChEMBL 362 4 0 5 3.6 COc1ccccc1N1CCN(CC2CSC3(CCCCC3)O2)CC1 10.1016/j.ejmech.2016.09.050
44288810 169438 0 None 1 3 Human 6.2 pKi = 6.2 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 483 9 2 3 4.5 Cc1ccc(C(C(=O)NCCCN2CCC(C(N)=O)(c3ccccc3)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
CHEMBL44288 169438 0 None 1 3 Human 6.2 pKi = 6.2 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 483 9 2 3 4.5 Cc1ccc(C(C(=O)NCCCN2CCC(C(N)=O)(c3ccccc3)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
12134994 163283 0 None -2 3 Human 6.2 pKi = 6.2 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 316 5 0 5 2.9 COc1ccccc1N1CCN(Cc2ccc(C=O)s2)CC1 10.1016/s0960-894x(02)00347-5
CHEMBL418882 163283 0 None -2 3 Human 6.2 pKi = 6.2 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 316 5 0 5 2.9 COc1ccccc1N1CCN(Cc2ccc(C=O)s2)CC1 10.1016/s0960-894x(02)00347-5
6075 150084 42 None -11 16 Rat 7.2 pKi = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 310 2 0 3 4.6 CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1 nan
CHEMBL395110 150084 42 None -11 16 Rat 7.2 pKi = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 310 2 0 3 4.6 CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1 nan
11568725 16066 0 None -104 3 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 454 8 1 4 6.1 Clc1cccc(N2CCN(CCCCNc3cc(-c4ccccc4)ccn3)CC2)c1Cl 10.1016/j.bmcl.2010.07.096
CHEMBL1223856 16066 0 None -104 3 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 454 8 1 4 6.1 Clc1cccc(N2CCN(CCCCNc3cc(-c4ccccc4)ccn3)CC2)c1Cl 10.1016/j.bmcl.2010.07.096
44362633 121521 0 None 95 3 Human 7.2 pKi = 7.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 597 9 3 6 3.9 CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCC(C)N2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990201h
CHEMBL358590 121521 0 None 95 3 Human 7.2 pKi = 7.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 597 9 3 6 3.9 CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCC(C)N2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990201h
10946567 16437 0 None -47 6 Human 7.2 pKi = 7.2 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 265 1 0 2 4.1 CCc1sc2ccc(Cl)c3c2c1CN(C)CC3 10.1021/jm00019a001
CHEMBL123448 16437 0 None -47 6 Human 7.2 pKi = 7.2 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 265 1 0 2 4.1 CCc1sc2ccc(Cl)c3c2c1CN(C)CC3 10.1021/jm00019a001
10508132 106990 0 None 13 6 Human 7.2 pKi = 7.2 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 621 10 2 6 5.5 CC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)N(C)C)=C(C)N1 10.1021/jm980077m
CHEMBL315392 106990 0 None 13 6 Human 7.2 pKi = 7.2 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 621 10 2 6 5.5 CC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)N(C)C)=C(C)N1 10.1021/jm980077m
10769499 44186 0 None 489 3 Human 7.2 pKi = 7.2 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 576 10 3 8 3.6 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(=O)O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1007/s00044-004-0120-9
CHEMBL151668 44186 0 None 489 3 Human 7.2 pKi = 7.2 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 576 10 3 8 3.6 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(=O)O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1007/s00044-004-0120-9
10508132 106990 0 None 13 6 Human 7.2 pKi = 7.2 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 621 10 2 6 5.5 CC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)N(C)C)=C(C)N1 10.1007/s00044-004-0120-9
CHEMBL315392 106990 0 None 13 6 Human 7.2 pKi = 7.2 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 621 10 2 6 5.5 CC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)N(C)C)=C(C)N1 10.1007/s00044-004-0120-9
155542075 176595 0 None -1 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 389 9 1 4 4.4 c1ccc(OCCNCCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
CHEMBL4520390 176595 0 None -1 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 389 9 1 4 4.4 c1ccc(OCCNCCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
CHEMBL4597826 176595 0 None -1 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 389 9 1 4 4.4 c1ccc(OCCNCCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
9934955 72247 0 None -165 6 Rat 6.2 pKi = 6.2 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 482 5 2 9 2.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@H](C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC 10.1021/jm980053f
CHEMBL19826 72247 0 None -165 6 Rat 6.2 pKi = 6.2 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 482 5 2 9 2.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@H](C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC 10.1021/jm980053f
23290944 81797 0 None -389 7 Human 6.2 pKi = 6.2 Binding
Binding affinity to adrenergic alpha1A receptor by radioligand binding assayBinding affinity to adrenergic alpha1A receptor by radioligand binding assay
ChEMBL 392 6 0 4 3.8 O=C(C1CCCCC1)N(CCN1CCN(c2ccccc2)CC1)c1ccccn1 10.1016/j.bmcl.2012.05.119
CHEMBL2164350 81797 0 None -389 7 Human 6.2 pKi = 6.2 Binding
Binding affinity to adrenergic alpha1A receptor by radioligand binding assayBinding affinity to adrenergic alpha1A receptor by radioligand binding assay
ChEMBL 392 6 0 4 3.8 O=C(C1CCCCC1)N(CCN1CCN(c2ccccc2)CC1)c1ccccn1 10.1016/j.bmcl.2012.05.119
11474152 100593 0 None -275 4 Rat 6.2 pKi = 6.2 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 369 4 0 4 2.8 Cc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1021/jm030944+
CHEMBL291908 100593 0 None -275 4 Rat 6.2 pKi = 6.2 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 369 4 0 4 2.8 Cc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1021/jm030944+
9816461 10687 7 None 2 4 Human 6.2 pKi = 6.2 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 253 4 2 5 0.5 CS(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL117094 10687 7 None 2 4 Human 6.2 pKi = 6.2 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 253 4 2 5 0.5 CS(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL544290 10687 7 None 2 4 Human 6.2 pKi = 6.2 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 253 4 2 5 0.5 CS(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
11034737 204505 0 None -2 6 Human 6.2 pKi = 6.2 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 289 4 2 4 2.8 CSc1ccc(C(F)(F)F)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL72724 204505 0 None -2 6 Human 6.2 pKi = 6.2 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 289 4 2 4 2.8 CSc1ccc(C(F)(F)F)cc1NCC1=NCCN1 10.1021/jm000542r
10769499 44186 0 None 489 3 Human 7.2 pKi = 7.2 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 576 10 3 8 3.6 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(=O)O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
CHEMBL151668 44186 0 None 489 3 Human 7.2 pKi = 7.2 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 576 10 3 8 3.6 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(=O)O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
44390756 63827 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 445 10 0 7 2.1 CCOC(=O)C1CCC(=O)N1CC(=O)CCN1CCN(c2ccccc2OC(C)C)CC1 10.1016/j.bmcl.2004.11.032
CHEMBL180312 63827 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 445 10 0 7 2.1 CCOC(=O)C1CCC(=O)N1CC(=O)CCN1CCN(c2ccccc2OC(C)C)CC1 10.1016/j.bmcl.2004.11.032
9822942 197914 0 None -48 4 Rat 7.2 pKi = 7.2 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 411 5 0 4 3.7 CCC1(C)CC(=O)N(CCN2CCN(c3cc(Cl)ccc3Cl)CC2)C(=O)C1 10.1021/jm030944+
CHEMBL57317 197914 0 None -48 4 Rat 7.2 pKi = 7.2 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 411 5 0 4 3.7 CCC1(C)CC(=O)N(CCN2CCN(c3cc(Cl)ccc3Cl)CC2)C(=O)C1 10.1021/jm030944+
9845181 208138 3 None -4168 14 Bovine 5.2 pKi = 5.2 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 423 4 0 4 3.3 C[C@H](CN1CCN(c2cc(F)c(F)cc2F)CC1)N1C(=O)CC2(CCCC2)CC1=O 10.1021/jm020938y
CHEMBL98241 208138 3 None -4168 14 Bovine 5.2 pKi = 5.2 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 423 4 0 4 3.3 C[C@H](CN1CCN(c2cc(F)c(F)cc2F)CC1)N1C(=O)CC2(CCCC2)CC1=O 10.1021/jm020938y
49865601 15990 0 None -34 3 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 378 7 1 4 4.1 FC(F)(F)c1cccc(N2CCN(CCCCNc3ccccn3)CC2)c1 10.1016/j.bmcl.2010.07.096
CHEMBL1223617 15990 0 None -34 3 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 378 7 1 4 4.1 FC(F)(F)c1cccc(N2CCN(CCCCNc3ccccn3)CC2)c1 10.1016/j.bmcl.2010.07.096
2865 4112 73 None -14 54 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 nan
59 4112 73 None -14 54 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 nan
60854 4112 73 None -14 54 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 nan
CHEMBL708 4112 73 None -14 54 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 nan
DB00246 4112 73 None -14 54 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 nan
44431574 87773 0 None -1 4 Human 8.2 pKi = 8.2 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 505 8 1 6 4.0 COc1ccc(F)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL233814 87773 0 None -1 4 Human 8.2 pKi = 8.2 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 505 8 1 6 4.0 COc1ccc(F)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
49865668 16019 0 None -6 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 390 8 1 5 4.3 COc1ccccc1N1CCN(CCCCNc2nccc3ccccc23)CC1 10.1016/j.bmcl.2010.07.096
CHEMBL1223748 16019 0 None -6 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 390 8 1 5 4.3 COc1ccccc1N1CCN(CCCCNc2nccc3ccccc23)CC1 10.1016/j.bmcl.2010.07.096
24805674 97790 0 None -1 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 390 8 1 5 4.3 COc1ccccc1N1CCN(CCCCNc2ccc3ccccc3n2)CC1 10.1016/j.bmcl.2010.07.096
CHEMBL271989 97790 0 None -1 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 390 8 1 5 4.3 COc1ccccc1N1CCN(CCCCNc2ccc3ccccc3n2)CC1 10.1016/j.bmcl.2010.07.096
10698880 120842 0 None 630 3 Human 8.2 pKi = 8.2 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 603 11 3 8 3.7 CCOC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(=O)NC)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
CHEMBL355910 120842 0 None 630 3 Human 8.2 pKi = 8.2 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 603 11 3 8 3.7 CCOC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(=O)NC)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
10698880 120842 0 None 630 3 Human 8.2 pKi = 8.2 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 603 11 3 8 3.7 CCOC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(=O)NC)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1007/s00044-004-0120-9
CHEMBL355910 120842 0 None 630 3 Human 8.2 pKi = 8.2 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 603 11 3 8 3.7 CCOC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(=O)NC)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1007/s00044-004-0120-9
9893246 121466 0 None 34 3 Human 8.2 pKi = 8.2 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 531 9 3 6 4.0 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
CHEMBL358253 121466 0 None 34 3 Human 8.2 pKi = 8.2 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 531 9 3 6 4.0 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
9893246 121466 0 None 34 3 Human 8.2 pKi = 8.2 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 531 9 3 6 4.0 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980506g
CHEMBL358253 121466 0 None 34 3 Human 8.2 pKi = 8.2 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 531 9 3 6 4.0 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980506g
11857792 169345 0 None -3 4 Human 8.2 pKi = 8.2 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 560 8 1 5 5.8 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1 10.1016/j.bmcl.2007.04.098
CHEMBL442059 169345 0 None -3 4 Human 8.2 pKi = 8.2 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 560 8 1 5 5.8 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1 10.1016/j.bmcl.2007.04.098
16041265 95308 0 None -1 4 Human 8.2 pKi = 8.2 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 504 6 2 4 6.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3c(Cl)cccc3Cl)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL256597 95308 0 None -1 4 Human 8.2 pKi = 8.2 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 504 6 2 4 6.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3c(Cl)cccc3Cl)CC2)CC1 10.1016/j.bmcl.2007.11.068
44431548 87017 0 None -2 4 Human 8.2 pKi = 8.2 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 502 8 1 7 3.8 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccccc3[N+](=O)[O-])CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL232592 87017 0 None -2 4 Human 8.2 pKi = 8.2 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 502 8 1 7 3.8 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccccc3[N+](=O)[O-])CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL5272034 194588 0 None -10 3 Human 8.2 pKi = 8.2 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 496 11 1 6 3.6 COCCNC(=O)CCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
CHEMBL5315277 194588 0 None -10 3 Human 8.2 pKi = 8.2 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 496 11 1 6 3.6 COCCNC(=O)CCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
136806218 112651 0 None 75 3 Human 8.2 pKi = 8.2 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 682 15 4 9 3.9 COc1ccc(C2(c3ccccc3)CCN(CCCNC(=O)C3=C(COCCN)NC(C)=C(C(N)=O)C3c3ccc([N+](=O)[O-])cc3)CC2)cc1 10.1016/s0960-894x(99)00484-9
44328754 112651 0 None 75 3 Human 8.2 pKi = 8.2 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 682 15 4 9 3.9 COc1ccc(C2(c3ccccc3)CCN(CCCNC(=O)C3=C(COCCN)NC(C)=C(C(N)=O)C3c3ccc([N+](=O)[O-])cc3)CC2)cc1 10.1016/s0960-894x(99)00484-9
CHEMBL330401 112651 0 None 75 3 Human 8.2 pKi = 8.2 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 682 15 4 9 3.9 COc1ccc(C2(c3ccccc3)CCN(CCCNC(=O)C3=C(COCCN)NC(C)=C(C(N)=O)C3c3ccc([N+](=O)[O-])cc3)CC2)cc1 10.1016/s0960-894x(99)00484-9
52944615 17077 0 None 1 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 431 11 1 4 5.6 Clc1cccc(Cl)c1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
CHEMBL1255002 17077 0 None 1 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 431 11 1 4 5.6 Clc1cccc(Cl)c1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
44298762 100601 0 None 15 3 Human 8.2 pKi = 8.2 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 473 8 1 7 1.9 CN(C)c1c[nH]c(=O)n(CCCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)c1=O 10.1016/s0960-894x(03)00305-6
CHEMBL291951 100601 0 None 15 3 Human 8.2 pKi = 8.2 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 473 8 1 7 1.9 CN(C)c1c[nH]c(=O)n(CCCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)c1=O 10.1016/s0960-894x(03)00305-6
10839389 100326 0 None -3 3 Rat 8.2 pKi = 8.2 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 472 4 1 7 3.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5c(C#N)cccc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL289627 100326 0 None -3 3 Rat 8.2 pKi = 8.2 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 472 4 1 7 3.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5c(C#N)cccc54)c3=O)C[C@@H]21 10.1021/jm990567u
487 3607 21 None -4 12 Rat 8.2 pKi = 8.2 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligand
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm960069a
60602 3607 21 None -4 12 Rat 8.2 pKi = 8.2 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligand
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm960069a
CHEMBL405355 3607 21 None -4 12 Rat 8.2 pKi = 8.2 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligand
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm960069a
DB09239 3607 21 None -4 12 Rat 8.2 pKi = 8.2 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligand
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm960069a
44288792 100288 0 None 134 3 Human 8.2 pKi = 8.2 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 451 8 1 3 5.5 Cc1ccccc1C1(C#N)CCN(CCCNC(=O)C(c2ccc(Cl)cc2)C(C)C)CC1 10.1016/s0960-894x(00)00307-3
CHEMBL289339 100288 0 None 134 3 Human 8.2 pKi = 8.2 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 451 8 1 3 5.5 Cc1ccccc1C1(C#N)CCN(CCCNC(=O)C(c2ccc(Cl)cc2)C(C)C)CC1 10.1016/s0960-894x(00)00307-3
124 2960 47 None -13 33 Rat 8.2 pKi = 8.2 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
2032 2960 47 None -13 33 Rat 8.2 pKi = 8.2 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
4636 2960 47 None -13 33 Rat 8.2 pKi = 8.2 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
CHEMBL762 2960 47 None -13 33 Rat 8.2 pKi = 8.2 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
DB00935 2960 47 None -13 33 Rat 8.2 pKi = 8.2 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
118716704 114971 0 None 1 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 423 5 0 6 3.2 COc1ccccc1N1CCN(CC2COC3(CCN(c4ccccc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342857 114971 0 None 1 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 423 5 0 6 3.2 COc1ccccc1N1CCN(CC2COC3(CCN(c4ccccc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
118716715 114983 0 None 1 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 521 6 0 7 3.1 COc1ccccc1N1CCN(CC2COC3(CCN(S(=O)(=O)c4ccc(Cl)cc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342868 114983 0 None 1 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 521 6 0 7 3.1 COc1ccccc1N1CCN(CC2COC3(CCN(S(=O)(=O)c4ccc(Cl)cc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
44331169 167923 0 None 14 3 Human 8.2 pKi = 8.2 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 444 6 1 6 3.1 COc1ccccc1CCN1CCC2(CC1)CC(=O)c1ccc(NS(C)(=O)=O)cc1O2 10.1016/s0960-894x(98)00732-x
CHEMBL431631 167923 0 None 14 3 Human 8.2 pKi = 8.2 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 444 6 1 6 3.1 COc1ccccc1CCN1CCC2(CC1)CC(=O)c1ccc(NS(C)(=O)=O)cc1O2 10.1016/s0960-894x(98)00732-x
16041449 95191 0 None -1 4 Human 8.2 pKi = 8.2 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 538 6 2 4 6.7 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3c(Cl)cc(Cl)cc3Cl)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL256040 95191 0 None -1 4 Human 8.2 pKi = 8.2 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 538 6 2 4 6.7 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3c(Cl)cc(Cl)cc3Cl)CC2)CC1 10.1016/j.bmcl.2007.11.068
57391896 69276 0 None 1 5 Pig 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 1013 36 2 15 5.4 COc1ccccc1N1CCN(CCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1 10.1016/j.bmc.2011.10.063
CHEMBL1928129 69276 0 None 1 5 Pig 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 1013 36 2 15 5.4 COc1ccccc1N1CCN(CCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1 10.1016/j.bmc.2011.10.063
2894 208048 6 None -12 6 Bovine 8.2 pKi = 8.2 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)C4CCCCC43)nc(N)c2cc1OC 10.1021/jm960510x
CHEMBL97698 208048 6 None -12 6 Bovine 8.2 pKi = 8.2 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)C4CCCCC43)nc(N)c2cc1OC 10.1021/jm960510x
46934791 16658 0 None -2 4 Human 8.2 pKi = 8.2 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 479 7 0 7 2.6 COc1ccccc1N1CCN(C[C@H]2CO[C@@](CN3C(=O)CCCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
CHEMBL1242818 16658 0 None -2 4 Human 8.2 pKi = 8.2 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 479 7 0 7 2.6 COc1ccccc1N1CCN(C[C@H]2CO[C@@](CN3C(=O)CCCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
145960918 161504 0 None -8 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 427 3 1 7 3.2 COc1cc2nc(N3CCN(C(=O)C(C)(C)C)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
CHEMBL4128460 161504 0 None -8 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 427 3 1 7 3.2 COc1cc2nc(N3CCN(C(=O)C(C)(C)C)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
46882085 5783 0 None -7 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 419 10 1 5 4.4 CCOc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.bmcl.2010.01.030
CHEMBL1078953 5783 0 None -7 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 419 10 1 5 4.4 CCOc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.bmcl.2010.01.030
21830793 91806 10 None -44 46 Human 8.2 pKi = 8.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 373 7 0 8 0.6 COc1ccccc1N1CCN(CCCCn2ncc(=O)n(C)c2=O)CC1 10.1016/j.bmc.2013.05.050
CHEMBL2413154 91806 10 None -44 46 Human 8.2 pKi = 8.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 373 7 0 8 0.6 COc1ccccc1N1CCN(CCCCn2ncc(=O)n(C)c2=O)CC1 10.1016/j.bmc.2013.05.050
11948707 166143 0 None -128 13 Human 8.2 pKi = 8.2 Binding
Binding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constantBinding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constant
ChEMBL 373 7 0 8 0.6 COc1cccc(N2CCN(CCCCn3ncc(=O)n(C)c3=O)CC2)c1 10.1021/acs.jmedchem.2c00633
CHEMBL426317 166143 0 None -128 13 Human 8.2 pKi = 8.2 Binding
Binding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constantBinding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constant
ChEMBL 373 7 0 8 0.6 COc1cccc(N2CCN(CCCCn3ncc(=O)n(C)c3=O)CC2)c1 10.1021/acs.jmedchem.2c00633
118716700 114967 0 None -1 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 437 6 0 6 3.2 COc1ccccc1N1CCN(CC2COC3(CCN(Cc4ccccc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342853 114967 0 None -1 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 437 6 0 6 3.2 COc1ccccc1N1CCN(CC2COC3(CCN(Cc4ccccc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
10841296 36426 0 None 46 3 Human 8.2 pKi = 8.2 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 601 8 0 7 6.1 COC(=O)C1=C(C)N=C(C)N(Cc2cccc(CN3CCC(C(=O)OC)(c4ccccc4)CC3)c2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL144731 36426 0 None 46 3 Human 8.2 pKi = 8.2 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 601 8 0 7 6.1 COC(=O)C1=C(C)N=C(C)N(Cc2cccc(CN3CCC(C(=O)OC)(c4ccccc4)CC3)c2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
10810527 100545 0 None -2 3 Rat 8.2 pKi = 8.2 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 392 4 1 6 1.8 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4ccncc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL291588 100545 0 None -2 3 Rat 8.2 pKi = 8.2 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 392 4 1 6 1.8 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4ccncc4c3=O)C[C@@H]21 10.1021/jm000541z
2142 3074 58 None -1 37 Bovine 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm020938y
4920903 3074 58 None -1 37 Bovine 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm020938y
502 3074 58 None -1 37 Bovine 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm020938y
5775 3074 58 None -1 37 Bovine 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm020938y
CHEMBL597 3074 58 None -1 37 Bovine 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm020938y
DB00692 3074 58 None -1 37 Bovine 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm020938y
3584 3748 64 None -2 14 Human 8.2 pKi = 8.2 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00010a001
5401 3748 64 None -2 14 Human 8.2 pKi = 8.2 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00010a001
7302 3748 64 None -2 14 Human 8.2 pKi = 8.2 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00010a001
CHEMBL611 3748 64 None -2 14 Human 8.2 pKi = 8.2 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00010a001
DB01162 3748 64 None -2 14 Human 8.2 pKi = 8.2 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00010a001
10507357 203913 0 None 58 2 Human 8.2 pKi = 8.2 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 574 10 1 7 4.0 COC(CNC(=O)c1ccc2c(c1)C(=O)N(c1cccc(F)c1)C2=O)CN1CCN(c2ccccc2OC(C)C)CC1 10.1021/jm9905918
CHEMBL69245 203913 0 None 58 2 Human 8.2 pKi = 8.2 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 574 10 1 7 4.0 COC(CNC(=O)c1ccc2c(c1)C(=O)N(c1cccc(F)c1)C2=O)CN1CCN(c2ccccc2OC(C)C)CC1 10.1021/jm9905918
3584 3748 64 None -2 14 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990200p
3584 3748 64 None -2 14 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990202+
5401 3748 64 None -2 14 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990200p
5401 3748 64 None -2 14 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990202+
7302 3748 64 None -2 14 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990200p
7302 3748 64 None -2 14 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990202+
CHEMBL611 3748 64 None -2 14 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990200p
CHEMBL611 3748 64 None -2 14 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990202+
DB01162 3748 64 None -2 14 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990200p
DB01162 3748 64 None -2 14 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990202+
3584 3748 64 None -2 14 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990201h
5401 3748 64 None -2 14 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990201h
7302 3748 64 None -2 14 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990201h
CHEMBL611 3748 64 None -2 14 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990201h
DB01162 3748 64 None -2 14 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990201h
10747021 120994 0 None 12 3 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 670 8 2 5 7.0 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(c3ccc(Cl)cc3)(c3ccc(Cl)cc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL356571 120994 0 None 12 3 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 670 8 2 5 7.0 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(c3ccc(Cl)cc3)(c3ccc(Cl)cc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
3584 3748 64 None -2 14 Human 8.2 pKi = 8.2 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980077m
5401 3748 64 None -2 14 Human 8.2 pKi = 8.2 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980077m
7302 3748 64 None -2 14 Human 8.2 pKi = 8.2 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980077m
CHEMBL611 3748 64 None -2 14 Human 8.2 pKi = 8.2 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980077m
DB01162 3748 64 None -2 14 Human 8.2 pKi = 8.2 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980077m
90645600 112406 0 None -1 3 Human 8.2 pKi = 8.2 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 640 12 2 9 4.6 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)CCCN(C)Cc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
CHEMBL3298018 112406 0 None -1 3 Human 8.2 pKi = 8.2 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 640 12 2 9 4.6 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)CCCN(C)Cc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
135398745 2893 112 None -39 66 Human 7.2 pKi = 7.2 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
47 2893 112 None -39 66 Human 7.2 pKi = 7.2 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
CHEMBL715 2893 112 None -39 66 Human 7.2 pKi = 7.2 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
DB00334 2893 112 None -39 66 Human 7.2 pKi = 7.2 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
3038495 705 37 None -40 19 Rat 7.2 pKi = 7.2 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 417 8 1 4 4.2 COc1ccccc1N1CCN(CC1)CCCCNC(=O)c1ccc2c(c1)cccc2 10.1021/jm0211220
7625 705 37 None -40 19 Rat 7.2 pKi = 7.2 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 417 8 1 4 4.2 COc1ccccc1N1CCN(CC1)CCCCNC(=O)c1ccc2c(c1)cccc2 10.1021/jm0211220
CHEMBL25236 705 37 None -40 19 Rat 7.2 pKi = 7.2 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 417 8 1 4 4.2 COc1ccccc1N1CCN(CC1)CCCCNC(=O)c1ccc2c(c1)cccc2 10.1021/jm0211220
44414264 12756 0 None -7 2 Rat 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 326 5 0 3 4.5 c1ccc2c(C3CCN(CCCN4CCCCC4)CC3)coc2c1 10.1016/j.bmcl.2006.05.002
CHEMBL1188050 12756 0 None -7 2 Rat 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 326 5 0 3 4.5 c1ccc2c(C3CCN(CCCN4CCCCC4)CC3)coc2c1 10.1016/j.bmcl.2006.05.002
CHEMBL534944 12756 0 None -7 2 Rat 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 326 5 0 3 4.5 c1ccc2c(C3CCN(CCCN4CCCCC4)CC3)coc2c1 10.1016/j.bmcl.2006.05.002
11705395 16020 0 None -19 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 428 7 1 4 5.6 Clc1cccc(N2CCN(CCCCNc3nccc4ccccc34)CC2)c1Cl 10.1016/j.bmcl.2010.07.096
CHEMBL1223749 16020 0 None -19 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 428 7 1 4 5.6 Clc1cccc(N2CCN(CCCCNc3nccc4ccccc34)CC2)c1Cl 10.1016/j.bmcl.2010.07.096
135398745 2893 112 None -39 66 Human 7.2 pKi = 7.2 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1021/jm401958n
47 2893 112 None -39 66 Human 7.2 pKi = 7.2 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1021/jm401958n
CHEMBL715 2893 112 None -39 66 Human 7.2 pKi = 7.2 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1021/jm401958n
DB00334 2893 112 None -39 66 Human 7.2 pKi = 7.2 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1021/jm401958n
197033 199129 64 None -7 8 Human 7.2 pKi = 7.2 Binding
Binding affinity to adrenergic alpha1A receptor by radioligand displacement assayBinding affinity to adrenergic alpha1A receptor by radioligand displacement assay
ChEMBL 319 3 0 3 3.9 Cc1ccc2c(c1)c1c(n2CCc2ccc(C)nc2)CCN(C)C1 10.1016/j.bmcl.2009.11.037
CHEMBL589390 199129 64 None -7 8 Human 7.2 pKi = 7.2 Binding
Binding affinity to adrenergic alpha1A receptor by radioligand displacement assayBinding affinity to adrenergic alpha1A receptor by radioligand displacement assay
ChEMBL 319 3 0 3 3.9 Cc1ccc2c(c1)c1c(n2CCc2ccc(C)nc2)CCN(C)C1 10.1016/j.bmcl.2009.11.037
76315668 85306 0 None 36 3 Rat 7.2 pKi = 7.2 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 323 4 3 5 1.6 CCS(=O)(=O)Nc1c(O)ccc2c1CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
CHEMBL2261347 85306 0 None 36 3 Rat 7.2 pKi = 7.2 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 323 4 3 5 1.6 CCS(=O)(=O)Nc1c(O)ccc2c1CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
155555859 176203 0 None -3 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 433 11 1 5 4.6 COc1ccccc1OCCNCC[C@H]1CO[C@H](C(c2ccccc2)c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
CHEMBL4551941 176203 0 None -3 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 433 11 1 5 4.6 COc1ccccc1OCCNCC[C@H]1CO[C@H](C(c2ccccc2)c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
CHEMBL4594653 176203 0 None -3 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 433 11 1 5 4.6 COc1ccccc1OCCNCC[C@H]1CO[C@H](C(c2ccccc2)c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
118716711 114979 0 None 1 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 389 4 0 6 1.6 COc1ccccc1N1CCN(CC2COC3(CCN(C(C)=O)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342864 114979 0 None 1 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 389 4 0 6 1.6 COc1ccccc1N1CCN(CC2COC3(CCN(C(C)=O)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
68712 100310 60 None -8 5 Human 5.2 pKi = 5.2 Binding
Binding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 10.1016/0960-894X(94)85032-1
CHEMBL289480 100310 60 None -8 5 Human 5.2 pKi = 5.2 Binding
Binding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 10.1016/0960-894X(94)85032-1
10326069 39266 1 None 23 9 Human 6.2 pKi = 6.2 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 589 10 3 8 3.3 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980506g
CHEMBL147077 39266 1 None 23 9 Human 6.2 pKi = 6.2 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 589 10 3 8 3.3 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980506g
73346334 92512 0 None -6 7 Human 5.2 pKi = 5.2 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin) by PDSP assayInhibition of adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 265 4 1 1 3.0 c1ccc(CCN[C@H]2C3C4CC5C6C4CC3C6C52)cc1 10.1016/j.bmc.2013.07.045
CHEMBL2432048 92512 0 None -6 7 Human 5.2 pKi = 5.2 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin) by PDSP assayInhibition of adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 265 4 1 1 3.0 c1ccc(CCN[C@H]2C3C4CC5C6C4CC3C6C52)cc1 10.1016/j.bmc.2013.07.045
44431560 145553 0 None -2 4 Human 7.2 pKi = 7.2 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 517 9 1 7 3.9 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.008
CHEMBL391530 145553 0 None -2 4 Human 7.2 pKi = 7.2 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 517 9 1 7 3.9 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.008
44288816 155287 0 None 17 3 Human 7.2 pKi = 7.2 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 443 8 1 3 5.4 N#CC1(c2ccccc2)CCN(CCCNC(=O)C(c2ccccc2)C2CCCCC2)CC1 10.1016/s0960-894x(00)00307-3
CHEMBL40303 155287 0 None 17 3 Human 7.2 pKi = 7.2 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 443 8 1 3 5.4 N#CC1(c2ccccc2)CCN(CCCNC(=O)C(c2ccccc2)C2CCCCC2)CC1 10.1016/s0960-894x(00)00307-3
3038603 101838 8 None -48 3 Human 7.2 pKi = 7.2 Binding
The compound was tested for binding affinity against Alpha-1 adrenergic receptor using WB-4101 as radioligandThe compound was tested for binding affinity against Alpha-1 adrenergic receptor using WB-4101 as radioligand
ChEMBL 335 1 0 1 5.4 CN(C)C1C=CC2(CC1)c1ccccc1C=Cc1ccc(Cl)cc12 10.1021/jm00109a026
CHEMBL300647 101838 8 None -48 3 Human 7.2 pKi = 7.2 Binding
The compound was tested for binding affinity against Alpha-1 adrenergic receptor using WB-4101 as radioligandThe compound was tested for binding affinity against Alpha-1 adrenergic receptor using WB-4101 as radioligand
ChEMBL 335 1 0 1 5.4 CN(C)C1C=CC2(CC1)c1ccccc1C=Cc1ccc(Cl)cc12 10.1021/jm00109a026
14378574 108560 0 None -24 5 Human 6.2 pKi = 6.2 Binding
In vitro binding affinity at human Alpha-1A adrenergic receptor.In vitro binding affinity at human Alpha-1A adrenergic receptor.
ChEMBL 327 2 2 5 2.8 COc1cc2c(cc1O)CCN1Cc3c(ccc(O)c3OC)C[C@@H]21 10.1021/jm0307741
CHEMBL320397 108560 0 None -24 5 Human 6.2 pKi = 6.2 Binding
In vitro binding affinity at human Alpha-1A adrenergic receptor.In vitro binding affinity at human Alpha-1A adrenergic receptor.
ChEMBL 327 2 2 5 2.8 COc1cc2c(cc1O)CCN1Cc3c(ccc(O)c3OC)C[C@@H]21 10.1021/jm0307741
10923927 204155 0 None 1 4 Human 6.2 pKi = 6.2 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 279 3 2 5 0.8 O=S1(=O)CCCc2cccc(NCC3=NCCN3)c21 10.1021/jm000542r
CHEMBL70740 204155 0 None 1 4 Human 6.2 pKi = 6.2 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 279 3 2 5 0.8 O=S1(=O)CCCc2cccc(NCC3=NCCN3)c21 10.1021/jm000542r
19968568 85310 0 None 2 3 Rat 6.2 pKi = 6.2 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 323 4 2 5 1.5 COc1ccc2c(c1NS(C)(=O)=O)CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
CHEMBL2261353 85310 0 None 2 3 Rat 6.2 pKi = 6.2 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 323 4 2 5 1.5 COc1ccc2c(c1NS(C)(=O)=O)CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
118717458 115114 0 None -4 4 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 412 10 2 4 6.9 Cc1ccc2nccc(NCCCCCCCNc3ccnc4ccc(C)cc34)c2c1 10.1016/j.bmc.2014.09.017
CHEMBL3343980 115114 0 None -4 4 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 412 10 2 4 6.9 Cc1ccc2nccc(NCCCCCCCNc3ccnc4ccc(C)cc34)c2c1 10.1016/j.bmc.2014.09.017
118717458 115114 0 None -4 4 Human 6.2 pKi = 6.2 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 412 10 2 4 6.9 Cc1ccc2nccc(NCCCCCCCNc3ccnc4ccc(C)cc34)c2c1 10.1016/j.bmc.2014.09.017
CHEMBL3343980 115114 0 None -4 4 Human 6.2 pKi = 6.2 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 412 10 2 4 6.9 Cc1ccc2nccc(NCCCCCCCNc3ccnc4ccc(C)cc34)c2c1 10.1016/j.bmc.2014.09.017
44295170 101795 0 None 19 3 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 554 6 2 7 2.8 COC(=O)C1(c2ccccc2)CCN(CCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc(F)c(F)c2)CC1 10.1016/s0960-894x(99)00653-8
CHEMBL300272 101795 0 None 19 3 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 554 6 2 7 2.8 COC(=O)C1(c2ccccc2)CCN(CCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc(F)c(F)c2)CC1 10.1016/s0960-894x(99)00653-8
10622206 102065 0 None 1 3 Rat 7.2 pKi = 7.2 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 423 6 1 6 3.6 COc1cc2c(cc1OC)NCN(CCN1C[C@@H]3CCc4c(OC)cccc4[C@@H]3C1)C2 10.1021/jm000541z
CHEMBL302192 102065 0 None 1 3 Rat 7.2 pKi = 7.2 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 423 6 1 6 3.6 COc1cc2c(cc1OC)NCN(CCN1C[C@@H]3CCc4c(OC)cccc4[C@@H]3C1)C2 10.1021/jm000541z
11211017 198211 0 None -43 7 Human 6.2 pKi = 6.2 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 373 4 0 4 2.7 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccc(F)cc2)CC1 10.1021/jm0491391
CHEMBL57546 198211 0 None -43 7 Human 6.2 pKi = 6.2 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 373 4 0 4 2.7 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccc(F)cc2)CC1 10.1021/jm0491391
2419 692 28 None -288 12 Rat 6.2 pKi = 6.2 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm980053f
9 692 28 None -288 12 Rat 6.2 pKi = 6.2 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm980053f
CHEMBL13647 692 28 None -288 12 Rat 6.2 pKi = 6.2 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm980053f
16785637 181553 80 None -11 2 Bovine 4.2 pKi = 4.2 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 206 2 2 4 -0.4 NC(=O)c1cccnc1N1CCNCC1 10.1021/jm00366a007
CHEMBL47688 181553 80 None -11 2 Bovine 4.2 pKi = 4.2 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 206 2 2 4 -0.4 NC(=O)c1cccnc1N1CCNCC1 10.1021/jm00366a007
5282322 78215 21 None - 1 Rat 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 785 11 4 15 2.4 CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O)/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]1O nan
CHEMBL2106399 78215 21 None - 1 Rat 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 785 11 4 15 2.4 CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O)/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]1O nan
11091738 118066 0 None -954 6 Rat 6.2 pKi = 6.2 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 456 7 1 4 4.9 O=C(NCCCCN1CCN(c2ccc(Cl)cc2Cl)CC1)c1cc2ccccc2cn1 10.1021/jm0211220
CHEMBL340641 118066 0 None -954 6 Rat 6.2 pKi = 6.2 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 456 7 1 4 4.9 O=C(NCCCCN1CCN(c2ccc(Cl)cc2Cl)CC1)c1cc2ccccc2cn1 10.1021/jm0211220
10792347 121980 0 None 8 3 Human 7.2 pKi = 7.2 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 531 9 3 6 3.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(C)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980506g
CHEMBL359375 121980 0 None 8 3 Human 7.2 pKi = 7.2 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 531 9 3 6 3.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(C)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980506g
52937630 61276 0 None -199 3 Human 7.2 pKi = 7.2 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 351 4 0 4 3.2 CN1CCC[C@@H]1Cn1nc(Cc2ccc(F)cc2)c2ccccc2c1=O 10.1021/jm1013874
CHEMBL1767140 61276 0 None -199 3 Human 7.2 pKi = 7.2 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 351 4 0 4 3.2 CN1CCC[C@@H]1Cn1nc(Cc2ccc(F)cc2)c2ccccc2c1=O 10.1021/jm1013874
24803638 61300 0 None -199 4 Human 7.2 pKi = 7.2 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 636 15 0 7 7.1 COc1ccc(Cc2nn(C[C@H]3CCCN3CCCCc3ccc(OCCCN4CCCCCC4)cc3)c(=O)c3ccccc23)cc1 10.1021/jm1013874
CHEMBL1767165 61300 0 None -199 4 Human 7.2 pKi = 7.2 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 636 15 0 7 7.1 COc1ccc(Cc2nn(C[C@H]3CCCN3CCCCc3ccc(OCCCN4CCCCCC4)cc3)c(=O)c3ccccc23)cc1 10.1021/jm1013874
53328873 63374 0 None 1 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 447 6 0 5 3.2 COc1ccccc1N1CCN(CCCN2C(=O)CC3(CCc4ccccc43)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796049 63374 0 None 1 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 447 6 0 5 3.2 COc1ccccc1N1CCN(CCCN2C(=O)CC3(CCc4ccccc43)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
9864325 101711 1 None -758 7 Human 6.2 pKi = 6.2 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 373 4 0 4 2.7 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2F)CC1 10.1021/jm0491391
CHEMBL299691 101711 1 None -758 7 Human 6.2 pKi = 6.2 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 373 4 0 4 2.7 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2F)CC1 10.1021/jm0491391
14378574 108560 0 None -24 5 Human 6.2 pKi = 6.2 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 327 2 2 5 2.8 COc1cc2c(cc1O)CCN1Cc3c(ccc(O)c3OC)C[C@@H]21 10.1016/j.bmcl.2004.11.032
CHEMBL320397 108560 0 None -24 5 Human 6.2 pKi = 6.2 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 327 2 2 5 2.8 COc1cc2c(cc1O)CCN1Cc3c(ccc(O)c3OC)C[C@@H]21 10.1016/j.bmcl.2004.11.032
11440979 197637 0 None -8 2 Rat 6.2 pKi = 6.2 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 400 5 1 6 1.3 COc1ccccc1N1CCN(CCN2C(=O)CC3(CCNCC3)CC2=O)CC1 10.1021/jm030944+
CHEMBL57098 197637 0 None -8 2 Rat 6.2 pKi = 6.2 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 400 5 1 6 1.3 COc1ccccc1N1CCN(CCN2C(=O)CC3(CCNCC3)CC2=O)CC1 10.1021/jm030944+
127036953 137490 0 None -63 22 Human 6.2 pKi = 6.2 Binding
Binding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 318 7 1 1 4.1 C=CCN(CC=C)CCc1c[nH]c2ccc(Br)cc12 10.1016/j.bmcl.2015.12.053
CHEMBL3754166 137490 0 None -63 22 Human 6.2 pKi = 6.2 Binding
Binding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 318 7 1 1 4.1 C=CCN(CC=C)CCc1c[nH]c2ccc(Br)cc12 10.1016/j.bmcl.2015.12.053
10571609 206674 0 None -2 2 Rat 7.2 pKi = 7.2 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 376 6 0 4 3.4 Clc1cccc(N2CCN(CCCCN3CC4CCCCN4C3)CC2)c1 10.1021/jm970216k
CHEMBL89677 206674 0 None -2 2 Rat 7.2 pKi = 7.2 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 376 6 0 4 3.4 Clc1cccc(N2CCN(CCCCN3CC4CCCCN4C3)CC2)c1 10.1021/jm970216k
10594858 165631 0 None -2 2 Rat 7.2 pKi = 7.2 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 362 6 0 4 3.0 Clc1cccc(N2CCN(CCCCN3CC4CCCN4C3)CC2)c1 10.1021/jm970216k
CHEMBL424432 165631 0 None -2 2 Rat 7.2 pKi = 7.2 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 362 6 0 4 3.0 Clc1cccc(N2CCN(CCCCN3CC4CCCN4C3)CC2)c1 10.1021/jm970216k
3565378 178793 8 None -26 2 Rat 7.2 pKi = 7.2 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 424 6 0 4 3.0 O=C1C2CCCN2C(=O)N1CCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1 10.1021/jm970216k
CHEMBL46918 178793 8 None -26 2 Rat 7.2 pKi = 7.2 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 424 6 0 4 3.0 O=C1C2CCCN2C(=O)N1CCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1 10.1021/jm970216k
44361064 31585 0 None -23 6 Rat 6.2 pKi = 6.2 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 338 7 2 4 4.5 N=CCC(O)CC1CCN(c2ccccc2Oc2ccccc2)CC1 10.1021/jm960510x
CHEMBL140450 31585 0 None -23 6 Rat 6.2 pKi = 6.2 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 338 7 2 4 4.5 N=CCC(O)CC1CCN(c2ccccc2Oc2ccccc2)CC1 10.1021/jm960510x
127025278 137689 0 None -33 3 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 387 9 1 4 3.7 COc1ccccc1N1CCN(CCCCNC(=O)CC2CCCCC2)CC1 10.1016/j.bmcl.2015.12.068
CHEMBL3758913 137689 0 None -33 3 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 387 9 1 4 3.7 COc1ccccc1N1CCN(CCCCNC(=O)CC2CCCCC2)CC1 10.1016/j.bmcl.2015.12.068
11994673 12284 0 None -3 6 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 419 7 1 5 4.5 COc1ccc2ccccc2c1OCCNC[C@H]1COc2cc3c(cc2O1)CCCC3 10.1021/jm060358r
CHEMBL1185036 12284 0 None -3 6 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 419 7 1 5 4.5 COc1ccc2ccccc2c1OCCNC[C@H]1COc2cc3c(cc2O1)CCCC3 10.1021/jm060358r
CHEMBL385371 12284 0 None -3 6 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 419 7 1 5 4.5 COc1ccc2ccccc2c1OCCNC[C@H]1COc2cc3c(cc2O1)CCCC3 10.1021/jm060358r
71449516 84575 0 None -3 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 361 8 2 7 2.2 COc1cccc(OC)c1OCCNC[C@@H]1COc2cccc(O)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153552 84575 0 None -3 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 361 8 2 7 2.2 COc1cccc(OC)c1OCCNC[C@@H]1COc2cccc(O)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2221146 84575 0 None -3 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 361 8 2 7 2.2 COc1cccc(OC)c1OCCNC[C@@H]1COc2cccc(O)c2O1 10.1016/j.ejmech.2012.09.049
11079593 204092 0 None -1 4 Human 6.2 pKi = 6.2 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1cc(F)ccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL70326 204092 0 None -1 4 Human 6.2 pKi = 6.2 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1cc(F)ccc1NCC1=NCCN1 10.1021/jm000542r
10454026 17875 0 None -2041 9 Rat 6.2 pKi = 6.2 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 406 8 2 4 3.5 COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3[nH]2)CC1 10.1021/jm0211220
CHEMBL125916 17875 0 None -2041 9 Rat 6.2 pKi = 6.2 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 406 8 2 4 3.5 COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3[nH]2)CC1 10.1021/jm0211220
49800167 17649 0 None -1 3 Rat 7.2 pKi = 7.2 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 514 9 2 6 3.1 CCOc1ccccc1N1CCN(CC(O)CN2C(=O)NC(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
CHEMBL1258457 17649 0 None -1 3 Rat 7.2 pKi = 7.2 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 514 9 2 6 3.1 CCOc1ccccc1N1CCN(CC(O)CN2C(=O)NC(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
53328507 63366 0 None 1 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 469 8 0 5 4.2 COc1ccccc1N1CCN(CCCCN2C(=O)CC(c3ccc(Cl)cc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796041 63366 0 None 1 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 469 8 0 5 4.2 COc1ccccc1N1CCN(CCCCN2C(=O)CC(c3ccc(Cl)cc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
11554490 16021 0 None -67 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 428 7 1 4 5.3 FC(F)(F)c1cccc(N2CCN(CCCCNc3nccc4ccccc34)CC2)c1 10.1016/j.bmcl.2010.07.096
CHEMBL1223750 16021 0 None -67 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 428 7 1 4 5.3 FC(F)(F)c1cccc(N2CCN(CCCCNc3nccc4ccccc34)CC2)c1 10.1016/j.bmcl.2010.07.096
9909471 196883 0 None -21 4 Rat 7.2 pKi = 7.2 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 409 4 0 4 3.4 O=C1CC2(CCCC2)C(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
CHEMBL56620 196883 0 None -21 4 Rat 7.2 pKi = 7.2 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 409 4 0 4 3.4 O=C1CC2(CCCC2)C(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
3039881 174233 10 None -19 3 Human 6.2 pKi = 6.2 Binding
The compound was tested for binding affinity against Alpha-1 adrenergic receptor using WB-4101 as radioligandThe compound was tested for binding affinity against Alpha-1 adrenergic receptor using WB-4101 as radioligand
ChEMBL 337 1 0 1 5.0 CN(C)C1C=CC2(CC1)c1ccccc1CCc1ccc(Cl)cc12 10.1021/jm00109a026
CHEMBL45491 174233 10 None -19 3 Human 6.2 pKi = 6.2 Binding
The compound was tested for binding affinity against Alpha-1 adrenergic receptor using WB-4101 as radioligandThe compound was tested for binding affinity against Alpha-1 adrenergic receptor using WB-4101 as radioligand
ChEMBL 337 1 0 1 5.0 CN(C)C1C=CC2(CC1)c1ccccc1CCc1ccc(Cl)cc12 10.1021/jm00109a026
11651319 181604 27 None -17 2 Bovine 5.2 pKi = 5.2 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 197 1 1 3 1.1 Clc1cnccc1N1CCNCC1 10.1021/jm00366a007
CHEMBL47740 181604 27 None -17 2 Bovine 5.2 pKi = 5.2 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 197 1 1 3 1.1 Clc1cnccc1N1CCNCC1 10.1021/jm00366a007
118717457 115111 0 None -1 4 Human 7.2 pKi = 7.2 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 374 7 2 6 4.3 COc1ccc2c(NCCNc3ccnc4cc(OC)ccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
CHEMBL3343978 115111 0 None -1 4 Human 7.2 pKi = 7.2 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 374 7 2 6 4.3 COc1ccc2c(NCCNc3ccnc4cc(OC)ccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
11857861 85647 0 None -1 4 Human 7.2 pKi = 7.2 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 520 10 1 6 4.5 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OCCF)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
CHEMBL228606 85647 0 None -1 4 Human 7.2 pKi = 7.2 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 520 10 1 6 4.5 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OCCF)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
11857861 85647 0 None -1 4 Human 7.2 pKi = 7.2 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 520 10 1 6 4.5 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OCCF)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
CHEMBL228606 85647 0 None -1 4 Human 7.2 pKi = 7.2 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 520 10 1 6 4.5 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OCCF)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
44275526 98838 0 None 2 3 Human 7.2 pKi = 7.2 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 621 11 2 6 7.3 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(OC(C)C)cc1 10.1021/jm960697s
CHEMBL27899 98838 0 None 2 3 Human 7.2 pKi = 7.2 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 621 11 2 6 7.3 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(OC(C)C)cc1 10.1021/jm960697s
118717457 115111 0 None -1 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 374 7 2 6 4.3 COc1ccc2c(NCCNc3ccnc4cc(OC)ccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
CHEMBL3343978 115111 0 None -1 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 374 7 2 6 4.3 COc1ccc2c(NCCNc3ccnc4cc(OC)ccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
9884513 12995 0 None -43 2 Rat 6.2 pKi = 6.2 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 343 5 1 2 4.4 Fc1ccc2[nH]cc(C3CCN(CCCN4CCCCC4)CC3)c2c1 10.1016/j.bmcl.2006.05.002
CHEMBL1189871 12995 0 None -43 2 Rat 6.2 pKi = 6.2 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 343 5 1 2 4.4 Fc1ccc2[nH]cc(C3CCN(CCCN4CCCCC4)CC3)c2c1 10.1016/j.bmcl.2006.05.002
CHEMBL539601 12995 0 None -43 2 Rat 6.2 pKi = 6.2 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 343 5 1 2 4.4 Fc1ccc2[nH]cc(C3CCN(CCCN4CCCCC4)CC3)c2c1 10.1016/j.bmcl.2006.05.002
11338630 9625 0 None -6 3 Bovine 6.2 pKi = 6.2 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assay
ChEMBL 403 4 2 3 4.8 O=S(=O)(Nc1cccc2c1CCCC2c1c[nH]cn1)c1ccc2ccccc2c1 10.1021/jm030551a
CHEMBL112814 9625 0 None -6 3 Bovine 6.2 pKi = 6.2 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assay
ChEMBL 403 4 2 3 4.8 O=S(=O)(Nc1cccc2c1CCCC2c1c[nH]cn1)c1ccc2ccccc2c1 10.1021/jm030551a
53328504 63363 0 None -4 3 Human 5.2 pKi = 5.2 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 445 5 0 4 4.0 O=C1CC(c2ccc(Cl)cc2)CC(=O)N1CCN1CCN(c2ccccc2Cl)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796038 63363 0 None -4 3 Human 5.2 pKi = 5.2 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 445 5 0 4 4.0 O=C1CC(c2ccc(Cl)cc2)CC(=O)N1CCN1CCN(c2ccccc2Cl)CC1 10.1016/j.ejmech.2011.03.054
101876962 115112 0 None 5 4 Human 8.2 pKi = 8.2 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 342 5 2 4 4.9 Cc1cccc2c(NCCNc3ccnc4c(C)cccc34)ccnc12 10.1016/j.bmc.2014.09.017
CHEMBL3343979 115112 0 None 5 4 Human 8.2 pKi = 8.2 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 342 5 2 4 4.9 Cc1cccc2c(NCCNc3ccnc4c(C)cccc34)ccnc12 10.1016/j.bmc.2014.09.017
11857794 85630 0 None -1 4 Human 8.2 pKi = 8.2 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 562 9 1 5 5.7 O=S(=O)(N[C@H]1CC[C@@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1cccc(OC(F)F)c1 10.1016/j.bmcl.2007.04.098
CHEMBL228496 85630 0 None -1 4 Human 8.2 pKi = 8.2 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 562 9 1 5 5.7 O=S(=O)(N[C@H]1CC[C@@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1cccc(OC(F)F)c1 10.1016/j.bmcl.2007.04.098
57390115 69267 0 None -1 5 Pig 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 455 13 1 6 3.4 CCOCCOc1cccc(C(=O)NCCCCN2CCN(c3ccccc3OC)CC2)c1 10.1016/j.bmc.2011.10.063
CHEMBL1928120 69267 0 None -1 5 Pig 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 455 13 1 6 3.4 CCOCCOc1cccc(C(=O)NCCCCN2CCN(c3ccccc3OC)CC2)c1 10.1016/j.bmc.2011.10.063
10841190 107015 0 None 28 6 Human 8.2 pKi = 8.2 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 593 10 2 6 6.5 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(OC)cc1 10.1021/jm980077m
CHEMBL315538 107015 0 None 28 6 Human 8.2 pKi = 8.2 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 593 10 2 6 6.5 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(OC)cc1 10.1021/jm980077m
10841190 85244 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 593 10 2 6 5.7 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(OC)cc1 10.1007/s00044-004-0120-9
CHEMBL2260150 85244 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 593 10 2 6 5.7 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(OC)cc1 10.1007/s00044-004-0120-9
44126269 201461 5 None -18 6 Human 8.2 pKi = 8.2 Binding
Binding affinity to adrenergic alpha1A receptor by radioligand displacement assayBinding affinity to adrenergic alpha1A receptor by radioligand displacement assay
ChEMBL 318 3 0 2 4.5 Cc1ccc(CCn2c3c(c4cc(C)ccc42)CN(C)CC3)cc1 10.1016/j.bmcl.2009.11.037
CHEMBL605081 201461 5 None -18 6 Human 8.2 pKi = 8.2 Binding
Binding affinity to adrenergic alpha1A receptor by radioligand displacement assayBinding affinity to adrenergic alpha1A receptor by radioligand displacement assay
ChEMBL 318 3 0 2 4.5 Cc1ccc(CCn2c3c(c4cc(C)ccc42)CN(C)CC3)cc1 10.1016/j.bmcl.2009.11.037
90645594 112459 0 None -2 3 Human 8.2 pKi = 8.2 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 597 10 2 8 4.7 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)CCCc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
CHEMBL3298747 112459 0 None -2 3 Human 8.2 pKi = 8.2 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 597 10 2 8 4.7 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)CCCc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
145962478 162225 0 None -13 3 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 459 5 2 9 2.8 COc1cc2nc(N3CCC[C@H](NC4=CC(=O)c5ccccc5C4=O)C3)nc(N)c2cc1OC 10.1016/j.ejmech.2017.05.003
CHEMBL4163587 162225 0 None -13 3 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 459 5 2 9 2.8 COc1cc2nc(N3CCC[C@H](NC4=CC(=O)c5ccccc5C4=O)C3)nc(N)c2cc1OC 10.1016/j.ejmech.2017.05.003
2470 3626 50 None -398 60 Rat 8.1 pKi = 8.1 Binding
Overall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary glandOverall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1021/jm00018a001
3300 3626 50 None -398 60 Rat 8.1 pKi = 8.1 Binding
Overall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary glandOverall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1021/jm00018a001
5265 3626 50 None -398 60 Rat 8.1 pKi = 8.1 Binding
Overall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary glandOverall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1021/jm00018a001
99 3626 50 None -398 60 Rat 8.1 pKi = 8.1 Binding
Overall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary glandOverall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1021/jm00018a001
CHEMBL267930 3626 50 None -398 60 Rat 8.1 pKi = 8.1 Binding
Overall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary glandOverall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1021/jm00018a001
155526629 176374 0 None -14 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 419 10 1 5 4.4 COc1ccccc1OCCNCCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
CHEMBL4458714 176374 0 None -14 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 419 10 1 5 4.4 COc1ccccc1OCCNCCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
CHEMBL4595984 176374 0 None -14 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 419 10 1 5 4.4 COc1ccccc1OCCNCCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
3584 3748 64 None -2 14 Human 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00018a001
5401 3748 64 None -2 14 Human 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00018a001
7302 3748 64 None -2 14 Human 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00018a001
CHEMBL611 3748 64 None -2 14 Human 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00018a001
DB01162 3748 64 None -2 14 Human 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00018a001
21712258 169239 0 None 194 2 Human 8.1 pKi = 8.1 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 465 8 1 3 5.5 Cc1ccc(C(C(=O)NCCCN2CCC(C#N)(c3ccccc3)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(01)00320-1
CHEMBL44124 169239 0 None 194 2 Human 8.1 pKi = 8.1 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 465 8 1 3 5.5 Cc1ccc(C(C(=O)NCCCN2CCC(C#N)(c3ccccc3)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(01)00320-1
21712258 169239 0 None 194 2 Human 8.1 pKi = 8.1 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 465 8 1 3 5.5 Cc1ccc(C(C(=O)NCCCN2CCC(C#N)(c3ccccc3)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
CHEMBL44124 169239 0 None 194 2 Human 8.1 pKi = 8.1 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 465 8 1 3 5.5 Cc1ccc(C(C(=O)NCCCN2CCC(C#N)(c3ccccc3)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
44288815 101427 0 None 87 3 Human 8.1 pKi = 8.1 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 431 8 1 3 5.1 Cc1ccc(C(C(=O)NCCCN2CCC(C#N)(c3ccccc3C)CC2)C(C)C)cc1 10.1016/s0960-894x(00)00307-3
CHEMBL297667 101427 0 None 87 3 Human 8.1 pKi = 8.1 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 431 8 1 3 5.1 Cc1ccc(C(C(=O)NCCCN2CCC(C#N)(c3ccccc3C)CC2)C(C)C)cc1 10.1016/s0960-894x(00)00307-3
101876962 115112 0 None 5 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 342 5 2 4 4.9 Cc1cccc2c(NCCNc3ccnc4c(C)cccc34)ccnc12 10.1016/j.bmc.2014.09.017
CHEMBL3343979 115112 0 None 5 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 342 5 2 4 4.9 Cc1cccc2c(NCCNc3ccnc4c(C)cccc34)ccnc12 10.1016/j.bmc.2014.09.017
44288392 100341 0 None -1 3 Rat 8.1 pKi = 8.1 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 475 6 1 6 4.4 COc1cccc2c1CCC1CN(CCCCn3c(=O)[nH]c4c(sc5ccccc54)c3=O)CC21 10.1021/jm990567u
CHEMBL289758 100341 0 None -1 3 Rat 8.1 pKi = 8.1 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 475 6 1 6 4.4 COc1cccc2c1CCC1CN(CCCCn3c(=O)[nH]c4c(sc5ccccc54)c3=O)CC21 10.1021/jm990567u
44431555 89134 0 None 1 4 Human 8.1 pKi = 8.1 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 535 8 1 7 3.3 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccc(S(C)(=O)=O)cc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL236618 89134 0 None 1 4 Human 8.1 pKi = 8.1 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 535 8 1 7 3.3 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccc(S(C)(=O)=O)cc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
10841819 118728 0 None 346 3 Human 8.1 pKi = 8.1 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 640 7 1 8 3.9 COCC1=C(C(=O)OC)C(c2ccc(F)c(F)c2)N(C(=O)N2CCC(N3CCC(C(=O)OC)(c4ccccc4)CC3)CC2)C(=O)N1 10.1021/jm990201h
CHEMBL341838 118728 0 None 346 3 Human 8.1 pKi = 8.1 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 640 7 1 8 3.9 COCC1=C(C(=O)OC)C(c2ccc(F)c(F)c2)N(C(=O)N2CCC(N3CCC(C(=O)OC)(c4ccccc4)CC3)CC2)C(=O)N1 10.1021/jm990201h
44289112 164873 0 None 75 3 Human 8.1 pKi = 8.1 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 495 9 1 4 5.5 COc1ccccc1C1(C#N)CCN(CCCNC(=O)C(c2ccc(C)cc2)c2ccc(C)cc2)CC1 10.1016/s0960-894x(00)00307-3
CHEMBL42220 164873 0 None 75 3 Human 8.1 pKi = 8.1 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 495 9 1 4 5.5 COc1ccccc1C1(C#N)CCN(CCCNC(=O)C(c2ccc(C)cc2)c2ccc(C)cc2)CC1 10.1016/s0960-894x(00)00307-3
8459 3273 4 None -7 3 Rat 8.1 pKi = 8.1 Binding
The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.
ChEMBL 495 8 1 9 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)COc1c(OC)cccc1C(C)C 10.1021/jm9805337
9891980 3273 4 None -7 3 Rat 8.1 pKi = 8.1 Binding
The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.
ChEMBL 495 8 1 9 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)COc1c(OC)cccc1C(C)C 10.1021/jm9805337
CHEMBL430717 3273 4 None -7 3 Rat 8.1 pKi = 8.1 Binding
The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.
ChEMBL 495 8 1 9 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)COc1c(OC)cccc1C(C)C 10.1021/jm9805337
10793504 41710 0 None 436 3 Human 8.1 pKi = 8.1 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 588 10 3 8 3.2 CCOC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(N)=O)C2c2ccc3c(c2)OCO3)CC1 10.1021/jm980506g
CHEMBL149263 41710 0 None 436 3 Human 8.1 pKi = 8.1 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 588 10 3 8 3.2 CCOC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(N)=O)C2c2ccc3c(c2)OCO3)CC1 10.1021/jm980506g
10721049 43692 0 None 245 3 Human 8.1 pKi = 8.1 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 533 9 4 7 2.8 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(O)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980506g
CHEMBL151045 43692 0 None 245 3 Human 8.1 pKi = 8.1 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 533 9 4 7 2.8 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(O)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980506g
10743111 198672 0 None -1 3 Rat 8.1 pKi = 8.1 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 473 5 1 6 4.1 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cc(-c5ccccc5)sc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL58105 198672 0 None -1 3 Rat 8.1 pKi = 8.1 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 473 5 1 6 4.1 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cc(-c5ccccc5)sc4c3=O)C[C@@H]21 10.1021/jm000541z
10793504 41710 0 None 436 3 Human 8.1 pKi = 8.1 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 588 10 3 8 3.2 CCOC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(N)=O)C2c2ccc3c(c2)OCO3)CC1 10.1007/s00044-004-0120-9
CHEMBL149263 41710 0 None 436 3 Human 8.1 pKi = 8.1 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 588 10 3 8 3.2 CCOC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(N)=O)C2c2ccc3c(c2)OCO3)CC1 10.1007/s00044-004-0120-9
10606659 100506 0 None 7 3 Rat 8.1 pKi = 8.1 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 436 6 0 5 3.4 COc1cc2c(cc1OC)C(=O)N(CCN1C[C@@H]3CCc4c(OC)cccc4[C@@H]3C1)CC2 10.1021/jm000541z
CHEMBL291305 100506 0 None 7 3 Rat 8.1 pKi = 8.1 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 436 6 0 5 3.4 COc1cc2c(cc1OC)C(=O)N(CCN1C[C@@H]3CCc4c(OC)cccc4[C@@H]3C1)CC2 10.1021/jm000541z
2470 3626 50 None -208 60 Human 8.1 pKi = 8.1 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1016/j.bmcl.2004.11.032
3300 3626 50 None -208 60 Human 8.1 pKi = 8.1 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1016/j.bmcl.2004.11.032
5265 3626 50 None -208 60 Human 8.1 pKi = 8.1 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1016/j.bmcl.2004.11.032
99 3626 50 None -208 60 Human 8.1 pKi = 8.1 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1016/j.bmcl.2004.11.032
CHEMBL267930 3626 50 None -208 60 Human 8.1 pKi = 8.1 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1016/j.bmcl.2004.11.032
10721730 37463 0 None 245 3 Human 8.1 pKi = 8.1 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 568 6 2 7 3.7 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC3(CC2)OC(=O)c2ccccc23)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL145571 37463 0 None 245 3 Human 8.1 pKi = 8.1 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 568 6 2 7 3.7 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC3(CC2)OC(=O)c2ccccc23)C1c1ccc(F)c(F)c1 10.1021/jm990201h
76326030 84792 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 404 5 0 5 4.1 COc1ccccc1N1CCN(CC2CO[C@H](c3cccc4ccccc34)O2)CC1 10.1007/s00044-010-9379-1
CHEMBL2234446 84792 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 404 5 0 5 4.1 COc1ccccc1N1CCN(CC2CO[C@H](c3cccc4ccccc34)O2)CC1 10.1007/s00044-010-9379-1
CHEMBL5286701 194606 0 None -12 3 Human 8.1 pKi = 8.1 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 482 10 1 6 3.3 COCCC(=O)NCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
CHEMBL5315483 194606 0 None -12 3 Human 8.1 pKi = 8.1 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 482 10 1 6 3.3 COCCC(=O)NCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
76326030 84792 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 404 5 0 5 4.1 COc1ccccc1N1CCN(CC2CO[C@H](c3cccc4ccccc34)O2)CC1 10.1007/s00044-010-9379-1
CHEMBL2234446 84792 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 404 5 0 5 4.1 COc1ccccc1N1CCN(CC2CO[C@H](c3cccc4ccccc34)O2)CC1 10.1007/s00044-010-9379-1
11619713 72788 0 None -8 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 468 14 1 8 4.2 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccccc1[N+](=O)[O-] 10.1021/jm0580398
CHEMBL200136 72788 0 None -8 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 468 14 1 8 4.2 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccccc1[N+](=O)[O-] 10.1021/jm0580398
52947088 17078 0 None 1 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 391 11 1 4 4.9 Cc1cccc(C)c1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
CHEMBL1255003 17078 0 None 1 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 391 11 1 4 4.9 Cc1cccc(C)c1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
118716713 114981 0 None 1 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 487 6 0 7 2.4 COc1ccccc1N1CCN(CC2COC3(CCN(S(=O)(=O)c4ccccc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342866 114981 0 None 1 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 487 6 0 7 2.4 COc1ccccc1N1CCN(CC2COC3(CCN(S(=O)(=O)c4ccccc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
118716719 114987 0 None 1 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 493 6 0 8 2.5 COc1ccccc1N1CCN(CC2COC3(CCN(S(=O)(=O)c4cccs4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342872 114987 0 None 1 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 493 6 0 8 2.5 COc1ccccc1N1CCN(CC2COC3(CCN(S(=O)(=O)c4cccs4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
10572794 207091 0 None - 1 Bovine 8.1 pKi = 8.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 395 7 1 5 3.0 Cc1cccc(C)c1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL92109 207091 0 None - 1 Bovine 8.1 pKi = 8.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 395 7 1 5 3.0 Cc1cccc(C)c1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
44213730 195633 0 None 7 3 Human 8.1 pKi = 8.1 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 460 8 2 7 1.3 O=c1[nH]cc(CO)c(=O)n1CCCN1CCN(c2ccc(F)cc2OCC(F)(F)F)CC1 10.1016/s0960-894x(03)00305-6
CHEMBL55645 195633 0 None 7 3 Human 8.1 pKi = 8.1 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 460 8 2 7 1.3 O=c1[nH]cc(CO)c(=O)n1CCCN1CCN(c2ccc(F)cc2OCC(F)(F)F)CC1 10.1016/s0960-894x(03)00305-6
11234230 101674 0 None -128 5 Human 7.2 pKi = 7.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 375 4 0 3 3.6 O=C1CC2(CCCC2)CCN1CCN1CCN(c2ccccc2Cl)CC1 10.1007/s00044-010-9379-1
CHEMBL299454 101674 0 None -128 5 Human 7.2 pKi = 7.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 375 4 0 3 3.6 O=C1CC2(CCCC2)CCN1CCN1CCN(c2ccccc2Cl)CC1 10.1007/s00044-010-9379-1
11234230 101674 0 None -128 5 Human 7.2 pKi = 7.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 375 4 0 3 3.6 O=C1CC2(CCCC2)CCN1CCN1CCN(c2ccccc2Cl)CC1 10.1007/s00044-010-9379-1
CHEMBL299454 101674 0 None -128 5 Human 7.2 pKi = 7.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 375 4 0 3 3.6 O=C1CC2(CCCC2)CCN1CCN1CCN(c2ccccc2Cl)CC1 10.1007/s00044-010-9379-1
44292196 179982 2 None -5 2 Bovine 6.2 pKi = 6.2 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 287 3 0 3 3.1 Clc1cccnc1N1CCN(Cc2ccccc2)CC1 10.1021/jm00366a007
CHEMBL47471 179982 2 None -5 2 Bovine 6.2 pKi = 6.2 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 287 3 0 3 3.1 Clc1cccnc1N1CCN(Cc2ccccc2)CC1 10.1021/jm00366a007
541604 165315 10 None 72 4 Human 6.2 pKi = 6.2 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
ChEMBL 201 3 4 4 0.5 CNCC(O)c1cc(O)c(O)cc1F 10.1021/jm00118a019
CHEMBL42359 165315 10 None 72 4 Human 6.2 pKi = 6.2 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
ChEMBL 201 3 4 4 0.5 CNCC(O)c1cc(O)c(O)cc1F 10.1021/jm00118a019
130442572 171884 0 None -147 24 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]-prazosin from recombinant human alpha1A adrenergic receptor measured after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-prazosin from recombinant human alpha1A adrenergic receptor measured after 90 mins by microbeta scintillation counting method
ChEMBL 395 3 0 5 6.0 FC(F)(F)c1cc(Oc2nccc3occc23)ccc1-c1cccc2nccn12 10.1021/acs.jmedchem.9b00351
CHEMBL4469848 171884 0 None -147 24 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]-prazosin from recombinant human alpha1A adrenergic receptor measured after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-prazosin from recombinant human alpha1A adrenergic receptor measured after 90 mins by microbeta scintillation counting method
ChEMBL 395 3 0 5 6.0 FC(F)(F)c1cc(Oc2nccc3occc23)ccc1-c1cccc2nccn12 10.1021/acs.jmedchem.9b00351
9796594 9341 0 None - 1 Rat 6.2 pKi = 6.2 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 307 3 3 4 2.0 CS(=O)(=O)Nc1ccc(O)c2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL111372 9341 0 None - 1 Rat 6.2 pKi = 6.2 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 307 3 3 4 2.0 CS(=O)(=O)Nc1ccc(O)c2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
11196451 168041 0 None -1 2 Rat 6.2 pKi = 6.2 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 268 5 2 3 1.7 CCS(=O)(=O)Nc1cccc(CC2CCCN2)c1 10.1021/jm030551a
CHEMBL432451 168041 0 None -1 2 Rat 6.2 pKi = 6.2 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 268 5 2 3 1.7 CCS(=O)(=O)Nc1cccc(CC2CCCN2)c1 10.1021/jm030551a
76326540 85309 0 None -1 3 Rat 5.2 pKi = 5.2 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 274 2 4 4 1.3 NC(=O)Nc1c(O)ccc2c1CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
CHEMBL2261352 85309 0 None -1 3 Rat 5.2 pKi = 5.2 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 274 2 4 4 1.3 NC(=O)Nc1c(O)ccc2c1CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
44331079 4287 0 None -1 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 355 3 0 2 5.3 C1=CC2(CCN(CCc3cccc4ccccc34)CC2)Oc2ccccc21 10.1016/s0960-894x(98)00732-x
CHEMBL100878 4287 0 None -1 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 355 3 0 2 5.3 C1=CC2(CCN(CCc3cccc4ccccc34)CC2)Oc2ccccc21 10.1016/s0960-894x(98)00732-x
24829343 158997 0 None -89 9 Human 7.2 pKi = 7.2 Binding
Inhibition of adrenergic alpha-1 receptorInhibition of adrenergic alpha-1 receptor
ChEMBL 429 7 1 3 5.1 CCC1(CCCCN2CCN(c3ccc(Cl)cc3)CC2)C(=O)Nc2cc(F)ccc21 10.1021/jm070279v
CHEMBL409662 158997 0 None -89 9 Human 7.2 pKi = 7.2 Binding
Inhibition of adrenergic alpha-1 receptorInhibition of adrenergic alpha-1 receptor
ChEMBL 429 7 1 3 5.1 CCC1(CCCCN2CCN(c3ccc(Cl)cc3)CC2)C(=O)Nc2cc(F)ccc21 10.1021/jm070279v
415628 208169 95 None -60 5 Rat 6.2 pKi = 6.2 Binding
Binding affinity measured for alpha-1 adrenergic receptor by displacement of [3H]prazosin from rat cortical membranesBinding affinity measured for alpha-1 adrenergic receptor by displacement of [3H]prazosin from rat cortical membranes
ChEMBL 196 1 1 2 1.8 Clc1ccccc1N1CCNCC1 10.1021/jm00110a014
CHEMBL9841 208169 95 None -60 5 Rat 6.2 pKi = 6.2 Binding
Binding affinity measured for alpha-1 adrenergic receptor by displacement of [3H]prazosin from rat cortical membranesBinding affinity measured for alpha-1 adrenergic receptor by displacement of [3H]prazosin from rat cortical membranes
ChEMBL 196 1 1 2 1.8 Clc1ccccc1N1CCNCC1 10.1021/jm00110a014
2771 194994 74 None -8 27 Rat 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 nan
CHEMBL1200781 194994 74 None -8 27 Rat 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 nan
CHEMBL549 194994 74 None -8 27 Rat 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 nan
11633992 16069 0 None -5 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 460 8 1 5 5.8 FC(F)(F)c1cccc(N2CCN(CCCCNc3nc(-c4ccccc4)cs3)CC2)c1 10.1016/j.bmcl.2010.07.096
CHEMBL1223859 16069 0 None -5 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 460 8 1 5 5.8 FC(F)(F)c1cccc(N2CCN(CCCCNc3nc(-c4ccccc4)cs3)CC2)c1 10.1016/j.bmcl.2010.07.096
44289058 165321 0 None 16 3 Human 7.1 pKi = 7.1 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 403 8 1 3 4.5 CC(C)C(C(=O)NCCCN1CCC(C#N)(c2ccccc2)CC1)c1ccccc1 10.1016/s0960-894x(00)00307-3
CHEMBL42361 165321 0 None 16 3 Human 7.1 pKi = 7.1 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 403 8 1 3 4.5 CC(C)C(C(=O)NCCCN1CCC(C#N)(c2ccccc2)CC1)c1ccccc1 10.1016/s0960-894x(00)00307-3
4384568 163079 8 None -7 3 Rat 7.1 pKi = 7.1 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 438 6 0 4 3.4 O=C1C2CCCCN2C(=O)N1CCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1 10.1021/jm970216k
CHEMBL417709 163079 8 None -7 3 Rat 7.1 pKi = 7.1 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 438 6 0 4 3.4 O=C1C2CCCCN2C(=O)N1CCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1 10.1021/jm970216k
10713438 107004 0 None -4 2 Rat 7.1 pKi = 7.1 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 358 7 0 5 2.3 COc1ccccc1N1CCN(CCCCN2CC3CCCN3C2)CC1 10.1021/jm970216k
CHEMBL315472 107004 0 None -4 2 Rat 7.1 pKi = 7.1 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 358 7 0 5 2.3 COc1ccccc1N1CCN(CCCCN2CC3CCCN3C2)CC1 10.1021/jm970216k
21302490 112778 32 None -10 9 Human 7.1 pKi = 7.1 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
ChEMBL 393 5 0 4 3.9 CN1CCN2c3c(cccc31)[C@@H]1CN(CCCC(=O)c3ccc(F)cc3)CC[C@@H]12 10.1021/jm401958n
CHEMBL3233142 112778 32 None -10 9 Human 7.1 pKi = 7.1 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
ChEMBL 393 5 0 4 3.9 CN1CCN2c3c(cccc31)[C@@H]1CN(CCCC(=O)c3ccc(F)cc3)CC[C@@H]12 10.1021/jm401958n
CHEMBL3306803 112778 32 None -10 9 Human 7.1 pKi = 7.1 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
ChEMBL 393 5 0 4 3.9 CN1CCN2c3c(cccc31)[C@@H]1CN(CCCC(=O)c3ccc(F)cc3)CC[C@@H]12 10.1021/jm401958n
44309199 204028 0 None - 1 Human 5.1 pKi = 5.1 Binding
In vitro binding affinity towards Alpha-1 adrenergic receptor by displacing [3H]prazosin radioligandIn vitro binding affinity towards Alpha-1 adrenergic receptor by displacing [3H]prazosin radioligand
ChEMBL 355 6 3 4 2.7 Cc1ccc(CC2(O)CCN(C[C@@H](O)Cc3ccc(O)cc3)CC2)cc1 10.1016/s0960-894x(01)00392-4
CHEMBL69967 204028 0 None - 1 Human 5.1 pKi = 5.1 Binding
In vitro binding affinity towards Alpha-1 adrenergic receptor by displacing [3H]prazosin radioligandIn vitro binding affinity towards Alpha-1 adrenergic receptor by displacing [3H]prazosin radioligand
ChEMBL 355 6 3 4 2.7 Cc1ccc(CC2(O)CCN(C[C@@H](O)Cc3ccc(O)cc3)CC2)cc1 10.1016/s0960-894x(01)00392-4
10473406 204197 0 None - 1 Human 5.1 pKi = 5.1 Binding
In vitro binding affinity towards Alpha-1 adrenergic receptor by displacing [3H]prazosin radioligandIn vitro binding affinity towards Alpha-1 adrenergic receptor by displacing [3H]prazosin radioligand
ChEMBL 355 6 3 4 2.7 Cc1ccc(CC2(O)CCN(C[C@H](O)Cc3ccc(O)cc3)CC2)cc1 10.1016/s0960-894x(01)00392-4
CHEMBL70918 204197 0 None - 1 Human 5.1 pKi = 5.1 Binding
In vitro binding affinity towards Alpha-1 adrenergic receptor by displacing [3H]prazosin radioligandIn vitro binding affinity towards Alpha-1 adrenergic receptor by displacing [3H]prazosin radioligand
ChEMBL 355 6 3 4 2.7 Cc1ccc(CC2(O)CCN(C[C@H](O)Cc3ccc(O)cc3)CC2)cc1 10.1016/s0960-894x(01)00392-4
118717462 115118 0 None 2 4 Human 7.1 pKi = 7.1 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 444 12 2 6 6.3 COc1cccc2c(NCCCCCCCNc3ccnc4c(OC)cccc34)ccnc12 10.1016/j.bmc.2014.09.017
CHEMBL3343984 115118 0 None 2 4 Human 7.1 pKi = 7.1 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 444 12 2 6 6.3 COc1cccc2c(NCCCCCCCNc3ccnc4c(OC)cccc34)ccnc12 10.1016/j.bmc.2014.09.017
9913449 106425 1 None 13 3 Human 7.1 pKi = 7.1 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog aorta preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog aorta preparations
ChEMBL 489 6 0 7 3.5 O=C1c2cc(Cl)ccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
CHEMBL313990 106425 1 None 13 3 Human 7.1 pKi = 7.1 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog aorta preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog aorta preparations
ChEMBL 489 6 0 7 3.5 O=C1c2cc(Cl)ccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
16041090 95364 0 None -1 4 Human 7.1 pKi = 7.1 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 496 8 2 6 4.7 COc1ccc(NC(=O)NC2CCC(N3CCN(c4ccccc4OC(C)C)CC3)CC2)c(OC)c1 10.1016/j.bmcl.2007.11.068
CHEMBL256853 95364 0 None -1 4 Human 7.1 pKi = 7.1 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 496 8 2 6 4.7 COc1ccc(NC(=O)NC2CCC(N3CCN(c4ccccc4OC(C)C)CC3)CC2)c(OC)c1 10.1016/j.bmcl.2007.11.068
56649649 67828 0 None -87 8 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assayDisplacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assay
ChEMBL 480 8 0 5 4.6 COc1ccccc1N1CCN(CCN(C(=O)C23CCC(CF)(CC2)CC3)c2ccccn2)CC1 10.1016/j.ejmech.2011.06.023
CHEMBL1910140 67828 0 None -87 8 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assayDisplacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assay
ChEMBL 480 8 0 5 4.6 COc1ccccc1N1CCN(CCN(C(=O)C23CCC(CF)(CC2)CC3)c2ccccn2)CC1 10.1016/j.ejmech.2011.06.023
44288741 168823 0 None 45 2 Human 7.1 pKi = 7.1 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 408 8 1 4 3.3 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)Cc2ccc(C)cc2)CC1 10.1016/s0960-894x(01)00320-1
CHEMBL43799 168823 0 None 45 2 Human 7.1 pKi = 7.1 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 408 8 1 4 3.3 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)Cc2ccc(C)cc2)CC1 10.1016/s0960-894x(01)00320-1
44288741 168823 0 None 45 2 Human 7.1 pKi = 7.1 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 408 8 1 4 3.3 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)Cc2ccc(C)cc2)CC1 10.1016/s0960-894x(00)00307-3
CHEMBL43799 168823 0 None 45 2 Human 7.1 pKi = 7.1 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 408 8 1 4 3.3 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)Cc2ccc(C)cc2)CC1 10.1016/s0960-894x(00)00307-3
76333282 84802 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 405 8 1 5 4.0 COc1ccccc1OCCNC1COC(c2ccccc2)(c2ccccc2)CO1 10.1007/s00044-010-9379-1
CHEMBL2234456 84802 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 405 8 1 5 4.0 COc1ccccc1OCCNC1COC(c2ccccc2)(c2ccccc2)CO1 10.1007/s00044-010-9379-1
118717462 115118 0 None 2 4 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 444 12 2 6 6.3 COc1cccc2c(NCCCCCCCNc3ccnc4c(OC)cccc34)ccnc12 10.1016/j.bmc.2014.09.017
CHEMBL3343984 115118 0 None 2 4 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 444 12 2 6 6.3 COc1cccc2c(NCCCCCCCNc3ccnc4c(OC)cccc34)ccnc12 10.1016/j.bmc.2014.09.017
44568917 187331 0 None -9 4 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 419 9 1 5 4.0 COc1ccccc1OCCNC[C@@H]1COC(c2ccccc2)(c2ccccc2)CO1 10.1021/jm800461k
CHEMBL493283 187331 0 None -9 4 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 419 9 1 5 4.0 COc1ccccc1OCCNC[C@@H]1COC(c2ccccc2)(c2ccccc2)CO1 10.1021/jm800461k
52945071 17611 0 None -1 3 Rat 6.1 pKi = 6.1 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 470 7 2 5 2.7 O=C1NC(=O)C(c2ccccc2)(c2ccccc2)N1CC(O)CN1CCN(c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
CHEMBL1258344 17611 0 None -1 3 Rat 6.1 pKi = 6.1 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 470 7 2 5 2.7 O=C1NC(=O)C(c2ccccc2)(c2ccccc2)N1CC(O)CN1CCN(c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
44288857 168759 0 None 43 3 Human 7.1 pKi = 7.1 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 439 9 1 6 2.9 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)Cc2ccc([N+](=O)[O-])cc2)CC1 10.1016/s0960-894x(00)00307-3
CHEMBL43749 168759 0 None 43 3 Human 7.1 pKi = 7.1 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 439 9 1 6 2.9 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)Cc2ccc([N+](=O)[O-])cc2)CC1 10.1016/s0960-894x(00)00307-3
49862238 14976 16 None 1 2 Human 7.1 pKi = 7.1 Binding
Binding affinity to adrenergic Alpha-1A receptorBinding affinity to adrenergic Alpha-1A receptor
ChEMBL 367 6 0 5 3.6 COc1cccc(F)c1OC1CN(Cc2cnn(-c3ccccc3)c2C)C1 10.1016/j.bmcl.2010.06.033
CHEMBL1209158 14976 16 None 1 2 Human 7.1 pKi = 7.1 Binding
Binding affinity to adrenergic Alpha-1A receptorBinding affinity to adrenergic Alpha-1A receptor
ChEMBL 367 6 0 5 3.6 COc1cccc(F)c1OC1CN(Cc2cnn(-c3ccccc3)c2C)C1 10.1016/j.bmcl.2010.06.033
44301680 101943 0 None - 1 Human 7.1 pKi = 7.1 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 521 7 0 5 5.8 Cc1ccc(C2(c3ccc(C)cc3)OC(=O)N(CCCN3CCC(C#N)(c4ccccc4C)CC3)C2=O)cc1 10.1016/s0960-894x(01)00320-1
CHEMBL301416 101943 0 None - 1 Human 7.1 pKi = 7.1 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 521 7 0 5 5.8 Cc1ccc(C2(c3ccc(C)cc3)OC(=O)N(CCCN3CCC(C#N)(c4ccccc4C)CC3)C2=O)cc1 10.1016/s0960-894x(01)00320-1
10688604 24720 0 None -4 5 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptorDisplacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptor
ChEMBL 341 5 2 5 2.4 O[C@@H]1[C@H](NC[C@@H]2COc3ccccc3O2)CC[C@H]1Oc1ccccc1 10.1021/jm991065j
CHEMBL134428 24720 0 None -4 5 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptorDisplacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptor
ChEMBL 341 5 2 5 2.4 O[C@@H]1[C@H](NC[C@@H]2COc3ccccc3O2)CC[C@H]1Oc1ccccc1 10.1021/jm991065j
9929277 100951 0 None -23 4 Rat 7.1 pKi = 7.1 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 369 4 0 4 2.7 O=C1CCCC(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
CHEMBL294235 100951 0 None -23 4 Rat 7.1 pKi = 7.1 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 369 4 0 4 2.7 O=C1CCCC(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
456387 100729 5 None -6 2 Human 6.1 pKi = 6.1 Binding
Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)
ChEMBL 376 2 3 1 5.5 Brc1ccc2c(-c3nc(-c4c[nH]c5ccccc45)c[nH]3)c[nH]c2c1 10.1016/0960-894X(96)00376-9
CHEMBL292801 100729 5 None -6 2 Human 6.1 pKi = 6.1 Binding
Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)
ChEMBL 376 2 3 1 5.5 Brc1ccc2c(-c3nc(-c4c[nH]c5ccccc45)c[nH]3)c[nH]c2c1 10.1016/0960-894X(96)00376-9
44271701 65483 0 None - 1 Bovine 5.1 pKi = 5.1 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 192 1 0 2 1.9 CN1CC=C(c2ccncc2F)CC1 10.1021/jm00375a017
CHEMBL18306 65483 0 None - 1 Bovine 5.1 pKi = 5.1 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 192 1 0 2 1.9 CN1CC=C(c2ccncc2F)CC1 10.1021/jm00375a017
145946265 167490 0 None -1 5 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 396 10 0 4 3.9 Cc1cc(C)c(OCCOCCN2CCN(CCc3ccccc3)CC2)c(C)c1 10.1016/j.bmcl.2018.04.059
CHEMBL4203310 167490 0 None -1 5 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 396 10 0 4 3.9 Cc1cc(C)c(OCCOCCN2CCN(CCc3ccccc3)CC2)c(C)c1 10.1016/j.bmcl.2018.04.059
CHEMBL4299892 167490 0 None -1 5 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 396 10 0 4 3.9 Cc1cc(C)c(OCCOCCN2CCN(CCc3ccccc3)CC2)c(C)c1 10.1016/j.bmcl.2018.04.059
10221005 204299 0 None 4 4 Human 6.1 pKi = 6.1 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 267 4 2 5 0.8 Cc1ccc(S(C)(=O)=O)c(NCC2=NCCN2)c1 10.1021/jm000542r
CHEMBL71479 204299 0 None 4 4 Human 6.1 pKi = 6.1 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 267 4 2 5 0.8 Cc1ccc(S(C)(=O)=O)c(NCC2=NCCN2)c1 10.1021/jm000542r
76330198 85307 0 None 2 3 Rat 6.1 pKi = 6.1 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 337 5 3 5 2.0 CCCS(=O)(=O)Nc1c(O)ccc2c1CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
CHEMBL2261348 85307 0 None 2 3 Rat 6.1 pKi = 6.1 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 337 5 3 5 2.0 CCCS(=O)(=O)Nc1c(O)ccc2c1CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
1547484 937 74 None -125 20 Rat 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
654 937 74 None -125 20 Rat 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
9072 937 74 None -125 20 Rat 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
CHEMBL43064 937 74 None -125 20 Rat 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
DB00568 937 74 None -125 20 Rat 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
10873978 168462 0 None -1905 6 Rat 6.1 pKi = 6.1 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 445 7 1 4 5.1 O=C(NCCCCN1CCN(c2ccc(Cl)cc2Cl)CC1)c1cc2ccccc2o1 10.1021/jm0211220
CHEMBL435218 168462 0 None -1905 6 Rat 6.1 pKi = 6.1 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 445 7 1 4 5.1 O=C(NCCCCN1CCN(c2ccc(Cl)cc2Cl)CC1)c1cc2ccccc2o1 10.1021/jm0211220
11698643 3603 11 None -15 4 Human 7.1 pKi = 7.1 Binding
Binding affinity to human adrenergic alpha-1A receptorBinding affinity to human adrenergic alpha-1A receptor
ChEMBL 479 6 0 4 6.0 O=C1C(=Nc2cccc(c2)C(F)(F)F)c2c(N1c1cccc(c1)OCCN1CCCC1)cccc2 10.1016/j.bmcl.2006.05.025
6125 3603 11 None -15 4 Human 7.1 pKi = 7.1 Binding
Binding affinity to human adrenergic alpha-1A receptorBinding affinity to human adrenergic alpha-1A receptor
ChEMBL 479 6 0 4 6.0 O=C1C(=Nc2cccc(c2)C(F)(F)F)c2c(N1c1cccc(c1)OCCN1CCCC1)cccc2 10.1016/j.bmcl.2006.05.025
CHEMBL209497 3603 11 None -15 4 Human 7.1 pKi = 7.1 Binding
Binding affinity to human adrenergic alpha-1A receptorBinding affinity to human adrenergic alpha-1A receptor
ChEMBL 479 6 0 4 6.0 O=C1C(=Nc2cccc(c2)C(F)(F)F)c2c(N1c1cccc(c1)OCCN1CCCC1)cccc2 10.1016/j.bmcl.2006.05.025
53248361 62052 0 None -50 7 Human 7.1 pKi = 7.1 Binding
Inhibition of adrenergic alpha1A receptorInhibition of adrenergic alpha1A receptor
ChEMBL 568 7 0 5 3.2 COc1ccccc1N1CCN(CCN(C(=O)C23C4C5C2C2C3C4C52I)c2ccccn2)CC1 10.1021/jm1009956
CHEMBL1774991 62052 0 None -50 7 Human 7.1 pKi = 7.1 Binding
Inhibition of adrenergic alpha1A receptorInhibition of adrenergic alpha1A receptor
ChEMBL 568 7 0 5 3.2 COc1ccccc1N1CCN(CCN(C(=O)C23C4C5C2C2C3C4C52I)c2ccccn2)CC1 10.1021/jm1009956
2105 3032 37 None -1258 33 Rat 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
47811 3032 37 None -1258 33 Rat 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
48 3032 37 None -1258 33 Rat 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
CHEMBL531 3032 37 None -1258 33 Rat 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
DB01186 3032 37 None -1258 33 Rat 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
9867138 195769 0 None -48 4 Rat 6.1 pKi = 6.1 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 425 7 0 4 4.1 CN(CCN1C(=O)CC2(CCCC2)CC1=O)CCN(C)c1cc(Cl)ccc1Cl 10.1021/jm030944+
CHEMBL55790 195769 0 None -48 4 Rat 6.1 pKi = 6.1 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 425 7 0 4 4.1 CN(CCN1C(=O)CC2(CCCC2)CC1=O)CCN(C)c1cc(Cl)ccc1Cl 10.1021/jm030944+
448537 160226 89 None -1584 25 Rat 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 nan
CHEMBL411 160226 89 None -1584 25 Rat 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 nan
12134985 204855 0 None - 1 Human 7.1 pKi = 7.1 Binding
Compound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptorCompound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptor
ChEMBL 438 7 1 7 2.7 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCC3=O)nc(N)n2)CC1 10.1016/s0960-894x(00)00472-8
CHEMBL75808 204855 0 None - 1 Human 7.1 pKi = 7.1 Binding
Compound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptorCompound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptor
ChEMBL 438 7 1 7 2.7 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCC3=O)nc(N)n2)CC1 10.1016/s0960-894x(00)00472-8
CHEMBL5276489 194620 0 None -70 3 Human 7.1 pKi = 7.1 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 492 8 1 5 4.4 O=C(NCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O)C1CCCC1 10.1021/acsmedchemlett.7b00112
CHEMBL5315725 194620 0 None -70 3 Human 7.1 pKi = 7.1 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 492 8 1 5 4.4 O=C(NCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O)C1CCCC1 10.1021/acsmedchemlett.7b00112
10314056 208127 1 None 1 3 Human 6.1 pKi = 6.1 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 322 3 0 4 3.1 O=C1CC2(CCN(CCc3ccccn3)CC2)Oc2ccccc21 10.1016/s0960-894x(98)00732-x
CHEMBL98167 208127 1 None 1 3 Human 6.1 pKi = 6.1 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 322 3 0 4 3.1 O=C1CC2(CCN(CCc3ccccn3)CC2)Oc2ccccc21 10.1016/s0960-894x(98)00732-x
9923051 108642 0 None - 1 Rat 6.1 pKi = 6.1 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 319 4 2 3 2.9 CCS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]c(C)n1 10.1007/s00044-004-0020-z
CHEMBL320765 108642 0 None - 1 Rat 6.1 pKi = 6.1 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 319 4 2 3 2.9 CCS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]c(C)n1 10.1007/s00044-004-0020-z
52937629 61274 0 None -158 3 Human 6.1 pKi = 6.1 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 377 6 0 5 3.5 CCOc1ccc(Cc2nn(C[C@H]3CCCN3C)c(=O)c3ccccc23)cc1 10.1021/jm1013874
CHEMBL1767139 61274 0 None -158 3 Human 6.1 pKi = 6.1 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 377 6 0 5 3.5 CCOc1ccc(Cc2nn(C[C@H]3CCCN3C)c(=O)c3ccccc23)cc1 10.1021/jm1013874
11288646 8642 0 None - 1 Rat 6.1 pKi = 6.1 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 268 4 2 3 1.8 CCS(=O)(=O)Nc1cccc2c1CCCC2CN 10.1021/jm030551a
CHEMBL109553 8642 0 None - 1 Rat 6.1 pKi = 6.1 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 268 4 2 3 1.8 CCS(=O)(=O)Nc1cccc2c1CCCC2CN 10.1021/jm030551a
9923051 108642 0 None - 1 Rat 6.1 pKi = 6.1 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 319 4 2 3 2.9 CCS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]c(C)n1 10.1021/jm030551a
CHEMBL320765 108642 0 None - 1 Rat 6.1 pKi = 6.1 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 319 4 2 3 2.9 CCS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]c(C)n1 10.1021/jm030551a
10626686 204296 0 None 7 2 Human 8.1 pKi = 8.1 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 560 9 2 7 3.3 CC(C)Oc1ccccc1N1CCN(C[C@H](O)CNC(=O)c2ccc3c(c2)C(=O)N(c2cccc(F)c2)C3=O)CC1 10.1021/jm9905918
CHEMBL71473 204296 0 None 7 2 Human 8.1 pKi = 8.1 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 560 9 2 7 3.3 CC(C)Oc1ccccc1N1CCN(C[C@H](O)CNC(=O)c2ccc3c(c2)C(=O)N(c2cccc(F)c2)C3=O)CC1 10.1021/jm9905918
44331150 4398 0 None 3 3 Human 8.1 pKi = 8.1 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 530 6 1 7 4.4 Cn1cnc(S(=O)(=O)Nc2ccc3c(c2)C(=O)CC2(CCN(CCc4cccc5ccccc45)CC2)O3)c1 10.1016/s0960-894x(98)00732-x
CHEMBL101579 4398 0 None 3 3 Human 8.1 pKi = 8.1 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 530 6 1 7 4.4 Cn1cnc(S(=O)(=O)Nc2ccc3c(c2)C(=O)CC2(CCN(CCc4cccc5ccccc45)CC2)O3)c1 10.1016/s0960-894x(98)00732-x
9847419 208171 0 None 14 3 Human 8.1 pKi = 8.1 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 467 5 2 5 3.9 Cc1[nH]c2ccccc2c1CCN1CCC2(CC1)CC(=O)c1ccc(NS(C)(=O)=O)cc1O2 10.1016/s0960-894x(98)00732-x
CHEMBL98430 208171 0 None 14 3 Human 8.1 pKi = 8.1 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 467 5 2 5 3.9 Cc1[nH]c2ccccc2c1CCN1CCC2(CC1)CC(=O)c1ccc(NS(C)(=O)=O)cc1O2 10.1016/s0960-894x(98)00732-x
10507129 121947 0 None 9 3 Human 8.1 pKi = 8.1 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 562 8 2 7 3.8 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(C)cc1 10.1021/jm990200p
CHEMBL359173 121947 0 None 9 3 Human 8.1 pKi = 8.1 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 562 8 2 7 3.8 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(C)cc1 10.1021/jm990200p
9867616 168302 0 None -1 3 Human 8.1 pKi = 8.1 Binding
The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.
ChEMBL 435 6 1 8 2.2 COc1cc2nc(N3CCN(C(=O)CC(=O)c4ccccc4)CC3)nc(N)c2cc1OC 10.1021/jm9805337
CHEMBL434228 168302 0 None -1 3 Human 8.1 pKi = 8.1 Binding
The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.
ChEMBL 435 6 1 8 2.2 COc1cc2nc(N3CCN(C(=O)CC(=O)c4ccccc4)CC3)nc(N)c2cc1OC 10.1021/jm9805337
115 342 71 None -3 7 Human 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm00018a001
2092 342 71 None -3 7 Human 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm00018a001
7109 342 71 None -3 7 Human 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm00018a001
CHEMBL709 342 71 None -3 7 Human 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm00018a001
DB00346 342 71 None -3 7 Human 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm00018a001
4149971 166608 7 None -1 4 Rat 8.1 pKi = 8.1 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 386 7 0 5 2.0 COc1ccccc1N1CCN(CCCCN2C(=O)C3CCCN3C2=O)CC1 10.1021/jm970216k
CHEMBL42810 166608 7 None -1 4 Rat 8.1 pKi = 8.1 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 386 7 0 5 2.0 COc1ccccc1N1CCN(CCCCN2C(=O)C3CCCN3C2=O)CC1 10.1021/jm970216k
44300166 196330 0 None 15 3 Human 8.1 pKi = 8.1 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 583 7 2 7 4.0 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@H]2CC[C@H](N3CCC(c4ccccn4)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
CHEMBL56248 196330 0 None 15 3 Human 8.1 pKi = 8.1 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 583 7 2 7 4.0 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@H]2CC[C@H](N3CCC(c4ccccn4)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
44420408 141733 0 None -5 3 Human 8.1 pKi = 8.1 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 453 5 2 6 2.7 COc1ccc(Cl)cc1N1CCN(CCn2c(=O)[nH]c3c([nH]c4ccccc43)c2=O)CC1 10.1016/j.bmcl.2006.09.034
CHEMBL386005 141733 0 None -5 3 Human 8.1 pKi = 8.1 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 453 5 2 6 2.7 COc1ccc(Cl)cc1N1CCN(CCn2c(=O)[nH]c3c([nH]c4ccccc43)c2=O)CC1 10.1016/j.bmcl.2006.09.034
10320782 99949 0 None 4 7 Bovine 8.1 pKi = 8.1 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligand
ChEMBL 435 9 1 6 4.6 COc1cccc(OC)c1OCCNC[C@H]1Oc2ccccc2O[C@@H]1c1ccc(C)cc1 10.1021/jm960069a
CHEMBL286565 99949 0 None 4 7 Bovine 8.1 pKi = 8.1 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligand
ChEMBL 435 9 1 6 4.6 COc1cccc(OC)c1OCCNC[C@H]1Oc2ccccc2O[C@@H]1c1ccc(C)cc1 10.1021/jm960069a
10811627 205527 0 None 11 3 Human 8.1 pKi = 8.1 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 412 7 0 6 3.3 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCC3=O)no2)CC1 10.1016/s0960-894x(02)00436-5
CHEMBL538529 205527 0 None 11 3 Human 8.1 pKi = 8.1 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 412 7 0 6 3.3 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCC3=O)no2)CC1 10.1016/s0960-894x(02)00436-5
CHEMBL81093 205527 0 None 11 3 Human 8.1 pKi = 8.1 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 412 7 0 6 3.3 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCC3=O)no2)CC1 10.1016/s0960-894x(02)00436-5
44268966 33407 0 None -6 6 Human 8.1 pKi = 8.1 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 476 7 1 7 3.6 COc1ccccc1N1CCN(CCCn2c(=O)[nH]c3scc(-c4ccccc4)c3c2=O)CC1 10.1016/s0960-894x(01)00159-7
CHEMBL14199 33407 0 None -6 6 Human 8.1 pKi = 8.1 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 476 7 1 7 3.6 COc1ccccc1N1CCN(CCCn2c(=O)[nH]c3scc(-c4ccccc4)c3c2=O)CC1 10.1016/s0960-894x(01)00159-7
11857861 194757 0 None -1 4 Human 8.1 pKi = 8.1 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 520 10 1 6 4.5 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OCCF)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
CHEMBL538397 194757 0 None -1 4 Human 8.1 pKi = 8.1 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 520 10 1 6 4.5 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OCCF)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
118716698 114966 0 None 1 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 364 4 0 6 2.5 COc1ccccc1N1CCN(CC2COC3(CCSCC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342852 114966 0 None 1 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 364 4 0 6 2.5 COc1ccccc1N1CCN(CC2COC3(CCSCC3)O2)CC1 10.1016/j.ejmech.2014.09.070
4165402 178744 8 None 1 2 Rat 8.1 pKi = 8.1 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 400 7 0 5 2.4 COc1ccccc1N1CCN(CCCCN2C(=O)C3CCCCN3C2=O)CC1 10.1021/jm970216k
CHEMBL46881 178744 8 None 1 2 Rat 8.1 pKi = 8.1 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 400 7 0 5 2.4 COc1ccccc1N1CCN(CCCCN2C(=O)C3CCCCN3C2=O)CC1 10.1021/jm970216k
9887378 98377 4 None 40 3 Human 8.1 pKi = 8.1 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 402 8 1 5 1.7 CC(C)Oc1ccccc1N1CCN(CCNC(=O)CN2CCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
CHEMBL275469 98377 4 None 40 3 Human 8.1 pKi = 8.1 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 402 8 1 5 1.7 CC(C)Oc1ccccc1N1CCN(CCNC(=O)CN2CCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
10790430 84790 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 431 9 1 5 4.5 COc1cccc(OC)c1OCCNC[C@@H]1C(=O)c2ccccc2C[C@H]1c1ccccc1 10.1007/s00044-010-9379-1
CHEMBL2234444 84790 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 431 9 1 5 4.5 COc1cccc(OC)c1OCCNC[C@@H]1C(=O)c2ccccc2C[C@H]1c1ccccc1 10.1007/s00044-010-9379-1
44431562 89254 0 None -1 4 Human 8.1 pKi = 8.1 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 517 9 1 7 3.9 COc1ccc(OC)c(S(=O)(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)c1 10.1016/j.bmcl.2007.04.008
CHEMBL236832 89254 0 None -1 4 Human 8.1 pKi = 8.1 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 517 9 1 7 3.9 COc1ccc(OC)c(S(=O)(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)c1 10.1016/j.bmcl.2007.04.008
10651080 105915 0 None 23 6 Human 8.1 pKi = 8.1 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 592 9 3 6 4.7 CC1=C(C(N)=O)C(c2ccc3c(c2)OCO3)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
CHEMBL312871 105915 0 None 23 6 Human 8.1 pKi = 8.1 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 592 9 3 6 4.7 CC1=C(C(N)=O)C(c2ccc3c(c2)OCO3)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
10531532 207071 0 None 8 6 Human 8.1 pKi = 8.1 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 594 9 2 7 6.0 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
CHEMBL91956 207071 0 None 8 6 Human 8.1 pKi = 8.1 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 594 9 2 7 6.0 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
10531532 85264 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 594 9 2 7 5.2 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
CHEMBL2260371 85264 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 594 9 2 7 5.2 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
10651080 105915 0 None 23 6 Human 8.1 pKi = 8.1 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 592 9 3 6 4.7 CC1=C(C(N)=O)C(c2ccc3c(c2)OCO3)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1007/s00044-004-0120-9
CHEMBL312871 105915 0 None 23 6 Human 8.1 pKi = 8.1 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 592 9 3 6 4.7 CC1=C(C(N)=O)C(c2ccc3c(c2)OCO3)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1007/s00044-004-0120-9
10790430 84790 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 431 9 1 5 4.5 COc1cccc(OC)c1OCCNC[C@@H]1C(=O)c2ccccc2C[C@H]1c1ccccc1 10.1007/s00044-010-9379-1
CHEMBL2234444 84790 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 431 9 1 5 4.5 COc1cccc(OC)c1OCCNC[C@@H]1C(=O)c2ccccc2C[C@H]1c1ccccc1 10.1007/s00044-010-9379-1
44288841 101112 0 None 3 3 Human 8.1 pKi = 8.1 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 440 8 1 2 5.8 Cc1ccc(C(C(=O)NCCCN2CCC(c3ccccc3)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
CHEMBL295304 101112 0 None 3 3 Human 8.1 pKi = 8.1 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 440 8 1 2 5.8 Cc1ccc(C(C(=O)NCCCN2CCC(c3ccccc3)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
57393627 69278 0 None 11 5 Pig 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 1101 42 2 17 5.4 COc1ccccc1N1CCN(CCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1 10.1016/j.bmc.2011.10.063
CHEMBL1928131 69278 0 None 11 5 Pig 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 1101 42 2 17 5.4 COc1ccccc1N1CCN(CCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1 10.1016/j.bmc.2011.10.063
10507651 206484 0 None 42 6 Human 8.1 pKi = 8.1 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 591 9 2 6 5.8 CC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2 10.1021/jm980077m
CHEMBL88388 206484 0 None 42 6 Human 8.1 pKi = 8.1 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 591 9 2 6 5.8 CC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2 10.1021/jm980077m
10507651 206484 0 None 42 6 Human 8.1 pKi = 8.1 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 591 9 2 6 5.8 CC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2 10.1007/s00044-004-0120-9
CHEMBL88388 206484 0 None 42 6 Human 8.1 pKi = 8.1 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 591 9 2 6 5.8 CC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2 10.1007/s00044-004-0120-9
4038180 204 14 None 2 8 Rat 8.1 pKi = 8.1 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm960354u
480 204 14 None 2 8 Rat 8.1 pKi = 8.1 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm960354u
CHEMBL109783 204 14 None 2 8 Rat 8.1 pKi = 8.1 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm960354u
118716716 114984 0 None 2 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 571 7 0 8 3.3 COc1ccccc1N1CCN(CC2COC3(CCN(S(=O)(=O)c4ccc(OC(F)(F)F)cc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342869 114984 0 None 2 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 571 7 0 8 3.3 COc1ccccc1N1CCN(CC2COC3(CCN(S(=O)(=O)c4ccc(OC(F)(F)F)cc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
73350823 102503 0 None -5 9 Human 7.1 pKi = 7.1 Binding
Binding affinity to human adrenergic alpha-1A receptor by competitive binding assayBinding affinity to human adrenergic alpha-1A receptor by competitive binding assay
ChEMBL 509 8 1 5 3.7 O=C(Cc1ccc(OC2CCNCC2)cc1OCCF)N1CCC(N2C(=O)CCc3ccccc32)CC1 10.1016/j.bmcl.2013.07.045
CHEMBL2424668 102503 0 None -5 9 Human 7.1 pKi = 7.1 Binding
Binding affinity to human adrenergic alpha-1A receptor by competitive binding assayBinding affinity to human adrenergic alpha-1A receptor by competitive binding assay
ChEMBL 509 8 1 5 3.7 O=C(Cc1ccc(OC2CCNCC2)cc1OCCF)N1CCC(N2C(=O)CCc3ccccc32)CC1 10.1016/j.bmcl.2013.07.045
CHEMBL3040578 102503 0 None -5 9 Human 7.1 pKi = 7.1 Binding
Binding affinity to human adrenergic alpha-1A receptor by competitive binding assayBinding affinity to human adrenergic alpha-1A receptor by competitive binding assay
ChEMBL 509 8 1 5 3.7 O=C(Cc1ccc(OC2CCNCC2)cc1OCCF)N1CCC(N2C(=O)CCc3ccccc32)CC1 10.1016/j.bmcl.2013.07.045
13141186 130665 0 None 7 2 Bovine 7.1 pKi = 7.1 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 312 0 0 2 4.2 CN1CCC(=C2c3cc(Cl)ccc3CCn3cccc32)CC1 10.1021/jm00361a008
CHEMBL368357 130665 0 None 7 2 Bovine 7.1 pKi = 7.1 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 312 0 0 2 4.2 CN1CCC(=C2c3cc(Cl)ccc3CCn3cccc32)CC1 10.1021/jm00361a008
10622156 200045 0 None 1 3 Rat 7.1 pKi = 7.1 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 422 6 0 5 3.7 COc1cc2c(cc1OC)CN(CCN1C[C@@H]3CCc4c(OC)cccc4[C@@H]3C1)CC2 10.1021/jm000541z
CHEMBL59575 200045 0 None 1 3 Rat 7.1 pKi = 7.1 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 422 6 0 5 3.7 COc1cc2c(cc1OC)CN(CCN1C[C@@H]3CCc4c(OC)cccc4[C@@H]3C1)CC2 10.1021/jm000541z
2771431 188258 52 None -1 2 Bovine 6.1 pKi = 6.1 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 231 1 1 3 1.8 Clc1cnc(N2CCNCC2)c(Cl)c1 10.1021/jm00366a007
CHEMBL50016 188258 52 None -1 2 Bovine 6.1 pKi = 6.1 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 231 1 1 3 1.8 Clc1cnc(N2CCNCC2)c(Cl)c1 10.1021/jm00366a007
13938357 101703 0 None -79 2 Bovine 5.1 pKi = 5.1 Binding
Evaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortexEvaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortex
ChEMBL 364 4 1 5 1.7 CN([C@H]1CCN2CCc3c(oc4ccccc34)[C@H]2C1)S(=O)(=O)CCO 10.1021/jm00150a002
CHEMBL299595 101703 0 None -79 2 Bovine 5.1 pKi = 5.1 Binding
Evaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortexEvaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortex
ChEMBL 364 4 1 5 1.7 CN([C@H]1CCN2CCc3c(oc4ccccc34)[C@H]2C1)S(=O)(=O)CCO 10.1021/jm00150a002
127025277 137826 0 None -44 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 376 7 1 5 1.6 COc1ccccc1N1CCN(CCCCNC(=O)N2CCOCC2)CC1 10.1016/j.bmcl.2015.12.068
CHEMBL3760063 137826 0 None -44 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 376 7 1 5 1.6 COc1ccccc1N1CCN(CCCCNC(=O)N2CCOCC2)CC1 10.1016/j.bmcl.2015.12.068
11801861 118762 0 None 181 3 Human 7.1 pKi = 7.1 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 609 6 2 6 4.0 CCC1=C(C(N)=O)C(c2ccc(F)cc2F)N(C(=O)N2CCC(N3CCC(C(=O)OC)(c4ccccc4)CC3)CC2)C(=O)N1 10.1021/jm990201h
CHEMBL342064 118762 0 None 181 3 Human 7.1 pKi = 7.1 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 609 6 2 6 4.0 CCC1=C(C(N)=O)C(c2ccc(F)cc2F)N(C(=O)N2CCC(N3CCC(C(=O)OC)(c4ccccc4)CC3)CC2)C(=O)N1 10.1021/jm990201h
44222842 195069 0 None -3 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 505 4 1 9 3.0 COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1021/jm8016046
CHEMBL549764 195069 0 None -3 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 505 4 1 9 3.0 COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1021/jm8016046
10367857 18080 0 None -21379 4 Rat 5.1 pKi = 5.1 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 478 7 2 3 5.5 O=C(NCCCCN1CCN(c2ccc(Cl)cc2Cl)CC1)c1cc2cc(Cl)ccc2[nH]1 10.1021/jm0211220
CHEMBL126889 18080 0 None -21379 4 Rat 5.1 pKi = 5.1 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 478 7 2 3 5.5 O=C(NCCCCN1CCN(c2ccc(Cl)cc2Cl)CC1)c1cc2cc(Cl)ccc2[nH]1 10.1021/jm0211220
10199335 204724 0 None 1 4 Human 6.1 pKi = 6.1 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1ccc(F)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL74467 204724 0 None 1 4 Human 6.1 pKi = 6.1 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1ccc(F)cc1NCC1=NCCN1 10.1021/jm000542r
10764133 84543 0 None -6 4 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2c(OC)cccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153560 84543 0 None -6 4 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2c(OC)cccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2220899 84543 0 None -6 4 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2c(OC)cccc2O1 10.1016/j.ejmech.2012.09.049
44318000 205374 0 None 51 2 Human 7.1 pKi = 7.1 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 480 7 0 7 4.0 CC(C)Oc1ccccc1N1CCN(Cc2nc(CN3C(=O)CC4(CCCC4)CC3=O)co2)CC1 10.1016/s0960-894x(02)00436-5
CHEMBL80036 205374 0 None 51 2 Human 7.1 pKi = 7.1 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 480 7 0 7 4.0 CC(C)Oc1ccccc1N1CCN(Cc2nc(CN3C(=O)CC4(CCCC4)CC3=O)co2)CC1 10.1016/s0960-894x(02)00436-5
16041091 95192 0 None 1 4 Human 7.1 pKi = 7.1 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 468 7 2 4 4.5 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)NCc3cccc(F)c3)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL256041 95192 0 None 1 4 Human 7.1 pKi = 7.1 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 468 7 2 4 4.5 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)NCc3cccc(F)c3)CC2)CC1 10.1016/j.bmcl.2007.11.068
44267817 163226 0 None 53 3 Human 7.1 pKi = 7.1 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 420 8 1 5 1.9 CC(C)Oc1cc(F)ccc1N1CCN(CCNC(=O)CN2CCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
CHEMBL418531 163226 0 None 53 3 Human 7.1 pKi = 7.1 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 420 8 1 5 1.9 CC(C)Oc1cc(F)ccc1N1CCN(CCNC(=O)CN2CCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
44593557 183894 11 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to adrenergic alpha1A receptorBinding affinity to adrenergic alpha1A receptor
ChEMBL 262 3 1 2 3.3 COCc1c(Cl)ccc2c1CC[C@H]2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
CHEMBL481322 183894 11 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to adrenergic alpha1A receptorBinding affinity to adrenergic alpha1A receptor
ChEMBL 262 3 1 2 3.3 COCc1c(Cl)ccc2c1CC[C@H]2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
155513941 176254 0 None -53 4 Human 7.1 pKi = 7.1 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 407 12 2 5 3.8 COc1ccccc1OCCNCC(CO)OC(c1ccccc1)c1ccccc1 10.1016/j.ejmech.2019.05.024
CHEMBL4439658 176254 0 None -53 4 Human 7.1 pKi = 7.1 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 407 12 2 5 3.8 COc1ccccc1OCCNCC(CO)OC(c1ccccc1)c1ccccc1 10.1016/j.ejmech.2019.05.024
CHEMBL4595078 176254 0 None -53 4 Human 7.1 pKi = 7.1 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 407 12 2 5 3.8 COc1ccccc1OCCNCC(CO)OC(c1ccccc1)c1ccccc1 10.1016/j.ejmech.2019.05.024
9880254 9269 0 None 43 2 Rat 7.1 pKi = 7.1 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 323 4 2 3 2.8 CCS(=O)(=O)Nc1cc(F)cc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL110975 9269 0 None 43 2 Rat 7.1 pKi = 7.1 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 323 4 2 3 2.8 CCS(=O)(=O)Nc1cc(F)cc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
10739024 69804 0 None -33 6 Human 6.1 pKi = 6.1 Binding
Compound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptorCompound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor
ChEMBL 388 4 3 8 0.9 COc1cc2nc(N3CCN[C@H](C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC 10.1021/jm980053f
CHEMBL19376 69804 0 None -33 6 Human 6.1 pKi = 6.1 Binding
Compound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptorCompound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor
ChEMBL 388 4 3 8 0.9 COc1cc2nc(N3CCN[C@H](C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC 10.1021/jm980053f
11049096 11164 0 None 1 2 Human 6.1 pKi = 6.1 Binding
Affinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assayAffinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay
ChEMBL 389 8 0 4 4.3 CN(CCOc1ccccc1)CC1COC(c2ccccc2)(c2ccccc2)O1 10.1021/jm021078o
CHEMBL1178700 11164 0 None 1 2 Human 6.1 pKi = 6.1 Binding
Affinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assayAffinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay
ChEMBL 389 8 0 4 4.3 CN(CCOc1ccccc1)CC1COC(c2ccccc2)(c2ccccc2)O1 10.1021/jm021078o
CHEMBL37962 11164 0 None 1 2 Human 6.1 pKi = 6.1 Binding
Affinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assayAffinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay
ChEMBL 389 8 0 4 4.3 CN(CCOc1ccccc1)CC1COC(c2ccccc2)(c2ccccc2)O1 10.1021/jm021078o
11049096 11164 0 None 1 2 Human 6.1 pKi = 6.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 389 8 0 4 4.3 CN(CCOc1ccccc1)CC1COC(c2ccccc2)(c2ccccc2)O1 10.1007/s00044-010-9379-1
CHEMBL1178700 11164 0 None 1 2 Human 6.1 pKi = 6.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 389 8 0 4 4.3 CN(CCOc1ccccc1)CC1COC(c2ccccc2)(c2ccccc2)O1 10.1007/s00044-010-9379-1
CHEMBL37962 11164 0 None 1 2 Human 6.1 pKi = 6.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 389 8 0 4 4.3 CN(CCOc1ccccc1)CC1COC(c2ccccc2)(c2ccccc2)O1 10.1007/s00044-010-9379-1
11334596 9388 1 None -1 2 Rat 6.1 pKi = 6.1 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 265 4 2 3 1.9 CC(c1cccc(NS(C)(=O)=O)c1)c1c[nH]cn1 10.1021/jm030551a
CHEMBL111682 9388 1 None -1 2 Rat 6.1 pKi = 6.1 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 265 4 2 3 1.9 CC(c1cccc(NS(C)(=O)=O)c1)c1c[nH]cn1 10.1021/jm030551a
9922027 115384 0 None 1 3 Rat 6.1 pKi = 6.1 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 289 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCC=C2c1c[nH]cn1 10.1021/jm030551a
CHEMBL3350265 115384 0 None 1 3 Rat 6.1 pKi = 6.1 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 289 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCC=C2c1c[nH]cn1 10.1021/jm030551a
71062708 154282 0 None -47 12 Mouse 5.1 pKi = 5.1 Binding
Radioligand Binding Assay: The detailed experimental protocols for the radioligand and functional receptor assays are available on the NIMH PDSP website at http://pdsp.med.unc.edu/UNC-CH %20Protocol %20Book.pdf. A. Serotonin receptors: 5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E, 5-HT2A, 5-HT2B, 5-HT2C, 5-HT3, 5-HT5A, 5-HT6 and 5-HT7. Assay Buffer: Standard Binding Buffer (50 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, pH 7.4) Membrane Fraction Source: Transiently or stably transfected cell lines (e.g., HEK293, COS, CHO, NIH3T3). Protocol adapted from Roth et al. (1986), J. Pharmacol. Exp. Ther., 238(2): 480-485; and Roth et al. (1994), J. Pharmacol. Exp. Ther., 268(3): 1403-1410. Adrenergic Receptors: alpha1A, alpha1B, alpha2A, alpha2B, alpha2C, beta1, beta2, beta3 Assay Buffers: For alpha1 receptors, alpha1 Binding Buffer (20 mM Tris-HCl, 145 mM NaCl, pH 7.4); for alpha2 receptors, alpha2 Binding Buffer (50 mM Tris-HCl, 5 mM MgCl2, pH 7.7); for beta receptors.Radioligand Binding Assay: The detailed experimental protocols for the radioligand and functional receptor assays are available on the NIMH PDSP website at http://pdsp.med.unc.edu/UNC-CH %20Protocol %20Book.pdf. A. Serotonin receptors: 5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E, 5-HT2A, 5-HT2B, 5-HT2C, 5-HT3, 5-HT5A, 5-HT6 and 5-HT7. Assay Buffer: Standard Binding Buffer (50 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, pH 7.4) Membrane Fraction Source: Transiently or stably transfected cell lines (e.g., HEK293, COS, CHO, NIH3T3). Protocol adapted from Roth et al. (1986), J. Pharmacol. Exp. Ther., 238(2): 480-485; and Roth et al. (1994), J. Pharmacol. Exp. Ther., 268(3): 1403-1410. Adrenergic Receptors: alpha1A, alpha1B, alpha2A, alpha2B, alpha2C, beta1, beta2, beta3 Assay Buffers: For alpha1 receptors, alpha1 Binding Buffer (20 mM Tris-HCl, 145 mM NaCl, pH 7.4); for alpha2 receptors, alpha2 Binding Buffer (50 mM Tris-HCl, 5 mM MgCl2, pH 7.7); for beta receptors.
ChEMBL 368 7 0 5 2.8 COc1cccc(OC[C@@H]2CN(CCN3CCc4ccccc43)CCO2)c1 nan
CHEMBL3986651 154282 0 None -47 12 Mouse 5.1 pKi = 5.1 Binding
Radioligand Binding Assay: The detailed experimental protocols for the radioligand and functional receptor assays are available on the NIMH PDSP website at http://pdsp.med.unc.edu/UNC-CH %20Protocol %20Book.pdf. A. Serotonin receptors: 5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E, 5-HT2A, 5-HT2B, 5-HT2C, 5-HT3, 5-HT5A, 5-HT6 and 5-HT7. Assay Buffer: Standard Binding Buffer (50 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, pH 7.4) Membrane Fraction Source: Transiently or stably transfected cell lines (e.g., HEK293, COS, CHO, NIH3T3). Protocol adapted from Roth et al. (1986), J. Pharmacol. Exp. Ther., 238(2): 480-485; and Roth et al. (1994), J. Pharmacol. Exp. Ther., 268(3): 1403-1410. Adrenergic Receptors: alpha1A, alpha1B, alpha2A, alpha2B, alpha2C, beta1, beta2, beta3 Assay Buffers: For alpha1 receptors, alpha1 Binding Buffer (20 mM Tris-HCl, 145 mM NaCl, pH 7.4); for alpha2 receptors, alpha2 Binding Buffer (50 mM Tris-HCl, 5 mM MgCl2, pH 7.7); for beta receptors.Radioligand Binding Assay: The detailed experimental protocols for the radioligand and functional receptor assays are available on the NIMH PDSP website at http://pdsp.med.unc.edu/UNC-CH %20Protocol %20Book.pdf. A. Serotonin receptors: 5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E, 5-HT2A, 5-HT2B, 5-HT2C, 5-HT3, 5-HT5A, 5-HT6 and 5-HT7. Assay Buffer: Standard Binding Buffer (50 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, pH 7.4) Membrane Fraction Source: Transiently or stably transfected cell lines (e.g., HEK293, COS, CHO, NIH3T3). Protocol adapted from Roth et al. (1986), J. Pharmacol. Exp. Ther., 238(2): 480-485; and Roth et al. (1994), J. Pharmacol. Exp. Ther., 268(3): 1403-1410. Adrenergic Receptors: alpha1A, alpha1B, alpha2A, alpha2B, alpha2C, beta1, beta2, beta3 Assay Buffers: For alpha1 receptors, alpha1 Binding Buffer (20 mM Tris-HCl, 145 mM NaCl, pH 7.4); for alpha2 receptors, alpha2 Binding Buffer (50 mM Tris-HCl, 5 mM MgCl2, pH 7.7); for beta receptors.
ChEMBL 368 7 0 5 2.8 COc1cccc(OC[C@@H]2CN(CCN3CCc4ccccc43)CCO2)c1 nan
2520 203985 70 None -147 12 Rat 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC nan
CHEMBL1280 203985 70 None -147 12 Rat 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC nan
CHEMBL6966 203985 70 None -147 12 Rat 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC nan
10479323 34663 0 None -9 3 Human 7.1 pKi = 7.1 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 459 5 2 5 4.4 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNC(=O)c1ccc(C(F)(F)F)cc1)C3 10.1021/jm030952q
CHEMBL143026 34663 0 None -9 3 Human 7.1 pKi = 7.1 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 459 5 2 5 4.4 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNC(=O)c1ccc(C(F)(F)F)cc1)C3 10.1021/jm030952q
10479323 34663 0 None -9 3 Human 7.1 pKi = 7.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 459 5 2 5 4.4 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNC(=O)c1ccc(C(F)(F)F)cc1)C3 10.1007/s00044-010-9379-1
CHEMBL143026 34663 0 None -9 3 Human 7.1 pKi = 7.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 459 5 2 5 4.4 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNC(=O)c1ccc(C(F)(F)F)cc1)C3 10.1007/s00044-010-9379-1
46882088 5795 0 None -11 4 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 435 10 1 6 4.0 COc1cccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)c1OC 10.1016/j.bmcl.2010.01.030
CHEMBL1079066 5795 0 None -11 4 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 435 10 1 6 4.0 COc1cccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)c1OC 10.1016/j.bmcl.2010.01.030
3198 205490 76 None -1698 34 Rat 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
CHEMBL1201049 205490 76 None -1698 34 Rat 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
CHEMBL808 205490 76 None -1698 34 Rat 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
44318075 205343 0 None 3 2 Human 7.1 pKi = 7.1 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 460 7 0 6 4.7 O=C1CCCCCN1Cc1cc(CN2CCN(c3ccccc3Oc3ccccc3)CC2)on1 10.1016/s0960-894x(02)00436-5
CHEMBL79817 205343 0 None 3 2 Human 7.1 pKi = 7.1 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 460 7 0 6 4.7 O=C1CCCCCN1Cc1cc(CN2CCN(c3ccccc3Oc3ccccc3)CC2)on1 10.1016/s0960-894x(02)00436-5
122187556 123032 0 None -7 2 Rat 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 307 5 1 2 4.2 c1ccc2c(C3CCN(CCCn4cccc4)CC3)c[nH]c2c1 10.1016/j.bmcl.2015.07.046
CHEMBL3609355 123032 0 None -7 2 Rat 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 307 5 1 2 4.2 c1ccc2c(C3CCN(CCCn4cccc4)CC3)c[nH]c2c1 10.1016/j.bmcl.2015.07.046
9844321 100834 0 None -478 5 Human 7.1 pKi = 7.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 407 4 0 4 3.3 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(F)ccc2Cl)CC1 10.1007/s00044-010-9379-1
CHEMBL293539 100834 0 None -478 5 Human 7.1 pKi = 7.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 407 4 0 4 3.3 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(F)ccc2Cl)CC1 10.1007/s00044-010-9379-1
42 2050 57 None -15 18 Human 7.1 pKi = 7.1 Binding
Binding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assayBinding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assay
ChEMBL 401 6 0 7 1.2 O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(CC1)c1ncccn1 10.1016/s0960-894x(98)00451-x
56971 2050 57 None -15 18 Human 7.1 pKi = 7.1 Binding
Binding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assayBinding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assay
ChEMBL 401 6 0 7 1.2 O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(CC1)c1ncccn1 10.1016/s0960-894x(98)00451-x
CHEMBL8412 2050 57 None -15 18 Human 7.1 pKi = 7.1 Binding
Binding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assayBinding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assay
ChEMBL 401 6 0 7 1.2 O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(CC1)c1ncccn1 10.1016/s0960-894x(98)00451-x
9844321 100834 0 None -478 5 Human 7.1 pKi = 7.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 407 4 0 4 3.3 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(F)ccc2Cl)CC1 10.1007/s00044-010-9379-1
CHEMBL293539 100834 0 None -478 5 Human 7.1 pKi = 7.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 407 4 0 4 3.3 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(F)ccc2Cl)CC1 10.1007/s00044-010-9379-1
11994915 11800 0 None -1 7 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 391 8 1 5 4.2 COc1cc(-c2ccccc2)ccc1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL1182145 11800 0 None -1 7 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 391 8 1 5 4.2 COc1cc(-c2ccccc2)ccc1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL214762 11800 0 None -1 7 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 391 8 1 5 4.2 COc1cc(-c2ccccc2)ccc1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
25132566 187299 0 None -14 4 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 343 8 1 5 2.8 COc1ccccc1OCCNC[C@@H]1COC[C@@H](c2ccccc2)O1 10.1021/jm800461k
CHEMBL493041 187299 0 None -14 4 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 343 8 1 5 2.8 COc1ccccc1OCCNC[C@@H]1COC[C@@H](c2ccccc2)O1 10.1021/jm800461k
11234230 101674 0 None -162 5 Rat 7.1 pKi = 7.1 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 375 4 0 3 3.6 O=C1CC2(CCCC2)CCN1CCN1CCN(c2ccccc2Cl)CC1 10.1021/jm030944+
CHEMBL299454 101674 0 None -162 5 Rat 7.1 pKi = 7.1 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 375 4 0 3 3.6 O=C1CC2(CCCC2)CCN1CCN1CCN(c2ccccc2Cl)CC1 10.1021/jm030944+
49783419 17717 0 None -263 13 Human 7.1 pKi = 7.1 Binding
Binding affinity to human adrenergic alpha1A receptorBinding affinity to human adrenergic alpha1A receptor
ChEMBL 366 6 1 6 2.8 CCCCN1CCC(COC(=O)c2cc(F)c(N)c3c2OCCO3)CC1 10.1021/jm100668r
CHEMBL1258671 17717 0 None -263 13 Human 7.1 pKi = 7.1 Binding
Binding affinity to human adrenergic alpha1A receptorBinding affinity to human adrenergic alpha1A receptor
ChEMBL 366 6 1 6 2.8 CCCCN1CCC(COC(=O)c2cc(F)c(N)c3c2OCCO3)CC1 10.1021/jm100668r
130442480 175246 0 None -107 24 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]-prazosin from recombinant human alpha1A adrenergic receptor measured after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-prazosin from recombinant human alpha1A adrenergic receptor measured after 90 mins by microbeta scintillation counting method
ChEMBL 410 3 0 6 5.7 Cc1ncc2nccn2c1-c1ccc(Oc2nccc3occc23)cc1C(F)(F)F 10.1021/acs.jmedchem.9b00351
CHEMBL4572614 175246 0 None -107 24 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]-prazosin from recombinant human alpha1A adrenergic receptor measured after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-prazosin from recombinant human alpha1A adrenergic receptor measured after 90 mins by microbeta scintillation counting method
ChEMBL 410 3 0 6 5.7 Cc1ncc2nccn2c1-c1ccc(Oc2nccc3occc23)cc1C(F)(F)F 10.1021/acs.jmedchem.9b00351
46915370 54937 0 None -1 6 Human 6.1 pKi = 6.1 Binding
Binding affinity to adrenergic alpha1A receptorBinding affinity to adrenergic alpha1A receptor
ChEMBL 195 0 3 5 -1.6 Cn1c(=O)[nH]c2c([nH]c(=O)n2C)c1=N 10.1021/jm100490m
CHEMBL1241328 54937 0 None -1 6 Human 6.1 pKi = 6.1 Binding
Binding affinity to adrenergic alpha1A receptorBinding affinity to adrenergic alpha1A receptor
ChEMBL 195 0 3 5 -1.6 Cn1c(=O)[nH]c2c([nH]c(=O)n2C)c1=N 10.1021/jm100490m
CHEMBL1615596 54937 0 None -1 6 Human 6.1 pKi = 6.1 Binding
Binding affinity to adrenergic alpha1A receptorBinding affinity to adrenergic alpha1A receptor
ChEMBL 195 0 3 5 -1.6 Cn1c(=O)[nH]c2c([nH]c(=O)n2C)c1=N 10.1021/jm100490m
12134987 204965 0 None 16 2 Human 7.1 pKi = 7.1 Binding
Compound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptorCompound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptor
ChEMBL 414 7 0 6 2.8 CC(C)Oc1ccccc1N1CCN(CC2=NOC(CN3CCCCC3=O)C2)CC1 10.1016/s0960-894x(00)00472-8
CHEMBL76643 204965 0 None 16 2 Human 7.1 pKi = 7.1 Binding
Compound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptorCompound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptor
ChEMBL 414 7 0 6 2.8 CC(C)Oc1ccccc1N1CCN(CC2=NOC(CN3CCCCC3=O)C2)CC1 10.1016/s0960-894x(00)00472-8
155565219 176541 0 None -1 4 Human 7.1 pKi = 7.1 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 403 10 1 4 4.6 c1ccc(OCCNCC[C@H]2CO[C@H](C(c3ccccc3)c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
CHEMBL4580335 176541 0 None -1 4 Human 7.1 pKi = 7.1 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 403 10 1 4 4.6 c1ccc(OCCNCC[C@H]2CO[C@H](C(c3ccccc3)c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
CHEMBL4597359 176541 0 None -1 4 Human 7.1 pKi = 7.1 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 403 10 1 4 4.6 c1ccc(OCCNCC[C@H]2CO[C@H](C(c3ccccc3)c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
44568918 187332 0 None 1 4 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 449 10 1 6 4.0 COc1cccc(OC)c1OCCNC[C@@H]1COC(c2ccccc2)(c2ccccc2)CO1 10.1021/jm800461k
CHEMBL493284 187332 0 None 1 4 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 449 10 1 6 4.0 COc1cccc(OC)c1OCCNC[C@@H]1COC(c2ccccc2)(c2ccccc2)CO1 10.1021/jm800461k
68712 100310 60 None -8 5 Human 5.1 pKi = 5.1 Binding
Binding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 10.1016/0960-894X(94)85032-1
CHEMBL289480 100310 60 None -8 5 Human 5.1 pKi = 5.1 Binding
Binding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 10.1016/0960-894X(94)85032-1
2351 3261 64 None -138 21 Rat 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
2820 3261 64 None -138 21 Rat 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
5035 3261 64 None -138 21 Rat 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
CHEMBL81 3261 64 None -138 21 Rat 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
DB00481 3261 64 None -138 21 Rat 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
1016 3720 78 None -1737 35 Rat 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
2561 3720 78 None -1737 35 Rat 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
2733526 3720 78 None -1737 35 Rat 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
5384 3720 78 None -1737 35 Rat 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
CHEMBL83 3720 78 None -1737 35 Rat 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
DB00675 3720 78 None -1737 35 Rat 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
44316072 204993 0 None 4 3 Human 8.1 pKi = 8.1 Binding
Compound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptorCompound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptor
ChEMBL 425 7 0 6 3.0 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCC3=O)nn2C)CC1 10.1016/s0960-894x(00)00472-8
CHEMBL76867 204993 0 None 4 3 Human 8.1 pKi = 8.1 Binding
Compound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptorCompound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptor
ChEMBL 425 7 0 6 3.0 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCC3=O)nn2C)CC1 10.1016/s0960-894x(00)00472-8
11567620 16044 0 None -5 3 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 404 8 1 4 4.9 Fc1ccccc1N1CCN(CCCCNc2cc(-c3ccccc3)ccn2)CC1 10.1016/j.bmcl.2010.07.096
CHEMBL1223802 16044 0 None -5 3 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 404 8 1 4 4.9 Fc1ccccc1N1CCN(CCCCNc2cc(-c3ccccc3)ccn2)CC1 10.1016/j.bmcl.2010.07.096
57395340 69271 0 None 1 5 Pig 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 469 14 1 6 3.6 CCOCCOCc1ccc(C(=O)NCCCCN2CCN(c3ccccc3OC)CC2)cc1 10.1016/j.bmc.2011.10.063
CHEMBL1928124 69271 0 None 1 5 Pig 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 469 14 1 6 3.6 CCOCCOCc1ccc(C(=O)NCCCCN2CCN(c3ccccc3OC)CC2)cc1 10.1016/j.bmc.2011.10.063
10095156 78514 0 None 1 3 Rat 8.0 pKi = 8.0 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 447 4 1 6 3.6 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccccc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL2112073 78514 0 None 1 3 Rat 8.0 pKi = 8.0 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 447 4 1 6 3.6 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccccc54)c3=O)C[C@@H]21 10.1021/jm990567u
10698907 121005 0 None 602 3 Human 8.0 pKi = 8.0 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 605 12 4 9 2.4 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(C(=O)OCCO)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980506g
CHEMBL356623 121005 0 None 602 3 Human 8.0 pKi = 8.0 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 605 12 4 9 2.4 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(C(=O)OCCO)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980506g
44295133 188704 0 None 13 3 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 586 7 2 5 5.0 O=C1OCC2=C1C(c1ccc(F)c(F)c1)N(C(=O)NCCCN1CCC(c3ccccc3)(c3ccccc3)CC1)C(=O)N2 10.1016/s0960-894x(99)00653-8
CHEMBL50490 188704 0 None 13 3 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 586 7 2 5 5.0 O=C1OCC2=C1C(c1ccc(F)c(F)c1)N(C(=O)NCCCN1CCC(c3ccccc3)(c3ccccc3)CC1)C(=O)N2 10.1016/s0960-894x(99)00653-8
71817710 102380 0 None 1 4 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 355 7 1 6 3.3 COc1ccc2ccoc2c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm400867d
CHEMBL2419770 102380 0 None 1 4 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 355 7 1 6 3.3 COc1ccc2ccoc2c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm400867d
CHEMBL3039705 102380 0 None 1 4 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 355 7 1 6 3.3 COc1ccc2ccoc2c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm400867d
10430193 161574 0 None -60 6 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 385 3 1 7 2.2 COc1cc2nc(N3CCN(C(C)=O)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
CHEMBL4129461 161574 0 None -60 6 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 385 3 1 7 2.2 COc1cc2nc(N3CCN(C(C)=O)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
3038495 705 37 None -6 19 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 417 8 1 4 4.2 COc1ccccc1N1CCN(CC1)CCCCNC(=O)c1ccc2c(c1)cccc2 10.1016/j.bmcl.2015.12.068
7625 705 37 None -6 19 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 417 8 1 4 4.2 COc1ccccc1N1CCN(CC1)CCCCNC(=O)c1ccc2c(c1)cccc2 10.1016/j.bmcl.2015.12.068
CHEMBL25236 705 37 None -6 19 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 417 8 1 4 4.2 COc1ccccc1N1CCN(CC1)CCCCNC(=O)c1ccc2c(c1)cccc2 10.1016/j.bmcl.2015.12.068
1588 2311 27 None -26 44 Rat 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
28864 2311 27 None -26 44 Rat 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
43 2311 27 None -26 44 Rat 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
CHEMBL157138 2311 27 None -26 44 Rat 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
DB00589 2311 27 None -26 44 Rat 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
10582624 202769 0 None -1 3 Rat 8.0 pKi = 8.0 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 393 4 1 7 1.2 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4nccnc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL62206 202769 0 None -1 3 Rat 8.0 pKi = 8.0 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 393 4 1 7 1.2 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4nccnc4c3=O)C[C@@H]21 10.1021/jm000541z
10530732 168027 0 None -1 3 Rat 8.0 pKi = 8.0 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 515 4 1 6 4.6 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cc(C(F)(F)F)ccc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL43234 168027 0 None -1 3 Rat 8.0 pKi = 8.0 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 515 4 1 6 4.6 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cc(C(F)(F)F)ccc54)c3=O)C[C@@H]21 10.1021/jm990567u
9887378 98377 4 None 40 3 Human 8.0 pKi = 8.0 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 402 8 1 5 1.7 CC(C)Oc1ccccc1N1CCN(CCNC(=O)CN2CCCCC2=O)CC1 10.1016/j.bmcl.2004.11.032
CHEMBL275469 98377 4 None 40 3 Human 8.0 pKi = 8.0 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 402 8 1 5 1.7 CC(C)Oc1ccccc1N1CCN(CCNC(=O)CN2CCCCC2=O)CC1 10.1016/j.bmcl.2004.11.032
11995034 11801 0 None 3 4 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 391 8 1 5 4.2 COc1cccc(-c2ccccc2)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL1182148 11801 0 None 3 4 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 391 8 1 5 4.2 COc1cccc(-c2ccccc2)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL214952 11801 0 None 3 4 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 391 8 1 5 4.2 COc1cccc(-c2ccccc2)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
44388495 63394 0 None - 1 Human 8.0 pKi = 8.0 Binding
Inhibition of [3H]prazosin binding to human adrenergic alpha-1A receptor expressed in CHO-K1 cell membranesInhibition of [3H]prazosin binding to human adrenergic alpha-1A receptor expressed in CHO-K1 cell membranes
ChEMBL 362 5 3 3 3.4 Nc1ccc(C(=O)NCCN2CCC(c3cccc4[nH]ccc34)CC2)cc1 10.1021/jm0491804
CHEMBL179721 63394 0 None - 1 Human 8.0 pKi = 8.0 Binding
Inhibition of [3H]prazosin binding to human adrenergic alpha-1A receptor expressed in CHO-K1 cell membranesInhibition of [3H]prazosin binding to human adrenergic alpha-1A receptor expressed in CHO-K1 cell membranes
ChEMBL 362 5 3 3 3.4 Nc1ccc(C(=O)NCCN2CCC(c3cccc4[nH]ccc34)CC2)cc1 10.1021/jm0491804
1212 1649 50 None -19 66 Rat 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
204 1649 50 None -19 66 Rat 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
3372 1649 50 None -19 66 Rat 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
CHEMBL726 1649 50 None -19 66 Rat 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
DB00623 1649 50 None -19 66 Rat 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
44268966 33407 0 None -7 6 Rat 8.0 pKi = 8.0 Binding
Binding affinity towards rat Alpha-1A adrenergic receptorBinding affinity towards rat Alpha-1A adrenergic receptor
ChEMBL 476 7 1 7 3.6 COc1ccccc1N1CCN(CCCn2c(=O)[nH]c3scc(-c4ccccc4)c3c2=O)CC1 10.1016/s0960-894x(01)00159-7
CHEMBL14199 33407 0 None -7 6 Rat 8.0 pKi = 8.0 Binding
Binding affinity towards rat Alpha-1A adrenergic receptorBinding affinity towards rat Alpha-1A adrenergic receptor
ChEMBL 476 7 1 7 3.6 COc1ccccc1N1CCN(CCCn2c(=O)[nH]c3scc(-c4ccccc4)c3c2=O)CC1 10.1016/s0960-894x(01)00159-7
3584 3748 64 None -2 14 Rat 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
5401 3748 64 None -2 14 Rat 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
7302 3748 64 None -2 14 Rat 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
CHEMBL611 3748 64 None -2 14 Rat 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
DB01162 3748 64 None -2 14 Rat 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
10644152 100367 7 None 1 3 Rat 8.0 pKi = 8.0 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 390 6 0 4 2.7 O=C1C2CCCN2C(=O)N1CCCCN1CCN(c2cccc(Cl)c2)CC1 10.1021/jm970216k
CHEMBL290039 100367 7 None 1 3 Rat 8.0 pKi = 8.0 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 390 6 0 4 2.7 O=C1C2CCCN2C(=O)N1CCCCN1CCN(c2cccc(Cl)c2)CC1 10.1021/jm970216k
44431546 88112 0 None -1 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 482 7 1 6 3.8 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccccc3C#N)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL234679 88112 0 None -1 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 482 7 1 6 3.8 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccccc3C#N)CC2)CC1 10.1016/j.bmcl.2007.04.008
57391897 69280 0 None 1 5 Pig 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 481 12 1 8 2.7 CCOCCOc1ccn2ncc(C(=O)NCCCN3CCN(c4ccccc4OC)CC3)c2c1 10.1016/j.bmc.2011.10.063
CHEMBL1928133 69280 0 None 1 5 Pig 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 481 12 1 8 2.7 CCOCCOc1ccn2ncc(C(=O)NCCCN3CCN(c4ccccc4OC)CC3)c2c1 10.1016/j.bmc.2011.10.063
44301573 202774 0 None 154 3 Human 8.0 pKi = 8.0 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 535 7 1 5 4.6 Cc1ccc(C2(c3ccc(C)cc3)CC(=O)N(CC(O)CN3CCC(C#N)(c4ccccc4C)CC3)C2=O)cc1 10.1016/s0960-894x(01)00320-1
CHEMBL62249 202774 0 None 154 3 Human 8.0 pKi = 8.0 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 535 7 1 5 4.6 Cc1ccc(C2(c3ccc(C)cc3)CC(=O)N(CC(O)CN3CCC(C#N)(c4ccccc4C)CC3)C2=O)cc1 10.1016/s0960-894x(01)00320-1
53327992 63375 0 None -1 3 Human 8.0 pKi = 8.0 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 461 7 0 5 3.6 COc1ccccc1N1CCN(CCCCN2C(=O)CC3(CCc4ccccc43)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796050 63375 0 None -1 3 Human 8.0 pKi = 8.0 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 461 7 0 5 3.6 COc1ccccc1N1CCN(CCCCN2C(=O)CC3(CCc4ccccc43)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
52948823 17025 0 None -8 4 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 421 13 1 5 4.9 COc1cccc(OC)c1CCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
CHEMBL1254659 17025 0 None -8 4 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 421 13 1 5 4.9 COc1cccc(OC)c1CCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
118716702 114969 0 None 5 4 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 396 4 0 7 1.1 COc1ccccc1N1CCN(CC2COC3(CCS(=O)(=O)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342855 114969 0 None 5 4 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 396 4 0 7 1.1 COc1ccccc1N1CCN(CC2COC3(CCS(=O)(=O)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
4110501 169070 8 None -2 2 Rat 8.0 pKi = 8 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 386 6 0 5 2.0 COc1ccccc1N1CCN(CCCN2C(=O)C3CCCCN3C2=O)CC1 10.1021/jm970216k
CHEMBL43992 169070 8 None -2 2 Rat 8.0 pKi = 8 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 386 6 0 5 2.0 COc1ccccc1N1CCN(CCCN2C(=O)C3CCCCN3C2=O)CC1 10.1021/jm970216k
9805944 56197 37 None -16 9 Human 8.0 pKi = 8 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptorDisplacement of [125I]HEAT from adrenergic alpha1A receptor
ChEMBL 462 7 2 3 4.7 CNC(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm800510m
CHEMBL1627 56197 37 None -16 9 Human 8.0 pKi = 8 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptorDisplacement of [125I]HEAT from adrenergic alpha1A receptor
ChEMBL 462 7 2 3 4.7 CNC(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm800510m
2247 504 81 None -5 42 Rat 8.0 pKi = 8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
249 504 81 None -5 42 Rat 8.0 pKi = 8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
2603 504 81 None -5 42 Rat 8.0 pKi = 8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
CHEMBL296419 504 81 None -5 42 Rat 8.0 pKi = 8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
DB00637 504 81 None -5 42 Rat 8.0 pKi = 8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
44461012 104246 0 None 7 3 Human 7.1 pKi = 7.1 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 509 6 0 7 3.7 O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3cc4c(cc32)CCCC4)CC1 10.1016/s0960-894x(98)00446-6
CHEMBL309949 104246 0 None 7 3 Human 7.1 pKi = 7.1 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 509 6 0 7 3.7 O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3cc4c(cc32)CCCC4)CC1 10.1016/s0960-894x(98)00446-6
9913449 106425 1 None 13 3 Human 7.1 pKi = 7.1 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in human aorta preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in human aorta preparations
ChEMBL 489 6 0 7 3.5 O=C1c2cc(Cl)ccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
CHEMBL313990 106425 1 None 13 3 Human 7.1 pKi = 7.1 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in human aorta preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in human aorta preparations
ChEMBL 489 6 0 7 3.5 O=C1c2cc(Cl)ccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
5019971 173247 4 None -15 2 Rat 7.0 pKi = 7.0 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 424 5 0 4 3.0 O=C1C2CCCCN2C(=O)N1CCCN1CCN(c2cccc(C(F)(F)F)c2)CC1 10.1021/jm970216k
CHEMBL45253 173247 4 None -15 2 Rat 7.0 pKi = 7.0 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 424 5 0 4 3.0 O=C1C2CCCCN2C(=O)N1CCCN1CCN(c2cccc(C(F)(F)F)c2)CC1 10.1021/jm970216k
3805301 101310 83 None 1 2 Bovine 6.1 pKi = 6.1 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 197 1 1 3 1.1 Clc1ccc(N2CCNCC2)nc1 10.1021/jm00366a007
CHEMBL296787 101310 83 None 1 2 Bovine 6.1 pKi = 6.1 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 197 1 1 3 1.1 Clc1ccc(N2CCNCC2)nc1 10.1021/jm00366a007
44414189 12782 0 None -12 2 Rat 6.1 pKi = 6.1 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 342 5 1 5 3.3 Oc1nc2ccccc2n1C1CCN(CCCN2CCCCC2)CC1 10.1016/j.bmcl.2006.05.002
CHEMBL1188266 12782 0 None -12 2 Rat 6.1 pKi = 6.1 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 342 5 1 5 3.3 Oc1nc2ccccc2n1C1CCN(CCCN2CCCCC2)CC1 10.1016/j.bmcl.2006.05.002
CHEMBL535838 12782 0 None -12 2 Rat 6.1 pKi = 6.1 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 342 5 1 5 3.3 Oc1nc2ccccc2n1C1CCN(CCCN2CCCCC2)CC1 10.1016/j.bmcl.2006.05.002
71061709 149503 0 None -63 12 Mouse 5.0 pKi = 5.0 Binding
Radioligand Binding Assay: The detailed experimental protocols for the radioligand and functional receptor assays are available on the NIMH PDSP website at http://pdsp.med.unc.edu/UNC-CH %20Protocol %20Book.pdf. A. Serotonin receptors: 5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E, 5-HT2A, 5-HT2B, 5-HT2C, 5-HT3, 5-HT5A, 5-HT6 and 5-HT7. Assay Buffer: Standard Binding Buffer (50 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, pH 7.4) Membrane Fraction Source: Transiently or stably transfected cell lines (e.g., HEK293, COS, CHO, NIH3T3). Protocol adapted from Roth et al. (1986), J. Pharmacol. Exp. Ther., 238(2): 480-485; and Roth et al. (1994), J. Pharmacol. Exp. Ther., 268(3): 1403-1410. Adrenergic Receptors: alpha1A, alpha1B, alpha2A, alpha2B, alpha2C, beta1, beta2, beta3 Assay Buffers: For alpha1 receptors, alpha1 Binding Buffer (20 mM Tris-HCl, 145 mM NaCl, pH 7.4); for alpha2 receptors, alpha2 Binding Buffer (50 mM Tris-HCl, 5 mM MgCl2, pH 7.7); for beta receptors.Radioligand Binding Assay: The detailed experimental protocols for the radioligand and functional receptor assays are available on the NIMH PDSP website at http://pdsp.med.unc.edu/UNC-CH %20Protocol %20Book.pdf. A. Serotonin receptors: 5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E, 5-HT2A, 5-HT2B, 5-HT2C, 5-HT3, 5-HT5A, 5-HT6 and 5-HT7. Assay Buffer: Standard Binding Buffer (50 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, pH 7.4) Membrane Fraction Source: Transiently or stably transfected cell lines (e.g., HEK293, COS, CHO, NIH3T3). Protocol adapted from Roth et al. (1986), J. Pharmacol. Exp. Ther., 238(2): 480-485; and Roth et al. (1994), J. Pharmacol. Exp. Ther., 268(3): 1403-1410. Adrenergic Receptors: alpha1A, alpha1B, alpha2A, alpha2B, alpha2C, beta1, beta2, beta3 Assay Buffers: For alpha1 receptors, alpha1 Binding Buffer (20 mM Tris-HCl, 145 mM NaCl, pH 7.4); for alpha2 receptors, alpha2 Binding Buffer (50 mM Tris-HCl, 5 mM MgCl2, pH 7.7); for beta receptors.
ChEMBL 372 6 0 4 3.5 Clc1cccc(OC[C@@H]2CN(CCN3CCc4ccccc43)CCO2)c1 nan
CHEMBL3946540 149503 0 None -63 12 Mouse 5.0 pKi = 5.0 Binding
Radioligand Binding Assay: The detailed experimental protocols for the radioligand and functional receptor assays are available on the NIMH PDSP website at http://pdsp.med.unc.edu/UNC-CH %20Protocol %20Book.pdf. A. Serotonin receptors: 5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E, 5-HT2A, 5-HT2B, 5-HT2C, 5-HT3, 5-HT5A, 5-HT6 and 5-HT7. Assay Buffer: Standard Binding Buffer (50 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, pH 7.4) Membrane Fraction Source: Transiently or stably transfected cell lines (e.g., HEK293, COS, CHO, NIH3T3). Protocol adapted from Roth et al. (1986), J. Pharmacol. Exp. Ther., 238(2): 480-485; and Roth et al. (1994), J. Pharmacol. Exp. Ther., 268(3): 1403-1410. Adrenergic Receptors: alpha1A, alpha1B, alpha2A, alpha2B, alpha2C, beta1, beta2, beta3 Assay Buffers: For alpha1 receptors, alpha1 Binding Buffer (20 mM Tris-HCl, 145 mM NaCl, pH 7.4); for alpha2 receptors, alpha2 Binding Buffer (50 mM Tris-HCl, 5 mM MgCl2, pH 7.7); for beta receptors.Radioligand Binding Assay: The detailed experimental protocols for the radioligand and functional receptor assays are available on the NIMH PDSP website at http://pdsp.med.unc.edu/UNC-CH %20Protocol %20Book.pdf. A. Serotonin receptors: 5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E, 5-HT2A, 5-HT2B, 5-HT2C, 5-HT3, 5-HT5A, 5-HT6 and 5-HT7. Assay Buffer: Standard Binding Buffer (50 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, pH 7.4) Membrane Fraction Source: Transiently or stably transfected cell lines (e.g., HEK293, COS, CHO, NIH3T3). Protocol adapted from Roth et al. (1986), J. Pharmacol. Exp. Ther., 238(2): 480-485; and Roth et al. (1994), J. Pharmacol. Exp. Ther., 268(3): 1403-1410. Adrenergic Receptors: alpha1A, alpha1B, alpha2A, alpha2B, alpha2C, beta1, beta2, beta3 Assay Buffers: For alpha1 receptors, alpha1 Binding Buffer (20 mM Tris-HCl, 145 mM NaCl, pH 7.4); for alpha2 receptors, alpha2 Binding Buffer (50 mM Tris-HCl, 5 mM MgCl2, pH 7.7); for beta receptors.
ChEMBL 372 6 0 4 3.5 Clc1cccc(OC[C@@H]2CN(CCN3CCc4ccccc43)CCO2)c1 nan
3658 4076 53 None -9 8 Human 7.0 pKi = 7.0 Binding
Binding affinity towards human Alpha-1 adrenergic receptorBinding affinity towards human Alpha-1 adrenergic receptor
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1016/j.bmcl.2004.06.085
517 4076 53 None -9 8 Human 7.0 pKi = 7.0 Binding
Binding affinity towards human Alpha-1 adrenergic receptorBinding affinity towards human Alpha-1 adrenergic receptor
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1016/j.bmcl.2004.06.085
5709 4076 53 None -9 8 Human 7.0 pKi = 7.0 Binding
Binding affinity towards human Alpha-1 adrenergic receptorBinding affinity towards human Alpha-1 adrenergic receptor
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1016/j.bmcl.2004.06.085
CHEMBL312448 4076 53 None -9 8 Human 7.0 pKi = 7.0 Binding
Binding affinity towards human Alpha-1 adrenergic receptorBinding affinity towards human Alpha-1 adrenergic receptor
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1016/j.bmcl.2004.06.085
DB06694 4076 53 None -9 8 Human 7.0 pKi = 7.0 Binding
Binding affinity towards human Alpha-1 adrenergic receptorBinding affinity towards human Alpha-1 adrenergic receptor
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1016/j.bmcl.2004.06.085
44269078 98569 7 None 1 2 Human 7.0 pKi = 7.0 Binding
Binding affinity towards human Alpha-1 adrenergic receptorBinding affinity towards human Alpha-1 adrenergic receptor
ChEMBL 202 1 1 2 2.3 CC(C)(C)c1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2004.06.085
CHEMBL276868 98569 7 None 1 2 Human 7.0 pKi = 7.0 Binding
Binding affinity towards human Alpha-1 adrenergic receptorBinding affinity towards human Alpha-1 adrenergic receptor
ChEMBL 202 1 1 2 2.3 CC(C)(C)c1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2004.06.085
135 2515 43 None -46 58 Rat 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
1796 2515 43 None -46 58 Rat 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
4184 2515 43 None -46 58 Rat 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
CHEMBL6437 2515 43 None -46 58 Rat 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
DB06148 2515 43 None -46 58 Rat 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
44123711 84794 0 None -17 3 Human 7.0 pKi = 7.0 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 346 4 0 5 2.9 COc1ccccc1N1CCN(CC2COC3(CCCCC3)O2)CC1 10.1007/s00044-010-9379-1
CHEMBL2234448 84794 0 None -17 3 Human 7.0 pKi = 7.0 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 346 4 0 5 2.9 COc1ccccc1N1CCN(CC2COC3(CCCCC3)O2)CC1 10.1007/s00044-010-9379-1
9900133 8953 0 None 1 4 Rat 7.0 pKi = 7.0 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 271 2 2 3 3.1 COC(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL109827 8953 0 None 1 4 Rat 7.0 pKi = 7.0 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 271 2 2 3 3.1 COC(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
46881443 5558 0 None -34 4 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 405 9 1 5 4.0 COc1cccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)c1 10.1016/j.bmcl.2010.01.030
CHEMBL1077168 5558 0 None -34 4 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 405 9 1 5 4.0 COc1cccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)c1 10.1016/j.bmcl.2010.01.030
44123711 84794 0 None -17 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 346 4 0 5 2.9 COc1ccccc1N1CCN(CC2COC3(CCCCC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL2234448 84794 0 None -17 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 346 4 0 5 2.9 COc1ccccc1N1CCN(CC2COC3(CCCCC3)O2)CC1 10.1016/j.ejmech.2014.09.070
44123711 84794 0 None -17 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting method
ChEMBL 346 4 0 5 2.9 COc1ccccc1N1CCN(CC2COC3(CCCCC3)O2)CC1 10.1016/j.ejmech.2016.09.050
CHEMBL2234448 84794 0 None -17 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting method
ChEMBL 346 4 0 5 2.9 COc1ccccc1N1CCN(CC2COC3(CCCCC3)O2)CC1 10.1016/j.ejmech.2016.09.050
11449200 78432 0 None 20 3 Rat 7.0 pKi = 7.0 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 291 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCC[C@H]2c1c[nH]cn1 10.1021/jm030551a
CHEMBL2111710 78432 0 None 20 3 Rat 7.0 pKi = 7.0 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 291 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCC[C@H]2c1c[nH]cn1 10.1021/jm030551a
9906677 101018 0 None -11 3 Rat 7.0 pKi = 7.0 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 355 4 0 4 2.3 O=C1CCC(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
CHEMBL294646 101018 0 None -11 3 Rat 7.0 pKi = 7.0 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 355 4 0 4 2.3 O=C1CCC(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
44312198 204566 0 None -3 4 Human 4.0 pKi = 4.0 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 292 1 1 5 2.2 Brc1c(NC2=NCCO2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
CHEMBL73164 204566 0 None -3 4 Human 4.0 pKi = 4.0 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 292 1 1 5 2.2 Brc1c(NC2=NCCO2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
145947560 167684 0 None -4 5 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 344 6 0 3 4.2 Cc1cc(OCCCN2CCN(c3ccccc3)CC2)ccc1Cl 10.1016/j.bmcl.2018.04.059
CHEMBL4212812 167684 0 None -4 5 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 344 6 0 3 4.2 Cc1cc(OCCCN2CCN(c3ccccc3)CC2)ccc1Cl 10.1016/j.bmcl.2018.04.059
CHEMBL4302457 167684 0 None -4 5 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 344 6 0 3 4.2 Cc1cc(OCCCN2CCN(c3ccccc3)CC2)ccc1Cl 10.1016/j.bmcl.2018.04.059
2146 3078 67 None 1 9 Bovine 6.0 pKi = 6.0 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
485 3078 67 None 1 9 Bovine 6.0 pKi = 6.0 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
6041 3078 67 None 1 9 Bovine 6.0 pKi = 6.0 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
CHEMBL1215 3078 67 None 1 9 Bovine 6.0 pKi = 6.0 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
DB00388 3078 67 None 1 9 Bovine 6.0 pKi = 6.0 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
9965896 110347 0 None - 1 Rat 6.0 pKi = 6.0 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 293 4 2 4 1.8 CCS(=O)(=O)Nc1cccc2c1COC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL324238 110347 0 None - 1 Rat 6.0 pKi = 6.0 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 293 4 2 4 1.8 CCS(=O)(=O)Nc1cccc2c1COC2c1c[nH]cn1 10.1021/jm030551a
136 3267 32 None -1479 16 Bovine 6.0 pKi = 6.0 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00366a007
223 3267 32 None -1479 16 Bovine 6.0 pKi = 6.0 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00366a007
643606 3267 32 None -1479 16 Bovine 6.0 pKi = 6.0 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00366a007
CHEMBL10347 3267 32 None -1479 16 Bovine 6.0 pKi = 6.0 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00366a007
136 3267 32 None -1479 16 Bovine 6.0 pKi = 6.0 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00375a017
223 3267 32 None -1479 16 Bovine 6.0 pKi = 6.0 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00375a017
643606 3267 32 None -1479 16 Bovine 6.0 pKi = 6.0 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00375a017
CHEMBL10347 3267 32 None -1479 16 Bovine 6.0 pKi = 6.0 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00375a017
9929936 167888 0 None -9 5 Human 7.0 pKi = 7.0 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 0 4 3.1 Cc1ccc(C)c(N2CCN(CCN3C(=O)CC4(CCCC4)CC3=O)CC2)c1 10.1007/s00044-010-9379-1
CHEMBL431354 167888 0 None -9 5 Human 7.0 pKi = 7.0 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 0 4 3.1 Cc1ccc(C)c(N2CCN(CCN3C(=O)CC4(CCCC4)CC3=O)CC2)c1 10.1007/s00044-010-9379-1
76318763 84795 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 381 5 2 6 3.0 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNC(=O)c1ccoc1)C3 10.1007/s00044-010-9379-1
CHEMBL2234449 84795 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 381 5 2 6 3.0 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNC(=O)c1ccoc1)C3 10.1007/s00044-010-9379-1
11338016 35946 0 None -7 3 Human 7.0 pKi = 7.0 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 381 5 2 6 3.0 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNC(=O)c1ccco1)C3 10.1021/jm030952q
CHEMBL144286 35946 0 None -7 3 Human 7.0 pKi = 7.0 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 381 5 2 6 3.0 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNC(=O)c1ccco1)C3 10.1021/jm030952q
9929936 167888 0 None -9 5 Human 7.0 pKi = 7.0 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 0 4 3.1 Cc1ccc(C)c(N2CCN(CCN3C(=O)CC4(CCCC4)CC3=O)CC2)c1 10.1007/s00044-010-9379-1
CHEMBL431354 167888 0 None -9 5 Human 7.0 pKi = 7.0 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 0 4 3.1 Cc1ccc(C)c(N2CCN(CCN3C(=O)CC4(CCCC4)CC3=O)CC2)c1 10.1007/s00044-010-9379-1
9926529 9357 2 None 1 5 Rat 7.0 pKi = 7.0 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 305 4 2 3 2.6 CCS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL111496 9357 2 None 1 5 Rat 7.0 pKi = 7.0 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 305 4 2 3 2.6 CCS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
44361064 31585 0 None -3 6 Human 7.0 pKi = 7.0 Binding
Compound was tested for binding affinity against human hippocampus Alpha-1A adrenergic receptor using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against human hippocampus Alpha-1A adrenergic receptor using radioligand ([3H]prazosin) binding assay
ChEMBL 338 7 2 4 4.5 N=CCC(O)CC1CCN(c2ccccc2Oc2ccccc2)CC1 10.1021/jm960510x
CHEMBL140450 31585 0 None -3 6 Human 7.0 pKi = 7.0 Binding
Compound was tested for binding affinity against human hippocampus Alpha-1A adrenergic receptor using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against human hippocampus Alpha-1A adrenergic receptor using radioligand ([3H]prazosin) binding assay
ChEMBL 338 7 2 4 4.5 N=CCC(O)CC1CCN(c2ccccc2Oc2ccccc2)CC1 10.1021/jm960510x
53328687 63372 0 None -1 3 Human 7.0 pKi = 7.0 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 483 8 0 5 4.4 COc1ccc(Cl)cc1N1CCN(CCCCN2C(=O)CC(C)(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796047 63372 0 None -1 3 Human 7.0 pKi = 7.0 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 483 8 0 5 4.4 COc1ccc(Cl)cc1N1CCN(CCCCN2C(=O)CC(C)(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
10804826 23583 2 None 1 4 Rat 6.0 pKi = 6.0 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 309 3 3 5 1.2 CS(=O)(=O)Nc1c(O)ccc2c1CCC[C@@H]2C1=NCCN1 10.1021/jm960354u
CHEMBL133451 23583 2 None 1 4 Rat 6.0 pKi = 6.0 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 309 3 3 5 1.2 CS(=O)(=O)Nc1c(O)ccc2c1CCC[C@@H]2C1=NCCN1 10.1021/jm960354u
10065903 22270 0 None -257 4 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptorDisplacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptor
ChEMBL 341 5 2 5 2.4 O[C@H]1[C@@H](NC[C@@H]2COc3ccccc3O2)CC[C@@H]1Oc1ccccc1 10.1021/jm991065j
CHEMBL132378 22270 0 None -257 4 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptorDisplacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptor
ChEMBL 341 5 2 5 2.4 O[C@H]1[C@@H](NC[C@@H]2COc3ccccc3O2)CC[C@@H]1Oc1ccccc1 10.1021/jm991065j
44276536 97340 0 None -1584 4 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 373 8 1 4 3.3 COc1ccccc1N1CCN(CCCCNC(=O)C2CCCCC2)CC1 10.1016/j.bmcl.2015.12.068
CHEMBL26962 97340 0 None -1584 4 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 373 8 1 4 3.3 COc1ccccc1N1CCN(CCCCNC(=O)C2CCCCC2)CC1 10.1016/j.bmcl.2015.12.068
10382537 204143 12 None -144 6 Human 6.0 pKi = 6.0 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 339 1 2 5 1.6 Ic1c(NC2=NCCN2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
CHEMBL70676 204143 12 None -144 6 Human 6.0 pKi = 6.0 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 339 1 2 5 1.6 Ic1c(NC2=NCCN2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
11488170 35200 0 None -24 3 Human 6.0 pKi = 6.0 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 467 10 2 8 3.6 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNCCOc1c(OC)cccc1OC)C3 10.1021/jm030952q
CHEMBL143558 35200 0 None -24 3 Human 6.0 pKi = 6.0 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 467 10 2 8 3.6 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNCCOc1c(OC)cccc1OC)C3 10.1021/jm030952q
2146 3078 67 None -12 9 Rat 6.0 pKi = 6.0 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
485 3078 67 None -12 9 Rat 6.0 pKi = 6.0 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
6041 3078 67 None -12 9 Rat 6.0 pKi = 6.0 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
CHEMBL1215 3078 67 None -12 9 Rat 6.0 pKi = 6.0 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
DB00388 3078 67 None -12 9 Rat 6.0 pKi = 6.0 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
2803 952 58 None -8 19 Human 6.0 pKi = 6.0 Binding
Binding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
516 952 58 None -8 19 Human 6.0 pKi = 6.0 Binding
Binding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
704 952 58 None -8 19 Human 6.0 pKi = 6.0 Binding
Binding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
CHEMBL134 952 58 None -8 19 Human 6.0 pKi = 6.0 Binding
Binding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
DB00575 952 58 None -8 19 Human 6.0 pKi = 6.0 Binding
Binding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
155544514 176331 0 None -309 4 Human 6.0 pKi = 6.0 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 419 10 1 5 4.2 COc1ccccc1OCCNC[C@@H]1CO[C@H](C(c2ccccc2)c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
CHEMBL4526865 176331 0 None -309 4 Human 6.0 pKi = 6.0 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 419 10 1 5 4.2 COc1ccccc1OCCNC[C@@H]1CO[C@H](C(c2ccccc2)c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
CHEMBL4595671 176331 0 None -309 4 Human 6.0 pKi = 6.0 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 419 10 1 5 4.2 COc1ccccc1OCCNC[C@@H]1CO[C@H](C(c2ccccc2)c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
9944937 111311 0 None 1 2 Bovine 6.0 pKi = 6.0 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assay
ChEMBL 320 4 2 3 2.1 CN(C)S(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL326862 111311 0 None 1 2 Bovine 6.0 pKi = 6.0 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assay
ChEMBL 320 4 2 3 2.1 CN(C)S(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
162265 202251 22 None -5 45 Rat 5.0 pKi = 5.0 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 10.1007/s00044-004-0020-z
4786 202251 22 None -5 45 Rat 5.0 pKi = 5.0 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 10.1007/s00044-004-0020-z
CHEMBL61006 202251 22 None -5 45 Rat 5.0 pKi = 5.0 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 10.1007/s00044-004-0020-z
162265 202251 22 None -5 45 Rat 5.0 pKi = 5.0 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 10.1021/jm030551a
4786 202251 22 None -5 45 Rat 5.0 pKi = 5.0 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 10.1021/jm030551a
CHEMBL61006 202251 22 None -5 45 Rat 5.0 pKi = 5.0 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 10.1021/jm030551a
118718431 115328 0 None 11 2 Human 7.0 pKi = 7.0 Binding
Binding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assayBinding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assay
ChEMBL 504 8 0 6 3.9 CCOC(=O)[C@H]1CN(CCCCN2C(=O)c3cc(Cl)ccc3S2(=O)=O)CC[C@H]1c1ccccc1 10.1016/s0960-894x(98)00451-x
CHEMBL3349545 115328 0 None 11 2 Human 7.0 pKi = 7.0 Binding
Binding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assayBinding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assay
ChEMBL 504 8 0 6 3.9 CCOC(=O)[C@H]1CN(CCCCN2C(=O)c3cc(Cl)ccc3S2(=O)=O)CC[C@H]1c1ccccc1 10.1016/s0960-894x(98)00451-x
44267912 16851 0 None 102 3 Human 7.0 pKi = 7.0 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 388 8 1 5 1.3 COc1ccccc1N1CCN(CCCNC(=O)CN2CCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
CHEMBL12501 16851 0 None 102 3 Human 7.0 pKi = 7.0 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 388 8 1 5 1.3 COc1ccccc1N1CCN(CCCNC(=O)CN2CCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
277 1289 62 None -117 46 Rat 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
2913 1289 62 None -117 46 Rat 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
765 1289 62 None -117 46 Rat 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
CHEMBL516 1289 62 None -117 46 Rat 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
DB00434 1289 62 None -117 46 Rat 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
10673466 161740 0 None -3 3 Rat 7.0 pKi = 7 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 481 4 1 6 4.2 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5c(Cl)cccc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL41396 161740 0 None -3 3 Rat 7.0 pKi = 7 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 481 4 1 6 4.2 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5c(Cl)cccc54)c3=O)C[C@@H]21 10.1021/jm990567u
10297 27081 30 None -37 44 Rat 5.0 pKi = 5.0 Binding
Binding affinity towards rat submaxillary gland Alpha-1 adrenergic receptor; value ranges from (6.2 - 15)Binding affinity towards rat submaxillary gland Alpha-1 adrenergic receptor; value ranges from (6.2 - 15)
ChEMBL 151 2 2 2 1.1 C[C@H](N)[C@H](O)c1ccccc1 10.1021/jm025550h
CHEMBL136560 27081 30 None -37 44 Rat 5.0 pKi = 5.0 Binding
Binding affinity towards rat submaxillary gland Alpha-1 adrenergic receptor; value ranges from (6.2 - 15)Binding affinity towards rat submaxillary gland Alpha-1 adrenergic receptor; value ranges from (6.2 - 15)
ChEMBL 151 2 2 2 1.1 C[C@H](N)[C@H](O)c1ccccc1 10.1021/jm025550h
25070031 65355 18 None -4897 4 Human 5.0 pKi = 5.0 Binding
Inhibition of adrenergic alpha 1A receptorInhibition of adrenergic alpha 1A receptor
ChEMBL 313 6 1 4 2.7 C[C@@H]1CCCN1CCCOc1ccc(-c2ccc(=O)[nH]n2)cc1 10.1021/jm200401v
CHEMBL1829335 65355 18 None -4897 4 Human 5.0 pKi = 5.0 Binding
Inhibition of adrenergic alpha 1A receptorInhibition of adrenergic alpha 1A receptor
ChEMBL 313 6 1 4 2.7 C[C@@H]1CCCN1CCCOc1ccc(-c2ccc(=O)[nH]n2)cc1 10.1021/jm200401v
2477 742 59 None - 29 Bovine 8.3 pIC50 = 8.3 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
Drug Central 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 None
36 742 59 None - 29 Bovine 8.3 pIC50 = 8.3 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
Drug Central 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 None
437 742 59 None - 29 Bovine 8.3 pIC50 = 8.3 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
Drug Central 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 None
CHEMBL49 742 59 None - 29 Bovine 8.3 pIC50 = 8.3 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
Drug Central 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 None
DB00490 742 59 None - 29 Bovine 8.3 pIC50 = 8.3 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
Drug Central 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 None
1816 2523 102 None - 18 Human 8.3 pIC50 = 8.3 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
Drug Central 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 None
4205 2523 102 None - 18 Human 8.3 pIC50 = 8.3 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
Drug Central 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 None
7241 2523 102 None - 18 Human 8.3 pIC50 = 8.3 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
Drug Central 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 None
CHEMBL654 2523 102 None - 18 Human 8.3 pIC50 = 8.3 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
Drug Central 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 None
DB00370 2523 102 None - 18 Human 8.3 pIC50 = 8.3 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
Drug Central 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 None
9952220 98228 6 None - 4 Rat 8.2 pIC50 = 8.2 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
Drug Central 387 6 2 4 3.8 CNc1cc(OC)c(C(=O)N[C@H]2CCN(Cc3ccccc3)[C@H]2C)cc1Cl None
CHEMBL274491 98228 6 None - 4 Rat 8.2 pIC50 = 8.2 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
Drug Central 387 6 2 4 3.8 CNc1cc(OC)c(C(=O)N[C@H]2CCN(Cc3ccccc3)[C@H]2C)cc1Cl None
135 2515 43 None -40 58 Human 8.2 pIC50 = 8.2 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
1796 2515 43 None -40 58 Human 8.2 pIC50 = 8.2 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
4184 2515 43 None -40 58 Human 8.2 pIC50 = 8.2 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
CHEMBL6437 2515 43 None -40 58 Human 8.2 pIC50 = 8.2 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
DB06148 2515 43 None -40 58 Human 8.2 pIC50 = 8.2 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
135398737 955 93 None - 92 Bovine 8.2 pIC50 = 8.2 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
38 955 93 None - 92 Bovine 8.2 pIC50 = 8.2 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
722 955 93 None - 92 Bovine 8.2 pIC50 = 8.2 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
CHEMBL42 955 93 None - 92 Bovine 8.2 pIC50 = 8.2 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
DB00363 955 93 None - 92 Bovine 8.2 pIC50 = 8.2 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
5656 203043 87 None - 43 Rat 8.2 pIC50 = 8.2 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
Drug Central 277 5 1 3 3.0 COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1 None
CHEMBL637 203043 87 None - 43 Rat 8.2 pIC50 = 8.2 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
Drug Central 277 5 1 3 3.0 COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1 None
125017 9419 99 None - 0 Rat 8.1 pIC50 = 8.1 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
Drug Central 263 4 2 3 2.7 CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1 None
CHEMBL1118 9419 99 None - 0 Rat 8.1 pIC50 = 8.1 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
Drug Central 263 4 2 3 2.7 CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1 None
1353 1898 93 None - 86 Bovine 8.1 pIC50 = 8.1 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
3559 1898 93 None - 86 Bovine 8.1 pIC50 = 8.1 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
86 1898 93 None - 86 Bovine 8.1 pIC50 = 8.1 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
CHEMBL54 1898 93 None - 86 Bovine 8.1 pIC50 = 8.1 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
DB00502 1898 93 None - 86 Bovine 8.1 pIC50 = 8.1 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
2435 3563 83 None - 49 Rat 8.1 pIC50 = 8.1 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
60149 3563 83 None - 49 Rat 8.1 pIC50 = 8.1 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
98 3563 83 None - 49 Rat 8.1 pIC50 = 8.1 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
CHEMBL12713 3563 83 None - 49 Rat 8.1 pIC50 = 8.1 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
DB06144 3563 83 None - 49 Rat 8.1 pIC50 = 8.1 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
1427 2000 54 None - 27 Rat 8.1 pIC50 = 8.1 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
Drug Central 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C None
357 2000 54 None - 27 Rat 8.1 pIC50 = 8.1 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
Drug Central 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C None
3696 2000 54 None - 27 Rat 8.1 pIC50 = 8.1 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
Drug Central 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C None
CHEMBL11 2000 54 None - 27 Rat 8.1 pIC50 = 8.1 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
Drug Central 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C None
DB00458 2000 54 None - 27 Rat 8.1 pIC50 = 8.1 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
Drug Central 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C None
102 4096 48 None -346 50 Human 8.2 pKd = 8.2 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
3659 4096 48 None -346 50 Human 8.2 pKd = 8.2 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
8969 4096 48 None -346 50 Human 8.2 pKd = 8.2 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
CHEMBL15245 4096 48 None -346 50 Human 8.2 pKd = 8.2 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
DB01392 4096 48 None -346 50 Human 8.2 pKd = 8.2 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
2803 952 58 None -3 19 Rat 8.2 pKd = 8.2 Binding
The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
516 952 58 None -3 19 Rat 8.2 pKd = 8.2 Binding
The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
704 952 58 None -3 19 Rat 8.2 pKd = 8.2 Binding
The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
CHEMBL134 952 58 None -3 19 Rat 8.2 pKd = 8.2 Binding
The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
DB00575 952 58 None -3 19 Rat 8.2 pKd = 8.2 Binding
The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
1353 1898 93 None -10 86 Rat 8.1 pKd = 8.1 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
3559 1898 93 None -10 86 Rat 8.1 pKd = 8.1 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
86 1898 93 None -10 86 Rat 8.1 pKd = 8.1 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
CHEMBL54 1898 93 None -10 86 Rat 8.1 pKd = 8.1 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
DB00502 1898 93 None -10 86 Rat 8.1 pKd = 8.1 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
4209 3141 75 None -3 34 Human 9.1 pKd = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 32608144
4893 3141 75 None -3 34 Human 9.1 pKd = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 32608144
503 3141 75 None -3 34 Human 9.1 pKd = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 32608144
5385 3141 75 None -3 34 Human 9.1 pKd = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 32608144
CHEMBL2 3141 75 None -3 34 Human 9.1 pKd = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 32608144
DB00457 3141 75 None -3 34 Human 9.1 pKd = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 32608144
4106 2485 22 3H-PRAZOSIN -1 34 Pig 10.2 pKi = 10.2 Binding
NoneNone
PDSP KiDatabase 356 2 0 4 4.4 CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C None
5358812 2485 22 3H-PRAZOSIN -1 34 Pig 10.2 pKi = 10.2 Binding
NoneNone
PDSP KiDatabase 356 2 0 4 4.4 CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C None
89 2485 22 3H-PRAZOSIN -1 34 Pig 10.2 pKi = 10.2 Binding
NoneNone
PDSP KiDatabase 356 2 0 4 4.4 CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C None
CHEMBL93240 2485 22 3H-PRAZOSIN -1 34 Pig 10.2 pKi = 10.2 Binding
NoneNone
PDSP KiDatabase 356 2 0 4 4.4 CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C None
None 215933 0 3H-PRAZOSIN -5 20 Pig 10.1 pKi = 10.1 Binding
NoneNone
PDSP KiDatabase 421 9 1 6 4.3 COC1=C(C(=CC=C1)OC)OCCNCC2C(OC3=CC=CC=C3O2)C4=CC=CC=C4 None
4209 3141 75 3H-PRAZOSIN -2 34 Pig 9.6 pKi = 9.6 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
4893 3141 75 3H-PRAZOSIN -2 34 Pig 9.6 pKi = 9.6 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
503 3141 75 3H-PRAZOSIN -2 34 Pig 9.6 pKi = 9.6 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
5385 3141 75 3H-PRAZOSIN -2 34 Pig 9.6 pKi = 9.6 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
CHEMBL2 3141 75 3H-PRAZOSIN -2 34 Pig 9.6 pKi = 9.6 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
DB00457 3141 75 3H-PRAZOSIN -2 34 Pig 9.6 pKi = 9.6 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
4106 2485 22 3H-PRAZOSIN -1 34 Pig 9.3 pKi = 9.3 Binding
NoneNone
PDSP KiDatabase 356 2 0 4 4.4 CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C None
5358812 2485 22 3H-PRAZOSIN -1 34 Pig 9.3 pKi = 9.3 Binding
NoneNone
PDSP KiDatabase 356 2 0 4 4.4 CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C None
89 2485 22 3H-PRAZOSIN -1 34 Pig 9.3 pKi = 9.3 Binding
NoneNone
PDSP KiDatabase 356 2 0 4 4.4 CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C None
CHEMBL93240 2485 22 3H-PRAZOSIN -1 34 Pig 9.3 pKi = 9.3 Binding
NoneNone
PDSP KiDatabase 356 2 0 4 4.4 CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C None
2389 3306 118 3H-PRAZOSIN -5 68 Pig 9.3 pKi = 9.3 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
5073 3306 118 3H-PRAZOSIN -5 68 Pig 9.3 pKi = 9.3 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
96 3306 118 3H-PRAZOSIN -5 68 Pig 9.3 pKi = 9.3 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
CHEMBL85 3306 118 3H-PRAZOSIN -5 68 Pig 9.3 pKi = 9.3 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
DB00734 3306 118 3H-PRAZOSIN -5 68 Pig 9.3 pKi = 9.3 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
None 215933 0 3H-PRAZOSIN -5 20 Pig 9.3 pKi = 9.3 Binding
NoneNone
PDSP KiDatabase 421 9 1 6 4.3 COC1=C(C(=CC=C1)OC)OCCNCC2C(OC3=CC=CC=C3O2)C4=CC=CC=C4 None
4209 3141 75 3H-PRAZOSIN -2 34 Pig 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
4893 3141 75 3H-PRAZOSIN -2 34 Pig 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
503 3141 75 3H-PRAZOSIN -2 34 Pig 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
5385 3141 75 3H-PRAZOSIN -2 34 Pig 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
CHEMBL2 3141 75 3H-PRAZOSIN -2 34 Pig 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
DB00457 3141 75 3H-PRAZOSIN -2 34 Pig 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
489 145 28 3H-PRAZOSIN -8 13 Pig 9.1 pKi = 9.1 Binding
NoneNone
PDSP KiDatabase 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C None
5640 145 28 3H-PRAZOSIN -8 13 Pig 9.1 pKi = 9.1 Binding
NoneNone
PDSP KiDatabase 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C None
CHEMBL420060 145 28 3H-PRAZOSIN -8 13 Pig 9.1 pKi = 9.1 Binding
NoneNone
PDSP KiDatabase 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C None
489 145 28 3H-PRAZOSIN -8 13 Pig 9.0 pKi = 9 Binding
NoneNone
PDSP KiDatabase 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C None
5640 145 28 3H-PRAZOSIN -8 13 Pig 9.0 pKi = 9 Binding
NoneNone
PDSP KiDatabase 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C None
CHEMBL420060 145 28 3H-PRAZOSIN -8 13 Pig 9.0 pKi = 9 Binding
NoneNone
PDSP KiDatabase 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C None
2389 3306 118 3H-PRAZOSIN -5 68 Pig 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
5073 3306 118 3H-PRAZOSIN -5 68 Pig 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
96 3306 118 3H-PRAZOSIN -5 68 Pig 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
CHEMBL85 3306 118 3H-PRAZOSIN -5 68 Pig 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
DB00734 3306 118 3H-PRAZOSIN -5 68 Pig 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
463 1393 22 None 5 13 Human 8.0 pKi = 8 Binding
GRAC: human a1A selective antagonistGRAC: human a1A selective antagonist
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
6918097 1393 22 None 5 13 Human 8.0 pKi = 8 Binding
GRAC: human a1A selective antagonistGRAC: human a1A selective antagonist
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
837 1393 22 None 5 13 Human 8.0 pKi = 8 Binding
GRAC: human a1A selective antagonistGRAC: human a1A selective antagonist
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
CHEMBL2051956 1393 22 None 5 13 Human 8.0 pKi = 8 Binding
GRAC: human a1A selective antagonistGRAC: human a1A selective antagonist
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
DB14068 1393 22 None 5 13 Human 8.0 pKi = 8 Binding
GRAC: human a1A selective antagonistGRAC: human a1A selective antagonist
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
4209 3141 75 None -3 34 Rat 8.0 pKi = 8.0 Binding
Inhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary glandInhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary gland
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
4893 3141 75 None -3 34 Rat 8.0 pKi = 8.0 Binding
Inhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary glandInhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary gland
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
503 3141 75 None -3 34 Rat 8.0 pKi = 8.0 Binding
Inhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary glandInhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary gland
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
5385 3141 75 None -3 34 Rat 8.0 pKi = 8.0 Binding
Inhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary glandInhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary gland
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
CHEMBL2 3141 75 None -3 34 Rat 8.0 pKi = 8.0 Binding
Inhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary glandInhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary gland
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
DB00457 3141 75 None -3 34 Rat 8.0 pKi = 8.0 Binding
Inhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary glandInhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary gland
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
4209 3141 75 None -3 34 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
4893 3141 75 None -3 34 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
503 3141 75 None -3 34 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
5385 3141 75 None -3 34 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
CHEMBL2 3141 75 None -3 34 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
DB00457 3141 75 None -3 34 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
4151 3580 89 None 33 3 Human 8.0 pKi = 8.0 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
Drug Central 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N None
493 3580 89 None 33 3 Human 8.0 pKi = 8.0 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
Drug Central 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N None
5312125 3580 89 None 33 3 Human 8.0 pKi = 8.0 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
Drug Central 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N None
CHEMBL24778 3580 89 None 33 3 Human 8.0 pKi = 8.0 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
Drug Central 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N None
DB06207 3580 89 None 33 3 Human 8.0 pKi = 8.0 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
Drug Central 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N None
129211 3722 78 None -2 16 Rat 8.0 pKi = 8.0 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
2562 3722 78 None -2 16 Rat 8.0 pKi = 8.0 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
488 3722 78 None -2 16 Rat 8.0 pKi = 8.0 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
CHEMBL836 3722 78 None -2 16 Rat 8.0 pKi = 8.0 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
DB00706 3722 78 None -2 16 Rat 8.0 pKi = 8.0 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
129211 3722 78 None -1 16 Human 8.0 pKi = 8.0 Binding
Binding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligandBinding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligand
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
2562 3722 78 None -1 16 Human 8.0 pKi = 8.0 Binding
Binding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligandBinding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligand
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
488 3722 78 None -1 16 Human 8.0 pKi = 8.0 Binding
Binding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligandBinding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligand
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
CHEMBL836 3722 78 None -1 16 Human 8.0 pKi = 8.0 Binding
Binding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligandBinding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligand
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
DB00706 3722 78 None -1 16 Human 8.0 pKi = 8.0 Binding
Binding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligandBinding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligand
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
484 2837 51 3H-PRAZOSIN -67 36 Pig 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
951 2837 51 3H-PRAZOSIN -67 36 Pig 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
CHEMBL432 2837 51 3H-PRAZOSIN -67 36 Pig 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
2470 3626 50 3H-PRAZOSIN -478 60 Pig 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
3300 3626 50 3H-PRAZOSIN -478 60 Pig 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
5265 3626 50 3H-PRAZOSIN -478 60 Pig 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
99 3626 50 3H-PRAZOSIN -478 60 Pig 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
CHEMBL267930 3626 50 3H-PRAZOSIN -478 60 Pig 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
100 3776 58 3H-PRAZOSIN -20 56 Pig 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
2637 3776 58 3H-PRAZOSIN -20 56 Pig 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
5452 3776 58 3H-PRAZOSIN -20 56 Pig 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
CHEMBL479 3776 58 3H-PRAZOSIN -20 56 Pig 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
DB00679 3776 58 3H-PRAZOSIN -20 56 Pig 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
2389 3306 118 3H-PRAZOSIN -5 68 Pig 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
5073 3306 118 3H-PRAZOSIN -5 68 Pig 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
96 3306 118 3H-PRAZOSIN -5 68 Pig 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
CHEMBL85 3306 118 3H-PRAZOSIN -5 68 Pig 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
DB00734 3306 118 3H-PRAZOSIN -5 68 Pig 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
100 3776 58 3H-PRAZOSIN -20 56 Pig 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
2637 3776 58 3H-PRAZOSIN -20 56 Pig 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
5452 3776 58 3H-PRAZOSIN -20 56 Pig 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
CHEMBL479 3776 58 3H-PRAZOSIN -20 56 Pig 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
DB00679 3776 58 3H-PRAZOSIN -20 56 Pig 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
None 215933 0 3H-PRAZOSIN -5 20 Pig 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 421 9 1 6 4.3 COC1=C(C(=CC=C1)OC)OCCNCC2C(OC3=CC=CC=C3O2)C4=CC=CC=C4 None
2726 916 68 3H-PRAZOSIN -20 73 Pig 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
621 916 68 3H-PRAZOSIN -20 73 Pig 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
83 916 68 3H-PRAZOSIN -20 73 Pig 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
CHEMBL71 916 68 3H-PRAZOSIN -20 73 Pig 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
DB00477 916 68 3H-PRAZOSIN -20 73 Pig 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
124 2960 47 3H-PRAZOSIN -36 33 Pig 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2032 2960 47 3H-PRAZOSIN -36 33 Pig 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
4636 2960 47 3H-PRAZOSIN -36 33 Pig 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
CHEMBL762 2960 47 3H-PRAZOSIN -36 33 Pig 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
DB00935 2960 47 3H-PRAZOSIN -36 33 Pig 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
None 216215 0 3H-PRAZOSIN -2 4 Pig 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 609 10 1 8 6.0 CC1=C(C(C(=C(N1)C)C(=O)OCCCN2CCC(CC2)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC(=CC=C5)[N+](=O)[O-])C(=O)OC None
126225 94947 5 3H-PRAZOSIN -41 8 Pig 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 263 1 0 2 4.2 C=Cc1sc2ccc(Cl)c3c2c1CN(C)CC3 None
CHEMBL25467 94947 5 3H-PRAZOSIN -41 8 Pig 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 263 1 0 2 4.2 C=Cc1sc2ccc(Cl)c3c2c1CN(C)CC3 None
None 216215 0 3H-PRAZOSIN -2 4 Pig 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 609 10 1 8 6.0 CC1=C(C(C(=C(N1)C)C(=O)OCCCN2CCC(CC2)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC(=CC=C5)[N+](=O)[O-])C(=O)OC None
135398737 955 93 3H-PRAZOSIN -9 92 Pig 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
38 955 93 3H-PRAZOSIN -9 92 Pig 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
722 955 93 3H-PRAZOSIN -9 92 Pig 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
CHEMBL42 955 93 3H-PRAZOSIN -9 92 Pig 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
DB00363 955 93 3H-PRAZOSIN -9 92 Pig 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
489 145 28 3H-PRAZOSIN -8 13 Pig 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C None
5640 145 28 3H-PRAZOSIN -8 13 Pig 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C None
CHEMBL420060 145 28 3H-PRAZOSIN -8 13 Pig 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C None
124 2960 47 3H-PRAZOSIN -36 33 Pig 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2032 2960 47 3H-PRAZOSIN -36 33 Pig 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
4636 2960 47 3H-PRAZOSIN -36 33 Pig 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
CHEMBL762 2960 47 3H-PRAZOSIN -36 33 Pig 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
DB00935 2960 47 3H-PRAZOSIN -36 33 Pig 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
None 216215 0 3H-PRAZOSIN -2 4 Pig 7.4 pKi = 7.4 Binding
NoneNone
PDSP KiDatabase 609 10 1 8 6.0 CC1=C(C(C(=C(N1)C)C(=O)OCCCN2CCC(CC2)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC(=CC=C5)[N+](=O)[O-])C(=O)OC None
100 3776 58 3H-PRAZOSIN -20 56 Pig 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
2637 3776 58 3H-PRAZOSIN -20 56 Pig 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
5452 3776 58 3H-PRAZOSIN -20 56 Pig 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
CHEMBL479 3776 58 3H-PRAZOSIN -20 56 Pig 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
DB00679 3776 58 3H-PRAZOSIN -20 56 Pig 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
1028 289 71 3H-PRAZOSIN -741 30 Pig 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
139148732 289 71 3H-PRAZOSIN -741 30 Pig 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
479 289 71 3H-PRAZOSIN -741 30 Pig 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
5816 289 71 3H-PRAZOSIN -741 30 Pig 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
CHEMBL679 289 71 3H-PRAZOSIN -741 30 Pig 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
DB00668 289 71 3H-PRAZOSIN -741 30 Pig 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
3016 1400 48 None 46 5 Human 8.4 pKi = 8.4 Binding
NoneNone
Drug Central 284 1 0 2 3.2 Clc1ccc2c(c1)C(=NCC(=O)N2C)c1ccccc1 None
3364 1400 48 None 46 5 Human 8.4 pKi = 8.4 Binding
NoneNone
Drug Central 284 1 0 2 3.2 Clc1ccc2c(c1)C(=NCC(=O)N2C)c1ccccc1 None
852 1400 48 None 46 5 Human 8.4 pKi = 8.4 Binding
NoneNone
Drug Central 284 1 0 2 3.2 Clc1ccc2c(c1)C(=NCC(=O)N2C)c1ccccc1 None
CHEMBL12 1400 48 None 46 5 Human 8.4 pKi = 8.4 Binding
NoneNone
Drug Central 284 1 0 2 3.2 Clc1ccc2c(c1)C(=NCC(=O)N2C)c1ccccc1 None
DB00829 1400 48 None 46 5 Human 8.4 pKi = 8.4 Binding
NoneNone
Drug Central 284 1 0 2 3.2 Clc1ccc2c(c1)C(=NCC(=O)N2C)c1ccccc1 None
4508 3117 98 None 1 13 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 183 3 4 4 0.4 CNCC(c1ccc(c(c1)O)O)O None
4866774 3117 98 None 1 13 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 183 3 4 4 0.4 CNCC(c1ccc(c(c1)O)O)O None
509 3117 98 None 1 13 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 183 3 4 4 0.4 CNCC(c1ccc(c(c1)O)O)O None
838 3117 98 None 1 13 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 183 3 4 4 0.4 CNCC(c1ccc(c(c1)O)O)O None
CHEMBL1740 3117 98 None 1 13 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 183 3 4 4 0.4 CNCC(c1ccc(c(c1)O)O)O None
162265 202251 22 None -5 45 Rat 8.3 pKi = 8.3 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
Drug Central 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 None
4786 202251 22 None -5 45 Rat 8.3 pKi = 8.3 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
Drug Central 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 None
CHEMBL61006 202251 22 None -5 45 Rat 8.3 pKi = 8.3 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
Drug Central 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 None
2470 3626 50 3H-PRAZOSIN -478 60 Pig 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
3300 3626 50 3H-PRAZOSIN -478 60 Pig 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
5265 3626 50 3H-PRAZOSIN -478 60 Pig 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
99 3626 50 3H-PRAZOSIN -478 60 Pig 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
CHEMBL267930 3626 50 3H-PRAZOSIN -478 60 Pig 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
68712 100310 60 None -8 5 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 None
CHEMBL289480 100310 60 None -8 5 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 None
2146 3078 67 None -2 9 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O None
485 3078 67 None -2 9 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O None
6041 3078 67 None -2 9 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O None
CHEMBL1215 3078 67 None -2 9 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O None
DB00388 3078 67 None -2 9 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O None
2695 3812 81 None 9 6 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
5504 3812 81 None 9 6 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
7310 3812 81 None 9 6 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
CHEMBL770 3812 81 None 9 6 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
DB00797 3812 81 None 9 6 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
2435 719 100 None -21 12 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
395 719 100 None -21 12 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
520 719 100 None -21 12 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
5386 719 100 None -21 12 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
CHEMBL844 719 100 None -21 12 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
DB00484 719 100 None -21 12 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
1830 2572 44 None 1 28 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 None
207 2572 44 None 1 28 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 None
23897 2572 44 None 1 28 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 None
CHEMBL460 2572 44 None 1 28 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 None
DB01618 2572 44 None 1 28 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 None
2162 41484 100 None -3 6 Human 8.3 pKi = 8.3 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
Drug Central 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl None
CHEMBL1491 41484 100 None -3 6 Human 8.3 pKi = 8.3 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
Drug Central 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl None
446220 133496 14 None 19 46 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 303 3 0 5 1.9 COC(=O)[C@H]1[C@@H](OC(=O)c2ccccc2)C[C@@H]2CC[C@H]1N2C None
CHEMBL370805 133496 14 None 19 46 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 303 3 0 5 1.9 COC(=O)[C@H]1[C@@H](OC(=O)c2ccccc2)C[C@@H]2CC[C@H]1N2C None
1028 289 71 None -48 30 Human 8.2 pKi = 8.2 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
139148732 289 71 None -48 30 Human 8.2 pKi = 8.2 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
479 289 71 None -48 30 Human 8.2 pKi = 8.2 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
5816 289 71 None -48 30 Human 8.2 pKi = 8.2 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
CHEMBL679 289 71 None -48 30 Human 8.2 pKi = 8.2 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
DB00668 289 71 None -48 30 Human 8.2 pKi = 8.2 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
1960 2838 67 None -57 26 Human 8.2 pKi = 8.2 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
439260 2838 67 None -57 26 Human 8.2 pKi = 8.2 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
505 2838 67 None -57 26 Human 8.2 pKi = 8.2 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
CHEMBL1437 2838 67 None -57 26 Human 8.2 pKi = 8.2 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
DB00368 2838 67 None -57 26 Human 8.2 pKi = 8.2 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
126225 94947 5 3H-PRAZOSIN -41 8 Pig 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 263 1 0 2 4.2 C=Cc1sc2ccc(Cl)c3c2c1CN(C)CC3 None
CHEMBL25467 94947 5 3H-PRAZOSIN -41 8 Pig 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 263 1 0 2 4.2 C=Cc1sc2ccc(Cl)c3c2c1CN(C)CC3 None
484 2837 51 3H-PRAZOSIN -67 36 Pig 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
951 2837 51 3H-PRAZOSIN -67 36 Pig 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
CHEMBL432 2837 51 3H-PRAZOSIN -67 36 Pig 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
2146 3078 67 None 1 9 Bovine 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O None
485 3078 67 None 1 9 Bovine 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O None
6041 3078 67 None 1 9 Bovine 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O None
CHEMBL1215 3078 67 None 1 9 Bovine 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O None
DB00388 3078 67 None 1 9 Bovine 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O None
2202 3110 96 None -2 21 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 None
4850 3110 96 None -2 21 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 None
49 3110 96 None -2 21 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 None
CHEMBL1371770 3110 96 None -2 21 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 None
DB12478 3110 96 None -2 21 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 None
135398737 955 93 3H-PRAZOSIN -9 92 Pig 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
38 955 93 3H-PRAZOSIN -9 92 Pig 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
722 955 93 3H-PRAZOSIN -9 92 Pig 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
CHEMBL42 955 93 3H-PRAZOSIN -9 92 Pig 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
DB00363 955 93 3H-PRAZOSIN -9 92 Pig 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
1960 2838 67 None -10 26 Bovine 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
439260 2838 67 None -10 26 Bovine 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
505 2838 67 None -10 26 Bovine 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
CHEMBL1437 2838 67 None -10 26 Bovine 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
DB00368 2838 67 None -10 26 Bovine 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
5284550 41691 15 None 1 9 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 295 3 0 2 4.7 CN(C)CC/C=C1\c2ccccc2CSc2ccccc21 None
CHEMBL1492500 41691 15 None 1 9 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 295 3 0 2 4.7 CN(C)CC/C=C1\c2ccccc2CSc2ccccc21 None
2477 742 59 None 1 29 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 None
36 742 59 None 1 29 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 None
437 742 59 None 1 29 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 None
CHEMBL49 742 59 None 1 29 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 None
DB00490 742 59 None 1 29 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 None
37 775 60 None -18 17 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C None
460 775 60 None -18 17 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C None
54746 775 60 None -18 17 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C None
CHEMBL1201087 775 60 None -18 17 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C None
DB00248 775 60 None -18 17 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C None
66265 93984 15 None -1 19 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCN[C@@H](C)Cc1cccc(C(F)(F)F)c1 None
CHEMBL248702 93984 15 None -1 19 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCN[C@@H](C)Cc1cccc(C(F)(F)F)c1 None
3151 1450 97 None -8 27 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 None
945 1450 97 None -8 27 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 None
965 1450 97 None -8 27 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 None
CHEMBL219916 1450 97 None -8 27 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 None
DB01184 1450 97 None -8 27 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 None
16362 3103 71 None -35 30 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 None
2172 3103 71 None -35 30 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 None
90 3103 71 None -35 30 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 None
CHEMBL1423 3103 71 None -35 30 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 None
DB01100 3103 71 None -35 30 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 None
15387 45792 55 None 1 24 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 263 5 0 2 3.5 CC1CCN(CCCC(=O)c2ccc(F)cc2)CC1 None
CHEMBL1531134 45792 55 None 1 24 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 263 5 0 2 3.5 CC1CCN(CCCC(=O)c2ccc(F)cc2)CC1 None
68617 205504 62 None 3 26 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 None
CHEMBL1709 205504 62 None 3 26 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 None
CHEMBL809 205504 62 None 3 26 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 None
2470 3626 50 3H-PRAZOSIN -478 60 Pig 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
3300 3626 50 3H-PRAZOSIN -478 60 Pig 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
5265 3626 50 3H-PRAZOSIN -478 60 Pig 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
99 3626 50 3H-PRAZOSIN -478 60 Pig 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
CHEMBL267930 3626 50 3H-PRAZOSIN -478 60 Pig 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
126225 94947 5 3H-PRAZOSIN -41 8 Pig 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 263 1 0 2 4.2 C=Cc1sc2ccc(Cl)c3c2c1CN(C)CC3 None
CHEMBL25467 94947 5 3H-PRAZOSIN -41 8 Pig 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 263 1 0 2 4.2 C=Cc1sc2ccc(Cl)c3c2c1CN(C)CC3 None
135398737 955 93 3H-PRAZOSIN -9 92 Pig 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
38 955 93 3H-PRAZOSIN -9 92 Pig 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
722 955 93 3H-PRAZOSIN -9 92 Pig 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
CHEMBL42 955 93 3H-PRAZOSIN -9 92 Pig 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
DB00363 955 93 3H-PRAZOSIN -9 92 Pig 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
484 2837 51 3H-PRAZOSIN -67 36 Pig 5.2 pKi = 5.2 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
951 2837 51 3H-PRAZOSIN -67 36 Pig 5.2 pKi = 5.2 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
CHEMBL432 2837 51 3H-PRAZOSIN -67 36 Pig 5.2 pKi = 5.2 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
2995 204382 53 None 3 23 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 None
CHEMBL1696 204382 53 None 3 23 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 None
CHEMBL72 204382 53 None 3 23 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 None
3947 206372 53 None -1 16 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 418 7 0 3 5.8 CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1 None
CHEMBL87708 206372 53 None -1 16 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 418 7 0 3 5.8 CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1 None
3658 4076 53 None -9 8 Human 8.2 pKi = 8.2 Binding
Binding affinity towards human Alpha-1 adrenergic receptorBinding affinity towards human Alpha-1 adrenergic receptor
Drug Central 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
517 4076 53 None -9 8 Human 8.2 pKi = 8.2 Binding
Binding affinity towards human Alpha-1 adrenergic receptorBinding affinity towards human Alpha-1 adrenergic receptor
Drug Central 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
5709 4076 53 None -9 8 Human 8.2 pKi = 8.2 Binding
Binding affinity towards human Alpha-1 adrenergic receptorBinding affinity towards human Alpha-1 adrenergic receptor
Drug Central 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
CHEMBL312448 4076 53 None -9 8 Human 8.2 pKi = 8.2 Binding
Binding affinity towards human Alpha-1 adrenergic receptorBinding affinity towards human Alpha-1 adrenergic receptor
Drug Central 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
DB06694 4076 53 None -9 8 Human 8.2 pKi = 8.2 Binding
Binding affinity towards human Alpha-1 adrenergic receptorBinding affinity towards human Alpha-1 adrenergic receptor
Drug Central 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
2448 99295 70 None -5 18 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 419 6 1 3 4.5 O=C(CCCN1CCC(O)(c2ccc(Br)cc2)CC1)c1ccc(F)cc1 None
CHEMBL28218 99295 70 None -5 18 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 419 6 1 3 4.5 O=C(CCCN1CCC(O)(c2ccc(Br)cc2)CC1)c1ccc(F)cc1 None
21302490 112778 32 None -10 9 Human 8.2 pKi = 8.2 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
Drug Central 393 5 0 4 3.9 CN1CCN2c3c(cccc31)[C@@H]1CN(CCCC(=O)c3ccc(F)cc3)CC[C@@H]12 None
CHEMBL3233142 112778 32 None -10 9 Human 8.2 pKi = 8.2 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
Drug Central 393 5 0 4 3.9 CN1CCN2c3c(cccc31)[C@@H]1CN(CCCC(=O)c3ccc(F)cc3)CC[C@@H]12 None
CHEMBL3306803 112778 32 None -10 9 Human 8.2 pKi = 8.2 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
Drug Central 393 5 0 4 3.9 CN1CCN2c3c(cccc31)[C@@H]1CN(CCCC(=O)c3ccc(F)cc3)CC[C@@H]12 None
242 469 124 None -14 52 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
34 469 124 None -14 52 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
60795 469 124 None -14 52 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
CHEMBL1112 469 124 None -14 52 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
DB01238 469 124 None -14 52 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
125564 663 97 None -12 7 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 367 3 0 3 4.7 CCN1CCN(CC1)c1nc2CCCCCCc2c(c1)c1ccc(cc1)F None
388 663 97 None -12 7 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 367 3 0 3 4.7 CCN1CCN(CC1)c1nc2CCCCCCc2c(c1)c1ccc(cc1)F None
7670 663 97 None -12 7 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 367 3 0 3 4.7 CCN1CCN(CC1)c1nc2CCCCCCc2c(c1)c1ccc(cc1)F None
CHEMBL178803 663 97 None -12 7 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 367 3 0 3 4.7 CCN1CCN(CC1)c1nc2CCCCCCc2c(c1)c1ccc(cc1)F None
DB09223 663 97 None -12 7 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 367 3 0 3 4.7 CCN1CCN(CC1)c1nc2CCCCCCc2c(c1)c1ccc(cc1)F None
1971 2846 38 None -1 30 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 None
2404 2846 38 None -1 30 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 None
4543 2846 38 None -1 30 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 None
CHEMBL445 2846 38 None -1 30 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 None
DB00540 2846 38 None -1 30 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 None
2267 557 71 None -15 7 Human 8.1 pKi = 8.1 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
Drug Central 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 None
271 557 71 None -15 7 Human 8.1 pKi = 8.1 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
Drug Central 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 None
7121 557 71 None -15 7 Human 8.1 pKi = 8.1 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
Drug Central 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 None
CHEMBL639 557 71 None -15 7 Human 8.1 pKi = 8.1 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
Drug Central 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 None
DB00972 557 71 None -15 7 Human 8.1 pKi = 8.1 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
Drug Central 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 None
2267 557 71 None -15 7 Rat 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptorDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptor
Drug Central 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 None
271 557 71 None -15 7 Rat 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptorDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptor
Drug Central 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 None
7121 557 71 None -15 7 Rat 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptorDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptor
Drug Central 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 None
CHEMBL639 557 71 None -15 7 Rat 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptorDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptor
Drug Central 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 None
DB00972 557 71 None -15 7 Rat 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptorDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptor
Drug Central 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 None
135 2515 43 None -9 58 Bovine 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
1796 2515 43 None -9 58 Bovine 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
4184 2515 43 None -9 58 Bovine 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
CHEMBL6437 2515 43 None -9 58 Bovine 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
DB06148 2515 43 None -9 58 Bovine 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
277 1289 62 None -20 46 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 None
2913 1289 62 None -20 46 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 None
765 1289 62 None -20 46 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 None
CHEMBL516 1289 62 None -20 46 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 None
DB00434 1289 62 None -20 46 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 None
3294 1993 111 None -10 45 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
71360 1993 111 None -10 45 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
87 1993 111 None -10 45 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
CHEMBL14376 1993 111 None -10 45 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
DB04946 1993 111 None -10 45 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
1613 2333 53 None -2 45 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
205 2333 53 None -2 45 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
3964 2333 53 None -2 45 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
CHEMBL831 2333 53 None -2 45 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
DB00408 2333 53 None -2 45 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
240 941 43 None -4 25 Rat 8.1 pKi = 8.1 Binding
The ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brainThe ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brain
Drug Central 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N None
2769 941 43 None -4 25 Rat 8.1 pKi = 8.1 Binding
The ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brainThe ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brain
Drug Central 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N None
44279790 941 43 None -4 25 Rat 8.1 pKi = 8.1 Binding
The ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brainThe ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brain
Drug Central 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N None
660 941 43 None -4 25 Rat 8.1 pKi = 8.1 Binding
The ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brainThe ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brain
Drug Central 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N None
CHEMBL1729 941 43 None -4 25 Rat 8.1 pKi = 8.1 Binding
The ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brainThe ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brain
Drug Central 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N None
CHEMBL560739 941 43 None -4 25 Rat 8.1 pKi = 8.1 Binding
The ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brainThe ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brain
Drug Central 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N None
DB00604 941 43 None -4 25 Rat 8.1 pKi = 8.1 Binding
The ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brainThe ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brain
Drug Central 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N None
3584 3748 64 None -3 14 Bovine 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
5401 3748 64 None -3 14 Bovine 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
7302 3748 64 None -3 14 Bovine 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
CHEMBL611 3748 64 None -3 14 Bovine 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
DB01162 3748 64 None -3 14 Bovine 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
2274 3151 58 None -3 32 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
4917 3151 58 None -3 32 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
7279 3151 58 None -3 32 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
CHEMBL728 3151 58 None -3 32 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
DB00433 3151 58 None -3 32 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
214 3831 58 None -9 30 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
2740 3831 58 None -9 30 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
5566 3831 58 None -9 30 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
66064 3831 58 None -9 30 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
CHEMBL422 3831 58 None -9 30 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
DB00831 3831 58 None -9 30 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
1225 1459 26 None -26 22 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 279 3 0 2 4.0 CN(CC/C=C\1/c2ccccc2OCc2c1cccc2)C None
3958 1459 26 None -26 22 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 279 3 0 2 4.0 CN(CC/C=C\1/c2ccccc2OCc2c1cccc2)C None
667477 1459 26 None -26 22 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 279 3 0 2 4.0 CN(CC/C=C\1/c2ccccc2OCc2c1cccc2)C None
CHEMBL860 1459 26 None -26 22 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 279 3 0 2 4.0 CN(CC/C=C\1/c2ccccc2OCc2c1cccc2)C None
DB01142 1459 26 None -26 22 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 279 3 0 2 4.0 CN(CC/C=C\1/c2ccccc2OCc2c1cccc2)C None
115 342 71 None -2 7 Bovine 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
Drug Central 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C None
2092 342 71 None -2 7 Bovine 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
Drug Central 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C None
7109 342 71 None -2 7 Bovine 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
Drug Central 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C None
CHEMBL709 342 71 None -2 7 Bovine 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
Drug Central 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C None
DB00346 342 71 None -2 7 Bovine 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
Drug Central 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C None
135398737 955 93 None -5 92 Rat 8.1 pKi = 8.1 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
38 955 93 None -5 92 Rat 8.1 pKi = 8.1 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
722 955 93 None -5 92 Rat 8.1 pKi = 8.1 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
CHEMBL42 955 93 None -5 92 Rat 8.1 pKi = 8.1 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
DB00363 955 93 None -5 92 Rat 8.1 pKi = 8.1 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
135398745 2893 112 None -39 66 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
47 2893 112 None -39 66 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
CHEMBL715 2893 112 None -39 66 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
DB00334 2893 112 None -39 66 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
1890 2739 49 None -1 16 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl None
4449 2739 49 None -1 16 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl None
7247 2739 49 None -1 16 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl None
CHEMBL623 2739 49 None -1 16 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl None
DB01149 2739 49 None -1 16 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl None
2470 3626 50 None -316 60 Bovine 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
3300 3626 50 None -316 60 Bovine 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
5265 3626 50 None -316 60 Bovine 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
99 3626 50 None -316 60 Bovine 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
CHEMBL267930 3626 50 None -316 60 Bovine 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
124 2960 47 None -14 33 Bovine 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2032 2960 47 None -14 33 Bovine 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
4636 2960 47 None -14 33 Bovine 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
CHEMBL762 2960 47 None -14 33 Bovine 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
DB00935 2960 47 None -14 33 Bovine 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2389 3306 118 None -6 68 Rat 8.1 pKi = 8.1 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
5073 3306 118 None -6 68 Rat 8.1 pKi = 8.1 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
96 3306 118 None -6 68 Rat 8.1 pKi = 8.1 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
CHEMBL85 3306 118 None -6 68 Rat 8.1 pKi = 8.1 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
DB00734 3306 118 None -6 68 Rat 8.1 pKi = 8.1 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
1353 1898 93 None -6 86 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
3559 1898 93 None -6 86 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
86 1898 93 None -6 86 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
CHEMBL54 1898 93 None -6 86 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
DB00502 1898 93 None -6 86 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
1443 2015 34 None -2 11 Bovine 8.1 pKi = 8.1 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.
Drug Central 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 None
33625 2015 34 None -2 11 Bovine 8.1 pKi = 8.1 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.
Drug Central 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 None
501 2015 34 None -2 11 Bovine 8.1 pKi = 8.1 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.
Drug Central 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 None
CHEMBL279516 2015 34 None -2 11 Bovine 8.1 pKi = 8.1 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.
Drug Central 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 None
DB08950 2015 34 None -2 11 Bovine 8.1 pKi = 8.1 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.
Drug Central 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 None
212 3777 47 None -7 25 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C None
2639 3777 47 None -7 25 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C None
941651 3777 47 None -7 25 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C None
CHEMBL1201 3777 47 None -7 25 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C None
DB01623 3777 47 None -7 25 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C None
2726 916 68 3H-PRAZOSIN -20 73 Pig 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
621 916 68 3H-PRAZOSIN -20 73 Pig 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
83 916 68 3H-PRAZOSIN -20 73 Pig 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
CHEMBL71 916 68 3H-PRAZOSIN -20 73 Pig 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
DB00477 916 68 3H-PRAZOSIN -20 73 Pig 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
4106 2485 22 3H-PRAZOSIN -1 34 Pig 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 356 2 0 4 4.4 CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C None
5358812 2485 22 3H-PRAZOSIN -1 34 Pig 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 356 2 0 4 4.4 CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C None
89 2485 22 3H-PRAZOSIN -1 34 Pig 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 356 2 0 4 4.4 CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C None
CHEMBL93240 2485 22 3H-PRAZOSIN -1 34 Pig 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 356 2 0 4 4.4 CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C None
209 3035 97 None -11 23 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
2113 3035 97 None -11 23 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
4748 3035 97 None -11 23 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
CHEMBL567 3035 97 None -11 23 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
DB00850 3035 97 None -11 23 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
2865 4112 73 None -14 54 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
59 4112 73 None -14 54 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
60854 4112 73 None -14 54 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
CHEMBL708 4112 73 None -14 54 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
DB00246 4112 73 None -14 54 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
115 342 71 None -3 7 Human 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
Drug Central 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C None
2092 342 71 None -3 7 Human 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
Drug Central 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C None
7109 342 71 None -3 7 Human 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
Drug Central 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C None
CHEMBL709 342 71 None -3 7 Human 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
Drug Central 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C None
DB00346 342 71 None -3 7 Human 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
Drug Central 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C None
2470 3626 50 None -208 60 Human 8.1 pKi = 8.1 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
Drug Central 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
3300 3626 50 None -208 60 Human 8.1 pKi = 8.1 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
Drug Central 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
5265 3626 50 None -208 60 Human 8.1 pKi = 8.1 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
Drug Central 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
99 3626 50 None -208 60 Human 8.1 pKi = 8.1 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
Drug Central 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
CHEMBL267930 3626 50 None -208 60 Human 8.1 pKi = 8.1 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
Drug Central 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
135398737 955 93 None -5 92 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
38 955 93 None -5 92 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
722 955 93 None -5 92 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
CHEMBL42 955 93 None -5 92 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
DB00363 955 93 None -5 92 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
2470 3626 50 None -398 60 Rat 8.1 pKi = 8.1 Binding
Overall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary glandOverall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary gland
Drug Central 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
3300 3626 50 None -398 60 Rat 8.1 pKi = 8.1 Binding
Overall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary glandOverall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary gland
Drug Central 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
5265 3626 50 None -398 60 Rat 8.1 pKi = 8.1 Binding
Overall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary glandOverall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary gland
Drug Central 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
99 3626 50 None -398 60 Rat 8.1 pKi = 8.1 Binding
Overall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary glandOverall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary gland
Drug Central 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
CHEMBL267930 3626 50 None -398 60 Rat 8.1 pKi = 8.1 Binding
Overall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary glandOverall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary gland
Drug Central 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
103 4122 61 None -6 54 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
2875 4122 61 None -6 54 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
5736 4122 61 None -6 54 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
CHEMBL285802 4122 61 None -6 54 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
DB09225 4122 61 None -6 54 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
2142 3074 58 None -1 37 Bovine 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
4920903 3074 58 None -1 37 Bovine 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
502 3074 58 None -1 37 Bovine 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
5775 3074 58 None -1 37 Bovine 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
CHEMBL597 3074 58 None -1 37 Bovine 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
DB00692 3074 58 None -1 37 Bovine 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
1212 1649 50 None -16 66 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
204 1649 50 None -16 66 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
3372 1649 50 None -16 66 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
CHEMBL726 1649 50 None -16 66 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
DB00623 1649 50 None -16 66 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
124 2960 47 None -13 33 Rat 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2032 2960 47 None -13 33 Rat 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
4636 2960 47 None -13 33 Rat 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
CHEMBL762 2960 47 None -13 33 Rat 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
DB00935 2960 47 None -13 33 Rat 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
3389 217683 0 None -1 26 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 549 12 0 6 6.8 CCCCCCC(=O)OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1 None
463 1393 22 None -7 13 Rat 8.1 pKi = 8.1 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligand
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
6918097 1393 22 None -7 13 Rat 8.1 pKi = 8.1 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligand
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
837 1393 22 None -7 13 Rat 8.1 pKi = 8.1 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligand
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
CHEMBL2051956 1393 22 None -7 13 Rat 8.1 pKi = 8.1 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligand
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
DB14068 1393 22 None -7 13 Rat 8.1 pKi = 8.1 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligand
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
1524 2168 96 None -5 52 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 None
197 2168 96 None -5 52 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 None
3822 2168 96 None -5 52 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 None
88 2168 96 None -5 52 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 None
CHEMBL51 2168 96 None -5 52 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 None
DB12465 2168 96 None -5 52 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 None
124 2960 47 None -19 33 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2032 2960 47 None -19 33 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
4636 2960 47 None -19 33 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
CHEMBL762 2960 47 None -19 33 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
DB00935 2960 47 None -19 33 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2284 3160 33 None -3 29 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C None
4926 3160 33 None -3 29 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C None
7281 3160 33 None -3 29 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C None
CHEMBL564 3160 33 None -3 29 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C None
DB00420 3160 33 None -3 29 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C None
1588 2311 27 None -23 44 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
28864 2311 27 None -23 44 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
43 2311 27 None -23 44 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
CHEMBL157138 2311 27 None -23 44 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
DB00589 2311 27 None -23 44 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
31101 726 40 None -12 36 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
35 726 40 None -12 36 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
403 726 40 None -12 36 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
CHEMBL493 726 40 None -12 36 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
DB01200 726 40 None -12 36 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
2142 3074 58 None -2 37 Human 8.1 pKi = 8.1 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
4920903 3074 58 None -2 37 Human 8.1 pKi = 8.1 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
502 3074 58 None -2 37 Human 8.1 pKi = 8.1 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
5775 3074 58 None -2 37 Human 8.1 pKi = 8.1 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
CHEMBL597 3074 58 None -2 37 Human 8.1 pKi = 8.1 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
DB00692 3074 58 None -2 37 Human 8.1 pKi = 8.1 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
11978813 718 79 None -10 24 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 433 7 1 5 4.7 O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2 None
5014 718 79 None -10 24 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 433 7 1 5 4.7 O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2 None
7672 718 79 None -10 24 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 433 7 1 5 4.7 O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2 None
CHEMBL2105760 718 79 None -10 24 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 433 7 1 5 4.7 O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2 None
DB09128 718 79 None -10 24 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 433 7 1 5 4.7 O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2 None
4418 34192 85 None -1 7 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 None
CHEMBL142635 34192 85 None -1 7 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 None
1443 2015 34 None 1 11 Human 8.1 pKi = 8.1 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.
Drug Central 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 None
33625 2015 34 None 1 11 Human 8.1 pKi = 8.1 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.
Drug Central 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 None
501 2015 34 None 1 11 Human 8.1 pKi = 8.1 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.
Drug Central 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 None
CHEMBL279516 2015 34 None 1 11 Human 8.1 pKi = 8.1 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.
Drug Central 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 None
DB08950 2015 34 None 1 11 Human 8.1 pKi = 8.1 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.
Drug Central 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 None
102 4096 48 None -85 50 Bovine 8.1 pKi = 8.1 Binding
Compound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pineal
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
3659 4096 48 None -85 50 Bovine 8.1 pKi = 8.1 Binding
Compound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pineal
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
8969 4096 48 None -85 50 Bovine 8.1 pKi = 8.1 Binding
Compound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pineal
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
CHEMBL15245 4096 48 None -85 50 Bovine 8.1 pKi = 8.1 Binding
Compound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pineal
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
DB01392 4096 48 None -85 50 Bovine 8.1 pKi = 8.1 Binding
Compound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pineal
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
2398 951 62 None 1 29 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C None
2801 951 62 None 1 29 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C None
701 951 62 None 1 29 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C None
CHEMBL415 951 62 None 1 29 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C None
DB01242 951 62 None 1 29 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C None
2601 3751 33 None -5 21 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
443951 3751 33 None -5 21 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
56 3751 33 None -5 21 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
CHEMBL73151 3751 33 None -5 21 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
DB13399 3751 33 None -5 21 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
2389 3306 118 None -11 68 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
5073 3306 118 None -11 68 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
96 3306 118 None -11 68 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
CHEMBL85 3306 118 None -11 68 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
DB00734 3306 118 None -11 68 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
115237 55555 119 None -36 55 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 426 4 1 7 3.1 Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O None
CHEMBL1621 55555 119 None -36 55 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 426 4 1 7 3.1 Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O None
2585 800 103 None -9 22 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
522 800 103 None -9 22 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
551 800 103 None -9 22 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
CHEMBL723 800 103 None -9 22 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
DB01136 800 103 None -9 22 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
5440 28693 37 None -1 9 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 399 6 0 5 5.0 CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2 None
CHEMBL1378 28693 37 None -1 9 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 399 6 0 5 5.0 CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2 None
2435 3563 83 None -16 49 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
60149 3563 83 None -16 49 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
98 3563 83 None -16 49 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
CHEMBL12713 3563 83 None -16 49 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
DB06144 3563 83 None -16 49 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
3157 1458 71 None -2 12 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 None
7170 1458 71 None -2 12 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 None
954 1458 71 None -2 12 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 None
CHEMBL707 1458 71 None -2 12 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 None
DB00590 1458 71 None -2 12 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 None
5639 98867 75 None -1 5 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 387 7 1 8 0.7 COc1ccccc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1 None
CHEMBL279229 98867 75 None -1 5 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 387 7 1 8 0.7 COc1ccccc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1 None
46780481 107504 20 None -52 54 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
9903970 107504 20 None -52 54 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
CHEMBL3187365 107504 20 None -52 54 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
CHEMBL3544974 107504 20 None -52 54 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
3584 3748 64 None -2 14 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
5401 3748 64 None -2 14 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
7302 3748 64 None -2 14 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
CHEMBL611 3748 64 None -2 14 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
DB01162 3748 64 None -2 14 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
3584 3748 64 None -2 14 Rat 8.0 pKi = 8.0 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
5401 3748 64 None -2 14 Rat 8.0 pKi = 8.0 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
7302 3748 64 None -2 14 Rat 8.0 pKi = 8.0 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
CHEMBL611 3748 64 None -2 14 Rat 8.0 pKi = 8.0 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
DB01162 3748 64 None -2 14 Rat 8.0 pKi = 8.0 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
1238 203151 24 None -3 17 Bovine 8.0 pKi = 8.0 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
Drug Central 344 1 0 3 4.3 CN1CCN(C2Cc3ccccc3Sc3ccc(Cl)cc32)CC1 None
CHEMBL64249 203151 24 None -3 17 Bovine 8.0 pKi = 8.0 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
Drug Central 344 1 0 3 4.3 CN1CCN(C2Cc3ccccc3Sc3ccc(Cl)cc32)CC1 None
2865 4112 73 None -4 54 Rat 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
Drug Central 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
59 4112 73 None -4 54 Rat 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
Drug Central 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
60854 4112 73 None -4 54 Rat 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
Drug Central 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
CHEMBL708 4112 73 None -4 54 Rat 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
Drug Central 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
DB00246 4112 73 None -4 54 Rat 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
Drug Central 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
463 1393 22 None -8 13 Bovine 8.0 pKi = 8.0 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligand
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
6918097 1393 22 None -8 13 Bovine 8.0 pKi = 8.0 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligand
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
837 1393 22 None -8 13 Bovine 8.0 pKi = 8.0 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligand
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
CHEMBL2051956 1393 22 None -8 13 Bovine 8.0 pKi = 8.0 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligand
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
DB14068 1393 22 None -8 13 Bovine 8.0 pKi = 8.0 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligand
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
2435 3563 83 None -3 49 Bovine 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
60149 3563 83 None -3 49 Bovine 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
98 3563 83 None -3 49 Bovine 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
CHEMBL12713 3563 83 None -3 49 Bovine 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
DB06144 3563 83 None -3 49 Bovine 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
4209 3141 75 None -4 34 Bovine 8.0 pKi = 8.0 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
4893 3141 75 None -4 34 Bovine 8.0 pKi = 8.0 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
503 3141 75 None -4 34 Bovine 8.0 pKi = 8.0 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
5385 3141 75 None -4 34 Bovine 8.0 pKi = 8.0 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
CHEMBL2 3141 75 None -4 34 Bovine 8.0 pKi = 8.0 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
DB00457 3141 75 None -4 34 Bovine 8.0 pKi = 8.0 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
129211 3722 78 None -7 16 Bovine 8.0 pKi = 8 Binding
NoneNone
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
2562 3722 78 None -7 16 Bovine 8.0 pKi = 8 Binding
NoneNone
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
488 3722 78 None -7 16 Bovine 8.0 pKi = 8 Binding
NoneNone
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
CHEMBL836 3722 78 None -7 16 Bovine 8.0 pKi = 8 Binding
NoneNone
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
DB00706 3722 78 None -7 16 Bovine 8.0 pKi = 8 Binding
NoneNone
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
4151 3580 89 None 33 3 Human 10.0 pKi = 10 Binding
UnclassifiedUnclassified
Guide to Pharmacology 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 31285236
4151 3580 89 None 33 3 Human 10.0 pKi = 10 Binding
UnclassifiedUnclassified
Guide to Pharmacology 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 32608144
4151 3580 89 None 33 3 Human 10.0 pKi = 10 Binding
UnclassifiedUnclassified
Guide to Pharmacology 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 7651358
493 3580 89 None 33 3 Human 10.0 pKi = 10 Binding
UnclassifiedUnclassified
Guide to Pharmacology 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 31285236
493 3580 89 None 33 3 Human 10.0 pKi = 10 Binding
UnclassifiedUnclassified
Guide to Pharmacology 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 32608144
493 3580 89 None 33 3 Human 10.0 pKi = 10 Binding
UnclassifiedUnclassified
Guide to Pharmacology 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 7651358
5312125 3580 89 None 33 3 Human 10.0 pKi = 10 Binding
UnclassifiedUnclassified
Guide to Pharmacology 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 31285236
5312125 3580 89 None 33 3 Human 10.0 pKi = 10 Binding
UnclassifiedUnclassified
Guide to Pharmacology 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 32608144
5312125 3580 89 None 33 3 Human 10.0 pKi = 10 Binding
UnclassifiedUnclassified
Guide to Pharmacology 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 7651358
CHEMBL24778 3580 89 None 33 3 Human 10.0 pKi = 10 Binding
UnclassifiedUnclassified
Guide to Pharmacology 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 31285236
CHEMBL24778 3580 89 None 33 3 Human 10.0 pKi = 10 Binding
UnclassifiedUnclassified
Guide to Pharmacology 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 32608144
CHEMBL24778 3580 89 None 33 3 Human 10.0 pKi = 10 Binding
UnclassifiedUnclassified
Guide to Pharmacology 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 7651358
DB06207 3580 89 None 33 3 Human 10.0 pKi = 10 Binding
UnclassifiedUnclassified
Guide to Pharmacology 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 31285236
DB06207 3580 89 None 33 3 Human 10.0 pKi = 10 Binding
UnclassifiedUnclassified
Guide to Pharmacology 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 32608144
DB06207 3580 89 None 33 3 Human 10.0 pKi = 10 Binding
UnclassifiedUnclassified
Guide to Pharmacology 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 7651358
129211 3722 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10334511
129211 3722 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10369480
129211 3722 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 31285236
129211 3722 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 32608144
129211 3722 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 7651358
129211 3722 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 7815325
129211 3722 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 9249248
129211 3722 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 9490024
2562 3722 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10334511
2562 3722 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10369480
2562 3722 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 31285236
2562 3722 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 32608144
2562 3722 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 7651358
2562 3722 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 7815325
2562 3722 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 9249248
2562 3722 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 9490024
488 3722 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10334511
488 3722 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10369480
488 3722 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 31285236
488 3722 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 32608144
488 3722 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 7651358
488 3722 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 7815325
488 3722 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 9249248
488 3722 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 9490024
CHEMBL836 3722 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10334511
CHEMBL836 3722 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10369480
CHEMBL836 3722 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 31285236
CHEMBL836 3722 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 32608144
CHEMBL836 3722 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 7651358
CHEMBL836 3722 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 7815325
CHEMBL836 3722 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 9249248
CHEMBL836 3722 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 9490024
DB00706 3722 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10334511
DB00706 3722 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10369480
DB00706 3722 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 31285236
DB00706 3722 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 32608144
DB00706 3722 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 7651358
DB00706 3722 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 7815325
DB00706 3722 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 9249248
DB00706 3722 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 9490024
4431 2710 25 None 1 12 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 393 7 0 5 2.9 COc1ccccc1N1CCN(CC1)CCCCN1C(=O)c2c(C1=O)cccc2 11459121
73 2710 25 None 1 12 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 393 7 0 5 2.9 COc1ccccc1N1CCN(CC1)CCCCN1C(=O)c2c(C1=O)cccc2 11459121
CHEMBL8618 2710 25 None 1 12 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 393 7 0 5 2.9 COc1ccccc1N1CCN(CC1)CCCCN1C(=O)c2c(C1=O)cccc2 11459121
1753 2487 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 10433504
1753 2487 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 20978120
1753 2487 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 28444738
1753 2487 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 34355529
1753 2487 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 7651358
1753 2487 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 7815325
483 2487 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 10433504
483 2487 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 20978120
483 2487 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 28444738
483 2487 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 34355529
483 2487 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 7651358
483 2487 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 7815325
6082 2487 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 10433504
6082 2487 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 20978120
6082 2487 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 28444738
6082 2487 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 34355529
6082 2487 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 7651358
6082 2487 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 7815325
CHEMBL524 2487 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 10433504
CHEMBL524 2487 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 20978120
CHEMBL524 2487 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 28444738
CHEMBL524 2487 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 34355529
CHEMBL524 2487 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 7651358
CHEMBL524 2487 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 7815325
DB00723 2487 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 10433504
DB00723 2487 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 20978120
DB00723 2487 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 28444738
DB00723 2487 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 34355529
DB00723 2487 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 7651358
DB00723 2487 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 7815325
247704 290 31 None -10 5 Human 5.0 pKi = 5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@H](c1ccc(c(c1)O)O)O 7815325
4450 290 31 None -10 5 Human 5.0 pKi = 5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@H](c1ccc(c(c1)O)O)O 7815325
CHEMBL42280 290 31 None -10 5 Human 5.0 pKi = 5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@H](c1ccc(c(c1)O)O)O 7815325
507 3303 0 None -2511 2 Rat 5.0 pKi = 5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 12824165
2146 3078 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10433504
2146 3078 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 20978120
2146 3078 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 28444738
2146 3078 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 34355529
485 3078 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10433504
485 3078 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 20978120
485 3078 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 28444738
485 3078 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 34355529
6041 3078 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10433504
6041 3078 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 20978120
6041 3078 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 28444738
6041 3078 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 34355529
CHEMBL1215 3078 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10433504
CHEMBL1215 3078 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 20978120
CHEMBL1215 3078 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 28444738
CHEMBL1215 3078 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 34355529
DB00388 3078 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10433504
DB00388 3078 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 20978120
DB00388 3078 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 28444738
DB00388 3078 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 34355529
1960 2838 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10433504
1960 2838 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 20978120
1960 2838 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 28444738
1960 2838 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 34355529
1960 2838 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 7651358
1960 2838 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 7815325
1960 2838 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 8564227
439260 2838 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10433504
439260 2838 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 20978120
439260 2838 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 28444738
439260 2838 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 34355529
439260 2838 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 7651358
439260 2838 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 7815325
439260 2838 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 8564227
505 2838 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10433504
505 2838 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 20978120
505 2838 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 28444738
505 2838 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 34355529
505 2838 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 7651358
505 2838 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 7815325
505 2838 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 8564227
CHEMBL1437 2838 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10433504
CHEMBL1437 2838 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 20978120
CHEMBL1437 2838 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 28444738
CHEMBL1437 2838 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 34355529
CHEMBL1437 2838 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 7651358
CHEMBL1437 2838 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 7815325
CHEMBL1437 2838 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 8564227
DB00368 2838 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10433504
DB00368 2838 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 20978120
DB00368 2838 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 28444738
DB00368 2838 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 34355529
DB00368 2838 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 7651358
DB00368 2838 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 7815325
DB00368 2838 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 8564227
1028 289 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 34355529
1028 289 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 7651358
1028 289 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 7815325
1028 289 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 8564227
139148732 289 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 34355529
139148732 289 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 7651358
139148732 289 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 7815325
139148732 289 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 8564227
479 289 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 34355529
479 289 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 7651358
479 289 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 7815325
479 289 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 8564227
5816 289 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 34355529
5816 289 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 7651358
5816 289 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 7815325
5816 289 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 8564227
CHEMBL679 289 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 34355529
CHEMBL679 289 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 7651358
CHEMBL679 289 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 7815325
CHEMBL679 289 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 8564227
DB00668 289 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 34355529
DB00668 289 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 7651358
DB00668 289 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 7815325
DB00668 289 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 8564227
481 2872 7 None 4 3 Human 6.2 pKi = 6.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 4 3 4 0.2 NC[C@@H](c1cc(ccc1F)NS(=O)(=O)C)O 8719417
9838763 2872 7 None 4 3 Human 6.2 pKi = 6.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 4 3 4 0.2 NC[C@@H](c1cc(ccc1F)NS(=O)(=O)C)O 8719417
CHEMBL72958 2872 7 None 4 3 Human 6.2 pKi = 6.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 4 3 4 0.2 NC[C@@H](c1cc(ccc1F)NS(=O)(=O)C)O 8719417
2765 940 19 None -10 9 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 20978120
2765 940 19 None -10 9 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 34355529
515 940 19 None -10 9 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 20978120
515 940 19 None -10 9 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 34355529
CHEMBL13852 940 19 None -10 9 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 20978120
CHEMBL13852 940 19 None -10 9 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 34355529
DB09202 940 19 None -10 9 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 20978120
DB09202 940 19 None -10 9 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 34355529
11079 2714 63 None -22 5 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 34355529
3369 2714 63 None -22 5 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 34355529
4436 2714 63 None -22 5 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 34355529
5509 2714 63 None -22 5 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 34355529
CHEMBL761 2714 63 None -22 5 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 34355529
DB06711 2714 63 None -22 5 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 34355529
2419 692 28 None -288 12 Human 6.8 pKi = 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 11354357
2419 692 28 None -288 12 Human 6.8 pKi = 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 11459121
2419 692 28 None -288 12 Human 6.8 pKi = 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 32608144
9 692 28 None -288 12 Human 6.8 pKi = 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 11354357
9 692 28 None -288 12 Human 6.8 pKi = 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 11459121
9 692 28 None -288 12 Human 6.8 pKi = 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 32608144
CHEMBL13647 692 28 None -288 12 Human 6.8 pKi = 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 11354357
CHEMBL13647 692 28 None -288 12 Human 6.8 pKi = 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 11459121
CHEMBL13647 692 28 None -288 12 Human 6.8 pKi = 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 32608144
2419 692 28 None -288 12 Rat 7.0 pKi = 7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 11354357
9 692 28 None -288 12 Rat 7.0 pKi = 7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 11354357
CHEMBL13647 692 28 None -288 12 Rat 7.0 pKi = 7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 11354357
5268 3629 40 None -251 18 Human 7.1 pKi = 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 11459121
5268 3629 40 None -251 18 Human 7.1 pKi = 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 32608144
53 3629 40 None -251 18 Human 7.1 pKi = 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 11459121
53 3629 40 None -251 18 Human 7.1 pKi = 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 32608144
CHEMBL300555 3629 40 None -251 18 Human 7.1 pKi = 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 11459121
CHEMBL300555 3629 40 None -251 18 Human 7.1 pKi = 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 32608144
4038180 204 14 None -6 8 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 20978120
4038180 204 14 None -6 8 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 28444738
4038180 204 14 None -6 8 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 34355529
4038180 204 14 None -6 8 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 7616455
4038180 204 14 None -6 8 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 9249248
480 204 14 None -6 8 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 20978120
480 204 14 None -6 8 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 28444738
480 204 14 None -6 8 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 34355529
480 204 14 None -6 8 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 7616455
480 204 14 None -6 8 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 9249248
CHEMBL109783 204 14 None -6 8 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 20978120
CHEMBL109783 204 14 None -6 8 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 28444738
CHEMBL109783 204 14 None -6 8 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 34355529
CHEMBL109783 204 14 None -6 8 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 7616455
CHEMBL109783 204 14 None -6 8 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 9249248
1531 2253 69 None -7 16 Human 7.3 pKi = 7.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 34355529
3869 2253 69 None -7 16 Human 7.3 pKi = 7.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 34355529
7207 2253 69 None -7 16 Human 7.3 pKi = 7.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 34355529
CHEMBL429 2253 69 None -7 16 Human 7.3 pKi = 7.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 34355529
DB00598 2253 69 None -7 16 Human 7.3 pKi = 7.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 34355529
216249 1293 51 None - 1 Human 7.4 pKi = 7.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 317 5 2 5 1.4 Clc1ccc(c(c1NS(=O)(=O)C)C)OCC1=NCCN1 14678390
3469 1293 51 None - 1 Human 7.4 pKi = 7.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 317 5 2 5 1.4 Clc1ccc(c(c1NS(=O)(=O)C)C)OCC1=NCCN1 14678390
CHEMBL257978 1293 51 None - 1 Human 7.4 pKi = 7.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 317 5 2 5 1.4 Clc1ccc(c(c1NS(=O)(=O)C)C)OCC1=NCCN1 14678390
10453764 2185 0 None -1 3 Rat 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 402 4 0 8 0.9 Clc1ccccc1N1CCN(CC1)CCn1cnc2c1c(=O)n(C)c(=O)n2C 17639498
8896 2185 0 None -1 3 Rat 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 402 4 0 8 0.9 Clc1ccccc1N1CCN(CC1)CCn1cnc2c1c(=O)n(C)c(=O)n2C 17639498
124 2960 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10433504
124 2960 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 20978120
124 2960 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 28444738
124 2960 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 34355529
124 2960 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 7651358
124 2960 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 7815325
124 2960 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 8564227
124 2960 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 8719417
2032 2960 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10433504
2032 2960 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 20978120
2032 2960 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 28444738
2032 2960 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 34355529
2032 2960 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 7651358
2032 2960 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 7815325
2032 2960 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 8564227
2032 2960 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 8719417
4636 2960 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10433504
4636 2960 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 20978120
4636 2960 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 28444738
4636 2960 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 34355529
4636 2960 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 7651358
4636 2960 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 7815325
4636 2960 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 8564227
4636 2960 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 8719417
CHEMBL762 2960 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10433504
CHEMBL762 2960 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 20978120
CHEMBL762 2960 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 28444738
CHEMBL762 2960 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 34355529
CHEMBL762 2960 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 7651358
CHEMBL762 2960 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 7815325
CHEMBL762 2960 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 8564227
CHEMBL762 2960 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 8719417
DB00935 2960 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10433504
DB00935 2960 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 20978120
DB00935 2960 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 28444738
DB00935 2960 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 34355529
DB00935 2960 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 7651358
DB00935 2960 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 7815325
DB00935 2960 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 8564227
DB00935 2960 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 8719417
115 342 71 None -3 7 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10812954
115 342 71 None -3 7 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 31285236
115 342 71 None -3 7 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 32608144
2092 342 71 None -3 7 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10812954
2092 342 71 None -3 7 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 31285236
2092 342 71 None -3 7 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 32608144
7109 342 71 None -3 7 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10812954
7109 342 71 None -3 7 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 31285236
7109 342 71 None -3 7 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 32608144
CHEMBL709 342 71 None -3 7 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10812954
CHEMBL709 342 71 None -3 7 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 31285236
CHEMBL709 342 71 None -3 7 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 32608144
DB00346 342 71 None -3 7 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10812954
DB00346 342 71 None -3 7 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 31285236
DB00346 342 71 None -3 7 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 32608144
1588 2311 27 None -23 44 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 12388666
1588 2311 27 None -23 44 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 32608144
28864 2311 27 None -23 44 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 12388666
28864 2311 27 None -23 44 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 32608144
43 2311 27 None -23 44 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 12388666
43 2311 27 None -23 44 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 32608144
CHEMBL157138 2311 27 None -23 44 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 12388666
CHEMBL157138 2311 27 None -23 44 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 32608144
DB00589 2311 27 None -23 44 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 12388666
DB00589 2311 27 None -23 44 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 32608144
2398 951 62 None 1 29 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 32608144
2801 951 62 None 1 29 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 32608144
701 951 62 None 1 29 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 32608144
CHEMBL415 951 62 None 1 29 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 32608144
DB01242 951 62 None 1 29 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 32608144
2142 3074 58 None -2 37 Rat 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 11331292
4920903 3074 58 None -2 37 Rat 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 11331292
502 3074 58 None -2 37 Rat 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 11331292
5775 3074 58 None -2 37 Rat 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 11331292
CHEMBL597 3074 58 None -2 37 Rat 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 11331292
DB00692 3074 58 None -2 37 Rat 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 11331292
135398737 955 93 None -5 92 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 11459121
135398737 955 93 None -5 92 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 32608144
38 955 93 None -5 92 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 11459121
38 955 93 None -5 92 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 32608144
722 955 93 None -5 92 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 11459121
722 955 93 None -5 92 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 32608144
CHEMBL42 955 93 None -5 92 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 11459121
CHEMBL42 955 93 None -5 92 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 32608144
DB00363 955 93 None -5 92 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 11459121
DB00363 955 93 None -5 92 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 32608144
180 400 56 None -12 40 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 32608144
200 400 56 None -12 40 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 32608144
2160 400 56 None -12 40 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 32608144
CHEMBL629 400 56 None -12 40 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 32608144
DB00321 400 56 None -12 40 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 32608144
1971 2846 38 None -1 30 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 32608144
2404 2846 38 None -1 30 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 32608144
4543 2846 38 None -1 30 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 32608144
CHEMBL445 2846 38 None -1 30 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 32608144
DB00540 2846 38 None -1 30 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 32608144
3584 3748 64 None -2 14 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 31285236
3584 3748 64 None -2 14 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 32608144
3584 3748 64 None -2 14 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 9379432
5401 3748 64 None -2 14 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 31285236
5401 3748 64 None -2 14 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 32608144
5401 3748 64 None -2 14 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 9379432
7302 3748 64 None -2 14 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 31285236
7302 3748 64 None -2 14 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 32608144
7302 3748 64 None -2 14 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 9379432
CHEMBL611 3748 64 None -2 14 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 31285236
CHEMBL611 3748 64 None -2 14 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 32608144
CHEMBL611 3748 64 None -2 14 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 9379432
DB01162 3748 64 None -2 14 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 31285236
DB01162 3748 64 None -2 14 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 32608144
DB01162 3748 64 None -2 14 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 9379432
132266 1267 12 None -28 9 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 32608144
132266 1267 12 None -28 9 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 8917649
486 1267 12 None -28 9 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 32608144
486 1267 12 None -28 9 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 8917649
CHEMBL423294 1267 12 None -28 9 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 32608144
CHEMBL423294 1267 12 None -28 9 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 8917649
2142 3074 58 None -2 37 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 32608144
2142 3074 58 None -2 37 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 7651358
4920903 3074 58 None -2 37 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 32608144
4920903 3074 58 None -2 37 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 7651358
502 3074 58 None -2 37 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 32608144
502 3074 58 None -2 37 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 7651358
5775 3074 58 None -2 37 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 32608144
5775 3074 58 None -2 37 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 7651358
CHEMBL597 3074 58 None -2 37 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 32608144
CHEMBL597 3074 58 None -2 37 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 7651358
DB00692 3074 58 None -2 37 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 32608144
DB00692 3074 58 None -2 37 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 7651358
2585 800 103 None -9 22 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 32608144
522 800 103 None -9 22 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 32608144
551 800 103 None -9 22 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 32608144
CHEMBL723 800 103 None -9 22 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 32608144
DB01136 800 103 None -9 22 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 32608144
1443 2015 34 None 1 11 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10334511
1443 2015 34 None 1 11 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 32608144
1443 2015 34 None 1 11 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 9249248
33625 2015 34 None 1 11 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10334511
33625 2015 34 None 1 11 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 32608144
33625 2015 34 None 1 11 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 9249248
501 2015 34 None 1 11 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10334511
501 2015 34 None 1 11 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 32608144
501 2015 34 None 1 11 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 9249248
CHEMBL279516 2015 34 None 1 11 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10334511
CHEMBL279516 2015 34 None 1 11 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 32608144
CHEMBL279516 2015 34 None 1 11 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 9249248
DB08950 2015 34 None 1 11 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10334511
DB08950 2015 34 None 1 11 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 32608144
DB08950 2015 34 None 1 11 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 9249248
2389 3306 118 None -11 68 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 11459121
2389 3306 118 None -11 68 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 32608144
5073 3306 118 None -11 68 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 11459121
5073 3306 118 None -11 68 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 32608144
96 3306 118 None -11 68 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 11459121
96 3306 118 None -11 68 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 32608144
CHEMBL85 3306 118 None -11 68 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 11459121
CHEMBL85 3306 118 None -11 68 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 32608144
DB00734 3306 118 None -11 68 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 11459121
DB00734 3306 118 None -11 68 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 32608144
490 191 8 None -25 12 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 11354357
9890547 191 8 None -25 12 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 11354357
CHEMBL268758 191 8 None -25 12 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 11354357
219050 3348 25 None -15 21 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 346 6 2 2 5.0 Oc1ccc2c(c1)c(CCCCN1CCC(=CC1)c1ccccc1)c[nH]2 12388666
52 3348 25 None -15 21 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 346 6 2 2 5.0 Oc1ccc2c(c1)c(CCCCN1CCC(=CC1)c1ccccc1)c[nH]2 12388666
CHEMBL431367 3348 25 None -15 21 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 346 6 2 2 5.0 Oc1ccc2c(c1)c(CCCCN1CCC(=CC1)c1ccccc1)c[nH]2 12388666
13134 698 0 None - 1 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None O=C(CCC1=CC=C2C=C3C(C)=CC(C)=[N]3[B+3]([F-])([N-]21)[F-])N4CCN(CC4)C5=NC6=C(C=C(C(OC)=C6)OC)C(N)=N5 19572943
3894573 3368 6 None -1 5 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 10334511
3894573 3368 6 None -1 5 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 32608144
3894573 3368 6 None -1 5 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 8632751
3894573 3368 6 None -1 5 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 9249248
3894573 3368 6 None -1 5 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 9490024
495 3368 6 None -1 5 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 10334511
495 3368 6 None -1 5 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 32608144
495 3368 6 None -1 5 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 8632751
495 3368 6 None -1 5 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 9249248
495 3368 6 None -1 5 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 9490024
CHEMBL88272 3368 6 None -1 5 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 10334511
CHEMBL88272 3368 6 None -1 5 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 32608144
CHEMBL88272 3368 6 None -1 5 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 8632751
CHEMBL88272 3368 6 None -1 5 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 9249248
CHEMBL88272 3368 6 None -1 5 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 9490024
3157 1458 71 None -2 12 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 31285236
3157 1458 71 None -2 12 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 32608144
7170 1458 71 None -2 12 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 31285236
7170 1458 71 None -2 12 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 32608144
954 1458 71 None -2 12 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 31285236
954 1458 71 None -2 12 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 32608144
CHEMBL707 1458 71 None -2 12 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 31285236
CHEMBL707 1458 71 None -2 12 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 32608144
DB00590 1458 71 None -2 12 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 31285236
DB00590 1458 71 None -2 12 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 32608144
497 3340 8 None 61 3 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 444 7 1 6 2.1 Fc1ccc(c(c1)OCC(F)(F)F)N1CCN(CC1)CCCn1c(=O)[nH]cc(c1=O)C 10369480
9872515 3340 8 None 61 3 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 444 7 1 6 2.1 Fc1ccc(c(c1)OCC(F)(F)F)N1CCN(CC1)CCCn1c(=O)[nH]cc(c1=O)C 10369480
CHEMBL24777 3340 8 None 61 3 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 444 7 1 6 2.1 Fc1ccc(c(c1)OCC(F)(F)F)N1CCN(CC1)CCCn1c(=O)[nH]cc(c1=O)C 10369480
489 145 28 None -3 13 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 11459121
489 145 28 None -3 13 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 32608144
489 145 28 None -3 13 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 7651358
489 145 28 None -3 13 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 8764344
489 145 28 None -3 13 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 9190863
489 145 28 None -3 13 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 9249248
489 145 28 None -3 13 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 9490024
5640 145 28 None -3 13 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 11459121
5640 145 28 None -3 13 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 32608144
5640 145 28 None -3 13 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 7651358
5640 145 28 None -3 13 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 8764344
5640 145 28 None -3 13 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 9190863
5640 145 28 None -3 13 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 9249248
5640 145 28 None -3 13 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 9490024
CHEMBL420060 145 28 None -3 13 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 11459121
CHEMBL420060 145 28 None -3 13 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 32608144
CHEMBL420060 145 28 None -3 13 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 7651358
CHEMBL420060 145 28 None -3 13 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 8764344
CHEMBL420060 145 28 None -3 13 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 9190863
CHEMBL420060 145 28 None -3 13 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 9249248
CHEMBL420060 145 28 None -3 13 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 9490024
498 3604 0 None 2511 2 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 608 10 2 7 5.6 COC(=O)C1=C(C)NC(=C([C@H]1c1ccc(cc1)[N+](=O)[O-])C(=O)NCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10812954
498 3604 0 None 2511 2 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 608 10 2 7 5.6 COC(=O)C1=C(C)NC(=C([C@H]1c1ccc(cc1)[N+](=O)[O-])C(=O)NCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 32608144
498 3604 0 None 2511 2 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 608 10 2 7 5.6 COC(=O)C1=C(C)NC(=C([C@H]1c1ccc(cc1)[N+](=O)[O-])C(=O)NCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 7752182
498 3604 0 None 2511 2 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 608 10 2 7 5.6 COC(=O)C1=C(C)NC(=C([C@H]1c1ccc(cc1)[N+](=O)[O-])C(=O)NCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 9190863
5311437 3604 0 None 2511 2 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 608 10 2 7 5.6 COC(=O)C1=C(C)NC(=C([C@H]1c1ccc(cc1)[N+](=O)[O-])C(=O)NCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10812954
5311437 3604 0 None 2511 2 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 608 10 2 7 5.6 COC(=O)C1=C(C)NC(=C([C@H]1c1ccc(cc1)[N+](=O)[O-])C(=O)NCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 32608144
5311437 3604 0 None 2511 2 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 608 10 2 7 5.6 COC(=O)C1=C(C)NC(=C([C@H]1c1ccc(cc1)[N+](=O)[O-])C(=O)NCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 7752182
5311437 3604 0 None 2511 2 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 608 10 2 7 5.6 COC(=O)C1=C(C)NC(=C([C@H]1c1ccc(cc1)[N+](=O)[O-])C(=O)NCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 9190863
178103275 3301 0 None - 1 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 20015090
178103275 3301 0 None - 1 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 23935897
6663 3301 0 None - 1 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 20015090
6663 3301 0 None - 1 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 23935897
499 4046 18 None 1 15 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10334511
499 4046 18 None 1 15 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 32608144
499 4046 18 None 1 15 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 7651358
499 4046 18 None 1 15 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 9249248
499 4046 18 None 1 15 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 9490024
5685 4046 18 None 1 15 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10334511
5685 4046 18 None 1 15 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 32608144
5685 4046 18 None 1 15 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 7651358
5685 4046 18 None 1 15 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 9249248
5685 4046 18 None 1 15 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 9490024
CHEMBL25554 4046 18 None 1 15 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10334511
CHEMBL25554 4046 18 None 1 15 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 32608144
CHEMBL25554 4046 18 None 1 15 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 7651358
CHEMBL25554 4046 18 None 1 15 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 9249248
CHEMBL25554 4046 18 None 1 15 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 9490024
4209 3141 75 None -3 34 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10334511
4209 3141 75 None -3 34 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10369480
4209 3141 75 None -3 34 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 32608144
4209 3141 75 None -3 34 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 7651358
4209 3141 75 None -3 34 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 9249248
4209 3141 75 None -3 34 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 9490024
4893 3141 75 None -3 34 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10334511
4893 3141 75 None -3 34 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10369480
4893 3141 75 None -3 34 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 32608144
4893 3141 75 None -3 34 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 7651358
4893 3141 75 None -3 34 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 9249248
4893 3141 75 None -3 34 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 9490024
503 3141 75 None -3 34 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10334511
503 3141 75 None -3 34 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10369480
503 3141 75 None -3 34 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 32608144
503 3141 75 None -3 34 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 7651358
503 3141 75 None -3 34 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 9249248
503 3141 75 None -3 34 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 9490024
5385 3141 75 None -3 34 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10334511
5385 3141 75 None -3 34 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10369480
5385 3141 75 None -3 34 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 32608144
5385 3141 75 None -3 34 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 7651358
5385 3141 75 None -3 34 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 9249248
5385 3141 75 None -3 34 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 9490024
CHEMBL2 3141 75 None -3 34 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10334511
CHEMBL2 3141 75 None -3 34 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10369480
CHEMBL2 3141 75 None -3 34 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 32608144
CHEMBL2 3141 75 None -3 34 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 7651358
CHEMBL2 3141 75 None -3 34 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 9249248
CHEMBL2 3141 75 None -3 34 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 9490024
DB00457 3141 75 None -3 34 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10334511
DB00457 3141 75 None -3 34 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10369480
DB00457 3141 75 None -3 34 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 32608144
DB00457 3141 75 None -3 34 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 7651358
DB00457 3141 75 None -3 34 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 9249248
DB00457 3141 75 None -3 34 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 9490024
487 3607 21 None -1 12 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 32608144
487 3607 21 None -1 12 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 7651358
487 3607 21 None -1 12 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 9249248
60602 3607 21 None -1 12 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 32608144
60602 3607 21 None -1 12 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 7651358
60602 3607 21 None -1 12 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 9249248
CHEMBL405355 3607 21 None -1 12 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 32608144
CHEMBL405355 3607 21 None -1 12 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 7651358
CHEMBL405355 3607 21 None -1 12 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 9249248
DB09239 3607 21 None -1 12 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 32608144
DB09239 3607 21 None -1 12 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 7651358
DB09239 3607 21 None -1 12 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 9249248
3567002 3362 9 None 58 3 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 426 7 1 6 2.0 O=c1[nH]cc(c(=O)n1CCCN1CCN(CC1)c1ccccc1OCC(F)(F)F)C 10369480
3567002 3362 9 None 58 3 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 426 7 1 6 2.0 O=c1[nH]cc(c(=O)n1CCCN1CCN(CC1)c1ccccc1OCC(F)(F)F)C 32608144
7381 3362 9 None 58 3 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 426 7 1 6 2.0 O=c1[nH]cc(c(=O)n1CCCN1CCN(CC1)c1ccccc1OCC(F)(F)F)C 10369480
7381 3362 9 None 58 3 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 426 7 1 6 2.0 O=c1[nH]cc(c(=O)n1CCCN1CCN(CC1)c1ccccc1OCC(F)(F)F)C 32608144
CHEMBL56331 3362 9 None 58 3 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 426 7 1 6 2.0 O=c1[nH]cc(c(=O)n1CCCN1CCN(CC1)c1ccccc1OCC(F)(F)F)C 10369480
CHEMBL56331 3362 9 None 58 3 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 426 7 1 6 2.0 O=c1[nH]cc(c(=O)n1CCCN1CCN(CC1)c1ccccc1OCC(F)(F)F)C 32608144
148842 3915 27 None 8 5 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 511 8 1 6 4.7 COc1ccccc1N1CCN(CC1)CCCNC(=O)c1cccc2c1oc(c1ccccc1)c(c2=O)C 9249248
496 3915 27 None 8 5 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 511 8 1 6 4.7 COc1ccccc1N1CCN(CC1)CCCNC(=O)c1cccc2c1oc(c1ccccc1)c(c2=O)C 9249248
CHEMBL278865 3915 27 None 8 5 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 511 8 1 6 4.7 COc1ccccc1N1CCN(CC1)CCCNC(=O)c1cccc2c1oc(c1ccccc1)c(c2=O)C 9249248
499 4046 18 None -1 15 Rat 9.9 pKi = 9.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 11331292
499 4046 18 None -1 15 Rat 9.9 pKi = 9.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 9384500
5685 4046 18 None -1 15 Rat 9.9 pKi = 9.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 11331292
5685 4046 18 None -1 15 Rat 9.9 pKi = 9.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 9384500
CHEMBL25554 4046 18 None -1 15 Rat 9.9 pKi = 9.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 11331292
CHEMBL25554 4046 18 None -1 15 Rat 9.9 pKi = 9.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 9384500
444 206643 53 None 6 18 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 239 3 1 2 3.3 CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1 None
CHEMBL894 206643 53 None 6 18 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 239 3 1 2 3.3 CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1 None
146570 43424 67 None 1 4 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 324 5 0 3 3.8 CN(C)CCC[C@@]1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 None
CHEMBL1508 43424 67 None 1 4 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 324 5 0 3 3.8 CN(C)CCC[C@@]1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 None
228 444 28 None -1 24 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O None
33 444 28 None -1 24 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O None
6005 444 28 None -1 24 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O None
CHEMBL53 444 28 None -1 24 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O None
DB00714 444 28 None -1 24 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O None
1209 1645 75 None -1 32 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F None
203 1645 75 None -1 32 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F None
3386 1645 75 None -1 32 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F None
CHEMBL41 1645 75 None -1 32 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F None
DB00472 1645 75 None -1 32 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F None
2105 3032 37 None -9 33 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
47811 3032 37 None -9 33 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
48 3032 37 None -9 33 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
CHEMBL531 3032 37 None -9 33 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
DB01186 3032 37 None -9 33 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
2803 952 58 None -8 19 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
516 952 58 None -8 19 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
704 952 58 None -8 19 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
CHEMBL134 952 58 None -8 19 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
DB00575 952 58 None -8 19 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
3337 206344 27 None 13 41 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
65801 206344 27 None 13 41 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
66264 206344 27 None 13 41 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
91452 206344 27 None 13 41 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
CHEMBL87493 206344 27 None 13 41 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
521 1392 69 None -16 7 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C None
5311068 1392 69 None -16 7 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C None
835 1392 69 None -16 7 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C None
CHEMBL778 1392 69 None -16 7 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C None
DB00633 1392 69 None -16 7 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C None
2726 916 68 None -5 73 Human 8.0 pKi None 8.0 Binding
NoneNone
Drug Central 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
621 916 68 None -5 73 Human 8.0 pKi None 8.0 Binding
NoneNone
Drug Central 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
83 916 68 None -5 73 Human 8.0 pKi None 8.0 Binding
NoneNone
Drug Central 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
CHEMBL71 916 68 None -5 73 Human 8.0 pKi None 8.0 Binding
NoneNone
Drug Central 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
DB00477 916 68 None -5 73 Human 8.0 pKi None 8.0 Binding
NoneNone
Drug Central 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
2202 3110 96 None -2 21 Human 6.1 pKi None 6.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 12388666
4850 3110 96 None -2 21 Human 6.1 pKi None 6.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 12388666
49 3110 96 None -2 21 Human 6.1 pKi None 6.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 12388666
CHEMBL1371770 3110 96 None -2 21 Human 6.1 pKi None 6.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 12388666
DB12478 3110 96 None -2 21 Human 6.1 pKi None 6.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 12388666
37 775 60 None -18 17 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 12388666
460 775 60 None -18 17 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 12388666
54746 775 60 None -18 17 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 12388666
CHEMBL1201087 775 60 None -18 17 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 12388666
DB00248 775 60 None -18 17 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 12388666
277 1289 62 None -20 46 Human 7.4 pKi None 7.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 11459121
2913 1289 62 None -20 46 Human 7.4 pKi None 7.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 11459121
765 1289 62 None -20 46 Human 7.4 pKi None 7.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 11459121
CHEMBL516 1289 62 None -20 46 Human 7.4 pKi None 7.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 11459121
DB00434 1289 62 None -20 46 Human 7.4 pKi None 7.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 11459121
135 2515 43 None -40 58 Human 7.6 pKi None 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 11459121
1796 2515 43 None -40 58 Human 7.6 pKi None 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 11459121
4184 2515 43 None -40 58 Human 7.6 pKi None 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 11459121
CHEMBL6437 2515 43 None -40 58 Human 7.6 pKi None 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 11459121
DB06148 2515 43 None -40 58 Human 7.6 pKi None 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 11459121
1524 2168 96 None -5 52 Human 8.2 pKi None 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 11459121
197 2168 96 None -5 52 Human 8.2 pKi None 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 11459121
3822 2168 96 None -5 52 Human 8.2 pKi None 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 11459121
88 2168 96 None -5 52 Human 8.2 pKi None 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 11459121
CHEMBL51 2168 96 None -5 52 Human 8.2 pKi None 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 11459121
DB12465 2168 96 None -5 52 Human 8.2 pKi None 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 11459121
2470 3626 50 None -208 60 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 11459121
3300 3626 50 None -208 60 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 11459121
5265 3626 50 None -208 60 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 11459121
99 3626 50 None -208 60 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 11459121
CHEMBL267930 3626 50 None -208 60 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 11459121
491 192 9 None -50 12 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 11354357
9891167 192 9 None -50 12 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 11354357
CHEMBL13856 192 9 None -50 12 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 11354357
5074 3307 80 None -6 30 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 477 5 0 5 5.5 Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F 11459121
97 3307 80 None -6 30 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 477 5 0 5 5.5 Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F 11459121
CHEMBL267777 3307 80 None -6 30 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 477 5 0 5 5.5 Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F 11459121
DB12693 3307 80 None -6 30 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 477 5 0 5 5.5 Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F 11459121
491 192 9 None -44 12 Rat 8.5 pKi None 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 11354357
9891167 192 9 None -44 12 Rat 8.5 pKi None 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 11354357
CHEMBL13856 192 9 None -44 12 Rat 8.5 pKi None 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 11354357
2601 3751 33 None -5 21 Human 8.5 pKi None 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 12388666
443951 3751 33 None -5 21 Human 8.5 pKi None 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 12388666
56 3751 33 None -5 21 Human 8.5 pKi None 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 12388666
CHEMBL73151 3751 33 None -5 21 Human 8.5 pKi None 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 12388666
DB13399 3751 33 None -5 21 Human 8.5 pKi None 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 12388666
490 191 8 None -36 12 Rat 8.6 pKi None 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 11354357
9890547 191 8 None -36 12 Rat 8.6 pKi None 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 11354357
CHEMBL268758 191 8 None -36 12 Rat 8.6 pKi None 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 11354357
489 145 28 None -2 13 Rat 9.0 pKi None 9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 11331292
5640 145 28 None -2 13 Rat 9.0 pKi None 9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 11331292
CHEMBL420060 145 28 None -2 13 Rat 9.0 pKi None 9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 11331292
487 3607 21 None -4 12 Rat 9.3 pKi None 9.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 11331292
60602 3607 21 None -4 12 Rat 9.3 pKi None 9.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 11331292
CHEMBL405355 3607 21 None -4 12 Rat 9.3 pKi None 9.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 11331292
DB09239 3607 21 None -4 12 Rat 9.3 pKi None 9.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 11331292
4209 3141 75 None -3 34 Rat 9.5 pKi None 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 11331292
4893 3141 75 None -3 34 Rat 9.5 pKi None 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 11331292
503 3141 75 None -3 34 Rat 9.5 pKi None 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 11331292
5385 3141 75 None -3 34 Rat 9.5 pKi None 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 11331292
CHEMBL2 3141 75 None -3 34 Rat 9.5 pKi None 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 11331292
DB00457 3141 75 None -3 34 Rat 9.5 pKi None 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 11331292